PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Agnoli, S; Pittarello, A; Hysenbelli, D; Rubaltelli, E				Agnoli, Sergio; Pittarello, Andrea; Hysenbelli, Dorina; Rubaltelli, Enrico			"Give, but Give until It Hurts": The Modulatory Role of Trait Emotional Intelligence on the Motivation to Help	PLOS ONE			English	Article							INCREMENTAL VALIDITY; PERSONALITY; ALTRUISM; RATIONALITY; VALIDATION; DONATIONS; NUMERACY; IMPACT	Two studies investigated the effect of trait Emotional Intelligence (trait EI) on people's motivation to help. In Study 1, we developed a new computer-based paradigm that tested participants' motivation to help by measuring their performance on a task in which they could gain a hypothetical amount of money to help children in need. Crucially, we manipulated participants' perceived efficacy by informing them that they had been either able to save the children (positive feedback) or unable to save the children (negative feedback). We measured trait EI using the Trait Emotional Intelligence Questionnaire-Short Form (TEIQue-SF) and assessed participants' affective reactions during the experiment using the PANAS-X. Results showed that high and low trait EI participants performed differently after the presentation of feedback on their ineffectiveness in helping others in need. Both groups showed increasing negative affective states during the experiment when the feedback was negative; however, high trait EI participants better managed their affective reactions, modulating the impact of their emotions on performance and maintaining a high level of motivation to help. In Study 2, we used a similar computerized task and tested a control situation to explore the effect of trait EI on participants' behavior when facing failure or success in a scenario unrelated to helping others in need. No effect of feedback emerged on participants' emotional states in the second study. Taken together our results show that trait EI influences the impact of success and failure on behavior only in affect-rich situation like those in which people are asked to help others in need.	[Agnoli, Sergio] Univ Bologna, MIC, Bologna, Italy; [Pittarello, Andrea; Hysenbelli, Dorina; Rubaltelli, Enrico] Univ Padua, Dept Dev & Socializat Psychol, Padua, Italy; [Rubaltelli, Enrico] Univ Padua, Ctr Cognit Neurosci, Padua, Italy	University of Bologna; University of Padua; University of Padua	Rubaltelli, E (corresponding author), Univ Padua, Dept Dev & Socializat Psychol, Padua, Italy.	enrico.rubaltelli@unipd.it		Agnoli, Sergio/0000-0003-3004-7988; Rubaltelli, Enrico/0000-0002-7521-755X				Ali F, 2009, PERS INDIV DIFFER, V47, P758, DOI 10.1016/j.paid.2009.06.016; Andrei F., 2014, BPA APPL PSYCHO B BO, V251, P2; ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; AXELROD LJ, 1993, J ENVIRON PSYCHOL, V13, P149, DOI 10.1016/S0272-4944(05)80147-1; Batson CD, 2007, J PERS SOC PSYCHOL, V93, P65, DOI 10.1037/0022-3514.93.1.65; BATSON CD, 1991, J PERS SOC PSYCHOL, V61, P413, DOI 10.1037/0022-3514.61.3.413; BATSON CD, 1990, AM PSYCHOL, V45, P336, DOI 10.1037/0003-066X.45.3.336; Brackett MA, 2006, J PERS SOC PSYCHOL, V91, P780, DOI 10.1037/0022-3514.91.4.780; Chamorro-Premuzic T, 2007, PERS INDIV DIFFER, V42, P1633, DOI 10.1016/j.paid.2006.10.029; CIALDINI RB, 1987, J PERS SOC PSYCHOL, V52, P749, DOI 10.1037/0022-3514.52.4.749; Cohen J.E., 1988, STAT POWER ANAL BEHA; DePalma MT, 1999, BASIC APPL SOC PSYCH, V21, P131, DOI 10.1207/15324839951036470; Dickert S, 2011, JUDGM DECIS MAK, V6, P638; Dickert S, 2011, J BEHAV DECIS MAKING, V24, P361, DOI 10.1002/bdm.697; EPSTEIN S, 1994, AM PSYCHOL, V49, P709, DOI 10.1037/0003-066X.49.8.709; Extremera N, 2006, SPAN J PSYCHOL, V9, P45, DOI 10.1017/S1138741600005965; Fetherstonhaugh D, 1997, J RISK UNCERTAINTY, V14, P283, DOI 10.1023/A:1007744326393; Freudenthaler HH, 2008, PERS INDIV DIFFER, V45, P673, DOI 10.1016/j.paid.2008.07.014; Furnham A, 2003, SOC BEHAV PERSONAL, V31, P815, DOI 10.2224/sbp.2003.31.8.815; Gardner KJ, 2010, AUST J PSYCHOL, V62, P5, DOI 10.1080/00049530903312857; HOFFMAN ML, 1981, J PERS SOC PSYCHOL, V40, P121, DOI 10.1037/0022-3514.40.1.121; Kahneman D, 2003, AM ECON REV, V93, P1449, DOI 10.1257/000282803322655392; Kahneman D., 2011, THINKING FAST SLOW; Kogut T, 2005, J BEHAV DECIS MAKING, V18, P157, DOI 10.1002/bdm.492; Kogut T, 2005, ORGAN BEHAV HUM DEC, V97, P106, DOI 10.1016/j.obhdp.2005.02.003; Kogut T, 2007, ORGAN BEHAV HUM DEC, V104, P150, DOI 10.1016/j.obhdp.2007.04.006; Laborde S, 2010, PERS INDIV DIFFER, V49, P784, DOI 10.1016/j.paid.2010.06.031; Long DA, 1996, PSYCHOL REP, V78, P987, DOI 10.2466/pr0.1996.78.3.987; Matthews G, 2002, EMOTIONAL INTELLIGENCE: SCIENCE AND MYTH, P1; Mikolajczak M, 2006, PSICOTHEMA, V18, P79; Mikolajczak M, 2009, INT J CLIN HLTH PSYC, V9, P455; Peters E, 2007, HEALTH AFFAIR, V26, P741, DOI 10.1377/hlthaff.26.3.741; Petrides KV, 2007, COGNITION EMOTION, V21, P26, DOI 10.1080/02699930601038912; Petrides KV, 2007, BRIT J PSYCHOL, V98, P273, DOI 10.1348/000712606X120618; Petrides KV, 2006, SOC DEV, V15, P537, DOI 10.1111/j.1467-9507.2006.00355.x; Petrides KV, 2006, J APPL SOC PSYCHOL, V36, P552, DOI 10.1111/j.0021-9029.2006.00019.x; Petrides KV, 2003, EUR J PERSONALITY, V17, P39, DOI 10.1002/per.466; Petrides KV, 2001, EUR J PERSONALITY, V15, P425, DOI 10.1002/per.416; Petrides KV, 2000, PERS INDIV DIFFER, V29, P313, DOI 10.1016/S0191-8869(99)00195-6; Rubaltelli E, 2012, COGNITION EMOTION, V26, P769, DOI 10.1080/02699931.2011.613921; Sevdalis N, 2007, PERS INDIV DIFFER, V42, P1347, DOI 10.1016/j.paid.2006.10.012; Shang J, 2009, ECON J, V119, P1422, DOI 10.1111/j.1468-0297.2009.02267.x; Singh M, 2008, J APPL SOC PSYCHOL, V38, P635, DOI 10.1111/j.1559-1816.2007.00320.x; Slovic P, 1992, HEURISTICS BIASES PS, P397; Slovic P, 2007, JUDGM DECIS MAK, V2, P79; Small DA, 2007, ORGAN BEHAV HUM DEC, V102, P143, DOI 10.1016/j.obhdp.2006.01.005; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Telle NT, 2011, PERS INDIV DIFFER, V50, P523, DOI 10.1016/j.paid.2010.11.010; Vernon PA, 2008, TWIN RES HUM GENET, V11, P524, DOI 10.1375/twin.11.5.524; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Watson D., 1994, PANAS X MANUAL POSIT, DOI [DOI 10.17077/48VTM4T2, 10.17077/48vt-m4t2]	52	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130704	10.1371/journal.pone.0130704	http://dx.doi.org/10.1371/journal.pone.0130704			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1BL	26121350	Green Submitted, Green Published, gold			2022-12-27	WOS:000358150400057
J	Maan, S; Maan, NS; Belaganahalli, MN; Rao, PP; Singh, KP; Hemadri, D; Putty, K; Kumar, A; Batra, K; Krishnajyothi, Y; Chandel, BS; Reddy, GH; Nomikou, K; Reddy, YN; Attoui, H; Hegde, NR; Mertens, PPC				Maan, Sushila; Maan, Narender S.; Belaganahalli, Manjunatha N.; Rao, Pavuluri Panduranga; Singh, Karam Pal; Hemadri, Divakar; Putty, Kalyani; Kumar, Aman; Batra, Kanisht; Krishnajyothi, Yadlapati; Chandel, Bharat S.; Reddy, G. Hanmanth; Nomikou, Kyriaki; Reddy, Yella Narasimha; Attoui, Houssam; Hegde, Nagendra R.; Mertens, Peter P. C.			Full-Genome Sequencing as a Basis for Molecular Epidemiology Studies of Bluetongue Virus in India	PLOS ONE			English	Article							SEROTYPE 21 BTV-21; NUCLEOTIDE-SEQUENCE; WESTERN TOPOTYPE; MULTIPLE ALIGNMENT; GENETIC-ANALYSIS; INSECT CELLS; PROTEIN; ORBIVIRUS; REASSORTMENT; CIRCULATION	Since 1998 there have been significant changes in the global distribution of bluetongue virus (BTV). Ten previously exotic BTV serotypes have been detected in Europe, causing severe disease outbreaks in naive ruminant populations. Previously exotic BTV serotypes were also identified in the USA, Israel, Australia and India. BTV is transmitted by biting midges (Culicoides spp.) and changes in the distribution of vector species, climate change, increased international travel and trade are thought to have contributed to these events. Thirteen BTV serotypes have been isolated in India since first reports of the disease in the country during 1964. Efficient methods for preparation of viral dsRNA and cDNA synthesis, have facilitated full-genome sequencing of BTV strains from the region. These studies introduce a new approach for BTV characterization, based on full-genome sequencing and phylogenetic analyses, facilitating the identification of BTV serotype, topotype and reassortant strains. Phylogenetic analyses show that most of the equivalent genome-segments of Indian BTV strains are closely related, clustering within a major eastern BTV 'topotype'. However, genome-segment 5 (Seg-5) encoding NS1, from multiple post 1982 Indian isolates, originated from a western BTV topotype. All ten genome-segments of BTV-2 isolates (IND2003/01, IND2003/02 and IND2003/03) are closely related (>99% identity) to a South African BTV-2 vaccine-strain (western topotype). Similarly BTV-10 isolates (IND2003/06; IND2005/04) show >99% identity in all genome segments, to the prototype BTV-10 (CA-8) strain from the USA. These data suggest repeated introductions of western BTV field and/or vaccine-strains into India, potentially linked to animal or vector-insect movements, or unauthorised use of 'live' South African or American BTV-vaccines in the country. The data presented will help improve nucleic acid based diagnostics for Indian serotypes/topotypes, as part of control strategies.	[Maan, Sushila; Maan, Narender S.; Belaganahalli, Manjunatha N.; Nomikou, Kyriaki; Attoui, Houssam; Mertens, Peter P. C.] Pirbright Inst, Vector Borne Viral Dis Programme, Woking GU24 0NF, Surrey, England; [Maan, Sushila; Maan, Narender S.; Kumar, Aman; Batra, Kanisht] LLR Univ Vet & Anim Sci, Coll Vet Sci, Hisar 125004, Haryana, India; [Rao, Pavuluri Panduranga; Hegde, Nagendra R.] Genome Valley Hyderabad, Ella Fdn, Hyderabad 500078, TS, India; [Singh, Karam Pal] Indian Vet Res Inst, Ctr Anim Dis Res & Diag, Pathol Lab, Izatnagar 243122, Uttar Pradesh, India; [Hemadri, Divakar] NIVEDI, Bengaluru 560024, KA, India; [Putty, Kalyani; Reddy, Yella Narasimha] Acharya NG Ranga Agr Univ, Coll Vet Sci, Hyderabad 500030, TS, India; [Krishnajyothi, Yadlapati; Reddy, G. Hanmanth] Govt Andhra Pradesh, Vet Biol & Res Inst, Hyderabad 500028, TS, India; [Chandel, Bharat S.] SD Agr Univ, Coll Vet Sci & AH, Sardar Krushinagar 385506, Gujarat, India	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Lala Lajpat Rai University of Veterinary & Animal Sciences; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Veterinary Epidemiology & Disease Informatics; Acharya N. G. Ranga Agricultural University	Maan, S (corresponding author), Pirbright Inst, Vector Borne Viral Dis Programme, Ash Rd, Woking GU24 0NF, Surrey, England.	sushilamaan105@gmail.com; peter.mertens@pirbright.ac.uk	Nomikou, Kyriaki/Q-5555-2016; Hegde, Nagendra R/H-3132-2019; Nomikou, Kyriaki/P-1840-2018; BATRA, KANISHT/J-4483-2016; Belaganahalli, Manjunatha N/I-1688-2019	Nomikou, Kyriaki/0000-0002-7013-1853; Hegde, Nagendra R/0000-0001-5260-2159; Nomikou, Kyriaki/0000-0002-7013-1853; BATRA, KANISHT/0000-0003-1607-7320; Belaganahalli, Manjunatha N/0000-0003-3401-5799; Chandel, Dr B S/0000-0002-7806-5803; Mertens, Peter/0000-0002-3438-3738; Attoui, Houssam/0000-0001-9639-9981	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L004690/1]; European Commission [245266]; Department for Environment, Food and Rural Affairs (Defra) [SE2617]; Department of Biotechnology. Government of India (DBT, GOI) [BT/IN/Indo-UK/FADH/46/SM/2013, BT/Bio-CARe/04/261/2011-12]; BBSRC [BB/I017259/1, BBS/E/I/00001720, BB/H531478/1, BB/L004690/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I017259/1, BBS/E/I/00001720, BB/H531478/1, BBS/E/I/00001144, BB/L004690/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Department of Biotechnology. Government of India (DBT, GOI); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by 1. Biotechnology and Biological Sciences Research Council (BBSRC) (grant no. BB/L004690/1); European Commission (grant no. 245266) and Department for Environment, Food and Rural Affairs (Defra) (SE2617) to PM. 2. Department of Biotechnology. Government of India (DBT, GOI) (grant no. BT/IN/Indo-UK/FADH/46/SM/2013 and BT/Bio-CARe/04/261/2011-12) to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison AB, 2010, J GEN VIROL, V91, P430, DOI 10.1099/vir.0.015651-0; Anthony S, 2007, J VIROL METHODS, V141, P188, DOI 10.1016/j.jviromet.2006.12.013; Anthony SJ, 2011, VIROLOGY, V420, P164, DOI 10.1016/j.virol.2011.09.009; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Attoui H, 2009, BIOL ANIM INFECT, P23, DOI 10.1016/B978-012369368-6.50007-1; Batten C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096049; Batten CA, 2008, VIRUS RES, V137, P56, DOI 10.1016/j.virusres.2008.05.016; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Boone JD, 2007, VACCINE, V25, P672, DOI 10.1016/j.vaccine.2006.08.025; Boyle DB, 2012, J VIROL, V86, P6724, DOI 10.1128/JVI.00182-12; Brenner J, 2010, EMERG INFECT DIS, V16, P2003, DOI 10.3201/eid1612.100239; Caporale M, 2011, J VIROL, V85, P11479, DOI 10.1128/JVI.05226-11; Carpi G, 2010, J MOL EVOL, V70, P583, DOI 10.1007/s00239-010-9354-y; Darpel KE, 2007, VET REC, V161, P253, DOI 10.1136/vr.161.8.253; De Clercq K, 2008, VET REC, V162, P564, DOI 10.1136/vr.162.17.564; DeMattos CC, 1996, J VIROL, V70, P5735, DOI 10.1128/JVI.70.8.5735-5739.1996; Desai GS, 2009, TRANSBOUND EMERG DIS, V56, P329, DOI 10.1111/j.1865-1682.2009.01089.x; Diprose JM, 2002, J VIROL, V76, P9533, DOI 10.1128/JVI.76.18.9533-9536.2002; Ferrari G, 2005, PREV VET MED, V68, P103, DOI 10.1016/j.prevetmed.2004.11.011; FRENCH TJ, 1989, J VIROL, V63, P3270, DOI 10.1128/JVI.63.8.3270-3278.1989; FUKUSHO A, 1989, J GEN VIROL, V70, P1677, DOI 10.1099/0022-1317-70-7-1677; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Han ZY, 2004, J BIOL CHEM, V279, P43092, DOI 10.1074/jbc.M403663200; He CQ, 2010, J VIROL, V84, P11487, DOI 10.1128/JVI.00889-10; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; HYATT AD, 1993, VIROLOGY, V193, P592, DOI 10.1006/viro.1993.1167; Jaafar FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086392; Jimenez-Clavero Miguel A., 2012, Frontiers in Genetics, V3, P105, DOI 10.3389/fgene.2012.00105; Johnson DJ, 2007, P ANN C AM ASS VET L, P118; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee F, 2011, VET MICROBIOL, V148, P140, DOI 10.1016/j.vetmic.2010.08.016; LEE JW, 1986, J GEN VIROL, V67, P2833, DOI 10.1099/0022-1317-67-12-2833; Maan NS, 2012, J VIROL, V86, P6375, DOI 10.1128/JVI.00671-12; Maan NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032601; Maan NS, 2012, J VIROL, V86, P5967, DOI 10.1128/JVI.00536-12; Maan NS, 2012, J VIROL, V86, P5404, DOI 10.1128/JVI.00420-12; Maan NS, 2012, J VIROL, V86, P4717, DOI 10.1128/JVI.00188-12; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Maan S, 2012, J VIROL, V86, P7011, DOI 10.1128/JVI.00731-12; Maan S, 2012, J VIROL, V86, P5971, DOI 10.1128/JVI.00596-12; Maan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026147; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; Maclachlan NJ, 2013, EMERG INFECT DIS, V19, P665, DOI 10.3201/eid1904.120347; MacLachlan NJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010007; Menzies FD, 2008, VET REC, V163, P203, DOI 10.1136/vr.163.7.203; Mertens PPC, 2009, BIOL ANIM INFECT, P101, DOI 10.1016/B978-012369368-6.50010-1; Mertens PPC, 1996, VIROLOGY, V217, P582, DOI 10.1006/viro.1996.0153; Mertens PPC., 2005, VIRUS TAXONOMY, P466; Minakshi P, 2012, J VIROL, V86, P8337, DOI 10.1128/JVI.01128-12; Nomikou K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006437; Patil AB, 2013, TACTFUL MANAGEMENT R, V1; Prasad G, 1992, Rev Sci Tech, V11, P699; Prasad G, 2009, BIOL ANIM INFECT, P167, DOI 10.1016/B978-012369368-6.50012-5; PRITCHARD LI, 1995, VIRUS RES, V35, P247, DOI 10.1016/0168-1702(94)00072-K; PURDY MA, 1986, J GEN VIROL, V67, P957, DOI 10.1099/0022-1317-67-5-957; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Rao PP, 2015, TRANSBOUND EMERG DIS, V62, pE52, DOI 10.1111/tbed.12199; Rao PP, 2016, TRANSBOUND EMERG DIS, V63, pE151, DOI 10.1111/tbed.12258; Rao PP, 2013, J VIROL METHODS, V193, P314, DOI 10.1016/j.jviromet.2013.06.033; Rao PP, 2012, J VIROL, V86, P8341, DOI 10.1128/JVI.00968-12; Rao PP, 2012, J VIROL, V86, P8333, DOI 10.1128/JVI.01101-12; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; Rodriguez-Sanchez B, 2008, TRANSBOUND EMERG DIS, V55, P205, DOI 10.1111/j.1865-1682.2008.01029.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sapre, 1964, INDIAN VET REV, V15, P69; Sarwar M. M., 1962, Pakistan Journal of Animal Science, V1, P1; Schwartz-Cornil I, 2008, VET RES, V39, DOI 10.1051/vetres:2008023; Shafiq M, 2013, VIRUS RES, V173, P336, DOI 10.1016/j.virusres.2013.01.009; Shaw AE, 2013, J VIROL, V87, P543, DOI 10.1128/JVI.02266-12; Shimshony A, 2004, VETER ITAL SER, V40, P116; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Sreenivasulu D, 2004, VETER ITAL SER, V40, P73; Susmitha B, 2012, VIRUS GENES, V44, P466, DOI 10.1007/s11262-012-0724-y; Takamatsu H, 2003, J GEN VIROL, V84, P227, DOI 10.1099/vir.0.18705-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tembhurne PA, 2010, ARCH VIROL, V155, P89, DOI 10.1007/s00705-009-0553-z; Veronesi E, 2010, VACCINE, V28, P1397, DOI 10.1016/j.vaccine.2009.10.107; Verwoerd D. W., 2004, Infectious diseases of livestock. Volume Two, P1201; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Wilson WC, 2000, VIRUS RES, V67, P141, DOI 10.1016/S0168-1702(00)00138-6; Wright IM, 2013, SEROLOGICAL GENETIC; Xu G, 1997, J GEN VIROL, V78, P1617, DOI 10.1099/0022-1317-78-7-1617; Zientara S, 2014, EMERG INFECT DIS, V20, P2123, DOI 10.3201/eid2012.140924	89	44	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131257	10.1371/journal.pone.0131257	http://dx.doi.org/10.1371/journal.pone.0131257			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121128	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000358150400091
J	Lee, SJ; Yi, CO; Heo, RW; Song, DH; Cho, YJ; Jeong, YY; Kang, KM; Roh, GS; Lee, JD				Lee, Seung Jun; Yi, Chin-ok; Heo, Rok Won; Song, Dae Hyun; Cho, Yu Ji; Jeong, Yi Yeong; Kang, Ki Mun; Roh, Gu Seob; Lee, Jong Deog			Clarithromycin Attenuates Radiation-Induced Lung Injury in Mice	PLOS ONE			English	Article							PULMONARY-FIBROSIS; INDUCED PNEUMONOPATHY; KAPPA-B; CANCER; MECHANISMS; INFLAMMATION; AMIFOSTINE; AIRWAY; RADIOTHERAPY; EXPRESSION	Radiation-induced lung injury (RILI) is a common and unavoidable complication of thoracic radiotherapy. The current study was conducted to evaluate the ability of clarithromycin (CLA) to prevent radiation-induced pneumonitis, oxidative stress, and lung fibrosis in an animal model. C57BL/6J mice were assigned to control, irradiation only, irradiation plus CLA, and CLA only groups. Test mice received single thoracic exposures to radiation and/or oral CLA (100 mg/kg/day). Histopathologic findings and markers of inflammation, fibrosis, and oxidative stress were compared by group. On a microscopic level, CLA inhibited macrophage influx, alveolar fibrosis, parenchymal collapse, consolidation, and epithelial cell changes. The concentration of collagen in lung tissue was lower in irradiation plus CLA mice. Radiation-induced expression of tumor necrosis factor (TNF)-alpha, TNF receptor 1, acetylated nuclear factor kappa B, cyclooxygenase 2, vascular cell adhesion molecule 1, and matrix metallopeptidase 9 were also attenuated by CLA. Expression levels of nuclear factor erythroid 2-related factor 2 and heme oxygenase 1, transforming growth factor-beta 1, connective tissue growth factor, and type I collagen in radiation-treated lungs were also attenuated by CLA. These findings indicate that CLA ameliorates the deleterious effects of thoracic irradiation in mice by reducing pulmonary inflammation, oxidative damage, and fibrosis.	[Lee, Seung Jun; Cho, Yu Ji; Jeong, Yi Yeong; Lee, Jong Deog] Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Sch Med, Div Pulm & Crit Care Med,Dept Internal Med, Jinju, South Korea; [Yi, Chin-ok; Heo, Rok Won; Roh, Gu Seob] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Dept Anat & Convergence Med Sci, Jinju, South Korea; [Song, Dae Hyun] Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Sch Med, Dept Pathol, Jinju, South Korea; [Kang, Ki Mun] Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Sch Med, Dept Radiat Oncol, Jinju, South Korea	Gyeongsang National University; Gyeongsang National University Hospital; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University Hospital; Gyeongsang National University; Gyeongsang National University Hospital	Roh, GS (corresponding author), Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Dept Anat & Convergence Med Sci, Jinju, South Korea.	anaroh@gnu.ac.kr; ljd8611@empal.com	Kang, Kimun/AAA-3684-2022; Song, Jin/HHS-8731-2022		Basic Science Research Program through the National Research Foundation of Korea [2014R1A2A1A11049588]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by a grant of the Basic Science Research Program through the National Research Foundation of Korea (No. 2014R1A2A1A11049588).	Anscher MS, 2006, INT J RADIAT ONCOL, V65, P876, DOI 10.1016/j.ijrobp.2006.02.051; Antonadou D, 2003, INT J RADIAT ONCOL, V57, P402, DOI 10.1016/S0360-3016(03)00590-X; Antonadou D, 2001, INT J RADIAT ONCOL, V51, P915, DOI 10.1016/S0360-3016(01)01713-8; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Benveniste MFK, 2013, CLIN RADIOL, V68, pE275, DOI 10.1016/j.crad.2013.01.013; Bertok S, 2011, AM J PHYSIOL-LUNG C, V300, pL781, DOI 10.1152/ajplung.00326.2010; Bush DA, 2013, INT J RADIAT ONCOL, V86, P964, DOI 10.1016/j.ijrobp.2013.05.002; Cheng DS, 2007, J IMMUNOL, V178, P6504, DOI 10.4049/jimmunol.178.10.6504; Cho HY, 2004, FASEB J, V18, P1258, DOI 10.1096/fj.03-1127fje; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Cho HY, 2010, TOXICOL APPL PHARM, V244, P43, DOI 10.1016/j.taap.2009.07.024; Cho YJ, 2013, KOREAN J PHYSIOL PHA, V17, P267, DOI 10.4196/kjpp.2013.17.4.267; Fang LC, 2006, INT J RADIAT ONCOL, V66, P108, DOI 10.1016/j.ijrobp.2006.04.015; Graves PR, 2010, SEMIN RADIAT ONCOL, V20, P201, DOI 10.1016/j.semradonc.2010.01.010; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Hong JH, 1999, INT J RADIAT BIOL, V75, P1421, DOI 10.1080/095530099139287; Hrvacic B, 2009, EUR J PHARMACOL, V616, P236, DOI 10.1016/j.ejphar.2009.06.032; Jackson IL, 2014, HEALTH PHYS, V106, P48, DOI 10.1097/HP.0b013e3182a32ccf; Jackson IL, 2012, HEALTH PHYS, V103, P463, DOI 10.1097/HP.0b013e31826386ef; Kim JH, 2014, J CLIN INVEST, V124, P730, DOI 10.1172/JCI70812; Lee IT, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/791231; Lee KH, 2008, J MICROBIOL BIOTECHN, V18, P369; Liu H, 2013, ONCOL LETT, V6, P453, DOI 10.3892/ol.2013.1365; Liu JY, 1998, AM J PATHOL, V153, P1839, DOI 10.1016/S0002-9440(10)65698-2; Machtay M, 2006, RADIOTHER ONCOL, V81, P196, DOI 10.1016/j.radonc.2006.09.013; Masson-Cote L, 2011, INT J RADIAT ONCOL, V80, P686, DOI 10.1016/j.ijrobp.2010.02.010; Mathew B, 2011, AM J RESP CELL MOL, V44, P415, DOI 10.1165/rcmb.2010-0122OC; Mehta V, 2005, INT J RADIAT ONCOL, V63, P5, DOI 10.1016/j.ijrobp.2005.03.047; Moltenti A, 2000, INT J RADIAT BIOL, V76, P523, DOI 10.1080/095530000138538; Movsas B, 2005, J CLIN ONCOL, V23, P2145, DOI 10.1200/JCO.2005.07.167; MULLER JM, 1993, IMMUNOBIOLOGY, V187, P233; Nakanishi Y, 2009, AM J RESP CRIT CARE, V179, P271, DOI 10.1164/rccm.200806-905OC; Ostrau C, 2009, RADIOTHER ONCOL, V92, P492, DOI 10.1016/j.radonc.2009.06.020; Otterbein LE, 1999, J CLIN INVEST, V103, P1047, DOI 10.1172/JCI5342; Ozturk B, 2004, INT J RADIAT ONCOL, V58, P213, DOI 10.1016/S0360-3016(03)01444-5; Para AE, 2009, RADIOTHER ONCOL, V92, P500, DOI 10.1016/j.radonc.2009.04.005; Peng YC, 2014, CLIN EXP MED, V14, P53, DOI 10.1007/s10238-012-0217-2; PIGUET PF, 1989, J EXP MED, V170, P655, DOI 10.1084/jem.170.3.655; Pinto Leonardo Araújo, 2004, Rev. Hosp. Clin., V59, P99, DOI 10.1590/S0041-87812004000300002; Rabbani ZN, 2007, FREE RADICAL RES, V41, P1273, DOI 10.1080/10715760701689550; Reynolds HY, 2005, AM J RESP CRIT CARE, V171, P98, DOI 10.1164/rccm.200406-788PP; Shinkai M, 2008, PHARMACOL THERAPEUT, V117, P393, DOI 10.1016/j.pharmthera.2007.11.001; Travis EL, 2007, SEMIN RADIAT ONCOL, V17, P149, DOI 10.1016/j.semradonc.2006.11.011; van Riet E, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-9; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Vogelius IR, 2012, ACTA ONCOL, V51, P975, DOI 10.3109/0284186X.2012.718093; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yarnold J, 2010, RADIOTHER ONCOL, V97, P149, DOI 10.1016/j.radonc.2010.09.002; Zarogoulidis P, 2012, EUR J CLIN PHARMACOL, V68, P479, DOI 10.1007/s00228-011-1161-x; Zhang Mingxia, 2009, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V23, P769	52	12	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131671	10.1371/journal.pone.0131671	http://dx.doi.org/10.1371/journal.pone.0131671			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114656	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500177
J	Liao, QB; Han, PY; Huang, Y; Wu, ZT; Chen, Q; Li, SS; Ye, JF; Wu, XB				Liao, Qibin; Han, Peiyu; Huang, Yue; Wu, Zhitong; Chen, Qing; Li, Shanshan; Ye, Jufeng; Wu, Xianbo			Potential Role of Circulating microRNA-21 for Hepatocellular Carcinoma Diagnosis: A Meta-Analysis	PLOS ONE			English	Article							CANCER; EPIDEMIOLOGY; BIOMARKERS; MIR-21	Background Circulating microRNA-21 (miR-21) is known to be aberrantly expressed in hepatocellular carcinoma (HCC) patients, and this implies that microRNA-21 is a promising and novel indicator of HCC. However, a systematic evaluation of the performance of microRNA-21 as a diagnostic marker for HCC has yet to be conducted. Therefore, the test performance of circulating miR-21 for HCC was assessed in this study. Methods Three common international databases and a Chinese electronic database were used to search for literature on the diagnostic accuracy of microRNA-21 for HCC. The pooled results included the sensitivity and specificity of microRNA-21 for HCC detection and were analyzed with a random effect model. The area under summary receiver operating characteristic curve (AUC) was used to estimate overall test performance. Results A total of 339 HCC patients and 338 controls without HCC from four published studies were eligible for the meta-analysis and included in our study. The test performance of circulating miR-21 in HCC detection was assessed with the summary estimates of sensitivity and specificity, which were 81.2% (95% CI: 70.8% to 88.4%) and 84.8% (95% CI: 75.1% to 91.2%), respectively. The value of AUC was 0.90 (95% CI: 0.87 to 0.92). Significant inter-study heterogeneity was detected by our analysis, and sub-group analyses suggested that the type of control group was probably a source of heterogeneity. Conclusions Our current findings suggested that circulating miR-21 can serve as a potential co-biomarker for early-stage HCC diagnosis. Thorough large-scale studies are needed to confirm the generalizability of our findings.	[Liao, Qibin; Han, Peiyu; Huang, Yue; Wu, Zhitong; Li, Shanshan] Southern Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China; [Chen, Qing; Wu, Xianbo] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Guangdong, Peoples R China; [Ye, Jufeng] Southern Med Univ, Sch Publ Hlth & Trop Med, Expt Teaching Ctr Prevent Med, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Ye, JF (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Expt Teaching Ctr Prevent Med, Guangzhou, Guangdong, Peoples R China.	yjfws@163.com; wxb70@126.com	Wu, Xianbo/AAL-2948-2020	Huang, Yue/0000-0002-0864-8990	Presidential Foundation of the School of Public Health and Tropical Medicine, Southern Medical University, China [GW201423]	Presidential Foundation of the School of Public Health and Tropical Medicine, Southern Medical University, China	This study was financially supported by the Presidential Foundation of the School of Public Health and Tropical Medicine, Southern Medical University, China (No. GW201423).	Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Corvalan AH, 2012, DIGEST DIS SCI, V57, P2737, DOI 10.1007/s10620-012-2384-0; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Dhanasekaran R, 2012, HEPATIC MED-EVID RES, V4, P19, DOI 10.2147/HMER.S16316; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Jelic S, 2010, ANN ONCOL, V21, pv59, DOI 10.1093/annonc/mdq166; Kew MC, 2010, PATHOL BIOL, V58, P273, DOI 10.1016/j.patbio.2010.01.005; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; Li BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041629; Liu AM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000825; Liu XW, 2010, J SURG ONCOL, V102, P249, DOI 10.1002/jso.21624; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Miyazawa M, 2006, J CLIN GASTROENTEROL, V40, P555, DOI 10.1097/00004836-200607000-00016; Qin Z, 2013, SICHUAN MED J, V34, P1463; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Shan LQ, 2015, CANCER BIOMARK, V15, P47, DOI 10.3233/CBM-140437; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Singal A, 2009, ALIMENT PHARM THER, V30, P37, DOI 10.1111/j.1365-2036.2009.04014.x; Tang DF, 2013, EUR J CANCER PREV, V22, P540, DOI 10.1097/CEJ.0b013e32835f3be9; Tomimaru Y, 2012, J HEPATOL, V56, P167, DOI 10.1016/j.jhep.2011.04.026; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Yang XR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097460; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zeng ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073278	35	37	40	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130677	10.1371/journal.pone.0130677	http://dx.doi.org/10.1371/journal.pone.0130677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114756	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500087
J	Pescatore, AM; Spycher, BD; Beardsmore, CS; Kuehni, CE				Pescatore, Anina M.; Spycher, Ben D.; Beardsmore, Caroline S.; Kuehni, Claudia E.			"Attacks" or "Whistling": Impact of Questionnaire Wording on Wheeze Prevalence Estimates	PLOS ONE			English	Article							HEALTH-SERVICE USE; PRESCHOOL-CHILDREN; RESPIRATORY SYMPTOMS; ASTHMA PREVALENCE; SCHOOLCHILDREN; ALLERGIES; TRENDS; WHITE; COUGH; YOUNG	Background Estimates of prevalence of wheeze depend on questionnaires. However, wording of questions may vary between studies. We investigated effects of alternative wording on estimates of prevalence and severity of wheeze, and associations with risk factors. Methods White and South Asian children from a population-based cohort (UK) were randomly assigned to two groups and followed up at one, four and six years (1998, 2001, 2003). Parents were asked either if their child ever had "attacks of wheeze" (attack group, N= 535), or "wheezing or whistling in the chest" (whistling group, N= 2859). All other study aspects were identical, including questions about other respiratory symptoms. Results Prevalence of wheeze ever was lower in the attack group than in the whistling group for all surveys (32 vs. 40% in white children aged one year, p< 0.001). Prevalence of other respiratory symptoms did not differ between groups. Wheeze tended to be more severe in the attack group. The strength of association with risk factors was comparable in the two groups. Conclusions The wording of questions on wheeze can affect estimates of prevalence, but has less impact on measured associations with risk factors. Question wording is a potential source of between-study-heterogeneity in meta-analyses.	[Pescatore, Anina M.; Spycher, Ben D.; Kuehni, Claudia E.] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Beardsmore, Caroline S.] Univ Leicester, Dept Infect Immun & Inflammat, Div Child Hlth, Leicester, Leics, England	University of Bern; University of Leicester	Kuehni, CE (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	claudia.kuehni@ispm.unibe.ch	Spycher, Ben D/B-3308-2008	Spycher, Ben D/0000-0002-1430-5695	Swiss National Science Foundation fellowship [PZ00P3_147987]; Asthma UK [07/048]; Swiss National Science Foundation [PDFMP3-123162, 3200B0-122341, 32003B_144068]	Swiss National Science Foundation fellowship(Swiss National Science Foundation (SNSF)); Asthma UK; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	B. D. Spycher has received support from a Swiss National Science Foundation fellowship (grant no. PZ00P3_147987, www.snf.ch). C.S. Beardsmore was in the receipt of grant 07/048 from Asthma UK (www.asthma.org.uk). C. E. Kuehni has received research support from the Swiss National Science Foundation (grant nos. PDFMP3-123162, 3200B0-122341, 32003B_144068; www.snf.ch). The remaining authors have no financial relationship relevant to this article to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON HR, 1994, BRIT MED J, V308, P1600, DOI 10.1136/bmj.308.6944.1600; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Brogger JC, 2000, INT J TUBERC LUNG D, V4, P83; BROOKE AM, 1995, AM J RESP CRIT CARE, V152, P1872, DOI 10.1164/ajrccm.152.6.8520749; Burney P, 1996, EUR RESPIR J, V9, P687; Duran-Tauleria E, 1999, THORAX, V54, P476, DOI 10.1136/thx.54.6.476; Ekerljung L, 2013, CLIN RESPIR J, V7, P53, DOI 10.1111/j.1752-699X.2012.00281.x; Krstic G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018492; Kuehni CE, 2007, CLIN EXP ALLERGY, V37, P1738, DOI 10.1111/j.1365-2222.2007.02784.x; Kuehni CE, 2001, LANCET, V357, P1821, DOI 10.1016/S0140-6736(00)04958-8; Kuehni CE, 2007, INT J EPIDEMIOL, V36, P977, DOI 10.1093/ije/dym090; Kuehni CE, 2006, J ALLERGY CLIN IMMUN, V118, P528, DOI 10.1016/j.jaci.2006.04.019; LUYT DK, 1993, BMJ-BRIT MED J, V306, P1386, DOI 10.1136/bmj.306.6889.1386; Michel G, 2006, EUR RESPIR J, V28, P1124, DOI 10.1183/09031936.06.00008406; Netuveli G, 2005, LANCET, V365, P312, DOI 10.1016/S0140-6736(05)17785-X; Neuman A, 2012, AM J RESP CRIT CARE, V186, P1037, DOI 10.1164/rccm.201203-0501OC; Patel SP, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-57; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Pescatore AM, 2014, J ALLERGY CLIN IMMUN, V133, P111, DOI 10.1016/j.jaci.2013.06.002; Powell CVE, 1999, ARCH DIS CHILD, V81, P159, DOI 10.1136/adc.81.2.159; Rusconi F, 2013, ERS HDB PAEDIAT RESP, P293; Savenije OE, 2011, J ALLERGY CLIN IMMUN, V127, P1505, DOI 10.1016/j.jaci.2011.02.002; Sonnenschein-van der Voort AM, 2014, J ALLERGY CLIN IMMUN; Spycher BD, 2008, EUR RESPIR J, V31, P974, DOI 10.1183/09031936.00153507; Strippoli MPF, 2013, PEDIATRICS, V131, pE1842, DOI 10.1542/peds.2012-3003; Townsend PP., 1988, HLTH DEPRIVATION INE; Venn A, 1998, EUR RESPIR J, V11, P1324, DOI 10.1183/09031936.98.11061324	27	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131618	10.1371/journal.pone.0131618	http://dx.doi.org/10.1371/journal.pone.0131618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114296	gold, Green Published			2022-12-27	WOS:000358147500174
J	Song, LK; Ma, KL; Yuan, YH; Mu, Z; Song, XY; Niu, F; Han, N; Chen, NH				Song, Lian-Kun; Ma, Kai-Li; Yuan, Yu-He; Mu, Zheng; Song, Xiu-Yun; Niu, Fei; Han, Ning; Chen, Nai-Hong			Targeted Overexpression of alpha-Synuclein by rAAV2/1 Vectors Induces Progressive Nigrostriatal Degeneration and Increases Vulnerability to MPTP in Mouse	PLOS ONE			English	Article							PARKINSON-LIKE NEURODEGENERATION; CELL-DEATH; DOPAMINERGIC-NEURONS; TRANSGENIC MICE; ANIMAL-MODELS; MEDIATED OVEREXPRESSION; INCLUSION FORMATION; SWIM-TEST; WILD-TYPE; DISEASE	Mutations, duplication and triplication of alpha-synuclein genes are linked to familial Parkinson's disease (PD), and aggregation of alpha-synuclein (alpha-syn) in Lewy bodies (LB) is involved in the pathogenesis of the disease. The targeted overexpression of alpha-syn in the substantia nigra (SN) mediated by viral vectors may provide a better alternative to recapitulate the neurodegenerative features of PD. Therefore, we overexpressed human wild-type alpha-syn using rAAV2/1 vectors in the bilateral SN of mouse and examined the effects for up to 12 weeks. Delivery of rAAV-2/1-alpha-syn caused significant nigrostriatal degeneration including appearance of dystrophic striatal neurites, loss of nigral dopaminergic (DA) neurons and dissolving nigral neuron bodies in a time-dependent manner. In addition, the alpha-syn overexpressed mice also developed significant deficits in motor function at 12 weeks when the loss of DA neurons exceeded a threshold of 50%. To investigate the sensitivity to neurotoxins in mice overexpressing alpha-syn, we performed an MPTP treatment with the subacute regimen 8 weeks after rAAV injection. The impact of the combined genetic and environmental insults on DA neuronal loss, striatal dopamine depletion, dopamine turnover and motor dysfunction was markedly greater than that of either alone. Moreover, we observed increased phosphorylation (S129), accumulation and nuclear distribution of alpha-syn after the combined insults. In summary, these results reveal that the overexpressed alpha-syn induces progressive nigrostriatal degeneration and increases the susceptibility of DA neurons to MPTP. Therefore, the targeted overexpression of a-syn and the combination with environmental toxins may provide valuable models for understanding PD pathogenesis and developing related therapies.	[Song, Lian-Kun; Ma, Kai-Li; Yuan, Yu-He; Mu, Zheng; Song, Xiu-Yun; Niu, Fei; Han, Ning; Chen, Nai-Hong] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Song, Lian-Kun; Ma, Kai-Li; Yuan, Yu-He; Mu, Zheng; Song, Xiu-Yun; Niu, Fei; Han, Ning; Chen, Nai-Hong] Chinese Acad Med Sci, Ctr Neurosci, Beijing 100050, Peoples R China; [Song, Lian-Kun; Ma, Kai-Li; Yuan, Yu-He; Mu, Zheng; Song, Xiu-Yun; Niu, Fei; Han, Ning; Chen, Nai-Hong] Peking Union Med Coll, Beijing 100050, Peoples R China; [Chen, Nai-Hong] Hunan Univ Chinese Med, Changsha 410208, Hunan, Peoples R China; [Ma, Kai-Li] Chinese Acad Med Sci, Inst Med Biol, Kunming, Peoples R China; [Ma, Kai-Li] Peking Union Med Coll, Kunming, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Hunan University of Chinese Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Chen, NH (corresponding author), Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China.	chennh@imm.ac.cn	Song, Xiu-Yun/AAI-2203-2019	Ma, Kaili/0000-0002-5242-3000	National Natural Science Foundation of China [81274122, 81373997, 81273629, 81473376, U1402221]; National Mega-project for Innovative Drugs [2012ZX09301002-004, 2012ZX09103101-006, 2012ZX09301002-001-002]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT1007]; Beijing Natural Science Foundation [7131013, 7142115]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20121106130001]; Yunnan Natural Science Foundation [2013FZ132, 2011FB116]; Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study [BZ0150]; Fundamental Research Funds for the Central Universities [3332013082, 3332013146]; Graduate Innovation Fund of Peking Union Medical College [2012-1007-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Mega-project for Innovative Drugs; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Yunnan Natural Science Foundation(Natural Science Foundation of Yunnan Province); Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Graduate Innovation Fund of Peking Union Medical College	This work was supported by National Natural Science Foundation of China Grants (81274122, 81373997, 81273629, 81473376, U1402221), the National Mega-project for Innovative Drugs (2012ZX09301002-004, 2012ZX09103101-006, No. 2012ZX09301002-001-002), the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) (No. IRT1007), Beijing Natural Science Foundation (7131013, 7142115), the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20121106130001), Yunnan Natural Science Foundation (2013FZ132, 2011FB116), Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study (BZ0150), and the Fundamental Research Funds for the Central Universities (3332013082, 3332013146) and Graduate Innovation Fund 2012 of Peking Union Medical College (2012-1007-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Beyer K, 2006, ACTA NEUROPATHOL, V112, P237, DOI 10.1007/s00401-006-0104-6; BIANCO CL, 2002, P NATL ACAD SCI USA, V99, P10813, DOI DOI 10.1073/PNAS.152339799; Bjorklund A, 2010, PROG BRAIN RES, V184, P133, DOI 10.1016/S0079-6123(10)84007-5; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Cannon JR, 2009, NEUROBIOL DIS, V34, P279, DOI 10.1016/j.nbd.2009.01.016; Chau KY, 2009, J NEUROCHEM, V110, P1005, DOI 10.1111/j.1471-4159.2009.06191.x; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chesselet MF, 2008, EXP NEUROL, V209, P22, DOI 10.1016/j.expneurol.2007.08.006; CHIBA K, 1984, BIOCHEM BIOPH RES CO, V120, P574, DOI 10.1016/0006-291X(84)91293-2; Cicchetti F, 2009, TRENDS PHARMACOL SCI, V30, P475, DOI 10.1016/j.tips.2009.06.005; Connor TJ, 1997, PHARMACOL BIOCHEM BE, V58, P961, DOI 10.1016/S0091-3057(97)00028-2; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Decressac M, 2012, NEUROBIOL DIS, V45, P939, DOI 10.1016/j.nbd.2011.12.013; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dong ZZ, 2002, J NEUROBIOL, V53, P1, DOI 10.1002/neu.10094; Drolet RE, 2004, NEUROTOXICOLOGY, V25, P761, DOI 10.1016/j.neuro.2004.05.002; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; Emmanouilidou E, 2010, NEUROBIOL AGING, V31, P953, DOI 10.1016/j.neurobiolaging.2008.07.008; Fernagut PO, 2004, NEUROBIOL DIS, V17, P123, DOI 10.1016/j.nbd.2004.07.001; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gao HM, 2008, J NEUROSCI, V28, P7687, DOI 10.1523/JNEUROSCI.0143-07.2008; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Gombash SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081426; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Haobam R, 2005, BEHAV BRAIN RES, V163, P159, DOI 10.1016/j.bbr.2005.04.011; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; Jethva PN, 2011, FEBS J, V278, P1688, DOI 10.1111/j.1742-4658.2011.08093.x; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Koprich JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017698; LANGSTON JW, 1983, NEW ENGL J MED, V309, P310; Lauwers E, 2003, BRAIN PATHOL, V13, P364; Lee M, 2001, J NEUROCHEM, V76, P998, DOI 10.1046/j.1471-4159.2001.00149.x; Low K, 2012, NEUROBIOL DIS, V48, P189, DOI 10.1016/j.nbd.2011.12.038; Luchtman DW, 2009, PHYSIOL BEHAV, V98, P130, DOI 10.1016/j.physbeh.2009.04.021; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Ma KL, 2014, NEUROPHARMACOLOGY, V82, P132, DOI 10.1016/j.neuropharm.2013.07.035; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Matsuoka Y, 2001, NEUROBIOL DIS, V8, P535, DOI 10.1006/nbdi.2001.0392; Mulcahy P, 2011, NEUROSCIENCE, V181, P234, DOI 10.1016/j.neuroscience.2011.01.038; Oliveras-Salva M, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-44; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5; Przedborski S, 1998, MOVEMENT DISORD, V13, P35; Rathke-Hartlieb S, 2001, J NEUROCHEM, V77, P1181, DOI 10.1046/j.1471-4159.2001.00366.x; Schell H, 2009, NEUROSCIENCE, V160, P796, DOI 10.1016/j.neuroscience.2009.03.002; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sugeno N, 2008, J BIOL CHEM, V283, P23179, DOI 10.1074/jbc.M802223200; Thomas B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016706; Tsui TY, 2005, HEPATOLOGY, V42, P335, DOI 10.1002/hep.20803; Van der Perren A, 2015, CURR TOP BEHAV NEURO, V22, P271, DOI 10.1007/7854_2014_310; Vila M, 2000, J NEUROCHEM, V74, P721, DOI 10.1046/j.1471-4159.2000.740721.x; Wakamatsu M, 2008, NEUROBIOL AGING, V29, P574, DOI 10.1016/j.neurobiolaging.2006.11.017; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; Xie WL, 2012, J NEUROCHEM, V122, P404, DOI 10.1111/j.1471-4159.2012.07769.x; Yamada M, 2004, J NEUROCHEM, V91, P451, DOI 10.1111/j.1471-4159.2004.02728.x; Yuan YH, 2008, CELL MOL NEUROBIOL, V28, P21, DOI 10.1007/s10571-007-9185-6	66	30	33	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131281	10.1371/journal.pone.0131281	http://dx.doi.org/10.1371/journal.pone.0131281			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114655	gold, Green Published, Green Submitted			2022-12-27	WOS:000358147500138
J	Takemoto, M; Kato, HE; Koyama, M; Ito, J; Kamiya, M; Hayashi, S; Maturana, AD; Deisseroth, K; Ishitani, R; Nureki, O				Takemoto, Mizuki; Kato, Hideaki E.; Koyama, Michio; Ito, Jumpei; Kamiya, Motoshi; Hayashi, Shigehiko; Maturana, Andres D.; Deisseroth, Karl; Ishitani, Ryuichiro; Nureki, Osamu			Molecular Dynamics of Channelrhodopsin at the Early Stages of Channel Opening	PLOS ONE			English	Article							STRUCTURAL-CHANGES; CHLORIDE CHANNEL; GREEN-ALGAE; PHOTOCYCLE; BACTERIORHODOPSIN; OPTOGENETICS; SIMULATION; DOMAIN; SPECTROSCOPY; RESOLUTION	Channelrhodopsin (ChR) is a light-gated cation channel that responds to blue light. Since ChR can be readily expressed in specific neurons to precisely control their activities by light, it has become a powerful tool in neuroscience. Although the recently solved crystal structure of a chimeric ChR, C1C2, provided the structural basis for ChR, our understanding of the molecular mechanism of ChR still remains limited. Here we performed electrophysiological analyses and all-atom molecular dynamics (MD) simulations, to investigate the importance of the intracellular and central constrictions of the ion conducting pore observed in the crystal structure of C1C2. Our electrophysiological analysis revealed that two glutamate residues, Glu122 and Glu129, in the intracellular and central constrictions, respectively, should be deprotonated in the photocycle. The simulation results suggested that the deprotonation of Glu129 in the central constriction leads to ion leakage in the ground state, and implied that the protonation of Glu129 is important for preventing ion leakage in the ground state. Moreover, we modeled the 13-cis retinal bound; i.e., activated C1C2, and performed MD simulations to investigate the conformational changes in the early stage of the photocycle. Our simulations suggested that retinal photoisomerization induces the conformational change toward channel opening, including the movements of TM6, TM7 and TM2. These insights into the dynamics of the ground states and the early photocycle stages enhance our understanding of the channel function of ChR.	[Takemoto, Mizuki; Kato, Hideaki E.; Koyama, Michio; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Ito, Jumpei; Maturana, Andres D.] Nagoya Univ, Grad Sch Bioagr Sci, Dept Bioengn Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Kamiya, Motoshi; Hayashi, Shigehiko] Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto 6068502, Japan; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	University of Tokyo; Nagoya University; Kyoto University; Stanford University; Howard Hughes Medical Institute; Stanford University	Ishitani, R (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ishitani@bs.s.u-tokyo.ac.jp; nureki@bs.s.u-tokyo.ac.jp	Kato, Hideaki/AAQ-4323-2020; NUREKI, OSAMU/G-4960-2014	Kato, Hideaki/0000-0002-1941-5535; Takemoto, Mizuki/0000-0002-6339-6431; Ito, Jumpei/0000-0001-5149-9962	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT); NIMH; HHMI; HPCI STRATEGIC PROGRAM Computational Life Science and Application in Drug Discovery and Medical Development from MEXT	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); HHMI(Howard Hughes Medical Institute); HPCI STRATEGIC PROGRAM Computational Life Science and Application in Drug Discovery and Medical Development from MEXT	This work was supported by a grant from the Japan Society for the Promotion of Science (JSPS), through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program)", to ON, by Grants-in-Aid for Scientific Research (S) and (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to ON and RI, respectively, by grants from NIMH and HHMI to KD, and by a grant for HPCI STRATEGIC PROGRAM Computational Life Science and Application in Drug Discovery and Medical Development from MEXT to RI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Eisenhauer K, 2012, J BIOL CHEM, V287, P6904, DOI 10.1074/jbc.M111.327700; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gaiko O, 2013, BIOPHYS J, V104, P1230, DOI 10.1016/j.bpj.2013.02.013; Gushchin I, 2011, J MOL BIOL, V412, P591, DOI 10.1016/j.jmb.2011.07.022; Han X, 2012, ACS CHEM NEUROSCI, V3, P577, DOI 10.1021/cn300065j; Hoffman J, 2010, PHYS CHEM CHEM PHYS, V12, P3480, DOI 10.1039/b924630d; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inaguma A, 2015, J BIOL CHEM, V290, P11623, DOI 10.1074/jbc.M115.642256; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Ito S, 2014, J AM CHEM SOC, V136, P3475, DOI 10.1021/ja410836g; Kato HE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8177; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Koyama M, 2012, J PHYS CHEM B, V116, P11798, DOI 10.1021/jp303198u; Krause N, 2013, FEBS LETT, V587, P3309, DOI 10.1016/j.febslet.2013.08.043; Kuhne J, 2015, ANGEW CHEM INT EDIT, V54, P4953, DOI 10.1002/anie.201410180; Lorenz-Fonfria VA, 2013, P NATL ACAD SCI USA, V110, pE1273, DOI 10.1073/pnas.1219502110; Matsui Y, 2002, J MOL BIOL, V324, P469, DOI 10.1016/S0022-2836(02)01110-5; Muller M, 2015, J MOL BIOL, V427, P341, DOI 10.1016/j.jmb.2014.11.004; Muller M, 2011, J MOL BIOL, V414, P86, DOI 10.1016/j.jmb.2011.09.049; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Neutze R, 2002, BBA-BIOMEMBRANES, V1565, P144, DOI 10.1016/S0005-2736(02)00566-7; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plazzo AP, 2012, J BIOL CHEM, V287, P4818, DOI 10.1074/jbc.M111.326207; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; Ritter E, 2013, J BIOL CHEM, V288, P10451, DOI 10.1074/jbc.M112.446427; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Ruffert K, 2011, BIOCHEM BIOPH RES CO, V410, P737, DOI 10.1016/j.bbrc.2011.06.024; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sattig T, 2013, ANGEW CHEM INT EDIT, V52, P9705, DOI 10.1002/anie.201301698; Stehfest K, 2010, J MOL BIOL, V398, P690, DOI 10.1016/j.jmb.2010.03.031; Stehfest K, 2010, CHEMPHYSCHEM, V11, P1120, DOI 10.1002/cphc.200900980; Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614; SUBRAMANIAM S, 1993, EMBO J, V12, P1; Tanimoto S, 2013, NEUROSCI RES, V75, P13, DOI 10.1016/j.neures.2012.05.008; Watanabe HC, 2013, J MOL BIOL, V425, P1795, DOI 10.1016/j.jmb.2013.01.033; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375	44	29	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131094	10.1371/journal.pone.0131094	http://dx.doi.org/10.1371/journal.pone.0131094			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114863	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500127
J	Yan, J; Liao, K; Wang, TJ; Mai, KS; Xu, W; Ai, QH				Yan, Jing; Liao, Kai; Wang, Tianjiao; Mai, Kangsen; Xu, Wei; Ai, Qinghui			Dietary Lipid Levels Influence Lipid Deposition in the Liver of Large Yellow Croaker (Larimichthys crocea) by Regulating Lipoprotein Receptors, Fatty Acid Uptake and Triacylglycerol Synthesis and Catabolism at the Transcriptional Level	PLOS ONE			English	Article							CARP CTENOPHARYNGODON-IDELLA; SOLEA-SENEGALENSIS JUVENILES; HIGH-DENSITY-LIPOPROTEIN; SALMON SALMO-SALAR; BREAM PAGRUS-MAJOR; ATLANTIC SALMON; GENE-EXPRESSION; HEPATIC LIPOGENESIS; GROWTH-PERFORMANCE; BINDING-PROTEIN	Ectopic lipid accumulation has been observed in fish fed a high-lipid diet. However, no information is available on the mechanism by which dietary lipid levels comprehensively regulate lipid transport, uptake, synthesis and catabolism in fish. Therefore, the present study aimed to gain further insight into how dietary lipids affect lipid deposition in the liver of large yellow croaker(Larimichthys crocea). Fish (150.00 +/- 4.95 g) were fed a diet with a low (6%), moderate (12%, the control diet) or high (18%) crude lipid content for 10 weeks. Growth performance, plasma biochemical indexes, lipid contents and gene expression related to lipid deposition, including lipoprotein assembly and clearance, fatty acid uptake and triacylglycerol synthesis and catabolism, were assessed. Growth performance was not significantly affected. However, the hepato-somatic and viscera-somatic indexes as well as plasma triacylglycerol, non-esterified fatty acids and LDL-cholesterol levels were significantly increased in fish fed the high-lipid diet. In the livers of fish fed the high-lipid diet, the expression of genes related to lipoprotein clearance (LDLR) and fatty acid uptake (FABP11) was significantly up-regulated, whereas the expression of genes involved in lipoprotein assembly (apoB100), triacylglycerol synthesis and catabolism (DGAT2, CPT I) was significantly down-regulated compared with fish fed the control diet, and hepatic lipid deposition increased. In fish fed the low-lipid diet, the expression of genes associated with lipoprotein assembly and clearance (apoB100, LDLR, LRP-1), fatty acid uptake (CD36, FATP1, FABP3) and triacylglycerol synthesis (FAS) was significantly increased, whereas the expression of triacylglycerol catabolism related genes (ATGL, CPT I) was reduced compared with fish fed the control diet. However, hepatic lipid content in fish fed the low-lipid diet decreased mainly due to low dietary lipid intake. In summary, findings of this study provide molecular insight into the role of lipid deposition in the liver in response to different dietary lipid contents.	[Yan, Jing; Liao, Kai; Wang, Tianjiao; Mai, Kangsen; Xu, Wei; Ai, Qinghui] Ocean Univ China, Minist Agr, Key Lab Aquaculture Nutr & Feed, Qingdao, Shandong, Peoples R China; [Yan, Jing; Liao, Kai; Wang, Tianjiao; Mai, Kangsen; Ai, Qinghui] Ocean Univ China, Minist Educ, Key Lab Mariculture, Qingdao, Shandong, Peoples R China	Ministry of Agriculture & Rural Affairs; Ocean University of China; Ocean University of China	Ai, QH (corresponding author), Ocean Univ China, Minist Agr, Key Lab Aquaculture Nutr & Feed, Qingdao, Shandong, Peoples R China.	qhai@ouc.edu.cn			National Natural Foundation of China [31372541, 31172425]; Doctoral Scientific Fund Project of the Ministry of Education of China [20120132110007]; National Basic Research Program of China (973 Program) [2014CB138600]	National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Scientific Fund Project of the Ministry of Education of China; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research was supported by the National Natural Foundation of China (31372541 and 31172425), the Doctoral Scientific Fund Project of the Ministry of Education of China (20120132110007), and the National Basic Research Program of China (973 Program, 2014CB138600). The funder's websites are http://www.nsfc.gov.cn/, http://www.cutech.edu.cn/cn/index.htm and http://www.most.gov.cn/index.htm, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Adiels M, 2007, DIABETOLOGIA, V50, P2356, DOI 10.1007/s00125-007-0790-1; Adiels M, 2006, DIABETOLOGIA, V49, P755, DOI 10.1007/s00125-005-0125-z; Agulleiro MJ, 2007, BIOL REPROD, V77, P504, DOI 10.1095/biolreprod.107.061598; Alvarez MJ, 2000, BRIT J NUTR, V84, P619; BENNETT AJ, 1995, BIOCHEM J, V311, P167, DOI 10.1042/bj3110167; Borges P, 2009, BRIT J NUTR, V102, P1007, DOI 10.1017/S0007114509345262; Boujard T, 2004, AQUACULTURE, V231, P529, DOI 10.1016/j.aquaculture.2003.11.010; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Colquhoun A, 2002, BBA-MOL CELL BIOL L, V1583, P74, DOI 10.1016/S1388-1981(02)00162-2; Cruz-Garcia L, 2011, COMP BIOCHEM PHYS A, V158, P391, DOI 10.1016/j.cbpa.2010.11.024; Degrace P, 2003, FEBS LETT, V546, P335, DOI 10.1016/S0014-5793(03)00610-0; Degrace P, 2006, J LIPID RES, V47, P2647, DOI 10.1194/jlr.M600140-JLR200; DESCAMPS O, 1993, J BIOL CHEM, V268, P974; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Dorfman SE, 2006, METABOLISM, V55, P635, DOI 10.1016/j.metabol.2005.12.005; Du ZY, 2008, AQUACULT NUTR, V14, P77, DOI 10.1111/j.1365-2095.2007.00507.x; Du ZY, 2006, BRIT J NUTR, V95, P905, DOI 10.1079/BJN20061733; FALHOLT K, 1973, CLIN CHIM ACTA, V46, P105, DOI 10.1016/0009-8981(73)90016-8; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garcia-Meilan I, 2014, AQUACULTURE, V434, P121, DOI 10.1016/j.aquaculture.2014.08.005; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gu M, 2014, BRIT J NUTR, V111, P432, DOI 10.1017/S0007114513002717; Hansen JO, 2008, AQUACULTURE, V284, P159, DOI 10.1016/j.aquaculture.2008.07.043; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; HELLERSTEIN MK, 1991, J CLIN INVEST, V87, P1841, DOI 10.1172/JCI115206; Huang TS, 2010, AQUACULT NUTR, V16, P72, DOI 10.1111/j.1365-2095.2008.00642.x; Ilmonen M., 2000, GENETIC VARIATION OF; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; Jobling M, 1998, AQUAC RES, V29, P601, DOI 10.1111/j.1365-2109.1998.tb01174.x; Kikuchi K, 2009, AQUACULTURE, V298, P111, DOI 10.1016/j.aquaculture.2009.10.026; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Kjaer MA, 2008, BBA-MOL CELL BIOL L, V1781, P112, DOI 10.1016/j.bbalip.2007.12.004; Kreeft AJ, 2005, ATHEROSCLEROSIS, V182, P249, DOI 10.1016/j.atherosclerosis.2005.01.049; Leaver MJ, 2008, REV FISH SCI, V16, P73, DOI 10.1080/10641260802325278; Li XF, 2012, FISH PHYSIOL BIOCHEM, V38, P529, DOI 10.1007/s10695-011-9533-9; Liang XF, 2002, COMP BIOCHEM PHYS A, V131, P335, DOI 10.1016/S1095-6433(01)00481-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez LM, 2009, AQUACULTURE, V289, P101, DOI 10.1016/j.aquaculture.2009.01.003; Lu KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093135; Lu KL, 2013, AQUACULTURE, V408, P160, DOI 10.1016/j.aquaculture.2013.06.003; Magkos F, 2009, PROG LIPID RES, V48, P171, DOI 10.1016/j.plipres.2009.02.003; Murayama T, 2000, ATHEROSCLEROSIS, V153, P295, DOI 10.1016/S0021-9150(00)00414-7; National Research Council, 2011, COMMITTEE ON THE NUT; Nickerson JG, 2009, J BIOL CHEM, V284, P16522, DOI 10.1074/jbc.M109.004788; Okada M, 1998, J LAB CLIN MED, V132, P195, DOI 10.1016/S0022-2143(98)90168-8; Oku H, 2000, FISHERIES SCI, V66, P25, DOI 10.1046/j.1444-2906.2000.00003.x; Peres H, 1999, AQUACULTURE, V179, P325, DOI 10.1016/S0044-8486(99)00168-4; Rader DJ, 2008, HARRISONS PRINCIPLES, P334; Regost C, 2001, AQUACULTURE, V193, P291, DOI 10.1016/S0044-8486(00)00493-2; RICHMOND W, 1973, CLIN CHEM, V19, P1350; Rueda-Jasso R, 2004, AQUACULTURE, V231, P417, DOI 10.1016/S0044-8486(03)00537-4; Sanchez-Gurmaches J, 2012, COMP BIOCHEM PHYS A, V163, P177, DOI 10.1016/j.cbpa.2012.06.010; Sanchez-Gurmaches J, 2011, AM J PHYSIOL-REG I, V301, pR947, DOI 10.1152/ajpregu.00289.2011; Schettler G., 1975, ARB MED SOZ MED PRAV, V10, P25; Shearer GC, 2012, BBA-MOL CELL BIOL L, V1821, P843, DOI 10.1016/j.bbalip.2011.10.011; SHERIDAN MA, 1988, COMP BIOCHEM PHYS B, V90, P679, DOI 10.1016/0305-0491(88)90322-7; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Storch J, 2010, J BIOL CHEM, V285, P32679, DOI 10.1074/jbc.R110.135210; Thirumaran A, 2014, GENOME, V57, P289, DOI 10.1139/gen-2014-0059; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Todorcevic M, 2008, BBA-MOL CELL BIOL L, V1781, P326, DOI 10.1016/j.bbalip.2008.04.014; Torstensen BE, 2009, AQUACULT NUTR, V15, P440, DOI 10.1111/j.1365-2095.2008.00609.x; Twisk J, 2000, J CLIN INVEST, V105, P521, DOI 10.1172/JCI8623; Vedala A, 2006, J LIPID RES, V47, P2562, DOI 10.1194/jlr.M600200-JLR200; Wang JT, 2005, AQUACULTURE, V249, P439, DOI 10.1016/j.aquaculture.2005.04.038; Wang X, 2013, ADV COMPUT ELECTR EN, P1, DOI 10.4018/978-1-4666-2503-7; Weil C, 2013, REV FISH BIOL FISHER, V23, P157, DOI 10.1007/s11160-012-9288-0; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yi XW, 2014, AQUACULTURE, V434, P355, DOI 10.1016/j.aquaculture.2014.08.035; Zhou J, 2010, LIPIDS, V45, P301, DOI 10.1007/s11745-010-3396-1; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	73	113	119	6	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129937	10.1371/journal.pone.0129937	http://dx.doi.org/10.1371/journal.pone.0129937			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114429	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500045
J	Aseer, KR; Kim, SW; Choi, MS; Yun, JW				Aseer, Kanikkai Raja; Kim, Sang Woo; Choi, Myung-Sook; Yun, Jong Won			Opposite Expression of SPARC between the Liver and Pancreas in Streptozotocin-Induced Diabetic Rats	PLOS ONE			English	Article							GENE-EXPRESSION; URIC-ACID; DEPENDENT EXPRESSION; MEDIATED INHIBITION; GENDER DIMORPHISM; SKELETAL-MUSCLE; ADIPOSE-TISSUE; PROTEIN-KINASE; PLASMA-LEVELS; BETA-CATENIN	Secreted protein acidic and rich in cysteine (SPARC) is a matricellular protein that regulates several cellular events, including inflammation and tissue remodelling. In this study, we investigated the tissue-specific expression of SPARC in streptozotocin (STZ)-induced diabetes, and found that SPARC was significantly up-regulated in the liver while down-regulated in the pancreas of STZ-induced diabetic rats. Chronic inflammation occurred in the diabetic pancreas accompanied by up-regulation of CCAAT/enhancer-binding protein beta (C/EBP beta) and its targets (TNF alpha, Il6, CRP, and Fn1) as well as myeloperoxidase (Mpo) and C-X-C chemokine receptor type 2 (Cxcr2). Diabetic liver showed significant up-regulation of Tgfb1 as well as moderately less up-regulated TNFa and reduced Fn1, resulting in elevated fibrogenesis. PARP-1 was not up-regulated during CD95-mediated apoptosis, resulting in restoration of high ATP levels in the diabetic liver. On the contrary, CD95-dependent apoptosis was not observed in the diabetic pancreas due to up-regulation of PARP-1 and ATP depletion, resulting in necrosis. The cytoprotective machinery was damaged by pancreatic inflammation, whereas adequate antioxidant capacity indicates low oxidative stress in the diabetic liver. High and low cellular insulin content was found in the diabetic liver and pancreas, respectively. Furthermore, we identified six novel interacting partner proteins of SPARC by coimmunoprecipitation in the diabetic liver and pancreas, and their interactions with SPARC were predicted by bioinformatics tools. Taken together, opposite expression of SPARC in the diabetic liver and pancreas may be related to inflammation and immune cell infiltration, degrees of apoptosis and fibrosis, cytoprotective machinery, and cellular insulin levels.	[Aseer, Kanikkai Raja; Kim, Sang Woo; Yun, Jong Won] Daegu Univ, Dept Biotechnol, Kyungsan 712714, Kyungbuk, South Korea; [Choi, Myung-Sook] Kyungpook Natl Univ, Ctr Food & Nutr Genom Res, Daegu 702701, South Korea; [Choi, Myung-Sook] Kyungpook Natl Univ, Dept Food Sci & Nutr, Daegu 702701, South Korea	Daegu University; Kyungpook National University; Kyungpook National University	Yun, JW (corresponding author), Daegu Univ, Dept Biotechnol, Kyungsan 712714, Kyungbuk, South Korea.	jwyun@daegu.ac.kr		Kim, Sang Woo/0000-0002-3144-4822; Yun, Jong Won/0000-0003-2453-2282	Mid-career Researcher Program [2013R1A2A2A05004195]; SRC Program (Center for Food & Nutritional Genomics) NRF grant - Ministry of Science, ICT and Future Planning, Korea [2015R1A5A6001906]	Mid-career Researcher Program; SRC Program (Center for Food & Nutritional Genomics) NRF grant - Ministry of Science, ICT and Future Planning, Korea	This work was supported by the Mid-career Researcher Program (2013R1A2A2A05004195) and SRC Program (Center for Food & Nutritional Genomics, Grant number 2015R1A5A6001906) through NRF grant funded by the Ministry of Science, ICT and Future Planning, Korea.	Afzali A, 2010, HEPATOLOGY, V52, P578, DOI 10.1002/hep.23717; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Aram G, 2008, HEPATOLOGY, V47, P2051, DOI 10.1002/hep.22278; Arnold SA, 2009, J CELL COMMUN SIGNAL, V3, P255, DOI 10.1007/s12079-009-0072-4; Aseer KR, 2013, BIOTECHNOL BIOPROC E, V18, P1122, DOI 10.1007/s12257-013-0324-2; Aughsteen AA, 2005, SAUDI MED J, V26, P73; Bhoopathi P, 2011, CANCER RES, V71, P4908, DOI 10.1158/0008-5472.CAN-10-3395; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Camino AM, 2008, J GENE MED, V10, P993, DOI 10.1002/jgm.1228; Catalan V, 2014, J CLIN ENDOCR METAB, V99, pE1407, DOI 10.1210/jc.2014-1191; Chamorro-Jorganes A, 2011, AM J PHYSIOL-CELL PH, V300, pC683, DOI 10.1152/ajpcell.00251.2010; Chen Y, 2009, AM J PATHOL, V175, P2676, DOI 10.2353/ajpath.2009.080945; Choi JW, 2013, PROTEOMICS, V13, P2482, DOI 10.1002/pmic.201200529; Choi M, 2013, CELL PHYSIOL BIOCHEM, V31, P408, DOI 10.1159/000343378; Clifford AJ, 2012, J NUTR, V142, P1764, DOI 10.3945/jn.112.160333; DANDONA P, 1984, J CLIN PATHOL, V37, P302, DOI 10.1136/jcp.37.3.302; de Cavanagh EMV, 2001, HYPERTENSION, V38, P1130, DOI 10.1161/hy1101.092845; Diana J, 2014, EMBO MOL MED, V6, P1090, DOI 10.15252/emmm.201404144; DODGSON SJ, 1990, ARCH BIOCHEM BIOPHYS, V277, P410, DOI 10.1016/0003-9861(90)90597-R; DOMINGUEZMUNOZ JE, 1993, DIGESTION, V54, P231; Elghazi L, 2012, SCI REP-UK, V2, DOI 10.1038/srep00693; Fernandez J, 1998, ELECTROPHORESIS, V19, P1036, DOI 10.1002/elps.1150190619; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; GILBERT RE, 1995, KIDNEY INT, V48, P1216, DOI 10.1038/ki.1995.405; Gojo A, 2007, EUR J PHARMACOL, V568, P242, DOI 10.1016/j.ejphar.2007.04.011; Greenwel P, 2000, MOL CELL BIOL, V20, P912, DOI 10.1128/MCB.20.3.912-918.2000; Harries LW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068253; Hojlund K, 2003, J BIOL CHEM, V278, P10436, DOI 10.1074/jbc.M212881200; Jain SK, 2009, ANTIOXID REDOX SIGN, V11, P241, DOI 10.1089/ars.2008.2140; Jandeleit-Dahm K, 2000, MICROVASC RES, V59, P61, DOI 10.1006/mvre.1999.2189; Jang YY, 2000, PHARMACOL RES, V42, P361, DOI 10.1006/phrs.2000.0705; Johnson RJ, 2013, DIABETES, V62, P3307, DOI 10.2337/db12-1814; Joo JI, 2011, PROTEOMICS, V11, P1429, DOI 10.1002/pmic.201000515; Justo R, 2005, AM J PHYSIOL-CELL PH, V289, pC372, DOI 10.1152/ajpcell.00035.2005; Kanauchi M, 2000, DIABETOLOGIA, V43, P1076; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kanters SDJM, 2001, DIABETES CARE, V24, P323, DOI 10.2337/diacare.24.2.323; Kavanagh K, 2009, CELL STRESS CHAPERON, V14, P291, DOI 10.1007/s12192-008-0084-7; Kawelke N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028181; Kim SI, 2000, KIDNEY INT, V58, pS88, DOI 10.1046/j.1523-1755.2000.07714.x; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Kos K, 2009, DIABETES, V58, P1780, DOI 10.2337/db09-0211; Lei ZB, 2003, ACTA PHARMACOL SIN, V24, P670; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lomas-Soria C, 2011, INT J MOL SCI, V12, P8431, DOI 10.3390/ijms12128431; Los M, 2002, MOL BIOL CELL, V13, P978, DOI 10.1091/mbc.01-05-0272; Lukic ML, 2014, DIABETES, V63, P835, DOI 10.2337/db13-1786; Mandrup-Poulsen T, 2010, NAT REV ENDOCRINOL, V6, P158, DOI 10.1038/nrendo.2009.271; Matsuda T, 2010, J CLIN INVEST, V120, P115, DOI 10.1172/JCI39721; Melloul D, 2008, BIOCHEM SOC T, V36, P334, DOI 10.1042/BST0360334; Mikael LG, 2008, CARDIOVASC RES, V80, P151, DOI 10.1093/cvr/cvn157; Mirza S, 2012, CYTOKINE, V57, P136, DOI 10.1016/j.cyto.2011.09.029; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Nakamura S, 1996, ARTHRITIS RHEUM, V39, P539, DOI 10.1002/art.1780390402; Nie J, 2009, J BIOL CHEM, V284, P1279, DOI 10.1074/jbc.M808285200; NISHITA T, 1995, INT J BIOCHEM CELL B, V27, P359, DOI 10.1016/1357-2725(94)00090-X; Ozveri ES, 2001, INFLAMM RES, V50, P585, DOI 10.1007/PL00000238; Patel R, 2006, ANN NY ACAD SCI, V1084, P71, DOI 10.1196/annals.1372.038; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Ratnam S, 2006, AM J PHYSIOL-ENDOC M, V290, pE933, DOI 10.1152/ajpendo.00498.2005; Reding T, 2009, PHYSIOL GENOMICS, V38, P196, DOI 10.1152/physiolgenomics.00028.2009; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Ryall CL, 2014, J BIOL CHEM, V289, P30614, DOI 10.1074/jbc.M114.573980; Sangaletti S, 2011, AM J PATHOL, V179, P3000, DOI 10.1016/j.ajpath.2011.08.027; Schneikert J, 2007, HUM MOL GENET, V16, P199, DOI 10.1093/hmg/ddl464; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Szabo C, 2002, CIRCULATION, V106, P2680, DOI 10.1161/01.CIR.0000038365.78031.9C; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Taneda S, 2003, J AM SOC NEPHROL, V14, P968, DOI 10.1097/01.ASN.0000054498.83125.90; Tartare-Deckert S, 2001, J BIOL CHEM, V276, P22231, DOI 10.1074/jbc.M010634200; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Vacek TP, 2012, ARCH PHYSIOL BIOCHEM, V118, P31, DOI 10.3109/13813455.2011.635660; Venojarvi M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/386351; Verrecchia F, 2000, J BIOL CHEM, V275, P30226, DOI 10.1074/jbc.M005310200; Vital P, 2006, J ENDOCRINOL, V190, P425, DOI 10.1677/joe.1.06596; Watanabe K, 2009, J ATHEROSCLER THROMB, V16, P69, DOI 10.5551/jat.E711; Wiersma JJ, 2008, MED SCI MONITOR, V14, pCR406; Wu DD, 2011, EUR J ENDOCRINOL, V165, P597, DOI 10.1530/EJE-11-0131; Xie X, 2013, MOL CELL ENDOCRINOL, V381, P56, DOI 10.1016/j.mce.2013.07.019; Xu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081615; Yoshimura A, 2011, CURR TOP MICROBIOL, V350, P127, DOI 10.1007/82_2010_87	81	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131189	10.1371/journal.pone.0131189	http://dx.doi.org/10.1371/journal.pone.0131189			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110898	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800126
J	Chen, CY; Chen, CI; Tsai, FY; Tsai, PH; Chan, WP				Chen, Chia-Yuen; Chen, Chin-I; Tsai, Fong Y.; Tsai, Ping-Huei; Chan, Wing P.			Prominent Vessel Sign on Susceptibility-Weighted Imaging in Acute Stroke: Prediction of Infarct Growth and Clinical Outcome	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; COMPUTED-TOMOGRAPHY; MRI; TISSUE; BRAIN; RECANALIZATION; CONTRAST; PENUMBRA; VOLUME; VEINS	Background and Purpose Predicting the risk of further infarct growth in stroke patients is critical to therapeutic decision making. We aimed to predict early infarct growth and clinical outcome from prominent vessel sign (PVS) identified on the first susceptibility-weighted image (SWI) after acute stroke. Materials and Methods Twenty-two patients with middle cerebral artery (MCA) infarction had diffusion-weighted imaging, SWI, MR angiography, and clinical evaluation using the National Institutes of Health Stroke Scale at 7-60 hours and 5-14 days after stroke onset. Late-stage clinical evaluation at 1 and 3 months used the modified Rankin Scale. The infarct area and growth were scored from 10 (none) to 0 (infarct or growth in all 10 zones) using the Alberta Stroke Program Early CT Score (ASPECTS) system. Results Infarct growth on the second MRI occurred in 13 of 15 patients with PVS on the first MRI and not in any patient without PVS (n=7; r=0.86, P<0.001). The extent of PVS was significantly correlated with infarct growth (r=0.82, P<0.001) and early-stage outcome (P=0.02). No between-group difference in late-stage clinical outcome was found. Conclusion PVS on the first SWI after acute MCA territory stroke is a useful predictor of early infarct growth. Extensive PVS within the large MCA territory is related to poor early-stage outcome and could be useful for clinical assessment of stroke.	[Chen, Chia-Yuen; Chan, Wing P.] Taipei Med Univ, Wan Fang Hosp, Dept Radiol, Taipei, Taiwan; [Chen, Chia-Yuen; Tsai, Ping-Huei; Chan, Wing P.] Taipei Med Univ, Coll Med, Sch Med, Dept Radiol, Taipei, Taiwan; [Chen, Chin-I] Taipei Med Univ, Wan Fang Hosp, Dept Neurol, Taipei, Taiwan; [Tsai, Fong Y.] Univ Calif Irvine, Dept Radiol Sci, Irvine, CA 92717 USA; [Tsai, Fong Y.; Tsai, Ping-Huei] Taipei Med Univ, Imaging Res Ctr, Taipei, Taiwan; [Tsai, Ping-Huei] Taipei Med Univ, Taipei Med Univ Hosp, Dept Med Imaging, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; University of California System; University of California Irvine; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Chan, WP (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Radiol, Taipei, Taiwan.	wingchan@tmu.edu.tw		Chan, Wing P./0000-0001-8322-6336	Wan Fang Hospital, Taipei Medical University (inter-agency research project) [103swf06]	Wan Fang Hospital, Taipei Medical University (inter-agency research project)	The authors are grateful to Wan Fang Hospital, Taipei Medical University for funding this study (inter-agency research project grant no. 103swf06).	Baik SK, 2012, CEREBROVASC DIS, V34, P206, DOI 10.1159/000342148; Barber PA, 2005, J NEUROL NEUROSUR PS, V76, P1528, DOI 10.1136/jnnp.2004.059261; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Bosemani T, 2013, NEURORADIOL J, V26, P579, DOI 10.1177/197140091302600512; Chalian M, 2011, J NEURORADIOLOGY, V38, P187, DOI 10.1016/j.neurad.2010.12.006; Cho KH, 2012, J NEUROL SCI, V316, P99, DOI 10.1016/j.jns.2012.01.015; Darby DG, 1999, STROKE, V30, P2043, DOI 10.1161/01.STR.30.10.2043; Davis SM, 2008, LANCET NEUROL, V7, P299, DOI 10.1016/S1474-4422(08)70044-9; Grohn OHJ, 2001, NMR BIOMED, V14, P432, DOI 10.1002/nbm.739; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P663, DOI 10.1002/jmri.22276; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; HEISS WD, 1992, J CEREBR BLOOD F MET, V12, P193, DOI 10.1038/jcbfm.1992.29; Heiss WD, 2000, J CEREBR BLOOD F MET, V20, P1276, DOI 10.1097/00004647-200009000-00002; Hermier M, 2004, STROKE, V35, P1989, DOI 10.1161/01.STR.0000133341.74387.96; Hermier M, 2003, J CEREBR BLOOD F MET, V23, P1362, DOI 10.1097/01.WCB.0000091764.61714.79; Hermier M, 2003, J CEREBR BLOOD F MET, V23, P240, DOI 10.1097/01.WCB.0000043340.09081.7E; Huang PY, 2012, J NEUROL, V259, P1426, DOI 10.1007/s00415-011-6369-2; Kao HW, 2012, EUR RADIOL, V22, P1397, DOI 10.1007/s00330-012-2387-4; Kaya D, 2009, AM J NEURORADIOL, V30, P1227, DOI 10.3174/ajnr.A1537; Kesavadas C, 2011, J NEUROL, V258, P932, DOI 10.1007/s00415-010-5843-6; Kesavadas C, 2010, NEURORADIOLOGY, V52, P1047, DOI 10.1007/s00234-010-0733-2; Markus R, 2004, BRAIN, V127, P1427, DOI 10.1093/brain/awh162; Meoded A, 2014, J NEURORADIOLOGY, V41, P108, DOI 10.1016/j.neurad.2013.04.002; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Morita N, 2008, CEREBROVASC DIS, V26, P367, DOI 10.1159/000151640; Park KT, 2012, INT J REFRACT MET H, V33, P33, DOI 10.1016/j.ijrmhm.2012.02.004; Polan RM, 2014, AM J NEURORADIOL; Reichenbach JR, 2001, NMR BIOMED, V14, P453, DOI 10.1002/nbm.722; Rivers CS, 2006, STROKE, V37, P98, DOI 10.1161/01.STR.0000195197.66606.bb; Rosso C, 2009, RADIOLOGY, V250, P184, DOI 10.1148/radiol.2493080107; Rovira A, 2004, RADIOLOGY, V232, P466, DOI 10.1148/radiol.2322030273; Sobesky J, 2005, STROKE, V36, P980, DOI 10.1161/01.STR.0000160751.79241.a3; Tamura H, 2002, STROKE, V33, P967, DOI 10.1161/01.STR.0000013672.70986.E2; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Tsui YK, 2009, J NEUROL SCI, V287, P7, DOI 10.1016/j.jns.2009.08.064; Wechsler LR, 2011, STROKE, V42, pS12, DOI 10.1161/STROKEAHA.110.599555; Yamashita E, 2011, ACTA RADIOL, V52, P905, DOI 10.1258/ar.2011.110159	37	41	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131118	10.1371/journal.pone.0131118	http://dx.doi.org/10.1371/journal.pone.0131118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110628	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800120
J	Fan, XZ; Wang, LF; Guo, YL; Tu, Z; Li, L; Tong, HP; Xu, Y; Li, R; Fang, KJ				Fan, Xiaozhou; Wang, Luofu; Guo, Yanli; Tu, Zhui; Li, Lang; Tong, Haipeng; Xu, Yang; Li, Rui; Fang, Kejing			Ultrasonic Nanobubbles Carrying Anti-PSMA Nanobody: Construction and Application in Prostate Cancer-Targeted Imaging	PLOS ONE			English	Article							CONTRAST-ENHANCED ULTRASOUND; RADIONUCLIDE THERAPY; MEMBRANE ANTIGEN; MICROBUBBLES; ANTIBODIES; TISSUES	To facilitate prostate cancer imaging using targeted molecules, we constructed ultrasonic nanobubbles coupled with specific anti-PSMA (prostate specific membrane antigen) nanobodies, and evaluated their in vitro binding capacity and in vivo imaging efficacy. The "targeted" nanobubbles, which were constructed via a biotin-streptavidin system, had an average diameter of 487.60 +/- 33.55 nm and carried the anti-PSMA nanobody as demonstrated by immunofluorescence. Microscopy revealed targeted binding of nanobubbles in vitro to PSMA-positive cells. Additionally, ultrasonography indicators of nanobubble imaging (including arrival time, peak time, peak intensity and enhanced duration) were evaluated for the ultrasound imaging in three kinds of animal xenografts (LNCaP, C4-2 and MKN45), and showed that these four indicators of targeted nanobubbles exhibited significant differences from blank nanobubbles. Therefore, this study not only presents a novel approach to target prostate cancer ultrasonography, but also provides the basis and methods for constructing small-sized and high-efficient targeted ultrasound nanobubbles.	[Fan, Xiaozhou; Guo, Yanli; Li, Lang; Tong, Haipeng; Li, Rui; Fang, Kejing] Third Mil Med Univ, Southwest Hosp, Dept Ultrasound, Chongqing, Peoples R China; [Wang, Luofu] Third Mil Med Univ, Inst Surg Res, Daping Hosp, Dept Urol, Chongqing, Peoples R China; [Tu, Zhui; Xu, Yang] Nanchang Univ, State Key Lab Food Sci & Technol, Nanchang City, Jiangxi, Peoples R China; [Xu, Yang] Nanchang Univ, Jiangxi QAI Joint Res Inst, Nanchang City, Jiangxi, Peoples R China	Army Medical University; Army Medical University; Nanchang University; Nanchang University	Guo, YL (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Ultrasound, Chongqing, Peoples R China.	guoyanli71@aliyun.com	Fang, Kejing/ACN-7217-2022; Tu, Zhui/E-3890-2010	Tu, Zhui/0000-0003-3187-0132	National Natural Science Foundation [30970830]; Chongqing Science Foundation [cstc2012jjB0072]; Youth Science Foundation of Jiangxi Department of Education [GJJ12142]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chongqing Science Foundation; Youth Science Foundation of Jiangxi Department of Education	This work has been financially supported by the National Natural Science Foundation (grant number: 30970830), the Chongqing Science Foundation (grant number: cstc2012jjB0072) and the Youth Science Foundation of Jiangxi Department of Education (grant number: GJJ12142).	Broisat A, 2012, CIRC RES, V110, P927, DOI 10.1161/CIRCRESAHA.112.265140; D'Huyvetter M, 2014, EXPERT OPIN DRUG DEL, V11, P1939, DOI 10.1517/17425247.2014.941803; D'Huyvetter M, 2014, THERANOSTICS, V4, P708, DOI 10.7150/thno.8156; De Meyer T, 2014, TRENDS BIOTECHNOL, V32, P263, DOI 10.1016/j.tibtech.2014.03.001; De Vos J, 2013, EXPERT OPIN BIOL TH, V13, P1149, DOI 10.1517/14712598.2013.800478; Deshpande N, 2010, CLIN RADIOL, V65, P567, DOI 10.1016/j.crad.2010.02.013; Elsasser-Beile U, 2009, CURR DRUG TARGETS, V10, P118, DOI 10.2174/138945009787354601; Emonds KM, 2009, METHODS, V48, P193, DOI 10.1016/j.ymeth.2009.03.021; Evazalipour M, 2012, HYBRIDOMA, V31, P424, DOI 10.1089/hyb.2012.0048; [范校周 Fan Xiaozhou], 2013, [第三军医大学学报, Journal of Third Military Medical University], V35, P2320; Fan XZ, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/32/325102; Foss CA, 2012, CURR MED CHEM, V19, P1346; Gessner R, 2010, MOL IMAGING, V9, P117, DOI 10.2310/7290.2010.00022; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hernot S, 2012, J CONTROL RELEASE, V158, P346, DOI 10.1016/j.jconrel.2011.12.007; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Johnson-Neitman JL, 2012, AM J VET RES, V73, P385, DOI 10.2460/ajvr.73.3.385; Klibanov AL, 2007, J NUCL CARDIOL, V14, P876, DOI 10.1016/j.nuclcard.2007.09.008; Li YM, 2013, ACAD RADIOL, V20, P156, DOI 10.1016/j.acra.2012.09.018; Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010; Matsumoto K, 2010, JPN J CLIN ONCOL, V40, P1099, DOI 10.1093/jjco/hyq102; Mhawech-Fauceglia P, 2007, HISTOPATHOLOGY, V50, P472, DOI 10.1111/j.1365-2559.2007.02635.x; Moestue SA, 2012, INT J MOL SCI, V13, P6679, DOI 10.3390/ijms13066679; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Oliveira S, 2013, J CONTROL RELEASE, V172, P607, DOI 10.1016/j.jconrel.2013.08.298; Saerens D, 2004, J BIOL CHEM, V279, P51965, DOI 10.1074/jbc.M409292200; Sanna V, 2011, MOL PHARMACEUT, V8, P748, DOI 10.1021/mp100360g; Schoonooghe S, 2012, IMMUNOBIOLOGY, V217, P1266, DOI 10.1016/j.imbio.2012.07.009; Seitz M, 2011, UROL ONCOL-SEMIN ORI, V29, P295, DOI 10.1016/j.urolonc.2009.03.032; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siontorou CG, 2013, INT J NANOMED, V8, P4215, DOI 10.2147/IJN.S39428; Tardy I, 2010, INVEST RADIOL, V45, P573, DOI 10.1097/RLI.0b013e3181ee8b83; Thurber GM, 2008, TRENDS PHARMACOL SCI, V29, P57, DOI 10.1016/j.tips.2007.11.004; Vaneycken I, 2011, CURR OPIN BIOTECH, V22, P877, DOI 10.1016/j.copbio.2011.06.009; Wang LF, 2013, PROSTATE, V73, P1147, DOI 10.1002/pros.22663; Yin TH, 2012, INT J NANOMED, V7, P895, DOI 10.2147/IJN.S28830; Yossepowitch O, 2008, EUR UROL, V53, P950, DOI 10.1016/j.eururo.2007.10.008	37	85	90	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0127419	10.1371/journal.pone.0127419	http://dx.doi.org/10.1371/journal.pone.0127419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111008	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800007
J	Fournier, AJ; Hogan, JD; Rajbhandari, L; Shrestha, S; Venkatesan, A; Ramesh, KT				Fournier, Adam J.; Hogan, James D.; Rajbhandari, Labchan; Shrestha, Shiva; Venkatesan, Arun; Ramesh, K. T.			Changes in Neurofilament and Microtubule Distribution following Focal Axon Compression	PLOS ONE			English	Article							IN-VITRO; STRETCH-INJURY; BRAIN-INJURY; OPTIC-NERVE; VISUALIZATION; ACCUMULATION; MECHANISMS; CULTURES; TRAUMA; STRAIN	Although a number of cytoskeletal derangements have been described in the setting of traumatic axonal injury (TAI), little is known of early structural changes that may serve to initiate a cascade of further axonal degeneration. Recent work by the authors has examined conformational changes in cytoskeletal constituents of neuronal axons undergoing traumatic axonal injury (TAI) following focal compression through confocal imaging data taken in vitro and in situ. The present study uses electron microscopy to understand and quantify in vitro alterations in the ultrastructural composition of microtubules and neurofilaments within neuronal axons of rats following focal compression. Standard transmission electron microscopy processing methods are used to identify microtubules, while neurofilament identification is performed using antibody labeling through gold nanoparticles. The number, density, and spacing of microtubules and neurofilaments are quantified for specimens in sham Control and Crushed groups with fixation at <1min following load. Our results indicate that the axon caliber dependency known to exist for microtubule and neurofilament metrics extends to axons undergoing TAI, with the exception of neurofilament spacing, which appears to remain constant across all Crushed axon diameters. Confidence interval comparisons between Control and Crushed cytoskeletal measures suggests early changes in the neurofilament spatial distributions within axons undergoing TAI may precede microtubule changes in response to applied loads. This may serve as a trigger for further secondary damage to the axon, representing a key insight into the temporal aspects of cytoskeletal degeneration at the component level, and suggests the rapid removal of neurofilament sidearms as one possible mechanism.	[Fournier, Adam J.; Ramesh, K. T.] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Hogan, James D.] Johns Hopkins Univ, Hopkins Extreme Mat Inst, Baltimore, MD USA; [Rajbhandari, Labchan; Shrestha, Shiva; Venkatesan, Arun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Fournier, AJ (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.	afourni3@jhu.edu	Ramesh, KT/D-5451-2009	Ramesh, KT/0000-0003-2659-4698; Hogan, James/0000-0002-9212-9252; Rajbhandari, Labchan/0000-0002-9252-2580	Hopkins Extreme Materials Institute; US Army	Hopkins Extreme Materials Institute; US Army(United States Department of DefenseUnited States Army)	Funding for this work came from the Hopkins Extreme Materials Institute and the US Army. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aberts B, 2008, MOL BIOL CELL; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chang R, 2009, J MOL BIOL, V391, P648, DOI 10.1016/j.jmb.2009.06.045; Chen XH, 1999, J NEUROPATH EXP NEUR, V58, P588, DOI 10.1097/00005072-199906000-00003; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; de Mey J., 1986, P229; DEMEY J, 1982, P NATL ACAD SCI-BIOL, V79, P1898; DEMEY J, 1981, CELL BIOL INT REP, V5, P889, DOI 10.1016/0309-1651(81)90204-6; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Finkelstein E., 2006, INCIDENCE EC BURDEN, DOI [10.1093/acprof:oso/9780195179484.001.0001, DOI 10.1093/ACPROF:OSO/9780195179484.001.0001]; Fournier AJ, 2014, FASEB J, V28, P5277, DOI 10.1096/fj.14-251942; Franck C, 2007, EXP MECH, V47, P427, DOI 10.1007/s11340-007-9037-9; Gennarelli T. A., 1993, HEAD INJURY, V2, P108; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Hermann R, 1996, HISTOCHEM CELL BIOL, V106, P31; Hosmane S, 2011, LAB CHIP, V11, P3888, DOI 10.1039/c1lc20549h; Jafari SS, 1998, J NEUROTRAUM, V15, P955, DOI 10.1089/neu.1998.15.955; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Koike T, 2008, NEUROCHEM INT, V52, P751, DOI 10.1016/j.neuint.2007.09.007; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Mukhopadhyay R, 2004, BIOESSAYS, V26, P1017, DOI 10.1002/bies.20088; NIXON RA, 1994, J CELL BIOL, V126, P1031, DOI 10.1083/jcb.126.4.1031; Ouyang H, 2010, MICR UGIM 2010 18 BI, P1; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Taber KH, 2007, J NEUROPSYCH CLIN N, V19, P100; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844	45	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131617	10.1371/journal.pone.0131617	http://dx.doi.org/10.1371/journal.pone.0131617			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111004	gold, Green Submitted, Green Published			2022-12-27	WOS:000356933800163
J	Kowalski, R; Baj, T; Kowalska, G; Pankiewicz, U				Kowalski, Radoslaw; Baj, Tomasz; Kowalska, Grazyna; Pankiewicz, Urszula			Estimation of Potential Availability of Essential Oil in Some Brands of Herbal Teas and Herbal Dietary Supplements	PLOS ONE			English	Article							MENTHA-PIPERITA L.; CHROMATOGRAPHY	Introduction The aim of the study was to estimate potential availability of essential oil in some brands of herbal products. Methods A comparison was performed on the basis of the essential oil yield in the unprocessed raw materials such as leaves of peppermint and lemon balm and inflorescence of chamomile as well as herbal tea bags and in dietary supplements. The yield of essential oil was determined by distillation. Essential oil was analyzed by GC-FID and GC-MS. Results It was found that the average potential availability of essential oils in the products such as dietary supplements for the doses recommended by the producers is lower than in the corresponding tea infusions: for peppermint formulations approximately 6-fold lower, for the formulations with lemon balm about 4-fold lower, and for the chamomile preparations about 3-fold lower. It was found that essential oils extracted from herbal teas have a similar chemical profile with characteristic deviations in the amount of individual components, which arise from the origin of the raw material. Discussion In contrast to homogenous pharmaceutical herbal mixtures consistent with, the Pharmacopoeia requirements, herbal teas (available in grocery stores) and dietary supplements are often out of control in terms of the yield and composition of the essential oil, which is primarily responsible for the health benefits and aromatic qualities of these products. Analysis of the composition of the dietary supplements showed that they contain on average significantly lower amounts of plant material compared to the herbal teas.	[Kowalski, Radoslaw; Pankiewicz, Urszula] Univ Life Sci Lublin, Dept Anal & Evaluat Food Qual, Lublin, Poland; [Kowalski, Radoslaw] Polish Acad Sci, Inst Agrophys, PL-20236 Lublin, Poland; [Baj, Tomasz] Med Univ Lublin, Dept Pharmacognosy Med Plant Unit, Lublin, Poland; [Kowalska, Grazyna] Univ Life Sci Lublin, Cent Lab Agroecol, Lublin, Poland	University of Life Sciences in Lublin; Polish Academy of Sciences; Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences; Medical University of Lublin; University of Life Sciences in Lublin	Kowalski, R (corresponding author), Univ Life Sci Lublin, Dept Anal & Evaluat Food Qual, Lublin, Poland.	radoslaw.kowalski@up.lublin.pl	Kowalski, Radosław/AAB-1166-2019; Baj, Tomasz/S-8374-2018; Baj, Tomasz/M-5642-2019; Kowalska, Grażyna/U-6025-2018	Kowalski, Radosław/0000-0003-3063-8710; Baj, Tomasz/0000-0001-7543-6771; Kowalska, Grażyna/0000-0002-1872-2381; Pankiewicz, Urszula/0000-0003-1477-5598				Adams R.P., 2004, IDENTIFICATION ESSEN, V3rd ed.; [Anonymous], 2003, ESCOP MON EUR SCI CO, P337; [Anonymous], 2008, POL PHARM, VVIII; [Anonymous], 2002, POL PHARM, VVI; [Anonymous], 1990, LIST GERMAN COMMISSI; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Basta A, 2005, FLAVOUR FRAG J, V20, P642, DOI 10.1002/ffj.1518; Chawla S, 2013, INT J PHARM RES DEV, V5, P73; Corby-Edwards AK, 2013, REGULATION DIETARY S, P1; ESCOP, 2003, ESCOP MON, P324; ESCOP Monographs, 2003, ESCOP MON, P312; Euromonitor International, 2010, VIT DIET SUPPL; Evaluation of Medicines for Human Use. Committee on Herbal Medicinal Products (HMPC), 2008, COMM HERB MON MENTH; Gora J., 2005, MOST VALUABLE ESSENT; Heuskin S, 2009, J CHROMATOGR A, V1216, P2768, DOI 10.1016/j.chroma.2008.09.109; HMPC, 2007, COMM HERB MON MEL OF; Joulain D., 1998, ATLAS SPECTRAL DATA; Konieczka P, 2009, ANAL CHEM SER, P1; Kowalski R, 2009, FLAVOUR FRAG J, V24, P31, DOI 10.1002/ffj.1914; Krasnowska G, 2011, ZYWN-NAUK TECHNOL JA, V18, P5; Mckay DL, 2006, PHYTOTHER RES, V20, P619, DOI 10.1002/ptr.1936; NIST/EPA, 2005, MASS SPECTR LIB SEAR; Orzeszko-Rywka A., 2011, Journal of Research and Applications in Agricultural Engineering, V56, P52; Patora Jolanta, 2003, Acta Pol Pharm, V60, P395; Raut JS, 2014, IND CROP PROD, V62, P250, DOI 10.1016/j.indcrop.2014.05.055; REVERCHON E, 1994, J AGR FOOD CHEM, V42, P154, DOI 10.1021/jf00037a027; Reyes-Jurado F, 2015, FOOD ENG REV, V7, P275, DOI 10.1007/s12393-014-9099-2; Strzelecka H., 2000, ENCY HERBALISM HERBA; U.S. Government Accountability Office, 2009, GAO09250; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X	30	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130714	10.1371/journal.pone.0130714	http://dx.doi.org/10.1371/journal.pone.0130714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110869	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800076
J	Nicoletti, P; Bansal, M; Lefebvre, C; Guarnieri, P; Shen, YF; Pe'er, I; Califano, A; Floratos, A				Nicoletti, Paola; Bansal, Mukesh; Lefebvre, Celine; Guarnieri, Paolo; Shen, Yufeng; Pe'er, Itsik; Califano, Andrea; Floratos, Aris			ABC Transporters and the Proteasome Complex Are Implicated in Susceptibility to Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis across Multiple Drugs	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; HYPERSENSITIVITY REACTIONS; GENE; IDENTIFICATION; ASSOCIATION; EXPRESSION; MARKER; DEATH	Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) represent rare but serious adverse drug reactions (ADRs). Both are characterized by distinctive blistering lesions and significant mortality rates. While there is evidence for strong drug-specific genetic predisposition related to HLA alleles, recent genome wide association studies (GWAS) on European and Asian populations have failed to identify genetic susceptibility alleles that are common across multiple drugs. We hypothesize that this is a consequence of the low to moderate effect size of individual genetic risk factors. To test this hypothesis we developed Pointer, a new algorithm that assesses the aggregate effect of multiple low risk variants on a pathway using a gene set enrichment approach. A key advantage of our method is the capability to associate SNPs with genes by exploiting physical proximity as well as by using expression quantitative trait loci (eQTLs) that capture information about both cis- and trans-acting regulatory effects. We control for known bias-inducing aspects of enrichment based analyses, such as: 1) gene length, 2) gene set size, 3) presence of biologically related genes within the same linkage disequilibrium (LD) region, and, 4) genes shared among multiple gene sets. We applied this approach to publicly available SJS/TEN genome-wide genotype data and identified the ABC transporter and Proteasome pathways as potentially implicated in the genetic susceptibility of non-drug-specific SJS/TEN. We demonstrated that the innovative SNP-to-gene mapping phase of the method was essential in detecting the significant enrichment for those pathways. Analysis of an independent gene expression dataset provides supportive functional evidence for the involvement of Proteasome pathways in SJS/TEN cutaneous lesions. These results suggest that Pointer provides a useful framework for the integrative analysis of pharmacogenetic GWAS data, by increasing the power to detect aggregate effects of multiple low risk variants. The software is available for download at https://sourceforge.net/projects/pointergsa/.	[Nicoletti, Paola; Bansal, Mukesh; Lefebvre, Celine; Guarnieri, Paolo; Shen, Yufeng; Pe'er, Itsik; Califano, Andrea; Floratos, Aris] Columbia Univ, Dept Syst Biol, New York, NY 10027 USA; [Lefebvre, Celine] Inst Gustave Roussy, INSERM, F-94805 Villejuif, France; [Guarnieri, Paolo; Califano, Andrea] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Shen, Yufeng; Califano, Andrea] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Shen, Yufeng] Columbia Univ, JP Sulzberger Columbia Genome Ctr, New York, NY USA; [Pe'er, Itsik] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Califano, Andrea] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA	Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Califano, A (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY 10027 USA.	ac2248@cumc.columbia.edu; af2202@cumc.columbia.edu	Lefebvre, Celine/E-6290-2013	Califano, Andrea/0000-0003-4742-3679	international Serious Adverse Events Consortium (iSAEC); NIH Roadmap Initiative grant [U54CA121852]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012351] Funding Source: NIH RePORTER	international Serious Adverse Events Consortium (iSAEC); NIH Roadmap Initiative grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the international Serious Adverse Events Consortium (iSAEC, http://www.saeconsortium.org/) and by the NIH Roadmap Initiative grant U54CA121852.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellon T, 2010, BRIT J DERMATOL, V162, P1014, DOI 10.1111/j.1365-2133.2009.09627.x; Bernassola F, 2010, CELL DEATH DIFFER, V17, P1, DOI 10.1038/cdd.2009.189; Chung WH, 2008, NAT MED, V14, P1343, DOI 10.1038/nm.1884; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Fujita P. A., 2010, NUCL ACIDS RES; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Hong MG, 2009, HUM GENET, V126, P289, DOI 10.1007/s00439-009-0676-z; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hung SL, 2006, PHARMACOGENET GENOM, V16, P297, DOI 10.1097/01.fpc.0000199500.46842.4a; Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102; Kaminski WE, 2006, BBA-MOL BASIS DIS, V1762, P510, DOI 10.1016/j.bbadis.2006.01.011; Kraft P, 2009, EPIDEMIOLOGY, V20, P508, DOI 10.1097/EDE.0b013e3181a93b98; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Lonjou C, 2008, PHARMACOGENET GENOM, V18, P99, DOI 10.1097/FPC.0b013e3282f3ef9c; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Okada Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002067; Park BE, 1998, CHEM RES TOXICOL, V11, P969, DOI 10.1021/tx980058f; Reiner AP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002108; ROUJEAU JC, 1990, ARCH DERMATOL, V126, P37, DOI 10.1001/archderm.126.1.37; ROUJEAU JC, 1994, NEW ENGL J MED, V331, P1272, DOI 10.1056/NEJM199411103311906; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Shen LJ, 2007, BLOOD, V110, P469, DOI 10.1182/blood-2007-02-072900; Shen Y, 2011, PHARMACOGENOMICS J; Sijts EJAM, 2011, CELL MOL LIFE SCI, V68, P1491, DOI 10.1007/s00018-011-0657-y; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ueta M, 2007, AM J OPHTHALMOL, V143, P367, DOI 10.1016/j.ajo.2006.09.029; Uitto J, 2005, TRENDS MOL MED, V11, P341, DOI 10.1016/j.molmed.2005.06.004; van Deventer S, 2010, CELL, V142, P517, DOI 10.1016/j.cell.2010.08.002; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Wang X, 1998, J IMMUNOL, V160, P788; Witko-Sarsat V, 2011, TRENDS IMMUNOL, V32, P117, DOI 10.1016/j.it.2011.01.001; Wu CL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000070; Yanaba K, 2010, J LEUKOCYTE BIOL, V88, P117, DOI 10.1189/jlb.1009666; Yewdell JW, 2005, P NATL ACAD SCI USA, V102, P9089, DOI 10.1073/pnas.0504018102; Zhang KL, 2010, NUCLEIC ACIDS RES, V38, pW90, DOI 10.1093/nar/gkq324; Zhong H, 2010, AM J HUM GENET, V86, P581, DOI 10.1016/j.ajhg.2010.02.020	41	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131038	10.1371/journal.pone.0131038	http://dx.doi.org/10.1371/journal.pone.0131038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110827	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800112
J	Sekiguchi, T; Umemura, T; Fujimori, N; Shibata, S; Ichikawa, Y; Kimura, T; Joshita, S; Komatsu, M; Matsumoto, A; Tanaka, E; Ota, M				Sekiguchi, Tomohiro; Umemura, Takeji; Fujimori, Naoyuki; Shibata, Soichiro; Ichikawa, Yuki; Kimura, Takefumi; Joshita, Satoru; Komatsu, Michiharu; Matsumoto, Akihiro; Tanaka, Eiji; Ota, Masao			Serum Cell Death Biomarkers for Prediction of Liver Fibrosis and Poor Prognosis in Primary Biliary Cirrhosis	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; NONALCOHOLIC STEATOHEPATITIS; NONINVASIVE BIOMARKER; CASPASE ACTIVATION; VIRUS-INFECTION; CYTOKERATIN 18; APOPTOSIS; BIOPSY; FAILURE; DISEASE	The development of simple, noninvasive markers of liver fibrosis is urgently needed for primary biliary cirrhosis (PBC). This study examined the ability of several serum biomarkers of cell death to estimate fibrosis and prognosis in PBC. A cohort of 130 patients with biopsyproven PBC and 90 healthy subjects were enrolled. We assessed the utility of the M30 ELISA, which detects caspase-cleaved cytokeratin-18 (CK-18) fragments and is representative of apoptotic cell death, as well as the M65 and newly developed M65 Epideath (M65ED) ELISAs, which detect total CK-18 as indicators of overall cell death, in predicting clinically relevant fibrosis stage. All 3 cell death biomarkers were significantly higher in patients with PBC than in healthy controls and were significantly correlated with fibrosis stage. The areas under the receiver operating characteristic curve for the M65 and M65ED assays for differentiation among significant fibrosis, severe fibrosis, and cirrhosis were 0.66 and 0.76, 0.66 and 0.73, and 0.74 and 0.82, respectively. In multivariate analysis, high M65ED (hazard ratio 6.13; 95% confidence interval 1.18-31.69; P = 0.031) and severe fibrosis (hazard ratio 7.45; 95% confidence interval 1.82-30.51; P = 0.005) were independently associated with liver-related death, transplantation, or decompensation. High serum M65ED was also significantly associated with poor outcome in PBC (log-rank test; P = 0.001). Noninvasive cell death biomarkers appear to be clinically useful in predicting fibrosis in PBC. Moreover, the M65ED assay may represent a new surrogate marker of adverse disease outcome.	[Sekiguchi, Tomohiro; Umemura, Takeji; Fujimori, Naoyuki; Shibata, Soichiro; Ichikawa, Yuki; Kimura, Takefumi; Joshita, Satoru; Komatsu, Michiharu; Matsumoto, Akihiro; Tanaka, Eiji] Shinshu Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Matsumoto, Nagano 390, Japan; [Ota, Masao] Shinshu Univ Hosp, Dept Legal Med, Matsumoto, Nagano, Japan	Shinshu University; Shinshu University	Umemura, T (corresponding author), Shinshu Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Matsumoto, Nagano 390, Japan.	tumemura@shinshu-u.ac.jp	Joshita, Satoru/K-5679-2019	Joshita, Satoru/0000-0002-6364-9654; Ota, Masao/0000-0002-6400-5658	Ministry of Education, Science, Sports, and Culture of Japan [26460996]; Grants-in-Aid for Scientific Research [15H01803, 26460996] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan (26460996). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afford SC, 2001, FASEB J, V15, P2345, DOI 10.1096/fj.01-0088com; Bantel H, 2004, HEPATOLOGY, V40, P1078, DOI 10.1002/hep.20411; Bechmann LP, 2010, J HEPATOL, V53, P639, DOI 10.1016/j.jhep.2010.04.029; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Cadranel JF, 2000, HEPATOLOGY, V32, P477, DOI 10.1053/jhep.2000.16602; De Petris L, 2011, EUR J CANCER, V47, P131, DOI 10.1016/j.ejca.2010.08.006; Denk G, 2014, HEPATOL RES; Diab DL, 2008, CLIN GASTROENTEROL H, V6, P1249, DOI 10.1016/j.cgh.2008.07.016; Eguchi A, 2014, J HEPATOL, V60, P1063, DOI 10.1016/j.jhep.2013.12.026; Feldstein AE, 2009, HEPATOLOGY, V50, P1072, DOI 10.1002/hep.23050; Francque SMA, 2012, CLIN GASTROENTEROL H, V10, P1162, DOI 10.1016/j.cgh.2012.06.019; Garrido MC, 1996, J CLIN PATHOL, V49, P556, DOI 10.1136/jcp.49.7.556; Harada K, 1997, HEPATOLOGY, V26, P1399; Hirschfield GM, 2010, GASTROENTEROLOGY, V139, P1481, DOI 10.1053/j.gastro.2010.09.004; Joka D, 2012, HEPATOLOGY, V55, P455, DOI 10.1002/hep.24734; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Koehler E, 2012, LIVER INT, V32, P279, DOI 10.1111/j.1478-3231.2011.02637.x; Koga H, 1997, HEPATOLOGY, V25, P1077, DOI 10.1002/hep.510250505; Li XH, 2010, HEPATOLOGY, V51, P1865, DOI 10.1002/hep.23433; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Luedde T, 2014, GASTROENTEROLOGY, V147, P765, DOI 10.1053/j.gastro.2014.07.018; Mehal W, 2010, SEMIN LIVER DIS, V30, P226, DOI 10.1055/s-0030-1255352; Odin JA, 2001, J CLIN INVEST, V108, P223, DOI 10.1172/JCI200110716; Papatheodoridis GV, 2008, GUT, V57, P500, DOI 10.1136/gut.2007.123943; Rutherford AE, 2007, CLIN GASTROENTEROL H, V5, P1477, DOI 10.1016/j.cgh.2007.08.007; Seidel N, 2005, HEPATOLOGY, V42, P113, DOI 10.1002/hep.20747; Tsutsui M, 2010, J CLIN GASTROENTEROL, V44, P440, DOI 10.1097/MCG.0b013e3181bdefe2; Umemura T, 2015, AM J GASTROENTEROL; Umemura T, 2007, HEPATOLOGY, V46, P463, DOI 10.1002/hep.21700; Umemura T, 2012, HEPATOLOGY, V55, P506, DOI 10.1002/hep.24705; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Volkmann X, 2008, HEPATOLOGY, V47, P1624, DOI 10.1002/hep.22237; Waidmann O, 2013, J HEPATOL, V59, P769, DOI 10.1016/j.jhep.2013.06.008; Younossi ZM, 2008, OBES SURG, V18, P1430, DOI 10.1007/s11695-008-9506-y	35	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131658	10.1371/journal.pone.0131658	http://dx.doi.org/10.1371/journal.pone.0131658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110613	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800168
J	Yamashita, S; Masuya, H; Abe, S; Masaki, T; Okabe, K				Yamashita, Satoshi; Masuya, Hayato; Abe, Shin; Masaki, Takashi; Okabe, Kimiko			Relationship between the Decomposition Process of Coarse Woody Debris and Fungal Community Structure as Detected by High-Throughput Sequencing in a Deciduous Broad-Leaved Forest in Japan	PLOS ONE			English	Article							FAGUS-SYLVATICA; WHITE-ROT; BROWN-ROT; DIVERSITY; DYNAMICS; DECAY; LOGS; BIODIVERSITY; MACROFUNGI; SUBSTRATE	We examined the relationship between the community structure of wood-decaying fungi, detected by high-throughput sequencing, and the decomposition rate using 13 years of data from a forest dynamics plot. For molecular analysis and wood density measurements, drill dust samples were collected from logs and stumps of Fagus and Quercus in the plot. Regression using a negative exponential model between wood density and time since death revealed that the decomposition rate of Fagus was greater than that of Quercus. The residual between the expected value obtained from the regression curve and the observed wood density was used as a decomposition rate index. Principal component analysis showed that the fungal community compositions of both Fagus and Quercus changed with time since death. Principal component analysis axis scores were used as an index of fungal community composition. A structural equation model for each wood genus was used to assess the effect of fungal community structure traits on the decomposition rate and how the fungal community structure was determined by the traits of coarse woody debris. Results of the structural equation model suggested that the decomposition rate of Fagus was affected by two fungal community composition components: one that was affected by time since death and another that was not affected by the traits of coarse woody debris. In contrast, the decomposition rate of Quercus was not affected by coarse woody debris traits or fungal community structure. These findings suggest that, in the case of Fagus coarse woody debris, the fungal community structure is related to the decomposition process of its host substrate. Because fungal community structure is affected partly by the decay stage and wood density of its substrate, these factors influence each other. Further research on interactive effects is needed to improve our understanding of the relationship between fungal community structure and the woody debris decomposition process.	[Yamashita, Satoshi; Abe, Shin; Masaki, Takashi; Okabe, Kimiko] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 305, Japan; [Masuya, Hayato] Forestry & Forest Prod Res Inst, Tohoku Res Ctr, Morioka, Iwate, Japan	Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan	Yamashita, S (corresponding author), Univ Tokushima, Dept Biosci & Bioind, Tokushima 770, Japan.	symsht@tokushima-u.ac.jp	Masuya, Hayato/AAN-8998-2021		Japan Environment Agency; Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [S9]	Japan Environment Agency; Environment Research and Technology Development Fund of the Ministry of the Environment, Japan(Ministry of the Environment, Japan)	This study was financially supported by the Japan Environment Agency, and the Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan (http://www.env.go.jp/policy/kenkyu/suishin/english/gaiyou/index.html) to KO.	Allmer J, 2006, FEMS MICROBIOL ECOL, V55, P57, DOI 10.1111/j.1574-6941.2005.00010.x; [Anonymous], 2015, PC ORD MULTIVARIATE; Boddy L, 2000, FEMS MICROBIOL ECOL, V31, P185, DOI 10.1111/j.1574-6941.2000.tb00683.x; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cebrian J, 1999, AM NAT, V154, P449, DOI 10.1086/303244; Clissmann F, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv050; Dang CK, 2005, ECOL LETT, V8, P1129, DOI 10.1111/j.1461-0248.2005.00815.x; Dickie IA, 2012, ECOL LETT, V15, P133, DOI 10.1111/j.1461-0248.2011.01722.x; Fukami T, 2010, ECOL LETT, V13, P675, DOI 10.1111/j.1461-0248.2010.01465.x; Fukasawa Y, 2009, J FOREST RES-JPN, V14, P20, DOI 10.1007/s10310-008-0098-0; Fukasawa Y, 2015, FUNGAL ECOL, V14, P44, DOI 10.1016/j.funeco.2014.11.003; Fukasawa Y, 2012, ECOL RES, V27, P211, DOI 10.1007/s11284-011-0890-8; Fukasawa Y, 2011, MYCOLOGIA, V103, P474, DOI 10.3852/10-246; Fukasawa Y, 2009, CAN J FOREST RES, V39, P1606, DOI 10.1139/X09-080; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Heilmann-Clausen J, 2005, MICROB ECOL, V49, P399, DOI 10.1007/s00248-004-0240-2; Heilmann-Clausen J, 2005, BIOL CONSERV, V122, P633, DOI 10.1016/j.biocon.2004.10.001; Heilmann-Clausen J, 2001, MYCOL RES, V105, P575, DOI 10.1017/S0953756201003665; Hoppe B, 2015, SCI REP-UK, V5, DOI 10.1038/srep09456; Hoppe B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088141; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Jumpponen A, 2010, MOL ECOL, V19, P41, DOI 10.1111/j.1365-294X.2009.04483.x; Kadowaki K, 2014, POPUL ECOL, V56, P301, DOI 10.1007/s10144-013-0424-z; KIRK TK, 1973, PHYTOPATHOLOGY, V63, P1338, DOI 10.1094/Phyto-63-1338; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Kuffer N, 2008, FUNGAL DIVERS, V30, P83; Li Zhou, 2007, Journal of Forestry Research (Harbin), V18, P48, DOI 10.1007/s11676-007-0009-9; MASAKI T, 1992, VEGETATIO, V98, P97, DOI 10.1007/BF00045549; Mizoguchi Y, 2002, ECOL STU AN, V158, P11; Muller-Using S, 2009, EUR J FOREST RES, V128, P287, DOI 10.1007/s10342-009-0264-8; Ostrofsky A, 1997, CAN J FOREST RES, V27, P567, DOI 10.1139/cjfr-27-4-567; Ovaskainen O, 2013, ISME J, V7, P1696, DOI 10.1038/ismej.2013.61; Peay KG, 2013, OIKOS, V122, P258, DOI 10.1111/j.1600-0706.2012.20813.x; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; Rajala T, 2012, FEMS MICROBIOL ECOL, V81, P494, DOI 10.1111/j.1574-6941.2012.01376.x; Rajala T, 2010, CAN J FOREST RES, V40, P2384, DOI 10.1139/X10-176; Rock J, 2008, EUR J FOREST RES, V127, P301, DOI 10.1007/s10342-008-0206-x; Schowalter TD, 1998, ECOGRAPHY, V21, P3, DOI 10.1111/j.1600-0587.1998.tb00388.x; Setala H, 2004, OECOLOGIA, V139, P98, DOI 10.1007/s00442-003-1478-y; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Stokland J.N., 2012, BIODIVERSITY DEAD WO; Suzuki W, 2002, ECOL STU AN, V158, P27; Toju H, 2013, ECOL EVOL, V3, P3112, DOI 10.1002/ece3.706; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Ushio M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080320; Yamashita S, 2010, MYCOLOGIA, V102, P11, DOI 10.3852/09-008; Yamashita S, 2009, MYCOL RES, V113, P1200, DOI 10.1016/j.mycres.2009.08.004; Zielonka T, 2006, J VEG SCI, V17, P739, DOI 10.1111/j.1654-1103.2006.tb02497.x	53	13	14	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131510	10.1371/journal.pone.0131510	http://dx.doi.org/10.1371/journal.pone.0131510			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110605	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800156
J	Diarra, M; Fall, M; Lancelot, R; Diop, A; Fall, AG; Dicko, A; Seck, MT; Garros, C; Allene, X; Rakotoarivony, I; Bakhoum, MT; Bouyer, J; Guis, H				Diarra, Maryam; Fall, Moussa; Lancelot, Renaud; Diop, Aliou; Fall, Assane G.; Dicko, Ahmadou; Seck, Momar Talla; Garros, Claire; Allene, Xavier; Rakotoarivony, Ignace; Bakhoum, Mame Thierno; Bouyer, Jeremy; Guis, Helene			Modelling the Abundances of Two Major Culicoides (Diptera: Ceratopogonidae) Species in the Niayes Area of Senegal	PLOS ONE			English	Article							AFRICAN HORSE SICKNESS; BREVITARSIS KIEFFER DIPTERA; LIFE-HISTORY PARAMETERS; BITING-MIDGES; SEASONAL ABUNDANCE; POISSON REGRESSION; SATELLITE IMAGERY; BLUETONGUE VIRUS; OVERDISPERSED POISSON; VARIIPENNIS DIPTERA	In Senegal, considerable mortality in the equine population and hence major economic losses were caused by the African horse sickness (AHS) epizootic in 2007. Culicoides oxystoma and Culicoides imicola, known or suspected of being vectors of bluetongue and AHS viruses are two predominant species in the vicinity of horses and are present all year-round in Niayes area, Senegal. The aim of this study was to better understand the environmental and climatic drivers of the dynamics of these two species. Culicoides collections were obtained using OVI (Onderstepoort Veterinary Institute) light traps at each of the 5 sites for three nights of consecutive collection per month over one year. Cross Correlation Map analysis was performed to determine the time-lags for which environmental variables and abundance data were the most correlated. C. oxystoma and C. imicola count data were highly variable and overdispersed. Despite modelling large Culicoides counts (over 220,000 Culicoides captured in 354 night-traps), using on-site climate measures, overdispersion persisted in Poisson, negative binomial, Poisson regression mixed-effect with random effect at the site of capture models. The only model able to take into account overdispersion was the Poisson regression mixed-effect model with nested random effects at the site and date of capture levels. According to this model, meteorological variables that contribute to explaining the dynamics of C. oxystoma and C. imicola abundances were: mean temperature and relative humidity of the capture day, mean humidity between 21 and 19 days prior a capture event, density of ruminants, percentage cover of water bodies within a 2 km radius and interaction between temperature and humidity for C. oxystoma; mean rainfall and NDVI of the capture day and percentage cover of water bodies for C. imicola. Other variables such as soil moisture, wind speed, degree days, land cover or landscape metrics could be tested to improve the models. Further work should also assess whether other trapping methods such as host-baited traps help reduce overdispersion.	[Diarra, Maryam; Fall, Moussa; Fall, Assane G.; Dicko, Ahmadou; Seck, Momar Talla; Bakhoum, Mame Thierno; Bouyer, Jeremy] Inst Senegalais Rech Agr, Lab Natl Elevage & Rech Vet, Dakar, Senegal; [Diarra, Maryam; Diop, Aliou] Univ Gaston Berger, Lab Etudes & Rech Stat & Dev, St Louis, Senegal; [Lancelot, Renaud; Garros, Claire; Allene, Xavier; Rakotoarivony, Ignace; Bouyer, Jeremy; Guis, Helene] Cirad, UMR15, CMAEE, F-34398 Montpellier, France; [Lancelot, Renaud; Garros, Claire; Allene, Xavier; Rakotoarivony, Ignace; Bouyer, Jeremy; Guis, Helene] INRA, UMR1309, CMAEE, F-34398 Montpellier, France	CIRAD; INRAE	Diarra, M (corresponding author), Inst Senegalais Rech Agr, Lab Natl Elevage & Rech Vet, Dakar, Senegal.	myriem85@yahoo.fr	Lancelot, Renaud/HGE-1086-2022; Bouyer, Jérémy/AAK-7370-2020; Garros, Claire/C-2715-2011; Dicko, Ahmadou Hamady/O-7998-2014	Lancelot, Renaud/0000-0002-5826-5242; Bouyer, Jérémy/0000-0002-1913-416X; Dicko, Ahmadou Hamady/0000-0002-9654-7582; Guis, Helene/0000-0002-0355-0898; Diarra, Maryam/0000-0001-9110-4435; Bakhoum, Mame Thierno/0000-0001-6794-4426; DIOP, Aliou/0000-0002-0808-5622	EU FP7-HEALTH (European Framework Programme 7 under the Health component)-single-stage grant EDENext (Emerging Disease in a changing European eNvironment) [261504]	EU FP7-HEALTH (European Framework Programme 7 under the Health component)-single-stage grant EDENext (Emerging Disease in a changing European eNvironment)	This study was funded partly by the EU FP7-HEALTH (European Framework Programme 7 under the Health component)-2010-single-stage grant 261504 EDENext (Emerging Disease in a changing European eNvironment) and is catalogued by the EDENext Steering Committee as EDENext323 (http://www.edenext.eu).	Acevedo P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014236; Akakpo AJ, 2011, B ANIM HLTH PROF AFR, V59, P1; Allain E, 2001, RECHERCHE TRANSPORTS, V72, P3; Bakhoum MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084316; Baylis M, 1998, MED VET ENTOMOL, V12, P255, DOI 10.1046/j.1365-2915.1998.00109.x; Baylis M, 1998, ARCH VIROL, P137; Baylis M, 2010, MED VET ENTOMOL, V24, P38, DOI 10.1111/j.1365-2915.2009.00842.x; Baylis M, 1997, MED VET ENTOMOL, V11, P203, DOI 10.1111/j.1365-2915.1997.tb00397.x; Baylis M, 1999, J S AFR VET ASSOC, V70, P80; Baylis M, 2001, VET REC, V149, P639, DOI 10.1136/vr.149.21.639; Bishop AL, 2000, AUST J ENTOMOL, V39, P29, DOI 10.1046/j.1440-6055.2000.00144.x; Blackwell A, 1997, MED VET ENTOMOL, V11, P361, DOI 10.1111/j.1365-2915.1997.tb00423.x; BOORMAN J, 1970, B ENTOMOL RES, V60, P189, DOI 10.1017/S0007485300058624; Borkent A, 2014, SUBGENERIC CLASSIFIC; Borkent A, WORLD SPECIES BITING; Bouche G, 2009, REV EPIDEMIOL SANTE, V57, P285, DOI 10.1016/j.respe.2009.02.209; BRAVERMAN Y, 1978, ECOL ENTOMOL, V3, P163, DOI 10.1111/j.1365-2311.1978.tb00915.x; BRESLOW N, 1990, J AM STAT ASSOC, V85, P565, DOI 10.2307/2289799; Brugger K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060330; Calvete C, 2008, MED VET ENTOMOL, V22, P124, DOI 10.1111/j.1365-2915.2008.00728.x; Calvete C, 2009, VET J, V182, P235, DOI 10.1016/j.tvjl.2008.06.010; Carpenter S, 2006, PHYSIOL ENTOMOL, V31, P89, DOI 10.1111/j.1365-3032.2005.00478.x; Conte A, 2007, VET PARASITOL, V150, P333, DOI 10.1016/j.vetpar.2007.09.021; Conte A, 2003, J VET MED B, V50, P139, DOI 10.1046/j.1439-0450.2003.00632.x; Conte Annamaria, 2007, Vet Ital, V43, P571; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Curriero FC, 2005, VECTOR-BORNE ZOONOT, V5, P267, DOI 10.1089/vbz.2005.5.267; DAVIS EL, 1983, J MED ENTOMOL, V20, P177, DOI 10.1093/jmedent/20.2.177; De Liberato C, 2010, J MED ENTOMOL, V47, P313, DOI 10.1603/ME09148; DEAN C, 1989, J AM STAT ASSOC, V84, P467, DOI 10.2307/2289931; Diarra M, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-147; Diouf ND, 2013, VET REC, V172, P152, DOI 10.1136/vr.101083; Ducheyne E, 2013, GEOSPATIAL HEALTH, V8, P241, DOI 10.4081/gh.2013.70; Elston DA, 2001, PARASITOLOGY, V122, P563, DOI 10.1017/S0031182001007740; Fall M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0624-1; Foxi C, 2010, MED VET ENTOMOL, V24, P199, DOI 10.1111/j.1365-2915.2010.00861.x; Garcia-Saenz A, 2011, MED VET ENTOMOL, V25, P113, DOI 10.1111/j.1365-2915.2010.00904.x; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Golyandina N., 2013, SINGULAR SPECTRUM AN; Golyandina N, 2013, ARXIV13095050V1STATM; Guis H, 2007, THESIS U FRANCHE COM, P392; Guis H, 2007, VET RES, V38, P669, DOI 10.1051/vetres:2007025; Guis H, 2012, J R SOC INTERFACE, V9, P339, DOI 10.1098/rsif.2011.0255; Harrison XA, 2014, PEERJ, V2, DOI 10.7717/peerj.616; Hartemink NA, 2009, EPIDEMICS-NETH, V1, P153, DOI 10.1016/j.epidem.2009.05.004; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Ippoliti C, 2013, GEOSPATIAL HEALTH, V8, P267, DOI 10.4081/gh.2013.72; Kirkeby C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-43; Kluiters G, 2013, J APPL ECOL, V50, P232, DOI 10.1111/1365-2664.12030; Kondrashov D, 2006, NONLINEAR PROC GEOPH, V13, P151, DOI 10.5194/npg-13-151-2006; Lebl K, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-129; Lysyk TJ, 2007, J MED ENTOMOL, V44, P741, DOI 10.1603/0022-2585(2007)44[741:EOTOLH]2.0.CO;2; McCullagh P, 1989, MONOGRAPHS STAT APPL, V37, P1, DOI DOI 10.1007/978-1-4899-3242-6; Meiswinkel R., 2004, Infectious diseases of livestock, Volume One, P93; Meiswinkel R, 2004, VETER ITAL SER, V40, P151; Mellor PS, 2009, BIOL ANIM INFECT, P295, DOI 10.1016/B978-012369368-6.50018-6; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mellor PS, 2004, VET RES, V35, P445, DOI 10.1051/vetres:2004021; MULLENS BA, 1983, ANN ENTOMOL SOC AM, V76, P747, DOI 10.1093/aesa/76.4.747; MURRAY MD, 1975, AUST VET J, V51, P216, DOI 10.1111/j.1751-0813.1975.tb00060.x; MURRAY MD, 1991, AUST J ZOOL, V39, P333, DOI 10.1071/ZO9910333; Nevill EM, 1967, THESIS U PRETORIA; Ortega MD, 1999, J AM MOSQUITO CONTR, V15, P391; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Peters J, 2014, ECOHYDROLOGY, V7, P622, DOI 10.1002/eco.1383; Poddar T.K., 1992, Annals of Entomology (Dehra Dun), V10, P19; Purse BV, 2015, ANNU REV ENTOMOL, V60, P373, DOI 10.1146/annurev-ento-010814-020614; Purse BV, 2011, MED VET ENTOMOL; R Core Team, 2012, R LANG ENV STAT COMP; RAO PVN, 1993, INT J REMOTE SENS, V14, P441, DOI 10.1080/01431169308904349; RAY S, 1988, INSECT SCI APPL, V9, P329, DOI 10.1017/S1742758400006287; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Rigot T, 2012, PARASITE VECTOR, V5, P1, DOI 10.1186/1756-3305-5-270; Roger FL, 2002, THESIS U LONDON; ROGERS DJ, 1991, NATURE, V351, P739, DOI 10.1038/351739a0; Searle KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111876; Shone SM, 2006, J MED ENTOMOL, V43, P393, DOI 10.1603/0022-2585(2006)043[0393:CPDOAS]2.0.CO;2; Tassi P, 2004, METHODES STAT; Tatem AJ, 2003, VET MICROBIOL, V97, P13, DOI 10.1016/j.vetmic.2003.08.009; TUCKER CJ, 1985, REMOTE SENS ENVIRON, V17, P233, DOI 10.1016/0034-4257(85)90097-5; Uslu U, 2007, PARASITE, V14, P173, DOI 10.1051/parasite/2007142173; VAUGHAN JA, 1987, J MED ENTOMOL, V24, P390, DOI 10.1093/jmedent/24.3.390; Venter GJ, 2000, MED VET ENTOMOL, V14, P245, DOI 10.1046/j.1365-2915.2000.00245.x; Venter GJ, 1998, MED VET ENTOMOL, V12, P378, DOI 10.1046/j.1365-2915.1998.00116.x; Veronesi E, 2009, VET PARASITOL, V163, P370, DOI 10.1016/j.vetpar.2009.04.031; WALKER AR, 1977, B ENTOMOL RES, V67, P217, DOI 10.1017/S0007485300011032; Walsh AS, 2008, ENVIRON ECOL STAT, V15, P279, DOI 10.1007/s10651-007-0056-6; Wirth W.W., 1989, MEM AM ENTOMOL INST, V44, P1; Yanase T, 2013, J MED ENTOMOL, V50, P1105, DOI 10.1603/ME11235; Zuur Alain F., 2009, P1	90	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131021	10.1371/journal.pone.0131021	http://dx.doi.org/10.1371/journal.pone.0131021			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121048	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400072
J	Kryuchkova-Mostacci, N; Robinson-Rechavi, M				Kryuchkova-Mostacci, Nadezda; Robinson-Rechavi, Marc			Tissue-Specific Evolution of Protein Coding Genes in Human and Mouse	PLOS ONE			English	Article							HIGHLY EXPRESSED GENES; POSITIVE SELECTION; MAMMALIAN GENES; INVERSE RELATIONSHIP; SUBSTITUTION RATES; LABORATORY MOUSE; GENOME; DATABASE; TRANSCRIPTION; DIVERGENCE	Protein-coding genes evolve at different rates, and the influence of different parameters, from gene size to expression level, has been extensively studied. While in yeast gene expression level is the major causal factor of gene evolutionary rate, the situation is more complex in animals. Here we investigate these relations further, especially taking in account gene expression in different organs as well as indirect correlations between parameters. We used RNA-seq data from two large datasets, covering 22 mouse tissues and 27 human tissues. Over all tissues, evolutionary rate only correlates weakly with levels and breadth of expression. The strongest explanatory factors of purifying selection are GC content, expression in many developmental stages, and expression in brain tissues. While the main component of evolutionary rate is purifying selection, we also find tissue-specific patterns for sites under neutral evolution and for positive selection. We observe fast evolution of genes expressed in testis, but also in other tissues, notably liver, which are explained by weak purifying selection rather than by positive selection.	[Kryuchkova-Mostacci, Nadezda; Robinson-Rechavi, Marc] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Kryuchkova-Mostacci, Nadezda; Robinson-Rechavi, Marc] Swiss Inst Bioinformat, Lausanne, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics	Robinson-Rechavi, M (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	marc.robinson-rechavi@unil.ch	Robinson-Rechavi, Marc/E-9727-2011	Robinson-Rechavi, Marc/0000-0002-3437-3329	Swiss National Science Foundation [31003A_133011/1, 31003A_153341/1]; Etat de Vaud	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Etat de Vaud	This work was supported by the Swiss National Science Foundation (grants number 31003A_133011/1 and 31003A_153341/1) and Etat de Vaud. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba MM, 2005, MOL BIOL EVOL, V22, P598, DOI 10.1093/molbev/msi045; Bastian F, 2008, LECT N BIOINFORMAT, V5109, P124, DOI 10.1007/978-3-540-69828-9_12; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Blake JA, 2014, NUCLEIC ACIDS RES, V42, pD810, DOI 10.1093/nar/gkt1225; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Bullaughey K, 2008, GENOME RES, V18, P544, DOI 10.1101/gr.071548.107; Canal L, 2005, COMPUT STAT DATA AN, V48, P803, DOI 10.1016/j.csda.2004.04.001; Chen JJ, 2005, GENETICS, V171, P2151, DOI 10.1534/genetics.105.048066; Chen WH, 2012, NUCLEIC ACIDS RES, V40, pD901, DOI 10.1093/nar/gkr986; Cho HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108095; Cox A, 2009, GENETICS, V182, P1335, DOI 10.1534/genetics.109.105486; Davis JC, 2004, PLOS BIOL, V2, P318, DOI 10.1371/journal.pbio.0020055; Dimitrieva S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095034; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; DURET L, 1995, J MOL EVOL, V40, P308, DOI 10.1007/BF00163235; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Elhaik E, 2006, MOL BIOL EVOL, V23, P1, DOI 10.1093/molbev/msj006; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Ezkurdia I, 2014, HUM MOL, P1; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Galtier N, 2009, TRENDS GENET, V25, P1, DOI 10.1016/j.tig.2008.10.011; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Glemin S, 2014, QUANTIFICATION GC BI; Gonzalez-Porta M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r70; Gu X, 2007, P NATL ACAD SCI USA, V104, P2779, DOI 10.1073/pnas.0610797104; Haygood R, 2010, P NATL ACAD SCI USA, V107, P7853, DOI 10.1073/pnas.0911249107; Jordan IK, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-22; Khaitovich P, 2006, NAT REV GENET, V7, P693, DOI 10.1038/nrg1940; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; KUMA K, 1995, MOL BIOL EVOL, V12, P123, DOI 10.1093/oxfordjournals.molbev.a040181; Lahens NF, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r86; Larracuente AM, 2008, TRENDS GENET, V24, P114, DOI 10.1016/j.tig.2007.12.001; Li SW, 2007, BIOCHEM BIOPH RES CO, V360, P586, DOI 10.1016/j.bbrc.2007.06.085; Liao BY, 2006, MOL BIOL EVOL, V23, P1119, DOI 10.1093/molbev/msj119; Liao BY, 2006, MOL BIOL EVOL, V23, P2072, DOI 10.1093/molbev/msl076; Macossay-Castillo M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003607; Makino T, 2009, TRENDS GENET, V25, P152, DOI 10.1016/j.tig.2009.03.001; Rodriguez JM, 2013, NUCLEIC ACIDS RES, V41, pD110, DOI 10.1093/nar/gks1058; Alba MM, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-53; McKusick-Nathans Institute of Genetic Medicine, 2014, ONL MEND INH MAN OMI; Montoya-Burgos JI, 2003, TRENDS GENET, V19, P128, DOI 10.1016/S0168-9525(03)00021-0; Moretti S, 2014, NUCLEIC ACIDS RES, V42, pD917, DOI 10.1093/nar/gkt1065; Moyers BA, 2014, MOL BIOL EVOL, P734; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Necsulea A, 2014, NAT REV GENET; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Pal C, 2001, GENETICS, V158, P927; Park SG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-241; R Core Team, 2012, R LANG ENV STAT COMP; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Rocha EPC, 2006, TRENDS GENET, V22, P412, DOI 10.1016/j.tig.2006.06.004; Rocha EPC, 2004, MOL BIOL EVOL, V21, P108, DOI 10.1093/molbev/msh004; Roux J, 2014, MOL BIOL EVOL, V31, P1661, DOI 10.1093/molbev/msu141; Roux J, 2011, GENOME RES, V21, P357, DOI 10.1101/gr.113803.110; Rubinstein ND, 2011, MOL BIOL EVOL, V28, P3297, DOI 10.1093/molbev/msr162; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Sarkar D, 2008, USE R, P1; Satake M, 2012, DNA RES, P1; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shannon PT, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-217; Subramanian S, 2004, GENETICS, V168, P373, DOI 10.1534/genetics.104.028944; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tuller T, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r142; Urrutia AO, 2003, GENOME RES, V13, P2260, DOI 10.1101/gr.641103; Villar D, 2015, CELL, V160, P554, DOI 10.1016/j.cell.2015.01.006; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wang C, 2014, NAT BIOTECHNOL; Warnefors M, 2013, GENOME BIOL EVOL, V5, P1324, DOI 10.1093/gbe/evt093; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yang L, 2011, MOL BIOL EVOL, V28, P2359, DOI 10.1093/molbev/msr058; Zaheri M, 2014, MOL BIOL EVOL, V31, P2528, DOI 10.1093/molbev/msu196; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	78	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131673	10.1371/journal.pone.0131673	http://dx.doi.org/10.1371/journal.pone.0131673			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121354	gold, Green Published, Green Submitted			2022-12-27	WOS:000358150400138
J	Oppong, R; Jowett, S; Roberts, TE				Oppong, Raymond; Jowett, Sue; Roberts, Tracy E.			Economic Evaluation alongside Multinational Studies: A Systematic Review of Empirical Studies	PLOS ONE			English	Article							COST-EFFECTIVENESS ANALYSIS; ACUTE MYOCARDIAL-INFARCTION; ACUTE CORONARY SYNDROMES; POLLEN INDUCED RHINOCONJUNCTIVITIS; CLINICAL-TRIALS; UTILITY ANALYSIS; THROMBOLYSIS REPERFUSION; EARLY INTERVENTION; HEART-FAILURE; HIGH-RISK	Purpose of the study This study seeks to explore methods for conducting economic evaluations alongside multinational trials by conducting a systematic review of the methods used in practice and the challenges that are typically faced by the researchers who conducted the economic evaluations. Methods A review was conducted for the period 2002 to 2012, with potentially relevant articles identified by searching the Medline, Embase and NHS EED databases. Studies were included if they were full economic evaluations conducted alongside a multinational trial. Results A total of 44 studies out of a possible 2667 met the inclusion criteria. Methods used for the analyses varied between studies, indicating a lack of consensus on how economic evaluation alongside multinational studies should be carried out. The most common challenge appeared to be related to addressing differences between countries, which potentially hinders the generalisability and transferability of results. Other challenges reported included inadequate sample sizes and choosing cost-effectiveness thresholds. Conclusions It is recommended that additional guidelines be developed to aid researchers in this area and that these be based on an understanding of the challenges associated with multinational trials and the strengths and limitations of alternative approaches. Guidelines should focus on ensuring that results will aid decision makers in their individual countries.	[Oppong, Raymond; Jowett, Sue; Roberts, Tracy E.] Univ Birmingham, Hlth Econ Unit, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Oppong, R (corresponding author), Univ Birmingham, Hlth Econ Unit, Sch Hlth & Populat Sci, Public Hlth Bldg, Birmingham B15 2TT, W Midlands, England.	r.a.oppong@bham.ac.uk	Oppong, Raymond/AAV-5867-2020; Jowett, Sue/AAO-4198-2021; Roberts, Tracy/AAO-4610-2021	Oppong, Raymond/0000-0002-0815-4616; Jowett, Sue/0000-0001-8936-3745; Roberts, Tracy/0000-0002-0624-0537				Annemans L, 2003, SUPPORT CARE CANCER, V11, P249, DOI 10.1007/s00520-002-0435-3; [Anonymous], SYST REV CRDS GUID U; [Anonymous], 2007, EC ANAL HLTH CARE; Antonanzas F, 2009, HEALTH ECON, V18, P629, DOI 10.1002/hec.1397; Appleby J, 2007, BRIT MED J, V335, P358, DOI 10.1136/bmj.39308.560069.BE; Aspelin P, 2005, AM HEART J, V149, P298, DOI 10.1016/j.ahj.2004.07.020; Bachert C, 2007, CLIN EXP ALLERGY, V37, P772, DOI 10.1111/j.1365-2222.2007.02706.x; Bakhai A, 2003, CIRCULATION, V108, P2857, DOI 10.1161/01.CIR.0000103121.26241.FA; Barbieri M, 2010, VALUE HEALTH, V13, P1028, DOI 10.1111/j.1524-4733.2010.00771.x; Bernert S, 2009, VALUE HEALTH, V12, P750, DOI 10.1111/j.1524-4733.2009.00509.x; Bracco A, 2007, VALUE HEALTH, V10, P238, DOI 10.1111/j.1524-4733.2007.00179.x; Briggs AH, 2010, EUR RESPIR J, V35, P532, DOI 10.1183/09031936.00153108; Briggs AH, 2006, ALLERGY, V61, P531, DOI 10.1111/j.1398-9995.2006.01038.x; Brown R, 2003, CAN J CARDIOL, V19, P161; Buxton MJ, 2004, EUR RESPIR J, V24, P568, DOI 10.1183/09031936.04.00108703; Canonica GW, 2007, RESP MED, V101, P1885, DOI 10.1016/j.rmed.2007.05.003; Canoui-Poitrine F, 2009, APPL HEALTH ECON HEA, V7, P19, DOI 10.2165/00148365-200907010-00003; Cook JR, 2003, STAT MED, V22, P1955, DOI 10.1002/sim.1389; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Drummond M., 2001, TRANSFERABILITY EC E; Drummond MF, 2003, CHEST, V124, P526, DOI 10.1378/chest.124.2.526; Drummond M, 2009, VALUE HEALTH, V12, P409, DOI 10.1111/j.1524-4733.2008.00489.x; Dukhovny D, 2011, PEDIATRICS, V127, pE146, DOI 10.1542/peds.2010-1014; Edbrooke DL, 2011, CRIT CARE, V15, DOI 10.1186/cc10029; Feng Y, 2014, QUALITY LIFE RES, V23; Fernandez JL, 2005, PHARMACOECONOMICS, V23, P155, DOI 10.2165/00019053-200523020-00007; Gheorghe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056560; Glasziou PP, 2010, MED J AUSTRALIA, V193, P320, DOI 10.5694/j.1326-5377.2010.tb03941.x; Glick H, 2007, EC EVALUATION CLIN T; Gomes M, 2010, BRIT J SURG, V97, P1218, DOI 10.1002/bjs.7110; Grieve R, 2005, HEALTH ECON, V14, P185, DOI 10.1002/hec.916; Heyland DK, 1996, CRIT CARE MED, V24, P1591, DOI 10.1097/00003246-199609000-00025; Janzon M, 2003, HEART, V89, P287, DOI 10.1136/heart.89.3.287; Jowett S, 2009, J THROMB HAEMOST, V7, P1482, DOI 10.1111/j.1538-7836.2009.03508.x; King JT, 2005, MED DECIS MAKING, V25, P667, DOI 10.1177/0272989X05282640; Knapp M, 2008, PHARMACOECONOMICS, V26, P341, DOI 10.2165/00019053-200826040-00006; Knies S, 2009, PHARMACOECONOMICS, V27, P767, DOI 10.2165/11314120-000000000-00000; Kolm P, 2007, CAN J CARDIOL, V23, P1037, DOI 10.1016/S0828-282X(07)70870-X; Koopmanschap MA, 2001, HEALTH POLICY, V58, P175, DOI 10.1016/S0168-8510(01)00142-7; Lamy A, 2004, EUR J CARDIOV PREV R, V11, P460, DOI 10.1097/00149831-200412000-00003; Lamy A, 2003, CIRCULATION, V107, P960, DOI 10.1161/01.CIR.0000050600.49419.25; Lindgren B, 2005, INT J CLIN PRACT, V59, P62, DOI 10.1111/j.1742-1241.2005.00347.x; Lofdahl CG, 2005, PHARMACOECONOMICS, V23, P365; Lorgelly PK, 2010, EUR J HEART FAIL, V12, P66, DOI 10.1093/eurjhf/hfp172; Lubell Y, 2009, TROP MED INT HEALTH, V14, P332, DOI 10.1111/j.1365-3156.2009.02227.x; Magnell C, 2005, HLTH TECHNOLOGIES DE; Manca A, 2005, HEALTH ECON, V14, P471, DOI 10.1002/hec.914; Manca A, 2003, BJOG-INT J OBSTET GY, V110, P255, DOI 10.1016/S1470-0328(03)02915-X; Manca A, 2007, MED DECIS MAKING, V27, P471, DOI 10.1177/0272989X07302132; Manca A, 2010, PHARMACOECONOMICS, V28, P1079, DOI 10.2165/11537760-000000000-00000; Marcoff L, 2009, J AM COLL CARDIOL, V54, P1271, DOI 10.1016/j.jacc.2009.05.060; Marschner IC, 2010, CLIN TRIALS, V7, P147, DOI 10.1177/1740774510361974; Martin SC, 2003, PHARMACOECONOMICS, V21, P1153, DOI 10.2165/00019053-200321160-00002; Mittmann N, 2009, J NATL CANCER I, V101, P1182, DOI 10.1093/jnci/djp232; Mulligan JA, 2005, TRANSFERRING COST EF; Nasser S, 2008, ALLERGY, V63, P1624, DOI 10.1111/j.1398-9995.2008.01743.x; Nixon J, 2009, EUR J HEALTH ECON, V10, P157, DOI 10.1007/s10198-008-0115-4; Oppong R, 2013, EUR J HEALTH ECON, V14, P197, DOI 10.1007/s10198-011-0360-9; Pang F, 2002, PHARMACOECONOMICS, V20, P75, DOI 10.2165/00019053-200220020-00001; Price D, 2002, PHARMACOECONOMICS, V20, P653, DOI 10.2165/00019053-200220100-00002; Radeva JI, 2005, CLIN TRANSPLANT, V19, P122, DOI 10.1111/j.1399-0012.2004.00312.x; Reed SD, 2005, AM HEART J, V149, P434, DOI 10.1016/j.ahj.2004.11.001; Reed SD, 2004, AM HEART J, V148, P122, DOI 10.1016/j.ahj.2003.12.040; Reed SD, 2004, J UROLOGY, V171, P1537, DOI 10.1097/01.ju.0000116777.94426.60; Reinhold T, 2010, J PUBLIC HEALTH-HEID, V18, P327, DOI 10.1007/s10389-010-0315-0; Rivero-Arias O, 2010, VALUE HEALTH, V13, P34, DOI 10.1111/j.1524-4733.2009.00582.x; Roberts T, 2002, BJOG-INT J OBSTET GY, V109, P44, DOI 10.1016/S1470-0328(02)00223-9; Rutten-van Molken MPMH, 2007, PHARMACOECONOMICS, V25, P695, DOI 10.2165/00019053-200725080-00007; Sakthong P, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-71; Schulman K, 1998, HEALTH ECON, V7, P629, DOI 10.1002/(SICI)1099-1050(1998110)7:7<629::AID-HEC378>3.0.CO;2-N; Simon J, 2006, BJOG-INT J OBSTET GY, V113, P144, DOI 10.1111/j.1471-0528.2005.00785.x; Spath HM, 1999, HEALTH POLICY, V49, P161, DOI 10.1016/S0168-8510(99)00057-3; Sullivan SD, 2003, J ALLERGY CLIN IMMUN, V112, P1229, DOI 10.1016/j.jaci.2003.09.025; Szende A, 2007, COMP REV TIME TRADE; Thompson SG, 2006, J HEALTH ECON, V25, P1015, DOI 10.1016/j.jhealeco.2006.02.001; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Torti FM, 2006, VALUE HEALTH, V9, P281, DOI 10.1111/j.1524-4733.2006.00117.x; Vemer P, 2013, PHARMACOECONOMICS, V31, P863, DOI 10.1007/s40273-013-0084-z; Wade AG, 2008, PHARMACOECONOMICS, V26, P969, DOI 10.2165/00019053-200826110-00008; Weintraub WS, 2005, J AM COLL CARDIOL, V45, P838, DOI 10.1016/j.jacc.2004.11.051; Welsh RC, 2009, CAN J CARDIOL, V25, pE399, DOI 10.1016/S0828-282X(09)70532-X; Welte R, 2004, PHARMACOECONOMICS, V22, P857, DOI 10.2165/00019053-200422130-00004; Wild D, 2009, VALUE HEALTH, V12, P430, DOI 10.1111/j.1524-4733.2008.00471.x; Willan AR, 2006, PHARMACOECONOMICS, V24, P93, DOI 10.2165/00019053-200624010-00008; Willke RJ, 1998, HEALTH ECON, V7, P481, DOI 10.1002/(SICI)1099-1050(199809)7:6<481::AID-HEC353>3.3.CO;2-B; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421	87	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131949	10.1371/journal.pone.0131949	http://dx.doi.org/10.1371/journal.pone.0131949			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1BL	26121465	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000358150400184
J	Koo, FK; Chen, X; Chow, EPF; Jing, J; Zheng, J; Zhao, JS; Zhang, L				Koo, Fung Kuen; Chen, Xi; Chow, Eric P. F.; Jing, Jun; Zheng, Jun; Zhao, Junshi; Zhang, Lei			Barriers and Potential Improvements for Needle and Syringe Exchange Programs (NSPs) in China: A Qualitative Study from Perspectives of Both Health and Public Security Sectors	PLOS ONE			English	Article							INJECTION-DRUG USERS; METHADONE-MAINTENANCE TREATMENT; HARM REDUCTION; HIV-INFECTION; PREVENTION; PREVALENCE; BEHAVIORS; ADVOCACY; PROVINCE; TRENDS	This study explores the acceptability, the barriers to the implementation of needle and syringe exchange programs (NSPs) and the potential improvement strategies in China from the perspectives of governmental health and public security officials. Purposive sampling was used for recruitment of participants who had been involved in NSPs implementation. Semi-Structured individual interviews were conducted in Mandarin to address three aspects of NSPs: (1) participants' attitudes towards NSPs, (2) participants' opinions on the effectiveness and barriers of NSPs, and (3) suggestions for improving the program. Content analysis was used to analyse the translated interview data. A total of 68 participants from 12 Hunan counties were interviewed (34 from each of the Bureau of Health and the Narcotic Division). Both groups recognised the importance and effectiveness of NSPs in HIV prevention, but public security officials regarded NSPs as a temporary intervention in place of punitive measures. Most health officials (32/34) regarded the main barriers to its implementation as administrative and structural, whereas participants from Narcotics Division (n=24) questioned the legitimacy of NSPs and concerned about the poor management of drug users' risk behaviours. Close cooperation between the health and public security sectors, engagement of the drug user community and an enabling policy environment were reportedly to be critical for potential improvements of NSPs in China. Misconceptions about NSPs encourage drug users' addictive behaviour, and an unclear leadership and insufficient support de-motivate the participants from the Bureau of Health and the Narcotics Division to actively support the program implementation.	[Koo, Fung Kuen] Univ Sydney, Sydney Nursing Sch, Sydney, NSW 2006, Australia; [Chen, Xi; Zheng, Jun; Zhao, Junshi] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Chow, Eric P. F.; Zhang, Lei] UNSW Australia, Kirby Inst, Sydney, NSW, Australia; [Chow, Eric P. F.; Zhang, Lei] Monash Univ, Fac Med Nursing & Hlth Sci, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Chow, Eric P. F.] Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Jing, Jun; Zhang, Lei] Tsinghua Univ, Res Ctr Publ Hlth, Beijing 100084, Peoples R China	University of Sydney; University of New South Wales Sydney; Kirby Institute; Monash University; Tsinghua University	Jing, J (corresponding author), Tsinghua Univ, Res Ctr Publ Hlth, Beijing 100084, Peoples R China.	jingjun@tsinghua.edu.cn; lzhang@kirby.unsw.edu.au	Zhang, Lei/D-4039-2011; Chow, Eric P.F./W-6684-2019; Chow, Eric Pui Fung/H-3196-2013	Zhang, Lei/0000-0003-2343-084X; Chow, Eric P.F./0000-0003-1766-0657; Chow, Eric Pui Fung/0000-0003-1766-0657; Koo, Fung Kuen (Tebbin)/0000-0002-5327-4051	National Science and Technology Major Project of China [2012ZX1001001]; Australian National Health and Medical Research Council [1091226]	National Science and Technology Major Project of China; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study is supported by National Science and Technology Major Project of China (No. 2012ZX1001001). EPFC is supported by the Early Career Fellowships from the Australian National Health and Medical Research Council (1091226). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooner R, 1998, Public Health Rep, V113 Suppl 1, P129; Cheng B K, 1997, J Long Term Home Health Care, V16, P39; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Elo S, 2014, SAGE OPEN, V4, DOI 10.1177/2158244014522633; Fang YX, 2006, ACTA PHARMACOL SIN, V27, P140, DOI 10.1111/j.1745-7254.2006.00270.x; Gao Ge, 1998, COMMUNICATING EFFECT; Glaser B.G., 1968, DISCOV GROUNDED THEO; Guo Wei, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P666; Hammett T M, 2007, Glob Public Health, V2, P125, DOI 10.1080/17441690600981806; Hammett TM, 2008, ADDICTION, V103, P137, DOI 10.1111/j.1360-0443.2007.02053.x; Hammett TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043141; Hammett TM, 2005, J URBAN HEALTH, V82, pIV34, DOI 10.1093/jurban/jti106; Hofstede G., 1980, CULTURES CONSEQUENCE; Holder HD, 1997, ADDICTION, V92, pS189, DOI 10.1111/j.1360-0443.1997.tb02991.x; Jia YJ, 2008, HARM REDUCT J, V5, DOI 10.1186/1477-7517-5-29; Koo FK, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.100293; Lu L, 2008, AM J DRUG ALCOHOL AB, V34, P127, DOI 10.1080/00952990701876989; Marx MA, 2000, AM J PUBLIC HEALTH, V90, P1933, DOI 10.2105/AJPH.90.12.1933; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mesquita F, 2008, HARM REDUCT J, V5, DOI 10.1186/1477-7517-5-26; Ministry of Commerce of the People's Republic of China, 2010, COUNTR REP; *NAT CTR HIV EP CL, 2004, HIV AIDS VIR HEP SEX; National Research Council, 2006, PREV HIV INF INJ DRU; Philbin MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086873; Philbin MM, 2010, AIDS CARE, V22, P623, DOI 10.1080/09540120903311490; Qian ZH, 2005, SEX TRANSM INFECT, V81, P442, DOI 10.1136/sti.2004.014258; Reid G, 2009, INT J DRUG POLICY, V20, P365, DOI 10.1016/j.drugpo.2008.10.004; Smith K, 2012, INT J DRUG POLICY, V23, P327, DOI 10.1016/j.drugpo.2011.09.010; Spooner C., 2004, ROLE POLICE PREVENTI; State Council AIDS Working Committee Office (SCAWCO), 2012, 2012 CHIN AIDS RESP; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Sullivan SG, 2007, INT J DRUG POLICY, V18, P118, DOI 10.1016/j.drugpo.2006.11.014; Thompson Drew, 2005, CHINA BRIEF, V5, P1; Vlahov D, 1997, J ACQ IMMUN DEF SYND, V16, P400, DOI 10.1097/00042560-199712150-00014; WATTERS JK, 1994, JAMA-J AM MED ASSOC, V271, P115, DOI 10.1001/jama.271.2.115; Wodak A, 2006, SUBST USE MISUSE, V41, P777, DOI 10.1080/10826080600669579; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Yang LJ, 2008, AM J DRUG ALCOHOL AB, V34, P5, DOI 10.1080/00952990701653867; Zhang L, 2011, SEX HEALTH, V9, P261; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7; Zhang L, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-8	42	4	4	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130654	10.1371/journal.pone.0130654	http://dx.doi.org/10.1371/journal.pone.0130654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1AM	26114556	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500085
J	Lange, K; Kuhn, S; Filevich, E				Lange, Kristian; Kuehn, Simone; Filevich, Elisa			"Just Another Tool for Online Studies" (JATOS): An Easy Solution for Setup and Management of Web Servers Supporting Online Studies	PLOS ONE			English	Article								We present here "Just Another Tool for Online Studies" (JATOS): an open source, cross-platform web application with a graphical user interface (GUI) that greatly simplifies setting up and communicating with a web server to host online studies that are written in Java-Script. JATOS is easy to install in all three major platforms (Microsoft Windows, Mac OS X, and Linux), and seamlessly pairs with a database for secure data storage. It can be installed on a server or locally, allowing researchers to try the application and feasibility of their studies within a browser environment, before engaging in setting up a server. All communication with the JATOS server takes place via a GUI (with no need to use a command line interface), making JATOS an especially accessible tool for researchers without a strong IT background. We describe JATOS' main features and implementation and provide a detailed tutorial along with example studies to help interested researchers to set up their online studies. JATOS can be found under the Internet address: www.jatos.org.	[Lange, Kristian; Kuehn, Simone; Filevich, Elisa] Max Planck Inst Human Dev, Dept Lifespan Psychol, Berlin, Germany	Max Planck Society	Filevich, E (corresponding author), Max Planck Inst Human Dev, Dept Lifespan Psychol, Berlin, Germany.	elisa.filevich@gmail.com	Kuehn, Simone/P-6145-2014	Kuhn, Simone/0000-0001-6823-7969; Filevich, Elisa/0000-0002-1158-8220; Lange, Kristian/0000-0002-2322-896X	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	SK and EF were supported by the Max Planck Society (http://www.mpg.de/en). KL received no specific sfunding for this work.	Barnhoorn JS, 2014, BEHAV RES METHODS; Chandler J, 2014, BEHAV RES METHODS, V46, P112, DOI 10.3758/s13428-013-0365-7; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; De Leeuw JR., 2014, BEHAV RES METHODS; Eimer M, 1998, J EXP PSYCHOL HUMAN, V24, P1737, DOI 10.1037/0096-1523.24.6.1737; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Keller F, 2009, BEHAV RES METHODS, V41, P1, DOI 10.3758/BRM.41.1.12; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Miller G, 2012, PERSPECT PSYCHOL SCI, V7, P221, DOI 10.1177/1745691612441215; PFEFFERBAUM A, 1985, ELECTROEN CLIN NEURO, V60, P423, DOI 10.1016/0013-4694(85)91017-X; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Schubert TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067769; Simons DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051876; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; von Bastian CC, 2013, BEHAV RES METHODS, V45, P108, DOI 10.3758/s13428-012-0224-y	15	114	113	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130834	10.1371/journal.pone.0130834	http://dx.doi.org/10.1371/journal.pone.0130834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1AM	26114751	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500100
J	Menachery, VD; Gralinski, LE; Baric, RS; Ferris, MT				Menachery, Vineet D.; Gralinski, Lisa E.; Baric, Ralph S.; Ferris, Martin T.			New Metrics for Evaluating Viral Respiratory Pathogenesis	PLOS ONE			English	Article							A H1N1 VIRUS; ANIMAL-MODELS; MICE; INFECTION; PENH; ATTENUATION; GENERATION; SEVERITY	Viral pathogenesis studies in mice have relied on markers of severe systemic disease, rather than clinically relevant measures, to evaluate respiratory virus infection; thus confounding connections to human disease. Here, whole-body plethysmography was used to directly measure changes in pulmonary function during two respiratory viral infections. This methodology closely tracked with traditional pathogenesis metrics, distinguished both virus and dose-specific responses, and identified long-term respiratory changes following both SARS-CoV and Influenza A Virus infection. Together, the work highlights the utility of examining respiratory function following infection in order to fully understand viral pathogenesis.	[Menachery, Vineet D.; Gralinski, Lisa E.; Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Baric, Ralph S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Ferris, Martin T.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ferris, MT (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27514 USA.	mtferris@email.unc.edu		Menachery, Vineet/0000-0001-8803-7606	National Institute of Allergy & Infectious Diseases of the NIH [HHSN272200800060C, U19AI100625, F32AI102561]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100625, F32AI102561] Funding Source: NIH RePORTER	National Institute of Allergy & Infectious Diseases of the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy & Infectious Diseases of the NIH under contract no. HHSN272200800060C and award numbers U19AI100625 and F32AI102561. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkina R, 2013, VIROLOGY, V435, P14, DOI 10.1016/j.virol.2012.10.007; Aylor DL, 2011, GENOME RES, V21, P1213, DOI 10.1101/gr.111310.110; Bates J, 2004, AM J RESP CELL MOL, V31, P373, DOI 10.1165/ajrcmb.31.3.1; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Castilow EM, 2008, J IMMUNOL, V181, P6692, DOI 10.4049/jimmunol.181.10.6692; de Souza N, 2013, NAT METHODS, V10, P288, DOI 10.1038/nmeth.2429; de Vrankrijker AMM, 2009, J MED VIROL, V81, P2096, DOI 10.1002/jmv.21623; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Gelfand EW, 2002, AM J RESP CRIT CARE, V166, P5, DOI 10.1164/rccm.2204023; Glaab T, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-139; Gralinski LE, 2013, MBIO, V4, DOI 10.1128/mBio.00271-13; Hoymann HG, 2006, EXP TOXICOL PATHOL, V57, P5, DOI 10.1016/j.etp.2006.02.011; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Julander JG, 2014, ANTIVIR RES, V108, P10, DOI 10.1016/j.antiviral.2014.05.002; Lomask M, 2006, EXP TOXICOL PATHOL, V57, P13, DOI 10.1016/j.etp.2006.02.014; Lundblad LKA, 2007, EUR RESPIR J, V30, P805, DOI 10.1183/09031936.00091307; McGovern TK, 2013, JOVE-J VIS EXP, DOI 10.3791/50172; Menachery VD, 2014, VIRUS RES, V194, P191, DOI 10.1016/j.virusres.2014.09.009; Menachery VD, 2014, J VIROL, V88, P4251, DOI 10.1128/JVI.03571-13; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Neumann G, 2011, INFLUENZA OTHER RESP, V5, P157, DOI 10.1111/j.1750-2659.2011.00231.x; Palmer LA, 2013, RESP PHYSIOL NEUROBI, V185, P497, DOI 10.1016/j.resp.2012.11.010; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Rasmussen AL, 2014, SCIENCE, V346, P987, DOI 10.1126/science.1259595; Roberts A, 2005, J VIROL, V79, P5833, DOI 10.1128/JVI.79.9.5833-5838.2005; Roberts A, 2007, PLOS PATHOG, V3, P23, DOI 10.1371/journal.ppat.0030005; Sanders CJ, 2013, AM J PHYSIOL-LUNG C, V304, pL481, DOI 10.1152/ajplung.00343.2012; Smith AM, 2014, CURR TOP MICROBIOL, V385, P327, DOI 10.1007/82_2014_394; Tchitchek N, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-69; Weinberger S. E., 2008, PRINCIPLES PULMONARY	32	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131451	10.1371/journal.pone.0131451	http://dx.doi.org/10.1371/journal.pone.0131451			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115403	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500159
J	Ren, XM; Li, DF; Jiang, S; Lan, XQ; Hu, YL; Sun, H; Wang, DC				Ren, Xiao-Ming; Li, De-Feng; Jiang, Shuai; Lan, Xian-Qing; Hu, Yonglin; Sun, Hui; Wang, Da-Cheng			Structural Basis of Specific Recognition of Non-Reducing Terminal N-Acetylglucosamine by an Agrocybe aegerita Lectin	PLOS ONE			English	Article							O-GLCNACYLATION; AFFINITY-CHROMATOGRAPHY; CRYSTAL-STRUCTURE; PHOSPHORYLATION	O-linked N-acetylglucosaminylation (O-GlcNAcylation) is a reversible post-translational modification that plays essential roles in many cellular pathways. Research in this field, however, is hampered by the lack of suitable probes to identify, accumulate, and purify the O-GlcNAcylated proteins. We have previously reported the identification of a lectin from the mushroom Agrocybe aegerita, i.e., Agrocybe aegerita lectin 2, or AAL2, that could bind terminal N-acetylglucosamine with higher affinities and specificity than other currently used probes. In this paper, we report the crystal structures of AAL2 and its complexes with GlcNAc and GlcNAc beta 1-3Gal beta 1-4GlcNAc and reveal the structural basis of GlcNAc recognition by AAL2 and residues essential for the binding of terminal N-acetylglucosamine. Study on AAL2 may enable us to design a protein probe that can be used to identify and purify O-GlcNAcylated proteins more efficiently.	[Ren, Xiao-Ming; Li, De-Feng; Hu, Yonglin; Wang, Da-Cheng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Ren, Xiao-Ming] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Jiang, Shuai; Lan, Xian-Qing; Sun, Hui] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Wuhan University	Sun, H (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	sunhui@whu.edu.cn; dcwang@ibp.ac.cn			Chinese Ministry of Science and Technology 973 Programs [2011CB911100, 2011CB910304]; National Natural Science Foundation of China [31370849]; Chinese 111 Project [B06018]; Wuhan University [2042014kf0226]	Chinese Ministry of Science and Technology 973 Programs; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 Project(Ministry of Education, China - 111 Project); Wuhan University	This work was supported by the funding from Chinese Ministry of Science and Technology 973 Programs (2011CB911100, 2011CB910304) to DCW, National Natural Science Foundation of China (31370849), the Chinese 111 Project (B06018), and from Wuhan University (2042014kf0226) to HS.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beisel HG, 1999, EMBO J, V18, P2313, DOI 10.1093/emboj/18.9.2313; Cioci G, 2006, J MOL BIOL, V357, P1575, DOI 10.1016/j.jmb.2006.01.066; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fardini Y, 2013, FRONT ENDOCRINOL, V4, DOI 10.3389/fendo.2013.00099; Feng L, 2010, FASEB J, V24, P3861, DOI 10.1096/fj.10-159111; Feroz Khan, 2011, International Journal of Biological Chemistry, V5, P1, DOI 10.3923/ijbc.2011.1.20; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Harwood KR, 2014, J CELL SCI, V127, P1857, DOI 10.1242/jcs.113233; Jiang S, 2012, BIOCHEM J, V443, P369, DOI 10.1042/BJ20112061; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lis H, 1998, CHEM REV, V92, P28; Nakamura-Tsuruta S, 2006, J BIOCHEM, V140, P285, DOI 10.1093/jb/mvj148; Ren XM, 2013, ACTA CRYSTALLOGR F, V69, P650, DOI 10.1107/S1744309113011639; Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122; She QB, 1998, BIOCHEM BIOPH RES CO, V247, P106, DOI 10.1006/bbrc.1998.8744; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Vijayan M, 1999, CURR OPIN STRUC BIOL, V9, P707, DOI 10.1016/S0959-440X(99)00034-2; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Wang HX, 2000, BIOCHEM BIOPH RES CO, V275, P810, DOI 10.1006/bbrc.2000.3373; Wasser SP, 1999, CRIT REV IMMUNOL, V19, P65	24	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129608	10.1371/journal.pone.0129608	http://dx.doi.org/10.1371/journal.pone.0129608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114302	gold, Green Submitted, Green Published			2022-12-27	WOS:000358147500031
J	Troyer, RR; Turner, AM				Troyer, Rachael R.; Turner, Andrew M.			Chemosensory Perception of Predators by Larval Amphibians Depends on Water Quality	PLOS ONE			English	Article							ECOLOGICAL CONSEQUENCES; BEHAVIORAL-RESPONSES; PREY INTERACTIONS; CHEMICAL CUES; SNAILS; AVOIDANCE; COMMUNICATION; COMPETITION; COMMUNITY; TADPOLES	The acquisition of sensory information by animals is central to species interactions. In aquatic environments, most taxa use chemical cues to assess predation risk and other key ecological factors. A number of laboratory studies suggest that anthropogenic pollutants can disrupt chemoreception, even when at low, non-toxic concentrations, but there are few tests of whether real-world variation in water quality affects chemoreception. Here we investigate whether chemosensory perception of predators by the gray treefrog, Hyla versicolor, depends on water quality. We evaluated the anti-predator response of anuran tadpoles housed in water collected from three sites that represent strong contrasts in the concentration and types of dissolved solids: de-chlorinated tap water, water from an impaired stream, and treated wastewater effluent. Behavioral assays were conducted in laboratory aquaria. Chemical cues associated with predation were generated by feeding tadpoles to dragonfly predators held in containers, and then transferring aliquots of water from dragonfly containers to experimental aquaria. Tadpoles housed in tap water responded to predator cues with an activity reduction of 49%. Tadpoles housed in stream water and wastewater effluent responded to predator cues by reducing activity by 29% and 24% respectively. The results of factorial ANOVA support the hypothesis that the response to predator cues depended on water type. These results show that alteration of the chemical environment can mediate chemical perception of predators in aquatic ecosystems. Because most aquatic species rely on chemoreception to gather information on the location of food and predators, any impairment of sensory perception likely has important ecological consequences.	[Troyer, Rachael R.; Turner, Andrew M.] Clar Univ, Dept Biol, Clarion, PA 16214 USA		Turner, AM (corresponding author), Clar Univ, Dept Biol, Clarion, PA 16214 USA.	aturner@clarion.edu			US National Science Foundation [DEB-0444939]	US National Science Foundation(National Science Foundation (NSF))	This work was funded by the US National Science Foundation, DEB-0444939. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAXTER J. H. S., 1992, AQUAT ECOL, V26, P43, DOI DOI 10.1007/BF02298027; Derby CD, 2008, J CHEM ECOL, V34, P898, DOI 10.1007/s10886-008-9489-0; Dicke M, 1988, FUNCT ECOL, V2, P131, DOI 10.2307/2389687; Dicke M, 2006, WAG UR FRON, V16, P175; DODSON SI, 1994, J N AM BENTHOL SOC, V13, P268, DOI 10.2307/1467245; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Hanazato T, 1999, ENVIRON POLLUT, V105, P137, DOI 10.1016/S0269-7491(98)00203-6; Hay ME, 2002, J CHEM ECOL, V28, P2001, DOI 10.1023/A:1020797827806; Klaschka U, 2008, ENVIRON SCI POLLUT R, V15, P452, DOI 10.1007/s11356-008-0019-y; LAWLER SP, 1989, ANIM BEHAV, V38, P1039, DOI 10.1016/S0003-3472(89)80142-3; Lefcort H, 1999, ECOL APPL, V9, P1477, DOI 10.1890/1051-0761(1999)009[1477:ROPAPA]2.0.CO;2; Lefcort H, 1998, ARCH ENVIRON CON TOX, V35, P447, DOI 10.1007/s002449900401; Lurling M, 2007, TRENDS ECOL EVOL, V22, P374, DOI 10.1016/j.tree.2007.04.002; Lurling M, 2012, CHEMICAL ECOLOGY IN AQUATIC SYSTEMS, P250; McCollum SA, 1996, EVOLUTION, V50, P583, DOI 10.1111/j.1558-5646.1996.tb03870.x; McCollum SA, 1997, OECOLOGIA, V109, P615, DOI 10.1007/s004420050124; Mccoy MW, 2008, J ANIM ECOL, V77, P478, DOI 10.1111/j.1365-2656.2008.01372.x; McPherson TD, 2004, CAN J ZOOL, V82, P694, DOI [10.1139/z04-034, 10.1139/Z04-034]; Olsen KH, 2011, CHEMICAL COMMUNICATION IN CRUSTACEANS, P507, DOI 10.1007/978-0-387-77101-4_26; Peacor SD, 2000, ECOLOGY, V81, P1998, DOI 10.2307/177288; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Relyea RA, 2000, ECOLOGY, V81, P2278, DOI 10.1890/0012-9658(2000)081[2278:TMIEIL]2.0.CO;2; Resetarits WJ, 2004, OECOLOGIA, V138, P532, DOI 10.1007/s00442-003-1466-2; SKELLY DK, 1994, ANIM BEHAV, V47, P465, DOI 10.1006/anbe.1994.1063; Smee DL, 2006, ECOLOGY, V87, P1587, DOI 10.1890/0012-9658(2006)87[1587:CUEFDT]2.0.CO;2; SUTTERLIN AM, 1974, CHEM SENS FLAV, V1, P167, DOI 10.1093/chemse/1.2.167; Tierney KB, 2010, AQUAT TOXICOL, V96, P2, DOI 10.1016/j.aquatox.2009.09.019; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Turner AM, 2003, ECOLOGY, V84, P616, DOI 10.1890/0012-9658(2003)084[0616:SATSOP]2.0.CO;2; Turner AM, 2000, OIKOS, V88, P148, DOI 10.1034/j.1600-0706.2000.880117.x; Turner AM, 2008, ANIM BEHAV, V76, P1211, DOI 10.1016/j.anbehav.2008.06.005; Turner AM, 2012, CHEMICAL ECOLOGY IN AQUATIC SYSTEMS, P140; Turner AM, 2010, ECOL APPL, V20, P2089, DOI 10.1890/10-0208.1; Weissburg M, 2012, CHEMICAL ECOLOGY IN AQUATIC SYSTEMS, P96; Weissburg M, 2014, AM NAT, V184, P141, DOI 10.1086/676644; Weissburg MJ, 2002, J CHEM ECOL, V28, P1953, DOI 10.1023/A:1020741710060	36	16	16	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131516	10.1371/journal.pone.0131516	http://dx.doi.org/10.1371/journal.pone.0131516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114749	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500165
J	Wang, SH; Chen, DY; Lin, YS; Mao, CT; Tsai, ML; Hsieh, MJ; Chou, CC; Wen, MS; Wang, CC; Hsieh, C; Hung, KC; Chen, TH				Wang, Szu-Heng; Chen, Dong-Yi; Lin, Yu-Sheng; Mao, Chun-Tai; Tsai, Ming-Lung; Hsieh, Ming-Jer; Chou, Chung-Chuan; Wen, Ming-Shien; Wang, Chun-Chieh; Hsieh, Chang; Hung, Kuo-Chun; Chen, Tien-Hsing			Cardiovascular Outcomes of Sitagliptin in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Population-Based Cohort Study in Taiwan	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; MORTALITY; DISEASE; RISK; VALIDATION; MELLITUS; SAFETY; DPP-4	Background The cardiovascular safety and efficacy of sitagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor, in type 2 diabetic patients after acute myocardial infarction (AMI) has so far remained uncertain. Methods We analyzed data from the National Health Insurance Research Database (NHIRD), a government-operated, population-based database, from March 1st, 2009 to December 31st, 2011. Type 2 diabetic patients hospitalized for AMI were included in our study. We compared subjects using sitagliptin with comparison group to evaluate its cardiovascular safety and efficacy. The primary endpoint was a composite of cardiovascular death, myocardial infarction, and ischemic stroke. Results We identified a total of 3,282 type 2 diabetic patients hospitalized for AMI (mean follow-up 1.15 years). Of these patients, 547 (16.7%) who were exposed to sitagliptin were defined as the sitagliptin group and 2,735 (83.3 %) who did not use sitagliptin were the comparison group. The incidence of primary composite cardiovascular outcomes was 9.50 per 100 person-years in the sitagliptin group and was 9.70 per 100 person-years in the comparison group (hazard ratio (HR), 0.97; 95% CI, 0.73-1.29, P=0.849). Compared to the non-sitagliptin group, the sitagliptin group had similar risks of all-cause mortality, hospitalization for heart failure (HF) or percutaneous coronary intervention (PCI) with a HR of 0.82 (95% CI, 0.61-1.11, P=0.195), 0.93 (95% CI, 0.67-1.29, P=0.660), and 0.93 (95% CI, 0.75-1.14, P=0.473), respectively. Conclusion The use of sitagliptin in type 2 diabetic patients with recent AMI was not associated with increased risk of adverse cardiovascular events.	[Wang, Szu-Heng] Chang Gung Mem Hosp, Dept Med Educ, Taoyuan, Taiwan; [Wang, Szu-Heng; Chen, Dong-Yi; Lin, Yu-Sheng; Mao, Chun-Tai; Tsai, Ming-Lung; Hsieh, Ming-Jer; Chou, Chung-Chuan; Wen, Ming-Shien; Wang, Chun-Chieh; Hsieh, Chang; Hung, Kuo-Chun; Chen, Tien-Hsing] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Chen, Dong-Yi; Tsai, Ming-Lung; Hsieh, Ming-Jer; Chou, Chung-Chuan; Wen, Ming-Shien; Wang, Chun-Chieh; Hsieh, Chang; Hung, Kuo-Chun; Chen, Tien-Hsing] Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Taoyuan, Taiwan; [Lin, Yu-Sheng] Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Chiayi, Taiwan; [Mao, Chun-Tai] Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Heart Failure Ctr, Keelung, Taiwan; [Chen, Tien-Hsing] Chang Gung Mem Hosp, Dept Cardiol, Xiamen, Peoples R China	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chen, TH (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	skyheart0826@gmail.com	Chou, Chung-Chuan/AAZ-9776-2021; Hsieh, Ming-Jer/M-1340-2013	Hsieh, Ming-Jer/0000-0002-0148-8357	Chang Gung Memorial Hospital [CMRPG3B1201]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The corresponding author Tien-Hsing Chen received grants from Chang Gung Memorial Hospital, grant number: CMRPG3B1201, website: https://www.cgmh.org.tw/eng2002/index.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration F.a.D., 2010, STANDARDIZED DEFINIT, P37; Austin PC, 2010, AM J EPIDEMIOL, V172, P1092, DOI 10.1093/aje/kwq224; Chen DY, 2015, INT J CARDIOL, V181, P200, DOI 10.1016/j.ijcard.2014.12.029; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Engel SS, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-3; Goldfine AB, 2008, NEW ENGL J MED, V359, P1092, DOI 10.1056/NEJMp0805758; Green JB, 2013, AM HEART J, V166, P983, DOI 10.1016/j.ahj.2013.09.003; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Jose T, 2012, DIABETES VASC DIS RE, V9, P109, DOI 10.1177/1479164111436236; Laakso M, 2001, J INTERN MED, V249, P225, DOI 10.1046/j.1365-2796.2001.00789.x; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Nakatani D, 2013, CIRC J, V77, P439, DOI 10.1253/circj.CJ-11-1059; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Patil HR, 2012, AM J CARDIOL, V110, P826, DOI 10.1016/j.amjcard.2012.04.061; Pratley RE, 2007, CURR MED RES OPIN, V23, P919, DOI 10.1185/030079906X162746; Scheller NM, 2014, DIABETES OBES METAB, V16, P231, DOI 10.1111/dom.12197; Scirica BM, 2014, CIRCULATION, V130, P1579, DOI 10.1161/CIRCULATIONAHA.114.010389; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Weir DL, 2014, SITAGLIPTIN USE IN P; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975	26	18	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131122	10.1371/journal.pone.0131122	http://dx.doi.org/10.1371/journal.pone.0131122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115092	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500130
J	Yu, Y; Wise, SG; Michael, PL; Bax, DV; Yuen, GSC; Hiob, MA; Yeo, GC; Filipe, EC; Dunn, LL; Chan, KH; Hajian, H; Celermajer, DS; Weiss, AS; Ng, MKC				Yu, Young; Wise, Steven G.; Michael, Praveesuda L.; Bax, Daniel V.; Yuen, Gloria S. C.; Hiob, Matti A.; Yeo, Giselle C.; Filipe, Elysse C.; Dunn, Louise L.; Chan, Kim H.; Hajian, Hamid; Celermajer, David S.; Weiss, Anthony S.; Ng, Martin K. C.			Characterization of Endothelial Progenitor Cell Interactions with Human Tropoelastin	PLOS ONE			English	Article							ADHESION; ELASTIN; COLLAGEN; ENHANCEMENT; ATTACHMENT; REENDOTHELIALIZATION; GLYCOSAMINOGLYCANS; IMMOBILIZATION; ANGIOGENESIS; FIBRONECTIN	The deployment of endovascular implants such as stents in the treatment of cardiovascular disease damages the vascular endothelium, increasing the risk of thrombosis and promoting neointimal hyperplasia. The rapid restoration of a functional endothelium is known to reduce these complications. Circulating endothelial progenitor cells (EPCs) are increasingly recognized as important contributors to device re-endothelialization. Extracellular matrix proteins prominent in the vessel wall may enhance EPC-directed re-endothelialization. We examined attachment, spreading and proliferation on recombinant human tropoelastin (rhTE) and investigated the mechanism and site of interaction. EPCs attached and spread on rhTE in a dose dependent manner, reaching a maximal level of 56 +/- 3% and 54 +/- 3%, respectively. EPC proliferation on rhTE was comparable to vitronectin, fibronectin and collagen. EDTA, but not heparan sulfate or lactose, reduced EPC attachment by 81 +/- 3%, while full attachment was recovered after add-back of manganese, inferring a classical integrin-mediated interaction. Integrin alpha(V)beta(3) blocking antibodies decreased EPC adhesion and spreading on rhTE by 39 +/- 3% and 56 +/- 10% respectively, demonstrating a large contribution from this specific integrin. Attachment of EPCs on N-terminal rhTE constructs N25 and N18 accounted for most of this interaction, accompanied by comparable spreading. In contrast, attachment and spreading on N10 was negligible. alpha(V)beta(3) blocking antibodies reduced EPC spreading on both N25 and N18 by 45 +/- 4% and 42 +/- 14%, respectively. In conclusion, rhTE supports EPC binding via an integrin mechanism involving alpha(V)beta(3). N25 and N18, but not N10 constructs of rhTE contribute to EPC binding. The regulation of EPC activity by rhTE may have implications for modulation of the vascular biocompatibility of endovascular implants.	[Yu, Young; Chan, Kim H.; Celermajer, David S.; Ng, Martin K. C.] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW 2050, Australia; [Yu, Young; Wise, Steven G.; Michael, Praveesuda L.; Yuen, Gloria S. C.; Hiob, Matti A.; Filipe, Elysse C.; Dunn, Louise L.; Chan, Kim H.; Hajian, Hamid; Celermajer, David S.; Ng, Martin K. C.] Heart Res Inst, Sydney, NSW 2042, Australia; [Yu, Young; Wise, Steven G.; Bax, Daniel V.; Yuen, Gloria S. C.; Hiob, Matti A.; Filipe, Elysse C.; Dunn, Louise L.; Chan, Kim H.; Hajian, Hamid; Celermajer, David S.; Ng, Martin K. C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Wise, Steven G.; Bax, Daniel V.; Hiob, Matti A.; Yeo, Giselle C.; Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Weiss, Anthony S.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Weiss, Anthony S.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; Heart Research Institute; University of Sydney; University of Sydney; University of Sydney; University of Sydney	Wise, SG (corresponding author), Heart Res Inst, Sydney, NSW 2042, Australia.	wises@hri.org.au	Wise, Steven/AAB-8170-2021; Wise, Steven G/G-2630-2018; Weiss, Anthony S/GYV-0157-2022; Hajian, Hamid/AFO-4667-2022; Weiss, Anthony S/F-8103-2010; Wise, Steven/B-1858-2009	Weiss, Anthony S/0000-0002-8106-4836; Celermajer, David/0000-0001-7640-0439; Wise, Steven/0000-0001-7964-819X; Filipe, Elysse/0000-0003-1956-0852; Yeo, Giselle/0000-0001-6071-8899	Australian Research Council; National Health and Medical Research Council [APP1033079, APP1039072]; National Institutes of Health [EB014283]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014283] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors acknowledge funding from the Australian Research Council (A.S.W.), National Health and Medical Research Council (APP1033079 and APP1039072; M.K.C.N. and A.S.W.) and National Institutes of Health (EB014283; A.S.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almine JF, 2010, CHEM SOC REV, V39, P3371, DOI 10.1039/b919452p; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525; Blanchevoye C, 2013, J BIOL CHEM, V288, P1317, DOI 10.1074/jbc.M112.419929; Brockmann MA, 2002, PLATELETS, V13, P443, DOI 10.1080/0953710021000057802; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; Cho JH, 2006, BLOOD, V107, P3555, DOI 10.1182/blood-2005-10-4168; Crosby JR, 2000, CIRC RES, V87, P728, DOI 10.1161/01.RES.87.9.728; DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C; Fukuda D, 2009, EUR J PHARMACOL, V612, P87, DOI 10.1016/j.ejphar.2009.04.006; Gulati R, 2003, CIRCULATION, V108, P1520, DOI 10.1161/01.CIR.0000089084.48655.49; Gunsilius E, 2003, ADV EXP MED BIOL, V522, P17; Heino J, 2007, BIOESSAYS, V29, P1001, DOI 10.1002/bies.20636; Hiob MA, 2013, BIOMATERIALS, V34, P7584, DOI 10.1016/j.biomaterials.2013.06.036; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Khew ST, 2007, TISSUE ENG, V13, P2451, DOI 10.1089/ten.2007.0063; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Lau AK, 2003, CIRCULATION, V107, P2031, DOI 10.1161/01.CIR.0000062682.40051.43; Lee P, 2014, J BIOL CHEM, V289, P1467, DOI 10.1074/jbc.M113.518381; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; MECHAM RP, 1989, BIOCHEMISTRY-US, V28, P3716, DOI 10.1021/bi00435a014; Mould AP, 1998, BIOCHEM J, V331, P821, DOI 10.1042/bj3310821; Padfield GJ, 2010, J AM COLL CARDIOL, V55, P1553, DOI 10.1016/j.jacc.2009.10.070; Petit A, 2010, J BIOMED MATER RES A, V94A, P744, DOI 10.1002/jbm.a.32739; Robinet A, 2005, J CELL SCI, V118, P343, DOI 10.1242/jcs.01613; Rodgers UR, 2005, PATHOL BIOL, V53, P390, DOI 10.1016/j.patbio.2004.12.022; Rosenzweig A, 2006, NEW ENGL J MED, V355, P1274, DOI 10.1056/NEJMe068172; RUOSLAHTI E, 1984, CANCER METAST REV, V3, P43, DOI 10.1007/BF00047692; Sarratt KL, 2005, BLOOD, V106, P1268, DOI 10.1182/blood-2004-11-4434; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059; SMITH JW, 1991, J BIOL CHEM, V266, P11429; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; WALLER BF, 1987, HUM PATHOL, V18, P476, DOI 10.1016/S0046-8177(87)80032-1; Waterhouse A, 2011, TISSUE ENG PART B-RE, V17, P93, DOI [10.1089/ten.teb.2010.0432, 10.1089/ten.TEB.2010.0432]; Waterhouse A, 2010, BIOMATERIALS, V31, P8332, DOI 10.1016/j.biomaterials.2010.07.062; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Williamson MR, 2007, BIOMATERIALS, V28, P5307, DOI 10.1016/j.biomaterials.2007.08.019; Wilson BD, 2011, ANN BIOMED ENG, V39, P337, DOI 10.1007/s10439-010-0142-z; Wise SG, 2012, J FUNCT BIOMATER, V3, P569, DOI 10.3390/jfb3030569; Wu KK, 1996, ANNU REV MED, V47, P315; Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719; Yin YB, 2009, BIOMATERIALS, V30, P1675, DOI 10.1016/j.biomaterials.2008.11.009; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yoshioka T, 2006, CARDIOVASC RES, V70, P61, DOI 10.1016/j.cardiores.2005.12.013; Zheng CL, 2005, SURF COAT TECH, V193, P361, DOI 10.1016/j.surfcoat.2004.08.152	47	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131101	10.1371/journal.pone.0131101	http://dx.doi.org/10.1371/journal.pone.0131101			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115013	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500129
J	Eggink, LL; Spyroulias, GA; Jones, NG; Hanson, CV; Hoober, JK				Eggink, Laura L.; Spyroulias, Georgios A.; Jones, Norman G.; Hanson, Carl V.; Hoober, J. Kenneth			A Peptide Mimetic of 5-Acetylneuraminic Acid-Galactose Binds with High Avidity to Siglecs and NKG2D	PLOS ONE			English	Article							RECEPTOR CROSS-LINKING; IMMUNE CELL-FUNCTION; IMMUNORECEPTOR NKG2D; NEGATIVE REGULATION; CRYSTAL-STRUCTURE; LECTIN RECEPTORS; CIS LIGANDS; CD22; SPECIFICITY; IDENTIFICATION	We previously identified several peptide sequences that mimicked the terminal sugars of complex glycans. Using plant lectins as analogs of lectin-type cell-surface receptors, a tetravalent form of a peptide with the sequence NPSHPLSG, designated svH1C, bound with high avidity to lectins specific for glycans with terminal 5-acetylneuraminic acid (Neu5Ac)-galactose (Gal)/N-acetylgalactosamine (GalNAc) sequences. In this report, we show by circular dichroism and NMR spectra that svH1C lacks an ordered structure and thus interacts with binding sites from a flexible conformation. The peptide binds with high avidity to several recombinant human siglec receptors that bind preferentially to Neu5Ac(alpha 2,3)Gal, Neu5Ac (alpha 2,6)GalNAc or Neu5Ac(alpha 2,8)Neu5Ac ligands. In addition, the peptide bound the receptor NKG2D, which contains a lectin-like domain that binds Neu5Ac(alpha 2,3)Gal. The peptide bound to these receptors with a K-D in the range of 0.6 to 1 mu M. Binding to these receptors was inhibited by the glycoprotein fetuin, which contains multiple glycans that terminate in Neu5Ac(alpha 2,3) Gal or Neu5Ac(alpha 2,6) Gal, and by sialyllactose. Binding of svH1C was not detected with CLEC9a, CLEC10a or DC-SIGN, which are lectin-type receptors specific for other sugars. Incubation of neuraminidase-treated human peripheral blood mononuclear cells with svH1C resulted in binding of the peptide to a subset of the CD14(+) monocyte population. Tyrosine phosphorylation of siglecs decreased dramatically when peripheral blood mononuclear cells were treated with 100 nM svH1C. Subcutaneous, alternate-day injections of svH1C into mice induced several-fold increases in populations of several types of immune cells in the peritoneal cavity. These results support the conclusion that svH1C mimics Neu5Ac-containing sequences and interacts with cell-surface receptors with avidities sufficient to induce biological responses at low concentrations. The attenuation of inhibitory receptors suggests that svH1C has characteristics of a checkpoint inhibitor.	[Eggink, Laura L.; Hoober, J. Kenneth] Susav Biosci Inc, Tempe, AZ 85281 USA; [Spyroulias, Georgios A.] Univ Patras, Dept Pharm, GR-26504 Patras, Greece; [Jones, Norman G.; Hanson, Carl V.] Calif Dept Publ Hlth, Viral & Rickettsial Dis Lab, Richmond, CA 94804 USA	University of Patras; California Department of Public Health	Hoober, JK (corresponding author), Susav Biosci Inc, Tempe, AZ 85281 USA.	jkhoober@susavion.com			Susavion Biosciences, Inc.	Susavion Biosciences, Inc.	The work was supported by Susavion Biosciences, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino M, 2011, EXPERT OPIN BIOL TH, V11, P211, DOI 10.1517/14712598.2011.542140; Angata T, 2007, GLYCOBIOLOGY, V17, P838, DOI 10.1093/glycob/cwm049; Angata T, 2006, FASEB J, V20, P1964, DOI 10.1096/fj.06-5800com; BAENZIGER JU, 1979, J BIOL CHEM, V254, P789; Bakker TR, 2002, EUR J IMMUNOL, V32, P1924, DOI 10.1002/1521-4141(200207)32:7<1924::AID-IMMU1924>3.0.CO;2-N; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Blixt O, 2002, J AM CHEM SOC, V124, P5739, DOI 10.1021/ja017881+; Blixt O, 2003, J BIOL CHEM, V278, P31007, DOI 10.1074/jbc.M304331200; Blixt O, 2008, J AM CHEM SOC, V130, P6680, DOI 10.1021/ja801052g; Bone H, 2001, INT IMMUNOL, V13, P807, DOI 10.1093/intimm/13.6.807; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Cairo CW, 2002, J AM CHEM SOC, V124, P1615, DOI 10.1021/ja016727k; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Changeux JP, 2013, J BIOL CHEM, V288, P26969, DOI 10.1074/jbc.X113.503375; Cointe D, 1998, CARBOHYD RES, V311, P51, DOI 10.1016/S0008-6215(98)00196-7; Collins BE, 2004, P NATL ACAD SCI USA, V101, P6104, DOI 10.1073/pnas.0400851101; Collins BE, 2006, J IMMUNOL, V177, P2994, DOI 10.4049/jimmunol.177.5.2994; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dam TK, 2009, BIOCHEMISTRY-US, V48, P3822, DOI 10.1021/bi9002919; Del Valle JM, 2003, J BIOL CHEM, V278, P17430, DOI 10.1074/jbc.M301569200; Denda-Nagai K, 2010, J BIOL CHEM, V285, P19193, DOI 10.1074/jbc.M110.113613; ECCLES C, 1991, Journal of Biomolecular NMR, V1, P111, DOI 10.1007/BF01877224; Eggink Laura L, 2009, BMC Res Notes, V2, P23, DOI 10.1186/1756-0500-2-23; Eggink LL, 2010, AIDS RES HUM RETROV, V26, P149, DOI 10.1089/aid.2009.0155; Eggink LL, 2010, GLYCOBIOL INSIGHTS, V2, P1; Ehrhardt GRA, 2005, J EXP MED, V202, P783, DOI 10.1084/jem.20050879; Feinberg H, 2013, J BIOL CHEM, V288, P36762, DOI 10.1074/jbc.M113.528000; Garcia-Vallejo JJ, 2009, IMMUNOL REV, V230, P22, DOI 10.1111/j.1600-065X.2009.00786.x; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Geisler C, 2011, GLYCOBIOLOGY, V21, P988, DOI 10.1093/glycob/cwr080; GOLDFARB AR, 1951, J BIOL CHEM, V193, P397; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Harris SL, 1997, P NATL ACAD SCI USA, V94, P2454, DOI 10.1073/pnas.94.6.2454; HAYASE T, 1992, BIOCHEMISTRY-US, V31, P4915, DOI 10.1021/bi00135a024; Hecht ML, 2009, J PROTEOME RES, V8, P712, DOI 10.1021/pr800747c; Ikehara Y, 2004, J BIOL CHEM, V279, P43117, DOI 10.1074/jbc.M403538200; Imaizumi Y, 2009, BIOCHEM BIOPH RES CO, V382, P604, DOI 10.1016/j.bbrc.2009.03.081; Ito K, 2011, BIOCHEM BIOPH RES CO, V406, P377, DOI 10.1016/j.bbrc.2011.02.050; Jain D, 2000, J BIOL CHEM, V275, P16098, DOI 10.1074/jbc.275.21.16098; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Jellusova J, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00096; Jin L, 2002, J EXP MED, V195, P1199, DOI 10.1084/jem.20011796; Kelm S, 2002, J EXP MED, V195, P1207, DOI 10.1084/jem.20011783; Lang HS, 2006, BIOCHEM BIOPH RES CO, V344, P214, DOI 10.1016/j.bbrc.2006.03.112; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Magesh S, 2011, CURR MED CHEM, V18, P3537, DOI 10.2174/092986711796642580; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Marsh CB, 1998, J IMMUNOL, V160, P3942; Martin M, 2005, J IMMUNOL, V174, P5977, DOI 10.4049/jimmunol.174.10.5977; Matsubara T, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/740982; McFarland BJ, 2003, STRUCTURE, V11, P411, DOI 10.1016/S0969-2126(03)00047-9; Meyaard L, 1997, IMMUNITY, V7, P283, DOI 10.1016/S1074-7613(00)80530-0; O'Reilly MK, 2010, METHOD ENZYMOL, V478, P343, DOI 10.1016/S0076-6879(10)78017-4; O'Reilly MK, 2009, TRENDS PHARMACOL SCI, V30, P240, DOI 10.1016/j.tips.2009.02.005; OLDENBURG KR, 1992, P NATL ACAD SCI USA, V89, P5393, DOI 10.1073/pnas.89.12.5393; Pashov A, 2005, J BIOL CHEM, V280, P28959, DOI 10.1074/jbc.M502964200; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; Prescher H, 2014, ACS CHEM BIOL, V9, P1444, DOI 10.1021/cb400952v; SAIDEL LJ, 1952, J BIOL CHEM, V197, P285; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; SPIRO RG, 1974, J BIOL CHEM, V249, P5704; TAKASAKI S, 1986, BIOCHEMISTRY-US, V25, P5709, DOI 10.1021/bi00367a054; Tam JP, 1996, J IMMUNOL METHODS, V196, P17, DOI 10.1016/0022-1759(96)00066-X; Tateno H, 2010, J BIOL CHEM, V285, P6390, DOI 10.1074/jbc.M109.041863; Terabayashi T, 1996, CARBOHYD POLYM, V29, P35, DOI 10.1016/0144-8617(95)00153-0; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; van Kooyk Y, 2015, IMMUNOBIOLOGY, V220, P185, DOI 10.1016/j.imbio.2014.10.002; van Vliet SJ, 2008, TRENDS IMMUNOL, V29, P83, DOI 10.1016/j.it.2007.10.010; Vasileiou Z, 2009, J PEPT SCI, V15, P824, DOI 10.1002/psc.1182; Veillette A, 2006, NAT REV IMMUNOL, V6, P56, DOI 10.1038/nri1761; Walter RB, 2008, J LEUKOCYTE BIOL, V83, P200, DOI 10.1189/jlb.0607388; Yu LM, 2009, BIOORGAN MED CHEM, V17, P4825, DOI 10.1016/j.bmc.2009.03.054; Zafirova B, 2011, CELL MOL LIFE SCI, V68, P3519, DOI 10.1007/s00018-011-0797-0; Zhang M, 2004, GLYCOBIOLOGY, V14, P939, DOI 10.1093/glycob/cwh126; Zhang Z, 2001, J PROTEIN CHEM, V20, P423, DOI 10.1023/A:1012289022412; Zhuravleva MA, 2008, J MOL BIOL, V375, P437, DOI 10.1016/j.jmb.2007.10.009; Zou ZC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024559	79	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130532	10.1371/journal.pone.0130532	http://dx.doi.org/10.1371/journal.pone.0130532			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110603	gold, Green Published, Green Submitted			2022-12-27	WOS:000356933800060
J	Hillen, MR; Hartgring, SAY; Willis, CR; Radstake, TRDJ; Hack, CE; Lafeber, FPJG; van Roon, JAG				Hillen, Maarten R.; Hartgring, Sarita A. Y.; Willis, Cynthia R.; Radstake, Timothy R. D. J.; Hack, Cornelis E.; Lafeber, Floris P. J. G.; van Roon, Joel A. G.			The Additive Inflammatory In Vivo and In Vitro Effects of IL-7 and TSLP in Arthritis Underscore the Therapeutic Rationale for Dual Blockade	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; COLLAGEN-INDUCED ARTHRITIS; HUMAN EPITHELIAL-CELLS; CD4(+) T-CELLS; RHEUMATOID-ARTHRITIS; INTERLEUKIN-7 RECEPTOR; DENDRITIC CELLS; MICE; HOMEOSTASIS; ACTIVATION	Introduction The cytokines interleukin (IL)-7 and thymic stromal lymphopoietin (TSLP) signal through the IL-7R subunit and play proinflammatory roles in experimental arthritis and rheumatoid arthritis (RA). We evaluated the effect of inhibition of IL-7R- and TSLPR-signalling as well as simultaneous inhibition of IL-7R-and TSLPR-signalling in murine experimental arthritis. In addition, the effects of IL-7 and TSLP in human RA dendritic cell (DC)/T-cell co-cultures were studied. Methods Arthritis was induced with proteoglycan in wildtype mice (WT) and in mice deficient for the TSLP receptor subunit (TSLPR-/-). Both mice genotypes were treated with anti-IL-7R or phosphate buffered saline. Arthritis severity was assessed and local and circulating cytokines were measured. Autologous CD1c-positive DCs and CD4 T-cells were isolated from peripheral blood of RA patients and were co-cultured in the presence of IL-7, TSLP or both and proliferation and cytokine production were assessed. Results Arthritis severity and immunopathology were decreased in WT mice treated with anti-IL-7R, in TSLPR-/-mice, and the most robustly in TSLPR-/-mice treated with anti-IL-7R. This was associated with strongly decreased levels of IL-17, IL-6 and CD40L. In human DC/T-cell co-cultures, TSLP and IL-7 additively increased T-cell proliferation and production of Th17-associated cytokines, chemokines and tissue destruction factors. Conclusion TSLP and IL-7 have an additive effect on the production of Th17-cytokines in a human in vitro model, and enhance arthritis in mice linked with enhanced inflammation and immunopathology. As both cytokines signal via the IL-7R, these data urge for IL-7R-targeting to prevent the activity of both cytokines in RA.	[Hillen, Maarten R.; Hartgring, Sarita A. Y.; Radstake, Timothy R. D. J.; Hack, Cornelis E.; Lafeber, Floris P. J. G.; van Roon, Joel A. G.] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands; [Hillen, Maarten R.; Hartgring, Sarita A. Y.; Radstake, Timothy R. D. J.; Hack, Cornelis E.; van Roon, Joel A. G.] Univ Med Ctr Utrecht, Lab Translat Immunol, Utrecht, Netherlands; [Willis, Cynthia R.] Amgen Inc, Inflammat Lab, Seattle, WA USA	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Amgen	van Roon, JAG (corresponding author), Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands.	j.vanroon@umcutrecht.nl	Levi, Marcel/AAZ-8559-2020; Hillen, Maarten/T-8079-2019	Hillen, Maarten/0000-0002-9505-3468	Dutch Arthritis Association (het Nationaal Reumafonds) [10-1-406]	Dutch Arthritis Association (het Nationaal Reumafonds)	Dutch Arthritis Association (het Nationaal Reumafonds), www.reumafonds.nl/, Grant number 10-1-406. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Alves NL, 2009, P NATL ACAD SCI USA, V106, P1512, DOI 10.1073/pnas.0809559106; ARNETT FC, 1987, ARTHRITIS RHEUM, V31, P315; Boldizsar F, 2009, INT IMMUNOL, V21, P511, DOI 10.1093/intimm/dxp018; Carpino N, 2004, MOL CELL BIOL, V24, P2584, DOI 10.1128/MCB.24.6.2584-2592.2004; Chappaz S, 2007, BLOOD, V110, P3862, DOI 10.1182/blood-2007-02-074245; Doodes PD, 2010, J IMMUNOL, V184, P1552, DOI 10.4049/jimmunol.0902907; Hartgring SAY, 2011, ARTHRITIS RHEUM-US, V63, P1878, DOI 10.1002/art.30336; Hartgring SAY, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3870; Hartgring SAY, 2010, ARTHRITIS RHEUM-US, V62, P2716, DOI 10.1002/art.27578; Huan J, 2008, J IMMUNOL, V180, P1249, DOI 10.4049/jimmunol.180.2.1249; Iezzi G, 2009, P NATL ACAD SCI USA, V106, P876, DOI 10.1073/pnas.0810769106; Kashyap M, 2011, J IMMUNOL, V187, P1207, DOI 10.4049/jimmunol.1100355; Kaur D, 2012, CHEST, V142, P76, DOI 10.1378/chest.11-1782; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Koyama K, 2007, BIOCHEM BIOPH RES CO, V357, P99, DOI 10.1016/j.bbrc.2007.03.081; Moret FM, 2013, ARTHRITIS RHEUM-US, V65, pS398; Moret FM, 2014, ARTHRITIS RHEUMATOL, V66, P1176, DOI 10.1002/art.38338; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Ozawa Tetsuro, 2007, Mod Rheumatol, V17, P459, DOI 10.1007/s10165-007-0620-9; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; Rochman I, 2007, J IMMUNOL, V178, P6720, DOI 10.4049/jimmunol.178.11.6720; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Tsuboi I, 2004, EXP BIOL MED, V229, P494, DOI 10.1177/153537020422900607; van Roon JAG, 2005, ARTHRITIS RHEUM, V52, P1700, DOI 10.1002/art.21045; van Roon JAG, 2003, ANN RHEUM DIS, V62, P113, DOI 10.1136/ard.62.2.113; Watanabe N, 2004, NAT IMMUNOL, V5, P426, DOI 10.1038/ni1048; Wu WH, 2010, J ALLERGY CLIN IMMUN, V126, P290, DOI 10.1016/j.jaci.2010.05.024; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183	35	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130830	10.1371/journal.pone.0130830	http://dx.doi.org/10.1371/journal.pone.0130830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110994	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800090
J	Somma, F; D'Angelo, R; Serra, N; Gatta, G; Grassi, R; Fiore, F				Somma, Francesco; D'Angelo, Roberto; Serra, Nicola; Gatta, Gianluca; Grassi, Roberto; Fiore, Francesco			Use of Ethanol in the Trans-Arterial Lipiodol Embolization (TAELE) of Intermediated-Stage HCC: Is This Safer than Conventional Trans-Arterial Chemo-Embolization (c-TACE)?	PLOS ONE			English	Article							UNRESECTABLE HEPATOCELLULAR-CARCINOMA; TRANSARTERIAL CHEMOEMBOLIZATION; TRANSCATHETER; SURVIVAL; ABLATION; MIXTURE; EFFICACY; THERAPY; LOBAR; TERM	Purpose To evaluate safety and efficacy of Trans-Arterial Ethanol-Lipiodol Embolization (TAELE) compared with conventional Trans-Arterial Chemo-Embolization (cTACE) in the treatment of small intermediate-HCC (BCLC-Stage B). Materials and Methods A random sample of 87 patients (37.93% male; 62.07% female; age range, 36-86 years) with documented small intermediate-HCC and treated with TAELE (mixture 1: 1 of Ethanol and Lipiodol) or cTACE (mixture of 50mg-Epirubicin and 5cc-Lipiodol) were retrospectively studied in an institutional review board approved protocol. The two procedures were compared with chi(2)-test, chi(2)-test with Yates correction, McNemar's exact test, ANOVA test and log-rank test. Results TAELE and cTACE therapies were performed in 45 and 42 patients, respectively. Thirty days after the procedure, a Multi-Detector Computed Tomography (MDCT) showed no significant difference in the number of patients with partial and complete response between the two groups (p-value = 0.958), according to mRECIST. Contrary, significant differences were found in tumor-devascularization, lesion-reduction and post-embolization syndrome occurrence (p-value = 0.0004, p-value = 0.0003 and p-value = 0.009, respectively). Similar survival was observed during 36-month follow-up (p-value = 0.884). Conclusion Compared to cTACE, TAELE showed a better toxicity profile with similar 36-month survival and similar one-month anti-tumor effects, which makes it better tolerated by patients, especially in case of more than one treatment.	[Somma, Francesco; Serra, Nicola; Gatta, Gianluca; Grassi, Roberto] SUN, Sect Radiol, Dept Med & Surg Magrassi & Lanzara, Naples, Italy; [D'Angelo, Roberto; Fiore, Francesco] Natl Canc Inst Naples Fdn Pascale, Dept Intervent Radiol, Naples, Italy	Universita della Campania Vanvitelli	Somma, F (corresponding author), SUN, Sect Radiol, Dept Med & Surg Magrassi & Lanzara, Naples, Italy.	fra1585@hotmail.it	Grassi, Roberto/AAL-5045-2020; Somma, Francesco/AAA-9462-2021	Grassi, Roberto/0000-0002-3587-474X; GATTA, Gianluca/0000-0003-0874-8294; Serra, Nicola/0000-0001-8086-6362; Somma, Francesco/0000-0002-8193-3050				BREEDIS C, 1954, AM J PATHOL, V30, P969; Bruix J, 2004, GASTROENTEROLOGY, V127, pS179, DOI 10.1053/j.gastro.2004.09.032; BRUIX J, 1994, HEPATOLOGY, V20, P643, DOI 10.1002/hep.1840200315; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2009, LANCET, V373, P614, DOI 10.1016/S0140-6736(09)60381-0; Buijs M, 2008, RADIOLOGY, V249, P346, DOI 10.1148/radiol.2483071902; Camma C, 2002, RADIOLOGY, V224, P47, DOI 10.1148/radiol.2241011262; Cheng YF, 2000, WORLD J SURG, V24, P844, DOI 10.1007/s002680010135; Cheung YC, 2005, WORLD J GASTROENTERO, V11, P2792, DOI 10.3748/wjg.v11.i18.2792; Choi JY, 2011, ONCOLOGY-BASEL, V81, P141, DOI 10.1159/000333277; Chung JW, 1996, RADIOLOGY, V198, P33, DOI 10.1148/radiology.198.1.8539401; Clayton D, 1993, STAT MODELS EPIDEMIO, p[27, 146]; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; FARMER DG, 1994, ANN SURG, V219, P236, DOI 10.1097/00000658-199403000-00003; Fiore F, 2014, ENDOCRINE; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; Gu YK, 2010, WORLD J GASTROENTERO, V16, P5766, DOI 10.3748/wjg.v16.i45.5766; Hogg RV., 1987, ENG STAT; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Leung DA, 2001, J VASC INTERV RADIOL, V12, P321, DOI 10.1016/S1051-0443(07)61911-3; Lewandowski RJ, 2009, AM J TRANSPLANT, V9, P1920, DOI 10.1111/j.1600-6143.2009.02695.x; Lewandowski RJ, 2010, RADIOLOGY, V255, P955, DOI 10.1148/radiol.10091473; Liapi E, 2007, J CLIN ONCOL, V25, P978, DOI 10.1200/JCO.2006.09.8657; Llovet JM, 2005, J GASTROENTEROL, V40, P225, DOI 10.1007/s00535-005-1566-3; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Marelli L, 2007, CARDIOVASC INTER RAD, V30, P6, DOI 10.1007/s00270-006-0062-3; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Oliveri RS, 2011, CAMPBELL SYSTEMATIC, V3, P1; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Park J H, 1993, J Vasc Interv Radiol, V4, P333; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Sangiovanni A, 2004, GASTROENTEROLOGY, V126, P1005, DOI 10.1053/j.gastro.2003.12.049; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Syha R, 2012, EUR J GASTROEN HEPAT, V24, P1325, DOI 10.1097/MEG.0b013e32835724bc; Varela M, 2003, CANCER TREAT REV, V29, P99, DOI 10.1016/S0305-7372(02)00123-8; Wigmore SJ, 2003, BRIT J CANCER, V89, P1423, DOI 10.1038/sj.bjc.6601329; Yu SCH, 2009, J VASC INTERV RADIOL, V20, P352, DOI 10.1016/j.jvir.2008.12.407	41	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0129573	10.1371/journal.pone.0129573	http://dx.doi.org/10.1371/journal.pone.0129573			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110810	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800027
J	Taylor-Burds, C; Cheng, P; Wray, S				Taylor-Burds, Carol; Cheng, Paul; Wray, Susan			Chloride Accumulators NKCC1 and AE2 in Mouse GnRH Neurons: Implications for GABA(A) Mediated Excitation	PLOS ONE			English	Article							HORMONE-RELEASING HORMONE; GAMMA-AMINOBUTYRIC-ACID; ROOT GANGLION NEURONS; NA-K-2CL COTRANSPORTER; CL-/HCO3-EXCHANGER; TARGETED DISRUPTION; CALCIUM OSCILLATOR; EXPRESSION; ADULT; ACTIVATION	A developmental "switch" in chloride transporters occurs in most neurons resulting in GABA(A) mediated hyperpolarization in the adult. However, several neuronal cell subtypes maintain primarily depolarizing responses to GABA(A) receptor activation. Among this group are gonadotropin-releasing hormone-1 (GnRH) neurons, which control puberty and reproduction. NKCC1 is the primary chloride accumulator in neurons, expressed at high levels early in development and contributes to depolarization after GABA(A) receptor activation. In contrast, KCC2 is the primary chloride extruder in neurons, expressed at high levels in the adult and contributes to hyperpolarization after GABA(A) receptor activation. Anion exchangers (AEs) are also potential modulators of responses to GABA(A) activation since they accumulate chloride and extrude bicarbonate. To evaluate the mechanism(s) underlying GABA(A) mediated depolarization, GnRH neurons were analyzed for 1) expression of chloride transporters and AEs in embryonic, pre-pubertal, and adult mice 2) responses to GABA(A) receptor activation in NKCC1(-/-) mice and 3) function of AEs in these responses. At all ages, GnRH neurons were immunopositive for NKCC1 and AE2 but not KCC2 or AE3. Using explants, calcium imaging and gramicidin perforated patch clamp techniques we found that GnRH neurons from NKCC1(-/-) mice retained relatively normal responses to the GABA(A) agonist muscimol. However, acute pharmacological inhibition of NKCC1 with bumetanide eliminated the depolarization/calcium response to muscimol in 40% of GnRH neurons from WT mice. In the remaining GnRH neurons, HCO3- mediated mechanisms accounted for the remaining calcium responses to muscimol. Collectively these data reveal mechanisms responsible for maintaining depolarizing GABA(A) mediated transmission in GnRH neurons.	[Taylor-Burds, Carol; Cheng, Paul; Wray, Susan] NINDS, Cellular & Dev Neurobiol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wray, S (corresponding author), NINDS, Cellular & Dev Neurobiol Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	wrays@ninds.nih.gov	Wray, Susan/AAT-2088-2021	Taylor-Burds, Carol/0000-0002-6784-2232; wray, susan/0000-0001-7670-3915; Cheng-Hathaway, Paul/0000-0002-3240-9316	Intramural Research Program of National Institutes of Health, National Institute of Neurological Disorder and Stroke Grant award [NS002824-23]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002824] Funding Source: NIH RePORTER	Intramural Research Program of National Institutes of Health, National Institute of Neurological Disorder and Stroke Grant award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Neurological Disorder and Stroke Grant NS002824-23 awarded to SW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper SL, 2006, EXP PHYSIOL, V91, P153, DOI 10.1113/expphysiol.2005.031765; Barragan-Iglesias P, 2014, EUR J PHARMACOL, V738, P91, DOI 10.1016/j.ejphar.2014.05.029; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Ben-Ari Y, 2012, NEUROSCIENTIST, V18, P467, DOI 10.1177/1073858412438697; Bhattarai JP, 2011, ENDOCRINOLOGY, V152, P1551, DOI 10.1210/en.2010-1191; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Chiang PH, 2012, J NEUROSCI, V32, P62, DOI 10.1523/JNEUROSCI.3393-11.2012; Choi HJ, 2008, J NEUROSCI, V28, P5450, DOI 10.1523/JNEUROSCI.5750-07.2008; Constantin S, 2008, ENDOCRINOLOGY, V149, P3500, DOI 10.1210/en.2007-1508; Constantin S, 2013, J NEUROSCI, V33, P9394, DOI 10.1523/JNEUROSCI.0533-13.2013; Constantin S, 2010, ENDOCRINOLOGY, V151, P3863, DOI 10.1210/en.2010-0118; Constantin S, 2010, ENDOCRINOLOGY, V151, P262, DOI 10.1210/en.2009-0817; Constantin S, 2009, ENDOCRINOLOGY, V150, P1400, DOI 10.1210/en.2008-0979; DeFazio RA, 2002, MOL ENDOCRINOL, V16, P2872, DOI 10.1210/me.2002-0163; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Forni PE, 2014, FRONT NEUROENDOCRINO; FUESHKO S, 1994, DEV BIOL, V166, P331, DOI 10.1006/dbio.1994.1319; Gangatirkar P, 2002, HYBRIDOMA HYBRIDOM, V21, P281, DOI 10.1089/153685902760213895; Gawenis LR, 2010, AM J PHYSIOL-GASTR L, V298, pG493, DOI 10.1152/ajpgi.00178.2009; Gawenis LR, 2004, J BIOL CHEM, V279, P30531, DOI 10.1074/jbc.M403779200; Giacobini P, 2004, J NEUROSCI, V24, P4737, DOI 10.1523/JNEUROSCI.0649-04.2004; Gonzalez-Islas C, 2009, J NEUROPHYSIOL, V101, P507, DOI 10.1152/jn.90986.2008; Haam J, 2012, J NEUROSCI, V32, P572, DOI 10.1523/JNEUROSCI.3826-11.2012; Haering C, 2015, J BIOL CHEM, V290, P9767, DOI 10.1074/jbc.M115.640656; Han SK, 2002, ENDOCRINOLOGY, V143, P1459, DOI 10.1210/en.143.4.1459; HAVENGA MJE, 1994, MOL BRAIN RES, V25, P97, DOI 10.1016/0169-328X(94)90283-6; Hemond PJ, 2012, J NEUROSCI, V32, P8756, DOI 10.1523/JNEUROSCI.4188-11.2012; Hentschke M, 2006, MOL CELL BIOL, V26, P182, DOI 10.1128/MCB.26.1.182-191.2006; Herbison AE, 2011, J NEUROENDOCRINOL, V23, P557, DOI 10.1111/j.1365-2826.2011.02145.x; Keep RF, 1997, ACT NEUR S, V70, P279; Klenke U., 2012, CURR PROTOC NEUROSCI, DOI DOI 10.1002/0471142301.NS0325S59; Klenke U, 2010, ENDOCRINOLOGY, V151, P2736, DOI 10.1210/en.2009-1198; KOPITO RR, 1989, CELL, V59, P927, DOI 10.1016/0092-8674(89)90615-6; Kramer PR, 2000, ENDOCRINOLOGY, V141, P1823, DOI 10.1210/en.141.5.1823; Kramer PR, 2000, GENE DEV, V14, P1824; Kramer PR, 2002, J STEROID BIOCHEM, V81, P203, DOI 10.1016/S0960-0760(02)00065-1; KUDRYCKI KE, 1990, J BIOL CHEM, V265, P462; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; Lee K, 2010, J NEUROSCI, V30, P6214, DOI 10.1523/JNEUROSCI.6156-09.2010; Leupen SM, 2003, ENDOCRINOLOGY, V144, P3031, DOI 10.1210/en.2002-220995; LEVINE JE, 1982, ENDOCRINOLOGY, V111, P1439, DOI 10.1210/endo-111-5-1439; Liu XH, 2011, J NEUROSCI, V31, P2421, DOI 10.1523/JNEUROSCI.5759-10.2011; Mao SH, 2012, J NEUROPHYSIOL, V108, P834, DOI 10.1152/jn.00970.2011; Medina JF, 2003, P NATL ACAD SCI USA, V100, P15847, DOI 10.1073/pnas.2536127100; Moenter SM, 2005, ENDOCRINOLOGY, V146, P5374, DOI 10.1210/en.2005-0788; Nickell WT, 2007, J PHYSIOL-LONDON, V583, P1005, DOI 10.1113/jphysiol.2007.129601; Pace AJ, 2000, J CLIN INVEST, V105, P441, DOI 10.1172/JCI8553; Pfeffer CK, 2009, J NEUROSCI, V29, P3419, DOI 10.1523/JNEUROSCI.1377-08.2009; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; RALEYSUSMAN KM, 1993, BRAIN RES, V614, P308, DOI 10.1016/0006-8993(93)91049-X; Reisert J, 2005, NEURON, V45, P553, DOI 10.1016/j.neuron.2005.01.012; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Romano N, 2008, ENDOCRINOLOGY, V149, P5335, DOI 10.1210/en.2008-0424; Schobel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048005; SCHWANZELFUKUDA M, 1989, MOL BRAIN RES, V6, P311, DOI 10.1016/0169-328X(89)90076-4; Sipila ST, 2009, J NEUROSCI, V29, P6982, DOI 10.1523/JNEUROSCI.0443-09.2009; Spergel DJ, 1999, J NEUROSCI, V19, P2037; Stein V, 2004, J COMP NEUROL, V468, P57, DOI 10.1002/cne.10983; Sun L, 2012, EUR J NEUROSCI, V35, P661, DOI 10.1111/j.1460-9568.2012.08007.x; Sung KW, 2000, J NEUROSCI, V20, P7531; Temple JL, 2005, J NEUROENDOCRINOL, V17, P591, DOI 10.1111/j.1365-2826.2005.01348.x; Watanabe M, 2009, BIOL REPROD, V81, P327, DOI 10.1095/biolreprod.108.074583; WRAY S, 1988, PEPTIDES, V9, P1151, DOI 10.1016/0196-9781(88)90103-9; Wray S, 1996, DEV BIOL, V180, P631, DOI 10.1006/dbio.1996.0334; WRAY S, 1989, DEV BRAIN RES, V46, P309, DOI 10.1016/0165-3806(89)90295-2; Yin SK, 2008, HEARING RES, V237, P32, DOI 10.1016/j.heares.2007.12.008	67	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131076	10.1371/journal.pone.0131076	http://dx.doi.org/10.1371/journal.pone.0131076			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110920	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800115
J	Yoshimi, K; Kumada, S; Weitemier, A; Jo, T; Inoue, M				Yoshimi, Kenji; Kumada, Shiori; Weitemier, Adam; Jo, Takayuki; Inoue, Masato			Reward-Induced Phasic Dopamine Release in the Monkey Ventral Striatum and Putamen	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS CORE; NEURONS; BRAIN; STIMULI; RESPONSES; DORSAL; MICROELECTRODES; TRANSMISSION; VOLTAMMETRY; DYNAMICS	In-vivo voltammetry has successfully been used to detect dopamine release in rodent brains, but its application to monkeys has been limited. We have previously detected dopamine release in the caudate of behaving Japanese monkeys using diamond microelectrodes (Yoshimi 2011); however it is not known whether the release pattern is the same in various areas of the forebrain. Recent studies have suggested variations in the dopaminergic projections to forebrain areas. In the present study, we attempted simultaneous recording at two locations in the striatum, using fast-scan cyclic voltammetry (FSCV) on carbon fibers, which has been widely used in rodents. Responses to unpredicted food and liquid rewards were detected repeatedly. The response to the liquid reward after conditioned stimuli was enhanced after switching the prediction cue. These characteristics were generally similar between the ventral striatum and the putamen. Overall, the technical application of FSCV recording in multiple locations was successful in behaving primates, and further voltammetric recordings in multiple locations will expand our knowledge of dopamine reward responses.	[Yoshimi, Kenji; Inoue, Masato] Juntendo Univ, Sch Med, Dept Neurophysiol, Bunkyo Ku, Tokyo 113, Japan; [Kumada, Shiori] Japan Womens Univ, Dept Psychol, Kawasaki, Kanagawa, Japan; [Weitemier, Adam] RIKEN, BSI, Wako, Saitama, Japan; [Jo, Takayuki] Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 113, Japan	Juntendo University; Japan Womens University; RIKEN; Juntendo University	Yoshimi, K (corresponding author), Juntendo Univ, Sch Med, Dept Neurophysiol, Bunkyo Ku, Tokyo 113, Japan.	yoshimik@juntendo.ac.jp			Juntendo University Research Institute for Diseases of Old Age, a MEXT-Supported Program for the Strategic Research Foundation at Private Universities	Juntendo University Research Institute for Diseases of Old Age, a MEXT-Supported Program for the Strategic Research Foundation at Private Universities	This study was supported by Juntendo University Research Institute for Diseases of Old Age, a MEXT-Supported Program for the Strategic Research Foundation at Private Universities.	Ariansen JL, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00036; Badrinarayan A, 2012, J NEUROSCI, V32, P15779, DOI 10.1523/JNEUROSCI.3557-12.2012; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Brown HD, 2011, EUR J NEUROSCI, V34, P1997, DOI 10.1111/j.1460-9568.2011.07914.x; Cacciapaglia F, 2012, NEUROPHARMACOLOGY, V62, P2050, DOI 10.1016/j.neuropharm.2011.12.027; Chang SY, 2013, J NEUROSURG, V119, P1556, DOI 10.3171/2013.8.JNS122142; Cheer JF, 2005, P NATL ACAD SCI USA, V102, P19150, DOI 10.1073/pnas.0509607102; Chuhma N, 2014, NEURON, V81, P901, DOI 10.1016/j.neuron.2013.12.027; Clark JJ, 2013, J NEUROSCI, V33, P3526, DOI 10.1523/JNEUROSCI.5119-12.2013; Danjo T, 2014, P NATL ACAD SCI USA, V111, P6455, DOI 10.1073/pnas.1404323111; Gale JT, 2013, STEREOT FUNCT NEUROS, V91, P355, DOI 10.1159/000351523; Gerhardt GA, 1996, J NEUROCHEM, V66, P579; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Heien MLAV, 2005, P NATL ACAD SCI USA, V102, P10023, DOI 10.1073/pnas.0504657102; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Natori S, 2009, NEUROSCI RES, V63, P267, DOI 10.1016/j.neures.2008.12.011; PIFL C, 1991, NEUROSCIENCE, V44, P591, DOI 10.1016/0306-4522(91)90080-8; Rice ME, 2011, NEUROSCIENCE, V198, P112, DOI 10.1016/j.neuroscience.2011.08.066; Roeper J, 2013, TRENDS NEUROSCI, V36, P336, DOI 10.1016/j.tins.2013.03.003; Saleem KS, 2012, BRAIN, DOI [10.1016/j.mri.2010.03.023, DOI 10.1016/J.MRI.2010.03.023]; Schluter EW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098692; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Shon YM, 2010, NEUROSCI LETT, V475, P136, DOI 10.1016/j.neulet.2010.03.060; Swamy BEK, 2007, ANAL CHEM, V79, P744, DOI 10.1021/ac061820i; Takikawa Y, 2004, J NEUROPHYSIOL, V92, P2520, DOI 10.1152/jn.00238.2004; Venton BJ, 2002, ANAL CHEM, V74, P539, DOI 10.1021/ac010819a; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; WIGHTMAN RM, 1988, NEUROSCIENCE, V25, P513, DOI 10.1016/0306-4522(88)90255-2; Yoshimi K, 2005, ANN NEUROL, V58, P31, DOI 10.1002/ana.20506; Yoshimi K, 2014, ANAL CHEM, V86, P8576, DOI 10.1021/ac500706m; Yoshimi K, 2011, NEUROSCI RES, V71, P49, DOI 10.1016/j.neures.2011.05.013; Zhang LF, 2009, MOL PHARMACOL, V76, P396, DOI 10.1124/mol.109.056317; Zhang T, 2009, J NEUROSCI, V29, P4035, DOI 10.1523/JNEUROSCI.0261-09.2009	35	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130443	10.1371/journal.pone.0130443	http://dx.doi.org/10.1371/journal.pone.0130443			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110516	gold, Green Published, Green Submitted			2022-12-27	WOS:000356933800047
J	Corbett-Detig, R; Jacobs-Palmer, E; Hartl, D; Hoekstra, H				Corbett-Detig, Russell; Jacobs-Palmer, Emily; Hartl, Daniel; Hoekstra, Hopi			Direct Gamete Sequencing Reveals No Evidence for Segregation Distortion in House Mouse Hybrids	PLOS ONE			English	Article							NON-MENDELIAN TRANSMISSION; MEIOTIC DRIVE; MALE-STERILITY; SPECIATION; EXPLANATION; INHERITANCE; DISCOVERY; GENETICS; LOCUS	Understanding the molecular basis of species formation is an important goal in evolutionary genetics, and Dobzhansky-Muller incompatibilities are thought to be a common source of postzygotic reproductive isolation between closely related lineages. However, the evolutionary forces that lead to the accumulation of such incompatibilities between diverging taxa are poorly understood. Segregation distorters are believed to be an important source of Dobzhansky-Muller incompatibilities between hybridizing species of Drosophila as well as hybridizing crop plants, but it remains unclear if these selfish genetic elements contribute to reproductive isolation in other taxa. Here, we collected viable sperm from first-generation hybrid male progeny of Mus musculus castaneus and M. m. domesticus, two subspecies of rodent in the earliest stages of speciation. We then genotyped millions of single nucleotide polymorphisms in these gamete pools and tested for a skew in the frequency of parental alleles across the genome. We show that segregation distorters are not measurable contributors to observed infertility in these hybrid males, despite sufficient statistical power to detect even weak segregation distortion with our novel method. Thus, reduced hybrid male fertility in crosses between these nascent species is attributable to other evolutionary forces.	[Corbett-Detig, Russell; Jacobs-Palmer, Emily; Hartl, Daniel; Hoekstra, Hopi] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Jacobs-Palmer, Emily; Hoekstra, Hopi] Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Museum Comparat Zool, Cambridge, MA 02138 USA	Harvard University; Harvard University; Howard Hughes Medical Institute	Corbett-Detig, R (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	russcd@gmail.com; hoekstra@oeb.harvard.edu	Corbett-Detig, Russ/Y-9659-2019; Hoekstra, Hopi E/I-6690-2012	Hoekstra, Hopi E/0000-0003-1431-1769	Howard Hughes Medical Institute; Harvard Prize Graduate Fellowship; UCB Chancellor's Postdoctoral Fellowship; NSF Predoctoral Fellowship	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Harvard Prize Graduate Fellowship; UCB Chancellor's Postdoctoral Fellowship; NSF Predoctoral Fellowship(National Science Foundation (NSF))	This work was funded by the Howard Hughes Medical Institute. RCD was supported by a Harvard Prize Graduate Fellowship and currently a UCB Chancellor's Postdoctoral Fellowship; EJP was supported by an NSF Predoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bohn GW, 1940, RESEARCH BULLETIN MI, V311; Boursot P, 1996, J EVOLUTION BIOL, V9, P391, DOI 10.1046/j.1420-9101.1996.9040391.x; Bradshaw HD, 2003, NATURE, DOI [10.1007/s00294-003, DOI 10.1007/S00294-003]; CAMERON DR, 1957, GENETICS, V42, P326; Cocquet J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002900; Cox A, 2009, GENETICS, V182, P1335, DOI 10.1534/genetics.109.105486; Coyne J.A., 2004, SPECIATION; Cutter AD, 2012, TRENDS ECOL EVOL, V27, P209, DOI 10.1016/j.tree.2011.11.004; Davis RC, 2007, GENOMICS, V90, P306, DOI 10.1016/j.ygeno.2007.05.009; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobzhansky T, 1937, GENETICS AND THE ORI; EVANS K, 1994, NAT GENET, V6, P210, DOI 10.1038/ng0294-210; FRANK SA, 1991, EVOLUTION, V45, P262, DOI 10.1111/j.1558-5646.1991.tb04401.x; Geraldes A, 2008, MOL ECOL, V17, P5349, DOI 10.1111/j.1365-294X.2008.04005.x; HARTL DL, 1975, THEOR POPUL BIOL, V7, P168, DOI 10.1016/0040-5809(75)90012-X; Holt WV, 2010, J EVOLUTION BIOL, V23, P598, DOI 10.1111/j.1420-9101.2010.01935.x; HURST LD, 1991, GENETICS, V128, P841; Ikeuchi T, 1996, AM J HUM GENET, V58, P730; JARVIK GP, 1994, AM J HUM GENET, V55, P710; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Lassance JM, 2010, NATURE, V466, P486, DOI 10.1038/nature09058; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LOEGERING WQ, 1963, CAN J GENET CYTOL, V5, P65, DOI 10.1139/g63-010; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; McDermott SR, 2010, PHILOS T R SOC B, V365, P1265, DOI 10.1098/rstb.2009.0264; Merrill C, 1999, SCIENCE, V283, P1742, DOI 10.1126/science.283.5408.1742; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Muller HJ, 1942, BIOL S, V6, P71; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Noor MAF, 2006, NAT REV GENET, V7, P851, DOI 10.1038/nrg1968; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; SANO Y, 1979, JPN J GENET, V54, P121, DOI 10.1266/jjg.54.121; Tao Y, 2007, PLOS BIOL, DOI [10.1371/journal.pbio.0050293.g001, DOI 10.1371/JOURNAL.PBIO.0050293.G001]; Tao Y, 2007, PLOS BIOL, V5, P2560, DOI 10.1371/journal.pbio.0050292; Taylor DR, 2003, GENETICA, V117, P27, DOI 10.1023/A:1022308414864; Team RDC, R LANG ENV STAT COMP; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Wagner J, 2010, THESIS; White MA, 2012, GENETICS, V191, P917, DOI 10.1534/genetics.112.140251; Wu CI, 2004, NAT REV GENET, V5, P114, DOI 10.1038/nrg1269; Yang J, 2012, SCIENCE, DOI [10.1126/science.1222597, DOI 10.1126/SCIENCE.1222597]	46	5	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131933	10.1371/journal.pone.0131933	http://dx.doi.org/10.1371/journal.pone.0131933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121240	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400182
J	Birgersson, E; Tang, EH; Lee, WLJ; Sak, KJ				Birgersson, Erik; Tang, Ee Ho; Lee, Wei Liang Jerome; Sak, Kwok Jiang			Reduction of Carbon Dioxide in Filtering Facepiece Respirators with an Active-Venting System: A Computational Study	PLOS ONE			English	Article							N95; HEALTH; IMPACT; FLOW	During expiration, the carbon dioxide (CO2) levels inside the dead space of a filtering face-piece respirator (FFR) increase significantly above the ambient concentration. To reduce the CO2 concentration inside the dead space, we attach an active lightweight venting system (AVS) comprising a one-way valve, a blower and a battery in a housing to a FFR. The achieved reduction is quantified with a computational-fluid-dynamics model that considers conservation of mass, momentum and the dilute species, CO2, inside the FFR with and without the AVS. The results suggest that the AVS can reduce the CO2 levels inside the dead space at the end of expiration to around 0.4% as compared to a standard FFR, for which the CO2 levels during expiration reach the same concentration as that of the expired alveolar air at around 5%. In particular, during inspiration, the average CO2 volume fraction drops to near-to ambient levels of around 0.08% with the AVS. Overall, the time-averaged CO2 volume fractions inside the dead space for the standard FFR and the one with AVS are around 3% and 0.3% respectively. Further, the ability of the AVS to vent the dead-space air in the form of a jet into the ambient - similar to the jets arising from natural expiration without a FFR ensures that the expired air is removed and diluted more efficiently than a standard FFR.	[Birgersson, Erik] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117548, Singapore; [Tang, Ee Ho; Lee, Wei Liang Jerome; Sak, Kwok Jiang] ST Dynam, Singapore, Singapore	National University of Singapore	Birgersson, E (corresponding author), Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117548, Singapore.	chebke@nus.edu.sg		Birgersson, Erik/0000-0003-4012-1467	ST Dynamics; National University of Singapore	ST Dynamics; National University of Singapore(National University of Singapore)	The financial support of ST Dynamics and National University of Singapore is gratefully acknowledged. ST Dynamics provided support in the form of salaries for authors EHT, WLJL, KJS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird R., 2006, WILEY INT EDITION; Gupta JK, 2010, INDOOR AIR, V20, P31, DOI 10.1111/j.1600-0668.2009.00623.x; Guyton A., 2004, TXB MED PHYSL; Lee JH, 2010, RESP PHYSIOL NEUROBI, V172, P136, DOI 10.1016/j.resp.2010.05.010; Lei ZP, 2013, ANN OCCUP HYG, V57, P493, DOI 10.1093/annhyg/mes085; Nield D.A., 1992, CONVECTION POROUS ME; Roberge R, 2012, ANN OCCUP HYG, V56, P808, DOI 10.1093/annhyg/mes001; Roberge RJ, 2012, J OCCUP ENVIRON HYG, V9, P166, DOI 10.1080/15459624.2012.660428; Roberge RJ, 2012, ANN OCCUP HYG, V56, P102, DOI 10.1093/annhyg/mer069; Roberge RJ, 2010, RESP CARE, V55, P569; Sinkule EJ, 2013, ANN OCCUP HYG, V57, P384, DOI 10.1093/annhyg/mes068; Smith CL, 2013, ERGONOMICS, V56, P781, DOI 10.1080/00140139.2013.777128; Versteeg H.K., 1998, INTRO COMPUTATIONAL; Williams W., 2010, J INT SOC RESP PROTE, V27, P27; Zhao D, 2014, SENSOR ACTUAT B-CHEM, V195, P171, DOI 10.1016/j.snb.2013.12.110	15	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130306	10.1371/journal.pone.0130306	http://dx.doi.org/10.1371/journal.pone.0130306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115090	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500065
J	Mai-Prochnow, A; Bradbury, M; Ostrikov, K; Murphy, AB				Mai-Prochnow, Anne; Bradbury, Mark; Ostrikov, Kostya; Murphy, Anthony B.			Pseudomonas aeruginosa Biofilm Response and Resistance to Cold Atmospheric Pressure Plasma Is Linked to the Redox-Active Molecule Phenazine	PLOS ONE			English	Article							NONTHERMAL PLASMA; DISCHARGE PLASMA; OXIDATIVE STRESS; IN-VITRO; PYOCYANIN; COMMUNITY; ANTIBIOTICS; DISPERSAL; TOLERANCE	Pseudomonas aeruginosa is an important opportunistic pathogen displaying high antibiotic resistance. Its resistance is in part due to its outstanding ability to form biofilms on a range of biotic and abiotic surfaces leading to difficult-to-treat, often long-term infections. Cold atmospheric plasma (CAP) is a new, promising antibacterial treatment to combat antibiotic-resistant bacteria. Plasma is ionized gas that has antibacterial properties through the generation of a mix of reactive oxygen and nitrogen species (RONS), excited molecules, charged particles and UV photons. Our results show the efficient removal of P. aeruginosa biofilms using a plasma jet (kINPen med), with no viable cells detected after 5 min treatment and no attached biofilm cells visible with confocal microscopy after 10 min plasma treatment. Because of its multi-factorial action, it is widely presumed that the development of bacterial resistance to plasma is unlikely. However, our results indicate that a short plasma treatment (3 min) may lead to the emergence of a small number of surviving cells exhibiting enhanced resistance to subsequent plasma exposure. Interestingly, these cells also exhibited a higher degree of resistance to hydrogen peroxide. Whole genome comparison between surviving cells and control cells revealed 10 distinct polymorphic regions, including four belonging to the redox active, antibiotic pigment phenazine. Subsequently, the interaction between phenazine production and CAP resistance was demonstrated in biofilms of transposon mutants disrupted in different phenazine pathway genes which exhibited significantly altered sensitivity to CAP.	[Mai-Prochnow, Anne; Ostrikov, Kostya; Murphy, Anthony B.] CSIRO Mfg Flagship, Lindfield, NSW 2070, Australia; [Bradbury, Mark] CSIRO Food & Nutr Flagship, N Ryde, NSW 2113, Australia; [Ostrikov, Kostya] Queensland Univ Technol, Sch Chem Phys & Earth Sci, Inst Hlth & Biomed Innovat, Brisbane, Qld 4000, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Queensland University of Technology (QUT)	Mai-Prochnow, A (corresponding author), CSIRO Mfg Flagship, POB 218, Lindfield, NSW 2070, Australia.	anne.mai-prochnow@csiro.au	Murphy, Anthony B/A-7796-2008; Mai-Prochnow, Anne/D-3954-2013	Murphy, Anthony B/0000-0002-2820-2304; Mai-Prochnow, Anne/0000-0003-0136-9144; Bradbury, Mark/0000-0002-3727-9055; Ostrikov, Kostya (Ken)/0000-0001-8672-9297	CSIRO; Australian Research Council	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Research Council(Australian Research Council)	This work was supported by the CSIRO Office of the Chief Executive Postdoctoral Fellowship to AMP and partially supported by the CSIRO Office of the Chief Executive Science Leadership Programme and the Australian Research Council to KO.	Abramzon N, 2006, IEEE T PLASMA SCI, V34, P1304, DOI 10.1109/TPS.2006.877515; Alkawareek MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044289; Alkawareek MY, 2012, FEMS IMMUNOL MED MIC, V65, P381, DOI 10.1111/j.1574-695X.2012.00942.x; Alshraiedeh NH, 2013, J APPL MICROBIOL, V115, P1420, DOI 10.1111/jam.12331; Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06; Bhargava N, 2014, INFECT IMMUN, V82, P3417, DOI 10.1128/IAI.01600-14; Bjarnsholt T, 2005, MICROBIOL-SGM, V151, P373, DOI 10.1099/mic.0.27463-0; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Borrero NV, 2014, ORG BIOMOL CHEM, V12, P881, DOI 10.1039/c3ob42416b; Brelles-Marino G, 2012, J APPL MICROBIOL, V112, P412, DOI 10.1111/j.1365-2672.2011.05198.x; Cezairliyan B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003101; Chen AI, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004480; Chen C, 2014, PLASMA CHEM PLASMA P, V34, P403, DOI 10.1007/s11090-014-9545-1; Conibear TCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006289; Cooper M, 2010, J APPL MICROBIOL, V109, P2039, DOI 10.1111/j.1365-2672.2010.04834.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; DAVIS CE, 1970, NEW ENGL J MED, V282, P117, DOI 10.1056/NEJM197001152820302; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Dietrich LEP, 2013, J BACTERIOL, V195, P1371, DOI 10.1128/JB.02273-12; Ermolaeva SA, 2011, J MED MICROBIOL, V60, P75, DOI 10.1099/jmm.0.020263-0; Fair RJ, 2014, PERSPECT MED CHEM, V6, P25, DOI 10.4137/PMC.S14459; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Gjodsbol Kristine, 2006, Int Wound J, V3, P225, DOI 10.1111/j.1742-481X.2006.00159.x; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goeres DM, 2005, MICROBIOL-SGM, V151, P757, DOI 10.1099/mic.0.27709-0; Graves DB, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/263001; HASSAN HM, 1980, J BACTERIOL, V141, P156, DOI 10.1128/JB.141.1.156-163.1980; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Hui JGK, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00654; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Joaquin JC, 2009, MICROBIOL-SGM, V155, P724, DOI 10.1099/mic.0.021501-0; Joshi SG, 2011, ANTIMICROB AGENTS CH, V55, P1053, DOI 10.1128/AAC.01002-10; Kirov SM, 2007, MICROBIOL-SGM, V153, P3264, DOI 10.1099/mic.0.2007/009092-0; Klampfl TG, 2012, APPL ENVIRON MICROB, V78, P5077, DOI 10.1128/AEM.00583-12; Lan LF, 2010, MOL MICROBIOL, V75, P76, DOI 10.1111/j.1365-2958.2009.06955.x; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mai-Prochnow A, 2014, INT J ANTIMICROB AG, V43, P508, DOI 10.1016/j.ijantimicag.2014.01.025; Marchal F, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/34/345202; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Michael CA, 2014, FRONTIERS PUBLIC HLT, V2; Niemira BA, 2012, ANNU REV FOOD SCI T, V3, P125, DOI 10.1146/annurev-food-022811-101132; Paphitou NI, 2013, INT J ANTIMICROB AG, V42, pS25, DOI 10.1016/j.ijantimicag.2013.04.007; Pei X, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/16/165205; Pinto D, 2013, CRIT REV MICROBIOL; Rada B, 2013, TRENDS MICROBIOL, V21, P73, DOI 10.1016/j.tim.2012.10.004; Salamitou S., 2009, BIOTECHNOLOGY, V8, P228, DOI DOI 10.1186/1475-2875-8-228; Sanders LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018824; Seneviratne CJ, 2012, PROTEOMICS, V12, P651, DOI 10.1002/pmic.201100356; Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026; Vinckx T, 2010, MICROBIOL-SGM, V156, P678, DOI 10.1099/mic.0.031971-0; Wang Y, 2008, ENVIRON SCI TECHNOL, V42, P2380, DOI 10.1021/es702290a; Wang Y, 2010, J BACTERIOL, V192, P365, DOI 10.1128/JB.01188-09; Weltmann KD, 2009, CONTRIB PLASM PHYS, V49, P631, DOI 10.1002/ctpp.200910067; Xiong Z, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3597622; Xu L, 2011, EUR J CLIN MICROBIOL, V30, P25, DOI 10.1007/s10096-010-1047-3; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zimmermann JL, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/7/073037	60	50	50	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130373	10.1371/journal.pone.0130373	http://dx.doi.org/10.1371/journal.pone.0130373			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114428	Green Submitted, gold, Green Published			2022-12-27	WOS:000358147500071
J	Moore, KA; Simpson, JA; Thomas, KH; Rijken, MJ; White, LJ; Dwell, SLM; Paw, MK; Wiladphaingern, J; Pukrittayakamee, S; Nosten, F; Fowkes, FJI; McGready, R				Moore, Kerryn A.; Simpson, Julie A.; Thomas, Kyla H.; Rijken, Marcus J.; White, Lisa J.; Dwell, Saw Lu Moo; Paw, Moo Kho; Wiladphaingern, Jacher; Pukrittayakamee, Sasithon; Nosten, Francois; Fowkes, Freya J. I.; McGready, Rose			Estimating Gestational Age in Late Presenters to Antenatal Care in a Resource-Limited Setting on the Thai-Myanmar Border	PLOS ONE			English	Article							LAST MENSTRUAL PERIOD; LOCAL HEALTH-WORKERS; CROWN-RUMP LENGTH; INTERGROWTH-21ST PROJECT; INTERNATIONAL STANDARDS; BIPARIETAL DIAMETER; IMPROVED PREDICTION; HEAD CIRCUMFERENCE; NEWBORN-INFANT; BURMESE BORDER	Estimating gestational age in resource-limited settings is prone to considerable inaccuracy because crown-rump length measured by ultrasound before 14 weeks gestation, the recommended method for estimating gestational age, is often unavailable. Judgements regarding provision of appropriate obstetric and neonatal care are dependent on accurate estimation of gestational age. We determined the accuracy of the Dubowitz Gestational Age Assessment, a population-specific symphysis-fundal height formula, and ultrasound biometry performed between 16 and 40 weeks gestation in estimating gestational age using pre-existing data from antenatal clinics of the Shoklo Malaria Research Unit on the Thai-Myanmar border, where malaria is endemic. Two cohorts of women who gave birth to live singletons were analysed: 1) 250 women who attended antenatal care between July 2001 and May 2006 and had both ultrasound crown-rump length (reference) and a Dubowitz Gestational Age Assessment; 2) 975 women attending antenatal care between April 2007 and October 2010 who had ultrasound crown-rump length, symphysis-fundal measurements, and an additional study ultrasound (biparietal diameter and head circumference) randomly scheduled between 16 and 40 weeks gestation. Mean difference in estimated newborn gestational age between methods and 95% limits of agreement (LOA) were determined from linear mixed-effects models. The Dubowitz method and the symphysis-fundal height formula performed well in term newborns, but overestimated gestational age of preterms by 2.57 weeks (95% LOA: 0.49, 4.65) and 3.94 weeks (95% LOA: 2.50, 5.38), respectively. Biparietal diameter overestimated gestational age by 0.83 weeks (95% LOA: -0.93, 2.58). Head circumference underestimated gestational age by 0.39 weeks (95% LOA: -2.60, 1.82), especially if measured after 24 weeks gestation. The results of this study can be used to quantify biases associated with alternative methods for estimating gestational age in the absence of ultrasound crown-rump length to inform critical clinical judgements in this population, and as a point of reference elsewhere.	[Moore, Kerryn A.; Simpson, Julie A.; Fowkes, Freya J. I.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia; [Moore, Kerryn A.; Fowkes, Freya J. I.] Macfarlane Burnet Inst Med Res, Melbourne, Vic, Australia; [Thomas, Kyla H.; Rijken, Marcus J.; Dwell, Saw Lu Moo; Paw, Moo Kho; Wiladphaingern, Jacher; Nosten, Francois; McGready, Rose] Mahidol Univ, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Mae Sot, Thailand; [Rijken, Marcus J.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [White, Lisa J.; Pukrittayakamee, Sasithon] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [White, Lisa J.; Nosten, Francois; McGready, Rose] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England; [Fowkes, Freya J. I.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Fowkes, Freya J. I.] Monash Univ, Dept Infect Dis, Melbourne, Vic 3004, Australia	University of Melbourne; Burnet Institute; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Utrecht University; Utrecht University Medical Center; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Monash University; Monash University	Moore, KA (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia.	kerrynmoore.kam@burnet.edu.au	Nosten, Francois/AAC-5509-2019; White, Lisa/AAC-9396-2020; McGready, Rose/A-3290-2014	Nosten, Francois/0000-0002-7951-0745; White, Lisa/0000-0002-6523-185X; McGready, Rose/0000-0003-1621-3257; Thomas, Kyla/0000-0001-5418-4034; Paw, Moo Kho/0000-0002-4008-3168; Rijken, Marcus/0000-0003-0914-5508; Moore, Kerryn/0000-0002-8333-8271; Fowkes, Freya/0000-0001-5832-9464	Wellcome Trust of Great Britain; Australian Postgraduate Award; Future Fellowship - Australian Research Council; Victorian State Government; Commonwealth Government of Australia; Shoklo Malaria Research Unit is part of the Mahidol Oxford University Research Unit, at the Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Academy of Medical Sciences (AMS) [AMS-SGCL12-Thomas] Funding Source: researchfish; National Institute for Health Research [CL-2013-25-003] Funding Source: researchfish	Wellcome Trust of Great Britain(Wellcome Trust); Australian Postgraduate Award(Australian Government); Future Fellowship - Australian Research Council(Australian Research Council); Victorian State Government; Commonwealth Government of Australia(Australian Government); Shoklo Malaria Research Unit is part of the Mahidol Oxford University Research Unit, at the Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR))	The Shoklo Malaria Research Unit is part of the Mahidol Oxford University Research Unit, at the Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand and supported by the Wellcome Trust of Great Britain (http://www.wellcome.ac.uk/). KAM was supported by an Australian Postgraduate Award, funded by the Commonwealth Government of Australia (http://www.australia.gov.au/). FJIF is supported by a Future Fellowship funded by the Australian Research Council (http://www.arc.gov.au/) and an Operational Infrastructure Support grant funded by the Victorian State Government (http://www.vic.gov.au/) and awarded to the Burnet Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MC, 1993, NEW ENGL J MED, V329, P1597, DOI 10.1056/NEJM199311253292201; Altman DG, 1997, ULTRASOUND OBST GYN, V10, P174, DOI 10.1046/j.1469-0705.1997.10030174.x; BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; Benson B, 1991, AJR, V157, P1275; Butt K, 2014, J OBSTET GYNAECOL CA, V36, P171, DOI 10.1016/S1701-2163(15)30664-2; CAMPBELL S, 1985, OBSTET GYNECOL, V65, P613; Carstensen B., 2008, INT J BIOSTAT, V4, P16, DOI DOI 10.2202/1557-4679.1107; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; DOUBILET PM, 1993, J ULTRAS MED, V12, P647, DOI 10.7863/jum.1993.12.11.647; DOUBILET PM, 1984, AM J ROENTGENOL, V142, P797, DOI 10.2214/ajr.142.4.797; DUBOWITZ LM, 1970, J PEDIATR-US, V77, P1, DOI 10.1016/S0022-3476(70)80038-5; Gilder ME, 2014, GLOB HLTH ACTION; Haddrill R, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-207; HADLOCK FP, 1991, J ULTRAS MED, V10, P557; HADLOCK FP, 1982, J ULTRAS MED, V1, P97; HADLOCK FP, 1984, RADIOLOGY, V152, P497, DOI 10.1148/radiology.152.2.6739822; Kalish RB, 2004, AM J OBSTET GYNECOL, V191, P975, DOI 10.1016/j.ajog.2004.06.053; Karunasekera KAW, 2002, J TROP PEDIATRICS, V48, P270, DOI 10.1093/tropej/48.5.270; LaGrone LN, 2012, TROP MED INT HEALTH, V17, P808, DOI 10.1111/j.1365-3156.2012.03014.x; Leung TN, 2008, ULTRASOUND OBST GYN, V31, P321, DOI 10.1002/uog.5192; Loughna P, 2009, ULTRASOUND, V17, P160, DOI 10.1179/174313409X448543; Lynch CD, 2007, PAEDIATR PERINAT EP, V21, P86, DOI 10.1111/j.1365-3016.2007.00865.x; McGready R, 2000, ANN TROP PAEDIATR, V20, P323, DOI 10.1080/02724936.2000.11748154; Mehta U, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-89; Mongelli M, 2003, ACTA RADIOL, V44, P452, DOI 10.1034/j.1600-0455.2003.00089.x; Mongelli M, 1996, AM J OBSTET GYNECOL, V174, P278, DOI 10.1016/S0002-9378(96)70408-8; Napolitano R, 2014, BJOG-INT J OBSTET GY, V121, P556, DOI 10.1111/1471-0528.12478; Neilson JP, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000944, DOI 10.1002/14651858.CD000944]; NOSTEN F, 1991, T ROY SOC TROP MED H, V85, P424, DOI 10.1016/0035-9203(91)90205-D; Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2; Rijken MJ, 2012, ULTRASOUND OBST GYN, V40, P151, DOI 10.1002/uog.11091; Rijken MJ, 2009, ULTRASOUND OBST GYN, V34, P395, DOI 10.1002/uog.7350; Rijken MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031411; Rijken MJ, 2012, LANCET INFECT DIS, V12, P75, DOI 10.1016/S1473-3099(11)70315-2; Robillard P Y, 1992, J Perinatol, V12, P115; ROBINSON HP, 1975, BRIT J OBSTET GYNAEC, V82, P702, DOI 10.1111/j.1471-0528.1975.tb00710.x; Rosenberg RE, 2009, J HEALTH POPUL NUTR, V27, P332; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Sola A, 1999, J PEDIATR-US, V135, P137, DOI 10.1016/S0022-3476(99)70011-9; Sunjoh F, 2004, J TROP PEDIATRICS, V50, P285, DOI 10.1093/tropej/50.5.285; The World Bank Group, 2014, WORLD DEV IND BIRTH; Tunon K, 1996, ULTRASOUND OBST GYN, V8, P178, DOI 10.1046/j.1469-0705.1996.08030178.x; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; White LJ, 2012, J R SOC INTERFACE, V9, P503, DOI 10.1098/rsif.2011.0376; White NJ, 2008, PLOS MED, V5, P843, DOI 10.1371/journal.pmed.0050133; WHO/UNICEF, 2003, ANT CAR DEV COUNTR A; Wylie BJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-183	47	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131025	10.1371/journal.pone.0131025	http://dx.doi.org/10.1371/journal.pone.0131025			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114295	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500122
J	Nishikawa, T; Miyahara, E; Kurauchi, K; Watanabe, E; Ikawa, K; Asaba, K; Tanabe, T; Okamoto, Y; Kawano, Y				Nishikawa, Takuro; Miyahara, Emiko; Kurauchi, Koichiro; Watanabe, Erika; Ikawa, Kazuro; Asaba, Kousuke; Tanabe, Takayuki; Okamoto, Yasuhiro; Kawano, Yoshifumi			Mechanisms of Fatal Cardiotoxicity following High-Dose Cyclophosphamide Therapy and a Method for Its Prevention	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; ALDEHYDE DEHYDROGENASE; CARDIAC COMPLICATIONS; ACROLEIN; TOXICITY; CARDIOMYOPATHY; MUTAGENICITY; CYTOTOXICITY; CARCINOGENS	2Observed only after administration of high doses, cardiotoxicity is the dose-limiting effect of cyclophosphamide (CY). We investigated the poorly understood cardiotoxic mechanisms of high-dose CY. A rat cardiac myocardial cell line, H9c2, was exposed to CY metabolized by S9 fraction of rat liver homogenate mixed with co-factors (CYS9). Cytotoxicity was then evaluated by 3-(4,5-dimethyl-2-thiazolyl)(sic)2,5-diphenyl(sic)2H-tetrazolium bromide (MTT) assay, lactate dehydrogenase release, production of reactive oxygen species (ROS), and incidence of apoptosis. We also investigated how the myocardial cellular effects of CYS9 were modified by acrolein scavenger N-acetylcysteine (NAC), antioxidant isorhamnetin (ISO), and CYP inhibitor beta-ionone (BIO). Quantifying CY and CY metabolites by means of liquid chromatography coupled with electrospray tandem mass spectrometry, we assayed culture supernatants of CYS9 with and without candidate cardioprotectant agents. Assay results for MTT showed that treatment with CY (125-500 mu M) did not induce cytotoxicity. CYS9, however, exhibited myocardial cytotoxicity when CY concentration was 250 mu M or more. After 250 mu M of CY was metabolized in S9 mix for 2 h, the concentration of CY was 73.6 +/- 8.0 mu M, 4-hydroxycyclophosphamide (HCY) 17.6 +/- 4.3, o-carboxyethyl-phosphoramide (CEPM) 26.6 +/- 5.3 mu M, and acrolein 26.7 +/- 2.5 mu M. Inhibition of CYS9-induced cytotoxicity occurred with NAC, ISO, and BIO. When treated with ISO or BIO, metabolism of CY was significantly inhibited. Pre-treatment with NAC, however, did not inhibit the metabolism of CY: compared to control samples, we observed no difference in HCY, a significant increase of CEPM, and a significant decrease of acrolein. Furthermore, NAC pre-treatment did not affect intracellular amounts of ROS produced by CYS9. Since acrolein seems to be heavily implicated in the onset of cardiotoxicity, any competitive metabolic processing of CY that reduces its transformation to acrolein is likely to be an important mechanism for preventing cardiotoxicity.	[Nishikawa, Takuro; Miyahara, Emiko; Kurauchi, Koichiro; Tanabe, Takayuki; Okamoto, Yasuhiro; Kawano, Yoshifumi] Kagoshima Univ, Dept Pediat, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Watanabe, Erika] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Clin Pharm & Pharmacol, Kagoshima 890, Japan; [Ikawa, Kazuro] Hiroshima Univ, Dept Clin Pharmacotherapy, Hiroshima, Japan; [Asaba, Kousuke] EPS Corp, Clin Dev Div, Clin Dev Dept 1, Saitama, Japan	Kagoshima University; Kagoshima University; Hiroshima University	Nishikawa, T (corresponding author), Kagoshima Univ, Dept Pediat, Grad Sch Med & Dent Sci, Kagoshima 890, Japan.	adu44150@ams.odn.ne.jp		Nishikawa, Takuro/0000-0001-5012-0906	Ministry of Education, Culture, Sports, Science and Technology of Japan [26870460]; EPS Corporation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); EPS Corporation	Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant number 26870460 to TN), https://kaken.nii.ac.jp/d/p/26870460/2014/1/ja.en.html. EPS Corporation provided support in the form of a salary for author KA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the "author contributions" section.	ALARCON RA, 1968, ANAL CHEM, V40, P1704, DOI 10.1021/ac60267a019; AMES BN, 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1; Anderson EJ, 2012, CLIN EXP PHARMACOL P, V39, P179, DOI 10.1111/j.1440-1681.2011.05641.x; APPELBAUM FR, 1976, LANCET, V1, P58; Asiri YA, 2010, OXID MED CELL LONGEV, V3, P308, DOI 10.4161/oxim.3.5.13107; AYASH LJ, 1992, J CLIN ONCOL, V10, P995, DOI 10.1200/JCO.1992.10.6.995; Bohnenstengel F, 1997, J CHROMATOGR B, V692, P163, DOI 10.1016/S0378-4347(96)00457-4; BRAVERMAN AC, 1991, J CLIN ONCOL, V9, P1215, DOI 10.1200/JCO.1991.9.7.1215; CAZIN B, 1986, CANCER, V57, P2061, DOI 10.1002/1097-0142(19860515)57:10<2061::AID-CNCR2820571031>3.0.CO;2-H; DARROUDI F, 1993, MUTAGENESIS, V8, P11, DOI 10.1093/mutage/8.1.11; DeFlora S, 1997, EUR RESPIR J, V10, P1535, DOI 10.1183/09031936.97.10071535; DeJarnett N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000934; Emadi A, 2009, NAT REV CLIN ONCOL, V6, P638, DOI 10.1038/nrclinonc.2009.146; FRAISER LH, 1991, DRUGS, V42, P781, DOI 10.2165/00003495-199142050-00005; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gomes-Carneiro MR, 2006, FOOD CHEM TOXICOL, V44, P522, DOI 10.1016/j.fct.2005.08.026; Hochman DJ, 2014, ENVIRON TOXICOL, V29, P908, DOI 10.1002/tox.21818; Jiang NF, 2000, TOXICOL APPL PHARM, V163, P221, DOI 10.1006/taap.1999.8886; JONES RJ, 1995, BLOOD, V85, P2742, DOI 10.1182/blood.V85.10.2742.bloodjournal85102742; Kanakry CG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006960; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kwolek-Mirek M., 2014, CELL BIOCH BIOPHYS; Lee CK, 1996, BONE MARROW TRANSPL, V18, P573; Luo C, 2015, ARCH TOXICOL, V89, P357, DOI 10.1007/s00204-014-1267-x; McDonald GB, 2003, BLOOD, V101, P2043, DOI 10.1182/blood-2002-06-1860; MILLS BA, 1979, CANCER, V43, P2223, DOI 10.1002/1097-0142(197906)43:6<2223::AID-CNCR2820430610>3.0.CO;2-Y; Moslehi A, 2014, BONE MARROW TRANSPL, V49, P818, DOI 10.1038/bmt.2014.34; Murdych T, 2001, BONE MARROW TRANSPL, V28, P283, DOI 10.1038/sj.bmt.1703133; Nagler A, 2013, J CLIN ONCOL, V31, P3549, DOI 10.1200/JCO.2013.48.8114; NELSON TJ, 1982, BIOCHEM PHARMACOL, V31, P509, DOI 10.1016/0006-2952(82)90152-6; Nishikawa T, 2012, ENVIRON HEALTH PERSP, V120, P62, DOI 10.1289/ehp.1103437; O'Donnell PV, 2002, BIOL BLOOD MARROW TR, V8, P377, DOI 10.1053/bbmt.2002.v8.pm12171484; Panda VS, 2009, ALTERN MED REV, V14, P161; Ren S, 1999, DRUG METAB DISPOS, V27, P133; SANTOS GW, 1972, TRANSPL P, V4, P559; Sekeroglu V, 2011, ASIAN PAC J CANCER P, V12, P2925; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Slattery JT, 1996, J CLIN ONCOL, V14, P1484, DOI 10.1200/JCO.1996.14.5.1484; Sun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064526; Sun Y, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/170309; TAN EL, 1982, MUTAT RES, V103, P359, DOI 10.1016/0165-7992(82)90068-9; Xie HJ, 2006, EUR J PHARM SCI, V27, P54, DOI 10.1016/j.ejps.2005.08.008; Yoshida M, 2009, BIOCHEM BIOPH RES CO, V378, P313, DOI 10.1016/j.bbrc.2008.11.054	43	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131394	10.1371/journal.pone.0131394	http://dx.doi.org/10.1371/journal.pone.0131394			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114497	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500150
J	Qin, S; Jin, P; Zhou, X; Chen, LM; Ma, F				Qin, Sheng; Jin, Ping; Zhou, Xue; Chen, Liming; Ma, Fei			The Role of Transposable Elements in the Origin and Evolution of MicroRNAs in Human	PLOS ONE			English	Article							BINDING-SITES; SMALL RNAS; GENOME; GENES; DATABASE	MicroRNAs (miRNAs) are crucial regulators of gene expression at the post-transcriptional level in eukaryotes via targeting gene 3'-untranslated regions. Transposable elements (TEs) are considered as natural origins of some miRNAs. However, what miRNAs are and how these miRNAs originate and evolve from TEs remain unclear. We identified 409 TE-derived miRNAs (386 overlapped with TEs and 23 un-overlapped with TEs) which are derived from TEs in human. This indicates that the TEs play important roles in origin of miRNAs in human. In addition, we found that the proportions of miRNAs derived from TEs (MDTEs) in human are more than other vertebrates especially non-mammal vertebrates. Furthermore, we classified MDTEs into three types and found that TE head or tail sequences along with adjacent genomic sequences contribute to generation of human miRNAs. Our current study will improve the understanding of origin and evolution of human miRNAs.	[Qin, Sheng; Jin, Ping; Ma, Fei] Nanjing Normal Univ, Lab Comparat Genom & Bioinformat, Coll Life Sci, Nanjing, Jiangsu, Peoples R China; [Qin, Sheng; Jin, Ping; Ma, Fei] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Chen, Liming] Southeast Univ, Inst Life Sci, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China; [Zhou, Xue] NanJing Normal Univ, TaiZhou Coll, Sch Chem & Biol Engn, Taizhou, Peoples R China	Nanjing Normal University; Nanjing Normal University; Southeast University - China; Nanjing Normal University; Taizhou University	Ma, F (corresponding author), Nanjing Normal Univ, Lab Comparat Genom & Bioinformat, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	mafei01@tsinghua.org.cn	Qin, Sheng/HCH-0856-2022		National Natural Science Foundation of China [30970348]; Major Program of Natural Science Research of Jiangsu Higher Education Institutions [12KJA180005]; Ph.D. Programs Foundation of Ministry of Education of China [20113207110009]; Jiangsu Province Ordinary University Innovative Research Project [CXLX13-382]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of Natural Science Research of Jiangsu Higher Education Institutions; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Jiangsu Province Ordinary University Innovative Research Project	This work was jointly supported by grants from the National Natural Science Foundation of China (No. 30970348), the Major Program of Natural Science Research of Jiangsu Higher Education Institutions (No. 12KJA180005), the Ph.D. Programs Foundation of Ministry of Education of China (No. 20113207110009), and the Jiangsu Province Ordinary University Innovative Research Project (No. CXLX13-382).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Borchert Glen M, 2011, Mob Genet Elements, V1, P8; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lai EC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-115; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Nozawa M, 2010, GENOME BIOL EVOL, V2, P180, DOI 10.1093/gbe/evq009; Piriyapongsa J, 2007, GENETICS, V176, P1323, DOI 10.1534/genetics.107.072553; Piriyapongsa J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000203; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smalheiser Neil R., 2006, V342, P115, DOI 10.1385/1-59745-123-1:115; Smalheiser NR, 2006, TRENDS GENET, V22, P532, DOI 10.1016/j.tig.2006.08.007; Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008; Smit A.F.A, 1996, REPEATMASKER OPEN 3; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Zemojtel Tomasz, 2012, Frontiers in Genetics, V3, P40, DOI 10.3389/fgene.2012.00040	36	37	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131365	10.1371/journal.pone.0131365	http://dx.doi.org/10.1371/journal.pone.0131365			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115450	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500146
J	Schmeltzer, C; Kihara, AH; Sokolov, IM; Rudiger, S				Schmeltzer, Christian; Kihara, Alexandre Hiroaki; Sokolov, Igor Michailovitsch; Ruediger, Sten			Degree Correlations Optimize Neuronal Network Sensitivity to Sub-Threshold Stimuli	PLOS ONE			English	Article							CORTICAL NETWORKS; INFORMATION; MODEL	Information processing in the brain crucially depends on the topology of the neuronal connections. We investigate how the topology influences the response of a population of leaky integrate-and-fire neurons to a stimulus. We devise a method to calculate firing rates from a self-consistent system of equations taking into account the degree distribution and degree correlations in the network. We show that assortative degree correlations strongly improve the sensitivity for weak stimuli and propose that such networks possess an advantage in signal processing. We moreover find that there exists an optimum in assortativity at an intermediate level leading to a maximum in input/output mutual information.	[Schmeltzer, Christian; Sokolov, Igor Michailovitsch; Ruediger, Sten] Humboldt Univ, Inst Phys, Berlin, Germany; [Kihara, Alexandre Hiroaki] Univ Fed ABC, Santo Andre, Brazil	Humboldt University of Berlin; Universidade Federal do ABC (UFABC)	Rudiger, S (corresponding author), Humboldt Univ, Inst Phys, Berlin, Germany.	sten.ruediger@physik.hu-berlin.de	Kihara, Alexandre H/C-2458-2012; KIHARA, ALEXANDRE HIROAKI/T-9590-2019; Sokolov, Igor M/D-1668-2009	Kihara, Alexandre H/0000-0002-4027-7261; KIHARA, ALEXANDRE HIROAKI/0000-0002-4027-7261; Sokolov, Igor M/0000-0002-4688-9162	Deutsche Forschungsgemeinschaft [IRTG 1740]; FAPESP	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	CS, IS, and SR were supported by the Deutsche Forschungsgemeinschaft (IRTG 1740). AK was supported by FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT LF, 1993, PHYS REV E, V48, P1483, DOI 10.1103/PhysRevE.48.1483; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Beggs JM, 2008, PHILOS T R SOC A, V366, P329, DOI 10.1098/rsta.2007.2092; Benayoun M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000846; Bettencourt LMA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021915; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Brede M, 2005, CONDMAT0507710 ARXIV; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burkitt AN, 2006, BIOL CYBERN, V95, P97, DOI 10.1007/s00422-006-0082-8; Cai D, 2012, COMMUN MATH SCI, V10, P307, DOI 10.4310/CMS.2012.v10.n1.a14; Dayan P., 2005, THEORETICAL NEUROSCI; de Franciscis S, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036114; de Santos-Sierra D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085828; Deco G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000092; Douglas RJ, 2007, CURR BIOL, V17, pR496, DOI 10.1016/j.cub.2007.04.024; Downes JH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002522; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Gerstner W, 2002, SPIKING NEURON MODEL; Houweling AR, 2010, J NEUROPHYSIOL, V103, P1696, DOI 10.1152/jn.00421.2009; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Jacobs AL, 2009, P NATL ACAD SCI USA, V106, P5936, DOI 10.1073/pnas.0900573106; Kandel ER, 2000, PRINCIPLES NEURAL SC, V4; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Kovacic G, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021904; Laughlin SB, 2001, CURR OPIN NEUROBIOL, V11, P475, DOI 10.1016/S0959-4388(00)00237-3; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Mejias JF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228102; Newhall KA, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041903; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026118; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Pernice V, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00072; Piraveenan M, 2012, IEEE ACM T COMPUT BI, V9, P66, DOI 10.1109/TCBB.2010.80; Pola G, 2003, NETWORK-COMP NEURAL, V14, P35, DOI 10.1088/0954-898X/14/1/303; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; Rieke F., 1999, SPIKES EXPLORING NEU; Risken H., 1989, SPRINGER SERIES SYNE, V18; Roxin A, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI 10.3389/fncom.2011.00008; Schmeltzer C, 2014, BMC NEUROSCIENCE S1, V15, pO14, DOI [10.1186/1471-2202-15-S1-O14, DOI 10.1186/1471-2202-15-S1-O14]; Shew WL, 2011, J NEUROSCI, V31, P55, DOI 10.1523/JNEUROSCI.4637-10.2011; Sporns O., 2011, NETWORKS BRAIN; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Teller S, 2013, ENTROPY, V15, P5464; Tkacik G, 2008, P NATL ACAD SCI USA, V105, P12265, DOI 10.1073/pnas.0806077105; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Vasquez JC, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00156; Voges N, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00041; Wang B, 2007, EUR PHYS J B, V60, P89, DOI 10.1140/epjb/e2007-00324-y; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Wu K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019608; Xulvi-Brunet R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066102; Xulvi-Brunet R., 2007, STRUCTURAL PROPERTIE; Yassin L, 2010, NEURON, V68, P1043, DOI 10.1016/j.neuron.2010.11.029; Zhao Liqiong, 2011, Front Comput Neurosci, V5, P28, DOI 10.3389/fncom.2011.00028	62	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0121794	10.1371/journal.pone.0121794	http://dx.doi.org/10.1371/journal.pone.0121794			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115374	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500002
J	Watanabe, T; Mitsuhashi, M; Sagawa, M; Ri, M; Suzuki, K; Abe, M; Ohmachi, K; Nakagawa, Y; Nakamura, S; Chosa, M; Iida, S; Kizaki, M				Watanabe, Takashi; Mitsuhashi, Masato; Sagawa, Morihiko; Ri, Masaki; Suzuki, Kenshi; Abe, Masahiro; Ohmachi, Ken; Nakagawa, Yasunori; Nakamura, Shingen; Chosa, Mizuki; Iida, Shinsuke; Kizaki, Masahiro			Lipopolysaccharide-Induced CXCL10 mRNA Level and Six Stimulant-mRNA Combinations in Whole Blood: Novel Biomarkers for Bortezomib Responses Obtained from a Prospective Multicenter Trial for Patients with Multiple Myeloma	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; THALIDOMIDE PLUS DEXAMETHASONE; CONSOLIDATION THERAPY; PERIPHERAL NEUROPATHY; INDUCIBLE PROTEIN-10; INITIAL TREATMENT; ELDERLY-PATIENTS; PREDNISONE; MELPHALAN; MAINTENANCE	To identify predictive biomarkers for clinical responses to bortezomib treatment, 0.06 mL of each whole blood without any cell separation procedures was stimulated ex vivo using five agents, and eight mRNAs were quantified. In six centers, heparinized peripheral blood was prospectively obtained from 80 previously treated or untreated, symptomatic multiple myeloma (MM) patients with measurable levels of M-proteins. The blood sample was procured prior to treatment as well as 2-3 days and 1-3 weeks after the first dose of bortezomib, which was intravenously administered biweekly or weekly, during the first cycle. Six stimulant-mRNA combinations; that is, lipopolysaccharide (LPS)-granulocyte-macrophage colony-stimulating factor (GM-CSF), LPS-CXCL chemokine 10 (CXCL10), LPS-CCL chemokine 4 (CCL4), phytohemagglutinin-CCL4, zymosan A (ZA)-GMCSF and ZA-CCL4 showed significantly higher induction in the complete and very good partial response group than in the stable and progressive disease group, as determined by both parametric (t-test) and non-parametric (unpaired Mann-Whitney test) tests. Moreover, LPS-induced CXCL10 mRNA expression was significantly suppressed 2-3 days after the first dose of bortezomib in all patients, as determined by both parametric (t-test) and non-parametric (paired Wilcoxon test) tests, whereas the complete and very good partial response group showed sustained suppression 1-3 weeks after the first dose. Thus, pretreatment LPS-CXCL10 mRNA and/or the six combinations may serve as potential biomarkers for the response to bortezomib treatment in MM patients.	[Watanabe, Takashi; Chosa, Mizuki] Natl Canc Ctr, Div Hematol, Tokyo, Japan; [Mitsuhashi, Masato] Hitachi Chem Res Ctr Inc, Irvine, CA USA; [Sagawa, Morihiko; Kizaki, Masahiro] Saitama Med Univ, Dept Hematol, Saitama Med Ctr, Kawagoe, Saitama, Japan; [Ri, Masaki; Iida, Shinsuke] Nagoya City Univ, Grad Sch Med Sci, Dept Med Oncol & Immunol, Nagoya, Aichi, Japan; [Suzuki, Kenshi; Nakagawa, Yasunori] Japanese Red Cross Med Ctr, Dept Hematol, Tokyo, Japan; [Abe, Masahiro; Nakamura, Shingen] Univ Tokushima, Dept Hematol, Endocrinol & Metab Instutute Biomed Sci, Grad Sch, Tokushima 770, Japan; [Ohmachi, Ken] Tokai Univ, Sch Med, Dept Internal Med, Div Hematol Oncol, Isehara, Kanagawa 25911, Japan	National Cancer Center - Japan; Hitachi Limited; Saitama Medical University; Nagoya City University; Japanese Red Cross Medical Center; University of Tokyo; Tokushima University; Tokai University	Watanabe, T (corresponding author), Komaki City Hosp, Dept Hematol, Komaki, Japan.	takawata@komakihp.gr.jp			National Cancer Center Research and Development Fund in Japan [21-8-5]; Hitachi Chemical Research Center, Inc.; Grants-in-Aid for Scientific Research [15K09490] Funding Source: KAKEN	National Cancer Center Research and Development Fund in Japan; Hitachi Chemical Research Center, Inc.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	National Cancer Center Research and Development Fund in Japan (21-8-5) and Hitachi Chemical Research Center, Inc. provided support in the form of salaries for MM and research support of his mRNA analysis, but did not have any additional role in the study design, analysis of data, decision to publish, and preparation of the manuscript.	Bringhen S, 2010, BLOOD, V116, P4745, DOI 10.1182/blood-2010-07-294983; Cavo M, 2012, BLOOD, V120, P9, DOI 10.1182/blood-2012-02-408898; Cavo M, 2010, LANCET, V376, P2075, DOI 10.1016/S0140-6736(10)61424-9; Chanan-Khan AA, 2010, J CLIN ONCOL, V28, P2612, DOI 10.1200/JCO.2009.25.4250; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Facon T, 2001, BLOOD, V97, P1566, DOI 10.1182/blood.V97.6.1566; Facon T, 2007, LANCET, V370, P1209, DOI 10.1016/S0140-6736(07)61537-2; Fonseca R, 2003, BLOOD, V101, P4569, DOI 10.1182/blood-2002-10-3017; Fonseca Rafael, 2004, Cancer Research, V64, P1546, DOI 10.1158/0008-5472.CAN-03-2876; Garderet L, 2012, J CLIN ONCOL, V30, P2475, DOI 10.1200/JCO.2011.37.4918; Gay F, 2011, BLOOD, V117, P3025, DOI 10.1182/blood-2010-09-307645; Giuliani N, 2006, HAEMATOLOGICA, V91, P1489; Huang H, 2002, CELL IMMUNOL, V217, P12, DOI 10.1016/S0008-8749(02)00508-7; Hulin C, 2009, J CLIN ONCOL, V27, P3664, DOI 10.1200/JCO.2008.21.0948; ISSEKUTZ TB, 1988, J IMMUNOL, V140, P2989; Kropff M, 2009, ANN HEMATOL, V88, P1125, DOI 10.1007/s00277-009-0726-6; Ling SCW, 2012, HAEMATOL-HEMATOL J, V97, P64, DOI 10.3324/haematol.2011.043331; Ludek P, 2010, EUR J HAEMATOL, V84, P332, DOI 10.1111/j.1600-0609.2009.01396.x; Martinez-Lopez J, 2011, BLOOD, V118, P529, DOI 10.1182/blood-2011-01-332320; Mateos MC, 2008, HAEMATOL-HEMATOL J, V93, P531; Mateos MV, 2012, BLOOD, V120, P2581, DOI 10.1182/blood-2012-05-427815; Mateos MV, 2010, LANCET ONCOL, V11, P934, DOI 10.1016/S1470-2045(10)70187-X; Mateos MV, 2010, J CLIN ONCOL, V28, P2259, DOI 10.1200/JCO.2009.26.0638; Mitsuhashi M, 2006, CLIN CHEM, V52, P634, DOI 10.1373/clinchem.2005.048983; Mitsuhashi M, 2010, J IMMUNOL METHODS, V363, P95, DOI 10.1016/j.jim.2010.10.002; Moreau P, 2011, BLOOD, V118, P5752, DOI 10.1182/blood-2011-05-355081; Moreau P, 2011, BLOOD, V117, P3041, DOI 10.1182/blood-2010-08-300863; Mulligan G, 2007, BLOOD, V109, P3177, DOI 10.1182/blood-2006-09-044974; Nguyen AN, 2006, EXP CELL RES, V312, P1909, DOI 10.1016/j.yexcr.2006.02.026; Palumbo A, 2006, LANCET, V367, P825, DOI 10.1016/S0140-6736(06)68338-4; Palumbo A, 2010, J CLIN ONCOL, V28, P5101, DOI 10.1200/JCO.2010.29.8216; Pellegrino A, 2004, CANCER LETT, V207, P221, DOI 10.1016/j.canlet.2003.10.036; Popat R, 2008, BRIT J HAEMATOL, V141, P512, DOI 10.1111/j.1365-2141.2008.06997.x; Ri M, 2010, LEUKEMIA, V24, P1506, DOI 10.1038/leu.2010.137; Richardson PG, 2007, BLOOD, V110, P3557, DOI 10.1182/blood-2006-08-036947; Richardson PG, 2010, BLOOD, V116, P679, DOI 10.1182/blood-2010-02-268862; Richardson PG, 2009, J CLIN ONCOL, V27, P5713, DOI 10.1200/JCO.2009.22.2679; Richardson PG, 2009, J CLIN ONCOL, V27, P3518, DOI 10.1200/JCO.2008.18.3087; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; Smadja NV, 2001, BLOOD, V98, P2229, DOI 10.1182/blood.V98.7.2229; Song MK, 2010, ACTA HAEMATOL-BASEL, V124, P34, DOI 10.1159/000313654; Sonneveld P, 2012, J CLIN ONCOL, V30, P2946, DOI 10.1200/JCO.2011.39.6820; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; van Rhee F, 2010, BLOOD, V116, P1220, DOI 10.1182/blood-2010-01-264333; Watanabe T, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.47	47	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0128662	10.1371/journal.pone.0128662	http://dx.doi.org/10.1371/journal.pone.0128662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115406	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500016
J	Burska, AN; Sakthiswary, R; Sattar, N				Burska, Agata N.; Sakthiswary, Rajalingham; Sattar, Naveed			Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							FACTOR-ALPHA THERAPY; BETA-CELL FUNCTION; TNF-ALPHA; INFLIXIMAB TREATMENT; CARDIOVASCULAR RISK; CLINICAL-TRIALS; RESISTANCE; BLOCKADE; INHIBITION; DISEASES	Objective Beyond the joints, TNFi (tumour necrosis factor inhibitor) therapy may confer systemic benefits in rheumatoid arthritis (RA). Several studies have investigated the role of TNFi on insulin resistance/sensitivity (IR/IS). This question is of general interest given the emerging evidence linking inflammation and insulin resistance. The main aim of this review was to summarise the published data and to determine the effects of TNFi on IR/IS. Methods We searched the PubMed and ISI Web of Knowledge databases for studies which examined the effects of TNFi on IR/IS. The studies were assessed independently by two reviewers according to a pre-specified protocol. The data on Homeostatic Model Assessment for Insulin resistance (HOMA) and Quantitative Insulin Sensitivity Check Index (QUICKI) were pooled and reported as standard difference in means (SDM) with 95% confidence interval (CI) using a random-effects model. Results A total of eight studies with 260 subjects met the selection criteria. The duration of the studies was from 8 weeks to 12 months. There was statistically significant reduction in HOMA index in six out of eight studies and four reported significant increment in QUICKI. The pooled analysis revealed significant reduction in HOMA [SDM-0.148, 95% CI[-0.278 to -0.017], p=0.026] and increment in QUICKI [SDM 0.312, 95% CI[0.019 to 0.606], p=0.037] with TNFi. Conclusion There is emerging evidence to support that TNFi therapy improves IS and reduces IR in RA. Further, well conducted trials are needed to determine if such effects translate to lower incidence of diabetes in RA or other autoimmune conditions on biologic therapy.	[Burska, Agata N.] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England; [Sakthiswary, Rajalingham] Univ Kebangsaan Malaysia, Dept Med, Kuala Lumpur, Malaysia; [Sattar, Naveed] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Leeds; Universiti Kebangsaan Malaysia; University of Glasgow	Sakthiswary, R (corresponding author), Univ Kebangsaan Malaysia, Dept Med, Kuala Lumpur, Malaysia.	sakthis5@hotmail.com	Sakthiswary, Rajalingham/E-8565-2017	Sattar, Naveed/0000-0002-1604-2593; Burska, Agata/0000-0003-3321-9087	Dana Lonjakan Penerbitan by Universiti kebangsaan Malaysia [DLP-2013-039]	Dana Lonjakan Penerbitan by Universiti kebangsaan Malaysia	This work was supported by Dana Lonjakan Penerbitan :(DLP-2013-039) by Universiti kebangsaan Malaysia. RS received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antohe JL, 2012, ARTHRIT CARE RES, V64, P215, DOI 10.1002/acr.20657; Chung CP, 2008, ARTHRITIS RHEUM-US, V58, P2105, DOI 10.1002/art.23600; Cuchacovich R, 2009, CLIN RHEUMATOL, V28, P1217, DOI 10.1007/s10067-009-1208-x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dessein PH, 2007, J RHEUMATOL, V34, P681; Dessein PH, 2006, ARTHRITIS RHEUM-US, V54, P2765, DOI 10.1002/art.22053; Dessein PH, 2002, J RHEUMATOL, V29, P462; Ferraz-Amaro I, 2011, HORM METAB RES, V43, P801, DOI 10.1055/s-0031-1287783; Gentile S, 2002, DIABETES OBES METAB, V4, P276, DOI 10.1046/j.1463-1326.2002.00210.x; Gonzalez-Gay MA, 2006, CLIN EXP RHEUMATOL, V24, P83; HALLGREN R, 1983, ACTA MED SCAND, V213, P351; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kiortsis DN, 2005, ANN RHEUM DIS, V64, P765, DOI 10.1136/ard.2004.026534; La Montagna Giovanni, 2007, Diab Vasc Dis Res, V4, P130; Ofei F, 1996, DIABETES, V45, P881, DOI 10.2337/diabetes.45.7.881; Oguz FM, 2007, ACTA CLIN BELG, V62, P218, DOI 10.1179/acb.2007.035; Otten J, 2014, DIABETOLOGIA, P1; Pamuk ON, 2006, J RHEUMATOL, V33, P2447; PAOLISSO G, 1991, METABOLISM, V40, P902, DOI 10.1016/0026-0495(91)90064-4; Paquot N, 2000, J CLIN ENDOCR METAB, V85, P1316, DOI 10.1210/jc.85.3.1316; Perez M, 2013, OPEN J RHEUMATOLOGY, V3, P167; Rajappa M, 2015, J EUR ACAD DERMATOL, V29, P69, DOI 10.1111/jdv.12451; Rosenvinge A, 2007, SCAND J RHEUMATOL, V36, P91, DOI 10.1080/03009740601179605; Sakthiswary R, 2012, EXCLI J, V11, P142; Seriolo B, 2008, CLIN EXP RHEUMATOL, V26, P159; Seriolo B, 2008, J RHEUMATOL, V35, P355; Shahin D, 2010, CLIN BIOCHEM, V43, P661, DOI 10.1016/j.clinbiochem.2010.01.012; Stagakis I, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3874; Stavropoulos-Kalinoglou A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3900; SVENSON KLG, 1988, METABOLISM, V37, P125, DOI 10.1016/S0026-0495(98)90005-1; Tam LS, 2007, CLIN RHEUMATOL, V26, P1495, DOI 10.1007/s10067-007-0539-8; TURNER RC, 1979, METABOLISM, V28, P1086, DOI 10.1016/0026-0495(79)90146-X; Wasko MC, 2011, ARTHRIT CARE RES, V63, P512, DOI 10.1002/acr.20414	36	58	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0128889	10.1371/journal.pone.0128889	http://dx.doi.org/10.1371/journal.pone.0128889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110878	Green Published, gold, Green Accepted			2022-12-27	WOS:000356933800016
J	Colombi, D; Dinkel, J; Weinheimer, O; Obermayer, B; Buzan, T; Nabers, D; Bauer, C; Oltmanns, U; Palmowski, K; Herth, F; Kauczor, HU; Sverzellati, N; Kreuter, M; Heussel, CP				Colombi, Davide; Dinkel, Julien; Weinheimer, Oliver; Obermayer, Berenike; Buzan, Teodora; Nabers, Diana; Bauer, Claudia; Oltmanns, Ute; Palmowski, Karin; Herth, Felix; Kauczor, Hans Ulrich; Sverzellati, Nicola; Kreuter, Michael; Heussel, Claus Peter			Visual vs Fully Automatic Histogram-Based Assessment of Idiopathic Pulmonary Fibrosis (IPF) Progression Using Sequential Multidetector Computed Tomography (MDCT)	PLOS ONE			English	Article							QUANTITATIVE CT INDEXES; PHYSIOLOGICAL TESTS; PIRFENIDONE; EMPHYSEMA; DISEASE; TRIAL; QUANTIFICATION; DIAGNOSIS; PATTERNS	Objectives To describe changes over time in extent of idiopathic pulmonary fibrosis (IPF) at multidetector computed tomography (MDCT) assessed by semi-quantitative visual scores (VSs) and fully automatic histogram-based quantitative evaluation and to test the relationship between these two methods of quantification. Methods Forty IPF patients (median age: 70 y, interquartile: 62-75 years; M:F, 33: 7) that underwent 2 MDCT at different time points with a median interval of 13 months (interquartile: 10-17 months) were retrospectively evaluated. In-house software YACTA quantified automatically lung density histogram (10th-90th percentile in 5th percentile steps). Longitudinal changes in VSs and in the percentiles of attenuation histogram were obtained in 20 untreated patients and 20 patients treated with pirfenidone. Pearson correlation analysis was used to test the relationship between VSs and selected percentiles. Results In follow-up MDCT, visual overall extent of parenchymal abnormalities (OE) increased in median by 5 %/year (interquartile: 0 %/y; +11 %/y). Substantial difference was found between treated and untreated patients in HU changes of the 40th and of the 80th percentiles of density histogram. Correlation analysis between VSs and selected percentiles showed higher correlation between the changes (Delta) in OE and Delta 40th percentile (r=0.69; p<0.001) as compared to Delta 80th percentile (r=0.58; p<0.001); closer correlation was found between Delta ground-glass extent and Delta 40th percentile (r=0.66, p<0.001) as compared to Delta 80th percentile (r=0.47, p=0.002), while the Delta reticulations correlated better with the Delta 80th percentile (r=0.56, p<0.001) in comparison to Delta 40th percentile (r=0.43, p=0.003). Conclusions There is a relevant and fully automatically measurable difference at MDCT in VSs and in histogram analysis at one year follow-up of IPF patients, whether treated or untreated: Delta 40th percentile might reflect the change in overall extent of lung abnormalities, notably of ground-glass pattern; furthermore Delta 80th percentile might reveal the course of reticular opacities.	[Colombi, Davide; Sverzellati, Nicola] Univ Parma, Dept Surg Sci, Sect Diagnost Imaging, I-43100 Parma, Italy; [Colombi, Davide; Dinkel, Julien; Weinheimer, Oliver; Buzan, Teodora; Bauer, Claudia; Oltmanns, Ute; Palmowski, Karin; Herth, Felix; Kauczor, Hans Ulrich; Kreuter, Michael; Heussel, Claus Peter] TLRC, Heidelberg, Germany; [Colombi, Davide; Dinkel, Julien; Weinheimer, Oliver; Obermayer, Berenike; Buzan, Teodora; Kauczor, Hans Ulrich; Heussel, Claus Peter] Heidelberg Univ, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Dinkel, Julien] Univ Munich, Dept Clin Radiol, Munich, Germany; [Buzan, Teodora] Iuliu Hatieganu Univ Med & Pharm Cluj Napoca, Dept Pneumol, Cluj Napoca, Romania; [Nabers, Diana] German Canc Res Ctr DFKZ, Div Med & Biol Informat E130, Heidelberg, Germany; [Bauer, Claudia; Oltmanns, Ute; Palmowski, Karin; Herth, Felix; Kreuter, Michael] Heidelberg Univ, Thoraxklin, Ctr Interstitial & Rare Lung Dis, Dept Pneumol & Resp Crit Care Med, Heidelberg, Germany	University of Parma; Ruprecht Karls University Heidelberg; University of Munich; Iuliu Hatieganu University of Medicine & Pharmacy; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Colombi, D (corresponding author), Univ Parma, Dept Surg Sci, Sect Diagnost Imaging, I-43100 Parma, Italy.	colombidavide@gmail.com; Kreuter@uni-heidelberg.de	Sverzellati, Nicola/AIC-5706-2022; Weinheimer, Oliver/AAN-3652-2021; Kauczor, HU/AAX-6033-2021; Colombi, Davide/ABD-3626-2020; Kauczor, Hans-Ulrich/AAU-5955-2021	SVERZELLATI, Nicola/0000-0002-4820-3785; Colombi, davide/0000-0002-2794-5237; Herth, Felix/0000-0002-7638-2506; Wetscherek (Buzan), Maria Teodora Antuaneta/0000-0003-2924-7587	Dietmar Hopp Stiftung; Bundesministerium fur Bildung und Forschung (BMBF) [82DZL00401, 82DZL00402, 82DZL00404]; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg within the funding program Open Access Publishing	Dietmar Hopp Stiftung; Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg within the funding program Open Access Publishing	This study was supported by grants from the Dietmar Hopp Stiftung, the Bundesministerium fur Bildung und Forschung (BMBF) to the German Center for Lung Research (DZL) (82DZL00401, 82DZL00402, 82DZL00404), the Deutsche Forschungsgemeinschaft, and the Ruprecht-Karls-Universitat Heidelberg within the funding program Open Access Publishing.	ADAMS H, 1991, CLIN RADIOL, V43, P238, DOI 10.1016/S0009-9260(05)80245-4; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Azuma A, 2005, AM J RESP CRIT CARE, V171, P1040, DOI 10.1164/rccm.200404-571OC; Best AC, 2003, RADIOLOGY, V228, P407, DOI 10.1148/radiol.2282020274; Best AC, 2008, RADIOLOGY, V246, P935, DOI 10.1148/radiol.2463062200; Choo JY, 2014, EUR RADIOL, V24, P799, DOI 10.1007/s00330-013-3078-5; du Bois RM, 2011, AM J RESP CRIT CARE, V184, P1382, DOI 10.1164/rccm.201105-0840OC; du Bois RM, 2011, AM J RESP CRIT CARE, V184, P459, DOI 10.1164/rccm.201011-1790OC; Ferguson EC, 2012, AM J ROENTGENOL, V199, pW464, DOI 10.2214/AJR.10.7309; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Heussel CP, 2009, EUR RADIOL, V19, P2391, DOI 10.1007/s00330-009-1437-z; Iwasawa T, 2014, EUR J RADIOL, V83, P32, DOI 10.1016/j.ejrad.2012.02.014; Kato S, 1996, CHEST, V109, P1439, DOI 10.1378/chest.109.6.1439; Kauczor HU, 1998, AM J ROENTGENOL, V171, P1091, DOI 10.2214/ajr.171.4.9763003; Kim HJ, 2015, ACAD RADIOL, V22, P70, DOI 10.1016/j.acra.2014.08.004; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kreuter M, 2014, EUR RESPIR REV, V23, P111, DOI 10.1183/09059180.00008513; Lee Y, 2009, COMPUT METH PROG BIO, V93, P206, DOI 10.1016/j.cmpb.2008.10.008; Matsuoka S, 2006, AM J ROENTGENOL, V186, P1272, DOI 10.2214/AJR.05.0047; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mura M, 2006, RESP CARE, V51, P257; Oltmanns U, 2014, RESPIRATION, V88, P199, DOI 10.1159/000363064; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Shin KE, 2011, J COMPUT ASSIST TOMO, V35, P266, DOI 10.1097/RCT.0b013e31820ccf18; Sverzellati N, 2007, RADIOL MED, V112, P1160, DOI 10.1007/s11547-007-0213-x; Walsh SLF, 2012, EUR RADIOL, V22, P1672, DOI 10.1007/s00330-012-2427-0; Watadani T, 2013, RADIOLOGY, V266, P936, DOI 10.1148/radiol.12112516; Weinheimer O, 2008, IEEE T MED IMAGING, V27, P64, DOI 10.1109/TMI.2007.902798; Wells AU, 1997, AM J RESP CRIT CARE, V155, P1367, DOI 10.1164/ajrccm.155.4.9105081; Westhoff M, 2014, MED KLIN INTENSI AUG; Yoon RG, 2013, EUR RADIOL, V23, P692, DOI 10.1007/s00330-012-2634-8	34	31	32	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130653	10.1371/journal.pone.0130653	http://dx.doi.org/10.1371/journal.pone.0130653			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110421	gold, Green Submitted, Green Published			2022-12-27	WOS:000356933800070
J	Higuera, C; Gardiner, KJ; Cios, KJ				Higuera, Clara; Gardiner, Katheleen J.; Cios, Krzysztof J.			Self-Organizing Feature Maps Identify Proteins Critical to Learning in a Mouse Model of Down Syndrome	PLOS ONE			English	Article							GENE-EXPRESSION; PLASTICITY; MEMANTINE; TS65DN; LANDSCAPE; REGULATOR; KNOWLEDGE; RESPONSES; PROFILES; PATTERNS	Down syndrome (DS) is a chromosomal abnormality (trisomy of human chromosome 21) associated with intellectual disability and affecting approximately one in 1000 live births worldwide. The overexpression of genes encoded by the extra copy of a normal chromosome in DS is believed to be sufficient to perturb normal pathways and normal responses to stimulation, causing learning and memory deficits. In this work, we have designed a strategy based on the unsupervised clustering method, Self Organizing Maps (SOM), to identify biologically important differences in protein levels in mice exposed to context fear conditioning (CFC). We analyzed expression levels of 77 proteins obtained from normal genotype control mice and from their trisomic littermates (Ts65Dn) both with and without treatment with the drug memantine. Control mice learn successfully while the trisomic mice fail, unless they are first treated with the drug, which rescues their learning ability. The SOM approach identified reduced subsets of proteins predicted to make the most critical contributions to normal learning, to failed learning and rescued learning, and provides a visual representation of the data that allows the user to extract patterns that may underlie novel biological responses to the different kinds of learning and the response to memantine. Results suggest that the application of SOM to new experimental data sets of complex protein profiles can be used to identify common critical protein responses, which in turn may aid in identifying potentially more effective drug targets.	[Higuera, Clara] Univ Complutense, Fac Ciencias Quim, Dept Bioquim & Biol Mol 1, E-28040 Madrid, Spain; [Higuera, Clara] Univ Complutense, Fac Informat, Dept Inteligencia Artificial & Ingn Software, E-28040 Madrid, Spain; [Gardiner, Katheleen J.] Univ Colorado, Sch Med, Linda Crnic Inst Syndrome, Dept Pediat,Dept Biochem & Mol Genet,Human Med Ge, Aurora, CO USA; [Gardiner, Katheleen J.] Univ Colorado, Sch Med, Linda Crnic Inst Syndrome, Dept Pediat,Dept Biochem & Mol Genet,Neurosci Pro, Aurora, CO USA; [Cios, Krzysztof J.] Virginia Commonwealth Univ, Dept Comp Sci, Richmond, VA 23284 USA; [Cios, Krzysztof J.] Polish Acad Sci, IITiS, Gliwice, Poland	Complutense University of Madrid; Complutense University of Madrid; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Virginia Commonwealth University; Polish Academy of Sciences	Cios, KJ (corresponding author), Virginia Commonwealth Univ, Dept Comp Sci, Richmond, VA 23284 USA.	kcios@vcu.edu			National Institutes of Health [1R01HD056235-01A1]; Ministerio de Economia y Competitividad [BFU2012-39816-C02-02]; Ministerio de Economia y Competitividad (Spain); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Economia y Competitividad(Spanish Government); Ministerio de Economia y Competitividad (Spain)(Spanish Government); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the National Institutes of Health (http://www.nih.gov/); grant number 1R01HD056235-01A1 (KG, KC); Ministerio de Economia y Competitividad (http://www.mineco.gob.es/portal/site/mineco/); grant number BFU2012-39816-C02-02 (CH). CH holds a FPI PhD scholarship from Ministerio de Economia y Competitividad (Spain). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MM, 2014, MOL CELL PROTEOMICS, V13, P919, DOI 10.1074/mcp.M113.035568; Ahmed MM, 2013, HUM MOL GENET, V22, P1709, DOI 10.1093/hmg/ddt017; Ahmed MM, 2012, J PROTEOME RES, V11, P1251, DOI 10.1021/pr2011582; Ahmed MM, 2015, PLOS ONE IN PRESS; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Babiec WE, 2014, J NEUROSCI, V34, P5285, DOI 10.1523/JNEUROSCI.5419-13.2014; Benavides-Piccione R, 2005, NEUROBIOL DIS, V20, P115, DOI 10.1016/j.nbd.2005.02.004; Block A, 2014, J ALZHEIMERS DIS; Boada R, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.66; Chavez-Alvarez R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093233; Costa ACS, 2008, NEUROPSYCHOPHARMACOL, V33, P1624, DOI 10.1038/sj.npp.1301535; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; FITCH WM, 1966, J MOL BIOL, V16, P9, DOI 10.1016/S0022-2836(66)80258-9; FRITZKE B, 1994, NEURAL NETWORKS, V7, P1441, DOI 10.1016/0893-6080(94)90091-4; Gardiner KJ, 2014, DRUG DES DEV THER, V9, P103, DOI 10.2147/DDDT.S51476; Hautaniemi S, ANAL VISUALIZATION G, V52, P45; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Iannello RC, 1999, J NEURAL TRANSM-SUPP, P257; Irving C, 2008, EUR J HUM GENET, V16, P1336, DOI 10.1038/ejhg.2008.122; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kim DH, 2015, CELL STEM CELL, V16, P88, DOI 10.1016/j.stem.2014.11.005; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Larranaga P, 2006, BRIEF BIOINFORM, V7, P86, DOI 10.1093/bib/bbk007; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Lipton SA, 2007, CURR DRUG TARGETS, V8, P621, DOI 10.2174/138945007780618472; Liu IYC, 2004, J NEUROSCI, V24, P7958, DOI 10.1523/JNEUROSCI.1948-04.2004; Mortazavi A, 2013, GENOME RES, V23, P2136, DOI 10.1101/gr.158261.113; Muranen TA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3015; Newman AM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-117; Nguyen CD, 2011, J NEUROGENET, V25, P40, DOI 10.3109/01677063.2011.558606; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Olivares D, 2012, CURR ALZHEIMER RES, V9, P746; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Radulovic J, 1998, BEHAV BRAIN RES, V95, P179, DOI 10.1016/S0166-4328(98)00039-4; Raman R, 2005, STAT MED, V24, P3331, DOI 10.1002/sim.2186; Riddick G, 2014, PHARMACOGENOMICS J; Rogers A, 2012, PANCREATOLOGY, V12, P130, DOI 10.1016/j.pan.2011.12.011; Rosin G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-79; Rueda N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/584071; Samuels IS, 2009, NEURON, V61, P160, DOI 10.1016/j.neuron.2009.01.001; Sananbenesi F, 2002, MOL CELL NEUROSCI, V21, P463, DOI 10.1006/mcne.2002.1188; Sengar AS, 2013, J NEUROSCI, V33, P4055, DOI 10.1523/JNEUROSCI.4428-12.2013; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Siddiqui A, 2008, GENES BRAIN BEHAV, V7, P810, DOI 10.1111/j.1601-183X.2008.00428.x; Stallings JD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1058; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stiedl O, 1999, BEHAV BRAIN RES, V104, P1, DOI 10.1016/S0166-4328(99)00047-9; Sturgeon X, 2012, PROG BRAIN RES, V197, P73, DOI 10.1016/B978-0-444-54299-1.00005-4; Sturgeon X, 2011, MAMM GENOME, V22, P261, DOI 10.1007/s00335-011-9321-y; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tanaka S, 2010, SURGERY, V147, P405, DOI 10.1016/j.surg.2009.09.037; Tejedor FJ, 2011, FEBS J, V278, P223, DOI 10.1111/j.1742-4658.2010.07954.x; Varras M, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-36; Veyrac A, 2014, PROG MOL BIOL TRANSL, V122, P89, DOI 10.1016/B978-0-12-420170-5.00004-0; Yu Y, 2008, HUM MOL GENET, V17, P3281, DOI 10.1093/hmg/ddn224; Zelikowsky M, 2014, J NEUROSCI, V34, P8462, DOI 10.1523/JNEUROSCI.3624-13.2014; Zhang LP, 2011, COMPUT BIOL CHEM, V35, P211, DOI 10.1016/j.compbiolchem.2011.05.002	63	66	67	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0129126	10.1371/journal.pone.0129126	http://dx.doi.org/10.1371/journal.pone.0129126			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111164	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800019
J	Lim, NK; Lee, JY; Lee, JY; Park, HY; Cho, MC				Lim, Nam-Kyoo; Lee, Ji-Young; Lee, Jong-Young; Park, Hyun-Young; Cho, Myeong-Chan			The Role of Genetic Risk Score in Predicting the Risk of Hypertension in the Korean population: Korean Genome and Epidemiology Study	PLOS ONE			English	Article							BLOOD-PRESSURE; WIDE ASSOCIATION; PROSPECTIVE COHORT; EAST ASIANS; VARIANTS; TRAITS	Hypertension is regarded as a multifactorial disease with a modest contribution of genetic factors and strongly affected by environmental factors. Recent genome-wide association studies have identified specific loci associated with high blood pressure (BP) and hypertension. This study aimed to examine the association between the genetic risk score (GRS), a linear function of multiple single nucleotide polymorphisms (SNPs) associated with hypertension, and high BP and prevalent hypertension at baseline examination and to evaluate the efficacy of the GRS for predicting incident hypertension with longitudinal data in Korean subjects. Data for 8,556 participants, aged 40 to 69, in a community-based cohort study were analyzed. Unweighted GRS (cGRS) and weighted GRS (wGRS) were constructed from 4 SNPs related to high BP or hypertension in previous genome-wide association and its replication studies for the Korean middle-aged population. Cross-sectional analysis (n=8,556) revealed that cGRS was significantly associated with prevalent hypertension (odds ratio=1.15 per risk allele; 95%CI, 1.09-1.20). Additionally, the odds ratios (ORs) of prevalent hypertension for those who in medium and the highest tertile compared with those who in the lowest tertile of wGRS were 1.31 (95% CI, 1.15-1.50) and 1.59 (95% CI, 1.38-1.82), respectively. In a longitudinal analysis (n=5,632), participants in the highest tertile of wGRS had a 1.22-fold (OR=1.22, 95% CI, 1.02-1.46) greater risk of incident hypertension relative to those in the lowest tertile, after adjusting for a number of confounding factors. However, wGRS topped with traditional risk factors had no significant effect on discrimination ability (c-statistics with and without wGRS were 0.811 and 0.810, P=0.1057). But, reclassification analysis showed that the addition of GRS to the model with conventional risk factors led to about 9% significant increment in category-free net reclassification improvement. GRSs based on 4 SNPs were independently associated with hypertension and may provide a statistically significant improvement over the existing model for prediction of incident hypertension.	[Lim, Nam-Kyoo; Park, Hyun-Young] Korea Natl Inst Hlth, Div Cardiovasc & Rare Dis, Cheongju, South Korea; [Lee, Ji-Young; Lee, Jong-Young] Korea Natl Inst Hlth, Div Struct & Funct Gen, Cheongju, South Korea; [Lee, Ji-Young] Yonsei Univ Hlth Syst, Cardiovasc Res Inst, Seoul, South Korea; [Lee, Ji-Young] Yonsei Univ Hlth Syst, Cardiovasc Genome Ctr, Seoul, South Korea; [Cho, Myeong-Chan] Chungbuk Natl Univ, Coll Med, Dept Cardiol, Cheongju, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Chungbuk National University	Park, HY (corresponding author), Korea Natl Inst Hlth, Div Cardiovasc & Rare Dis, Cheongju, South Korea.	mdhypark@gmail.com	; Lee, Jong-Young/M-6319-2013	Lee, Ji-Young/0000-0002-7784-1401; Lee, Jong-Young/0000-0002-0092-9958	Research of Korea Centers for Disease Control and Prevention [4800-4845-302-210 (2011-NG6302-00), 4800-4845-302-210 (2010-N63001-00)]	Research of Korea Centers for Disease Control and Prevention	This research was supported by a fund [4800-4845-302-210 (2011-NG6302-00 and 2010-N63001-00)] by Research of Korea Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Efron B, 1993, INTRO BOOTSTRAP, DOI [DOI 10.1007/978-1-4899-4541-9, 10.1007/978-1-4899-4541-9]; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Fava C, 2015, EUR J HUM GENET, V23, P969, DOI 10.1038/ejhg.2014.212; Fava C, 2013, HYPERTENSION, V61, P319, DOI 10.1161/HYPERTENSIONAHA.112.202655; Ganesh SK, 2013, HUM MOL GENET, V22, P1663, DOI 10.1093/hmg/dds555; Havulinna AS, 2013, HYPERTENSION, V61, P987, DOI 10.1161/HYPERTENSIONAHA.111.00649; Hiura Y, 2010, CIRC J, V74, P2353, DOI 10.1253/circj.CJ-10-0353; Hong KW, 2010, J HUM HYPERTENS, V24, P367, DOI 10.1038/jhh.2009.86; Hong KW, 2010, J HUM GENET, V55, P336, DOI 10.1038/jhg.2010.31; Hosmer DW, 1997, STAT MED, V16, P965; Hughes MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040922; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Kim YJ, 2011, NAT GENET, V43, P990, DOI 10.1038/ng.939; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Malik R, 2014, STROKE, V45, P394, DOI 10.1161/STROKEAHA.113.002938; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Oikonen M, 2011, HYPERTENSION, V58, P1079, DOI 10.1161/HYPERTENSIONAHA.111.179291; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Shin C, 2004, J HUM HYPERTENS, V18, P717, DOI 10.1038/sj.jhh.1001732; Taal HR, 2012, HYPERTENSION, V59, P241, DOI 10.1161/HYPERTENSIONAHA.111.179481; Yang HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005459; Zhu XF, 2011, HUM MOL GENET, V20, P2285, DOI 10.1093/hmg/ddr113	27	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131603	10.1371/journal.pone.0131603	http://dx.doi.org/10.1371/journal.pone.0131603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110887	gold, Green Submitted, Green Published			2022-12-27	WOS:000356933800162
J	Liu, YN; Li, A; Feng, HQ; Wang, MH				Liu, Yuanning; Li, Ao; Feng, Huanqing; Wang, Minghui			TAFFYS: An Integrated Tool for Comprehensive Analysis of Genomic Aberrations in Tumor Samples	PLOS ONE			English	Article							COPY NUMBER ANALYSIS; HIDDEN MARKOV MODEL; CHROMOSOMAL-ABERRATIONS; STATISTICAL APPROACH; CANCER; HETEROZYGOSITY; IDENTIFICATION	Background Tumor single nucleotide polymorphism (SNP) array is a common platform for investigating the cancer genomic aberration and the functionally important altered genes. Original SNP array signals are usually corrupted by noise, and need to be de-convoluted into absolute copy number profile by analytical methods. Unfortunately, in contrast with the popularity of tumor Affymetrix SNP array, the methods that are specifically designed for this platform are still limited. The complicated characteristics of noise in signals is one of the difficulties for dissecting tumor Affymetrix SNP array data, as they inevitably blur the distinction between aberrations and create an obstacle for the copy number aberration (CNA) identification. Results We propose a tool named TAFFYS for comprehensive analysis of tumor Affymetrix SNP array data. TAFFYS introduce a wavelet-based de-noising approach and copy number-specific signal variance model for suppressing and modelling the noise in signals. Then a hidden Markov model is employed for copy number inference. Finally, by using the absolute copy number profile, statistical significance of each aberration region is calculated in term of different aberration types, including amplification, deletion and loss of heterozygosity (LOH). The result shows that copy number specific-variance model and wavelet de-noising algorithm fits well with the Affymetrix SNP array signals, leading to more accurate estimation for diluted tumor sample (even with only 30% of cancer cells) than other existed methods. Results of examinations also demonstrate a good compatibility and extensibility for different Affymetrix SNP array platforms. Application on the 35 breast tumor samples shows that TAFFYS can automatically dissect the tumor samples and reveal statistically significant aberration regions where cancer-related genes locate. Conclusions TAFFYS provide an efficient and convenient tool for identifying the copy number alteration and allelic imbalance and assessing the recurrent aberrations for the tumor Affymetrix SNP array data.	[Liu, Yuanning; Li, Ao; Feng, Huanqing; Wang, Minghui] Univ Sci & Technol China, Sch Informat Sci & Technol, Hefei 230026, Peoples R China; [Li, Ao; Wang, Minghui] Univ Sci & Technol China, Res Ctr Biomed Engn, Hefei 230026, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Li, A (corresponding author), Univ Sci & Technol China, Sch Informat Sci & Technol, AH230027, Hefei 230026, Peoples R China.	aoli@ustc.edu.cn	Li, Ao/GRR-5311-2022; Li, aoyu/GXV-4925-2022		National Natural Science Foundation of China [31100955, 61101061]; Fundamental Research Funds for the Central Universities [WK2100230007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from National Natural Science Foundation of China (31100955 and 61101061) and Fundamental Research Funds for the Central Universities (WK2100230007).	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; [Anonymous], ATLAS GENETICS CYTOG; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Chen GK, 2013, BIOINFORMATICS, V29, P2964, DOI 10.1093/bioinformatics/btt521; Curtis C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-588; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Eckel-Passow JE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-220; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Ha G, 2012, GENOME RES, V22, P1995, DOI 10.1101/gr.137570.112; Hanczar B, 2010, BIOINFORMATICS, V26, P822, DOI 10.1093/bioinformatics/btq037; Hsu L, 2005, BIOSTATISTICS, V6, P211, DOI 10.1093/biostatistics/kxi004; Li A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087212; Li A, 2011, NUCLEIC ACIDS RES, V39, P4928, DOI 10.1093/nar/gkr014; Liu ZZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010909; Mayrhofer M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r24; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Nancarrow DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001093; Ortiz-Estevez M, 2010, BIOINFORMATICS, V26, P1827, DOI 10.1093/bioinformatics/btq300; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Popova T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r128; Rasmussen M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r108; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Teo SM, 2012, BIOINFORMATICS, V28, P2711, DOI 10.1093/bioinformatics/bts535; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Yau C, 2013, BIOINFORMATICS, V29, P2482, DOI 10.1093/bioinformatics/btt416; Yau C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r92	29	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0129835	10.1371/journal.pone.0129835	http://dx.doi.org/10.1371/journal.pone.0129835			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111017	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800030
J	Yang, JM; Qiu, HZ; Qu, PF; Zhang, R; Zeng, LX; Yan, H				Yang, Jiaomei; Qiu, Huizhen; Qu, Pengfei; Zhang, Ruo; Zeng, Lingxia; Yan, Hong			Prenatal Alcohol Exposure and Congenital Heart Defects: A Meta-Analysis	PLOS ONE			English	Article							VENTRICULAR SEPTAL-DEFECT; RISK-FACTORS; BIRTH-DEFECTS; CONSUMPTION; PREGNANCY; MALFORMATIONS; DISEASE; WOMEN; ASSOCIATION; CHILDREN	Background There are still inconsistent conclusions about the association of prenatal alcohol drinking with congenital heart defects (CHDs). We conducted this meta-analysis to investigate the association between prenatal alcohol exposure and the risk of overall CHDs and the CHDs subtypes. Methods Case-control and cohort studies published before March 2015 were searched through PubMed and Embase. Two authors independently extracted data and scored the study quality according to the Newcastle-ottawa Scale. The pooled ORs and 95% CI were estimated using the random-effects model and heterogeneity was assessed by the Q test and I-2 statistic. Results A total of 20 studies were finally included. The results provided no evidence of the association between prenatal alcohol exposure and the risk of overall CHDs (OR = 1.06, 95%CI = 0.93-1.22), ventricular septal defects (VSDs) (OR = 1.04, 95%CI = 0.86-1.25), or atrial septal defects (ASDs) (OR = 1.40, 95%CI = 0.88-2.23). However, prenatal alcohol drinking was marginally significantly associated with conotruncal defects (CTDs) (OR = 1.24, 95%CI = 0.97-1.59) and statistically significantly associated with d-Transposition of the Great Arteries (dTGA) (OR = 1.64, 95%CI = 1.17-2.30). Moreover, both prenatal heavy drinking and binge drinking have a strong association with overall CHDs (heavy drinking: OR = 3.76, 95%CI = 1.00-14.10; binge drinking: OR = 2.49, 95%CI = 1.04-5.97), and prenatal moderate drinking has a modest association with CTDs (OR = 1.35, 95%CI = 1.05-1.75) and dTGA (OR = 1.86, 95%CI = 1.09-3.20). Conclusions In conclusion, the results suggested that prenatal alcohol exposure was not associated with overall CHDs or some subtypes, whereas marginally significant association was found for CTDs and statistically significant association was found for dTGA. Further prospective studies with large population and better designs are needed to explore the association of prenatal alcohol exposure with CHDs including the subtypes in specific groups.	[Yang, Jiaomei; Qiu, Huizhen; Qu, Pengfei; Zhang, Ruo; Zeng, Lingxia; Yan, Hong] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Xian 710049, Shaanxi, Peoples R China; [Yan, Hong] Nutr & Food Safety Engn Res Ctr Shaanxi Prov, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	Yan, H (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Xian 710049, Shaanxi, Peoples R China.	xjtu_yh2014@163.com			National Natural Science Foundation of China [81230016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (grant number: 81230016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MM, 1989, J AM COLL CARDIOL, V14, P432, DOI 10.1016/0735-1097(89)90199-X; BEAUCHEMIN RR, 1984, ANAT ANZEIGER, V155, P17; BONTHIUS DJ, 1988, ALCOHOL, V5, P209, DOI 10.1016/0741-8329(88)90054-7; Botto LD, 2007, BIRTH DEFECTS RES A, V79, P714, DOI 10.1002/bdra.20403; Burd Larry, 2007, Congenit Heart Dis, V2, P250, DOI 10.1111/j.1747-0803.2007.00105.x; Cameron CM, 2013, MED J AUSTRALIA, V199, P355, DOI 10.5694/mja12.11723; Carmichael SL, 2003, BIRTH DEFECTS RES A, V67, P875, DOI 10.1002/bdra.10087; Cedergren MI, 2002, SCAND J WORK ENV HEA, V28, P12, DOI 10.5271/sjweh.641; Cresci M, 2011, AM J CARDIOL, V108, P1625, DOI 10.1016/j.amjcard.2011.07.022; DAFT PA, 1986, TERATOLOGY, V33, P93, DOI 10.1002/tera.1420330112; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dolk H, 2011, CIRCULATION, V123, P841, DOI 10.1161/CIRCULATIONAHA.110.958405; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ethen M, 2009, MATERN CHILD HLTH J, V13, P274, DOI 10.1007/s10995-008-0328-2; Ewing CK, 1997, AM J MED GENET, V71, P42, DOI 10.1002/(SICI)1096-8628(19970711)71:1<42::AID-AJMG8>3.3.CO;2-A; FELDMAN Y, 1989, TERATOLOGY, V40, P37, DOI 10.1002/tera.1420400106; Gilboa SM, 2010, CIRCULATION, V122, P2254, DOI 10.1161/CIRCULATIONAHA.110.947002; Grewal J, 2008, BIRTH DEFECTS RES A, V82, P519, DOI 10.1002/bdra.20461; Henderson J, 2007, BJOG-INT J OBSTET GY, V114, P243, DOI 10.1111/j.1471-0528.2006.01163.x; Henderson J, 2007, J EPIDEMIOL COMMUN H, V61, P1069, DOI 10.1136/jech.2006.054213; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hobbs CA, 2011, BIRTH DEFECTS RES A, V91, P195, DOI 10.1002/bdra.20784; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; JONES KL, 1973, LANCET, V2, P999; Kuciene R, 2009, MEDICINA-LITHUANIA, V45, P904, DOI 10.3390/medicina45110116; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Martinez-Frias ML, 2004, BIRTH DEFECTS RES A, V70, P194, DOI 10.1002/bdra.20017; Mateja WA, 2012, J WOMENS HEALTH, V21, P26, DOI 10.1089/jwh.2010.2582; MCDONALD AD, 1992, AM J PUBLIC HEALTH, V82, P91, DOI 10.2105/AJPH.82.1.91; MILLS JL, 1987, PEDIATRICS, V80, P309; O'Leary CM, 2013, BIRTH DEFECTS RES A, V97, P497, DOI 10.1002/bdra.23142; Patel SS, 2012, AM J MED GENET A, V158A, P2447, DOI 10.1002/ajmg.a.35555; Patra J, 2011, BJOG-INT J OBSTET GY, V118, P1411, DOI 10.1111/j.1471-0528.2011.03050.x; Polygenis D, 1998, NEUROTOXICOL TERATOL, V20, P61, DOI 10.1016/S0892-0362(97)00073-1; Sands AJ, 1999, ARCH DIS CHILD-FETAL, V81, pF61, DOI 10.1136/fn.81.1.F61; Shillingford AJ, 2008, PEDIATRICS, V121, pE759, DOI 10.1542/peds.2007-1066; Strandberg-Larsen K, 2011, BIRTH DEFECTS RES A, V91, P616, DOI 10.1002/bdra.20818; TIKKANEN J, 1990, EUR J EPIDEMIOL, V6, P348, DOI 10.1007/BF00151707; TIKKANEN J, 1994, TERATOLOGY, V50, P112, DOI 10.1002/tera.1420500205; TIKKANEN J, 1993, TERATOLOGY, V47, P565, DOI 10.1002/tera.1420470608; Ungerer M, 2013, ALCOHOL RES-CURR REV, V35, P37; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Wells G.A., 2000, VIS COMMUN Q; Williams LJ, 2004, BIRTH DEFECTS RES A, V70, P59, DOI 10.1002/bdra.10145	44	45	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130681	10.1371/journal.pone.0130681	http://dx.doi.org/10.1371/journal.pone.0130681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110619	gold, Green Submitted, Green Published			2022-12-27	WOS:000356933800072
J	Young, D; Rice, J; Martin, R; Lindquist, E; Lipzen, A; Grigoriev, I; Hibbett, D				Young, Darcy; Rice, James; Martin, Rachael; Lindquist, Erika; Lipzen, Anna; Grigoriev, Igor; Hibbett, David			Degradation of Bunker C Fuel Oil by White-Rot Fungi in Sawdust Cultures Suggests Potential Applications in Bioremediation	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; PHANEROCHAETE-CHRYSOSPORIUM; IRPEX-LACTEUS; MANGANESE PEROXIDASE; LIGNINOLYTIC ENZYMES; PLEUROTUS-OSTREATUS; CRUDE-OIL; SOIL; BIODEGRADATION; DECOLORIZATION	Fungal lignocellulolytic enzymes are promising agents for oxidizing pollutants. This study investigated degradation of Number 6 "Bunker C" fuel oil compounds by the white-rot fungi Irpex lacteus, Trichaptum biforme, Phlebia radiata, Trametes versicolor, and Pleurotus ostreatus (Basidiomycota, Agaricomycetes). Averaging across all studied species, 98.1%, 48.6%, and 76.4% of the initial Bunker C C10 alkane, C14 alkane, and phenanthrene, respectively were degraded after 180 days of fungal growth on pine media. This study also investigated whether Bunker C oil induces changes in gene expression in the white-rot fungus Punctularia strigosozonata, for which a complete reference genome is available. After 20 days of growth, a monokaryon P. strigosozonata strain degraded 99% of the initial C10 alkane in both pine and aspen media but did not affect the amounts of the C14 alkane or phenanthrene. Differential gene expression analysis identified 119 genes with >= log(2)(2-fold) greater expression in one or more treatment comparisons. Six genes were significantly upregulated in media containing oil; these genes included three enzymes with potential roles in xenobiotic biotransformation. Carbohydrate metabolism genes showing differential expression significantly accumulated transcripts on aspen vs. pine substrates, perhaps reflecting white-rot adaptations to growth on hardwood substrates. The mechanisms by which P. strigosozonata may degrade complex oil compounds remain obscure, but degradation results of the 180-day cultures suggest that diverse white-rot fungi have promise for bioremediation of petroleum fuels.	[Young, Darcy; Martin, Rachael; Hibbett, David] Clark Univ, Dept Biol, Worcester, MA 01610 USA; [Rice, James] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Lindquist, Erika; Lipzen, Anna; Grigoriev, Igor] Joint Genome Inst, Walnut Creek, CA USA	Clark University; Brown University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Young, D (corresponding author), Clark Univ, Dept Biol, Worcester, MA 01610 USA.	darcyfyoung@gmail.com		Grigoriev, Igor/0000-0002-3136-8903; Lipzen, Anna/0000-0003-2293-9329	Mosakowski Institute for Public Enterprise at Clark University; Office of Science of the United States Department of Energy [DE-AC02-05CH11231]; National Institute of Environmental Health Sciences [P42ES013660]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES013660] Funding Source: NIH RePORTER; Direct For Biological Sciences [0933081] Funding Source: National Science Foundation	Mosakowski Institute for Public Enterprise at Clark University; Office of Science of the United States Department of Energy(United States Department of Energy (DOE)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work conducted at Clark University was funded by a grant to DH from the Mosakowski Institute for Public Enterprise at Clark University (http://www.clarku.edu/research/mosakowskiinstitute/). The work conducted by the United States Department of Energy Joint Genome Institute is supported by the Office of Science of the United States Department of Energy (science.energy.gov) under Contract No. DE-AC02-05CH11231. The work conducted at Brown University was supported by grant number P42ES013660 from the National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Environmental Health Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggelis G, 2003, WATER RES, V37, P3897, DOI 10.1016/S0043-1354(03)00313-0; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2013, FUNGAL DATABASES; Asgher M, 2008, BIODEGRADATION, V19, P771, DOI 10.1007/s10532-008-9185-3; ATLAS RM, 1981, MICROBIOL REV, V45, P180, DOI 10.1128/MMBR.45.1.180-209.1981; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bamforth SM, 2005, J CHEM TECHNOL BIOT, V80, P723, DOI 10.1002/jctb.1276; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bezalel L, 1996, APPL ENVIRON MICROB, V62, P292, DOI 10.1128/AEM.62.1.292-295.1996; Bezalel L, 1996, APPL ENVIRON MICROB, V62, P2547, DOI 10.1128/AEM.62.7.2547-2553.1996; Boddy L, 1992, FUNGAL COMMUNITY ITS, V9, P749; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Cajthaml T, 2008, FOLIA MICROBIOL, V53, P289, DOI 10.1007/s12223-008-0045-7; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Collins PJ, 1996, APPL ENVIRON MICROB, V62, P4563, DOI 10.1128/AEM.62.12.4563-4567.1996; da Cruz GF, 2008, ORG GEOCHEM, V39, P1204, DOI 10.1016/j.orggeochem.2008.04.010; DONAGHY J, 1992, APPL MICROBIOL BIOT, V37, P742; Eshghi H, 2011, EUROPEAN J CHEM, V2, P463; FIELD JA, 1992, APPL ENVIRON MICROB, V58, P2219, DOI 10.1128/AEM.58.7.2219-2226.1992; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; FREITAG M, 1992, CAN J MICROBIOL, V38, P811, DOI 10.1139/m92-133; Gadd G. M., 2007, P69; Gilbertson RL, 1987, N AM POLYPORES; Ginns J, 1993, MYCOLOGIA MEMOIRS, V19, P1; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Harvey P.J., 2009, FUNGI BIOREMEDIATION, P27, DOI [10.1017/CBO9780511541780.003, DOI 10.1017/CBO9780511541780.003]; Kanaly RA, 2006, CHEMOSPHERE, V63, P202, DOI 10.1016/j.chemosphere.2005.08.022; Kim HY, 2003, APPL MICROBIOL BIOT, V61, P150, DOI 10.1007/s00253-002-1211-5; Kristanti RA, 2011, J MICROBIOL BIOTECHN, V21, P995, DOI 10.4014/jmb.1105.05047; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marquez-Rocha FJ, 2000, BIOTECHNOL LETT, V22, P469, DOI 10.1023/A:1005663419547; Martinez AT, 2002, ENZYME MICROB TECH, V30, P425, DOI 10.1016/S0141-0229(01)00521-X; MOEN MA, 1994, APPL ENVIRON MICROB, V60, P1956, DOI 10.1128/AEM.60.6.1956-1961.1994; MULKINSPHILLIPS GJ, 1974, APPL MICROBIOL, V28, P915, DOI 10.1128/AEM.28.6.915-922.1974; Novotny C, 1999, BIODEGRADATION, V10, P159, DOI 10.1023/A:1008324111558; Novotny C, 2009, FOLIA MICROBIOL, V54, P375, DOI 10.1007/s12223-009-0053-2; Novotny C, 2000, APPL MICROBIOL BIOT, V54, P850, DOI 10.1007/s002530000432; Ollila P, 2008, P ANN INT C SOILS SE; Parkinson A, 2001, CASARETT DOULLS TOXI, P133, DOI DOI 10.1036/0071470514; Pozdnyakova NN, 2008, APPL BIOCHEM MICRO+, V44, P60, DOI 10.1134/S0003683808010109; ROGALSKI J, 1991, PHYTOCHEMISTRY, V30, P2869, DOI 10.1016/S0031-9422(00)98215-3; Shin KS, 2005, J MICROBIOL, V43, P503; Svobodova K, 2008, BIORESOURCE TECHNOL, V99, P463, DOI 10.1016/j.biortech.2007.01.019; Syed K, 2013, APPL ENVIRON MICROB, V79, P2692, DOI 10.1128/AEM.03767-12; Syed K, 2010, BIOCHEM BIOPH RES CO, V399, P492, DOI 10.1016/j.bbrc.2010.07.094; U.S. Environmental Protection Agency, 2007, 8015C US EPA; Valegard K, 1998, NATURE, V394, P805, DOI 10.1038/29575; van Beilen JB, 2006, APPL ENVIRON MICROB, V72, P59, DOI 10.1128/AEM.72.1.59-65.2006; van Beilen JB, 2003, OIL GAS SCI TECHNOL, V58, P427, DOI 10.2516/ogst:2003026; VANDERMEULEN JH, 1994, CAN J FISH AQUAT SCI, V51, P845, DOI 10.1139/f94-083; Wang Jian, 2012, Huanjing Kexue, V33, P1352; Wang ZD, 2001, J CHROMATOGR A, V926, P275, DOI 10.1016/S0021-9673(01)01051-2; Wymelenberg AV, 2011, APPL ENVIRON MICROB, V77, P4499, DOI 10.1128/AEM.00508-11; ZAJIC JE, 1972, BIOTECHNOL BIOENG, V14, P331, DOI 10.1002/bit.260140306	54	25	26	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130381	10.1371/journal.pone.0130381	http://dx.doi.org/10.1371/journal.pone.0130381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111162	Green Published, gold			2022-12-27	WOS:000356933800044
J	Burchett, GG; Folsom, CG; Lane, KT				Burchett, Gina G.; Folsom, Charles G.; Lane, Kimberly T.			Native Electrophoresis-Coupled Activity Assays Reveal Catalytically-Active Protein Aggregates of Escherichia coli beta-Glucuronidase	PLOS ONE			English	Article							RATS; MICROFLORA; EXPRESSION; TOXICITY; DOCKING; CANCER; DESIGN	beta-glucuronidase is found as a functional homotetramer in a variety of organisms, including humans and other animals, as well as a number of bacteria. This enzyme is important in these organisms, catalyzing the hydrolytic removal of a glucuronide moiety from substrate molecules. This process serves to break down sugar conjugates in animals and provide sugars for metabolism in bacteria. While beta-glucuronidase is primarily found as a homotetramer, previous studies have indicated that the human form of the protein is also catalytically active as a dimer. Here we present evidence for not only an active dimer of the E. coli form of the protein, but also for several larger active complexes, including an octomer and a 16-mer. Additionally, we propose a model for the structures of these large complexes, based on computationally-derived molecular modeling studies. These structures may have application in the study of human disease, as several diseases have been associated with the aggregation of proteins.	[Burchett, Gina G.; Folsom, Charles G.; Lane, Kimberly T.] Radford Univ, Dept Chem, Radford, VA 24142 USA	Radford University	Lane, KT (corresponding author), Radford Univ, Dept Chem, Radford, VA 24142 USA.	ktlane@radford.edu						ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; BROT FE, 1978, BIOCHEMISTRY-US, V17, P385, DOI 10.1021/bi00596a001; BUEHLER HJ, 1951, P SOC EXP BIOL MED, V76, P672, DOI 10.3181/00379727-76-18591; Fernandez-Recio J, 2005, PROTEINS, V58, P134, DOI 10.1002/prot.20285; Flores H, 2002, J MOL BIOL, V315, P325, DOI 10.1006/jmbi.2001.5223; GEHRMANN MC, 1994, BIOCHEM J, V301, P821, DOI 10.1042/bj3010821; Glacer JA, 1973, J LAB CLIN MED, V82, P969; Hassan MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079687; Jain S, 1996, NAT STRUCT BIOL, V3, P375, DOI 10.1038/nsb0496-375; Kaneda N, 1997, CANCER RES, V57, P5305; Kim DH, 2001, ARCH PHARM RES, V24, P564, DOI 10.1007/BF02975166; Kopen GC, 1999, J HISTOCHEM CYTOCHEM, V47, P965, DOI 10.1177/002215549904700714; Lebendiker M, 2014, FEBS LETT, V588, P236, DOI 10.1016/j.febslet.2013.10.044; Manchenko GP, 2002, HDB DETECTION ENZYME; OSHIMA A, 1987, P NATL ACAD SCI USA, V84, P685, DOI 10.1073/pnas.84.3.685; Roberts CJ, 2014, TRENDS BIOTECHNOL, V32, P372, DOI 10.1016/j.tibtech.2014.05.005; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SLY WS, 1973, J PEDIATR-US, V82, P249, DOI 10.1016/S0022-3476(73)80162-3; Stringer AM, 2008, CANCER BIOL THER, V7, P1919, DOI 10.4161/cbt.7.12.6940; Takasuna K, 1996, CANCER RES, V56, P3752; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Wilson KJ, 1992, GUS PROTOCOLS USING, V1, P7	23	1	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130269	10.1371/journal.pone.0130269	http://dx.doi.org/10.1371/journal.pone.0130269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121040	Green Published, Green Submitted, gold			2022-12-27	WOS:000358150400036
J	Nash, D; Arrington, CB; Kennedy, BJ; Yandell, M; Wu, W; Zhang, W; Ware, S; Jorde, LB; Gruber, PJ; Yost, HJ; Bowles, NE; Bleyl, SB				Nash, Dustin; Arrington, Cammon B.; Kennedy, Brett J.; Yandell, Mark; Wu, Wilfred; Zhang, Wenying; Ware, Stephanie; Jorde, Lynn B.; Gruber, Peter J.; Yost, H. Joseph; Bowles, Neil E.; Bleyl, Steven B.			Shared Segment Analysis and Next-Generation Sequencing Implicates the Retinoic Acid Signaling Pathway in Total Anomalous Pulmonary Venous Return (TAPVR)	PLOS ONE			English	Article							GENE; ZEBRAFISH; DIFFERENTIATION; ASSOCIATION; EXPRESSION; MUTATIONS	Most isolated congenital heart defects are thought to be sporadic and are often ascribed to multifactorial mechanisms with poorly understood genetics. Total Anomalous Pulmonary Venous Return (TAPVR) occurs in 1 in 15,000 live-born infants and occurs either in isolation or as part of a syndrome involving aberrant left-right development. Previously, we reported causative links between TAVPR and the PDGFRA gene. TAPVR has also been linked to the ANKRD1/CARP genes. However, these genes only explain a small fraction of the heritability of the condition. By examination of phased single nucleotide polymorphism genotype data from 5 distantly related TAPVR patients we identified a single 25 cM shared, Identical by Descent genomic segment on the short arm of chromosome 12 shared by 3 of the patients and their obligate-carrier parents. Whole genome sequence (WGS) analysis identified a non-synonymous variant within the shared segment in the retinol binding protein 5 (RBP5) gene. The RBP5 variant is predicted to be deleterious and is overrepresented in the TAPVR population. Gene expression and functional analysis of the zebrafish orthologue, rbp7, supports the notion that RBP5 is a TAPVR susceptibility gene. Additional sequence analysis also uncovered deleterious variants in genes associated with retinoic acid signaling, including NODAL and retinol dehydrogenase 10. These data indicate that genetic variation in the retinoic acid signaling pathway confers, in part, susceptibility to TAPVR.	[Nash, Dustin; Arrington, Cammon B.; Bowles, Neil E.; Bleyl, Steven B.] Univ Utah, Sch Med, Dept Pediat, Div Cardiol, Salt Lake City, UT 84112 USA; [Kennedy, Brett J.; Yandell, Mark; Wu, Wilfred; Jorde, Lynn B.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Yandell, Mark] USTAR, Ctr Genet Discovery, Salt Lake City, UT USA; [Zhang, Wenying; Ware, Stephanie] Cincinnati Childrens Hosp, Inst Heart, Med Ctr, Cincinnati, OH USA; [Gruber, Peter J.] Univ Utah, Sch Med, Cardiothorac Surg, Salt Lake City, UT USA; [Yost, H. Joseph] Univ Utah, Neurobiol & Anat, Salt Lake City, UT USA; [Bleyl, Steven B.] Intermountain Healthcare, Clin Genet Inst, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Cincinnati Children's Hospital Medical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center	Bowles, NE (corresponding author), Univ Utah, Sch Med, Dept Pediat, Div Cardiol, Salt Lake City, UT 84112 USA.	neil.bowles@hsc.utah.edu; steven.bleyl@hsc.utah.edu	Ware, Stephanie M./AAF-5577-2020	Kennedy, Brett/0000-0001-5018-5654	American Heart Association [12GRNT11090001]; Primary Children's Medical Foundation; Doris Duke Charitable Foundation [2012069]; Eunice Kennedy Shriver National Institute of Child Health [K08HD062638]; NHLBI Bench-to-Bassinet Consortium [U01HL0981, U01 HL098188]; NIGMS [R01GM104390]; NHGRI [R44HG006579]; National Center for Advancing Translational Sciences, National Institutes of Health [1ULTR001067]; Public Health Services research grant from the National Center for Research Resources [M01-RR00064]; Children's Health Research Center at the University of Utah; Clinical Genetics Research Program at the University of Utah; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD062638] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001066, UL1TR001067] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UM1HL098160, U01HL098160, T35HL007744, Z01HL000981, U01HL098188] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R44HG006579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104390] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Primary Children's Medical Foundation; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Eunice Kennedy Shriver National Institute of Child Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI Bench-to-Bassinet Consortium; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Public Health Services research grant from the National Center for Research Resources; Children's Health Research Center at the University of Utah; Clinical Genetics Research Program at the University of Utah; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds to N.E.B from the American Heart Association (12GRNT11090001) and Primary Children's Medical Foundation. C.B.A was supported by the Doris Duke Charitable Foundation (Grant #:2012069) and by a grant from the Eunice Kennedy Shriver National Institute of Child Health [K08HD062638]. This study was funded in part by a NHLBI Bench-to-Bassinet Consortium (http://www.benchtobassinet.com) grant to HJY (U01HL0981) and a core facilities support grant to New England Research Institute (U01 HL098188). Portions of this work were supported by NIGMS R01GM104390 and NHGRI R44HG006579 (Yandell, P.I.). Brett Kennedy was supported by a training award from the National Center for Advancing Translational Sciences, National Institutes of Health (1ULTR001067). DNA isolations were performed in the University of Utah Center for Clinical and Translational Science DNA laboratory which is supported by Public Health Services research grant #M01-RR00064 from the National Center for Research Resources, the Children's Health Research Center at the University of Utah, and the Clinical Genetics Research Program at the University of Utah. Partial support for datasets within the Utah Population Database is provided by the Huntsman Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arrington CB, 2012, AM J MED GENET A, V158A, P3137, DOI 10.1002/ajmg.a.35664; Arrington CB, 2010, AM J MED GENET A, V152A, P2919, DOI 10.1002/ajmg.a.33718; Arrington CB, 2008, AM J CARDIOL, V102, P629, DOI 10.1016/j.amjcard.2008.04.044; Arrington CB, 2012, EUR J MED GENET; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bleyl SB, 2006, AM J MED GENET A, V140A, P2368, DOI 10.1002/ajmg.a.31471; Bleyl SB, 2010, HUM MOL GENET, V19, P1286, DOI 10.1093/hmg/ddq005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cinquetti R, 2008, HUM MUTAT, V29, P468, DOI 10.1002/humu.20711; CORREAVILLASENOR A, 1991, TERATOLOGY, V44, P415, DOI 10.1002/tera.1420440408; Douglas YL, 2011, INT J CARDIOL, V147, P13, DOI 10.1016/j.ijcard.2010.07.004; Duester G, 2013, SEMIN CELL DEV BIOL, V24, P694, DOI 10.1016/j.semcdb.2013.08.001; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Huang SZ, 2011, J BIOL CHEM, V286, P28533, DOI 10.1074/jbc.M111.244327; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Kostetskii I, 1999, DEV BIOL, V206, P206, DOI 10.1006/dbio.1998.9139; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li P, 2010, DEV CELL, V18, P480, DOI 10.1016/j.devcel.2009.12.019; McCrindle BW, 1996, CAN J CARDIOL, V12, P81; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sharma S, 2013, J HUM NUTR DIET, V26, P578, DOI 10.1111/jhn.12091; Stainier DYR, 2015, DEV CELL, V32, P7, DOI 10.1016/j.devcel.2014.12.012; Staudt D, 2012, ANNU REV GENET, V46, P397, DOI 10.1146/annurev-genet-110711-155646; Uehara M, 2009, GENE DEV, V23, P1689, DOI 10.1101/gad.1776209; Yandell M, 2011, GENOME RES, V21, P1529, DOI 10.1101/gr.123158.111	27	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131514	10.1371/journal.pone.0131514	http://dx.doi.org/10.1371/journal.pone.0131514			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121141	Green Published, gold			2022-12-27	WOS:000358150400118
J	Yen, CH; Yeh, YW; Liang, CS; Ho, PS; Kuo, SC; Huang, CC; Chen, CY; Shih, MC; Ma, KH; Peng, GS; Lu, RB; Huang, SY				Yen, Che-Hung; Yeh, Yi-Wei; Liang, Chih-Sung; Ho, Pei-Shen; Kuo, Shin-Chang; Huang, Chang-Chih; Chen, Chun-Yen; Shih, Mei-Chen; Ma, Kuo-Hsing; Peng, Giia-Sheun; Lu, Ru-Band; Huang, San-Yuan			Reduced Dopamine Transporter Availability and Neurocognitive Deficits in Male Patients with Alcohol Dependence	PLOS ONE			English	Article							DUAL-ISOTOPE SPECT; CARD SORTING TEST; HEALTHY-VOLUNTEERS; NOVELTY SEEKING; AGE; TOMOGRAPHY; DEPRESSION; WITHDRAWAL; RECEPTORS; SEROTONIN	Dopamine plays an important role in the development of alcohol dependence, cognitive dysfunction, and is regulated via dopamine transporter activity. Although dopamine transporter activity is critically involved in alcohol dependence, studies observing this relationship are limited. Thus the current study examined whether dopamine transporter availability is associated with developing of alcohol dependence and cognitive dysfunction. Brain imaging with Tc-99m-TRODAT-1 as a ligand was used to measure dopamine transporter availability among 26 male patients with pure alcohol dependence and 22 age- and sex-matched healthy volunteers. The Wisconsin Card Sorting Test (WCST) and Tridimensional Personality Questionnaire (TPQ) were administered to assess neurocognitive functioning and personality traits, respectively. Compared to healthy controls, patients with alcohol dependence showed a significant reduction in dopamine transporter availability (p < 0.001), as well as diminished performance on the WCST (p < 0.001). Dopamine transporter availability was negatively correlated with both total and perseverative WCST errors among healthy controls, but only patients with alcohol dependence showed a positive correlation between dopamine transporter availability and a harm avoidance personality profile. Thus, reductions in dopamine transporter availability may play a pathophysiological role in the development of pure alcohol dependence, given its association with neurocognitive deficits. Moreover, personality may influence the development of pure alcohol dependence; however, additional clinical subgroups should be examined to confirm this possibility.	[Yen, Che-Hung; Liang, Chih-Sung; Kuo, Shin-Chang; Huang, Chang-Chih; Chen, Chun-Yen; Huang, San-Yuan] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Yen, Che-Hung; Peng, Giia-Sheun] Natl Def Med Ctr, Dept Neurol, Triserv Gen Hosp, Taipei, Taiwan; [Yeh, Yi-Wei; Kuo, Shin-Chang; Chen, Chun-Yen; Shih, Mei-Chen; Huang, San-Yuan] Natl Def Med Ctr, Dept Psychiat, Triserv Gen Hosp, Taipei, Taiwan; [Liang, Chih-Sung; Ho, Pei-Shen] Natl Def Med Ctr, Triserv Gen Hosp, Dept Psychiat, Beitou Branch, Taipei, Taiwan; [Huang, Chang-Chih] Buddhist Tzu Chi Gen Hosp, Taipei Branch, Dept Psychiat, Taipei, Taiwan; [Ma, Kuo-Hsing] Natl Def Med Ctr, Dept Anat & Biol, Taipei, Taiwan; [Lu, Ru-Band] Natl Cheng Kung Univ, Coll Med, Inst Behav Med, Tainan 70101, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Buddhist Tzu Chi General Hospital; National Defense Medical Center; National Cheng Kung University	Huang, SY (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	hsy@ndmctsgh.edu.tw	Peng, Giia-Sheun/AAE-4778-2022; Liang, Chih-Sung/V-6720-2019	Liang, Chih-Sung/0000-0003-1138-5586; Chen, Chun-Yen/0000-0002-8330-9569; Yeh, Yi-Wei/0000-0001-8690-6206	National Science Council [NSC101-2325-B-016-003]; Tri-Service General Hospital [TSGHC101-122, TSGHC102-120, TSGHC103-133]; Medical Affairs Bureau, Ministry of National Defense, Taiwan [DOD100-C09-01, DOD102-114]	National Science Council(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital; Medical Affairs Bureau, Ministry of National Defense, Taiwan	This work was supported by National Science Council NSC101-2325-B-016-003 (SYH), Tri-Service General Hospital TSGHC101-122 (SYH), TSGHC102-120 (SYH), TSGHC103-133 (SYH); and Medical Affairs Bureau, Ministry of National Defense, Taiwan, DOD100-C09-01 (SYH), DOD102-114 (SYH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2013, PERSONAL DISORD, V4, P55, DOI 10.1037/a0030224; Ando B, 2014, SUBST USE MISUSE, V49, P418, DOI 10.3109/10826084.2013.841250; Barcelo F, 2002, NEUROPSYCHOLOGIA, V40, P349, DOI 10.1016/S0028-3932(01)00110-5; Bentue-Ferrer D, 2001, EUR NEUROPSYCHOPHARM, V11, P41, DOI 10.1016/S0924-977X(00)00137-1; Burke SM, 2011, PSYCHOL MED, V41, P419, DOI 10.1017/S0033291710000486; Chen WJ, 2002, COMPR PSYCHIAT, V43, P158, DOI 10.1053/comp.2002.30797; CILIAX BJ, 1995, J NEUROSCI, V15, P1714, DOI 10.1523/JNEUROSCI.15-03-01714.1995; Cosgrove KP, 2009, NEUROPSYCHOPHARMACOL, V34, P2218, DOI 10.1038/npp.2009.49; Dresel SHJ, 1998, EUR J NUCL MED, V25, P31; Frank MJ, 2006, BEHAV NEUROSCI, V120, P497, DOI 10.1037/0735-7044.120.3.497; Gainetdinov RR, 2008, N-S ARCH PHARMACOL, V377, P301, DOI 10.1007/s00210-007-0216-0; Gainetdinov RR, 1998, BRAIN RES REV, V26, P148, DOI 10.1016/S0165-0173(97)00063-5; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; Heaton R.K., 1993, WISCONSIN CARD SORTI; Hsiao MC, 2013, PSYCHIAT RES-NEUROIM, V211, P72, DOI 10.1016/j.pscychresns.2012.06.004; Hsieh PC, 2010, J PSYCHIATR NEUROSCI, V35, P90, DOI 10.1503/jpn.090007; Huang CC, 2011, PHARMACOGENET GENOM, V21, P94, DOI 10.1097/FPC.0b013e3283424d94; Huang HY, 2010, J FORMOS MED ASSOC, V109, P736, DOI 10.1016/S0929-6646(10)60119-2; Huang SY, 2004, ALCOHOL CLIN EXP RES, V28, P374, DOI 10.1097/01.ALC.0000117832.62901.61; Hwang WJ, 2004, J NUCL MED, V45, P207; Koch W, 2007, J NUCL MED, V48, P27; Laine TPJ, 1999, PSYCHIAT RES-NEUROIM, V90, P153, DOI 10.1016/S0925-4927(99)00019-0; Laine TPJ, 2001, J ADDICT DIS, V20, P91; Landau SM, 2009, CEREB CORTEX, V19, P445, DOI 10.1093/cercor/bhn095; Lavalaye J, 2000, EUR J NUCL MED, V27, P867, DOI 10.1007/s002590000279; Ma Hui, 2014, Shanghai Arch Psychiatry, V26, P61, DOI 10.3969/j.issn.1002-0829.2014.02.002; Mash DC, 1996, NEUROREPORT, V7, P457, DOI 10.1097/00001756-199601310-00020; Miller LR, 2007, J BIOCHEM MOL TOXIC, V21, P325, DOI 10.1002/jbt.20197; Mozley PD, 1999, J NUCL MED, V40, P1812; Narendran R, 2014, AM J PSYCHIAT, V171, P881, DOI 10.1176/appi.ajp.2014.13121581; Neumeister A, 2001, PSYCHOL MED, V31, P1467, DOI 10.1017/S003329170105434z; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Nikolaus S, 2013, NUCL MED COMMUN, V34, P1223, DOI 10.1097/MNM.0b013e3283657404; Nowakowska K, 2007, PSYCHIATR POL, V41, P693; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Repo E, 1999, PSYCHOPHARMACOLOGY, V147, P314, DOI 10.1007/s002130051173; Shan IK, 2008, J CHIN MED ASSOC, V71, P517, DOI 10.1016/S1726-4901(08)70160-6; Sim M, 2012, COMPR PSYCHIAT, V53, P372, DOI 10.1016/j.comppsych.2011.05.004; Spielewoy C, 2001, PSYCHOPHARMACOLOGY, V159, P2, DOI 10.1007/s002130100901; Thomsen G, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-39; Tiihonen J, 1998, MOL PSYCHIATR, V3, P156, DOI 10.1038/sj.mp.4000365; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Tupala E, 2003, NEUROIMAGE, V19, P145, DOI 10.1016/S1053-8119(03)00060-0; van Dyck CH, 2002, AM J GERIAT PSYCHIAT, V10, P36, DOI 10.1176/appi.ajgp.10.1.36; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; Volkow ND, 1996, ALCOHOL CLIN EXP RES, V20, P1594, DOI 10.1111/j.1530-0277.1996.tb05936.x; Yang YK, 2008, PSYCHIAT RES-NEUROIM, V162, P230, DOI 10.1016/j.pscychresns.2007.08.008; Yang YK, 2008, PROG NEURO-PSYCHOPH, V32, P274, DOI 10.1016/j.pnpbp.2007.08.018	48	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131017	10.1371/journal.pone.0131017	http://dx.doi.org/10.1371/journal.pone.0131017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26120847	Green Submitted, Green Published, gold			2022-12-27	WOS:000358150400071
J	Bogusch, P; Astapenkova, A; Heneberg, P				Bogusch, Petr; Astapenkova, Alena; Heneberg, Petr			Larvae and Nests of Six Aculeate Hymenoptera (Hymenoptera: Aculeata) Nesting in Reed Galls Induced by Lipara spp. (Diptera: Chloropidae) with a Review of Species Recorded	PLOS ONE			English	Article							APOIDEA; BEES	Wetland species of aculeate Hymenoptera are poorly known, even though many of them may serve as diagnostic or flagship species in nature conservation. Here we examined 6,018 galls induced >= 1 year prior their collection by the chloropid flies Lipara spp. The galls were collected at 34 sites in Central Europe. We examined 1,389 nests (4,513 individuals) of nine species, part of which were parasitized by one dipteran and two chrysidid parasitoid species. We describe the nests of seven dominant species and larvae of four species (Pemphredon fabricii, Trypoxylon deceptorium, Hoplitis leucomelanaand Hylaeus pectoralis) and two parasitoids (Trichrysis cyanea and Thyridanthrax fenestratus, both in nests of Pemphredon fabriciiand Trypoxylon deceptorium). All the species, but H. pectoralis, preferred robust galls at very thin stalks (induced typically by Lipara lucens) over the narrow galls on thick stalks. The larvae of P. fabricii and T. deceptoriumresembled strongly their sibling species (Pemphredon lethiferand Trypoxylon attenuatum sensu lato, respectively). The larvae of T. fenestratus showed features different from those previously described. By hatching set of another 10,583 galls induced by Lipara spp. >= 1 year prior their collection, we obtained 4,469 individuals of 14 nesting hymenopteran species, two cleptoparasites, three chrysidid and one dipteran parasitoid. Of these species, four new nesting species have been recorded for the first time in galls induced by Lipara spp.: Chelostoma campanularum, Heriades rubicola, Pseudoanthidium lituratum and Hylaeus incongruus. We also provide first records of their nest cleptoparasites Stelis breviuscula and Stelis ornatula, and the parasitoid Holopyga fastuosa generosa. Thyridanthrax fenestratus formed strong populations in nests of Pemphredon fabricii and Trypoxylon deceptorium, which are both newly recorded hosts for T. fenestratus. The descriptions provided here allow for the first time to identify the larvae of the most widespread central European aculeate hymenopteran reed gall specialists.	[Bogusch, Petr; Astapenkova, Alena] Univ Hradec Kralove, Dept Biol, Fac Sci, Hradec Kralove, Czech Republic; [Heneberg, Petr] Charles Univ Prague, Fac Med 3, Prague, Czech Republic	University of Hradec Kralove; Charles University Prague	Bogusch, P (corresponding author), Univ Hradec Kralove, Dept Biol, Fac Sci, Hradec Kralove, Czech Republic.	bogusch.petr@gmail.com	Heneberg, Petr/C-1881-2012; Bogusch, Petr/Q-6111-2016; Bogusch, Petr/AAN-6667-2020	Heneberg, Petr/0000-0002-0703-951X; Bogusch, Petr/0000-0002-4554-6141	University Hradec Kralove - Specificky vyzkum [2117/2014]	University Hradec Kralove - Specificky vyzkum	The study was funded only by an internal grant of University Hradec Kralove - Specificky vyzkum 2117/2014, main holder AA, co-holder PB.	Amiet F., 1994, ROTE LISTEN GEFAHRDE, P38; ANTROPOV A V, 1991, Entomologicheskoe Obozrenie, V70, P672; ASIS JD, 1994, J KANSAS ENTOMOL SOC, V67, P199; Balthasar V., 1954, ZLATENKY CHRYSIDOIDE, V3; Banaszak J, 1998, HYMENOPTERA APOIDEA; Beaumont J., 1964, HYMENOPTERA SPHECIDA, V3; Blosch M., 2000, GRABWESPEN DEUTSHLAN; Bogusch P., 2007, ACTA ENT MUS NAT PRA, V11, P1; Dely-Draskovits A., 1994, Folia Entomologica Hungarica, V55, P65; Else George R., 1995, British Journal of Entomology and Natural History, V8, P43; EVANS H. E., 1964, TRANS AMER ENTOMOL SOC, V90, P235; Farka J., 2005, CERVENY SEZNAM OHROZ; Heneberg P, 2014, BIOL CONSERV, V172, P146, DOI 10.1016/j.biocon.2014.02.037; Janvier H, 1961, ANN SCI NAT ZOOL, V12, P1; JANVIER H, 2012, ENTOMOFAUNA, V2, P1; Janvier H, 1961, ANN SCI NAT ZOOL, V12, P281; Kunz Peter X., 1994, Beihefte zu den Veroeffentlichungen fuer Naturschutz und Landschaftspflege in Baden-Wuerttemberg, V77, P1; Linsenmaier W, 1997, VEROFF NAT MUS LUZER, V9, P5; Macek J., 2010, BLANOKRIDLI CESKE RE, V1; Ohl Michael, 2011, Zoosystematics and Evolution, V87, P335, DOI 10.1002/zoos.201100011; Oldroyd H, 1969, DIPTERA BRACHYCERA A; Peeters TMJ, 2003, BEDREIGDE VERDWENEN; Pridal A., 2001, SBOR PRIR KLUBU UHER, V6, P139, DOI DOI 10.1371/JOURNAL.PONE.0109235; Pridal Antonin, 2014, Klapalekiana, V50, P73; Romasenko Ludmila P., 1995, P65; SEGUY E., 1932, ENCYCLOP ENT SER B DIPTERA, V6, P11; SMISSEN J, 2003, NOT FAUN GEMBLOUX, V52, P53; Staab M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101592; Stubbs A., 2001, BRIT SOLDIERFLIES TH; Svacha P., 1987, ACTA U CAROLINAE BIO, V30, P1; TSCHARNTKE T, 1992, CONSERV BIOL, V6, P530, DOI 10.1046/j.1523-1739.1992.06040530.x; Tscharntke T, 1998, J APPL ECOL, V35, P708, DOI 10.1046/j.1365-2664.1998.355343.x; Tscharntke T, 1994, USDA N CENT, P73; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Westrich P., 2012, NATURSCHUTZ BIOL VIE, V70, P373; Westrich P., 1989, WILDBIENEN BADEN WUR, V1; Westrich P., 1998, ROTE LISTE GEFAHRDET, P119; WESTRICH P, 1989, WILDBIENEN BADEN WUR, V2; Westrich P., 2008, EUCERA, V1, P1; Wolf H., 1988, Hessische Faunistische Briefe, V8, P16	40	13	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130802	10.1371/journal.pone.0130802	http://dx.doi.org/10.1371/journal.pone.0130802			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114290	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500096
J	de Soarez, PC; Sartori, AMC; Freitas, AC; Nishikawa, AM; Novaes, HMD				de Soarez, Patricia Coelho; Christovam Sartori, Ana Marli; Freitas, Angela Carvalho; Nishikawa, Alvaro Mitsunori; Dutilh Novaes, Hillegonda Maria			Cost-Effectiveness Analysis of Universal Vaccination of Adults Aged 60 Years with 23-Valent Pneumococcal Polysaccharide Vaccine versus Current Practice in Brazil	PLOS ONE			English	Article							CONJUGATE VACCINE; CLINICAL-FEATURES; DISEASE; POPULATION; PNEUMONIA; HEALTH; IMPACT; MENINGITIS	Objective To evaluate the cost-effectiveness of introducing universal vaccination of adults aged 60 years with the 23-valent pneumococcal polysaccharide vaccine (PPV23) into the National Immunization Program (NIP) in Brazil. Methods Economic evaluation using a Markov model to compare two strategies: (1) universal vaccination of adults aged 60 years with one dose of PPV23 and 2) current practice (vaccination of institutionalized elderly and elderly with underlying diseases). The perspective was from the health system and society. Temporal horizon was 10 years. Discount rate of 5% was applied to costs and benefits. Clinical syndromes of interest were invasive pneumococcal disease (IPD) including meningitis, sepsis and others and pneumonia. Vaccine efficacy against IPD was obtained from a meta-analysis of randomized control trials and randomized studies, whereas vaccine effectiveness against pneumonia was obtained from cohort studies. Resource utilization and costs were obtained from the Brazilian Health Information Systems. The primary outcome was cost per life year saved (LYS). Univariate and multivariate sensitivity analysis were performed. Results The universal vaccination strategy avoided 7,810 hospitalizations and 514 deaths, saving 3,787 years of life and costing a total of USD$31,507,012 and USD$44,548,180, respectively, from the health system and societal perspective. The universal immunization would result in ICERs of USD$1,297 per LYS, from the perspective of the health system, and USD $904 per LYS, from the societal perspective. Conclusion The results suggest that universal vaccination of adults aged 60 years with the 23-valent pneumococcal polysaccharide vaccine (PPV23) is a very cost-effective intervention for preventing hospitalization and deaths for IPD and pneumonia is this age group in Brazil.	[de Soarez, Patricia Coelho; Nishikawa, Alvaro Mitsunori; Dutilh Novaes, Hillegonda Maria] Univ Sao Paulo, Fac Med, Dept Prevent Med, Sao Paulo, Brazil; [Christovam Sartori, Ana Marli; Freitas, Angela Carvalho] Univ Sao Paulo, Clin Molestias Infecciosas & Parasitarias, Hosp Clin, Fac Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	de Soarez, PC (corresponding author), Univ Sao Paulo, Fac Med, Dept Prevent Med, Sao Paulo, Brazil.	patricia.soarez@usp.br	Freitas, Angela Carvalho/ABN-9764-2022; Sartori, Ana Marli Christovam/I-6663-2012; de Soarez, Patricia Coelho/D-9710-2012; Novaes, Hillegonda M. D./F-7060-2011	Freitas, Angela Carvalho/0000-0002-9198-2649; Sartori, Ana Marli Christovam/0000-0003-3777-0757; de Soarez, Patricia Coelho/0000-0001-8383-0728; Novaes, Hillegonda M. D./0000-0001-9849-0324	Ministry of Health, Brazil [BR/LOA/1300011.001]	Ministry of Health, Brazil	This work was funded by the Ministry of Health, Brazil (grant number: Carta Acordo no BR/LOA/1300011.001). PCS received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso ET, 2013, EMERG INFECT DIS, V19, P589, DOI 10.3201/eid1904.121198; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P373; Associacao Nacional de Transportes Publicos (ANTP), 2011, TAR CAP CID COM MAIS; Brasil. Ministerio da Saude, 2009, DIR MET EST AV EC TE; Castaneda-Orjuela C, 2011, VACCINE, V29, P7644, DOI 10.1016/j.vaccine.2011.08.006; Chen JL, 2014, ADV THER, V31, P392, DOI 10.1007/s12325-014-0115-y; Domingues CMAS, 2014, LANCET RESP MED, V2, P464, DOI 10.1016/S2213-2600(14)70060-8; Donalisio Maria Rita, 2007, J. bras. pneumol., V33, P51, DOI 10.1590/S1806-37132007000100011; Novaes HMD, 2011, REV SAUDE PUBL, V45, P539, DOI 10.1590/S0034-89102011005000028; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; Instituto Brasileiro de Geografia, 2012, PESQ NAC AM DOM 2008; INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA, 2010, CENS DEM 2010; Jiang Y, 2014, EXPERT REV PHARM OUT, V14, P913, DOI 10.1586/14737167.2014.950232; Jit M, 2010, J INFECTION, V61, P114, DOI 10.1016/j.jinf.2010.04.008; Merito M, 2007, VACCINE, V25, P458, DOI 10.1016/j.vaccine.2006.08.005; Ministerio da Saude (Brasil). Departamento de Informatica do SUS, DATASUS INF SAUD TAB; Ministerio da Saude / Secretaria de Vigilancia em Saude, 2003, PROGR NAC IM 30 AN C; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; Myint TTH, 2013, ADV THER, V30, P127, DOI 10.1007/s12325-013-0007-6; Novaes HMD, 2012, AVALIACAO TECNOLOGIC; Ochoa-Gondar O, 2014, CLIN INFECT DIS, V58, P909, DOI 10.1093/cid/ciu002; Sartori AMC, 2013, VACCINE, V31, pC63, DOI 10.1016/j.vaccine.2013.05.029; Scotta MC, 2014, VACCINE, V32, P4495, DOI 10.1016/j.vaccine.2014.06.042; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; SIH/SUS, SIST INF HOSP SUS 20; Sistema de Informacoes de Agravos de Notificacao-SINAN, 2011, MEN; Smith KJ, 2012, JAMA-J AM MED ASSOC, V307, P804, DOI 10.1001/jama.2012.169; Tabuas completas de mortalidade, 2011, TAB COMPL MORT; Tomczyk S, 2014, MMWR-MORBID MORTAL W, V63, P822; Neto JT, 2011, HUM VACCINES, V7, P1037, DOI 10.4161/hv.7.10.15987; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Vila-Corcoles A, 2006, CLIN INFECT DIS, V43, P860, DOI 10.1086/507340; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Weisfelt M, 2006, LANCET NEUROL, V5, P123, DOI 10.1016/S1474-4422(05)70288-X; Weycker D, 2012, VACCINE, V30, P5437, DOI 10.1016/j.vaccine.2012.05.076; World Bank, 2008, DAT OFF EXC RAT LCU; World Health Organization, 2001, MACR HLTH INV HLTH E	37	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130217	10.1371/journal.pone.0130217	http://dx.doi.org/10.1371/journal.pone.0130217			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114297	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500057
J	Janssen, A; Fiebiger, S; Bros, H; Hertwig, L; Romero-Suarez, S; Hamann, I; Chanvillard, C; Bellmann-Strobl, J; Paul, F; Millward, JM; Infante-Duarte, C				Janssen, Antonia; Fiebiger, Sebastian; Bros, Helena; Hertwig, Laura; Romero-Suarez, Silvina; Hamann, Isabell; Chanvillard, Coralie; Bellmann-Strobl, Judith; Paul, Friedemann; Millward, Jason M.; Infante-Duarte, Carmen			Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; HEME OXYGENASE-1; OXIDATIVE STRESS; SJL MICE; IRON; CELLS; NEURODEGENERATION; LESIONS; MODEL	We previously demonstrated that epigallocatechin-3-gallate (EGCG) synergizes with the immunomodulatory agent glatiramer acetate (GA) in eliciting anti-inflammatory and neuroprotective effects in the relapsing-remitting EAE model. Thus, we hypothesized that mice with chronic EAE may also benefit from this combination therapy. We first assessed how a treatment with a single dose of GA together with daily application of EGCG may modulate EAE. Although single therapies with a suboptimal dose of GA or EGCG led to disease amelioration and reduced CNS inflammation, the combination therapy had no effects. While EGCG appeared to preserve axons and myelin, the single GA dose did not improve axonal damage or demyelination. Interestingly, the neuroprotective effect of EGCG was abolished when GA was applied in combination. To elucidate how a single dose of GA may interfere with EGCG, we focused on the anti-inflammatory, iron chelating and anti-oxidant properties of EGCG. Surprisingly, we observed that while EGCG induced a downregulation of the gene expression of heme oxygenase-1 (HO-1) in affected CNS areas, the combined therapy of GA+EGCG seems to promote an increased HO-1 expression. These data suggest that upregulation of HO-1 may contribute to diminish the neuroprotective benefits of EGCG alone in this EAE model. Altogether, our data indicate that neuroprotection by EGCG in chronic EAE may involve regulation of oxidative processes, including downmodulation of HO-1. Further investigation of the re-dox balance in chronic neuroinflammation and in particular functional studies on HO-1 are warranted to understand its role in disease progression.	[Janssen, Antonia; Fiebiger, Sebastian; Bros, Helena; Hertwig, Laura; Romero-Suarez, Silvina; Hamann, Isabell; Chanvillard, Coralie; Millward, Jason M.; Infante-Duarte, Carmen] Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Janssen, Antonia; Fiebiger, Sebastian; Bros, Helena; Hertwig, Laura; Romero-Suarez, Silvina; Hamann, Isabell; Chanvillard, Coralie; Bellmann-Strobl, Judith; Paul, Friedemann; Millward, Jason M.; Infante-Duarte, Carmen] Expt & Clin Res Ctr, Berlin, Germany; [Bros, Helena; Bellmann-Strobl, Judith; Paul, Friedemann] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Bellmann-Strobl, Judith; Paul, Friedemann] Charite, Dept Neurol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Infante-Duarte, C (corresponding author), Charite, Inst Med Immunol, D-13353 Berlin, Germany.	carmen.infante@charite.de	Paul, Friedemann/ABF-9415-2020	Infante Duarte, Carmen/0000-0003-3005-351X; paul, friedemann/0000-0002-6378-0070; Hertwig, Laura/0000-0002-1170-0948; Bellmann-Strobl, Judith/0000-0003-2615-1643; Millward, Jason/0000-0003-4484-2798	Experimental and Clinical Research Center (Charite/MDC); German Research Council [KFO213]; European Community's Seventh Research Framework Programme [F4-2012-305397]; DAAD -La Caixa Fellowship	Experimental and Clinical Research Center (Charite/MDC); German Research Council(German Research Foundation (DFG)); European Community's Seventh Research Framework Programme; DAAD -La Caixa Fellowship	The work was supported by a grant from the Experimental and Clinical Research Center (Charite/MDC) to CID, JBS and FP, by the German Research Council (KFO213 to CID), by the European Community's Seventh Research Framework Programme (CombiMS. Ref: HEALTH-F4-2012-305397) and by a DAAD -La Caixa Fellowship to HB.	Aharoni R, 2005, P NATL ACAD SCI USA, V102, P19045, DOI 10.1073/pnas.0509438102; Aharoni R, 2008, P NATL ACAD SCI USA, V105, P11358, DOI 10.1073/pnas.0804632105; Aharoni R, 2011, J AUTOIMMUN, V37, P228, DOI 10.1016/j.jaut.2011.06.003; Aktas O, 2004, J IMMUNOL, V173, P5794, DOI 10.4049/jimmunol.173.9.5794; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Bjartmar C, 2001, CURR OPIN NEUROL, V14, P271, DOI 10.1097/00019052-200106000-00003; Chakrabarty A, 2003, MULT SCLER, V9, P372, DOI 10.1191/1352458503ms928oa; di Penta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054722; Emerson MR, 2000, J NEUROCHEM, V75, P2555, DOI 10.1046/j.1471-4159.2000.0752555.x; Fiebiger SM, 2013, J NEUROIMMUNOL, V262, P66, DOI 10.1016/j.jneuroim.2013.07.002; Forge JK, 1998, LIFE SCI, V63, P2271, DOI 10.1016/S0024-3205(98)00512-8; Herges K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025456; Infante-Duarte C, 2008, J MOL MED, V86, P975, DOI 10.1007/s00109-007-0292-0; Khan O, 2005, MULT SCLER J, V11, P646, DOI 10.1191/1352458505ms1234oa; LeVine SM, 2004, ANN NY ACAD SCI, V1012, P252, DOI 10.1196/annals.1306.021; LeVine SM, 2013, EXPERT REV NEUROTHER, V13, P247, DOI [10.1586/ern.13.14, 10.1586/ERN.13.14]; Liu YR, 2001, NEUROREPORT, V12, P1841, DOI 10.1097/00001756-200107030-00016; Mahler Anja, 2013, EPMA J, V4, P5, DOI 10.1186/1878-5085-4-5; Maier K, 2006, AM J PATHOL, V169, P1353, DOI 10.2353/ajpath.2006.060159; Marques KB, 2009, BRAZ J MED BIOL RES, V42, P179, DOI 10.1590/S0100-879X2009000200006; Millward JM, 2013, ASN NEURO, V5, P89, DOI 10.1042/AN20120081; Riek K, 2012, NEUROIMAGE-CLIN, V1, P81, DOI 10.1016/j.nicl.2012.09.003; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Rovaris M, 2006, LANCET NEUROL, V5, P343, DOI 10.1016/S1474-4422(06)70410-0; Schipper HM, 2009, J NEUROCHEM, V110, P469, DOI 10.1111/j.1471-4159.2009.06160.x; Schluesener HJ, 2000, J NEUROIMMUNOL, V110, P114, DOI 10.1016/S0165-5728(00)00352-0; Schroeder EK, 2009, ANTIOXID REDOX SIGN, V11, P469, DOI [10.1089/ars.2008.2215, 10.1089/ARS.2008.2215]; Scorisa JM, 2009, NEUROSCI LETT, V451, P34, DOI 10.1016/j.neulet.2008.12.017; Song W, 2012, J NEUROCHEM, V123, P325, DOI 10.1111/j.1471-4159.2012.07914.x; Stahnke T, 2007, J MOL NEUROSCI, V32, P25, DOI 10.1007/s12031-007-0005-8; Unuma K, 2013, HEPATOL RES, V43, P91, DOI 10.1111/j.1872-034X.2012.01049.x; van Horssen J, 2008, FREE RADICAL BIO MED, V45, P1729, DOI 10.1016/j.freeradbiomed.2008.09.023; Wang JP, 2013, J MOL MED, V91, P485, DOI 10.1007/s00109-012-0964-2; Wang JP, 2012, AM J PATHOL, V180, P221, DOI 10.1016/j.ajpath.2011.09.007; Weinreb O, 2009, GENES NUTR, V4, P283, DOI 10.1007/s12263-009-0143-4	35	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130251	10.1371/journal.pone.0130251	http://dx.doi.org/10.1371/journal.pone.0130251			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114502	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000358147500059
J	Peng, XQ; Wang, JX; Wang, J; Wu, FX; Pan, Y				Peng, Xiaoqing; Wang, Jianxin; Wang, Jun; Wu, Fang-Xiang; Pan, Yi			Rechecking the Centrality-Lethality Rule in the Scope of Protein Subcellular Localization Interaction Networks	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; ESSENTIAL GENES; GLOBAL ANALYSIS; YEAST; IDENTIFICATION; INTEGRATION; PREDICTION; ESSENTIALITY; INFORMATION; ORTHOLOGY	Essential proteins are indispensable for living organisms to maintain life activities and play important roles in the studies of pathology, synthetic biology, and drug design. Therefore, besides experiment methods, many computational methods are proposed to identify essential proteins. Based on the centrality-lethality rule, various centrality methods are employed to predict essential proteins in a Protein-protein Interaction Network (PIN). However, neglecting the temporal and spatial features of protein-protein interactions, the centrality scores calculated by centrality methods are not effective enough for measuring the essentiality of proteins in a PIN. Moreover, many methods, which overfit with the features of essential proteins for one species, may perform poor for other species. In this paper, we demonstrate that the centrality-lethality rule also exists in Protein Subcellular Localization Interaction Networks (PSLINs). To do this, a method based on Localization Specificity for Essential protein Detection (LSED), was proposed, which can be combined with any centrality method for calculating the improved centrality scores by taking into consideration PSLINs in which proteins play their roles. In this study, LSED was combined with eight centrality methods separately to calculate Localization-specific Centrality Scores (LCSs) for proteins based on the PSLINs of four species (Saccharomyces cerevisiae, Homo sapiens, Mus musculus and Drosophila melanogaster). Compared to the proteins with high centrality scores measured from the global PINs, more proteins with high LCSs measured from PSLINs are essential. It indicates that proteins with high LCSs measured from PSLINs are more likely to be essential and the performance of centrality methods can be improved by LSED. Furthermore, LSED provides a wide applicable prediction model to identify essential proteins for different species.	[Peng, Xiaoqing; Wang, Jianxin; Pan, Yi] Cent S Univ, Sch Informat Sci & Engn, Changsha 410083, Hunan, Peoples R China; [Wang, Jun] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Wu, Fang-Xiang] Univ Saskatchewan, Dept Mech Engn, Saskatoon, SK S7N 0W0, Canada; [Wu, Fang-Xiang] Univ Saskatchewan, Div Biomed Engn, Saskatoon, SK, Canada; [Pan, Yi] Georgia State Univ, Dept Comp Sci, Atlanta, GA 30302 USA	Central South University; Baylor College of Medicine; University of Saskatchewan; University of Saskatchewan; University System of Georgia; Georgia State University	Wang, JX (corresponding author), Cent S Univ, Sch Informat Sci & Engn, Changsha 410083, Hunan, Peoples R China.	jxwang@csu.edu.cn	Wang, Jianxin/V-2800-2018; Pan, Yi/AAJ-2341-2021; wang, jian/GVS-0711-2022	Wang, Jianxin/0000-0003-1516-0480; Pan, Yi/0000-0002-2766-3096; Wu, Fang-Xiang/0000-0002-4593-9332	National Natural Science Foundation of China [61232001, 61379108, 61370172]; Hunan Provincial Innovation Foundation for Postgraduate [CX2013B070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Innovation Foundation for Postgraduate	This work is supported by the National Natural Science Foundation of China under grant nos. 61232001, 61379108, and 61370172, and Hunan Provincial Innovation Foundation for Postgraduate (CX2013B070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acencio ML, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-290; Binder JX, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau012; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Cheng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086805; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Cullen LM, 2005, IMMUNOL CELL BIOL, V83, P217, DOI 10.1111/j.1440-1711.2005.01332.x; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; Estrada E, 2006, PROTEOMICS, V6, P35, DOI 10.1002/pmic.200500209; Estrada E, 2006, J PROTEOME RES, V5, P2177, DOI 10.1021/pr060106e; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Gustafson AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-265; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; JIAWEI L, 2014, J COMPUTATIONAL THEO, V11, P619, DOI DOI 10.1166/JCTN.2014.3403; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Li M, 2013, J BIOINF COMPUT BIOL, V11, DOI 10.1142/S0219720013410023; Li M, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-15; Li M, 2011, COMPUT BIOL CHEM, V35, P143, DOI 10.1016/j.compbiolchem.2011.04.002; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Loo LH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003504; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Peng W, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-87; Poulin R, 2000, SOC NETWORKS, V22, P187, DOI 10.1016/S0378-8733(00)00020-4; Ren J, 2011, LECT N BIOINFORMAT, V6674, P12, DOI 10.1007/978-3-642-21260-4_6; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; STEPHENSON K, 1989, SOC NETWORKS, V11, P1, DOI 10.1016/0378-8733(89)90016-6; Tang X, 2013, COMPUTATIONAL BIOL B, V11, P407, DOI [10.1109/TCBB.2013.2295318, DOI 10.1109/TCBB.2013.2295318]; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wang JX, 2012, IEEE ACM T COMPUT BI, V9, P1070, DOI 10.1109/TCBB.2011.147; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wuchty S, 2003, J THEOR BIOL, V223, P45, DOI 10.1016/S0022-5193(03)00071-7; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zhong J., 2013, BMC GENOMICS, V14, P1; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	43	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130743	10.1371/journal.pone.0130743	http://dx.doi.org/10.1371/journal.pone.0130743			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115027	gold, Green Published, Green Submitted			2022-12-27	WOS:000358147500090
J	Siebert, T; Leichsenring, K; Rode, C; Wick, C; Stutzig, N; Schubert, H; Blickhan, R; Bol, M				Siebert, Tobias; Leichsenring, Kay; Rode, Christian; Wick, Carolin; Stutzig, Norman; Schubert, Harald; Blickhan, Reinhard; Boel, Markus			Three-Dimensional Muscle Architecture and Comprehensive Dynamic Properties of Rabbit Gastrocnemius, Plantaris and Soleus: Input for Simulation Studies	PLOS ONE			English	Article							LUMBAR PARASPINAL MUSCLES; SKELETAL-MUSCLE; CAT SOLEUS; IN-VIVO; HINDLIMB MUSCLES; FORCE DEPRESSION; FELINE SOLEUS; LENGTH; MODEL; TENDON	The vastly increasing number of neuro-muscular simulation studies (with increasing numbers of muscles used per simulation) is in sharp contrast to a narrow database of necessary muscle parameters. Simulation results depend heavily on rough parameter estimates often obtained by scaling of one muscle parameter set. However, in vivo muscles differ in their individual properties and architecture. Here we provide a comprehensive dataset of dynamic (n = 6 per muscle) and geometric (three-dimensional architecture, n = 3 per muscle) muscle properties of the rabbit calf muscles gastrocnemius, plantaris, and soleus. For completeness we provide the dynamic muscle properties for further important shank muscles (flexor digitorum longus, extensor digitorum longus, and tibialis anterior; n = 1 per muscle). Maximum shortening velocity (normalized to optimal fiber length) of the gastrocnemius is about twice that of soleus, while plantaris showed an intermediate value. The force-velocity relation is similar for gastrocnemius and plantaris but is much more bent for the soleus. Although the muscles vary greatly in their three-dimensional architecture their mean pennation angle and normalized force-length relationships are almost similar. Forces of the muscles were enhanced in the isometric phase following stretching and were depressed following shortening compared to the corresponding isometric forces. While the enhancement was independent of the ramp velocity, the depression was inversely related to the ramp velocity. The lowest effect strength for soleus supports the idea that these effects adapt to muscle function. The careful acquisition of typical dynamical parameters (e.g. force-length and force-velocity relations, force elongation relations of passive components), enhancement and depression effects, and 3D muscle architecture of calf muscles provides valuable comprehensive datasets for e.g. simulations with neuro-muscular models, development of more realistic muscle models, or simulation of muscle packages.	Univ Stuttgart, Dept Sport & Mot Sci, D-70174 Stuttgart, Germany; Univ Jena, Inst Mot Sci, Jena, Germany; [Schubert, Harald] Univ Klinikum Jena, Inst Versuchstierkunde & Tierschutz, Jena, Germany; [Boel, Markus] Tech Univ Carolo Wilhelmina Braunschweig, Inst Solid Mech, D-38106 Braunschweig, Germany	University of Stuttgart; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Braunschweig University of Technology	Siebert, T (corresponding author), Univ Stuttgart, Dept Sport & Mot Sci, D-70174 Stuttgart, Germany.	tobias.siebert@inspo.uni-stuttgart.de	Stutzig, Norman/AAS-9930-2021; Rode, Christian/P-7340-2018; Siebert, Tobias/C-9626-2012; Böl, Markus/P-8333-2019	Rode, Christian/0000-0003-1938-2478; Siebert, Tobias/0000-0003-4090-5480; Stutzig, Norman/0000-0003-1233-9485	Deutsche Forschungsgemeinschaft [BO 3091/4, SI 841/3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/) under Grants BO 3091/4 to MB, and SI 841/3 to TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT BC, 1952, J PHYSIOL-LONDON, V117, P77; Arampatzis A, 2005, J BIOMECH, V38, P833, DOI 10.1016/j.jbiomech.2004.04.031; ASMUSSEN G, 1989, J PHYSIOL-LONDON, V416, P245, DOI 10.1113/jphysiol.1989.sp017758; Barclay CJ, 1996, J PHYSIOL-LONDON, V497, P781, DOI 10.1113/jphysiol.1996.sp021809; Biewener AA, 2004, J EXP BIOL, V207, P211, DOI 10.1242/jeb.00764; BIEWENER AA, 1988, J EXP BIOL, V137, P191; Biewener AA, 1998, AM ZOOL, V38, P703; BINKHORST RA, 1973, PFLUG ARCH EUR J PHY, V342, P145, DOI 10.1007/BF00587845; Blemker SS, 2007, J MAGN RESON IMAGING, V25, P441, DOI 10.1002/jmri.20805; Bobbert MF, 2013, NEUROSCIENCE, V237, P232, DOI 10.1016/j.neuroscience.2013.01.055; BOBBERT MF, 1986, J BIOMECH, V19, P887, DOI 10.1016/0021-9290(86)90184-3; Bock P, 1989, ROMEIS MIKROSKOPISCH, V17; Bol M, 2013, BIOMECH MODEL MECHAN, V12, P1205, DOI 10.1007/s10237-013-0476-1; Bol M, 2012, J BIOMECH, V45, P2673, DOI 10.1016/j.jbiomech.2012.08.023; Bol M, 2011, J MECH BEHAV BIOMED, V4, P1299, DOI 10.1016/j.jmbbm.2011.04.017; Bol M, 2011, COMPUT MECH, V47, P591, DOI 10.1007/s00466-010-0567-0; Brown IE, 1999, J MUSCLE RES CELL M, V20, P627, DOI 10.1023/A:1005585030764; Brown IE, 1996, J MUSCLE RES CELL M, V17, P221, DOI 10.1007/BF00124244; Campbell Stuart G, 2011, Biophys Rev, V3, P199, DOI 10.1007/s12551-011-0059-2; Campbell SG, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002156; Cohen J.E., 1988, STAT POWER ANAL BEHA; Edman KAP, 2010, ADV EXP MED BIOL, V682, P7, DOI 10.1007/978-1-4419-6366-6_2; EDMAN KAP, 1978, J PHYSIOL-LONDON, V281, P139, DOI 10.1113/jphysiol.1978.sp012413; Epstein M, 1998, THEORETICAL MODELS S; ETTEMA GJC, 1994, ANAT RECORD, V239, P414, DOI 10.1002/ar.1092390408; Froeling M, 2010, MAGN RESON MED, V64, P1182, DOI 10.1002/mrm.22477; GAREIS H, 1992, J BIOMECH, V25, P903, DOI 10.1016/0021-9290(92)90230-X; Gorb SN, 2000, ZOOMORPHOLOGY, V120, P91, DOI 10.1007/s004350000026; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909; Heemskerk AM, 2005, MAGNET RESON MED, V53, P1333, DOI 10.1002/mrm.20476; Herzog W, 1997, J BIOMECH, V30, P865, DOI 10.1016/S0021-9290(97)00046-8; Herzog W, 2008, J APPL BIOMECH, V24, P1, DOI 10.1123/jab.24.1.1; HIDES JA, 1994, SPINE, V19, P165, DOI 10.1097/00007632-199401001-00009; Hiepe P, 2014, NMR BIOMED, V27, P146, DOI 10.1002/nbm.3046; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Holzbaur KRS, 2005, ANN BIOMED ENG, V33, P829, DOI 10.1007/s10439-005-3320-7; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; JACOBS R, 1993, MED SCI SPORT EXER, V25, P1163; Kermarrec E, 2010, AM J ROENTGENOL, V195, pW352, DOI 10.2214/AJR.09.3368; Leonard TR, 2010, AM J PHYSIOL-CELL PH, V299, pC14, DOI 10.1152/ajpcell.00049.2010; LIEBER RL, 1989, J MORPHOL, V199, P93, DOI 10.1002/jmor.1051990108; LOREN GJ, 1995, J BIOMECH, V28, P791, DOI 10.1016/0021-9290(94)00137-S; LUFF AR, 1981, J PHYSIOL-LONDON, V313, P161, DOI 10.1113/jphysiol.1981.sp013656; Mannion AF, 1997, J ORTHOPAED RES, V15, P881, DOI 10.1002/jor.1100150614; Martin RB, 1998, SKELETAL TISSUE MECH; McGowan CP, 2010, J BIOMECH, V43, P449, DOI 10.1016/j.jbiomech.2009.09.047; MENDEZ J, 1960, METABOLISM, V9, P184; Mengiardi B, 2006, RADIOLOGY, V240, P786, DOI 10.1148/radiol.2403050820; Monti RJ, 2003, J EXP BIOL, V206, P3437, DOI 10.1242/jeb.00550; MORGAN DL, 1982, BIOPHYS J, V39, P189, DOI 10.1016/S0006-3495(82)84507-4; Neptune RR, 2008, GAIT POSTURE, V28, P135, DOI 10.1016/j.gaitpost.2007.11.004; Neptune RR, 2009, ANNU REV BIOMED ENG, V11, P81, DOI 10.1146/annurev-bioeng-061008-124941; OTTEN E, 1987, J NEUROSCI METH, V21, P287, DOI 10.1016/0165-0270(87)90123-3; Paxton H, 2010, J ANAT, V217, P153, DOI 10.1111/j.1469-7580.2010.01251.x; Prado LG, 2005, J GEN PHYSIOL, V126, P461, DOI 10.1085/jgp.200509364; Prilutsky BI, 1996, J EXP BIOL, V199, P801; RANATUNGA KW, 1990, J MUSCLE RES CELL M, V11, P240, DOI 10.1007/BF01843577; Rode C, 2009, J MECH MED BIOL, V9, P105, DOI 10.1142/S0219519409002870; Rode C, 2009, J THEOR BIOL, V259, P350, DOI 10.1016/j.jtbi.2009.03.015; Rohrle O, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00358; Rupp TK, 2015, BIOMECH MODEL MECHAN, V14, P1081, DOI 10.1007/s10237-015-0656-2; SACKS RD, 1982, J MORPHOL, V173, P185, DOI 10.1002/jmor.1051730206; Savelberg HHCM, 2001, J MORPHOL, V250, P89, DOI 10.1002/jmor.1061; Schenk P, 2013, J ANAT, V223, P61, DOI 10.1111/joa.12062; Schilling N, 2003, PRAVENTION ARBEITSBE, P343; Scott SH, 1996, J MUSCLE RES CELL M, V17, P207, DOI 10.1007/BF00124243; SHADWICK RE, 1990, J APPL PHYSIOL, V68, P1033, DOI 10.1152/jappl.1990.68.3.1033; Siebert T, 2014, COMPUTATIONAL MODELI, P173, DOI DOI 10.1533/9780857096739.2.173; Siebert T, 2008, BIOL CYBERN, V98, P133, DOI [10.1007/s00422-007-0197-6, 10.1007/S00422-007-0197-6]; Siebert T, 2014, J BIOMECH, V47, P1822, DOI 10.1016/j.jbiomech.2014.03.029; Siebert T, 2014, COMPUT METHOD BIOMEC, V17, P217, DOI 10.1080/10255842.2012.675056; Sinha S, 2006, J MAGN RESON IMAGING, V24, P182, DOI 10.1002/jmri.20593; Stark H, 2013, J ANAT, V222, P214, DOI 10.1111/joa.12005; Stark H, 2010, J BIOMECH, V43, P2897, DOI 10.1016/j.jbiomech.2010.07.031; Till O, 2008, J THEOR BIOL, V255, P176, DOI 10.1016/j.jtbi.2008.08.009; Till O, 2010, J THEOR BIOL, V266, P117, DOI 10.1016/j.jtbi.2010.06.021; vanZandwijk JP, 1997, BIOL CYBERN, V77, P277, DOI 10.1007/s004220050388; Wagner H, 2005, BIOMECH MODEL MECHAN, V4, P10, DOI 10.1007/s10237-005-0068-9; Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011; Wang LC, 2001, J ANAT, V199, P631, DOI 10.1046/j.1469-7580.2001.19960631.x; Wank V, 1996, MODELLIERUNG SIMULAT; Winters JA., 1990, MULTIPLE MUSCLE SYST, P69, DOI DOI 10.1007/978-1-4613-9030-5_5; Winters TM, 2011, J BIOMECH, V44, P109, DOI 10.1016/j.jbiomech.2010.08.033; WOITTIEZ RD, 1983, PFLUG ARCH EUR J PHY, V399, P275, DOI 10.1007/BF00652752; Yucesoy C. A., 2003, Archives of Physiology and Biochemistry, V111, P377; ZAHALAK GI, 1986, J BIOMECH ENG-T ASME, V108, P131, DOI 10.1115/1.3138592	86	41	41	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130985	10.1371/journal.pone.0130985	http://dx.doi.org/10.1371/journal.pone.0130985			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114955	gold, Green Published			2022-12-27	WOS:000358147500115
J	Wan, YH; Chen, J; Sun, Y; Tao, FB				Wan, Yuhui; Chen, Jing; Sun, Ying; Tao, Fangbiao			Impact of Childhood Abuse on the Risk of Non-Suicidal Self-Injury in Mainland Chinese Adolescents	PLOS ONE			English	Article							SEXUAL-ABUSE; HOUSEHOLD DYSFUNCTION; SUICIDE IDEATION; NATIONAL SAMPLE; UNITED-STATES; HARM; MALTREATMENT; EXPERIENCES; POPULATION; HEALTH	Background Childhood abuse has been associated with significant increases in non-suicidal self-injury (NSSI) behaviors in adolescents; however, only general definitions of this risk indicator have been examined. This study identified relationships between specific forms of childhood abuse and NSSI in mainland Chinese adolescents. Method A total of 14,221 cases were retained from an epidemiological study involving adolescents from junior and senior middle schools. Information relating to the perpetrator, perceived harm, timing of exposure to different types of childhood abuse, and NSSI were obtained. Logistic regression was used to analyze relationships between each form of childhood abuse and NSSI. Results Approximately 51.0% of the students reported at least one abusive childhood experience. Nearly one in four students (24.9%) reported that they had engaged in NSSI in the past 12 months. Each type of childhood abuse, occurring at any time within the first 16 years of life, especially in situations of continuous exposure, was significantly associated with NSSI. A significant graded relationship was found between number of abusive childhood experiences and NSSI. Students maltreated by parents or others were at high risk of engaging in NSSI, the risk was greater in students maltreated by both; students who had been exposed to childhood abuse with no perceived harm still demonstrated an elevated risk for NSSI. The pattern of associations did not vary by gender. Conclusions These findings suggest that experiencing any of various forms of childhood abuse should be considered a risk factor for NSSI during adolescence. Further research should focus upon psychosocial, neural, and genetic factors that might moderate or mediate the onset of NSSI in adolescents who have experienced childhood abuse.	[Wan, Yuhui; Chen, Jing; Sun, Ying; Tao, Fangbiao] Anhui Med Univ, Sch Publ Hlth, Dept Maternal Child & Adolescent Hlth, Hefei 230032, Anhui, Peoples R China; [Wan, Yuhui; Chen, Jing; Sun, Ying; Tao, Fangbiao] Anhui Prov Key Lab Populat Hlth & Aristogen, Hefei 230032, Anhui, Peoples R China	Anhui Medical University	Tao, FB (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Maternal Child & Adolescent Hlth, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.	taofangbiao@126.com		Sun, Ying/0000-0002-5432-4620	National Natural Science Foundation of China [81202223]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding for the project was provided by the National Natural Science Foundation of China (81202223).	Anda RF, 2010, AM J PREV MED, V39, P93, DOI 10.1016/j.amepre.2010.03.015; Arensman E, 2014, EUR J PUBLIC HEALTH, V24, P292, DOI 10.1093/eurpub/ckt087; Baetens I, 2011, ARCH SUICIDE RES, V15, P56, DOI 10.1080/13811118.2011.540467; Bellis MA, 2014, J PUBLIC HEALTH-UK, V36, P81, DOI 10.1093/pubmed/fdt038; Blaauw E, 2002, J TRAUMA STRESS, V15, P9, DOI 10.1023/A:1014323009493; Brown GW, 2007, J AFFECT DISORDERS, V103, P205, DOI 10.1016/j.jad.2007.05.022; Butler AC, 2013, CHILD ABUSE NEGLECT, V37, P643, DOI 10.1016/j.chiabu.2013.06.009; Cankaya B, 2012, CAN J PSYCHIAT, V57, P45, DOI 10.1177/070674371205700108; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1609; Chou CY, 2011, CHILD ABUSE NEGLECT, V35, P58, DOI 10.1016/j.chiabu.2010.08.005; CLAUSSEN AH, 1991, CHILD ABUSE NEGLECT, V15, P5, DOI 10.1016/0145-2134(91)90085-R; Croyle KL, 2007, AM J ORTHOPSYCHIAT, V77, P332, DOI 10.1037/0002-9432.77.2.332; Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564; Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089; Duke NN, 2010, PEDIATRICS, V125, pE778, DOI 10.1542/peds.2009-0597; Finkelhor D, 2009, PEDIATRICS, V124, P1411, DOI 10.1542/peds.2009-0467; Fisher HL, 2010, PSYCHOL MED, V40, P1967, DOI 10.1017/S0033291710000231; Fleming TM, 2014, AUST NZ J PSYCHIAT, V48, P472, DOI 10.1177/0004867413514489; Giletta M, 2012, PSYCHIAT RES, V197, P66, DOI 10.1016/j.psychres.2012.02.009; Glassman LH, 2007, BEHAV RES THER, V45, P2483, DOI 10.1016/j.brat.2007.04.002; Hasking PA, 2010, J ADOLESCENCE, V33, P767, DOI 10.1016/j.adolescence.2009.12.006; Hawton K, 2008, J CHILD PSYCHOL PSYC, V49, P441, DOI 10.1111/j.1469-7610.2007.01852.x; Hawton K, 2012, LANCET, V379, P2373, DOI 10.1016/S0140-6736(12)60322-5; Isohookana R, 2013, EUR CHILD ADOLES PSY, V22, P13, DOI 10.1007/s00787-012-0311-8; Kessler RC, 2005, JAMA-J AM MED ASSOC, V293, P2487, DOI 10.1001/jama.293.20.2487; Lang CM, 2011, TRAUMA VIOLENCE ABUS, V12, P23, DOI 10.1177/1524838010386975; Lansford JE, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/672780; Lin DH, 2011, CHILD ABUSE NEGLECT, V35, P680, DOI 10.1016/j.chiabu.2011.05.006; Madge N, 2008, J CHILD PSYCHOL PSYC, V49, P667, DOI 10.1111/j.1469-7610.2008.01879.x; Moran P, 2012, LANCET, V379, P236, DOI 10.1016/S0140-6736(11)61141-0; Morey C, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-79; Mueller-Pfeiffer C, 2013, J NERV MENT DIS, V201, P471, DOI 10.1097/NMD.0b013e3182948096; Nixon MK, 2008, CAN MED ASSOC J, V178, P306, DOI 10.1503/cmaj.061693; da Silva SSP, 2013, J INTERPERS VIOLENCE, V28, P1989, DOI 10.1177/0886260512471077; Perera Billesha, 2009, Ceylon Medical Journal, V54, P10; Romero-Martinez A, 2014, CHILD ABUSE NEGLECT, V38, P510, DOI 10.1016/j.chiabu.2013.09.010; Shek DTL, 2012, SCI WORLD J, P1, DOI 10.1100/2012/932540; Shen LJ, 2015, ASIA-PAC PSYCHIAT, V7, P85, DOI 10.1111/appy.12105; Shin YM, 2009, J KOREAN MED SCI, V24, P215, DOI 10.3346/jkms.2009.24.2.215; Skegg K, 2005, LANCET, V366, P1471, DOI 10.1016/S0140-6736(05)67600-3; Straus MA, 1998, CHILD ABUSE NEGLECT, V22, P249, DOI 10.1016/S0145-2134(97)00174-9; Swannell S, 2012, CHILD ABUSE NEGLECT, V36, P572, DOI 10.1016/j.chiabu.2012.05.005; Tang CSK, 2006, CHILD ABUSE NEGLECT, V30, P893, DOI 10.1016/j.chiabu.2006.02.012; van der Vegt EJM, 2009, J ABNORM CHILD PSYCH, V37, P239, DOI 10.1007/s10802-008-9272-2; Wan YH, 2015, SOC PSYCH PSYCH EPID, V50, P237, DOI 10.1007/s00127-014-0917-x; Wan Yu-hui, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P474; Wan YH, 2011, EUR CHILD ADOLES PSY, V20, P517, DOI 10.1007/s00787-011-0213-1; Watanabe N, 2012, SUICIDE LIFE-THREAT, V42, P550, DOI 10.1111/j.1943-278X.2012.00111.x; Weismoore JT, 2010, J YOUTH ADOLESCENCE, V39, P281, DOI 10.1007/s10964-009-9452-6; Wong WCW, 2009, CHILD ABUSE NEGLECT, V33, P441, DOI 10.1016/j.chiabu.2008.02.010; Zink T, 2009, J INTERPERS VIOLENCE, V24, P537, DOI 10.1177/0886260508317198	51	43	52	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131239	10.1371/journal.pone.0131239	http://dx.doi.org/10.1371/journal.pone.0131239			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1AM	26114574	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500137
J	Atif, F; Patel, NR; Yousuf, S; Stein, DG				Atif, Fahim; Patel, Neil R.; Yousuf, Seema; Stein, Donald G.			The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells	PLOS ONE			English	Article							GROWTH-FACTOR; UP-REGULATION; STEM-CELLS; APOPTOSIS; INVASION; MIGRATION; CANCER; EXPRESSION; PREGNANCY; RADIATION	Glioblastoma multiforme (GBM) is the most common and most aggressive malignant brain tumor. Despite optimal treatment and evolving standard of care, the median survival of patients diagnosed with GBM is only 12-15 months. In this study, we combined progesterone (PROG) and temozolomide (TMZ), a standard chemotherapeutic agent for human GBM, to test whether PROG enhances the antitumor effects of TMZ and reduces its side effects. Two WHO grade IV human GBM cells lines (U87MG and U118MG) and primary human dermal fibroblasts (HDFs) were repeatedly exposed to PROG and TMZ either alone or in combination for 3 and 6 days. Cell death was measured by MTT reduction assay. PROG and TMZ individually induced tumor cell death in a dose-dependent manner. PROG at high doses produced more cell death than TMZ alone. When combined, PROG enhanced the cell death-inducing effect of TMZ. In HDFs, PROG did not reduce viability even at the same high cytotoxic doses, but TMZ did so in a dose-dependent manner. In combination, PROG reduced TMZ toxicity in HDFs. PROG alone and in combination with TMZ suppressed the EGFR/PI3K/Akt/mTOR signaling pathway and MGMT expression in U87MG cells, thus suppressing cell proliferation. PROG and TMZ individually reduced cell migration in U87MG cells but did so more effectively in combination. PROG enhances the cytotoxic effects of TMZ in GBM cells and reduces its toxic side effects in healthy primary cells.	[Atif, Fahim; Patel, Neil R.; Yousuf, Seema; Stein, Donald G.] Emory Univ, Sch Med, Dept Emergency Med, Brain Res Lab, Atlanta, GA 30322 USA	Emory University	Atif, F (corresponding author), Emory Univ, Sch Med, Dept Emergency Med, Brain Res Lab, Atlanta, GA 30322 USA.	fatif@emory.edu	Stein, Donald/AAJ-5139-2020		Allen and Company; Marcus Foundation; Laney Graduate School of Emory University; Stein Family Research Fund	Allen and Company; Marcus Foundation; Laney Graduate School of Emory University; Stein Family Research Fund	This research was supported in part by gifts from Allen and Company, The Marcus Foundation, The Laney Graduate School of Emory University and the Stein Family Research Fund.	Anai S, 2014, CANCER SCI, V105, P583, DOI 10.1111/cas.12397; Arck P, 2007, AM J REPROD IMMUNOL, V58, P268, DOI 10.1111/j.1600-0897.2007.00512.x; Atif F, 2014, J STEROID BIOCH MOL; Atif F, 2011, MOL MED, V17, P1084, DOI 10.2119/molmed.2010.00255; Atif F, 2009, MOL MED, V15, P328, DOI 10.2119/molmed.2009.00016; Bolyard C, 2014, CLIN CANCER RES, V20, P6479, DOI 10.1158/1078-0432.CCR-14-0463; Bu SZ, 1997, CANCER, V79, P1944, DOI 10.1002/(SICI)1097-0142(19970515)79:10<1944::AID-CNCR15>3.0.CO;2-V; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Cattaneo M, 2014, J BIOL CHEM, V289, P2826, DOI 10.1074/jbc.M113.527754; Choi EJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-17; Cong DM, 2014, CARCINOGENESIS, V35, P2014, DOI 10.1093/carcin/bgu089; Dressing GE, 2009, STEROIDS, V74, P573, DOI 10.1016/j.steroids.2008.12.001; Formby B, 1999, MOL CELL BIOCHEM, V202, P53, DOI 10.1023/A:1007081021483; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Goffart N, 2015, NEURO-ONCOLOGY, V17, P81, DOI 10.1093/neuonc/nou144; Gratas C, 2014, ONCOTARGET; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Horita K, 2001, ANTICANCER RES, V21, P3871; Huang L, 2014, J BIOL CHEM, V289, P2217, DOI 10.1074/jbc.M113.515932; Huang TT, 2013, CANCER GENE THER, V20, P544, DOI 10.1038/cgt.2013.51; Hurmath KF, 2014, CELL BIOL INT, V38, P1415, DOI 10.1002/cbin.10353; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Kim JK, 2014, CANCER LETT, V353, P194, DOI 10.1016/j.canlet.2014.07.034; Kita D, 2007, ACTA NEUROPATHOL, V113, P295, DOI 10.1007/s00401-006-0186-1; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080363; Li RJ, 2014, J NEURO-ONCOL, V116, P25, DOI 10.1007/s11060-013-1255-7; Liccardi G, 2014, CLIN CANCER RES, V20, P3496, DOI 10.1158/1078-0432.CCR-13-2695; Lin F, 2014, CLIN CANCER RES, V20, P2703, DOI 10.1158/1078-0432.CCR-14-0084; Medina D, 2007, Ernst Schering Found Symp Proc, P109; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Ochs K, 2000, CANCER RES, V60, P5815; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Peck JD, 2002, CANCER EPIDEM BIOMAR, V11, P361; Rogers SJ, 2005, CANCER METAST REV, V24, P47, DOI 10.1007/s10555-005-5047-1; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; Stolimenov I, 2009, BIOCHEM SOC T, V37, P605, DOI 10.1042/BST0370605; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Uzzaman M, 2007, J NEUROSURG, V106, P646, DOI 10.3171/jns.2007.106.4.646; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Zhang L, 2014, TUMOR BIOL, V35, P10707, DOI 10.1007/s13277-014-2386-y; Zou YH, 2014, MOL MED REP, V10, P411, DOI 10.3892/mmr.2014.2151	45	25	25	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131441	10.1371/journal.pone.0131441	http://dx.doi.org/10.1371/journal.pone.0131441			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110872	gold, Green Published, Green Submitted			2022-12-27	WOS:000356933800149
J	Boyle, EE; Adamowicz, SJ				Boyle, Elizabeth E.; Adamowicz, Sarah J.			Community Phylogenetics: Assessing Tree Reconstruction Methods and the Utility of DNA Barcodes	PLOS ONE			English	Article							CADDISFLIES INSECTA; BODY-SIZE; TRICHOPTERA; NUCLEAR; MITOCHONDRIAL; PATTERNS; SIGNAL; GENES; EPHEMEROPTERA; PERFORMANCE	Studies examining phylogenetic community structure have become increasingly prevalent, yet little attention has been given to the influence of the input phylogeny on metrics that describe phylogenetic patterns of co-occurrence. Here, we examine the influence of branch length, tree reconstruction method, and amount of sequence data on measures of phylogenetic community structure, as well as the phylogenetic signal (Pagel's.) in morphological traits, using Trichoptera larval communities from Churchill, Manitoba, Canada. We find that model-based tree reconstruction methods and the use of a backbone family-level phylogeny improve estimations of phylogenetic community structure. In addition, trees built using the barcode region of cytochrome c oxidase subunit I (COI) alone accurately predict metrics of phylogenetic community structure obtained from a multi-gene phylogeny. Input tree did not alter overall conclusions drawn for phylogenetic signal, as significant phylogenetic structure was detected in two body size traits across input trees. As the discipline of community phylogenetics continues to expand, it is important to investigate the best approaches to accurately estimate patterns. Our results suggest that emerging large datasets of DNA barcode sequences provide a vast resource for studying the structure of biological communities.	[Adamowicz, Sarah J.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph	Adamowicz, SJ (corresponding author), Univ Guelph, Biodivers Inst Ontario, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada.	sadamowi@uoguelph.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [386591-2010]; Northern Research Internship; Government of Canada through Genome Canada; Ontario Genomics Institute [2008-OGI-ICI-03]; Canadian Foundation for Innovation [28206]; Churchill Northern Studies Centre; Aboriginal Affairs and Northern Development Canada; Ontario Ministry of Research and Innovation through the Global Leadership Round in Genomics and Life Sciences program [ORF-RE GL2-01-015]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Northern Research Internship; Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Canadian Foundation for Innovation(Canada Foundation for Innovation); Churchill Northern Studies Centre; Aboriginal Affairs and Northern Development Canada; Ontario Ministry of Research and Innovation through the Global Leadership Round in Genomics and Life Sciences program	Financial support was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) through a Discovery Grant to SJA (386591-2010) and a Northern Research Internship to EEB. Additional support was provided by the Government of Canada through Genome Canada and the Ontario Genomics Institute to the International Barcode of Life Project led by PDN Hebert (2008-OGI-ICI-03), a Leader's Opportunity Fund award from the Canadian Foundation for Innovation (project #28206) to SJA, a Northern Research Fund award from the Churchill Northern Studies Centre to EEB, and a Northern Scientific Training Program award to EEB from Aboriginal Affairs and Northern Development Canada. The authors also thank the Ontario Ministry of Research and Innovation through the Global Leadership Round in Genomics and Life Sciences program (ORF-RE GL2-01-015) for funding the ongoing development of BOLD, used for data management and analysis for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Boyle EE, 2012, COMMUNITY PHYLOGENET; Campbell V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-64; CUMMINGS MP, 1995, MOL BIOL EVOL, V12, P814; Danforth BN, 2006, MOL PHYLOGENET EVOL, V39, P358, DOI 10.1016/j.ympev.2005.09.022; Espeland M, 2010, J BIOGEOGR, V37, P879, DOI 10.1111/j.1365-2699.2009.02263.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gonzalez-Caro S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035472; Hardy OJ, 2008, J ECOL, V96, P914, DOI 10.1111/j.1365-2745.2008.01421.x; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holzenthal RW, 2007, ZOOTAXA, P639; Ivanova N., 2007, CCDB PROTOCOLS SEQUE; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Ivanova NV, 2007, CCDB PROTOCOLS COI A; Johanson KA, 2010, MOL PHYLOGENET EVOL, V54, P535, DOI 10.1016/j.ympev.2009.09.025; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kembel SW, 2009, ECOL LETT, V12, P949, DOI 10.1111/j.1461-0248.2009.01354.x; Kjer KM, 2001, SYST BIOL, V50, P781, DOI 10.1080/106351501753462812; Kjer KM, 2002, ZOOL SCR, V31, P83, DOI 10.1046/j.0300-3256.2001.00079.x; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lin CP, 2004, MOL PHYLOGENET EVOL, V30, P686, DOI 10.1016/S1055-7903(03)00241-0; Maddison WP, 2009, MESQUITE MODULAR SYS; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; McKenna DD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011887; Mitchell A, 2000, SYST BIOL, V49, P202, DOI 10.1093/sysbio/49.2.202; Munkemuller T, 2012, METHODS ECOL EVOL, V3, P743, DOI 10.1111/j.2041-210X.2012.00196.x; Nylander J.A.A, 2004, MRMODELTEST V2; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pei NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021273; R Core Team, 2021, R LANGUAGE ENV STAT; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rokas A, 2005, MOL BIOL EVOL, V22, P1337, DOI 10.1093/molbev/msi121; Ruiter DE, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-5; Sagnes P, 2008, LIMNOLOGICA, V38, P23, DOI 10.1016/j.limno.2007.09.002; Solymos P, 2012, GLOBAL ECOL BIOGEOGR, V21, P109, DOI 10.1111/j.1466-8238.2011.00655.x; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Swenson NG, 2013, ECOGRAPHY, V36, P264, DOI 10.1111/j.1600-0587.2012.00121.x; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Talavera G, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-315; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tolonen KT, 2003, HYDROBIOLOGIA, V499, P179, DOI 10.1023/A:1026325432000; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Wiggins GB, 1977, LARVAE N AM CADDISFL; Wilson JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010525; Zhou X, 2010, J N AM BENTHOL SOC, V29, P814, DOI 10.1899/09-121.1; Zhou X, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-30	56	29	29	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0126662	10.1371/journal.pone.0126662	http://dx.doi.org/10.1371/journal.pone.0126662			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110886	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800006
J	Nallar, R; Papp, Z; Epp, T; Leighton, FA; Swafford, SR; DeLiberto, TJ; Dusek, RJ; Ip, HS; Hall, J; Berhane, Y; Gibbs, SEJ; Soos, C				Nallar, Rodolfo; Papp, Zsuzsanna; Epp, Tasha; Leighton, Frederick A.; Swafford, Seth R.; DeLiberto, Thomas J.; Dusek, Robert J.; Ip, Hon S.; Hall, Jeffrey; Berhane, Yohannes; Gibbs, Samantha E. J.; Soos, Catherine			Demographic and Spatiotemporal Patterns of Avian Influenza Infection at the Continental Scale, and in Relation to Annual Life Cycle of a Migratory Host	PLOS ONE			English	Article							WILD BIRDS; A VIRUSES; SURVEILLANCE; PREVALENCE; WATERFOWL; DUCKS; PARAMYXOVIRUSES; TRANSMISSION; DRIVERS; ECOLOGY	Since the spread of highly pathogenic avian influenza (HPAI) H5N1 in the eastern hemisphere, numerous surveillance programs and studies have been undertaken to detect the occurrence, distribution, or spread of avian influenza viruses (AIV) in wild bird populations worldwide. To identify demographic determinants and spatiotemporal patterns of AIV infection in long distance migratory waterfowl in North America, we fitted generalized linear models with binominal distribution to analyze results from 13,574 blue-winged teal (Anas discors, BWTE) sampled in 2007 to 2010 year round during AIV surveillance programs in Canada and the United States. Our analyses revealed that during late summer staging (July-August) and fall migration (September-October), hatch year (HY) birds were more likely to be infected than after hatch year (AHY) birds, however there was no difference between age categories for the remainder of the year (winter, spring migration, and breeding period), likely due to maturing immune systems and newly acquired immunity of HY birds. Probability of infection increased non-linearly with latitude, and was highest in late summer prior to fall migration when densities of birds and the proportion of susceptible HY birds in the population are highest. Birds in the Central and Mississippi flyways were more likely to be infected compared to those in the Atlantic flyway. Seasonal cycles and spatial variation of AIV infection were largely driven by the dynamics of AIV infection in HY birds, which had more prominent cycles and spatial variation in infection compared to AHY birds. Our results demonstrate demographic as well as seasonal, latitudinal and flyway trends across Canada and the US, while illustrating the importance of migratory host life cycle and age in driving cyclical patterns of prevalence.	[Nallar, Rodolfo; Leighton, Frederick A.; Soos, Catherine] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Pathol, Saskatoon, SK S7N 0W0, Canada; [Nallar, Rodolfo] Wildlife Conservat Soc, Greater Madidi Tambopata Landscape Conservat Prog, La Paz, Bolivia; [Papp, Zsuzsanna; Soos, Catherine] Environm Canada, Sci & Technol Branch, Saskatoon, SK, Canada; [Epp, Tasha] Univ Saskatchewan, Western Coll Vet Med, Dept Large Anim Clin Sci, Saskatoon, SK S7N 0W0, Canada; [Leighton, Frederick A.] Univ Saskatchewan, Canadian Wildlife Hlth Cooperat, Saskatoon, SK S7N 0W0, Canada; [Swafford, Seth R.] US Fish & Wildlife Serv, US Dept Interior, Yazoo City, MS USA; [DeLiberto, Thomas J.] USDA, Anim & Plant Hlth Inspect Serv, Wildlife Serv, Natl Wildlife Dis Program, Ft Collins, CO USA; [Dusek, Robert J.; Ip, Hon S.; Hall, Jeffrey] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA; [Berhane, Yohannes] Natl Ctr Foreign Anim Dis, Canadian Food Inspect Agcy, Winnipeg, MB, Canada; [Gibbs, Samantha E. J.] US Fish & Wildlife Serv, Div Migratory Bird Management, Laurel, MD USA	University of Saskatchewan; Environment & Climate Change Canada; University of Saskatchewan; University of Saskatchewan; United States Department of the Interior; US Fish & Wildlife Service; United States Department of Agriculture (USDA); United States Department of the Interior; United States Geological Survey; Canadian Food Inspection Agency; United States Department of the Interior; US Fish & Wildlife Service	Soos, C (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Vet Pathol, Saskatoon, SK S7N 0W0, Canada.	catherine.soos@ec.gc.ca	Soos, Catherine/Q-4983-2019	Soos, Catherine/0000-0003-4610-3614; Hall, Jeffrey/0000-0001-5599-2826; Dusek, Robert/0000-0001-6177-7479; Ip, Hon/0000-0003-4844-7533	Alberta Conservation Association, Canada's Inter-agency Wild Bird Influenza Survey; Ducks Unlimited Canada's Institute for Wetland and Waterfowl Research, Environment Canada; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN266200700007C]; University of Saskatchewan; Wildlife Conservation Society; Canadian Food Inspection Agency; Public Health Agency of Canada; Environment Canada; participating provinces; USDA-APHIS	Alberta Conservation Association, Canada's Inter-agency Wild Bird Influenza Survey; Ducks Unlimited Canada's Institute for Wetland and Waterfowl Research, Environment Canada; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Saskatchewan; Wildlife Conservation Society; Canadian Food Inspection Agency; Public Health Agency of Canada; Environment Canada(CGIAR); participating provinces; USDA-APHIS(United States Department of Agriculture (USDA))	This research was funded by the Alberta Conservation Association, Canada's Inter-agency Wild Bird Influenza Survey (which is funded by the Canadian Food Inspection Agency, Public Health Agency of Canada, Environment Canada, participating provinces, and USDA-APHIS), Ducks Unlimited Canada's Institute for Wetland and Waterfowl Research, Environment Canada, the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN266200700007C (USA), the University of Saskatchewan, the Wildlife Conservation Society (Graduate Fellowship Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, AVIAN DIS; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Canadian Food Inspection Agency, 2015, AV INFL H5N8 CONF WI; Carney S.M., 1992, SPECIES AGE SEX IDEN; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; DeLiberto TJ, 2009, INTEGR ZOOL, V4, P426, DOI 10.1111/j.1749-4877.2009.00180.x; ESRI, 2012, ARCGIS REL 10 1; Farnsworth ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032729; Ferro PJ, 2010, EMERG INFECT DIS, V16, P1224, DOI 10.3201/eid1608.091864; Gaidet N, 2012, P ROY SOC B-BIOL SCI, V279, P1131, DOI 10.1098/rspb.2011.1417; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Garamszegi LZ, 2007, P ROY SOC B-BIOL SCI, V274, P2003, DOI 10.1098/rspb.2007.0124; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; HINSHAW VS, 1985, B WORLD HEALTH ORGAN, V63, P711; Horimoto T, 2001, CLIN MICROBIOL REV, V14, P129, DOI 10.1128/CMR.14.1.129-149.2001; Hoye BJ, 2010, EMERG INFECT DIS, V16, P1827, DOI 10.3201/eid1612.100589; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; Ip HS, 2015, EMERG INFECT DIS, V21, P886, DOI 10.3201/eid2105.142020; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Ledoux H, 2005, DEVELOPMENTS IN SPATIAL DATA HANDLING, P97, DOI 10.1007/3-540-26772-7_8; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Parmley EJ, 2008, EMERG INFECT DIS, V14, P84, DOI 10.3201/eid1401.061562; Pasick J, 2010, AVIAN DIS, V54, P440, DOI 10.1637/8800-040109-Reg.1; Rohwer CF, 2002, BIRDS N AM ONLINE; Runstadler JA, 2007, ARCH VIROL, V152, P1901, DOI 10.1007/s00705-007-0994-1; SHARP GB, 1993, EPIDEMIOL INFECT, V110, P161, DOI 10.1017/S0950268800050780; Shoham Dany, 2012, Influenza Res Treat, V2012, P912326, DOI 10.1155/2012/912326; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; STALLKNECHT DE, 1990, AVIAN DIS, V34, P398, DOI 10.2307/1591427; Stryhn H., 2012, METHODS EPIDEMIOLOGI; Szymanski M. L., 2013, BIOL TECHNICAL PUBLI; Takekawa JY, 2010, AVIAN BIOL RES, V3, P51, DOI 10.3184/175815510X12737339356701; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; USDA, 2006, EARL DET SYST HIGHL; van Dijk JGB, 2014, J ANIM ECOL, V83, P266, DOI 10.1111/1365-2656.12131; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wilcox BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024010; Xu CL, 2013, EMERG INFECT DIS, V19, P1289, DOI 10.3201/eid1908.130662	42	14	14	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130662	10.1371/journal.pone.0130662	http://dx.doi.org/10.1371/journal.pone.0130662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110538	Green Published, gold			2022-12-27	WOS:000356933800071
J	Pang, JMB; Byrne, DJ; Takano, EA; Jene, N; Petelin, L; McKinley, J; Poliness, C; Saunders, C; Taylor, D; Mitchell, G; Fox, SB				Pang, Jia-Min B.; Byrne, David J.; Takano, Elena A.; Jene, Nicholas; Petelin, Lara; McKinley, Joanne; Poliness, Catherine; Saunders, Christobel; Taylor, Donna; Mitchell, Gillian; Fox, Stephen B.			Breast Tissue Composition and Immunophenotype and Its Relationship with Mammographic Density in Women at High Risk of Breast Cancer	PLOS ONE			English	Article							RABBIT MONOCLONAL-ANTIBODY; ESTROGEN-RECEPTOR; HORMONE-THERAPY; ER-ALPHA; EXPRESSION; PROGESTERONE; REDUCTION	Aim To investigate the cellular and immunophenotypic basis of mammographic density in women at high risk of breast cancer. Methods Mammograms and targeted breast biopsies were accrued from 24 women at high risk of breast cancer. Mammographic density was classified into Wolfe categories and ranked by increasing density. The histological composition and immunophenotypic profile were quantified from digitized haematoxylin and eosin-stained and immunohistochemically-stained (ER alpha, ER beta, PgR, HER2, Ki-67, and CD31) slides and correlated to mammographic density. Results Increasing mammographic density was significantly correlated with increased fibrous stroma proportion (rs (22) = 0.5226, p = 0.0088) and significantly inversely associated with adipose tissue proportion (rs (22) = -0.5409, p = 0.0064). Contrary to previous reports, stromal expression of ER alpha was common (19/20 cases, 95%). There was significantly higher stromal PgR expression in mammographically-dense breasts (p=0.026). Conclusions The proportion of stroma and fat underlies mammographic density in women at high risk of breast cancer. Increased expression of PgR in the stroma of mammographically dense breasts and frequent and unexpected presence of stromal ER alpha expression raises the possibility that hormone receptor expression in breast stroma may have a role in mediating the effects of exogenous hormonal therapy on mammographic density.	[Pang, Jia-Min B.; Byrne, David J.; Takano, Elena A.; Jene, Nicholas; Fox, Stephen B.] Peter MacCallum Canc Ctr, Dept Pathol, East Melbourne, Vic, Australia; [Petelin, Lara; McKinley, Joanne; Mitchell, Gillian] Peter MacCallum Canc Ctr, Familial Canc Ctr, East Melbourne, Vic, Australia; [Poliness, Catherine] Peter MacCallum Canc Ctr, Dept Surg Oncol, East Melbourne, Vic, Australia; [Pang, Jia-Min B.; Fox, Stephen B.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Mitchell, Gillian; Fox, Stephen B.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Saunders, Christobel; Taylor, Donna] Univ Western Australia, Sch Surg, Perth, WA 6009, Australia; [Saunders, Christobel; Taylor, Donna] Royal Perth Hosp, Perth, WA 6001, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; University of Western Australia; Royal Perth Hospital; University of Western Australia	Pang, JMB (corresponding author), Peter MacCallum Canc Ctr, Dept Pathol, East Melbourne, Vic, Australia.	Jia-Min.Pang@petermac.org	Taylor, Donna B/I-5714-2015; Taylor, Donna B/U-7622-2019; Petelin, Lara/AAQ-8978-2021; Saunders, Christobel M/H-5779-2014; Fox, Stephen/G-9719-2016	Taylor, Donna B/0000-0002-1481-1141; Taylor, Donna B/0000-0002-1481-1141; Petelin, Lara/0000-0003-3245-8895; Saunders, Christobel M/0000-0003-2281-9829; Fox, Stephen/0000-0002-7648-8896	National Health and Medical Research Council, Australia [509302]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funding to GM, SF, CS and DT from National Health and Medical Research Council, Australia, grant number 509302. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alowami S, 2003, BREAST CANCER RES, V5, pR129, DOI 10.1186/bcr622; Bae YK, 2012, AM J SURG PATHOL, V36, P1817, DOI 10.1097/PAS.0b013e318267b012; Boyd MT, 1996, BREAST CANCER RES TR, V37, P243, DOI 10.1007/BF01806506; Boyd NF, 2002, NEW ENGL J MED, V347, P886, DOI 10.1056/NEJMoa013390; Cheang MCU, 2006, J CLIN ONCOL, V24, P5637, DOI 10.1200/JCO.2005.05.4155; Cuzick J, 2011, J NATL CANCER I, V103, P744, DOI 10.1093/jnci/djr079; Dowsett M, 2015, BREAST CANCER RES TR, V149, P1, DOI 10.1007/s10549-014-3211-4; Ghosh K, 2012, BREAST CANCER RES TR, V131, P267, DOI 10.1007/s10549-011-1727-4; Ginsburg OM, 2008, BRIT J CANCER, V99, P1369, DOI 10.1038/sj.bjc.6604635; Greendale GA, 2003, J NATL CANCER I, V95, P30, DOI 10.1093/jnci/95.1.30; Harvey JA, 2008, MENOPAUSE, V15, P67, DOI 10.1097/gme.0b013e318054e29a; Hawes D, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1408; Huang ZD, 2005, APPL IMMUNOHISTO M M, V13, P91, DOI 10.1097/00129039-200503000-00015; Jensen EV, 2001, P NATL ACAD SCI USA, V98, P15197, DOI 10.1073/pnas.211556298; Keeling JW, 2000, J PATHOL, V191, P449; Kim J, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3221; Ko KL, 2013, BREAST CANCER RES TR, V142, P559, DOI 10.1007/s10549-013-2726-4; Koerner F, 2001, J STEROID BIOCHEM, V78, P285, DOI 10.1016/S0960-0760(01)00095-4; Kuhl H, 2013, CLIMACTERIC, V16, P54, DOI 10.3109/13697137.2013.768806; Li JM, 2013, J CLIN ONCOL, V31, P2249, DOI 10.1200/JCO.2012.44.5015; Li T, 2005, CANCER EPIDEM BIOMAR, V14, P343, DOI 10.1158/1055-9965.EPI-04-0490; Lin SJ, 2011, BREAST CANCER RES TR, V128, P505, DOI 10.1007/s10549-011-1346-0; Lundstrom E, 2002, AM J OBSTET GYNECOL, V186, P717, DOI 10.1067/mob.2002.121896; National Breast and Ovarian Cancer Centre, 2010, ADV FAM ASP BREAST C; Nyante SJ, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju425; Palmieri C, 2004, J MOL ENDOCRINOL, V33, P35, DOI 10.1677/jme.0.0330035; Speirs V, 2002, J CLIN PATHOL, V55, P371, DOI 10.1136/jcp.55.5.371; Ursin G, 2009, CANCER EPIDEM BIOMAR, V18, P102, DOI 10.1158/1055-9965.EPI-07-2857; Vachon CM, 2011, BREAST CANCER RES TR, V125, P243, DOI 10.1007/s10549-010-0944-6; Vachon CM, 2002, CANCER EPIDEM BIOMAR, V11, P1382; WOLFE JN, 1976, CANCER, V37, P2486, DOI 10.1002/1097-0142(197605)37:5<2486::AID-CNCR2820370542>3.0.CO;2-8; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yan M, 2011, BREAST CANCER RES TR, V126, P395, DOI 10.1007/s10549-010-0941-9; Yang WT, 2010, BREAST CANCER RES TR, V119, P305, DOI 10.1007/s10549-009-0350-0	34	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0128861	10.1371/journal.pone.0128861	http://dx.doi.org/10.1371/journal.pone.0128861			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110820	gold, Green Published			2022-12-27	WOS:000356933800015
J	Wang, HT; Huang, C; Guo, HL; Li, XM; Zhao, WX; Dai, BS; Yan, ZH; Lin, ZX				Wang, Hantao; Huang, Cong; Guo, Huanle; Li, Ximei; Zhao, Wenxia; Dai, Baosheng; Yan, Zhenhua; Lin, Zhongxu			QTL Mapping for Fiber and Yield Traits in Upland Cotton under Multiple Environments	PLOS ONE			English	Article							GOSSYPIUM-HIRSUTUM; LINKAGE MAP; GENETIC-MAP; BC1 POPULATION; QUALITY TRAITS; LOCI; CONSTRUCTION; SSR; COMPONENTS; GERMPLASM	A population of 178 recombinant inbred lines (RILs) was developed using a single seed descendant from a cross between G. hirsutum. acc DH962 and G. hirsutum. cv Jimian5, was used to construct a genetic map and to map QTL for fiber and yield traits. A total of 644 polymorphic loci were used to construct a final genetic map, containing 616 loci and spanning 2016.44 cM, with an average of 3.27 cM between adjacent markers. Statistical analysis revealed that segregation distortion in the intraspecific population was more serious than that in the interspecific population. The RIL population and the two parents were phenotyped under 8 environments (two locations, six years), revealing a total of 134 QTL, including 64 for fiber qualities and 70 for yield components, independently detected in seven environments, explaining 4.40-15.28% of phenotypic variation (PV). Among the 134 QTL, 9 common QTL were detected in more than one environment, and 22 QTL and 19 new QTL were detected in combined analysis (E9). A total of 26 QTL hotspot regions were observed on 13 chromosomes and 2 larger linkage groups, and some QTL clusters related to fiber qualities or yield components were also observed. The results obtained in the present study suggested that to map accurate QTL in crops with larger plant types, such as cotton, phenotyping under multiple environments is necessary to effectively apply the obtained results in molecular marker-assisted selection breeding and QTL cloning.	[Wang, Hantao; Huang, Cong; Guo, Huanle; Li, Ximei; Zhao, Wenxia; Dai, Baosheng; Yan, Zhenhua; Lin, Zhongxu] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Hunan, Peoples R China	Huazhong Agricultural University	Lin, ZX (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Hunan, Peoples R China.	linzhongxu@mail.hzau.edu.cn	Wang, Han/GPW-9809-2022					Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; BRIDGE RR, 1983, CROP SCI, V23, P949, DOI 10.2135/cropsci1983.0011183X002300050032x; Chen H, 2010, EUPHYTICA, V176, P321, DOI 10.1007/s10681-010-0204-1; Chen L, 2008, ACTA AGRON SIN, V7, P015; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Fang DD, 2012, J COTTON SCI, V16, P229; Fang DD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-397; Guo WZ, 2006, J INTEGR PLANT BIOL, V48, P320, DOI 10.1111/j.1744-7909.2006.00174.x; He DH, 2007, EUPHYTICA, V153, P181, DOI 10.1007/s10681-006-9254-9; KNAPP SJ, 1985, CROP SCI, V25, P192, DOI 10.2135/cropsci1985.0011183X002500010046x; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; KWON S. H., 1964, CROP SCI, V4, P196, DOI 10.2135/cropsci1964.0011183X000400020023x; Lacape JM, 2013, FIELD CROP RES, V144, P256, DOI 10.1016/j.fcr.2013.01.001; Lacape JM, 2003, GENOME, V46, P612, DOI [10.1139/G03-050, 10.1139/g03-050]; Li X. B., 2013, THESIS; Li XM, 2012, GENOME, V55, P459, DOI [10.1139/G2012-032, 10.1139/g2012-032]; Liang Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-539; Lin Z, 2005, PLANT BREEDING, V124, P180, DOI 10.1111/j.1439-0523.2004.01039.x; [林忠旭 LIN Zhong-xu], 2009, [中国农业科学, Scientia Agricultura Sinica], V42, P3036; Lin ZX, 2009, EUPHYTICA, V166, P35, DOI 10.1007/s10681-008-9822-2; Liu RZ, 2012, MOL BREEDING, V29, P297, DOI 10.1007/s11032-011-9547-0; McCarty JC, 2004, CROP SCI, V44, P1226, DOI 10.2135/cropsci2004.1226; McCouch SR, 1997, RICE GENET NEWSLETT, V14, P11, DOI [DOI 10.1007/S10142-013-0328-1, DOI 10.1007/S10681-005-0449-2]; Mei M, 2004, THEOR APPL GENET, V108, P280, DOI 10.1007/s00122-003-1433-7; Meredith WR, 2005, CROP SCI, V45, P807, DOI 10.2135/cropsci2005.0807; Muhammad Naveed, 2004, International Journal of Agriculture and Biology, V6, P712; Ning ZY, 2014, EUPHYTICA, V195, P143, DOI 10.1007/s10681-013-0990-3; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Qin HD, 2008, THEOR APPL GENET, V117, P883, DOI 10.1007/s00122-008-0828-x; Rong JK, 2004, GENETICS, V166, P389, DOI 10.1534/genetics.166.1.389; Said JI, 2014, MOL GENET GENOMICS, P1; Said JI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-776; Shao QS, 2014, EUPHYTICA, V198, P43, DOI 10.1007/s10681-014-1082-8; Shen XL, 2007, EUPHYTICA, V155, P371, DOI 10.1007/s10681-006-9338-6; Shen XL, 2005, MOL BREEDING, V15, P169, DOI 10.1007/s11032-004-4731-0; Shen XL, 2006, CROP SCI, V46, P61, DOI 10.2135/cropsci2005.0056; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Sun FD, 2012, MOL BREEDING, V30, P569, DOI 10.1007/s11032-011-9645-z; Tang B, EUPHYTICA, P315; Tang SY, 2015, EUPHYTICA, V201, P195, DOI [10.1007/s10681-014-1189-y, 10.1007/s10681-]; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang BH, 2006, EUPHYTICA, V152, P367, DOI 10.1007/s10681-006-9224-2; Wang HT, 2015, DNA RES, V22, P147, DOI 10.1093/dnares/dsu047; Wang HT, 2014, EUPHYTICA, V198, P277, DOI 10.1007/s10681-014-1104-6; Wang XiaQing, 2013, Australian Journal of Crop Science, V7, P1252; Wang XQ, 2012, PLANT MOL BIOL REP, V30, P605, DOI 10.1007/s11105-011-0369-3; Yu JW, 2007, J INTEGR PLANT BIOL, V49, P716, DOI 10.1111/j.1744-7909.2007.00459.x; Yu JW, 2013, THEOR APPL GENET, V126, P275, DOI 10.1007/s00122-012-1980-x; Yu JZ, 2014, MOL GENET GENOMICS, V289, P1347, DOI 10.1007/s00438-014-0930-5; Yu Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-15; Zhang K, 2012, MOL BREEDING, V29, P335, DOI 10.1007/s11032-011-9549-y; Zhang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057220; Zhang TZ, 2003, THEOR APPL GENET, V106, P262, DOI 10.1007/s00122-002-1101-3; Zhang YX, 2008, GENOME, V51, P534, DOI 10.1139/G08-033; Zhang ZS, 2009, MOL BREEDING, V24, P49, DOI 10.1007/s11032-009-9271-1; Zhang ZS, 2005, EUPHYTICA, V144, P91, DOI 10.1007/s10681-005-4629-x	56	46	52	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130742	10.1371/journal.pone.0130742	http://dx.doi.org/10.1371/journal.pone.0130742			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110526	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800083
J	Cai, W; Liu, W; Wang, WS; Fu, ZW; Han, TT; Lu, YT				Cai, Wei; Liu, Wen; Wang, Wen-Shu; Fu, Zheng-Wei; Han, Tong-Tong; Lu, Ying-Tang			Overexpression of Rat Neurons Nitric Oxide Synthase in Rice Enhances Drought and Salt Tolerance	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; INTERACTING PROTEIN; INDUCED INHIBITION; OXIDATIVE STRESS; ROOT ELONGATION; ARABIDOPSIS; NO; AUXIN; SIGNAL; DAMAGE	Nitric oxide (NO) has been shown to play an important role in the plant response to biotic and abiotic stresses in Arabidopsis mutants with lower or higher levels of endogenous NO. The exogenous application of NO donors or scavengers has also suggested an important role for NO in plant defense against environmental stress. In this study, rice plants under drought and high salinity conditions showed increased nitric oxide synthase (NOS) activity and NO levels. Overexpression of rat neuronal NO synthase (nNOS) in rice increased both NOS activity and NO accumulation, resulting in improved tolerance of the transgenic plants to both drought and salt stresses. nNOS-overexpressing plants exhibited stronger water-holding capability, higher proline accumulation, less lipid peroxidation and reduced electrolyte leakage under drought and salt conditions than wild rice. Moreover, nNOS-overexpressing plants accumulated less H2O2, due to the observed up-regulation of OsCATA, OsCATB and OsPOX1. In agreement, the activities of CAT and POX were higher in transgenic rice than wild type. Additionally, the expression of six tested stress-responsive genes including OsDREB2A, OsDREB2B, OsSNAC1, OsSNAC2, OsLEA3 and OsRD29A, in nNOS-overexpressing plants was higher than that in the wild type under drought and high salinity conditions. Taken together, our results suggest that nNOS overexpression suppresses the stress-enhanced electrolyte leakage, lipid peroxidation and H2O2 accumulation, and promotes proline accumulation and the expression of stress-responsive genes under stress conditions, thereby promoting increased tolerance to drought and salt stresses.	[Cai, Wei; Liu, Wen; Wang, Wen-Shu; Fu, Zheng-Wei; Han, Tong-Tong; Lu, Ying-Tang] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China	Wuhan University	Lu, YT (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	yingtlu@whu.edu.cn			Major State Basic Research Program [2013CB126901]	Major State Basic Research Program(National Basic Research Program of China)	This work was supported by Major State Basic Research Program (2013CB126901) to YT Lu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdElgawad H, 2015, PLANT SCI, V231, P1, DOI 10.1016/j.plantsci.2014.11.001; Arasimowicz-Jelonek M, 2011, PLANT BIOLOGY, V13, P747, DOI 10.1111/j.1438-8677.2010.00430.x; Arasimowicz-Jelonek M, 2012, PLANT PHYSIOL BIOCH, V58, P124, DOI 10.1016/j.plaphy.2012.06.018; Beligni MV, 2000, PLANTA, V210, P215, DOI 10.1007/PL00008128; De Michele R, 2009, PLANT PHYSIOL, V150, P217, DOI 10.1104/pp.108.133397; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Du H, 2015, J INTEGR PLANT BIOL, V57, P954, DOI 10.1111/jipb.12313; Du H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00397; Fan Huaifu, 2007, Frontiers of Agriculture in China, V1, P308, DOI 10.1007/s11703-007-0052-5; Farooq M, 2009, J AGRON CROP SCI, V195, P254, DOI 10.1111/j.1439-037X.2009.00367.x; Fernandez-Marcos M, 2011, P NATL ACAD SCI USA, V108, P18506, DOI 10.1073/pnas.1108644108; Floryszak-Wieczorek J, 2006, PLANTA, V224, P1363, DOI 10.1007/s00425-006-0321-1; Gao X, 2014, PLANT CELL ENVIRON, V37, P175, DOI 10.1111/pce.12144; Gross F, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00419; Guo FQ, 2005, PLANT CELL, V17, P3436, DOI 10.1105/tpc.105.037770; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Gupta KJ, 2011, TRENDS PLANT SCI, V16, P160, DOI 10.1016/j.tplants.2010.11.007; Gupta KJ, 2011, NEW PHYTOL, V189, P360, DOI 10.1111/j.1469-8137.2010.03586.x; He YK, 2004, SCIENCE, V305, P1968, DOI 10.1126/science.1098837; Hey SJ, 2010, ANN BOT-LONDON, V105, P197, DOI 10.1093/aob/mcp285; Hou X, 2009, P NATL ACAD SCI USA, V106, P6410, DOI 10.1073/pnas.0901940106; Jin JW, 2010, AFR J BIOTECHNOL, V9, P1619; Kishor PBK, 2014, PLANT CELL ENVIRON, V37, P300, DOI 10.1111/pce.12157; Klessig DF, 2004, CELL, V119, P445, DOI 10.1016/j.cell.2004.10.007; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kumar P, 2010, AOB PLANTS, DOI 10.1093/aobpla/plq002; Lei Y, 2007, BIOL PLANTARUM, V51, P386, DOI 10.1007/s10535-007-0082-0; Liao WB, 2012, PLANT PHYSIOL BIOCH, V58, P6, DOI 10.1016/j.plaphy.2012.06.012; Lin AH, 2012, PLANT PHYSIOL, V158, P451, DOI 10.1104/pp.111.184531; Mata CG, 2001, PLANT PHYSIOL, V126, P1196, DOI 10.1104/pp.126.3.1196; Ning J, 2010, PLANT PHYSIOL, V152, P876, DOI 10.1104/pp.109.149856; Qian BY, 2015, J PLANT PHYSIOL, V175, P9, DOI 10.1016/j.jplph.2014.09.019; Rao XL, 2011, FUNCT PLANT BIOL, V38, P441, DOI 10.1071/FP10205; Ribeiro DM, 2009, PLANT CELL ENVIRON, V32, P46, DOI 10.1111/j.1365-3040.2008.01906.x; ROMAN LJ, 1995, P NATL ACAD SCI USA, V92, P8428, DOI 10.1073/pnas.92.18.8428; Shi HT, 2012, PLANT CELL PHYSIOL, V53, P344, DOI 10.1093/pcp/pcr181; Shi QH, 2007, PLANT PHYSIOL BIOCH, V45, P542, DOI 10.1016/j.plaphy.2007.05.005; Siddiqui MH, 2011, PROTOPLASMA, V248, P447, DOI 10.1007/s00709-010-0206-9; Singh HP, 2009, NITRIC OXIDE-BIOL CH, V20, P289, DOI 10.1016/j.niox.2009.02.004; Singh P, 2014, PLANT PHYSIOL BIOCH, V83, P180, DOI 10.1016/j.plaphy.2014.07.018; Tan JinFang, 2008, World Journal of Agricultural Sciences, V4, P307; Tian QY, 2007, NEW PHYTOL, V174, P322, DOI 10.1111/j.1469-8137.2007.02005.x; Verma K, 2013, BIOMETALS, V26, P255, DOI 10.1007/s10534-013-9608-4; Wang YS, 2005, PLANT CELL PHYSIOL, V46, P1915, DOI 10.1093/pcp/pci202; Xiong J, 2012, J PLANT RES, V125, P155, DOI 10.1007/s10265-011-0417-y; Zhang XH, 2011, PLANT CELL TISS ORG, V107, P1, DOI 10.1007/s11240-011-9950-6; Zhao MG, 2009, PLANT PHYSIOL, V151, P755, DOI 10.1104/pp.109.140996; Zhou Y, 2012, PHYTOCHEMISTRY, V76, P46, DOI 10.1016/j.phytochem.2011.12.004; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	49	62	65	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131599	10.1371/journal.pone.0131599	http://dx.doi.org/10.1371/journal.pone.0131599			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121399	Green Published, Green Submitted, gold			2022-12-27	WOS:000358150400129
J	Choudhary, P; Dodsworth, BT; Sidders, B; Gutteridge, A; Michaelides, C; Duckworth, JK; Whiting, PJ; Benn, CL				Choudhary, Parul; Dodsworth, Benjamin Thomas; Sidders, Ben; Gutteridge, Alex; Michaelides, Christos; Duckworth, Joshua Kane; Whiting, Paul John; Benn, Caroline Louise			A FOXM1 Dependent Mesenchymal-Epithelial Transition in Retinal Pigment Epithelium Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR FOXM1; GENE-EXPRESSION; DIRECTED DIFFERENTIATION; MACULAR DEGENERATION; MOLECULAR SIGNATURE; VISUAL FUNCTION; CANCER-CELLS; RPE; INDUCTION	The integrity of the epithelium is maintained by a complex but regulated interplay of processes that allow conversion of a proliferative state into a stably differentiated state. In this study, using human embryonic stem cell (hESC) derived Retinal Pigment Epithelium (RPE) cells as a model; we have investigated the molecular mechanisms that affect attainment of the epithelial phenotype. We demonstrate that RPE undergo a Mesenchymal-Epithelial Transition in culture before acquiring an epithelial phenotype in a FOXM1 dependent manner. We show that FOXM1 directly regulates proliferation of RPE through transcriptional control of cell cycle associated genes. Additionally, FOXM1 modulates expression of the signaling ligands BMP7 and Wnt5B which act reciprocally to enable epithelialization. This data uncovers a novel effect of FOXM1 dependent activities in contributing towards epithelial fate acquisition and furthers our understanding of the molecular regulators of a cell type that is currently being evaluated as a cell therapy.	[Choudhary, Parul; Dodsworth, Benjamin Thomas; Sidders, Ben; Gutteridge, Alex; Michaelides, Christos; Duckworth, Joshua Kane; Whiting, Paul John; Benn, Caroline Louise] Pfizer Ltd, Neusentis, Cambridge, England	Pfizer	Choudhary, P (corresponding author), Pfizer Ltd, Neusentis, Granta Pk, Cambridge, England.	parul.choudhary@pfizer.com; caroline.benn@pfizer.com		Gutteridge, Alex/0000-0001-7515-634X; Whiting, Paul/0000-0002-4121-1379; Sidders, Ben/0000-0003-2733-3078; Dodsworth, Benjamin/0000-0001-7908-7855				Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Bella L., 2014, SEMIN CANC BIOL; Benayoun BA, 2011, TRENDS GENET, V27, P224, DOI 10.1016/j.tig.2011.03.003; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; Buchholz DE, 2013, STEM CELL TRANSL MED, V2, P384, DOI 10.5966/sctm.2012-0163; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Carr JR, 2012, CELL REP, V1, P715, DOI 10.1016/j.celrep.2012.05.005; Chen X, 2013, MOL CELL BIOL, V33, P227, DOI 10.1128/MCB.00881-12; Chindelevitch L, 2012, BIOINFORMATICS, V28, P1114, DOI 10.1093/bioinformatics/bts090; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; da Cruz L, 2007, PROG RETIN EYE RES, V26, P598, DOI 10.1016/j.preteyeres.2007.07.001; Fan W, 2002, OPHTHALMIC RES, V34, P357, DOI 10.1159/000067048; Hegde NS, 2011, NAT CHEM, V3, P725, DOI [10.1038/NCHEM.1114, 10.1038/nchem.1114]; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Kandyba E, 2013, P NATL ACAD SCI USA, V110, P1351, DOI 10.1073/pnas.1121312110; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Kim SW, 2004, NAT CELL BIOL, V6, P1212, DOI 10.1038/ncb1191; Klimanskaya I, 2004, CLONING STEM CELLS, V6, P217, DOI 10.1089/clo.2004.6.217; Kokkinopoulos I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018921; Korver W, 1998, CURR BIOL, V8, P1327, DOI 10.1016/S0960-9822(07)00563-5; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Liao JL, 2010, HUM MOL GENET, V19, P4229, DOI 10.1093/hmg/ddq341; Lin JP, 2013, ONCOL REP, V30, P1739, DOI 10.3892/or.2013.2654; Liu YQ, 2009, INVEST OPHTH VIS SCI, V50, P5080, DOI 10.1167/iovs.08-2911; Lu B, 2009, STEM CELLS, V27, P2126, DOI 10.1002/stem.149; Lund RD, 2006, CLONING STEM CELLS, V8, P189, DOI 10.1089/clo.2006.8.189; Okamoto S, 2011, INVEST OPHTH VIS SCI, V52, P8785, DOI 10.1167/iovs.11-8129; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; Pelletier JC, 2009, J MED CHEM, V52, P6962, DOI 10.1021/jm9014197; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Qu K, 2013, CANCER LETT, V331, P105, DOI 10.1016/j.canlet.2012.12.008; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sanders DA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r6; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwartz SD, 2014, LANCET; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Shu XD, 2014, CURR OPIN GENET DEV, V28, P32, DOI 10.1016/j.gde.2014.08.005; Singh S, 2001, GRAEF ARCH CLIN EXP, V239, P946, DOI 10.1007/s004170100371; Sonoda S, 2009, NAT PROTOC, V4, P662, DOI 10.1038/nprot.2009.33; Stewart S, 2014, CELL REP, V6, P482, DOI 10.1016/j.celrep.2014.01.010; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Suzuki A, 1997, BIOCHEM BIOPH RES CO, V232, P153, DOI 10.1006/bbrc.1997.6219; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vaajasaari H, 2011, MOL VIS, V17, P558; VIELKIND U, 1988, PIGM CELL RES, V1, P419, DOI 10.1111/j.1600-0749.1988.tb00146.x; Vugler A, 2008, EXP NEUROL, V214, P347, DOI 10.1016/j.expneurol.2008.09.007; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang NK, 2010, TRANSPLANTATION, V89, P911, DOI 10.1097/TP.0b013e3181d45a61; Wierstra I, 2011, BIOCHEM BIOPH RES CO, V413, P230, DOI 10.1016/j.bbrc.2011.08.075; Xue JF, 2014, J CLIN INVEST, V124, P564, DOI 10.1172/JCI71104; Zahabi A., 2012, STEM CELLS DEV	55	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130379	10.1371/journal.pone.0130379	http://dx.doi.org/10.1371/journal.pone.0130379			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121260	Green Submitted, gold, Green Published			2022-12-27	WOS:000358150400038
J	Garcia-Fernandez, A; Gallina, S; Owczarek, S; Dionisi, AM; Benedetti, I; Decastelli, L; Luzzi, I				Garcia-Fernandez, Aurora; Gallina, Silvia; Owczarek, Slawomir; Dionisi, Anna Maria; Benedetti, Ildo; Decastelli, Lucia; Luzzi, Ida			Emergence of Ciprofloxacin-Resistant Salmonella enterica Serovar Typhi in Italy	PLOS ONE			English	Article							ANTIMICROBIAL DRUG-RESISTANCE; FLUOROQUINOLONE RESISTANCE; QUINOLONE RESISTANCE; MUTATIONS; FEVER; SUSCEPTIBILITY; ACCUMULATION; GENES; PARC; GYRB	In developed countries, typhoid fever is often associated with persons who travel to endemic areas or immigrate from them. Typhoid fever is a systemic infection caused by Salmonella enterica serovar Typhi. Because of the emergence of antimicrobial resistance to standard first-line drugs, fluoroquinolones are the drugs of choice. Resistance to ciprofloxacin by this Salmonella serovar represents an emerging public health issue. Two S. enterica ser. Typhi strains resistant to ciprofloxacin (CIP) were reported to the Italian surveillance system for foodborne and waterborne diseases (EnterNet-Italia) in 2013. The strains were isolated from two Italian tourists upon their arrival from India. A retrospective analysis of 17 other S. enterica ser. Typhi strains isolated in Italy during 2011-2013 was performed to determine their resistance to CIP. For this purpose, we assayed for susceptibility to antimicrobial agents and conducted PCR and nucleotide sequence analyses. Moreover, all strains were typed using pulsed-field gel electrophoresis to evaluate possible clonal relationships. Sixty-eight percent of the S. enterica ser. Typhi strains were resistant to CIP (MICs, 0.125-16 mg/L), and all isolates were negative for determinants of plasmid-mediated quinolone resistance. Analysis of sequences encoding DNA gyrase and topoisomerase IV subunits revealed mutations in gyrA, gyrB, and parC. Thirteen different clonal groups were detected, and the two CIP-resistant strains isolated from the individuals who visited India exhibited the same PFGE pattern. Because of these findings, the emergence of CIP-resistant S. enterica ser. Typhi isolates in Italy deserves attention, and monitoring antibiotic susceptibility is important for efficiently managing cases of typhoid fever.	[Garcia-Fernandez, Aurora; Owczarek, Slawomir; Dionisi, Anna Maria; Benedetti, Ildo; Luzzi, Ida] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy; [Gallina, Silvia] Ist Zooprofilatt Sperimentale Piemonte, Reg Reference Ctr Salmonella Serotyping, Turin, Italy; [Decastelli, Lucia] Ist Zooprofilatt Sperimentale Piemonte, Food Hyg & Safety Dept, Turin, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); IZS Piemonte Liguria e Valle D'aosta; IZS Piemonte Liguria e Valle D'aosta	Garcia-Fernandez, A (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	aurora.garciafernandez@iss.it	García-Fernández, Aurora/K-2560-2016; Decastelli, Lucia/K-7586-2016; Dionisi, Anna Maria/B-8722-2016; LUZZI, IDA/B-8715-2016	García-Fernández, Aurora/0000-0002-5070-6154; Decastelli, Lucia/0000-0001-9400-6144; Dionisi, Anna Maria/0000-0002-4492-8498; LUZZI, IDA/0000-0002-7614-601X	Italian Ministry of Health, Centro Nazionale per la Prevenzione ed il Controllo delle Malattie (CCM) [project "Sorveglianza delle malattie trasmesse da alimenti e acqua (EnterNet): adeguamento del sistema italiano.al quadro normativo europeo"] [5M10-1616-2014]	Italian Ministry of Health, Centro Nazionale per la Prevenzione ed il Controllo delle Malattie (CCM) [project "Sorveglianza delle malattie trasmesse da alimenti e acqua (EnterNet): adeguamento del sistema italiano.al quadro normativo europeo"]	Funding was provided by the Italian Ministry of Health, Centro Nazionale per la Prevenzione ed il Controllo delle Malattie (CCM) [project "Sorveglianza delle malattie trasmesse da alimenti e acqua (EnterNet): adeguamento del sistema italiano.al quadro normativo europeo" 5M10-1616-2014]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya D, 2012, JPN J INFECT DIS, V65, P264, DOI 10.7883/yoken.65.264; Butt T, 2003, EMERG INFECT DIS, V9, P1621, DOI 10.3201/eid0912.030230; Casin I, 2003, EMERG INFECT DIS, V9, P1455; Chandel DS, 2001, EMERG INFECT DIS, V7, P762; Chau TT, 2007, ANTIMICROB AGENTS CH, V51, P4315, DOI 10.1128/AAC.00294-07; Commons RJ, 2012, MED J AUSTRALIA, V196, P332, DOI 10.5694/mja12.10082; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Eaves DJ, 2004, ANTIMICROB AGENTS CH, V48, P4012, DOI 10.1128/AAC.48.10.4012-4015.2004; Farmakiotis D, 2013, J TRAVEL MED, V20, P17, DOI 10.1111/j.1708-8305.2012.00665.x; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Geetha VK, 2014, INDIAN J MED MICROBI, V32, P31, DOI 10.4103/0255-0857.124292; Guibourdenche M, 2010, RES MICROBIOL, V161, P26, DOI 10.1016/j.resmic.2009.10.002; Harish BN, 2011, INDIAN J MED MICROBI, V29, P223, DOI 10.4103/0255-0857.83904; Hume S, 2009, EUR J CLIN MICROBIOL, V28, P963, DOI 10.1007/s10096-009-0732-6; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; Keddy KH, 2010, EMERG INFECT DIS, V16, P879, DOI 10.3201/eid1605.091917; Kim HB, 2009, ANTIMICROB AGENTS CH, V53, P3582, DOI 10.1128/AAC.01574-08; Lee CJ, 2013, J MICROBIOL IMMUNOL, V46, P469, DOI 10.1016/j.jmii.2013.01.002; Menezes GA, 2012, CLIN MICROBIOL INFEC, V18, P239, DOI 10.1111/j.1469-0691.2011.03546.x; Miro E, 2004, ENFERM INFEC MICR CL, V22, P204, DOI 10.1157/13059049; Parry CM, 2008, CURR OPIN INFECT DIS, V21, P531, DOI 10.1097/QCO.0b013e32830f453a; Parry CM, 2003, CURR OPIN INFECT DIS, V16, P467, DOI 10.1097/00001432-200310000-00014; Pfeifer Y, 2009, EMERG INFECT DIS, V15, P1533, DOI 10.3201/eid1509.090567; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Ruiz J, 2003, J ANTIMICROB CHEMOTH, V51, P1109, DOI 10.1093/jac/dkg222; Singhal L, 2014, INDIAN J MED MICROBI, V32, P149, DOI 10.4103/0255-0857.129799; Threlfall E J, 2003, Euro Surveill, V8, P41; Turner AK, 2006, J ANTIMICROB CHEMOTH, V58, P733, DOI 10.1093/jac/dkl333	28	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0132065	10.1371/journal.pone.0132065	http://dx.doi.org/10.1371/journal.pone.0132065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121266	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400191
J	Grondin, Y; Bortoni, ME; Sepulveda, R; Ghelfi, E; Bartos, A; Cotanche, D; Clifford, RE; Rogers, RA				Grondin, Yohann; Bortoni, Magda E.; Sepulveda, Rosalinda; Ghelfi, Elisa; Bartos, Adam; Cotanche, Douglas; Clifford, Royce E.; Rogers, Rick A.			Genetic Polymorphisms Associated with Hearing Threshold Shift in Subjects during First Encounter with Occupational Impulse Noise	PLOS ONE			English	Article							RIBOSOMAL-PROTEIN L26; HAIR CELL-DEATH; INNER-EAR; POTASSIUM CHANNELS; OXIDATIVE STRESS; COCHLEAR; NUCLEOLIN; DISEASE; MOUSE; HEAT-SHOCK-PROTEIN-70	Noise-induced hearing loss (NIHL) is the most significant occupational health issue worldwide. We conducted a genome-wide association study to identify single-nucleotide polymorphisms (SNPs) associated with hearing threshold shift in young males undergoing their first encounter with occupational impulse noise. We report a significant association of SNP rs7598759 (p < 5 x 10(-7); p = 0.01 after permutation and correction; Odds Ratio = 12.75) in the gene coding for nucleolin, a multifunctional phosphoprotein involved in the control of senescence and protection against apoptosis. Interestingly, nucleolin has been shown to mediate the anti-apoptotic effect of HSP70, a protein found to prevent ototoxicity and whose polymorphisms have been associated with susceptibility to NIHL. Increase in nucleolin expression has also been associated with the prevention of apoptosis in cells undergoing oxidative stress, a well-known metabolic sequela of noise exposure. To assess the potential role of nucleolin in hearing loss, we tested down-regulation of nucleolin in cochlear sensory cells HEI-OC1 under oxidative stress conditions and report increased sensitivity to cisplatin, a chemotherapeutic drug with ototoxic side effects. Additional SNPs were found with suggestive association (p < 5 x 10(-4)), of which 7 SNPs were located in genes previously reported to be related to NIHL and 43 of them were observed in 36 other genes previously not reported to be associated with NIHL. Taken together, our GWAS data and in vitro studies reported herein suggest that nucleolin is a potential candidate associated with NIHL in this population.	[Grondin, Yohann; Bortoni, Magda E.; Sepulveda, Rosalinda; Ghelfi, Elisa; Bartos, Adam; Cotanche, Douglas; Clifford, Royce E.; Rogers, Rick A.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Mol & Integrat Physiol Sci Program, Boston, MA 02115 USA; [Clifford, Royce E.] Naval Med Ctr, Dept Otolaryngol Head & Neck Surg, San Diego, CA 92134 USA	Harvard University; Harvard T.H. Chan School of Public Health; United States Department of Defense; United States Navy; Naval Medical Center San Diego	Rogers, RA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Mol & Integrat Physiol Sci Program, 665 Huntington Ave, Boston, MA 02115 USA.	rogers@bioimage.harvard.edu	Clifford, Royce/X-8799-2019; Sepulveda, Rosalinda/GWC-1935-2022	Clifford, Royce/0000-0002-5515-4336; Cotanche, Douglas/0000-0001-7972-0446	Office of Naval Research [N000141110523]	Office of Naval Research(Office of Naval Research)	The authors would like to gratefully acknowledge funding from the Office of Naval Research, award# N000141110523 awarded to Dr. Rogers.	Abdelmohsen K, 2012, RNA BIOL, V9, P799, DOI 10.4161/rna.19718; Abreu-Silva RS, 2011, ANN HUM BIOL, V38, P210, DOI 10.3109/03014460.2010.513774; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X; Berulava T, 2010, EUR J HUM GENET, V18, P1054, DOI 10.1038/ejhg.2010.71; Bottger EC, 2013, HEARING RES, V303, P12, DOI 10.1016/j.heares.2013.01.006; Brock PR, 2012, J CLIN ONCOL, V30, P2408, DOI 10.1200/JCO.2011.39.1110; Chang NC, 2011, AUDIOL NEURO-OTOL, V16, P168, DOI 10.1159/000317119; Chang NC, 2009, AM J OTOLARYNG, V30, P396, DOI 10.1016/j.amjoto.2008.08.001; Chen J, 2012, J BIOL CHEM, V287, P16467, DOI 10.1074/jbc.M112.349274; Chien CY, 2012, AUDIOL NEURO-OTOL, V17, P381, DOI 10.1159/000341815; Coffin AB, 2013, JARO-J ASSOC RES OTO, V14, P645, DOI 10.1007/s10162-013-0404-1; Collee A, 2011, NOISE HEALTH, V13, P64, DOI 10.4103/1463-1741.73997; Cross JH, 2013, DEV MED CHILD NEUROL, V55, P846, DOI 10.1111/dmcn.12171; Cunningham LL, 2004, J NEUROBIOL, V60, P89, DOI 10.1002/neu.20006; Daniely Y, 2002, MOL CELL BIOL, V22, P6014, DOI 10.1128/MCB.22.16.6014-6022.2002; de Beeck KO, 2011, HEARING RES, V281, P18, DOI 10.1016/j.heares.2011.07.002; Fetoni AR, 2013, J NEUROSCI, V33, P4011, DOI 10.1523/JNEUROSCI.2282-12.2013; Fetoni AR, 2014, NEUROSCI RES, P1; Fortunato G, 2004, CLIN CHEM, V50, P2012, DOI 10.1373/clinchem.2004.037788; Fujioka M, 2006, J NEUROSCI RES, V83, P575, DOI 10.1002/jnr.20764; Fujioka M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090089; Ginisty H, 1999, J CELL SCI, V112, P761; Girotto G, 2011, J MED GENET, V48, P369, DOI 10.1136/jmg.2010.088310; Grondin Y, 2013, HEARING RES, V298, P93, DOI 10.1016/j.heares.2012.12.011; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Gurgel RK, 2014, OTOL NEUROTOL, P1; Hajas A, 2009, J RHEUMATOL, V36, P1930, DOI 10.3899/jrheum.081314; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Holt JR, 2007, J NEUROSCI, V27, P8940, DOI 10.1523/JNEUROSCI.2085-07.2007; Ignatov A, 2003, BIOCHEM BIOPH RES CO, V311, P329, DOI 10.1016/j.bbrc.2003.10.006; Ishimaru D, 2009, MOL CANCER RES, V7, P1354, DOI 10.1158/1541-7786.MCR-08-0476; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Jiang BM, 2014, CARDIOVASC RES, V102, P56, DOI 10.1093/cvr/cvu006; Jiang BM, 2010, FEBS J, V277, P642, DOI 10.1111/j.1742-4658.2009.07510.x; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kalinec GM, 2003, AUDIOL NEURO-OTOL, V8, P177, DOI 10.1159/000071059; Konings A, 2009, ANN HUM GENET, V73, P215, DOI 10.1111/j.1469-1809.2008.00499.x; Konings A, 2007, HUM MOL GENET, V16, P1872, DOI 10.1093/hmg/ddm135; Konings A, 2009, EUR J HUM GENET, V17, P329, DOI 10.1038/ejhg.2008.172; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Koyama A, 2013, J GERONTOL A-BIOL, V68, P433, DOI 10.1093/gerona/gls187; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lantier L, 2014, FASEB J, V28, P3211, DOI 10.1096/fj.14-250449; Le Prell CG, 2012, EAR HEARING, V33, pE44, DOI 10.1097/AUD.0b013e31825f9d89; Li S, 2013, P NATL ACAD SCI USA, V110, P9980, DOI 10.1073/pnas.1302770110; Lin CY, 2009, HEARING RES, V257, P8, DOI 10.1016/j.heares.2009.07.008; Lin CD, 2011, LAB INVEST, V91, P1092, DOI 10.1038/labinvest.2011.69; Lin FR, 2011, ARCH NEUROL-CHICAGO, V68, P214, DOI 10.1001/archneurol.2010.362; Lindenboim L, 2010, CELL DEATH DIFFER, V17, P346, DOI 10.1038/cdd.2009.145; Lu JZ, 2014, JARO-J ASSOC RES OTO, V15, P353, DOI 10.1007/s10162-014-0441-4; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; Manzanares D, 2014, AM J PHYSIOL-LUNG C, V306, pL453, DOI 10.1152/ajplung.00247.2013; Mathers JC, 2010, ADV GENET, V71, P3, DOI [10.1016/B978-0-12-380864-6.00001-8, 10.1016/S0065-2660(10)71001-4]; Meltser I, 2010, NEUROSCIENCE, V165, P1439, DOI 10.1016/j.neuroscience.2009.11.025; Mitchell P, 2009, DIABETIC MED, V26, P483, DOI 10.1111/j.1464-5491.2009.02710.x; Moore DF, 2012, TWOSTAGEGWASPOWER CO; Moser T, 2013, OTOL NEUROTOL, V34, P995, DOI 10.1097/MAO.0b013e3182814d4a; N'Gouemo P, 2011, EXPERT OPIN THER TAR, V15, P1283, DOI 10.1517/14728222.2011.620607; Nakayama M, 2014, NEUROSCI LETT, V561, P91, DOI 10.1016/j.neulet.2013.12.063; Nash SD, 2014, J GERONTOL A-BIOL, V69, P207, DOI 10.1093/gerona/glt075; Nelson DI, 2005, AM J IND MED, V48, P446, DOI 10.1002/ajim.20223; Ohlemiller KK, 2008, HEARING RES, V245, P5, DOI 10.1016/j.heares.2008.08.007; Pawelczyk M, 2009, ANN HUM GENET, V73, P411, DOI 10.1111/j.1469-1809.2009.00521.x; Pejovic S, 2013, AM J PHYSIOL-ENDOC M, V305, pE890, DOI 10.1152/ajpendo.00301.2013; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANGUAGE ENV STAT; Shi XR, 2011, HEARING RES, V282, P10, DOI 10.1016/j.heares.2011.08.006; Shin YS, 2013, NEUROSCIENCE, V232, P1, DOI 10.1016/j.neuroscience.2012.12.008; Simone MJ, 2011, CNS NEUROSCI THER, V17, P506, DOI 10.1111/j.1755-5949.2010.00173.x; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sliwinska-Kowalska M, 2013, MUTAT RES-REV MUTAT, V752, P61, DOI 10.1016/j.mrrev.2012.11.001; Tajrishi Marjan M, 2011, Commun Integr Biol, V4, P267, DOI 10.4161/cib.4.3.14884; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Taleb M, 2009, CELL STRESS CHAPERON, V14, P427, DOI 10.1007/s12192-008-0097-2; Trevino-Villarreal JH, 2011, J HISTOCHEM CYTOCHEM, V59, P1060, DOI 10.1369/0022155411428078; US Army Center for Health Promotion and Preventive Medicine, 2008, NOIS LEV COMM ARM EQ; Van Laer L, 2006, HUM MUTAT, V27, P786, DOI 10.1002/humu.20360; Wakabayashi K, 2010, NEUROSCI RES, V66, P345, DOI 10.1016/j.neures.2009.12.008; Wang KK, 2012, CELL STRESS CHAPERON, V17, P121, DOI 10.1007/s12192-011-0292-4; Wilhelm M, 2012, SCAND J MED SCI SPOR, P1; Willimott S, 2010, BIOCHEM SOC T, V38, P1571, DOI 10.1042/BST0381571; Yang M, 2006, CELL STRESS CHAPERON, V11, P233, DOI 10.1379/CSC-192R.1; Yankaskas K, 2013, HEARING RES, V295, P3, DOI 10.1016/j.heares.2012.04.016; Yuan BC, 2012, J CHIN MED ASSOC, V75, P36, DOI 10.1016/j.jcma.2011.09.015; Zdebik AA, 2009, PHYSIOLOGY, V24, P307, DOI 10.1152/physiol.00018.2009; Zhang B, 2010, CELL STRESS CHAPERON, V15, P249, DOI 10.1007/s12192-009-0138-5; Zhang WK, 2011, INT J NANOMED, V6, P535, DOI 10.2147/IJN.S16973; Zheng GL, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-71; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606; Zhou X, 2011, CELL DEATH DIFFER, V18, P493, DOI 10.1038/cdd.2010.120	94	18	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130827	10.1371/journal.pone.0130827	http://dx.doi.org/10.1371/journal.pone.0130827			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121033	Green Published, Green Submitted, gold			2022-12-27	WOS:000358150400063
J	McGlynn, LM; McCluney, S; Jamieson, NB; Thomson, J; MacDonald, AI; Oien, K; Dickson, EJ; Carter, CR; McKay, CJ; Shiels, PG				McGlynn, Liane M.; McCluney, Simon; Jamieson, Nigel B.; Thomson, Jackie; MacDonald, Alasdair I.; Oien, Karin; Dickson, Euan J.; Carter, C. Ross; McKay, Colin J.; Shiels, Paul G.			SIRT3 & SIRT7: Potential Novel Biomarkers for Determining Outcome in Pancreatic Cancer Patients	PLOS ONE			English	Article							HISTONE DEACETYLASE SIRT6; TUMOR-SUPPRESSOR; METABOLIC-REGULATION; PREDICT PROGNOSIS; CELL-GROWTH; SIRTUINS; EXPRESSION; AGE; PROLIFERATION; TUMORIGENESIS	Purpose The sirtuin gene family has been linked with tumourigenesis, in both a tumour promoter and suppressor capacity. Information regarding the function of sirtuins in pancreatic cancer is sparse and equivocal. We undertook a novel study investigating SIRT1-7 protein expression in a cohort of pancreatic tumours. The aim of this study was to establish a protein expression profile for SIRT1-7 in pancreatic ductal adenocarcinomas (PDAC) and to determine if there were associations between SIRT1-7 expression, clinico-pathological parameters and patient outcome. Material and Methods Immunohistochemical analysis of SIRT1-7 protein levels was undertaken in a tissue micro-array comprising 77 resected PDACs. Statistical analyses determined if SIRT1-7 protein expression was associated with clinical parameters or outcome. Results Two sirtuin family members demonstrated significant associations with clinico-pathological parameters and patient outcome. Low level SIRT3 expression in the tumour cytoplasm correlated with more aggressive tumours, and a shorter time to relapse and death, in the absence of chemotherapeutic intervention. Low levels of nuclear SIRT7 expression were also associated with an aggressive tumour phenotype and poorer outcome, as measured by disease-free and disease-specific survival time, 12 months post-diagnosis. Conclusions Our data suggests that SIRT3 and SIRT7 possess tumour suppressor properties in the context of pancreatic cancer. SIRT3 may also represent a novel predictive biomarker to determine which patients may or may not respond to chemotherapy. This study opens up an interesting avenue of investigation to potentially identify predictive biomarkers and novel therapeutic targets for pancreatic cancer, a disease that has seen no significant improvement in survival over the past 40 years.	[McGlynn, Liane M.; McCluney, Simon; Thomson, Jackie; MacDonald, Alasdair I.; Shiels, Paul G.] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland; [Jamieson, Nigel B.; Dickson, Euan J.; Carter, C. Ross; McKay, Colin J.] Glasgow Royal Infirm, West Scotland Pancreat Unit, Glasgow G4 0SF, Lanark, Scotland; [Jamieson, Nigel B.] Univ Glasgow, Acad Dept Surg, Glasgow, Lanark, Scotland; [Oien, Karin] Beatson Labs, Inst Canc Sci, Pathol, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow; University of Glasgow; Beatson Institute; University of Glasgow	Shiels, PG (corresponding author), Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland.	paul.shiels@glasgow.ac.uk	Jamieson, Nigel/X-1071-2019; Oien, Karin/AAH-3849-2019	Jamieson, Nigel/0000-0002-9552-4725; Shiels, Paul/0000-0002-7577-9843	Academy of Medical Sciences (AMS) [AMS-SGCL9-Jamieson] Funding Source: researchfish	Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS))		Alhazzazi TY, 2011, BBA-REV CANCER, V1816, P80, DOI 10.1016/j.bbcan.2011.04.004; Allison SJ, 2007, CELL CYCLE, V6, P2669, DOI 10.4161/cc.6.21.4866; Ashraf N, 2006, BRIT J CANCER, V95, P1056, DOI 10.1038/sj.bjc.6603384; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Bauer I, 2012, J BIOL CHEM, V287, P40924, DOI 10.1074/jbc.M112.405837; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Bradbury C, 2005, LEUKEMIA, V19, P1751, DOI 10.1038/sj.leu.2403910; Cancer Research UK, 2013, PANCR CANC SURV STAT; Cho IR, 2012, BIOCHEM BIOPH RES CO, V423, P270, DOI 10.1016/j.bbrc.2012.05.107; de Nigris F, 2002, BRIT J CANCER, V87, P1479, DOI 10.1038/sj.bjc.6600636; Edwards BK, 2002, CANCER-AM CANCER SOC, V94, P2766, DOI 10.1002/cncr.10593; Finley LWS, 2012, TRENDS MOL MED, V18, P516, DOI 10.1016/j.molmed.2012.05.004; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Frye R, 2002, BRIT J CANCER, V87, P1479, DOI 10.1038/sj.bjc.6600635; Gartenberg MR, 2000, CURR OPIN MICROBIOL, V3, P132, DOI 10.1016/S1369-5274(00)00064-3; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Haigis MC, 2012, CANCER RES, V72, P2468, DOI 10.1158/0008-5472.CAN-11-3633; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Jamieson NB, 2010, ANN SURG, V251, P1003, DOI 10.1097/SLA.0b013e3181d77369; Keleg Shereen, 2003, Mol Cancer, V2, P14, DOI 10.1186/1476-4598-2-14; Kelly GS, 2010, ALTERN MED REV, V15, P313; Kirkegaard T, 2006, HISTOPATHOLOGY, V48, P787, DOI 10.1111/j.1365-2559.2006.02412.x; Lee C, 2011, ONCOGENE, V30, P3305, DOI 10.1038/onc.2011.91; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Li L, 2013, CELL RES, V23, P10, DOI 10.1038/cr.2012.112; Li SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010486; LM M, 2012, CANC RES UNPUB; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Manuyakorn A, 2010, J CLIN ONCOL, V28, P1358, DOI 10.1200/JCO.2009.24.5639; Martinez-Redondo P, 2012, CANCER CELL, V21, P719, DOI 10.1016/j.ccr.2012.05.028; McGlynn LM, 2014, EUR J CANCER, V50, P290, DOI 10.1016/j.ejca.2013.10.005; McGuinness D, 2011, J Aging Res, V2011, P235754, DOI 10.4061/2011/235754; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Schumacker PT, 2010, CANCER CELL, V17, P5, DOI 10.1016/j.ccr.2009.12.032; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Shiels PG, 2010, J GERONTOL A-BIOL, V65, P789, DOI 10.1093/gerona/glq095; Shiels PG, 2003, MOL BIOL NEURONE, P435; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Stunkel W, 2011, J BIOMOL SCREEN, V16, P1153, DOI 10.1177/1087057111422103; Vakhrusheva O, 2008, J PHYSIOL PHARMACOL, V59, P201; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wauters E, 2013, CANCER RES, V73, P2357, DOI 10.1158/0008-5472.CAN-12-3359; Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079; Zhao G, 2011, GENE THER, V18, P920, DOI 10.1038/gt.2011.81; Zhong L, 2010, TRANSCR-AUSTIN, V1, P17, DOI 10.4161/trns.1.1.12143; Zhu YM, 2013, CURR OPIN ONCOL, V25, P630, DOI 10.1097/01.cco.0000432527.49984.a3	54	44	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131344	10.1371/journal.pone.0131344	http://dx.doi.org/10.1371/journal.pone.0131344			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121130	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000358150400100
J	Coburger, J; Hagel, V; Wirtz, CR; Konig, R				Coburger, Jan; Hagel, Vincent; Wirtz, Christian Rainer; Koenig, Ralph			Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival	PLOS ONE			English	Article							MAXIMUM-SAFE-RESECTION; RESPONSE ASSESSMENT; VOLUMETRIC-ANALYSIS; MALIGNANT GLIOMA; GUIDED SURGERY; FLUORESCENCE; GUIDANCE; NEUROONCOLOGY; RECURRENCE; MULTIFORME	Background There is rising evidence that in glioblastoma(GBM) surgery an increase of extent of resection( EoR) leads to an increase of patient's survival. Based on histopathological assessments tumor depiction of Gd-DTPA enhancement and 5-aminolevulinic-acid-fluorescence (5-ALA) might be synergistic for intraoperative resection control. Objective To assess impact of additional use of 5-ALA in intraoperative MRI(iMRI) assisted surgery of GBMs on extent of resection(EoR), progression free survival(PFS) and overall survival (OS). Methods We prospectively enrolled 33 patients with GBMs eligible for gross-total-resection(GTR) and performed a combined approach using 5-ALA and iMRI. As a control group, we performed a retrospective matched pair assessment, based on 144 patients with iMRI-assisted surgery. Matching criteria were, MGMT promotor methylation, recurrent surgery, eloquent location, tumor size and age. Only patients with an intended GTR and primary GBMs were included. We calculated Kaplan Mayer estimates to compare OS and PFS using the Log-Rank-Test. We used the T-test to compare volumetric results of EoR and the Chi-Square-Test to compare new permanent neurological deficits(nPND) and general complications between the two groups. Results Median follow up was 31 months. No significant differences between both groups were found concerning the matching criteria. GTR was achieved significantly more often (p < 0.010) using 5-ALA&iMRI (100%) compared to iMRI alone(82%). Mean EoR was significantly(p<0.004) higher in 5-ALA&iMRI-group(99.7%) than in iMRI-alone-group (97.4%) Rate of complications did not differ significantly between groups(21% iMRI-group, 27% 5-ALA& iMRI-group, p<0.518). nPND were found in 6% in both groups. Median PFS (6mo resp.; p<0.309) and median OS(iMRI: 17mo;5-ALA&iMRI-group: 18mo; p<0.708)) were not significantly different between both groups. Conclusion We found a significant increase of EoR when combining 5-ALA&iMRI compared to use of iMRI alone. Maximizing EoR did not lead to an increase of complications or neurological deficits if used with neurophysiological monitoring in eloquent lesions. No final conclusion can be drawn whether a further increase of EoR benefits patient's progression free survival and overall survival.	[Coburger, Jan; Hagel, Vincent; Wirtz, Christian Rainer; Koenig, Ralph] Univ Ulm, Dept Neurosurg, Gunzburg, Germany	Ulm University	Coburger, J (corresponding author), Univ Ulm, Dept Neurosurg, Campus Gunzburg,Ludwig Heilmeyerstr 2, Gunzburg, Germany.	jan.coburger@uni-ulm.de	Coburger, Jan/ABB-1360-2020	Coburger, Jan/0000-0002-3677-8258; Wirtz, Christian Rainer/0000-0001-8358-1813				Albert FK, 1998, MINIMALLY INVASIVE TECHNIQUES FOR NEUROSURGERY, P229; Arbizu J, 2012, EUR J NUCL MED MOL I, V39, P771, DOI 10.1007/s00259-011-2049-9; Barajas RF, 2012, NEURO-ONCOLOGY, V14, P942, DOI 10.1093/neuonc/nos128; Chaichana KL, 2014, NEURO-ONCOLOGY, V16, P113, DOI 10.1093/neuonc/not137; Coburger J, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2013.11.FOCUS13463; Duffau H, 2013, NEUROCHIRURGIE, V59, P2, DOI 10.1016/j.neuchi.2012.11.001; Eyupoglu IY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044885; Floeth FW, 2011, EUR J NUCL MED MOL I, V38, P731, DOI 10.1007/s00259-010-1690-z; Hatiboglu MA, 2009, NEUROSURGERY, V64, P1073, DOI 10.1227/01.NEU.0000345647.58219.07; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Kuhnt D, 2011, NEUROSURGERY, V69, P852, DOI 10.1227/NEU.0b013e318225ea6b; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Lacroix M, 2014, J CLIN ONCOL, V32, P727, DOI 10.1200/JCO.2013.53.2788; Larsen VA, 2013, NEURORADIOLOGY, V55, P361, DOI 10.1007/s00234-012-1127-4; Marko NF, 2014, J CLIN ONCOL, V32, P774, DOI 10.1200/JCO.2013.51.8886; Orzaiz GA, 2013, NEUROSURGERY, DOI [10.1227/NEU.0b013e31828c3974., DOI 10.1227/NEU.0B013E31828C3974]; Roder C, 2014, EJSO-EUR J SURG ONC, V40, P297, DOI 10.1016/j.ejso.2013.11.022; Roder C, 2012, NEUROSURGERY; Sabel M, 2008, CURR MED RES OPIN, V24, P3239, DOI 10.1185/03007990802508180 ; Sanai N, 2008, NEUROSURGERY, V62, P753, DOI 10.1227/01.neu.0000318159.21731.cf; Sanai N, 2011, J NEUROSURG, V115, P3, DOI 10.3171/2011.2.JNS10998; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Schucht P, 2015, EJSO-EUR J SURG ONC, V41, P604, DOI 10.1016/j.ejso.2014.07.044; Schucht P, 2014, ACTA NEUROCHIR, V156, P305, DOI 10.1007/s00701-013-1906-7; Schucht P, 2012, NEUROSURGERY, V71, P927, DOI 10.1227/NEU.0b013e31826d1e6b; Senft C, 2012, J NEURO-ONCOL, V109, P81, DOI 10.1007/s11060-012-0864-x; Senft C, 2011, LANCET ONCOL, V12, P997, DOI 10.1016/S1470-2045(11)70196-6; Stockhammer F, 2009, ACTA NEUROCHIR, V151, P1377, DOI 10.1007/s00701-009-0462-7; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]; Stummer W, 2011, J NEUROSURG, V114, P613, DOI 10.3171/2010.3.JNS097; Suki D, 2009, NEUROSURGERY, V64, P664, DOI 10.1227/01.NEU.0000341535.53720.3E; Tsugu A, 2011, WORLD NEUROSURG, V76, P120, DOI 10.1016/j.wneu.2011.02.005; Ulmer S, 2009, J NEURO-ONCOL, V91, P213, DOI 10.1007/s11060-008-9701-7; van den Bent MJ, 2011, LANCET ONCOL, V12, P583, DOI 10.1016/S1470-2045(11)70057-2; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Widhalm G, 2010, CANCER-AM CANCER SOC, V116, P1545, DOI 10.1002/cncr.24903; Yamahara T, 2010, BRAIN TUMOR PATHOL, V27, P81, DOI 10.1007/s10014-010-0275-7	38	74	74	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e013187	10.1371/journal.pone.0131872	http://dx.doi.org/10.1371/journal.pone.0131872			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115409	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500184
J	Fu, ZR; Thorpe, M; Hellman, L				Fu, Zhirong; Thorpe, Michael; Hellman, Lars			rMCP-2, the Major Rat Mucosal Mast Cell Protease, an Analysis of Its Extended Cleavage Specificity and Its Potential Role in Regulating Intestinal Permeability by the Cleavage of Cell Adhesion and Junction Proteins	PLOS ONE			English	Article							SUBSTRATE RECOGNITION PROFILE; TRICHINELLA-SPIRALIS; MAMMALIAN EVOLUTION; GRANULE PROTEASES; SERINE PROTEASES; CHYMASE LOCUS; MOUSE; IMMUNITY; SIMILARITIES; EXPRESSION	Mast cells of the rat intestinal mucosa express three chymotryptic enzymes named rMCP-2, -3 and 4. rMCP-2, the most abundant of these enzymes, has been shown to increase the permeability of the intestinal epithelium, most likely by cleavage of cell adhesion and junction proteins and thereby play a role in intestinal parasite clearance. However, no target for this effect has yet been identified. To address this question we here present its extended cleavage specificity. Phage display analysis showed that it is a chymase with a specificity similar to the corresponding enzyme in mice, mMCP-1, with a preference for Phe or Tyr in the P1 position, and a general preference for aliphatic amino acids both upstream and downstream of the cleavage site. The consensus sequence obtained from the phage display analysis was used to screen the rat proteome for potential targets. A few of the most interesting candidate substrates were cell adhesion and cell junction molecules. To see if these proteins were also susceptible to cleavage in their native conformation we cleaved 5 different recombinant cell adhesion and cell junction proteins. Three potential targets were identified: the loop 1 of occludin, protocadherin alpha 4 and cadherin 17, which indicated that these proteins were at least partly responsible for the previously observed prominent role of rMCP-2 in mucosal permeability and in parasite clearance.	[Fu, Zhirong] Zhejiang Univ, Educ Minist, Key Lab Biomed Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Fu, Zhirong; Thorpe, Michael; Hellman, Lars] Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, SE-75124 Uppsala, Sweden	Zhejiang University; Uppsala University	Hellman, L (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, Box 596, SE-75124 Uppsala, Sweden.	Lars.Hellman@icm.uu.se	Thorpe, Michael/P-6838-2015	Thorpe, Michael/0000-0002-4771-0080	Swedish National Research Council (VRNT)	Swedish National Research Council (VRNT)	This study was supported by grants from the Swedish National Research Council (VRNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MK, 2008, MOL IMMUNOL, V45, P2548, DOI 10.1016/j.molimm.2008.01.012; Andersson MK, 2008, MOL IMMUNOL, V45, P766, DOI 10.1016/j.molimm.2007.06.360; Andersson MK, 2010, FEBS J, V277, P2255, DOI 10.1111/j.1742-4658.2010.07642.x; Andersson MK, 2009, INT IMMUNOL, V21, P95, DOI 10.1093/intimm/dxn128; Angkasekwinai P, 2013, INFECT IMMUN, V81, P3731, DOI 10.1128/IAI.00646-13; Blankenhaus B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003913; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Chandrasekharan UM, 1996, SCIENCE, V271, P502, DOI 10.1126/science.271.5248.502; ENERBACK L, 1966, ACTA PATHOL MIC SC, V66, P289, DOI 10.1111/apm.1966.66.3.289; Fujita H, 2006, J HISTOCHEM CYTOCHEM, V54, P933, DOI 10.1369/jhc.6A6944.2006; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Gallwitz M, 2006, IMMUNOGENETICS, V58, P655, DOI 10.1007/s00251-006-0126-1; Gallwitz M, 2006, IMMUNOGENETICS, V58, P641, DOI 10.1007/s00251-006-0123-4; Gallwitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031756; Gallwitz M, 2010, INT IMMUNOL, V22, P421, DOI 10.1093/intimm/dxq021; Hellman L, 2014, BIOL CHEM, V395, P15, DOI 10.1515/hsz-2013-0211; Karlson L, 2002, J BIOL CHEM, V277, P18579, DOI 10.1074/jbc.M110356200; Karlson U, 2003, J BIOL CHEM, V278, P39625, DOI 10.1074/jbc.M301512200; Knight PA, 2000, J EXP MED, V192, P1849, DOI 10.1084/jem.192.12.1849; Lenaerts K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-91; Licona-Limon P, 2013, IMMUNITY, V39, P744, DOI 10.1016/j.immuni.2013.07.020; Lutzelschwab C, 1997, J EXP MED, V185, P13, DOI 10.1084/jem.185.1.13; Lutzelschwab C, 1998, EUR J IMMUNOL, V28, P3730, DOI 10.1002/(SICI)1521-4141(199811)28:11&lt;3730::AID-IMMU3730&gt;3.0.CO;2-0; Lutzelschwab C, 1998, EUR J IMMUNOL, V28, P1022, DOI 10.1002/(SICI)1521-4141(199803)28:03<1022::AID-IMMU1022>3.0.CO;2-1; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nik AM, 2013, BIOTECHNIQUES, V55, P42, DOI 10.2144/000114055; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Reimer JM, 2008, MOL IMMUNOL, V45, P2116, DOI 10.1016/j.molimm.2007.10.015; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCUDAMORE CL, 1995, J EXP MED, V182, P1871, DOI 10.1084/jem.182.6.1871; Scudamore CL, 1998, EUR J CELL BIOL, V75, P321, DOI 10.1016/S0171-9335(98)80065-4; Sehra S, 2015, J ALLERGY CLIN IMMUN, V136, P433, DOI 10.1016/j.jaci.2015.01.021; Thorpe M, 2012, INT IMMUNOL; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; Tsuji NM, 2008, TRENDS IMMUNOL, V29, P532, DOI 10.1016/j.it.2008.09.002; Vernersson M, 2002, FASEB J, V16, P875, DOI 10.1096/fj.01-0879fje; Wang XQ, 2009, AMINO ACIDS, V37, P209, DOI 10.1007/s00726-009-0242-y	38	26	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131720	10.1371/journal.pone.0131720	http://dx.doi.org/10.1371/journal.pone.0131720			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114959	gold, Green Submitted, Green Published			2022-12-27	WOS:000358147500180
J	Obermayr, U; Ruther, J; Bernier, UR; Rose, A; Geier, M				Obermayr, Ulla; Ruther, Joachim; Bernier, Ulrich R.; Rose, Andreas; Geier, Martin			Evaluation of a Push-Pull Approach for Aedes aegypti (L.) Using a Novel Dispensing System for Spatial Repellents in the Laboratory and in a Semi-Field Environment	PLOS ONE			English	Article							L-LACTIC ACID; CONTROL STRATEGY; FIELD EFFICACY; ESSENTIAL OIL; BG-SENTINEL; CATNIP-OIL; MOSQUITO; CULICIDAE; DIPTERA; TRAPS	The increase in insecticide resistant mosquito populations necessitates the exploration of novel vector control intervention measures. Push-pull strategies for insect control have been successful when used in integrated crop pest management. Through the combinatory use of deterring and attracting stimuli, the abundance of insect pests can be changed in a given area. A push-pull strategy might also significantly reduce human-vector contacts and augment existing mosquito control strategies, e.g. through the combination of an attractive trapping system and a potent spatial repellent. Our approach includes the BG-Sentinel (BGS) trap in combination with catnip oil (Nepeta cataria), a known spatial repellent for Aedes aegypti. To impart a deterrent effect on mosquitoes at a distance, a homogenous and continuous dispersal of volatile repellent compounds is crucial. We have developed a repellent dispensing system that is easy to use and provides a homogenous dispersal of repellent in an air curtain. The use of five 9 V fans and custom-made repellent sachets containing 10% catnip essential oil created a repellent loaded air curtain that provided coverage of an area of 2 m(2) (1.2 x 1.65 m). Air was sampled at four different heights in the curtain and analysed via thermal desorption (TD) and consecutive gas chromatography-mass spectrometry (GC-MS). Nepetalactone, the main constituent of the oil, was detected in air at a concentration range of 80 to 100 mu g/m(3) and the amounts were comparable at all four sampling positions. When a human volunteer was sitting behind the repellent curtain and a BGS trap was installed in front of the curtain in laboratory push-pull trials, Ae. aegypti landing collections decreased significantly by 50% compared to repellent-free controls. However, in a semi-field environment, comparable protective effects could not be achieved and further research on suitable repellent concentrations for outdoor implementation will be required.	[Obermayr, Ulla; Rose, Andreas; Geier, Martin] Biogents AG, D-93055 Regensburg, Germany; [Ruther, Joachim] Univ Regensburg, Inst Zool, D-93053 Regensburg, Germany; [Bernier, Ulrich R.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA	University of Regensburg; United States Department of Agriculture (USDA)	Obermayr, U (corresponding author), Biogents AG, Weissenburgstr 22, D-93055 Regensburg, Germany.	ulla.obermayr@biogents.com	Ruther, Joachim/AAE-3568-2019	Ruther, Joachim/0000-0002-1295-347X; Bernier, Ulrich/0000-0002-4710-6801	Biogents AG, Regensburg, Germany; ARS [ARS-0427759] Funding Source: Federal RePORTER	Biogents AG, Regensburg, Germany; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The project was fully funded by Biogents AG, Regensburg, Germany. Funding was received by UO. The funder provided support in the form of salaries for author UO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Achee N, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-300; Achee NL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-164; ACREE F, 1968, SCIENCE, V161, P1346, DOI 10.1126/science.161.3848.1346; Aponte HA, 2013, PESTIC BIOCHEM PHYS, V107, P226, DOI 10.1016/j.pestbp.2013.07.005; BATES RB, 1963, EXPERIENTIA, V19, P564, DOI 10.1007/BF02150988; Bernier UR, 2007, J AM MOSQUITO CONTR, V23, P288, DOI 10.2987/8756-971X(2007)23[288:LCOAAA]2.0.CO;2; Bernier UR, 2005, J MED ENTOMOL, V42, P306, DOI 10.1603/0022-2585(2005)042[0306:COCASR]2.0.CO;2; Bernier UR, 2003, J MED ENTOMOL, V40, P653, DOI 10.1603/0022-2585-40.5.653; Bosch OJ, 2000, CHEM SENSES, V25, P323, DOI 10.1093/oxfordjournals.chemse.a014042; BRETT G. A., 1938, TRANS ROY SOC TROP MED AND HYG, V32, P113, DOI 10.1016/S0035-9203(38)90101-4; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; EISNER T, 1964, SCIENCE, V146, P1318, DOI 10.1126/science.146.3649.1318; Fonseca-Gonzalez I, 2011, PEST MANAG SCI, V67, P430, DOI 10.1002/ps.2081; Geier M, 1999, CHEM SENSES, V24, P647, DOI 10.1093/chemse/24.6.647; Geier M, 1996, CIBA F SYMP, V200, P132; Gjullin CM, 1947, J ECON ENTOMOL, V19, P68; GOUCK H, 1967, J ECON ENTOMOL, V60, P1587, DOI 10.1093/jee/60.6.1587; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hao HL, 2008, J MED ENTOMOL, V45, P533, DOI 10.1603/0022-2585(2008)45[533:HABBOA]2.0.CO;2; Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027; Howlett F. M., 1910, Parasitology Cambridge, V3; Kitau J, 2010, J AM MOSQUITO CONTR, V26, P287, DOI 10.2987/09-5979.1; Kline DL, 2003, J MED ENTOMOL, V40, P463, DOI 10.1603/0022-2585-40.4.463; Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017; Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992; Marcombe S, 2011, AM J TROP MED HYG, V84, P118, DOI 10.4269/ajtmh.2011.10-0335; Matthews G. A., 1996, PESTIC OUTLOOK, V7, P25; Meeraus WH, 2008, J AM MOSQUITO CONTR, V24, P244, DOI 10.2987/5676.1; Menger DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123415; Menger DJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-119; Mng'ong'o FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025927; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Muller GC, 2008, J AM MOSQUITO CONTR, V24, P150, DOI 10.2987/8756-971X(2008)24[150:IPAMAS]2.0.CO;2; Nolen JA, Patent, Patent No. [6,362,235, 6362235]; Obermayr U, 2012, J MED ENTOMOL, V49, P1387, DOI 10.1603/ME12084; Ogoma SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110433; Paz-Soldan VA, 2011, AM J TROP MED HYG, V84, P208, DOI 10.4269/ajtmh.2011.09-0615; Peterson CJ, 2011, ACS SYM SER, V1090, P59; Peterson Christopher John, 2001, THESIS; Peterson CJ, 2002, J ECON ENTOMOL, V95, P377, DOI 10.1603/0022-0493-95.2.377; Polsomboon S, 2008, J AM MOSQUITO CONTR, V24, P513, DOI 10.2987/08-5760.1; Polson KA, 2011, ACTA TROP, V117, P31, DOI 10.1016/j.actatropica.2010.09.005; Pyke B., 1987, AUST COTTON GROW, V9, P7; Revay EE, 2013, ACTA TROP, V127, P63, DOI 10.1016/j.actatropica.2013.03.011; Salazar F. V., 2012, Kasetsart Journal, Natural Science, V46, P851; Salazar FV, 2012, J VECTOR ECOL, V37, P8, DOI 10.1111/j.1948-7134.2012.00195.x; Schmaedick MA, 2008, J AM MOSQUITO CONTR, V24, P319, DOI 10.2987/5652.1; Williams CR, 2006, J AM MOSQUITO CONTR, V22, P296, DOI 10.2987/8756-971X(2006)22[296:FEOTBC]2.0.CO;2; Zhu JWJ, 2010, J AGR FOOD CHEM, V58, P12320, DOI 10.1021/jf102811k	49	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129878	10.1371/journal.pone.0129878	http://dx.doi.org/10.1371/journal.pone.0129878			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115365	Green Submitted, gold, Green Published			2022-12-27	WOS:000358147500041
J	Xie, CB; Fan, M; Wang, X; Chen, M				Xie, Congbo; Fan, Meng; Wang, Xin; Chen, Ming			Dynamic Model for Life History of Scyphozoa	PLOS ONE			English	Article							JELLYFISH AURELIA-AURITA; LOW DISSOLVED-OXYGEN; BLACK-SEA ECOSYSTEM; ASEXUAL REPRODUCTION; POPULATION-DYNAMICS; COMMON JELLYFISH; CHRYSAORA-QUINQUECIRRHA; PELAGIC CNIDARIANS; PLANULA LARVAE; COASTAL LAGOON	A two-state life history model governed by ODEs is formulated to elucidate the population dynamics of jellyfish and to illuminate the triggering mechanism of its blooms. The polyp-medusa model admits trichotomous global dynamic scenarios: extinction, polyps survival only, and both survival. The population dynamics sensitively depend on several biotic and abiotic limiting factors such as substrate, temperature, and predation. The combination of temperature increase, substrate expansion, and predator diminishment acts synergistically to create a habitat that is more favorable for jellyfishes. Reducing artificial marine constructions, aiding predator populations, and directly controlling the jellyfish population would help to manage the jellyfish blooms. The theoretical analyses and numerical experiments yield several insights into the nature underlying the model and shed some new light on the general control strategy for jellyfish.	[Xie, Congbo; Fan, Meng; Wang, Xin; Chen, Ming] NE Normal Univ, Sch Math & Stat, Changchun, Jilin, Peoples R China; [Xie, Congbo] Dalian Nationalities Univ, Coll Sci, Dalian, Liaoning, Peoples R China	Northeast Normal University - China; Dalian Minzu University	Fan, M (corresponding author), NE Normal Univ, Sch Math & Stat, Changchun, Jilin, Peoples R China.	mfan@nenu.edu.cn	Fan, Meng/C-9682-2011	Fan, Meng/0000-0002-4596-7093	National Natural Science Foundation of China [11271065]; Research Fund for the Doctoral Program of Higher Education of P. R. China [20130043110001]; Fundamental Research Funds for the Central Universities [DC201502050203, DC12010310, 14ZZ1309]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of P. R. China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research is supported by National Natural Science Foundation of China (no. 11271065, http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list (MF)), the Research Fund for the Doctoral Program of Higher Education of P. R. China (no. 20130043110001, (MF), the Fundamental Research Funds for the Central Universities (no. DC201502050203, DC12010310 (CBX) and no. 14ZZ1309 (MC)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai MN, 2001, HYDROBIOLOGIA, V451, P69, DOI 10.1023/A:1011840123140; Brodeur RD, 2002, MAR ECOL PROG SER, V233, P89, DOI 10.3354/meps233089; Brodeur RD, 2008, PROG OCEANOGR, V77, P103, DOI 10.1016/j.pocean.2008.03.017; Condon RH, 2001, HYDROBIOLOGIA, V451, P89, DOI 10.1023/A:1011892107211; Condon RH, 2013, P NATL ACAD SCI USA, V110, P1000, DOI 10.1073/pnas.1210920110; Conley K, 2015, J EXP MAR BIOL ECOL, V462, P14, DOI 10.1016/j.jembe.2014.10.018; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; Dawson MN, 2005, P NATL ACAD SCI USA, V102, P11968, DOI 10.1073/pnas.0503811102; Decker MB, 2007, MAR ECOL PROG SER, V329, P99, DOI 10.3354/meps329099; Dong Jing, 2008, Plankton & Benthos Research, V3, P118, DOI 10.3800/pbr.3.118; Dong ZJ, 2010, MAR POLLUT BULL, V60, P954, DOI 10.1016/j.marpolbul.2010.04.022; Duarte CM, 2013, FRONT ECOL ENVIRON, V11, P91, DOI 10.1890/110246; Fussmann GF, 2008, INT REV HYDROBIOL, V93, P532, DOI 10.1002/iroh.200811072; Graham William M., 2007, V193, P239; GRONDAHL F, 1989, MAR ECOL PROG SER, V56, P119, DOI 10.3354/meps056119; Grove M, 2005, MAR ECOL PROG SER, V301, P185, DOI 10.3354/meps301185; Han Chang-Hoon, 2010, Plankton & Benthos Research, V5, P98; Haraldsson M, 2012, MAR ECOL PROG SER, V471, P73, DOI 10.3354/meps10036; Holst S, 2007, MAR BIOL, V151, P863, DOI 10.1007/s00227-006-0530-y; Hoover RA, 2009, HYDROBIOLOGIA, V616, P259, DOI 10.1007/s10750-008-9595-6; Ishii H, 2001, HYDROBIOLOGIA, V451, P311, DOI 10.1023/A:1011814525325; Ishii Haruto, 2008, Plankton & Benthos Research, V3, P107, DOI 10.3800/pbr.3.107; Katsuki T, 2013, CURR BIOL, V23, pR592, DOI 10.1016/j.cub.2013.03.057; Kawahara M, 2006, MAR ECOL PROG SER, V307, P161, DOI 10.3354/meps307161; Kideys AE, 2002, SCIENCE, V297, P1482, DOI 10.1126/science.1073002; KIDEYS AE, 1994, J MARINE SYST, V5, P171, DOI 10.1016/0924-7963(94)90030-2; Kolmogorov A., 1936, GIORNALE ISTITUTO DE, V7, P74; LEGOVIC T, 1987, ECOL MODEL, V38, P243, DOI 10.1016/0304-3800(87)90099-8; Li ZY, 2012, COMPUT ENG APPL, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0040132; Liu CS, 2014, CHIN J OCEANOL LIMN, V32, P71, DOI 10.1007/s00343-014-3034-5; Liu WC, 2009, HYDROBIOLOGIA, V616, P247, DOI 10.1007/s10750-008-9597-4; Lo WT, 2008, ICES J MAR SCI, V65, P453, DOI 10.1093/icesjms/fsm185; Lucas CH, 2012, ADV MAR BIOL, V63, P133, DOI 10.1016/B978-0-12-394282-1.00003-X; Lucas CH, 1996, J PLANKTON RES, V18, P987, DOI 10.1093/plankt/18.6.987; Lucas CH, 2001, HYDROBIOLOGIA, V451, P229, DOI 10.1023/A:1011836326717; Lynam CP, 2006, CURR BIOL, V16, pR492, DOI 10.1016/j.cub.2006.06.018; Melica V, 2014, ECOL MODEL, V291, P1, DOI 10.1016/j.ecolmodel.2014.07.009; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; Miyake H, 2002, J OCEANOGR, V58, P451, DOI 10.1023/A:1021628314041; MOLLER H, 1980, MAR BIOL, V60, P123, DOI 10.1007/BF00389155; Oguz T, 2008, MAR ECOL PROG SER, V369, P229, DOI 10.3354/meps07540; Palomares MLD, 2009, HYDROBIOLOGIA, V616, P11, DOI 10.1007/s10750-008-9582-y; Pauly D, 2009, HYDROBIOLOGIA, V616, P67, DOI 10.1007/s10750-008-9583-x; Pitt KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072683; Prieto L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013793; Purcell JE, 2001, COAST EST S, V58, P77; Purcell JE, 2001, HYDROBIOLOGIA, V451, P27, DOI 10.1023/A:1011883905394; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2007, MAR ECOL PROG SER, V348, P183, DOI 10.3354/meps07056; Purcell JE, 2009, MAR ECOL PROG SER, V375, P139, DOI 10.3354/meps07785; Purcell JE, 2009, HYDROBIOLOGIA, V616, P23, DOI 10.1007/s10750-008-9585-8; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Roux JP, 2013, B MAR SCI, V89, P249, DOI 10.5343/bms.2011.1145; Ruiz J, 2012, ECOL MODEL, V233, P59, DOI 10.1016/j.ecolmodel.2012.03.019; SCHNEIDER G, 1989, OPHELIA, V31, P17, DOI 10.1080/00785326.1989.10430848; Uye Shin-Ichi, 2014, P185; Uye Siain-Icth, 2008, Plankton & Benthos Research, V3, P125, DOI 10.3800/pbr.3.125; VANDERVEER HW, 1985, NETH J SEA RES, V19, P38, DOI 10.1016/0077-7579(85)90041-9; Willcox S, 2008, MAR BIOL, V154, P661, DOI 10.1007/s00227-008-0959-2; Willcox S, 2007, J EXP MAR BIOL ECOL, V353, P107, DOI 10.1016/j.jembe.2007.09.006; Zhang F, 2012, HYDROBIOLOGIA, V690, P81, DOI 10.1007/s10750-012-1057-5	61	5	5	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130669	10.1371/journal.pone.0130669	http://dx.doi.org/10.1371/journal.pone.0130669			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114642	Green Submitted, gold, Green Published			2022-12-27	WOS:000358147500086
J	Chahal, G; Thorpe, M; Hellman, L				Chahal, Gurdeep; Thorpe, Michael; Hellman, Lars			The Importance of Exosite Interactions for Substrate Cleavage by Human Thrombin	PLOS ONE			English	Article							MAST-CELL CHYMASE; HUMAN PROTEIN-C; FACTOR-VIII; FACTOR-V; CATALYZED ACTIVATION; MOLECULAR-CLONING; HIRUDIN COMPLEX; THROMBOMODULIN; BINDING; COAGULATION	Thrombin is a serine protease of the chymotrypsin family that acts both as a procoagulant and as an anticoagulant by cleaving either factor VIII, factor V and fibrinogen or protein C, respectively. Numerous previous studies have shown that electropositive regions at a distance from the active site, so called exosites, are of major importance for the cleavage by human thrombin. Upstream of all the known major cleavage sites for thrombin in factor VIII, factor V and fibrinogen are clusters of negatively charged amino acids. To study the importance of these sites for the interaction with the exosites and thereby the cleavage by thrombin, we have developed a new type of recombinant substrate. We have compared the cleavage rate of the minimal cleavage site, involving only 8-9 amino acids (typically the P4-P4' positions) surrounding the cleavage site, with the substrates also containing the negatively charged regions upstream of the cleavage sites. The results showed that addition of these regions enhanced the cleavage rate by more than fifty fold. However, the enhancement was highly dependent on the sequence of the actual cleavage site. A minimal site that showed poor activity by itself could be cleaved as efficiently as an optimal cleavage site when presented together with these negatively charged regions. Whereas sites conforming closely to the optimal site were only minimally enhanced by the addition of these regions. The possibility to mimic this interaction for the sites in factor V and factor VIII by recombinant substrates, which do not have the same folding as the full size target, indicates that the enhancement was primarily dependent on a relatively simple electrostatic interaction. However, the situation was very different for fibrinogen and protein C where other factors than only charge is of major importance.	[Chahal, Gurdeep; Thorpe, Michael; Hellman, Lars] Uppsala Univ, Dept Cell & Mol Biol, BMC, SE-75124 Uppsala, Sweden	Uppsala University	Hellman, L (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, BMC, Box 596, SE-75124 Uppsala, Sweden.	Lars.Hellman@icm.uu.se	Thorpe, Michael/P-6838-2015	Thorpe, Michael/0000-0002-4771-0080; Chahal, Gurdeep/0000-0001-9601-3057	Swedish Research Council [621-2011-5007]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was funded by The Swedish Research Council gant number 621-2011-5007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MK, 2010, FEBS J, V277, P2255, DOI 10.1111/j.1742-4658.2010.07642.x; BECKMANN RJ, 1985, NUCLEIC ACIDS RES, V13, P5233, DOI 10.1093/nar/13.14.5233; BETZ A, 1991, BIOCHEMISTRY-US, V30, P9848, DOI 10.1021/bi00105a006; BETZ A, 1991, BIOCHEM J, V275, P801, DOI 10.1042/bj2750801; BINNIE CG, 1993, BLOOD, V81, P3186; Bode W, 2006, SEMIN THROMB HEMOST, V32, P16, DOI 10.1055/s-2006-939551; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bukys MA, 2006, J BIOL CHEM, V281, P18569, DOI 10.1074/jbc.M600752200; Caughey GH, 2008, J BIOL CHEM, V283, P13943, DOI 10.1074/jbc.M710502200; Davie EW, 2006, SEMIN THROMB HEMOST, V32, P3, DOI 10.1055/s-2006-939550; ESMON CT, 1979, J BIOL CHEM, V254, P964; ESMON CT, 1989, J BIOL CHEM, V264, P4743; Esmon CT, 1996, J BIOL CHEM, V271, P13882, DOI 10.1074/jbc.271.23.13882; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; FOSTER D, 1984, P NATL ACAD SCI-BIOL, V81, P4766, DOI 10.1073/pnas.81.15.4766; FOSTER DC, 1985, P NATL ACAD SCI USA, V82, P4673, DOI 10.1073/pnas.82.14.4673; Fuentes-Prior P, 2000, NATURE, V404, P518, DOI 10.1038/35006683; FULCHER CA, 1983, BLOOD, V61, P807; Gallwitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031756; Gallwitz M, 2010, INT IMMUNOL, V22, P421, DOI 10.1093/intimm/dxq021; Hellman L, 2014, BIOL CHEM, V395, P15, DOI 10.1515/hsz-2013-0211; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; JENNY RJ, 1987, P NATL ACAD SCI USA, V84, P4846, DOI 10.1073/pnas.84.14.4846; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Mann KG, 2003, ARTERIOSCL THROM VAS, V23, P17, DOI 10.1161/01.ATV.0000046238.23903.FC; MIKKELSEN J, 1991, BIOCHEMISTRY-US, V30, P1533, DOI 10.1021/bi00220a013; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; MUSCI G, 1988, BIOCHEMISTRY-US, V27, P769, DOI 10.1021/bi00402a042; NESHEIM ME, 1981, METHOD ENZYMOL, V80, P249; NESHEIM ME, 1979, J BIOL CHEM, V254, P1326; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; PITTMAN DD, 1992, BIOCHEMISTRY-US, V31, P3315, DOI 10.1021/bi00128a003; Pozzi N, 2012, BLOOD, V120, P664, DOI 10.1182/blood-2012-03-415323; REGAN LM, 1995, J BIOL CHEM, V270, P8546, DOI 10.1074/jbc.270.15.8546; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; STONE SR, 1987, BIOCHEMISTRY-US, V26, P4617, DOI 10.1021/bi00389a004; SUZUKI K, 1982, J BIOL CHEM, V257, P6556; Thorpe M, 2012, INT IMMUNOL, V24, P771, DOI 10.1093/intimm/dxs081; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; TSIANG M, 1995, J BIOL CHEM, V270, P16854, DOI 10.1074/jbc.270.28.16854; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; VEHAR GA, 1980, BIOCHEMISTRY-US, V19, P401, DOI 10.1021/bi00544a001; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wildhagen KCAA, 2011, THROMB HAEMOSTASIS, V106, P1034, DOI 10.1160/TH11-08-0522; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; YE J, 1991, J BIOL CHEM, V266, P23016	46	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0129511	10.1371/journal.pone.0129511	http://dx.doi.org/10.1371/journal.pone.0129511			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110612	gold, Green Submitted, Green Published			2022-12-27	WOS:000356933800024
J	Leveroni, CL; Leveroni, CL; Tanaka, N; Emerton, BC; Cole, AC; Reinsberger, C; Stufflebeam, SM				Douw, Linda; Leveroni, Catherine L.; Tanaka, Naoaki; Emerton, Britt C.; Cole, Andrew C.; Reinsberger, Claus; Stufflebeam, Steven M.			Loss of Resting-State Posterior Cingulate Flexibility Is Associated with Memory Disturbance in Left Temporal Lobe Epilepsy	PLOS ONE			English	Article							FUNCTIONAL BRAIN NETWORKS; HUMAN CEREBRAL-CORTEX; DEFAULT MODE; CONNECTIVITY; SCALE; ORGANIZATION; DYNAMICS; MRI	The association between cognition and resting-state fMRI (rs-fMRI) has been the focus of many recent studies, most of which use stationary connectivity. The dynamics or flexibility of connectivity, however, may be seminal for understanding cognitive functioning. In temporal lobe epilepsy (TLE), stationary connectomic correlates of impaired memory have been reported mainly for the hippocampus and posterior cingulate cortex (PCC). We therefore investigate resting-state and task-based hippocampal and PCC flexibility in addition to stationary connectivity in left TLE (LTLE) patients. Sixteen LTLE patients were analyzed with respect to rs-fMRI and task-based fMRI (t-fMRI), and underwent clinical neuropsychological testing. Flexibility of connectivity was calculated using a sliding-window approach by determining the standard deviation of Fisher-transformed Pearson correlation coefficients over all windows. Stationary connectivity was also calculated. Disturbed memory was operationalized as having at least one memory subtest score equal to or below the 5th percentile compared to normative data. Lower PCC flexibility, particularly in the contralateral (i.e. right) hemisphere, was found in memory-disturbed LTLE patients, who had up to 22% less flexible connectivity. No significant group differences were found with respect to hippocampal flexibility, stationary connectivity during both rs-fMRI and t-fMRI, or flexibility during t-fMRI. Contralateral resting-state PCC flexibility was able to classify all but one patient with respect to their memory status (94% accuracy). Flexibility of the PCC during rest relates to memory functioning in LTLE patients. Loss of flexible connectivity to the rest of the brain originating from the PCC, particularly contralateral to the seizure focus, is able to discern memory disturbed patients from their preserved counterparts. This study indicates that the dynamics of resting-state connectivity are associated with cognitive status of LTLE patients, rather than stationary connectivity.	[Douw, Linda; Tanaka, Naoaki; Reinsberger, Claus; Stufflebeam, Steven M.] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Douw, Linda; Tanaka, Naoaki; Stufflebeam, Steven M.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Douw, Linda] Vrije Univ Amsterdam, Med Ctr, Dept Anat & Neurosci, Amsterdam, Netherlands; [Leveroni, Catherine L.; Emerton, Britt C.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Cole, Andrew C.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Reinsberger, Claus] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Reinsberger, Claus] Univ Paderborn, Fac Sci, Inst Sports Med, D-33098 Paderborn, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Vrije Universiteit Amsterdam; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; University of Paderborn	Leveroni, CL (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.	douw@nmr.mgh.harvard.edu		Douw, Linda/0000-0001-7058-4062	NCRR [S10RR014978]; NIH [5R01-NS060918, U01MH093765, 1S10RR023043, R01-NS069696]; Dutch Organization for Scientific Research Rubicon [825.11.002, Veni 016.146.086]; Society in Science-Branco Weiss Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH093765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069696, R01NS060918] Funding Source: NIH RePORTER	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Organization for Scientific Research Rubicon; Society in Science-Branco Weiss Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the following grants: NCRR S10RR014978 (http://www.nih.gov/about/almanac/organization/NCRR.htm;SMS), NIH 5R01-NS060918, U01MH093765, 1S10RR023043, R01-NS069696 (http://www.nih.gov/;SMS), the Dutch Organization for Scientific Research Rubicon 825.11.002 and Veni 016.146.086 (http://www.nwo.nl/en; LD), and a Society in Science-Branco Weiss Fellowship (http://www.society-in-science.org/;LD).	BARBIZET J, 1968, INT J NEUROL, V7, P44; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Benedict RHB, 1996, PSYCHOL ASSESSMENT, V8, P145, DOI 10.1037/1040-3590.8.2.145; Bettus G, 2010, J NEUROL NEUROSUR PS, V81, P1147, DOI 10.1136/jnnp.2009.191460; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; Binder JR, 2011, NEUROSURG CLIN N AM, V22, P219, DOI 10.1016/j.nec.2010.12.002; Cole MW, 2013, NAT NEUROSCI, V16, P1348, DOI 10.1038/nn.3470; Daducci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048121; Damaraju E, 2014, NEUROIMAGE-CLIN, V5, P298, DOI 10.1016/j.nicl.2014.07.003; de Pasquale F, 2012, NEURON, V74, P753, DOI 10.1016/j.neuron.2012.03.031; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Elger CE, 2004, LANCET NEUROL, V3, P663, DOI 10.1016/S1474-4422(04)00906-8; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fornito A, 2012, P NATL ACAD SCI USA, V109, P12788, DOI 10.1073/pnas.1204185109; Gerhard Stephan, 2011, Front Neuroinform, V5, P3, DOI 10.3389/fninf.2011.00003; Gonzalez-Castillo J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00138; Haneef Z, 2012, EPILEPSY BEHAV, V25, P350, DOI 10.1016/j.yebeh.2012.07.019; HANNAY HJ, 1985, J CLIN EXP NEUROPSYC, V7, P251, DOI 10.1080/01688638508401258; Holmes M, 2014, HUM BRAIN MAPP, V35, P735, DOI 10.1002/hbm.22210; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Hutchison RM, 2013, HUM BRAIN MAPP, V34, P2154, DOI 10.1002/hbm.22058; Jia H, 2014, BRAIN CONNECT, V4, P741, DOI 10.1089/brain.2014.0300; Leonardi N, 2015, NEUROIMAGE, V104, P430, DOI 10.1016/j.neuroimage.2014.09.007; Liao W, 2014, BRAIN STRUCT FUNCT, V219, P2001, DOI 10.1007/s00429-013-0619-2; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; McCormick C, 2013, EPILEPSIA, V54, P809, DOI 10.1111/epi.12098; Niu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096850; Panda R, 2014, BRAIN COGNITION, V86, P75, DOI 10.1016/j.bandc.2014.01.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schmidt M., 1996, W PSYCHOL SERVICES; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Thompson GJ, 2013, HUM BRAIN MAPP, V34, P3280, DOI 10.1002/hbm.22140; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zhang ZQ, 2015, HUM BRAIN MAPP, V36, P2756, DOI 10.1002/hbm.22805	39	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131209	10.1371/journal.pone.0131209	http://dx.doi.org/10.1371/journal.pone.0131209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110431	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800130
J	Lee, YJ; Han, ME; Baek, SJ; Kim, SY; Oh, SO				Lee, Yong Joo; Han, Myoung-Eun; Baek, Su-Jin; Kim, Seon-Young; Oh, Sae-Ock			MED30 Regulates the Proliferation and Motility of Gastric Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MEDIATOR COMPLEX; TRANSCRIPTION CONTROL; TGF-BETA/SMAD; REQUIREMENT; BETA; TRAP/MEDIATOR; CARCINOMA; REVEALS; PATHWAY	MED30 is an essential member of the mediator complex that forms a hub between transcriptional activators and RNA polymerase II. However, the expressions and roles of MED30 have been poorly characterized in cancer. In this study, we examined the functional roles of MED30 during gastric cancer progression. It was found that MED30 was overexpressed in gastric cancer tissues and cell lines. Moreover, MED30 overexpression increased the proliferation, migration, and invasion of gastric cancer cells, whereas MED30 knockdown inhibited these effects. Furthermore the knockdown significantly inhibited tumorigenicity in SCID mice. MED30 also promoted the expressions of genes related to epithelial-mesenchymal transition and induced a fibroblast-like morphology. This study shows MED30 has pathophysiological roles in the proliferation, migration, and invasion of gastric cancer cells and suggests that MED30 should be viewed as a potent therapeutic target for malignant gastric carcinoma	[Lee, Yong Joo; Han, Myoung-Eun; Oh, Sae-Ock] Pusan Natl Univ, Sch Med, Dept Anat, Busan, South Korea; [Han, Myoung-Eun] Pusan Natl Univ, Med Res Ctr Ischem Tissue Regenerat, Busan, South Korea; [Baek, Su-Jin; Kim, Seon-Young] KRIBB, Med Genom Res Ctr, Daejeon, South Korea	Pusan National University; Pusan National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Oh, SO (corresponding author), Pusan Natl Univ, Sch Med, Dept Anat, Busan, South Korea.	hedgehog@pusan.ac.kr	KIM, JIYOUNG/AAD-7884-2019	KIM, JIYOUNG/0000-0003-2540-2391	Bio & Medical Technology Development Program [2012M3A9C6050213]; Basic Science Research Foundation of National Research Foundation (NRF) - Korean government (MEST) [2012R1A1A3010521]; National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea [0920050]	Bio & Medical Technology Development Program; Basic Science Research Foundation of National Research Foundation (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the Bio & Medical Technology Development Program (2012M3A9C6050213) and Basic Science Research Foundation (2012R1A1A3010521) of the National Research Foundation (NRF) funded by the Korean government (MEST) and a grant from the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea (0920050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek HJ, 2002, MOL CELL BIOL, V22, P2842, DOI 10.1128/MCB.22.8.2842-2852.2002; Balamotis MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.1164302; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Ding XF, 2012, GENE, V504, P262, DOI 10.1016/j.gene.2012.04.033; Espinoza I, 2013, CANCER LETT, V341, P41, DOI 10.1016/j.canlet.2013.08.027; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang YK, 2002, P NATL ACAD SCI USA, V99, P2642, DOI 10.1073/pnas.261715899; Kato Y, 2002, NATURE, V418, P641, DOI 10.1038/nature00969; Kim H, 2014, J BIOL CHEM, V289, P22151, DOI 10.1074/jbc.M114.556126; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Krebs P, 2011, P NATL ACAD SCI USA, V108, P19678, DOI 10.1073/pnas.1117835108; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Ooi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000676; Pacelli F, 2001, AM SURGEON, V67, P697; Schiano C, 2014, BBA-REV CANCER, V1845, P66, DOI 10.1016/j.bbcan.2013.12.001; Shah MA, 2011, CLIN CANCER RES, V17, P2693, DOI 10.1158/1078-0432.CCR-10-2203; Smith MG, 2006, WORLD J GASTROENTERO, V12, P2979, DOI 10.3748/wjg.v12.i19.2979; Stevens JL, 2002, SCIENCE, V296, P755, DOI 10.1126/science.1068943; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tan IB, 2011, GASTROENTEROLOGY, V141, P476, DOI 10.1053/j.gastro.2011.04.042; Tay ST, 2003, CANCER RES, V63, P3309; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Xie M, 2012, J CELL BIOCHEM, V113, P1501, DOI 10.1002/jcb.24019; Yan S, 2013, INT J ONCOL, V42, P1801, DOI 10.3892/ijo.2013.1852; Yang X, 2012, P NATL ACAD SCI USA, V109, pE2813, DOI 10.1073/pnas.1204311109; Yin JW, 2014, DEVELOPMENT, V141, P977, DOI 10.1242/dev.098392; Yu CY, 2011, ONCOL REP, V25, P1581, DOI 10.3892/or.2011.1251; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	34	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130826	10.1371/journal.pone.0130826	http://dx.doi.org/10.1371/journal.pone.0130826			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110885	gold, Green Submitted, Green Published			2022-12-27	WOS:000356933800089
J	Vlastos, D; Drosopoulou, E; Efthimiou, I; Gavriilidis, M; Panagaki, D; Mpatziou, K; Kalamara, P; Mademtzoglou, D; Mavragani-Tsipidou, P				Vlastos, Dimitris; Drosopoulou, Elena; Efthimiou, Ioanna; Gavriilidis, Maximos; Panagaki, Dimitra; Mpatziou, Krystalenia; Kalamara, Paraskevi; Mademtzoglou, Despoina; Mavragani-Tsipidou, Penelope			Genotoxic and Antigenotoxic Assessment of Chios Mastic Oil by the In Vitro Micronucleus Test on Human Lymphocytes and the In Vivo Wing Somatic Test on Drosophila	PLOS ONE			English	Article							PISTACIA-LENTISCUS; CHEMICAL-COMPOSITION; BETA-MYRCENE; ANTIOXIDANT ACTIVITIES; RECOMBINATION TEST; MITOMYCIN-C; ANTIMICROBIAL ACTIVITY; MAJOR CONSTITUENTS; ALPHA-PINENE; SAMPLE-SIZE	Chios mastic oil (CMO), the essential oil derived from Pistacia lentiscus (L.) var. chia (Duham), has generated considerable interest because of its antimicrobial, anticancer, antioxidant and other beneficial properties. In the present study, the potential genotoxic activity of CMO as well as its antigenotoxic properties against the mutagenic agent mitomycin-C (MMC) were evaluated by employing the in vitro Cytokinesis Block MicroNucleus (CBMN) assay and the in vivo Somatic Mutation And Recombination Test (SMART). In the in vitro experiments, lymphocytes were treated with 0.01, 0.05 and 0.10% (v/v) of CMO with or without 0.05 mu g/ml MMC, while in the in vivo assay Drosophila larvae were fed with 0.05, 0.10, 0.50 and 1.00% (v/v) of CMO with or without 2.50 mu g/ml MMC. CMO did not significantly increase the frequency of micronuclei (MN) or total wing spots, indicating lack of mutagenic or recombinogenic activity. However, the in vitro analysis suggested cytotoxic activity of CMO. The simultaneous administration of MMC with CMO did not alter considerably the frequencies of MMC-induced MN and wing spots showing that CMO doesn't exert antigenotoxic or antire-combinogenic action. Therefore, CMO could be considered as a safe product in terms of genotoxic potential. Even though it could not afford any protection against DNA damage, at least under our experimental conditions, its cytotoxic potential could be of interest.	[Vlastos, Dimitris; Efthimiou, Ioanna] Univ Patras, Dept Environm & Nat Resources Management, Agrinion, Greece; [Drosopoulou, Elena; Gavriilidis, Maximos; Panagaki, Dimitra; Mpatziou, Krystalenia; Kalamara, Paraskevi; Mademtzoglou, Despoina; Mavragani-Tsipidou, Penelope] Aristotle Univ Thessaloniki, Fac Sci, Sch Biol, Dept Genet Dev & Mol Biol, Thessaloniki, Greece	University of Patras; Aristotle University of Thessaloniki	Mavragani-Tsipidou, P (corresponding author), Aristotle Univ Thessaloniki, Fac Sci, Sch Biol, Dept Genet Dev & Mol Biol, Thessaloniki, Greece.	mavragan@bio.auth.gr	Vlastos, Dimitris/GSD-9592-2022; Drosopoulou, Elena/AAX-6493-2020; DROSOPOULOU, ELENA/N-2176-2015	Vlastos, Dimitris/0000-0002-3157-7529; Drosopoulou, Elena/0000-0001-9805-0572; MADEMTZOGLOU, Despoina/0000-0002-4494-7234				Abdelwahed A, 2009, FOOD SCI TECHNOL INT, V15, P215, DOI 10.1177/1082013208339705; Abdelwahed A, 2007, CHEM-BIOL INTERACT, V165, P1, DOI 10.1016/j.cbi.2006.10.003; Abraham SK, 1999, FOOD CHEM TOXICOL, V37, P733, DOI 10.1016/S0278-6915(99)00053-8; Al-Zubairi AS, 2010, TOXICOL IN VITRO, V24, P707, DOI 10.1016/j.tiv.2010.01.011; Attoub S, 2014, CELL PHYSIOL BIOCHEM, V33, P1400, DOI 10.1159/000358706; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Balan KV, 2005, IN VIVO, V19, P93; Banfi S, 1996, NAT GENET, V13, P167, DOI 10.1038/ng0696-167; Bargonetti J, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/698960; Bonassi S, 2011, MUTAGENESIS, V26, P93, DOI 10.1093/mutage/geq075; Catanzaro I, 2012, MUTAGENESIS, V27, P463, DOI 10.1093/mutage/ges005; Clare G, 2006, MUTAT RES, V607, P37, DOI DOI 10.1016/J.MRGENTOX.2006.04.001; Cole RA, 2007, J NAT MED, V61, P414, DOI 10.1007/s11418-007-0155-6; Daferera D, 2002, FOOD CHEM, V77, P511, DOI 10.1016/S0308-8146(01)00382-X; DALLACQUA F, 1978, PHOTOCHEM PHOTOBIOL, V27, P77, DOI 10.1111/j.1751-1097.1978.tb07568.x; Dar MY, 2011, FOOD CHEM, V129, P1606, DOI 10.1016/j.foodchem.2011.06.016; de Kok TM, 2008, EUR J NUTR, V47, P51, DOI 10.1007/s00394-008-2006-y; Demsia G, 2007, MUTAT RES-GEN TOX EN, V634, P32, DOI 10.1016/j.mrgentox.2007.05.018; DeOliveira ACAX, 1997, TOXICOL LETT, V92, P39, DOI 10.1016/S0378-4274(97)00034-9; Di Sotto A, 2008, MUTAT RES-GEN TOX EN, V653, P130, DOI 10.1016/j.mrgentox.2008.04.004; Di Sotto A, 2010, MUTAT RES-GEN TOX EN, V699, P23, DOI 10.1016/j.mrgentox.2010.04.008; Dimas KS, 2012, IN VIVO, V26, P777; Doi K, 2009, TOXICOL APPL PHARM, V234, P135, DOI 10.1016/j.taap.2008.10.001; Fenech M, 1997, MUTAT RES-GEN TOX EN, V392, P11, DOI 10.1016/S0165-1218(97)00041-4; Fenech M, 2003, MUTAT RES-GEN TOX EN, V534, P65, DOI 10.1016/S1383-5718(02)00249-8; Fernandez-Bedmar Z, 2011, J TOXICOL ENV HEAL A, V74, P1052, DOI 10.1080/15287394.2011.582306; FLORIN I, 1980, TOXICOLOGY, V15, P219, DOI 10.1016/0300-483X(80)90055-4; Franzios G, 1997, J AGR FOOD CHEM, V45, P2690, DOI 10.1021/jf960685f; FREI H, 1995, MUTAT RES-ENVIR MUTA, V334, P247, DOI 10.1016/0165-1161(95)90018-7; FREI H, 1988, MUTAT RES, V203, P297, DOI 10.1016/0165-1161(88)90019-2; Giaginis C, 2011, NUTR CANCER, V63, P1174, DOI 10.1080/01635581.2011.607546; Gkogka E, 2013, J ESSENT OIL BEAR PL, V16, P714, DOI 10.1080/0972060X.2013.862074; Gminski R, 2010, TOXICOL LETT, V196, P33, DOI 10.1016/j.toxlet.2010.03.015; Gomes-Carneiro MR, 2005, FOOD CHEM TOXICOL, V43, P247, DOI 10.1016/j.fct.2004.09.011; GRAF U, 1992, MUTAT RES, V271, P59, DOI 10.1016/0165-1161(92)90032-H; Graf U, 1998, MUTAT RES-FUND MOL M, V402, P203, DOI 10.1016/S0027-5107(97)00298-4; GRAF U, 1984, ENVIRON MUTAGEN, V6, P153, DOI 10.1002/em.2860060206; Hashimoto K, 2010, TOXICOL IN VITRO, V24, P208, DOI 10.1016/j.tiv.2009.09.006; Herrmann F, 2011, PHYTOMEDICINE, V18, P1191, DOI 10.1016/j.phymed.2011.08.070; IYER VN, 1964, SCIENCE, V145, P55, DOI 10.1126/science.145.3627.55; KASTENBAUM MA, 1970, MUTAT RES, V9, P527, DOI 10.1016/0027-5107(70)90038-2; KAUDERER B, 1991, ENVIRON MOL MUTAGEN, V18, P28, DOI 10.1002/em.2850180106; Kim SI, 2011, J ASIA-PAC ENTOMOL, V14, P509, DOI 10.1016/j.aspen.2011.07.001; Kirsch-Volders M, 2000, MUTAT RES-GEN TOX EN, V464, P3, DOI 10.1016/S1383-5718(99)00161-8; Kirsch-Volders M, 2011, MUTAGENESIS, V26, P177, DOI 10.1093/mutage/geq068; Kounatidis I, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120075; Koutsoudaki C, 2005, J AGR FOOD CHEM, V53, P7681, DOI 10.1021/jf050639s; Lehmann M, 2000, ENVIRON MOL MUTAGEN, V36, P195, DOI 10.1002/1098-2280(2000)36:3<195::AID-EM2>3.0.CO;2-B; Lindsley D.L., 1992, ELSEVIER SCI, V1, P1133; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; Loizzo MR, 2008, CELL PROLIFERAT, V41, P1002, DOI 10.1111/j.1365-2184.2008.00561.x; Lorge E, 2006, MUTAT RES-GEN TOX EN, V607, P13, DOI 10.1016/j.mrgentox.2006.04.006; Loutrari H, 2006, NUTR CANCER, V55, P86, DOI 10.1207/s15327914nc5501_11; Mademtzoglou D, 2013, FLAVOUR FRAG J, V28, P188, DOI 10.1002/ffj.3157; Mademtzoglou D, 2011, FLAVOUR FRAG J, V26, P447, DOI 10.1002/ffj.2081; Magiatis P, 1999, PLANTA MED, V65, P749, DOI 10.1055/s-2006-960856; Magkouta S, 2009, NUTR CANCER, V61, P640, DOI 10.1080/01635580902825647; Mahmoudi M, 2010, EUR REV MED PHARMACO, V14, P765; MAREC F, 1994, MUTAT RES-FUND MOL M, V311, P305, DOI 10.1016/0027-5107(94)90189-9; Margaris NS, 1981, ECOSYSTEMS WORLD, P309; MARGOLIN BH, 1983, ENVIRON MUTAGEN, V5, P705, DOI 10.1002/em.2860050509; Mazumdar M, 2011, MUTAT RES-GEN TOX EN, V721, P147, DOI 10.1016/j.mrgentox.2011.01.007; Mendanha SA, 2013, TOXICOL IN VITRO, V27, P323, DOI 10.1016/j.tiv.2012.08.022; Molina-Jasso D, 2009, BIOL PHARM BULL, V32, P520, DOI 10.1248/bpb.32.520; Moulos P, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-68; Nibret E, 2010, PHYTOMEDICINE, V17, P911, DOI 10.1016/j.phymed.2010.02.009; Niikawa M, 2007, BIOMED PHARMACOTHER, V61, P113, DOI 10.1016/j.biopha.2006.07.094; OECD, 2014, IN VITR MAMM CELL MI, DOI [10.1787/9789264224438-en, DOI 10.1787/9789264224438-EN]; Papapaulou P, 2001, FRESEN ENVIRON BULL, V10, P431; Paraschos S, 2012, CURR MED CHEM, V19, P2292; Perikos J, 1993, CHIOS GUM MASTIC; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Saverini M, 2012, J PHOTOCH PHOTOBIO B, V108, P8, DOI 10.1016/j.jphotobiol.2011.12.003; Schmidt J. M., 2006, Journal of Herbs, Spices & Medicinal Plants, V12, P43, DOI 10.1300/J044v12n03_04; SELBY PB, 1981, MUTAT RES, V83, P403, DOI 10.1016/0027-5107(81)90022-1; SENGSTAG C, 1994, CRIT REV TOXICOL, V24, P323, DOI 10.3109/10408449409017922; Speit G, 2012, MUTAGENESIS, V27, P743, DOI 10.1093/mutage/ges041; SURRALLES J, 1992, MUTAGENESIS, V7, P407, DOI 10.1093/mutage/7.6.407; SURRALLES J, 1995, MUTAT RES-GENET TOX, V341, P169, DOI 10.1016/0165-1218(95)90007-1; Turkez H, 2012, CYTOTECHNOLOGY, V64, P679, DOI 10.1007/s10616-012-9447-0; Vlastos D, 1998, ARCH DERMATOL RES, V290, P312, DOI 10.1007/s004030050310; Vlastos D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069494; WARING MJ, 1968, NATURE, V219, P1320, DOI 10.1038/2191320a0; ZAMITH HPS, 1993, BRAZ J MED BIOL RES, V26, P93; [No title captured]	85	13	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130498	10.1371/journal.pone.0130498	http://dx.doi.org/10.1371/journal.pone.0130498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110900	Green Published, gold			2022-12-27	WOS:000356933800054
J	Yao, N; Foltz, SM; Odisho, AY; Wheeler, DC				Yao, Nengliang; Foltz, Steven M.; Odisho, Anobel Y.; Wheeler, David C.			Geographic Analysis of Urologist Density and Prostate Cancer Mortality in the United States	PLOS ONE			English	Article							PRIMARY-CARE; HEALTH; ASSOCIATION; ACCURACY	Context Financial and demographic pressures in US require an understanding of the most efficient distribution of physicians to maximize population-level health benefits. Prior work has assumed a constant negative relationship between physician supply and mortality outcomes throughout the US and has not addressed regional variation. Methods In this ecological analysis, geographically weighted regression was used to identify spatially varying relationships between local urologist density and prostate cancer mortality at the county level. Data from 1,492 counties in 30 eastern and southern states from 2006-2010 were analyzed. Findings The ordinary least squares (OLS) regression found that, on average, increasing urologist density by 1 urologist per 100,000 people resulted in an expected decrease in prostate cancer mortality of -0.499 deaths per 100,000 men (95% CI -0.709 to -0.289, p-value < 0.001), or a 1.5% decrease. Geographic weighted regression demonstrated that the addition of one urologist per 100,000 people in counties in the southern Mississippi River states of Arkansas, Mississippi, and Louisiana, as well as parts of Illinois, Indiana, and Wisconsin is associated with decrease of 0.411 to 0.916 in prostate cancer mortality per 100,000 men (1.63.6%). In contrast, the urologist density was not significantly associated with the prostate state mortality in the new England region. Conclusions The strength of association between urologist density and prostate cancer mortality varied regionally. Those areas with the highest potential for effects could be targeted for increasing the supply of urologists, as it associated with the largest predicted improvement in prostate cancer mortality.	[Yao, Nengliang; Foltz, Steven M.] Virginia Commonwealth Univ, Dept Healthcare Policy & Res, Richmond, VA USA; [Odisho, Anobel Y.] Univ Calif San Francisco, Dept Urol, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Wheeler, David C.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA	Virginia Commonwealth University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Virginia Commonwealth University	Yao, N (corresponding author), Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22903 USA.	nyao@vcu.edu	yao, na/HDL-8772-2022	Foltz, Steven/0000-0002-9526-8194; Odisho, Anobel/0000-0003-0975-0812	National Cancer Institute [2R25CA093423]; NATIONAL CANCER INSTITUTE [R25CA093423] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Yao was supported under a fellowship from the National Cancer Institute (2R25CA093423). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarrak JS, 2011, J CLIN ONCOL S, V29, P2011; Aneja S, 2012, INT J RADIAT ONCOL, V82, P1723, DOI 10.1016/j.ijrobp.2011.01.070; Aneja S, 2012, ARCH DERMATOL, V148, P174, DOI 10.1001/archdermatol.2011.345; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Byrne G, 2009, 10 INT C GEOC UNSW S; Dall TM, 2013, HEALTH AFFAIR, V32, P2013, DOI 10.1377/hlthaff.2013.0714; Eide MJ, 2009, J AM ACAD DERMATOL, V60, P51, DOI 10.1016/j.jaad.2008.08.040; Ferrante JM, 2000, J AM BOARD FAM PRACT, V13, P408, DOI DOI 10.3122/15572625-13-6-408; Fotheringham A.S., 2002, GEOGRAPHICALLY WEIGH; Geography UCB, TOP INT GEOGR ENC RE; Getis A., 2010, HDB APPL SPATIAL ANA, P461, DOI [10.1007/978-3-642-03647-7_22, DOI 10.1007/978-3-642-03647-7_22]; Goovaerts P, 2008, EPIDEMIOLOGY, V19, pS20; HRSA/Bureau of Health Professions, 2013, AHRF AR HLTH RES FIL; Huang ES, 2013, HEALTH AFFAIR, V32, P614, DOI 10.1377/hlthaff.2012.0913; Hung WW, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-47; ISRAEL R A, 1990, World Health Statistics Quarterly, V43, P259; KIRCHER T, 1985, NEW ENGL J MED, V313, P1263, DOI 10.1056/NEJM198511143132005; Lu B, 2013, GWMODEL GEOGRAPHICAL; Macinko J, 2007, INT J HEALTH SERV, V37, P111, DOI 10.2190/3431-G6T7-37M8-P224; MCKINLAY JB, 1977, MILBANK FUND Q, V55, P405, DOI 10.2307/3349539; National Cancer Institute, CANC PROST SEER STAT; National Center for Health Statistics, US MORT DAT SEER DAT; Odisho AY, 2010, J CLIN ONCOL, V28, P2499, DOI 10.1200/JCO.2009.26.9597; PERCY C, 1981, AM J PUBLIC HEALTH, V71, P242, DOI 10.2105/AJPH.71.3.242; Ricketts TC, 2007, HEALTH SERV RES, V42, P2233, DOI 10.1111/j.1475-6773.2007.00728.x; Roetzheim RG, 1999, J FAM PRACTICE, V48, P850; SORLIE PD, 1992, EPIDEMIOLOGY, V3, P181, DOI 10.1097/00001648-199203000-00018; Starfield B, 2005, HEALTH AFFAIR, V24, pW97, DOI 10.1377/hlthaff.W5.97; U.S. Census Bureau DIS, 2012 NAT POP PROJ; Wheeler David, R PACKAGE GWRR; Wheeler DC, 2007, ENVIRON PLANN A, V39, P2464, DOI 10.1068/a38325; Young FW, 2001, J EPIDEMIOL COMMUN H, V55, P80, DOI 10.1136/jech.55.2.80; Young LJ, 2010, QUANT GEO G, V16, P89, DOI 10.1007/978-90-481-2322-3_8	34	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131578	10.1371/journal.pone.0131578	http://dx.doi.org/10.1371/journal.pone.0131578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OY	26110832	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800160
J	Yuan, AH; Su, L; Yu, SY; Li, CB; Yu, T; Sun, JH				Yuan, Aihua; Su, Liang; Yu, Shunying; Li, Chunbo; Yu, Tao; Sun, Jinhua			Association between DRD2/ANKK1 TaqIA Polymorphism and Susceptibility with Tourette Syndrome: A Meta-Analysis	PLOS ONE			English	Article							RECEPTOR GENE; POSTMORTEM ANALYSIS; DOPAMINERGIC GENES; DRD2; DISORDERS; FAMILY; HETEROGENEITY; AVAILABILITY; TRANSMISSION; PUBLICATION	Background Genetic factors are important in the pathogenesis of Tourette syndrome (TS). Notably, Dopamine receptor D2 (DRD2) gene has been suggested as a possible candidate gene for this disorder. Several studies have demonstrated that DRD2/ANKK1 TaqIA polymorphism is associated with an increased risk of developing TS. However, past results remain conflicting. We addressed this controversy by performing a meta-analysis of the relationship between DRD2/ANKK1 TaqIA polymorphism and TS. Methods Literature was searched in multiple databases including PUBMED, COCHRANE and WEB OF SCIENCE up to July 2014. The number of the genotypes for DRD2/ANKK1 TaqIA in the TS and control subjects was extracted and statistical analysis was performed using Review Manager 5.0.16 and Stata 12.0 software. Summary odds ratios (ORs) and 95% confidence intervals (95%CIs) were utilized to calculate the risk of TS with DRD2/ANKK1 TaqIA. Stratified analysis based on ethnicity was also conducted. Results 523 patients with TS, 564 controls and 87 probands plus 152 relatives from five published studies were finally involved in this meta-analysis. Combined analysis revealed that the overall ORs for the DRD2/ANKK1 TaqIA A1 allele were 1.69 (95%CIs = 1.42-2.00) in the fixed-effect model and 1.66 (95%CIs = 1.33-2.08) in the random-effects model. Stratification by ethnicity indicated the TaqIA A1 allele was significantly associated with TS in Caucasians (fixed-effect model: OR=1.75, 95%CI = 1.43-2.16; random-effect model: OR=1.69, 95%CI = 1.25-2.28) and in Asians (OR=1.54, 95%CI = 1.12-2.10). Meta-analysis of the A1A1 vs. A2A2 (homozygous model), A1A2 vs. A2A2 (heterozygous model) and A1A1 +A1A2 vs. A2A2 (dominant model) of this polymorphism revealed a significant association with TS in overall populations and Caucasians. Conclusions This meta-analysis suggested that the DRD2/ANKK1 TaqIA polymorphism might contribute to TS susceptibility, especially in Caucasian population. However, further investigation with a larger number of worldwide studies should be conducted to verify the association.	[Yuan, Aihua; Yu, Shunying] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Dept Genet, Shanghai 200030, Peoples R China; [Yuan, Aihua] Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA; [Yuan, Aihua] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Su, Liang; Li, Chunbo] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai Key Lab Psychot Disorders, Shanghai 200030, Peoples R China; [Yu, Tao] Shanghai Jiao Tong Univ, Biox Ctr, Key Lab Genet Dev & Neuropsychiatr Disorders, Minist Educ, Shanghai 200030, Peoples R China; [Sun, Jinhua] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Med Psychol, Shanghai 200030, Peoples R China; [Sun, Jinhua] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Dept Child & Adolescent Psychiat, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; University of Rochester; University of Rochester; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Sun, JH (corresponding author), Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Med Psychol, Shanghai 200030, Peoples R China.	2005sunjinhua@163.com	shen, xiaoping/ABF-7863-2021; SUN, JIN/GPX-9641-2022	shen, xiaoping/0000-0003-0366-6433; 	National Natural Science Foundation of China [81301146]; Shanghai Natural Science Foundation [10ZR1425600, 12ZR1427000, 14ZR1435800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	The study was supported by grants from the National Natural Science Foundation of China (81301146) (http://www.nsfc.gov.cn/; discussion about the data and results) and the Shanghai Natural Science Foundation (10ZR1425600, 12ZR1427000, 14ZR1435800) (http://www.stcsm.gov.cn/; data collection). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Comings DE, 1996, AM J MED GENET, V67, P264, DOI 10.1002/(SICI)1096-8628(19960531)67:3<264::AID-AJMG4>3.0.CO;2-N; COMINGS DE, 1991, JAMA-J AM MED ASSOC, V266, P1793, DOI 10.1001/jama.266.13.1793; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diaz-Anzaldua A, 2004, MOL PSYCHIATR, V9, P272, DOI 10.1038/sj.mp.4001411; Fachinetto R, 2007, PROG NEURO-PSYCHOPH, V31, P1478, DOI 10.1016/j.pnpbp.2007.06.028; FAHN S, 1993, ARCH NEUROL-CHICAGO, V50, P1013; Gade R, 1998, MOL PSYCHIATR, V3, P50, DOI 10.1038/sj.mp.4000326; Grice DE, 1996, AM J HUM GENET, V59, P644; Gunther J, 2012, PSYCHIAT RES, V200, P593, DOI 10.1016/j.psychres.2012.04.034; Herzberg I, 2010, PSYCHIAT GENET, V20, P179, DOI 10.1097/YPG.0b013e32833a215a; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hirvonen MM, 2009, SYNAPSE, V63, P907, DOI 10.1002/syn.20672; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; HYDE TM, 1992, NEUROLOGY, V42, P652, DOI 10.1212/WNL.42.3.652; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; KIDD KK, 1980, ARCH GEN PSYCHIAT, V37, P1336; Kurlan RM, 2014, NEUROTHERAPEUTICS, V11, P161, DOI 10.1007/s13311-013-0215-4; Lee CC, 2005, PEDIATR NEUROL, V33, P272, DOI 10.1016/j.pediatrneurol.2005.05.005; Lv H, 2012, J TRADIT CHIN MED, V32, P283, DOI 10.1016/S0254-6272(13)60026-6; Minzer K, 2004, J NEUROL SCI, V219, P55, DOI 10.1016/j.jns.2003.12.006; NEE LE, 1980, ANN NEUROL, V7, P41, DOI 10.1002/ana.410070109; NOTHEN MM, 1994, AM J MED GENET, V54, P249, DOI 10.1002/ajmg.1320540311; Paschou P, 2013, NEUROSCI BIOBEHAV R, V37, P1026, DOI 10.1016/j.neubiorev.2013.01.016; Peterson BS, 2001, J AM ACAD CHILD PSY, V40, P685, DOI 10.1097/00004583-200106000-00014; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; PRICE RA, 1985, ARCH GEN PSYCHIAT, V42, P815; Robertson MM, 2008, J PSYCHOSOM RES, V65, P461, DOI 10.1016/j.jpsychores.2008.03.006; Robertson MM, 2000, BRAIN, V123, P425, DOI 10.1093/brain/123.3.425; Sandor P, 2003, J PSYCHOSOM RES, V55, P41, DOI 10.1016/S0022-3999(03)00060-6; Scharf JM, 2013, MOL PSYCHIATR, V18, P721, DOI 10.1038/mp.2012.69; Simonic I, 2001, AM J MED GENET, V105, P163, DOI 10.1002/ajmg.1192; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Yeh CB, 2007, PSYCHIAT RES-NEUROIM, V156, P75, DOI 10.1016/j.pscychresns.2007.01.003; Yoon DY, 2007, J NEUROL SCI, V255, P50, DOI 10.1016/j.jns.2007.01.069	34	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131060	10.1371/journal.pone.0131060	http://dx.doi.org/10.1371/journal.pone.0131060			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110876	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800114
J	Abbasi, MK; Anwar, AA				Abbasi, M. Kaleem; Anwar, Ahsan Ali			Ameliorating Effects of Biochar Derived from Poultry Manure and White Clover Residues on Soil Nutrient Status and Plant growth Promotion - Greenhouse Experiments	PLOS ONE			English	Article							ENVIRONMENTAL BENEFITS; NITROGEN-RETENTION; TEMPERATE SOILS; CHARCOAL; CARBON; BIOAVAILABILITY; AMENDMENTS; PYROLYSIS; NUTRITION; FERRALSOL	Biochar application to agricultural soils is rapidly emerging as a new management strategy for its potential role in carbon sequestration, soil quality improvements, and plant growth promotion. The aim of our study was to investigate the effects of biochars derived from white clover residues and poultry manure on soil quality characteristics, growth and N accumulation in maize (Zea mays L.) and wheat (Triticum aestivum L.) grown in a loam soil under greenhouse conditions. Treatments comprised of: untreated control; mineral N fertilizer (urea N, UN) at the rate of 200, and 100 mg N kg(-1), white clover residues biochar (WCRB), poultry manure biochar (PMB) at 30 Mg ha(-1), and the possible combinations of WCRB+PMB (50:50), UN+WCRB (50: 50), UN+PMB (50:50), and UN+WCRB+PMB (50:25:25). The treatments were arranged in a completely randomized design with three replications. Results indicated a significant increase in the growth and biomass production of maize and wheat supplemented with biochars alone or mixed with N fertilizer. Biochars treatments showed varying impact on plant growth depended upon the type of the biochar, and in general plant growth under PMB was significantly higher than that recorded under WCRB. The growth characteristics in the combined treatments (half biochar+half N) were either higher or equivalent to that recorded under full fertilizer N treatment (N-200). The biochar treatments WCRB, PMB, and WCRB+PMB (50:50) increased maize shoot N by 18, 26 and 21%, respectively compared to the control while wheat shoot N did not show positive response. The N-uptake by maize treated with WCRB, PMB, and WCRB+PMB (50:50) was 54, 116, and 90 mg g(-1) compared to the 33 mg g(-1) in the control while the N-uptake by wheat was 41, 60, and 53 mg g(-1) compared to 24 mg g(-1) in the control. The mixed treatments (half biochar+half N) increased N-uptake by 2.3folds in maize and 1.7 to 2.5folds in wheat compared to the N-100 showing increasing effect of biochar on N use efficiency of applied N. Post-harvest soil analysis indicated a significant increase in pH, organic matter, organic C, total N, C:N, and porosity (% pore space) by the added biochars while bulk density (BD) was significantly decreased. The organic matter content in the soil amended with biochars ranged between 19.5 and 23.2 g kg(-1) compared to 11.7 and 10.2 g kg(-1) in the control and N fertilizer treatments while the BD of biochars amended soils (WCRB, PMB, and WCRB+PMB) was 1.07, 1.17, and 1.11 g cm(-3) compared to 1.28 g cm(-1) in the control. In summary, the results of present study highlight the agronomic benefits of biochars in improving the quality of the soil, and promoting growth, yield and N accumulation of both maize and wheat with a consequent benefit to agriculture.	[Abbasi, M. Kaleem; Anwar, Ahsan Ali] Univ Poonch, Fac Agr, Dept Soil & Environm Sci, Rawalakot, Azad Jammu & Ka, Pakistan		Abbasi, MK (corresponding author), Univ Poonch, Fac Agr, Dept Soil & Environm Sci, Rawalakot, Azad Jammu & Ka, Pakistan.	mkaleemabbasi@gmail.com						Agegnehu G, 2015, SOIL RES, V53, P1, DOI 10.1071/SR14118; Anderson CR, 2011, PEDOBIOLOGIA, V54, P309, DOI 10.1016/j.pedobi.2011.07.005; Alburquerque JA, 2013, AGRON SUSTAIN DEV, V33, P475, DOI 10.1007/s13593-012-0128-3; Atkinson CJ, 2010, PLANT SOIL, V337, P1, DOI 10.1007/s11104-010-0464-5; Ball PN, 2010, J ENVIRON QUAL, V39, P1243, DOI 10.2134/jeq2009.0082; Barrow CJ, 2012, APPL GEOGR, V34, P21, DOI 10.1016/j.apgeog.2011.09.008; Brady N. C., 1984, The nature and properties of soils.; Bremner J. M., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P595; Bruun EW, 2012, SOIL BIOL BIOCHEM, V46, P73, DOI 10.1016/j.soilbio.2011.11.019; Chan KY, 2007, AUST J SOIL RES, V45, P629, DOI 10.1071/SR07109; Deal C, 2012, BIOMASS BIOENERG, V37, P161, DOI 10.1016/j.biombioe.2011.12.017; Downie A., 2007, BIOENERGY, V2007; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gaskin JW, 2010, AGRON J, V102, P623, DOI 10.2134/agronj2009.0083; Gathorne-Hardy A., 2009, IOP C SERIES EARTH E, V6, P372052, DOI [10.1088/1755-1307/6/7/372052, DOI 10.1088/1755-1307/6/37/372052, 10.1088/1755-1307/6/37/372052, DOI 10.1088/1755-1307/6/7/372052]; Glaser B, 2002, BIOL FERT SOILS, V35, P219, DOI 10.1007/s00374-002-0466-4; Graber ER, 2010, PLANT SOIL, V337, P481, DOI 10.1007/s11104-010-0544-6; Guerena D, 2013, PLANT SOIL, V365, P239, DOI 10.1007/s11104-012-1383-4; Hossain MK, 2010, CHEMOSPHERE, V78, P1167, DOI 10.1016/j.chemosphere.2010.01.009; Ioannidou O, 2007, RENEW SUST ENERG REV, V11, P1966, DOI 10.1016/j.rser.2006.03.013; Ippolito JA, 2012, J ENVIRON QUAL, V41, P967, DOI 10.2134/jeq2012.0151; Jien SH, 2013, CATENA, V110, P225, DOI 10.1016/j.catena.2013.06.021; Karer J, 2013, AGR FOOD SCI, V22, P390, DOI 10.23986/afsci.8155; Keeney D. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P643; Khaliq A, 2015, CATENA, V126, P209, DOI 10.1016/j.catena.2014.11.015; Kookana RS, 2011, ADV AGRON, V112, P103, DOI 10.1016/B978-0-12-385538-1.00003-2; Laird D, 2010, GEODERMA, V158, P436, DOI 10.1016/j.geoderma.2010.05.012; Lal R, 2009, AGRON SUSTAIN DEV, V29, P113, DOI 10.1051/agro:2008044; Lehmann J, 2003, PLANT SOIL, V249, P343, DOI 10.1023/A:1022833116184; Lehmann J., 2009, BIOCHAR ENV MANAGEME, DOI DOI 10.1007/S13593-016-0372-Z; Lehmann J, 2007, NATURE, V447, P143, DOI 10.1038/447143a; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; Major J, 2010, PLANT SOIL, V333, P117, DOI 10.1007/s11104-010-0327-0; Prommer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086388; Qadeer S, 2014, SOIL ENVIRON, V33, P149; Rajkovich S, 2012, BIOL FERT SOILS, V48, P271, DOI 10.1007/s00374-011-0624-7; SAS Institute, 2009, SAS SYST MICR WIND V; Singh B, 2010, AUST J SOIL RES, V48, P516, DOI 10.1071/SR10058; Sohi SP, 2010, ADV AGRON, V105, P47, DOI 10.1016/S0065-2113(10)05002-9; Sohi SP, 2012, SCIENCE, V338, P1034, DOI 10.1126/science.1225987; Solaiman ZM, 2012, PLANT SOIL, V353, P273, DOI 10.1007/s11104-011-1031-4; Solaiman ZM, 2010, AUST J SOIL RES, V48, P546, DOI 10.1071/SR10002; Steiner C, 2008, J PLANT NUTR SOIL SC, V171, P893, DOI 10.1002/jpln.200625199; Sun ZC, 2013, SOIL SCI, V178, P465, DOI 10.1097/SS.0000000000000010; Thies J.E, 2009, BIOCHAR ENV MANAGEME, P85, DOI [DOI 10.4324/9781849770552, 10.4324/9781849770552]; Uzoma KC, 2011, SOIL USE MANAGE, V27, P205, DOI 10.1111/j.1475-2743.2011.00340.x; Van Zwieten L, 2010, PLANT SOIL, V327, P235, DOI 10.1007/s11104-009-0050-x; Wang JY, 2012, PLANT SOIL, V360, P287, DOI 10.1007/s11104-012-1250-3; Yuan JH, 2011, SOIL USE MANAGE, V27, P110, DOI 10.1111/j.1475-2743.2010.00317.x; Zhang AF, 2012, PLANT SOIL, V351, P263, DOI 10.1007/s11104-011-0957-x; Zhang Q, 2014, RES J BIOTECHNOL, V9, P7; Zheng H, 2013, GEODERMA, V206, P32, DOI 10.1016/j.geoderma.2013.04.018	52	22	23	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131592	10.1371/journal.pone.0131592	http://dx.doi.org/10.1371/journal.pone.0131592			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121057	gold, Green Published, Green Submitted			2022-12-27	WOS:000358150400126
J	Bender, D; Champ, CM; Kline, D; Diaz-Pulido, G; Dove, S				Bender, Dorothea; Champ, Connor Michael; Kline, David; Diaz-Pulido, Guillermo; Dove, Sophie			Effects of "Reduced" and "Business-As-Usual" CO2 Emission Scenarios on the Algal Territories of the Damselfish Pomacentrus wardi (Pomacentridae)	PLOS ONE			English	Article							CORAL-REEF; CLIMATE-CHANGE; ELEVATED CO2; CONCENTRATING MECHANISMS; BENTHIC COMMUNITIES; OCEAN ACIDIFICATION; PRODUCTIVITY; PHOTOSYNTHESIS; RESPIRATION; DETERMINANTS	Turf algae are a very important component of coral reefs, featuring high growth and turnover rates, whilst covering large areas of substrate. As food for many organisms, turf algae have an important role in the ecosystem. Farming damselfish can modify the species composition and productivity of such algal assemblages, while defending them against intruders. Like all organisms however, turf algae and damselfishes have the potential to be affected by future changes in seawater (SW) temperature and pCO(2). In this study, algal assemblages, in the presence and absence of farming Pomacentrus wardi were exposed to two combinations of SW temperature and pCO2 levels projected for the austral spring of 2100 (the B1 "reduced" and the A1FI "business-as-usual" CO2 emission scenarios) at Heron Island (GBR, Australia). These assemblages were dominated by the presence of red algae and non-epiphytic cyanobacteria, i.e. cyanobacteria that grow attached to the substrate rather than on filamentous algae. The endpoint algal composition was mostly controlled by the presence/absence of farming damselfish, despite a large variability found between the algal assemblages of individual fish. Different scenarios appeared to be responsible for a mild, species specific change in community composition, observable in some brown and green algae, but only in the absence of farming fish. Farming fish appeared unaffected by the conditions to which they were exposed. Algal biomass reductions were found under "reduced" CO2 emission, but not "business-as-usual" scenarios. This suggests that action taken to limit CO2 emissions may, if the majority of algae behave similarly across all seasons, reduce the potential for phase shifts that lead to algal dominated communities. At the same time the availability of food resources to damselfish and other herbivores would be smaller under "reduced" emission scenarios.	[Bender, Dorothea; Kline, David; Diaz-Pulido, Guillermo; Dove, Sophie] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Bender, Dorothea; Kline, David; Diaz-Pulido, Guillermo; Dove, Sophie] Univ Queensland, Global Change Inst, Brisbane, Qld 4072, Australia; [Bender, Dorothea; Diaz-Pulido, Guillermo; Dove, Sophie] Univ Queensland, ARC Ctr Excellence Coral Reef Studies, Brisbane, Qld 4072, Australia; [Champ, Connor Michael] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Diaz-Pulido, Guillermo] Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia; [Diaz-Pulido, Guillermo] Griffith Univ, Australian Rivers Inst, Nathan, Qld 4111, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland; Griffith University; Griffith University	Bender, D (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia.	d.bender@uq.edu.au	Dove, Sophie/I-7873-2013; /AAL-3738-2021; Diaz-Pulido, Guillermo/B-3648-2013	Dove, Sophie/0000-0003-1823-8634; Kline, David/0000-0001-5128-9439; Diaz-Pulido, Guillermo/0000-0002-0901-3727	ARC Linkage grant [LP 0775303]; Queensland Smart State Fellowship; Great Barrier Reef Foundation	ARC Linkage grant(Australian Research Council); Queensland Smart State Fellowship; Great Barrier Reef Foundation	This research was funded by an ARC Linkage grant (LP 0775303 to A/Prof S. Dove) and a Queensland Smart State Fellowship to Prof O. Hoegh-Guldberg co-funded by the Great Barrier Reef Foundation.	AMTHOR JS, 1984, PLANT CELL ENVIRON, V7, P561, DOI 10.1111/1365-3040.ep11591833; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2000, SPECIAL REPORT EMISS; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P1798, DOI 10.1111/j.1365-2486.2010.02364.x; ATKINSON MJ, 1983, LIMNOL OCEANOGR, V28, P568, DOI 10.4319/lo.1983.28.3.0568; Bay LK, 2001, CORAL REEFS, V20, P289; Beardall J, 2004, PHYCOLOGIA, V43, P26, DOI 10.2216/i0031-8884-43-1-26.1; Beardall J, 2002, FUNCT PLANT BIOL, V29, P335, DOI 10.1071/PP01195; Beardall J, 1998, BOT MAR, V41, P113, DOI 10.1515/botm.1998.41.1-6.113; Borowitzka MA, 1983, P IN GREAT BARR REEF, P287; BRAWLEY S H, 1977, Environmental Biology of Fishes, V2, P45, DOI 10.1007/BF00001415; BROOKS A, 1985, PLANTA, V165, P397, DOI 10.1007/BF00392238; CARPENTER RC, 1986, ECOL MONOGR, V56, P345, DOI 10.2307/1942551; CARPENTER RC, 1985, LIMNOL OCEANOGR, V30, P784, DOI 10.4319/lo.1985.30.4.0784; Ceccarelli DM, 2007, CORAL REEFS, V26, P853, DOI 10.1007/s00338-007-0275-1; Ceccarelli DM, 2005, CORAL REEFS, V24, P606, DOI 10.1007/s00338-005-0035-z; Ceccarelli DM, 2005, OECOLOGIA, V145, P445, DOI 10.1007/s00442-005-0144-y; Ceccarelli DM, 2001, OCEANOGR MAR BIOL, V39, P355; Connell SD, 2010, P ROY SOC B-BIOL SCI, V277, P1409, DOI 10.1098/rspb.2009.2069; Cornwall CE, 2012, J PHYCOL, V48, P137, DOI 10.1111/j.1529-8817.2011.01085.x; Crawley A, 2010, GLOBAL CHANGE BIOL, V16, P851, DOI 10.1111/j.1365-2486.2009.01943.x; Cripps IL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022736; Dickson AG, 2003, MAR CHEM, V80, P185, DOI 10.1016/S0304-4203(02)00133-0; Dove S, 2004, MAR ECOL PROG SER, V272, P99, DOI 10.3354/meps272099; Ferrari MCO, 2012, FUNCT ECOL, V26, P553, DOI 10.1111/j.1365-2435.2011.01951.x; GAO K, 1993, J APPL PHYCOL, V5, P563, DOI 10.1007/BF02184635; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Hata H, 2004, J EXP MAR BIOL ECOL, V313, P285, DOI 10.1016/j.jembe.2004.08.009; HATCHER BG, 1988, TRENDS ECOL EVOL, V3, P106, DOI 10.1016/0169-5347(88)90117-6; HATCHER BG, 1983, J EXP MAR BIOL ECOL, V69, P61, DOI 10.1016/0022-0981(83)90172-7; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Javahery S, 2012, FISH PHYSIOL BIOCHEM, V38, P1545, DOI 10.1007/s10695-012-9682-5; Jompa J, 2003, MAR ECOL PROG SER, V258, P79, DOI 10.3354/meps258079; Kline DI, 2012, SCI REP-UK, V2, DOI 10.1038/srep00413; KLUMPP DW, 1987, MAR ECOL PROG SER, V40, P41, DOI 10.3354/meps040041; KLUMPP DW, 1989, J EXP MAR BIOL ECOL, V125, P145, DOI 10.1016/0022-0981(89)90040-3; KLUMPP DW, 1992, MAR ECOL PROG SER, V86, P77, DOI 10.3354/meps086077; KLUMPP DW, 1989, J EXP MAR BIOL ECOL, V131, P1, DOI 10.1016/0022-0981(89)90008-7; Kubler JE, 1999, PLANT CELL ENVIRON, V22, P1303, DOI 10.1046/j.1365-3040.1999.00492.x; Montgomery WL., 1980, B MAR SCI, V30, P290; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; NOAA, 2012, NOAA NAT ENV SAT DAT; ODUM HT, 1955, ECOL MONOGR, V25, P291, DOI 10.2307/1943285; Osborne CP, 2006, PHILOS T R SOC B, V361, P173, DOI 10.1098/rstb.2005.1737; POLUNIN NVC, 1987, J EXP MAR BIOL ECOL, V111, P285, DOI 10.1016/0022-0981(87)90034-7; Raven JA, 1997, EUR J PHYCOL, V32, P319, DOI 10.1017/S0967026297001388; Raven JA, 2005, CAN J BOT, V83, P879, DOI 10.1139/B05-074; Raven JA, 2003, ADV PHOTO RESPIRAT, V14, P225; RUSS GR, 1987, J EXP MAR BIOL ECOL, V110, P1, DOI 10.1016/0022-0981(87)90062-1; Russell BD, 2009, GLOBAL CHANGE BIOL, V15, P2153, DOI 10.1111/j.1365-2486.2009.01886.x; SALE PF, 1976, J EXP MAR BIOL ECOL, V24, P297, DOI 10.1016/0022-0981(76)90061-7; SAMMARCO PW, 1982, MAR ECOL PROG SER, V8, P53, DOI 10.3354/meps008053; SMITH SV, 1973, LIMNOL OCEANOGR, V18, P953, DOI 10.4319/lo.1973.18.6.0953; Steneck R.S., 1988, P 6 INT COR REEF S A, P37; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; VINE PJ, 1974, MAR BIOL, V24, P131, DOI 10.1007/BF00389347; WANDERS J B W, 1976, Aquatic Botany, V2, P235, DOI 10.1016/0304-3770(76)90023-1; Williams D.M., 1982, Coral Reefs, V1, P35, DOI 10.1007/BF00286538; Yates KK, 2006, ESTUARIES COASTS, V29, P24, DOI 10.1007/BF02784696; Zhao W, 2009, ECOL RES, V24, P99, DOI 10.1007/s11284-008-0486-0; Zou DH, 2011, J PHYCOL, V47, P87, DOI 10.1111/j.1529-8817.2010.00929.x; Zou DH, 2009, PHYCOLOGIA, V48, P510, DOI 10.2216/08-99.1	64	10	10	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131442	10.1371/journal.pone.0131442	http://dx.doi.org/10.1371/journal.pone.0131442			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121163	Green Published, gold			2022-12-27	WOS:000358150400109
J	Kniss, AR; Coburn, CW				Kniss, Andrew R.; Coburn, Carl W.			Quantitative Evaluation of the Environmental Impact Quotient (EIQ) for Comparing Herbicides	PLOS ONE			English	Article							LIMITATIONS; GLYPHOSATE; SYSTEMS; RISKS; CROPS	Various indicators of pesticide environmental risk have been proposed, and one of the most widely known and used is the environmental impact quotient (EIQ). The EIQ has been criticized by others in the past, but it continues to be used regularly in the weed science literature. The EIQ is typically considered an improvement over simply comparing the amount of herbicides applied by weight. Herbicides are treated differently compared to other pesticide groups when calculating the EIQ, and therefore, it is important to understand how different risk factors affect the EIQ for herbicides. The purpose of this work was to evaluate the suitability of the EIQ as an environmental indicator for herbicides. Simulation analysis was conducted to quantify relative sensitivity of the EIQ to changes in risk factors, and actual herbicide EIQ values were used to quantify the impact of herbicide application rate on the EIQ Field Use Rating. Herbicide use rate was highly correlated with the EIQ Field Use Rating (Spearman's rho >0.96, P-value <0.001) for two herbicide datasets. Two important risk factors for herbicides, leaching and surface runoff potential, are included in the EIQ calculation but explain less than 1% of total variation in the EIQ. Plant surface half-life was the risk factor with the greatest relative influence on herbicide EIQ, explaining 26 to 28% of the total variation in EIQ for actual and simulated EIQ values, respectively. For herbicides, the plant surface half-life risk factor is assigned values without any supporting quantitative data, and can result in EIQ estimates that are contrary to quantitative risk estimates for some herbicides. In its current form, the EIQ is a poor measure of herbicide environmental impact.	[Kniss, Andrew R.; Coburn, Carl W.] Univ Wyoming, Dept Plant Sci, Laramie, WY 82071 USA	University of Wyoming	Kniss, AR (corresponding author), Univ Wyoming, Dept Plant Sci, Laramie, WY 82071 USA.	akniss@uwyo.edu	Kniss, Andrew/B-3247-2010	Kniss, Andrew/0000-0003-2551-4959				[Anonymous], 2014, R LANG ENV STAT COMP; Beckie HJ, 2014, WEED SCI, V62, P385, DOI 10.1614/WS-D-13-00093.1; Benbrook Charles M., 2012, Environmental Sciences Europe, V24, P24, DOI 10.1186/2190-4715-24-24; Brookes Graham, 2012, GM Crops Food, V3, P129, DOI 10.4161/gmcr.20061; Carter AD, 2000, WEED RES, V40, P113, DOI 10.1046/j.1365-3180.2000.00157.x; Cox LA, 2005, RISK ANAL, V25, P651, DOI 10.1111/j.1539-6924.2005.00615.x; Dowdy S., 1991, STAT RES, V2nd, P270; Dushoff J., 1994, AM ENTOMOL, V40, P180; Green JM, 2012, PEST MANAG SCI, V68, P1323, DOI 10.1002/ps.3374; Greitens TJ, 2007, RENEW AGR FOOD SYST, V22, P213, DOI 10.1017/S1742170507001755; KOVACH J, 2010, METHOD MEASURE ENV I; KOVACH JC, 1992, NEW YORK FOOD LIFE S, V139; Laengle T, 2010, BIOCONTROL SCI TECHN, V20, P659, DOI 10.1080/09583151003706667; PANTONE DJ, 1992, J ENVIRON QUAL, V21, P567, DOI 10.2134/jeq1992.00472425002100040007x; Peterson RKD, 2004, WEED SCI, V52, P834, DOI 10.1614/WS-03-149R; Peterson RKD, 2014, PEERJ, V2, DOI 10.7717/peerj.364; Senseman S., 2007, HERBICIDE HDB, V9th, P458	17	34	34	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131200	10.1371/journal.pone.0131200	http://dx.doi.org/10.1371/journal.pone.0131200			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121252	gold, Green Published, Green Submitted			2022-12-27	WOS:000358150400083
J	Chang, ETY; Strong, M; Clayton, RH				Chang, Eugene T. Y.; Strong, Mark; Clayton, Richard H.			Bayesian Sensitivity Analysis of a Cardiac Cell Model Using a Gaussian Process Emulator	PLOS ONE			English	Article							ELECTROPHYSIOLOGY; UNCERTAINTY; RESTITUTION; SIMULATIONS; VARIABILITY; REGRESSION; HEART	Models of electrical activity in cardiac cells have become important research tools as they can provide a quantitative description of detailed and integrative physiology. However, cardiac cell models have many parameters, and how uncertainties in these parameters affect the model output is difficult to assess without undertaking large numbers of model runs. In this study we show that a surrogate statistical model of a cardiac cell model (the Luo-Rudy 1991 model) can be built using Gaussian process (GP) emulators. Using this approach we examined how eight outputs describing the action potential shape and action potential duration restitution depend on six inputs, which we selected to be the maximum conductances in the Luo-Rudy 1991 model. We found that the GP emulators could be fitted to a small number of model runs, and behaved as would be expected based on the underlying physiology that the model represents. We have shown that an emulator approach is a powerful tool for uncertainty and sensitivity analysis in cardiac cell models.	[Chang, Eugene T. Y.; Clayton, Richard H.] Univ Sheffield, Insigneo Inst In Sil Med, Sheffield, S Yorkshire, England; [Chang, Eugene T. Y.; Clayton, Richard H.] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England; [Strong, Mark] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Clayton, RH (corresponding author), Univ Sheffield, Insigneo Inst In Sil Med, Sheffield, S Yorkshire, England.	r.h.clayton@sheffield.ac.uk	Clayton, Richard/CAF-3400-2022; Chang, Eugene/I-5834-2015; Strong, Mark/A-4638-2010	Clayton, Richard/0000-0002-8438-7518; Chang, Eugene/0000-0002-1097-4189; Strong, Mark/0000-0003-1486-8233; Burrage, Kevin/0000-0002-8111-1137	UK Engineering and Physical Sciences Research Council [EP/K037145/1]; National Institute for Health Research [PDF-2012-05-258]; Engineering and Physical Sciences Research Council [EP/K037145/1] Funding Source: researchfish; Medical Research Council [MR/J000434/1, G0601721] Funding Source: researchfish; EPSRC [EP/K037145/1] Funding Source: UKRI; MRC [MR/J000434/1, G0601721] Funding Source: UKRI	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Engineering and Physical Sciences Research Council (www.epsrc.ac.uk) grant number EP/K037145/1. Mark Strong is funded by a post-doctoral fellowship grant from the National Institute for Health Research http://www.nihr.ac.uk (Post-Doctoral Fellowship, PDF-2012-05-258). The funding agreement ensured the authors' independence in designing the study, interpreting the data, writing, and publishing the report. This report is independent research supported by the National Institute for Health Research (Post-Doctoral Fellowship, PDF-2012-05-258). The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.	Bastos LS, 2009, TECHNOMETRICS, V51, P425, DOI 10.1198/TECH.2009.08019; Becker W, 2012, MECH SYST SIGNAL PR, V32, P18, DOI 10.1016/j.ymssp.2012.03.009; Bingham D, 2009, BIOMETRIKA, V96, P51, DOI 10.1093/biomet/asn057; Britton OJ, 2013, P NATL ACAD SCI USA, V110, pE2098, DOI 10.1073/pnas.1304382110; Clayton RH, 2011, PROG BIOPHYS MOL BIO, V104, P22, DOI 10.1016/j.pbiomolbio.2010.05.008; Colman MA, 2013, J PHYSIOL-LONDON, V591, P4249, DOI 10.1113/jphysiol.2013.254987; Davies MR, 2012, AM J PHYSIOL-HEART C, V302, pH1466, DOI 10.1152/ajpheart.00808.2011; Fink M, 2011, PROG BIOPHYS MOL BIO, V104, P2, DOI 10.1016/j.pbiomolbio.2010.03.002; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Garfinkel A, 2000, P NATL ACAD SCI USA, V97, P6061, DOI 10.1073/pnas.090492697; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Heijman J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003202; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Kharche S, 2009, LECT NOTES COMPUT SC, V5528, P366, DOI 10.1007/978-3-642-01932-6_40; Lee LA, 2013, ATMOS CHEM PHYS, V13, P8879, DOI 10.5194/acp-13-8879-2013; LUO CH, 1991, CIRC RES, V68, P1501, DOI 10.1161/01.RES.68.6.1501; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Mirams GR, 2012, BRIT J PHARMACOL, V167, P932, DOI 10.1111/j.1476-5381.2012.02020.x; Nash MP, 2006, EXP PHYSIOL, V91, P339, DOI 10.1113/expphysiol.2005.031070; Niederer SA, 2009, EXP PHYSIOL, V94, P486, DOI 10.1113/expphysiol.2008.044610; NOBLE D, 1962, J PHYSIOL-LONDON, V160, P317, DOI 10.1113/jphysiol.1962.sp006849; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Oakley J, 2002, BIOMETRIKA, V89, P769, DOI 10.1093/biomet/89.4.769; Oakley JE, 2004, J R STAT SOC B, V66, P751, DOI 10.1111/j.1467-9868.2004.05304.x; Qu ZL, 2000, BIOPHYS J, V78, P2761, DOI 10.1016/S0006-3495(00)76821-4; Rantner LJ, 2013, HEART RHYTHM, V10, P1209, DOI 10.1016/j.hrthm.2013.04.027; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Roberts BN, 2012, AM J PHYSIOL-HEART C, V303, pH766, DOI 10.1152/ajpheart.01081.2011; Romero L, 2009, AM J PHYSIOL-HEART C, V297, pH1436, DOI 10.1152/ajpheart.00263.2009; Sarkar AX, 2012, J PHYSIOL-LONDON, V590, P2555, DOI 10.1113/jphysiol.2011.223313; Sobie EA, 2009, BIOPHYS J, V96, P1264, DOI 10.1016/j.bpj.2008.10.056; Stewart P, 2009, PHILOS T R SOC A, V367, P2225, DOI 10.1098/rsta.2008.0283; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; Vernon I, 2010, BAYESIAN ANAL, V5, P619, DOI 10.1214/10-BA524	34	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130252	10.1371/journal.pone.0130252	http://dx.doi.org/10.1371/journal.pone.0130252			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114610	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500060
J	Cordingley, JE; Newton, AC; Rose, RJ; Clarke, RT; Bullock, JM				Cordingley, Justine E.; Newton, Adrian C.; Rose, Robert J.; Clarke, Ralph T.; Bullock, James M.			Habitat Fragmentation Intensifies Trade-Offs between Biodiversity and Ecosystem Services in a Heathland Ecosystem in Southern England	PLOS ONE			English	Article							LONG-TERM; CARBON SEQUESTRATION; ECOLOGICAL NETWORKS; LAND-USE; CONSERVATION; LANDSCAPE; TIME; SUCCESSION; SCIENCE; DORSET	While habitat fragmentation represents a major threat to global biodiversity, its impacts on provision of ecosystem services are largely unknown. We analysed biodiversity value and provision of multiple ecosystem services in 110 fragments of lowland heathland ecosystems in southern England, in which vegetation dynamics have been monitored for over 30 years. Decreasing fragment size was found to be associated with a decrease in biodiversity and recreational values, but an increase in relative carbon storage, aesthetic value and timber value. The trade-off between either biodiversity or recreational values with the other ecosystem services therefore became more pronounced as heathland size decreased. This was attributed to a higher rate of woody succession in smaller heathland fragments over the past three decades, and contrasting values of different successional vegetation types for biodiversity and provision of ecosystem services. These results suggest that habitat fragmentation can reduce the potential for developing "win win" solutions that contribute to biodiversity conservation while also supporting socio-economic development. Approaches to multi-purpose management of fragmented landscapes should therefore consider the potential trade-offs in ecosystem services and biodiversity associated with fragmentation, in order to make an effective contribution to sustainable development.	[Cordingley, Justine E.; Newton, Adrian C.; Clarke, Ralph T.] Bournemouth Univ, Fac Sci & Technol, Ctr Conservat Ecol & Environm Sci, Poole BH12 5BB, Dorset, England; [Rose, Robert J.; Clarke, Ralph T.] Ctr Ecol & Hydrol, Lancaster, England; [Bullock, James M.] Ctr Ecol & Hydrol, Wallingford, Oxon, England	Bournemouth University; UK Centre for Ecology & Hydrology (UKCEH); UK Centre for Ecology & Hydrology (UKCEH)	Newton, AC (corresponding author), Bournemouth Univ, Fac Sci & Technol, Ctr Conservat Ecol & Environm Sci, Poole BH12 5BB, Dorset, England.	anewton@bournemouth.ac.uk	Rose, Robert/J-5744-2012; Clarke, Ralph T/B-3859-2009; Bullock, James M/F-9997-2011	Rose, Robert/0000-0001-9993-5743; 	joint Natural Environment Research Council / Bournemouth University PhD studentship; Natural Environment Research Council [ceh020002] Funding Source: researchfish; NERC [ceh020002] Funding Source: UKRI	joint Natural Environment Research Council / Bournemouth University PhD studentship; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research was supported by joint Natural Environment Research Council / Bournemouth University PhD studentship awarded to JEC.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Banks-Leite C, 2012, ECOLOGY, V93, P2560, DOI 10.1890/11-2054.1; Bateman IJ, 2013, SCIENCE, V341, P45, DOI 10.1126/science.1234379; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Boitani L, 2007, CONSERV BIOL, V21, P1414, DOI 10.1111/j.1523-1739.2007.00828.x; Bullock JM, 2011, TRENDS ECOL EVOL, V26, P541, DOI 10.1016/j.tree.2011.06.011; Bullock JM, 2009, J ECOL, V97, P646, DOI 10.1111/j.1365-2745.2009.01502.x; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Collins CD, 2009, ECOLOGY, V90, P2577, DOI 10.1890/08-1405.1; Cook WM, 2005, ECOLOGY, V86, P1267, DOI 10.1890/04-0320; Diaz A, 2013, BIOL CONSERV, V167, P325, DOI 10.1016/j.biocon.2013.08.018; Dickie IA, 2011, J APPL ECOL, V48, P926, DOI 10.1111/j.1365-2664.2011.01980.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fisher B, 2008, ECOL APPL, V18, P2050, DOI 10.1890/07-1537.1; Goldstein JH, 2012, P NATL ACAD SCI USA, V109, P7565, DOI 10.1073/pnas.1201040109; Gonzalez A., 2009, BIODIVERSITY ECOSYST, P134, DOI DOI 10.1093/ACPROF:OSO/9780199547951; Hodder Kathy H., 2014, International Journal of Biodiversity Science Ecosystem Services & Management, V10, P71, DOI 10.1080/21513732.2014.883430; Jiang MK, 2013, J APPL ECOL, V50, P841, DOI 10.1111/1365-2664.12093; Kinzig AP, 2011, SCIENCE, V334, P603, DOI 10.1126/science.1210297; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Kreyling J, 2011, ECOL LETT, V14, P758, DOI 10.1111/j.1461-0248.2011.01637.x; Larigauderie A, 2010, CURR OPIN ENV SUST, V2, P9, DOI 10.1016/j.cosust.2010.02.006; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Liley D, 2008, ACCESS PATTERNS S E; Maes J, 2012, BIOL CONSERV, V155, P1, DOI 10.1016/j.biocon.2012.06.016; Martin PA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2236; McGarigal K., 2002, FRAGSTATS SPATIAL PA; McShane TO, 2011, BIOL CONSERV, V144, P966, DOI 10.1016/j.biocon.2010.04.038; Midgley GF, 2010, CURR OPIN ENV SUST, V2, P264, DOI 10.1016/j.cosust.2010.06.001; Mitchell M., 2013, ECOSYSTEMS, V16, P1; MOORE NW, 1962, J ECOL, V50, P369, DOI 10.2307/2257449; Muradian R, 2013, CONSERV LETT, V6, P274, DOI 10.1111/j.1755-263X.2012.00309.x; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Nelson E, 2008, P NATL ACAD SCI USA, V105, P9471, DOI 10.1073/pnas.0706178105; Neuvonen Mario, 2007, Urban Forestry & Urban Greening, V6, P235, DOI 10.1016/j.ufug.2007.05.003; Newton A.C., 2014, INTRO GREEN EC; Newton AC, 2012, J APPL ECOL, V49, P571, DOI 10.1111/j.1365-2664.2012.02140.x; Newton AC, 2009, BIOL CONSERV, V142, P935, DOI 10.1016/j.biocon.2008.10.018; Nicholson E, 2009, J APPL ECOL, V46, P1139, DOI 10.1111/j.1365-2664.2009.01716.x; Prach K, 2011, TRENDS ECOL EVOL, V26, P119, DOI 10.1016/j.tree.2010.12.007; Rodriguez JP, 2006, ECOL SOC, V11; Rose RJ, 2000, BIOL CONSERV, V93, P117, DOI 10.1016/S0006-3207(99)00047-6; Sen Antara, 2011, EC ASSESSMENT RECREA; Seppelt R, 2011, J APPL ECOL, V48, P630, DOI 10.1111/j.1365-2664.2010.01952.x; Villard MA, 2014, J APPL ECOL, V51, P309, DOI 10.1111/1365-2664.12190; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296; Wardle DA, 2012, J ECOL, V100, P16, DOI 10.1111/j.1365-2745.2011.01907.x	49	23	24	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130004	10.1371/journal.pone.0130004	http://dx.doi.org/10.1371/journal.pone.0130004			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114753	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000358147500048
J	Gershburg, S; Geltz, J; Peterson, KE; Halford, WP; Gershburg, E				Gershburg, Svetlana; Geltz, Joshua; Peterson, Karin E.; Halford, William P.; Gershburg, Edward			The UL13 and US3 Protein Kinases of Herpes Simplex Virus 1 Cooperate to Promote the Assembly and Release of Mature, Infectious Virions	PLOS ONE			English	Article							OPEN READING FRAME; OPEN-READING-FRAME-47 ORF47 PROTEIN; INNER NUCLEAR-MEMBRANE; PROGRAMMED CELL-DEATH; DNA-DAMAGE RESPONSE; RNA-POLYMERASE-II; HUMAN T-CELLS; HUMAN CYTOMEGALOVIRUS; POSTTRANSLATIONAL MODIFICATION; VIRAL REPLICATION	Herpes simplex virus type 1 (HSV-1) encodes two bona fide serine/threonine protein kinases, the US3 and UL13 gene products. HSV-1 Delta US3 mutants replicate with wild-type efficiency in cultured cells, and HSV-1 Delta UL13 mutants exhibit < 10-fold reduction in infectious viral titers. Given these modest phenotypes, it remains unclear how the US3 and UL13 protein kinases contribute to HSV-1 replication. In the current study, we designed a panel of HSV-1 mutants, in which portions of UL13 and US3 genes were replaced by expression cassettes encoding mCherry protein or green fluorescent protein (GFP), respectively, and analyzed DNA replication, protein expression, and spread of these mutants in several cell types. Loss of US3 function alone had largely negligible effect on viral DNA accumulation, gene expression, virion release, and spread. Loss of UL13 function alone also had no appreciable effects on viral DNA levels. However, loss of UL13 function did result in a measurable decrease in the steady-state levels of two viral glycoproteins (gC and gD), release of total and infectious virions, and viral spread. Disruption of both genes did not affect the accumulation of viral DNA, but resulted in further reduction in gC and gD steady-state levels, and attenuation of viral spread and infectious virion release. These data show that the UL13 kinase plays an important role in the late phase of HSV-1 infection, likely by affecting virion assembly and/or release. Moreover, the data suggest that the combined activities of the US3 and UL13 protein kinases are critical to the efficient assembly and release of infectious virions from HSV-1-infected cells.	[Gershburg, Svetlana; Geltz, Joshua; Halford, William P.; Gershburg, Edward] So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62794 USA; [Peterson, Karin E.] NIAID, Rocky Mt Labs, Hamilton, MT 59840 USA	Southern Illinois University System; Southern Illinois University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Gershburg, E (corresponding author), So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62794 USA.	egershburg@siumed.edu	Peterson, Karin/D-1492-2016	Peterson, Karin/0000-0003-4177-7249; Gershburg, Edward/0000-0003-3584-9947	Southern Illinois University School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001102, ZIAAI001101] Funding Source: NIH RePORTER	Southern Illinois University School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by start-up funds and by the Research Seed Grant from Southern Illinois University School of Medicine (EG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvin A, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P1, DOI 10.2277/ 0521827140; Asa R, 2007, MICROBES INFECT, V9, P1434, DOI 10.1016/j.micinf.2007.07.008; Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; Belur Lalitha R., 2008, V434, P267, DOI 10.1007/978-1-60327-248-3_16; Benetti L, 2003, J VIROL, V77, P6567, DOI 10.1128/JVI.77.11.6567-6573.2003; Benetti L, 2006, J VIROL, V80, P3341, DOI 10.1128/JVI.80.7.3341-3348.2006; Benetti L, 2004, P NATL ACAD SCI USA, V101, P9411, DOI 10.1073/pnas.0403160101; Benetti L, 2007, J VIROL, V81, P10242, DOI 10.1128/JVI.00820-07; Bjerke SL, 2006, VIROLOGY, V347, P261, DOI 10.1016/j.virol.2005.11.053; Bruni R, 1999, J VIROL, V73, P3810, DOI 10.1128/JVI.73.5.3810-3817.1999; Cartier A, 2003, EXP CELL RES, V291, P242, DOI 10.1016/S0014-4827(03)00375-6; Cartier A, 2004, SCAND J IMMUNOL, V60, P592, DOI 10.1111/j.0300-9475.2004.01523.x; Chambers CB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122253; CHEE MS, 1989, J GEN VIROL, V70, P1151, DOI 10.1099/0022-1317-70-5-1151; Chuluunbaatar U, 2012, J VIROL, V86, P7771, DOI 10.1128/JVI.00622-12; Chuluunbaatar U, 2010, GENE DEV, V24, P2627, DOI 10.1101/gad.1978310; Coller KE, 2008, TRAFFIC, V9, P1458, DOI 10.1111/j.1600-0854.2008.00782.x; COULTER LJ, 1993, J GEN VIROL, V74, P387, DOI 10.1099/0022-1317-74-3-387; CUNNINGHAM C, 1992, J GEN VIROL, V73, P303, DOI 10.1099/0022-1317-73-2-303; Davison AJ, 2002, VET MICROBIOL, V86, P69, DOI 10.1016/S0378-1135(01)00492-8; Derakhshan M, 2006, J GEN VIROL, V87, P2155, DOI 10.1099/vir.0.81949-0; Deruelle MJ, 2011, J GEN VIROL, V92, P18, DOI 10.1099/vir.0.025593-0; Eaton HE, 2014, J VIROL, V88, P7379, DOI 10.1128/JVI.00712-14; Feederle R, 2009, J VIROL, V83, P10877, DOI 10.1128/JVI.00525-09; Gershburg E, 2004, J VIROL, V78, P12140, DOI 10.1128/JVI.78.22.12140-12146.2004; Gershburg E, 2008, BBA-PROTEINS PROTEOM, V1784, P203, DOI 10.1016/j.bbapap.2007.08.009; Gershburg E, 2007, J VIROL, V81, P5407, DOI 10.1128/JVI.02398-06; Hagglund R, 2002, J VIROL, V76, P743, DOI 10.1128/JVI.76.2.743-754.2002; HEINEMAN TC, 1995, J VIROL, V69, P7367, DOI 10.1128/JVI.69.11.7367-7370.1995; Hildinger M, 1999, GENE THER, V6, P1222, DOI 10.1038/sj.gt.3300942; Hu HL, 2005, VIROLOGY, V337, P304, DOI 10.1016/j.virol.2005.04.024; Imai T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072050; Imai T, 2011, J VIROL, V85, P5003, DOI 10.1128/JVI.02314-10; Imai T, 2010, J VIROL, V84, P153, DOI 10.1128/JVI.01447-09; Jacob T, 2011, J VIROL, V85, P1158, DOI 10.1128/JVI.01369-10; Jenkins HL, 2001, J VIROL, V75, P9872, DOI 10.1128/JVI.75.20.9872-9884.2001; Jerome KR, 1999, J VIROL, V73, P8950, DOI 10.1128/JVI.73.11.8950-8957.1999; Kalamvoki M, 2014, P NATL ACAD SCI USA, V111, pE611, DOI 10.1073/pnas.1323414111; Kato A, 2006, J VIROL, V80, P1476, DOI 10.1128/JVI.80.3.1476-1486.2006; Kato A, 2008, J VIROL, V82, P6172, DOI 10.1128/JVI.00044-08; Kato A, 2014, J VIROL, V88, P2775, DOI 10.1128/JVI.03300-13; Kato A, 2014, J VIROL, V88, P655, DOI 10.1128/JVI.02710-13; Kato A, 2011, J VIROL, V85, P9599, DOI 10.1128/JVI.00845-11; Kato A, 2009, J VIROL, V83, P250, DOI 10.1128/JVI.01451-08; Kawaguchi Y, 2003, J VIROL, V77, P2359, DOI 10.1128/JVI.77.4.2359-2368.2003; Krosky PM, 2003, J VIROL, V77, P905, DOI 10.1128/JVI.77.2.905-914.2003; Kuny CV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001092; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leach N, 2007, J VIROL, V81, P10792, DOI 10.1128/JVI.00196-07; Lee CP, 2008, J VIROL, V82, P11913, DOI 10.1128/JVI.01100-08; Lee LY, 1998, J VIROL, V72, P4250, DOI 10.1128/JVI.72.5.4250-4264.1998; Leopardi R, 1997, P NATL ACAD SCI USA, V94, P7891, DOI 10.1073/pnas.94.15.7891; Li RF, 2011, CELL HOST MICROBE, V10, P390, DOI 10.1016/j.chom.2011.08.013; Liang L, 2008, J VIROL, V82, P4688, DOI 10.1128/JVI.02763-07; Long MC, 1999, J VIROL, V73, P5593, DOI 10.1128/JVI.73.7.5593-5604.1999; LONGNECKER R, 1987, SCIENCE, V236, P573, DOI 10.1126/science.3033823; Perez-Perez JM, 2009, TRENDS GENET, V25, P368, DOI 10.1016/j.tig.2009.06.004; Marschall M, 2005, J BIOL CHEM, V280, P33357, DOI 10.1074/jbc.M502672200; MCGEOCH DJ, 1986, NUCLEIC ACIDS RES, V14, P1765, DOI 10.1093/nar/14.4.1765; Michel D, 1996, J VIROL, V70, P6340, DOI 10.1128/JVI.70.9.6340-6346.1996; Moffat JF, 1998, P NATL ACAD SCI USA, V95, P11969, DOI 10.1073/pnas.95.20.11969; Mori I, 2003, NEUROSCI LETT, V351, P201, DOI 10.1016/j.neulet.2003.08.033; Morris JB, 2007, J VIROL, V81, P4429, DOI 10.1128/JVI.02354-06; Morrison EE, 1998, J VIROL, V72, P7108, DOI 10.1128/JVI.72.9.7108-7114.1998; Mou F, 2008, J VIROL, V82, P8094, DOI 10.1128/JVI.00874-08; Mou F, 2007, J VIROL, V81, P6459, DOI 10.1128/JVI.00380-07; Mou F, 2009, J VIROL, V83, P5181, DOI 10.1128/JVI.00090-09; Munger J, 2001, J VIROL, V75, P5491, DOI 10.1128/JVI.75.12.5491-5497.2001; Munger J, 2001, P NATL ACAD SCI USA, V98, P10410, DOI 10.1073/pnas.181344498; Murata T, 2009, VIROLOGY, V389, P75, DOI 10.1016/j.virol.2009.04.007; Naghavi MH, 2013, P NATL ACAD SCI USA, V110, P18268, DOI 10.1073/pnas.1310760110; Ng TI, 1998, VIROLOGY, V241, P37, DOI 10.1006/viro.1997.8963; Ogg PD, 2004, VIROLOGY, V319, P212, DOI 10.1016/j.virol.2003.10.019; Ogle WO, 1997, VIROLOGY, V235, P406, DOI 10.1006/viro.1997.8710; Park R, 2006, J VIROL, V80, P494, DOI 10.1128/JVI.80.1.494-504.2006; Peri P, 2011, J GEN VIROL, V92, P173, DOI 10.1099/vir.0.025080-0; Piroozmand A, 2004, INT J MOL MED, V14, P641; Poon APW, 2006, P NATL ACAD SCI USA, V103, P9993, DOI 10.1073/pnas.0604142103; Prichard MN, 1999, J VIROL, V73, P5663, DOI 10.1128/JVI.73.7.5663-5670.1999; PURVES FC, 1991, J VIROL, V65, P5757, DOI 10.1128/JVI.65.11.5757-5764.1991; PURVES FC, 1992, P NATL ACAD SCI USA, V89, P7310, DOI 10.1073/pnas.89.16.7310; PURVES FC, 1987, J VIROL, V61, P2896, DOI 10.1128/JVI.61.9.2896-2901.1987; PURVES FC, 1993, P NATL ACAD SCI USA, V90, P6701, DOI 10.1073/pnas.90.14.6701; Reynolds AE, 2002, J VIROL, V76, P8939, DOI 10.1128/JVI.76.17.8939-8952.2002; Reynolds AE, 2001, J VIROL, V75, P8803, DOI 10.1128/JVI.75.18.8803-8817.2001; Romaker D, 2006, J MED CHEM, V49, P7044, DOI 10.1021/jm060696s; Ryckman BJ, 2004, J VIROL, V78, P399, DOI 10.1128/JVI.78.1.399-412.2004; Sato H, 2003, J VIROL, V77, P11180, DOI 10.1128/JVI.77.20.11180-11185.2003; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sen J, 2013, VIROLOGY, V439, P65, DOI 10.1016/j.virol.2013.01.026; Sharma M, 2014, J VIROL, V88, P249, DOI 10.1128/JVI.02358-13; Shibaki T, 2001, J INTERF CYTOK RES, V21, P279, DOI 10.1089/107999001300177466; Shin MC, 2006, ACTA VIROL, V50, P263; SMITH KO, 1964, P SOC EXP BIOL MED, V115, P814, DOI 10.3181/00379727-115-29045; Tanaka M, 2005, VIROLOGY, V341, P301, DOI 10.1016/j.virol.2005.07.010; Tarakanova VL, 2007, CELL HOST MICROBE, V1, P275, DOI 10.1016/j.chom.2007.05.008; Walters MS, 2010, J VIROL, V84, P9666, DOI 10.1128/JVI.00981-10; Wang KZ, 2014, J VIROL, V88, P7941, DOI 10.1128/JVI.03394-13; Wang S, 2013, J VIROL, V87, P12814, DOI 10.1128/JVI.02355-13; Wang XJ, 2011, P NATL ACAD SCI USA, V108, P14632, DOI 10.1073/pnas.1111942108; Wild P, 2015, VIRUSES-BASEL, V7, P52, DOI 10.3390/v7010052; Wild P, 2012, VIROLOGY, V432, P353, DOI 10.1016/j.virol.2012.06.020; Wisner TW, 2009, J VIROL, V83, P3115, DOI 10.1128/JVI.01462-08; YANAGI K, 1981, J VIROL, V38, P737, DOI 10.1128/JVI.38.2.737-748.1981; Yokota S, 2004, J VIROL, V78, P6282, DOI 10.1128/JVI.78.12.6282-6286.2004; Zhu Z, 2014, J VIROL, V88, P5437, DOI 10.1128/JVI.00542-14	106	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131420	10.1371/journal.pone.0131420	http://dx.doi.org/10.1371/journal.pone.0131420			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115119	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500157
J	Kail, J; Guse, B; Radinger, J; Schroder, M; Kiesel, J; Kleinhans, M; Schuurman, F; Fohrer, N; Hering, D; Wolter, C				Kail, Jochem; Guse, Bjoern; Radinger, Johannes; Schroeder, Maria; Kiesel, Jens; Kleinhans, Maarten; Schuurman, Filip; Fohrer, Nicola; Hering, Daniel; Wolter, Christian			A Modelling Framework to Assess the Effect of Pressures on River Abiotic Habitat Conditions and Biota	PLOS ONE			English	Article							GRAVEL-BED RIVERS; COMMUNITY STRUCTURE; SEDIMENT DYNAMICS; BANK STABILITY; BEND THEORY; STREAM; FLOW; ECOSYSTEMS; CATCHMENT; FISH	River biota are affected by global reach-scale pressures, but most approaches for predicting biota of rivers focus on river reach or segment scale processes and habitats. Moreover, these approaches do not consider long-term morphological changes that affect habitat conditions. In this study, a modelling framework was further developed and tested to assess the effect of pressures at different spatial scales on reach-scale habitat conditions and biota. Ecohydrological and 1D hydrodynamic models were used to predict discharge and water quality at the catchment scale and the resulting water level at the downstream end of a study reach. Long-term reach morphology was modelled using empirical regime equations, meander migration and 2D morphodynamic models. The respective flow and substrate conditions in the study reach were predicted using a 2D hydrodynamic model, and the suitability of these habitats was assessed with novel habitat models. In addition, dispersal models for fish and macroinvertebrates were developed to assess the re-colonization potential and to finally compare habitat suitability and the availability / ability of species to colonize these habitats. Applicability was tested and model performance was assessed by comparing observed and predicted conditions in the lowland Treene River in northern Germany. Technically, it was possible to link the different models, but future applications would benefit from the development of open source software for all modelling steps to enable fully automated model runs. Future research needs concern the physical modelling of long-term morphodynamics, feedback of biota (e.g., macrophytes) on abiotic habitat conditions, species interactions, and empirical data on the hydraulic habitat suitability and dispersal abilities of macroinvertebrates. The modelling framework is flexible and allows for including additional models and investigating different research and management questions, e.g., in climate impact research as well as river restoration and management.	[Kail, Jochem; Radinger, Johannes; Kiesel, Jens; Wolter, Christian] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany; [Guse, Bjoern; Kiesel, Jens; Fohrer, Nicola] Univ Kiel, Dept Hydrol & Water Resources Management, Kiel, Germany; [Kail, Jochem; Schroeder, Maria; Hering, Daniel] Univ Duisburg Essen, Dept Aquat Ecol, Essen, Germany; [Kleinhans, Maarten; Schuurman, Filip] Univ Utrecht, Dept Phys Geog, Utrecht, Netherlands	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Kiel; University of Duisburg Essen; Utrecht University	Kail, J (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany.	jochem.kail@uni-due.de	Radinger, Johannes/B-9113-2013; , Nicola Fohrer/C-6313-2011; Wolter, Christian/F-6210-2014; Hering, Daniel/D-4280-2012; Kleinhans, Maarten G./L-6697-2016	Radinger, Johannes/0000-0002-2637-9464; , Nicola Fohrer/0000-0002-7456-6301; Kleinhans, Maarten G./0000-0002-9484-1673; Wolter, Christian/0000-0002-2819-2900	Commission of the European Communities; German Federal Ministry for Education and Research [02WM1134, 02WM1135, 02WM1136]	Commission of the European Communities(European Commission); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	This project has been carried out with financial support from the Commission of the European Communities, specifically RTD programme "IWRMNET". It does not necessarily reflect its views and in no way anticipates the Commission's future policy in this area. The German authors have been funded by the German Federal Ministry for Education and Research (grant numbers 02WM1134, 02WM1135, 02WM1136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad JD, 2006, COMPUT GEOSCI-UK, V32, P92, DOI 10.1016/j.cageo.2005.05.006; Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Ahmadi-Nedushan B, 2006, RIVER RES APPL, V22, P503, DOI 10.1002/rra.918; Allan JD, 1997, FRESHWATER BIOL, V37, P149, DOI 10.1046/j.1365-2427.1997.d01-546.x; [Anonymous], 2007, OPEN SOURCE GIS GRAS; Arnold JG, 1998, J AM WATER RESOUR AS, V34, P73, DOI 10.1111/j.1752-1688.1998.tb05961.x; Asahi K, 2013, J GEOPHYS RES-EARTH, V118, P2208, DOI 10.1002/jgrf.20150; Berry W, 2003, BIOL EFFECTS SUSPEND; Black RW, 2004, J N AM BENTHOL SOC, V23, P340, DOI 10.1899/0887-3593(2004)023&lt;0340:UMTIBC&gt;2.0.CO;2; Boix D, 2010, J HYDROL, V383, P135, DOI 10.1016/j.jhydrol.2010.01.014; Bornette G, 2011, AQUAT SCI, V73, P1, DOI 10.1007/s00027-010-0162-7; Bovee KD, 1977, 3 US DEP INT FISH WI; Bray D.I., 1982, GRAVEL BED RIVERS FL, P517; Bryce SA, 2010, J N AM BENTHOL SOC, V29, P657, DOI 10.1899/09-061.1; Chow V.T., 1959, OPEN CHANNEL HYDRAUL; Conallin J, 2010, INT J RIVER BASIN MA, V8, P93, DOI 10.1080/15715121003715123; Crosato A, 1989, GNI, V4, P169; Crosato A., 2008, THESIS DELFT U TECHN; Crosato A, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005087; Crowder DW, 2000, J HYDROL, V230, P172, DOI 10.1016/S0022-1694(00)00177-3; Davidson SL, 2013, GEOMORPHOLOGY, V202, P59, DOI 10.1016/j.geomorph.2012.10.005; Dedecker AP, 2007, ECOL MODEL, V203, P72, DOI 10.1016/j.ecolmodel.2006.04.029; Dunbar MJ, 2012, FISHERIES MANAG ECOL, V19, P500, DOI 10.1111/j.1365-2400.2011.00825.x; Eaton BC, 2004, EARTH SURF PROC LAND, V29, P511, DOI 10.1002/esp.1062; Eaton BC, 2006, EARTH SURF PROC LAND, V31, P1438, DOI 10.1002/esp.1364; Elliott JM, 2006, J ANIM ECOL, V75, P54, DOI 10.1111/j.1365-2656.2005.01022.x; ESRI, 2011, PATH DIST SPAT AN; ESRI, 2011, COST DIST SPAT AN; Franklin P, 2008, SCI TOTAL ENVIRON, V400, P369, DOI 10.1016/j.scitotenv.2008.06.018; French TD, 1996, FRESHWATER BIOL, V36, P509, DOI 10.1046/j.1365-2427.1996.00105.x; Gellert G, 2014, ENVIRON MONIT ASSESS, V186, P3365, DOI 10.1007/s10661-014-3623-y; Guse B, 2014, HYDROL PROCESS, V28, P2651, DOI 10.1002/hyp.9777; Habersack H, 2008, DEV EARTH S, V11, P1; HEY RD, 1986, J HYDRAUL ENG-ASCE, V112, P671, DOI 10.1061/(ASCE)0733-9429(1986)112:8(671); Hojberg AL, 2013, ENVIRON MODELL SOFTW, V40, P202, DOI 10.1016/j.envsoft.2012.09.010; Hughes SJ, 2008, AQUAT CONSERV, V18, P742, DOI 10.1002/aqc.866; IKEDA S, 1981, J FLUID MECH, V112, P363, DOI 10.1017/S0022112081000451; Illies J, 1961, INT REV GESAMTEN HYD, V46, P205, DOI [10.1002/iroh, DOI 10.1002/IROH.19610460205, 10.1002/iroh.19610460205]; Jahnig SC, 2012, J BIOGEOGR, V39, P2253, DOI 10.1111/jbi.12009; Jasiewicz J, 2011, COMPUT GEOSCI-UK, V37, P1525, DOI 10.1016/j.cageo.2010.09.008; Jobson HE, 1997, WATER RESOURCES INVE; Julian JP, 2006, GEOMORPHOLOGY, V76, P193, DOI 10.1016/j.geomorph.2005.11.003; Kail J, 2012, ECOL INDIC, V18, P63, DOI 10.1016/j.ecolind.2011.09.038; Kiesel J., 2009, Ecohydrology of surface and groundwater dependent systems: concepts, methods and recent developments. Proceedings of Symposium JS.1 at the Joint Convention of the International Association of Hydrological Sciences (IAHS) and the International Association of Hydrogeologists (IAH) held in Hyderabad, India, 6-12 September 2009, P24; Kiesel J, 2012, P 10 INT C HYDR HAMB, P1; Kiesel J, FUNDAMENTAL APPL LIM, V186, P117; Knighton D, 1984, FLUVIAL FORMS PROCES; Leopold L.B., 1953, 252 GEOL SURV; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Madsen JD, 2001, HYDROBIOLOGIA, V444, P71, DOI 10.1023/A:1017520800568; MAMDANI EH, 1975, INT J MAN MACH STUD, V7, P1, DOI 10.1016/S0020-7373(75)80002-2; Millar RG, 1998, J HYDRAUL ENG-ASCE, V124, P1005, DOI 10.1061/(ASCE)0733-9429(1998)124:10(1005); MILLAR RG, 1993, J HYDRAUL ENG-ASCE, V119, P1343, DOI 10.1061/(ASCE)0733-9429(1993)119:12(1343); Millar RG, 2005, GEOMORPHOLOGY, V64, P207, DOI 10.1016/j.geomorph.2004.07.001; Molinas A., 2000, USERS NANUAL BRI STA; Mouton AM, 2007, ECOL ENG, V29, P305, DOI 10.1016/j.ecoleng.2006.11.002; Navratil O, 2006, EARTH SURF PROC LAND, V31, P1345, DOI 10.1002/esp.1337; Neary VS, 2012, J HYDRAUL ENG, V138, P765, DOI 10.1061/(ASCE)HY.1943-7900.0000168; O'Hare JM, 2011, RIVER RES APPL, V27, P671, DOI 10.1002/rra.1379; ODGAARD AJ, 1989, J HYDRAUL ENG-ASCE, V115, P1433, DOI 10.1061/(ASCE)0733-9429(1989)115:11(1433); Orlowsky B, 2008, THEOR APPL CLIMATOL, V92, P209, DOI 10.1007/s00704-007-0352-y; PARKER G, 1982, J FLUID MECH, V115, P303, DOI 10.1017/S0022112082000767; Parker G, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000549; Payne, 2003, IFIM US WORKSH 1 5 J, P1; Poff NL, 2006, J N AM BENTHOL SOC, V25, P730, DOI 10.1899/0887-3593(2006)025[0730:FTNONA]2.0.CO;2; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Pottgiesser T., 2008, BESCHREIBUNG BEWERTU; R DEVELOPMENT CORE TEAM, 2014, R PROJECT STAT COMPU; Radinger J, 2014, ECOL INFORM, V24, P238, DOI 10.1016/j.ecoinf.2013.06.002; Radinger J, 2014, FISH FISH, V15, P456, DOI 10.1111/faf.12028; Rey SJ, 2009, J GEOGR SYST, V11, P191, DOI 10.1007/s10109-009-0086-8; Richter BD, 1996, CONSERV BIOL, V10, P1163, DOI 10.1046/j.1523-1739.1996.10041163.x; Riis T, 2003, LIMNOL OCEANOGR, V48, P1488, DOI 10.4319/lo.2003.48.4.1488; Roth NE, 1996, LANDSCAPE ECOL, V11, P141, DOI 10.1007/BF02447513; Schmutz, 2004, STATE OF THE ART DAT; Schuwirth N, 2013, ECOLOGY, V94, P368, DOI 10.1890/12-0591.1; Soar PJ, 2001, FLOOD DAMAGE REDUCTI; Stephenson JM, 2009, FRESHWATER BIOL, V54, P2139, DOI 10.1111/j.1365-2427.2008.02142.x; Sundermann A, 2013, ECOL INDIC, V27, P83, DOI 10.1016/j.ecolind.2012.12.003; Suren AM, 2010, J N AM BENTHOL SOC, V29, P711, DOI 10.1899/08-127.1; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025; Syvitski JPM, 2007, GLOBAL PLANET CHANGE, V57, P261, DOI 10.1016/j.gloplacha.2006.12.001; US Army Corps of Engineers (USACE), 2010, HEC RAS RIV AN SYST; Van Oorschot M, 2014, P 10 INT S EC TRONDH; Wang LZ, 2007, ENVIRON MANAGE, V39, P194, DOI 10.1007/s00267-006-0135-8; Wilkerson GV, 2011, J HYDRAUL ENG-ASCE, V137, P739, DOI 10.1061/(ASCE)HY.1943-7900.0000352; WINSTON MR, 1991, T AM FISH SOC, V120, P98, DOI 10.1577/1548-8659(1991)120<0098:UEOFMS>2.3.CO;2; Wolter C, 2005, RIVER RES APPL, V21, P245, DOI 10.1002/rra.844; Wu W, 2002, ONE DIMENSIONAL CHAN; Xu JX, 2004, EARTH SURF PROC LAND, V29, P645, DOI 10.1002/esp.1059; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; [No title captured]	92	14	15	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130228	10.1371/journal.pone.0130228	http://dx.doi.org/10.1371/journal.pone.0130228			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114430	Green Submitted, gold, Green Published			2022-12-27	WOS:000358147500058
J	Lee, YJ; Shin, SD; Lee, EJ; Cho, JS; Cha, WC				Lee, Yu Jin; Shin, Sang Do; Lee, Eui Jung; Cho, Jin Seong; Cha, Won Chul			Emergency Department Overcrowding and Ambulance Turnaround Time	PLOS ONE			English	Article							MEDICAL-SERVICES SYSTEMS; DIVERSION; IMPACT; MODEL	Objective The aims of this study were to describe overcrowding in regional emergency departments in Seoul, Korea and evaluate the effect of crowdedness on ambulance turnaround time. Methods This study was conducted between January 2010 and December 2010. Patients who were transported by 119-responding ambulances to 28 emergency centers within Seoul were eligible for enrollment. Overcrowding was defined as the average occupancy rate, which was equal to the average number of patients staying in an emergency department (ED) for 4 hours divided by the number of beds in the ED. After selecting groups for final analysis, multi-level regression modeling (MLM) was performed with random-effects for EDs, to evaluate associations between occupancy rate and turnaround time. Results Between January 2010 and December 2010, 163,659 patients transported to 28 EDs were enrolled. The median occupancy rate was 0.42 (range: 0.10-1.94; interquartile range (IQR): 0.20-0.76). Overcrowded EDs were more likely to have older patients, those with normal mentality, and non-trauma patients. Overcrowded EDs were more likely to have longer turnaround intervals and traveling distances. The MLM analysis showed that an increase of 1% in occupancy rate was associated with 0.02-minute decrease in turnaround interval (95% CI: 0.01 to 0.03). In subgroup analyses limited to EDs with occupancy rates over 100%, we also observed a 0.03 minute decrease in turnaround interval per 1% increase in occupancy rate (95% CI: 0.01 to 0.05). Conclusions In this study, we found wide variation in emergency department crowding in a metropolitan Korean city. Our data indicate that ED overcrowding is negatively associated with turnaround interval with very small practical significance.	[Lee, Yu Jin; Shin, Sang Do; Lee, Eui Jung] Seoul Natl Univ Hosp, Dept Emergency Med, Seoul 110744, South Korea; [Lee, Yu Jin; Shin, Sang Do; Lee, Eui Jung; Cho, Jin Seong; Cha, Won Chul] Seoul Natl Univ, Hosp Biomed Res Inst, Lab Emergency Med Serv, Seoul, South Korea; [Lee, Yu Jin] Inha Univ, Grad Sch Med, Dept Social & Prevent Med, Seoul, South Korea; [Cho, Jin Seong] Gachon Univ, Gil Hosp, Dept Emergency Med, Seoul, South Korea; [Cha, Won Chul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Emergency Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Inha University; Gachon University; Sungkyunkwan University (SKKU); Samsung Medical Center	Cha, WC (corresponding author), Seoul Natl Univ, Hosp Biomed Res Inst, Lab Emergency Med Serv, Seoul, South Korea.	docchaster@gmail.com	Lee, Jae Hyuk/W-5616-2018	Lee, Jae Hyuk/0000-0003-2429-4085				[Anonymous], 2003, CJEM, V5, P81; [Anonymous], 2013, OECD REG GLANC 2013; Asplin BR, 2003, ANN EMERG MED, V42, P173, DOI 10.1067/mem.2003.302; Bernstein SL, 2006, EMERG MED CLIN N AM, V24, P821, DOI 10.1016/j.emc.2006.06.013; Bernstein SL, 2009, ACAD EMERG MED, V16, P1, DOI 10.1111/j.1553-2712.2008.00295.x; Carter AJE, 2007, PREHOSP EMERG CARE, V11, P421, DOI 10.1080/10903120701536909; Carter AJE, 2014, J EMERG MED, V47, P30, DOI 10.1016/j.jemermed.2013.08.109; Cha WC, 2011, PEDIATR EMERG CARE, V27, P1136, DOI 10.1097/PEC.0b013e31823ab90b; Cone DC, 1998, ANN EMERG MED, V31, P241, DOI 10.1016/S0196-0644(98)70314-2; Di Somma S, 2015, INTERN EMERG MED, V10, P171, DOI 10.1007/s11739-014-1154-8; Eckstein M, 2004, ANN EMERG MED, V43, P100, DOI 10.1016/S0196-0644(03)00747-9; Hoot NR, 2007, ANN EMERG MED, V49, P747, DOI 10.1016/j.annemergmed.2007.01.017; Institute of Medicine CotFoECitUSHS, 2007, HOSP BAS EM CAR BREA; Neely K W, 1994, Prehosp Disaster Med, V9, P172; Olshaker JS, 2006, J EMERG MED, V30, P351, DOI 10.1016/j.jemermed.2005.05.023; Richardson LD, 2002, ANN EMERG MED, V40, P388, DOI 10.1067/mem.2002.128012; Schull Michael J, 2002, CJEM, V4, P76; Schull MJ, 2003, ANN EMERG MED, V41, P467, DOI 10.1067/mem.2003.23; Shih FY, 1999, AM J EMERG MED, V17, P198, DOI 10.1016/S0735-6757(99)90061-X; Shin SD, 2012, PREHOSP EMERG CARE, V16, P477, DOI 10.3109/10903127.2012.695433; SPAITE DW, 1993, ANN EMERG MED, V22, P638, DOI 10.1016/S0196-0644(05)81840-2; Weiss SJ, 2007, PEDIATR EMERG CARE, V23, P641, DOI 10.1097/PEC.0b013e31814a69e2	23	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130758	10.1371/journal.pone.0130758	http://dx.doi.org/10.1371/journal.pone.0130758			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115183	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500092
J	Massaro, M; Martinelli, R; Gatta, V; Scoditti, E; Pellegrino, M; Carluccio, MA; Calabriso, N; Buonomo, T; Stuppia, L; Storelli, C; De Caterina, R				Massaro, Marika; Martinelli, Rosanna; Gatta, Valentina; Scoditti, Egeria; Pellegrino, Mariangela; Carluccio, Maria Annunziata; Calabriso, Nadia; Buonomo, Tonia; Stuppia, Liborio; Storelli, Carlo; De Caterina, Raffaele			Transcriptome-based identification of new anti-anti-inflammatory and vasodilating properties of the n-3 fatty acid docosahexaenoic acid in vascular endothelial cell under proinflammatory conditions	PLOS ONE			English	Article							FISH-OIL SUPPLEMENTATION; GROWTH-FACTOR-BETA; NF-KAPPA-B; GENE-EXPRESSION PROFILES; ADHESION MOLECULE; DYSLIPIDEMIC MEN; CELIAC-DISEASE; CROSS-LINKING; JAM-A; ACTIVATION	Scope High intakes of n-3 fatty acids exert anti-inflammatory effects and cardiovascular protection, but the underlying molecular basis is incompletely defined. By genome-wide analysis we searched for novel effects of docosahexaenoic acid (DHA) on gene expression and pathways in human vascular endothelium under pro-inflammatory conditions. Methods and Results Human umbilical vein endothelial cells were treated with DHA and then stimulated with interleukin(IL)-1 beta. Total RNA was extracted, and gene expression examined by DNA microarray. DHA alone altered the expression of 188 genes, decreasing 92 and increasing 96. IL-1 beta changed the expression of 2031 genes, decreasing 997 and increasing 1034. Treatment with DHA before stimulation significantly affected the expression of 116 IL-1 beta-deregulated genes, counter-regulating the expression of 55 genes among those decreased and of 61 among those increased. Functional and network analyses identified immunological, inflammatory and metabolic pathways as the most affected. Newly identified DHA-regulated genes are involved in stemness, cellular growth, cardiovascular system function and cancer, and included cytochrome p450 4F2(CYP4F2), transforming growth factor(TGF)-beta 2, Cluster of Differentiation (CD) 47, caspase recruitment domain(CARD)11 and phosphodiesterase(PDE)5 alpha. Conclusions Endothelial exposure to DHA regulates novel genes and related pathways. Such unbiased identification should increase our understanding of mechanisms by which n-3 fatty acids affect human diseases.	[Massaro, Marika; Scoditti, Egeria; Pellegrino, Mariangela; Carluccio, Maria Annunziata; Calabriso, Nadia] Natl Res Council CNR, Inst Clin Physiol, Lecce, Italy; [Martinelli, Rosanna; Buonomo, Tonia] CEINGE Biotecnol Avanzate, Naples, Italy; [Martinelli, Rosanna] Univ Salerno, Dept Med & Surg, I-84100 Salerno, Italy; [Gatta, Valentina; Stuppia, Liborio; De Caterina, Raffaele] Gabriele dAnnunzio Univ, Chieti, Italy; [Pellegrino, Mariangela; Storelli, Carlo] Univ Salento, Dept Biol & Environm Sci & Technol Disteba, Lecce, Italy; [De Caterina, Raffaele] Fdn Toscana Gabriele Monasterio, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); CEINGE Biotecnologie Avanzate; University of Salerno; G d'Annunzio University of Chieti-Pescara; University of Salento	De Caterina, R (corresponding author), Gabriele dAnnunzio Univ, Chieti, Italy.	rdecater@unich.it	Martinelli, Rosanna/B-2938-2012; Carluccio, Maria Annunziata/AAO-1683-2020; Martinelli, Rosanna/AAD-9290-2021; massaro, marika/AAQ-1204-2020; Gatta, Valentina/G-5765-2014; De Caterina, Raffaele/K-3857-2016; SCODITTI, EGERIA/J-8609-2016	Martinelli, Rosanna/0000-0002-6524-6752; Martinelli, Rosanna/0000-0002-6524-6752; massaro, marika/0000-0001-6124-5077; De Caterina, Raffaele/0000-0003-1637-574X; GATTA, Valentina/0000-0002-9999-5823; Calabriso, Nadia/0000-0003-0726-2081; SCODITTI, EGERIA/0000-0003-2753-8487; CARLUCCIO, MARIA ANNUNZIATA/0000-0002-8307-1829	Ministry of Instruction, University and Research - MIUR; Italian Ministry of Health (Convenzione CEINGE- MIUR); Italian Ministry of Health (Convenzione CEINGE-Regione Campania); Italian Ministry of Health (Progetto S.co.Pe to CEINGE); Italian Ministry of Health (Centro di Eccellenza riconosciuto dal MIUR) [D.M. 11/2000]	Ministry of Instruction, University and Research - MIUR(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health (Convenzione CEINGE- MIUR); Italian Ministry of Health (Convenzione CEINGE-Regione Campania); Italian Ministry of Health (Progetto S.co.Pe to CEINGE); Italian Ministry of Health (Centro di Eccellenza riconosciuto dal MIUR)	The study was supported by institutional funding by the Ministry of Instruction, University and Research - MIUR to RDC at "G. d'Annunzio" University, Chieti, Italy, and by the Italian Ministry of Health (Convenzione CEINGE- MIUR (2000) art. 5.2, Convenzione CEINGE-Regione Campania, Progetto S.co.Pe to CEINGE, Centro di Eccellenza riconosciuto dal MIUR ex-D.M. 11/2000), to RM.	Abraham S, 2009, J INTERF CYTOK RES, V29, P1, DOI 10.1089/jir.2008.0036; Babinska A, 2007, THROMB HAEMOSTASIS, V97, P272, DOI 10.1160/TH06-08-0454; Balakumar P, 2012, FREE RADICAL BIO MED, V53, P271, DOI 10.1016/j.freeradbiomed.2012.05.005; Bandman O, 2002, ANN NY ACAD SCI, V975, P77, DOI 10.1111/j.1749-6632.2002.tb05943.x; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Blonska M, 2011, CELL RES, V21, P55, DOI 10.1038/cr.2010.182; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Borghi C, 2006, HEART INT, V2, P98, DOI 10.4081/hi.2006.98; Bouwens M, 2009, AM J CLIN NUTR, V90, P415, DOI 10.3945/ajcn.2009.27680; Bradfield PF, 2007, ARTERIOSCL THROM VAS, V27, P2104, DOI 10.1161/ATVBAHA.107.147694; Buonomo T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-2; Cai HB, 2012, EXP THER MED, V3, P433, DOI 10.3892/etm.2011.426; Cavusoglu E, 2007, J AM COLL CARDIOL, V50, P1768, DOI 10.1016/j.jacc.2007.05.051; Chrysant SG, 2012, J CLIN HYPERTENS, V14, P644, DOI 10.1111/j.1751-7176.2012.00669.x; Curley CR, 2006, EUR J HUM GENET, V14, P1215, DOI 10.1038/sj.ejhg.5201687; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; DECATERINA R, 1994, ARTERIOSCLER THROMB, V14, P1829, DOI 10.1161/01.ATV.14.11.1829; Devaraj S, 2013, ATHEROSCLEROSIS, V228, P94, DOI 10.1016/j.atherosclerosis.2013.02.036; Diosdado B, 2007, CLIN GASTROENTEROL H, V5, P574, DOI 10.1016/j.cgh.2006.11.014; Egert S, 2011, CURR OPIN CLIN NUTR, V14, P121, DOI 10.1097/MCO.0b013e3283439622; Fer M, 2008, J LIPID RES, V49, P2379, DOI 10.1194/jlr.M800199-JLR200; Finlin BS, 2013, J NUTR BIOCH; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gkaliagkousi E, 2011, FRONT BIOSCI-LANDMRK, V16, P1873, DOI 10.2741/3828; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; GUENGERICH FP, 1991, J BIOL CHEM, V266, P10019; Huet O, 2013, SHOCK, V39, P83, DOI 10.1097/SHK.0b013e318278ae36; Isenberg JS, 2006, J BIOL CHEM, V281, P26069, DOI 10.1074/jbc.M605040200; Jin RY, 1998, ARCH BIOCHEM BIOPHYS, V359, P89, DOI 10.1006/abbi.1998.0880; Kalsotra A, 2006, PHARMACOL THERAPEUT, V112, P589, DOI 10.1016/j.pharmthera.2006.03.008; Kass DA, 2007, CARDIOVASC RES, V75, P303, DOI 10.1016/j.cardiores.2007.02.031; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Kirstein MN, 2006, RECENT PAT ANTI-CANC, V1, P153, DOI 10.2174/157489206777442269; Koch M, 2013, CURR PHARM DESIGN, V19, P790, DOI 10.2174/138161213804581864; Kris-Etherton PM, 2003, ARTERIOSCL THROM VAS, V23, pE20, DOI 10.1161/01.ATV.0000038493.65177.94; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; LAWSON DL, 1991, EICOSANOIDS, V4, P217; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Liu GM, 2001, P NATL ACAD SCI USA, V98, P7510, DOI 10.1073/pnas.131195198; Lu T, 2004, P NATL ACAD SCI USA, V101, P7112, DOI 10.1073/pnas.0402048101; Lu T, 2007, P NATL ACAD SCI USA, V104, P4365, DOI 10.1073/pnas.0700118104; LYONS RM, 1991, MOL ENDOCRINOL, V5, P1887, DOI 10.1210/mend-5-12-1887; Madonna R, 2012, VASC PHARMACOL, V57, P41, DOI 10.1016/j.vph.2012.02.005; MALIPIERO U, 1990, BIOCHEM BIOPH RES CO, V171, P1145, DOI 10.1016/0006-291X(90)90804-V; Mammi C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014542; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Martinelli R, 2013, ARTERIOSCL THROM VAS, V33, P2566, DOI 10.1161/ATVBAHA.113.301903; Massaro M, 2002, THROMB HAEMOSTASIS, V88, P335; Massaro M, 2010, CELL MOL BIOL, V56, P59, DOI 10.1170/T880; Massaro M, 2006, P NATL ACAD SCI USA, V103, P15184, DOI 10.1073/pnas.0510086103; Massaro M, 2010, CARDIOVASC RES, V86, P311, DOI 10.1093/cvr/cvp375; Mayer H, 2004, ARTERIOSCL THROM VAS, V24, P1192, DOI 10.1161/01.ATV.0000131263.06296.77; Muratoglu SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028846; Myhrstad MCW, 2014, J INTERN MED, V276, P498, DOI 10.1111/joim.12217; NAIK UP, 1995, BIOCHEM J, V310, P155, DOI 10.1042/bj3100155; Narizhneva NV, 2005, FASEB J, V19, P1158, DOI 10.1096/fj.04-3310fje; Nourshargh S, 2006, J LEUKOCYTE BIOL, V80, P714, DOI 10.1189/jlb.1105645; O'Brien KD, 1998, CIRCULATION, V98, P519, DOI 10.1161/01.CIR.98.6.519; Olofsson PS, 2009, CIRC J, V73, P1531, DOI 10.1253/circj.CJ-08-1150; Perisic L, 2013, ARTERIOSCL THROM VAS, V33, P2432, DOI 10.1161/ATVBAHA.113.301743; Qamar A, 2012, CURR OPIN LIPIDOL, V23, P548, DOI 10.1097/MOL.0b013e328359b0a6; Rajashekhar G, 2006, J VASC RES, V43, P193, DOI 10.1159/000090949; Rajeevan MS, 2001, J MOL DIAGN, V3, P26, DOI 10.1016/S1525-1578(10)60646-0; Raju J, 2002, MOL CELL BIOCHEM, V231, P139, DOI 10.1023/A:1014468932482; Rogers NM, 2014, MATRIX BIOL, V37, P92, DOI 10.1016/j.matbio.2014.01.002; Sana TR, 2005, CYTOKINE, V29, P256, DOI 10.1016/j.cyto.2004.11.003; Schmidt S, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-172; Schmidt S, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-105; Schmidt S, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-45; SHIMOKAWA H, 1987, CIRCULATION, V76, P898, DOI 10.1161/01.CIR.76.4.898; Singh NN, 2006, CYTOKINE GROWTH F R, V17, P487, DOI 10.1016/j.cytogfr.2006.09.002; Slevin M, 2006, AM J PATHOL, V168, P1004, DOI 10.2353/ajpath.2006.050471; Sobocki T, 2006, GENE, V366, P128, DOI 10.1016/j.gene.2005.08.025; Spigoni V, 2014, FOOD FUNCT, V5, P1881, DOI [10.1039/C3FO60641D, 10.1039/c3fo60641d]; Sporn MB, 2006, CYTOKINE GROWTH F R, V17, P3, DOI 10.1016/j.cytogfr.2005.09.012; Stiles JM, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-6; Vedin I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035425; Wang TM, 2011, J NUTR BIOCHEM, V22, P187, DOI 10.1016/j.jnutbio.2010.01.007; Williams MR, 2008, ENDOTHELIUM-J ENDOTH, V15, P73, DOI 10.1080/10623320802092443; Woodfin A, 2009, BLOOD, V113, P6246, DOI 10.1182/blood-2008-11-188375; Wu CC, 2014, CARDIOL REV, V22, P1, DOI 10.1097/CRD.0b013e3182961659; Zhao BT, 2003, AM J PHYSIOL-CELL PH, V284, pC1577, DOI 10.1152/ajpcell.00243.2002	82	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129652	10.1371/journal.pone.0129652	http://dx.doi.org/10.1371/journal.pone.0129652			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114549	Green Published, gold			2022-12-27	WOS:000358147500033
J	Provan, SA; Berg, IJ; Hammer, HB; Mathiessen, A; Kvien, TK; Semb, AG				Provan, Sella Aarrestad; Berg, Inger Jorid; Hammer, Hilde Berner; Mathiessen, Alexander; Kvien, Tore Kristian; Semb, Anne Grete			The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab, Abatacept and Tociliziumab	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; ARTERIAL STIFFNESS; DOUBLE-BLIND; THERAPY; MULTICENTER; IMPROVEMENT; REMISSION; LIPIDS	Objectives To assess whether treatment with one of three novel biological DMARDs; rituximab, abatacept or tocilizumab reduce cardiovascular disease (CVD) risk factors in patients with rheumatoid arthritis (RA). Methods This is an open, observational and prospective study with visits at baseline, 3, 6, and 12 months. Patients were assigned to receive rituximab, abatacept or tocilizumab according to clinical indications assessed by an independent rheumatologist. Disease activity was quantified by the disease activity score (DAS28) and extensive ultrasonography. CVD risk was assessed by total cholesterol (TC), high-density lipoprotein cholesterol (HDL-c), blood pressure and arterial stiffness measurements [pulse wave velocity (PWV) and augmentation index (AIx)]. Within group change in disease activity and CVD risk over 3 months was explored using paired samples bivariate tests. Predictors of change in CVD risk at 3 months were identified in linear regression models. Changes in CVD risk markers over the 12-month follow-up in patients receiving rituximab were assessed by mixed models repeated analyses. Results 24 patients on rituximab, 5 on abatacept and 7 on tocilizumab were included. At 3 months PWV was significantly reduced in the tocilizumab group only, but at 12 months rituximab patients showed a significant reduction in PWV. Reduced inflammation at 3 months was associated with increased TC and HDL-c in the entire cohort. Conclusion Treatment with tocilizumab and rituximab reduces PWV, a marker of CVD risk, in patients with RA.	[Provan, Sella Aarrestad; Berg, Inger Jorid; Hammer, Hilde Berner; Mathiessen, Alexander; Kvien, Tore Kristian] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway; [Semb, Anne Grete] Diakonhjemmet Hosp, Dept Rheumatol, Prevent Cardiorheuma Clin, Oslo, Norway	Diakonhjemmet Hospital; Diakonhjemmet Hospital	Provan, SA (corresponding author), Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway.	sellaprovan@gmail.com	emery, paul/B-3560-2013	Provan, Sella/0000-0001-5442-902X	Pahle Legacy	Pahle Legacy	The first Author has received an unrestricted grant of 5000 dollars from the Pahle Legacy. This is an independent Legacy commemorating a deceased rheumatologist in Norway. The money is awarded after Application to an independent board administered by the Norwegian Womens Public Health Association.	Angel K, 2012, AM J HYPERTENS, V25, P644, DOI 10.1038/ajh.2012.12; Backhaus M, 2001, ANN RHEUM DIS, V60, P641, DOI 10.1136/ard.60.7.641; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Fransen J, 2004, RHEUMATOLOGY, V43, P1252, DOI 10.1093/rheumatology/keh297; Gonzalez-Juanatey C, 2008, ARTHRIT RHEUM-ARTHR, V59, P1821, DOI 10.1002/art.24308; Hammer HB, 2010, ANN RHEUM DIS, V69, P1349, DOI 10.1136/ard.2009.126995; Kerekes G, 2009, CLIN RHEUMATOL, V28, P705, DOI 10.1007/s10067-009-1095-1; Kremer JM, 2005, ARTHRITIS RHEUM, V52, P2263, DOI 10.1002/art.21201; Kume K, 2011, J RHEUMATOL, V38, P2169, DOI 10.3899/jrheum.110340; Mathieu S, 2013, BIOL-TARGETS THER, V7, P259, DOI 10.2147/BTT.S52003; Mathieu S, 2012, RHEUMATOLOGY, V51, P1107, DOI 10.1093/rheumatology/kes006; McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037; Nishimoto N, 2004, ARTHRITIS RHEUM-US, V50, P1761, DOI 10.1002/art.20303; Provan SA, 2011, ANN RHEUM DIS, V70, P812, DOI 10.1136/ard.2010.141523; Semb AG, 2010, ANN RHEUM DIS, V69, P1996, DOI 10.1136/ard.2009.126128; Vlachopoulos C, 2005, CIRCULATION, V112, P2193, DOI 10.1161/CIRCULATIONAHA.105.535435; Wong M, 2009, ANN RHEUM DIS, V68, P1277, DOI 10.1136/ard.2007.086157; Zhang J, 2014, ANN RHEUM DIS, V73, P1301, DOI 10.1136/annrheumdis-2013-204715	18	40	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130709	10.1371/journal.pone.0130709	http://dx.doi.org/10.1371/journal.pone.0130709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114946	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500089
J	Truong, T; Karlinski, ZA; O'Hara, C; Cabe, M; Kim, H; Bakowska, JC				Truong, Timothy; Karlinski, Zachary A.; O'Hara, Christopher; Cabe, Maleen; Kim, Hongkyun; Bakowska, Joanna C.			Oxidative Stress in Caenorhabditis elegans: Protective Effects of Spartin	PLOS ONE			English	Article							HEREDITARY SPASTIC PARAPLEGIA; SYNDROME PROTEIN SPARTIN; TROYER-SYNDROME; IDENTIFICATION	Troyer syndrome is caused by a mutation in the SPG20 gene, which results in complete loss of expression of the protein spartin. We generated a genetic model of Troyer syndrome in worms to explore the locomotor consequences of a null mutation of the Caenorhabditis elegans SPG20 orthologue, F57B10.9, also known as spg-20. Spg-20mutants showed decreased length, crawling speed, and thrashing frequency, and had a shorter lifespan than wild-type animals. These results suggest an age-dependent decline in motor function in mutant animals. The drug paraquat was used to induce oxidative stress for 4 days in the animals. We measured survival rate and examined locomotion by measuring crawling speed and thrashing frequency. After 4 days of paraquat exposure, 77% of wild-type animals survived, but only 38% of spg-20 mutant animals survived. Conversely, animals overexpressing spg-20 had a survival rate of 95%. We also tested lifespan after a 1 hour exposure to sodium azide. After a 24 hour recovery period, 87% of wild type animals survived, 57% of spg-20 mutant animals survived, and 82% of animals overexpressing spg-20 survived. In the behavioral assays, spg-20mutant animals showed a significant decrease in both crawling speed and thrashing frequency compared with wild-type animals. Importantly, the locomotor phenotype for both crawling and thrashing was rescued in animals overexpressing spg-20. The animals overexpressing spg-20 had crawling speeds and thrashing frequencies similar to those of wild-type animals. These data suggest that the protein F57B10.9/SPG-20 might have a protective role against oxidative stress.	[Truong, Timothy; Karlinski, Zachary A.; O'Hara, Christopher; Cabe, Maleen; Bakowska, Joanna C.] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Kim, Hongkyun] Rosalind Franklin Univ Med & Sci, Dept Cell Biol & Anat, N Chicago, IL USA	Loyola University Chicago; Rosalind Franklin University Medical & Science	Bakowska, JC (corresponding author), Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA.	jbakowska@luc.edu		Kim, Hongkyun/0000-0002-4879-7122	National Institutes of Health [NS 073967]; Loyola University Chicago; Department of Molecular Pharmacology and Therapeutics; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Loyola University Chicago; Department of Molecular Pharmacology and Therapeutics; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health (NS 073967; http://www.nih.gov/), Loyola University Chicago, Department of Molecular Pharmacology and Therapeutics (start up; http://www.stritch.luc.edu/pharmacology/).	Back P, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/608478; Bakowska JC, 2005, BIOCHEM BIOPH RES CO, V334, P1042, DOI 10.1016/j.bbrc.2005.06.201; Bakowska JC, 2008, ARCH NEUROL-CHICAGO, V65, P520, DOI 10.1001/archneur.65.4.520; Bakowska JC, 2007, MOL BIOL CELL, V18, P1683, DOI 10.1091/mbc.E06-09-0833; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; Chakraborty S, 2013, INT J MOL SCI, V14, P23103, DOI 10.3390/ijms141123103; Ciccarelli FD, 2003, GENOMICS, V81, P437, DOI 10.1016/S0888-7543(03)00011-9; Collins James J, 2008, WormBook, P1, DOI 10.1895/wormbook.1.137.1; Crosby AH, 2002, AM J HUM GENET, V71, P1009, DOI 10.1086/344206; CROSS HE, 1967, ARCH NEUROL-CHICAGO, V16, P473, DOI 10.1001/archneur.1967.00470230025003; HARDING AE, 1983, LANCET, V1, P1151; Joshi DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019290; Karlsson AB, 2014, MOL BIOL CELL, V25, P1355, DOI 10.1091/mbc.E13-11-0705; Kumsta C, 2011, ANTIOXID REDOX SIGN, V14, P1023, DOI 10.1089/ars.2010.3203; Lu J, 2006, J NEUROCHEM, V98, P1908, DOI 10.1111/j.1471-4159.2006.04008.x; Milewska M, 2009, J NEUROCHEM, V111, P1022, DOI 10.1111/j.1471-4159.2009.06382.x; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Nahm M, 2013, NEURON, V77, P680, DOI 10.1016/j.neuron.2012.12.015; Park J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023211; Proukakis C, 2002, J NEUROL SCI, V201, P65, DOI 10.1016/S0022-510X(02)00192-2; Renvoise B, 2012, HUM MOL GENET, V21, P3604, DOI 10.1093/hmg/dds191; Robay D, 2006, EXP CELL RES, V312, P2764, DOI 10.1016/j.yexcr.2006.05.003; Sarmann J, 2009, J BIOL CHEM, V284, P16482, DOI 10.1074/jbc.M808255200; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Therrien M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083450; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Zhou KI, 2011, AGING-US, V3, P733, DOI 10.18632/aging.100367	27	9	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130455	10.1371/journal.pone.0130455	http://dx.doi.org/10.1371/journal.pone.0130455			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114733	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500074
J	Wu, ZH; Lu, K; Zhu, Y				Wu, Zhihong; Lu, Ke; Zhu, Yuan			A Practical Torque Estimation Method for Interior Permanent Magnet Synchronous Machine in Electric Vehicles	PLOS ONE			English	Article							ENERGY MANAGEMENT; MOTOR-DRIVES; HYBRID BUS; COMPENSATION; PMSM; EFFICIENCY	The torque output accuracy of the IPMSM in electric vehicles using a state of the art MTPA strategy highly depends on the accuracy of machine parameters, thus, a torque estimation method is necessary for the safety of the vehicle. In this paper, a torque estimation method based on flux estimator with a modified low pass filter is presented. Moreover, by taking into account the non-ideal characteristic of the inverter, the torque estimation accuracy is improved significantly. The effectiveness of the proposed method is demonstrated through MATLAB/Simulink simulation and experiment.	[Wu, Zhihong; Lu, Ke] Tongji Univ, Sch Automot Engn, Shanghai 200092, Peoples R China; [Wu, Zhihong; Lu, Ke; Zhu, Yuan] Tongji Univ, Sino German Sch Postgrad Studies, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Zhu, Y (corresponding author), Tongji Univ, Sino German Sch Postgrad Studies, Shanghai 200092, Peoples R China.	yuan.zhu@tongji.edu.cn						Chen W, 2012, 7 INT POW EL MOT CON, V4, P2462; Choi JW, 1996, IEEE T POWER ELECTR, V11, P221, DOI 10.1109/63.486169; Choudhury A, 2012, 38 ANN C IEEE IND EL, P2965; Frieske B, 2013, HYBRID FUEL CELL ELE, V11, P1; Hu XS, 2015, IEEE-ASME T MECH, V20, P457, DOI 10.1109/TMECH.2014.2336264; Hu XS, 2014, IEEE T INTELL TRANSP, V15, P1193, DOI 10.1109/TITS.2013.2294675; Hu XS, 2013, APPL ENERG, V111, P1001, DOI 10.1016/j.apenergy.2013.06.056; Kim HW, 2006, IEEE T CONTR SYST T, V14, P589, DOI 10.1109/TCST.2006.876622; Kim HB, 2002, IEEE POWER ELECTRON, P815, DOI 10.1109/PSEC.2002.1022554; Kim YS, 2007, 42 IAS ANN M 2007 IE, V9, P1301; Li ZY, 2012, COMPUT ENG APPL, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0040132; Mohamed YARB, 2007, IEEE T IND ELECTRON, V54, P2491, DOI 10.1109/TIE.2007.900320; MORIMOTO S, 1993, IEEE T IND APPL, V29, P338, DOI 10.1109/28.216541; MORIMOTO S, 1994, IEEE T IND APPL, V30, P1632, DOI 10.1109/TIA.1994.350318; Rang G, 2004, 19 ANN IEEE APPL POW, V3, P1617; Wijenayake AH, 1997, 1997 INTERNATIONAL CONFERENCE ON POWER ELECTRONICS AND DRIVE SYSTEMS, PROCEEDINGS, VOLS 1 AND 2, P530, DOI 10.1109/PEDS.1997.627416; Xu JX, 2004, IEEE T IND ELECTRON, V51, P526, DOI 10.1109/TIE.2004.825365; Zhong L, 1997, IEEE T POWER ELECTR, V12, P528, DOI 10.1109/63.575680	18	1	1	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130923	10.1371/journal.pone.0130923	http://dx.doi.org/10.1371/journal.pone.0130923			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114557	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500111
J	Zolotarov, Y; Stromvik, M				Zolotarov, Yevgen; Stroemvik, Martina			De Novo Regulatory Motif Discovery Identifies Significant Motifs in Promoters of Five Classes of Plant Dehydrin Genes	PLOS ONE			English	Article							DRAFT GENOME SEQUENCE; LOW-TEMPERATURE; COLD-ACCLIMATION; CIS-ELEMENTS; RESPONSIVE ELEMENT; FREEZING TOLERANCE; MOLECULAR-BIOLOGY; PROVIDES INSIGHTS; PROTEIN-BINDING; G-BOX	Plants accumulate dehydrins in response to osmotic stresses. Dehydrins are divided into five different classes, which are thought to be regulated in different manners. To better understand differences in transcriptional regulation of the five dehydrin classes, de novo motif discovery was performed on 350 dehydrin promoter sequences from a total of 51 plant genomes. Overrepresented motifs were identified in the promoters of five dehydrin classes. The K-n dehydrin promoters contain motifs linked with meristem specific expression, as well as motifs linked with cold/dehydration and abscisic acid response. KS dehydrin promoters contain a motif with a GATA core. SKn and YnSKn dehydrin promoters contain motifs that match elements connected with cold/dehydration, abscisic acid and light response. YnKn dehydrin promoters contain motifs that match abscisic acid and light response elements, but not cold/dehydration response elements. Conserved promoter motifs are present in the dehydrin classes and across different plant lineages, indicating that dehydrin gene regulation is likely also conserved.	[Zolotarov, Yevgen; Stroemvik, Martina] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ H9X 3V9, Canada	McGill University	Stromvik, M (corresponding author), McGill Univ, Dept Plant Sci, Macdonald Campus,21111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada.	martina.stromvik@mcgill.ca	Zolotarov, Yevgen/AAK-6125-2021	Zolotarov, Yevgen/0000-0001-5445-1219; Stromvik, Martina/0000-0002-0501-3703	Natural Sciences and Engineering Research Council of Canada (NSERC) [283303]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from Natural Sciences and Engineering Research Council of Canada (NSERC) (Grant no. 283303) to M.V.S.	Abba' S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-39; Agarwal PK, 2010, BIOL PLANTARUM, V54, P201, DOI 10.1007/s10535-010-0038-7; Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Albert VA, 2013, SCIENCE, V342, P1467, DOI 10.1126/science.1241089; Allagulova CR, 2003, BIOCHEMISTRY-MOSCOW+, V68, P945, DOI 10.1023/A:1026077825584; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Archambault A, 2012, MOL GENET GENOMICS, V287, P123, DOI 10.1007/s00438-011-0664-6; Archambault A, 2011, FUNCT INTEGR GENOMIC, V11, P497, DOI 10.1007/s10142-011-0223-6; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Busk PK, 1997, PLANT CELL, V9, P2261, DOI 10.1105/tpc.9.12.2261; Busk PK, 1998, PLANT MOL BIOL, V37, P425, DOI 10.1023/A:1006058700720; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Chen Jiajia, 2013, Biomed Res Int, V2013, P658925, DOI 10.1155/2013/658925; Cheng F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-136; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Choi DW, 1999, THEOR APPL GENET, V98, P1234, DOI 10.1007/s001220051189; Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x; Close TJ, 1996, PHYSIOL PLANTARUM, V97, P795, DOI 10.1111/j.1399-3054.1996.tb00546.x; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Degenhardt J, 1996, PLANT CELL, V8, P31, DOI 10.1105/tpc.8.1.31; Delahaie J, 2013, J EXP BOT, V64, P4559, DOI 10.1093/jxb/ert274; Deng ZX, 2005, DNA SEQUENCE, V16, P28, DOI 10.1080/10425170500040180; Dohm JC, 2014, NATURE, V505, P546, DOI 10.1038/nature12817; DONALD RGK, 1990, EMBO J, V9, P1717, DOI 10.1002/j.1460-2075.1990.tb08295.x; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Drira M, 2013, MOL BIOTECHNOL, V54, P643, DOI 10.1007/s12033-012-9606-8; Eriksson SK, 2011, ECOL STUD-ANAL SYNTH, V215, P289, DOI 10.1007/978-3-642-19106-0_14; Ezcurra I, 1999, PLANT MOL BIOL, V40, P699, DOI 10.1023/A:1006206124512; Fauteux F, 2008, BIOINFORMATICS, V24, P2303, DOI 10.1093/bioinformatics/btn444; Fauteux F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-126; FINCHSAVAGE WE, 1994, PLANTA, V193, P478, DOI 10.1007/BF02411551; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fowler SG, 2005, PLANT PHYSIOL, V137, P961, DOI 10.1104/pp.104.058354; Garcia-Banuelos ML, 2009, PLANT MOL BIOL REP, V27, P476, DOI 10.1007/s11105-009-0110-7; GIULIANO G, 1988, P NATL ACAD SCI USA, V85, P7089, DOI 10.1073/pnas.85.19.7089; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Hara M, 2011, ACTA PHYSIOL PLANT, V33, P2103, DOI 10.1007/s11738-011-0749-1; Hellsten U, 2013, P NATL ACAD SCI USA, V110, P19478, DOI 10.1073/pnas.1319032110; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; HONG JC, 1995, PLANT J, V8, P199, DOI 10.1046/j.1365-313X.1995.08020199.x; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Huang SX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3640; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kans J., 2022, ENTREZ PROGRAMMING U; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kim HJ, 2002, PLANT J, V29, P693, DOI 10.1046/j.1365-313X.2002.01249.x; Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x; Koag MC, 2009, PLANT PHYSIOL, V150, P1503, DOI 10.1104/pp.109.136697; KOSUGI S, 1995, PLANT J, V7, P877, DOI 10.1046/j.1365-313X.1995.07060877.x; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; Kreps J, 2003, PLANT BIOTECHNOL J, V1, P345, DOI 10.1046/j.1467-7652.2003.00032.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Lee CM, 2012, P NATL ACAD SCI USA, V109, P15054, DOI 10.1073/pnas.1211295109; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Martinez-Hernandez A, 2002, PLANT PHYSIOL, V128, P1223, DOI 10.1104/pp.010678; Maruyama K, 2009, PLANT PHYSIOL, V150, P1972, DOI 10.1104/pp.109.135327; Mikkelsen MD, 2009, PLANT J, V60, P328, DOI 10.1111/j.1365-313X.2009.03957.x; Millman KJ, 2011, COMPUT SCI ENG, V13, P9, DOI 10.1109/MCSE.2011.36; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Motamayor JC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r53; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Ngai N, 1997, PLANT J, V12, P1021, DOI 10.1046/j.1365-313X.1997.12051021.x; NORDIN K, 1993, PLANT MOL BIOL, V21, P641, DOI 10.1007/BF00014547; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Ohno R, 2003, J PLANT PHYSIOL, V160, P193, DOI 10.1078/0176-1617-00925; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Ono A, 1996, PLANT PHYSIOL, V112, P483, DOI 10.1104/pp.112.2.483; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Pavesi G, 2001, Bioinformatics, V17 Suppl 1, pS207; Prochnik S, 2012, TROP PLANT BIOL, V5, P88, DOI 10.1007/s12042-011-9088-z; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; Qin F, 2004, PLANT CELL PHYSIOL, V45, P1042, DOI 10.1093/pcp/pch118; Rahman LN, 2013, BBA-BIOMEMBRANES, V1828, P967, DOI 10.1016/j.bbamem.2012.11.031; Rahman LN, 2011, BIOCHEMISTRY-US, V50, P9587, DOI 10.1021/bi201205m; Rawat R, 2005, PLANT MOL BIOL, V57, P629, DOI 10.1007/s11103-005-0954-7; Rorat T, 2004, PLANTA, V218, P878, DOI 10.1007/s00425-003-1171-8; Rorat T, 2006, CELL MOL BIOL LETT, V11, P536, DOI 10.2478/s11658-006-0044-0; Sarnighausen E., 2004, Journal of Crop Improvement, V10, P17, DOI 10.1300/J411v10n01_03; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shih MD, 2008, ADV BOT RES, V48, P211, DOI 10.1016/S0065-2296(08)00404-7; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Skinner JS, 2005, PLANT MOL BIOL, V59, P533, DOI 10.1007/s11103-005-2498-2; Slotte T, 2013, NAT GENET, V45, P831, DOI 10.1038/ng.2669; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; STRAUB PF, 1994, PLANT MOL BIOL, V26, P617, DOI 10.1007/BF00013748; Sunderlikova V, 2009, PLANT CELL REP, V28, P1011, DOI 10.1007/s00299-009-0710-6; Suzuki M, 2005, PLANT PHYSIOL, V139, P437, DOI 10.1104/pp.104.058412; Tatematsu K, 2005, PLANT PHYSIOL, V138, P757, DOI 10.1104/pp.104.057984; Thomashow MF, 2001, PHYSIOL PLANTARUM, V112, P171, DOI 10.1034/j.1399-3054.2001.1120204.x; Tommasini L, 2008, FUNCT INTEGR GENOMIC, V8, P387, DOI 10.1007/s10142-008-0081-z; Toth R, 2001, PLANT PHYSIOL, V127, P1607, DOI 10.1104/pp.010467; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4311; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang ZW, 2012, PLANT J, V72, P461, DOI 10.1111/j.1365-313X.2012.05093.x; Wegrzyn JL, 2014, GENETICS, V196, P891, DOI 10.1534/genetics.113.159996; Welling A, 2004, J EXP BOT, V55, P507, DOI 10.1093/jxb/erh045; Wisniewski ME, 2006, TREE PHYSIOL, V26, P575, DOI 10.1093/treephys/26.5.575; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Xu NF, 1997, PLANT SCI, V126, P193, DOI 10.1016/S0168-9452(97)00110-6; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yamasaki Y, 2013, PLANT PHYSIOL BIOCH, V70, P213, DOI 10.1016/j.plaphy.2013.05.013; Yang RL, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00046; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zimmer AD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-498	130	18	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129016	10.1371/journal.pone.0129016	http://dx.doi.org/10.1371/journal.pone.0129016			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114291	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500018
J	Beckmann, BC; Purse, BV; Roy, DB; Roy, HE; Sutton, PG; Thomas, CD				Beckmann, Bjoern C.; Purse, Bethan V.; Roy, David B.; Roy, Helen E.; Sutton, Peter G.; Thomas, Chris D.			Two Species with an Unusual Combination of Traits Dominate Responses of British Grasshoppers and Crickets to Environmental Change	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; CLIMATE-CHANGE; RANGE EXPANSION; BUSH-CRICKET; DISTRIBUTION PATTERNS; HABITAT ASSOCIATIONS; LAND-USE; ORTHOPTERA; BUTTERFLIES; DISPERSAL	There are large variations in the responses of species to the environmental changes of recent decades, heightening interest in whether their traits may explain inter-specific differences in range expansions and contractions. Using a long-term distributional dataset, we calculated range changes of grasshoppers and crickets in Britain between the 1980s and the 2000s and assessed whether their traits (resource use, life history, dispersal ability, geographic location) explain relative performance of different species. Our analysis showed large changes in the distributions of some species, and we found a positive relationship between three traits and range change: ranges tended to increase for habitat generalists, species that oviposit in the vegetation above ground, and for those with a southerly distribution. These findings accord well with the nature of environmental changes over this period (climatic warming; reductions in the diversity and increases in the height of vegetation). However, the trait effects applied mainly to just two species, Conocephalus discolorand Metrioptera roeselii, which had shown the greatest range increases. Once they were omitted from the analysis, trait effects were no longer statistically significant. Previous studies on these two species emphasised wing-length dimorphism as the key to their success, resulting in a high phenotypic plasticity of dispersal and evolutionary-ecological feedback at their expanding range margins. This, combined with our results, suggests that an unusual combination of traits have enabled these two species to undertake extremely rapid responses to recent environmental changes. The fact that our results are dominated by two species only became apparent through cautious testing of the results' robustness, not through standard statistical checks. We conclude that trait-based analyses may contribute to the assessment of species responses to environmental change and provide insights into underlying mechanisms, but results need to be interpreted with caution and may have limited predictive power.	[Beckmann, Bjoern C.; Purse, Bethan V.; Roy, David B.; Roy, Helen E.] Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Beckmann, Bjoern C.; Thomas, Chris D.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Beckmann, Bjoern C.; Sutton, Peter G.] Ctr Ecol & Hydrol, Biol Records Ctr, Orthoptera & Allied Insects Recording Scheme Brit, Wallingford, Oxon, England	UK Centre for Ecology & Hydrology (UKCEH); University of York - UK; UK Centre for Ecology & Hydrology (UKCEH)	Beckmann, BC (corresponding author), Ctr Ecol & Hydrol, Wallingford, Oxon, England.	bjck@ceh.ac.uk	Roy, David/A-6619-2009; Thomas, Chris D/A-1894-2012; Thomas, Chris D/A-1460-2014; Roy, Helen/A-1488-2010; Purse, Bethan V/I-6640-2012	Roy, David/0000-0002-5147-0331; Thomas, Chris D/0000-0003-2822-1334; Thomas, Chris D/0000-0003-2822-1334; Purse, Bethan V/0000-0001-5140-2710; Beckmann, Bjorn/0000-0002-9918-3198	Joint Nature Conservation Committee; Natural Environment Research Council [EC04932]; Natural Environment Research Council [ceh020002] Funding Source: researchfish; NERC [ceh020002] Funding Source: UKRI	Joint Nature Conservation Committee; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work of BCB, BVP, DBR and HER for the Biological Records Centre (www.brc.ac.uk) was co-funded by the Joint Nature Conservation Committee (http://jncc.defra.gov.uk) and the Natural Environment Research Council (www.nerc.ac.uk), through national capability funding to the Centre for Ecology & Hydrology (www.ceh.ac.uk) (project EC04932). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Altermatt F, 2010, P ROY SOC B-BIOL SCI, V277, P1281, DOI 10.1098/rspb.2009.1910; Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; [Anonymous], 2013, ORTH REC SCHEM GRASS; [Anonymous], 2013, ORTH REC SCH ORTH AL; [Anonymous], 2014, ORTHOPTERA ALLIED IN; Bennie J, 2013, ECOL LETT, V16, P921, DOI 10.1111/ele.12129; Benton T., 2012, NEW NATURALIST LIB 1; Blockeel T. L., 2014, ATLAS BRIT IRISH BRY, V1; Buckley LB, 2012, ANNU REV ECOL EVOL S, V43, P205, DOI 10.1146/annurev-ecolsys-110411-160516; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burton J.F., 2003, P 13 INT C EUR INV S, P13; Carey P.D., 2008, COUNTRYSIDE SURVEY U; Carvell C, 2002, BIOL CONSERV, V103, P33, DOI 10.1016/S0006-3207(01)00114-8; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cherrill Andrew, 2010, Journal of Orthoptera Research, V19, P293, DOI 10.1665/034.019.0217; Comont RF, 2012, J BIOGEOGR, V39, P1772, DOI 10.1111/j.1365-2699.2012.02734.x; Crozier RH, 2005, EVOL BIOINFORM, V1, P11; Dapporto L, 2013, BIOL CONSERV, V157, P229, DOI 10.1016/j.biocon.2012.09.016; Davies ZG, 2006, J ANIM ECOL, V75, P247, DOI 10.1111/j.1365-2656.2006.01044.x; Department for Environment Food and Rural Affairs, 2010, JUN SURV AGR HORT EN; Detzel P, 1998, HEUSCHRECKEN BADEN W; DEURA K, 1982, PHYSIOL ENTOMOL, V7, P253, DOI 10.1111/j.1365-3032.1982.tb00298.x; Dudley R, 2002, BIOMECHANICS INSECT; Dziock F, 2011, AGR ECOSYST ENVIRON, V145, P85, DOI 10.1016/j.agee.2011.07.015; Eades DC, 2013, ORTHOPTERA SPECIES F; Evans M, 2007, PHOTOGRAPHIC GUIDE G; Fox R, 2014, J APPL ECOL, V51, P949, DOI 10.1111/1365-2664.12256; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gallagher AJ, 2015, TRENDS ECOL EVOL, V30, P61, DOI 10.1016/j.tree.2014.12.001; Gardiner Tim, 2009, Journal of Orthoptera Research, V18, P95; Grafen A., 1989, BIOL SCI, V326, P119, DOI DOI 10.1098/RSTB.1989.0106; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hanski I., 1999, METAPOPULATION ECOLO; Harris S., 2008, MAMMALS BRIT ISLES H, V4th; Hendriks RJJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071736; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hill JK, 1999, OECOLOGIA, V121, P165, DOI 10.1007/s004420050918; Hochkirch A, 2009, BIOL J LINN SOC, V97, P118, DOI 10.1111/j.1095-8312.2008.01199.x; HOLM S, 1979, SCAND J STAT, V6, P65; INGRISCH S, 1984, OECOLOGIA, V61, P254, DOI 10.1007/BF00396769; Ingrisch S, 1998, NEUE BREHM BUCHEREI, V629; IPCC, 2014, INT PAN CLIM CHANG W; Isaac NJB, 2014, METHODS ECOL EVOL, V5, P1052, DOI 10.1111/2041-210X.12254; Kleukers R. M. J. C., 1996, Entomologist's Gazette, V47, P37; Mair L, 2012, GLOBAL CHANGE BIOL, V18, P2439, DOI 10.1111/j.1365-2486.2012.02730.x; Marini L, 2010, BIOL CONSERV, V143, P2164, DOI 10.1016/j.biocon.2010.05.029; Marshall JA, 1988, GRASSHOPPERS ALLIED; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Millennium Ecosystem Assessment, 2005, POL RESP NUTR MAN WA; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Ockinger E, 2010, ECOL LETT, V13, P969, DOI 10.1111/j.1461-0248.2010.01487.x; Oliver T, 2009, ECOL LETT, V12, P1091, DOI 10.1111/j.1461-0248.2009.01367.x; Oliver TH, 2012, GLOBAL CHANGE BIOL, V18, P2720, DOI 10.1111/j.1365-2486.2012.02737.x; Orme D., 2018, R PACKAGE VERSION, V5, P1; OSCHMANN M, 1991, Faunistische Abhandlungen (Dresden), V18, P51; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2011, ANAL PHYLOGENETICS E, DOI DOI 10.1086/523369; PARKER DE, 1992, INT J CLIMATOL, V12, P317, DOI 10.1002/joc.3370120402; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pocock MJO, 2011, P ROY SOC B-BIOL SCI, V278, P1532, DOI 10.1098/rspb.2010.1971; Pocock MJO, 2006, J ECOL, V94, P581, DOI 10.1111/j.1365-2745.2006.01123.x; Poniatowski D, 2012, EVOL ECOL, V26, P759, DOI 10.1007/s10682-011-9534-2; Poniatowski D, 2011, AGR ECOSYST ENVIRON, V145, P5, DOI 10.1016/j.agee.2010.10.006; Powney GD, 2014, GLOBAL ECOL BIOGEOGR, V23, P1009, DOI 10.1111/geb.12189; Purse BV, 2012, EUR J ENTOMOL, V109, P543, DOI 10.14411/eje.2012.068; R Core Team, 2013, LANG ENV STAT COMP, DOI [DOI 10.3758/S13428-013-0330-5, 10.3758/s13428-013-0330-5]; Reinhardt K, 2005, ECOGRAPHY, V28, P593, DOI 10.1111/j.2005.0906-7590.04285.x; Roy DB, 2000, GLOB CHANGE BIOL, V6, P407, DOI 10.1046/j.1365-2486.2000.00322.x; Schouten MA, 2007, J BIOGEOGR, V34, P1938, DOI 10.1111/j.1365-2699.2007.01742.x; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Simmons AD, 2004, AM NAT, V164, P378, DOI 10.1086/423430; Stevens CJ, 2011, COLLATION EVIDENCE N; Suggitt AJ, 2011, OIKOS, V120, P1, DOI 10.1111/j.1600-0706.2010.18270.x; Sutherland W.J., 1995, MANAGING HABITATS CO; Sutton PG, 2007, BRIT WILDLIFE, V18, P203; Sutton PG, 2008, BRIT WILDLIFE, V19, P432; Telfer MG, 2002, BIOL CONSERV, V107, P99, DOI 10.1016/S0006-3207(02)00050-2; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Thomas JA, 2009, SCIENCE, V325, P80, DOI 10.1126/science.1175726; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; Travis JMJ, 2002, EVOL ECOL RES, V4, P1119; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Whitman Douglas W., 2008, Journal of Orthoptera Research, V17, P117, DOI 10.1665/1082-6467-17.2.117; Williamson M, 1999, ECOGRAPHY, V22, P674, DOI 10.1111/j.1600-0587.1999.tb00516.x; Willott SJ, 1998, FUNCT ECOL, V12, P232, DOI 10.1046/j.1365-2435.1998.00180.x; Wilson RJ, 2004, NATURE, V432, P393, DOI 10.1038/nature03031; Wolff E, 2014, CLIMATE CHANGE EVIDE; [No title captured]	93	17	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130488	10.1371/journal.pone.0130488	http://dx.doi.org/10.1371/journal.pone.0130488			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110844	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000356933800053
J	Brivio, F; Grignolio, S; Sica, N; Cerise, S; Bassano, B				Brivio, Francesca; Grignolio, Stefano; Sica, Nicoletta; Cerise, Stefano; Bassano, Bruno			Assessing the Impact of Capture on Wild Animals: The Case Study of Chemical Immobilisation on Alpine Ibex	PLOS ONE			English	Article							SHEEP OVIS-CANADENSIS; CAPRA-IBEX; ROE DEER; BIOLOGICAL PARAMETERS; CORTISOL METABOLITES; BEHAVIORAL ECOLOGY; PHYSICAL RESTRAINT; ACTIVITY PATTERNS; MODEL SELECTION; PREGNANT MOOSE	The importance of capturing wild animals for research and conservation projects is widely shared. As this activity continues to become more common, the need to assess its negative effects increases so as to ensure ethical standards and the validity of research results. Increasing evidence has revealed that indirect (physiological and behavioural) effects of capture are as important as direct risks (death or injury) and that different capture methodologies can cause heterogeneous effects. We investigated the influence of chemical immobilisation on Alpine ibex (Capra ibex): during the days following the capture we collected data on spatial behaviour, activity levels of both males and females, and male hormone levels. Moreover, we recorded the reproductive status of each marked female during the breeding seasons of 15 years. Then, by several a priori models we investigated the effects of the capture taking into account biological factors and changes in environmental conditions. Our results showed that chemical immobilisation did not affect either spatial behaviour (for both males and females) or male hormone levels, though both sexes showed reduced activity levels up to two days after the capture. The capture did not significantly affect the likelihood for a female to give birth in the following summer. Our findings highlighted the scarce impact of chemical immobilisation on ibex biology, as we detected alteration of activity levels only immediately after the capture if compared to the following days (i.e., baseline situation). Hence, the comparison of our findings with previous research showed that our methodology is one of the less invasive procedures to capture large mammals. Nonetheless, in areas characterised by high predator density, we suggest that animals released be carefully monitored for some hours after the capture. Moreover, researchers should avoid considering data collected during the first days after the manipulation in order to avoid biased information.	[Brivio, Francesca; Grignolio, Stefano; Sica, Nicoletta] Univ Sassari, Dept Sci Nat & Environm Resources, I-07100 Sassari, Italy; [Cerise, Stefano; Bassano, Bruno] Alpine Wildlife Res Ctr & Surveillance Serv, Turin, Italy	University of Sassari	Brivio, F (corresponding author), Univ Sassari, Dept Sci Nat & Environm Resources, I-07100 Sassari, Italy.	fbrivio@uniss.it	Grignolio, Stefano/AAS-2988-2020; Francesca, Brivio/ABF-9092-2020	Grignolio, Stefano/0000-0002-0786-2004; Francesca, Brivio/0000-0002-1449-8335	GREAT (Great Herbivores in Transforming Alpine Ecosystems); UE-ERDF (European Regional Development Fund); Italian Ministry of Education, University and Research (PRIN) [20108 TZKHC, J81J12000790001]; Autonomous Region of Sardinia "P.O.R. F.S.E. Obiettivo competitivita regionale e occupazione. Asse IV Capitale umano-Linea di attivita 1.3.1"	GREAT (Great Herbivores in Transforming Alpine Ecosystems); UE-ERDF (European Regional Development Fund); Italian Ministry of Education, University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Autonomous Region of Sardinia "P.O.R. F.S.E. Obiettivo competitivita regionale e occupazione. Asse IV Capitale umano-Linea di attivita 1.3.1"	Part of this work was funded within the framework of GREAT (Great Herbivores in Transforming Alpine Ecosystems), a project co-funded by the UE-ERDF (European Regional Development Fund) through the cross-border cooperation programme Interreg IVA, Italy-Switzerland 2007-2013. FB post-doc grant and this project were also supported by the Italian Ministry of Education, University and Research (PRIN 2010-2011, 20108 TZKHC, J81J12000790001). SG had the support of the fund granted by the Autonomous Region of Sardinia "P.O.R. F.S.E. 2007-2013 Obiettivo competitivita regionale e occupazione. Asse IV Capitale umano-Linea di attivita 1.3.1". All these funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibhai SK, 2001, J ZOOL, V253, P333, DOI 10.1017/S0952836901000309; [Anonymous], 2014, R LANG ENV STAT COMP; Apollonio M, 2013, BEHAV PROCESS, V98, P44, DOI 10.1016/j.beproc.2013.05.001; Arnemo JM, 2006, WILDLIFE BIOL, V12, P109, DOI 10.2981/0909-6396(2006)12[109:ROCMIL]2.0.CO;2; Aublet JF, 2009, OECOLOGIA, V159, P237, DOI 10.1007/s00442-008-1198-4; Bassano B, 2004, CALTURA UNGULATI MON; BERGER J, 1983, J WILDLIFE DIS, V19, P265, DOI 10.7589/0090-3558-19.3.265; Beringer J, 1996, J WILDLIFE MANAGE, V60, P373, DOI 10.2307/3802238; Bishop CJ, 2007, J WILDLIFE MANAGE, V71, P945, DOI 10.2193/2006-123; Blanc F, 1997, Z SAUGETIERKD, V62, P18; BOAG DA, 1972, J WILDLIFE MANAGE, V36, P511, DOI 10.2307/3799082; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Casady DS, 2013, CALIF FISH GAME, V99, P104; Cattet M, 2008, J MAMMAL, V89, P973, DOI 10.1644/08-MAMM-A-095.1; Chi DK, 1998, URSUS-SERIES, V10, P563; Cote SD, 1998, J WILDLIFE MANAGE, V62, P745, DOI 10.2307/3802351; Creel S, 1997, CONSERV BIOL, V11, P544, DOI 10.1046/j.1523-1739.1997.95476.x; DELGIUDICE GD, 1990, J WILDLIFE MANAGE, V54, P299, DOI 10.2307/3809046; DELGIUDICE GD, 1986, J WILDLIFE DIS, V22, P245, DOI 10.7589/0090-3558-22.2.245; Dematteis A, 2009, EUR J WILDLIFE RES, V55, P567, DOI 10.1007/s10344-009-0270-7; DeNicola AJ, 1997, WILDLIFE SOC B, V25, P500; Diverio S, 1996, APPL ANIM BEHAV SCI, V49, P83, DOI 10.1016/0168-1591(95)00670-2; Dochtermann NA, 2011, BEHAV ECOL SOCIOBIOL, V65, P37, DOI 10.1007/s00265-010-1039-4; Ferris R.M., 1990, Transactions of the Western Section of the Wildlife Society, V26, P68; Garshelis DL, 2006, URSUS, V17, P109, DOI 10.2192/1537-6176(2006)17[109:OTAONG]2.0.CO;2; GEORGII B, 1981, OECOLOGIA, V49, P127, DOI 10.1007/BF00376910; Ghurashi M. A. H., 2009, Australian Journal of Basic and Applied Sciences, V3, P455; Grignolio S, 2004, ETHOL ECOL EVOL, V16, P255; Grignolio S, 2007, J MAMMAL, V88, P1488, DOI 10.1644/06-MAMM-A-351R.1; Haulton SM, 2001, WILDLIFE SOC B, V29, P255; Haviernick M, 1998, J WILDLIFE DIS, V34, P342, DOI 10.7589/0090-3558-34.2.342; Ingram JR, 1999, J ENDOCRINOL, V162, P289, DOI 10.1677/joe.0.1620289; Jacques CN, 2009, J WILDLIFE MANAGE, V73, P1282, DOI 10.2193/2009-039; KATILA T, 1988, EQUINE VET J, V20, P323, DOI 10.1111/j.2042-3306.1988.tb01536.x; Kilpatrick HJ, 1999, WILDLIFE SOC B, V27, P566; KO JCH, 1990, THERIOGENOLOGY, V33, P601, DOI 10.1016/0093-691X(90)90537-4; KOCK MD, 1987, J WILDLIFE DIS, V23, P641, DOI 10.7589/0090-3558-23.4.641; KOCK MD, 1987, J WILDLIFE DIS, V23, P652, DOI 10.7589/0090-3558-23.4.652; Kreeger TJ, 2002, HDB WILDLIFE CHEM IM; Krop-Benesch A, 2011, ACTIVITY PATTERN USE; KUMAR A, 1979, LAB ANIM SCI, V29, P486; LARSEN DG, 1989, J WILDLIFE MANAGE, V53, P564, DOI 10.2307/3809177; Laske Timothy G., 2011, BMC Physiology, V11, P13, DOI 10.1186/1472-6793-11-13; LIN HC, 1996, LUMB JONES VET ANEST, P241; Linnell JDC, 1997, BIODIVERS CONSERV, V6, P1245, DOI 10.1023/B:BIOC.0000034011.05412.cd; Mayer D, 1996, J VET MED B, V43, P155, DOI 10.1111/j.1439-0450.1996.tb00300.x; Moa P, 2001, WILDLIFE SOC B, V29, P86; Mohammed A.A., 2011, AUST J BASIC APPL SC, V5, P1296; Montane J, 2003, J WILDLIFE DIS, V39, P375, DOI 10.7589/0090-3558-39.2.375; Morellet N, 2009, WILDLIFE BIOL, V15, P278, DOI 10.2981/08-084; Mostl E, 2002, VET RES COMMUN, V26, P127, DOI 10.1023/A:1014095618125; Neumann W, 2011, CAN J ZOOL, V89, P1013, DOI 10.1139/Z11-076; Northrup JM, 2014, J WILDLIFE MANAGE, V78, P731, DOI 10.1002/jwmg.705; Pagon N, 2013, CHRONOBIOL INT, V30, P772, DOI 10.3109/07420528.2013.765887; PALME R, 1994, ADVANCES IN STEROID ANALYSIS '93, P111; Palme R, 1997, Z SAUGETIERKD, V62, P192; Palmegiani I, 2013, FOLIA ZOOL, V62, P59; PEINADO VI, 1993, VET REC, V132, P580, DOI 10.1136/vr.132.23.580; Pettorelli N, 2007, ECOLOGY, V88, P381, DOI 10.1890/06-0875; Posautz C, 2010, THESIS; Powell RA, 2003, ILAR J, V44, P259, DOI 10.1093/ilar.44.4.259; Quinn ACD, 2012, J MAMMAL, V93, P456, DOI 10.1644/10-MAMM-A-422.1; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Sakamoto H, 1996, J VET MED SCI, V58, P211, DOI 10.1292/jvms.58.211; Sica N, 2014, THESIS; Signer C, 2011, FUNCT ECOL, V25, P537, DOI 10.1111/j.1365-2435.2010.01806.x; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Solberg Erling Johan, 2003, Alces, V39, P65; Spraker Terry R., 1993, P481; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Tettamanti F, 2014, THESIS; VALKENBURG P, 1983, J WILDLIFE MANAGE, V47, P1233, DOI 10.2307/3808201; Veilleux-Lemieux D, 2012, VET MED-RES REP, V3, P99, DOI 10.2147/VMRR.S35666; von Hardenberg A, 2004, J ZOOL, V263, P425, DOI 10.1017/S0952836904005485; Wasserman MD, 2013, INT J PRIMATOL, V34, P1020, DOI 10.1007/s10764-013-9711-y; WESSON JA, 1979, CAN J ZOOL, V57, P756, DOI 10.1139/z79-093; WESSON JA, 1979, CAN J ZOOL, V57, P768, DOI 10.1139/z79-094; Wiesner H, 1985, Tierarztl Prax, V13, P113; Yadav GU, 2008, VET WORLD, V1, P340	80	33	33	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130957	10.1371/journal.pone.0130957	http://dx.doi.org/10.1371/journal.pone.0130957			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111118	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800103
J	Diao, YN; Rodriguez, V; Klingbeil, M; Arsuaga, J				Diao, Yuanan; Rodriguez, Victor; Klingbeil, Michele; Arsuaga, Javier			Orientation of DNA Minicircles Balances Density and Topological Complexity in Kinetoplast DNA	PLOS ONE			English	Article							SEQUENCE-BINDING-PROTEIN; TOPOISOMERASE-II; TRYPANOSOME MITOCHONDRIA; UNIVERSAL MINICIRCLE; REPLICATION; NETWORK; PROTOZOAN; GENE; ULTRASTRUCTURE; PROBABILITY	Kinetoplast DNA (kDNA), a unique mitochondrial structure common to trypanosomatid parasites, contains thousands of DNA minicircles that are densely packed and can be topologically linked into a chain mail-like network. Experimental data indicate that every minicircle in the network is, on average, singly linked to three other minicircles (i.e., has mean valence 3) before replication and to six minicircles in the late stages of replication. The biophysical factors that determine the topology of the network and its changes during the cell cycle remain unknown. Using a mathematical modeling approach, we previously showed that volume confinement alone can drive the formation of the network and that it induces a linear relationship between mean valence and minicircle density. Our modeling also predicted a minicircle valence two orders of magnitude greater than that observed in kDNA. To determine the factors that contribute to this discrepancy we systematically analyzed the relationship between the topological properties of the network (i.e., minicircle density and mean valence) and its biophysical properties such as DNA bending, electrostatic repulsion, and minicircle relative position and orientation. Significantly, our results showed that most of the discrepancy between the theoretical and experimental observations can be accounted for by the orientation of the minicircles with volume exclusion due to electrostatic interactions and DNA bending playing smaller roles. Our results are in agreement with the three dimensional kDNA organization model, initially proposed by Delain and Riou, in which minicircles are oriented almost perpendicular to the horizontal plane of the kDNA disk. We suggest that while minicircle confinement drives the formation of kDNA networks, it is minicircle orientation that regulates the topological complexity of the network.	[Diao, Yuanan] Univ N Carolina, Dept Math & Stat, Charlotte, NC 28223 USA; [Rodriguez, Victor] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Klingbeil, Michele] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Arsuaga, Javier] Univ Calif Davis, Dept Math, Davis, CA 95616 USA; [Arsuaga, Javier] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of North Carolina; University of North Carolina Charlotte; Columbia University; University of Massachusetts System; University of Massachusetts Amherst; University of California System; University of California Davis; University of California System; University of California Davis	Arsuaga, J (corresponding author), Univ Calif Davis, Dept Math, Davis, CA 95616 USA.	jarsuaga@ucdavis.edu		Klingbeil, Michele/0000-0002-7236-8424	NSF [DMS-0920887, DMS-0920880, DMS-1016460]; NIH [1R01GM109457]; Chinese NSF grant [91324201]; NIH MBRS-RISE Program [5R25-GM048972]; Binational Science Foundation [2011-156]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109457] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1519133] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese NSF grant; NIH MBRS-RISE Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	J. Arsuaga is partially supported by NSF grants DMS-0920887 and by NIH grant 1R01GM109457 and was a long term visitor at the Institute of Mathematics and Its Applications (IMA) during the academic year 2013-2014. Y. Diao is partially supported by NSF grants DMS-0920880 and DMS-1016460, and by Chinese NSF grant 91324201. V. Rodriguez is supported by the NIH MBRS-RISE Program 5R25-GM048972 (to Dr. F. Bayliss) and by NSF grant DMS-0920887. M. Klingbeil is supported by the Binational Science Foundation 2011-156. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elneel K, 1999, J BIOL CHEM, V274, P13419, DOI 10.1074/jbc.274.19.13419; [Anonymous], 2006, COMPUTATIONAL STUDIE; [Anonymous], PREPRINT; [Anonymous], KNOTPLOT PROGRAM DRA; [Anonymous], J PHYS A; [Anonymous], 2014, MOL BASED MATH BIOL; Arsuaga J, 2012, J STAT PHYS, V146, P434, DOI 10.1007/s10955-011-0386-5; Arsuaga J, 2002, P NATL ACAD SCI USA, V99, P5373, DOI 10.1073/pnas.032095099; Avliyakulov NK, 2004, EUKARYOT CELL, V3, P518, DOI 10.1128/EC.3.2.518-526.2004; AVRAHAMI D, 1995, P NATL ACAD SCI USA, V92, P10511, DOI 10.1073/pnas.92.23.10511; Balana-Fouce R, 2014, INT J PARASITOL-DRUG, V4, P326, DOI 10.1016/j.ijpddr.2014.07.006; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; Cantor C.R., 1980, BIOPHYSICAL CHEM 2; Cavalcanti DP, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-120; Cejka P, 2012, MOL CELL, V47, P886, DOI 10.1016/j.molcel.2012.06.032; Chen JH, 1995, EMBO J, V14, P6339, DOI 10.1002/j.1460-2075.1995.tb00325.x; CHEN JH, 1995, CELL, V80, P61, DOI 10.1016/0092-8674(95)90451-4; Chowdhury AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001226; DELAIN E, 1969, CR ACAD SCI D NAT, V268, P1225; Diao Y, 2012, J MATH BIOL, V64, P1087, DOI 10.1007/s00285-011-0438-0; Diao Y, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/3/035004; Englund PT, 2014, J BIOL CHEM, V289, P33712, DOI 10.1074/jbc.X114.620666; FERGUSON M, 1992, CELL, V70, P621, DOI 10.1016/0092-8674(92)90431-B; Flegontov P, 2013, CURR BIOL, V23, P1787, DOI 10.1016/j.cub.2013.07.045; Harmon FG, 2003, J BIOL CHEM, V278, P42668, DOI 10.1074/jbc.M302994200; Hines JC, 1998, MOL BIOCHEM PARASIT, V94, P41, DOI 10.1016/S0166-6851(98)00048-6; Hirayama N, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/10/105001; HSIEH T, 1983, J BIOL CHEM, V258, P8413; Jensen RE, 2012, ANNU REV MICROBIOL, V66, P473, DOI 10.1146/annurev-micro-092611-150057; Kapeller K, 2011, J BIOL CHEM, V286, P40566, DOI 10.1074/jbc.M111.270322; Kimura K, 1999, CELL, V98, P239, DOI 10.1016/S0092-8674(00)81018-1; Klenin K, 2000, BIOPOLYMERS, V54, P307, DOI 10.1002/1097-0282(20001015)54:5<307::AID-BIP20>3.0.CO;2-Y; KREUZER KN, 1980, CELL, V20, P245, DOI 10.1016/0092-8674(80)90252-4; LEFORESTIER A, 1993, BIOPHYS J, V65, P56, DOI 10.1016/S0006-3495(93)81063-4; Lindsay ME, 2008, MOL MICROBIOL, V70, P1465, DOI 10.1111/j.1365-2958.2008.06493.x; Lukes J, 1998, EMBO J, V17, P838, DOI 10.1093/emboj/17.3.838; Lukes J, 2002, EUKARYOT CELL, V1, P495, DOI 10.1128/EC.1.4.495-502.2002; Lukes J, 2001, MOL BIOCHEM PARASIT, V117, P179, DOI 10.1016/S0166-6851(01)00348-6; Lukes J, 2014, MOL BIOCHEM PARASIT, V195, P115, DOI 10.1016/j.molbiopara.2014.05.007; MARINI JC, 1982, COLD SPRING HARB SYM, V47, P279; MASLOV DA, 1994, MOL CELL BIOL, V14, P8174, DOI 10.1128/MCB.14.12.8174; Ogbadoyi EO, 2003, MOL BIOL CELL, V14, P1769, DOI 10.1091/mbc.E02-08-0525; Onn I, 2006, J BIOL CHEM, V281, P37468, DOI 10.1074/jbc.M606374200; Pelta J, 1996, BIOPHYS J, V71, P48, DOI 10.1016/S0006-3495(96)79232-9; RAUCH CA, 1993, EMBO J, V12, P403, DOI 10.1002/j.1460-2075.1993.tb05672.x; RENGER HC, 1972, J CELL BIOL, V54, P346, DOI 10.1083/jcb.54.2.346; RYBENKOV VV, 1993, P NATL ACAD SCI USA, V90, P5307, DOI 10.1073/pnas.90.11.5307; Rybenkov VV, 1997, J MOL BIOL, V267, P299, DOI 10.1006/jmbi.1996.0876; Schnarwiler F, 2014, P NATL ACAD SCI USA, V111, P7624, DOI 10.1073/pnas.1404854111; SHAPIRO TA, 1995, ANNU REV MICROBIOL, V49, P117, DOI 10.1146/annurev.mi.49.100195.001001; Simpson L, 2003, RNA, V9, P265, DOI 10.1261/rna.2178403; SIMPSON L, 1972, INT REV CYTOL, V32, P139, DOI 10.1016/S0074-7696(08)60340-X; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Varela R, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/9/095204; Vologodskii A, 2009, PHYS CHEM CHEM PHYS, V11, P10543, DOI 10.1039/b910812b; WALDECK W, 1983, EMBO J, V2, P1255, DOI 10.1002/j.1460-2075.1983.tb01578.x; Wang JY, 2014, EUKARYOT CELL, V13, P919, DOI 10.1128/EC.00260-13; Wang ZF, 2001, EMBO J, V20, P4674, DOI 10.1093/emboj/20.17.4674; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Yasuhira S, 1996, RNA, V2, P1153; Zhao Z, 2008, EMBO J, V27, P143, DOI 10.1038/sj.emboj.7601956; Zuma AA, 2015, PARASITOL RES, V114, P419, DOI 10.1007/s00436-014-4199-8	63	9	9	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130998	10.1371/journal.pone.0130998	http://dx.doi.org/10.1371/journal.pone.0130998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110537	Green Published, gold			2022-12-27	WOS:000356933800107
J	Gerson, SA; Schiavio, A; Timmers, R; Hunnius, S				Gerson, Sarah A.; Schiavio, Andrea; Timmers, Renee; Hunnius, Sabine			Active Drumming Experience Increases Infants' Sensitivity to Audiovisual Synchrony during Observed Drumming Actions	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; MOTOR REACTIVATION; PERCEPTION; OBJECT; FMRI	In the current study, we examined the role of active experience on sensitivity to multisensory synchrony in six-month-old infants in a musical context. In the first of two experiments, we trained infants to produce a novel multimodal effect (i.e., a drum beat) and assessed the effects of this training, relative to no training, on their later perception of the synchrony between audio and visual presentation of the drumming action. In a second experiment, we then contrasted this active experience with the observation of drumming in order to test whether observation of the audiovisual effect was as effective for sensitivity to multimodal synchrony as active experience. Our results indicated that active experience provided a unique benefit above and beyond observational experience, providing insights on the embodied roots of (early) music perception and cognition.	[Gerson, Sarah A.] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Gerson, Sarah A.; Hunnius, Sabine] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Cognit, Nijmegen, Netherlands; [Schiavio, Andrea; Timmers, Renee] Univ Sheffield, Dept Mus, Mus Mind Machine Sheffield, Sheffield, S Yorkshire, England	University of St Andrews; Radboud University Nijmegen; University of Sheffield	Gerson, SA (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland.	sg233@st-andrews.ac.uk	Hunnius, Sabine/D-5834-2012	Timmers, Renee/0000-0002-1981-0834; Gerson, Sarah/0000-0001-8710-1178; Schiavio, Andrea/0000-0001-8109-9185	Brain-and-Cognition-Excellence-Grant from NWO [433-09-253]; Erasmus Travel Grant; British Academy International Partnership & Mobility Scheme [PM120092]	Brain-and-Cognition-Excellence-Grant from NWO; Erasmus Travel Grant; British Academy International Partnership & Mobility Scheme	This work was funded by a Brain-and-Cognition-Excellence-Grant from NWO (433-09-253) to SH, an Erasmus Travel Grant to AS, and a British Academy International Partnership & Mobility Scheme (PM120092) to RT.	Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Bahrick LE, 2001, J EXP CHILD PSYCHOL, V79, P253, DOI 10.1006/jecp.2000.2588; Bigand E, 2006, COGNITION, V100, P100, DOI 10.1016/j.cognition.2005.11.007; Burnham D, 2004, DEV PSYCHOBIOL, V45, P204, DOI 10.1002/dev.20032; Butler AJ, 2013, J COGNITIVE NEUROSCI, V25, P203, DOI 10.1162/jocn_a_00284; Butler AJ, 2011, J COGNITIVE NEUROSCI, V23, P3515, DOI 10.1162/jocn_a_00015; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Chemero A, 2009, BRADFORD BOOKS, P1; Clarke E., 2002, WAYS LISTENING ECOLO, P185; Elliott D. J., 1995, MUSIC MATTERS NEW PH; Gerry D, 2012, DEVELOPMENTAL SCI, V15, P398, DOI 10.1111/j.1467-7687.2012.01142.x; Gerry DW, 2010, DEVELOPMENTAL SCI, V13, P545, DOI 10.1111/j.1467-7687.2009.00912.x; Gerson SA, J COGNITIVE IN PRESS; Gerson SA, 2013, INFANCY, V18, P289, DOI 10.1111/j.1532-7078.2012.00112.x; Hillock AR, 2011, NEUROPSYCHOLOGIA, V49, P461, DOI 10.1016/j.neuropsychologia.2010.11.041; James Karin Harman, 2011, Cogn Brain Behav, V15, P485; Janata P, 2002, SCIENCE, V298, P2167, DOI 10.1126/science.1076262; Kopp F, 2014, DEV COGN NEUROS-NETH, V9, P56, DOI 10.1016/j.dcn.2014.01.001; Krogh-Jespersen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098085; Krueger JW, 2009, J CONSCIOUSNESS STUD, V16, P98; Lappe C, 2008, J NEUROSCI, V28, P9632, DOI 10.1523/JNEUROSCI.2254-08.2008; Lee H, 2011, P NATL ACAD SCI USA, V108, pE1441, DOI 10.1073/pnas.1115267108; LEMAN M, 2008, EMBODIED MUSIC COGNI; Lewkowicz DJ, 2013, DEVELOPMENTAL SCI, V16, P352, DOI 10.1111/desc.12029; Lewkowicz DJ, 2010, INFANCY, V15, P46, DOI 10.1111/j.1532-7078.2009.00005.x; Lewkowicz DJ, 2010, DEV PSYCHOL, V46, P66, DOI 10.1037/a0015579; Lewkowicz DJ, 1996, J EXP PSYCHOL HUMAN, V22, P1094, DOI 10.1037/0096-1523.22.5.1094; Lewkowicz DJ, 2000, PSYCHOL BULL, V126, P281, DOI 10.1037/0033-2909.126.2.281; Lu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090686; Matyja JR, 2013, CONSTR FOUND, V8, P351; Menin D, 2012, AVANT, V3, P202; Mohring W, 2013, CHILD DEV, V84, P1554, DOI 10.1111/cdev.12065; Overy K, 2009, MUSIC PERCEPT, V26, P489, DOI 10.1525/MP.2009.26.5.489; Ozturk O, 2013, J EXP CHILD PSYCHOL, V114, P173, DOI 10.1016/j.jecp.2012.05.004; Paraskevopoulos E, 2013, TRANSL NEUROSCI, V4, P337, DOI 10.2478/s13380-013-0134-1; Petrini K, 2011, NEUROIMAGE, V56, P1480, DOI 10.1016/j.neuroimage.2011.03.009; Petrini K, 2009, EXP BRAIN RES, V198, P339, DOI 10.1007/s00221-009-1817-2; Petrini K, 2009, COGNITION, V110, P432, DOI 10.1016/j.cognition.2008.11.015; Phillips-Silver J, 2005, SCIENCE, V308, P1430, DOI 10.1126/science.1110922; Rakison DH, 2012, DEVELOPMENTAL SCI, V15, P43, DOI 10.1111/j.1467-7687.2011.01096.x; Reybrouck M, 2012, BIOSEMIOTICS-NETH, V5, P391, DOI 10.1007/s12304-012-9144-6; RUFF HA, 1982, DEV PSYCHOL, V18, P682, DOI 10.1037/0012-1649.18.5.682; Schiavio A, 2015, P INT C MULT EXP MUS; Schiavio A, 2012, TEOREMA, V31, P63; Sheya A, 2010, ENACTION NEW PARADIG, P125; Smith L, 2005, ARTIF LIFE, V11, P13, DOI 10.1162/1064546053278973; Sommerville JA, 2005, COGNITION, V95, P1, DOI 10.1016/j.cognition.2003.12.004; Sommerville JA, 2008, DEV PSYCHOL, V44, P1249, DOI 10.1037/a0012296; SPELKE E, 1976, COGNITIVE PSYCHOL, V8, P553, DOI 10.1016/0010-0285(76)90018-9; SPELKE ES, 1979, DEV PSYCHOL, V15, P626; Stein BE, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.021.2009; Stern D., 2004, PRESENT MOMENT PSYCH; THELEN E, 1994, PSYCHOL SCI, V5, P280, DOI 10.1111/j.1467-9280.1994.tb00626.x; Thelen E, 1989, SYSTEMS DEV MINNESOT, V22, P17; Thelen E., 1994, DYNAMIC SYSTEMS APPR; Thelen E, 2000, INFANCY, V1, P3, DOI 10.1207/S15327078IN0101_02; Tillmann B, 2006, EUR J COGN PSYCHOL, V18, P343, DOI 10.1080/09541440500269548; Trainor LJ, 2002, MUSIC PERCEPT, V20, P187, DOI 10.1525/mp.2002.20.2.187; Trevarthen C., 1999, RHYTHMS MUSICAL NARR, V3, P155, DOI [DOI 10.1177/10298649000030S109, 10.1177/10298649000030S109]; Trevarthen C, 1997, EMPATIA E BIOL; Virji-Babul N, 2012, BRAIN BEHAV, V2, P237, DOI 10.1002/brb3.50; Wallace MT, 2004, J NEUROSCI, V24, P9580, DOI 10.1523/JNEUROSCI.2535-04.2004; Woodward A, 2013, SOCIAL PERCEPTION: DETECTION AND INTERPRETATION OF ANIMACY, AGENCY, AND INTENTION, P383	63	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130960	10.1371/journal.pone.0130960	http://dx.doi.org/10.1371/journal.pone.0130960			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111226	gold, Green Published, Green Accepted			2022-12-27	WOS:000356933800104
J	Lorenzoni, C; Vilajeliu, A; Carrilho, C; Ismail, MR; Castillo, P; Augusto, O; Garcia-Basteiro, AL; Sidat, M; de Sanjose, S; Menendez, C; Ordi, J				Lorenzoni, Cesaltina; Vilajeliu, Alba; Carrilho, Carla; Ismail, Mamudo R.; Castillo, Paola; Augusto, Orvalho; Garcia-Basteiro, Alberto L.; Sidat, Mohsin; de Sanjose, Silvia; Menendez, Clara; Ordi, Jaume			Trends in Cancer Incidence in Maputo, Mozambique, 1991-2008	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; INDIGENOUS AFRICANS; BLACK-POPULATION; PREVALENCE; INFECTION; HIV; EPIDEMIOLOGY; UGANDA	Background Very limited information is available regarding the incidence of cancer in sub-Saharan Africa. We analyzed changes in cancer patterns from 1991 to 2008 in Maputo (Mozambique). Methods We calculated the rates of incidence of different cancer sites by sex in the 5-year age-group of the population of Maputo city as well as age-standardized rates (ASRs) and average annual percentage changes (AAPC). Results Over the 18-year study period a total of 12,674 cases of cancer (56.9% females) were registered with an overall increase in the risk of cancer in both sexes. In males, the most common cancers were those of the prostate, Kaposi sarcoma (KS) and the liver. Prostate cancer showed the most dramatic increase over the whole study period (AAPC +11.3%; 95% CI: 9.7-13.0), with an ASR of 61.7 per 10(5) in 2003-2008. In females, the most frequent cancers were of the uterine cervix, the breast and KS, with the former increasing along the whole study period (AAPC + 4.7%; 95% CI: 3.4-6) with an ASR of 62.0 per 10(5) in 2003-2008 as well as breast cancer (AAPC +6.5%; 95% CI: 4.3-8.7). Conclusions Overall, the risk of cancer rose in both sexes during the study period, particularly among cancers associated with westernization of lifestyles (prostate, breast), combined with increasingly rising incidences or limited changes in cancers associated with infection and poverty (uterine cervix, liver). Moreover, the burden of AIDS-associated cancers has shown a marked increase.	[Lorenzoni, Cesaltina; Carrilho, Carla; Ismail, Mamudo R.] Maputo Cent Hosp, Dept Pathol, Maputo, Mozambique; [Lorenzoni, Cesaltina; Carrilho, Carla; Ismail, Mamudo R.] Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique; [Vilajeliu, Alba; Castillo, Paola; Garcia-Basteiro, Alberto L.; Menendez, Clara; Ordi, Jaume] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Vilajeliu, Alba] Univ Barcelona, Hosp Clin, Dept Prevent Med & Epidemiol, Barcelona, Spain; [Augusto, Orvalho; Sidat, Mohsin] Eduardo Mondlane Univ, Fac Med, Dept Microbiol, Maputo, Mozambique; [de Sanjose, Silvia] Inst Catala Oncol, Unit Infect & Canc, Lhospitalet De Llobregat, Barcelona, Spain; [Garcia-Basteiro, Alberto L.; Menendez, Clara] CISM, Maputo, Mozambique; [Ordi, Jaume] Univ Barcelona, Hosp Clin, Dept Pathol, Barcelona, Spain	Eduardo Mondlane University; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Eduardo Mondlane University; Catalan Institute of Oncology; Centro de Investigacao em Saude de Manhica; University of Barcelona; Hospital Clinic de Barcelona	Ordi, J (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.	jordi@clinic.ub.es	Menéndez, Clara/Q-3446-2016; Augusto, Orvalho/J-8767-2019; de Sanjosé Llongueras, Silvia/H-6339-2014; castillo, paola/K-8434-2017; castillo, paola/AAH-3999-2019; Ordi, Jaume/X-4524-2018	Menéndez, Clara/0000-0002-2641-6907; Augusto, Orvalho/0000-0002-0005-3968; castillo, paola/0000-0002-9284-8601; castillo, paola/0000-0002-9284-8601; Ordi, Jaume/0000-0002-4820-7954; Ismail, Mamudo Rafik/0000-0001-9044-2694; Vilajeliu, Alba/0000-0001-9888-6951; Sidat, Mohsin/0000-0002-8378-2014; Carrilho, Carla/0000-0003-0208-7309				[Anonymous], 1982, IARC PUBL, P671; [Anonymous], 2013, GLOBAL REPORT UNAIDS; Ateenyi-Agaba C, 2010, BRIT J CANCER, V102, P262, DOI 10.1038/sj.bjc.6605466; Augusto G, 2009, AM J TROP MED HYG, V81, P799, DOI 10.4269/ajtmh.2009.08-0344; Bah E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075775; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Carrilho C, 2005, J CLIN PATHOL, V58, P61, DOI 10.1136/jcp.2004.020552; Carrilho C, 2009, VIRCHOWS ARCH, V454, P153, DOI 10.1007/s00428-008-0713-7; Chokunonga E, 2013, INT J CANCER, V133, P721, DOI 10.1002/ijc.28063; De Vuyst H, 2012, INT J CANCER, V131, P949, DOI 10.1002/ijc.26470; Fay MP, 2006, BIOMETRICS, V62, P847, DOI 10.1111/j.1541-0420.2006.00528.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fritz AG., 2000, INT CLASSIFICATION D, V3rd; Gonzalez R, 2012, HIV MED, V13, P581, DOI 10.1111/j.1468-1293.2012.01018.x; Instituto Nacional de Estadistica, 2007, 3 REC GER POP HAB 20; Instituto Nacional de Estadistica, 1999, 2 REC GER POP HAB 19; Instituto Nacional de Estadistica, 1980, MAC REC GER POP 1980; JASKIEWICZ K, 1989, ANTICANCER RES, V9, P1847; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2012, CANCER-AM CANCER SOC, V118, P4372, DOI 10.1002/cncr.27410; Johansson SL, 1997, SEMIN SURG ONCOL, V13, P291; Mbulaiteye SM, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-16; Menendez C, 2010, INFECT DIS OBS GYNEC, V2010, P6093; Moodley M, INT J GYNECOL CANC, V16, P1036; Newton R, 2002, BRIT J CANCER, V87, P301, DOI 10.1038/sj.bjc.6600451; Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X; Parkin DM, 2009, EUR J CANCER, V45, P756, DOI 10.1016/j.ejca.2008.11.033; Parkin DM, 2010, INT J CANCER, V126, P1187, DOI 10.1002/ijc.24838; Percy C., 1990, INT CLASSIFICATION D; Pineros M, 2013, CANCER EPIDEMIOL, V37, P233, DOI 10.1016/j.canep.2013.02.003; PRATES MD, 1965, J NATL CANCER I, V35, P729; Rebbeck TR, 2013, PROSTATE CANCER, V2013, DOI 10.1155/2013/560857; Sitas F, 2008, LANCET ONCOL, V9, P786, DOI 10.1016/S1470-2045(08)70198-0; Stein L, 2008, INT J CANCER, V122, P2260, DOI 10.1002/ijc.23391; Stokx J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-141; Wabinga HR, 2000, BRIT J CANCER, V82, P1585, DOI 10.1054/bjoc.1999.1071; Watson-Jones D, 2013, SEX TRANSM INFECT, V89, P358, DOI 10.1136/sextrans-2012-050685; WHO, 2018, INT STAT CLASS DIS R	39	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130469	10.1371/journal.pone.0130469	http://dx.doi.org/10.1371/journal.pone.0130469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110774	gold, Green Published, Green Submitted			2022-12-27	WOS:000356933800051
J	Wang, SP; Zhou, M; Ouyang, J; Geng, ZR; Wang, ZL				Wang, Shuping; Zhou, Min; Ouyang, Jian; Geng, Zhirong; Wang, Zhilin			Tetraarsenictetrasulfide and Arsenic Trioxide Exert Synergistic Effects on Induction of Apoptosis and Differentiation in Acute Promyelocytic Leukemia Cells	PLOS ONE			English	Article							RETINOIC ACID; REALGAR AS4S4; CYCLE ARREST; STRESS; CONTRIBUTES; ACTIVATION; MECHANISMS; PATHWAYS; AS2O3; PML	Since arsenic trioxide (As3+) has been successfully used in the treatment of acute promyelocytic leukemia (APL), its adverse effects on patients have been problematic and required a solution. Considering the good therapeutic potency and low toxicity of tetraarsenictetrasulfide (As4S4) in the treatment of APL, we investigated the effects of combining As4S4 and As3+ on the apoptosis and differentiation of NB4 and primary APL cells. As4S4, acting similarly to As3+, arrested the G(1)/S transition, induced the accumulation of cellular reactive oxygen species, and promoted apoptosis. Additionally, low concentrations of As4S4 (0.1-0.4 mu M) induced differentiation of NB4 and primary APL cells. Compared with the As4S4- or As3+-treated groups, the combination of As4S4 and As3+ obviously promoted apoptosis and differentiation of NB4 and primary APL cells. Mechanistic studies suggested that As4S4 acted synergistically with As3+ to down-regulate Bcl-2 and nuclear factor-kappa B expression, up-regulate Bax and p53 expression, and induce activation of caspase-12 and caspase-3. Moreover, the combination of low concentrations of As4S4 and As3+ enhanced degradation of the promyelocytic leukemia-retinoic acid receptor a oncoprotein. In summary, As4S4 and As3+ synergistically induce the apoptosis and differentiation of NB4 and primary APL cells.	[Wang, Shuping; Geng, Zhirong; Wang, Zhilin] Nanjing Univ, Collaborat Innovat Ctr Adv Microstruct, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210093, Jiangsu, Peoples R China; [Zhou, Min; Ouyang, Jian] Nanjing Univ, Sch Med, DrumTower Hosp, Dept Hematol, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Geng, ZR (corresponding author), Nanjing Univ, Collaborat Innovat Ctr Adv Microstruct, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210093, Jiangsu, Peoples R China.	gengzr@nju.edu.cn; wangzl@nju.edu.cn	Geng, Zhirong/HGC-1447-2022	Geng, Zhirong/0000-0003-3766-9034	National Basic Research Program of China [2013CB922102]; National Natural Science Foundation of China [21275072, 21475059, 21201101]; Scientific Research Innovation Project for Postgraduates of Jiansu Province [CXZZ12-0038]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Innovation Project for Postgraduates of Jiansu Province	ZW was supported by the National Basic Research Program of China (2013CB922102), (http://www.973.gov.cn/English/Index.aspx) and the National Natural Science Foundation of China (21275072 and 21475059) (www.nsfc.gov.cn). ZG was supported by the National Natural Science Foundation of China (21201101) (www.nsfc.gov.cn). SW was supported by the Scientific Research Innovation Project for Postgraduates of Jiansu Province (CXZZ12-0038) (http://www.ec.js.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Cai X, 2000, LEUKEMIA, V14, P262, DOI 10.1038/sj.leu.2401650; Chen GQ, 1997, BLOOD, V89, P3345; Chen J, 2012, LEUKEMIA RES, V36, P1526, DOI 10.1016/j.leukres.2012.08.018; Chen SJ, 2011, BLOOD, V117, P6425, DOI 10.1182/blood-2010-11-283598; CHOU TC, 1994, JNCI-J NATL CANCER I, V86, P1517, DOI 10.1093/jnci/86.20.1517; Darzynkiewicz Z, 2012, CRIT REV CL LAB SCI, V49, P199, DOI 10.3109/10408363.2012.738808; Degos L, 2003, BRIT J HAEMATOL, V122, P539, DOI 10.1046/j.1365-2141.2003.04460.x; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; He YA, 2010, J VIROL, V84, P12832, DOI 10.1128/JVI.01216-10; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Iland HJ, 2013, CURR TREAT OPTION ON, V14, P170, DOI 10.1007/s11864-012-0223-3; Jakoby M, 2004, CURR OPIN PLANT BIOL, V7, P661, DOI 10.1016/j.pbi.2004.09.015; Kumar S, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-42; LANOTTE M, 1991, BLOOD, V77, P1080; Lengfelder E, 2012, LEUKEMIA, V26, P433, DOI 10.1038/leu.2011.245; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Liu J, 2011, J ETHNOPHARMACOL, V134, P26, DOI 10.1016/j.jep.2010.11.052; Liu Q, 2003, BLOOD, V101, P4078, DOI 10.1182/blood-2002-10-3231; Lu DP, 2002, BLOOD, V99, P3136, DOI 10.1182/blood.V99.9.3136; MAJNO G, 1995, AM J PATHOL, V146, P3; Mathas S, 2003, BLOOD, V102, P1028, DOI 10.1182/blood-2002-04-1154; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Morse D, 2005, AM J RESP CRIT CARE, V172, P660, DOI 10.1164/rccm.200404-465SO; Pastorek M, 2014, NEOPLASMA, V61, P700, DOI 10.4149/neo_2014_085; Ratnaike RN, 2003, POSTGRAD MED J, V79, P391, DOI 10.1136/pmj.79.933.391; Sharma VK, 2009, ENVIRON INT, V35, P743, DOI 10.1016/j.envint.2009.01.005; Shen ZX, 2004, P NATL ACAD SCI USA, V101, P5328, DOI 10.1073/pnas.0400053101; Tapio S, 2006, MUTAT RES-REV MUTAT, V612, P215, DOI 10.1016/j.mrrev.2006.02.001; Thomas DJ, 2001, TOXICOL APPL PHARM, V176, P127, DOI 10.1006/taap.2001.9258; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Wang S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.563; Wang SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110924; Wang SP, 2014, BIOCHIMIE, V106, P167, DOI 10.1016/j.biochi.2014.08.017; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Wu JZ, 2011, J ETHNOPHARMACOL, V135, P595, DOI 10.1016/j.jep.2011.03.071; Zhang GH, 1997, BIOTECHNIQUES, V23, P525, DOI 10.2144/97233pf01; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	42	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130343	10.1371/journal.pone.0130343	http://dx.doi.org/10.1371/journal.pone.0130343			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110921	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800042
J	Casale, M; Moffa, A; Sabatino, L; Pace, A; Oliveto, G; Vitali, M; Baptista, P; Salvinelli, F				Casale, Manuele; Moffa, Antonio; Sabatino, Lorenzo; Pace, Annalisa; Oliveto, Giuseppe; Vitali, Massimiliano; Baptista, Peter; Salvinelli, Fabrizio			Hyaluronic Acid: Perspectives in Upper Aero-Digestive Tract. A Systematic Review	PLOS ONE			English	Article							INTRANASAL SODIUM HYALURONATE; ENDOSCOPIC SINUS SURGERY; CHRONIC RHINOSINUSITIS; EFFICACY; SYMPTOMS; FORMULATION; TRIAL; GEL	Background To date, topical therapies guarantee a better delivery of high concentrations of pharmacologic agents to the mucosa of the upper aerodigestive tract (UADT). The use of topical drugs, which are able to reduce mucosal inflammation and to improve healing tissues, can represent a relevant therapeutic advance. Topical sodium hyaluronate (SH) has recently been recognized as adjuvant treatment in the chronic inflammatory disease of the UADT. Aims The aim of our work was to review the published literature regarding all the potential therapeutic effects of SH in the chronic inflammatory disease of UADT. Methods Relevant published studies were searched in Pubmed, Google Scholar, Ovid using keywords ("sodium hyaluronate" and "upper airways") or Medical Subject Headings. Results At the end of our selection process, sixteen publications have been included. Six of them in the post-operative period of nasal-sinus surgery, 2 of them in pediatric patients affected by recurrent upper respiratory tract infections, 4 of them in reducing symptoms and preventing exacerbations of chronic upper airways in adult population, 4 of them in patients with chronic inflammatory disease of UADT, including gastro-esophageal reflux disease (GERD). Conclusions Topical administration of SH plays a pivotkey role in the postoperative phase of patients undergoing FESS and nasal surgery, and positive results are generally observed in all the patients suffering from UADT chronic inflammatory disease.	[Casale, Manuele; Moffa, Antonio; Sabatino, Lorenzo; Pace, Annalisa; Oliveto, Giuseppe; Salvinelli, Fabrizio] Univ Campus Biomed, Area Otolaringol, Rome, Italy; [Vitali, Massimiliano] Univ Campus Biomed, Dept Biostat, Rome, Italy; [Baptista, Peter] Univ Navarra, Dept Otolaringol, E-31080 Pamplona, Spain	University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; University of Navarra	Casale, M (corresponding author), Univ Campus Biomed, Area Otolaringol, Via Alvaro del Portillo 21, Rome, Italy.	m.casale@unicampus.it	Casale, Manuele/GPF-7869-2022; Pace, Annalisa/AAP-5561-2020; Sabatino, Lorenzo/GPF-5740-2022	Pace, Annalisa/0000-0001-6744-5280; Vitali, Massimiliano Andrea/0000-0001-7335-4406; casale, manuele/0000-0002-8223-0824; Moffa, Antonio/0000-0002-6181-8194; Sabatino, Lorenzo/0000-0002-1052-8197; salvinelli, fabrizio/0000-0003-0442-2596				Allegra Luigi, 2012, Handb Exp Pharmacol, P385, DOI 10.1007/978-3-642-23056-1_17; Barber C, 2007, SUPPORT CARE CANCER, V15, P427, DOI 10.1007/s00520-006-0171-1; Cantone E, 2014, INT FORUM ALLERGY RH, V4, P484, DOI 10.1002/alr.21310; CAPOROSSI A, 1995, J CATARACT REFR SURG, V21, P710, DOI 10.1016/S0886-3350(13)80572-X; Casale M, 2014, AM J RHINOL ALLERGY, V28, P345, DOI 10.2500/ajra.2014.28.4045; Cassandro E, 2014, INDIAN J OTOLARYNGOL; Di Cicco M, 2014, J CYST FIBROS, V13, P455, DOI 10.1016/j.jcf.2014.02.006; Forteza R, 2001, FASEB J, V15, P2179, DOI 10.1096/fj.01-0036com; Gelardi M, 2013, EUR ANN ALLERGY CLIN, V45, P103; Gelardi M, 2013, INT FORUM ALLERGY RH, V3, P807, DOI 10.1002/alr.21193; Gouteva I, 2014, J ALLERGY CAIRO, V2014; IALENTI A, 1994, AGENTS ACTIONS, V43, P44, DOI 10.1007/BF02005763; Jentsch H, 2003, J CLIN PERIODONTOL, V30, P159, DOI 10.1034/j.1600-051X.2003.300203.x; Lam K, 2013, LARYNGOSCOPE, V123, P2950, DOI 10.1002/lary.24239; Lee JH, 2008, J EUR ACAD DERMATOL, V22, P590, DOI 10.1111/j.1468-3083.2007.02564.x; Macchi A, 2013, INT J IMMUNOPATH PH, V26, P137, DOI 10.1177/039463201302600113; Macchi A, 2013, INT J IMMUNOPATH PH, V26, P127, DOI 10.1177/039463201302600112; Manuele C, 2013, AM J RHINOL ALLERGY, V27, P234, DOI 10.2500/ajra.2013.27.3869; Manzanares D, 2007, AM J RESP CELL MOL, V37, P160, DOI 10.1165/rcmb.2006-0413OC; Migliore A, 2008, CLIN INTERV AGING, V3, P365, DOI 10.2147/CIA.S778; Modrzynski M, 2011, AM J RHINOL ALLERGY, V25, P103, DOI 10.2500/ajra.2011.25.3577; Nolan A, 2006, J ORAL PATHOL MED, V35, P461, DOI 10.1111/j.1600-0714.2006.00433.x; Palmieri B, 2013, EUR REV MED PHARMACO, V17, P3272; Proctor M, 2006, AM J RHINOL, V20, P206, DOI 10.1177/194589240602000218; Rajapaksa SP, 2005, AM J RHINOL, V19, P572, DOI 10.1177/194589240501900607; Rodriguez-Merchan E Carlos, 2013, HSS J, V9, P180, DOI 10.1007/s11420-012-9320-x; Soldati D, 1999, DRUG EXP CLIN RES, V25, P253; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Weindl G, 2004, SKIN PHARMACOL PHYS, V17, P207, DOI 10.1159/000080213; Wolny PM, 2010, J BIOL CHEM, V285, P30170, DOI 10.1074/jbc.M110.137562	30	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130637	10.1371/journal.pone.0130637	http://dx.doi.org/10.1371/journal.pone.0130637			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26120837	gold, Green Published, Green Submitted			2022-12-27	WOS:000358150400053
J	Cuthbert, BJ; Brennan, RG; Schumacher, MA				Cuthbert, Bonnie J.; Brennan, Richard G.; Schumacher, Maria A.			Structural and Biochemical Characterization of the Francisella tularensis Pathogenicity Regulator, Macrophage Locus Protein A (MglA)	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; VIBRIO-CHOLERAE; IDENTIFICATION; TRANSCRIPTION; SSPA; PHASE	Francisella tularensis is one of the most infectious bacteria known and is the etiologic agent of tularemia. Francisella virulence arises from a 33 kilobase (Kb) pathogenicity island (FPI) that is regulated by the macrophage locus protein A (MglA) and the stringent starvation protein A (SspA). These proteins interact with both RNA polymerase (RNAP) and the pathogenicity island gene regulator (PigR) to activate FPI transcription. However, the molecular mechanisms involved are not well understood. Indeed, while most bacterial SspA proteins function as homodimers to activate transcription, F. tularensis SspA forms a heterodimer with the MglA protein, which is unique to F. tularensis. To gain insight into MglA function, we performed structural and biochemical studies. The MglA structure revealed that it contains a fold similar to the SspA protein family. Unexpectedly, MglA also formed a homodimer in the crystal. Chemical crosslinking and size exclusion chromatography (SEC) studies showed that MglA is able to self-associate in solution to form a dimer but that it preferentially hetero-dimerizes with SspA. Finally, the MglA structure revealed malate, which was used in crystallization, bound in an open pocket formed by the dimer, suggesting the possibility that this cleft could function in small molecule ligand binding. The location of this binding region relative to recently mapped PigR and RNAP interacting sites suggest possible roles for small molecule binding in MglA and SspA center dot MglA function.	[Cuthbert, Bonnie J.; Brennan, Richard G.; Schumacher, Maria A.] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA	Duke University	Brennan, RG (corresponding author), Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA.	richard.brennan@duke.edu; maria.schumacher@duke.edu	Cuthbert, Bonnie/ABD-8360-2021	Cuthbert, Bonnie/0000-0001-5176-8245; Brennan, Richard/0000-0001-7647-485X	Duke startup funds; National Institutes of Health [F32GM008487]	Duke startup funds; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: The funding was provided by Duke startup funds to R.G.B. and M.A.S. This work was supported in part by the National Institutes of Health grant F32GM008487.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bell BL, 2010, INFECT IMMUN, V78, P2189, DOI 10.1128/IAI.00021-10; Broms JE, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00136; Broteke A, 2008, INFECT IMMUN, V76, P3473, DOI 10.1128/IAI.00430-08; Buchan BW, 2009, INFECT IMMUN, V77, P2517, DOI 10.1128/IAI.00229-09; Charity JC, 2007, PLOS PATHOG, V3, P770, DOI 10.1371/journal.ppat.0030084; Charity JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000641; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; DeReuse H, 1997, RES MICROBIOL, V148, P289, DOI 10.1016/S0923-2508(97)81585-9; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hansen AM, 2005, J BIOL CHEM, V280, P17380, DOI 10.1074/jbc.M501444200; Hansen AM, 2005, MOL MICROBIOL, V56, P719, DOI 10.1111/j.1365-2958.2005.04567.x; Hansen AM, 2003, MOL MICROBIOL, V48, P1621, DOI 10.1046/j.1365-2958.2003.03533.x; Hansen AM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-231; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOWELL PL, 1992, J APPL CRYSTALLOGR, V25, P81, DOI 10.1107/S0021889891010385; ISHIHAMA A, 1979, J MOL BIOL, V129, P517, DOI 10.1016/0022-2836(79)90466-2; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Ludu JS, 2008, J BACTERIOL, V190, P4584, DOI 10.1128/JB.00198-08; Meibom KL, 2010, CURR OPIN MICROBIOL, V13, P11, DOI 10.1016/j.mib.2009.11.007; Meibom KL, 2009, INFECT IMMUN, V77, P1866, DOI 10.1128/IAI.01496-08; Merrell DS, 2002, MOL MICROBIOL, V43, P1471, DOI 10.1046/j.1365-2958.2002.02857.x; Mohapatra NP, 2007, INFECT IMMUN, V75, P3305, DOI 10.1128/IAI.00351-07; Nishida M, 1998, J MOL BIOL, V281, P135, DOI 10.1006/jmbi.1998.1927; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Ramsey KM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004793; Rohlfing AE, 2014, J BACTERIOL, V196, P3516, DOI 10.1128/JB.01700-14; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Williams MD, 1992, THESIS U MINNESOTA; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wrench AP, 2013, PLOS ONE, V8; Xu Q, 2003, P NATL ACAD SCI USA, V100, P1286, DOI 10.1073/pnas.0337479100; Yin Y, 2013, PLOS ONE, V8	41	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0128225	10.1371/journal.pone.0128225	http://dx.doi.org/10.1371/journal.pone.0128225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121147	gold, Green Published, Green Submitted			2022-12-27	WOS:000358150400010
J	Schwarz, LK; Villegas-Amtmann, S; Beltran, RS; Costa, DP; Goetsch, C; Huckstadt, L; Maresh, JL; Peterson, SH				Schwarz, Lisa K.; Villegas-Amtmann, Stella; Beltran, Roxanne S.; Costa, Daniel P.; Goetsch, Chandra; Hueckstaedt, Luis; Maresh, Jennifer L.; Peterson, Sarah H.			Comparisons and Uncertainty in Fat and Adipose Tissue Estimation Techniques: The Northern Elephant Seal as a Case Study	PLOS ONE			English	Article							HYDROGEN-ISOTOPE-DILUTION; TOTAL-BODY WATER; MIROUNGA-ANGUSTIROSTRIS; PHOCA-GROENLANDICA; BLUBBER THICKNESS; MARINE PREDATOR; GRAY SEALS; HARP SEAL; PUPS; MASS	Fat mass and body condition are important metrics in bioenergetics and physiological studies. They can also link foraging success with demographic rates, making them key components of models that predict population-level outcomes of environmental change. Therefore, it is important to incorporate uncertainty in physiological indicators if results will lead to species management decisions. Maternal fat mass in elephant seals (Mirounga spp) can predict reproductive rate and pup survival, but no one has quantified or identified the sources of uncertainty for the two fat mass estimation techniques (labeled-water and truncated cones). The current cones method can provide estimates of proportion adipose tissue in adult females and proportion fat of juveniles in northern elephant seals (M. angustirostris) comparable to labeled-water methods, but it does not work for all cases or species. We reviewed components and assumptions of the technique via measurements of seven early-molt and seven late-molt adult females. We show that seals are elliptical on land, rather than the assumed circular shape, and skin may account for a high proportion of what is often defined as blubber. Also, blubber extends past the neck-to-pelvis region, and comparisons of new and old ultrasound instrumentation indicate previous measurements of sculp thickness may be biased low. Accounting for such differences, and incorporating new measurements of blubber density and proportion of fat in blubber, we propose a modified cones method that can isolate blubber from non-blubber adipose tissue and separate fat into skin, blubber, and core compartments. Lastly, we found that adipose tissue and fat estimates using tritiated water may be biased high during the early molt. Both the tritiated water and modified cones methods had high, but reducible, uncertainty. The improved cones method for estimating body condition allows for more accurate quantification of the various tissue masses and may also be transferrable to other species.	[Schwarz, Lisa K.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Villegas-Amtmann, Stella; Costa, Daniel P.; Goetsch, Chandra; Hueckstaedt, Luis; Maresh, Jennifer L.; Peterson, Sarah H.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Beltran, Roxanne S.] Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of Alaska System; University of Alaska Anchorage	Schwarz, LK (corresponding author), Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA.	lisa.schwarz@ucsc.edu	Huckstadt, Luis/A-5838-2018; Huckstadt, Luis A./J-8532-2019; Costa, Daniel/E-2616-2013	Huckstadt, Luis/0000-0002-2453-7350; Huckstadt, Luis A./0000-0002-2453-7350; Peterson, Sarah/0000-0003-2773-3901; Costa, Daniel/0000-0002-0233-5782; Beltran, Roxanne/0000-0002-8520-1105	Office of Naval Research [N00014-08-1-1195, N00014-13-1-0134, N00014-10-1-0356]; E&P Sound and Marine Life Joint Industry Project of the International Association of Oil and Gas Producers [JIP2207-23]; National Science Foundation [ANT-0838937]; Friends of Long Marine Lab; Earl and Ethel Myers Oceanographic Trust; University of California; Rebecca and Steve Sooy Graduate Fellowship in Marine Mammals	Office of Naval Research(Office of Naval Research); E&P Sound and Marine Life Joint Industry Project of the International Association of Oil and Gas Producers; National Science Foundation(National Science Foundation (NSF)); Friends of Long Marine Lab; Earl and Ethel Myers Oceanographic Trust; University of California(University of California System); Rebecca and Steve Sooy Graduate Fellowship in Marine Mammals	Supplies and LKS were funded by the Office of Naval Research (N00014-08-1-1195, N00014-13-1-0134, and N00014-10-1-0356) and the E&P Sound and Marine Life Joint Industry Project of the International Association of Oil and Gas Producers (JIP2207-23). LH was supported by National Science Foundation OPP grant ANT-0838937, and CG was supported by an NSF predoctoral fellowship. SHP was funded by the Friends of Long Marine Lab, the Earl and Ethel Myers Oceanographic Trust, the University of California NRS Mildred Mathias Graduate Student Research Grant Program, and the Rebecca and Steve Sooy Graduate Fellowship in Marine Mammals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnould JPY, 1996, PHYSIOL ZOOL, V69, P93, DOI 10.1086/physzool.69.1.30164202; Bowen WD, 1998, PHYSIOL ZOOL, V71, P329, DOI 10.1086/515921; Bryden MM, 1967, STUDY BIOL SO ELEPHA; Champagne CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038442; COSTA DP, 1986, J ZOOL, V209, P21, DOI 10.1111/j.1469-7998.1986.tb03563.x; Cowles MK, 1996, J AM STAT ASSOC, V91, P883, DOI 10.2307/2291683; Crocker DE, 2012, COMP BIOCHEM PHYS A, V161, P388, DOI 10.1016/j.cbpa.2011.12.013; Crocker DE, 2001, ECOLOGY, V82, P3541, DOI 10.2307/2680171; Crocker DE, 1997, CAN J ZOOL, V75, P27, DOI 10.1139/z97-004; DAVIDSON N C, 1982, Ringing and Migration, V4, P51; FOLCH J, 1957, J BIOL CHEM, V226, P497; GALES NJ, 1987, AUST J ZOOL, V35, P207, DOI 10.1071/ZO9870207; Hayes KR, 2007, ENV RISK ASSESS GENE, V3, P188, DOI 10.1079/9781845932961.0188; HEIDELBERGER P, 1983, OPER RES, V31, P1109, DOI 10.1287/opre.31.6.1109; Huckstadt LA, 2012, OECOLOGIA, V169, P395, DOI 10.1007/s00442-011-2202-y; Iverson SJ, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P115; IVERSON SJ, 1993, PHYSIOL ZOOL, V66, P61, DOI 10.1086/physzool.66.1.30158287; Iverson SJ, 2001, LIPIDS, V36, P1283, DOI 10.1007/s11745-001-0843-0; Koopman HN, 2007, MAR BIOL, V151, P277, DOI 10.1007/s00227-006-0489-8; Liwanag HEM, 2012, BIOL J LINN SOC, V107, P774, DOI 10.1111/j.1095-8312.2012.01992.x; Louis C, 2014, ENVIRON RES, V132, P438, DOI 10.1016/j.envres.2014.04.016; LOVVORN JR, 1991, CAN J ZOOL, V69, P2879, DOI 10.1139/z91-406; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; LYDERSEN C, 1992, J ZOOL, V228, P361, DOI 10.1111/j.1469-7998.1992.tb04441.x; Maresh JL, 2014, J EXP BIOL, V217, P1485, DOI 10.1242/jeb.094201; Mayrovitz HN, 2003, LYMPHOLOGY, V36, P140; McMahon CR, 2000, ANTARCT SCI, V12, P149, DOI 10.1017/S0954102000000195; Mellish JAE, 2004, J ZOO WILDLIFE MED, V35, P116, DOI 10.1638/03-028; Miller PJO, 2012, J EXP BIOL, V215, P3622, DOI 10.1242/jeb.070128; Nagy K.A., 1975, P227; New LF, 2014, MAR ECOL PROG SER, V496, P99, DOI 10.3354/meps10547; Noren DP, 2004, FUNCT ECOL, V18, P233, DOI 10.1111/j.0269-8463.2004.00840.x; ORTIZ CL, 1978, PHYSIOL ZOOL, V51, P166, DOI 10.1086/physzool.51.2.30157864; PACE N, 1945, J BIOL CHEM, V158, P685; Palmquist DL, 2003, J ANIM SCI, V81, P3250; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; RATHBUN EN, 1945, J BIOL CHEM, V158, P667; Regan TJ, 2013, CONSERV BIOL, V27, P821, DOI 10.1111/cobi.12055; REILLY JJ, 1990, J APPL PHYSIOL, V69, P885, DOI 10.1152/jappl.1990.69.3.885; Robinson PW, 2010, J ANIM ECOL, V79, P1146, DOI 10.1111/j.1365-2656.2010.01735.x; Schwarz LK, 2008, MAR MAMMAL SCI, V24, P881, DOI 10.1111/j.1748-7692.2008.00232.x; Severinsen T, 2000, MAR ENVIRON RES, V49, P291, DOI 10.1016/S0141-1136(99)00078-1; SHENG HP, 1979, AM J CLIN NUTR, V32, P630, DOI 10.1093/ajcn/32.3.630; Shero MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091233; SLIP DJ, 1992, AUST J ZOOL, V40, P143, DOI 10.1071/ZO9920143; Speakman John R., 2001, P56, DOI 10.1017/CBO9780511551741.005; Speakman JR, 2005, PHYSIOL BIOCHEM ZOOL, V78, P650, DOI 10.1086/430234; Trites Andrew W., 2000, Aquatic Mammals, V26, P151; Vanden Berghe M, 2012, ENVIRON INT, V46, P6, DOI 10.1016/j.envint.2012.04.011; Vernon RGFDJ, 2003, ENCY FOOD SCI NUTR, P23, DOI [DOI 10.1016/B0-12-227055-X/00007-9, 10.1016/B0-12-227055-X/00007-9]; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wang ZM, 1999, AM J CLIN NUTR, V69, P833; Webb PM, 1998, J EXP BIOL, V201, P2349; WORTHY GAJ, 1983, J MAMMAL, V64, P89, DOI 10.2307/1380753; WORTHY GAJ, 1983, CAN J ZOOL, V61, P447, DOI 10.1139/z83-059; WORTHY GAJ, 1987, PHYSIOL ZOOL, V60, P352, DOI 10.1086/physzool.60.3.30162289; WORTHY GAJ, 1992, J ZOOL, V227, P257, DOI 10.1111/j.1469-7998.1992.tb04821.x	57	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131877	10.1371/journal.pone.0131877	http://dx.doi.org/10.1371/journal.pone.0131877			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121044	Green Published, gold			2022-12-27	WOS:000358150400171
J	Zhao, H; Wang, SS; Wang, WX; Liu, R; Zhou, B				Zhao, Heng; Wang, Shanshan; Wang, Wenxin; Liu, Rui; Zhou, Bin			Investigation of Ground-Level Ozone and High-Pollution Episodes in a Megacity of Eastern China	PLOS ONE			English	Article							DIFFERENTIAL OPTICAL-ABSORPTION; RELATIVE-HUMIDITY DEPENDENCE; TEXAS AIR-QUALITY; CROSS-SECTIONS; SURFACE OZONE; NITROUS-ACID; TEMPERATURE-DEPENDENCE; HONO CHEMISTRY; YANGTZE DELTA; RURAL SITE	Differential Optical Absorption Spectroscopy (DOAS) was used for the long-term observation of ground-level ozone (O-3) from March 2010 to March 2013 over Shanghai, China. The 1-hour average concentration of O-3 was 27.2 +/- 17.0 ppbv. O-3 level increased during spring, reached the peak in late spring and early summer, and then decreased in autumn and finally dropped to the bottom in winter. The highest monthly average O-3 concentration in June (41.1 ppbv) was nearly three times as high as the lowest level recorded in December (15.2 ppbv). In terms of pollution episodes, 56 hourly samples (on 14 separate days) in 2010 exceeded the 1-hour ozone limit of 200 mu g/m(3) specified by the Grade II of the Chinese Ambient Air Quality Standards (CAAQS, revised GB 3095-2012). Utilizing the Hybrid Single Particle Lagrangian Integrated Trajectory (HYSPLIT) model, the primary contribution to high ozone days (HODs) was identified as the regional transportation of volatile organic compounds (VOC) and high concentrations of O-3 from the chemical industrial zone in the Jinshan district of Shanghai. HODs showed higher concentrations of HONO and NO2 than non-episode conditions, implying that HONO at high concentration during HODs was capable of increasing the O-3 concentration. The photolysis rate of HONO was estimated, suggesting that the larger number of OH radicals resulting from high concentrations of HONO have a considerable impact on ozone concentrations.	[Zhao, Heng; Wang, Wenxin; Liu, Rui; Zhou, Bin] Fudan Univ, Dept Environm Sci & Engn, Shanghai Key Lab Atmospher Particle Pollut & Prev, Shanghai 200433, Peoples R China; [Wang, Shanshan] Univ Shanghai Sci & Technol, Sch Environm & Architecture, Shanghai 200093, Peoples R China; [Zhou, Bin] Fudan Univ, Fudan Tyndall Ctr, Shanghai 200433, Peoples R China	Fudan University; University of Shanghai for Science & Technology; Fudan University	Wang, SS (corresponding author), Univ Shanghai Sci & Technol, Sch Environm & Architecture, Shanghai 200093, Peoples R China.	shanshan.wang@usst.edu.cn; binzhou@fudan.edu.cn	wang, wenxin/HGD-7043-2022	Wang, Shanshan/0000-0003-2590-9563	National Natural Science Foundation of China [21477021, 21277029, 40975076, 41405117]; Science and Technology Commission of Shanghai Municipality [12DJ1400102]; China Meteorological Administration [GYHY201106045-8]; National Hightech R&D Program ("863" Program) [2006AA06Z417]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); China Meteorological Administration; National Hightech R&D Program ("863" Program)(National High Technology Research and Development Program of China)	This work was partially supported by the National Natural Science Foundation of China under grant No. 21477021, 21277029, 40975076, 41405117, Science and Technology Commission of Shanghai Municipality (Grant: 12DJ1400102), China Meteorological Administration (Grant: GYHY201106045-8), and National Hightech R&D Program ("863" Program, No. 2006AA06Z417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alicke B, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000075; Cheung VTF, 2001, ATMOS ENVIRON, V35, P4947, DOI 10.1016/S1352-2310(01)00351-X; Contran N, 2007, THESCIENTIFICWORLDJO, V7, P90, DOI 10.1100/tsw.2007.10; Czader BH, 2012, ATMOS CHEM PHYS, V12, P6939, DOI 10.5194/acp-12-6939-2012; Elminir HK, 2005, SCI TOTAL ENVIRON, V350, P225, DOI 10.1016/j.scitotenv.2005.01.043; Geng FH, 2008, ATMOS ENVIRON, V42, P6873, DOI 10.1016/j.atmosenv.2008.05.045; Geng FH, 2007, ATMOS ENVIRON, V41, P989, DOI 10.1016/j.atmosenv.2006.09.023; Hao N, 2006, J ENVIRON SCI-CHINA, V18, P910, DOI 10.1016/S1001-0742(06)60013-2; Hao N, 2006, ANN CHIM-ROME, V96, P365, DOI 10.1002/adic.200690039; He JW, 2012, ENVIRON SCI POLLUT R, V19, P4016, DOI 10.1007/s11356-012-0970-5; Jenkin ME, 2000, ATMOS ENVIRON, V34, P2499, DOI 10.1016/S1352-2310(99)00478-1; Khiem M, 2010, ADV METEOROL, V2010, DOI 10.1155/2010/349248; Li G, 2010, ATMOS CHEM PHYS, V10, P6551, DOI 10.5194/acp-10-6551-2010; Li X, 2014, ENVIRON SCI-PROC IMP, V16, P291, DOI 10.1039/c3em00545c; Meller R, 2000, J GEOPHYS RES-ATMOS, V105, P7089, DOI 10.1029/1999JD901074; Nie W, 2015, ATMOS CHEM PHYS, V15, P1147, DOI 10.5194/acp-15-1147-2015; Paoletti E, 2006, ENVIRON POLLUT, V144, P463, DOI 10.1016/j.envpol.2005.12.051; PLATT U, 1979, J GEOPHYS RES-OCEANS, V84, P6329, DOI 10.1029/JC084iC10p06329; Platt U, 2008, PHYS EARTH SPACE ENV, P1, DOI 10.1007/978-3-540-75776-4_1; PLATT U, 1980, J GEOPHYS RES-OCEANS, V85, P7453, DOI 10.1029/JC085iC12p07453; Premuda M, 2013, ATMOS ENVIRON, V71, P104, DOI 10.1016/j.atmosenv.2013.01.050; Psiloglou BE, 2013, ENVIRON MONIT ASSESS, V185, P7763, DOI 10.1007/s10661-013-3134-2; Ran L, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010752; Safieddine S, 2013, J GEOPHYS RES-ATMOS, V118, P10555, DOI 10.1002/jgrd.50669; Saiz-Lopez A, 2009, WATER AIR SOIL POLL, V200, P277, DOI 10.1007/s11270-008-9912-8; Screpanti A, 2009, ENVIRON POLLUT, V157, P1513, DOI 10.1016/j.envpol.2008.09.046; Sicard P, 2013, ATMOS ENVIRON, V79, P705, DOI 10.1016/j.atmosenv.2013.07.042; Sicard P, 2009, ENVIRON MONIT ASSESS, V156, P141, DOI 10.1007/s10661-008-0470-8; Steiner AL, 2010, P NATL ACAD SCI USA, V107, P19685, DOI 10.1073/pnas.1008336107; Stutz J, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004209; Stutz J, 2000, J GEOPHYS RES-ATMOS, V105, P14585, DOI 10.1029/2000JD900003; Stutz J, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004135; Su H, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009060; Tang WY, 2008, SCI CHINA SER D, V51, P1354, DOI 10.1007/s11430-008-0088-2; Tie X, 2013, ATMOS CHEM PHYS, V13, P5655, DOI 10.5194/acp-13-5655-2013; Triantafyllou AG, 2008, GLOBAL NEST J, V10, P161; Vautard R, 2007, CR GEOSCI, V339, P747, DOI 10.1016/j.crte.2007.08.003; Virkkula A, 1997, ATMOS ENVIRON, V31, P545, DOI 10.1016/S1352-2310(96)00225-7; Voigt S, 2002, J PHOTOCH PHOTOBIO A, V149, P1, DOI 10.1016/S1010-6030(01)00650-5; Voigt S, 2001, J PHOTOCH PHOTOBIO A, V143, P1, DOI 10.1016/S1010-6030(01)00480-4; Wang HX, 2006, J ATMOS CHEM, V54, P255, DOI 10.1007/s10874-006-9024-z; Wang SS, 2013, ATMOS ENVIRON, V77, P718, DOI 10.1016/j.atmosenv.2013.05.071; Wang SS, 2013, ATMOS ENVIRON, V70, P401, DOI 10.1016/j.atmosenv.2013.01.022; Xu WY, 2011, ATMOS CHEM PHYS, V11, P4353, DOI 10.5194/acp-11-4353-2011; Xu X, 2008, ATMOS CHEM PHYS, V8, P2595, DOI 10.5194/acp-8-2595-2008; Xue LK, 2014, ATMOS CHEM PHYS, V14, P13175, DOI 10.5194/acp-14-13175-2014; Zhang RY, 2004, P NATL ACAD SCI USA, V101, P6346, DOI 10.1073/pnas.0401484101	47	19	19	4	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131878	10.1371/journal.pone.0131878	http://dx.doi.org/10.1371/journal.pone.0131878			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121146	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400172
J	Berman, AG; Clauser, CA; Wunderlin, C; Hammond, MA; Wallace, JM				Berman, Alycia G.; Clauser, Creasy A.; Wunderlin, Caitlin; Hammond, Max A.; Wallace, Joseph M.			Structural and Mechanical Improvements to Bone Are Strain Dependent with Axial Compression of the Tibia in Female C57BL/6 Mice	PLOS ONE			English	Article							CORTICAL BONE; ADAPTIVE RESPONSE; FUNCTIONAL ADAPTATION; CANCELLOUS BONE; TRABECULAR BONE; YOUNG-ADULT; AGE; EXERCISE; MASS; DEFICIENT	Strain-induced adaption of bone has been well-studied in an axial loading model of the mouse tibia. However, most outcomes of these studies are restricted to changes in bone architecture and do not explore the mechanical implications of those changes. Herein, we studied both the mechanical and morphological adaptions of bone to three strain levels using a targeted tibial loading mouse model. We hypothesized that loading would increase bone architecture and improve cortical mechanical properties in a dose-dependent fashion. The right tibiae of female C57BL/6 mice (8 week old) were compressively loaded for 2 weeks to a maximum compressive force of 8.8N, 10.6N, or 12.4N (generating periosteal strains on the anteromedial region of the mid-diaphysis of 1700 mu epsilon, 2050 mu epsilon, or 2400 mu epsilon as determined by a strain calibration), while the left limb served as an non-loaded control. Following loading, ex vivo analyses of bone architecture and cortical mechanical integrity were assessed by micro-computed tomography and 4-point bending. Results indicated that loading improved bone architecture in a dose-dependent manner and improved mechanical outcomes at 2050 mu epsilon. Loading to 2050 mu epsilon resulted in a strong and compelling formation response in both cortical and cancellous regions. In addition, both structural and tissue level strength and energy dissipation were positively impacted in the diaphysis. Loading to the highest strain level also resulted in rapid and robust formation of bone in both cortical and cancellous regions. However, these improvements came at the cost of a woven bone response in half of the animals. Loading to the lowest strain level had little effect on bone architecture and failed to impact structural-or tissue-level mechanical properties. Potential systemic effects were identified for trabecular bone volume fraction, and in the pre-yield region of the force-displacement and stress-strain curves. Future studies will focus on a moderate load level which was largely beneficial in terms of cortical/cancellous structure and cortical mechanical function.	[Berman, Alycia G.; Clauser, Creasy A.; Wunderlin, Caitlin; Wallace, Joseph M.] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Hammond, Max A.; Wallace, Joseph M.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Wallace, Joseph M.] Indiana Univ, Sch Med, Dept Orthopaed Surg, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis	Wallace, JM (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.	jmwalla@iupui.edu	Wallace, Joseph Michael/G-7906-2012	Wallace, Joseph Michael/0000-0001-6077-8058	IUPUI; IUPUI Biomechanics and Biomaterials Research Center	IUPUI; IUPUI Biomechanics and Biomaterials Research Center	This work was supported by IUPUI (Indiana University-Purdue University at Indianapolis) departmental start-up funds, Research Support Funds Grant from the IUPUI Office of the Vice Chancellor for Research and funding from the IUPUI Biomechanics and Biomaterials Research Center.	Birkhold AI, 2014, BONE, V66, P15, DOI 10.1016/j.bone.2014.05.013; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brodt MD, 2010, J BONE MINER RES, V25, P2006, DOI 10.1002/jbmr.96; Ciani C, 2014, BONE, V59, P229, DOI 10.1016/j.bone.2013.11.026; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; Fritton JC, 2008, J BONE MINER RES, V23, P663, DOI [10.1359/jbmr.080104, 10.1359/JBMR.080104]; Fritton JC, 2005, BONE, V36, P1030, DOI 10.1016/j.bone.2005.02.013; Gardner MJ, 2006, J ORTHOP RES, V24, P1679, DOI 10.1002/jor.20230; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Hammond MA, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.12; Holguin N, 2014, BONE, V65, P83, DOI 10.1016/j.bone.2014.05.006; Holguin N, 2013, CALCIFIED TISSUE INT, V93, P211, DOI 10.1007/s00223-013-9744-4; KANNUS P, 1994, J BONE MINER RES, V9, P1613; Ko FC, 2013, ARTHRITIS RHEUM-US, V65, P1569, DOI 10.1002/art.37906; Kodama Y, 2000, CALCIFIED TISSUE INT, V66, P298, DOI 10.1007/s002230010060; Lee KCL, 2002, BONE, V31, P407, DOI 10.1016/S8756-3282(02)00842-6; Lee KCL, 2004, J ENDOCRINOL, V182, P193, DOI 10.1677/joe.0.1820193; Lynch ME, 2013, J BONE MINER RES, V28, P2357, DOI 10.1002/jbmr.1966; Lynch ME, 2011, BONE, V49, P439, DOI 10.1016/j.bone.2011.05.017; Lynch ME, 2010, J APPL PHYSIOL, V109, P685, DOI 10.1152/japplphysiol.00210.2010; Main RP, 2014, J EXP BIOL, V217, P1775, DOI 10.1242/jeb.085522; Main RP, 2010, J BIOMECH, V43, P2689, DOI 10.1016/j.jbiomech.2010.06.019; Martinez MD, 2010, BONE, V46, P1604, DOI 10.1016/j.bone.2010.02.030; Mathey J, 2002, CALCIFIED TISSUE INT, V70, P305, DOI 10.1007/s00223-001-2077-8; Meakin LB, 2014, J BONE MINER RES, V29, P1859, DOI 10.1002/jbmr.2222; Meakin LB, 2013, BONE, V54, P113, DOI 10.1016/j.bone.2013.01.029; Patel TK, 2014, J BIOMECH, V47, P451, DOI 10.1016/j.jbiomech.2013.10.052; Razi H, 2015, ACTA BIOMATER, V13, P301, DOI 10.1016/j.actbio.2014.11.021; Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1; Silva MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034980; Sinnesael M, 2015, ENDOCRINOLOGY; Sugiyama T, 2012, J BONE MINER RES, V27, P1784, DOI 10.1002/jbmr.1599; Sugiyama T, 2010, BONE, V46, P314, DOI 10.1016/j.bone.2009.08.054; SWISSASIVAN A, 1989, BONE MINER, V7, P91, DOI 10.1016/0169-6009(89)90067-6; Wallace JM, 2007, BONE, V40, P1120, DOI 10.1016/j.bone.2006.12.002; Wallace JM, 2010, ANN BIOMED ENG, V38, P1607, DOI 10.1007/s10439-009-9881-0; Wallace JM, 2009, J BONE MINER RES, V24, P1002, DOI [10.1359/jbmr.081259, 10.1359/JBMR.081259]; Warner SE, 2006, CALCIFIED TISSUE INT, V79, P395, DOI 10.1007/s00223-005-0293-3; Weatherholt AM, 2013, BONE, V52, P372, DOI 10.1016/j.bone.2012.10.026; Willie BM, 2013, BONE	40	44	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130504	10.1371/journal.pone.0130504	http://dx.doi.org/10.1371/journal.pone.0130504			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114891	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500076
J	Bhattacharya, D; Mehle, A; Kamp, TJ; Balijepalli, RC				Bhattacharya, Dipankar; Mehle, Andrew; Kamp, Timothy J.; Balijepalli, Ravi C.			Intramolecular ex vivo Fluorescence Resonance Energy Transfer (FRET) of Dihydropyridine Receptor (DHPR) beta(1a) Subunit Reveals Conformational Change Induced by RYR1 in Mouse Skeletal Myotubes	PLOS ONE			English	Article							MUSCLE RYANODINE-RECEPTOR; GUANYLATE KINASE DOMAINS; C-TERMINAL TAIL; II-III-LOOP; CALCIUM-CHANNEL; CA2+ CHANNEL; CHARGE MOVEMENT; ELECTRON CRYOMICROSCOPY; CARBOXYL-TERMINUS; BETA-1A SUBUNIT	The dihydropyridine receptor (DHPR) beta(1a) subunit is essential for skeletal muscle excitation-contraction coupling, but the structural organization of beta(1a) as part of the macromolecular DHPR-ryanodine receptor type I (RyR1) complex is still debatable. We used fluorescence resonance energy transfer (FRET) to probe proximity relationships within the beta(1a) subunit in cultured skeletal myotubes lacking or expressing RyR1. The fluorescein biarsenical reagent FlAsH was used as the FRET acceptor, which exhibits fluorescence upon binding to specific tetracysteine motifs, and enhanced cyan fluorescent protein (CFP) was used as the FRET donor. Ten beta(1a) reporter constructs were generated by inserting the CCPGCC FlAsH binding motif into five positions probing the five domains of beta(1a) with either carboxyl or amino terminal fused CFP. FRET efficiency was largest when CCPGCC was positioned next to CFP, and significant intramolecular FRET was observed for all constructs suggesting that in situ the beta(1a) subunit has a relatively compact conformation in which the carboxyl and amino termini are not extended. Comparison of the FRET efficiency in wild type to that in dyspedic (lacking RyR1) myotubes revealed that in only one construct (H458 CCPGCC beta(1a) -CFP) FRET efficiency was specifically altered by the presence of RyR1. The present study reveals that the C-terminal of the beta(1a) subunit changes conformation in the presence of RyR1 consistent with an interaction between the C-terminal of beta(1a) and RyR1 in resting myotubes.	[Bhattacharya, Dipankar; Kamp, Timothy J.; Balijepalli, Ravi C.] Univ Wisconsin, Dept Med, Cellular & Mol Arrhythmia Res Program, Madison, WI 53706 USA; [Mehle, Andrew] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Balijepalli, RC (corresponding author), Univ Wisconsin, Dept Med, Cellular & Mol Arrhythmia Res Program, Madison, WI 53706 USA.	rcb@medicine.wisc.edu	Kamp, Timothy/ABD-1343-2020	Kamp, Timothy/0000-0003-2103-7876; Mehle, Andrew/0000-0001-6060-4330	National Institutes of Health R01 [HL105713, HL078878, AR046448]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078878, R01HL105713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046448] Funding Source: NIH RePORTER	National Institutes of Health R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a grant from the National Institutes of Health R01 grants HL105713 to RCB, HL078878 and AR046448 to TJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Ahern CA, 2003, BIOPHYS J, V84, P942, DOI 10.1016/S0006-3495(03)74911-X; Beurg M, 1999, BIOPHYS J, V76, P1744, DOI 10.1016/S0006-3495(99)77336-4; Beurg M, 1997, BIOPHYS J, V73, P807, DOI 10.1016/S0006-3495(97)78113-X; Bhattacharya D, 2014, J GEN VIROL, V95, P363, DOI 10.1099/vir.0.054569-0; Bhattacharya D, 2012, J VIROL, V86, P8277, DOI 10.1128/JVI.00645-12; CASTELLANO A, 1993, J BIOL CHEM, V268, P12359; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Cheng WJ, 2005, P NATL ACAD SCI USA, V102, P19225, DOI 10.1073/pnas.0504334102; Cohen RM, 2005, AM J PHYSIOL-HEART C, V288, pH2363, DOI 10.1152/ajpheart.00348.2004; Colecraft HM, 2002, J PHYSIOL-LONDON, V541, P435, DOI 10.1113/jphysiol.2002.018515; DOSREMEDIOS CG, 1995, J STRUCT BIOL, V115, P175, DOI 10.1006/jsbi.1995.1042; ELHAYEK R, 1995, J BIOL CHEM, V270, P22116, DOI 10.1074/jbc.270.38.22116; Foell JD, 2004, PHYSIOL GENOMICS, V17, P183, DOI 10.1152/physiolgenomics.00207.2003; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; Griffin BA, 2000, METHOD ENZYMOL, V327, P565; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; HEIDECKER M, 1995, BIOCHEMISTRY-US, V34, P11017, DOI 10.1021/bi00035a007; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Hough CD, 1997, GENE DEV, V11, P3242, DOI 10.1101/gad.11.23.3242; Kamp TJ, 1996, J PHYSIOL-LONDON, V492, P89, DOI 10.1113/jphysiol.1996.sp021291; Karunasekara Y, 2012, FASEB J, V26, P5049, DOI 10.1096/fj.12-211334; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Leong P, 1998, J BIOL CHEM, V273, P7791, DOI 10.1074/jbc.273.14.7791; Leong P, 1998, BIOCHEM CELL BIOL, V76, P681, DOI 10.1139/bcb-76-5-681; Leong P, 1998, J BIOL CHEM, V273, P29958, DOI 10.1074/jbc.273.45.29958; LEUNG AT, 1988, J BIOL CHEM, V263, P994; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; MARTY I, 1994, P NATL ACAD SCI USA, V91, P2270, DOI 10.1073/pnas.91.6.2270; McGee AW, 2004, NEURON, V42, P89, DOI 10.1016/S0896-6273(04)00149-7; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; NEELY A, 1993, SCIENCE, V262, P575, DOI 10.1126/science.8211185; Nix SL, 2000, J BIOL CHEM, V275, P41192, DOI 10.1074/jbc.M002078200; Noceti F, 1996, J GEN PHYSIOL, V108, P143, DOI 10.1085/jgp.108.3.143; Olcese R, 1996, J PHYSIOL-LONDON, V497, P675, DOI 10.1113/jphysiol.1996.sp021799; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Opatowsky Y, 2003, J BIOL CHEM, V278, P52323, DOI 10.1074/jbc.M303564200; Papadopoulos S, 2004, J BIOL CHEM, V279, P44046, DOI 10.1074/jbc.M405317200; Polster A, 2012, J BIOL CHEM, V287, P41560, DOI 10.1074/jbc.M112.404194; Proenza C, 2002, J BIOL CHEM, V277, P6530, DOI 10.1074/jbc.M106471200; Qin N, 1996, AM J PHYSIOL-CELL PH, V271, pC1539, DOI 10.1152/ajpcell.1996.271.5.C1539; Rebbeck RT, 2011, BIOPHYS J, V100, P922, DOI 10.1016/j.bpj.2011.01.022; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schredelseker J, 2005, P NATL ACAD SCI USA, V102, P17219, DOI 10.1073/pnas.0508710102; Sencer S, 2001, J BIOL CHEM, V276, P38237; Serysheva II, 2002, P NATL ACAD SCI USA, V99, P10370, DOI 10.1073/pnas.162363499; Sheridan DC, 2004, BIOPHYS J, V87, P929, DOI 10.1529/biophysj.104.043810; Sheridan DC, 2003, BIOPHYS J, V85, P3739, DOI 10.1016/S0006-3495(03)74790-0; Sheridan DC, 2003, BIOPHYS J, V84, P220, DOI 10.1016/S0006-3495(03)74844-9; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; Stroffekova K, 2001, PFLUG ARCH EUR J PHY, V442, P859, DOI 10.1007/s004240100619; Strube C, 1996, BIOPHYS J, V71, P2531, DOI 10.1016/S0006-3495(96)79446-8; Takahashi SX, 2004, P NATL ACAD SCI USA, V101, P7193, DOI 10.1073/pnas.0306665101; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Wei S, 2000, CIRC RES, V86, P175, DOI 10.1161/01.RES.86.2.175; Wolf M, 2003, J MOL BIOL, V332, P171, DOI 10.1016/S0022-2836(03)00899-4; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Yan YL, 2003, CURR OPIN CHEM BIOL, V7, P635, DOI 10.1016/j.cbpa.2003.08.017	65	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131399	10.1371/journal.pone.0131399	http://dx.doi.org/10.1371/journal.pone.0131399			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114725	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500152
J	Hatazawa, Y; Senoo, N; Tadaishi, M; Ogawa, Y; Ezaki, O; Kamei, Y; Miura, S				Hatazawa, Yukino; Senoo, Nanami; Tadaishi, Miki; Ogawa, Yoshihiro; Ezaki, Osamu; Kamei, Yasutomi; Miura, Shinji			Metabolomic Analysis of the Skeletal Muscle of Mice Overexpressing PGC-1a	PLOS ONE			English	Article							COACTIVATOR 1-ALPHA PGC-1-ALPHA; IONIZATION MASS-SPECTROMETRY; TRANSCRIPTIONAL COACTIVATOR; EXERCISE METABOLISM; MESSENGER-RNA; INCREASES	Peroxisome proliferator-activated receptor (PPAR). coactivator 1a (PGC-1a) is a coactivator of various nuclear receptors and other transcription factors whose expression increases in the skeletal muscle during exercise. We have previously made transgenic mice overexpressing PGC-1a in the skeletal muscle (PGC-1a-Tg mice). PGC-1a upregulates the expression of genes associated with red fibers, mitochondrial function, fatty acid oxidation, and branched chain amino acid (BCAA) degradation. However, global analyses of the actual metabolic products have not been investigated. In this study, we conducted metabolomic analysis of the skeletal muscle in PGC-1a-Tg mice by capillary electrophoresis with electrospray ionization time-of-flight mass spectrometry. Principal component analysis and hierarchical cluster analysis showed clearly distinguishable changes in the metabolites between PGC-1a-Tg and wild-type control mice. Changes were observed in metabolite levels of various metabolic pathways such as the TCA cycle, pentose phosphate pathway, nucleotide synthesis, purine nucleotide cycle, and amino acid metabolism, including BCAA and beta-alanine. Namely, metabolic products of the TCA cycle increased in PGC-1a-Tg mice, with increased levels of citrate (2.3-fold), succinate (2.2-fold), fumarate (2.8-fold), and malate (2.3-fold) observed. Metabolic products associated with the pentose phosphate pathway and nucleotide biosynthesis also increased in PGC-1a-Tg mice. Meanwhile, BCAA levels decreased (Val, 0.7-fold; Leu, 0.8-fold; and Ile, 0.7-fold), and Glu (3.1-fold) and Asp (2.2-fold) levels increased. Levels of beta-alanine and related metabolites were markedly decreased in PGC-1a-Tg mice. Coordinated regulation of the TCA cycle and amino acid metabolism, including BCAA, suggests that PGC-1a plays important roles in energy metabolism. Moreover, our metabolomics data showing the activation of the purine nucleotide pathway, malate-aspartate shuttle, as well as creatine metabolism, which are known to be active during exercise, further suggests that PGC-1a regulates metabolism in exercise. Thus, we demonstrated the roles of PGC-1a in the skeletal muscle at the metabolite level.	[Hatazawa, Yukino; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Dept Mol Endocrinol & Metab, Grad Sch Med & Dent Sci, Tokyo, Japan; [Hatazawa, Yukino; Kamei, Yasutomi] Kyoto Prefectural Univ, Lab Mol Nutr, Grad Sch Environm & Life Sci, Kyoto 606, Japan; [Senoo, Nanami; Miura, Shinji] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Lab Nutrit Biochem, Shizuoka 4228526, Japan; [Tadaishi, Miki] Tokyo Univ Agr, Dept Nutrit Sci, Fac Appl Biosci, Tokyo, Japan; [Ezaki, Osamu] Showa Womens Univ, Dept Human Hlth & Design, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Kyoto Prefectural University; University of Shizuoka; Tokyo University of Agriculture	Kamei, Y (corresponding author), Kyoto Prefectural Univ, Lab Mol Nutr, Grad Sch Environm & Life Sci, Kyoto 606, Japan.	kamei@kpu.ac.jp; miura@u-shizuoka-ken.ac.jp	Miura, Shinji/K-6516-2013	Miura, Shinji/0000-0001-8806-9763; Ogawa, Yoshihiro/0000-0002-0834-2836	Council for Science, Technology and Innovation (CSTI); Cross-ministerial Strategic Innovation Promotion Program (SIP); "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT, Tokyo); Uehara Memorial Foundation (Tokyo, Japan); Kao Research Council for the Study of Healthcare Science (Tokyo, Japan); University of Shizuoka Grant for Scientific and Educational Research	Council for Science, Technology and Innovation (CSTI); Cross-ministerial Strategic Innovation Promotion Program (SIP); "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT, Tokyo)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation (Tokyo, Japan)(Uehara Memorial Foundation); Kao Research Council for the Study of Healthcare Science (Tokyo, Japan); University of Shizuoka Grant for Scientific and Educational Research	Y. Kamei and S. Miura were supported by the Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP), and "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO). Y. Kamei and S. Miura were also supported by grants-in-aid for scientific research (KAKENHI) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT, Tokyo) and The Uehara Memorial Foundation (Tokyo, Japan). S. Miura was supported by The Kao Research Council for the Study of Healthcare Science (Tokyo, Japan), and a University of Shizuoka Grant for Scientific and Educational Research. Y. Hatazawa is a Research Fellow of Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARABADJIS PG, 1993, AM J PHYSIOL, V264, pC1246, DOI 10.1152/ajpcell.1993.264.5.C1246; Brown EL, 2014, BBA-MOL CELL RES, V1843, P2937, DOI 10.1016/j.bbamcr.2014.08.010; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Hatazawa Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091006; Horton R, 2005, PRINCIPLES BIOCH; Kiilerich K, 2010, AM J PHYSIOL-REG I, V299, pR1350, DOI 10.1152/ajpregu.00400.2010; Liang H, 2009, AM J PHYSIOL-ENDOC M, V296, pE945, DOI 10.1152/ajpendo.90292.2008; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Miura S, 2003, J BIOL CHEM, V278, P31385, DOI 10.1074/jbc.M304312200; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Miura S, 2006, AM J PATHOL, V169, P1129, DOI 10.2353/ajpath.2006.060034; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Roberts LD, 2014, CELL METAB, V19, P96, DOI 10.1016/j.cmet.2013.12.003; Salway J.G., 2017, METABOLISM GLANCE; Salway JG, 2007, MED BIOCH GLANCE; She PX, 2010, J APPL PHYSIOL, V108, P941, DOI 10.1152/japplphysiol.01248.2009; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Soga T, 2002, ANAL CHEM, V74, P6224, DOI 10.1021/ac0202684; Summermatter S, 2010, J BIOL CHEM, V285, P32793, DOI 10.1074/jbc.M110.145995; Tadaishi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028290; Ward HJ, 1963, J AM STAT ASSOC, V58, P236; Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911	25	49	50	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129084	10.1371/journal.pone.0129084	http://dx.doi.org/10.1371/journal.pone.0129084			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114427	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500019
J	Noell, S; Fallier-Becker, P; Mack, AF; Hoffmeister, M; Beschorner, R; Ritz, R				Noell, Susan; Fallier-Becker, Petra; Mack, Andreas F.; Hoffmeister, Maike; Beschorner, Rudi; Ritz, Rainer			Water Channels Aquaporin 4 and-1 Expression in Subependymoma Depends on the Localization of the Tumors	PLOS ONE			English	Article							HUMAN BRAIN-TUMORS; ORTHOGONAL ARRAYS; CULTURED ASTROCYTES; HUMAN GLIOBLASTOMA; HUMAN-ERYTHROCYTES; MEMBRANE-PROTEINS; AGRIN; PARTICLES; TRANSPORT; AQP4	Background We analyzed aquaporin 4 and -1 expression in subependymomas, benign and slow growing brain tumors WHO grade I. Ten subependymoma cases were investigated, five of the fossa inferior and five of the fossa superior. Methods and Results Using immunohistochemistry, we observed different aquaporin expression patterns depending on localization: aquaporin 4 and -1 were detected in infratentorial subependymomas in the entire tumor tissue. In contrast, supratentorial subependymomas revealed aquaporin 4 and -1 expression only in border areas of the tumor. PCR analyses however showed no difference in aquaporin 4 expression between all subependymomas independent of localization but at higher levels than in normal brain. In contrast, aquaporin 1 RNA levels were found to be higher only in infratentorial samples compared to supratentorial and normal brain samples. The reason for the different distribution pattern of aquaporin 4 in subependymomas still remains unclear. On the cellular level, aquaporin 4 was redistributed on the surface of the tumor cells, and in freeze fracture replicas no orthogonal arrays of particles were found. This was similar to our previous findings in malignant glioblastomas. From these studies, we know that extracellular matrix molecules within the tumor like agrin and its receptor alpha-dystroglycan are involved in forming orthogonal arrays of particles. In subependymomas neither agrin nor alpha-dystroglycan were detected around blood vessels. Conclusions Taken together, we show in this study that in the benign subependymomas aquaporins 1 and 4 are dramatically redistributed and upregulated. We speculate that extracellular environments of infra- and supratentorial subependymomas are different and lead to different distribution patterns of aquaporin 4 and -1.	[Noell, Susan] Univ Tubingen, Dept Neurosurg, Tubingen, Germany; [Fallier-Becker, Petra; Hoffmeister, Maike; Beschorner, Rudi] Univ Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany; [Mack, Andreas F.] Univ Tubingen, Inst Clin Anat & Cell Anal, Tubingen, Germany; [Ritz, Rainer] Univ Marburg, Dept Neurosurg, Marburg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Philipps University Marburg	Noell, S (corresponding author), Univ Tubingen, Dept Neurosurg, Tubingen, Germany.	susan.noell@med.uni-tuebingen.de; petra.fallier-becker@med.uni-tuebingen.de	Beschorner, Rudi/M-6397-2014	Mack, Andreas/0000-0001-7591-4374	TUFF-Programm Antragsnummer [2242-0-0]	TUFF-Programm Antragsnummer	This work was funded by TUFF-Programm Antragsnummer (2242-0-0).	BENGA G, 1986, BIOCHEMISTRY-US, V25, P1535, DOI 10.1021/bi00355a011; BENGA G, 1986, EUR J CELL BIOL, V41, P252; DENKER BM, 1988, J BIOL CHEM, V263, P15634; Endo M, 1999, MICROVASC RES, V58, P89, DOI 10.1006/mvre.1999.2158; Fallier-Becker P, 2011, BRAIN RES, V1367, P2, DOI 10.1016/j.brainres.2010.09.092; Ishibashi K, 2009, CLIN EXP NEPHROL, V13, P107, DOI 10.1007/s10157-008-0118-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; MacAulay N, 2010, NEUROSCIENCE, V168, P941, DOI 10.1016/j.neuroscience.2009.09.016; Mack AF, 2013, NEUROSCIENTIST, V19, P195, DOI 10.1177/1073858412447981; Mathiisen TM, 2010, GLIA, V58, P1094, DOI 10.1002/glia.20990; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; NEUHAUS J, 1990, NEUROSCI LETT, V109, P163, DOI 10.1016/0304-3940(90)90556-O; Nielsen S, 1997, J NEUROSCI, V17, P171; Noell S, 2012, PLOS ONE, V7; NOELL S, 2011, J NEUROSCI, V33, P2179, DOI DOI 10.1111/J.1460-9568.2011.07688.X; Noell S, 2007, EUR J NEUROSCI, V26, P2109, DOI 10.1111/j.1460-9568.2007.05850.x; Noell S, 2012, CELL TISSUE RES, V347, P429, DOI 10.1007/s00441-011-1321-4; Noell S, 2009, CELL TISSUE RES, V337, P185, DOI 10.1007/s00441-009-0812-z; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; Papadopoulos M. C., 2014, BIOCH BIOPHYS ACTA; ROHLMANN A, 1992, GLIA, V5, P259, DOI 10.1002/glia.440050404; Saadoun S, 2002, BRIT J CANCER, V87, P621, DOI 10.1038/sj.bjc.6600512; Saadoun S, 2002, J NEUROL NEUROSUR PS, V72, P262, DOI 10.1136/jnnp.72.2.262; Saadoun S, 2009, NEUROSCIENCE, V161, P764, DOI 10.1016/j.neuroscience.2009.03.069; Sole S, 2004, J NEUROPATH EXP NEUR, V63, P338, DOI 10.1093/jnen/63.4.338; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Wang DW, 2011, J CLIN NEUROSCI, V18, P122, DOI 10.1016/j.jocn.2010.07.115; Warth A, 2004, ACTA NEUROPATHOL, V107, P311, DOI 10.1007/s00401-003-0812-0; Wolburg H, 2011, INT REV CEL MOL BIO, V287, P1, DOI 10.1016/B978-0-12-386043-9.00001-3; Wolburg-Buchholz K, 2009, ACTA NEUROPATHOL, V118, P583, DOI 10.1007/s00401-009-0579-z	31	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131367	10.1371/journal.pone.0131367	http://dx.doi.org/10.1371/journal.pone.0131367			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115524	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500147
J	Tamehiro, N; Oda, H; Shirai, M; Suzuki, H				Tamehiro, Norimasa; Oda, Hiroyo; Shirai, Mutsunori; Suzuki, Harumi			Overexpression of RhoH Permits to Bypass the Pre-TCR Checkpoint	PLOS ONE			English	Article							T-CELL PROGENITORS; THYMOCYTE DEVELOPMENT; V(D)J RECOMBINATION; GTPASE-DEFICIENT; DIFFERENTIATION; EXPRESSION; MICE; REARRANGEMENT; MATURATION; P53	RhoH, an atypical small Rho-family GTPase, critically regulates thymocyte differentiation through the coordinated interaction with Lck and Zap70. Therefore, RhoH deficiency causes defective T cell development, leading to a paucity of mature T cells. Since there has been no gain-of-function study on RhoH before, we decided to take a transgenic approach to assess how the overexpression of RhoH affects the development of T cells. Although RhoH transgenic (RhoH(tg)) mice expressed three times more RhoH protein than wild-type mice, beta-selection, positive, and negative selection in the thymus from RhoH(tg) mice were unaltered. However, transgenic introduction of RhoH into Rag2 deficient mice resulted in the generation of CD4(+)CD8(+) (DP) thymocytes, indicating that overexpression of RhoH could bypass beta-selection without TCR beta gene rearrangement. This was confirmed by the in vitro development of DP cells from Rag2-/-RhoHtg DN3 cells on TSt-4/Dll-1 stroma in an Lck dependent manner. Collectively, our results indicate that an excess amount of RhoH is able to initiate pre-TCR signaling in the absence of pre-TCR complexes.	[Tamehiro, Norimasa; Oda, Hiroyo; Suzuki, Harumi] Natl Ctr Global Hlth & Med, Res Inst, Dept Pathol & Immunol, Chiba, Japan; [Shirai, Mutsunori] Yamaguchi Univ, Sch Med, Dept Microbiol, Ube, Yamaguchi 755, Japan	National Center for Global Health & Medicine - Japan; Yamaguchi University	Suzuki, H (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Pathol & Immunol, Chiba, Japan.	hsuzuki@ri.ncgm.go.jp	Suzuki, Harumi/L-1271-2013	Suzuki, Harumi/0000-0003-3616-9361	National Center for Global Health and Medicine [25103]; Grants-in-Aid for Scientific Research [25871164] Funding Source: KAKEN	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grant for National Center for Global Health and Medicine (25103) to HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM KM, 1991, P NATL ACAD SCI USA, V88, P3977, DOI 10.1073/pnas.88.9.3977; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Bogue MA, 1996, GENE DEV, V10, P553, DOI 10.1101/gad.10.5.553; Chae HD, 2008, BLOOD, V111, P2597, DOI 10.1182/blood-2007-06-093237; Chae HD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013970; Chakraborty AK, 2014, NAT IMMUNOL, V15, P798, DOI 10.1038/ni.2940; Cimbro R, 2012, BLOOD, V120, P2610, DOI 10.1182/blood-2012-06-434779; Cleverley S, 1999, CURR BIOL, V9, P657, DOI 10.1016/S0960-9822(99)80289-9; Crequer A, 2012, J CLIN INVEST, V122, P3239, DOI 10.1172/JCI62949; DANSKA JS, 1994, SCIENCE, V266, P450, DOI 10.1126/science.7524150; Di JA, 1996, J EXP MED, V183, P1923, DOI 10.1084/jem.183.4.1923; Dorn T, 2007, BLOOD, V109, P2346, DOI 10.1182/BLOOD-2006-04-019034; Gascoigne NRJ, 2011, CURR OPIN IMMUNOL, V23, P207, DOI 10.1016/j.coi.2010.12.017; Gomez M, 2000, NAT IMMUNOL, V1, P348, DOI 10.1038/79808; Gu Y, 2006, NAT IMMUNOL, V7, P1182, DOI 10.1038/ni1396; GUIDOS CJ, 1995, J EXP MED, V181, P1187, DOI 10.1084/jem.181.3.1187; Guidos CJ, 1996, GENE DEV, V10, P2038, DOI 10.1101/gad.10.16.2038; Haks MC, 1999, IMMUNITY, V11, P91, DOI 10.1016/S1074-7613(00)80084-9; Koltsova EK, 2007, J IMMUNOL, V179, P4694, DOI 10.4049/jimmunol.179.7.4694; LAKE RA, 1990, EMBO J, V9, P3129, DOI 10.1002/j.1460-2075.1990.tb07510.x; Leduc I, 2000, INT IMMUNOL, V12, P1389, DOI 10.1093/intimm/12.10.1389; Li XY, 2002, MOL CELL BIOL, V22, P1158, DOI 10.1128/MCB.22.4.1158-1171.2002; Merck E, 2011, J IMMUNOL, V187, P110, DOI 10.4049/jimmunol.1002755; Miyazaki T, 1997, J EXP MED, V186, P877, DOI 10.1084/jem.186.6.877; MOMBAERTS P, 1994, IMMUNITY, V1, P261, DOI 10.1016/1074-7613(94)90077-9; MURPHY WJ, 1994, J IMMUNOL, V153, P1004; Nacht M, 1996, GENE DEV, V10, P2055, DOI 10.1101/gad.10.16.2055; Newton K, 2000, EMBO J, V19, P931, DOI 10.1093/emboj/19.5.931; Norment AM, 2003, J IMMUNOL, V170, P1141, DOI 10.4049/jimmunol.170.3.1141; Norment AM, 1997, J EXP MED, V185, P121, DOI 10.1084/jem.185.1.121; Oda H, 2013, IMMUNOL LETT, V151, P1, DOI 10.1016/j.imlet.2013.02.007; Oda H, 2009, J IMMUNOL, V182, P957, DOI 10.4049/jimmunol.182.2.957; RODEWALD HR, 1993, J EXP MED, V177, P1079, DOI 10.1084/jem.177.4.1079; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Stritesky GL, 2013, P NATL ACAD SCI USA, V110, P4679, DOI 10.1073/pnas.1217532110; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; Troeger A, 2013, J BIOL CHEM, V288, P36451, DOI 10.1074/jbc.M113.505727; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Wang H, 2011, CELL SIGNAL, V23, P249, DOI 10.1016/j.cellsig.2010.09.009; Williams JA, 2005, J IMMUNOL, V175, P4199, DOI 10.4049/jimmunol.175.7.4199; Xi HK, 2004, J IMMUNOL, V172, P964, DOI 10.4049/jimmunol.172.2.964; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S; ZUNIGAPFLUCKER JC, 1994, J EXP MED, V180, P1517, DOI 10.1084/jem.180.4.1517	45	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131047	10.1371/journal.pone.0131047	http://dx.doi.org/10.1371/journal.pone.0131047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114424	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500123
J	Amblee, V; Jeffery, CJ				Amblee, Vaishak; Jeffery, Constance J.			Physical Features of Intracellular Proteins that Moonlight on the Cell Surface	PLOS ONE			English	Article							LISTERIA ADHESION PROTEIN; HEAT-SHOCK-PROTEIN; FIBRONECTIN-BINDING PROTEIN; GROUP-A STREPTOCOCCI; ELONGATION-FACTOR TU; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PLASMINOGEN-BINDING; ALPHA-ENOLASE; PARACOCCIDIOIDES-BRASILIENSIS; CANDIDA-ALBICANS	Moonlighting proteins comprise a subset of multifunctional proteins that perform two or more biochemical functions that are not due to gene fusions, multiple splice variants, proteolytic fragments, or promiscuous enzyme activities. The project described herein focuses on a sub-set of moonlighting proteins that have a canonical biochemical function inside the cell and perform a second biochemical function on the cell surface in at least one species. The goal of this project is to consider the biophysical features of these moonlighting proteins to determine whether they have shared characteristics or defining features that might suggest why these particular proteins were adopted for a second function on the cell surface, or if these proteins resemble typical intracellular proteins. The latter might suggest that many other normally intracellular proteins found on the cell surface might also be moonlighting in this fashion. We have identified 30 types of proteins that have different functions inside the cell and on the cell surface. Some of these proteins are found to moonlight on the surface of multiple species, sometimes with different extracellular functions in different species, so there are a total of 98 proteins in the study set. Although a variety of intracellular proteins (enzymes, chaperones, etc.) are observed to be re-used on the cell surface, for the most part, these proteins were found to have physical characteristics typical of intracellular proteins. Many other intracellular proteins have also been found on the surface of bacterial pathogens and other organisms in proteomics experiments. It is quite possible that many of those proteins also have a moonlighting function on the cell surface. The increasing number and variety of known moonlighting proteins suggest that there may be more moonlighting proteins than previously thought, and moonlighting might be a common feature of many more proteins.	[Amblee, Vaishak; Jeffery, Constance J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Jeffery, CJ (corresponding author), Univ Illinois, Dept Biol Sci, MC567,900 S Ashland Ave, Chicago, IL 60607 USA.	cjeffery@uic.edu		Jeffery, Constance/0000-0002-2147-3638	Sarah Madonna Kabbes Award for Undergraduate Research; University of Illinois Honors College Research Grant	Sarah Madonna Kabbes Award for Undergraduate Research; University of Illinois Honors College Research Grant	The research reported herein was supported by a Sarah Madonna Kabbes Award for Undergraduate Research to V.A. and a University of Illinois Honors College Research Grant (www.uic.edu/honors/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, BBA-PROTEINS PROTEOM, V1784, P986, DOI 10.1016/j.bbapap.2008.03.017; Aguilera L, 2009, INT MICROBIOL, V12, P187, DOI 10.2436/20.1501.01.97; Alvarez RA, 2003, MOL MICROBIOL, V48, P1417, DOI 10.1046/j.1365-2958.2003.03518.x; Antikainen J, 2007, FEMS IMMUNOL MED MIC, V51, P526, DOI 10.1111/j.1574-695X.2007.00330.x; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barbosa MS, 2006, INFECT IMMUN, V74, P382, DOI 10.1128/IAI.74.1.382-389.2006; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bergonzelli GE, 2006, INFECT IMMUN, V74, P425, DOI 10.1128/IAI.74.1.425-434.2006; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bocharov AV, 2000, BIOCHEM BIOPH RES CO, V277, P228, DOI 10.1006/bbrc.2000.3663; Boone TJ, 2011, MICROB PATHOGENESIS, V51, P255, DOI 10.1016/j.micpath.2011.06.005; Brix K, 1998, J CLIN INVEST, V102, P283, DOI 10.1172/JCI1614; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Burkholder KM, 2010, INFECT IMMUN, V78, P5062, DOI 10.1128/IAI.00516-10; Candela M, 2007, J BACTERIOL, V189, P5929, DOI 10.1128/JB.00159-07; Candela M, 2010, MICROBIOL-SGM, V156, P1609, DOI 10.1099/mic.0.038307-0; Candela M, 2009, MICROBIOL-SGM, V155, P3294, DOI 10.1099/mic.0.028795-0; Carneiro CRW, 2004, MICROBES INFECT, V6, P604, DOI 10.1016/j.micinf.2004.02.003; Castaldo C, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-14; COLLEN D, 1975, THROMB DIATH HAEMOST, V34, P403, DOI 10.1055/s-0038-1651399; Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Daniely D, 2006, CLIN EXP IMMUNOL, V144, P254, DOI 10.1111/j.1365-2249.2006.03047.x; de la Torre-Escudero E, 2010, VET PARASITOL, V173, P76, DOI 10.1016/j.vetpar.2010.06.011; Donofrio FC, 2009, J MED MICROBIOL, V58, P706, DOI 10.1099/jmm.0.003830-0; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Ehinger S, 2004, J MOL BIOL, V343, P997, DOI 10.1016/j.jmb.2004.08.088; ENSGRABER M, 1992, INFECT IMMUN, V60, P3072, DOI 10.1128/IAI.60.8.3072-3078.1992; Esgleas M, 2008, MICROBIOL-SGM, V154, P2668, DOI 10.1099/mic.0.2008/017145-0; Floden AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027502; Frisk A, 1998, INFECT IMMUN, V66, P1252, DOI 10.1128/IAI.66.3.1252-1257.1998; Fulde M, 2013, THROMB HAEMOST, V111; Gancedo C, 2008, MICROBIOL MOL BIOL R, V72, P197, DOI 10.1128/MMBR.00036-07; Garduno RA, 1998, INFECT IMMUN, V66, P4602; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Ghosh K, 2009, P NATL ACAD SCI USA, V106, P10649, DOI 10.1073/pnas.0903995106; Goulhen F, 1998, INFECT IMMUN, V66, P5307, DOI 10.1128/IAI.66.11.5307-5313.1998; Gozalbo D, 1998, INFECT IMMUN, V66, P2052, DOI 10.1128/IAI.66.5.2052-2059.1998; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Henderson B, 2013, CURR TOP MICROBIOL, V358, P155, DOI 10.1007/82_2011_188; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Hennequin C, 2001, MICROBIOL-UK, V147, P87, DOI 10.1099/00221287-147-1-87; Hickey TBM, 2009, INFECT IMMUN, V77, P3389, DOI 10.1128/IAI.00143-09; Hurmalainen V, 2007, MICROBIOL-SGM, V153, P1112, DOI 10.1099/mic.0.2006/000901-0; Hussain M, 1999, INFECT IMMUN, V67, P6688; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Jagadeesan B, 2010, MICROBIOL-SGM, V156, P2782, DOI 10.1099/mic.0.036509-0; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jeffery CJ, 2000, BIOCHEMISTRY-US, V39, P955, DOI 10.1021/bi991604m; Jeffery CJ, 2003, ANN MED, V35, P28, DOI 10.1080/07853890310004101; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; Jin H, 2005, J MOL BIOL, V350, P27, DOI 10.1016/j.jmb.2005.04.063; Jobin MC, 2004, INFECT IMMUN, V72, P606, DOI 10.1128/IAI.72.1.606-610.2004; Jolodar A, 2003, BBA-GENE STRUCT EXPR, V1627, P111, DOI 10.1016/S0167-4781(03)00083-6; Jones MN, 2007, BIOCHEM BIOPH RES CO, V364, P924, DOI 10.1016/j.bbrc.2007.10.098; Jong AY, 2003, J MED MICROBIOL, V52, P615, DOI 10.1099/jmm.0.05060-0; Kainulainen V, 2012, J BACTERIOL, V194, P2509, DOI 10.1128/JB.06704-11; Kamiya S, 1998, J CLIN GASTROENTEROL, V27, pS35, DOI 10.1097/00004836-199800001-00007; Katakura Y, 2010, APPL MICROBIOL BIOT, V86, P319, DOI 10.1007/s00253-009-2295-y; Kim KP, 2006, FEMS MICROBIOL LETT, V256, P324, DOI 10.1111/j.1574-6968.2006.00140.x; Kinhikar AG, 2006, MOL MICROBIOL, V60, P999, DOI 10.1111/j.1365-2958.2006.05151.x; Kinnby B, 2008, MICROBIOL-SGM, V154, P924, DOI 10.1099/mic.0.2007/013235-0; Kinoshita H, 2008, J APPL MICROBIOL, V104, P1667, DOI 10.1111/j.1365-2672.2007.03679.x; Knaust A, 2007, J BACTERIOL, V189, P3246, DOI 10.1128/JB.01966-06; Kolberg J, 2006, MICROBIOL-SGM, V152, P1307, DOI 10.1099/mic.0.28747-0; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lama A, 2009, INFECT IMMUN, V77, P2703, DOI 10.1128/IAI.00157-09; Lipman DJ, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-20; Long KH, 2003, J IMMUNOL, V170, P487, DOI 10.4049/jimmunol.170.1.487; Mani M, 2015, NUCLEIC ACIDS RES, V43, pD277, DOI 10.1093/nar/gku954; Matta SK, 2010, BBA-PROTEINS PROTEOM, V1804, P2111, DOI 10.1016/j.bbapap.2010.08.004; Meza-Cervantez P, 2011, MICROBIOL-SGM, V157, P3469, DOI 10.1099/mic.0.053033-0; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Modun B, 1999, INFECT IMMUN, V67, P1086, DOI 10.1128/IAI.67.3.1086-1092.1999; Molkanen T, 2002, FEBS LETT, V517, P72, DOI 10.1016/S0014-5793(02)02580-2; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; NAKAJIMA K, 1994, J NEUROCHEM, V63, P2048; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Pantzar M, 2006, MICROBES INFECT, V8, P2452, DOI 10.1016/j.micinf.2006.05.009; Pereira LA, 2007, FEMS YEAST RES, V7, P1381, DOI 10.1111/j.1567-1364.2007.00292.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PIATIGORSKY J, 1989, CELL, V57, P197, DOI 10.1016/0092-8674(89)90956-2; PIATIGORSKY J, 1989, FASEB J, V3, P1933, DOI 10.1096/fasebj.3.8.2656357; Reddy VA, 2004, MICROB PATHOGENESIS, V36, P67, DOI 10.1016/j.micpath.2003.09.005; Reddy VM, 2000, J INFECT DIS, V181, P1189, DOI 10.1086/315327; Redlitz A, 1985, EUR J BIOCHEM, V227, P407; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; Schwartz R, 2001, GENOME RES, V11, P703, DOI 10.1101/gr.GR-1587R; Seifert KN, 2003, CAN J MICROBIOL, V49, P350, DOI 10.1139/W03-042; Sha J, 2009, J BACTERIOL, V191, P3095, DOI 10.1128/JB.00005-09; Sillitoe I, 2013, NUCLEIC ACIDS RES, V41, pD490, DOI 10.1093/nar/gks1211; Sjostrom I, 1997, BBA-BIOMEMBRANES, V1324, P182, DOI 10.1016/S0005-2736(96)00218-0; Skovgaard M, 2001, TRENDS GENET, V17, P425, DOI 10.1016/S0168-9525(01)02372-1; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tsugawa H, 2007, J MED MICROBIOL, V56, P23, DOI 10.1099/jmm.0.46766-0; Tunio SA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-280; Tunio SA, 2010, MOL MICROBIOL, V76, P605, DOI 10.1111/j.1365-2958.2010.07098.x; Vanegas G, 2007, PARASITOL RES, V101, P1511, DOI 10.1007/s00436-007-0668-7; Wampler JL, 2004, INFECT IMMUN, V72, P931, DOI 10.1128/IAI.72.2.931-936.2004; Winram SB, 1996, MICROBIOL-SGM, V142, P2311, DOI 10.1099/13500872-142-8-2311; WISTOW G, 1987, SCIENCE, V236, P1554, DOI 10.1126/science.3589669; Wuppermann FN, 2008, J BACTERIOL, V190, P3757, DOI 10.1128/JB.01638-07; Xolalpa W, 2007, PROTEOMICS, V7, P3332, DOI 10.1002/pmic.200600876; Yamaguchi H, 1997, J MED MICROBIOL, V46, P825, DOI 10.1099/00222615-46-10-825; Yamaguchi M, 2010, MICROBIOL IMMUNOL, V54, P368, DOI 10.1111/j.1348-0421.2010.00225.x; YANG WG, 1994, MOL BIOCHEM PARASIT, V64, P253, DOI 10.1016/0166-6851(93)00020-A	114	63	63	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130575	10.1371/journal.pone.0130575	http://dx.doi.org/10.1371/journal.pone.0130575			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110848	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800065
J	Garimalla, S; Kieber-Emmons, T; Pashov, AD				Garimalla, Swetha; Kieber-Emmons, Thomas; Pashov, Anastas D.			The Patterns of Coevolution in Clade B HIV Envelope's N-Glycosylation Sites	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CONFORMATIONAL-CHANGES; CARBOHYDRATE ANTIGENS; CONCANAVALIN-A; ANTIBODY 2G12; CD4 BINDING; GP120; PROTEIN; GLYCOPROTEIN; LOOP	The co-evolution of the potential N-glycosylation sites of HIV Clade B gp120 was mapped onto the coevolution network of the protein structure using mean field direct coupling analysis (mfDCA). This was possible for 327 positions with suitable entropy and gap content. Indications of pressure to preserve the evolving glycan shield are seen as well as strong dependencies between the majority of the potential N-glycosylation sites and the rest of the structure. These findings indicate that although mainly an adaptation against antibody neutralization, the evolving glycan shield is structurally related to the core polypeptide, which, thus, is also under pressure to reflect the changes in the N-glycosylation. The map we propose fills the gap in previous attempts to tease out sequon evolution by providing a more general molecular context. Thus, it will help design strategies guiding HIV gp120 evolution in a rational way.	[Garimalla, Swetha] Univ Michigan Hlth Syst, Ann Arbor, MI USA; [Kieber-Emmons, Thomas; Pashov, Anastas D.] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA; [Pashov, Anastas D.] Bulgarian Acad Sci, Stephan Angeloff Inst Microbiol, Sofia, Bulgaria; [Pashov, Anastas D.] Ctr Rech Cordeliers, INSERM UMRS 872, Equip 16, UMRS872, Paris, France	University of Michigan System; University of Michigan; University of Arkansas System; University of Arkansas Medical Sciences; Bulgarian Academy of Sciences; Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Pashov, AD (corresponding author), Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA.	a_pashov@microbio.bas.bg	Pashov, Anastas/AAE-7997-2019	Pashov, Anastas/0000-0002-6033-3566	Translational Research Institute (TRI) through the NIH National Center for Research Resources [UL1TR000039]; Translational Research Institute (TRI) through the National Center for Advancing Translational Sciences; Arkansas INBRE from the NIH National Institute of General Medical Sciences [P20 GM103429]	Translational Research Institute (TRI) through the NIH National Center for Research Resources; Translational Research Institute (TRI) through the National Center for Advancing Translational Sciences; Arkansas INBRE from the NIH National Institute of General Medical Sciences	The project described was supported by the Translational Research Institute (TRI), grant UL1TR000039 through the NIH National Center for Research Resources and National Center for Advancing Translational Sciences and the Arkansas INBRE from the NIH National Institute of General Medical Sciences (P20 GM103429). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Balzarini J, 2005, MOL PHARMACOL, V67, P1556, DOI 10.1124/mol.104.005082; Balzarini O, 2005, LANCET INFECT DIS, V5, P726, DOI 10.1016/S1473-3099(05)70271-1; Bastian M., 2009, 3 INT AAAI C WEBL SO; Boehr DD, 2013, BIOCHEMISTRY-US, V52, P4605, DOI 10.1021/bi400563c; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Cocco S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003176; Dacheux L, 2004, J VIROL, V78, P12625, DOI 10.1128/JVI.78.22.12625-12637.2004; Gandhi PS, 2008, P NATL ACAD SCI USA, V105, P1832, DOI 10.1073/pnas.0710894105; Gloor GB, 2010, MOL BIOL EVOL, V27, P1181, DOI 10.1093/molbev/msq004; Hsu STD, 2004, PROTEINS, V55, P582, DOI 10.1002/prot.20061; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang X, 2011, J GEN VIROL, V92, P2367, DOI 10.1099/vir.0.033092-0; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Kowarsch A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000923; Lakemeyer G., 2003, EXPLORING ARTIFICIAL, P239; Liu L, 2011, P NATL ACAD SCI USA, V108, P20148, DOI 10.1073/pnas.1104840108; Liu SQ, 2008, J MOL MODEL, V14, P857, DOI 10.1007/s00894-008-0327-7; Lunzer M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001162; Meyerson JR, 2013, P NATL ACAD SCI USA, V110, P513, DOI 10.1073/pnas.1214810110; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; MYERS G, 1992, AIDS RES HUM RETROV, V8, P1459, DOI 10.1089/aid.1992.8.1459; Pashov A, 2005, GLYCOBIOLOGY, V15, P994, DOI 10.1093/glycob/cwi083; Pashov A, 2007, CURR PHARM DESIGN, V13, P185, DOI 10.2174/138161207779313678; Pashov AD, 2006, J BIOL CHEM, V281, P29675, DOI 10.1074/jbc.M604137200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poon AFY, 2007, PLOS COMPUT BIOL, V3, P110, DOI 10.1371/journal.pcbi.0030011; Rusert P, 2011, J EXP MED, V208, P1419, DOI 10.1084/jem.20110196; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Sethi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003046; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Wei Bo, 2011, Virologica Sinica, V26, P95, DOI 10.1007/s12250-011-3188-7; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Witvrouw M, 2005, J VIROL, V79, P7777, DOI 10.1128/JVI.79.12.7777-7784.2005; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514	39	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0128664	10.1371/journal.pone.0128664	http://dx.doi.org/10.1371/journal.pone.0128664			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110648	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800013
J	Hansen, JF; Nielsen, CH; Brorson, MM; Frederiksen, H; Hartoft-Nielsen, ML; Rasmussen, AK; Bendtzen, K; Feldt-Rasmussen, U				Hansen, Juliana Frohnert; Nielsen, Claus Henrik; Brorson, Marianne Moller; Frederiksen, Hanne; Hartoft-Nielsen, Marie-Louise; Rasmussen, Ase Krogh; Bendtzen, Klaus; Feldt-Rasmussen, Ulla			Influence of Phthalates on in vitro Innate and Adaptive Immune Responses	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; EXPOSURE; ACID; SERUM; METABOLITES; CHEMICALS; PLASMA; ASTHMA; ESTERS; URINE	Phthalates are a group of endocrine disrupting chemicals, suspected to influence the immune system. The aim of this study was to investigate the influence of phthalates on cytokine secretion from human peripheral blood mononuclear cells. Escherichia coli lipopolysaccharide and phytohemagglutinin-P were used for stimulation of monocytes/ macrophages and T cells, respectively. Cells were exposed for 20 to 22 hours to either diethyl, di-n-butyl or mono-n-butyl phthalate at two different concentrations. Both diesters were metabolised to their respective monoester and influenced cytokine secretion from both monocytes/macrophages and T cells in a similar pattern: the secretion of interleukin (IL)-6, IL-10 and the chemokine CXCL8 by monocytes/macrophages was enhanced, while tumour necrosis factor (TNF)-a secretion by monocytes/macrophages was impaired, as was the secretion of IL-2 and IL-4, TNF-alpha and interferon-gamma by T cells. The investigated phthalate monoester also influenced cytokine secretion from monocytes/macrophages similar to that of the diesters. In T cells, however, the effect of the monoester was different compared to the diesters. The influence of the phthalates on the cytokine secretion did not seem to be a result of cell death. Thus, results indicate that both human innate and adaptive immunity is influenced in vitro by phthalates, and that phthalates therefore may affect cell differentiation and regenerative and inflammatory processes in vivo.	[Hansen, Juliana Frohnert; Brorson, Marianne Moller; Hartoft-Nielsen, Marie-Louise; Rasmussen, Ase Krogh; Feldt-Rasmussen, Ulla] Univ Copenhagen, Rigshosp, Dept Med Endocrinol, DK-2100 Copenhagen, Denmark; [Nielsen, Claus Henrik; Bendtzen, Klaus] Univ Copenhagen, Rigshosp, Inst Inflammat Res, DK-2100 Copenhagen, Denmark; [Frederiksen, Hanne] Univ Copenhagen, Rigshosp, Dept Growth & Reprod, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Feldt-Rasmussen, U (corresponding author), Univ Copenhagen, Rigshosp, Dept Med Endocrinol, PE 2132, DK-2100 Copenhagen, Denmark.	ufeldt@rh.dk	Feldt-Rasmussen, Ulla/AAB-9218-2021; Frederiksen, Hanne/N-8632-2013	Feldt-Rasmussen, Ulla/0000-0002-5903-3355; Frederiksen, Hanne/0000-0002-3180-9879; Nielsen, Claus Henrik/0000-0001-7543-9016	Danish public fund Capital Region of Denmark; Danish public fund Rigshospitalets Forskningspuljer; Danish public fund Danish Council for Independent Research, Medical Science-Grant [11-107874]; Novo Nordisk Foundation; Arvid Nilsson's Fund; DAKO A/S; Novo Nordisk Fonden [NNF15OC0014622, NNF13OC0008005] Funding Source: researchfish	Danish public fund Capital Region of Denmark; Danish public fund Rigshospitalets Forskningspuljer; Danish public fund Danish Council for Independent Research, Medical Science-Grant; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Arvid Nilsson's Fund; DAKO A/S; Novo Nordisk Fonden(Novo Nordisk Foundation)	Juliana Frohnert Hansen received salary from three Danish public funds (The Capital Region of Denmark, Rigshospitalets Forskningspuljer and The Danish Council for Independent Research, Medical Science-Grant number: 11-107874). Equipment and materials were also sponsored by these funds as well as by the Novo Nordisk Foundation. Ulla Feldt-Rasmussen received funding for her research salary by Arvid Nilsson's Fund. Marie-Louise Hartoft-Nielsen is an employee of Novo Nordisk A/S, Denmark. Marianne Moller Brorson is an employee of Dako A/S, Denmark. The funders provided support in the form of salaries for authors MLHN and MMB (MMB was employed and received salary from DAKO A/S only during the manuscript preparation, but not during performance and analysis of experiments), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the authors is articulated in the 'author contributions' section.	[Anonymous], 2002, SCCNFP041101; ATSDR, 1995, AG TOX SUBST DIS REG; ATSDR, 2001, AG TOX SUBST DIS REG; BAILLY S, 1990, Cytokine, V2, P205, DOI 10.1016/1043-4666(90)90017-N; Bornehag CG, 2010, INT J ANDROL, V33, P333, DOI 10.1111/j.1365-2605.2009.01023.x; Bornehag CG, 2005, ENVIRON HEALTH PERSP, V113, P1399, DOI 10.1289/ehp.7809; Corsini E, 2011, TOXICOL APPL PHARM, V250, P108, DOI 10.1016/j.taap.2010.11.004; Desdoits-Lethimonier C, 2012, HUM REPROD, V27, P1451, DOI 10.1093/humrep/des069; Dooper MMBW, 2002, IMMUNOLOGY, V107, P152, DOI 10.1046/j.1365-2567.2002.01474.x; European Union, 2003, RISK ASS REP DIB PHT, V29; Fracasso A, 1993, Perit Dial Int, V13 Suppl 2, pS517; Frederiksen H, 2014, ENV HLTH PERSPECT; Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.200600243; Frederiksen H, 2014, REPRODUCTION, V147, P555, DOI 10.1530/REP-13-0522; Frederiksen H, 2010, J ANAL TOXICOL, V34, P400, DOI 10.1093/jat/34.7.400; Glue C, 2002, TOXICOL IN VITRO, V16, P657, DOI 10.1016/S0887-2333(02)00082-6; Grandjean P, 2012, JAMA-J AM MED ASSOC, V307, P391, DOI 10.1001/jama.2011.2034; Hait EJ, 2014, ENDOCR DISRUPTORS AU, P1; Hass U, 2012, REPROD TOXICOL, V34, P261, DOI 10.1016/j.reprotox.2012.05.090; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Jaakkola JJK, 2008, ENVIRON HEALTH PERSP, V116, P845, DOI 10.1289/ehp.10846; Kay VR, 2014, CRIT REV TOXICOL, V44, P467, DOI 10.3109/10408444.2013.875983; Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3; Kristensen DM, 2011, ENVIRON HEALTH PERSP, V119, P534, DOI 10.1289/ehp.1002635; Kusk KO, 2011, ENVIRON TOXICOL CHEM, V30, P413, DOI 10.1002/etc.385; Lhuguenot J-C, 1985, TOXICOLOGY APPL PHAR, V80, P1985; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; MADSEN SN, 1976, ACTA ENDOCRINOL-COP, V81, P208, DOI 10.1530/acta.0.0810208; Mankidy R, 2013, TOXICOL LETT, V217, P50, DOI 10.1016/j.toxlet.2012.11.025; Pavan B, 2001, TOXICOL LETT, V118, P157, DOI 10.1016/S0378-4274(00)00279-4; Peng SL, 2005, CURR OPIN IMMUNOL, V17, P230, DOI 10.1016/j.coi.2005.03.003; RASMUSSEN AK, 1994, J ENDOCRINOL, V143, P359, DOI 10.1677/joe.0.1430359; Rasmussen AK, 1996, MOL CELL ENDOCRINOL, V116, P165, DOI 10.1016/0303-7207(95)03711-X; Schlezinger JJ, 2004, J IMMUNOL, V173, P3165, DOI 10.4049/jimmunol.173.5.3165; Seldon Paul M., 1998, Cell Biochemistry and Biophysics, V29, P179, DOI 10.1007/BF02737835; TAVARES IA, 1984, EUR J PHARMACOL, V106, P449, DOI 10.1016/0014-2999(84)90738-6; Ventrice P, 2013, ENVIRON TOXICOL PHAR, V36, P88, DOI 10.1016/j.etap.2013.03.014; Wang X, 2010, DOMEST ANIM ENDOCRIN, V39, P131, DOI 10.1016/j.domaniend.2010.03.002; Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121; Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x; Xu Y, 2008, PLACENTA, V29, P962, DOI 10.1016/j.placenta.2008.08.011	42	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131168	10.1371/journal.pone.0131168	http://dx.doi.org/10.1371/journal.pone.0131168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110840	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800124
J	Manrique-Poyato, MI; Lopez-Leon, MD; Cabrero, J; Gomez, R; Perfectti, F; Camacho, JPM				Inmaculada Manrique-Poyato, Maria; Dolores Lopez-Leon, Maria; Cabrero, Josefa; Gomez, Ricardo; Perfectti, Francisco; Camacho, Juan Pedro M.			Geographical Barriers Impeded the Spread of a Parasitic Chromosome	PLOS ONE			English	Article							GRASSHOPPER EYPREPOCNEMIS-PLORANS; B-CHROMOSOME; POPULATION-STRUCTURE; POLYMORPHISM; DYNAMICS; MARKERS; ORIGIN	Parasitic supernumerary (B) chromosomes show high capability to spread across populations. But the existence of abrupt discontinuities in their distribution demands an explanation. The grasshopper Eyprepocnemis plorans plorans harbour supernumerary chromosomes in all natural populations hitherto analyzed from the Circum-Mediterranean region, with the single exception of the headwaters of the Iberian Segura River and several of its tributaries. To ascertain the causes of this distribution pattern, we analyze here the genetic structure of five natural populations collected in this zone (two +B and three -B), by means of ISSR markers. We found significant population structure, with two kinds of populations coinciding with +B and -B ones, separated by strong barriers to gene flow. This gives strong support to the hypothesis that the non-B populations precede B origin, and that Bcarrying individuals from coastal zones have been able to colonize upstream areas, until geographical barriers (usually narrow canyons and arid areas surrounding them) impeded their advance.	[Inmaculada Manrique-Poyato, Maria; Dolores Lopez-Leon, Maria; Cabrero, Josefa; Perfectti, Francisco; Camacho, Juan Pedro M.] Univ Granada, Fac Ciencias, Dept Genet, E-18071 Granada, Spain; [Gomez, Ricardo] Univ Castilla La Mancha, ETS Ingn Agronomos, Dept Ciencia Tecnol Agroforestal, Albacete, Spain	University of Granada; Universidad de Castilla-La Mancha	Camacho, JPM (corresponding author), Univ Granada, Fac Ciencias, Dept Genet, E-18071 Granada, Spain.	jpmcamac@ugr.es	Cabrero, Josefa/L-8899-2014; Camacho, Juan Pedro M/L-6869-2014; Perfectti, Francisco/C-5087-2008	Cabrero, Josefa/0000-0002-5848-6985; Camacho, Juan Pedro M/0000-0002-2507-9814; Perfectti, Francisco/0000-0002-5551-213X; Gomez Ladron de Guevara, Ricardo/0000-0003-3430-0346	Spanish Ministerio de Economia y Competividad	Spanish Ministerio de Economia y Competividad(Spanish Government)	We thank Tatiana Lopez for technical assistance, and David Nesbitt for English corrections. This paper has been finished despite rejection of our requests for funding by the Spanish Ministerio de Economia y Competividad for the last three years.	Abdelaziz M, 2007, CYTOGENET GENOME RES, V119, P143, DOI 10.1159/000109631; Bakkali M, 1999, HEREDITY, V83, P428, DOI 10.1038/sj.hdy.6885950; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Cabrero J, 2014, CYTOGENET GENOME RES, V142, P54, DOI 10.1159/000356052; Cabrero J, 2003, CHROMOSOMA, V112, P207, DOI 10.1007/s00412-003-0264-2; Cabrero J, 1997, CHROMOSOME RES, V5, P194, DOI 10.1023/A:1018499015091; Camacho JPM, 1997, AM NAT, V149, P1030, DOI 10.1086/286037; CAMACHO JPM, 1991, GENOME, V34, P638, DOI 10.1139/g91-097; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dirsh V. M., 1958, Proceedings of the Royal Entomological Society of London (B), V27, P33; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans G.M., 1972, CHROMOSOMES TODAY, V3, P24; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; HARVEY AW, 1979, HEREDITY, V42, P397, DOI 10.1038/hdy.1979.43; HENRIQUESGIL N, 1984, CHROMOSOMA, V89, P290, DOI 10.1007/BF00292477; Hernandez F, 1994, B SERVICIO DEFENSA C, V10, P245; Herrera JA, 1996, HEREDITY, V76, P633, DOI 10.1038/hdy.1996.90; HEWITT GM, 1978, HEREDITY, V41, P347, DOI 10.1038/hdy.1978.105; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; Hundsdoerfer AK, 2006, J ZOOL SYST EVOL RES, V44, P316, DOI 10.1111/j.1439-0469.2006.00366.x; Manrique-Poyato MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083712; Manrique-Poyato MI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059041, 10.1371/journal.pone.0083712]; Munoz-Pajares A, 2011, GENETICS, V187, P853, DOI 10.1534/genetics.110.122713; Lopez-Leon MD, 2008, CYTOGENET GENOME RES, V121, P260, DOI 10.1159/000138894; LOPEZFERNANDEZ C, 1992, HEREDITY, V68, P365, DOI 10.1038/hdy.1992.52; LOPEZLEON MD, 1993, HEREDITY, V71, P352, DOI 10.1038/hdy.1993.149; LOPEZLEON MD, 1994, PHYSIOL ENTOMOL, V19, P46, DOI 10.1111/j.1365-3032.1994.tb01072.x; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; NUR U, 1966, GENETICS, V54, P1239; PARDO MC, 1995, HEREDITY, V74, P654, DOI 10.1038/hdy.1995.89; Perfectti F, 2004, CYTOGENET GENOME RES, V106, P376, DOI 10.1159/000079315; Ren ZM, 2008, GENETICA, V132, P103, DOI 10.1007/s10709-007-9153-6; Riera L, 2004, J EVOLUTION BIOL, V17, P716, DOI 10.1111/j.1420-9101.2004.00696.x; Riera L, 2004, J EVOLUTION BIOL, V17; Schluter PM, 2006, MOL ECOL NOTES, V6, P569, DOI 10.1111/j.1471-8286.2006.01225.x; Slatkin Montgomery, 1994, P3; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Zurita S, 1998, EVOLUTION, V52, P274, DOI 10.1111/j.1558-5646.1998.tb05163.x	40	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131277	10.1371/journal.pone.0131277	http://dx.doi.org/10.1371/journal.pone.0131277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111020	Green Published, gold			2022-12-27	WOS:000356933800140
J	Das, A; Nagendra, H; Anand, M; Bunyan, M				Das, Arundhati; Nagendra, Harini; Anand, Madhur; Bunyan, Milind			Topographic and Bioclimatic Determinants of the Occurrence of Forest and Grassland in Tropical Montane Forest-Grassland Mosaics of the Western Ghats, India	PLOS ONE			English	Article							REGRESSION TREES; VEGETATION; SOUTH; CLASSIFICATION; BIODIVERSITY; CLIMATE; FIRE; CONSERVATION; DIVERSITY; PATTERNS	The objective of this analysis was to identify topographic and bioclimatic factors that predict occurrence of forest and grassland patches within tropical montane forest-grassland mosaics. We further investigated whether interactions between topography and bioclimate are important in determining vegetation pattern, and assessed the role of spatial scale in determining the relative importance of specific topographic features. Finally, we assessed the role of elevation in determining the relative importance of diverse explanatory factors. The study area consists of the central and southern regions of the Western Ghats of Southern India, a global biodiversity hotspot. Random forests were used to assess prediction accuracy and predictor importance. Conditional inference classification trees were used to interpret predictor effects and examine potential interactions between predictors. GLMs were used to confirm predictor importance and assess the strength of interaction terms. Overall, topographic and bioclimatic predictors classified vegetation pattern with approximately 70% accuracy. Prediction accuracy was higher for grassland than forest, and for mosaics at higher elevations. Elevation was the most important predictor, with mosaics above 2000m dominated largely by grassland. Relative topographic position measured at a local scale (within a 300m neighbourhood) was another important predictor of vegetation pattern. In high elevation mosaics, northness and concave land surface curvature were important predictors of forest occurrence. Important bioclimatic predictors were: dry quarter precipitation, annual temperature range and the interaction between the two. The results indicate complex interactions between topography and bioclimate and among topographic variables. Elevation and topography have a strong influence on vegetation pattern in these mosaics. There were marked regional differences in the roles of various topographic and bioclimatic predictors across the range of study mosaics, indicating that the same pattern of grass and forest seems to be generated by different sets of mechanisms across the region, depending on spatial scale and elevation.	[Das, Arundhati; Bunyan, Milind] ATREE, Bangalore, Karnataka, India; [Das, Arundhati] Manipal Univ, Manipal, Karnataka, India; [Nagendra, Harini] Azim Premji Univ, Sch Dev, Bangalore, Karnataka, India; [Anand, Madhur] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada	Manipal Academy of Higher Education (MAHE); University of Guelph	Das, A (corresponding author), ATREE, Bangalore, Karnataka, India.	arundhatid74@gmail.com	Das, Arundhati/H-5988-2019; Nagendra, Harini/P-9087-2019	Nagendra, Harini/0000-0002-1585-0724; Bunyan, Milind/0000-0002-0810-7422; Das, Arundhati/0000-0002-3103-5957	Tata Social Welfare Trust of India	Tata Social Welfare Trust of India	The lead author was supported by the Tata Social Welfare Trust of India in the form of a PhD student stipend during the conception, data gathering, analysis and writing of the work presented here. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader MY, 2008, J BIOGEOGR, V35, P711, DOI 10.1111/j.1365-2699.2007.01818.x; Behling H, 2007, PHILOS T R SOC B, V362, P243, DOI 10.1098/rstb.2006.1984; Bennie J, 2008, ECOL MODEL, V216, P47, DOI 10.1016/j.ecolmodel.2008.04.010; Beven K.J., 1979, HYDROL SCI B, V24, P43, DOI [10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Blanco CC, 2014, ECOL MODEL, V291, P224, DOI 10.1016/j.ecolmodel.2014.07.024; Bond WJ, 2010, BIOL CONSERV, V143, P2395, DOI 10.1016/j.biocon.2009.12.012; BOR N. L., 1938, INDIAN FORESTER, V64, P600; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Bunyan M., 2012, American Journal of Plant Sciences, V3, P1632, DOI 10.4236/ajps.2012.311198; Bunyan M, 2015, J TROP FOR IN PRESS; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Caner L, 2007, HOLOCENE, V17, P195, DOI 10.1177/0959683607075833; Champion H. G., 1968, REVISED SURVEY FORES, P404; Coblentz D, 2008, J BIOGEOGR, V35, P2026, DOI 10.1111/j.1365-2699.2008.01956.x; Cox SB, 2002, PLANT SOIL, V247, P189, DOI 10.1023/A:1021488313783; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Daws MI, 2002, PLANT SOIL, V238, P79, DOI 10.1023/A:1014289930621; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; Fletcher MS, 2014, ECOLOGY, V95, P2504, DOI 10.1890/12-1766.1; GELDENHUYS CJ, 1994, J BIOGEOGR, V21, P49, DOI 10.2307/2845603; Google-Earth, 2013, SAT IM SO IND; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hook PB, 2000, ECOLOGY, V81, P2686, DOI 10.1890/0012-9658(2000)081[2686:BIASLC]2.0.CO;2; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Jenness J., 2006, TOPOGRAPHIC POSITION; JOSE S, 1994, FOREST ECOL MANAG, V65, P279, DOI 10.1016/0378-1127(94)90176-7; Korner C, 1998, OECOLOGIA, V115, P445, DOI 10.1007/s004420050540; Korner C, 2004, J BIOGEOGR, V31, P713, DOI 10.1111/j.1365-2699.2003.01043.x; Lauer W., 1981, Mt. Res. Dev., V1, P209, DOI [DOI 10.2307/3673058, 10.2307/3673058]; Lippok D, 2014, J VEG SCI, V25, P724, DOI 10.1111/jvs.12132; Lookingbill T, 2004, LANDSCAPE ECOL, V19, P417, DOI 10.1023/B:LAND.0000030451.29571.8b; Martin PH, 2007, J BIOGEOGR, V34, P1792, DOI 10.1111/j.1365-2699.2007.01726.x; McCune B, 2002, J VEG SCI, V13, P603, DOI 10.1111/j.1654-1103.2002.tb02087.x; MEHERHOMJI VM, 1967, B TORREY BOT CLUB, V94, P230, DOI 10.2307/2483901; METI NASA, 2011, ASTER GLOB DEM VERS; Mohandass D, 2010, PLANT ECOL DIVERS, V3, P67, DOI 10.1080/17550874.2010.492843; Muller SC, 2012, FLORA, V207, P586, DOI 10.1016/j.flora.2012.06.012; Myers N, 2003, BIOSCIENCE, V53, P916; Nair K.K.N., 2001, P3; Narayanan MKR, 2013, PHYTOTAXA, V83, P54; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nichols JD, 2012, BIOSCIENCE, V62, P497, DOI 10.1525/bio.2012.62.5.11; OHSAWA M, 1991, VEGETATIO, V97, P1; Prabhakar R, 1994, THESIS; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; R Core Team, 2021, R LANGUAGE ENV STAT; Ramesh BR, 1997, ATLAS ENDEMICS W GHA; RANGANATHAN C. R., 1938, INDIAN FORESTER, V64, P523; Riley S.J., 1999, INTERMOUNTAIN J SCI, V5, P23, DOI DOI 10.1016/j.geomorph.2010.11.003; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Sankaran M, 2009, BIODIVERS CONSERV, V18, P1099, DOI 10.1007/s10531-008-9519-9; Silva LCR, 2011, ECOSYSTEMS, V14, P1354, DOI 10.1007/s10021-011-9486-y; Srivastava RK, 2001, MANAGEMENT PLAN MUDU; Stambaugh MC, 2008, FOREST ECOL MANAG, V254, P463, DOI 10.1016/j.foreco.2007.08.029; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Sukumar R, 1995, J BIOGEOGR, V22, P533, DOI 10.2307/2845951; Thomas SM, 2007, COMMUNITY ECOL, V8, P67, DOI 10.1556/ComEc.8.2007.1.9; Veldman JW, 2015, SCIENCE, V347, P484, DOI 10.1126/science.347.6221.484-c; Wood SW, 2011, J BIOGEOGR, V38, P1807, DOI 10.1111/j.1365-2699.2011.02524.x; Zar J.H., 2010, BIOSTAT ANAL	64	22	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130566	10.1371/journal.pone.0130566	http://dx.doi.org/10.1371/journal.pone.0130566			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121353	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400048
J	Hill, SE; Donegan, RK; Nguyen, E; Desai, TM; Lieberman, RL				Hill, Shannon E.; Donegan, Rebecca K.; Elaine Nguyen; Desai, Tanay M.; Lieberman, Raquel L.			Molecular Details of Olfactomedin Domains Provide Pathway to Structure-Function Studies	PLOS ONE			English	Article							GLAUCOMA-ASSOCIATED MYOCILIN; BETA-PROPELLER; SECONDARY-STRUCTURE; PROTEIN-STRUCTURE; RECEPTOR COMPLEX; BINDING SITES; GLIOMEDIN; GENE; EXPRESSION; SEQUENCE	Olfactomedin (OLF) domains are found within extracellular, multidomain proteins in numerous tissues of multicellular organisms. Even though these proteins have been implicated in human disorders ranging from cancers to attention deficit disorder to glaucoma, little is known about their structure(s) and function(s). Here we biophysically, biochemically, and structurally characterize OLF domains from H. sapiens olfactomedin-1 (npoh-OLF, also called noelin, pancortin, OLFM1, and hOlfA), and M. musculus gliomedin (glio-OLF, also called collomin, collmin, and CRG-L2), and compare them with available structures of myocilin (myoc-OLF) recently reported by us and R. norvegicus glio-OLF and M. musculus latrophilin-3 (lat3-OLF) by others. Although the five-bladed beta-propeller architecture remains unchanged, numerous physicochemical characteristics differ among these OLF domains. First, npoh-OLF and glio-OLF exhibit prominent, yet distinct, positive surface charges and copurify with polynucleotides. Second, whereas npoh-OLF and myoc-OLF exhibit thermal stabilities typical of human proteins near 55 degrees C, and most myoc-OLF variants are destabilized and highly prone to aggregation, glio-OLF is nearly 20 degrees C more stable and significantly more resistant to chemical denaturation. Phylogenetically, glio-OLF is most similar to primitive OLFs, and structurally, glio-OLF is missing distinguishing features seen in OLFs such as the disulfide bond formed by N- and C-terminal cysteines, the sequestered Ca2+ ion within the propeller central hydrophilic cavity, and a key loop-stabilizing cation-p interaction on the top face of npoh-OLF and myoc-OLF. While deciphering the explicit biological functions, ligands, and binding partners for OLF domains will likely continue to be a challenging long-term experimental pursuit, we used structural insights gained here to generate a new antibody selective for myoc-OLF over npoh-OLF and glio-OLF as a first step in overcoming the impasse in detailed functional characterization of these biomedically important protein domains.	[Hill, Shannon E.; Donegan, Rebecca K.; Elaine Nguyen; Desai, Tanay M.; Lieberman, Raquel L.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Lieberman, RL (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	raquel.lieberman@chemistry.gatech.edu			National Institutes of Health [R01EY021205]; Pew Scholar in Biomedical Sciences program; Georgia Tech Molecular Biophysics Senior Award; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL EYE INSTITUTE [R01EY021205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholar in Biomedical Sciences program; Georgia Tech Molecular Biophysics Senior Award; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by grants from the National Institutes of Health (R01EY021205), and Pew Scholar in Biomedical Sciences program to RLL, and a Georgia Tech Molecular Biophysics Senior Award to RKD. Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amor V, 2014, J NEUROSCI, V34, P5089, DOI 10.1523/JNEUROSCI.4752-13.2014; Arcos-Burgos M, 2010, MOL PSYCHIATR, V15, P1053, DOI 10.1038/mp.2010.6; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barembaum M, 2000, NAT CELL BIOL, V2, P219, DOI 10.1038/35008643; Bohr DC, 2011, NEPHROL DIAL TRANSPL, V26, P83, DOI 10.1093/ndt/gfq366; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; Burns JN, 2011, BIOCHEMISTRY-US, V50, P5824, DOI 10.1021/bi200231x; Burns JN, 2010, ACS CHEM BIOL, V5, P477, DOI 10.1021/cb900282e; Chen CKM, 2011, TRENDS BIOCHEM SCI, V36, P553, DOI 10.1016/j.tibs.2011.07.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng AW, 2007, J NEUROSCI, V27, P1519, DOI 10.1523/JNEUROSCI.5154-06.2007; Donegan RK, 2015, HUM MOL GENET, V24, P2111, DOI 10.1093/hmg/ddu730; Donegan RK, 2012, J BIOL CHEM, V287, P43370, DOI 10.1074/jbc.M112.408906; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eshed Y, 2007, J CELL BIOL, V177, P551, DOI 10.1083/jcb.200612139; Gersemann M, 2012, J CROHNS COLITIS, V6, P425, DOI 10.1016/j.crohns.2011.09.013; Gong G, 2004, HUM MOL GENET, V13, pR91, DOI 10.1093/hmg/ddh074; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Han HJ, 2015, J BIOL CHEM, V290, P3612, DOI 10.1074/jbc.M114.627547; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Hewitt AW, 2008, HUM MUTAT, V29, P207, DOI 10.1002/humu.20634; Hill SE, 2014, J MOL BIOL, V426, P921, DOI 10.1016/j.jmb.2013.12.002; Jackson VA, 2015, STRUCTURE, V23, P774, DOI 10.1016/j.str.2015.01.013; Jawad Z, 2002, STRUCTURE, V10, P447, DOI 10.1016/S0969-2126(02)00750-5; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Kodithuwakku SP, 2011, HUM REPROD, V26, P167, DOI 10.1093/humrep/deq298; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kulkarni NH, 2000, GENET RES, V76, P41, DOI 10.1017/S0016672300004584; Labasque M, 2011, J BIOL CHEM, V286, P42426, DOI 10.1074/jbc.M111.266353; Lencinas A, 2013, DIS MODEL MECH, V6, P632, DOI 10.1242/dmm.010595; Liu WL, 2012, J IMMUNOL, V189, P2460, DOI 10.4049/jimmunol.1103179; Maertens B, 2007, J BIOL CHEM, V282, P10647, DOI 10.1074/jbc.M611339200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNeill E, 2012, NEURON, V75, P363, DOI 10.1016/j.neuron.2012.07.005; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mottarella SE, 2014, J CHEM INF MODEL, V54, P2068, DOI 10.1021/ci500115j; Nakaya N, 2008, J NEUROSCI, V28, P7900, DOI 10.1523/JNEUROSCI.0617-08.2008; Nakaya N, 2012, J BIOL CHEM, V287, P37171, DOI 10.1074/jbc.M112.389916; Orwig SD, 2014, ACS CHEM BIOL, V9, P517, DOI 10.1021/cb4007776; Orwig SD, 2012, J MOL BIOL, V421, P242, DOI 10.1016/j.jmb.2011.12.016; Orwig SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016347; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Resch ZT, 2009, EXP EYE RES, V88, P704, DOI 10.1016/j.exer.2008.08.011; Rice HC, 2012, DEVELOPMENT, V139, P3986, DOI 10.1242/dev.082909; RICHARDSON JS, 1978, P NATL ACAD SCI USA, V75, P2574, DOI 10.1073/pnas.75.6.2574; Sambrook J., 2001, MOL CLONING LAB MANU; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Stothert AR, 2014, HUM MOL GENET, V23, P6470, DOI 10.1093/hmg/ddu367; Sultana A, 2014, EXP NEUROL, V261, P802, DOI 10.1016/j.expneurol.2014.09.002; Suntharalingam A, 2012, J BIOL CHEM, V287, P40661, DOI 10.1074/jbc.M112.384800; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tjong H, 2007, NUCLEIC ACIDS RES, V35, P1465, DOI 10.1093/nar/gkm008; Tomarev SI, 2009, MOL NEUROBIOL, V40, P122, DOI 10.1007/s12035-009-8076-x; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Verkhratsky A, 2014, BIOESSAYS, V36, P697, DOI 10.1002/bies.201400024; Witarto AB, 2001, PROTEIN ENG, V14, P891, DOI 10.1093/protein/14.11.891; Zenga LC, 2005, FEBS LETT, V579, P5443, DOI 10.1016/j.febslet.2005.08.064; Zhou ZH, 1999, HUM MOL GENET, V8, P2221, DOI 10.1093/hmg/8.12.2221	61	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130888	10.1371/journal.pone.0130888	http://dx.doi.org/10.1371/journal.pone.0130888			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121352	gold, Green Submitted, Green Published			2022-12-27	WOS:000358150400066
J	Jiang, Z; Watts, LT; Huang, SL; Shen, Q; Rodriguez, P; Chen, CH; Zhou, CM; Duong, TQ				Jiang, Zhao; Watts, Lora Talley; Huang, Shiliang; Shen, Qiang; Rodriguez, Pavel; Chen, Chunhua; Zhou, Changman; Duong, Timothy Q.			The Effects of Methylene Blue on Autophagy and Apoptosis in MRI-Defined Normal Tissue, Ischemic Penumbra and Ischemic Core	PLOS ONE			English	Article							QUANTITATIVE PERFUSION; CARDIAC-ARREST; STROKE; OXYGEN; REPERFUSION; DIFFUSION; NEUROPROTECTION; BRAIN; RESPONSES; RELEASE	Methylene blue (MB) USP, which has energy-enhancing and antioxidant properties, is currently used to treat methemoglobinemia and cyanide poisoning in humans. We recently showed that MB administration reduces infarct volume and behavioral deficits in rat models of ischemic stroke and traumatic brain injury. This study reports the underlying molecular mechanisms of MB neuroprotection following transient ischemic stroke in rats. Rats were subjected to transient (60-mins) ischemic stroke. Multimodal MRI during the acute phase and at 24hrs were used to define three regions of interest (ROIs): i) the perfusion-diffusion mismatch salvaged by reperfusion, ii) the perfusion-diffusion mismatch not salvaged by reperfusion, and iii) the ischemic core. The tissues from these ROIs were extracted for western blot analyses of autophagic and apoptotic markers. The major findings were: 1) MB treatment reduced infarct volume and behavioral deficits, 2) MB improved cerebral blood flow to the perfusion-diffusion mismatch tissue after reperfusion and minimized harmful hyperperfusion 24hrs after stroke, 3) MB inhibited apoptosis and enhanced autophagy in the perfusion-diffusion mismatch, 4) MB inhibited apoptotic signaling cascades (p53-Bax-Bcl2- Caspase3), and 5) MB enhanced autophagic signaling cascades (p53-AMPK-TSC2-mTOR). MB induced neuroprotection, at least in part, by enhancing autophagy and reducing apoptosis in the perfusion-diffusion mismatch tissue following ischemic stroke.	[Jiang, Zhao; Chen, Chunhua; Zhou, Changman] Peking Univ, Hlth Sci Ctr, Dept Anat & Embryol, Beijing 100871, Peoples R China; [Jiang, Zhao; Watts, Lora Talley; Huang, Shiliang; Shen, Qiang; Rodriguez, Pavel; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Chen, Chunhua] Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA	Peking University; University of Texas System; University of Texas Health San Antonio; University of Pennsylvania; Pennsylvania Medicine	Duong, TQ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA.	DuongT@uthscsa.edu	Shen, Qiang/B-8784-2008; Duong, Tim/AAL-8357-2021	Shen, Qiang/0000-0002-4287-3403; Duong, Tim/0000-0001-6403-2827; jiang, zhao/0000-0002-8192-9908	NIH [R01-NS45879]; American Heart Association [EIA 0940104N, 12BGIA 9300047]; Translational Technology Resource grant [UL1TR000149]; National Natural Science Foundation of China [31271280]; Clinical Translational Science Award Pilot Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120, KL2TR001118, UL1TR000149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045879] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Translational Technology Resource grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Clinical Translational Science Award Pilot Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the NIH (R01-NS45879), the American Heart Association (EIA 0940104N and 12BGIA 9300047), a Clinical Translational Science Award Pilot Grant and a Translational Technology Resource grant (parent grant UL1TR000149) to TQD. This work was also supported in part by the National Natural Science Foundation of China (31271280) to CZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwal S, 1998, STROKE, V29, P1037, DOI 10.1161/01.STR.29.5.1037; Barbier EL, 2001, J MAGN RESON IMAGING, V13, P496, DOI 10.1002/jmri.1073; Bonova P, 2013, NEUROCHEM INT, V62, P8, DOI 10.1016/j.neuint.2012.10.015; Calamante F, 1999, J CEREBR BLOOD F MET, V19, P701, DOI 10.1097/00004647-199907000-00001; Chen CH, 2013, CNS NEUROSCI THER, V19, P566, DOI 10.1111/cns.12114; Congdon EE, 2012, AUTOPHAGY, V8, P609, DOI 10.4161/auto.19048; Dani KA, 2011, ANN NEUROL, V70, P384, DOI 10.1002/ana.22500; Davis SM, 2008, LANCET NEUROL, V7, P299, DOI 10.1016/S1474-4422(08)70044-9; Duong TQ, 2012, TRANSL STROKE RES, V3, P8, DOI 10.1007/s12975-011-0140-y; Feng X, 2011, EMBO J, V30, P3397, DOI 10.1038/emboj.2011.248; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Geisler BS, 2006, STROKE, V37, P1778, DOI 10.1161/01.STR.0000226738.97426.6f; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gomes B, 2012, ANN ONCOL, V23, P2006, DOI 10.1093/annonc/mdr602; Hacke W, 2005, STROKE, V36, P66, DOI 10.1161/01.STR.0000149938.08731.2c; Hacke W, 2009, LANCET NEUROL, V8, P141, DOI 10.1016/S1474-4422(08)70267-9; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Huang SL, 2013, NEUROIMAGE, V72, P237, DOI 10.1016/j.neuroimage.2013.01.027; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kidwell CS, 2000, ANN NEUROL, V47, P462, DOI 10.1002/1531-8249(200004)47:4<462::AID-ANA9>3.3.CO;2-P; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li PA, 2001, BRAIN RES, V896, P69, DOI 10.1016/S0006-8993(01)01997-7; Lin AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046585; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Martijn C, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-27; Peter C, 2000, EUR J CLIN PHARMACOL, V56, P247, DOI 10.1007/s002280000124; Poteet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048279; Rojas JC, 2012, PROG NEUROBIOL, V96, P32, DOI 10.1016/j.pneurobio.2011.10.007; Rosse T, 1998, NATURE, V391, P496, DOI 10.1038/35160; SALARIS SC, 1991, BIOCHEM PHARMACOL, V42, P499, DOI 10.1016/0006-2952(91)90311-R; Santosh C, 2008, J CEREBR BLOOD F MET, V28, P1742, DOI 10.1038/jcbfm.2008.56; Sharma HS, 2011, J NEURAL TRANSM, V118, P87, DOI 10.1007/s00702-010-0486-4; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P280, DOI 10.1097/01.WCB.0000110048.43905.E5; Shen Q, 2003, J CEREBR BLOOD F MET, V23, P1479, DOI 10.1097/01.WCB.0000100064.36077.03; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P887, DOI 10.1097/01.WCB.0000124321.60992.87; Shen Q, 2014, J CEREBR BLOOD F MET, V34, P169, DOI 10.1038/jcbfm.2013.179; Shen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079833; Shen Q, 2011, BRAIN RES, V1425, P132, DOI 10.1016/j.brainres.2011.09.052; Shen Q, 2011, J CEREBR BLOOD F MET, V31, P2076, DOI 10.1038/jcbfm.2011.64; Sun PZ, 2007, J CEREBR BLOOD F MET, V27, P1129, DOI 10.1038/sj.jcbfm.9600424; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; van der Plaat L W, 2012, Eur Spine J, V21 Suppl 4, pS445, DOI 10.1007/s00586-011-2053-6; Wang P, 2012, AUTOPHAGY, V8, P77, DOI 10.4161/auto.8.1.18274; Watts LT, 2014, J NEUROTRAUM; Wei K, 2012, CNS NEUROSCI THER, V18, P879, DOI 10.1111/cns.12005; Xie LK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00056; Yoo AJ, 2012, J STROKE CEREBROVASC; Yuan JY, 2009, APOPTOSIS, V14, P469, DOI 10.1007/s10495-008-0304-8	53	29	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131929	10.1371/journal.pone.0131929	http://dx.doi.org/10.1371/journal.pone.0131929			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121129	Green Published, gold			2022-12-27	WOS:000358150400181
J	Sorbye, H; Dragomir, A; Sundstrom, M; Pfeiffer, P; Thunberg, U; Bergfors, M; Aasebo, K; Eide, GE; Ponten, F; Qvortrup, C; Glimelius, B				Sorbye, Halfdan; Dragomir, Anca; Sundstrom, Magnus; Pfeiffer, Per; Thunberg, Ulf; Bergfors, Monica; Aasebo, Kristine; Eide, Geir Egil; Ponten, Fredrik; Qvortrup, Camilla; Glimelius, Bengt			High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort	PLOS ONE			English	Article							1ST-LINE TREATMENT; MICROSATELLITE INSTABILITY; CIGARETTE-SMOKING; COLON-CANCER; KRAS; TRIAL; IMPACT; FLUOROURACIL; BEVACIZUMAB; LEUCOVORIN	RAS and BRAF mutations impact treatment and prognosis of metastatic colorectal cancer patients (mCRC), but the knowledge is based on trial patients usually not representative for the general cancer population. Patient characteristics, treatment and efficacy according to KRAS, BRAF and MSI status were analyzed in a prospectively collected unselected population-based cohort of 798 non-resectable mCRC patients. The cohort contained many patients with poor performance status (39% PS 2-4) and elderly (37% age>75), groups usually not included in clinical trials. Patients without available tissue micro array (TMA) (42%) had worse prognostic factors and inferior survival (all patients; 7m vs 11m, chemotherapy-treated; 12m vs 17m). The 92 patients (21%) with BRAF mutation had a poor prognosis regardless of microsatellite instability, but receipt of 1-2nd chemotherapy was similar to wildtype BRAF patients. Median survival in this cohort varied from 1 month in BRAF mutated patients not given chemotherapy to 26 months in wildtype KRAS/BRAF patients <75 years in good PS. TMA availability, BRAF mutation and KRAS mutation were all independent prognostic factors for survival. The observed 21% BRAF mutation incidence is higher than the previously and repeatedly reported incidence of 5-12% in mCRC. Screening for BRAF mutations before selection of treatment is relevant for many patients, especially outside clinical trials. A BRAF mutation only partly explained the very poor prognosis of many mCRC patients. Survival in unselected metastatic colorectal cancer patients is extremely variable and subgroups have an extremely short survival compared to trial patients. Patients without available TMA had worse prognostic factors and shorter survival, which questions the total generalizability of present TMA studies and implies that we lack information on the biologically worst mCRC cases. Lack of available tissue is an important underexposed issue which introduces sample bias, and this should be recognized more clearly when conclusions are made from translational mCRC studies.	[Sorbye, Halfdan; Aasebo, Kristine] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway; [Dragomir, Anca; Bergfors, Monica] Univ Uppsala Hosp, Dept Pathol, S-75185 Uppsala, Sweden; [Dragomir, Anca; Sundstrom, Magnus; Thunberg, Ulf; Glimelius, Bengt] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Pfeiffer, Per; Qvortrup, Camilla] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark; [Eide, Geir Egil] Univ Bergen, Dept Global Publ Hlth & Primary Care, Lifestyle Epidemiol Grp, Bergen, Norway; [Ponten, Fredrik] Uppsala Univ, Sci Life Lab, Uppsala, Sweden	University of Bergen; Haukeland University Hospital; Uppsala University; Uppsala University Hospital; Uppsala University; University of Southern Denmark; Odense University Hospital; University of Bergen; Uppsala University	Sorbye, H (corresponding author), Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway.	halfdan.sorbye@helse-bergen.no	Qvortrup, Camilla/AAD-3366-2019	Dragomir, Anca/0000-0003-2777-8114; Qvortrup, Camilla/0000-0001-9338-9841; Pfeiffer, Per/0000-0002-2925-0586	Swedish Cancer Society; Norwegian Cancer Society; Danish Cancer Society; Stockholm Cancer Society	Swedish Cancer Society(Swedish Cancer Society); Norwegian Cancer Society(Norwegian Cancer Society); Danish Cancer Society(Danish Cancer Society); Stockholm Cancer Society	This study has been supported by the Swedish, Norwegian and Danish Cancer Societies and the Stockholm Cancer Society.	Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; Hanna MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074950; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; Karagkounis G, 2013, CANCER-AM CANCER SOC, V119, P4137, DOI 10.1002/cncr.28347; Khattak MA, 2012, EUR J CANCER, V48, P1293, DOI 10.1016/j.ejca.2011.09.029; Kohne CH, 2002, ANN ONCOL, V13, P308, DOI 10.1093/annonc/mdf034; Lemmens VEPP, 2011, CLIN EXP METASTAS, V28, P283, DOI 10.1007/s10585-010-9370-8; Limsui D, 2010, JNCI-J NATL CANCER I, V102, P1012, DOI 10.1093/jnci/djq201; Lochhead P, 2013, JNCI-J NATL CANCER I, V105, P1151, DOI 10.1093/jnci/djt173; Loupakis F, 2014, EUR J CANCER, V50, P57, DOI 10.1016/j.ejca.2013.08.024; Maughan TS, 2011, LANCET, V377, P2103, DOI 10.1016/S0140-6736(11)60613-2; Mitry E, 2013, EUR J CANCER, V49, P2919, DOI 10.1016/j.ejca.2013.04.001; Modest DP, 2012, INT J CANCER, V131, P980, DOI 10.1002/ijc.26467; Morris VK, 2014, ANN ONCOL, V25, P2008, DOI 10.1093/annonc/mdu252; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Price TJ, 2011, J CLIN ONCOL, V29, P2675, DOI 10.1200/JCO.2010.34.5520; Richman SD, 2009, J CLIN ONCOL, V27, P5931, DOI 10.1200/JCO.2009.22.4295; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Rozek LS, 2010, CANCER EPIDEM BIOMAR, V19, P838, DOI 10.1158/1055-9965.EPI-09-1112; Russo AL, 2014, CANCER-AM CANCER SOC, V120, P1482, DOI 10.1002/cncr.28599; Samadder NJ, 2013, GASTROENTEROLOGY, V145, P348, DOI 10.1053/j.gastro.2013.05.001; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Saridaki Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084604; Schernhammer ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021102; Schirripa M, 2015, INT J CANCER, V136, P83, DOI 10.1002/ijc.28955; Schwartzberg LS, 2014, J CLIN ONCOL, V32, P2240, DOI 10.1200/JCO.2013.53.2473; Schweiger T, 2014, ANN SURG ONCOL, V21, P946, DOI 10.1245/s10434-013-3386-7; Sorbye H, 2013, ANN ONCOL, V24, P2354, DOI 10.1093/annonc/mdt197; Sorbye H, 2009, CANCER, V115, P4679, DOI 10.1002/cncr.24527; Sundstrom M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-660; Tie J, 2011, INT J CANCER, V128, P2075, DOI 10.1002/ijc.25555; Tol J, 2010, EUR J CANCER, V46, P1997, DOI 10.1016/j.ejca.2010.03.036; Tran B, 2011, CANCER-AM CANCER SOC, V117, P4623, DOI 10.1002/cncr.26086; Tveit KM, 2012, J CLIN ONCOL, V30, P1755, DOI 10.1200/JCO.2011.38.0915; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; van Steenbergen LN, 2010, ANN ONCOL, V21, P2206, DOI 10.1093/annonc/mdq227; VanGeel R, 2014, J CLIN ONCOL S, V32, p5s; Vauthey JN, 2013, ANN SURG, V258, P619, DOI 10.1097/SLA.0b013e3182a5025a; Venderbosch S, 2014, CLIN CANCER RES, V20, P5322, DOI 10.1158/1078-0432.CCR-14-0332; Yaeger R, 2014, CANCER-AM CANCER SOC, V120, P2316, DOI 10.1002/cncr.28729; Yamauchi M, 2012, GUT, V61, P794, DOI 10.1136/gutjnl-2012-302014; Yokota T, 2011, BRIT J CANCER, V104, P856, DOI 10.1038/bjc.2011.19; Zhu Y, 2014, BRIT J CANCER, V110, P1359, DOI 10.1038/bjc.2014.6; Zlobec I, 2010, INT J CANCER, V127, P367, DOI 10.1002/ijc.25042	44	70	72	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131046	10.1371/journal.pone.0131046	http://dx.doi.org/10.1371/journal.pone.0131046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121270	Green Submitted, gold, Green Published			2022-12-27	WOS:000358150400074
J	Yang, EJ; Lee, SY; Kim, K; Jung, SH; Jang, SN; Han, SJ; Kim, WH; Lim, JY				Yang, Eun Joo; Lee, Seung Yeol; Kim, Keewon; Jung, Se Hee; Jang, Soong-Nang; Han, Soo Jeong; Kim, Wan-Ho; Lim, Jae-Young			Factors Associated with Reduced Quality of Life in Polio Survivors in Korea	PLOS ONE			English	Article							POSTPOLIO SYNDROME; HEALTH; VERSION; DISABILITY; DEPRESSION; INVENTORY; SWEDISH; PEOPLE; PAIN; AGE	The purpose of this study is to assess health-related quality of life in polio survivors (PS) compared with that in the general population in Korea. Polio survivors (n = 120) from outpatient clinics at two hospitals, healthy controls (HC, n = 121) and members of the general population with activity limitations (AL, n = 121) recruited through a proportional-allocation, systematic sampling strategy from the Fourth Korean National Health and Nutrition Examination Survey were surveyed with self-rated health-related quality of life (Euro QoL five-dimensions). The proportion of participants who reported problems in mobility, usual activity, and symptoms of anxiety/depression were higher in the PS group compared with the HC and AL groups. There was no significant difference in the self-care dimension across the groups. Polio-specific questionnaire, pain, depression, fatigue, Modified Barthel Index (K-MBI) and Short Physical Performance Battery (SPPB) were assessed in the PS group. Those with post-poliomyelitis syndrome had greater problems in mobility, usual activity, and depression/anxiety. Polio survivors, especially those with more pain and fatigue symptoms, and those who did not have access to medical services had poorer health-related quality of life. These findings afford useful information for potential intervention improving quality of life in polio survivors.	[Yang, Eun Joo; Lim, Jae-Young] Seoul Natl Univ, Bundang Hosp, Dept Rehabil Med, Songnam, South Korea; [Lee, Seung Yeol] Soonchunhyang Univ, Bucheon Hosp, Dept Phys Med & Rehabil, Gyeonggi, South Korea; [Kim, Keewon] Seoul Natl Univ Hosp, Dept Rehabil Med, Seoul 110744, South Korea; [Jung, Se Hee] Seoul Natl Univ, Boramae Med Ctr, Dept Rehabil Med, Seoul, South Korea; [Jang, Soong-Nang] Chung Ang Univ, Red Cross Coll Nursing, Seoul 156756, South Korea; [Han, Soo Jeong] Ewha Womans Univ, Med Ctr Seoul, Dept Rehabil Med, Seoul, South Korea; [Kim, Wan-Ho] Natl Rehabil Ctr, Dept Rehabil Med, Seoul, South Korea	Seoul National University (SNU); Soonchunhyang University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Chung Ang University; Ewha Womans University	Lim, JY (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Rehabil Med, Songnam, South Korea.	drlim1@snu.ac.kr	Lim, Jae-Young/J-5622-2012; Jang, Soong-nang/AAC-1322-2020	Lim, Jae-Young/0000-0002-9454-0344; Jang, Soong-nang/0000-0003-2621-945X	National Rehabilitation Center's RD Program [2012302]; Dr. Chung Gi Lee Research Fund by Korean Academy of Rehabilitation Medicine	National Rehabilitation Center's RD Program; Dr. Chung Gi Lee Research Fund by Korean Academy of Rehabilitation Medicine	This work was supported by the National Rehabilitation Center's R&D Program (grant 2012302) and the Dr. Chung Gi Lee Research Fund by Korean Academy of Rehabilitation Medicine.	AGRE JC, 1995, SCAND J REHABIL MED, V27, P183; [Anonymous], 2003, MEASUREMENT VALIDATI; Burger H, 2000, DISABIL REHABIL, V22, P318; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Cunningham PJ, 2007, MED CARE, V45, P842, DOI 10.1097/MLR.0b013e318053678f; DALAKAS MC, 1986, NEW ENGL J MED, V314, P959, DOI 10.1056/NEJM198604103141505; DIARD C, 1994, AM J PHYS MED REHAB, V73, P264, DOI 10.1097/00002060-199407000-00007; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; HALSTEAD LS, 1985, ORTHOPEDICS, V8, P845; Halstead LS, 2006, NEW HLTH PROBLEMS PE, P20; Jacob T, 2010, J REHABIL MED, V42, P377, DOI 10.2340/16501977-0515; JUBELT B, 1993, SEMIN NEUROL, V13, P283, DOI 10.1055/s-2008-1041136; Kang JH, 2011, J NEUROL, V258, P1026, DOI 10.1007/s00415-010-5875-y; Kemp BJ, 1997, ARCH PHYS MED REHAB, V78, P187, DOI 10.1016/S0003-9993(97)90262-8; Kling C, 2000, J ADV NURS, V32, P164; Lane P, 2008, PHARM STAT, V7, P93, DOI 10.1002/pst.267; Lee YK, 2009, VALUE HEALTH, V12, P1187, DOI 10.1111/j.1524-4733.2009.00579.x; MoHa W, 2009, NATL SURVEY PERSONS; Neumann PJ, 2000, ANNU REV PUBL HEALTH, V21, P587, DOI 10.1146/annurev.publhealth.21.1.587; Nilsson J, 2012, ASIA-PAC J PUBLIC HE, V24, P610, DOI 10.1177/1010539510396699; Nollet F, 1999, ARCH PHYS MED REHAB, V80, P136, DOI 10.1016/S0003-9993(99)90110-7; Park HS, 2006, AM J ORTHOD DENTOFAC, V130, P18, DOI 10.1016/j.ajodo.2004.11.032; Rao D, 2008, J PAIN SYMPTOM MANAG, V36, P488, DOI 10.1016/j.jpainsymman.2007.11.012; Riegel B, 2008, J CARD FAIL, V14, P41, DOI 10.1016/j.cardfail.2007.09.008; ROBBINS PR, 1984, J PERS ASSESS, V48, P42, DOI 10.1207/s15327752jpa4801_8; Rosenkranz RR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1071; Stanghelle JK, 1997, SPINAL CORD, V35, P503, DOI 10.1038/sj.sc.3100425; Takemura J, 2004, J REHABIL MED, V36, P1, DOI 10.1080/16501970310017423; Thoren-Jonsson AL, 2001, J REHABIL MED, V33, P119; Thoren-Jonsson AL, 2001, J REHABIL MED, V33, P4; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Widar M, 1999, SCAND J CARING SCI, V13, P33, DOI 10.1080/02839319950162750; Winberg C, 2014, DISABIL HEALTH J, V7, P302, DOI 10.1016/j.dhjo.2014.02.003; Yagiz A, 2006, J REHABIL MED, V38, P329, DOI 10.1080/16501970600722395; Yun YH, 2005, J PAIN SYMPTOM MANAG, V29, P165, DOI 10.1016/j.jpainsymman.2004.04.013; Yun YH, 2004, ONCOLOGY-BASEL, V66, P439, DOI 10.1159/000079497	36	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130448	10.1371/journal.pone.0130448	http://dx.doi.org/10.1371/journal.pone.0130448			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1BL	26120843	Green Submitted, Green Published, gold			2022-12-27	WOS:000358150400044
J	Assis, J; Zupan, M; Nicastro, KR; Zardi, GI; McQuaid, CD; Serrao, EA				Assis, Jorge; Zupan, Mirta; Nicastro, Katy R.; Zardi, Gerardo I.; McQuaid, Christopher D.; Serrao, Ester A.			Oceanographic Conditions Limit the Spread of a Marine Invader along Southern African Shores	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; INDIGENOUS PERNA-PERNA; MUSSELS MYTILUS-GALLOPROVINCIALIS; MOSAIC HYBRID ZONE; BLUE MUSSELS; INTERTIDAL MUSSELS; LARVAL-DISPERSAL; SPATIAL AUTOCORRELATION; GENETIC-STRUCTURE; PSEUDO-ABSENCES	Invasive species can affect the function and structure of natural ecological communities, hence understanding and predicting their potential for spreading is a major ecological challenge. Once established in a new region, the spread of invasive species is largely controlled by their dispersal capacity, local environmental conditions and species interactions. The mussel Mytilus galloprovincialis is native to the Mediterranean and is the most successful marine invader in southern Africa. Its distribution there has expanded rapidly and extensively since the 1970s, however, over the last decade its spread has ceased. In this study, we coupled broad scale field surveys, Ecological Niche Modelling (ENM) and Lagrangian Particle Simulations (LPS) to assess the current invaded distribution of M. galloprovincialis in southern Africa and to evaluate what prevents further spread of this species. Results showed that all environmentally suitable habitats in southern Africa have been occupied by the species. This includes rocky shores between Rocky Point in Namibia and East London in South Africa (approx. 2800 km) and these limits coincide with the steep transitions between cool-temperate and subtropical-warmer climates, on both west and southeast African coasts. On the west coast, simulations of drifting larvae almost entirely followed the northward and offshore direction of the Benguela current, creating a clear dispersal barrier by advecting larvae away from the coast. On the southeast coast, nearshore currents give larvae the potential to move eastwards, against the prevalent Agulhas current and beyond the present distributional limit, however environmental conditions prevent the establishment of the species. The transition between the cooler and warmer water regimes is therefore the main factor limiting the northern spread on the southeast coast; however, biotic interactions with native fauna may also play an important role.	[Assis, Jorge; Zupan, Mirta; Nicastro, Katy R.; Serrao, Ester A.] Univ Algarve, Ctr Marine Sci, Faro, Portugal; [Zardi, Gerardo I.; McQuaid, Christopher D.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa	Universidade do Algarve; Rhodes University	Assis, J (corresponding author), Univ Algarve, Ctr Marine Sci, Faro, Portugal.	jorgemfa@gmail.com	Assis, Jorge/AAC-6524-2019; Zardi, Gerardo/M-4026-2013; McQuaid, Christopher/AAT-3725-2020; Serrao, Ester A/C-6686-2012; Nicastro, Katy R/ABI-1531-2020; Nicastro, Katy/AAY-3692-2021	Assis, Jorge/0000-0002-6624-4820; Zardi, Gerardo/0000-0001-8798-5794; McQuaid, Christopher/0000-0002-3473-8308; Serrao, Ester A/0000-0003-1316-658X; Nicastro, Katy R/0000-0002-7071-141X; Zupan, Mirta/0000-0001-5781-1718	Portuguese National Science Foundation (FCT) [EXCL/AAG-GLO/0661/2012, EXPL/BIA-BIC/1471/2012, CCMAR/BPD/0045/2013]; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation	Portuguese National Science Foundation (FCT)(Portuguese Foundation for Science and Technology); South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation	This research was supported by the Portuguese National Science Foundation (FCT, project EXCL/AAG-GLO/0661/2012, EXPL/BIA-BIC/1471/2012 and fellowship CCMAR/BPD/0045/2013 to JA), and partially supported by a bilateral project (Acordo Portugal-Tunisia: 2010/11, to GIZ), the South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation.	AGENBAG JJ, 1988, S AFR J MARINE SCI, V6, P119, DOI 10.2989/025776188784480726; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ANDREWS W R H, 1980, Progress in Oceanography, V9, P1, DOI 10.1016/0079-6611(80)90015-4; [Anonymous], 2004, PERMDISP FORTRAN COM; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Assis J, 2014, MOL ECOL, V23, P2797, DOI 10.1111/mec.12772; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Bax N, 2003, MAR POLICY, V27, P313, DOI 10.1016/S0308-597X(03)00041-1; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Bierne N, 2002, MAR ECOL PROG SER, V245, P157, DOI 10.3354/meps245157; Bierne N, 2003, MOL ECOL, V12, P447, DOI 10.1046/j.1365-294X.2003.01730.x; Bownes SJ, 2006, J EXP MAR BIOL ECOL, V338, P140, DOI 10.1016/j.jembe.2006.07.006; Bownes SJ, 2009, MAR BIOL, V156, P991, DOI 10.1007/s00227-009-1143-z; Braby CE, 2006, J EXP BIOL, V209, P2554, DOI 10.1242/jeb.02259; Braby CE, 2006, MAR BIOL, V148, P1249, DOI 10.1007/s00227-005-0177-0; Branch GM, 2004, J EXP MAR BIOL ECOL, V300, P189, DOI 10.1016/j.jembe.2003.12.007; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Butler MJ, 2011, MAR ECOL PROG SER, V422, P223, DOI 10.3354/meps08878; Calenge C, 2008, ECOLOGY, V89, P555, DOI 10.1890/06-1750.1; Chassignet EP, 2007, J MARINE SYST, V65, P60, DOI 10.1016/j.jmarsys.2005.09.016; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Crase B, 2012, ECOGRAPHY, V35, P879, DOI 10.1111/j.1600-0587.2011.07138.x; DAFF, 2012, DEP AGR FOR FISH AQ; de Greef K, 2013, AFR J MAR SCI, V35, P307, DOI 10.2989/1814232X.2013.829789; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Donlon CJ, 2012, REMOTE SENS ENVIRON, V116, P140, DOI 10.1016/j.rse.2010.10.017; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P129, DOI 10.1111/j.1466-8238.2006.00279.x; Drake John M., 2007, Aquatic Invasions, V2, P121, DOI 10.3391/ai.2007.2.2.7; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elton C.S., 2000, ECOLOGY INVASIONS AN; Erlandsson J, 2006, MAR ECOL PROG SER, V320, P169, DOI 10.3354/meps320169; Fiksen O, 2007, MAR ECOL PROG SER, V347, P195, DOI 10.3354/meps06978; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; Fossette S, 2012, MAR ECOL PROG SER, V457, P285, DOI 10.3354/meps09581; Foster V, 2010, AFR DEV FORUM, P249; Gallardo B, 2013, J APPL ECOL, V50, P757, DOI 10.1111/1365-2664.12079; Gilg MR, 2003, ECOLOGY, V84, P2989, DOI 10.1890/02-0498; Gilman SE, 2006, P NATL ACAD SCI USA, V103, P9560, DOI 10.1073/pnas.0510992103; GORDON AL, 1995, DEEP-SEA RES PT I, V42, P1, DOI 10.1016/0967-0637(94)00032-N; GRANT WS, 1985, J EXP MAR BIOL ECOL, V90, P179, DOI 10.1016/0022-0981(85)90119-4; GRIFFITHS CL, 1992, S AFR J MARINE SCI, V12, P713; Hagen E, 2001, OCEANOL ACTA, V24, P557, DOI 10.1016/S0399-1784(01)01173-2; Hall J, 2015, THESIS RHODES U; Hamann M, 2011, ECOL MODEL, V222, P1515, DOI 10.1016/j.ecolmodel.2011.02.003; Harrison TD, 2002, MAR FRESHWATER RES, V53, P479, DOI 10.1071/MF01121; Hastwell GT, 2008, DIVERS DISTRIB, V14, P243, DOI 10.1111/j.1472-4642.2007.00367.x; Helmuth B, 1999, ECOLOGY, V80, P15; Hilbish TJ, 2000, MAR BIOL, V136, P69, DOI 10.1007/s002270050010; Huenerlage K, 2013, J PLANKTON RES, V35, P337, DOI 10.1093/plankt/fbs086; Jackson JM, 2012, CONT SHELF RES, V49, P10, DOI 10.1016/j.csr.2012.09.005; Jones GP, 2007, OCEANOGRAPHY, V20, P100, DOI 10.5670/oceanog.2007.33; JORGENSEN CB, 1981, OPHELIA, V20, P185, DOI 10.1080/00785236.1981.10426570; Kaluza P, 2010, J R SOC INTERFACE, V7, P1093, DOI 10.1098/rsif.2009.0495; KAMYKOWSKI D, 1986, DEEP-SEA RES, V33, P89, DOI 10.1016/0198-0149(86)90109-3; Keller RP, 2008, CONSERV BIOL, V22, P80, DOI 10.1111/j.1523-1739.2007.00811.x; Kohler SA, 2011, MAR ECOL PROG SER, V435, P235, DOI 10.3354/meps09215; Kornis MS, 2010, CAN J FISH AQUAT SCI, V67, P553, DOI 10.1139/F10-002; Lee JE, 2007, MAR ECOL PROG SER, V339, P307, DOI 10.3354/meps339307; Lett C, 2008, ENVIRON MODELL SOFTW, V23, P1210, DOI 10.1016/j.envsoft.2008.02.005; Levitus S., 2013, DATA SCI J, V12, pWDS229; Mariani P, 2010, PROG OCEANOGR, V86, P45, DOI 10.1016/j.pocean.2010.04.027; McGregor HV, 2007, SCIENCE, V315, P637, DOI 10.1126/science.1134839; McQuaid CD, 2000, MAR ECOL PROG SER, V201, P211, DOI 10.3354/meps201211; McQuaid CD, 2015, OCEANOGR MAR BIOL, V53, P127; Mead A, 2011, BIOL INVASIONS, V13, P1991, DOI 10.1007/s10530-011-0016-9; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Mora C, 2012, ECOGRAPHY, V35, P89, DOI 10.1111/j.1600-0587.2011.06874.x; Moreno-Letelier A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078228; Neiva J, 2014, J BIOGEOGR, V41, P1137, DOI 10.1111/jbi.12278; Nicastro KR, 2010, BIOL INVASIONS, V12, P2165, DOI 10.1007/s10530-009-9619-9; Nicastro Katy R., 2010, BMC Ecology, V10, P17, DOI 10.1186/1472-6785-10-17; Ospina-Alvarez A, 2012, FISH RES, V117, P86, DOI 10.1016/j.fishres.2011.01.030; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Quinn A, 2014, AQUAT CONSERV, V24, P324, DOI 10.1002/aqc.2414; R Core Team, 2016, R FDN STAT COMP; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Rawson PD, 1999, MAR BIOL, V134, P201, DOI 10.1007/s002270050538; Richardson DM, 2008, DIVERS DISTRIB, V14, P161, DOI 10.1111/j.1472-4642.2007.00464.x; Rius M, 2006, MAR BIOL, V150, P69, DOI 10.1007/s00227-006-0322-4; Robinson TB, 2005, AFR J MAR SCI, V27, P297, DOI 10.2989/18142320509504088; Ruiz GM, 2000, NATURE, V408, P49, DOI 10.1038/35040695; Sara G, 2013, DIVERS DISTRIB, V19, P1235, DOI 10.1111/ddi.12074; SARVER SK, 1993, MAR BIOL, V117, P105, DOI 10.1007/BF00346431; Schneider KR, 2007, MAR ECOL PROG SER, V339, P157, DOI 10.3354/meps339157; Schneider KR, 2008, BIOL BULL-US, V215, P253, DOI 10.2307/25470709; SCHURINK CV, 1991, MAR ECOL PROG SER, V76, P123; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; SUCHANEK TH, 1978, J EXP MAR BIOL ECOL, V31, P105, DOI 10.1016/0022-0981(78)90139-9; Teske PR, 2011, S AFR J SCI, V107, P43, DOI 10.4102/sajs.v107i5/6.514; Teske PR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-341; Teske PR, 2013, FRONT BIOGEOGR, V5, P48, DOI DOI 10.21425/F55115591); Thresher RE, 2004, BIOL INVASIONS, V6, P295, DOI 10.1023/B:BINV.0000034598.28718.2e; Verbruggen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068337; Viard F, 2006, HELGOLAND MAR RES, V60, P144, DOI 10.1007/s10152-006-0033-8; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Zardi GI, 2007, MAR ECOL PROG SER, V337, P135, DOI 10.3354/meps337135; Zardi GI, 2006, MAR BIOL, V150, P79, DOI 10.1007/s00227-006-0328-y; Zardi GI, 2011, OECOLOGIA, V165, P947, DOI 10.1007/s00442-010-1788-9; Zardi GI, BMC EVOL BI IN PRESS	103	45	45	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0128124	10.1371/journal.pone.0128124	http://dx.doi.org/10.1371/journal.pone.0128124			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114766	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500010
J	Awais, M; Hayat, T; Irum, S; Alsaedi, A				Awais, Muhammad; Hayat, Tasawar; Irum, Sania; Alsaedi, Ahmed			Heat Generation/Absorption Effects in a Boundary Layer Stretched Flow of Maxwell Nanofluid: Analytic and Numeric Solutions	PLOS ONE			English	Article							STAGNATION-POINT FLOW; MASS-TRANSFER; FLUID; SHEET	Analysis has been done to investigate the heat generation/absorption effects in a steady flow of non-Newtonian nanofluid over a surface which is stretching linearly in its own plane. An upper convected Maxwell model (UCM) has been utilized as the non-Newtonian fluid model in view of the fact that it can predict relaxation time phenomenon which the Newtonian model cannot. Behavior of the relaxations phenomenon has been presented in terms of Deborah number. Transport phenomenon with convective cooling process has been analyzed. Brownian motion "D-b" and thermophoresis effects "D-t" occur in the transport equations. The momentum, energy and nanoparticle concentration profiles are examined with respect to the involved rheological parameters namely the Deborah number, source/sink parameter, the Brownian motion parameters, thermophoresis parameter and Biot number. Both numerical and analytic solutions are presented and found in nice agreement. Comparison with the published data is also made to ensure the validity. Stream lines for Maxwell and Newtonian fluid models are presented in the analysis.	[Awais, Muhammad; Irum, Sania] COMSATS Inst Informat Technol, Dept Math, Attock 43600, Pakistan; [Hayat, Tasawar] Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Dept Math, Jeddah 21589, Saudi Arabia	COMSATS University Islamabad (CUI); Quaid I Azam University; King Abdulaziz University	Awais, M (corresponding author), COMSATS Inst Informat Technol, Dept Math, Attock 43600, Pakistan.	awais_mm@yahoo.com	Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/Y-2524-2019; Awais, Muhammad/HCI-3725-2022; Hayat, Tasawar/A-3853-2013; Awais, Muhammad/AAZ-3455-2020	Alsaedi, Ahmed/0000-0003-3452-8922; 	Higher Education Commission (HEC) of Pakistan [IPFP/HRD/HEC/2014/870]	Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan)	We sincerely thank the editor and the reviewer for the constructive suggestions for the improvement of this article. The first author thanks Higher Education Commission (HEC) of Pakistan for the support via IPFP/HRD/HEC/2014/870.	Abbasbandy S, 2011, COMMUN NONLINEAR SCI, V16, P4268, DOI 10.1016/j.cnsns.2011.03.031; Abbasbandy S, 2011, COMMUN NONLINEAR SCI, V16, P112, DOI 10.1016/j.cnsns.2010.04.004; Abbasbandy S, 2014, APPL MATH COMPUT, V242, P569, DOI 10.1016/j.amc.2014.04.102; Alsaedi A, 2012, COMMUN NONLINEAR SCI, V17, P4210, DOI 10.1016/j.cnsns.2012.03.008; Awais M, 2014, COMPUT FLUIDS, V91, P21, DOI 10.1016/j.compfluid.2013.12.002; Choi SUS., 1995, ASME PUBLICATIONS FE, P99; Fetecau C, 2009, COMPUT MATH APPL, V57, P596, DOI 10.1016/j.camwa.2008.09.052; Hamad MAA, 2012, COMMUN NONLINEAR SCI, V17, P132, DOI 10.1016/j.cnsns.2011.02.024; Hassani M, 2011, INT J THERM SCI, V50, P2256, DOI 10.1016/j.ijthermalsci.2011.05.015; Hayat T, 2012, J HEAT TRANS-T ASME, V134, DOI 10.1115/1.4006032; Hayat T, 2012, INT J HEAT MASS TRAN, V55, P2129, DOI 10.1016/j.ijheatmasstransfer.2011.12.016; Hayat T, 2011, INT J MOD PHYS B, V25, P2863, DOI 10.1142/S0217979211101375; Hayat T, 2011, INT J HEAT MASS TRAN, V54, P3777, DOI 10.1016/j.ijheatmasstransfer.2011.03.003; Jamil M, 2010, NONLINEAR ANAL-REAL, V11, P4302, DOI 10.1016/j.nonrwa.2010.05.016; Khan WA, 2010, INT J HEAT MASS TRAN, V53, P2477, DOI 10.1016/j.ijheatmasstransfer.2010.01.032; Liao SJ, 2009, COMMUN NONLINEAR SCI, V14, P983, DOI 10.1016/j.cnsns.2008.04.013; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Masuda H., 1993, NETSU BUSSEI, V4, P227, DOI [10.2963/jjtp.7.227, DOI 10.2963/JJTP.7.227]; Nadeem S, 2013, INT J HEAT MASS TRAN, V57, P679, DOI 10.1016/j.ijheatmasstransfer.2012.10.019; Rana P, 2012, COMMUN NONLINEAR SCI, V17, P212, DOI 10.1016/j.cnsns.2011.05.009; Rashidi MM, 2011, COMMUN NONLINEAR SCI, V16, P4303, DOI 10.1016/j.cnsns.2011.03.015; Rashidi MM, 2010, NONLINEAR ANAL-MODEL, V15, P83, DOI 10.15388/NA.2010.15.1.14366; Renardy M, 2012, J NON-NEWTON FLUID, V189, P14, DOI 10.1016/j.jnnfm.2012.09.010; Shateyi S, 2013, BOUND VALUE PROBL, DOI 10.1186/1687-2770-2013-196; Xu H, 2009, COMPUT MATH APPL, V57, P1425, DOI 10.1016/j.camwa.2009.01.029; Zhao ML, 2014, APPL MATH MODEL, V38, P2345, DOI 10.1016/j.apm.2013.10.053; Zierep J, 2007, INT J ENG SCI, V45, P617, DOI 10.1016/j.ijengsci.2007.04.015	27	32	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129814	10.1371/journal.pone.0129814	http://dx.doi.org/10.1371/journal.pone.0129814			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115101	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500039
J	Chou, SH; Tung, YC; Lin, YS; Wu, LS; Lin, CP; Liou, EJW; Chang, CJ; Kung, SF; Chu, PH				Chou, Shing-Hsien; Tung, Ying-Chang; Lin, Yu-Sheng; Wu, Lung-Sheng; Lin, Chia-Pin; Liou, Eric Jein-Wein; Chang, Chee-Jen; Kung, Suefang; Chu, Pao-Hsien			Major Adverse Cardiovascular Events in Treated Periodontitis: A Population-Based Follow-Up Study from Taiwan	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; ATHEROMATOUS PLAQUES; RISK-FACTOR; INFLAMMATION; ASSOCIATION; STROKE; METAANALYSIS; INFECTIONS; PATHOGENS	Background The aim of the present study was to identify the long-term major adverse cardiovascular events (MACE) in treated periodontitis patients in Taiwan. Methods From the National Health Insurance Research Database (2001-2010), adult patients (>= 18 years) with treated periodontitis were identified. Comparison was made between patients with mild form and severe form of treated periodontitis after propensity score matching. The primary end point was the incidence of MACE. Results A total of 32,504 adult patients with treated periodontitis were identified between 2001 and 2010. After propensity score matching, 27,146 patients were preserved for comparison, including 13,573 patients with mild form and 13,573 patients with severe form of treated periodontitis. During follow-up, 728 individuals in mild treated periodontitis group and 1,206 individuals in severe treated periodontitis group had at least 1 MACE event. After adjustment for gender, hyperlipidemia, hypertension and diabetes mellitus, severe treated periodontitis was associated with a mildly but significantly increased risk of MACE among older patients > 60 years of age (incidence rate ratio, 1.26; 95% confidence interval, 1.08-1.46). No association was found among younger patients <= 60 years of age. Conclusions Severe form of treated periodontitis was associated with an increased risk of MACE among older Taiwanese patients, but not among younger Taiwanese patients. We should put more efforts on the improvement of periodontal health to prevent further MACE.	[Chou, Shing-Hsien; Tung, Ying-Chang; Lin, Yu-Sheng; Wu, Lung-Sheng; Lin, Chia-Pin; Chu, Pao-Hsien] Chang Gung Mem Hosp, Div Cardiol, Dept Internal Med, Taipei 10591, Taiwan; [Chang, Chee-Jen] Chang Gung Mem Hosp, Clin Informat & Med Stat Res Ctr, Taipei 10591, Taiwan; [Liou, Eric Jein-Wein] Chang Gung Mem Hosp, Dept Orthodont & Craniofacial Dent, Taipei 10591, Taiwan; [Kung, Suefang] Chang Gung Mem Hosp, Div Periodontol, Taipei 10591, Taiwan; [Kung, Suefang] Cheers Dent Clin, New Taipei, Taiwan; [Chu, Pao-Hsien] Chang Gung Mem Hosp, Healthcare Ctr, Taipei 10591, Taiwan; [Chu, Pao-Hsien] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Heart Failure Ctr, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Kung, SF (corresponding author), Chang Gung Mem Hosp, Div Periodontol, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	pskung@gmail.com; pchu@adm.cgmh.org.tw	Chu, Pao-Hsien/P-5249-2019; Chu, Pao-Hsien/G-3685-2010; Stefanadis, Christodoulos/ABH-2232-2020	Chu, Pao-Hsien/0000-0003-0361-6348; Stefanadis, Christodoulos/0000-0001-5974-6454	Chang Gung Memorial Hospital, Taiwan [CLRPG340599]; Chang Gung Memorial Hospital [CMRPG32057]; National Sciences Council, Taiwan [NSC 96-2314-B-182-026, 97-2314-B-182-028-MY2, 99-2314-B-182A-106-MY3]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Sciences Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Chang Gung Memorial Hospital, Taiwan (CLRPG340599). Dr. Chu was supported by a grant from the Chang Gung Memorial Hospital (CMRPG32057) and grants from the National Sciences Council, Taiwan (NSC 96-2314-B-182-026, 97-2314-B-182-028-MY2, and 99-2314-B-182A-106-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimetti M, 2007, J PERIODONTOL, V78, P1718, DOI 10.1902/jop.2007.060473; Beck J, 1996, J PERIODONTOL, V67, P1123, DOI 10.1902/jop.1996.67.10s.1123; Blaizot A, 2009, INT DENT J, V59, P197, DOI 10.1922/IDJ_2114Sixou13; Bokhari SAH, 2014, J CLIN PERIODONTOL, V41, P1048, DOI 10.1111/jcpe.12284; Cairo F, 2004, J PERIODONTAL RES, V39, P442, DOI 10.1111/j.1600-0765.2004.00761.x; Calandrini CA, 2014, ORAL DIS, V20, pe128, DOI 10.1111/odi.12205; Chun YHP, 2005, J PERIODONTAL RES, V40, P87, DOI 10.1111/j.1600-0765.2004.00771.x; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; de Oliveira C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2451; DESTEFANO F, 1993, BRIT MED J, V306, P688, DOI 10.1136/bmj.306.6879.688; Dietrich T, 2008, CIRCULATION, V117, P1668, DOI 10.1161/CIRCULATIONAHA.107.711507; Dietrich Thomas, 2013, J Periodontol, V84, pS70, DOI [10.1111/jcpe.12062, 10.1902/jop.2013.134008]; Dorn JM, 2010, J PERIODONTOL, V81, P502, DOI 10.1902/jop.2009.090499; Emingil G, 2000, J PERIODONTOL, V71, P1882, DOI 10.1902/jop.2000.71.12.1882; Fiehn NE, 2005, J PERIODONTOL, V76, P731, DOI 10.1902/jop.2005.76.5.731; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Ford PJ, 2007, J DENT RES, V86, P35, DOI 10.1177/154405910708600105; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Grau AJ, 2004, STROKE, V35, P496, DOI 10.1161/01.STR.0000110789.20526.9D; Grau AJ, 2010, NAT REV NEUROL, V6, P681, DOI 10.1038/nrneurol.2010.163; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Howell TH, 2001, J AM COLL CARDIOL, V37, P445, DOI 10.1016/S0735-1097(00)01130-X; Hujoel PP, 2000, JAMA-J AM MED ASSOC, V284, P1406, DOI 10.1001/jama.284.11.1406; Janket SJ, 2003, ORAL SURG ORAL MED O, V95, P559, DOI 10.1067/moe.2003.107; Jimenez M, 2009, ANN NEUROL, V66, P505, DOI 10.1002/ana.21742; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Katz J, 2001, J CLIN PERIODONTOL, V28, P865, DOI 10.1034/j.1600-051x.2001.028009865.x; Kornman K S, 2001, Ann Periodontol, V6, P48; Kozarov EV, 2005, ARTERIOSCL THROM VAS, V25, pE17, DOI 10.1161/01.ATV.0000155018.67835.1a; Lafon A, 2014, EUR J NEUROL, V21, P1155, DOI 10.1111/ene.12415; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lin YS, 2011, AM J CARDIOL, V107, P325, DOI 10.1016/j.amjcard.2010.08.073; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Loos BG, 2000, J PERIODONTOL, V71, P1528, DOI 10.1902/jop.2000.71.10.1528; Loos BG, 2005, J PERIODONTOLOGY S, V76, P2106; Losche W, 2005, J CLIN PERIODONTOL, V32, P640, DOI 10.1111/j.1600-051X.2005.00725.x; Losche W, 2000, J CLIN PERIODONTOL, V27, P537, DOI 10.1034/j.1600-051x.2000.027008537.x; Lu JFR, 2011, HEALTH ECON POLICY L, V6, P85, DOI 10.1017/S1744133109990351; Montebugnoli L, 2005, J CLIN PERIODONTOL, V32, P188, DOI 10.1111/j.1600-051X.2005.00641.x; Morrison HI, 1999, J CARDIOVASC RISK, V6, P7; Nibali L, 2007, J CLIN PERIODONTOL, V34, P931, DOI 10.1111/j.1600-051X.2007.01133.x; Noack B, 2001, J PERIODONTOL, V72, P1221, DOI 10.1902/jop.2000.72.9.1221; Oz SG, 2007, SOUTH MED J, V100, P686, DOI 10.1097/SMJ.0b013e31802fa327; Paraskevas S, 2008, J CLIN PERIODONTOL, V35, P277, DOI 10.1111/j.1600-051X.2007.01173.x; Piconi S, 2009, FASEB J, V23, P1196, DOI 10.1096/fj.08-119578; Pussinen PJ, 2007, ATHEROSCLEROSIS, V193, P222, DOI 10.1016/j.atherosclerosis.2006.06.027; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Schenkein Harvey A, 2013, J Clin Periodontol, V40 Suppl 14, pS51, DOI [10.1902/jop.2013.134006, 10.1111/jcpe.12060]; Schwahn C, 2004, THROMBOSIS HAEMOSTAS; Seymour GJ, 2007, CLIN MICROBIOL INFEC, V13, P3, DOI 10.1111/j.1469-0691.2007.01798.x; Sim SJ, 2008, J PERIODONTOL, V79, P1652, DOI [10.1902/jop.2008.080015, 10.1902/jop.2008.080015 ]; Slade GD, 2000, J DENT RES, V79, P49, DOI 10.1177/00220345000790010701; Tabeta K, 2000, CLIN EXP IMMUNOL, V120, P285, DOI 10.1046/j.1365-2249.2000.01216.x; Tang CH, 2009, STROKE, V40, P1162, DOI 10.1161/STROKEAHA.108.540880; Thomopoulos C, 2011, AM J CARDIOVASC DIS, V1, P76; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Tonetti MS, 2013, J CLIN PERIODONTOL, V40, pS24, DOI 10.1111/jcpe.12089; Tuominen R, 2003, J DENT RES, V82, P713, DOI 10.1177/154405910308200911; Welfare MoHa, 2013, TAIW PUBL HLTH REP, V2014, P1; Wu LS, 2012, AM J MED SCI; Wu TJ, 2000, AM J EPIDEMIOL, V151, P273, DOI 10.1093/oxfordjournals.aje.a010203; Wu TJ, 2000, ARCH INTERN MED, V160, P2749, DOI 10.1001/archinte.160.18.2749	65	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130807	10.1371/journal.pone.0130807	http://dx.doi.org/10.1371/journal.pone.0130807			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114433	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500097
J	Gao, SY; Steeg, GV; Galstyan, A				Gao, Shuyang; Steeg, Greg Ver; Galstyan, Aram			Understanding Confounding Effects in Linguistic Coordination: An Information-Theoretic Approach	PLOS ONE			English	Article							LANGUAGE USE; WORD USE; STYLE	We suggest an information-theoretic approach for measuring stylistic coordination in dialogues. The proposed measure has a simple predictive interpretation and can account for various confounding factors through proper conditioning. We revisit some of the previous studies that reported strong signatures of stylistic accommodation, and find that a significant part of the observed coordination can be attributed to a simple confounding effect-length coordination. Specifically, longer utterances tend to be followed by longer responses, which gives rise to spurious correlations in the other stylistic features. We propose a test to distinguish correlations in length due to contextual factors (topic of conversation, user verbosity, etc.) and turn-by-turn coordination. We also suggest a test to identify whether stylistic coordination persists even after accounting for length coordination and contextual factors.	[Gao, Shuyang; Steeg, Greg Ver; Galstyan, Aram] Univ So Calif, Inst Informat Sci, Marina Del Rey, CA 90292 USA	University of Southern California	Gao, SY (corresponding author), Univ So Calif, Inst Informat Sci, Marina Del Rey, CA 90292 USA.	sgao@isi.edu		Ver Steeg, Greg/0000-0002-0793-141X	DARPA [W911NF-12-1-0034]	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	G.V. and A.G. acknowledge DARPA grant no. W911NF-12-1-0034.	Bell A.J., 2003, P 5 INT WORKSHOP IND, V2003; Boals A, 2005, J LANG SOC PSYCHOL, V24, P252, DOI 10.1177/0261927X05278386; BOCK JK, 1986, COGNITIVE PSYCHOL, V18, P355, DOI 10.1016/0010-0285(86)90004-6; Brennan SE, 1996, J EXP PSYCHOL LEARN, V22, P1482, DOI 10.1037/0278-7393.22.6.1482; Brennan Susan E, 1996, P ISSD, V96, P41; Campbell RS, 2003, PSYCHOL SCI, V14, P60, DOI 10.1111/1467-9280.01419; Cover TM., 2006, WILEY SERIES TELECOM; Cristian Danescu-Niculescu-Mizil, 2012, P 21 INT C WORLD WID, P699, DOI DOI 10.1145/2187836.2187931; Danescu-Niculescu-Mizil Cristian, 2011, P INT C WORLD WIDE W, P745, DOI [10.1145/1963405.1963509, DOI 10.1145/1963405.1963509]; Danescu-Niculescu-Mizil Cristian, 2011, P 2 WORKSH COGN MOD, P76; DeDeo S, 2013, ENTROPY-SWITZ, V15, P2246, DOI 10.3390/e15062246; Giles H, 1991, ACCOMMODATION THEORY, P1; Gonzales AL, 2010, COMMUN RES, V37, P3, DOI 10.1177/0093650209351468; Ireland ME, 2011, PSYCHOL SCI, V22, P39, DOI 10.1177/0956797610392928; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; McGill WJ., 1954, IRE PROFESSIONAL GRO, DOI [10.1109/TIT.1954.1057469, DOI 10.1109/TIT.1954.1057469]; Niederhoffer KG, 2002, J LANG SOC PSYCHOL, V21, P337, DOI 10.1177/026192702237953; Pennebaker JW, 1999, J PERS SOC PSYCHOL, V77, P1296, DOI 10.1037/0022-3514.77.6.1296; Pennebaker JW, 2007, LINGUISTIC INQUIRY W; Pesarin F., 2010, PERMUTATION TESTS CO; Pickering MJ, 2008, PSYCHOL BULL, V134, P427, DOI 10.1037/0033-2909.134.3.427; Rude SS, 2004, COGNITION EMOTION, V18, P1121, DOI 10.1080/02699930441000030; SIMPSON EH, 1951, J ROY STAT SOC B, V13, P238; Stirman SW, 2001, PSYCHOSOM MED, V63, P517; Taylor P.J., 2008, NEGOTIATION CONFLICT, V1, P263, DOI [DOI 10.1111/J.1750-4716.2008.00016.X, 10.1111/j.1750-4716.2008.00016.x]; Ver Steeg G, 2013, WORKSH INF NETW WIN; Ver Steeg G, 2013, AISTATS 13; Wang Q, 2008, FOUND TRENDS COMMUN, V5, DOI 10.1561/0100000021	29	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130167	10.1371/journal.pone.0130167	http://dx.doi.org/10.1371/journal.pone.0130167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1AM	26115446	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500055
J	Geaney, JT; Treadway, MT; Smillie, LD				Geaney, Joachim T.; Treadway, Michael T.; Smillie, Luke D.			Trait Anticipatory Pleasure Predicts Effort Expenditure for Reward	PLOS ONE			English	Article							INSTRUMENTAL RESPONSE SELECTION; AFFECTIVE-REACTIVITY HYPOTHESIS; INCENTIVE-SENSITIZATION THEORY; DECISION-MAKING; NUCLEUS-ACCUMBENS; BEHAVIORAL ACTIVATION; CONSUMMATORY PLEASURE; MOTIVATIONAL DEFICITS; DOPAMINE DEPLETIONS; HEDONIC EXPERIENCE	Research in motivation and emotion has been increasingly influenced by the perspective that processes underpinning the motivated approach of rewarding goals are distinct from those underpinning enjoyment during reward consummation. This distinction recently inspired the construction of the Temporal Experience of Pleasure Scale (TEPS), a self-report measure that distinguishes trait anticipatory pleasure (pre-reward feelings of desire) from consummatory pleasure (feelings of enjoyment and gratification upon reward attainment). In a university community sample (N = 97), we examined the TEPS subscales as predictors of (1) the willingness to expend effort for monetary rewards, and (2) affective responses to a pleasant mood induction procedure. Results showed that both anticipatory pleasure and a well-known trait measure of reward motivation predicted effort-expenditure for rewards when the probability of being rewarded was relatively low. Against expectations, consummatory pleasure was unrelated to induced pleasant affect. Taken together, our findings provide support for the validity of the TEPS anticipatory pleasure scale, but not the consummatory pleasure scale.	[Geaney, Joachim T.; Smillie, Luke D.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Treadway, Michael T.] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA	University of Melbourne; Emory University	Geaney, JT (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia.	j.geaney@student.unimelb.edu.au	Treadway, Michael/O-9056-2017	Smillie, Luke/0000-0001-5148-8358				Aberman JE, 1999, NEUROSCIENCE, V92, P545, DOI 10.1016/S0306-4522(99)00004-4; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Applegate E, 2009, PERS INDIV DIFFER, V47, P452, DOI 10.1016/j.paid.2009.04.017; Assogna F, 2011, MOVEMENT DISORD, V26, P1825, DOI 10.1002/mds.23815; Barbano MF, 2007, PSYCHOPHARMACOLOGY, V191, P497, DOI 10.1007/s00213-006-0521-1; Barch DM, 2014, J ABNORM PSYCHOL, V123, P387, DOI 10.1037/a0036299; Bardgett ME, 2009, BEHAV NEUROSCI, V123, P242, DOI 10.1037/a0014625; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; BERRIDGE KC, 1989, BEHAV NEUROSCI, V103, P36, DOI 10.1037/0735-7044.103.1.36; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Buck B, 2013, PSYCHIAT RES, V205, P30, DOI 10.1016/j.psychres.2012.09.008; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Cassidy CM, 2012, SCHIZOPHR RES, V137, P39, DOI 10.1016/j.schres.2012.02.028; Chentsova-Dutton Y, 2010, PSYCHIAT RES, V179, P176, DOI 10.1016/j.psychres.2009.06.013; COUSINS MS, 1993, PHARMACOL BIOCHEM BE, V46, P943, DOI 10.1016/0091-3057(93)90226-J; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; Damiano CR, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-13; Depue RA, 2005, BEHAV BRAIN SCI, V28, P313; Dichter G.S., 2010, OPEN PSYCHIAT J, V4, P1, DOI [10.2174/1874354401004010001, DOI 10.2174/1874354401004010001]; Engel M, 2013, PSYCHIAT RES, V210, P422, DOI 10.1016/j.psychres.2013.07.025; Epstein LH, 2003, PHYSIOL BEHAV, V78, P221, DOI 10.1016/S0031-9384(02)00978-2; Favrod J, 2009, ENCEPHALE, V35, P241, DOI 10.1016/j.encep.2008.02.013; Fervaha G, 2013, J PSYCHIATR RES, V47, P1590, DOI 10.1016/j.jpsychires.2013.08.003; Finlayson G, 2007, PHYSIOL BEHAV, V90, P36, DOI 10.1016/j.physbeh.2006.08.020; Freud S, 1950, BEYOND THE PLEASURE; Gable P.A., 2008, NETHERLANDS J PSYCHO, V64, P132, DOI [10.1007/BF03076416, DOI 10.1007/BF03076416]; Gard DE, 2006, J RES PERS, V40, P1086, DOI 10.1016/j.jrp.2005.11.001; Gard DE, 2007, SCHIZOPHR RES, V93, P253, DOI 10.1016/j.schres.2007.03.008; Gard DE, 2014, J ABNORM PSYCHOL, V123, P771, DOI 10.1037/abn0000005; Gold JM, 2013, BIOL PSYCHIAT, V74, P130, DOI 10.1016/j.biopsych.2012.12.022; Gooding DC, 2014, PSYCHIAT RES, V215, P771, DOI 10.1016/j.psychres.2013.11.009; Gooding DC, 2014, PSYCHIAT RES, V215, P237, DOI 10.1016/j.psychres.2013.10.012; Harmon-Jones E, 1998, J PERS SOC PSYCHOL, V74, P1310, DOI 10.1037/0022-3514.74.5.1310; Harmon-Jones E, 2010, BIOL PSYCHOL, V84, P451, DOI 10.1016/j.biopsycho.2009.08.010; Ho PM, 2015, J PERS ASSESS, V97, P200, DOI 10.1080/00223891.2014.940625; Holst G, 1993, BERLIN PHILHARMONIC; Hughes DM, SOC COGN AF IN PRESS, DOI [10.1093/scan/nsu149, DOI 10.1093/SCAN/NSU149]; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Kurniawan IT, 2013, J NEUROSCI, V33, P6160, DOI 10.1523/JNEUROSCI.4777-12.2013; Loas G, 2009, ANN MED-PSYCHOL, V167, P641, DOI 10.1016/j.amp.2009.09.002; Mann CL, 2013, J ABNORM PSYCHOL, V122, P745, DOI 10.1037/a0033069; Mayer J.D., 1995, J MENT IMAG, V19, P151; Mela DJ, 2006, APPETITE, V47, P10, DOI 10.1016/j.appet.2006.02.006; Mote J, 2014, SCHIZOPHR RES, V159, P76, DOI 10.1016/j.schres.2014.07.048; Pecina S, 2003, J NEUROSCI, V23, P9395; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; Revelle W, 1996, PAPER PRESENTED AT T; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; SALAMONE JD, 1994, BEHAV BRAIN RES, V65, P221, DOI 10.1016/0166-4328(94)90108-2; Schmidt L, 2008, BRAIN, V131, P1303, DOI 10.1093/brain/awn045; Schweiger D, 2014, SOC COGN AFFECT NEUR, V9, P1608, DOI 10.1093/scan/nst152; Sherdell L, 2012, J ABNORM PSYCHOL, V121, P51, DOI 10.1037/a0024945; Smillie LD, 2013, J RES PERS, V47, P580, DOI 10.1016/j.jrp.2013.04.008; Smillie LD, 2012, J PERS SOC PSYCHOL, V103, P306, DOI 10.1037/a0028372; SNAITH RP, 1995, BRIT J PSYCHIAT, V167, P99, DOI 10.1192/bjp.167.1.99; Strauss GP, 2013, SCHIZOPHRENIA BULL, V39, P872, DOI 10.1093/schbul/sbs186; Strauss GP, 2011, PSYCHIAT RES, V187, P36, DOI 10.1016/j.psychres.2011.01.012; Treadway MT, 2015, SCHIZOPHR RES, V161, P382, DOI 10.1016/j.schres.2014.11.024; Treadway MT, 2013, CURR DIR PSYCHOL SCI, V22, P244, DOI 10.1177/0963721412474460; Treadway MT, 2012, J ABNORM PSYCHOL, V121, P553, DOI 10.1037/a0028813; Treadway MT, 2012, J NEUROSCI, V32, P6170, DOI 10.1523/JNEUROSCI.6459-11.2012; Treadway MT, 2011, NEUROSCI BIOBEHAV R, V35, P537, DOI 10.1016/j.neubiorev.2010.06.006; Treadway MT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006598; Triscoli C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113425; Tso IF, 2014, PSYCHIAT RES, V219, P470, DOI 10.1016/j.psychres.2014.06.030; Wardle MC, 2011, J NEUROSCI, V31, P16597, DOI 10.1523/JNEUROSCI.4387-11.2011; Westermann R, 1996, EUR J SOC PSYCHOL, V26, P557, DOI 10.1002/(SICI)1099-0992(199607)26:4<557::AID-EJSP769>3.0.CO;2-4; WHEELER RE, 1993, PSYCHOPHYSIOLOGY, V30, P82, DOI 10.1111/j.1469-8986.1993.tb03207.x; Winer ES, 2014, J AFFECT DISORDERS, V152, P193, DOI 10.1016/j.jad.2013.09.010; Wynn JK, 2010, INT J PSYCHOPHYSIOL, V77, P141, DOI 10.1016/j.ijpsycho.2010.05.009; Yang XH, 2014, PSYCHIAT RES, V220, P874, DOI 10.1016/j.psychres.2014.08.056; Yik M, 2011, EMOTION, V11, P705, DOI 10.1037/a0023980; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	75	31	33	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131357	10.1371/journal.pone.0131357	http://dx.doi.org/10.1371/journal.pone.0131357			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1AM	26115223	gold, Green Published			2022-12-27	WOS:000358147500144
J	Liu, CH; Chen, CX; Xu, J; Wang, HL; Ke, XB; Zhuang, ZY; Lai, ZL; Wu, ZQ; Lin, Q				Liu, Chun-Hua; Chen, Chang-Xian; Xu, Jie; Wang, Han-Long; Ke, Xiao-Bin; Zhuang, Zhi-Yong; Lai, Zhan-Long; Wu, Zhi-Qiang; Lin, Qin			Anterior Subcutaneous versus Submuscular Transposition of the Ulnar Nerve for Cubital Tunnel Syndrome: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							SIMPLE DECOMPRESSION; INTRAMUSCULAR TRANSPOSITION; ELBOW; NEUROPATHY; ENTRAPMENT; MANAGEMENT; ULTRASOUND	Objective To pool reliable evidences for the optimum anterior transposition technique in the treatment of cubital tunnel syndrome by comparing the clinical efficacy of subcutaneous and submuscular anterior ulnar nerve transposition. Methods A comprehensive search was conducted in PubMed MEDLINE, Cochrane Library, EMBASE, Web of Science, OVID AMED, EBSCO and potentially relevant surgical archives. Risk of bias of each included studies was evaluated according to Cochrane Handbook for Systematic Reviews of Interventions. The risk ratio (RR) and 95% confidence intervals (CI) were calculated for the clinical improvement in function compared to baseline. Heterogeneity was assessed across studies, and subgroup analysis was also performed based on the study type and follow- up duration. Results Three studies with a total of 352 participants were identified, and the clinically relevant improvement was used as the primary outcomes. Our meta- analysis revealed that no significant difference was observed between two comparison groups in terms of postoperative clinical improvement in those studies (RR 1.04, 95% CI 0.86 to 1.25, P = 0.72). Meanwhile, subgroup analyses by study type and follow- up duration revealed the consistent results with the overall estimate. Additionally, the pre- and postoperative motor nerve conduction velocities were reported in two studies with a total of 326 patients, but we could not perform a meta- analysis because of the lack of concrete numerical value in one study. The quality of evidence for clinical improvement was 'low' or 'moderate' on the basis of GRADE approach. Conclusions Based on small numbers of studies with relatively poor methodological quality, the limited evidence is insufficient to identify the optimum anterior transposition technique in the treatment of cubital tunnel syndrome. The results of the present study suggest that anterior subcutaneous and submuscular transposition might be equally effective in patients with ulnar neuropathy at the elbow. Therefore, more high-quality randomized controlled trials with standardized clinical improvement metrics are required to further clarify this topic and to provide reproducible pre- and postoperative objective outcomes.	[Liu, Chun-Hua; Chen, Chang-Xian; Wang, Han-Long; Ke, Xiao-Bin; Zhuang, Zhi-Yong; Lai, Zhan-Long; Wu, Zhi-Qiang] Fujian Univ Tradit Chinese Med, Dept Orthopaed Surg, Quanzhou Orthoped Traumatol Hosp, Quanzhou, Fujian Province, Peoples R China; [Xu, Jie] Fujian Med Univ, Shengli Hosp, Dept Orthopaed Surg, Fuzhou, Fujian Province, Peoples R China; [Lin, Qin] Xiamen Univ, Fuzhou Hosp 2, Dept Orthopaed Surg, Xiamen, Fujian Province, Peoples R China	Fujian University of Traditional Chinese Medicine; Fujian Medical University; Xiamen University	Liu, CH (corresponding author), Fujian Univ Tradit Chinese Med, Dept Orthopaed Surg, Quanzhou Orthoped Traumatol Hosp, Quanzhou, Fujian Province, Peoples R China.	spinezg@163.com						Artico M, 2000, ACTA NEUROCHIR, V142, P303, DOI 10.1007/s007010050039; Assmus H, 2011, CENT EUR NEUROSURG, V72, P90, DOI 10.1055/s-0031-1271800; Bartels RHMA, 1998, J NEUROSURG, V89, P722, DOI 10.3171/jns.1998.89.5.0722; Beekman R, 2004, NEUROLOGY, V62, P767, DOI 10.1212/01.wnl.0000113733.62689.0d; Brauer CA, 2007, J HAND SURG-EUR VOL, V32E, P654, DOI 10.1016/j.jhse.2007.07.001; Caliandro P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006839.pub3; Chen HW, 2014, CLIN NEUROL NEUROSUR, V126, P150, DOI 10.1016/j.clineuro.2014.08.005; Dijkers M., INTRODUCING GRADE A; FOSTER RJ, 1981, J HAND SURG-AM, V6, P181, DOI 10.1016/S0363-5023(81)80173-6; Henry M, 2006, J HAND SURG-AM, V31A, P1535, DOI 10.1016/j.jhsa.2006.04.016; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HIGGINS JPT, COCHRANE HANDBOOK FO; Jaddue Dhia A K, 2009, Open Orthop J, V3, P78, DOI 10.2174/1874325000903010078; KLEINMAN WB, 1989, J HAND SURG-AM, V14A, P972, DOI 10.1016/S0363-5023(89)80046-2; Kroonen LT, 2012, ORTHOP CLIN N AM, V43, P475, DOI 10.1016/j.ocl.2012.07.017; Lee SK, 2009, J HAND SURG-AM, V34A, P1811, DOI 10.1016/j.jhsa.2009.08.007; Macadam SA, 2008, J HAND SURG-AM, V33A, P1314, DOI 10.1016/j.jhsa.2008.03.006; MCGOWAN AJ, 1950, J BONE JOINT SURG BR, V32, P293, DOI 10.1302/0301-620X.32B3.293; Mondelli M, 2005, J NEUROL SCI, V234, P5, DOI 10.1016/j.jns.2005.02.010; Mowlavi A, 2000, PLAST RECONSTR SURG, V106, P327, DOI 10.1097/00006534-200008000-00014; Nabhan A, 2005, J HAND SURG-BRIT EUR, V30B, P521, DOI 10.1016/j.jhsb.2005.05.011; Nouhan R, 1997, J HAND SURG-AM, V22A, P127, DOI 10.1016/S0363-5023(05)80192-3; SRIWATANAKUL K, 1983, CLIN PHARMACOL THER, V34, P234, DOI 10.1038/clpt.1983.159; Tada H, 1997, CLIN ORTHOP RELAT R, P107, DOI 10.1097/00003086-199703000-00014; Van Allen MW., 1977, ARCH NEUROL-CHICAGO, V34, P61, DOI DOI 10.1001/ARCHNEUR.1977.00500130081027; Volpe A, 2009, RHEUMATOLOGY, V48, P1098, DOI 10.1093/rheumatology/kep167; Wiesler ER, 2006, J HAND SURG-AM, V31A, P1088, DOI 10.1016/j.jhsa.2006.06.007; Zarezadeh A, 2012, J RES MED SCI, V17, P745; Zhong W, 2011, J INT MED RES, V39, P1766, DOI 10.1177/147323001103900519; Zimmerman RM, 2013, J HAND SURG-AM, V38A, P2398, DOI 10.1016/j.jhsa.2013.09.017; Zlowodzki M, 2007, J BONE JOINT SURG AM, V89A, P2591, DOI 10.2106/JBJS.G.00183	31	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130843	10.1371/journal.pone.0130843	http://dx.doi.org/10.1371/journal.pone.0130843			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114865	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500101
J	Wu, WT; Tsai, SS; Shih, TS; Lin, MH; Chou, TC; Ting, H; Wu, TN; Liou, SH				Wu, Wei-Te; Tsai, Su-Shan; Shih, Tung-Sheng; Lin, Ming-Hsiu; Chou, Tzu-Chieh; Ting, Hua; Wu, Trong-Neng; Liou, Saou-Hsing			The Association between Obstructive Sleep Apnea and Metabolic Markers and Lipid Profiles	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; INTERMITTENT HYPOXIA; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; OBESE SUBJECTS; RISK-FACTORS; EPIDEMIOLOGY; PREVALENCE; OVERWEIGHT; DISORDERS	Purpose The purpose of this study was to investigate the association between apnea-hypopnea index (AHI) and metabolic markers and whether the elevated risk of Metabolic Syndrome (MetS) is related to Obstructive Sleep Apnea (OSA). Methods This cross-sectional study recruited 246 male bus drivers from one transportation company in Taiwan. Each participant was evaluated by a polysomnography (PSG) test and by blood lipids examination. Severity of OSA was categorized according to the apnea-hypopnea index (AHI). Results The results showed that a 73.3% prevalence of MetS in OSA (AHI > 15) and a 80.0% prevalence of MetS in severe OSA (AHI > 30) were found. After adjusting for confounding variables, an increased level of Body-Mass Index (BMI) and two non-MetS cardiovascular risk factors, total cholesterol/HDL-C ratio and TG/HDL-C ratio was significantly associated with AHI in subjects with severe OSA. MetS was about three times to be present in subjects with severe OSA, even adjusted for BMI. Conclusions The findings showed a high prevalence of MetS in OSA among professional drivers, especially in the severe group category. BMI was the major contributing factor to OSA. However, the present study did not find a sensitive clinical marker of a detrimental metabolic profile in OSA patients.	[Wu, Wei-Te; Wu, Trong-Neng; Liou, Saou-Hsing] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Miaoli, Taiwan; [Tsai, Su-Shan] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Shih, Tung-Sheng; Lin, Ming-Hsiu] Minist Labor, Inst Labor Occupat Safety & Hlth, Taipei, Taiwan; [Chou, Tzu-Chieh; Liou, Saou-Hsing] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Ting, Hua] Chung Shan Med Univ, Dept Phys Med & Rehabil, Taichung, Taiwan; [Ting, Hua] Chung Shan Med Univ Hosp, Ctr Sleep Med, Taichung, Taiwan; [Wu, Trong-Neng] HungKuang Univ, Dept Nursing, Taichung, Taiwan; [Liou, Saou-Hsing] Natl Def Med Ctr, Dept Publ Hlth, Taipei, Taiwan	National Health Research Institutes - Taiwan; National Defense Medical Center; China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Hungkuang University; National Defense Medical Center	Liou, SH (corresponding author), Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Miaoli, Taiwan.	shliou@nhri.org.tw	Wu, Wei-Te/S-8189-2019; Chou, Tzu-Chieh/D-2372-2014	Chou, Tzu-Chieh/0000-0002-9634-0637	National Health Research Institutes of Taiwan [98EOPP01, 99EOPP01, 00EOPP01]; Institute of Occupational Safety and Health, Taiwan [IOSH96M102, IOSH97M102]	National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); Institute of Occupational Safety and Health, Taiwan	This study was partly supported by the National Health Research Institutes of Taiwan (98EOPP01, 99EOPP01, and 00EOPP01) and the Institute of Occupational Safety and Health (IOSH96M102 and IOSH97M102), Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosetti M, 2006, J CARDIOVASC MED, V7, P826, DOI 10.2459/01.JCM.0000250873.01649.41; Barreiro Bienvenido, 2013, Open Respir Med J, V7, P71, DOI 10.2174/1874306401307010071; Bonsignore MR, 2012, EUR RESPIR J, V39, P1136, DOI 10.1183/09031936.00151110; Borgel J, 2006, EUR RESPIR J, V27, P121, DOI 10.1183/09031936.06.00131304; Coughlin SR, 2004, EUR HEART J, V25, P735, DOI 10.1016/j.ehj.2004.02.021; Drager LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012065; Fuhrman C, 2012, SLEEP MED, V13, P852, DOI 10.1016/j.sleep.2012.04.005; Garvey JF, 2009, EUR RESPIR J, V33, P1195, DOI 10.1183/09031936.00111208; Health Promotion Administration. Ministry of health and Welfare, 2007, DEF MET SYNDR AD; International Obesity Task Force (IOTF), 2000, AS PAC PERSP RED OB; Isono S, 2009, ANESTHESIOLOGY, V110, P908, DOI 10.1097/ALN.0b013e31819c74be; James WPT, 2008, J INTERN MED, V263, P336, DOI 10.1111/j.1365-2796.2008.01922.x; Johnson H, 2011, J CLIN MICROBIOL, V49, P4031, DOI 10.1128/JCM.05447-11; Kagawa M, 2007, ASIA PAC J CLIN NUTR, V16, P31; Kapur Vishesh, 2002, Sleep Breath, V6, P49, DOI 10.1007/s11325-002-0049-5; Lakka TA, 2003, MED SCI SPORT EXER, V35, P1279, DOI 10.1249/01.MSS.0000079076.74931.9A; Lam B, 2005, THORAX, V60, P504, DOI 10.1136/thx.2004.031591; Levy P, 2009, EUR RESPIR J, V34, P243, DOI 10.1183/09031936.00166808; Li JG, 2005, J APPL PHYSIOL, V99, P1643, DOI 10.1152/japplphysiol.00522.2005; Li JG, 2005, CIRC RES, V97, P698, DOI 10.1161/01.RES.0000183879.60089.a9; Li KK, 2000, LARYNGOSCOPE, V110, P1689, DOI 10.1097/00005537-200010000-00022; Lin YC, 2003, PREV MED, V37, P233, DOI 10.1016/S0091-7435(03)00119-1; Lindberg E, 2000, SLEEP MED REV, V4, P411, DOI 10.1053/smrv.2000.0118; Misra A, 2005, NUTRITION, V21, P969, DOI 10.1016/j.nut.2005.01.007; Newman AB, 2001, AM J EPIDEMIOL, V154, P50, DOI 10.1093/aje/154.1.50; Ohga E, 2003, J APPL PHYSIOL, V94, P179, DOI 10.1152/japplphysiol.00177.2002; Ong KC, 1998, RESP MED, V92, P843, DOI 10.1016/S0954-6111(98)90386-9; Pan WH, 2004, AM J CLIN NUTR, V79, P31; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Punjabi NM, 2002, AM J RESP CRIT CARE, V165, P677, DOI 10.1164/ajrccm.165.5.2104087; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Resta O, 2001, INT J OBESITY, V25, P669, DOI 10.1038/sj.ijo.0801603; Roche F, 2009, SLEEP MED, V10, P882, DOI 10.1016/j.sleep.2008.07.017; Romero-Corral A, 2010, CHEST, V137, P711, DOI 10.1378/chest.09-0360; Ruehland WR, 2009, SLEEP, V32, P150, DOI 10.1093/sleep/32.2.150; Schwartz Alan R, 2008, Proc Am Thorac Soc, V5, P185, DOI 10.1513/pats.200708-137MG; Shinohara E, 1997, J INTERN MED, V241, P11, DOI 10.1046/j.1365-2796.1997.63889000.x; Strollo PJ, 1996, NEW ENGL J MED, V334, P99, DOI 10.1056/NEJM199601113340207; Tan KCB, 2006, ATHEROSCLEROSIS, V184, P377, DOI 10.1016/j.atherosclerosis.2005.04.024; Tasali Esra, 2008, Proc Am Thorac Soc, V5, P207, DOI 10.1513/pats.200708-139MG; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Young T, 2004, JAMA-J AM MED ASSOC, V291, P2013, DOI 10.1001/jama.291.16.2013; Zito A, 2011, EUR RESPIR J, V37, P717, DOI 10.1183/09031936.00120510	43	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130279	10.1371/journal.pone.0130279	http://dx.doi.org/10.1371/journal.pone.0130279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115005	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500064
J	Yao, JJ; Zhou, GQ; Yu, XL; Tang, LL; Chen, L; Mao, YP; Lin, L; Zhang, LL; Shao, JY; Guo, Y; Ma, J; Sun, Y				Yao, Ji-Jin; Zhou, Guan-Qun; Yu, Xiao-Li; Tang, Ling-Long; Chen, Lei; Mao, Yan-Ping; Lin, Li; Zhang, Lu-Lu; Shao, Jian-Yong; Guo, Ying; Ma, Jun; Sun, Ying			Incidence of and Risk Factors for Mastoiditis after Intensity Modulated Radiotherapy in Nasopharyngeal Carcinoma	PLOS ONE			English	Article							SUPPURATIVE OTITIS-MEDIA; DISEASES; PLANS; MRI	Purpose To report the incidence of and risk factors for mastoiditis after intensity-modulated radiotherapy (IMRT) in nasopharyngeal carcinoma (NPC). Patients and Methods Retrospective analysis of pretreatment and follow-up magnetic resonance imaging (MRI) data for 451 patients with NPC treated with IMRT at a single institution. The diagnosis of mastoiditis was based on MRI; otomastoid opacification was rated as Grade 0 (none), 1 (mild), 2 (moderate) or 3 (severe) by radiologists blinded to clinical outcome. This study mainly focused on severe mastoiditis; patients were divided into three groups: the G0M (Grade 0 mastoiditis before treatment) group, G1-2M (Grade 1 to 2 mastoiditis before treatment) group and G3M (Grade 3 mastoiditis before treatment) group. The software SAS9.3 program was used to analyze the data. Results For the entire cohort, the incidence of Grade 3 mastoiditis was 20% before treatment and 31%, 19% and 17% at 3, 12 and 24 months after radiotherapy, respectively. In the G0M group, the incidence of severe mastoiditis was 0% before treatment and 23%, 15% and 13% at 3, 12 and 24 months after radiotherapy, respectively. Multivariate analysis revealed T category (OR=0.68, 95% CI = 0.469 to 0.984), time (OR=0.668, 95% CI = 0.59 to 0.757) and chemotherapy (OR= 0.598, 95% CI = 0.343 to 0.934) were independent factors associated with severe mastoiditis in the G0M group after treatment. Conclusions Mastoiditis, as diagnosed by MRI, occurs as a progressive process that regresses and resolves over time in patients with NPC treated using IMRT.	[Yao, Ji-Jin; Zhou, Guan-Qun; Tang, Ling-Long; Chen, Lei; Mao, Yan-Ping; Lin, Li; Zhang, Lu-Lu; Ma, Jun; Sun, Ying] Sun Yat Sen Univ, Dept Radiat Oncol, State Key Lab Oncol South China, Ctr Canc,Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China; [Yu, Xiao-Li] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Radiat Oncol, Guangzhou 510060, Guangdong, Peoples R China; [Shao, Jian-Yong] Sun Yat Sen Univ, Dept Pathol, State Key Lab Oncol South China, Ctr Canc,Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China; [Guo, Ying] Sun Yat Sen Univ, Ctr Canc, Dept Med Stat & Epidemiol, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Sun, Y (corresponding author), Sun Yat Sen Univ, Dept Radiat Oncol, State Key Lab Oncol South China, Ctr Canc,Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China.	sunying@sysucc.org.cn			National Natural Science Foundation of China [81372409]; Sun Yat-Sen University Clinical Research 5010 Program [2012011]; Natural Science Foundation of Guangdong Province [S2013010012220]; Science and Technology project of Guangzhou City, China [132000507]; Health & Medical Collaborative Innovation Project of Guangzhou City, China [201400000001]; National Science & Technology Pillar Program [2014BAI09B10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sun Yat-Sen University Clinical Research 5010 Program; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology project of Guangzhou City, China; Health & Medical Collaborative Innovation Project of Guangzhou City, China; National Science & Technology Pillar Program	This work was supported by grants from the National Natural Science Foundation of China (No. 81372409), the Sun Yat-Sen University Clinical Research 5010 Program (No. 2012011), the Natural Science Foundation of Guangdong Province (No. S2013010012220), the Science and Technology project of Guangzhou City, China (No. 132000507), the Health & Medical Collaborative Innovation Project of Guangzhou City, China (201400000001), and the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2014BAI09B10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRILL AH, 1974, ARCH OTOLARYNGOL, V99, P406; Calabrese EJ, 2014, HUM EXP TOXICOL, V33, P542, DOI 10.1177/0960327113493303; Cooper J, 2002, AJCC CANC STAGING MA, P157; Edge SB, 2009, ARCH PATHOL LAB MED, V133, P1256, DOI [10.1043/1543-2165-133.8.1256, DOI 10.1043/1543-2165-133.8.1256]; HOLLIDAY RA, 1989, RADIOL CLIN N AM, V27, P283; Hsin CH, 2013, LARYNGOSCOPE, V123, P2148, DOI 10.1002/lary.23215; HSU MM, 1995, ANN OTO RHINOL LARYN, V104, P453, DOI 10.1177/000348949510400607; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kam MKM, 2003, INT J RADIAT ONCOL, V56, P145, DOI 10.1016/S0360-3016(03)00075-0; KANGSANARAK J, 1995, AM J OTOL, V16, P104; Lai PH, 2002, AM J NEURORADIOL, V23, P1369; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Lee N, 2009, J CLIN ONCOL, V27, P3684, DOI 10.1200/JCO.2008.19.9109; Lin SJ, 2009, INT J RADIAT ONCOL, V75, P1071, DOI 10.1016/j.ijrobp.2008.12.015; Low WK, 2006, J CLIN ONCOL, V24, P1904, DOI 10.1200/JCO.2005.05.0096; Melaku A, 1999, ETHIOPIAN MED J, V37, P237; Meredith JR, 2008, ENT-EAR NOSE THROAT, V87, P514, DOI 10.1177/014556130808700909; Nishimura R, 1997, INT J RADIAT ONCOL, V39, P155, DOI 10.1016/S0360-3016(97)00302-7; Pickles JO., 1999, INTRO PHYSL HEARING; Platzek I, 2014, ACTA RADIOL SHORT RE, V3; Polat S, 2011, EUR ARCH OTO-RHINO-L, V268, P1135, DOI 10.1007/s00405-011-1506-1; Rodel F, 2007, INT J RADIAT BIOL, V83, P357, DOI 10.1080/09553000701317358; Sanders CL, 2012, DOSE-RESPONSE, V10, P610, DOI 10.2203/dose-response.12-017.Sanders; Swart JD., 1996, HEAD NECK IMAGING, P1391; Tham IWK, 2009, INT J RADIAT ONCOL, V75, P1481, DOI 10.1016/j.ijrobp.2009.01.018; WALKER DA, 1989, MED PEDIATR ONCOL, V17, P48, DOI 10.1002/mpo.2950170110; Walker GV, 2011, INT J RADIAT ONCOL, V81, pE819, DOI 10.1016/j.ijrobp.2010.11.047; Xia P, 2000, INT J RADIAT ONCOL, V48, P329, DOI 10.1016/S0360-3016(00)00585-X	28	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131284	10.1371/journal.pone.0131284	http://dx.doi.org/10.1371/journal.pone.0131284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114761	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500139
J	Zhang, J; Wang, TM; Ge, JP				Zhang, Jien; Wang, Tianming; Ge, Jianping			Assessing Vegetation Cover Dynamics Induced by Policy-Driven Ecological Restoration and Implication to Soil Erosion in Southern China	PLOS ONE			English	Article							FOR-GREEN PROGRAM; LOESS PLATEAU; LAND-USE; CARBON SEQUESTRATION; YANGTZE-RIVER; ECOSYSTEM SERVICES; GUIZHOU PROVINCE; CLIMATE-CHANGE; UPPER REACHES; YELLOW-RIVER	In the aftermath of the severe droughts and floods at the end of the 20th century, the Chinese government launched several ecological restoration projects, including the Natural Forest Protection Program in 1998 and the Grain-for-Green Program in 1999, to promote afforestation and reforestation to reduce surface runoff and consequent soil erosion nationwide. However, it is still unclear how vegetation has changed in southern China since the launch of these programs. In this study, we used the MODIS Enhanced Vegetation Index (EVI) to analyze the vegetation cover dynamics in southern China from 2000 to 2009 and evaluate the resulting effects of controlling soil erosion. Our observations indicate that 5.3% of the study area significantly increased and 0.98% significantly decreased in EVI value (p < 0.05). The spring EVI had largest increase in space. The conversions of croplands on steep slopes to forests resulting from national policies led to significant increases in EVI. The increase in EVI was not driven by annual average temperature and annual precipitation. By referencing ecological restoration statistical data and field observations, we showed that ecological restoration programs significantly improved vegetation cover in southern China. Increase in the area of farmland-converted forestlands has reduced soil erosion based upon monitoring sediment yields at hydrologic stations in the Yangtze River. This study displays the spatial patterns of trend in vegetation growth since the beginning of the 21st century in southern China and highlights the important role of China's afforestation program.	[Zhang, Jien; Wang, Tianming; Ge, Jianping] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; [Zhang, Jien; Wang, Tianming; Ge, Jianping] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Zhang, Jien] Lehigh Univ, Earth & Environm Sci Dept, Bethlehem, PA 18015 USA	Beijing Normal University; Beijing Normal University; Lehigh University	Wang, TM (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	wangtianming@bnu.edu.cn			National Natural Science Foundation of China [30900221]; special fund project for the scientific research of the forest public welfare industry [201004018]; State Key Laboratory of Earth Surface Processes and Resource Ecology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special fund project for the scientific research of the forest public welfare industry; State Key Laboratory of Earth Surface Processes and Resource Ecology	This research was supported by the National Natural Science Foundation of China (30900221), the special fund project for the scientific research of the forest public welfare industry (201004018), and by the State Key Laboratory of Earth Surface Processes and Resource Ecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, CHANGJIANG YANGTZE R; Belle G., 1984, WATER RESOUR RES, V20, P127, DOI DOI 10.1029/WR020I001P00127; Cai HY, 2014, REMOTE SENS-BASEL, V6, P9895, DOI 10.3390/rs6109895; Chen XG, 2009, FOREST ECOL MANAG, V258, P199, DOI 10.1016/j.foreco.2008.07.010; Cheng JZ, 2015, AGR FOREST METEOROL, V203, P88, DOI 10.1016/j.agrformet.2015.01.004; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Deng L, 2012, INT J SEDIMENT RES, V27, P120, DOI 10.1016/S1001-6279(12)60021-3; Feng XM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02846; Fu G, 2007, HYDROL PROCESS, V21, P3431, DOI 10.1002/hyp.6574; Fuller DO, 1998, INT J REMOTE SENS, V19, P2013, DOI 10.1080/014311698215135; Ge Q, 2000, ACTA GEOGR SIN, V55, P668; Ge QS, 2008, SCI CHINA SER D, V51, P871, DOI 10.1007/s11430-008-0046-z; Hill RD, 1998, HYDROL PROCESS, V12, P2029, DOI 10.1002/(SICI)1099-1085(19981030)12:13/14&lt;2029::AID-HYP717&gt;3.0.CO;2-O; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Knight JF, 2006, GISCI REMOTE SENS, V43, P1, DOI 10.2747/1548-1603.43.1.1; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Long HL, 2006, LAND DEGRAD DEV, V17, P589, DOI 10.1002/ldr.736; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031782; Lunetta RS, 2006, REMOTE SENS ENVIRON, V105, P142, DOI 10.1016/j.rse.2006.06.018; Milich L, 2000, INT J REMOTE SENS, V21, P261, DOI 10.1080/014311600210821; Pimentel D, 1993, WORLD SOIL EROSION C; [史培军 SHI Peijun], 2006, [地球科学进展, Advance in Earth Sciences], V21, P111; Smit B, 1996, GLOBAL ENVIRON CHANG, V6, P205, DOI 10.1016/0959-3780(96)00018-0; Song XZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04460; Stehman SV, 1996, PHOTOGRAMM ENG REM S, V62, P401; Tottrup C, 2004, AGR ECOSYST ENVIRON, V103, P545, DOI 10.1016/j.agee.2003.11.009; Wang TM, 2010, ECOL APPL, V20, P1126, DOI 10.1890/09-0229.1; Wang TM, 2010, INT J REMOTE SENS, V31, P1943, DOI 10.1080/01431160902929263; Xiao JF, 2014, J GEOPHYS RES-BIOGEO, V119, P2261, DOI 10.1002/2014JG002820; Xu YQ, 2011, J GEOGR SCI, V21, P1138, DOI 10.1007/s11442-011-0906-x; Yin HF, 2001, GEOMORPHOLOGY, V41, P105, DOI 10.1016/S0169-555X(01)00108-8; Yuan WP, 2014, REMOTE SENS LETT, V5, P221, DOI 10.1080/2150704X.2014.894655; Zhang B, 2004, CATENA, V57, P77, DOI 10.1016/j.catena.2003.07.001; Zhang ZG, 1980, GEOJOURNAL, V4, P541, DOI DOI 10.1007/BF00214219; Zhao SQ, 1994, GEOGRAPHY CHINA ENV; Zheng H, 2005, LAND DEGRAD DEV, V16, P387, DOI 10.1002/ldr.650; Zheng H, 2008, J HYDROL, V356, P174, DOI 10.1016/j.jhydrol.2008.04.007; Zhou ZC, 2009, INT J SUST DEV WORLD, V16, P234, DOI 10.1080/13504500903007931	39	24	26	5	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131352	10.1371/journal.pone.0131352	http://dx.doi.org/10.1371/journal.pone.0131352			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115116	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500143
J	Zhang, YQ; Lv, F; Yang, YL; Qian, XL; Lang, RG; Fan, Y; Liu, FF; Li, YQ; Li, S; Shen, BB; Pringle, GA; Zhang, XM; Fu, L; Guo, XJ				Zhang, Yiqian; Lv, Feng; Yang, Yiling; Qian, Xiaolong; Lang, Ronggang; Fan, Yu; Liu, Fangfang; Li, Yaqing; Li, Shuai; Shen, Beibei; Pringle, Gordon A.; Zhang, Xinmin; Fu, Li; Guo, Xiaojing			Clinicopathological Features and Prognosis of Metaplastic Breast Carcinoma: Experience of a Major Chinese Cancer Center	PLOS ONE			English	Article							INVASIVE DUCTAL CARCINOMA; GROWTH-FACTOR RECEPTOR; BASAL-LIKE SUBTYPE; CLINICAL ONCOLOGY/COLLEGE; AMERICAN SOCIETY; EGFR; RECOMMENDATIONS; OUTCOMES; HER2	Metaplastic breast carcinoma (MBC) is a rare heterogeneous group of primary breast malignancies, with low hormone receptor expression and poor outcomes. To date, no prognostic markers for this tumor have been validated. The current study was undertaken to evaluate the clinicopathologic characteristics, the response to various therapeutic regimens and the prognosis of MBCs in a large cohort of patients from Tianjin Medical University Cancer Hospital in China. Ninety cases of MBCs diagnosed in our hospital between January 2000 and September 2014 were retrieved from the archives. In general, MBCs presented with larger size, a lower rate of lymph node metastasis, and demonstrated more frequent local recurrence/distant metastasis than 1,090 stage-matched cases of invasive carcinoma of no specific type (IDC-NST), independent of the status of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 expressions. The five-year disease-free survival (DFS) of MBC was significantly worse than IDC-NST. Using univariate analysis, lymph node metastasis, advanced clinical stage at diagnosis, high tumor proliferation rate assessed by Ki-67 labeling, and epidermal growth factor receptor (EGFR) overexpression/gene amplification were associated significantly with reduced DFS, while decreased OS was associated significantly with lymph node metastasis and EGFR overexpression/gene amplification. With multivariate analysis, lymph node status was an independent predictor for DFS, and lymph node status and EGFR overexpression/gene amplification were independent predictors for OS. Histologic subtyping and molecular subgrouping of MBCs were not significant factors in prognosis. We also found that MBCs were insensitive to neoadjuvant chemotherapy, routine chemotherapy, and radiation therapy. This study indicates that MBC is an aggressive type of breast cancer with poor prognosis, and that identification and optimization of an effective comprehensive therapeutic regimen is needed.	[Zhang, Yiqian; Lv, Feng; Yang, Yiling; Qian, Xiaolong; Lang, Ronggang; Fan, Yu; Liu, Fangfang; Li, Yaqing; Li, Shuai; Shen, Beibei; Fu, Li; Guo, Xiaojing] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Breast Canc Breast Canc Prevent & Therapy, Dept Breast Pathol & Lab, Tianjin, Peoples R China; [Pringle, Gordon A.; Zhang, Xinmin] Temple Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA USA	Tianjin Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Guo, XJ (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Breast Canc Breast Canc Prevent & Therapy, Dept Breast Pathol & Lab, Tianjin, Peoples R China.	guoxiaojing0728@126.com			National Natural Science Foundation of China [81172531, 81302294, 81302292, 81202101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (Grant No. 81172531) to Xiaojing Guo, National Natural Science Foundation of China (Grant No. 81302294) to Yiling Yang, National Natural Science Foundation of China (Grant No. 81302292) to Xiaolong Qian and National Natural Science Foundation of China (Grant No. 81202101) to Fangfang Liu.	Al Sayed AD, 2006, ACTA ONCOL, V45, P188, DOI 10.1080/02841860500513235; Altaf FJ, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-139; Bae SY, 2011, BREAST CANCER RES TR, V126, P471, DOI 10.1007/s10549-011-1359-8; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Dancey JE, 2003, LANCET, V362, P62, DOI 10.1016/S0140-6736(03)13810-X; Esbah O, 2012, ASIAN PAC J CANCER P, V13, P4645, DOI 10.7314/APJCP.2012.13.9.4645; Gilbert JA, 2008, MOL CANCER THER, V7, P944, DOI 10.1158/1535-7163.MCT-07-0570; Gultekin M, 2014, ASIAN PAC J CANCER P, V15, P2851, DOI 10.7314/APJCP.2014.15.6.2851; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, pE48, DOI 10.1043/1543-2165-134.7.e48; Hu Q, 2013, ASIAN PAC J CANCER P, V14, P6221, DOI 10.7314/APJCP.2013.14.11.6221; Kim HM, 2014, PATHOBIOLOGY, V81, P69, DOI 10.1159/000354270; Kim MJ, 2006, HUM PATHOL, V37, P1217, DOI 10.1016/j.humpath.2006.04.015; Lai HW, 2013, BREAST, V22, P968, DOI 10.1016/j.breast.2013.05.010; Lakhani SR, 2012, WHO CLASSIFICATION O; Lee H, 2012, J CLIN PATHOL, V65, P441, DOI 10.1136/jclinpath-2011-200586; Lester TR, 2012, BREAST CANCER RES TR, V131, P41, DOI 10.1007/s10549-011-1393-6; Lim KH, 2010, JPN J CLIN ONCOL, V40, P112, DOI 10.1093/jjco/hyp139; Luini A, 2007, BREAST CANCER RES TR, V101, P349, DOI 10.1007/s10549-006-9301-1; Nelson RA, 2015, ANN SURG ONCOL, V22, P24, DOI 10.1245/s10434-014-3890-4; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Park HS, 2010, YONSEI MED J, V51, P864, DOI 10.3349/ymj.2010.51.6.864; Rakha EA, 2015, BRIT J CANCER, V112, P283, DOI 10.1038/bjc.2014.592; Reis JS, 2005, BREAST CANCER RES, V7, pR1028, DOI 10.1186/bcr1341; Sanguinetti A, 2014, ANN ITAL CHIR, V85, P109; Song YN, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-129; Steinman S, 2007, ANN CLIN LAB SCI, V37, P127; Tseng WH, 2011, ANN SURG ONCOL, V18, P94, DOI 10.1245/s10434-010-1198-6; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984	29	42	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131409	10.1371/journal.pone.0131409	http://dx.doi.org/10.1371/journal.pone.0131409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115045	gold, Green Published, Green Submitted			2022-12-27	WOS:000358147500156
J	Zhu, M; Wu, G; Li, YX; Stevens, JK; Fan, CX; Spang, A; Dong, MQ				Zhu, Ming; Wu, Gang; Li, Yu-Xin; Stevens, Julia Kathrin; Fan, Chao-Xuan; Spang, Anne; Dong, Meng-Qiu			Serum- and Glucocorticoid-Inducible Kinase-1 (SGK-1) Plays a Role in Membrane Trafficking in Caenorhabditis elegans	PLOS ONE			English	Article							THREONINE PROTEIN-KINASE; C. ELEGANS; RETROGRADE TRANSPORT; LIFE-SPAN; CELLS; ENDOCYTOSIS; DOMAIN; MIG-14/WNTLESS; TRANSCRIPTION; LOCALIZATION	The mammalian serum- and glucocorticoid-inducible kinase SGK1 regulates the endocytosis of ion channels. Here we report that in C. elegans sgk-1 null mutants, GFP-tagged MIG-14/Wntless, the sorting receptor of Wnt, failed to localize to the basolateral membrane of intestinal cells; instead, it was mis-sorted to lysosomes. This effect can be explained in part by altered sphingolipid levels, because reducing glucosylceramide biosynthesis restored the localization of MIG-14::GFP. Membrane traffic was not perturbed in general, as no obvious morphological defects were detected for early endosomes, the Golgi apparatus, and the endoplasmic reticulum (ER) in sgk-1 null animals. The recycling of MIG-14/Wntless through the Golgi might be partially responsible for the observed phenotype because the subcellular distribution of two plasma membrane cargoes that do not recycle through the trans-Golgi network (TGN) was affected to a lesser degree. Consistently, knockdown of the ArfGEF gbf-1 altered the distribution of SGK-1 at the basolateral membrane of intestinal cells. In addition, we found that sgk-1(RNAi) induced unfolded protein response in the ER, suggesting at least an indirect role of SGK-1 early in the secretory pathway. We propose that SGK-1 function is required for lipid homeostasis and that it acts at different intracellular trafficking steps.	[Zhu, Ming; Dong, Meng-Qiu] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Zhu, Ming; Wu, Gang; Li, Yu-Xin; Fan, Chao-Xuan; Dong, Meng-Qiu] Natl Inst Biol Sci, Beijing, Peoples R China; [Wu, Gang; Dong, Meng-Qiu] Tsinghua Univ, Peking Univ, Natl Inst Biol Sci, Joint Grad Program,Natl Inst Biol Sci, Beijing 100084, Peoples R China; [Stevens, Julia Kathrin; Spang, Anne] Univ Basel, Biozentrum, Growth & Dev, Basel, Switzerland	Beijing Normal University; National Institute of Biological Sciences, Beijing; National Institute of Biological Sciences, Beijing; Peking University; Tsinghua University; University of Basel	Dong, MQ (corresponding author), Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China.	dongmengqiu@nibs.ac.cn	li, yu/HGL-9518-2022; Li, yu/HHZ-5236-2022; Li, yuxin/GSD-1668-2022; Spang, Anne/M-7223-2019; li, Yu/HCI-9086-2022	Spang, Anne/0000-0002-2387-6203; 	Ministry of Science and Technology of China; municipal government of Beijing; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); municipal government of Beijing; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the Ministry of Science and Technology of China and by the municipal government of Beijing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackema KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067076; APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; BelAiba RS, 2006, CIRC RES, V98, P828, DOI 10.1161/01.RES.0000210539.54861.27; Bomberger JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089599; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Chen ATY, 2013, AGING CELL, V12, P932, DOI 10.1111/acel.12120; Chen BH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001235; Chen CCH, 2006, MOL BIOL CELL, V17, P1286, DOI 10.1091/mbc.E05-08-0787; Chen D, 2013, CELL REP, V5, P1600, DOI 10.1016/j.celrep.2013.11.018; CHITWOOD DJ, 1995, LIPIDS, V30, P567, DOI 10.1007/BF02537032; Efe JA, 2005, J CELL SCI, V118, P4751, DOI 10.1242/jcs.02599; Eyster CA, 2009, TRAFFIC, V10, P590, DOI 10.1111/j.1600-0854.2009.00894.x; Faresse N, 2012, AM J PHYSIOL-RENAL, V302, pF977, DOI 10.1152/ajprenal.00535.2011; Firestone GL, 2003, CELL PHYSIOL BIOCHEM, V13, P1, DOI 10.1159/000070244; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; GOLDSTEIN JL, 1979, NATURE, V279, P679, DOI 10.1038/279679a0; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; HARFORD J, 1983, J BIOL CHEM, V258, P3191; Haynes LP, 2007, TRAFFIC, V8, P1080, DOI 10.1111/j.1600-0854.2007.00594.x; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kubota Y, 2006, DEVELOPMENT, V133, P263, DOI 10.1242/dev.02195; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lang F, 2013, HORM-INT J ENDOCRINO, V12, P160, DOI 10.14310/horm.2002.1401; Lang F, 2013, FASEB J, V27, P3, DOI 10.1096/fj.12-218230; Lang F, 2012, CLIN EXP NEPHROL, V16, P73, DOI 10.1007/s10157-011-0488-z; Lang F, 2009, CURR OPIN NEPHROL HY, V18, P439, DOI 10.1097/MNH.0b013e32832f125e; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; Li J, 2014, G3-GENES GENOM GENET, V4, P1297, DOI 10.1534/g3.114.011841; Li X, 2013, MOL BIOL CELL, V24, P1163, DOI 10.1091/mbc.E12-10-0730; Lu M, 2010, J AM SOC NEPHROL, V21, P811, DOI 10.1681/ASN.2009111168; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Morinaga N, 1996, P NATL ACAD SCI USA, V93, P12856, DOI 10.1073/pnas.93.23.12856; Muir A, 2014, ELIFE, V3, DOI 10.7554/eLife.03779; Mukherjee S, 1997, ENDOCYTOSIS; Nomura KH, 2011, GLYCOBIOLOGY, V21, P834, DOI 10.1093/glycob/cwr019; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Pan CL, 2008, DEV CELL, V14, P132, DOI 10.1016/j.devcel.2007.12.001; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Shi AB, 2009, EMBO J, V28, P3290, DOI 10.1038/emboj.2009.272; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Suvorova ES, 2001, J BIOL CHEM, V276, P22810, DOI 10.1074/jbc.M011624200; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tai DJC, 2009, J BIOL CHEM, V284, P4073, DOI 10.1074/jbc.M805055200; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Vallon V, 2006, J MOL MED, V84, P396, DOI 10.1007/s00109-005-0027-z; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; WEBSTER MK, 1993, J BIOL CHEM, V268, P11482; Xiao R, 2013, CELL, V152, P806, DOI 10.1016/j.cell.2013.01.020; Xu T, 2006, PROLUCID FAST SENSIT; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004; Zhang HJ, 2011, NAT CELL BIOL, V13, P1189, DOI 10.1038/ncb2328; Zhu HH, 2013, ELIFE, V2, DOI 10.7554/eLife.00429	59	8	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130778	10.1371/journal.pone.0130778	http://dx.doi.org/10.1371/journal.pone.0130778			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115433	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000358147500094
J	Benzoubir, N; Mussini, C; Lejamtel, C; Dos Santos, A; Guillaume, C; Desterke, C; Samuel, D; Brechot, C; Bourgeade, MF; Guettier, C				Benzoubir, Nassima; Mussini, Charlotte; Lejamtel, Charlene; Dos Santos, Alexandre; Guillaume, Claire; Desterke, Christophe; Samuel, Didier; Brechot, Christian; Bourgeade, Marie-Francoise; Guettier, Catherine			Gamma-Smooth Muscle Actin Expression Is Associated with Epithelial-Mesenchymal Transition and Stem-Like Properties in Hepatocellular Carcinoma	PLOS ONE			English	Article							LIVER-TRANSPLANTATION; POOR-PROGNOSIS; CELLS; METASTASIS; PHENOTYPE; DISEASE; IDENTIFICATION; FIBROBLASTS; SURVIVAL; ISOFORMS	Background and Aims The prognosis of hepatocellular carcinoma (HCC) is hampered by frequent tumour recurrence and metastases. Epithelial-Mesenchymal Transition (EMT) is now recognized as a key process in tumour invasion, metastasis and the generation of cancer initiating cells. The morphological identification of EMT in tumour samples from the expression of novel mesenchymal markers could provide relevant prognostic information and aid in understanding the metastatic process. Methods The expression of Smooth Muscle Actins was studied using immunofluorescence and immunohistochemistry assays in cultured liver cells during an induced EMT process and in liver specimens from adult and paediatric HCC series. Results We report here that in HCC cell lines treated with TGF-beta and in HCC specimens, the expression of alpha SMA, a known mesenchymal marker of EMT, could never be detected. In addition, our in vitro studies identified the enteric form of SMA, gamma SMA, as being a marker of EMT. Moreover, this SMA isoform was expressed in 46% of 58 tumours from 42 adult HCC patients and in 90% of 16 tumours from 12 paediatric HCC patients. Interestingly, this expression was significantly correlated with poor tumour differentiation and progenitor cell features characterized by the expression of EpCAM and K19. Conclusion Taken together, our results support the conclusion that gamma SMA expression in HCC is strongly correlated with the EMT process, HCC aggressiveness and the identification of cancer stem cells. This correlation suggests that gamma SMA represents a novel and powerful marker to predict HCC progression.	[Benzoubir, Nassima; Lejamtel, Charlene; Dos Santos, Alexandre; Samuel, Didier; Brechot, Christian; Bourgeade, Marie-Francoise; Guettier, Catherine] INSERM, Unite 785, F-94800 Villejuif, France; [Benzoubir, Nassima; Lejamtel, Charlene; Dos Santos, Alexandre; Samuel, Didier; Brechot, Christian; Bourgeade, Marie-Francoise; Guettier, Catherine] Univ Paris 11, UMR S 785, F-94800 Villejuif, France; [Samuel, Didier; Bourgeade, Marie-Francoise] Hop Paul Brousse, AP HP, Ctr Hepatobiliaire, Villejuif, France; [Desterke, Christophe] SFR Andre Lwoff, F-94800 Villejuif, France; [Brechot, Christian] Inst Pasteur, Paris, France; [Mussini, Charlotte; Guillaume, Claire; Guettier, Catherine] Hop Kremlin Bicetre, AP HP, Serv Anatomopathol, Paris, France; [Benzoubir, Nassima; Mussini, Charlotte; Dos Santos, Alexandre; Guillaume, Claire; Desterke, Christophe; Samuel, Didier; Bourgeade, Marie-Francoise; Guettier, Catherine] DHU Hepatinov, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP	Bourgeade, MF (corresponding author), INSERM, Unite 785, F-94800 Villejuif, France.	marion.bourgeade@inserm.fr	Dos Santos, Alexandre/S-1933-2018; desterke, christophe/AAM-7083-2021; desterke, christophe/F-9803-2016	desterke, christophe/0000-0001-7679-2524; BENZOUBIR, Nassima/0000-0001-7502-7441	Agence nationale de recherche sur le SIDA et les hepatites virales	Agence nationale de recherche sur le SIDA et les hepatites virales(ANRSFrench National Research Agency (ANR))	This work was funded by Agence nationale de recherche sur le SIDA et les hepatites virales. www.anrs.fr MFB Institut national du Cancer www.ecancer.fr MFB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoldi R, 2013, EUR J CELL BIOL, V92, P187, DOI 10.1016/j.ejcb.2013.06.002; Battaglia S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004355; Dang HE, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-396; Dos Santos A, 2010, MOL CELL PROTEOMICS, V9, P1991, DOI 10.1074/mcp.M110.000026; Herman IM, 1993, CURR OPIN CELL BIOL, V5, P48, DOI 10.1016/S0955-0674(05)80007-9; Hirschi KK, 2002, J BIOL CHEM, V277, P6287, DOI 10.1074/jbc.M106649200; Hu L, 2004, ONCOGENE, V23, P298, DOI 10.1038/sj.onc.1206483; Kim H, 2011, HEPATOLOGY, V54, P1707, DOI 10.1002/hep.24559; Lauvrak SU, 2013, BRIT J CANCER, V109, P2228, DOI 10.1038/bjc.2013.549; Lehtonen HJ, 2012, GASTROENTEROLOGY, V143, P1482, DOI 10.1053/j.gastro.2012.08.045; Li H, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-183; Lin ZY, 2012, BIOMED PHARMACOTHER, V66, P454, DOI 10.1016/j.biopha.2012.04.001; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MANTEL N, 1959, J NATL CANCER I, V22, P719; Matsuo N, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-240; Mima K, 2013, ONCOL LETT, V5, P149, DOI 10.3892/ol.2012.954; Mima K, 2012, CANCER RES, V72, P3414, DOI 10.1158/0008-5472.CAN-12-0299; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Parikh JG, 2014, ONCOL LETT, V7, P573, DOI 10.3892/ol.2013.1720; RONCALLI M, 2010, J ITALIAN SOC GAS S3, V42, pS228, DOI DOI 10.1016/S1590-8658(10)60510-5; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Takamura H, 2013, ONCOL REP, V30, P1561, DOI 10.3892/or.2013.2616; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tomasek JJ, 2013, WOUND REPAIR REGEN, V21, P166, DOI 10.1111/wrr.12001; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; Yang XY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0593-9; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zen C, 2011, LIVER TRANSPLANT, V17, P943, DOI 10.1002/lt.22314; Zen Y, 2014, HISTOPATHOLOGY, V64, P671, DOI 10.1111/his.12312	32	16	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130559	10.1371/journal.pone.0130559	http://dx.doi.org/10.1371/journal.pone.0130559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110787	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800063
J	Glaza, P; Osipiuk, J; Wenta, T; Zurawa-Janicka, D; Jarzab, M; Lesner, A; Banecki, B; Skorko-Glonek, J; Joachimiak, A; Lipinska, B				Glaza, Przemyslaw; Osipiuk, Jerzy; Wenta, Tomasz; Zurawa-Janicka, Dorota; Jarzab, Miroslaw; Lesner, Adam; Banecki, Bogdan; Skorko-Glonek, Joanna; Joachimiak, Andrzej; Lipinska, Barbara			Structural and Functional Analysis of Human HtrA3 Protease and Its Subdomains	PLOS ONE			English	Article							HIGH-TEMPERATURE REQUIREMENT; HEAT-SHOCK PROTEASE; FACTOR A3 HTRA3; SERINE-PROTEASE; ESCHERICHIA-COLI; PDZ DOMAINS; OLIGOMERIC STRUCTURE; THERAPEUTIC TARGETS; ENDOMETRIAL CANCER; CRYSTAL-STRUCTURE	Human HtrA3 protease, which induces mitochondria-mediated apoptosis, can be a tumor suppressor and a potential therapeutic target in the treatment of cancer. However, there is little information about its structure and biochemical properties. HtrA3 is composed of an N-terminal domain not required for proteolytic activity, a central serine protease domain and a C-terminal PDZ domain. HtrA3S, its short natural isoform, lacks the PDZ domain which is substituted by a stretch of 7 C-terminal amino acid residues, unique for this isoform. This paper presents the crystal structure of the HtrA3 protease domain together with the PDZ domain (Delta N-HtrA3), showing that the protein forms a trimer whose protease domains are similar to those of human HtrA1 and HtrA2. The Delta N-HtrA3 PDZ domains are placed in a position intermediate between that in the flat saucer-like HtrA1 SAXS structure and the compact pyramidal HtrA2 X-ray structure. The PDZ domain interacts closely with the LB loop of the protease domain in a way not found in other human HtrAs. Delta N-HtrA3 with the PDZ removed (Delta N-HtrA3-Delta PDZ) and an N-terminally truncated HtrA3S (Delta N-HtrA3S) were fully active at a wide range of temperatures and their substrate affinity was not impaired. This indicates that the PDZ domain is dispensable for HtrA3 activity. As determined by size exclusion chromatography, Delta N-HtrA3 formed stable trimers while both Delta N-HtrA3-Delta PDZ and Delta N-HtrA3S were monomeric. This suggests that the presence of the PDZ domain, unlike in HtrA1 and HtrA2, influences HtrA3 trimer formation. The unique C-terminal sequence of Delta N-HtrA3S appeared to have little effect on activity and oligomerization. Additionally, we examined the cleavage specificity of Delta N-HtrA3. Results reported in this paper provide new insights into the structure and function of Delta N-HtrA3, which seems to have a unique combination of features among human HtrA proteases.	[Glaza, Przemyslaw; Wenta, Tomasz; Zurawa-Janicka, Dorota; Jarzab, Miroslaw; Skorko-Glonek, Joanna; Lipinska, Barbara] Univ Gdansk, Fac Biol, Dept Biochem, PL-80308 Gdansk, Poland; [Osipiuk, Jerzy; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom, Argonne, IL 60439 USA; [Osipiuk, Jerzy; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA; [Lesner, Adam] Univ Gdansk, Fac Chem, Dept Biochem, PL-80308 Gdansk, Poland; [Banecki, Bogdan] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Mol & Cellular Biol, PL-80822 Gdansk, Poland; [Banecki, Bogdan] Med Univ Gdansk, PL-80822 Gdansk, Poland	Fahrenheit Universities; University of Gdansk; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk	Lipinska, B (corresponding author), Univ Gdansk, Fac Biol, Dept Biochem, PL-80308 Gdansk, Poland.	barbara.lipinska@biol.ug.edu.pl	Skorko-Glonek, Joanna/AAF-5516-2020; Lipinska, Barbara/ABA-6124-2020; Lesner, Adam/M-2732-2019	Skorko-Glonek, Joanna/0000-0002-8084-5251; Lipinska, Barbara/0000-0001-9510-4811; Glaza, Przemyslaw/0000-0003-3532-1085; Banecki, Bogdan/0000-0003-3286-2388; Zurawa-Janicka, Dorota/0000-0001-5048-2245; Jarzab, Miroslaw/0000-0002-6097-3555; Wenta, Tomasz/0000-0002-1927-9959; Lesner, Adam/0000-0001-8335-3431; Joachimiak, Andrzej/0000-0003-2535-6209	National Institutes of Health [GM094585]; National Science Center (Poland) [UMO-2013/09/B/NZ1/01068]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Center (Poland); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant number GM094585 to A.J. and by the National Science Center (Poland), project grant no. UMO-2013/09/B/NZ1/01068 to B.L. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beleford D, 2010, CLIN CANCER RES, V16, P398, DOI 10.1158/1078-0432.CCR-09-1677; Beleford D, 2010, J BIOL CHEM, V285, P12011, DOI 10.1074/jbc.M109.097790; Bowden MA, 2010, MOL CELL ENDOCRINOL, V327, P13, DOI 10.1016/j.mce.2010.06.001; Bowden MA, 2006, GYNECOL ONCOL, V103, P253, DOI 10.1016/j.ygyno.2006.03.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chien J, 2009, CURR CANCER DRUG TAR, V9, P451, DOI 10.2174/156800909788486704; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dynon K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045956; Eigenbrot C, 2012, STRUCTURE, V20, P1040, DOI 10.1016/j.str.2012.03.021; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Figaj D, 2014, J BIOL CHEM, V289, P15880, DOI 10.1074/jbc.M113.532895; Gorrec F, 2011, ACTA CRYSTALLOGR D, V67, P463, DOI 10.1107/S0907444911008754; GOTTESMAN S, 1981, CELL, V24, P225, DOI 10.1016/0092-8674(81)90518-3; Hansen G, 2013, CELL MOL LIFE SCI, V70, P761, DOI 10.1007/s00018-012-1076-4; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Iwanczyk J, 2007, J BACTERIOL, V189, P3176, DOI 10.1128/JB.01788-06; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Kim S, 2012, P NATL ACAD SCI USA, V109, P7263, DOI 10.1073/pnas.1204791109; Kim S, 2011, CELL, V145, P67, DOI 10.1016/j.cell.2011.02.024; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; Li Y, 2011, J CLIN ENDOCR METAB, V96, P403, DOI 10.1210/jc.2010-1405; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; Martins LM, 2003, J BIOL CHEM, V278, P49417, DOI 10.1074/jbc.M308659200; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; MohamedMohaideen NN, 2008, BIOCHEMISTRY-US, V47, P6092, DOI 10.1021/bi701929m; Nam MK, 2006, EXP MOL MED, V38, P36, DOI 10.1038/emm.2006.5; Narkiewicz J, 2009, ONCOL REP, V21, P1529, DOI 10.3892/or_00000385; Narklewicz J, 2008, CLIN BIOCHEM, V41, P561, DOI 10.1016/j.clinbiochem.2008.01.004; Nie GY, 2006, DEV DYNAM, V235, P3448, DOI 10.1002/dvdy.20999; Nie GY, 2003, MOL HUM REPROD, V9, P279, DOI 10.1093/molehr/gag036; Nie GY, 2006, BIOL REPROD, V74, P366, DOI 10.1095/biolreprod.105.047324; Nie GY, 2003, BIOCHEM J, V371, P39, DOI 10.1042/BJ20021569; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Runyon ST, 2007, PROTEIN SCI, V16, P2454, DOI 10.1110/ps.073049407; Sassoon N, 1999, MOL MICROBIOL, V33, P583, DOI 10.1046/j.1365-2958.1999.01505.x; Singh H, 2010, PLACENTA, V31, P1085, DOI 10.1016/j.placenta.2010.10.003; Singh H, 2012, BIOTECHNIQUES, V52, P23, DOI 10.2144/000113798; Skorko-Glonek J, 2003, BBA-PROTEINS PROTEOM, V1649, P171, DOI 10.1016/S1570-9639(03)00170-5; Skorko-Glonek J, 2013, CURR PHARM DESIGN, V19, P977, DOI 10.2174/1381612811319060003; SKORKOGLONEK J, 1995, J BIOL CHEM, V270, P11140, DOI 10.1074/jbc.270.19.11140; Sohn J, 2007, CELL, V131, P572, DOI 10.1016/j.cell.2007.08.044; Sohn J, 2010, J BIOL CHEM, V285, P34039, DOI 10.1074/jbc.M110.135541; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Than NG, 2008, PLACENTA, V29, pS83, DOI 10.1016/j.placenta.2007.10.008; Tocharus J, 2004, DEV GROWTH DIFFER, V46, P257; Truebestein L, 2011, NAT STRUCT MOL BIOL, V18, P386, DOI 10.1038/nsmb.2013; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Wrase R, 2011, P NATL ACAD SCI USA, V108, P10490, DOI 10.1073/pnas.1101084108; Zhao M, 2014, CANCER INVEST, V32, P464, DOI 10.3109/07357907.2014.958496; Zurawa-Janicka D, 2013, CELL STRESS CHAPERON, V18, P35, DOI 10.1007/s12192-012-0355-1	61	31	33	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131142	10.1371/journal.pone.0131142	http://dx.doi.org/10.1371/journal.pone.0131142			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110759	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800122
J	Hart, AG; Rolfe, RN; Dandy, S; Stubbs, H; MacTavish, D; MacTavish, L; Goodenough, AE				Hart, Adam G.; Rolfe, Richard N.; Dandy, Shantelle; Stubbs, Hannah; MacTavish, Dougal; MacTavish, Lynne; Goodenough, Anne E.			Can Handheld Thermal Imaging Technology Improve Detection of Poachers in African Bushveldt?	PLOS ONE			English	Article							INFRARED THERMOGRAPHY; TRADE; WILDLIFE; MAMMALS	Illegal hunting (poaching) is a global threat to wildlife. Anti-poaching initiatives are making increasing use of technology, such as infrared thermography (IRT), to support traditional foot and vehicle patrols. To date, the effectiveness of IRT for poacher location has not been tested under field conditions, where thermal signatures are often complex. Here, we test the hypothesis that IRT will increase the distance over which a poacher hiding in African scrub bushveldt can be detected relative to a conventional flashlight. We also test whether any increase in effectiveness is related to the cost and complexity of the equipment by comparing comparatively expensive (22000 USD) and relatively inexpensive (2000 USD) IRT devices. To test these hypotheses we employ a controlled, fully randomised, double-blind procedure to find a poacher in nocturnal field conditions in African bushveldt. Each of our 27 volunteer observers walked three times along a pathway using one detection technology on each pass in randomised order. They searched a prescribed search area of bushveldt within which the target was hiding. Hiding locations were pre-determined, randomised, and changed with each pass. Distances of first detection and positive detection were noted. All technologies could be used to detect the target. Average first detection distance for flashlight was 37.3m, improving by 19.8m to 57.1m using LIRT and by a further 11.2m to 68.3m using HIRT. Although detection distances were significantly greater for both IRTs compared to flashlight, there was no significant difference between LIRT and HIRT. False detection rates were low and there was no significant association between technology and accuracy of detection. Although IRT technology should ideally be tested in the specific environment intended before significant investment is made, we conclude that IRT technology is promising for anti-poaching patrols and that for this purpose low cost IRT units are as effective as units ten times more expensive.	[Hart, Adam G.; Rolfe, Richard N.; Dandy, Shantelle; Stubbs, Hannah; Goodenough, Anne E.] Univ Gloucestershire, Sch Nat & Social Sci, Cheltenham, Glos, England; [MacTavish, Dougal; MacTavish, Lynne] Mankwe Wildlife Reserve, Rustenburg, Northwest Provi, South Africa	University of Gloucestershire	Hart, AG (corresponding author), Univ Gloucestershire, Sch Nat & Social Sci, Cheltenham, Glos, England.	ahart@glos.ac.uk		Goodenough, Anne/0000-0002-7662-6670	Mankwe Wildlife Reserve	Mankwe Wildlife Reserve	Co-authors Dougal MacTavish and Lynne MacTavish are employed by Mankwe Wildlife Reserve. Mankwe Wildlife Reserve provided support in the form of salaries for authors DM and LM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allison NL, 2006, WILDLIFE SOC B, V34, P1036, DOI 10.2193/0091-7648(2006)34[1036:EATFNW]2.0.CO;2; Banzi J, 2014, SENSOR BASED ANTIPOA; BOONSTRA R, 1994, J MAMMAL, V75, P1063, DOI 10.2307/1382490; Bowen-Jones E., 2002, ASSESSMENT SOLUTION; Chaber AL, 2010, CONSERV LETT, V3, P317, DOI 10.1111/j.1755-263X.2010.00121.x; Challender DWS, 2014, CONSERV LETT, V7, P484, DOI 10.1111/conl.12082; Drews C, 2001, SOC ANIM, V9, P107, DOI 10.1163/156853001753639233; Dunn WC, 2002, WILDLIFE SOC B, V30, P963; Emslie R., 1999, STATUS SURVEY CONSER; Festus I. A., 2014, Research on Humanities and Social Sciences, V4, P13; Gastrow P., 2001, TRIAD SOC CHINESE OR; Hristov NI, 2008, INTEGR COMP BIOL, V48, P50, DOI 10.1093/icb/icn053; Hutton J, 2002, WILDERNESS ENV MED, V16, P143; Kamins AO, 2011, BIOL CONSERV, V144, P3000, DOI 10.1016/j.biocon.2011.09.003; Kaplan H, 2007, PRACTICAL APPL INFRA, P169; Katuwal Hem Bahadur, 2013, Asian Journal of Conservation Biology, V2, P21; Lee J., 1995, NW J INT LAW BUSINES, V16, P497; Lindsey PA, 2013, BIOL CONSERV, V160, P80, DOI 10.1016/j.biocon.2012.12.020; Mahmood T, 2012, PAK J ZOOL, V44, P1457; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; McCafferty DJ, 1998, J THERM BIOL, V23, P311, DOI 10.1016/S0306-4565(98)00022-9; Mccafferty DJ, 2007, MAMMAL REV, V37, P207, DOI 10.1111/j.1365-2907.2007.00111.x; Mulero-Pazmany M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083873; Nijman V, 2007, CONTRIB ZOOL, V76, P207, DOI 10.1163/18759866-07603007; Philip A, 2013, AERIAL SURVEILLANCE; SADER SA, 1986, REMOTE SENS ENVIRON, V19, P105, DOI 10.1016/0034-4257(86)90064-7; Schaefer AL, 2004, CAN J ANIM SCI, V84, P73, DOI 10.4141/A02-104; Servheen C, 1990, INT C BEAR RES MANAG, V2, P33; Stein AB, 2010, PACHYDERM, P67; Stiles D, 2004, ENVIRON CONSERV, V31, P309, DOI 10.1017/S0376892904001614; Stiles D., 2011, ELEPHANT MEAT TRADE; Sykes DJ, 2012, THERIOGENOLOGY, V78, P147, DOI 10.1016/j.theriogenology.2012.01.030; Wyler L.S., 2008, POLICY, V52	33	8	9	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131584	10.1371/journal.pone.0131584	http://dx.doi.org/10.1371/journal.pone.0131584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110865	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000356933800161
J	Yang, W; Sun, WK; Li, Q; Yao, YW; Lv, TF; Zeng, JL; Liang, WJ; Zhou, XJ; Song, Y				Yang, Wen; Sun, Wenkui; Li, Qian; Yao, Yanwen; Lv, Tangfeng; Zeng, Junli; Liang, Wenjun; Zhou, Xiaojun; Song, Yong			Diagnostic Accuracy of CT-Guided Transthoracic Needle Biopsy for Solitary Pulmonary Nodules	PLOS ONE			English	Article							PERIPHERAL LUNG LESIONS; ELECTROMAGNETIC NAVIGATION BRONCHOSCOPY; METAANALYSIS; PROBABILITY; MANAGEMENT; ULTRASOUND; CANCER	To evaluate the diagnostic accuracy of computed tomography (CT)-guided percutaneous lung biopsy for solitary pulmonary nodules. Three hundred and eleven patients (211 males and 100 females), with a mean age of 59.6 years (range, 19-87 years), who were diagnosed with solitary pulmonary nodules and underwent CT-guided percutaneous transthoracic needle biopsy between January 2008 and January 2014 were reviewed. All patients were confirmed by surgery or the clinical course. The overall diagnostic accuracy and incidence of complications were calculated, and the factors influencing these were statistically evaluated and compared. Specimens were successfully obtained from all 311 patients. A total of 217 and 94 cases were found to be malignant and benign lesions, respectively, by biopsy. Two hundred and twenty-five (72.3%) carcinomas, 78 (25.1%) benign lesions, and 8 (2.6%) inconclusive lesions were confirmed by surgery and the clinical course. The diagnostic accuracy, sensitivity, and specificity of CT-guided percutaneous transthoracic needle biopsy were 92.9%, 95.3%, and 95.7%, respectively. The incidences of pneumothorax and self-limiting bleeding were 17.7% and 11.6%, respectively. Taking account of all evidence, CT-guided percutaneous lung biopsy for solitary pulmonary nodules is an efficient, and safe diagnostic method associated with few complications.	[Yang, Wen; Sun, Wenkui; Li, Qian; Yao, Yanwen; Lv, Tangfeng; Zeng, Junli; Liang, Wenjun; Song, Yong] Nanjing Univ, Jinling Hosp, Sch Med, Dept Resp Med, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Xiaojun] Nanjing Univ, Jinling Hosp, Sch Med, Dept Pathol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Song, Y (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Resp Med, Nanjing 210008, Jiangsu, Peoples R China.	yong_song6310@yahoo.com			National Natural Scientific Foundation of 257 China [81302032]	National Natural Scientific Foundation of 257 China	The present study was supported by the National Natural Scientific Foundation of 257 China (no. 81302032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eberhardt R, 2009, EUR RESPIR J, V34, P1284, DOI 10.1183/09031936.00166708; Eberhardt R, 2007, CHEST, V131, P1800, DOI 10.1378/chest.06-3016; Gex G, 2014, RESPIRATION, V87, P165, DOI 10.1159/000355710; Gould MK, 2007, CHEST, V131, P383, DOI 10.1378/chest.06-1261; HAAGA JR, 1976, RADIOLOGY, V118, P603, DOI 10.1148/118.3.603; Lamprecht B, 2009, LUNG, V187, P55, DOI 10.1007/s00408-008-9120-8; Makris D, 2007, EUR RESPIR J, V29, P1187, DOI 10.1183/09031936.00165306; McNulty W, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2759; Ost D, 2000, AM J RESP CRIT CARE, V162, P782, DOI 10.1164/ajrccm.162.3.9812152; Ost D, 2003, NEW ENGL J MED, V348, P2535, DOI 10.1056/NEJMcp012290; Steinfort DP, 2011, EUR RESPIR J, V37, P902, DOI 10.1183/09031936.00075310; Swensen SJ, 1997, ARCH INTERN MED, V157, P849, DOI 10.1001/archinte.157.8.849; Wahidi MM, 2007, CHEST, V132, p94S, DOI DOI 10.1378/CHEST.07-1352; Yeow KM, 2001, J VASC INTERV RADIOL, V12, P1305, DOI 10.1016/S1051-0443(07)61556-5; Yoshikawa M, 2007, CHEST, V131, P1788, DOI 10.1378/chest.06-2506; Zhan P, 2013, J THORAC DIS, V5, P824, DOI 10.3978/j.issn.2072-1439.2013.12.13	16	54	65	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131373	10.1371/journal.pone.0131373	http://dx.doi.org/10.1371/journal.pone.0131373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110775	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800147
J	Zhuang, Y; Zhou, FQ; Gong, HH				Zhuang, Ying; Zhou, Fuqing; Gong, Honghan.			Intrinsic Functional Plasticity of the Sensorimotor Network in Relapsing-Remitting Multiple Sclerosis: Evidence from a Centrality Analysis	PLOS ONE			English	Article							CENTRAL MOTOR PLASTICITY; BRAIN ATROPHY; AXONAL INJURY; CONNECTIVITY; REORGANIZATION; RECOVERY; CORTEX; PATHOLOGY; DAMAGE; HAND	Background and Purpose Advanced MRI studies have revealed regional alterations in the sensorimotor cortex of patients with relapsing-remitting multiple sclerosis (RRMS). However, the organizational features underlying the relapsing phase and the subsequent remitting phase have not been directly shown at the functional network or the connectome level. Therefore, this study aimed to characterize MS-related centrality disturbances of the sensorimotor network (SMN) and to assess network integrity and connectedness. Methods Thirty-four patients with clinically definite RRMS and well-matched healthy controls participated in the study. Twenty-three patients in the remitting phase underwent one resting-state functional MRI, and 11 patients in the relapsing-remitting phase underwent two different MRIs. We measured voxel-wise centrality metrics to determine direct (degree centrality, DC) and global (eigenvector centrality, EC) functional relationships across the entire SMN. Results In the relapsing phase, DC was significantly decreased in the bilateral primary motor and somatosensory cortex (M1/S1), left dorsal premotor (PMd), and operculum-integrated regions. However, DC was increased in the peripheral SMN areas. The decrease in DC in the bilateral M1/S1 was associated with the expanded disability status scale (EDSS) and total white matter lesion loads (TWMLLs), suggesting that this adaptive response is related to the extent of brain damage in the rapid-onset attack stage. During the remission process, these alterations in centrality were restored in the bilateral M1/S1 and peripheral SMN areas. In the remitting phase, DC was reduced in the premotor, supplementary motor, and operculum-integrated regions, reflecting an adaptive response due to brain atrophy. However, DC was enhanced in the right M1 and left parietal-integrated regions, indicating chronic reorganization. In both the relapsing and remitting phases, the changes in EC and DC were similar. Conclusions The alterations in centrality within the SMN indicate rapid plasticity and chronic reorganization with a biased impairment of specific functional areas in RRMS patients.	[Zhuang, Ying; Zhou, Fuqing; Gong, Honghan.] Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang, Jiangxi, Peoples R China; [Zhuang, Ying] Second Hosp Nanchang, Dept Oncol, Nanchang, Jiangxi, Peoples R China; [Zhou, Fuqing; Gong, Honghan.] Jiangxi Prov Med Imaging Res Inst, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University	Zhou, FQ (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang, Jiangxi, Peoples R China.	fq.chou@yahoo.com			National Science Foundation of China [81101041, 81260217]; Natural Science Foundation of Jiangxi, China [2013BAB215008]; Science and Technology Project of Jiangxi Provincial Education Department, China [GJJ13136]; "Gan Po" engineering excellence 555 project of Jiangxi Province	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi, China(Natural Science Foundation of Jiangxi Province); Science and Technology Project of Jiangxi Provincial Education Department, China; "Gan Po" engineering excellence 555 project of Jiangxi Province	This study was supported by the National Science Foundation of China (Grant no. 81101041, 81260217), the Natural Science Foundation of Jiangxi, China (Grant no. 2013BAB215008), the Science and Technology Project of Jiangxi Provincial Education Department, China (Grant no. GJJ13136), and "Gan Po" engineering excellence 555 project of Jiangxi Province. The funders have not role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiez C, 2014, CEREB CORTEX, V24, P563, DOI 10.1093/cercor/bhs329; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bermel RA, 2006, LANCET NEUROL, V5, P158, DOI 10.1016/S1474-4422(06)70349-0; Bodini B, 2011, J NEUROL NEUROSUR PS, V82, P72, DOI 10.1136/jnnp.2009.201574; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Cheng Q, 2009, MULT SCLER J, V15, P655, DOI 10.1177/1352458509102921; Codeca C, 2010, MULT SCLER J, V16, P1308, DOI 10.1177/1352458510376957; Cuypers K, 2013, NEUROSCIENCE, V250, P1, DOI 10.1016/j.neuroscience.2013.06.046; Dogonowski AM, 2014, NEUROIMAGE-CLIN, V4, P130, DOI 10.1016/j.nicl.2013.11.005; Dutta R, 2014, CURR OPIN NEUROL, V27, P271, DOI 10.1097/WCO.0000000000000094; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Filippi M, 2012, LANCET NEUROL, V11, P349, DOI 10.1016/S1474-4422(12)70003-0; Fox RJ, 2011, AM J NEURORADIOL, V32, P85, DOI 10.3174/ajnr.A2238; Geurts JJG, 2008, LANCET NEUROL, V7, P841, DOI 10.1016/S1474-4422(08)70191-1; Giorgio A, 2010, MULT SCLER J, V16, P1326, DOI 10.1177/1352458510377333; Hawellek DJ, 2011, P NATL ACAD SCI USA, V108, P19066, DOI 10.1073/pnas.1110024108; Hou JM, 2014, J PSYCHIATR NEUROSCI, V39, P304, DOI 10.1503/jpn.130220; Hurwitz BJ, 2009, ANN INDIAN ACAD NEUR, V12, P226, DOI 10.4103/0972-2327.58276; Lassmann H, 2013, J NEUROL SCI, V333, P1, DOI 10.1016/j.jns.2013.05.010; Lee M, 2000, ANN NEUROL, V47, P606, DOI 10.1002/1531-8249(200005)47:5<606::AID-ANA8>3.3.CO;2-C; Lyksborg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095540; Mancini L, 2009, NEUROIMAGE, V45, P500, DOI 10.1016/j.neuroimage.2008.12.006; Mazzola L, 2012, NEUROIMAGE, V60, P409, DOI 10.1016/j.neuroimage.2011.12.072; Mezzapesa DM, 2008, HUM BRAIN MAPP, V29, P562, DOI 10.1002/hbm.20418; Mori F, 2014, MULT SCLER J, V20, P451, DOI 10.1177/1352458513512541; Pantano P, 2002, BRAIN, V125, P1607, DOI 10.1093/brain/awf164; Pantano P, 2011, MULT SCLER J, V17, P1177, DOI 10.1177/1352458511411757; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Reddy H, 2000, BRAIN, V123, P2314, DOI 10.1093/brain/123.11.2314; Reddy H, 2000, NEUROLOGY, V54, P236, DOI 10.1212/WNL.54.1.236; Rocca MA, 2007, NEUROLOGY, V69, P2136, DOI 10.1212/01.wnl.0000295504.92020.ca; Rocca MA, 2014, BRAIN STRUCT FUNC; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Schoonheim MM, 2014, MULT SCLER J, V20, P1058, DOI 10.1177/1352458513516892; Sepulcre J, 2014, NEUROSCIENTIST, V20, P499, DOI 10.1177/1073858414531657; Tedeschi G, 2005, NEUROLOGY, V65, P280, DOI 10.1212/01.wnl.0000168837.87351.1f; Tomassini V, 2012, NEUROREHAB NEURAL RE, V26, P581, DOI 10.1177/1545968311433208; Valsasina P, 2011, EUR J NEUROSCI, V33, P1256, DOI 10.1111/j.1460-9568.2011.07623.x; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wang J, 2007, NEUROL RES, V29, P3, DOI 10.1179/174313206X153833; Wang LF, 2014, HUM BRAIN MAPP, V35, P1154, DOI 10.1002/hbm.22241; Wink AM, 2012, BRAIN CONNECT, V2, P265, DOI 10.1089/brain.2012.0087; Yan CG, 2013, NEUROIMAGE, V80, P246, DOI 10.1016/j.neuroimage.2013.04.081; Zeller D, 2014, NEUROSCIENCE, V283, P222, DOI 10.1016/j.neuroscience.2014.05.043; Zeller D, 2010, NEUROLOGY, V74, P728, DOI 10.1212/WNL.0b013e3181d31dcf; Zeller D, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-92; Zhou FQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09975; Zhou FQ, 2014, CLIN IMAG, V38, P605, DOI 10.1016/j.clinimag.2014.05.006; Zhou FQ, 2013, NEUROREPORT, V24, P657, DOI 10.1097/WNR.0b013e328363148c; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	50	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130524	10.1371/journal.pone.0130524	http://dx.doi.org/10.1371/journal.pone.0130524			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110420	gold, Green Published, Green Submitted			2022-12-27	WOS:000356933800058
J	Michel, AL; Geoghegan, C; Hlokwe, T; Raseleka, K; Getz, WM; Marcotty, T				Michel, Anita L.; Geoghegan, Claire; Hlokwe, Tiny; Raseleka, Keneilwe; Getz, Wayne M.; Marcotty, Tanguy			Longevity of Mycobacterium bovis in Raw and Traditional Souring Milk as a Function of Storage Temperature and Dose	PLOS ONE			English	Article							NONTUBERCULOUS MYCOBACTERIA; TUBERCULOSIS; EPIDEMIOLOGY; SAMPLES; REGION; PCR	Background Unpasteurised fresh and souring dairy products form an essential component of household diets throughout many rural communities in southern Africa. The presence of milk-borne zoonotic pathogens such as Mycobacterium bovis (M. bovis), the causative agent of bovine tuberculosis and zoonotic tuberculosis in humans, constitute a public health threat, especially in remote areas with poor disease surveillance in livestock and highly compromised human health due to HIV/AIDS. Methods In this study we used culture to determine the longevity of M. bovis in experimentally inoculated fresh and naturally souring milk obtained from communal cattle in the KwaZulu-Natal province of South Africa. The effect of bacterial load and storage temperature on the survival of M. bovis was evaluated by spiking mixtures of fresh milk and starter soured milk (aMasi) culture with three concentrations of bacteria (10(2), 10(4), 10(7) colony forming units/ml), followed by incubation under controlled laboratory conditions that mimicked ambient indoor (20 degrees C) and outdoor (33 degrees C) temperatures and periodic sampling and testing over time (0-56 days). Results M. bovis cultured from samples of the fresh and souring milk was identified by PCR analysis. At the highest spiking concentration (10(7) cfu/ml), M. bovis survived for at least 2 weeks at 20 degrees C; but, at all concentrations in the 33 degrees C treatment, M. bovis was absent by three days after inoculation. Logistic regression analysis was used to assess the effects of bacterial concentration and time since inoculation, as well as determine the potential half-life of M. bovis in raw souring milk. Given the most favourable tested conditions for bacterial survival (20 degrees C), approximately 25% of mycobacteria were alive after one day of storage (95% CI: 953%), giving an estimated half-life of M. bovis in raw souring milk of approximately 12 hours (95% CI: 7-27 hours). Conclusions This study demonstrates that M. bovis may survive in fresh and souring milk for periods of time that represent a risk of exposure to people consuming these products, as well as domestic or wild animal populations that have reported opportunities to consume home-made unpasteurised dairy products. The temperature at which the milk is soured and stored substantially affects the survival time of M. bovis.	[Michel, Anita L.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0110 Onderstepoort, South Africa; [Geoghegan, Claire] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Michel, Anita L.; Hlokwe, Tiny; Raseleka, Keneilwe] Onderstepoort Vet Inst, ARC, Zoonot Dis Sect, Onderstepoort, South Africa; [Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Getz, Wayne M.] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa; [Marcotty, Tanguy] Inst Trop Med, B-2000 Antwerp, Belgium	University of Pretoria; University of Pretoria; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; University of California System; University of California Berkeley; University of Kwazulu Natal; Institute of Tropical Medicine (ITM)	Michel, AL (corresponding author), Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0110 Onderstepoort, South Africa.	anita.michel@up.ac.za	Michel, Anita/N-8996-2014; Getz, Wayne/I-4521-2013	Michel, Anita/0000-0001-9240-2653; Getz, Wayne/0000-0001-8784-9354	Department of Veterinary Tropical Diseases, Faculty of Veterinary Science of the University of Pretoria; Institute of Tropical Medicine, Antwerp, Belgium; ARC-Onderstepoort Veterinary Institute; NSF [DEB-0090323]	Department of Veterinary Tropical Diseases, Faculty of Veterinary Science of the University of Pretoria; Institute of Tropical Medicine, Antwerp, Belgium; ARC-Onderstepoort Veterinary Institute; NSF(National Science Foundation (NSF))	This project was funded by the Department of Veterinary Tropical Diseases, Faculty of Veterinary Science of the University of Pretoria with the support of the Institute of Tropical Medicine, Antwerp, Belgium. Additional funds were contributed by the ARC-Onderstepoort Veterinary Institute and the NSF Grant DEB-0090323 to WMG.	Ashford DA, 2001, REV SCI TECH OIE, V20, P325, DOI 10.20506/rst.20.1.1266; Aydin FE, 2012, MIKROBIYOL BUL, V46, P283; Ben Kahla I, 2011, AFR HEALTH SCI, V11, pS2; Centers for Disease Control and Prevention, 2009, BIOS MICR BIOM LAB, P145; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; DORMER B. A., 1953, S AFRICAN MED JOUR, V27, P1121; Firdessa R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052851; Gcebe N, 2013, TRANSBOUND EMERG DIS, V60, P74, DOI 10.1111/tbed.12133; Geoghegan C, 2013, 14 INT C ASS I TROP, P24; Hlokwe TM, 2014, PREV VET MED, V115, P10, DOI 10.1016/j.prevetmed.2014.03.011; Zumarraga MJ, 2012, FOODBORNE PATHOG DIS, V9, P132, DOI 10.1089/fpd.2011.0963; Franco MMJ, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-85; Kleeberg H H, 1984, Rev Sci Tech, V3, P11, DOI 10.20506/rst.3.1.156; Mapekula M, 2010, TROP ANIM HEALTH PRO, V42, P1413, DOI 10.1007/s11250-010-9575-5; Mariam SH, 2014, BMC RES NOTES, V7; MATTICK ATR, 1946, LANCET, V250, P417; Michel AL, 2006, VET MICROBIOL, V112, P91, DOI 10.1016/j.vetmic.2005.11.035; Moiane I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091527; Ndambi OA, 2007, LIVESTOCK RES RURAL, V19; Oloya J, 2008, EPIDEMIOL INFECT, V136, P636, DOI 10.1017/S0950268807009004; OREILLY LM, 1995, TUBERCLE LUNG DIS, V76, P1, DOI 10.1016/0962-8479(95)90591-X; Roug A, 2014, PREV VET MED, V115, P157, DOI 10.1016/j.prevetmed.2014.04.014; Skuce RA, 2012, VET MED INT, P1, DOI [10.1155/2012/621210, DOI 10.1155/2012/621210]; Warren RM, 2006, INT J TUBERC LUNG D, V10, P818; Zarden CFO, 2013, VET REC, V172, P130, DOI 10.1136/vr.101054	25	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0129926	10.1371/journal.pone.0129926	http://dx.doi.org/10.1371/journal.pone.0129926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121261	Green Published, gold			2022-12-27	WOS:000358150400029
J	Abazari, A; Meimetis, LG; Budin, G; Bale, SS; Weissleder, R; Toner, M				Abazari, Alireza; Meimetis, Labros G.; Budin, Ghyslain; Bale, Shyam Sundhar; Weissleder, Ralph; Toner, Mehmet			Engineered Trehalose Permeable to Mammalian Cells	PLOS ONE			English	Article							RED-BLOOD-CELLS; INTRACELLULAR TREHALOSE; DESICCATION TOLERANCE; PHASE-SEPARATION; PRESERVATION; PROTECTION; LIPOSOMES; ACCUMULATION; MITOCHONDRIA; DEHYDRATION	Trehalose is a naturally occurring disaccharide which is associated with extraordinary stress-tolerance capacity in certain species of unicellular and multicellular organisms. In mammalian cells, presence of intra- and extracellular trehalose has been shown to confer improved tolerance against freezing and desiccation. Since mammalian cells do not synthesize nor import trehalose, the development of novel methods for efficient intracellular delivery of trehalose has been an ongoing investigation. Herein, we studied the membrane permeability of engineered lipophilic derivatives of trehalose. Trehalose conjugated with 6 acetyl groups (trehalose hexaacetate or 6-O-Ac-Tre) demonstrated superior permeability in rat hepatocytes compared with regular trehalose, trehalose diacetate (2-O-Ac-Tre) and trehalose tetraacetate (4-O-Ac-Tre). Once in the cell, intracellular esterases hydrolyzed the 6-O-Ac-Tre molecules, releasing free trehalose into the cytoplasm. The total concentration of intracellular trehalose (plus acetylated variants) reached as high as 10 fold the extracellular concentration of 6-O-Ac-Tre, attaining concentrations suitable for applications in biopreservation. To describe this accumulation phenomenon, a diffusion-reaction model was proposed and the permeability and reaction kinetics of 6-O-Ac-Tre were determined by fitting to experimental data. Further studies suggested that the impact of the loading and the presence of intracellular trehalose on cellular viability and function were negligible. Engineering of trehalose chemical structure rather than manipulating the cell, is an innocuous, cell-friendly method for trehalose delivery, with demonstrated potential for trehalose loading in different types of cells and cell lines, and can facilitate the wide-spread application of trehalose as an intracellular protective agent in biopreservation studies.	[Abazari, Alireza; Bale, Shyam Sundhar; Toner, Mehmet] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Ctr Engn Med, Boston, MA 02114 USA; [Abazari, Alireza; Bale, Shyam Sundhar; Toner, Mehmet] Shriners Hosp Children, Boston, MA USA; [Meimetis, Labros G.; Budin, Ghyslain; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Meimetis, Labros G.; Budin, Ghyslain; Weissleder, Ralph] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Toner, M (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Ctr Engn Med, Boston, MA 02114 USA.	mtoner@hms.harvard.edu	Budin, Ghyslain/AAJ-8688-2020	/0000-0003-0828-4143	Natural Sciences and Engineering Research Council (NSERC) of Canada; NIH [2 R01 DK046270-14A1, R01 EB010011.]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046270] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD016985] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Alireza Abazari held a Postdoctoral Fellowship from The Natural Sciences and Engineering Research Council (NSERC) of Canada. This research was also funded by NIH grants 2 R01 DK046270-14A1 and R01 EB010011.	Aksan A, 2004, LANGMUIR, V20, P5521, DOI 10.1021/la0355186; Albertorio F, 2007, LANGMUIR, P10567; Beattie GM, 1997, DIABETES, V46, P519, DOI 10.2337/diabetes.46.3.519; BREEUWER P, 1995, APPL ENVIRON MICROB, V61, P1614, DOI 10.1128/AEM.61.4.1614-1619.1995; Chen T, 2001, CRYOBIOLOGY, V43, P168, DOI 10.1006/cryo.2001.2360; CROWE JH, 1988, BIOCHIM BIOPHYS ACTA, V939, P327, DOI 10.1016/0005-2736(88)90077-6; CROWE JH, 1984, SCIENCE, V223, P701, DOI 10.1126/science.223.4637.701; Crowe JH, 2005, INTEGR COMP BIOL, V45, P810, DOI 10.1093/icb/45.5.810; Crowe JH, 2000, NAT BIOTECHNOL, V18, P145, DOI 10.1038/72580; Crowe LM, 1996, BIOPHYS J, V71, P2087, DOI 10.1016/S0006-3495(96)79407-9; CROWE LM, 1985, ARCH BIOCHEM BIOPHYS, V242, P240, DOI 10.1016/0003-9861(85)90498-9; Elliott GD, 2006, CRYOBIOLOGY, V52, P114, DOI 10.1016/j.cryobiol.2005.10.009; Eroglu A, 2003, CRYOBIOLOGY, V46, P121, DOI 10.1016/S0011-2240(03)00018-X; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Eroglu A, 2002, FERTIL STERIL, V77, P152, DOI 10.1016/S0015-0282(01)02959-4; Gordon SL, 2001, CRYOBIOLOGY, V43, P182, DOI 10.1006/cryo.2001.2361; Guo N, 2000, NAT BIOTECHNOL, V18, P168, DOI 10.1038/72616; Heller MC, 1999, BIOTECHNOL BIOENG, V63, P166, DOI 10.1002/(SICI)1097-0290(19990420)63:2<166::AID-BIT5>3.0.CO;2-H; Hincha DK, 2008, EUR BIOPHYS J BIOPHY, V37, P503, DOI 10.1007/s00249-007-0245-0; Holovati JL, 2009, CRYOBIOLOGY, V58, P75, DOI 10.1016/j.cryobiol.2008.11.002; Jamil K., 2005, CELL PRESERV TECHNOL, V3, P244, DOI DOI 10.1089/CPT.2005.3.244; Kikawada T, 2007, P NATL ACAD SCI USA, V104, P11585, DOI 10.1073/pnas.0702538104; Li S, 2012, P NATL ACAD SCI USA, V109, P20859, DOI 10.1073/pnas.1214893109; Lynch AL, 2011, BIOMATERIALS, V32, P4443, DOI 10.1016/j.biomaterials.2011.02.062; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Puhlev I, 2001, CRYOBIOLOGY, V42, P207, DOI 10.1006/cryo.2001.2324; Ross MF, 2008, BIOCHEM J, V411, P633, DOI 10.1042/BJ20080063; Ross MF, 2006, BIOCHEM J, V400, P199, DOI 10.1042/BJ20060919; Russo MJ, 1997, NAT BIOTECHNOL, V15, P278, DOI 10.1038/nbt0397-278; Satpathy GR, 2004, CRYOBIOLOGY, V49, P123, DOI 10.1016/j.cryobiol.2004.06.001; Sharp DMC, 2013, CRYOBIOLOGY, V67, P305, DOI 10.1016/j.cryobiol.2013.09.002; Shimizu T, 2010, BIOCHEMISTRY-US, V49, P1093, DOI 10.1021/bi901745f; Shirakashi R, 2002, J MEMBRANE BIOL, V189, P45, DOI 10.1007/s00232-002-1003-y; Sun WQ, 1998, BBA-GEN SUBJECTS, V1425, P235, DOI 10.1016/S0304-4165(98)00076-2; Wolkers WF, 2004, BBA-BIOMEMBRANES, V1661, P125, DOI 10.1016/j.bbamem.2003.12.006; Wolkers WF, 2003, BBA-BIOMEMBRANES, V1612, P154, DOI 10.1016/S0005-2736(03)00114-7; Wolkers WF, 2001, CRYOBIOLOGY, V42, P79, DOI 10.1006/cryo.2001.2306	37	41	44	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130323	10.1371/journal.pone.0130323	http://dx.doi.org/10.1371/journal.pone.0130323			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115179	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500066
J	Jakobsson, ME; Davydova, E; Malecki, J; Moen, A; Falnes, PO				Jakobsson, Magnus E.; Davydova, Erna; Malecki, Jedrzej; Moen, Anders; Falnes, Pal O.			Saccharomyces cerevisiae Eukaryotic Elongation Factor 1A (eEF1A) Is Methylated at Lys-390 by a METTL21-Like Methyltransferase	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; DIRECTED MUTAGENESIS; STRUCTURE PREDICTION; ACTIN CYTOSKELETON; LYSINE METHYLATION; TRYPTIC HYDROLYSIS; PROTEIN-SYNTHESIS; YEAST EEF1A; TRANSLATION; SET	The human methyltransferases (MTases) METTL21A and VCP-KMT (METTL21D) were recently shown to methylate single lysine residues in Hsp70 proteins and in VCP, respectively. The yet uncharacterized MTase encoded by the YNL024C gene in Saccharomyces cerevisiae shows high sequence similarity to METTL21A and VCP-KMT, as well as to their uncharacterized paralogues METTL21B and METTL21C. Despite being most similar to METTL21A, the Ynl024c protein does not methylate yeast Hsp70 proteins, which were found to be unmethylated on the relevant lysine residue. Eukaryotic translation elongation factor eEF1A in yeast has been reported to contain four methylated lysine residues (Lys30, Lys79, Lys318 and Lys390), and we here show that the YNL024C gene is required for methylation of eEF1A at Lys390, the only of these methylations for which the responsible MTase has not yet been identified. Lys390 was found in a partially monomethylated state in wildtype yeast cells but was exclusively unmethylated in a ynl024c Delta strain, and over-expression of Ynl024c caused a dramatic increase in Lys390 methylation, with trimethylation becoming the predominant state. Our results demonstrate that Ynl024c is the enzyme responsible for methylation of eEF1A at Lys390, and in accordance with prior naming of similar enzymes, we suggest that Ynl024c is renamed to Efm6 (Elongation factor MTase 6).	[Jakobsson, Magnus E.; Davydova, Erna; Malecki, Jedrzej; Moen, Anders; Falnes, Pal O.] Univ Oslo, Fac Math & Nat Sci, Dept Biosci, N-0316 Oslo, Norway	University of Oslo	Jakobsson, ME (corresponding author), Univ Oslo, Fac Math & Nat Sci, Dept Biosci, N-0316 Oslo, Norway.	magnus.jakobsson@ibv.uio.no; pal.falnes@ibv.uio.no	Falnes, Pål Ø./AAA-4581-2020	Malecki, Jedrzej/0000-0003-0825-7962; Falnes, Pal/0000-0001-8114-6025; Davydova, Erna/0000-0001-7072-4539	Norwegian Cancer Society and the Research Council of Norway	Norwegian Cancer Society and the Research Council of Norway(Research Council of Norway)	Research performed in the Falnes lab is supported by the University of Oslo and by grants from the Norwegian Cancer Society and the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; Aravind L, 2011, PROG MOL BIOL TRANSL, V101, P105, DOI 10.1016/B978-0-12-387685-0.00004-4; Cavallius J, 1997, BBA-GENE STRUCT EXPR, V1350, P345, DOI 10.1016/S0167-4781(96)00181-9; Cavallius J, 1998, J BIOL CHEM, V273, P28752, DOI 10.1074/jbc.273.44.28752; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Couttas TA, 2012, PROTEOMICS, V12, P960, DOI 10.1002/pmic.201100570; Davydova E, 2014, J BIOL CHEM, V289, P30499, DOI 10.1074/jbc.M114.601658; Del Rizzo PA, 2011, EPIGENETICS-US, V6, P1059, DOI 10.4161/epi.6.9.16069; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Dzialo MC, 2014, BIOCHEM BIOPH RES CO, V455, P382, DOI 10.1016/j.bbrc.2014.11.022; Dzialo MC, 2014, J BIOL CHEM, V289, P30511, DOI 10.1074/jbc.M114.605527; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; FONZI WA, 1985, MOL CELL BIOL, V5, P1100, DOI 10.1128/MCB.5.5.1100; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; Hart-Smith G, 2014, J PROTEOME RES, V13, P1744, DOI 10.1021/pr401251k; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; JOYS TM, 1979, BIOCHIM BIOPHYS ACTA, V581, P360, DOI 10.1016/0005-2795(79)90256-3; Kaul G, 2011, CELL BIOCHEM FUNCT, V29, P227, DOI 10.1002/cbf.1740; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; Lipson RS, 2010, ARCH BIOCHEM BIOPHYS, V500, P137, DOI 10.1016/j.abb.2010.05.023; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; Malecki J, 2015, J BIOL CHEM, V290, P423, DOI 10.1074/jbc.M114.614115; Moore K. E., 2014, BIOCH BIOPHYS ACTA; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; PONCZ L, 1983, J BIOL CHEM, V258, P1844; Porras-Yakushi TR, 2006, J BIOL CHEM, V281, P35835, DOI 10.1074/jbc.M606578200; Rhein VF, 2014, J BIOL CHEM, V289, P24640, DOI 10.1074/jbc.M114.580464; Sanderson LE, 2007, J MOL BIOL, V368, P119, DOI 10.1016/j.jmb.2007.01.075; Sanges C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.16; Sasikumar AN, 2012, WIRES RNA, V3, P543, DOI 10.1002/wrna.1118; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Shimazu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105394; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; von der Haar T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001078; WANG C, 1984, BIOCHEM BIOPH RES CO, V119, P735, DOI 10.1016/S0006-291X(84)80312-5; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Webb KJ, 2011, J BIOL CHEM, V286, P18405, DOI 10.1074/jbc.M110.200410; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787; Zhang LL, 2014, BIOCHEM BIOPH RES CO, V451, P229, DOI 10.1016/j.bbrc.2014.07.110	52	28	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131426	10.1371/journal.pone.0131426	http://dx.doi.org/10.1371/journal.pone.0131426			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115316	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500158
J	Mukaide, T; Iida, A; Watanabe, M; Takada, K; Noma, T				Mukaide, Taihei; Iida, Atsuo; Watanabe, Masatoshi; Takada, Kazuhiro; Noma, Takashi			Quantitative Mass Density Image Reconstructed from the Complex X-Ray Refractive Index	PLOS ONE			English	Article							CONTRAST; TOMOGRAPHY	We demonstrate a new analytical X-ray computed tomography technique for visualizing and quantifying the mass density of materials comprised of low atomic number elements with unknown atomic ratios. The mass density was obtained from the experimentally observed ratio of the imaginary and real parts of the complex X-ray refractive index. An empirical linear relationship between the X-ray mass attenuation coefficient of the materials and X-ray energy was found for X-ray energies between 8 keV and 30 keV. The mass density image of two polymer fibers was quantified using the proposed technique using a scanning-type X-ray microbeam computed tomography system equipped with a wedge absorber. The reconstructed mass density agrees well with the calculated one.	[Mukaide, Taihei; Watanabe, Masatoshi; Takada, Kazuhiro; Noma, Takashi] Canon Inc, Nanomat R&D Ctr, Ohta ku, Tokyo, Japan; [Iida, Atsuo] High Energy Accelerator Res Org, Inst Mat Struct Sci, Photon Factory, Tsukuba, Ibaraki, Japan	Canon Incorporated; High Energy Accelerator Research Organization (KEK)	Mukaide, T (corresponding author), Canon Inc, Nanomat R&D Ctr, Ohta ku, Tokyo, Japan.	mukadie.taihei@canon.co.jp			Canon Inc.	Canon Inc.	This study was supported by Canon Inc. The funder did not have any additional roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels M., 2012, OPT NANOSCOPY, V1, P10, DOI DOI 10.1186/2192-2853-1-10; Chantler C. T., 2005, XRAY FORM FACTOR ATT; Chapman HN, 2010, NAT PHOTONICS, V4, P833, DOI 10.1038/nphoton.2010.240; CHO ZH, 1975, PHYS MED BIOL, V20, P879, DOI 10.1088/0031-9155/20/6/001; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; Diaz A, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.020104; Dierolf M, 2010, NATURE, V467, P436, DOI 10.1038/nature09419; Fitzgerald R, 2000, PHYS TODAY, V53, P23, DOI 10.1063/1.1292471; Guinier A., 1994, XRAY DIFFRACTION CRY; JACKSON DF, 1981, PHYS REP, V70, P169, DOI 10.1016/0370-1573(81)90014-4; Kagoshima Y, 2004, JPN J APPL PHYS 2, V43, pL1449, DOI 10.1143/JJAP.43.L1449; Kak A.V., 1988, PRINCIPLES COMPUTERI, DOI DOI 10.1137/1.9780898719277.CH7; Kaulich B, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/8/083002; KIRKPATRICK P, 1948, J OPT SOC AM, V38, P766, DOI 10.1364/JOSA.38.000766; Langer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035691; Mark J. E., 2007, PHYS PROPERTIES POLY; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Mukaide T, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3565171; Mukaide T, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3095440; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Takano H, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.040204; Takeuchi A, 2013, J SYNCHROTRON RADIAT, V20, P793, DOI 10.1107/S0909049513018876; Takeya S, 2012, J SYNCHROTRON RADIAT, V19, P1038, DOI 10.1107/S0909049512033857; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Zanette I, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.248102	26	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131401	10.1371/journal.pone.0131401	http://dx.doi.org/10.1371/journal.pone.0131401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114770	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500153
J	Srinivasjois, R; Slimings, C; Einarsdottir, K; Burgner, D; Leonard, H				Srinivasjois, Ravisha; Slimings, Claudia; Einarsdottir, Kristjana; Burgner, David; Leonard, Helen			Association of Gestational Age at Birth with Reasons for Subsequent Hospitalisation: 18 Years of Follow-Up in a Western Australian Population Study	PLOS ONE			English	Article							PRETERM INFANTS; 1ST YEAR; MODERATE PRETERM; HEALTH-SERVICES; WEIGHT INFANTS; OTITIS-MEDIA; REHOSPITALIZATION; CHILDREN; MORBIDITY; LIFE	Background Preterm infants are at a higher risk of hospitalisation following discharge from the hospital after birth. The reasons for rehospitalisation and the association with gestational age are not well understood. Methods This was a retrospective birth cohort study of all live, singleton infants born in Western Australia between 1st January 1980 and 31st December 2010, followed to 18 years of age. Risks of rehospitalisation following birth discharge by principal diagnoses were compared for gestational age categories (< 32, 32-33, 34-36, 37-38 weeks) and term births (39-41weeks). Causes of hospitalisations at various gestational age categories were identified using ICD-based discharge diagnostic codes. Results Risk of rehospitalisation was inversely correlated with gestational age. Growth-related concerns were the main causes for rehospitalisation in the neonatal period (< 1 month of age) for all gestational ages. Infection was the most common reason for hospitalisation from 29 days to 1 year of age, and up to 5 years of age. Injury-related hospitalisations increased in prevalence from 5 years to 18 years of age. Risk of rehospitalisation was higher for all preterm infants for most causes. Conclusions The highest risks of rehospitalisation were for infection related causes for most GA categories. Compared with full term born infants, those born at shorter GA remain vulnerable to subsequent hospitalisation for a variety of causes up until 18 years of age.	[Srinivasjois, Ravisha] Univ Western Australia, Dept Paediat, Perth, WA 6027, Australia; [Slimings, Claudia; Einarsdottir, Kristjana] Univ Western Australia, Telethon Kids Inst, Perth, WA 6008, Australia; [Burgner, David] Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Burgner, David] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Burgner, David] Monash Univ, Dept Paediat, Clayton, Vic 3168, Australia	University of Western Australia; Telethon Kids Institute; University of Western Australia; Murdoch Children's Research Institute; University of Melbourne; Monash University	Leonard, H (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA 6008, Australia.	helen.leonard@telethonkids.org.au	Slimings, Claudia/AAE-6550-2019; Einarsdóttir, Kristjana/E-8337-2011; Leonard, Helen/A-1010-2013	Slimings, Claudia/0000-0001-7988-1186; Einarsdóttir, Kristjana/0000-0003-4931-7650; Leonard, Helen/0000-0001-6405-5834; Burgner, David/0000-0002-8304-4302	Australia's National Health and Medical Research Council (NHMRC) [572742]; NHMRC [634533, 572568]	Australia's National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The study was funded by the Australia's National Health and Medical Research Council (NHMRC) Program Grant 572742. KE received funding from an NHMRC Postdoctoral Training Fellowship grant (634533), and HL received funding from an NHMRC Senior Research Fellowship grant (572568).	[Anonymous], 2013, Obstet Gynecol, V122, P1139, DOI 10.1097/01.AOG.0000437385.88715.4a; Australian Bureau of Statistics, 2007, HLTH CHILDR AUSTR SN; Australian Bureau of Statistics, 2013, REG POP GROWTH AUSTR; Bentdal YE, 2010, INT J PEDIATR OTORHI, V74, P168, DOI 10.1016/j.ijporl.2009.11.001; Berry JG, 2013, JAMA PEDIATR, V167, P170, DOI 10.1001/jamapediatrics.2013.432; Boyle EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e896; Brissaud O, 2005, ARCH PEDIATRIE, V12, P1462, DOI 10.1016/j.arcped.2005.04.078; Calling S, 2013, ACTA PAEDIATR, V102, P287, DOI 10.1111/apa.12106; Carbonell-Estrany X, 2000, PEDIATR INFECT DIS J, V19, P592, DOI 10.1097/00006454-200007000-00002; Carville KS, 2007, PEDIATR INFECT DIS J, V26, P210, DOI 10.1097/01.inf.0000254148.09831.7f; Daly KA, 1999, PEDIATRICS, V103, P1158, DOI 10.1542/peds.103.6.1158; Doyle LW, 1999, MED J AUSTRALIA, V170, P528, DOI 10.5694/j.1326-5377.1999.tb127877.x; Elder DE, 1999, J PAEDIATR CHILD H, V35, P145, DOI 10.1046/j.1440-1754.1999.00308.x; Engel JAM, 2005, INT J PEDIATR OTORHI, V69, P533, DOI 10.1016/j.ijporl.2004.11.026; Engle WA, 2011, CLIN PERINATOL, V38, P493, DOI 10.1016/j.clp.2011.06.009; Escobar GJ, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e2; Fanaroff AA, 2003, SEMIN PERINATOL, V27, P281, DOI 10.1016/S0146-0005(03)00055-7; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; Kuzniewicz MW, 2013, CLIN PERINATOL, V40, P753, DOI [10.1016/j.c1p.2013.07.008, 10.1016/j.clp.2013.07.008]; Lamarche-Vadel A, 2004, ACTA PAEDIATR, V93, P1340, DOI 10.1080/08035250410032926; Luu TM, 2010, ARCH DIS CHILD-FETAL, V95, pF320, DOI 10.1136/adc.2009.173138; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; McLaurin KK, 2009, PEDIATRICS, V123, P653, DOI 10.1542/peds.2008-1439; Paranjothy S, 2013, PEDIATRICS, V132, pE1562, DOI 10.1542/peds.2013-1737; Pezzotti P, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-56; Qiu XM, 2012, AM J PERINAT, V29, P87, DOI 10.1055/s-0031-1295647; Ralser E, 2012, ACTA PAEDIATR, V101, pE1, DOI 10.1111/j.1651-2227.2011.02404.x; Ray Kristin N, 2013, Hosp Pediatr, V3, P194; ROBERTSON PA, 1992, AM J OBSTET GYNECOL, V166, P1629, DOI 10.1016/0002-9378(92)91551-K; Russell RB, 2007, PEDIATRICS, V120, pE1, DOI 10.1542/peds.2006-2386; Slattery MM, 2002, LANCET, V360, P1489, DOI 10.1016/S0140-6736(02)11476-0; Slimings C, 2014, PAEDIATR PERINAT EP, V28, P536, DOI 10.1111/ppe.12155; Szabo SM, 2014, J PEDIATR-US, V165, P123, DOI 10.1016/j.jpeds.2014.02.053; Underwood MA, 2007, J PERINATOL, V27, P614, DOI 10.1038/sj.jp.7211801; Vrijlandt EJLE, 2013, AM J RESP CRIT CARE, V187, P1234, DOI 10.1164/rccm.201211-2070OC; Wilson-Costello D, 2005, PEDIATRICS, V115, P997, DOI 10.1542/peds.2004-0221; Young PC, 2013, PEDIATRICS, V131, pE1538, DOI 10.1542/peds.2012-2634	39	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130535	10.1371/journal.pone.0130535	http://dx.doi.org/10.1371/journal.pone.0130535			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114969	gold, Green Published			2022-12-27	WOS:000358147500077
J	Wang, K; Redeker, V; Madiona, K; Melki, R; Kabani, M				Wang, Kai; Redeker, Virginie; Madiona, Karine; Melki, Ronald; Kabani, Mehdi			The 26S Proteasome Degrades the Soluble but Not the Fibrillar Form of the Yeast Prion Ure2p In Vitro	PLOS ONE			English	Article							C-TERMINAL DOMAIN; PSI PLUS PRION; STRUCTURAL-CHARACTERIZATION; ASSEMBLY PROPERTIES; AMYLOID CORE; SUP35P; CONFORMATION; INSIGHTS; STRAINS	Yeast prions are self-perpetuating protein aggregates that cause heritable and transmissible phenotypic traits. Among these, [PSI+] and [URE3] stand out as the most studied yeast prions, and result from the self-assembly of the translation terminator Sup35p and the nitrogen catabolism regulator Ure2p, respectively, into insoluble fibrillar aggregates. Protein quality control systems are well known to govern the formation, propagation and transmission of these prions. However, little is known about the implication of the cellular proteolytic machineries in their turnover. We previously showed that the 26S proteasome degrades both the soluble and fibrillar forms of Sup35p and affects [PSI+] propagation. Here, we show that soluble native Ure2p is degraded by the proteasome in an ubiquitin-independent manner. Proteasomal degradation of Ure2p yields amyloidogenic N-terminal peptides and a C-terminal resistant fragment. In contrast to Sup35p, fibrillar Ure2p resists proteasomal degradation. Thus, structural variability within prions may dictate their ability to be degraded by the cellular proteolytic systems.	[Wang, Kai; Redeker, Virginie; Madiona, Karine; Melki, Ronald; Kabani, Mehdi] CNRS, Paris Saclay Inst Neurosci, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Melki, R (corresponding author), CNRS, Paris Saclay Inst Neurosci, Gif Sur Yvette, France.	Ronald.Melki@lebs.cnrs-gif.fr; Mehdi.Kabani@lebs.cnrs-gif.fr	Redeker, Virginie/L-8929-2018; Kabani, Mehdi/G-7456-2012	Redeker, Virginie/0000-0003-2694-8388; Kabani, Mehdi/0000-0001-7440-6394	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Agence Nationale de la Recherche [ANR-12-BS08-0013-02]; French Ministry of National Education, Research and Technology	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche(French National Research Agency (ANR)); French Ministry of National Education, Research and Technology	M.K., V.R. and R.M. are supported by the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Sante et de la Recherche Medicale (INSERM), and the Agence Nationale de la Recherche (ANR-12-BS08-0013-02). K.W. is the beneficiary of a doctoral grant from the French Ministry of National Education, Research and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KD, 2007, J BIOL CHEM, V282, P3004, DOI 10.1074/jbc.M609597200; Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Baxa U, 2011, MOL MICROBIOL, V79, P523, DOI 10.1111/j.1365-2958.2010.07466.x; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Bousset L, 2004, BIOCHEMISTRY-US, V43, P5022, DOI 10.1021/bi049828e; Bousset L, 2002, EMBO J, V21, P2903, DOI 10.1093/emboj/cdf303; Bousset L, 2001, STRUCTURE, V9, P39, DOI 10.1016/S0969-2126(00)00553-0; Bousset L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009760; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Chernova TA, 2014, FEMS MICROBIOL REV, V38, P326, DOI 10.1111/1574-6976.12053; Derkatch IL, 1996, GENETICS, V144, P1375; Fay N, 2005, J BIOL CHEM, V280, P37149, DOI 10.1074/jbc.M506917200; Frederick KK, 2014, CHEM BIOL, V21, P295, DOI 10.1016/j.chembiol.2013.12.013; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Habenstein B, 2012, ANGEW CHEM INT EDIT, V51, P7963, DOI 10.1002/anie.201202093; Kabani M, 2014, MOL MICROBIOL, V92, P507, DOI 10.1111/mmi.12572; Kabani M, 2011, PRION, V5, P277, DOI [10.4161/pri.5.4.18070, 10.4161/pri.18070]; Kabani M, 2011, MOL MICROBIOL, V81, P640, DOI 10.1111/j.1365-2958.2011.07719.x; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Krzewska J, 2006, EMBO J, V25, P822, DOI 10.1038/sj.emboj.7600985; Krzewska J, 2007, J BIOL CHEM, V282, P1679, DOI 10.1074/jbc.M608110200; Leggett David S., 2005, V301, P57; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; Loquet A, 2009, J MOL BIOL, V394, P108, DOI 10.1016/j.jmb.2009.09.016; Luckgei N, 2014, BIOMOL NMR ASSIGN, V8, P365, DOI 10.1007/s12104-013-9518-y; Luckgei N, 2013, ANGEW CHEM INT EDIT, V52, P12741, DOI 10.1002/anie.201304699; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pezza JA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5384; Ranson N, 2006, PROTEIN SCI, V15, P2481, DOI 10.1110/ps.062215206; Redeker V, 2007, J MOL BIOL, V369, P1113, DOI 10.1016/j.jmb.2007.04.018; Schlumpberger M, 2001, MOL CELL BIOL, V21, P7035, DOI 10.1128/MCB.21.20.7035-7046.2001; Schutz AK, 2014, BIOMOL NMR ASSIGN, V8, P349, DOI 10.1007/s12104-013-9515-1; Shewmaker F, 2007, GENETICS, V176, P1557, DOI 10.1534/genetics.107.074153; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Tank EMH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000382; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; Thual C, 2001, BIOCHEMISTRY-US, V40, P1764, DOI 10.1021/bi001916l; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Uptain SM, 2001, EMBO J, V20, P6236, DOI 10.1093/emboj/20.22.6236; Vishveshwara N, 2009, MOL MICROBIOL, V73, P1101, DOI 10.1111/j.1365-2958.2009.06836.x; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Wickner RB, 2011, PRION, V5, P258, DOI [10.4161/pri.5.4.17748, 10.4161/pri.17748]	50	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131789	10.1371/journal.pone.0131789	http://dx.doi.org/10.1371/journal.pone.0131789			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115123	gold, Green Submitted, Green Published			2022-12-27	WOS:000358147500182
J	Zhang, L; Fang, Y; Xu, YM; Lian, YJ; Xie, NC; Wu, TW; Zhang, HF; Sun, LM; Zhang, RF; Wang, ZH				Zhang, Lu; Fang, Yu; Xu, Yuming; Lian, Yajun; Xie, Nanchang; Wu, Tianwen; Zhang, Haifeng; Sun, Limin; Zhang, Ruifang; Wang, Zhenhua			Curcumin Improves Amyloid beta-Peptide (1-42) Induced Spatial Memory Deficits through BDNF-ERK Signaling Pathway	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; ALZHEIMERS-DISEASE; NEUROTROPHIC-FACTOR; CORTICAL-NEURONS; INDUCED NEUROTOXICITY; DECREASED-LEVELS; MESSENGER-RNA; HUMAN BRAIN; IN-VITRO; PROTEIN	Curcumin, the most active component of turmeric, has various beneficial properties, such as antioxidant, anti-inflammatory, and antitumor effects. Previous studies have suggested that curcumin reduces the levels of amyloid and oxidized proteins and prevents memory deficits and thus is beneficial to patients with Alzheimer's disease (AD). However, the molecular mechanisms underlying curcumin's effect on cognitive functions are not well-understood. In the present study, we examined the working memory and spatial reference memory in rats that received a ventricular injection of amyloid-beta 1-42 (A beta 1-42), representing a rodent model of Alzheimer's disease (AD). The rats treated with A beta 1-42 exhibited obvious cognitive deficits in behavioral tasks. Chronic (seven consecutive days, once per day) but not acute (once a day) curcumin treatments (50, 100, and 200 mg/kg) improved the cognitive functions in a dose-dependent manner. In addition, the beneficial effect of curcumin is accompanied by increased BDNF levels and elevated levels of phosphorylated ERK in the hippocampus. Furthermore, the cognition enhancement effect of curcumin could be mimicked by the overexpression of BDNF in the hippocampus and blocked by either bilateral hippocampal injections with lentiviruses that express BDNF shRNA or a microinjection of ERK inhibitor. These findings suggest that chronic curcumin ameliorates AD-related cognitive deficits and that upregulated BDNF-ERK signaling in the hippocampus may underlie the cognitive improvement produced by curcumin.	[Zhang, Lu; Fang, Yu; Xu, Yuming] Key Disciplines Lab Clin Med Henan, Zhengzhou, Henan, Peoples R China; [Zhang, Lu; Xu, Yuming; Lian, Yajun; Xie, Nanchang; Wu, Tianwen; Zhang, Haifeng] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan, Peoples R China; [Fang, Yu; Sun, Limin; Zhang, Ruifang; Wang, Zhenhua] Zhengzhou Univ, Affiliated Hosp 1, Dept Intens Care Unit, Zhengzhou 450052, Henan, Peoples R China	Zhengzhou University; Zhengzhou University	Fang, Y (corresponding author), Key Disciplines Lab Clin Med Henan, Zhengzhou, Henan, Peoples R China.	Fang_Yuys@126.com	Zhang, Rui/GXN-3801-2022		Zhengzhou Science & Technology Basic Research Program [340600531794]; Henan Science & Technology Basic Research Program [122300410365]	Zhengzhou Science & Technology Basic Research Program; Henan Science & Technology Basic Research Program	This work was supported by Zhengzhou Science & Technology Basic Research Program (No. 340600531794) and by Henan Science & Technology Basic Research Program (No. 122300410365). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta D., 2009, ALZHEIMERS DIS INT W, P1; Amadoro G, 2006, P NATL ACAD SCI USA, V103, P2892, DOI 10.1073/pnas.0511065103; Barde YA, 1987, PROG BRAIN RES <D>, V71, P185; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; Conner JM, 1997, J NEUROSCI, V17, P2295; Connor B, 1998, BRAIN RES REV, V27, P1, DOI 10.1016/S0165-0173(98)00004-6; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Croll SD, 1999, NEUROSCIENCE, V93, P1491, DOI 10.1016/S0306-4522(99)00296-1; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DaRocha-Souto B, 2012, NEUROBIOL DIS, V45, P425, DOI 10.1016/j.nbd.2011.09.002; DAVIES P, 1976, LANCET, V2, P1403; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Duman RS, 2000, BIOL PSYCHIAT, V48, P732, DOI 10.1016/S0006-3223(00)00935-5; Ferrer I, 1999, J NEUROPATH EXP NEUR, V58, P729, DOI 10.1097/00005072-199907000-00007; FISCHER W, 1994, P NATL ACAD SCI USA, V91, P8607, DOI 10.1073/pnas.91.18.8607; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; Hoppe JB, 2013, NEUROBIOL LEARN MEM, V106, P134, DOI 10.1016/j.nlm.2013.08.001; Hoppe JB, 2013, TOXICOL IN VITRO, V27, P2325, DOI 10.1016/j.tiv.2013.10.002; HYMAN BT, 1994, AM J PATHOL, V144, P565; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Laske C, 2007, J PSYCHIATR RES, V41, P387, DOI 10.1016/j.jpsychires.2006.01.014; Laske C, 2011, INT J NEUROPSYCHOPH, V14, P399, DOI 10.1017/S1461145710001008; Lee J, 2005, EXP NEUROL, V194, P91, DOI 10.1016/j.expneurol.2005.01.026; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Llorens-Martin M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00046; Lu B, 2014, Handb Exp Pharmacol, V220, P223, DOI 10.1007/978-3-642-45106-5_9; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; Nakamura S, 2001, BRAIN RES, V912, P128, DOI 10.1016/S0006-8993(01)02704-4; NarisawaSaito M, 1996, NEUROREPORT, V7, P2925, DOI 10.1097/00001756-199611250-00024; Pelleymounter MA, 1996, MOL CHEM NEUROPATHOL, V29, P211, DOI 10.1007/BF02815003; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Qin XY, 2010, NEUROSCI LETT, V480, P21, DOI 10.1016/j.neulet.2010.05.062; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Sun CY, 2013, PHARMACOL BIOCHEM BE, V105, P76, DOI 10.1016/j.pbb.2013.02.002; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Tong LQ, 2004, J NEUROSCI, V24, P6799, DOI 10.1523/JNEUROSCI.5463-03.2004; Typlt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081270; Wang R, 2010, PROG NEURO-PSYCHOPH, V34, P147, DOI 10.1016/j.pnpbp.2009.10.016; Wang YL, 2011, NEUROSCI LETT, V487, P70, DOI 10.1016/j.neulet.2010.09.076; Webster B, 2006, J NEUROPATH EXP NEUR, V65, P142, DOI 10.1097/01.jnen.0000199599.63204.6f; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Xu X, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r234; Xu Y, 2009, NEUROPHARMACOLOGY, V57, P463, DOI 10.1016/j.neuropharm.2009.06.010; Yamada K, 1999, BRIT J PHARMACOL, V126, P235, DOI 10.1038/sj.bjp.0702309; Yamada K, 1999, EUR J NEUROSCI, V11, P83, DOI 10.1046/j.1460-9568.1999.00408.x; Ye J, 2012, INT J CLIN EXP MED, V5, P44; Zhang L, 2012, BEHAV BRAIN RES, V235, P67, DOI 10.1016/j.bbr.2012.07.019; Zhu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035823	50	43	45	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131525	10.1371/journal.pone.0131525	http://dx.doi.org/10.1371/journal.pone.0131525			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114940	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500167
J	Bogatan, S; Cevik, D; Demidov, V; Vanderploeg, J; Panchbhaya, A; Vitkin, A; Jacobs, JR				Bogatan, Simina; Cevik, Duygu; Demidov, Valentin; Vanderploeg, Jessica; Panchbhaya, Abdullah; Vitkin, Alex; Jacobs, J. Roger			Talin Is Required Continuously for Cardiomyocyte Remodeling during Heart Growth in Drosophila	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; ADULT HEART; EXPRESSION; MORPHOGENESIS; GENES; IDENTIFICATION; MAINTENANCE; MECHANISMS; SUBUNIT; MODEL	Mechanotransduction of tension can govern the remodeling of cardiomyocytes during growth or cardiomyopathy. Tension is signaled through the integrin adhesion complexes found at muscle insertions and costameres but the relative importance of signalling during cardiomyocyte growth versus remodelling has not been assessed. Employing the Drosophila cardiomyocyte as a genetically amenable model, we depleted the levels of Talin, a central component of the integrin adhesion complex, at different stages of heart growth and remodeling. We demonstrate a continuous requirement for Talin during heart growth to maintain the one-to-one apposition of myofibril ends between cardiomyocytes. Retracted myofibrils cannot regenerate appositions to adjacent cells after restoration of normal Talin expression, and the resulting deficit reduces heart contraction and lifespan. Reduction of Talin during heart remodeling after hatching or during metamorphosis results in pervasive degeneration of cell contacts, myofibril length and number, for which restored Talin expression is insufficient for regeneration. Resultant dilated cardiomyopathy results in a fibrillating heart with poor rhythmicity. Cardiomyocytes have poor capacity to regenerate deficits in myofibril orientation and insertion, despite an ongoing capacity to remodel integrin based adhesions.	[Bogatan, Simina; Cevik, Duygu; Panchbhaya, Abdullah; Jacobs, J. Roger] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Demidov, Valentin; Vitkin, Alex] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Vanderploeg, Jessica] Taylor Univ, Dept Biol, Upland, IN 46989 USA	McMaster University; University of Toronto	Jacobs, JR (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	jacobsr@mcmaster.ca	Demidov, Valentin/C-4050-2015; Vitkin, Alex/I-8166-2012; Vitkin, Alex/C-8123-2016	Demidov, Valentin/0000-0002-0960-3858; Vitkin, Alex/0000-0001-5495-8888; jacobs, j roger/0000-0002-5878-5416	Natural Sciences and Engineering Research Council of Canada [46651]; Canadian Institutes of Health Research [126172]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by Natural Sciences and Engineering Research Council of Canada 46651 [JRJ] (http://www.nserc-crsng.gc.ca/), Canadian Institutes of Health Research 126172 [AV] (http://www.cihr-irsc.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bier E, 2004, GENE, V342, P1, DOI 10.1016/j.gene.2004.07.018; Brancaccio M, 2006, CARDIOVASC RES, V70, P422, DOI 10.1016/j.cardiores.2005.12.015; Chartier A, 2002, DEVELOPMENT, V129, P3241; Chico TJA, 2008, TRENDS CARDIOVAS MED, V18, P150, DOI 10.1016/j.tcm.2008.04.002; Cook JR, 2015, CLIN GENET, V87, P11, DOI 10.1111/cge.12436; Curtis NJ, 1999, J MORPHOL, V240, P225, DOI 10.1002/(SICI)1097-4687(199906)240:3<225::AID-JMOR2>3.3.CO;2-M; Das M, 2014, BBA-BIOMEMBRANES, V1838, P579, DOI 10.1016/j.bbamem.2013.07.017; dos Santos G, 2015, NUCLEIC ACIDS RES, V43, pD690, DOI 10.1093/nar/gku1099; Dowse H, 1995, J NEUROGENET, V10, P153, DOI 10.3109/01677069509083461; Dullens HFJ, 2012, CARDIOVASC PATHOL, V21, P291, DOI 10.1016/j.carpath.2011.09.009; Ellis SJ, 2011, J CELL SCI, V124, P1844, DOI 10.1242/jcs.083337; Esposito T, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-91; Fink M, 2009, BIOTECHNIQUES, V46, P101, DOI 10.2144/000113078; GERDES AM, 1995, J MOL CELL CARDIOL, V27, P849, DOI 10.1016/0022-2828(95)90000-4; Haag TA, 1999, DEV BIOL, V208, P56, DOI 10.1006/dbio.1998.9188; Harston Rebecca K, 2011, J Signal Transduct, V2011, P521742, DOI 10.1155/2011/521742; Harvey PA, 2011, J CELL BIOL, V194, P355, DOI 10.1083/jcb.201101100; Israeli-Rosenberg S, 2014, CIRC RES, V114, P572, DOI 10.1161/CIRCRESAHA.114.301275; Johnson E, 1998, J NEUROGENET, V12, P1, DOI 10.3109/01677069809108552; Katzemich A, 2011, GENE EXPR PATTERNS, V11, P484, DOI 10.1016/j.gep.2011.08.004; Kim IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007132; Knoll R, 2007, CIRCULATION, V116, P515, DOI 10.1161/CIRCULATIONAHA.107.689984; Kresh JY, 2011, PFLUG ARCH EUR J PHY, V462, P75, DOI 10.1007/s00424-011-0954-1; LaBeau-DiMenna EM, 2012, P NATL ACAD SCI USA, V109, P17983, DOI 10.1073/pnas.1208408109; Lehmacher C, 2012, ARTHROPOD STRUCT DEV, V41, P459, DOI 10.1016/j.asd.2012.02.002; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Lin GN, 2013, DEV BIOL, V377, P177, DOI 10.1016/j.ydbio.2013.01.032; Lu HZ, 2006, CIRCULATION, V114, P2271, DOI 10.1161/CIRCULATIONAHA.106.642330; Manso AM, 2013, J BIOL CHEM, V288, P4252, DOI 10.1074/jbc.M112.427484; Mariampillai A, 2010, OPT LETT, V35, P1257, DOI 10.1364/OL.35.001257; Monier B, 2007, FLY, V1, P59, DOI 10.4161/fly.3993; Nishimura M, 2014, AGING CELL, V13, P431, DOI 10.1111/acel.12193; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Perkins AD, 2010, DEV BIOL, V338, P15, DOI 10.1016/j.ydbio.2009.10.034; Petrich BG, 2009, THROMB HAEMOSTASIS, V101, P1020, DOI 10.1160/TH08-08-0553; Piazza N, 2011, PROG MOL BIOL TRANSL, V100, P155, DOI 10.1016/B978-0-12-384878-9.00005-4; Pines M, 2012, NAT CELL BIOL, V14, P935, DOI 10.1038/ncb2555; Qian L, 2012, J CELL MOL MED, V16, P972, DOI 10.1111/j.1582-4934.2012.01529.x; Sellin J, 2006, GENE EXPR PATTERNS, V6, P360, DOI 10.1016/j.modgep.2005.09.012; Shah AP, 2011, MECH DEVELOP, V128, P222, DOI 10.1016/j.mod.2011.01.001; Shai SY, 2002, CIRC RES, V90, P458, DOI 10.1161/hh0402.105790; Stark KA, 1997, DEVELOPMENT, V124, P4583; Traister A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037802; Tsai MT, 2013, J BIOPHOTONICS, V6, P708, DOI 10.1002/jbio.201200164; Valencik ML, 2006, CIRC RES, V99, P1403, DOI 10.1161/01.RES.0000252291.88540.ac; Vanderploeg J, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-8; Vogler Georg, 2009, J Vis Exp, DOI 10.3791/1425; Whitman SA, 2011, CIRC RES, V109, P262, DOI 10.1161/CIRCRESAHA.111.244244; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; YEE GH, 1993, DEVELOPMENT, V118, P845; Zeitouni B, 2007, PLOS GENET, V3, P1907, DOI 10.1371/journal.pgen.0030174; Zemljic-Harpf A, 2009, J INVEST MED, V57, P849, DOI 10.2310/JIM.0b013e3181c5e074	52	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131238	10.1371/journal.pone.0131238	http://dx.doi.org/10.1371/journal.pone.0131238			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110760	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800134
J	Howard, IS; Franklin, DW				Howard, Ian S.; Franklin, David W.			Neural Tuning Functions Underlie Both Generalization and Interference	PLOS ONE			English	Article							ARM MOVEMENTS; UNSTABLE DYNAMICS; IMPEDANCE CONTROL; MOTOR ADAPTATION; SYSTEM; DIRECTION; MODELS; LEARN; CUES; REPRESENTATION	In sports, the role of backswing is considered critical for generating a good shot, even though it plays no direct role in hitting the ball. We recently demonstrated the scientific basis of this phenomenon by showing that immediate past movement affects the learning and recall of motor memories. This effect occurred regardless of whether the past contextual movement was performed actively, passively, or shown visually. In force field studies, it has been shown that motor memories generalize locally and that the level of compensation decays as a function of movement angle away from the trained movement. Here we examine if the contextual effect of past movement exhibits similar patterns of generalization and whether it can explain behavior seen in interference studies. Using a single force-field learning task, the directional tuning curves of both the prior contextual movement and the subsequent force field adaptive movements were measured. The adaptation movement direction showed strong directional tuning, decaying to zero by 90 degrees relative to the training direction. The contextual movement direction exhibited a similar directional tuning, although the effect was always above 60%. We then investigated the directional tuning of the passive contextual movement using interference tasks, where the contextual movements that uniquely specified the force field direction were separated by mu 15 degrees or mu 45 degrees. Both groups showed a pronounced tuning effect, which could be well explained by the directional tuning functions for single force fields. Our results show that contextual effect of past movement influences predictive force compensation, even when adaptation does not require contextual information. However, when such past movement contextual information is crucial to the task, such as in an interference study, it plays a strong role in motor memory learning and recall. This work demonstrates that similar tuning responses underlie both generalization of movement direction during dynamic learning and contextual movements in both single force field and interference tasks.	[Howard, Ian S.] Univ Plymouth, Sch Comp Elect & Math, Ctr Robot & Neural Syst, Plymouth PL4 8AA, Devon, England; [Franklin, David W.] Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England	University of Plymouth; University of Cambridge	Howard, IS (corresponding author), Univ Plymouth, Sch Comp Elect & Math, Ctr Robot & Neural Syst, Plymouth PL4 8AA, Devon, England.	ian.howard@plymouth.ac.uk	Franklin, David/A-2371-2009	Franklin, David/0000-0001-9530-0820; Howard, Ian/0000-0002-6041-9669	Wellcome Trust [WT091547MA]; Plymouth University	Wellcome Trust(Wellcome TrustEuropean Commission); Plymouth University	The authors thank the Wellcome Trust (WT091547MA) and Plymouth University for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addou T, 2011, J NEUROPHYSIOL, V106, P163, DOI 10.1152/jn.00869.2010; Berniker M, 2014, J NEUROPHYSIOL, V111, P1165, DOI 10.1152/jn.00493.2013; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Brayanov JB, 2012, J NEUROSCI, V32, P14951, DOI 10.1523/JNEUROSCI.1928-12.2012; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Caithness G, 2004, J NEUROSCI, V24, P8662, DOI 10.1523/JNEUROSCI.2214-04.2004; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Conditt MA, 1997, J NEUROPHYSIOL, V78, P554, DOI 10.1152/jn.1997.78.1.554; Cothros N, 2009, J NEUROPHYSIOL, V102, P2112, DOI 10.1152/jn.00493.2009; Donchin O, 2003, J NEUROSCI, V23, P9032; Fabbri S, 2010, J NEUROSCI, V30, P13488, DOI 10.1523/JNEUROSCI.2571-10.2010; Franklin DW, 2008, J NEUROSCI, V28, P11165, DOI 10.1523/JNEUROSCI.3099-08.2008; Franklin DW, 2003, J NEUROPHYSIOL, V90, P3270, DOI 10.1152/jn.01112.2002; Franklin DW, 2003, EXP BRAIN RES, V151, P145, DOI 10.1007/s00221-003-1443-3; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; Hirashima M, 2012, CURR BIOL, V22, P432, DOI 10.1016/j.cub.2012.01.042; Howard IS, 2015, CURR BIOL, V25, P397, DOI 10.1016/j.cub.2014.12.037; Howard IS, 2013, J NEUROPHYSIOL, V109, P2632, DOI 10.1152/jn.00773.2012; Howard IS, 2012, J NEUROSCI, V32, P12756, DOI 10.1523/JNEUROSCI.5909-11.2012; Howard IS, 2009, J NEUROSCI METH, V181, P199, DOI 10.1016/j.jneumeth.2009.05.005; Hwang EJ, 2003, PLOS BIOL, V1, P209, DOI 10.1371/journal.pbio.0000025; Izawa J, 2008, J NEUROSCI, V28, P2883, DOI 10.1523/JNEUROSCI.5359-07.2008; Kadiallah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045075; Karniel A, 2002, EXP BRAIN RES, V143, P520, DOI 10.1007/s00221-002-1054-4; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Lee JY, 2009, J NEUROSCI, V29, P10396, DOI 10.1523/JNEUROSCI.1294-09.2009; Malfait N, 2002, J NEUROSCI, V22, P9656; Mattar AAG, 2007, J NEUROPHYSIOL, V98, P3321, DOI 10.1152/jn.00576.2007; Milner TE, 2005, J PHYSIOL-LONDON, V567, P651, DOI 10.1113/jphysiol.2005.090449; Nozaki D, 2006, NAT NEUROSCI, V9, P1364, DOI 10.1038/nn1785; Nozaki D, 2009, EXP BRAIN RES, V194, P451, DOI 10.1007/s00221-009-1720-x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Scheidt RA, 2000, J NEUROPHYSIOL, V84, P853, DOI 10.1152/jn.2000.84.2.853; Scott SH, 1997, J NEUROPHYSIOL, V77, P826, DOI 10.1152/jn.1997.77.2.826; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Thoroughman KA, 2005, J NEUROSCI, V25, P8948, DOI 10.1523/JNEUROSCI.1771-05.2005; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; Wainscott SK, 2005, J NEUROPHYSIOL, V93, P786, DOI 10.1152/jn.00240.2004; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Yokoi A, 2011, J NEUROSCI, V31, P17058, DOI 10.1523/JNEUROSCI.2982-11.2011	48	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131268	10.1371/journal.pone.0131268	http://dx.doi.org/10.1371/journal.pone.0131268			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110871	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800138
J	Afeworki, R; Smits, J; Tolboom, J; van der Ven, A				Afeworki, Robel; Smits, Jeroen; Tolboom, Jules; van der Ven, Andre			Positive Effect of Large Birth Intervals on Early Childhood Hemoglobin Levels in Africa Is Limited to Girls: Cross-Sectional DHS Study	PLOS ONE			English	Article							AGED 6-59 MONTHS; PERINATAL OUTCOMES; NUTRITIONAL-STATUS; IRON-DEFICIENCY; SEX-DIFFERENCES; ANEMIA; DETERMINANTS; CHILDREN; INFANT; MORTALITY	Background Short birth intervals are independently associated with increased risk of adverse maternal, perinatal, infant and child outcomes. Anemia in children, which is highly prevalent in Africa, is associated with an increased risk of morbidity and mortality. Birth spacing is advocated as a tool to reduce anemia in preschool African children, but the role of gender differences and contextual factors has been neglected. The present study aims to determine to what extent the length of preceding birth interval influences the hemoglobin levels of African preschool children in general, as well as for boys and girls separately, and which contextual factors thereby play a crucial role. Methods and Findings This cross-sectional study uses data from Demographic and Health Surveys (DHS) conducted between 2003 and 2011 in 20 African countries. All preschool children aged 6-59 months with a valid hemoglobin measurement and a preceding birth interval of 7-72 months as well as their corresponding multigravida mothers aged 21-49 years were included in the study. Hemoglobin levels of children and mothers were measured in g/l, while birth intervals were calculated as months difference between consecutive births. Multivariate analyses were done to examine the relationship between length of preceding birth interval and child hemoglobin levels, adjusted for factors at the individual, household, community, district, and country level. A positive linear relationship was observed between birth interval and the 49,260 included children's hemoglobin level, whereby age and sex of the child, hemoglobin level of the mother, household wealth, mother's education and urbanization of place of residence also showed positive associations. In the interaction models, the effect of a month increase in birth interval is associated with an average increase of 0.025 g/l in hemoglobin level (P = 0.001) in girls, while for boys the effect was not significant. In addition, for girls, the effect of length of preceding birth interval was highest in young mothers and mothers with higher hemoglobin levels, while for boys, the highest effect was noticed for those living in more highly educated regions. Finally, significantly higher hemoglobin levels of girls compared to boys were observed at birth but with increasing age, the sex difference in hemoglobin level gradually becomes smaller. Conclusions A longer birth interval has a modest positive effect on early childhood hemoglobin levels of girls, and this effect is strongest when their mothers are in their early twenties and have a high hemoglobin level. Remarkably, although the physiological iron requirement is higher for boys than girls, birth spacing has little influence on hemoglobin levels of preschool boys. We speculate that the preference for male offspring in large parts of Africa significantly influences nutritional patterns of African preschool boys and girls, and as such also determines the different effect of birth spacing. Finally, gender aspects should be considered in intervention programs that aim to improve anemia in African children.	[Afeworki, Robel; van der Ven, Andre] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Int Hlth, NL-6525 ED Nijmegen, Netherlands; [Smits, Jeroen] Radboud Univ Nijmegen, Nijmegen Ctr Econ, Inst Management & Res, NL-6525 ED Nijmegen, Netherlands; [Tolboom, Jules] Radboud Univ Nijmegen, Med Ctr, Dept Paediat, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Afeworki, R (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Int Hlth, NL-6525 ED Nijmegen, Netherlands.	robrix99@gmail.com	smits, jeroen pjm/D-3840-2012; van der Ven, A.J.A.M./H-8102-2014	smits, jeroen pjm/0000-0002-5802-975X; van der Ven, A.J.A.M./0000-0003-1833-3391				Abdi H., BONFERRONI TEST ENCY; Agho KE, 2008, J HEALTH POPUL NUTR, V26, P200; [Anonymous], DEM HLTH SURV; Conde-Agudelo A, 2006, JAMA-J AM MED ASSOC, V295, P1809, DOI 10.1001/jama.295.15.1809; Conde-Agudelo A, 2005, OBSTET GYNECOL, V106, P359, DOI 10.1097/01.AOG.0000171118.79529.a3; Conde-Agudelo A, 2012, STUD FAMILY PLANN, V43, P93, DOI 10.1111/j.1728-4465.2012.00308.x; DaVanzo J, 2008, POP STUD-J DEMOG, V62, P131, DOI 10.1080/00324720802022089; DeFranco EA, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.042; Dewey KG, 2007, MATERN CHILD NUTR, V3, P151, DOI 10.1111/j.1740-8709.2007.00092.x; Domellof M, 2002, PEDIATRICS, V110, P545, DOI 10.1542/peds.110.3.545; Eea Michael A., 2013, ACAD RES INT, V4, P3; Fishman SM, 2000, PUBLIC HEALTH NUTR, V3, P125, DOI 10.1017/S1368980000000173; Friedman JF, 2005, TRENDS PARASITOL, V21, P386, DOI 10.1016/j.pt.2005.06.006; GERTLER P, 1992, WORLD BANK ECON REV, V6, P171, DOI 10.1093/wber/6.1.171; Haverkate M, 2014, J EPIDEMIOL COMMUN H, V68, P116, DOI 10.1136/jech-2012-202336; ICF International, 2012, DEM HLTH SURV SAMPL; Jaeggi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057513; King JC, 2003, J NUTR, V133, p1732S, DOI 10.1093/jn/133.5.1732S; Klebanoff MA, 1999, NEW ENGL J MED, V340, P643, DOI 10.1056/NEJM199902253400809; Kouanda S, 2008, GROWTH HORM IGF RES, V18, P345, DOI 10.1016/j.ghir.2008.01.008; Lakew Y, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006001; Leone T, 2003, INT FAM PLAN PERSPEC, V29, P69, DOI 10.2307/3181060; McDonald SJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004074.pub3; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; MERCHANT K, 1988, PROG FOOD NUTR SCI, V12, P339; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; Osorio MM, 2004, BRIT J NUTR, V91, P307, DOI 10.1079/BJN20031042; Pasricha SR, 2013, BLOOD, V121, P2607, DOI 10.1182/blood-2012-09-453522; Pasricha SR, 2010, PEDIATRICS, V126, pE140, DOI 10.1542/peds.2009-3108; Pongou R, 2013, DEMOGRAPHY, V50, P421, DOI 10.1007/s13524-012-0161-5; Quisumbing ARaM J.A., 2003, OXFORD B ECON STAT, V65, P283; Rafael N, 2013, ISER WORKING PAPER S; Ramakrishnan U, 2002, J NUTR, V132, p820S, DOI 10.1093/jn/132.4.820S; Report of a WHO, 2005, TECHNICAL CONSULATIO; Rodriquez RM, 2001, J CRIT CARE, V16, P36, DOI 10.1053/jcrc.2001.21795; Rutstein S., 2008, DHS WORKING PAPERS; Rutstein SO, 2005, INT J GYNECOL OBSTET, V89, pS7, DOI 10.1016/j.ijgo.2004.11.012; Rutstein SO, 2006, GUIDE DHS STAT; Scholl TO, 2005, AM J CLIN NUTR, V81, p1218S; Soukaloun D, 2003, ANN TROP PAEDIATR, V23, P181, DOI 10.1179/027249303322296493; Tengco LW, 2008, J AM COLL NUTR, V27, P229, DOI 10.1080/07315724.2008.10719695; USAID, 2014, COMP INT PACK AN PRE; VALBERG LS, 1976, CAN MED ASSOC J, V114, P417; Vidya S, 2002, POPULATION INFORM PR; Wieringa FT, 2007, BRIT J NUTR, V98, P1070, DOI 10.1017/S0007114507756945; Windsor JS, 2007, POSTGRAD MED J, V83, P148, DOI 10.1136/pgmj.2006.049734; WINKVIST A, 1992, AM J PUBLIC HEALTH, V82, P691, DOI 10.2105/AJPH.82.5.691; Yohannes S, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-38	48	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131897	10.1371/journal.pone.0131897	http://dx.doi.org/10.1371/journal.pone.0131897			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121362	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400174
J	Hauk, G; Bowman, GD				Hauk, Glenn; Bowman, Gregory D.			Formation of a Trimeric Xpo1-Ran[GTP]-Ded1 Exportin Complex Modulates ATPase and Helicase Activities of Ded1	PLOS ONE			English	Article							DEAD-BOX HELICASE; NUCLEAR EXPORT; STRUCTURAL BASIS; SIGNAL RECOGNITION; SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION; NUCLEOPORIN NUP214; CRYSTAL-STRUCTURE; IMPORTIN-BETA; RNA HELICASES	The DEAD-box RNA helicase Ded1, which is essential in yeast and known as DDX3 in humans, shuttles between the nucleus and cytoplasm and takes part in several basic processes including RNA processing and translation. A key interacting partner of Ded1 is the exportin Xpo1, which together with the GTP-bound state of the small GTPase Ran, facilitates unidirectional transport of Ded1 out of the nucleus. Here we demonstrate that Xpo1 and Ran[GTP] together reduce the RNA-stimulated ATPase and helicase activities of Ded1. Binding and inhibition of Ded1 by Xpo1 depend on the affinity of the Ded1 nuclear export sequence (NES) for Xpo1 and the presence of Ran[GTP]. Association with Xpo1/Ran[GTP] reduces RNA-stimulated ATPase activity of Ded1 by increasing the apparent KM for the RNA substrate. Despite the increased KM, the Ded1: Xpo1: Ran[GTP] ternary complex retains the ability to bind single stranded RNA, suggesting that Xpo1/Ran[GTP] may modulate the substrate specificity of Ded1. These results demonstrate that, in addition to transport, exportins such as Xpo1 also have the capability to alter enzymatic activities of their cargo.	[Hauk, Glenn; Bowman, Gregory D.] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA	Johns Hopkins University	Bowman, GD (corresponding author), Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA.	gdbowman@jhu.edu			National Institute of General Medical Sciences/National Institutes of Health to GDB [R01 GM084192]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084192] Funding Source: NIH RePORTER	National Institute of General Medical Sciences/National Institutes of Health to GDB; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institute of General Medical Sciences/National Institutes of Health to GDB (R01 GM084192). This was our sole source of funding for the research submitted in this manuscript. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavian CN, 2004, BIOCHEM BIOPH RES CO, V313, P351, DOI 10.1016/j.bbrc.2003.11.126; Askjaer P, 2000, J BIOL CHEM, V275, P11561, DOI 10.1074/jbc.275.16.11561; Askjaer P, 1999, MOL CELL BIOL, V19, P6276; Banroques J, 2008, MOL CELL BIOL, V28, P3359, DOI 10.1128/MCB.01555-07; Banroques J, 2011, J MOL BIOL, V413, P451, DOI 10.1016/j.jmb.2011.08.032; Banroques J, 2010, J MOL BIOL, V396, P949, DOI 10.1016/j.jmb.2009.12.025; Bizebard T, 2004, BIOCHEMISTRY-US, V43, P7857, DOI 10.1021/bi049852s; Burckin T, 2005, NAT STRUCT MOL BIOL, V12, P175, DOI 10.1038/nsmb891; Chang JH, 2009, P NATL ACAD SCI USA, V106, P3148, DOI 10.1073/pnas.0808275106; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Ciufo LF, 2000, CURR BIOL, V10, P1256, DOI 10.1016/S0960-9822(00)00743-0; Cook AG, 2010, CURR OPIN STRUC BIOL, V20, P247, DOI 10.1016/j.sbi.2010.01.012; Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; Dong XH, 2009, NAT STRUCT MOL BIOL, V16, P558, DOI 10.1038/nsmb.1586; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Edelheit O, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-61; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fukuhara N, 2004, J BIOL CHEM, V279, P2176, DOI 10.1074/jbc.M309112200; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; Grosshans H, 2001, J CELL BIOL, V153, P745, DOI 10.1083/jcb.153.4.745; Guttler T, 2011, EMBO J, V30, P3457, DOI 10.1038/emboj.2011.287; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Hauk G, 2011, CURR OPIN STRUC BIOL, V21, P719, DOI 10.1016/j.sbi.2011.09.003; Hilliker A, 2011, MOL CELL, V43, P962, DOI 10.1016/j.molcel.2011.08.008; Iost I, 1999, J BIOL CHEM, V274, P17677, DOI 10.1074/jbc.274.25.17677; Kiianitsa K, 2003, ANAL BIOCHEM, V321, P266, DOI 10.1016/S0003-2697(03)00461-5; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koyama M, 2010, EMBO J, V29, P2002, DOI 10.1038/emboj.2010.89; Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; Murdoch K, 2002, EUR J CELL BIOL, V81, P549, DOI 10.1078/0171-9335-00271; Napetschnig J, 2009, P NATL ACAD SCI USA, V106, P3089, DOI 10.1073/pnas.0813267106; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; Richards SA, 1997, SCIENCE, V276, P1842, DOI 10.1126/science.276.5320.1842; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Sato H, 2009, GENE DEV, V23, P2537, DOI 10.1101/gad.1817109; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Senissar M, 2014, NUCLEIC ACIDS RES, V42, P10005, DOI 10.1093/nar/gku584; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stevens SW, 2002, MOL CELL, V9, P31, DOI 10.1016/S1097-2765(02)00436-7; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561; Yang J, 2001, MOL CELL, V8, P397, DOI 10.1016/S1097-2765(01)00303-3; Yang Q, 2007, MOL CELL, V28, P253, DOI 10.1016/j.molcel.2007.08.016; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	54	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131690	10.1371/journal.pone.0131690	http://dx.doi.org/10.1371/journal.pone.0131690			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26120835	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400143
J	Higgins, LE; de Castro, NR; Addo, N; Wareing, M; Greenwood, SL; Jones, RL; Sibley, CP; Johnstone, ED; Heazell, AEP				Higgins, Lucy E.; de Castro, Nicolas Rey; Addo, Naa; Wareing, Mark; Greenwood, Susan L.; Jones, Rebecca L.; Sibley, Colin P.; Johnstone, Edward D.; Heazell, Alexander E. P.			Placental Features of Late-Onset Adverse Pregnancy Outcome	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; FETAL MOVEMENTS; MATERNAL SERUM; LACTOGEN; TERM; EXPRESSION; AGE; PREECLAMPSIA; MORPHOLOGY; MANAGEMENT	Objective Currently, no investigations reliably identify placental dysfunction in late pregnancy. To facilitate the development of such investigations we aimed to identify placental features that differ between normal and adverse outcome in late pregnancy in a group of pregnancies with reduced fetal movement. Methods Following third trimester presentation with reduced fetal movement (N = 100), placental structure ex vivo was measured. Placental function was then assessed in terms of (i) chorionic plate artery agonist responses and length-tension characteristics using wire myography and (ii) production and release of placentally derived hormones (by quantitative polymerase chain reaction and enzyme linked immunosorbant assay of villous tissue and explant conditioned culture medium). Results Placentas from pregnancies ending in adverse outcome (N = 23) were similar to 25% smaller in weight, volume, length, width and disc area (all p<0.0001) compared with those from normal outcome pregnancies. Villous and trophoblast areas were unchanged, but villous vascularity was reduced (median (interquartile range): adverse outcome 10 (10-12) vessels/mm(2) vs. normal outcome 13 (12-15), p = 0.002). Adverse outcome pregnancy placental arteries were relatively insensitive to nitric oxide donated by sodium nitroprusside compared to normal outcome pregnancy placental arteries (50% Effective Concentration 30 (19-50) nM vs. 12 (6-24), p = 0.02). Adverse outcome pregnancy placental tissue contained less human chorionic gonadotrophin (20 (11-50) vs. 55 (24-102) mIU/mg, p = 0.007) and human placental lactogen (11 (6-14) vs. 27 (9-50) mg/mg, p = 0.006) and released more soluble fms-like tyrosine kinase-1 (21 (13-29) vs. 5 (2-15) ng/mg, p = 0.01) compared with normal outcome pregnancy placental tissue. Conclusion These data provide a description of the placental phenotype of adverse outcome in late pregnancy. Antenatal tests that accurately reflect elements of this phenotype may improve its prediction.	[Higgins, Lucy E.; de Castro, Nicolas Rey; Addo, Naa; Wareing, Mark; Greenwood, Susan L.; Jones, Rebecca L.; Sibley, Colin P.; Johnstone, Edward D.; Heazell, Alexander E. P.] Univ Manchester, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester M13 9WL, Lancs, England; [Higgins, Lucy E.; de Castro, Nicolas Rey; Addo, Naa; Wareing, Mark; Greenwood, Susan L.; Jones, Rebecca L.; Sibley, Colin P.; Johnstone, Edward D.; Heazell, Alexander E. P.] Cent Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Maternal & Fetal Hlth Res Ctr, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England	University of Manchester; University of Manchester	Higgins, LE (corresponding author), Univ Manchester, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester M13 9WL, Lancs, England.	Lucy.higgins@doctors.org.uk	Jones, Rebecca/E-4481-2011	Jones, Rebecca/0000-0002-8871-0589; Heazell, Alexander/0000-0002-4303-7845; Rey de Castro, Nicolas/0000-0003-1908-3494; Higgins, Lucy/0000-0003-0993-497X; Greenwood, Susan/0000-0003-2867-4368; Johnstone, Ed/0000-0001-9732-8544	NIHR Manchester Biomedical Research Centre; Research Training Fellowship from Action Medical Research [GN2136]; Action Medical Research [2136] Funding Source: researchfish	NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Research Training Fellowship from Action Medical Research; Action Medical Research	Funding: The work was supported by pump priming from the NIHR Manchester Biomedical Research Centre (www.manchesterbrc.org) and a Research Training Fellowship from Action Medical Research (GN2136, www.action.org.uk), both awarded to LH. The sponsor (University of Manchester) and funders (Action Medical Research and NIHR Manchester Biomedical Research Centre) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, FETAL AND INFANT DEA; Barrett JFR, 2013, NEW ENGL J MED, V369, P1295, DOI 10.1056/NEJMoa1214939; Benton SJ, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.09.019; Biswas S, 2008, J OBSTET GYNAECOL RE, V34, P487, DOI 10.1111/j.1447-0756.2008.00719.x; Biswas S, 2008, EARLY HUM DEV, V84, P357, DOI 10.1016/j.earlhumdev.2007.09.017; Boers KE, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c7087; Bonifacio SI, 2011, J PEDIATR-US, V158, P360, DOI 10.1016/j.jpeds.2010.09.003; Bricker L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001451.pub3; Cox S, 2009, CONFIDENTIAL ENQUIRY; Crocker IP, 2004, J PATHOL, V204, P11, DOI 10.1002/path.1610; Daayana S, 2004, J SOC GYNECOL INVEST, V11, P545, DOI 10.1016/j.jsgi.2004.06.009; Denison FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042926; Doctor BA, 2001, AM J OBSTET GYNECOL, V185, P652, DOI 10.1067/mob.2001.116749; Dutton PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039784; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Flenady V, 2009, AUST NZ J OBSTET GYN, V49, P358, DOI 10.1111/j.1479-828X.2009.01026.x; Froen JF, 2008, SEMIN PERINATOL, V32, P243, DOI 10.1053/j.semperi.2008.04.004; Fu GD, 2013, INT J MOL SCI, V14, P5519, DOI 10.3390/ijms14035519; Gagnon A, 2008, J OBSTET GYNAECOL CA, V30, P918, DOI 10.1016/S1701-2163(16)32973-5; Garrod A, 2013, PLACENTA, V34, P1116, DOI 10.1016/j.placenta.2013.07.067; Girard S, 2014, AM J REPROD IMMUNOL, V72, P422, DOI 10.1111/aji.12274; Gu Y, 2008, J CLIN ENDOCR METAB, V93, P260, DOI 10.1210/jc.2007-1550; Hannah ME, 1996, NEW ENGL J MED, V334, P1005, DOI 10.1056/NEJM199604183341601; Hayward CE, 2013, PLACENTA, V34, P281, DOI 10.1016/j.placenta.2013.01.001; Hayward CE, 2011, PLACENTA, V32, P990, DOI 10.1016/j.placenta.2011.09.016; Heazell AEP, 2008, J OBSTET GYNAECOL, V28, P147, DOI 10.1080/01443610801912618; Heazell AEP, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-95; Heazell AEP, 2012, REPROD SCI, V19, P863, DOI 10.1177/1933719112438446; Hofmeyr GJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009148.pub2; Huen I, 2013, MAGN RESON MED, V70, P1427, DOI 10.1002/mrm.24581; Iliodromiti S, 2014, LANCET, V384, P1749, DOI 10.1016/S0140-6736(14)61135-1; ISOUARD G, 1979, AUST NZ J OBSTET GYN, V19, P69; Junaid TO, 2014, PLACENTA, V35, P808, DOI 10.1016/j.placenta.2014.07.013; Kingdom J, 2000, EUR J OBSTET GYN R B, V92, P35, DOI 10.1016/S0301-2115(00)00423-1; Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4; KREYE VAW, 1975, N-S ARCH PHARMACOL, V288, P381, DOI 10.1007/BF00501284; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; LEADER LR, 1980, S AFR MED J, V58, P609; LETCHWORTH AT, 1978, LANCET, V1, P955; MacDorman MF, 2012, NATIONAL VITAL STATI, V60; Malin GL, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1471; Mannik J, 2010, J CLIN ENDOCR METAB, V95, P2433, DOI 10.1210/jc.2010-0023; Maulik D., 1997, DOPPLER ULTRASOUND I; McCowan LME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070917; Mifsud W, 2014, FETAL DIAGN THER, V36, P117, DOI 10.1159/000359969; Mills TA, 2005, EUR J CLIN INVEST, V35, P758, DOI 10.1111/j.1365-2362.2005.01577.x; Mills TA, 2011, REPRODUCTIVE SCIENCE, V19; MORRISON I, 1980, AM J OBSTET GYNECOL, V136, P1055, DOI 10.1016/0002-9378(80)90637-7; Nagamatsu T, 2004, ENDOCRINOLOGY, V145, P4838, DOI 10.1210/en.2004-0533; Neilson JP, 2012, COCHRANE DB SYST REV, V8; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; Newhouse SM, 2007, PLACENTA, V28, P999, DOI 10.1016/j.placenta.2007.04.008; Nice D, 2014, PLACENTA SUPPL, V35; O'Sullivan O, 2009, J OBSTET GYNAECOL, V29, P705, DOI 10.3109/01443610903229598; Oros D, 2011, ULTRASOUND OBST GYN, V37, P191, DOI 10.1002/uog.7738; Orzechowski K, 2014, OBSTET GYNECOL, V123, p164S, DOI 10.1097/01.AOG.0000447167.68145.87; OUT HJ, 1991, EUR J OBSTET GYN R B, V41, P179, DOI 10.1016/0028-2243(91)90021-C; Pagani G, 2014, ULTRASOUND OBST GYN, V43, P548, DOI 10.1002/uog.13220; Pasupathy Dharmintra, 2008, BMC Pregnancy Childbirth, V8, P51, DOI 10.1186/1471-2393-8-51; Pinar H, 2014, OBSTET GYNECOL, V123, P325, DOI 10.1097/AOG.0000000000000100; Roje D, 2011, J MATERN-FETAL NEO M, V24, P745, DOI 10.3109/14767058.2010.526158; Romero R, 2010, J MATERN-FETAL NEO M, V23, P1384, DOI 10.3109/14767051003681121; Sibley CP, 2005, PEDIATR RES, V58, P827, DOI 10.1203/01.PDR.0000181381.82856.23; Siman CM, 2001, AM J PHYSIOL-REG I, V280, pR1116, DOI 10.1152/ajpregu.2001.280.4.R1116; Smith GCS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001274; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P1395, DOI 10.1016/S0002-9378(97)70081-4; SPELLACY WN, 1977, OBSTET GYNECOL, V49, P113; Spinillo A, 2012, PRENATAL DIAG, V32, P1263, DOI 10.1002/pd.3988; Tantbirojn P, 2009, PLACENTA, V30, P1083, DOI 10.1016/j.placenta.2009.09.005; Thompson JMD, 2007, BJOG-INT J OBSTET GY, V114, P715, DOI 10.1111/j.1471-0528.2007.01327.x; Tuckey RC, 1999, EUR J BIOCHEM, V263, P319, DOI 10.1046/j.1432-1327.1999.00483.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vedmedovska N, 2011, EUR J OBSTET GYN R B, V155, P36, DOI 10.1016/j.ejogrb.2010.11.017; Wareing M, 2006, PLACENTA, V27, P42, DOI 10.1016/j.placenta.2004.11.008; Wareing M, 2002, PLACENTA, V23, P400, DOI 10.1053/plac.2002.0825; Warrander LK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034851; Warrander LK, 2011, MED HYPOTHESES, V76, P17, DOI 10.1016/j.mehy.2010.08.020; Winje BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039259; Worton S, 2014, PLACENTA, V35, pA15, DOI 10.1016/j.placenta.2014.06.053; Wright C, 2011, PLACENTA, V32, P1010, DOI 10.1016/j.placenta.2011.07.008; Yao RF, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.044; Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193; Zeitlin J, 2013, EURO PERISTAT PROJEC; ZLATNIK FJ, 1979, OBSTET GYNECOL, V54, P205	84	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0129117	10.1371/journal.pone.0129117	http://dx.doi.org/10.1371/journal.pone.0129117			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26120838	Green Submitted, Green Published, gold			2022-12-27	WOS:000358150400017
J	Oksuzyan, A; Shkolnikova, M; Vaupel, JW; Christensen, K; Shkolnikov, VM				Oksuzyan, Anna; Shkolnikova, Maria; Vaupel, James W.; Christensen, Kaare; Shkolnikov, Vladimir M.			Sex Differences in Biological Markers of Health in the Study of Stress, Aging and Health in Russia	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; SELF-RATED HEALTH; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; RISK-FACTORS; GENDER-DIFFERENCES; METABOLIC SYNDROME	Background The apparent contradiction that women live longer but have worse health than men, the so called male-female health-survival paradox, is very pronounced in Russia. The present study investigates whether men in Moscow are healthier than women at the level of biomarkers, and whether the associations between biomarkers and subjective health have sex-specific patterns. Materials Previously collected data in the study of Stress, Aging, and Health in Russia (SAHR, n = 1800) were used to examine sex differences in biomarkers and their associations with physical functioning and self-rated health. Results The present study found mixed directions and magnitudes for sex differences in biomarkers. Women were significantly disadvantaged with regard to obesity and waist circumference, whereas men had a tendency toward higher prevalence of electrocardiographic abnormalities. No sex differences were indicated in the prevalence of immunological biomarkers, and mixed patterns were found for lipid profiles. Many biomarkers were associated with physical functioning and general health. Obesity and waist circumference were related to lower physical functioning among females only, while major Q-wave abnormalities with high probabilities of myocardial infarction and atrial fibrillation or atrial flutter were associated with physical functioning and self-rated health among males only. Conclusion No clear patterns of sex differences in prevalence of high-risk levels of biomarkers suggest that the male-female health-survival paradox is weaker at the level of health biomarkers. We found some evidence that certain biomarkers reflecting pathophysiological changes in the organism that do not possess acute health risks, but over many years may lead to physical disability, are associated with physical functioning and self-rated health in women, whereas others reflecting more serious life-threatening pathophysiological changes are associated with physical functioning and self-rated health in men.	[Oksuzyan, Anna; Vaupel, James W.; Shkolnikov, Vladimir M.] Max Planck Inst Demog Res, Rostock, Germany; [Oksuzyan, Anna; Christensen, Kaare] Univ Southern Denmark, Dept Epidemiol Biostat & Biodemog, Odense, Denmark; [Shkolnikova, Maria] Pirogov Moscow Med Univ, Sci & Clin Inst Pediatry, Moscow, Russia; [Vaupel, James W.; Christensen, Kaare] Max Planck Odense Ctr Biodemog Aging, Odense, Denmark; [Christensen, Kaare] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Christensen, Kaare] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense, Denmark; [Shkolnikov, Vladimir M.] New Econ Sch, Moscow, Russia	Max Planck Society; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; New Economic School	Oksuzyan, A (corresponding author), Max Planck Inst Demog Res, Rostock, Germany.	oksuzyan@demogr.mpg.de	Andersen, Mette Adalheidur/D-5608-2017; Shkolnikova, Maria/E-2782-2014; Shkolnikov, Vladimir/D-2986-2017; Christensen, Kaare/C-2360-2009	Shkolnikova, Maria/0000-0001-7115-0186; Shkolnikov, Vladimir/0000-0003-2259-5423; Oksuzyan, Anna/0000-0003-4138-5886; Vaupel, James/0000-0003-0783-3905; Christensen, Kaare/0000-0002-5429-5292	US National Institute of Health [P01AG031719, R01AG026786]; VELUX foundation; Dynasty Foundation, Russia; NATIONAL INSTITUTE ON AGING [R01AG026786, P30AG034424, P01AG031719] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VELUX foundation(Velux Fonden); Dynasty Foundation, Russia; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by the US National Institute of Health, grants P01AG031719 and R01AG026786 (http://fds.duke.edu/db/Sanford/pparc/grants.html), and the VELUX foundation (http://veluxfonden.dk). Vladimir Shkolnikov was partly funded by the Dynasty Foundation, Russia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad OB, 2001, GPE DISCUSSION PAPER, V31, P1; AHMED SA, 1985, AM J PATHOL, V121, P531; Akerblom JL, 2008, AGE AGEING, V37, P207, DOI 10.1093/ageing/afn017; Aksel E.M., 2009, J NN BLOKHIN RUSS CA, V20, P52; Andersen FK, 2007, SCAND J PUBLIC HEALT, V35, P164, DOI 10.1080/14034940600975674; Andersen-Ranberg K, 2009, EUR J AGEING, V6, P227, DOI 10.1007/s10433-009-0128-6; Andreev EM, 2003, B WORLD HEALTH ORGAN, V81, P778; Averina M, 2003, EUR J EPIDEMIOL, V18, P871, DOI 10.1023/A:1025626202235; Bambra C., 2008, J EPIDEMIOLOGY COMMU, V63, P38, DOI [10.1136/jech.2007.070292, DOI 10.1136/JECH.2007.070292]; Bobak M, 2004, BRIT MED J, V329, P767, DOI 10.1136/bmj.38202.667130.55; Brescianini S, 2003, J AM GERIATR SOC, V51, P991, DOI 10.1046/j.1365-2389.2003.51313.x; Carlson P, 2001, J EPIDEMIOL COMMUN H, V55, P806, DOI 10.1136/jech.55.11.806; Case A, 2005, DEMOGRAPHY, V42, P189, DOI 10.1353/dem.2005.0011; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Crimmins EM, 2011, EUR J PUBLIC HEALTH, V21, P81, DOI 10.1093/eurpub/ckq022; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; De Bacquer D, 1998, HEART, V80, P570, DOI 10.1136/hrt.80.6.570; De Bacquer D, 2000, HEART, V84, P625, DOI 10.1136/heart.84.6.625; ELIASSON M, 1993, FIBRINOLYSIS, V7, P316, DOI 10.1016/0268-9499(93)90147-N; ETTINGER WH, 1992, CIRCULATION, V86, P858, DOI 10.1161/01.CIR.86.3.858; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Glei DA, 2013, SOC SCI MED, V77, P164, DOI 10.1016/j.socscimed.2012.11.022; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; GROSSMAN CJ, 1985, SCIENCE, V227, P257, DOI 10.1126/science.3871252; Hammar N, 2001, INT J EPIDEMIOL, V30, pS30, DOI 10.1093/ije/30.suppl_1.S30; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; KROBOT K, 1992, ARTERIOSCLER THROMB, V12, P780, DOI 10.1161/01.ATV.12.7.780; Lawlor DA, 2001, BRIT MED J, V323, P541, DOI 10.1136/bmj.323.7312.541; Leon DA, 2013, EUR J EPIDEMIOL, V28, P393, DOI 10.1007/s10654-013-9808-9; LIAO YL, 1987, CIRCULATION, V75, P347, DOI 10.1161/01.CIR.75.2.347; Lofmark U, 2007, NEUROEPIDEMIOLOGY, V28, P135, DOI 10.1159/000102141; Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d; MANOLIO TA, 1994, J AM COLL CARDIOL, V23, P916, DOI 10.1016/0735-1097(94)90638-6; Marzona I, 2012, CAN MED ASSOC J, V184, pE329, DOI 10.1503/cmaj.111173; McConnell JP, 2002, CLIN CHEM LAB MED, V40, P56, DOI 10.1515/CCLM.2002.011; MESLE F., 2004, DEMOGRAPHIC RES SPEC, V2, P45, DOI DOI 10.4054/DEMRES.2004.S2.3; Metelskaya VA, 2012, ARCH GERONTOL GERIAT, V55, P231, DOI 10.1016/j.archger.2011.09.005; Nakamura Y, 2013, J ELECTROCARDIOL, V46, P360, DOI 10.1016/j.jelectrocard.2013.03.009; NATHANSON CA, 1975, SOC SCI MED, V9, P57, DOI 10.1016/0037-7856(75)90094-3; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Oksuzyan A, 2014, EUR J EPIDEMIOL, V29, P243, DOI 10.1007/s10654-014-9893-4; Oksuzyan A, 2010, EUR J EPIDEMIOL, V25, P471, DOI 10.1007/s10654-010-9460-6; Olsen KM, 2007, SOC SCI MED, V64, P1665, DOI 10.1016/j.socscimed.2006.11.031; Owens IPF, 2002, SCIENCE, V297, P2008, DOI 10.1126/science.1076813; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; PELKONEN R, 1977, BRIT MED J, V2, P1185, DOI 10.1136/bmj.2.6096.1185; Perlman F, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-19; Petrea RE, 2009, STROKE, V40, P1032, DOI 10.1161/STROKEAHA.108.542894; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Pieroni L, 2003, DIABETES METAB, V29, P133, DOI 10.1016/S1262-3636(07)70019-8; Prineas RJ, 2010, MINNESOTA CODE MANUA; Psaty BM, 2004, J AM GERIATR SOC, V52, P1639, DOI 10.1111/j.1532-5415.2004.52455.x; Rautaharju PM, 2006, AM J CARDIOL, V97, P309, DOI 10.1016/j.amjcard.2005.08.046; Read JG, 2006, SOC SCI MED, V62, P1045, DOI 10.1016/j.socscimed.2005.07.009; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Rifai N, 2003, CLIN CHEM, V49, P666, DOI 10.1373/49.4.666; Rigby JE, 2007, J EPIDEMIOL COMMUN H, V61, P159, DOI 10.1136/jech.2006.047381; Rodbard Helena W, 2007, Endocr Pract, V13 Suppl 1, P1; Rogowski O, 2004, BIOMARKERS, V9, P85, DOI 10.1080/13547500410001670303; Rosengren A, 2001, EUR HEART J, V22, P314, DOI 10.1053/euhj.2000.2368; Sandberg K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-7; Schupf N, 2005, J AM GERIATR SOC, V53, P219, DOI 10.1111/j.1532-5415.2005.53106.x; Shkolnikova M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-293; SIMONS LA, 1986, AM J CARDIOL, V57, pG5, DOI 10.1016/0002-9149(86)90659-4; StataCorp, 2021, STATA STAT SOFTWARE; Syddall H, 2009, J AGING HEALTH, V21, P913, DOI 10.1177/0898264309340793; Tanriverdi F, 2003, J ENDOCRINOL, V176, P293, DOI 10.1677/joe.0.1760293; Thrall G, 2006, AM J MED, V119, DOI 10.1016/jamjmed.2005.10.057; Tiainen K, 2012, EXP GERONTOL, V47, P109, DOI 10.1016/j.exger.2011.11.002; Truelsen T, 2006, EUR J NEUROL, V13, P581, DOI 10.1111/j.1468-1331.2006.01138.x; VERBRUGGE LM, 1987, WOMEN HEALTH, V12, P103, DOI 10.1300/J013v12n02_07; Ware J., 1993, SF 36 HLTH SURVEY MA; Ware J.E., 1994, SF 36 PHYS MENTAL HL; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; WIINBERG N, 1995, AM J HYPERTENS, V8, P978, DOI 10.1016/0895-7061(95)00216-2; Wilsgaard T, 2000, ARCH INTERN MED, V160, P2847, DOI 10.1001/archinte.160.18.2847; World Health Organization, 2008, WAIST CIRCUMFERENCE; Yamada S, 2001, AM J EPIDEMIOL, V153, P1183, DOI 10.1093/aje/153.12.1183; Ye XW, 2007, J AM COLL CARDIOL, V49, P1798, DOI 10.1016/j.jacc.2007.01.065; Zhang ZM, 2011, AM J CARDIOL, V107, P817, DOI 10.1016/j.amjcard.2010.11.004	86	11	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131691	10.1371/journal.pone.0131691	http://dx.doi.org/10.1371/journal.pone.0131691			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121035	Green Published, Green Submitted, gold			2022-12-27	WOS:000358150400144
J	Parisutham, V; Lee, SK				Parisutham, Vinuselvi; Lee, Sung Kuk			Novel Functions and Regulation of Cryptic Cellobiose Operons in Escherichia coli	PLOS ONE			English	Article							GENES; METABOLISM; TRANSCRIPTION; BACTERIA; SEQUENCE; STRAINS; GROWTH; YIELDS; SITES; K-12	Presence of cellobiose as a sole carbon source induces mutations in the chb and asc operons of Escherichia coli and allows it to grow on cellobiose. We previously engineered these two operons with synthetic constitutive promoters and achieved efficient cellobiose metabolism through adaptive evolution. In this study, we characterized two mutations observed in the efficient cellobiose metabolizing strain: duplication of RBS of ascB gene, (beta-glucosidase of asc operon) and nonsense mutation in yebK, (an uncharacterized transcription factor). Mutations in yebK play a dominant role by modulating the length of lag phase, relative to the growth rate of the strain when transferred from a rich medium to minimal cellobiose medium. Mutations in ascB, on the other hand, are specific for cellobiose and help in enhancing the specific growth rate. Taken together, our results show that ascB of the asc operon is controlled by an internal putative promoter in addition to the native cryptic promoter, and the transcription factor yebK helps to remodel the host physiology for cellobiose metabolism. While previous studies characterized the stress-induced mutations that allowed growth on cellobiose, here, we characterize the adaptation-induced mutations that help in enhancing cellobiose metabolic ability. This study will shed new light on the regulatory changes and factors that are needed for the functional coupling of the host physiology to the activated cryptic cellobiose metabolism.	[Parisutham, Vinuselvi; Lee, Sung Kuk] UNIST, Sch Life Sci, Ulsan, South Korea; [Lee, Sung Kuk] UNIST, Sch Energy & Chem Engn, Ulsan, South Korea	Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST)	Lee, SK (corresponding author), UNIST, Sch Life Sci, Ulsan, South Korea.	sklee@unist.ac.kr	Lee, Sung K/E-6525-2010; Parisutham, Vinuselvi/AAA-4030-2019; Lee, Sung K/HGC-6832-2022	Parisutham, Vinuselvi/0000-0002-0349-4072; 	National Research Foundation of Korea (NRF) through grants - Ministry of Science, ICT & Future Planning (MSIP) [NRF-2009-C1AAA001-2009-0093491]; Intelligent Synthetic Biology Center of Global Frontier Project - MSIP [2011-0031948]; Next-Generation Bio Green 21 Program (SSAC), Rural Development Administration, Republic of Korea [PJ0099058]	National Research Foundation of Korea (NRF) through grants - Ministry of Science, ICT & Future Planning (MSIP); Intelligent Synthetic Biology Center of Global Frontier Project - MSIP; Next-Generation Bio Green 21 Program (SSAC), Rural Development Administration, Republic of Korea	This work was supported by the National Research Foundation of Korea (NRF) through grants funded by the Ministry of Science, ICT & Future Planning (MSIP) (NRF-2009-C1AAA001-2009-0093491), by the Intelligent Synthetic Biology Center of Global Frontier Project funded by the MSIP (2011-0031948), and by a grant from the Next-Generation Bio Green 21 Program (SSAC, PJ0099058), Rural Development Administration, Republic of Korea.	Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Cheng KK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4233; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Conrad TM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r118; Daddaoua A, 2009, J BIOL CHEM, V284, P21360, DOI 10.1074/jbc.M109.014555; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Dwidar M, 2015, ENVIRON MICROBIOL, V17, P1009, DOI 10.1111/1462-2920.12463; HALL BG, 1992, MOL BIOL EVOL, V9, P688; Hua Q, 2007, APPL ENVIRON MICROB, V73, P4639, DOI 10.1128/AEM.00527-07; Ito M, 2005, METAB ENG, V7, P318, DOI 10.1016/j.ymben.2005.06.004; Kachroo AH, 2007, MOL MICROBIOL, V66, P1382, DOI 10.1111/j.1365-2958.2007.05999.x; Keyhani NO, 1997, P NATL ACAD SCI USA, V94, P14367, DOI 10.1073/pnas.94.26.14367; Kochanowski K, 2013, CURR OPIN BIOTECH, V24, P987, DOI 10.1016/j.copbio.2013.03.014; Leyn SA, 2011, J BIOL CHEM, V286, P35782, DOI 10.1074/jbc.M111.267963; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Na D, 2010, BIOINFORMATICS, V26, P2633, DOI 10.1093/bioinformatics/btq458; Neelakanta G, 2009, APPL ENVIRON MICROB, V75, P2284, DOI 10.1128/AEM.02621-08; Parisutham V, 2013, CHEM ENG SCI, V103, P50, DOI 10.1016/j.ces.2012.08.006; Raghavan R, 2011, J BACTERIOL, V193, P2871, DOI 10.1128/JB.00398-11; Raghunand TR, 2003, FEMS MICROBIOL LETT, V223, P267, DOI 10.1016/S0378-1097(03)00393-8; Rolfe MD, 2012, J BACTERIOL, V194, P686, DOI 10.1128/JB.06112-11; Ryu YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094266; Saito N, 2009, J BIOL CHEM, V284, P16442, DOI 10.1074/jbc.M109.002089; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2555, DOI 10.1038/nprot.2006.480; Vinuselvi P, 2011, APPL MICROBIOL BIOT, V92, P125, DOI 10.1007/s00253-011-3434-9	26	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131928	10.1371/journal.pone.0131928	http://dx.doi.org/10.1371/journal.pone.0131928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121029	Green Published, Green Submitted, gold			2022-12-27	WOS:000358150400180
J	Tholking, G; Koch, R; Pavenstadt, H; Schuette-Nuetgen, K; Busch, V; Wolters, H; Kelsch, R; Reuter, S; Suwelack, B				Thoeking, Gerold; Koch, Raphael; Pavenstaedt, Hermann; Schuette-Nuetgen, Katharina; Busch, Veit; Wolters, Heiner; Kelsch, Reinhard; Reuter, Stefan; Suwelack, Barbara			Antigen-Specific versus Non-Antigen-Specific Immunoadsorption in ABO-Incompatible Renal Transplantation	PLOS ONE			English	Article							DONOR KIDNEY-TRANSPLANTATION; INFECTIOUS COMPLICATIONS; ALLOGRAFT SURVIVAL; ANTIBODY REMOVAL; RECIPIENTS; RITUXIMAB; IMMUNOSUPPRESSION; IMPLEMENTATION; SPLENECTOMY; EXPERIENCE	Introduction ABO-incompatible (ABOi) renal transplantation (RTx) from living donors is an established procedure to expand the donor pool for patients with end stage renal disease. Immunoadsorption (IA) is a standard procedure for the removal of preformed antibodies against the allograft. In this study, antigen-specific and non-antigen-specific IA in ABOi RTx were compared. Patients and Methods 10 patients underwent antigen-specific IA (Glycosorb group) and 13 patients non-antigen-specific IA (Immunosorba group). The effects of both procedures regarding antibody reduction, number of treatments, complications, costs, as well as the allograft function and patient survival were compared between both groups. Results Although the IgG levels were reduced equally by both procedures (p=0.82), the reduction of the IgM level was more effective in the Glycosorb group (p=0.0172). Patients in both groups required a median number of 6 IA before ABOi RTx. Allograft function at one year after AB0i RTx was similar in both groups (estimated glomerular filtration rate: 66 vs. 64 ml/min/1.73m(2) respectively), with a death-censored graft survival of 90.0% and 92.3% respectively. Complication rates did not differ between procedures. Due to the reuse of non-antigen-specific Immunosorba columns, costs were considerably lower in this group; however, the use of the Immunosorba-based IA was less time-efficient. Conclusion Considering upcoming alternatives as simultaneous performance of dialysis and IA or a possible reuse of Glycosorb columns, this might become less relevant in the future.	[Thoeking, Gerold; Pavenstaedt, Hermann; Schuette-Nuetgen, Katharina; Busch, Veit; Reuter, Stefan; Suwelack, Barbara] Univ Hosp, Dept Med D, Div Gen Internal Med Nephrol & Rheumatol, Munster, Germany; [Koch, Raphael] Univ Munster, Inst Biostat & Clin Res, D-48149 Munster, Germany; [Wolters, Heiner] Univ Hosp, Dept Gen Surg, Munster, Germany; [Kelsch, Reinhard] Univ Hosp, Inst Transfus Med & Transplantat Immunol, Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster	Tholking, G (corresponding author), Univ Hosp, Dept Med D, Div Gen Internal Med Nephrol & Rheumatol, Munster, Germany.	Gerold.Thoelking@ukmuenster.de	Koch, Raphael/A-7857-2013	Koch, Raphael/0000-0002-5581-5122	Deutsche Forschungsgemeinschaft; University of Munster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Munster	The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Munster.	ALEXANDRE GPJ, 1987, TRANSPLANT P, V19, P4538; Bahde R, 2014, ANN TRANSPL, V19, P201, DOI 10.12659/AOT.890125; Chuang JP, 2008, TRANSPL P, V40, P2685, DOI 10.1016/j.transproceed.2008.08.018; de Freitas DG, 2012, AM J TRANSPLANT, V12, P191, DOI 10.1111/j.1600-6143.2011.03784.x; de Weerd AE, 2014, TRANSPL INT; El Ters M, 2013, AM J TRANSPLANT, V13, P2334, DOI 10.1111/ajt.12370; Flint SM, 2011, AM J TRANSPLANT, V11, P1016, DOI 10.1111/j.1600-6143.2011.03464.x; Grim SA, 2007, CLIN TRANSPLANT, V21, P628, DOI 10.1111/j.1399-0012.2007.00700.x; Habicht A, 2011, NEPHROL DIAL TRANSPL, V26, P4124, DOI 10.1093/ndt/gfr215; Ishida H, 2007, AM J TRANSPLANT, V7, P825, DOI 10.1111/j.1600-6143.2006.01676.x; Kahwaji J, 2011, CLIN J AM SOC NEPHRO, V6, P2894, DOI 10.2215/CJN.03710411; Klein K, 2013, ATHEROSCLEROSIS SUPP, V14, P199, DOI 10.1016/j.atherosclerosissup.2012.10.030; Lentine KL, 2014, TRANSPLANTATION, V98, P54, DOI 10.1097/TP.0000000000000029; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Maggioni S, 2014, J REN CARE, V40, P164, DOI 10.1111/jorc.12057; Masterson R, 2014, AM J TRANSPLANT, V14, P2807, DOI 10.1111/ajt.12920; Montgomery RA, 2007, TRANSPLANTATION, V84, pS8, DOI 10.1097/01.tp.0000296032.12974.bb; Montgomery RA, 2009, TRANSPLANTATION, V87, P1246, DOI 10.1097/TP.0b013e31819f2024; Morath C, 2003, NEPHROL DIAL TRANSPL, V18, P644, DOI 10.1093/ndt/gfg036; Morath C, 2012, TRANSPLANTATION, V93, P827, DOI 10.1097/TP.0b013e31824836ae; Ohdan H, 2014, TRANSPL INT; Opelz G, 2014, TRANSPLANTATION; Renner FC, 2010, TRANSPL P, V42, P4164, DOI 10.1016/j.transproceed.2010.09.056; Schaefer B, 2013, PEDIATR NEPHROL, V28, P327, DOI 10.1007/s00467-012-2302-x; Schiesser M, 2014, TRANSPLANTATION; Schneider KM, 1998, KIDNEY INT, pS61; Sienko J, 2003, TRANSPLANT P, V35, P2153, DOI 10.1016/S0041-1345(03)00766-8; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Takahashi K, 2004, AM J TRANSPLANT, V4, P1089, DOI 10.1111/j.1600-6143.2004.00464.x; Thalgahagoda S, 2014, PEDIATR TRANSPLANT, V18, pE74, DOI 10.1111/petr.12227; Tyden G, 2006, XENOTRANSPLANTATION, V13, P105, DOI 10.1111/j.1399-3089.2006.00292.x; Tyden G, 2003, TRANSPLANTATION, V76, P730, DOI 10.1097/01.TP.0000078622.43689.D4; van Agteren M, 2014, J TRANSPLANT, V2014, DOI 10.1155/2014/913902; Wahrmann M, 2012, NEPHROL DIAL TRANSPL, V27, P2122, DOI 10.1093/ndt/gfr610; Wilpert J, 2010, NEPHROL DIAL TRANSPL, V25, P3778, DOI 10.1093/ndt/gfq229	35	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131465	10.1371/journal.pone.0131465	http://dx.doi.org/10.1371/journal.pone.0131465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121389	Green Published, gold			2022-12-27	WOS:000358150400111
J	Bao, XD; de Soet, JJ; Tong, HC; Gao, XJ; He, LB; van Loveren, C; Deng, DM				Bao, Xudong; de Soet, Johannes Jacob; Tong, Huichun; Gao, Xuejun; He, Libang; van Loveren, Cor; Deng, Dong Mei			Streptococcus oligofermentans Inhibits Streptococcus mutans in Biofilms at Both Neutral pH and Cariogenic Conditions	PLOS ONE			English	Article							INTERSPECIES COMPETITION; ACID TOLERANCE; OXIDASE; COMMUNITIES; LACTATE; CARIES; FLORA; H2O2	Homeostasis of oral microbiota can be maintained through microbial interactions. Previous studies showed that Streptococcus oligofermentans, a non-mutans streptococci frequently isolated from caries-free subjects, inhibited the cariogenic Streptococcus mutans by the production of hydrogen peroxide (HP). Since pH is a critical factor in caries formation, we aimed to study the influence of pH on the competition between S. oligofermentans and S. mutans in biofilms. To this end, S. mutans and S. oligofermentans were inoculated alone or mixed at 1:1 ratio in buffered biofilm medium in a 96-well active attachment model. The single-and dual-species biofilms were grown under either constantly neutral pH or pH-cycling conditions. The latter includes two cycles of 8 h neutral pH and 16 h pH 5.5, used to mimic cariogenic condition. The 48 h biofilms were analysed for the viable cell counts, lactate and HP production. The last two measurements were carried out after incubating the 48 h biofilms in buffers supplemented with 1% glucose (pH 7.0) for 4 h. The results showed that S. oligofermentans inhibited the growth of S. mutans in dual-species biofilms under both tested pH conditions. The lactic acid production of dual-species biofilms was significantly lower than that of single-species S. mutans biofilms. Moreover, dual-species and single-species S. oligofermentans biofilms grown under pH-cycling conditions (with a 16 h low pH period) produced a significantly higher amount of HP than those grown under constantly neutral pH. In conclusion, S. oligofermentans inhibited S. mutans in biofilms not only under neutral pH, but also under pH-cycling conditions, likely through HP production. S. oligofermentans may be a compelling probiotic candidate against caries.	[Bao, Xudong; Gao, Xuejun] Peking Univ, Sch & Hosp Stomatol, Dept Cariol & Endodontol, Beijing 100871, Peoples R China; [Bao, Xudong; de Soet, Johannes Jacob; van Loveren, Cor; Deng, Dong Mei] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Prevent Dent, Amsterdam, Netherlands; [Bao, Xudong; de Soet, Johannes Jacob; van Loveren, Cor; Deng, Dong Mei] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Tong, Huichun] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China; [He, Libang] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China	Peking University; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Chinese Academy of Sciences; Institute of Microbiology, CAS; Sichuan University	Deng, DM (corresponding author), Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Prevent Dent, Amsterdam, Netherlands.	d.deng@acta.nl	Deng, Dongmei/V-9230-2017					Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; BENDER GR, 1986, INFECT IMMUN, V53, P331, DOI 10.1128/IAI.53.2.331-338.1986; Berkowitz Robert J, 2003, J Can Dent Assoc, V69, P304; Bradshaw DJ, 1998, CARIES RES, V32, P456, DOI 10.1159/000016487; Bradshawa DJ, 2002, CARIES RES, V36, P81, DOI 10.1159/000057864; de Soet JJ, 2000, CARIES RES, V34, P486, DOI 10.1159/000016628; Gutmann I., 1974, METHODS ENZYMATIC AN, P1464; HARPER DS, 1984, ARCH ORAL BIOL, V29, P843, DOI 10.1016/0003-9969(84)90015-3; JENSEN ME, 1983, J DENT RES, V62, P1058, DOI 10.1177/00220345830620101001; Li XL, 2014, J BASIC MICROB, V54, P97, DOI 10.1002/jobm.201200457; Liu L, 2012, APPL ENVIRON MICROB, V78, P2120, DOI 10.1128/AEM.07539-11; Liu Y, 2014, EUR J ORAL SCI, V122, P57, DOI 10.1111/eos.12102; Liu Y, 2012, EUR J ORAL SCI, V120, P179, DOI 10.1111/j.1600-0722.2012.00957.x; Marsh P D, 1994, Adv Dent Res, V8, P263; Marsh Philip D, 2006, BMC Oral Health, V6 Suppl 1, pS14, DOI 10.1186/1472-6831-6-S1-S14; Nyvad B, 2013, CARIES RES, V47, P89, DOI 10.1159/000345367; Seki M, 2004, J BACTERIOL, V186, P2046, DOI 10.1128/JB.186.7.2046-2051.2004; Tanzer JM, 2012, J DENT RES, V91, P513, DOI 10.1177/0022034512442894; Tong HC, 2003, INT J SYST EVOL MICR, V53, P1101, DOI 10.1099/ijs.0.02493-0; Tong HC, 2008, J BACTERIOL, V190, P4716, DOI 10.1128/JB.00363-08; Tong HC, 2007, MOL MICROBIOL, V63, P872, DOI 10.1111/j.1365-2958.2006.05546.x; Zhang J, 2010, CARIES RES, V44, P345, DOI 10.1159/000315277	23	15	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130962	10.1371/journal.pone.0130962	http://dx.doi.org/10.1371/journal.pone.0130962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114758	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500113
J	Mekuria, LA; Prins, JM; Yalew, AW; Sprangers, MAG; Nieuwkerk, PT				Mekuria, Legese A.; Prins, Jan M.; Yalew, Alemayehu W.; Sprangers, Mirjam A. G.; Nieuwkerk, Pythia T.			Retention in HIV Care and Predictors of Attrition from Care among HIV-Infected Adults Receiving Combination Anti-Retroviral Therapy in Addis Ababa	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; PATIENT RETENTION; INCOME COUNTRIES; UNITED-STATES; SCALE-UP; TREATMENT PROGRAM; DRUG-RESISTANCE; LIFE EXPECTANCY; SOUTH-AFRICA; MORTALITY	Background Patient retention in chronic HIV care is a major challenge following the rapid expansion of combination antiretroviral therapy (cART) in Ethiopia. Objective To describe the proportion of patients who are retained in HIV care and characterize predictors of attrition among HIV-infected adults receiving cART in Addis Ababa. Method A retrospective analysis was conducted among 836 treatment naive patients, who started cART between May 2009 and April 2012. Patients were randomly selected from ten healthcare facilities, and their current status in HIV care was determined based on routinely available data in the medical records. Patients lost to follow-up (LTFU) were traced by telephone. Kaplan-Meier technique was used to estimate survival probabilities of retention and Cox proportional hazards regression was performed to identify the predictors of attrition. Results Based on individual patient data from the medical records, nearly 80% (95%CI: 76.7, 82.1) of the patients were retained in care in the first 3 and half years of antiretroviral therapy. After successfully tracing more than half of the LTFU patients, the updated one year retention in care estimate became 86% (95% CI: 83.41%, 88.17%). In the multivariate Cox regression analyses, severe immune deficiency at enrolment in care/or at cART initiation and 'bed-ridden' or 'ambulatory' functional status at the start of cART predicted attrition. Conclusion Retention in HIV care in Addis Ababa is comparable with or even better than previous findings from other resource-limited as well as EU/USA settings. However, measures to detect and enroll patients in HIV care as early as possible are still necessary.	[Mekuria, Legese A.; Sprangers, Mirjam A. G.; Nieuwkerk, Pythia T.] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, NL-1105 AZ Amsterdam, Netherlands; [Mekuria, Legese A.] Erasmus MC, Netherlands Inst Hlth Sci, Dept Epidemiol, Rotterdam, Netherlands; [Mekuria, Legese A.; Yalew, Alemayehu W.] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia; [Prins, Jan M.] Univ Amsterdam, Acad Med Ctr, Trop Med & AIDS, Dept Internal Med,Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Addis Ababa University; University of Amsterdam; Academic Medical Center Amsterdam	Mekuria, LA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	legesealex@gmail.com	Nieuwkerk, Pythia/S-4084-2017; Prins, Jan M./AAF-4945-2020	Nieuwkerk, Pythia/0000-0002-2616-1414; Prins, Jan/0000-0002-5415-8933	Netherlands Fellowship Program (NFP) - Netherlands Government; HIV Research Trust [HIVRT13-049]; Netherlands Universities' Foundation for International Cooperation [CF7455/2011]	Netherlands Fellowship Program (NFP) - Netherlands Government; HIV Research Trust; Netherlands Universities' Foundation for International Cooperation	LAM was granted a fellowship for PhD studies from the Netherlands Fellowship Program (NFP), funded by the Netherlands Government. He has also been granted a scholarship from the HIV Research Trust to study Epidemiology at NIHES/Erasmus Medical Center. This research work was supported by the Netherlands Universities' Foundation for International Cooperation (grant number CF7455/2011) and by the HIV Research Trust (grant number HIVRT13-049). For the remaining authors none were declared. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosioni J, 2014, EXPERT REV ANTI-INFE, V12, P523, DOI 10.1586/14787210.2014.906900; Araya T, 2011, TROP MED INT HEALTH, V16, P1483, DOI 10.1111/j.1365-3156.2011.02867.x; Assefa Y, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-43; Assefa Y, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-81; Assefa Y, 2010, AIDS PATIENT CARE ST, V24, P521, DOI 10.1089/apc.2009.0286; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brown DM, 2006, AIDS CARE, V18, P821, DOI 10.1080/09540120500466747; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Deribew A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-408; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; FMoH/FHAPCO (Ethiopia), 2009, ART SCAL ETH SUCC CH; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Hall HI, 2013, JAMA INTERN MED, V173, P1337, DOI 10.1001/jamainternmed.2013.6841; Hall HI, 2012, JAIDS-J ACQ IMM DEF, V60, P77, DOI 10.1097/QAI.0b013e318249fe90; Harries AD, 2010, TROP MED INT HEALTH, V15, P70, DOI 10.1111/j.1365-3156.2010.02506.x; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Howe CJ, 2010, AIDS RES HUM RETROV, V26, P875, DOI 10.1089/aid.2009.0282; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Krentz HB, 2005, HIV MED, V6, P99, DOI 10.1111/j.1468-1293.2005.00271.x; Lawn SD, 2006, CLIN INFECT DIS, V42, P431, DOI 10.1086/499527; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; MoH/FHAPCO, HIV AIDS EST PROJ ET; MoH/FHAPCO, 2007, SINGL POINT HIV PREV; MoH/FHAPCO [Ethiopia], 2007, GUID MAN OPP INF ANT; Molfino L, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23758; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Mugavero MJ, 2010, AIDS PATIENT CARE ST, V24, P607, DOI 10.1089/apc.2010.0086; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Mutasa-Apollo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086305; Narita M, 1998, AM J RESP CRIT CARE, V158, P157, DOI 10.1164/ajrccm.158.1.9712001; Reniers G, 2009, AIDS, V23, P511, DOI 10.1097/QAD.0b013e32832403d0; Stricker SM, 2014, AIDS BEHAV, V18, pS465, DOI 10.1007/s10461-013-0598-6; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Torian LV, 2011, AIDS PATIENT CARE ST, V25, P79, DOI 10.1089/apc.2010.0151; Tweya H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075761; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; Wester CW, 2005, JAIDS-J ACQ IMM DEF, V40, P336, DOI 10.1097/01.qai.0000159668.80207.5b; WHO, 2010, ANT THER HIV INF AD; WHO, 2005, TREAT 3 MILL 2005 IN	51	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130649	10.1371/journal.pone.0130649	http://dx.doi.org/10.1371/journal.pone.0130649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1AM	26114436	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500084
J	Tatke, G; Kumari, H; Silva-Herzog, E; Ramirez, L; Mathee, K				Tatke, Gorakh; Kumari, Hansi; Silva-Herzog, Eugenia; Ramirez, Lourdes; Mathee, Kalai			Pseudomonas aeruginosa MifS-MifR Two-Component System Is Specific for alpha-Ketoglutarate Utilization	PLOS ONE			English	Article							CATABOLITE REPRESSION CONTROL; CITRIC-ACID CYCLE; C-4-DICARBOXYLATE TRANSPORT GENES; ESCHERICHIA-COLI; RHIZOBIUM-LEGUMINOSARUM; SIGNAL-TRANSDUCTION; CYSTIC-FIBROSIS; CORYNEBACTERIUM-GLUTAMICUM; SACCHAROMYCES-CEREVISIAE; NITROGEN-UTILIZATION	Pseudomonas aeruginosa is a Gram-negative, metabolically versatile opportunistic pathogen that elaborates a multitude of virulence factors, and is extraordinarily resistant to a gamut of clinically significant antibiotics. This ability, in part, is mediated by two-component regulatory systems (TCS) that play a crucial role in modulating virulence mechanisms and metabolism. MifS (PA5512) and MifR (PA5511) form one such TCS implicated in biofilm formation. MifS is a sensor kinase whereas MifR belongs to the NtrC superfamily of transcriptional regulators that interact with RpoN (sigma(54)). In this study we demonstrate that the mifS and mifR genes form a two-gene operon. The close proximity of mifSR operon to poxB (PA5514) encoding a beta-lactamase hinted at the role of MifSR TCS in regulating antibiotic resistance. To better understand this TCS, clean in-frame deletions were made in P. aeruginosa PAO1 creating PAO Delta mifS, PAO Delta mifR and PAO Delta mifSR. The loss of mifSR had no effect on the antibiotic resistance profile. Phenotypic microarray (BioLOG) analyses of PAO Delta mifS and PAO Delta mifR revealed that these mutants were unable to utilize C-5-dicarboxylate alpha-ketoglutarate (alpha-KG), a key tricarboxylic acid cycle intermediate. This finding was confirmed using growth analyses, and the defect can be rescued by mifR or mifSR expressed in trans. These mifSR mutants were able to utilize all the other TCA cycle intermediates (citrate, succinate, fumarate, oxaloacetate or malate) and sugars (glucose or sucrose) except alpha-KG as the sole carbon source. We confirmed that the mifSR mutants have functional dehydrogenase complex suggesting a possible defect in alpha-KG transport. The inability of the mutants to utilize alpha-KG was rescued by expressing PA5530, encoding C-5-dicarboxylate transporter, under a regulatable promoter. In addition, we demonstrate that besides MifSR and PA5530, alpha-KG utilization requires functional RpoN. These data clearly suggests that P. aeruginosa MifSR TCS is involved in sensing a-KG and regulating its transport and subsequentmetabolism.	[Tatke, Gorakh; Ramirez, Lourdes] Florida Int Univ, Coll Arts & Sci, Dept Biol Sci, Miami, FL 33199 USA; [Tatke, Gorakh; Kumari, Hansi; Silva-Herzog, Eugenia; Mathee, Kalai] Florida Int Univ, Herbert Wertheim Coll Med, Dept Mol Microbiol & Infect Dis, Miami, FL 33199 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University	Mathee, K (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Dept Human & Mol Genet, Miami, FL 33199 USA.	matheelabfor65roses@gmail.com	Silva-Herzog, Eugenia/AFP-3674-2022; Mathee, Kalai/AAE-2085-2021	Mathee, Kalai/0000-0003-4569-5419	National Institutes of Health - Minority Biomedical Research Support SCORE [SC1AI081376]; National Science Foundation [IIP-1237818]; Biomedical Research Initiative (BRI) student research award [NIH/NIGMS R25 GM061347]; Florida International University (FIU) teaching assistantship (Biological Sciences); FIU research assistantship (Herbert Wertheim College of Medicine); MBRS-RISE fellowship [NIH/NIGMS R25 GM061347]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061347] Funding Source: NIH RePORTER	National Institutes of Health - Minority Biomedical Research Support SCORE; National Science Foundation(National Science Foundation (NSF)); Biomedical Research Initiative (BRI) student research award; Florida International University (FIU) teaching assistantship (Biological Sciences); FIU research assistantship (Herbert Wertheim College of Medicine); MBRS-RISE fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by the National Institutes of Health - Minority Biomedical Research Support SCORE (SC1AI081376; to KM), National Science Foundation IIP-1237818 [PFI-AIR: CREST-I/UCRC-Industry Ecosystem to Pipeline Research] (to KM), Biomedical Research Initiative (BRI) student research award (NIH/NIGMS R25 GM061347; to GT), Florida International University (FIU) teaching assistantship (Biological Sciences; to GT), FIU research assistantship (Herbert Wertheim College of Medicine; to GT), MBRS-RISE fellowship (NIH/NIGMS R25 GM061347; to LR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, M07A09 CLIN LAB STAN, V32, pM07; Asai K, 2000, MICROBIOL-UK, V146, P263, DOI 10.1099/00221287-146-2-263; Balasubramanian D, 2013, NUCLEIC ACIDS RES, V41, P1, DOI 10.1093/nar/gks1039; Balasubramanian D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034067; Barakat M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-315; Barrios H, 1999, NUCLEIC ACIDS RES, V27, P4305, DOI 10.1093/nar/27.22.4305; Bascom-Slack CA, 1998, MOL GEN GENET, V258, P512, DOI 10.1007/s004380050762; Behrends V, 2013, J BIOL CHEM, V288, P15098, DOI 10.1074/jbc.M112.442814; BOTT M, 1995, MOL MICROBIOL, V18, P533, DOI 10.1111/j.1365-2958.1995.mmi_18030533.x; Bourrellier ABF, 2010, P NATL ACAD SCI USA, V107, P502, DOI 10.1073/pnas.0910097107; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Brocker M, 2009, J BACTERIOL, V191, P3869, DOI 10.1128/JB.00113-09; Browne P, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-300; Busch W, 2004, MOL BIOTECHNOL, V27, P253, DOI 10.1385/MB:27:3:253; Busch W, 2002, CRIT REV BIOCHEM MOL, V37, P287, DOI 10.1080/10409230290771528; CAMPBELL JJR, 1953, BIOCHIM BIOPHYS ACTA, V11, P594, DOI 10.1016/0006-3002(53)90107-3; Cases I, 2003, ENVIRON MICROBIOL, V5, P1281, DOI 10.1111/j.1462-2920.2003.00528.x; Chakravarty A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-249; Chen YT, 2004, J MOL EVOL, V59, P725, DOI 10.1007/s00239-004-2663-2; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Cohen-Cymberknoh M, 2013, THORAX, V68, P1157, DOI 10.1136/thoraxjnl-2013-203204; Collier DN, 1996, RES MICROBIOL, V147, P551, DOI 10.1016/0923-2508(96)84011-3; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; DART JKG, 1988, EYE, V2, pS46, DOI 10.1038/eye.1988.133; Davies SJ, 1999, J BACTERIOL, V181, P5624, DOI 10.1128/JB.181.18.5624-5635.1999; DERETIC V, 1992, MOL MICROBIOL, V6, P2761, DOI 10.1111/j.1365-2958.1992.tb01455.x; Doucette CD, 2011, NAT CHEM BIOL, V7, P894, DOI [10.1038/NCHEMBIO.685, 10.1038/nchembio.685]; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; FINAN TM, 1981, J BACTERIOL, V148, P193, DOI 10.1128/JB.148.1.193-202.1981; Fraimow H, 2013, CRIT CARE CLIN, V29, P895, DOI 10.1016/j.ccc.2013.06.010; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; FROHMAN CE, 1951, J BIOL CHEM, V193, P277; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; Golby P, 1999, J BACTERIOL, V181, P1238, DOI 10.1128/JB.181.4.1238-1248.1999; Gooderham WJ, 2009, FEMS MICROBIOL REV, V33, P279, DOI 10.1111/j.1574-6976.2008.00135.x; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Hebert SC, 2004, NATURE, V429, P143, DOI 10.1038/429143a; Heurlier K, 2003, J BACTERIOL, V185, P2227, DOI 10.1128/JB.185.7.2227-2235.2003; Hoch JA, 1995, 2 COMPONENT SIGNAL T; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Janausch IG, 2002, BBA-BIOENERGETICS, V1553, P39, DOI 10.1016/S0005-2728(01)00233-X; JIANG J, 1989, J BACTERIOL, V171, P5244, DOI 10.1128/jb.171.10.5244-5253.1989; KESSLER B, 1992, MOL GEN GENET, V233, P293, DOI 10.1007/BF00587591; KING EO, 1954, J LAB CLIN MED, V44, P301; KOHLER T, 1989, NUCLEIC ACIDS RES, V17, P10125, DOI 10.1093/nar/17.23.10125; Kong KF, 2005, GENE, V358, P82, DOI 10.1016/j.gene.2005.05.027; KORNBERG H. L., 1966, ESSAYS BIOCHEM, V2, P1; Krebs HA, 1940, BIOCHEM J, V34, P775, DOI 10.1042/bj0340775; Kumari H, 2014, J MED MICROBIOL, V63, P544, DOI 10.1099/jmm.0.070185-0; Ledizet M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049578; Lee PC, 2010, MOL MICROBIOL, V75, P924, DOI 10.1111/j.1365-2958.2009.07027.x; Lehninger AL, 2013, LEHNINGER PRINCIPLES; Li W, 2007, J BACTERIOL, V189, P5413, DOI 10.1128/JB.00432-07; LIU P, 1952, J BACTERIOL, V64, P773, DOI 10.1128/JB.64.6.773-781.1952; Long LH, 2011, BIOCHEM BIOPH RES CO, V406, P20, DOI 10.1016/j.bbrc.2011.01.091; LOOMIS WF, 1967, J BACTERIOL, V93, P1397, DOI 10.1128/JB.93.4.1397-1401.1967; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Lundgren BR, 2014, J BACTERIOL, V196, P2543, DOI 10.1128/JB.01615-14; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Manfredi R, 2000, EUR J EPIDEMIOL, V16, P111, DOI 10.1023/A:1007626410724; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; MERRICK MJ, 1993, MOL MICROBIOL, V10, P903, DOI 10.1111/j.1365-2958.1993.tb00961.x; Moreno R, 2007, MOL MICROBIOL, V64, P665, DOI 10.1111/j.1365-2958.2007.05685.x; MORETT E, 1993, J BACTERIOL, V175, P6067, DOI 10.1128/JB.175.19.6067-6074.1993; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; Nishijyo T, 2001, MOL MICROBIOL, V40, P917, DOI 10.1046/j.1365-2958.2001.02435.x; Osuna J, 1997, PROTEIN SCI, V6, P543; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Petrova OE, 2012, MOL MICROBIOL, V86, P819, DOI 10.1111/mmi.12018; Petrova OE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000668; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Prevatt AR, 2004, OTOLARYNG HEAD NECK, V131, P248, DOI 10.1016/j.otohns.2004.01.017; Ramos J, 2004, PSEUDOMONAS; Reid CJ, 1998, J BACTERIOL, V180, P2660, DOI 10.1128/JB.180.10.2660-2669.1998; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; RONSON CW, 1987, J BACTERIOL, V169, P2424, DOI 10.1128/jb.169.6.2424-2431.1987; RONSON CW, 1987, NUCLEIC ACIDS RES, V15, P7921, DOI 10.1093/nar/15.19.7921; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Sambrook J., 2001, MOL CLONING LAB MANU; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; SEOL W, 1991, P NATL ACAD SCI USA, V88, P3802, DOI 10.1073/pnas.88.9.3802; Shanks RMQ, 2006, APPL ENVIRON MICROB, V72, P5027, DOI 10.1128/AEM.00682-06; Shanks RMQ, 2009, PLASMID, V62, P88, DOI 10.1016/j.plasmid.2009.05.002; Shen JS, 2002, J BACTERIOL, V184, P3268, DOI 10.1128/JB.184.12.3268-3275.2002; Sonnleitner E, 2009, P NATL ACAD SCI USA, V106, P21866, DOI 10.1073/pnas.pnas.0910308106; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Stulke J, 2000, ANNU REV MICROBIOL, V54, P849, DOI 10.1146/annurev.micro.54.1.849; Suh SJ, 2002, MICROBIOL-SGM, V148, P1561, DOI 10.1099/00221287-148-5-1561; Sun Y, 2010, J IMMUNOL, V185, P4272, DOI 10.4049/jimmunol.1000874; Turner KH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004518; Valderrey AD, 2010, DIAGN MICR INFEC DIS, V68, P20, DOI 10.1016/j.diagmicrobio.2010.04.008; Valentini M, 2011, J BACTERIOL, V193, P4307, DOI 10.1128/JB.05074-11; Varughese KL, 2002, CURR OPIN MICROBIOL, V5, P142, DOI 10.1016/S1369-5274(02)00305-3; Waite RD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-162; WANNER BL, 1992, J BACTERIOL, V174, P2124, DOI 10.1128/JB.174.7.2124-2130.1992; WATSON RJ, 1990, MOL PLANT MICROBE IN, V3, P174, DOI 10.1094/MPMI-3-174; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; WOLFF JA, 1991, J BACTERIOL, V173, P4700, DOI 10.1128/jb.173.15.4700-4706.1991; Wurtzel O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002945; Yamamoto H, 2000, MOL MICROBIOL, V37, P898, DOI 10.1046/j.1365-2958.2000.02055.x; YAROSH OK, 1989, MOL MICROBIOL, V3, P813, DOI 10.1111/j.1365-2958.1989.tb00230.x; Yeo SG, 2007, ACTA OTO-LARYNGOL, V127, P1062, DOI 10.1080/00016480601126978; Yeung ATY, 2011, J BACTERIOL, V193, P918, DOI 10.1128/JB.00911-10; Youn JW, 2009, J BACTERIOL, V191, P5480, DOI 10.1128/JB.00640-09; Zhang XX, 2008, GENETICS, V178, P185, DOI 10.1534/genetics.107.081984	114	20	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129629	10.1371/journal.pone.0129629	http://dx.doi.org/10.1371/journal.pone.0129629			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114434	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500032
J	Kong, QS; Yuan, JX; Gao, LY; Zhao, LQ; Cheng, F; Huang, Y; Bie, ZL				Kong, Qiusheng; Yuan, Jingxian; Gao, Lingyun; Zhao, Liqiang; Cheng, Fei; Huang, Yuan; Bie, Zhilong			Evaluation of Appropriate Reference Genes for Gene Expression Normalization during Watermelon Fruit Development	PLOS ONE			English	Article							TIME RT-PCR; INTERNAL CONTROL GENES; SYSTEMATIC VALIDATION; CITRULLUS-LANATUS; PROFILES; GENOME	Gene expression analysis in watermelon (Citrullus lanatus) fruit has drawn considerable attention with the availability of genome sequences to understand the regulatory mechanism of fruit development and to improve its quality. Real-time quantitative reverse-transcription PCR (qRT-PCR) is a routine technique for gene expression analysis. However, appropriate reference genes for transcript normalization in watermelon fruits have not been well characterized. The aim of this study was to evaluate the appropriateness of 12 genes for their potential use as reference genes in watermelon fruits. Expression variations of these genes were measured in 48 samples obtained from 12 successive developmental stages of parthenocarpic and fertilized fruits of two watermelon genotypes by using qRT-PCR analysis. Considering the effects of genotype, fruit setting method, and developmental stage, geNorm determined clathrin adaptor complex subunit (ClCAC), beta-actin (ClACT), and alpha tubulin 5 (ClTUA5) as the multiple reference genes in watermelon fruit. Furthermore, ClCAC alone or together with SAND family protein (ClSAND) was ranked as the single or two best reference genes by NormFinder. By using the top-ranked reference genes to normalize the transcript abundance of phytoene synthase (ClPSY1), a good correlation between lycopene accumulation and ClPSY1 expression pattern was observed in ripening watermelon fruit. These validated reference genes will facilitate the accurate measurement of gene expression in the studies on watermelon fruit biology.	[Kong, Qiusheng; Yuan, Jingxian; Gao, Lingyun; Zhao, Liqiang; Cheng, Fei; Huang, Yuan; Bie, Zhilong] Huazhong Agr Univ, Coll Hort & Forestry Sci, Key Lab Hort Plant Biol, Minist Educ, Wuhan, Peoples R China	Huazhong Agricultural University	Bie, ZL (corresponding author), Huazhong Agr Univ, Coll Hort & Forestry Sci, Key Lab Hort Plant Biol, Minist Educ, Wuhan, Peoples R China.	biezhilong@hotmail.com	Kong, Qiusheng/F-7710-2012	Kong, Qiusheng/0000-0003-0939-4424	National Natural Science Foundation of China [31471894]; earmarked fund for Modern Agro-industry Technology Research System [CARS-26-16]; Special Fund for Agro-scientific Research in the Public Interest [201203080-2]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for Modern Agro-industry Technology Research System; Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the National Natural Science Foundation of China (31471894) (QK), the earmarked fund for Modern Agro-industry Technology Research System (CARS-26-16) (ZB), and the Special Fund for Agro-scientific Research in the Public Interest (201203080-2) (ZB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amil-Ruiz F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070603; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chao WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042839; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Die JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073354; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Fan ML, 2014, PLANTA, V239, P397, DOI 10.1007/s00425-013-1976-z; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Grassi S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-781; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Guo SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-454; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090612; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087197; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Levi A, 2006, PLANT CELL REP, V25, P1233, DOI 10.1007/s00299-006-0163-0; Li J, 2014, PLANT CELL PHYSIOL, V55, P1325, DOI 10.1093/pcp/pcu051; Li Q, 2012, J PLANT PHYSIOL, V169, P78, DOI 10.1016/j.jplph.2011.08.005; Liu CH, 2012, FOOD SCI BIOTECHNOL, V21, P531, DOI 10.1007/s10068-012-0068-3; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Monteiro F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072998; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Park SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051502; Reddy DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078555; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Warzybok A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072887; Wechter WP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-275; Zhong HY, 2011, PLANT CELL REP, V30, P641, DOI 10.1007/s00299-010-0992-8; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	38	30	36	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130865	10.1371/journal.pone.0130865	http://dx.doi.org/10.1371/journal.pone.0130865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110539	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800095
J	Xing, XZ; Gao, Y; Wang, HJ; Huang, CL; Qu, SN; Zhang, H; Wang, H; Sun, KL				Xing, XueZhong; Gao, Yong; Wang, HaiJun; Huang, ChuLin; Qu, ShiNing; Zhang, Hao; Wang, Hao; Sun, Kelin			Performance of Three Prognostic Models in Patients with Cancer in Need of Intensive Care in a Medical Center in China	PLOS ONE			English	Article							CHRONIC HEALTH-EVALUATION; CRITICALLY-ILL PATIENTS; ACUTE PHYSIOLOGY; HOSPITAL MORTALITY; OUTCOME PREDICTION; UNITED-STATES; APACHE IV; ADMISSION; PROBABILITY; VALIDATION	Objective The aim of this study was to evaluate the performance of Acute Physiology and Chronic Health Evaluation II (APACHE II), Simplified Acute Physiology Score 3 (SAPS 3), and Acute Physiology and Chronic Health Evaluation IV (APACHE IV) in patients with cancer admitted to intensive care unit (ICU) in a single medical center in China. Materials and Methods This is a retrospective observational cohort study including nine hundred and eighty one consecutive patients over a 2-year period. Results The hospital mortality rate was 4.5%. When all 981 patients were evaluated, the area under the receiver operating characteristic curve (AUROC, 95% Confidential Intervals) of the three models in predicting hospital mortality were 0.948 (0.914-0.982), 0.863 (0.804-0.923), and 0.873 (0.813-0.934) for SAPS 3, APACHE II and APACHE IV respectively. The p values of Hosmer-Lemeshow statistics for the models were 0.759, 0.900 and 0.878 for SAPS 3, APACHE II and APACHE IV respectively. However, SAPS 3 and APACHE IV underestimated the in-hospital mortality with standardized mortality ratio (SMR) of 1.5 and 1.17 respectively, while APACHE II overestimated the in-hospital mortality with SMR of 0.72. Further analysis showed that discrimination power was better with SAPS 3 than with APACHE II and APACHE IV whether for emergency surgical and medical patients (AUROC of 0.912 vs 0.866 and 0.857) or for scheduled surgical patients (AUROC of 0.945 vs 0.834 and 0.851). Calibration was good for all models (all p > 0.05) whether for scheduled surgical patients or emergency surgical and medical patients. However, in terms of SMR, SAPS 3 was both accurate in predicting the in-hospital mortality for emergency surgical and medical patients and for scheduled surgical patients, while APACHE IV and APACHE II were not. Conclusion In this cohort, we found that APACHE II, APACHE IV and SAPS 3 models had good discrimination and calibration ability in predicting in-hospital mortality of critically ill patients with cancer in need of intensive care. Of these three severity scores, SAPS 3 was superior to APACHE II and APACHE IV, whether in terms of discrimination and calibration power, or standardized mortality ratios.	[Gao, Yong] Chinese Acad Med Sci, Canc Hosp, Dept Intens Care Unit, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Gao, Y (corresponding author), Chinese Acad Med Sci, Canc Hosp, Dept Intens Care Unit, Beijing 100730, Peoples R China.	2354839907@qq.com			Beijing Hope Run Special Fund [LC2011B38]	Beijing Hope Run Special Fund	The study was funded by Beijing Hope Run Special Fund (LC2011B38) (http://www.cfchina.org.cn/list.php?catid=301).	Chang LL, 2006, AM J CRIT CARE, V15, P47; Chen LM, 2013, NEW ENGL J MED, V368, P594, DOI 10.1056/NEJMp1213273; Du B, 2013, CRIT CARE MED, V41, P84, DOI 10.1097/CCM.0b013e31826a4082; Gilani Mahryar Taghavi, 2014, Niger Med J, V55, P144, DOI 10.4103/0300-1652.129651; Groeger JS, 1998, J CLIN ONCOL, V16, P761, DOI 10.1200/JCO.1998.16.2.761; Higgins TL, 2007, CRIT CARE MED, V35, P827, DOI 10.1097/01.CCM.0000257337.63529.9F; Juneja D, 2012, MINERVA ANESTESIOL, V78, P194; Keegan MT, 2012, CHEST, V142, P851, DOI 10.1378/chest.11-2164; Keegan MT, 2011, CRIT CARE MED, V39, P163, DOI 10.1097/CCM.0b013e3181f96f81; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Kopterides P, 2011, AM J CRIT CARE, V20, P56, DOI 10.4037/ajcc2011763; Kramer AA, 2014, CRIT CARE MED, V42, P544, DOI 10.1097/CCM.0b013e3182a66a49; Lee H, 2014, KOREAN J ANESTHESIOL, V67, P115, DOI [10.4097/kjae.2014.67.2.115, 10.4097/kjae.2014.66.2.157]; Lilly CM, 2011, CHEST, V140, P1232, DOI 10.1378/chest.11-0718; Lim SY, 2011, YONSEI MED J, V52, P59, DOI 10.3349/ymj.2011.52.1.59; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Nassar AP, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.08.016; Peek N, 2007, J CLIN EPIDEMIOL, V60, P491, DOI 10.1016/j.jclinepi.2006.08.011; Sakr Y, 2008, BRIT J ANAESTH, V101, P798, DOI 10.1093/bja/aen291; Sawicka W, 2014, ANAESTH INTENSIVE TH, V46, P166, DOI 10.5603/AIT.2014.0030; Soares M, 2004, CRIT CARE, V8, pR194, DOI 10.1186/cc2870; Soares M, 2006, INTENS CARE MED, V32, P1839, DOI 10.1007/s00134-006-0374-4; Soares M, 2010, INTENS CARE MED, V36, P1188, DOI 10.1007/s00134-010-1807-7; Taccone FS, 2009, CRIT CARE, V13, DOI 10.1186/cc7713; Wunsch H, 2011, AM J RESP CRIT CARE, V183, P1666, DOI 10.1164/rccm.201012-1961OC; Xing XZ, 2013, WORLD J EMERG MED, V4, P43, DOI [10.5847/wjem.j.issn.1920-8642.2013.01.008, 10.5847/wjem.j.1920-8642.2013.01.008]; Zhou JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107181; Zimmerman JE, 2014, CURR OPIN CRIT CARE, V20, P550, DOI 10.1097/MCC.0000000000000138; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	29	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131329	10.1371/journal.pone.0131329	http://dx.doi.org/10.1371/journal.pone.0131329			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110534	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000356933800143
J	Mon, D; Zakynthinaki, MS; Cordente, CA; Anton, AJM; Rodriguez, BR; Jimenez, DL				Mon, Daniel; Zakynthinaki, Maria S.; Cordente, Carlos A.; Monroy Anton, Antonio J.; Rodriguez Rodriguez, Barbara; Lopez Jimenez, David			Finger Flexor Force Influences Performance in Senior Male Air Pistol Olympic Shooting	PLOS ONE			English	Article								The ability to stabilize the gun is crucial for performance in Olympic pistol shooting and is thought to be related to the shooters muscular strength. The present study examines the relation between performance and finger flexor force as well as shoulder abduction isometric force in senior male air pistol shooting. 46 Spanish national level shooters served as test subjects of the study. Two maximal force tests were carried out recording handgrip and deltoid force data under competition conditions, during the official training time at national Spanish championships. Performance was measured as the total score of 60 shots at competition. Linear regressions were calculated to examine the relations between performance and peak and average finger flexor forces, peak and average finger flexor forces relative to the BMI, peak and average shoulder abduction isometric forces, peak shoulder abduction isometric force relative to the BMI. The connection between performance and other variables such as age, weight, height, BMI, experience in years and training hours per week was also analyzed. Significant correlations were found between performance at competition and average and peak finger flexor forces. For the rest of the force variables no significant correlations were found. Significant correlations were also found between performance at competition and experience as well as training hours. No significant correlations were found between performance and age, weight, height or BMI. The study concludes that hand grip strength training programs are necessary for performance in air pistol shooting.	[Mon, Daniel; Cordente, Carlos A.] Univ Politecn Madrid, Sports Dept, Madrid, Spain; [Zakynthinaki, Maria S.] Tech Univ, Appl Math & Comp Lab, Iraklion, Greece; [Monroy Anton, Antonio J.] Univ Int la Rioja, Phys Educ, Madrid, Spain; [Rodriguez Rodriguez, Barbara] Univ Francisco Vitoria, Sports Dept, Madrid, Spain; [Lopez Jimenez, David] Univ Catolica Norte, Antofagasta, Chile	Universidad Politecnica de Madrid; Universidad Internacional de La Rioja (UNIR); Universidad Francisco de Vitoria; Universidad Catolica del Norte	Anton, AJM (corresponding author), Univ Int la Rioja, Phys Educ, Madrid, Spain.	amonroy111@hotmail.com	Mon-López, Daniel/AAB-2034-2019; David Jimenez, DL López Jiménez/N-6460-2013	Mon-López, Daniel/0000-0001-8333-1304; David Jimenez, DL López Jiménez/0000-0002-7013-9556				Anderson GS, 2000, POLICING, V23, P525, DOI 10.1108/13639510010355611; Belinchon F, 2010, ESTUDIO MED DEPORTIV; de Salles BF, 2009, SPORTS MED, V39, P765, DOI 10.2165/11315230-000000000-00000; Gonzalez Chas J, 1997, CORUNA EUROTRA, DOI [10.1016/S0213-005X(14)70176-4, DOI 10.1016/S0213-005X(14)70176-4]; Gulbinskiene V, 2009, PECULIARITIES INVEST, V21; Kennedy K, 2009, FACTORS INFLUENCING; Krasilshchikov O, 2007, ASIAN J EXERC SPORT, V4, P01; MASON BR, 1990, EXCEL, V6, P2; Mon D, 2006, TIRO OLIMPICO, V60, P18; Mon D, 2009, TIRO OLIMPICO, V70, P22; Pellegrini B, 2005, J SPORT MED PHYS FIT, V45, P467; RFEDETO, 2012, REGL TECN GEN TOD MO, V2009; Tang WT, 2008, J SPORT SCI, V26, P1579, DOI 10.1080/02640410802287063; VERCRUYSSEN M, 1989, Journal of Human Ergology, V18, P153; Yuan CK, 1997, APPL ERGON, V28, P121	15	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0129862	10.1371/journal.pone.0129862	http://dx.doi.org/10.1371/journal.pone.0129862			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121145	Green Submitted, Green Published, gold			2022-12-27	WOS:000358150400028
J	Pendell, DL; Marsh, TL; Coble, KH; Lusk, JL; Szmania, SC				Pendell, Dustin L.; Marsh, Thomas L.; Coble, Keith H.; Lusk, Jayson L.; Szmania, Sara C.			Economic Assessment of FMDv Releases from the National Bio and Agro Defense Facility	PLOS ONE			English	Article							US MEAT DEMAND; MOUTH-DISEASE; MITIGATION STRATEGIES; UNITED-STATES; IMPACTS; OUTBREAK; CONSUMER; INDUSTRY	This study evaluates the economic consequences of hypothetical foot-and-mouth disease releases from the future National Bio and Agro Defense Facility in Manhattan, Kansas. Using an economic framework that estimates the impacts to agricultural firms and consumers, quantifies costs to non-agricultural activities in the epidemiologically impacted region, and assesses costs of response to the government, we find the distribution of economic impacts to be very significant. Furthermore, agricultural firms and consumers bear most of the impacts followed by the government and the regional non-agricultural firms.	[Pendell, Dustin L.] Kansas State Univ, Dept Agr Econ, Manhattan, KS 66506 USA; [Marsh, Thomas L.] Washington State Univ, Sch Econ Sci, Pullman, WA 99164 USA; [Marsh, Thomas L.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Coble, Keith H.] Mississippi State Univ, Dept Agr Econ, Starkville, MS USA; [Lusk, Jayson L.] Oklahoma State Univ, Dept Agr Econ, Stillwater, OK 74078 USA; [Szmania, Sara C.] Signat Sci LLC, Austin, TX USA	Kansas State University; Washington State University; Washington State University; Mississippi State University; Oklahoma State University System; Oklahoma State University - Stillwater	Pendell, DL (corresponding author), Kansas State Univ, Dept Agr Econ, Manhattan, KS 66506 USA.	dpendell@ksu.edu		Coble, Keith/0000-0003-4148-2870	Department of Homeland Security	Department of Homeland Security(United States Department of Homeland Security (DHS))	The authors acknowledge financial support to the Department of Homeland Security for conducting the research and the School of Economic Sciences IMPACT center for writing of this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla A., 2005, 056 ABARE; Blake A., 2003, Tourism Economics, V9, P449; Blayney D.P, 2005, LDPM133101 USDA EC R; Carpenter TE, 2011, J VET DIAGN INVEST, V23, P26, DOI 10.1177/104063871102300104; Coffey B., 2005, MF2678 KANS STAT U A; Elbakidze L, 2009, REV AGR ECON, V31, P931, DOI 10.1111/j.1467-9353.2009.01477.x; GAO (U.S. Government Accountability Office), 2008, HIGH CONT BIOS LAB D; Government Accountability Office (GAO), 2009, GAO09747; Hagerman AD, 2012, APPL ECON PERSPECT P, V34, P119, DOI 10.1093/aepp/ppr039; Harvey N, 2007, PREV VET MED, V82, P176, DOI 10.1016/j.prevetmed.2007.05.019; Hosono H., 2006, P 11 ISVEE; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; King LJ, 2004, REV SCI TECH OIE, V23, P429, DOI 10.20506/rst.23.2.1496; Kuchler F. T., 2006, 7251 USDA EC RES SER; Livestock Marketing Information Center (LMIC), 2012, VAR SPREADSH DAT; Mak J., 1989, Journal of Travel Research, V28, P3, DOI 10.1177/004728758902800202; Marsh TL, 2004, APPL ECON, V36, P897, DOI 10.1080/0003684042000233113; Melius C., 2006, UCRLTR226008 DEP HOM; National Research Council (NRC), 2012, M CRIT LAB NEEDS AN; Nelson F. J., 1996, AIB729 USDA EC RES S, pAIB729; Nogueira L, 2011, AGR ECON-BLACKWELL, V42, P33, DOI 10.1111/j.1574-0862.2011.00550.x; NRC, 2012, EV UPD SIT SPEC RISK EV UPD SIT SPEC RISK; NRC, 2010, EV SIT SPEC RISK ASS EV SIT SPEC RISK ASS; OIE, 2018, TERR AN HLTH COD; Paarlberg PL, 2009, J SWINE HEALTH PROD, V17, P155; Paarlberg PL., 2008, 57 USDA; Pendell DL, 2016, TRANSBOUND EMERG DIS, V63, P203, DOI 10.1111/tbed.12246; Pendell D. L., 2007, Journal of Agricultural and Applied Economics, V39, P19; PENDELL DL, 2006, THESIS KANSAS STATE; Piggott NE, 2004, AM J AGR ECON, V86, P154, DOI 10.1111/j.0092-5853.2004.00569.x; Randolph TF, 2005, REV AGR ECON, V27, P465, DOI 10.1111/j.1467-9353.2005.00245.x; Rich KM, 2007, AM J AGR ECON, V89, P682, DOI 10.1111/j.1467-8276.2007.01006.x; Schlenker W, 2009, AM J AGR ECON, V91, P1140, DOI 10.1111/j.1467-8276.2009.01315.x; Schoenbaum MA, 2003, PREV VET MED, V58, P25, DOI 10.1016/S0167-5877(03)00004-7; Schroeder T.C., 2015, J AGR APPL IN PRESS; Shiflett J. S., 2007, ANAL LAMB DEMAND US; Thompson D, 2002, REV SCI TECH OIE, V21, P675, DOI 10.20506/rst.21.3.1353; Tonsor GT, 2010, J AGR RESOUR ECON, V35, P1; Tozer P, 2012, AUST J AGR RESOUR EC, V56, P385, DOI 10.1111/j.1467-8489.2012.00586.x; U.S. Bureau of Labor Statistics (BLS), 2009, CONS EXP SURV; U.S. Department of Homeland Security (DHS), 2010, SIT SPEC BIOS BIOS M; U.S. Department of Homeland Security (DHS), 2012, UPD SIT SPEC BIOS BI; United Kingdom Department for Environment Food and Rural Affairs (UK DEFRA), 2010, FAM FOOD DAT SETS; United Kingdom Department for Environment Food and Rural Affairs (UK DEFRA), 2008, FOOT MOUTH DIS 2007; USDA-Economic Research Service (ERS), 2012, VAR COMM OUTL REP DA; USDA-Foreign Agricultural Service (FAS), 2012, TRAD DAT; USDA-National Agricultural Statistics Service (NASS), 2010, VAR LIV AN REP; World Bank, 2010, 50833GLB WORLD BANK, V1; Zhao Z. S., 2006, Agricultural and Resource Economics Review, V35, P98; Zheng Y. Q., 2008, Journal of Agricultural and Applied Economics, V40, P837	50	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129134	10.1371/journal.pone.0129134	http://dx.doi.org/10.1371/journal.pone.0129134			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1AM	26114546	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500020
J	Brandner, M; Thaler-Saliba, S; Plainer, S; Vidic, B; El-Shabrawi, Y; Ardjomand, N				Brandner, Martina; Thaler-Saliba, Sarah; Plainer, Sophie; Vidic, Bertram; El-Shabrawi, Yosuf; Ardjomand, Navid			Retropupillary Fixation of Iris-Claw Intraocular Lens for Aphakic Eyes in Children	PLOS ONE			English	Article							TERM-FOLLOW-UP; INTRASCLERAL FIXATION; CAPSULAR SUPPORT; MARFAN-SYNDROME; IMPLANTATION; LENSECTOMY; CATARACT; ANTERIOR; SURGERY; ABSENCE	Purpose To report outcome, complications and safety of retropupillary fixated iris-claw intraocular lenses in a pediatric population. Design Retrospective study. Patients and Methods Ten consecutive pediatric patients (15 eyes) underwent placement of retropupillary fixated iris-claw intraocular lenses between October 2007 and July 2013 at the Department of Ophthalmology, Medical University Graz and General Hospital Klagenfurt, Austria. Postoperative visual acuity and complications were analyzed. Results Median final best-corrected visual acuity improved by 0.12 logMAR from preoperative baseline. Mean postoperative spherical equivalent was -0.05 +/- 1.76 D. No serious complications were observed intra-or postoperatively during the entire follow-up period of up to 40 months. One patient experienced a haptic disenclavation with IOL subluxation immediately after a car accident. Conclusion Our study demonstrates that iris-claw intraocular lens implantation behind the iris is safe in children with lack of capsular support and yields excellent visual outcome with low complication rate.	[Brandner, Martina; Thaler-Saliba, Sarah; Vidic, Bertram; Ardjomand, Navid] Med Univ Graz, Dept Ophthalmol, Graz, Austria; [Plainer, Sophie; El-Shabrawi, Yosuf] Gen Hosp, Dept Ophthalmol, Klagenfurt, Austria	Medical University of Graz	Ardjomand, N (corresponding author), Med Univ Graz, Dept Ophthalmol, Graz, Austria.	vid@ardjomand.at						Bardorf CM, 2004, J AAPOS, V8, P318, DOI 10.1016/j.jaapos.2004.04.006; Baykara M, 2007, AM J OPHTHALMOL, V144, P586, DOI 10.1016/j.ajo.2007.06.009; Buckley EG, 2008, J AAPOS, V12, P431, DOI 10.1016/j.jaapos.2008.04.016; Cleary C, 2012, BRIT J OPHTHALMOL, V96, P419, DOI 10.1136/bjophthalmol-2011-300579; Epley KD, 2001, J AAPOS, V5, P301, DOI 10.1067/mpa.2001.117567; Fellner P, 2005, ARCH OPHTHALMOL-CHIC, V123, P1061, DOI 10.1001/archopht.123.8.1061; Gabor SGB, 2007, J CATARACT REFR SURG, V33, P1851, DOI 10.1016/j.jcrs.2007.07.013; Gonnermann J, 2014, KLIN MONATSBL AUGENH, V231, P784, DOI 10.1055/s-0034-1368453; Gonnermann J, 2013, AM J OPHTHALMOL, V156, P382, DOI 10.1016/j.ajo.2013.03.002; Hsing YE, 2012, CLIN EXP OPHTHALMOL, V40, P849, DOI 10.1111/j.1442-9071.2012.02808.x; Kaiura TL, 2005, J CATARACT REFR SURG, V31, P2420, DOI 10.1016/j.jcrs.2005.06.048; Kumar DA, 2012, AM J OPHTHALMOL, V153, P594, DOI 10.1016/j.ajo.2011.09.027; Lin AA, 2010, CURR OPIN OPHTHALMOL, V21, P55, DOI 10.1097/ICU.0b013e32833383cb; Morrison D, 2005, J AAPOS, V9, P240, DOI 10.1016/j.jaapos.2005.02.004; Prasad S, 2010, J CATARACT REFR SURG, V36, P1063, DOI 10.1016/j.jcrs.2010.03.031; RIJNEVELD WJ, 1994, J REFRACT CORNEAL S, V10, P14; Scharioth GB, 2010, J CATARACT REFR SURG, V36, P254, DOI 10.1016/j.jcrs.2009.09.024; Siddiqui SN, 2013, J PEDIATR OPHTHALMOL, P1; Sminia ML, 2008, J AAPOS, V12, P268, DOI 10.1016/j.jaapos.2007.11.014; Sminia ML, 2012, J AAPOS, V16, P92, DOI 10.1016/j.jaapos.2011.10.014; Sminia ML, 2011, J CATARACT REFR SURG, V37, P866, DOI 10.1016/j.jcrs.2010.07.040; Wolter-Roessler M, 2008, KLIN MONATSBL AUGENH, V225, P1041, DOI 10.1055/s-2008-1027721; WORST JGF, 1977, OPHTHALMIC SURG LAS, V8, P33	23	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0126614	10.1371/journal.pone.0126614	http://dx.doi.org/10.1371/journal.pone.0126614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110864	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800005
J	Forcada, CFI; Oraguzie, N; Reyes-Chin-Wo, S; Espiau, MT; Company, RSI; Marti, AFI				Font i Forcada, Carolina; Oraguzie, Nnadozie; Reyes-Chin-Wo, Sebastian; Teresa Espiau, Maria; Socias i Company, Rafael; Fernandez i Marti, Angel			Identification of Genetic Loci Associated with Quality Traits in Almond via Association Mapping	PLOS ONE			English	Article							PRUNUS-PERSICA L.; LINKAGE DISEQUILIBRIUM; MICROSATELLITE MARKERS; ARABIDOPSIS-THALIANA; POPULATION-STRUCTURE; KERNEL COMPOSITION; DIVERSITY; PEACH; BATSCH; GENOME	To design an appropriate association study, we need to understand population structure and the structure of linkage disequilibrium within and among populations as well as in different regions of the genome in an organism. In this study, we have used a total of 98 almond accessions, from five continents located and maintained at the Centro de Investigacion y Tecnologia Agroalimentaria de Aragon (CITA; Spain), and 40 microsatellite markers. Population structure analysis performed in 'Structure' grouped the accessions into two principal groups; the Mediterranean (Western-Europe) and the non-Mediterranean, with K = 3, being the best fit for our data. There was a strong subpopulation structure with linkage disequilibrium decaying with increasing genetic distance resulting in lower levels of linkage disequilibrium between more distant markers. A significant impact of population structure on linkage disequilibrium in the almond cultivar groups was observed. The mean r(2) value for all intrachromosomal loci pairs was 0.040, whereas, the r(2) for the inter-chromosomal loci pairs was 0.036. For analysis of association between the markers and phenotypic traits, five models comprising both general linear models and mixed linear models were selected to test the marker trait associations. The mixed linear model (MLM) approach using co-ancestry values from population structure and kinship estimates (K model) as covariates identified a maximum of 16 significant associations for chemical traits and 12 for physical traits. This study reports for the first time the use of association mapping for determining marker-locus trait associations in a world-wide almond germplasm collection. It is likely that association mapping will have the most immediate and largest impact on the tier of crops such as almond with the greatest economic value.	[Font i Forcada, Carolina; Reyes-Chin-Wo, Sebastian; Fernandez i Marti, Angel] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Oraguzie, Nnadozie] Washington State Univ, Irrigated Agr Res & Extens Ctr, Prosser, WA 99350 USA; [Teresa Espiau, Maria; Socias i Company, Rafael; Fernandez i Marti, Angel] Ctr Invest & Tecnol Agroalimentaria Aragon CITA, Unidad Hortofruticultura, Zaragoza 50059, Spain	University of California System; University of California Davis; Washington State University	Marti, AFI (corresponding author), Univ Calif Davis, Genome Ctr, 451 Hlth Sci Dr, Davis, CA 95616 USA.	afernandezmarti@ucdavis.edu	Espiau, Mayte/ABG-6943-2020; Forcada, Carolina Font i/E-1316-2017	Espiau, Mayte/0000-0003-4287-4606; Forcada, Carolina Font i/0000-0003-3956-9344	Research Group A12 of Aragon;  [AGL2010-22197-C02-01];  [INIA RF2011-00020-C02-01]	Research Group A12 of Aragon; ; 	This research was conducted under the Spanish projects AGL2010-22197-C02-01 and INIA RF2011-00020-C02-01, and the Research Group A12 of Aragon.	Abbott AG, 1998, ACTA HORTIC, P41, DOI 10.17660/ActaHortic.1998.465.2; Alonso JM, 2005, J AM SOC HORTIC SCI, V130, P308, DOI 10.21273/JASHS.130.3.308; Aranzana MJ, 2002, PLANT BREEDING, V121, P87, DOI 10.1046/j.1439-0523.2002.00656.x; Arunyawat U, 2007, MOL BIOL EVOL, V24, P2310, DOI 10.1093/molbev/msm162; Arunyawat U, 2012, TREE GENET GENOMES, V8, P737, DOI 10.1007/s11295-011-0460-9; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Caldwell KS, 2006, GENETICS, V172, P557, DOI 10.1534/genetics.104.038489; Cantini C, 2001, J AM SOC HORTIC SCI, V126, P205, DOI 10.21273/JASHS.126.2.205; Cao K, 2012, TREE GENET GENOMES, V8, P975, DOI 10.1007/s11295-012-0477-8; Chagne D, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-12; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Cipriani G, 1999, THEOR APPL GENET, V99, P65, DOI 10.1007/s001220051209; Comadran J, 2009, THEOR APPL GENET, V119, P175, DOI 10.1007/s00122-009-1027-0; de Souza VAB, 1998, J AM SOC HORTIC SCI, V123, P604, DOI 10.21273/JASHS.123.4.604; Dirlewanger E, 2002, THEOR APPL GENET, V105, P127, DOI 10.1007/s00122-002-0867-7; Downey SL, 2000, J AM SOC HORTIC SCI, V125, P76, DOI 10.21273/JASHS.125.1.76; Dumas J. B. A, 1831, ANN CHIM PHYS, V2, P198; Elhamzaoui A., 2012, American Journal of Plant Sciences, V3, P1294; Espiau MT, 2002, ACTA HORTIC, P275, DOI 10.17660/ActaHortic.2002.591.42; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Felipe A., 2000, ALMENDRO MAT VEGETAL; FELIPE AJ, 1992, HORTSCIENCE, V27, P718; Marti AFI, 2015, GENET RESOUR CROP EV, V62, P205, DOI 10.1007/s10722-014-0146-x; Marti AFI, 2013, TREE GENET GENOMES, V9, P455, DOI 10.1007/s11295-012-0566-8; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Forcada CFI, 2011, SPAN J AGRIC RES, V9, P781; Forcada CFI, 2013, TREE GENET GENOMES, V9, P331, DOI 10.1007/s11295-012-0553-0; Forcada CFI, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-47; Ganopoulos IV, 2011, EUPHYTICA, V181, P237, DOI 10.1007/s10681-011-0416-z; GRADZIEL TM, 1994, HORTSCIENCE, V29, P33, DOI 10.21273/HORTSCI.29.1.33; Grasselly C, 1972, THESIS U BORDEAUX FR; Haudry A, 2007, MOL BIOL EVOL, V24, P1506, DOI 10.1093/molbev/msm077; Howad W, 2005, GENETICS, V171, P1305, DOI 10.1534/genetics.105.043661; Joobeur T, 2000, GENOME, V43, P649, DOI 10.1139/gen-43-4-649; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; Khan MA, 2012, J EXP BOT, V63, P4045, DOI 10.1093/jxb/ers105; Kodad O, 2011, J AGR FOOD CHEM, V59, P6137, DOI 10.1021/jf200323c; Lopez-Ortiz CM, 2008, J FOOD COMPOS ANAL, V21, P144, DOI 10.1016/j.jfca.2007.09.004; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; Malysheva-Otto LV, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-6; Martinez-Gomez P, 2003, EUPHYTICA, V131, P313, DOI 10.1023/A:1024028518263; Mnejja M, 2005, MOL ECOL NOTES, V5, P531, DOI 10.1111/j.1471-8286.2005.00977.x; Mnejja M, 2004, MOL ECOL NOTES, V4, P163, DOI 10.1111/j.1471-8286.2004.00603.x; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Oraguzie N. C., 2007, Association mapping in plants, P11, DOI 10.1007/978-0-387-36011-9_2; Oraguzie N. C., 2007, Association mapping in plants, P1, DOI 10.1007/978-0-387-36011-9_1; Ostrowski MF, 2006, MOL ECOL, V15, P1507, DOI 10.1111/j.1365-294X.2006.02865.x; Peace C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048305; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schulze TG, 2002, AM J MED GENET, V114, P1, DOI 10.1002/ajmg.10042; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x; Company RSI, 2012, HANDB PLANT BREED, V8, P697, DOI 10.1007/978-1-4419-0763-9_18; Stich B, 2008, GENETICS, V178, P1745, DOI 10.1534/genetics.107.079707; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Teare MD, 2002, ANN HUM GENET, V66, P223, DOI 10.1017/S0003480002001082; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Wilson LM, 2004, PLANT CELL, V16, P2719, DOI 10.1105/tpc.104.025700; Yamamoto T, 2002, MOL ECOL NOTES, V2, P298, DOI 10.1046/j.1471-8286.2002.00242.x; Yao Q, 2000, PLANT BREEDING, V119, P369, DOI 10.1046/j.1439-0523.2000.00524.x; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang GR, 2010, TREE GENET GENOMES, V6, P25, DOI 10.1007/s11295-009-0225-x	70	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0127656	10.1371/journal.pone.0127656	http://dx.doi.org/10.1371/journal.pone.0127656			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111146	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800008
J	Portillo-Lara, R; Alvarez, MM				Portillo-Lara, Roberto; Moises Alvarez, Mario			Enrichment of the Cancer Stem Phenotype in Sphere Cultures of Prostate Cancer Cell Lines Occurs through Activation of Developmental Pathways Mediated by the Transcriptional Regulator Delta Np63 alpha	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR; THERAPEUTIC TARGETS; GENE-EXPRESSION; RECEPTOR; PROTEIN; EGR1; IDENTIFICATION; METASTASIS; RESISTANCE	Background Cancer stem cells (CSC) drive prostate cancer tumor survival and metastasis. Nevertheless, the development of specific therapies against CSCs is hindered by the scarcity of these cells in prostate tissues. Suspension culture systems have been reported to enrich CSCs in primary cultures and cell lines. However, the molecular mechanisms underlying this phenomenon have not been fully explored. Methodology/Principal Findings We describe a prostasphere assay for the enrichment of CD133(+) CSCs in four commercial PCa cell lines: 22Rv1, DU145, LNCaP, and PC3. Overexpression of CD133, as determined by flow cytometric analysis, correlated with an increased clonogenic, chemoresistant, and invasive potential in vitro. This phenotype is concordant to that of CSCs in vivo. Gene expression profiling was then carried out using the Cancer Reference panel and the nCounter system from NanoString Technologies. This analysis revealed several upregulated transcripts that can be further explored as potential diagnostic markers or therapeutic targets. Furthermore, functional annotation analysis suggests that Delta Np63 alpha modulates the activation of developmental pathways responsible for the increased stem identity of cells growing in suspension cultures. Conclusions/Significance We conclude that profiling the genetic mechanisms involved in CSC enrichment will help us to better understand the molecular pathways that underlie CSC pathophysiology. This platform can be readily adapted to enrich and assay actual patient samples, in order to design patient-specific therapies that are aimed particularly against CSCs.	[Portillo-Lara, Roberto; Moises Alvarez, Mario] Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, Nuevo Leon, Mexico; [Moises Alvarez, Mario] Brigham & Womens Hosp, Harvard MIT Hlth Sci & Technol, Cambridge, MA USA	Tecnologico de Monterrey; Harvard University; Brigham & Women's Hospital	Alvarez, MM (corresponding author), Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, Nuevo Leon, Mexico.	mario.alvarez@itesm.mx	Portillo-Lara, Roberto/AAX-5002-2020	Portillo-Lara, Roberto/0000-0002-1781-3126; Alvarez, Mario Moises/0000-0002-9131-5344	Zambrano-Hellion Family (Project ZH-Stem); Tecnologico de Monterrey [CAT-122]; Consejo Nacional de Ciencia y Tecnologia of Mexico (CONACyT); CONACyT	Zambrano-Hellion Family (Project ZH-Stem); Tecnologico de Monterrey; Consejo Nacional de Ciencia y Tecnologia of Mexico (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors gratefully acknowledge funding from the Zambrano-Hellion Family (Project ZH-Stem), Tecnologico de Monterrey (Seed funding CAT-122), and Consejo Nacional de Ciencia y Tecnologia of Mexico (CONACyT). The authors are thankful to (CONACyT) for the economic support to RPL in the form of a Doctoral Scholarship.	Adamson ED, 2002, TUMOR BIOL, V23, P93, DOI 10.1159/000059711; Brien G, 2011, BIOCHEMISTRY-US, V50, P5120, DOI 10.1021/bi101839p; Chen X, 2013, CELL CYCLE, V12, P579, DOI 10.4161/cc.23721; Cheng JW, 2012, MOL MED REP, V6, P955, DOI 10.3892/mmr.2012.1019; Cocciadiferro L, 2009, ANN NY ACAD SCI, V1155, P257, DOI 10.1111/j.1749-6632.2009.03696.x; Collins AT, 2006, EUR J CANCER, V42, P1213, DOI 10.1016/j.ejca.2006.01.037; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Craig AL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-195; Di Lorenzo G, 2002, CLIN CANCER RES, V8, P3438; Dobrenis K, 2014, INT J CANC; Du ZJ, 2010, CANCER SCI, V101, P2417, DOI 10.1111/j.1349-7006.2010.01700.x; Duhagon MA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-324; Fan XL, 2012, UROL ONCOL-SEMIN ORI, V30, P314, DOI 10.1016/j.urolonc.2010.03.019; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Germain Marc, 2003, Sci STKE, V2003, ppe10, DOI 10.1126/stke.2003.173.pe10; Gillet JP, 2010, METHODS MOL BIOL, V596, P47, DOI 10.1007/978-1-60761-416-6_4; Grosse-Gehling P, 2013, J PATHOL, V229, P355, DOI 10.1002/path.4086; Hadler-Olsen E, 2013, TUMOR BIOL, V34, P2041, DOI 10.1007/s13277-013-0842-8; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irollo E, 2013, AM J TRANSL RES, V5, P563; Jimenez A, 2014, EXP CELL RES; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Kelly BD, 2013, BJU INT, V111, P17, DOI 10.1111/j.1464-410X.2012.11244.x; Kerr CL, 2014, CURR OPIN ONCOL, V26, P328, DOI 10.1097/CCO.0000000000000080; Kim K, 2010, J CLIN EPIDEMIOL, V63, P950, DOI 10.1016/j.jclinepi.2010.02.018; Kim MH, 2008, PROSTATE, V68, P1362, DOI 10.1002/pros.20801; Kwon SJ, 2014, PROSTATE, V74, P121, DOI 10.1002/pros.22734; Lawrence MG, 2007, CELLS TISSUES ORGANS, V185, P111, DOI 10.1159/000101311; Lee KKH, 2001, DEV BIOL, V234, P188, DOI 10.1006/dbio.2001.0249; Liu Qingxin, 2011, Chin J Cancer, V30, P612, DOI 10.5732/cjc.011.10225; Marin-Aguilera M, 2014, MOL CANCER THER, V13, P1270, DOI 10.1158/1535-7163.MCT-13-0775; Marques Gregory, 2002, Cerebellum, V1, P259, DOI 10.1080/147342202320883560; Mehta HH, 2011, CANCER RES, V71, P5154, DOI 10.1158/0008-5472.CAN-10-4513; Oh JE, 2011, J BIOL CHEM, V286, P38757, DOI 10.1074/jbc.M111.244939; Oktem G, 2014, ONCOL LETT, V7, P2103, DOI 10.3892/ol.2014.1992; Parra E, 2009, ONCOL REP, V22, P1513, DOI 10.3892/or_00000595; Petz M, 2012, NUCLEIC ACIDS RES, V40, P9738, DOI 10.1093/nar/gks760; Pfeiffer MJ, 2010, EUR UROL, V57, P246, DOI 10.1016/j.eururo.2009.01.015; Pignon JC, 2013, P NATL ACAD SCI USA, V110, P8105, DOI 10.1073/pnas.1221216110; Rappa G, 2008, EXP CELL RES, V314, P2110, DOI 10.1016/j.yexcr.2008.03.008; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Russell MR, 2010, CLIN CANCER RES, V16, P5002, DOI 10.1158/1078-0432.CCR-10-1863; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Sampson N, 2013, ENDOCRINOLOGY, V154, P2586, DOI 10.1210/en.2012-2259; Schoenborn JR, 2013, CLIN CANCER RES, V19, P4058, DOI 10.1158/1078-0432.CCR-12-3606; Setoguchi T, 2004, CELL CYCLE, V3, P414; Shepherd CJ, 2008, PROSTATE, V68, P1007, DOI 10.1002/pros.20765; Spagnuolo R, 2004, BLOOD, V103, P3005, DOI 10.1182/blood-2003-07-2459; Svaren J, 2000, J BIOL CHEM, V275, P38524, DOI 10.1074/jbc.M005220200; Takahashi T, 1999, INT J UROL, V6, P526, DOI 10.1046/j.1442-2042.1999.00104.x; Tang DG, 2007, MOL CARCINOGEN, V46, P1, DOI 10.1002/mc.20255; Thorek DLJ, 2013, THROMB HAEMOSTASIS, V110, P484, DOI 10.1160/TH13-04-0275; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Wang L, 2013, INT J BIOL SCI, V9, P472, DOI 10.7150/ijbs.5855; Wang SQ, 2014, INT J CLIN EXP PATHO, V7, P184; Wei C, 2007, CANCER BIOL THER, V6, P763, DOI 10.4161/cbt.6.5.3996; Wu S, 2014, EUR UROL, V65, P274, DOI 10.1016/j.eururo.2013.10.038; Xu B, 2014, INT J CLIN EXP PATHO, V7, P2883; Yu C, 2012, MINERVA UROL NEFROL, V64, P19	59	23	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130118	10.1371/journal.pone.0130118	http://dx.doi.org/10.1371/journal.pone.0130118			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110651	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800037
J	Henderson, KC; Benitez, AJ; Ratliff, AE; Crabb, DM; Sheppard, ES; Winchell, JM; Dluhy, RA; Waites, KB; Atkinson, TP; Krause, DC				Henderson, Kelley C.; Benitez, Alvaro J.; Ratliff, Amy E.; Crabb, Donna M.; Sheppard, Edward S.; Winchell, Jonas M.; Dluhy, Richard A.; Waites, Ken B.; Atkinson, T. Prescott; Krause, Duncan C.			Specificity and Strain-Typing Capabilities of Nanorod Array-Surface Enhanced Raman Spectroscopy for Mycoplasma pneumoniae Detection	PLOS ONE			English	Article							REAL-TIME PCR; SEQUENCE-ANALYSIS; SILVER SURFACE; P1 ADHESIN; SCATTERING; SUBSTRATE; IDENTIFICATION; GENOME; SERS	Mycoplasma pneumoniae is a cell wall-less bacterial pathogen of the human respiratory tract that accounts for > 20% of all community-acquired pneumonia (CAP). At present the most effective means for detection and strain-typing is quantitative polymerase chain reaction (qPCR), which can exhibit excellent sensitivity and specificity but requires separate tests for detection and genotyping, lacks standardization between available tests and between labs, and has limited practicality for widespread, point-of-care use. We have developed and previously described a silver nanorod array-surface enhanced Raman Spectroscopy (NA-SERS) biosensing platform capable of detecting M. pneumoniae with statistically significant specificity and sensitivity in simulated and true clinical throat swab samples, and the ability to distinguish between reference strains of the two main genotypes of M. pneumoniae. Furthermore, we have established a qualitative lower endpoint of detection for NA-SERS of < 1 genome equivalent (cell/mu l) and a quantitative multivariate detection limit of 5.3 +/- 1 cells/mu l. Here we demonstrate using partial least squares-discriminatory analysis (PLS-DA) of sample spectra that NA-SERS correctly identified M. pneumoniae clinical isolates from globally diverse origins and distinguished these from a panel of 12 other human commensal and pathogenic mycoplasma species with 100% cross-validated statistical accuracy. Furthermore, PLS-DA correctly classified by strain type all 30 clinical isolates with 96% cross-validated accuracy for type 1 strains, 98% cross-validated accuracy for type 2 strains, and 90% cross-validated accuracy for type 2V strains.	[Henderson, Kelley C.; Sheppard, Edward S.; Krause, Duncan C.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Benitez, Alvaro J.; Winchell, Jonas M.] Ctr Dis Control & Prevent, Pneumonia Response & Surveillance Lab, Atlanta, GA USA; [Ratliff, Amy E.; Crabb, Donna M.; Waites, Ken B.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Atkinson, T. Prescott] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA; [Dluhy, Richard A.] Univ Georgia, Dept Chem, Athens, GA 30602 USA	University System of Georgia; University of Georgia; Centers for Disease Control & Prevention - USA; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University System of Georgia; University of Georgia	Krause, DC (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	dkrause@uga.edu			National Institute of Allergy and Infectious Disease [AI096364]; National Institute of General Medical Sciences [GM102546]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI096364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102546] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by Public Health Service grants AI096364 to DCK from the National Institute of Allergy and Infectious Disease (www.niaid.nih.gov) and GM102546 to RAD from the National Institute of General Medical Sciences (www.nigms.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell JL, 2009, BIOSENS BIOELECTRON, V24, P3663, DOI 10.1016/j.bios.2009.05.039; Adams MJ, 2004, CHEMOMETRICS IN ANAL; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Beebe K. R., 1998, CHEMOMETRICS A PRACT; Chalker VJ, 2012, EURO SURVEILL, V17; Chu HY, 2008, APPL SPECTROSC, V62, P922, DOI 10.1366/000370208785284330; Culha M, 2008, APPL SPECTROSC, V62, P1226, DOI 10.1366/000370208786401545; Cullum BM, 2000, REV SCI INSTRUM, V71, P1602, DOI 10.1063/1.1150504; Daxboeck F, 2003, CLIN MICROBIOL INFEC, V9, P263, DOI 10.1046/j.1469-0691.2003.00590.x; Driskell JD, 2008, J PHYS CHEM C, V112, P895, DOI 10.1021/jp075288u; Driskell JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010222; Dumke R, 2008, INT J MED MICROBIOL, V298, P483, DOI 10.1016/j.ijmm.2007.06.002; Dumke R, 2006, J CLIN MICROBIOL, V44, P2567, DOI 10.1128/JCM.00495-06; Flores SC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-167; GERSTENECKER B, 1990, J GEN MICROBIOL, V136, P471, DOI 10.1099/00221287-136-3-471; Golightly RS, 2009, ACS NANO, V3, P2859, DOI 10.1021/nn9013593; GRANATO PA, 1983, J CLIN MICROBIOL, V17, P1077, DOI 10.1128/JCM.17.6.1077-1080.1983; Harz A, 2009, CYTOM PART A, V75A, P104, DOI 10.1002/cyto.a.20682; Henderson KC, 2014, ANALYST, V139, P6426, DOI 10.1039/c4an01141d; Hennigan SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013633; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; JACOBS E, 1990, J CLIN MICROBIOL, V28, P1194, DOI 10.1128/JCM.28.6.1194-1197.1990; Jacobs E., 2012, EURO SURVEILL, V17; Jehlicka J, 2011, SPECTROCHIM ACTA A, V80, P36, DOI 10.1016/j.saa.2011.01.005; Kanack K, 2011, ANALYTICAL AND CLNIC; Kim KS, 2003, FEMS MICROBIOL LETT, V226, P299, DOI 10.1016/S0378-1097(03)00618-9; Krause DC, 1998, TRENDS MICROBIOL, V6, P15, DOI 10.1016/S0966-842X(97)01168-2; Kung CM, 2007, JPN J INFECT DIS, V60, P352; Leverette CL, 2006, APPL SPECTROSC, V60, P906, DOI 10.1366/000370206778062084; LIPMAN RP, 1969, J BACTERIOL, V100, P1037, DOI 10.1128/JB.100.2.1037-1043.1969; Liu YJ, 2009, J PHYS CHEM C, V113, P9664, DOI 10.1021/jp902142y; Loens K, 2010, EUR J CLIN MICROBIOL, V29, P1055, DOI 10.1007/s10096-010-0975-2; Moore DS, 2009, ANAL BIOANAL CHEM, V393, P1571, DOI 10.1007/s00216-008-2499-5; Mrazek J, 2006, MOL BIOL EVOL, V23, P1370, DOI 10.1093/molbev/msk023; Mrozek MF, 2002, ANAL CHEM, V74, P4069, DOI 10.1021/ac020115g; Musumarra G, 2004, J CHEMOMETR, V18, P125, DOI 10.1002/cem.846; Negri P, 2011, APPL SPECTROSC, V65, P66, DOI 10.1366/10-06037; Otto A, 2002, J RAMAN SPECTROSC, V33, P593, DOI 10.1002/jrs.879; Podstawka E, 2004, APPL SPECTROSC, V58, P1147, DOI 10.1366/0003702042336073; Schwartz SB, 2009, CLIN MICROBIOL INFEC, V15, P756, DOI 10.1111/j.1469-0691.2009.02814.x; Schwartz SB, 2009, J CLIN MICROBIOL, V47, P4117, DOI 10.1128/JCM.01696-09; Shanmukh S, 2006, NANO LETT, V6, P2630, DOI 10.1021/nl061666f; Simmons WL, 2013, MICROBIOL-SGM, V159, P737, DOI 10.1099/mic.0.064782-0; Smith PF, 1971, THE BIOLOGY OF MYCOP; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stewart S, 1999, SPECTROCHIM ACTA A, V55, P1641, DOI 10.1016/S1386-1425(98)00294-7; Thibodeau KP, 2004, AM FAM PHYSICIAN, V69, P1699; Thurman KA, 2009, CLIN INFECT DIS, V48, P1244, DOI 10.1086/597775; Waitest KB, 2008, FUTURE MICROBIOL, V3, P635, DOI 10.2217/17460913.3.6.635; Willemse-Erix DFM, 2009, J CLIN MICROBIOL, V47, P652, DOI 10.1128/JCM.01900-08; Winchell JM, 2008, J CLIN MICROBIOL, V46, P3116, DOI 10.1128/JCM.00440-08; Zhao F, 2011, J CLIN MICROBIOL, V49, P3000, DOI 10.1128/JCM.00105-11; Zhao YP, 2006, J PHYS CHEM B, V110, P3153, DOI 10.1021/jp057406o; Zubkov MV, 1999, APPL ENVIRON MICROB, V65, P3251	54	16	17	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131831	10.1371/journal.pone.0131831	http://dx.doi.org/10.1371/journal.pone.0131831			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121242	Green Submitted, gold, Green Published			2022-12-27	WOS:000358150400164
J	Pimienta, G; Fok, V; Haslip, M; Nagy, M; Takyar, S; Steitz, JA				Pimienta, Genaro; Fok, Victor; Haslip, Maria; Nagy, Maria; Takyar, Seyedtaghi; Steitz, Joan A.			Proteomics and Transcriptomics of BJAB Cells Expressing the Epstein-Barr Virus Noncoding RNAs EBER1 and EBER2	PLOS ONE			English	Article							GENE-EXPRESSION; AUF1/HNRNP D; PROTEIN; RECEPTOR; GROWTH; VEGF; QUANTIFICATION; SUBSTRATE; PARTNER	In Epstein-Barr virus (EBV) latent infection, the EBV-encoded RNAs EBER1 and EBER2 accumulate in the host cell nucleus to similar to 10(6) copies. While the expression of EBERs in cell lines is associated with transformation, a mechanistic explanation of their roles in EBV latency remains elusive. To identify EBER-specific gene expression features, we compared the proteome and mRNA transcriptome from BJAB cells (an EBV-negative B lymphoma cell line) stably transfected with an empty plasmid or with one carrying both EBER genes. We identified similar to 1800 proteins with at least 2 SILAC pair measurements, of which only 8 and 12 were up-and downregulated >= 2-fold, respectively. One upregulated protein was PIK3AP1, a B-cell specific protein adapter known to activate the PI3K-AKT signaling pathway, which regulates alternative splicing and translation in addition to its pro-survival effects. In the mRNA-seq data, the mRNA levels for some of the proteins changing in the SILAC data did not change. We instead observed isoform switch events. We validated the most relevant findings with biochemical assays. These corroborated the upregulation of PIK3AP1 and AKT activation in BJAB cells expressing high levels of both EBERs and EBNA1 (a surrogate of Burkitt's lymphoma EBV latency I) relative to those expressing only EBNA1. The mRNA-seq data in these cells showed multiple upregulated oncogenes whose mRNAs are enriched for 3'-UTR AU-rich elements (AREs), such as ccl3, ccr7, il10, vegfa and zeb1. The CCL3, CCR7, IL10 and VEGFA proteins promote cell proliferation and are associated with EBV-mediated lymphomas. In EBV latency, ZEB1 represses the transcription of ZEBRA, an EBV lytic phase activation factor. We previously found that EBER1 interacts with AUF1 in vivo and proposed stabilization of ARE-containing mRNAs. Thus, the similar to 10(6) copies of EBER1 may promote not only cell proliferation due to an increase in the levels of ARE-containing genes like ccl3, ccr7, il10, and vegfa, but also the maintenance of latency, through higher levels of zeb1.	[Pimienta, Genaro; Fok, Victor; Steitz, Joan A.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Haslip, Maria; Takyar, Seyedtaghi] Yale Univ, Sch Med, Dept Internal Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT 06510 USA; [Nagy, Maria] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Pimienta, G (corresponding author), CONACYT, Ctr Invest Estudios Super Ensenada CICESE, Ensenada, Baja California, Mexico.	pimienta@cicese.mx; joan.steitz@yale.edu			NIH [CA16038]; NATIONAL CANCER INSTITUTE [P01CA016038] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This work was supported by grant CA16038 from the NIH. JAS is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcondeguy T, 2013, NUCLEIC ACIDS RES, V41, P7997, DOI 10.1093/nar/gkt539; Beck M, 2011, CURR OPIN BIOTECH, V22, P3, DOI 10.1016/j.copbio.2010.09.002; BIRKENBACH M, 1993, J VIROL, V67, P2209, DOI 10.1128/JVI.67.4.2209-2220.1993; Burger JA, 2013, TRENDS IMMUNOL, V34, P592, DOI 10.1016/j.it.2013.07.002; Canaan A, 2009, P NATL ACAD SCI USA, V106, P22421, DOI 10.1073/pnas.0911676106; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Damania B, 2004, NAT REV MICROBIOL, V2, P656, DOI 10.1038/nrmicro958; Davis RS, 2007, ANNU REV IMMUNOL, V25, P525, DOI 10.1146/annurev.immunol.25.022106.141541; Facchetti F, 2002, P NATL ACAD SCI USA, V99, P3776, DOI 10.1073/pnas.022042699; Fellows A, 2012, MOL BIOL CELL, V23, P1414, DOI 10.1091/mbc.E11-06-0545; Fok V, 2006, J CELL BIOL, V173, P319, DOI 10.1083/jcb.200601026; Fok V, 2006, RNA, V12, P872, DOI 10.1261/rna.2339606; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; GLICKMAN JN, 1988, J VIROL, V62, P902, DOI 10.1128/JVI.62.3.902-911.1988; Graveley BR, 2005, NAT STRUCT MOL BIOL, V12, P1022, DOI 10.1038/nsmb1205-1022; Gregorovic G, 2011, J VIROL, V85, P3535, DOI 10.1128/JVI.02086-10; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Homa NJ, 2013, J VIROL, V87, P12291, DOI 10.1128/JVI.02464-13; Houmani JL, 2009, J VIROL, V83, P9844, DOI 10.1128/JVI.01014-09; HOWE JG, 1989, CELL, V57, P825, DOI 10.1016/0092-8674(89)90797-6; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iwakiri D, 2010, ADV CANCER RES, V107, P119, DOI 10.1016/S0065-230X(10)07004-1; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kitagawa N, 2000, EMBO J, V19, P6742, DOI 10.1093/emboj/19.24.6742; Lee N, 2012, RNA, V18, P2073, DOI 10.1261/rna.034900.112; LERNER MR, 1981, P NATL ACAD SCI-BIOL, V78, P805, DOI 10.1073/pnas.78.2.805; Mechetina LV, 2002, EUR J IMMUNOL, V32, P87, DOI 10.1002/1521-4141(200201)32:1<87::AID-IMMU87>3.0.CO;2-#; Minnicelli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046005; Moon SL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003762; Moore PS, 2010, NAT REV CANCER, V10, P878, DOI 10.1038/nrc2961; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pullirsch D, 2010, RNA BIOL, V7, P205, DOI 10.4161/rna.7.2.11286; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; ROSA MD, 1981, MOL CELL BIOL, V1, P785, DOI 10.1128/MCB.1.9.785; Ruf IK, 2000, J VIROL, V74, P10223, DOI 10.1128/JVI.74.21.10223-10228.2000; Samanta M, 2010, CANCER SCI, V101, P29, DOI 10.1111/j.1349-7006.2009.01377.x; Sarkar S, 2011, MOL CELL BIOL, V31, P602, DOI 10.1128/MCB.00835-10; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shinozaki A, 2010, CANCER RES, V70, P4719, DOI 10.1158/0008-5472.CAN-09-4620; Speck SH, 2010, CELL HOST MICROBE, V8, P100, DOI 10.1016/j.chom.2010.06.014; Stevenson D, 2005, CANCER RES, V65, P8826, DOI 10.1158/0008-5472.CAN-05-0591; SWAMINATHAN S, 1991, P NATL ACAD SCI USA, V88, P1546, DOI 10.1073/pnas.88.4.1546; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Williamson A, 2011, MOL CELL, V42, P744, DOI 10.1016/j.molcel.2011.04.022; Wilson TJ, 2005, GENES IMMUN, V6, P341, DOI 10.1038/sj.gene.6364185; Wu Y, 2007, J VIROL, V81, P11236, DOI 10.1128/JVI.00579-07; Yajima M, 2005, J VIROL, V79, P4298, DOI 10.1128/JVI.79.7.4298-4307.2005; Yamamoto N, 2000, FEBS LETT, V484, P153, DOI 10.1016/S0014-5793(00)02145-1; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Yu XM, 2012, J VIROL, V86, P8086, DOI 10.1128/JVI.00234-12	55	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0124638	10.1371/journal.pone.0124638	http://dx.doi.org/10.1371/journal.pone.0124638			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121143	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400001
J	Chen, SJ; Kung, PT; Huang, KH; Wang, YH; Tsai, WC				Chen, Su Jing; Kung, Pei-Tseng; Huang, Kuang Hua; Wang, Yueh-Hsin; Tsai, Wen-Chen			Characteristics of the Delayed or Refusal Therapy in Breast Cancer Patients: A Longitudinal Population-Based Study in Taiwan	PLOS ONE			English	Article							SURGICAL-TREATMENT; HEALTH-INSURANCE; OLDER WOMEN; DIAGNOSIS; CARE; STATISTICS; GUIDELINES; EXPERIENCE; SURVIVAL; BELIEFS	Background The evidence indicated breast cancer was a cancer with high survival rate. However, there were still some breast cancer patients delaying or refusing therapy. So we conducted a cohort study to explore the relationship between characteristics of breast cancer patients and delay or refusal of therapy within four months after cancer diagnosed. Methods This was a retrospective national population-based study from 2004 to 2010 in Taiwan. This study included 35,095 patients with new diagnosis breast cancer from Taiwan Cancer Registry Database. Several analysis methods, including t test, Chi-square test, generalized estimating equations of logistic regression analysis, and Cox proportional hazards model, were performed to explore the characteristics of these patients and the relative risk of mortality with delay or refusal of therapy. Results Our study showed that the overall survival rates were significantly different (p < 0.05) between the breast cancer patients who delayed or refused therapy and those with treatment. The patients who delayed or refused therapy had lower 5-year overall survival rate compared with the treated group. The related factors included age, Charlson comorbidity index, cancer staging (OR = 1.30-19.69; p < 0.05), other catastrophic illnesses or injuries and the level of diagnostic hospitals. However, the patients with different income levels and degree of urbanization in living area were not statistically significant factors. Conclusion Our results demonstrated that age and cancer staging were the main patient characteristics affecting whether the patients delayed or refused therapy. The delay or refusal of treatment was associated with the level of diagnosing hospital.	[Chen, Su Jing; Huang, Kuang Hua; Wang, Yueh-Hsin; Tsai, Wen-Chen] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Chen, Su Jing] China Med Univ Hosp, Dept Pharm, Taichung, Taiwan; [Chen, Su Jing] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Kung, Pei-Tseng] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan	Tsai, WC (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.	wtsai@mail.cmu.edu.tw	; Tsai, Wen-Chen/O-3095-2015	Wang, Yueh-Hsin/0000-0002-1282-5945; Tsai, Wen-Chen/0000-0002-9684-0789	China Medical University, Asia University, and the Health Promotion Administration [CMU101-ASIA-14, 100-ASIA-21, DOH101-HP-1501]	China Medical University, Asia University, and the Health Promotion Administration	The study was supported by the grants (CMU101-ASIA-14, 100-ASIA-21, DOH101-HP-1501) from the China Medical University, Asia University, and the Health Promotion Administration.	Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Bickell NA, 2006, J CLIN ONCOL, V24, P1357, DOI 10.1200/JCO.2005.04.5799; Bickell NA, 2009, J CLIN ONCOL, V27, P5160, DOI 10.1200/JCO.2009.22.9773; Boer Katalin, 2005, Orvosi Hetilap, V146, P15; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Citrin DL, 2012, ONCOLOGIST, V17, P607, DOI 10.1634/theoncologist.2011-0468; Clegg-Lamptey J N A, 2009, East Afr Med J, V86, P348; Colyer H, 1996, J ADV NURS, V23, P496, DOI 10.1111/j.1365-2648.1996.tb00011.x; Dwivedi AK, 2012, HEALTH, V4; Ettinger DS, 2012, J NATL COMPR CANC NE, V10, P456, DOI 10.6004/jnccn.2012.0047; Fanchiang C., 2004, TAIWAN TODAY; Fink AK, 2004, J CLIN ONCOL, V22, P3309, DOI 10.1200/JCO.2004.11.064; Gabriel CA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2647; GANZ PA, 1995, CA-CANCER J CLIN, V45, P114, DOI 10.3322/canjclin.45.2.114; Helms Rebecca L, 2008, Psychol Health Med, V13, P313, DOI 10.1080/13548500701405509; HUCHCROFT SA, 1993, CANCER CAUSE CONTROL, V4, P179; Hudson PL, 2006, PALLIATIVE MED, V20, P693, DOI 10.1177/0269216306071799; Jassem J, 2014, EUR J PUBLIC HEALTH, V24, P761, DOI 10.1093/eurpub/ckt131; Krugman P., 2005, NY TIMES, V7; Lavelle K, 2007, BRIT J SURG, V94, P1209, DOI 10.1002/bjs.5834; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Mcgee SA, 2013, CANCER EPIDEM BIOMAR, V22, P1227, DOI 10.1158/1055-9965.EPI-12-1432; McLaughlin JM, 2012, J CLIN ONCOL, V30, P4493, DOI 10.1200/JCO.2012.39.7695; Mystakidou K, 2007, INT J PSYCHIAT MED, V37, P201, DOI 10.2190/0509-7332-388N-566W; Neal RD, 2009, BRIT J CANCER, V101, pS9, DOI 10.1038/sj.bjc.6605384; Puts MTE, 2010, SUPPORT CARE CANCER, V18, P969, DOI 10.1007/s00520-010-0883-0; Radley A, 2009, MORTALITY, V14, P309, DOI DOI 10.1080/13576270903257422; Rashid YA, 2012, J PAK MED ASSOC, V62, P905; Reinhardt UE, 2008, BRIT MED J, V336, P72, DOI 10.1136/bmj.39450.473380.0F; Sainio C, 2001, NURS ETHICS, V8, P97, DOI 10.1191/096973301677733388; Sankaranarayanan R, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-3; Sariego J, 2010, AM SURGEON, V76, P1397; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smith EC, 2013, JAMA SURG, V148, P516, DOI 10.1001/jamasurg.2013.1680; Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; Tsai WC, 2013, 101HP1501 DOH MIN HL; Valente SM, 2004, CANCER NURS, V27, P314, DOI 10.1097/00002820-200407000-00008; Wagner JL, 2011, ANN SURG, V254, P119, DOI 10.1097/SLA.0b013e318217e97f; Williams DL, 2010, WOMEN HEALTH, V50, P705, DOI 10.1080/03630242.2010.530928; Williams I, 2008, DISSENT, V55, P13	41	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131305	10.1371/journal.pone.0131305	http://dx.doi.org/10.1371/journal.pone.0131305			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1AM	26114875	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500140
J	Khorozyan, I; Soofi, M; Hamidi, AK; Ghoddousi, A; Waltert, M				Khorozyan, Igor; Soofi, Mahmood; Hamidi, Amirhossein Khaleghi; Ghoddousi, Arash; Waltert, Matthias			Dissatisfaction with Veterinary Services Is Associated with Leopard (Panthera pardus) Predation on Domestic Animals	PLOS ONE			English	Article							LIVESTOCK PREDATION; GOLESTAN PROVINCE; MOUTH-DISEASE; NATIONAL-PARK; CONSERVATION; CARNIVORES; CONFLICT; PATTERNS; PREY; ATTACKS	Human-carnivore conflicts challenge biodiversity conservation and local livelihoods, but the role of diseases of domestic animals in their predation by carnivores is poorly understood. We conducted a human-leopard (Panthera pardus) conflict study throughout all 34 villages around Golestan National Park, Iran in order to find the most important conflict determinants and to use them in predicting the probabilities of conflict and killing of cattle, sheep and goats, and dogs. We found that the more villagers were dissatisfied with veterinary services, the more likely they were to lose livestock and dogs to leopard predation. Dissatisfaction occurred when vaccination crews failed to visit villages at all or, in most cases, arrived too late to prevent diseases from spreading. We suggest that increased morbidity of livestock makes them particularly vulnerable to leopard attacks. Moreover, conflicts and dog killing were higher in villages located closer to the boundaries of the protected area than in distant villages. Therefore, we appeal for improved enforcement and coordination of veterinary services in our study area, and propose several priority research topics such as veterinarian studies, role of wild prey in diseases of domestic animals, and further analysis of potential conflict predictors.	[Khorozyan, Igor; Ghoddousi, Arash; Waltert, Matthias] Univ Gottingen, Workgrp Endangered Species, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Soofi, Mahmood; Hamidi, Amirhossein Khaleghi] Persian Wildlife Heritage Fdn, Tehran, Iran	University of Gottingen	Khorozyan, I (corresponding author), Univ Gottingen, Workgrp Endangered Species, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany.	igor.khorozyan@biologie.uni-goettingen.de	Soofi, Mahmood/AAL-5283-2021; Khorozyan, Igor/A-2510-2019; Waltert, Matthias/E-9134-2010; Ghoddousi, Arash/B-3914-2015	Soofi, Mahmood/0000-0002-6167-2527; Waltert, Matthias/0000-0001-7053-0291; Ghoddousi, Arash/0000-0001-9605-3091; Khorozyan, Igor/0000-0002-0657-7500	Mohammed bin Zayed Species Conservation Fund [12255025]; Erasmus Mundus/ALRAKIS [2011-2577, 2012-2733]; Alexander von Humboldt Foundation [1151598]; Erasmus Mundus/SALAM [2013-2437-001-001-EMA2]; German Academic Exchange Service (DAAD) [A/11/96604]; Panthera Kaplan Graduate Awards	Mohammed bin Zayed Species Conservation Fund; Erasmus Mundus/ALRAKIS; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Erasmus Mundus/SALAM; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Panthera Kaplan Graduate Awards	This study was supported by the Mohammed bin Zayed Species Conservation Fund (IK, MS, AKH, AG, http://www.speciesconservation.org/, project No. 12255025) and Erasmus Mundus/ALRAKIS (IK, http://www.alrakis.eu/, projects No. 2011-2577 and No. 2012-2733). Currently, IK and MW receive funding from Alexander von Humboldt Foundation (http://www.humboldt-foundation.de/, project No. 1151598), MS from Erasmus Mundus/SALAM (http://portal.uw.edu.pl/en/web/salam/, project No. 2013-2437-001-001-EMA2), and AG from German Academic Exchange Service (DAAD, https://www.daad.de, project No. A/11/96604) and Panthera Kaplan Graduate Awards (http://www.panthera.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhani H., 2005, ILLUSTRATED FLORA GO, V1; Amador-Alcala S, 2013, ORYX, V47, P243, DOI 10.1017/S0030605311001359; APPEL MJG, 1994, J VET DIAGN INVEST, V6, P277, DOI 10.1177/104063879400600301; Baker PJ, 2008, MAMMAL REV, V38, P123, DOI 10.1111/j.1365-2907.2008.00122.x; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Butler JRA, 2004, BIOL CONSERV, V115, P369, DOI 10.1016/S0006-3207(03)00152-6; Chapman CA, 2015, ORYX, V49, P636, DOI 10.1017/S0030605313001592; Dar NI, 2009, BIOL CONSERV, V142, P2076, DOI 10.1016/j.biocon.2009.04.003; de Azevedo FCC, 2007, J WILDLIFE MANAGE, V71, P2379, DOI 10.2193/2006-520; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Duffy MA, 2011, FUNCT ECOL, V25, P945, DOI 10.1111/j.1365-2435.2011.01872.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Frank LG, 2005, CONSERV BIOL SER, V9, P286; Ghaemi Peyman, 2011, World Applied Sciences Journal, V13, P1471; Goodrich JM, 2012, DIS PARASITES WILDLI, P19; Graham K, 2005, BIOL CONSERV, V122, P159, DOI 10.1016/j.biocon.2004.06.006; Hamidi Amirhossein Kh., 2014, Cat News, V60, P12; Hemson G, 2009, BIOL CONSERV, V142, P2718, DOI 10.1016/j.biocon.2009.06.024; Hosseini SH, 2012, IRAN J VET RES, V13, P64; Huttner M, 2009, INT J PARASITOL, V39, P1269, DOI 10.1016/j.ijpara.2009.02.015; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Jafarzadeh SR, 2014, PREV VET MED, V115, P101, DOI 10.1016/j.prevetmed.2014.03.018; Kagendo D, 2014, PARASITOL INT, V63, P604, DOI 10.1016/j.parint.2014.04.001; Kang Y, 2014, MATH BIOSCI ENG, V11, P877, DOI 10.3934/mbw.4.11.877; Karlsson J, 2010, J APPL ECOL, V47, P166, DOI 10.1111/j.1365-2664.2009.01747.x; Kissui BM, 2008, ANIM CONSERV, V11, P422, DOI 10.1111/j.1469-1795.2008.00199.x; Loveridge Andrew J., 2010, P161; Mansoorlakooraj F, 2011, VET PARASITOL, V182, P364, DOI 10.1016/j.vetpar.2011.05.013; Motavali H.S.M., 2013, RES MOL MED, V1, P35; Munson Linda, 2010, P237; Munson L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002545; Packer C, 2003, ECOL LETT, V6, P797, DOI 10.1046/j.1461-0248.2003.00500.x; Perez AM, 2005, PREV VET MED, V71, P197, DOI 10.1016/j.prevetmed.2005.07.005; Sarani Moslem, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS246, DOI 10.12980/APJTB.4.2014C746; Seimon TA, 2013, MBIO, V4, DOI 10.1128/mBio.00410-13; Sofizadeh A, 2014, J ARTHROPOD-BORNE DI, V8, P108; Treves A, 2011, BIOSCIENCE, V61, P451, DOI 10.1525/bio.2011.61.6.7; Woodroffe R, 2007, BIODIVERS CONSERV, V16, P1245, DOI 10.1007/s10531-006-9124-8; Yan X., 2009, LINEAR REGRESSION AN, DOI DOI 10.1142/6986; Zarco-Gonzalez MM, 2013, BIOL CONSERV, V159, P80, DOI 10.1016/j.biocon.2012.11.007	40	17	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129221	10.1371/journal.pone.0129221	http://dx.doi.org/10.1371/journal.pone.0129221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114626	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500021
J	Spustek, T; Jedrzejczak, WW; Blinowska, KJ				Spustek, Tomasz; Jedrzejczak, Wieslaw Wiktor; Blinowska, Katarzyna Joanna			Matching Pursuit with Asymmetric Functions for Signal Decomposition and Parameterization	PLOS ONE			English	Article							EVOKED OTOACOUSTIC EMISSIONS; TIME-FREQUENCY ANALYSIS; ADAPTIVE APPROXIMATIONS; HIGH-RESOLUTION; EEG TRANSIENTS; POTENTIALS; LATENCY; EVENTS; CORTEX	The method of adaptive approximations by Matching Pursuit makes it possible to decompose signals into basic components (called atoms). The approach relies on fitting, in an iterative way, functions from a large predefined set (called dictionary) to an analyzed signal. Usually, symmetric functions coming from the Gabor family (sine modulated Gaussian) are used. However Gabor functions may not be optimal in describing waveforms present in physiological and medical signals. Many biomedical signals contain asymmetric components, usually with a steep rise and slower decay. For the decomposition of this kind of signal we introduce a dictionary of functions of various degrees of asymmetry - from symmetric Gabor atoms to highly asymmetric waveforms. The application of this enriched dictionary to Otoacoustic Emissions and Steady-State Visually Evoked Potentials demonstrated the advantages of the proposed method. The approach provides more sparse representation, allows for correct determination of the latencies of the components and removes the "energy leakage" effect generated by symmetric waveforms that do not sufficiently match the structures of the analyzed signal. Additionally, we introduced a time-frequency-amplitude distribution that is more adequate for representation of asymmetric atoms than the conventional time-frequency-energy distribution.	[Spustek, Tomasz; Blinowska, Katarzyna Joanna] Warsaw Univ, Dept Biomed Phys, Warsaw, Poland; [Jedrzejczak, Wieslaw Wiktor] Inst Physiol & Pathol Hearing, Warsaw, Poland; [Blinowska, Katarzyna Joanna] Polish Acad Sci, Inst Biocybernet & Biomed Engn, Warsaw, Poland	University of Warsaw; Institute of Physiology & Hearing Pathology; Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences	Blinowska, KJ (corresponding author), Warsaw Univ, Dept Biomed Phys, Warsaw, Poland.	kjbli@fuw.edu.pl	Jedrzejczak, W. Wiktor/L-2529-2015	Jedrzejczak, W. Wiktor/0000-0001-8404-0672; Blinowska, Katarzyna/0000-0001-6429-4421	Polish Ministry of Science and Higher Education	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was partly supported by a grant from the Polish Ministry of Science and Higher Education to the Institute of Experimental Physics of the University of Warsaw.	Atlas L.E., 1992, TIME FREQUENCY SIGNA; Blinowska K. J., 2012, PRACTICAL BIOMEDICAL; Blinowska KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037988; Blinowska KJ, 2004, METHOD INFORM MED, V43, P70; Blinowska KJ, 2001, ACTA NEUROBIOL EXP, V61, P157; CHENG J, 1995, SCAND AUDIOL, V24, P91, DOI 10.3109/01050399509047520; Clementz BA, 2004, COGNITIVE BRAIN RES, V18, P121, DOI 10.1016/j.cogbrainres.2003.09.007; Cui J, 2006, IEEE T BIO-MED ENG, V53, P1378, DOI 10.1109/TBME.2006.873700; DURKA PJ, 1995, ANN BIOMED ENG, V23, P608, DOI 10.1007/BF02584459; Fawcett IP, 2004, NEUROIMAGE, V21, P1542, DOI 10.1016/j.neuroimage.2003.10.045; Gao XR, 2003, IEEE T NEUR SYS REH, V11, P137, DOI 10.1109/TNSRE.2003.814449; Ghofrani S, 2005, SIGNAL PROCESS, V85, P1984, DOI 10.1016/j.sigpro.2005.04.005; Goodwin MM, 1999, IEEE T SIGNAL PROCES, V47, P1890, DOI 10.1109/78.771038; Gribonval R, 2003, IEEE T SIGNAL PROCES, V51, P101, DOI 10.1109/TSP.2002.806592; Hatzopoulos S, 2000, AUDIOLOGY, V39, P1; Jedrzejczak WW, 2007, HEARING RES, V231, P54, DOI 10.1016/j.heares.2007.05.009; Jedrzejczak WW, 2009, J ACOUST SOC AM, V126, P3137, DOI 10.1121/1.3243294; Jedrzejczak WW, 2005, HEARING RES, V205, P249, DOI 10.1016/j.heares.2005.03.024; Jedrzejczak WW, 2004, J ACOUST SOC AM, V115, P2148, DOI 10.1121/1.1690077; Malinowska U, 2007, COMPUT BIOL MED, V37, P534, DOI 10.1016/j.compbiomed.2006.08.005; MALLAT SG, 1993, IEEE T SIGNAL PROCES, V41, P3397, DOI 10.1109/78.258082; Moratti S, 2008, ARCH GEN PSYCHIAT, V65, P532, DOI 10.1001/archpsyc.65.5.532; Moratti S, 2007, HUM BRAIN MAPP, V28, P1318, DOI 10.1002/hbm.20342; NATARAJAN BK, 1995, SIAM J COMPUT, V24, P227, DOI 10.1137/S0097539792240406; Ozdamar O, 1997, BRIT J AUDIOL, V31, P461, DOI 10.3109/03005364000000040; Ren T, 2000, J NEUROSCI METH, V96, P97, DOI 10.1016/S0165-0270(99)00187-9; Rihaczek W., 1968, IEEE T INFORM THEORY, VLT-14, P369; SILBERSTEIN RB, 1995, EVOKED POTENTIAL, V96, P24, DOI 10.1016/0013-4694(94)00189-R; Sisto R, 2002, J ACOUST SOC AM, V111, P297, DOI 10.1121/1.1428547; Strohmeier D, 2010, IFMBE P, V29; Tognola G, 1997, HEARING RES, V106, P112, DOI 10.1016/S0378-5955(97)00007-5; Vialatte FB, 2009, COGN NEURODYNAMICS, V3, P251, DOI 10.1007/s11571-009-9082-4; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; WEIDERPASS HA, 2008, SOC PHOT INSTR ENG S, P6917; WIT HP, 1994, HEARING RES, V73, P141, DOI 10.1016/0378-5955(94)90228-3; Zhang ZG, 2008, HEARING RES, V243, P18, DOI 10.1016/j.heares.2008.07.002; Zygierewicz J, 1999, CLIN NEUROPHYSIOL, V110, P2136, DOI 10.1016/S1388-2457(99)00175-3; Zygierewicz J, 1998, J NEUROSCI METH, V81, P121, DOI 10.1016/S0165-0270(98)00016-8	38	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131007	10.1371/journal.pone.0131007	http://dx.doi.org/10.1371/journal.pone.0131007			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115480	gold, Green Submitted, Green Published			2022-12-27	WOS:000358147500120
J	Zou, M; Zhang, XT; Shi, ZC; Lin, L; Ouyang, G; Zhang, GR; Zheng, H; Wei, KJ; Ji, W				Zou, Ming; Zhang, Xiaoting; Shi, Zechao; Lin, Li; Ouyang, Gang; Zhang, Guirong; Zheng, Huan; Wei, Kaijian; Ji, Wei			A Comparative Transcriptome Analysis between Wild and Albino Yellow Catfish (Pelteobagrus fulvidraco)	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; RNA-SEQ DATA; GENE; INHERITANCE; EVOLUTION; COLORATION; ALIGNMENT; CARP; PATHWAYS; SEQUENCE	Body colours are important and striking features for individual survival and reproductive success, in particular in vertebrates where mating behaviour and mate preference may be strongly influenced by non-normal phenotypes. Pigmentation disorders may be generated by disruption of one or many independent genes as well as by environmental factors. The first discovery of albino yellow catfish (Pelteobagrus fulvidraco Richardson) with golden skin colour from fish farms in China provides us valuable material to study the molecular mechanism underlying the abnormalities of pigmentation. In this study, transcriptome sequencing of fin tissues corresponding to the distinct body colours, wild type and mutant albino yellow catfish, were performed using Illumina sequencing technology. Based on next-generation sequencing technology and de novo assembly, we generated a transcriptome of P. fulvidraco. A number of genes differentially expressed between the wild types and albinos were identified, suggesting their contribution to the different phenotypes and fitness. However, non-synonymous mutations result from single nucleotide substitutions residing in coding regions may not contribute to such differences. Based on the highthroughput expression data generated for the two different types of P. fulvidraco, we found that alterations of expression pattern may be more common than non-synonymous mutations. The transcriptome of P. fulvidraco will be an invaluable resource for subsequent comparative genomics and evolutionary analyses of this economically important fish.	[Lin, Li; Ji, Wei] Huazhong Agr Univ, Coll Fisheries, Dept Aquat Anim Med, Wuhan 430070, Hubei, Peoples R China; [Zou, Ming; Zhang, Xiaoting; Lin, Li; Zhang, Guirong; Zheng, Huan; Wei, Kaijian; Ji, Wei] Huazhong Agr Univ, Coll Fisheries, Key Lab Freshwater Anim Breeding, Minist Agr, Wuhan 430070, Hubei, Peoples R China; [Zou, Ming; Lin, Li; Zhang, Guirong; Wei, Kaijian; Ji, Wei] Freshwater Aquaculture Collaborat Innovat Ctr Hub, Wuhan 430070, Hubei, Peoples R China; [Shi, Zechao] Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Key Lab Freshwater Biodivers Conservat, Minist Agr, Wuhan 430223, Hubei, Peoples R China; [Ouyang, Gang] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan 430070, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Fishery Sciences; Yangtze River Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Wei, KJ (corresponding author), Huazhong Agr Univ, Coll Fisheries, Key Lab Freshwater Anim Breeding, Minist Agr, Wuhan 430070, Hubei, Peoples R China.	kjwei@mail.hzau.edu.cn; wei-ji@mail.hzau.edu.cn			Natural Science Foundation of China [31301122]; Natural Science Foundation of Hubei Province [2014CFB924]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported by the Natural Science Foundation of China (Grant No. 31301122, http://www.nsfc.gov.cn/, to WJ) and Natural Science Foundation of Hubei Province (Grant No. 2014CFB924, http://www.hbstd.gov.cn/, to MZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ames RM, 2011, MOL BIOL EVOL, V28, P3331, DOI 10.1093/molbev/msr167; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BONDARI K, 1984, FISH MANAGE, V15, P131; Braasch I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-74; Braasch I, 2009, PIGM CELL MELANOMA R, V22, P839, DOI 10.1111/j.1755-148X.2009.00614.x; Caro T, 2013, SEMIN CELL DEV BIOL, V24, P542, DOI 10.1016/j.semcdb.2013.03.016; De Wit P, 2012, MOL ECOL RESOUR, V12, P1058, DOI 10.1111/1755-0998.12003; Delgado J, 2009, J APPL ICHTHYOL, V25, P483, DOI 10.1111/j.1439-0426.2009.01196.x; Dobosz S, 1999, J HERED, V90, P312, DOI 10.1093/jhered/90.2.312; Dobosz S, 2000, J APPL ICHTHYOL, V16, P117, DOI 10.1046/j.1439-0426.2000.00147.x; Fisheries Bureau of the Agriculture Ministry of China, 2013, CHIN FISH STAT YB; Goda M, 2011, PIGM CELL MELANOMA R, V24, P614, DOI 10.1111/j.1755-148X.2011.00861.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hofreiter M, 2010, CELL MOL LIFE SCI, V67, P2591, DOI 10.1007/s00018-010-0333-7; Hutton SM, 2008, INVEST OPHTH VIS SCI, V49, P868, DOI 10.1167/iovs.07-0791; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kelsh RN, 2000, DEV BIOL, V225, P277, DOI 10.1006/dbio.2000.9840; Kofler R, 2011, BIOINFORMATICS, V27, P3435, DOI 10.1093/bioinformatics/btr589; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lapedriza A., 2014, NEURAL CREST CELLS E, P287, DOI DOI 10.1016/B978-0-12-401730-6.00015-6; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043328; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu Shiping, 1997, Chinese Journal of Zoology, V32, P10; Logan DW, 2006, PIGM CELL RES, V19, P206, DOI 10.1111/j.1600-0749.2006.00307.x; Maan ME, 2013, SEMIN CELL DEV BIOL, V24, P516, DOI 10.1016/j.semcdb.2013.05.003; Nakatani M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-177; Oetting WS, 2000, PIGM CELL RES, V13, P320, DOI 10.1034/j.1600-0749.2000.130503.x; Olsson M, 2013, SEMIN CELL DEV BIOL, V24, P529, DOI 10.1016/j.semcdb.2013.04.001; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROTHBARD S, 1993, AQUACULTURE, V115, P13, DOI 10.1016/0044-8486(93)90354-2; Roulin A, 2013, SEMIN CELL DEV BIOL, V24, P594, DOI 10.1016/j.semcdb.2013.05.005; Rudh A, 2013, SEMIN CELL DEV BIOL, V24, P553, DOI 10.1016/j.semcdb.2013.05.004; Sarna T, 2006, PIGMENTARY SYSTEM PH, P311; SEARLE AG, 1990, OPHTHALMIC PAED GEN, V11, P159, DOI 10.3109/13816819009020974; Seyednasrollah F, 2013, BRIEF BIOINFORM; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Spritz R.A., 2013, EMERY RIMOINS PRINCI, P1, DOI [10.1016/B978-0-12-383834-6.00154-3, DOI 10.1016/B978-0-12-383834-6.00154-3]; Wang CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090074; Wang JQ, 2007, FISH PHYSIOL BIOCHEM, V33, P143, DOI 10.1007/s10695-006-9125-2; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu P, 2014, NAT GENET, V46, P1212, DOI 10.1038/ng.3098; YAMAMOTO T, 1973, JPN J GENET, V48, P53, DOI 10.1266/jjg.48.53; YAMAMOTO TO, 1969, GENETICS, V62, P797; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zou M, 2014, GENE, V547, P267, DOI 10.1016/j.gene.2014.06.056	50	27	29	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131504	10.1371/journal.pone.0131504	http://dx.doi.org/10.1371/journal.pone.0131504			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114548	gold, Green Published, Green Submitted			2022-12-27	WOS:000358147500163
J	He, M; Fang, YX; Lin, JY; Ma, KJ; Li, BX				He, Meng; Fang, You-Xin; Lin, Jun-Yi; Ma, Kai-Jun; Li, Bei-Xu			Unnatural Deaths in Shanghai from 2000 to 2009: A Retrospective Study of Forensic Autopsy Cases at the Shanghai Public Security Bureau	PLOS ONE			English	Article							BIOLOGICAL TERRORISM; HEALTH; CHINA	Shanghai is the most developed city in China and has a soaring population. This study uses forensic epidemiology to determine the relationship between unnatural deaths and the development in Shanghai, based on recently released forensic autopsy cases from the 2000s at the Shanghai Public Security Bureau (SPSB). There were 5425 accidental deaths, 2696 homicides, 429 suicides, 186 natural deaths, and 1399 deaths of undetermined cause. There was a male-to-female ratio of 2.02:1, and the average age was 40.9 +/- 18.7 years. Traffic accidents (84.2%) were the number one cause of accidental deaths, which decreased during the study period. Sharp force injury (50.6%) was the leading cause of homicides, different from Western countries, where firearms are the leading cause. Hanging (24.5%) was the leading cause of suicides, whereas drug and chemical intoxication was the leading cause in the previous decade; pesticide ingestion decreased in the 2000s. In addition to traffic accidents, manual strangulation was the leading cause of death in childhood fatalities. Children under age 2 were vulnerable to homicides. In the 2000s, there were a large number of drug overdoses, and illegal medical practices and subway-related deaths first appeared in Shanghai. A new type of terrorist attack that involved injecting people with syringes in public places was reflected in the SPSB archives. The forensic epidemiology and changes in unnatural deaths in this decade reflected their relationship with the law, policy and changes in Shanghai. Illegal medical practices, subway-related deaths and terrorist attacks were closely related to the development in Shanghai. Identifying the risks of unnatural deaths will improve public health.	[He, Meng; Lin, Jun-Yi; Li, Bei-Xu] Fudan Univ, Sch Basic Med Sci, Dept Forens Med, Shanghai 200032, Peoples R China; [Fang, You-Xin] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200040, Peoples R China; [Ma, Kai-Jun] Shanghai Publ Secur Bur, Inst Forens Sci, Shanghai Key Lab Crime Scene Evidence, Shanghai 200083, Peoples R China	Fudan University; Fudan University; Institute of Forensic Science Ministry of Justice PRC	Li, BX (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Forens Med, Shanghai 200032, Peoples R China.	libeixu@gmail.com			Funds for Youth in Department of Forensic Medicine, School of Basic Medical Sciences, Fudan University [FY2014-04]	Funds for Youth in Department of Forensic Medicine, School of Basic Medical Sciences, Fudan University	This study is supported by Funds for Youth in Department of Forensic Medicine, School of Basic Medical Sciences, Fudan University (FY2014-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett Russell L, 2006, Int J Environ Res Public Health, V3, P67, DOI 10.3390/ijerph2006030008; Hamele Mitchell, 2014, World J Crit Care Med, V3, P15, DOI 10.5492/wjccm.v3.i1.15; He M, 2014, AM J FOREN MED PATH, V35, P218, DOI 10.1097/PAF.0000000000000115; Hesketh T, 1997, BRIT MED J, V314, P1685, DOI 10.1136/bmj.314.7095.1685; Hesketh T, 2006, P NATL ACAD SCI USA, V103, P13271, DOI 10.1073/pnas.0602203103; Lathrop SL, 2013, J FORENSIC SCI, V58, P700, DOI 10.1111/1556-4029.12106; Lin PT, 2009, J FORENSIC SCI, V54, P1414, DOI 10.1111/j.1556-4029.2009.01165.x; Matzopoulos Richard, 2006, Int J Inj Contr Saf Promot, V13, P81, DOI 10.1080/17457300500249582; Miller BD, 2001, AM ANTHROPOL, V103, P1083, DOI 10.1525/aa.2001.103.4.1083; Mohanty MK, 2007, MED SCI LAW, V47, P156, DOI 10.1258/rsmmsl.47.2.156; MOODY DE, 1991, J FORENSIC SCI, V36, P1474; Shi Y, 2012, INT J INF TECH DECIS, V11, P1, DOI 10.1142/S0219622012010018; Tucker JB, 1997, JAMA-J AM MED ASSOC, V278, P362, DOI 10.1001/jama.278.5.362; Wang Y, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-158; Wetter DC, 2001, AM J PUBLIC HEALTH, V91, P710, DOI 10.2105/AJPH.91.5.710; Xu Jiaquan, 2010, Natl Vital Stat Rep, V58, P1; Zhan SK, 2002, HEALTH POLICY PLANN, V17, P47, DOI 10.1093/heapol/17.suppl_1.47; Zhao Q, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1012; Zhou LP, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/215653	19	11	11	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131309	10.1371/journal.pone.0131309	http://dx.doi.org/10.1371/journal.pone.0131309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OY	26110435	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800142
J	Suh, DH; Cho, HY; Kim, K; No, JH; Kim, YB				Suh, Dong Hoon; Cho, Hye-Yon; Kim, Kidong; No, Jae Hong; Kim, Yong-Beom			Matched-Case Comparisons in a Single Institution to Determine Critical Points for Inexperienced Surgeons' Successful Performances of Laparoscopic Radical Hysterectomy versus Abdominal Radical Hysterectomy in Stage IA2-IIA Cervical Cancer	PLOS ONE			English	Article							LEARNING-CURVE; LYMPHADENECTOMY; MARGINS	This is a retrospective study which aims to identify major determinants of successful laparoscopic radical hysterectomy (LRH) versus abdominal radical hysterectomy (ARH) performed by inexperienced surgeons for stage IA2-IIA cervical cancer. A total of 161 consecutive patients with stage IA2-IIA cervical cancer who underwent RH were grouped into 2 groups according to the surgeons' experience with LRH: experienced surgeon versus inexperienced surgeon. After matching for age and risk factors, surgical and survival outcomes were compared. Experienced surgeon selected patients with earlierstage and fewer risk factors for LRH than ARH, but inexperience surgeons did not. After matching, the vaginal tumor-free margin of LRH was shorter than that of ARH in experienced surgeon group (1.3 versus 1.7 cm, p=0.007); however, the vaginal tumor-free margin was longer than that of ARH in the inexperienced surgeon group (1.8 versus 1.3 cm, p=0.035). The postoperative hospital stay of LRH was shorter than that of ARH in experienced surgeon group (5.5 versus 7.7 days, p<0.001), but not different from that of ARH in the inexperienced surgeon group. Vaginal tumor-free margin >1.8 cm (OR 7.33, 95% CI 1.22-40.42), stage >IB1 (OR 8.83, 95% CI 1.51-51.73), and estimated blood loss >575 mL (OR 33.95, 95% CI 4.87-236.79) were independent risk factors for longer postoperative hospital stay in the inexperienced surgeon group. There was no difference of 5-yearprofression-free survival of LRH patients between experienced surgeon and inexperienced surgeon groups after matching (55.1 versus 33.3%, p=0.391). Selection of earlierstage disease and moderate vaginal tumor-free margin might be important for an	[Suh, Dong Hoon; Kim, Kidong; No, Jae Hong; Kim, Yong-Beom] Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Songnam, South Korea; [Cho, Hye-Yon] Hallym Univ, Dongtan Sacred Heart Hosp, Dept Obstet & Gynecol, Hwasung, South Korea	Seoul National University (SNU); Hallym University	Kim, YB (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Songnam, South Korea.	ybkimlh@snubh.org		No, Jae Hong/0000-0002-2389-6757	Seoul National University Bundang Hospital general research grant [02-2012-068]	Seoul National University Bundang Hospital general research grant	This work was supported by Seoul National University Bundang Hospital general research grant [grant number 02-2012-068]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2008, ANN SURG ONCOL, V15, P2847, DOI 10.1245/s10434-008-0063-3; Chong GO, 2009, INT J GYNECOL CANCER, V19, P1459, DOI 10.1111/IGC.0b013e3181b76640; ElMasri WM, 2009, CANCER TREAT RES, V149, P297, DOI 10.1007/978-0-387-98094-2_14; Estape RE, 1998, GYNECOL ONCOL, V68, P229, DOI 10.1006/gyno.1998.4960; Frumovitz M, 2007, OBSTET GYNECOL, V110, P96, DOI 10.1097/01.AOG.0000268798.75353.04; Hwang JH, 2012, EUR J OBSTET GYN R B, V163, P219, DOI 10.1016/j.ejogrb.2012.05.005; Li GY, 2007, GYNECOL ONCOL, V105, P176, DOI 10.1016/j.ygyno.2006.11.011; McCann GA, 2013, GYNECOL ONCOL, V128, P44, DOI 10.1016/j.ygyno.2012.10.028; Nam JH, 2012, ANN ONCOL, V23, P903, DOI 10.1093/annonc/mdr360; Obermair A, 2008, J MINIM INVAS GYN, V15, P584, DOI 10.1016/j.jmig.2008.06.013; Park JY, 2013, J SURG ONCOL, V108, P63, DOI 10.1002/jso.23347; Protopapas A, 2009, INT J GYNECOL CANCER, V19, P712, DOI 10.1111/IGC.0b013e3181a3e2be; Ramirez PT, 2006, GYNECOL ONCOL, V102, P252, DOI 10.1016/j.ygyno.2005.12.013; Viswanathan AN, 2006, INT J RADIAT ONCOL, V65, P1501, DOI 10.1016/j.ijrobp.2006.03.010	14	10	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131170	10.1371/journal.pone.0131170	http://dx.doi.org/10.1371/journal.pone.0131170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110866	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800125
J	Taft, DH; Ambalavanan, N; Schibler, KR; Yu, ZT; Newburg, DS; Deshmukh, H; Ward, DV; Morrow, AL				Taft, Diana H.; Ambalavanan, Namasivayam; Schibler, Kurt R.; Yu, Zhuoteng; Newburg, David S.; Deshmukh, Hitesh; Ward, Doyle V.; Morrow, Ardythe L.			Center Variation in Intestinal Microbiota Prior to Late-Onset Sepsis in Preterm Infants	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; NECROTIZING ENTEROCOLITIS; NEONATAL SEPSIS; GUT; INFECTION; TERM; BACTERIA	Objective Late onset sepsis (LOS) contributes to mortality and morbidity in preterm infants. We tested the hypotheses that microbes causing LOS originate from the gut, and that distortions in the gut microbial community increases subsequent risk of LOS. Study Design We examined the gut microbial community in prospectively collected stool samples from preterm infants with LOS and an equal number of age-matched controls at two sites (Cincinnati, OH and Birmingham, AL), by sequencing the bacterial 16S rDNA. We confirmed our findings in a subset of infants by whole genome shotgun sequencing, and analyzed the data using R and LEfSe. Results Infants with LOS in Cincinnati, as compared to controls, had less abundant Actinobacteria in the first samples after birth (median 18 days before sepsis onset), and less abundant Pseudomonadales in the last samples collected prior to LOS (median 8 days before sepsis onset). Infants with LOS in Birmingham, as compared to controls, had no differences identified in the first sample microbial communities, but Lactobacillales was less abundant in the last samples prior to LOS (median 4 days before sepsis onset). Sequencing identified detectable levels of the sepsis-causative organism in stool samples prior to disease onset for 82% of LOS cases. Conclusions Translocation of gut microbes may account for the majority of LOS cases. Distortions in the fecal microbiota occur prior to LOS, but the form of distortion depends on timing and site. The microbial composition of fecal samples does not predict LOS onset in a generalizable fashion.	[Taft, Diana H.; Schibler, Kurt R.; Deshmukh, Hitesh; Morrow, Ardythe L.] Childrens Hosp, Perinatal Inst, Cincinnati, OH 45229 USA; [Taft, Diana H.] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA; [Ambalavanan, Namasivayam] Univ Alabama Birmingham, Pediat, Birmingham, AL USA; [Yu, Zhuoteng; Newburg, David S.] Boston Coll, Biol, Chestnut Hill, MA 02167 USA; [Ward, Doyle V.] Broad Inst, Cambridge, MA USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Alabama System; University of Alabama Birmingham; Boston College; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Morrow, AL (corresponding author), Childrens Hosp, Perinatal Inst, Cincinnati, OH 45229 USA.	Ardythe.Morrow@cchmc.org	Ambalavanan, Namasivayam/AAI-4088-2020; Morrow, Ardythe/GQO-8482-2022; Ambalavanan, Namasivayam/AAL-3832-2020	Ambalavanan, Namasivayam/0000-0003-0731-9092; Deshmukh, Hitesh/0000-0001-9632-164X; Taft, Diana/0000-0002-9306-9968	National Institute of Child Health and Human Development, National Institutes of Health [R01HD059140, P01HD13021, HD27853]; National Center for Research Resources, National Institutes of Health [5UL1RR026314-03, U54HG004969]; National Human Genome Research Institute, National Institutes of Health [HG005969]; Danone Research [PLF-5972-GD]; National Institute of Environmental Health Sciences, National Institutes of Health [T32 ES 10957-11]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900018C]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD084686, UG1HD027853, R01HD059140, U10HD027853, P01HD013021] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR026314] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004969, R01HG005969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES010957] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Danone Research(Danone Nutricia); National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project has been funded in whole or in part with Federal funds from the National Institute of Child Health and Human Development, National Institutes of Health (grant numbers R01HD059140, P01HD13021, and HD27853); National Center for Research Resources, National Institutes of Health (grant numbers 5UL1RR026314-03, U54HG004969); National Human Genome Research Institute, National Institutes of Health (HG005969); Danone Research (PLF-5972-GD); National Institute of Environmental Health Sciences, National Institutes of Health (T32 ES 10957-11); and the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200900018C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V303, pG675, DOI 10.1152/ajpgi.00152.2012; Boghossian NS, 2013, J PEDIATR-US, V162, P1120, DOI 10.1016/j.jpeds.2012.11.089; Candela M, 2010, INT J FOOD MICROBIOL, V140, P93, DOI 10.1016/j.ijfoodmicro.2010.04.017; Carl MA, 2014, CLIN INFECT DIS, V58, P1211, DOI 10.1093/cid/ciu084; CLARKE DE, 1990, CHEST, V97, P966, DOI 10.1378/chest.97.4.966; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Graham PL, 2007, PEDIATR INFECT DIS J, V26, P1153, DOI 10.1097/INF.0b013e31814619d4; Greenwood C, 2014, J PEDIATR-US, V165, P23, DOI 10.1016/j.jpeds.2014.01.010; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Hornik CP, 2012, EARLY HUM DEV, V88, pS69, DOI 10.1016/S0378-3782(12)70019-1; Kaplan HC, 2011, PEDIATRICS, V127, P427, DOI 10.1542/peds.2010-2141; La Rosa PS, 2014, P NATL ACAD SCI USA, V111, P12522, DOI 10.1073/pnas.1409497111; Ley RE, 2014, NAT MED, V20, P248, DOI 10.1038/nm.3494; Madan JC, 2012, ARCH DIS CHILD-FETAL, V97, pF456, DOI 10.1136/fetalneonatal-2011-301373; Mai V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052876; Morrow AL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-13; Nakayama M, 2003, PEDIATR RES, V54, P364, DOI 10.1203/01.PDR.0000077482.28990.2D; Ng PC, 2010, CLIN PERINATOL, V37, P599, DOI 10.1016/j.clp.2010.05.005; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Polin RA, 2008, J PEDIAT-BRAZIL, V84, P188, DOI [10.2223/JPED.1784, 10.1590/S0021-75572008000300002]; Schwiertz A, 2003, PEDIATR RES, V54, P393, DOI 10.1203/01.PDR.0000078274.74607.7A; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shah DK, 2008, J PEDIATR-US, V153, P170, DOI 10.1016/j.jpeds.2008.02.033; Silveira RC, 2008, J PEDIAT-BRAZIL, V84, P211, DOI 10.2223/JPED.1777; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Sriskandan S, 1999, INFECT DIS CLIN N AM, V13, P397, DOI 10.1016/S0891-5520(05)70082-9; Stewart CJ, 2012, ACTA PAEDIATR, V101, P1121, DOI 10.1111/j.1651-2227.2012.02801.x; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Taft DH, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-36; Therneau T.M., 2011, RPART RECURSIVE PART; Torrazza RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083304	34	48	49	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130604	10.1371/journal.pone.0130604	http://dx.doi.org/10.1371/journal.pone.0130604			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110908	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800067
J	Westcot, SE; Hatzold, J; Urban, MD; Richetti, SK; Skuster, KJ; Harm, RM; Cervera, RL; Umemoto, N; McNulty, MS; Clark, KJ; Hammerschmidt, M; Ekker, SC				Westcot, Stephanie E.; Hatzold, Julia; Urban, Mark D.; Richetti, Stefania K.; Skuster, Kimberly J.; Harm, Rhianna M.; Cervera, Roberto Lopez; Umemoto, Noriko; McNulty, Melissa S.; Clark, Karl J.; Hammerschmidt, Matthias; Ekker, Stephen C.			Protein-Trap Insertional Mutagenesis Uncovers New Genes Involved in Zebrafish Skin Development, Including a Neuregulin 2a-Based ErbB Signaling Pathway Required during Median Fin Fold Morphogenesis	PLOS ONE			English	Article							LETHAL-GIANT-LARVAE; QUALITY-OF-LIFE; FRASER-SYNDROME; CELL-MIGRATION; EXTRACELLULAR-MATRIX; TRANSGENIC ZEBRAFISH; NUCLEAR-LOCALIZATION; BLEBBED PHENOTYPE; GROWTH-FACTOR; NEURAL CREST	Skin disorders are widespread, but available treatments are limited. A more comprehensive understanding of skin development mechanisms will drive identification of new treatment targets and modalities. Here we report the Zebrafish Integument Project (ZIP), an expression-driven platform for identifying new skin genes and phenotypes in the vertebrate model Danio rerio (zebrafish). In vivo selection for skin-specific expression of gene-break transposon (GBT) mutant lines identified eleven new, revertible GBT alleles of genes involved in skin development. Eight genes-fras1, grip1, hmcn1, msxc, col4a4, ahnak, capn12, and nrg2a-had been described in an integumentary context to varying degrees, while arh-gef25b, fkbp10b, and megf6a emerged as novel skin genes. Embryos homozygous for a GBT insertion within neuregulin 2a (nrg2a) revealed a novel requirement for a Neuregulin 2a (Nrg2a) - ErbB2/3 - AKT signaling pathway governing the apicobasal organization of a subset of epidermal cells during median fin fold (MFF) morphogenesis. In nrg2a mutant larvae, the basal keratinocytes within the apical MFF, known as ridge cells, displayed reduced pAKT levels as well as reduced apical domains and exaggerated basolateral domains. Those defects compromised proper ridge cell elongation into a flattened epithelial morphology, resulting in thickened MFF edges. Pharmacological inhibition verified that Nrg2a signals through the ErbB receptor tyrosine kinase network. Moreover, knockdown of the epithelial polarity regulator and tumor suppressor lgl2 ameliorated the nrg2a mutant phenotype. Identifying Lgl2 as an antagonist of Nrg2a - ErbB signaling revealed a significantly earlier role for Lgl2 during epidermal morphogenesis than has been described to date. Furthermore, our findings demonstrated that successive, coordinated ridge cell shape changes drive apical MFF development, making MFF ridge cells a valuable model for investigating how the coordinated regulation of cell polarity and cell shape changes serves as a crucial mechanism of epithelial morphogenesis.	[Westcot, Stephanie E.; Ekker, Stephen C.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Westcot, Stephanie E.; Urban, Mark D.; Skuster, Kimberly J.; Harm, Rhianna M.; Cervera, Roberto Lopez; Umemoto, Noriko; McNulty, Melissa S.; Clark, Karl J.; Ekker, Stephen C.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Hatzold, Julia; Richetti, Stefania K.; Hammerschmidt, Matthias] Univ Cologne, Bioctr, Inst Dev Biol, D-50931 Cologne, Germany; [Hatzold, Julia; Hammerschmidt, Matthias] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Hammerschmidt, Matthias] Univ Cologne, Cologne Cluster Excellence Cellular Stress Respon, D-50931 Cologne, Germany	University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; University of Cologne; University of Cologne; University of Cologne	Ekker, SC (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	ekker.stephen@mayo.edu	Hatzold, Julia/AAN-2996-2021	Ichino, Noriko/0000-0002-7009-8299; Clark, Karl/0000-0002-9637-0967; Hatzold, Julia/0000-0002-5491-1921; Ekker, Stephen/0000-0003-0726-4212; Lopez Cervera, Roberto/0000-0001-6584-486X	NIH [DA14546, GM63904, HG 006431, R25 GM075148]; Mayo Foundation; German Research Foundation (DFG) [SFB 829]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM075148, R56GM063904, R01GM063904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014546] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants DA14546, GM63904 and HG 006431 to SCE, NIH grant R25 GM075148 (Mayo Clinic PREP), the Mayo Foundation, and the German Research Foundation (DFG, SFB 829; to MH).	Abe G, 2007, DEV BIOL, V304, P355, DOI 10.1016/j.ydbio.2006.12.040; Abreu-Velez AM, 2012, N AM J MED SCI, V4, P1, DOI 10.4103/1947-2714.92892; Amagai M, 2004, J INVEST DERMATOL, V123, pXIV, DOI 10.1111/j.0022-202X.2004.23432.x; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Amsterdam A, 1999, GENE DEV, V13, P2713, DOI 10.1101/gad.13.20.2713; Bakkers J, 2002, DEV CELL, V2, P617, DOI 10.1016/S1534-5807(02)00163-6; Bedell VM, 2012, DEVELOPMENT, V139, P793, DOI 10.1242/dev.071720; Bickers DR, 2006, J AM ACAD DERMATOL, V55, P490, DOI 10.1016/j.jaad.2006.05.048; Brameier M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-478; Britto JM, 2004, MOL CELL BIOL, V24, P8221, DOI 10.1128/MCB.24.18.8221-8226.2004; Bryant DM, 2005, TRAFFIC, V6, P947, DOI 10.1111/j.1600-0854.2005.00332.x; Budi EH, 2008, DEVELOPMENT, V135, P2603, DOI 10.1242/dev.019299; Carney TJ, 2007, DEVELOPMENT, V134, P3461, DOI 10.1242/dev.004556; Carney TJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000907; Carraway KL, 1997, NATURE, V387, P512, DOI 10.1038/387512a0; Chang H, 1997, NATURE, V387, P509, DOI 10.1038/387509a0; Choo BG, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-5; Chren MM, 1996, J INVEST DERMATOL, V107, P707, DOI 10.1111/1523-1747.ep12365600; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Clark KJ, 2012, NUCLEIC ACIDS RES, V40, pD907, DOI 10.1093/nar/gkr957; Clark KJ, 2011, NAT METHODS, V8, P506, DOI [10.1038/NMETH.1606, 10.1038/nmeth.1606]; COATES MI, 1994, DEVELOPMENT, P169; Cook RS, 2011, CANCER RES, V71, P3941, DOI 10.1158/0008-5472.CAN-10-3775; Cooper MS, 2005, DEV DYNAM, V232, P359, DOI 10.1002/dvdy.20252; DANE PJ, 1985, J EMBRYOL EXP MORPH, V87, P145; Dear TN, 2000, GENOMICS, V68, P152, DOI 10.1006/geno.2000.6289; Ding YH, 2013, CIRC RES, V112, P606, DOI 10.1161/CIRCRESAHA.112.300603; Ding YH, 2011, CIRC RES, V109, P658, DOI 10.1161/CIRCRESAHA.111.248260; Dodd ME, 2009, DEVELOPMENT, V136, P2591, DOI 10.1242/dev.038448; Driever W, 1996, DEVELOPMENT, V123, P37; Dunn M, 2004, J PATHOL, V203, P672, DOI 10.1002/path.1561; Duran I, 2011, DEV BIOL, V354, P160, DOI 10.1016/j.ydbio.2011.03.014; EKKER M, 1992, NEURON, V9, P27, DOI 10.1016/0896-6273(92)90217-2; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; FEDI P, 1994, MOL CELL BIOL, V14, P492, DOI 10.1128/MCB.14.1.492; Feitosa NM, 2012, DEV BIOL, V369, P235, DOI 10.1016/j.ydbio.2012.06.023; Feitosa NM, 2011, METHOD CELL BIOL, V105, P191, DOI 10.1016/B978-0-12-381320-6.00008-4; Finlay AY, 2009, CLIN MED, V9, P592, DOI 10.7861/clinmedicine.9-6-592; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Fischer B, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004048; Forthmann B, 2015, CELL MOL LIFE SCI; FRIEDLANDER M, 1985, NATURE, V318, P338, DOI 10.1038/318338a0; Fukazawa C, 2010, DEV BIOL, P1, DOI [10.1016/j.ydbio.2010.07.037, DOI 10.1016/J.YDBI0.2010.07.037]; Gautier P, 2008, DEV DYNAM, V237, P3295, DOI 10.1002/dvdy.21729; Gong ZY, 2002, DEV DYNAM, V223, P204, DOI 10.1002/dvdy.10051; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Guzman A, 2013, BIOL OPEN, V2, P1179, DOI 10.1242/bio.20136023; Habif TP, 2011, SKIN DISEASE DIAGNOS; Hadzhiev Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-75; Haffter P, 1996, DEVELOPMENT, V123, P1; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; Hardy KM, 2010, J MAMMARY GLAND BIOL, V15, P191, DOI 10.1007/s10911-010-9172-2; HASHIMOTO T, 1993, J CELL SCI, V105, P275; Hobbs SS, 2002, ONCOGENE, V21, P8442, DOI 10.1038/sj.onc.1205960; Honjo Y, 2008, DEVELOPMENT, V135, P2615, DOI 10.1242/dev.022178; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Jacobs NL, 2011, JOVE-J VIS EXP, DOI 10.3791/2533; Jadeja S, 2005, NAT GENET, V37, P520, DOI 10.1038/ng1549; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lee H, 2002, DEV CELL, V2, P607, DOI 10.1016/S1534-5807(02)00166-1; Lee RTH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084858; Lee RTH, 2013, DEVELOPMENT, V140, P2923, DOI 10.1242/dev.093534; Li QL, 2011, J INVEST DERMATOL, V131, P565, DOI 10.1038/jid.2010.388; Liao HK, 2012, DEV DYNAM, V241, P415, DOI 10.1002/dvdy.23725; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Longo I, 2006, NEPHROL DIAL TRANSPL, V21, P665, DOI 10.1093/ndt/gfi312; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Marshall C, 2006, BREAST CANCER RES TR, V96, P163, DOI 10.1007/s10549-005-9073-z; Marti U, 2001, THYROID, V11, P137, DOI 10.1089/105072501300042785; MASUNAGA T, 1995, J INVEST DERMATOL, V104, P941, DOI 10.1111/1523-1747.ep12606213; McGregor L, 2003, NAT GENET, V34, P203, DOI 10.1038/ng1142; MECHLER BM, 1985, EMBO J, V4, P1551, DOI 10.1002/j.1460-2075.1985.tb03816.x; METCALFE WK, 1985, J COMP NEUROL, V233, P377, DOI 10.1002/cne.902330307; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mohideen MAPK, 2003, DEV DYNAM, V228, P414, DOI 10.1002/dvdy.10407; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nassar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037084; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petzold AM, 2010, ZEBRAFISH, V7, P149, DOI 10.1089/zeb.2010.0660; Petzold AM, 2009, P NATL ACAD SCI USA, V106, P18662, DOI 10.1073/pnas.0908247106; Postel R, 2013, J INVEST DERMATOL, V133, P2180, DOI 10.1038/jid.2013.154; Radoja N, 2006, PHYSIOL GENOMICS, V27, P65, DOI 10.1152/physiolgenomics.00031.2006; Reischauer S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000720; Rojas-Munoz A, 2009, DEV BIOL, V327, P177, DOI 10.1016/j.ydbio.2008.12.012; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; Sabaliauskas NA, 2006, METHODS, V39, P246, DOI 10.1016/j.ymeth.2006.03.001; Schanze D, 2014, AM J MED GENET A, V164, P837, DOI 10.1002/ajmg.a.36343; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slanchev K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000563; Sonawane M, 2005, DEVELOPMENT, V132, P3255, DOI 10.1242/dev.01904; St Sauver JL, 2013, MAYO CLIN PROC, V88, P56, DOI 10.1016/j.mayocp.2012.08.020; Stachowiak MK, 1997, MOL NEUROBIOL, V15, P257, DOI 10.1007/BF02740663; Takamiya K, 2004, NAT GENET, V36, P172, DOI 10.1038/ng1292; Talbot JC, 2012, DEVELOPMENT, V139, P2804, DOI 10.1242/dev.074906; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; van der Velden YU, 2011, P NATL ACAD SCI USA, V108, P4358, DOI 10.1073/pnas.1010210108; vanEeden FJM, 1996, DEVELOPMENT, V123, P255; Verhoeven EWM, 2008, ANN FAM MED, V6, P349, DOI 10.1370/afm.861; Vogel BE, 2001, DEVELOPMENT, V128, P883; Vogel MJ, 2012, J MED GENET, V49, P303, DOI 10.1136/jmedgenet-2011-100590; Vrontou S, 2003, NAT GENET, V34, P209, DOI 10.1038/ng1168; WALTER P, 1986, ANNU REV CELL BIOL, V2, P499, DOI 10.1146/annurev.cellbio.2.1.499; Wansbury O, 2008, J INVEST DERMATOL, V128, P1009, DOI 10.1038/sj.jid.5701118; Webb AE, 2007, DEV BIOL, V311, P369, DOI 10.1016/j.ydbio.2007.08.034; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; WOOD A, 1984, J CELL SCI, V66, P205; Wu XY, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0903-x; Xu J, 2012, J GENET GENOMICS, V39, P69, DOI 10.1016/j.jgg.2012.01.005; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zhang XG, 2004, J EVOLUTION BIOL, V17, P1162, DOI 10.1111/j.1420-9101.2004.00741.x; Zimmermann T, 2008, BIOCHEM BIOPH RES CO, V366, P1067, DOI 10.1016/j.bbrc.2007.12.084	121	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130688	10.1371/journal.pone.0130688	http://dx.doi.org/10.1371/journal.pone.0130688			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110643	gold, Green Submitted, Green Published			2022-12-27	WOS:000356933800073
J	Krivosikova, Z; Gajdos, M; Sebekova, K				Krivosikova, Zora; Gajdos, Martin; Sebekova, Katarina			Vitamin D Levels Decline with Rising Number of Cardiometabolic Risk Factors in Healthy Adults: Association with Adipokines, Inflammation, Oxidative Stress and Advanced Glycation Markers	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE RISK; CYTOKINE-INDUCED APOPTOSIS; SERUM 25-HYDROXYVITAMIN D; NF-KAPPA-B; END-PRODUCTS; 1,25-DIHYDROXYVITAMIN D-3; INSULIN-RESISTANCE; CALCITRIOL BLUNTS; SOLUBLE RECEPTOR	Introduction Hypovitaminosis D associates with obesity, insulin resistance, hypertension, and dyslipoproteinemia. We asked whether the presence of multiple cardiometabolic risk factors, and which particular combination, exerts additive negative effects on 25(OH)D-3 levels; and whether 25(OH)D-3 levels associate with markers of inflammation and oxidative stress. Subjects and Methods In non-diabetic medication-free adults central obesity (waist-to-height ratio > 0.5); elevated blood pressure (systolic BP >= 130 mm Hg and/or diastolic BP >= 85 mm Hg); increased atherogenic risk (log(TAG/HDL) >= 0.11); and insulin resistance (QUICKI < 0.322) were considered as cardiometabolic risk factors. 25(OH)D-3 status was classified as deficiency (25(OH)D-3 <= 20 ng/ml); insufficiency (levels between 20-to-30 ng/ml), or as satisfactory (> 30 ng/ml). Plasma adipokines, inflammatory and oxidative stress markers, advanced glycation end-products, and their soluble receptor were determined. Results 162 subjects were cardiometabolic risk factors-free, 162 presented increased (i.e. 1 or 2), and 87 high number (i.e. 3 or 4) of cardiometabolic risk factors. Mean 25(OH) D3 decreased with rising number of manifested risk factors (36 +/- 14 ng/ml, 33 +/- 14 ng/ml, and 31 +/- 15 ng/ml, respectively; pANOVA: 0.010), while prevalence of hypovitaminosis D did not differ significantly. Elevated blood pressure and insulin resistance appeared as significant determinants of hypovitaminosis D. Subjects presenting these risk factors concurrently displayed the lowest 25(OH)D-3 levels (29 +/- 15 ng/ml). Plasma adipokines, inflammatory and oxidative stress markers, advanced glycation end-products, and their soluble receptor generally differed significantly between the groups, but only advanced oxidation protein products and advanced glycation end-products associated fluorescence of plasma showed significant independent association with 25(OH)D-3 levels. Conclusion In apparently healthy adults increasing number of cardiometabolic risk factors associates with poorer 25(OH)D-3 status, while the association between 25(OH)D-3 status and inflammatory or oxidative stress markers remains equivocal.	[Krivosikova, Zora; Gajdos, Martin] Slovak Med Univ, Fac Med, Dept Clin & Expt Pharmacotherapy, Bratislava, Slovakia; [Sebekova, Katarina] Comenius Univ, Fac Med, Inst Mol BioMed, Bratislava, Slovakia	Comenius University Bratislava; Slovak Medical University Bratislava; Comenius University Bratislava	Sebekova, K (corresponding author), Comenius Univ, Fac Med, Inst Mol BioMed, Bratislava, Slovakia.	kata.sebekova@gmail.com	Sebekova, Katarina/H-4906-2016; Sebekova, Katarina/GSD-7056-2022	Sebekova, Katarina/0000-0002-9641-9265; Sebekova, Katarina/0000-0002-9641-9265	Slovak Ministry of Health [2005/27-SZU-05]; Operational Research and Development Program from the European Regional Development Fund [26240120033]	Slovak Ministry of Health; Operational Research and Development Program from the European Regional Development Fund	This work was supported by the Slovak Ministry of Health, https://www.minedu.sk/vedeckagrantova-agentura-msvvas-sr-a-sav-vega/, grant No. 2005/27-SZU-05 (to MG) and Operational Research and Development Program financed from the European Regional Development Fund, http://www.asfeu.sk/operacny-program-vyskum-a-vyvoj/opatrenie-41/, grant No.: 26240120033 (to Slovak Medical University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2015, AM J HYPERTENS, V28, P266, DOI 10.1093/ajh/hpu136; Anderstam B, 2008, CLIN CHIM ACTA, V393, P114, DOI 10.1016/j.cca.2008.03.029; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bland R, 2004, J STEROID BIOCHEM, V89-90, P121, DOI 10.1016/j.jsbmb.2004.03.115; Boucher BJ, 2011, CURR DRUG TARGETS, V12, P61; Brazdilova K, 2012, BRATISL MED J, V113, P412, DOI 10.4149/BLL_2012_093; Cho HJ, 2005, BIOL PHARM BULL, V28, P1418, DOI 10.1248/bpb.28.1418; Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903; Christakos S, 2013, ANN NY ACAD SCI, V1287, P45, DOI 10.1111/nyas.12129; Crowley SD, 2014, ANTIOXID REDOX SIGN, V20, P102, DOI 10.1089/ars.2013.5258; De Vita F, 2014, AGE, V36, DOI 10.1007/s11357-014-9694-4; Descamps-Latscha A, 2005, AM J KIDNEY DIS, V45, P39, DOI 10.1053/j.ajkd.2004.09.011; Ding C, 2012, BRIT J NUTR, V108, P1915, DOI 10.1017/S0007114512003285; Dobiasova M, 2001, CLIN BIOCHEM, V34, P583, DOI 10.1016/S0009-9120(01)00263-6; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; El-Fakhri N, 2014, HORM RES PAEDIAT, V81, P363, DOI 10.1159/000357731; Fukami K, 2014, CURR PHARM DESIGN, V20, P2395, DOI 10.2174/13816128113199990475; Garcia-Bailo B, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120230; Gonzalez-Gross M, 2012, BRIT J NUTR, V107, P755, DOI 10.1017/S0007114511003527; Gradinaru D, 2012, AGING CLIN EXP RES, V24, P595, DOI 10.3275/8591; Henriksen EJ, 2011, FREE RADICAL BIO MED, V51, P993, DOI 10.1016/j.freeradbiomed.2010.12.005; Husemoen LLN, 2014, EUR J CLIN NUTR, V68, P189, DOI 10.1038/ejcn.2013.233; Irani M, 2014, J CLIN ENDOCR METAB, V99, pE886, DOI 10.1210/jc.2013-4374; Jorde R, 2011, PROG LIPID RES, V50, P303, DOI 10.1016/j.plipres.2011.05.001; Kamycheva E, 2007, J ENDOCRINOL INVEST, V30, P126, DOI 10.1007/BF03347410; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Khan H, 2013, P NUTR SOC, V72, P89, DOI 10.1017/S0029665112002765; Kuloglu O, 2013, J INVEST MED, V61, P989, DOI 10.2310/JIM.0b013e31829a82bc; Kunutsor SK, 2013, EUR J EPIDEMIOL, V28, P205, DOI 10.1007/s10654-013-9790-2; Lee TW, 2014, INT J CARDIOL, V173, P236, DOI 10.1016/j.ijcard.2014.02.041; Li YC, 2013, SEMIN NEPHROL, V33, P433, DOI 10.1016/j.semnephrol.2013.07.005; Lin R, 2002, J BONE MINER RES, V17, P1604, DOI 10.1359/jbmr.2002.17.9.1604; Maestro B, 2003, J STEROID BIOCHEM, V84, P223, DOI 10.1016/S0960-0760(03)00032-3; Mallipattu SK, 2014, CURR OPIN NEPHROL HY, V23, P547, DOI 10.1097/MNH.0000000000000062; Manucha W, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-014-0504-2; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Munch G, 1997, EUR J CLIN CHEM CLIN, V35, P669; Mutt SJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00228; Ngo DT, 2010, AM J MED, V123, P335, DOI 10.1016/j.amjmed.2009.09.024; Norata GD, 2009, NUTR METAB CARDIOVAS, V19, P129, DOI 10.1016/j.numecd.2008.03.004; Papoutsidakis N, 2014, MED CHEM, V10, P643, DOI 10.2174/1573406410666140318101936; de Heredia FP, 2012, P NUTR SOC, V71, P332, DOI 10.1017/S0029665112000092; Piccolo BD, 2013, NUTRIENTS, V5, P3352, DOI 10.3390/nu5093352; Pludowski P, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/589587; Riachy R, 2006, APOPTOSIS, V11, P151, DOI 10.1007/s10495-006-3558-z; Riachy R, 2002, ENDOCRINOLOGY, V143, P4809, DOI 10.1210/en.2002-220449; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Rizzo M, 2009, TRANSL RES, V153, P217, DOI 10.1016/j.trsl.2009.01.008; Sadeghi K, 2006, EUR J IMMUNOL, V36, P361, DOI 10.1002/eji.200425995; Salum E, 2013, DIABETES RES CLIN PR, V100, P243, DOI 10.1016/j.diabres.2013.03.008; Schottker B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3656; Sebekova K, 2009, INT J PEDIATR OBES, V4, P112, DOI 10.1080/17477160802248039; Semba RD, 2011, J NUTR, V141, P1726, DOI 10.3945/jn.111.143172; Sooy K, 1999, J BIOL CHEM, V274, P34343, DOI 10.1074/jbc.274.48.34343; Stefikova K, 2011, PHYSIOL RES, V60, P149, DOI 10.33549/physiolres.931814; Stefikova K, 2003, Bratisl Lek Listy, V104, P305; Sturmer M, 2015, J RENAL NUTR, V25, P209, DOI 10.1053/j.jrn.2014.10.027; Sung CC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/634195; Talmor Y, 2008, EUR J CLIN INVEST, V38, P548, DOI 10.1111/j.1365-2362.2008.01977.x; Talmor Y, 2008, AM J PHYSIOL-RENAL, V294, pF1059, DOI 10.1152/ajprenal.00051.2008; Tamez H, 2013, CURR OPIN NEPHROL HY, V22, P204, DOI 10.1097/MNH.0b013e32835d919b; Tuomisto K, 2006, THROMB HAEMOSTASIS, V95, P511, DOI 10.1160/TH05-08-0571; Vaidya A, 2012, OBESITY, V20, P186, DOI 10.1038/oby.2011.210; Vilarrasa N, 2010, ENDOCRINE, V38, P235, DOI 10.1007/s12020-010-9379-4; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Vlassara H, 2013, ENDOCRIN METAB CLIN, V42, P697, DOI 10.1016/j.ecl.2013.07.005; Vojtkova Jarmila, 2012, Acta Medica (Hradec Kralove), V55, P18; Wang L, 2012, CIRC-CARDIOVASC QUAL, V5, P819, DOI 10.1161/CIRCOUTCOMES.112.967604; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Witko-Sarsat V, 1998, J IMMUNOL, V161, P2524; Wolden-Kirk H, 2012, ENDOCRIN METAB CLIN, V41, P571, DOI 10.1016/j.ecl.2012.05.004; Wong MSK, 2010, AM J PHYSIOL-HEART C, V299, pH1226, DOI 10.1152/ajpheart.00288.2010; Yudkin JS, 2007, HORM METAB RES, V39, P707, DOI 10.1055/s-2007-985898; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132; Zhang L, 2008, J BIOL CHEM, V283, P35507, DOI 10.1074/jbc.M806948200; Zittermann A, 2009, AM J CLIN NUTR, V89, P1321, DOI 10.3945/ajcn.2008.27004	79	17	18	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131753	10.1371/journal.pone.0131753	http://dx.doi.org/10.1371/journal.pone.0131753			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26120828	gold, Green Published, Green Submitted			2022-12-27	WOS:000358150400152
J	Berghof, TVL; van der Klein, SAS; Arts, JAJ; Parmentier, HK; van der Poel, JJ; Bovenhuis, H				Berghof, T. V. L.; van der Klein, S. A. S.; Arts, J. A. J.; Parmentier, H. K.; van der Poel, J. J.; Bovenhuis, H.			Genetic and Non-Genetic Inheritance of Natural Antibodies Binding Keyhole Limpet Hemocyanin in a Purebred Layer Chicken Line	PLOS ONE			English	Article							PARAMETERS; IGA; SURVIVAL; ISOTYPES; ASSOCIATIONS; SENSITIVITY; RESPONSES; IMMUNITY; DISEASE; CELLS	Natural antibodies (NAb) are defined as antibodies present in individuals without known antigenic challenge. Levels of NAb binding keyhole limpet hemocyanin (KLH) in chickens were earlier shown to be heritable, and to be associated with survival. Selective breeding may thus provide a strategy to improve natural disease resistance. We phenotyped 3,689 white purebred laying chickens for KLH binding NAb of different isotypes around 16 weeks of age. Heritabilities of 0.12 for the titers of total antibodies (IgT), 0.14 for IgM, 0.10 for IgA, and 0.07 for IgG were estimated. We also estimated high, positive genetic, and moderate to high, positive phenotypic correlations of IgT, IgM, IgA, and IgG, suggesting that selective breeding for NAb can be done on all antibody isotypes simultaneously. In addition, a relatively substantial non-genetic maternal environmental effect of 0.06 was detected for IgM, which may reflect a transgenerational effect. This suggests that not only the genes of the mother, but also the maternal environment affects the immune system of the offspring. Breaking strength and early eggshell whiteness of the mother's eggs were predictive for IgM levels in the offspring, and partly explained the observed maternal environmental effects. The present results confirm that NAb are heritable, however maternal effects should be taken into account.	[Berghof, T. V. L.; van der Klein, S. A. S.; van der Poel, J. J.; Bovenhuis, H.] Wageningen Univ, Dept Anim Sci, Anim Breeding & Genom Ctr, NL-6700 AP Wageningen, Netherlands; [Berghof, T. V. L.; Arts, J. A. J.; Parmentier, H. K.] Wageningen Univ, Dept Anim Sci, Adaptat Physiol Grp, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Berghof, TVL (corresponding author), Wageningen Univ, Dept Anim Sci, Anim Breeding & Genom Ctr, NL-6700 AP Wageningen, Netherlands.	tom.berghof@wur.nl	Bovenhuis, Henk/E-4750-2012; Berghof, Tom/T-4641-2019; Berghof, Tom/AAF-5927-2021	Berghof, Tom/0000-0003-4879-6784; Berghof, Tom/0000-0003-4879-6784	Science and Technology Foundation of the Netherlands Organization for Scientific Research (NWOSTW) [12208]; Institut de Selection Animale (ISA) - a Hendrix Genetics company	Science and Technology Foundation of the Netherlands Organization for Scientific Research (NWOSTW)(Netherlands Organization for Scientific Research (NWO)); Institut de Selection Animale (ISA) - a Hendrix Genetics company	Funding was provided by the Science and Technology Foundation of the Netherlands Organization for Scientific Research (NWOSTW), grant number: 12208, url: http://www.stw.nl/en/. This funder had no role in study design, data collection, and analyses, decision to publish, or preparation of the manuscript. Funding was also provided by the Institut de Selection Animale (ISA) - a Hendrix Genetics company, url: http://www.isapoultry.com/, whose role was in data collection. ISA had no role in study design, data analyses, or preparation of the manuscript. ISA agreed on publication of the collected data and the results.	Adriaansen-Tennekes R, 2009, POULTRY SCI, V88, P1869, DOI 10.3382/ps.2009-00159; Balsari A, 1997, BIOTHERAPY, V10, P25, DOI 10.1007/BF02678214; Baumgarth N, 2005, SPRINGER SEMIN IMMUN, V26, P347, DOI 10.1007/s00281-004-0182-2; Berghof TVL, 2013, POULTRY SCI, V92, P2904, DOI 10.3382/ps.2013-03177; Berghof TVL, 2010, POULTRY SCI, V89, P227, DOI 10.3382/ps.2009-00449; Biscarini F, 2010, ANIM GENET, V41, P26, DOI 10.1111/j.1365-2052.2009.01960.x; Boes M, 2000, MOL IMMUNOL, V37, P1141, DOI 10.1016/S0161-5890(01)00025-6; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Cotter PF, 2005, POULTRY SCI, V84, P220, DOI 10.1093/ps/84.2.220; de Klerk B, 2015, J DAIRY SCI, V98, P2746, DOI 10.3168/jds.2014-8818; Gilmour A. R., 2014, ASREML USER GUIDE RE; Lammers A, 2004, DEV COMP IMMUNOL, V28, P51, DOI 10.1016/S0145-305X(03)00102-2; LEBACQVE.AM, 1974, IMMUNOLOGY, V27, P683; Lutz HU, 2007, J AUTOIMMUN, V29, P287, DOI 10.1016/j.jaut.2007.07.007; Lutz HU, 2009, TRENDS IMMUNOL, V30, P43, DOI 10.1016/j.it.2008.10.002; Megens HJ, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-86; MICHEL C, 1990, ANN RECH VET, V21, P211; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Ozdemir M, 2011, INT J MED SCI, V8, P428; Pap PL, 2015, OECOLOGIA, V177, P147, DOI 10.1007/s00442-014-3108-2; Parmentier HK, 2012, POULTRY SCI, V91, P3044, DOI 10.3382/ps.2012-02460; Parmentier HK, 2004, DEV COMP IMMUNOL, V28, P39, DOI 10.1016/S0145-305X(03)00087-9; Reid RR, 1997, J IMMUNOL, V159, P970; ROMBOUT JHWM, 1992, BRIT J NUTR, V68, P753, DOI 10.1079/BJN19920131; Star L, 2007, POULTRY SCI, V86, P1090, DOI 10.1093/ps/86.6.1090; Sun Y, 2013, POULTRY SCI, V92, P2024, DOI 10.3382/ps.2013-03144; Sun Y, 2013, ANIM GENET, V44, P413, DOI 10.1111/age.12014; Sun Y, 2011, POULTRY SCI, V90, P2263, DOI 10.3382/ps.2011-01613; Thompson-Crispi KA, 2013, J DAIRY SCI, V96, P3965, DOI 10.3168/jds.2012-5919; TOMER Y, 1988, IMMUNOL INVEST, V17, P389, DOI 10.3109/08820138809049846; Ujvari B, 2011, FUNCT ECOL, V25, P813, DOI 10.1111/j.1365-2435.2011.01860.x; van der Klein SAS, 2015, POULTRY SCI, V94, P875, DOI 10.3382/ps/pev052; van Egmond M, 2001, TRENDS IMMUNOL, V22, P205, DOI 10.1016/S1471-4906(01)01873-7; VANDERZIJPP AJ, 1980, POULTRY SCI, V59, P1363, DOI 10.3382/ps.0591363; Wijga S, 2013, ANIM GENET, V44, P485, DOI 10.1111/age.12038; Wijga S, 2009, POULTRY SCI, V88, P1805, DOI 10.3382/ps.2009-00064; Zheng WM, 1997, J REPROD FERTIL, V111, P277, DOI 10.1530/jrf.0.1110277; Zinkernagel RM, 2012, CELL MOL LIFE SCI, V69, P1635, DOI 10.1007/s00018-012-0972-y	38	28	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131088	10.1371/journal.pone.0131088	http://dx.doi.org/10.1371/journal.pone.0131088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114750	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500126
J	Foreman, MGG; Guo, M; Garver, KA; Stucchi, D; Chandler, P; Wan, D; Morrison, J; Tuele, D				Foreman, Michael G. G.; Guo, Ming; Garver, Kyle A.; Stucchi, Dario; Chandler, Peter; Wan, Di; Morrison, John; Tuele, Darren			Modelling Infectious Hematopoietic Necrosis Virus Dispersion from Marine Salmon Farms in the Discovery Islands, British Columbia, Canada	PLOS ONE			English	Article							ATLANTIC SALMON; CIRCULATION MODEL; QUODDY REGION; TRANSMISSION; SALAR	Finite volume ocean circulation and particle tracking models are used to simulate water-borne transmission of infectious hematopoietic necrosis virus (IHNV) among Atlantic salmon (Salmo salar) farms in the Discovery Islands region of British Columbia, Canada. Historical simulations for April and July 2010 are carried out to demonstrate the seasonal impact of river discharge, wind, ultra-violet (UV) radiation, and heat flux conditions on near-surface currents, viral dispersion and survival. Numerical particles released from infected farm fish in accordance with IHNV shedding rates estimated through laboratory experiments are dispersed by model oceanic flows. Viral particles are inactivated by ambient UV radiation levels and by the natural microbial community at rates derived through laboratory studies. Viral concentration maps showing temporal and spatial changes are produced and combined with lab-determined minimum infectious dosages to estimate the infective connectivity among farms. Results demonstrate that neighbouring naive farms can become exposed to IHNV via water-borne transport from an IHNV diseased farm, with a higher risk in April than July, and that many events in the sequence of farm outbreaks in 2001-2002 are consistent with higher risks in our farm connectivity matrix. Applications to other diseases, transfers between farmed and wild fish, and the effect of vaccinations are also discussed.	[Foreman, Michael G. G.; Guo, Ming; Stucchi, Dario; Chandler, Peter; Wan, Di; Morrison, John; Tuele, Darren] Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC V8L 4B2, Canada; [Garver, Kyle A.] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC V9T 6N7, Canada; [Wan, Di] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8P 5C2, Canada	Fisheries & Oceans Canada; Fisheries & Oceans Canada; University of Victoria	Foreman, MGG (corresponding author), Fisheries & Oceans Canada, Inst Ocean Sci, POB 6000, Sidney, BC V8L 4B2, Canada.	mike.foreman@dfo-mpo.gc.ca			Fisheries and Oceans Canada; Program for Aquaculture Regulatory Research; Cermaq Canada; Grieg Seafood; Marine Harvest	Fisheries and Oceans Canada; Program for Aquaculture Regulatory Research; Cermaq Canada; Grieg Seafood; Marine Harvest	Funding provided by Fisheries and Oceans Canada through the Aquaculture Collaborative Research and Development Program, and the Program for Aquaculture Regulatory Research; and Cermaq Canada, Grieg Seafood and Marine Harvest through the Aquaculture Collaborative Research and Development Program.	Adams T, 2012, AQUACULT ENV INTERAC, V3, P51, DOI 10.3354/aei00052; Amundrud TL, 2009, J FISH DIS, V32, P27, DOI 10.1111/j.1365-2761.2008.00980.x; Asplin L, 2011, SALMON LICE: AN INTEGRATED APPROACH TO UNDERSTANDING PARASITE ABUNDANCE AND DISTRIBUTION, P31; Canadian Tide, 2010, DISCOVERY PASSAGE W, V6; Chang BD, 2005, CANADIAN TECHNICAL R, V2598; Chen CS, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007054; Chen CS, 2003, J ATMOS OCEAN TECH, V20, P159, DOI 10.1175/1520-0426(2003)020<0159:AUGFVT>2.0.CO;2; Cohen B., 2012, UNCERTAIN FUTURE FRA; Fairall CW, 2003, J CLIMATE, V16, P571, DOI 10.1175/1520-0442(2003)016<0571:BPOASF>2.0.CO;2; Foreman MGG, 2012, ATMOS OCEAN, V50, P301, DOI 10.1080/07055900.2012.686900; Foreman MGG, 2009, J ATMOS OCEAN TECH, V26, P806, DOI 10.1175/2008JTECHO615.1; Garver KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082296; Gillibrand PA, 2007, AQUAT BIOL, V1, P63, DOI 10.3354/ab00006; Greenberg DA, 2005, OCEAN MODEL, V10, P211, DOI 10.1016/j.ocemod.2004.06.005; Gustafson LL, 2007, PREV VET MED, V78, P35, DOI 10.1016/j.prevetmed.2006.09.006; Johansen LH, 2011, AQUACULTURE, V315, P167, DOI 10.1016/j.aquaculture.2011.02.014; Kurath G, 2003, J GEN VIROL, V84, P803, DOI 10.1099/vir.0.18771-0; Kurath G, 2011, CURR OPIN VIROL, V1, P73, DOI 10.1016/j.coviro.2011.05.010; Lafferty KD, 2014, ANNU REV MAR SCI, V7; Mardones FO, 2009, DIS AQUAT ORGAN, V84, P105, DOI 10.3354/dao02040; Masson D, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008151; McVicar Alasdair H., 1997, Bulletin of the European Association of Fish Pathologists, V17, P197; Morrison J, 2012, ATMOS OCEAN, V50, P1, DOI 10.1080/07055900.2011.637667; Murray A. G., 2005, Bulletin of the Aquaculture Association of Canada, V105, P79; Murray AG, 2011, SALMON LICE: AN INTEGRATED APPROACH TO UNDERSTANDING PARASITE ABUNDANCE AND DISTRIBUTION, P51; Murray AG, 2013, CURR OPIN VIROL, V3, P74, DOI 10.1016/j.coviro.2012.11.002; Olivares GR, 2014, DEFINITION SANITARY; Page FH, 2005, CANADIAN TECHNICAL R, V2595; Saksida SM, 2006, DIS AQUAT ORGAN, V72, P213, DOI 10.3354/dao072213; Saksida SM, 2014, S LICE INTEGRATED AP, P235; Salama NKG, 2013, AQUACULT ENV INTERAC, V4, P91, DOI 10.3354/aei00077; Salonius K, 2007, CURR OPIN INVEST DR, V8, P635; St-Hilaire S, 2002, AQUACULTURE, V212, P49, DOI 10.1016/S0044-8486(02)00201-6; Stagg RM, 2003, INT RESP INF SALM AN, V1902, P111; Stene A, 2013, J FISH DIS, DOI 10.111/jfd.12090; Stucchi D, 2011, SALMON LICE INTEGRAT, DOI [10.1002/9780470961568.ch4, DOI 10.1002/9780470961568.CH4]; Tian RC, 2015, ICES J MAR SCI, V72, P388, DOI 10.1093/icesjms/fsu090; TRAXLER GS, 1993, DIS AQUAT ORGAN, V16, P111, DOI 10.3354/dao016111; Viljugrein H, 2009, DIS AQUAT ORGAN, V88, P35, DOI 10.3354/dao02151	39	32	32	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130951	10.1371/journal.pone.0130951	http://dx.doi.org/10.1371/journal.pone.0130951			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114643	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500112
J	Giampieri, E; De Cecco, M; Remondini, D; Sedivy, J; Castellani, G				Giampieri, Enrico; De Cecco, Marco; Remondini, Daniel; Sedivy, John; Castellani, Gastone			Active Degradation Explains the Distribution of Nuclear Proteins during Cellular Senescence	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; CHEMICAL MASTER EQUATION; FLUORESCENCE MICROSCOPY; ENHANCED SENSITIVITY; SINGLE-CELL; NOISE; MOLECULE; FIBROBLASTS; BISTABILITY; PROTEASOME	The amount of cellular proteins is a crucial parameter that is known to vary between cells as a function of the replicative passages, and can be important during physiological aging. The process of protein degradation is known to be performed by a series of enzymatic reactions, ranging from an initial step of protein ubiquitination to their final fragmentation by the proteasome. In this paper we propose a stochastic dynamical model of nuclear proteins concentration resulting from a balance between a constant production of proteins and their degradation by a cooperative enzymatic reaction. The predictions of this model are compared with experimental data obtained by fluorescence measurements of the amount of nuclear proteins in murine tail fibroblast (MTF) undergoing cellular senescence. Our model provides a three-parameter stationary distribution that is in good agreement with the experimental data even during the transition to the senescent state, where the nuclear protein concentration changes abruptly. The estimation of three parameters (cooperativity, saturation threshold, and maximal velocity of the reaction), and their evolution during replicative passages shows that only the maximal velocity varies significantly. Based on our modeling we speculate the reduction of functionality of the protein degradation mechanism as a possible competitive inhibition of the proteasome.	[Giampieri, Enrico; Castellani, Gastone] Univ Bologna, Dept Phys & Astron, I-40126 Bologna, Italy; [Giampieri, Enrico; Remondini, Daniel; Castellani, Gastone] INFN Bologna, Bologna, Italy; [De Cecco, Marco; Sedivy, John] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Ctr Genom & Prote, Providence, RI 02912 USA	University of Bologna; Istituto Nazionale di Fisica Nucleare (INFN); Brown University	Giampieri, E (corresponding author), Univ Bologna, Dept Phys & Astron, I-40126 Bologna, Italy.	enrico.giampieri@unibo.it	Castellani, Gastone c/L-3333-2017; Remondini, Daniel/ABA-9971-2020; Giampieri, Enrico/AAC-7354-2022	Castellani, Gastone c/0000-0003-4892-925X; Giampieri, Enrico/0000-0003-2269-2338; Remondini, Daniel/0000-0003-3185-7456	Italian Ministry of Education and Research [PB05]; EU [200880]; FIBEBIOTICS [289517]; MIMOMICS [305280]; INFN BO61 initiative; INFN TO61 initiative; NATIONAL INSTITUTE ON AGING [R37AG016694] Funding Source: NIH RePORTER	Italian Ministry of Education and Research(Ministry of Education, Universities and Research (MIUR)); EU(European Commission); FIBEBIOTICS; MIMOMICS; INFN BO61 initiative; INFN TO61 initiative; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	GC, DR, and EG acknowledge support by the Italian Ministry of Education and Research through the Flagship (PB05) InterOmic, The FP7 EU projects MARKAGE (n. 200880), FIBEBIOTICS (n. 289517) and the MIMOMICS (n. 305280), and the INFN BO61 and TO61 initiatives. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin A, 1998, GENETICS, V149, P1633; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Baumeister W, 1997, CURR OPIN STRUC BIOL, V7, P273, DOI 10.1016/S0959-440X(97)80036-X; BAYREUTHER K, 1988, P NATL ACAD SCI USA, V85, P5112, DOI 10.1073/pnas.85.14.5112; Bazzani A, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4725180; Beynon Robert J., 2005, Briefings in Functional Genomics & Proteomics, V3, P382, DOI 10.1093/bfgp/3.4.382; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Cecarini V, 2007, BBA-MOL CELL RES, V1773, P93, DOI 10.1016/j.bbamcr.2006.08.039; Chan HM, 2010, ANAL CHEM, V82, P6911, DOI 10.1021/ac101133x; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Ciechanover A, 2000, J CELL BIOCHEM, P40; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; CRISTOFALO VJ, 1988, EXP GERONTOL, V23, P297, DOI 10.1016/0531-5565(88)90032-0; De Cecco M, 2011, AGING-US, V3, P955, DOI 10.18632/aging.100372; de Oliveira LR, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4891515; DICE JF, 1989, EXP GERONTOL, V24, P451; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; English BP, 2006, NAT CHEM BIOL, V2, P87, DOI 10.1038/nchembio759; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Gardiner C. W., 1985, HDB STOCHASTIC METHO, V3; Giampieri E, 2011, MOL BIOSYST, V7, P2796, DOI 10.1039/c1mb05086a; Giannini C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064042; Gohlke S, 2014, AGE, V36, P57, DOI 10.1007/s11357-013-9543-x; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Hensel Z, 2012, NATURE STRUCT MOL BI, V8; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Jones E., 2001, SCIPY OPEN SOURCE SC; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; KAFTORY A, 1978, J CELL PHYSIOL, V94, P147, DOI 10.1002/jcp.1040940204; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kikis EA, 2010, ADV EXP MED BIOL, V694, P138; Kreiling JA, 2011, AGING CELL, V10, P292, DOI 10.1111/j.1474-9726.2010.00666.x; Liang J, 2010, J COMPUT SCI TECH-CH, V25, P154, DOI 10.1007/s11390-010-9312-6; Maynard SP, 2006, AGING CELL, V5, P89, DOI 10.1111/j.1474-9726.2006.00187.x; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; Mettetal JT, 2007, SCIENCE, V317, P463, DOI 10.1126/science.1146747; Mishto M, 2003, AGEING RES REV, V2, P419, DOI 10.1016/S1568-1637(03)00030-8; MITSUI Y, 1976, EXP CELL RES, V100, P147, DOI 10.1016/0014-4827(76)90336-0; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Patil A, 2010, J STAT SOFTWARE, V35; Paulsson J, 2000, P NATL ACAD SCI USA, V97, P7148, DOI 10.1073/pnas.110057697; Paulsson J, 2000, PHYS REV LETT, V84, P5447, DOI 10.1103/PhysRevLett.84.5447; Pereira-Smith OM, 1985, CRC HDB CELL BIOL, P375; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Qian H, 2002, BIOPHYS CHEM, V101, P565, DOI 10.1016/S0301-4622(02)00145-X; Qian H, 2012, ANNU REV BIOPHYS, V41, P179, DOI 10.1146/annurev-biophys-050511-102240; Qian H, 2010, INT J MOL SCI, V11, P3472, DOI 10.3390/ijms11093472; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Remondini D, 2013, PHYSICA A, V392, P336, DOI 10.1016/j.physa.2012.09.005; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; Schmidtke G, 2000, J BIOL CHEM, V275, P22056, DOI 10.1074/jbc.M002513200; SHAKESPEARE VA, 1979, GERONTOLOGY, V25, P305, DOI 10.1159/000212358; Stein RL, 1996, BIOCHEMISTRY-US, V35, P3899, DOI 10.1021/bi952262x; *SYMPY DEV TEAM, 2009, SYMPY PYTH LIB SYMB; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; To TL, 2010, SCIENCE, V327, P1142, DOI 10.1126/science.1178962; van Kampen N. G., 1981, STOCHASTIC PROCESSES; van Rossum G., 1995, CSR9525; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zanker D, 2014, EUR J IMMUNOL, V44, P3500, DOI 10.1002/eji.201445272	67	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0118442	10.1371/journal.pone.0118442	http://dx.doi.org/10.1371/journal.pone.0118442			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115222	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500001
J	Heckel, A; Weiler, M; Xia, A; Ruetters, M; Pham, M; Bendszus, M; Heiland, S; Baeumer, P				Heckel, A.; Weiler, M.; Xia, A.; Ruetters, M.; Pham, M.; Bendszus, M.; Heiland, S.; Baeumer, P.			Peripheral Nerve Diffusion Tensor Imaging: Assessment of Axon and Myelin Sheath Integrity	PLOS ONE			English	Article							CARPAL-TUNNEL-SYNDROME; MEDIAN NERVE; MULTIPLE-SCLEROSIS; WHITE-MATTER; SPINAL-CORD; IN-VIVO; RETINAL ISCHEMIA; MR NEUROGRAPHY; OPTIC-NERVE; MOUSE MODEL	Purpose To investigate the potential of diffusion tensor imaging (DTI) parameters as in-vivo biomarkers of axon and myelin sheath integrity of the median nerve in the carpal tunnel as validated by correlation with electrophysiology. Methods MRI examinations at 3T including DTI were conducted on wrists in 30 healthy subjects. After manual segmentation of the median nerve quantitative analysis of fractional anisotropy (FA) as well as axial, radial and mean diffusivity (AD, RD, and MD) was carried out. Pairwise Pearson correlations with electrophysiological parameters comprising sensory nerve action potential (SNAP) and compound muscle action potential (CMAP) as markers of axon integrity, and distal motor latency (dml) and sensory nerve conduction velocity (sNCV) as markers of myelin sheath integrity were computed. The significance criterion was set at P=0.05, Bonferroni corrected for multiple comparisons. Results DTI parameters showed a distinct proximal-to-distal profile with FA, MD, and RD extrema coinciding in the center of the carpal tunnel. AD correlated with CMAP (r=0.50, p=0.04, Bonf. corr.) but not with markers of myelin sheath integrity. RD correlated with sNCV (r=-0.53, p=0.02, Bonf. corr.) but not with markers of axon integrity. FA correlated with dml (r=-0.63, p=0.002, Bonf. corr.) and sNCV (r=0.68, p= 0.001, Bonf. corr.) but not with markers of axon integrity. Conclusion AD reflects axon integrity, while RD (and FA) reflect myelin sheath integrity as validated by correlation with electrophysiology. DTI parameters consistently indicate a slight decrease of structural integrity in the carpal tunnel as a physiological site of median nerve entrapment. DTI is particularly sensitive, since these findings are observed in healthy participants. Our results encourage future studies to evaluate the potential of DTI in differentiating axon from myelin sheath injury in patients with manifest peripheral neuropathies.	[Heckel, A.; Xia, A.; Ruetters, M.; Pham, M.; Bendszus, M.; Baeumer, P.] Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany; [Heckel, A.] Freiburg Univ Hosp, Dept Diagnost Radiol, Freiburg, Germany; [Weiler, M.] Univ Heidelberg Hosp, Dept Neurol, Heidelberg, Germany; [Weiler, M.] German Canc Res Ctr, Clin Cooperat Unit Neurooncol, Heidelberg, Germany; [Heiland, S.] Univ Heidelberg Hosp, Dept Neuroradiol, Sect Expt Neuroradiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Freiburg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Baeumer, P (corresponding author), Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany.	philipp.baeumer@med.uni-heidelberg.de	Pham, Mirko/AAI-8713-2020		Medical Faculty of the University of Heidelberg; Ruprecht-Karls-Universitat Heidelberg	Medical Faculty of the University of Heidelberg; Ruprecht-Karls-Universitat Heidelberg	The study was supported by a Postdoctoral Fellowship granted to AH and PB from the Medical Faculty of the University of Heidelberg. We acknowledge financial support by Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aung Wint Yan, 2013, Imaging Med, V5, P427; Baumer P, 2011, RADIOLOGY, V260, P199, DOI 10.1148/radiol.11102357; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Baumer P, 2014, RADIOLOGY; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BEHSE F, 1978, BRAIN, V101, P473, DOI 10.1093/brain/101.3.473; Bendszus M, 2005, NAT CLIN PRACT NEURO, V1, P45, DOI 10.1038/ncpneuro0017; BOLTON CF, 1979, NEUROLOGY, V29, P354, DOI 10.1212/WNL.29.3.354; Bromberg MB, 2013, PHYS MED REH CLIN N, V24, P153, DOI 10.1016/j.pmr.2012.08.020; Budde MD, 2008, NMR BIOMED, V21, P589, DOI 10.1002/nbm.1229; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Colak T, 2005, J SCI MED SPORT, V8, P403, DOI 10.1016/S1440-2440(05)80055-6; Colak T, 2004, BRIT J SPORT MED, V38, P632, DOI 10.1136/bjsm.2003.008029; Deboy CA, 2007, BRAIN, V130, P2199, DOI 10.1093/brain/awm122; Fox J., 1991, SAGE U PAPER SERIES; Fox RJ, 2011, NEUROL CLIN, V29, P357, DOI 10.1016/j.ncl.2010.12.011; Guggenberger R, 2012, RADIOLOGY, V265, P194, DOI 10.1148/radiol.12111403; Guggenberger R, 2012, SKELETAL RADIOL, V41, P971, DOI 10.1007/s00256-011-1310-4; Hiltunen J, 2005, CLIN NEUROPHYSIOL, V116, P2315, DOI 10.1016/j.clinph.2005.05.014; Hiltunen J, 2012, EUR RADIOL, V22, P1310, DOI 10.1007/s00330-012-2381-x; Jambawalikar S, 2010, SKELETAL RADIOL, V39, P1073, DOI 10.1007/s00256-010-0974-5; Kabakci N, 2007, AM J ROENTGENOL, V189, P923, DOI 10.2214/AJR.07.2423; Kakuda T, 2011, NEURORADIOLOGY, V53, P955, DOI 10.1007/s00234-010-0833-z; Kasprian G, 2014, MUSCLE NERVE; Khalil C, 2008, EUR RADIOL, V18, P2283, DOI 10.1007/s00330-008-0971-4; Khalil C, 2010, EUR J RADIOL, V76, P391, DOI 10.1016/j.ejrad.2010.03.012; Kim JH, 2006, NEUROBIOL DIS, V21, P626, DOI 10.1016/j.nbd.2005.09.009; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lehmann HC, 2010, EXP NEUROL, V223, P238, DOI 10.1016/j.expneurol.2009.10.012; Lindberg PG, 2013, EUR RADIOL, V23, P3115, DOI 10.1007/s00330-013-2986-8; LOGIGIAN EL, 1994, MUSCLE NERVE, V17, P1010, DOI 10.1002/mus.880170908; MEIERRUGE W, 1992, ANN NY ACAD SCI, V673, P260, DOI 10.1111/j.1749-6632.1992.tb27462.x; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Peters A, 2002, J NEUROCYTOL, V31, P581, DOI 10.1023/A:1025731309829; Pfefferbaum A, 2003, MAGNET RESON MED, V49, P953, DOI 10.1002/mrm.10452; Pham M, 2014, NEUROLOGY, V82, P598, DOI 10.1212/WNL.0000000000000128; Schmierer K, 2007, NEUROIMAGE, V35, P467, DOI 10.1016/j.neuroimage.2006.12.010; Sheikh KA, 2010, EXP NEUROL, V223, P72, DOI 10.1016/j.expneurol.2009.07.008; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stein D, 2009, J MAGN RESON IMAGING, V29, P657, DOI 10.1002/jmri.21553; Sun SW, 2007, NEUROBIOL DIS, V28, P30, DOI 10.1016/j.nbd.2007.06.011; Sun SW, 2006, NEUROIMAGE, V32, P1195, DOI 10.1016/j.neuroimage.2006.04.212; Takagi T, 2009, NEUROIMAGE, V44, P884, DOI 10.1016/j.neuroimage.2008.09.022; Vass A, 2009, J NEUROL NEUROCHIR P, V10, P44; Verdu E, 2000, J PERIPHER NERV SYST, V5, P191, DOI 10.1046/j.1529-8027.2000.00026.x; WATSON BV, 1992, MUSCLE NERVE, V15, P701, DOI 10.1002/mus.880150612; Werner RA, 2002, CLIN NEUROPHYSIOL, V113, P1373, DOI 10.1016/S1388-2457(02)00169-4; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Yao L, 2009, SKELETAL RADIOL, V38, P355, DOI 10.1007/s00256-008-0626-1; Zhou YX, 2012, J MAGN RESON IMAGING, V36, P920, DOI 10.1002/jmri.23709	55	76	79	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130833	10.1371/journal.pone.0130833	http://dx.doi.org/10.1371/journal.pone.0130833			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114630	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500099
J	Hsieh, MC; Sung, MT; Chiang, PH; Huang, CH; Tang, Y; Su, YL				Hsieh, Meng-Che; Sung, Ming-Tse; Chiang, Po-Hui; Huang, Cheng-Hua; Tang, Yeh; Su, Yu-Li			The Prognostic Impact of Histopathological Variants in Patients with Advanced Urothelial Carcinoma	PLOS ONE			English	Article							BLADDER-CANCER; RADICAL CYSTECTOMY; GLANDULAR DIFFERENTIATION; POOR-PROGNOSIS; SURVIVAL; CHEMOTHERAPY; CISPLATIN; OUTCOMES; CARBOPLATIN	Purpose This study investigated the prognostic role of histopathological variants in patients with advanced urothelial carcinoma (UC) who were treated with systemic chemotherapy. Materials and Methods We conducted a retrospective analysis of patients with unresectable and/ ormetastatic UC who underwent systemic chemotherapy between January 1997 and December 2013 in Kaohsiung Chang Gung Memorial Hospital. Histopathological types were categorized as pure UC (PUC) and variants of UC (VUC). The overall survival (OS) and progression-free survival (PFS) were calculated using Kaplan-Meier analyses and Cox proportional regression models. Results A total of 206 patients were enrolled; 53 of the patients (25.7%) had histopathological variants. The most common variant was squamous differentiation (68%). Compared with patients with PUC, patients with VUC significantly exhibited upper urinary tract origin (75% vs 52%, P =.008), chronic renal insufficiency (40% vs 23%, P =.03), and carboplatin-based chemotherapy (28% vs 10%, P =.003). According to univariate analysis, the median OS for PUC patients was significantly higher than that for VUC patients (15.9 vs 11.3 months, P =.007). The median PFS for patients who received first-line chemotherapy was 6.1 and 3.8 months for PUC patients and VUC patients, respectively (P =.004). Multivariate analysis revealed that VUC (hazard ratio [HR] 1.67, 95% confidence interval [CI] 1.16-2.40, P =.006), an age <= 60 years (HR 0.70, 95% CI 0.49-0.99, P =.045) and presence of visceral metastasis (HR 1.54, 95% CI 1.11-2.13, P = .009) were independent factors facilitating OS prediction. Conclusions The presence of histopathological variants indicates poor survival outcomes in patients with metastatic UC. Accordingly, VUC should be integrated into and considered an independent factor in a predictive model of survival.	[Hsieh, Meng-Che; Huang, Cheng-Hua; Su, Yu-Li] Kaohsiung Chang Gung Mem Hosp, Div Hematol Oncol, Dept Internal Med, Kaohsiung, Taiwan; [Sung, Ming-Tse] Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung, Taiwan; [Sung, Ming-Tse; Chiang, Po-Hui] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chiang, Po-Hui] Kaohsiung Chang Gung Mem Hosp, Dept Urol, Kaohsiung, Taiwan; [Tang, Yeh] I Shou Univ, E Da Hosp, Div Hematol Oncol, Dept Internal Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; E-Da Hospital; I Shou University	Su, YL (corresponding author), Kaohsiung Chang Gung Mem Hosp, Div Hematol Oncol, Dept Internal Med, Kaohsiung, Taiwan.	yolisu@mac.com	Su, Harvey Yu-Li/N-9726-2019	Su, Harvey Yu-Li/0000-0002-1289-473X				Alexander RE, 2012, MODERN PATHOL, V25, P1526, DOI 10.1038/modpathol.2012.103; Blacks PC, 2009, UROL ONCOL-SEMIN ORI, V27, P3, DOI 10.1016/j.urolonc.2007.07.010; Chalasani Venu, 2009, Can Urol Assoc J, V3, pS193; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Dayyani F, 2013, J UROLOGY, V189, P1656, DOI 10.1016/j.juro.2012.11.084; Dogliotti L, 2007, EUR UROL, V52, P134, DOI 10.1016/j.eururo.2006.12.029; Eble JN, 2006, WHO CLASSIFICATION T, V1; Fairey AS, 2014, UROL ONCOL-SEMIN ORI, V32, P110, DOI 10.1016/j.urolonc.2012.04.020; Gaisa NT, 2011, VIRCHOWS ARCH, V458, P301, DOI 10.1007/s00428-010-1017-2; Galsky MD, 2012, ANN ONCOL, V23, P406, DOI 10.1093/annonc/mdr156; Galsky MD, 2013, CANCER-AM CANCER SOC, V119, P3012, DOI 10.1002/cncr.28146; Keck B, 2013, BMC CANCER, V13, P1, DOI [10.1186/1471-2407-13-1, DOI 10.1186/1471-2407-13-1]; Kim SP, 2012, J UROLOGY, V188, P405, DOI 10.1016/j.juro.2012.04.020; Lee YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107027; Linder BJ, 2013, J UROLOGY, V189, P1670, DOI 10.1016/j.juro.2012.11.006; Lopez-Beltran A, 2006, HUM PATHOL, V37, P1371, DOI 10.1016/j.humpath.2006.05.009; Masson-Lecomte A, 2014, WORLD J UROL, V32, P531, DOI 10.1007/s00345-013-1141-0; Mitra AP, 2014, UROL ONCOL-SEMIN ORI, V32, P117, DOI 10.1016/j.urolonc.2012.08.017; Perez-Montiel D, 2006, MODERN PATHOL, V19, P494, DOI 10.1038/modpathol.3800559; Rink M, 2012, J UROLOGY, V188, P398, DOI 10.1016/j.juro.2012.04.009; Sanchez-Carbayo M, 2002, CANCER RES, V62, P6973; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Soave A, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2014.10.013; Wang JK, 2012, WORLD J UROL, V30, P801, DOI 10.1007/s00345-012-0976-0; Wasco MJ, 2007, UROLOGY, V70, P69, DOI 10.1016/j.urology.2007.03.033; Xylinas E, 2013, BJU INT, V112, P453, DOI 10.1111/j.1464-410X.2012.11649.x; Xylinas E, 2012, EUR UROL, V62, pE25, DOI 10.1016/j.eururo.2012.04.023; Yang MH, 2002, UROLOGY, V59, P681, DOI 10.1016/S0090-4295(02)01529-7	28	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129268	10.1371/journal.pone.0129268	http://dx.doi.org/10.1371/journal.pone.0129268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114748	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500022
J	Jiang, LY; Wu, JJ; Fan, SJ; Li, WB; Dong, LD; Cheng, Q; Xu, PF; Zhang, SZ				Jiang, Liangyu; Wu, Junjiang; Fan, Sujie; Li, Wenbin; Dong, Lidong; Cheng, Qun; Xu, Pengfei; Zhang, Shuzhen			Isolation and Characterization of a Novel Pathogenesis-Related Protein Gene (GmPRP) with Induced Expression in Soybean (Glycine max) during Infection with Phytophthora sojae	PLOS ONE			English	Article							THAUMATIN-LIKE PROTEIN; LIPID TRANSFER PROTEIN; F-SP GLYCINEA; RICE PLANTS; MOLECULAR CHARACTERIZATION; ENHANCED RESISTANCE; TRANSGENIC TOBACCO; DEFENSE RESPONSES; BOTRYTIS-CINEREA; LEAF SENESCENCE	Pathogenesis-related proteins (PR proteins) play crucial roles in the plant defense system. A novel PRP gene was isolated from highly resistant soybean infected with Phytophthora sojae (P. sojae) and was named GmPRP (GenBank accession number: KM506762). The amino acid sequences of GmPRP showed identities of 74%, 73%, 72% and 69% with PRP proteins from Vitis vinifera, Populus trichocarpa, Citrus sinensis and Theobroma cacao, respectively. Quantitative real-time reverse transcription PCR (qRT-PCR) data showed that the expression of GmPRP was highest in roots, followed by the stems and leaves. GmPRP expression was upregulated in soybean leaves infected with P. sojae. Similarly, GmPRP expression also responded to defense/stress signaling molecules, including salicylic acid (SA), ethylene (ET), abscisic acid (ABA) and jasmonic acid (JA). GmPRP was localized in the cell plasma membrane and cytoplasm. Recombinant GmPRP protein exhibited ribonuclease activity and significant inhibition of hyphal growth of P. sojae 1 in vitro. Overexpression of the GmPRP gene in T-2 transgenic tobacco and T-2 soybean plants resulted in enhanced resistance to Phytophthora nicotianae (P. nicotianae) and P. sojae race 1, respectively. These results indicated that the GmPRP protein played an important role in the defense of soybean against P. sojae infection.	[Jiang, Liangyu; Fan, Sujie; Li, Wenbin; Dong, Lidong; Cheng, Qun; Xu, Pengfei; Zhang, Shuzhen] Northeast Agr Univ, Soybean Res Inst, Chinese Educ Minist, Key Lab Soybean Biol, Harbin 150030, Heilongjiang, Peoples R China; [Wu, Junjiang] Heilongjiang Acad Agr Sci, Soybean Res Inst, Collaborat Innovat Ctr Grain Prod Capac Improveme, Harbin 150086, Heilongjiang, Peoples R China	Northeast Agricultural University - China; Heilongjiang Academy of Agricultural Sciences	Xu, PF (corresponding author), Northeast Agr Univ, Soybean Res Inst, Chinese Educ Minist, Key Lab Soybean Biol, Harbin 150030, Heilongjiang, Peoples R China.	xupengfei@neau.edu.cn; zhangshuzhen@neau.edu.cn			Heilongjiang Province outstanding youth fund [JC201308]; National Natural Science Foundation of China Projects [31071439, 31171577, 13 31101167]; Specialized Research Fund for the Doctoral Program of Higher Education [20112325120005]; Science and Technology Innovation Project in Harbin [2012RFQXN011, 2012RFXXN019]; Research Fund for Young Teachers in Northeast Agricultural University [2012 RCB 08]	Heilongjiang Province outstanding youth fund; National Natural Science Foundation of China Projects(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science and Technology Innovation Project in Harbin; Research Fund for Young Teachers in Northeast Agricultural University	The research was supported through funding from the Heilongjiang Province outstanding youth fund (JC201308), National Natural Science Foundation of China Projects (31071439, 31171577, 13 31101167), the Specialized Research Fund for the Doctoral Program of Higher Education (20112325120005), the Science and Technology Innovation Project in Harbin (2012RFQXN011, 2012RFXXN019), and the Research Fund for Young Teachers in Northeast Agricultural University (2012 RCB 08).	Agrawal GK, 2002, PLANT PHYSIOL BIOCH, V40, P1061, DOI 10.1016/S0981-9428(02)01471-7; Anderson TR, 2003, DIS FIELD CROPS CANA; Asselbergh B, 2007, PLANT PHYSIOL, V144, P1863, DOI 10.1104/pp.107.099226; Bai SH, 2013, PLANT PHYSIOL BIOCH, V62, P23, DOI 10.1016/j.plaphy.2012.10.016; Bantignies B, 2000, PLANT MOL BIOL, V42, P871, DOI 10.1023/A:1006475303115; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; BEAGLERISTAINO JE, 1983, PHYTOPATHOLOGY, V73, P590, DOI 10.1094/Phyto-73-590; Borsics T, 2002, J EXP BOT, V53, P1831, DOI 10.1093/jxb/erf039; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; Chassot C, 2007, PLANT J, V49, P972, DOI 10.1111/j.1365-313X.2006.03017.x; Christensen AB, 2002, MOL PLANT PATHOL, V3, P135, DOI 10.1046/j.1364-3703.2002.00105.x; Clarkson WD, 1997, J MOL BIOL, V272, P716, DOI 10.1006/jmbi.1997.1255; Datta K, 1999, THEOR APPL GENET, V98, P1138, DOI 10.1007/s001220051178; Dou DaoLong, 2003, Scientia Agricultura Sinica, V36, P1120; Durner J, 1997, TRENDS PLANT SCI, V2, P266, DOI 10.1016/S1360-1385(97)86349-2; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gonzalez G, 2013, PHYSIOL MOL PLANT P, V82, P73, DOI 10.1016/j.pmpp.2013.02.001; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hou MM, 2012, PLANT CELL REP, V31, P895, DOI 10.1007/s00299-011-1210-z; Iwai T, 2002, MOL PLANT MICROBE IN, V15, P515, DOI 10.1094/MPMI.2002.15.6.515; Jacobs AS, 1996, PHYTOPATHOLOGY, V86, P588, DOI 10.1094/Phyto-86-588; Jayasankar S, 2003, FUNCT PLANT BIOL, V30, P1105, DOI 10.1071/FP03066; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jung HW, 2005, PLANTA, V221, P361, DOI 10.1007/s00425-004-1461-9; Jwa NS, 2001, BIOCHEM BIOPH RES CO, V286, P973, DOI 10.1006/bbrc.2001.5507; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; LIU D, 1994, P NATL ACAD SCI USA, V91, P1888, DOI 10.1073/pnas.91.5.1888; Liu XJ, 2006, J PLANT PHYSIOL, V163, P546, DOI 10.1016/j.jplph.2005.04.031; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; Loon L. C. van, 1994, Plant Molecular Biology Reporter, V12, P245, DOI 10.1007/BF02668748; LORITO M, 1994, MICROBIOL-UK, V140, P623, DOI 10.1099/00221287-140-3-623; MACHIDA S, 1993, J BIOL CHEM, V268, P1702; McGhee JD, 2001, MOL PLANT MICROBE IN, V14, P877, DOI 10.1094/MPMI.2001.14.7.877; Mitsuhara I, 2008, MOL GENET GENOMICS, V279, P415, DOI 10.1007/s00438-008-0322-9; Monteiro S, 2007, PHYTOCHEMISTRY, V68, P416, DOI 10.1016/j.phytochem.2006.11.014; Montillet JL, 2005, PLANT PHYSIOL, V138, P1516, DOI 10.1104/pp.105.059907; MORRIS PF, 1991, PHYSIOL MOL PLANT P, V39, P229, DOI 10.1016/0885-5765(91)90006-4; Moy P, 2004, MOL PLANT MICROBE IN, V17, P1051, DOI 10.1094/MPMI.2004.17.10.1051; Narayanan N, 2009, THEOR APPL GENET, V118, P399, DOI 10.1007/s00122-008-0895-z; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Okushima Y, 2000, PLANT MOL BIOL, V42, P479, DOI 10.1023/A:1006393326985; Park CJ, 2004, PLANTA, V219, P797, DOI 10.1007/s00425-004-1290-x; Park CJ, 2004, PLANT J, V37, P186, DOI 10.1046/j.1365-313X.2003.01951.x; Park SH, 2011, EXP CELL RES, V317, P941, DOI 10.1016/j.yexcr.2010.12.023; PAUTOT V, 1991, MOL PLANT MICROBE IN, V4, P284, DOI 10.1094/MPMI-4-284; Poupard P, 1998, AUST J PLANT PHYSIOL, V25, P459, DOI 10.1071/PP97114; Pozo MJ, 2002, J EXP BOT, V53, P525, DOI 10.1093/jexbot/53.368.525; Prasath D, 2011, PLANT CELL REP, V30, P1799, DOI 10.1007/s00299-011-1087-x; Quirino BF, 2000, TRENDS PLANT SCI, V5, P278, DOI 10.1016/S1360-1385(00)01655-1; Rakwal R, 1999, ELECTROPHORESIS, V20, P3472, DOI 10.1002/(SICI)1522-2683(19991101)20:17<3472::AID-ELPS3472>3.0.CO;2-0; Robert N, 2001, EUR J PLANT PATHOL, V107, P249, DOI 10.1023/A:1011241001383; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Sambrook J, MOL CLONING LAB MANU, P9; Saravanakumar D, 2009, BIOCONTROL, V54, P273, DOI 10.1007/s10526-008-9166-9; Sarowar S, 2005, PLANT CELL REP, V24, P216, DOI 10.1007/s00299-005-0928-x; SCHLUMBAUM A, 1986, NATURE, V324, P365, DOI 10.1038/324365a0; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Senthilraja G, 2013, PHYSIOL MOL PLANT P, V82, P10, DOI 10.1016/j.pmpp.2012.12.002; TERRAS FRG, 1995, PLANT CELL, V7, P573, DOI 10.1105/tpc.7.5.573; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; van Loon LC, 1999, PATHOGENESIS-RELATED PROTEINS IN PLANTS, P1; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Wang CS, 1999, PLANT MOL BIOL, V40, P807, DOI 10.1023/A:1006285028495; Wang HZ, 2008, PLANT CELL REP, V27, P251, DOI 10.1007/s00299-007-0450-4; Wang SY, 2004, PEPTIDES, V25, P1235, DOI 10.1016/j.peptides.2004.06.004; WARD EWB, 1979, PHYTOPATHOLOGY, V69, P951, DOI 10.1094/Phyto-69-951; Wei YD, 1998, PLANT MOL BIOL, V36, P101, DOI 10.1023/A:1005955119326; WORRALL D, 1992, PLANT CELL, V4, P759, DOI 10.1105/tpc.4.7.759; Xie YR, 2010, J PLANT PHYSIOL, V167, P121, DOI 10.1016/j.jplph.2009.07.004; Xu PF, 2012, J INTEGR AGR, V11, P368, DOI 10.1016/S2095-3119(12)60021-5; Xu PF, 2014, MOL BIOL REP, V41, P4899, DOI 10.1007/s11033-014-3356-6; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang SZ, 2010, PLANT DIS, V94, P87, DOI 10.1094/PDIS-94-1-0087; Zhang YH, 2007, J PLANT PHYSIOL, V164, P68, DOI 10.1016/j.jplph.2006.02.002; ZHU BL, 1995, PLANT MOL BIOL, V28, P17, DOI 10.1007/BF00042034	77	25	29	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129932	10.1371/journal.pone.0129932	http://dx.doi.org/10.1371/journal.pone.0129932			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114301	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500044
J	Tom-Aba, D; Olaleye, A; Olayinka, AT; Nguku, P; Waziri, N; Adewuyi, P; Adeoye, O; Oladele, S; Adeseye, A; Oguntimehin, O; Shuaib, F				Tom-Aba, Daniel; Olaleye, Adeniyi; Olayinka, Adebola Tolulope; Nguku, Patrick; Waziri, Ndadilnasiya; Adewuyi, Peter; Adeoye, Olawunmi; Oladele, Saliu; Adeseye, Aderonke; Oguntimehin, Olukayode; Shuaib, Faisal			Innovative Technological Approach to Ebola Virus Disease Outbreak Response in Nigeria Using the Open Data Kit and Form Hub Technology	PLOS ONE			English	Article								The recent outbreak of Ebola Virus Disease (EVD) in West Africa has ravaged many lives. Effective containment of this outbreak relies on prompt and effective coordination and communication across various interventions; early detection and response being critical to successful control. The use of information and communications technology (ICT) in active surveillance has proved to be effective but its use in Ebola outbreak response has been limited. Due to the need for timeliness in reporting and communication for early discovery of new EVD cases and promptness in response; it became imperative to empower the response team members with technologies and solutions which would enable smooth and rapid data flow. The Open Data Kit and Form Hub technology were used in combination with the Dashboard technology and ArcGIS mapping for follow up of contacts, identification of cases, case investigation and management and also for strategic planning during the response. A remarkable improvement was recorded in the reporting of daily follow-up of contacts after the deployment of the integrated real time technology. The turnaround time between identification of symptomatic contacts and evacuation to the isolation facility and also for receipt of laboratory results was reduced and informed decisions could be taken by all concerned. Accountability in contact tracing was ensured by the use of a GPS enabled device. The use of innovative technologies in the response of the EVD outbreak in Nigeria contributed significantly to the prompt control of the outbreak and containment of the disease by providing a valuable platform for early warning and guiding early actions.	[Tom-Aba, Daniel] Abuja Off, African Field Epidemiol Network, Abuja, Nigeria; [Olaleye, Adeniyi] UNICEF Off, Lagos, Nigeria; [Olayinka, Adebola Tolulope; Nguku, Patrick; Waziri, Ndadilnasiya; Adewuyi, Peter; Adeoye, Olawunmi] Nigeria Field Epidemiol & Lab, Training Programme, Abuja, Nigeria; [Olayinka, Adebola Tolulope] Ahmadu Bello Univ, Zaria, Nigeria; [Oladele, Saliu] WHO Country Off, Abuja, Nigeria; [Adeseye, Aderonke] Lagos State Minist Hlth, Lagos, Nigeria; [Oguntimehin, Olukayode] Lagos State Primary Hlth Care Board, Lagos, Nigeria; [Shuaib, Faisal] Fed Minist Hlth, Abuja, Nigeria	Ahmadu Bello University	Tom-Aba, D (corresponding author), Abuja Off, African Field Epidemiol Network, Abuja, Nigeria.	dtomaba@gmail.com	Tom-Aba, Daniel/AAF-5619-2020; ADEWUYI, PETER/GVU-0444-2022; Adewuyi, Adebayo Peter/AAY-2190-2021	Adewuyi, Adebayo Peter/0000-0001-8375-1632; Olayinka, Adebola/0000-0002-6023-8403	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Kalra S, 2014, J GLOB INFECT DIS, V6, P164, DOI 10.4103/0974-777X.145247; Louis MS., 2012, MMWR SURVEILL SUMM S, V61, P15; mHealth for development, 2009, MHEALTH DEV OPP MOB; Randrianasolo L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-31	4	43	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131000	10.1371/journal.pone.0131000	http://dx.doi.org/10.1371/journal.pone.0131000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115402	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500119
J	Valenta, K; Brown, KA; Melin, AD; Monckton, SK; Styler, SA; Jackson, DA; Chapman, CA				Valenta, Kim; Brown, Kevin A.; Melin, Amanda D.; Monckton, Spencer K.; Styler, Sarah A.; Jackson, Derek A.; Chapman, Colin A.			It's Not Easy Being Blue: Are There Olfactory and Visual Trade-Offs in Plant Signalling?	PLOS ONE			English	Article							COLOR-VISION; TRICHROMATIC VISION; DISPERSED PLANTS; FOOD DETECTION; YOUNG LEAVES; BROWN LEMURS; FRUIT; SELECTION; SHAPE; ADAPTATION	Understanding the signals used by plants to attract seed disperses is a pervasive quest in evolutionary and sensory biology. Fruit size, colour, and odour variation have long been discussed in the controversial context of dispersal syndromes targeting olfactory-oriented versus visually-oriented foragers. Trade-offs in signal investment could impose important physiological constraints on plants, yet have been largely ignored. Here, we measure the reflectance and volatile organic compounds of a community of Malagasy plants and our results indicate that extant plant signals may represent a trade-off between olfactory and chromatic signals. Blue pigments are the most visually-effective - blue is a colour that is visually salient to all known seed dispersing animals within the study system. Additionally, plants with blue-reflecting fruits are less odiferous than plants that reflect primarily in other regions of the colour spectrum.	[Valenta, Kim; Chapman, Colin A.] McGill Univ, Dept Anthropol, Montreal, PQ, Canada; [Brown, Kevin A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Melin, Amanda D.] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Monckton, Spencer K.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Styler, Sarah A.] Leibniz Inst Tropospher Res, Leipzig, Germany; [Jackson, Derek A.] Univ Toronto, Dept Chem, Toronto, ON M5S 1A1, Canada	McGill University; University of Toronto; Washington University (WUSTL); York University - Canada; Leibniz Institut fur Tropospharenforschung (TROPOS); University of Toronto	Valenta, K (corresponding author), McGill Univ, Dept Anthropol, Montreal, PQ, Canada.	valentakim@gmail.com	Chapman, Colin/S-1911-2019; Monckton, Spencer K./H-7827-2019	Chapman, Colin/0000-0002-8827-8140; Monckton, Spencer K./0000-0002-9879-9118; Styler, Sarah/0000-0002-6078-9387; Brown, Kevin Antoine/0000-0002-1483-2188; Melin, Amanda/0000-0002-0612-2514	Sigma Xi; GM Women in Science; University of Toronto; Natural Sciences and Engineering Research Council of Canada	Sigma Xi; GM Women in Science; University of Toronto(University of Toronto); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	For funding the authors thank Sigma Xi, GM Women in Science (KV), the University of Toronto and Natural Sciences and Engineering Research Council of Canada (KV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backlund M, 2000, AM J BOT, V87, P1029, DOI 10.2307/2657003; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bremer B, 2009, INT J PLANT SCI, V170, P766, DOI 10.1086/599077; Chase MW, 2009, BOT J LINN SOC, V161, P122, DOI 10.1111/j.1095-8339.2009.01002.x; COLEY PD, 1989, J TROP ECOL, V5, P293, DOI 10.1017/S0266467400003667; Dominy NJ, 2001, NATURE, V410, P363, DOI 10.1038/35066567; FARRIS JS, 1989, CLADISTICS, V5, P417, DOI 10.1111/j.1096-0031.1989.tb00573.x; FISCHER KE, 1993, OIKOS, V66, P472, DOI 10.2307/3544942; Gadek PA, 1996, AM J BOT, V83, P802, DOI 10.2307/2445857; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; GOULD KS, 1995, NATURE, V378, P241, DOI 10.1038/378241b0; Hakala-Yatkin M, 2010, PLANT CELL PHYSIOL, V51, P1745, DOI 10.1093/pcp/pcq133; HERRERA CM, 1992, ECOLOGY, V73, P1832, DOI 10.2307/1940034; HERRERA CM, 1987, ECOL MONOGR, V57, P305, DOI 10.2307/2937089; Hirsch BT, 2010, ETHOLOGY, V116, P671, DOI 10.1111/j.1439-0310.2010.01783.x; HOWE HF, 1993, VEGETATIO, V108, P3; JACOBS GH, 1993, AM J PRIMATOL, V30, P243, DOI 10.1002/ajp.1350300307; Jacobs GH, 1981, COMP COLOR VISION; JANSON CH, 1983, SCIENCE, V219, P187, DOI 10.1126/science.219.4581.187; Korine C, 2000, OECOLOGIA, V123, P560, DOI 10.1007/PL00008861; Korine C, 2005, BEHAV ECOL SOCIOBIOL, V59, P12, DOI 10.1007/s00265-005-0003-1; Lahann P, 2007, J ZOOL, V271, P88, DOI 10.1111/j.1469-7998.2006.00222.x; Langrand O., 1990, GUIDE BIRDS MADAGASC; Linn CE, 2004, P NATL ACAD SCI USA, V101, P17753, DOI 10.1073/pnas.0408255101; Lomascolo SB, 2010, J EVOLUTION BIOL, V23, P614, DOI 10.1111/j.1420-9101.2010.01931.x; Lomascolo SB, 2008, OECOLOGIA, V156, P783, DOI 10.1007/s00442-008-1023-0; Lomascolo SB, 2010, P NATL ACAD SCI USA, V107, P14668, DOI 10.1073/pnas.1008773107; Luft S, 2003, NATURWISSENSCHAFTEN, V90, P84, DOI 10.1007/s00114-002-0393-0; MAZER SJ, 1993, EVOL ECOL, V7, P556, DOI 10.1007/BF01237821; MCKITRICK MC, 1993, ANNU REV ECOL SYST, V24, P307; Melin AD, 2012, AM J PRIMATOL, V74, P185, DOI 10.1002/ajp.21996; Mittermeier C. G., 2010, LEMURS OF MADAGASCAR; MOLLON JD, 1989, J EXP BIOL, V146, P21; Nazar N, 2013, BOT J LINN SOC, V171, P482, DOI 10.1111/boj.12005; Osorio D, 2004, AM NAT, V164, P696, DOI 10.1086/425332; Otte D., 1974, Annual Rev Ecol Syst, V5, P385, DOI 10.1146/annurev.es.05.110174.002125; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Perry GH, 2007, MOL BIOL EVOL, V24, P1963, DOI 10.1093/molbev/msm124; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Sato H, 2012, BIOTROPICA, V44, P479, DOI 10.1111/j.1744-7429.2011.00838.x; Schaefer HM, 2007, AM NAT, V169, pS159, DOI 10.1086/510097; Schaefer HM, 2009, ECOLOGY, V90, P1564, DOI 10.1890/08-1346.1; Schaefer HM, 2004, TRENDS ECOL EVOL, V19, P577, DOI 10.1016/j.tree.2004.08.003; Schaefer HM, 2004, P ROY SOC B-BIOL SCI, V271, pS370, DOI 10.1098/rsbl.2004.0191; Schatz, 2001, GENERIC TREE FLORA M; Siemers BM, 2007, INT J PRIMATOL, V28, P291, DOI 10.1007/s10764-007-9135-7; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; STONE BC, 1979, BIOTROPICA, V11, P126, DOI 10.2307/2387788; Stournaras KE, 2013, NEW PHYTOL, V198, P617, DOI 10.1111/nph.12157; Tan Y, 1999, NATURE, V402, P36, DOI 10.1038/46947; Tokuoka T, 2006, J PLANT RES, V119, P599, DOI 10.1007/s10265-006-0025-4; Valenta K., 2013, SCI REPORTS, V3, P1, DOI DOI 10.1038/SREP02424; Valido A, 2011, J EVOLUTION BIOL, V24, P751, DOI 10.1111/j.1420-9101.2010.02206.x; Veilleux CC, 2013, MOL BIOL EVOL, V30, P1420, DOI 10.1093/molbev/mst058; WHEELWRIGHT N, 1981, AM NAT, V119, P402; WHEELWRIGHT NT, 1985, AM NAT, V126, P777, DOI 10.1086/284453; Whitney KD, 2009, P ROY SOC B-BIOL SCI, V276, P2941, DOI 10.1098/rspb.2009.0483; Willson MF, 1990, AM NAT, V136, P780	59	10	10	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131725	10.1371/journal.pone.0131725	http://dx.doi.org/10.1371/journal.pone.0131725			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115040	Green Submitted, gold, Green Published			2022-12-27	WOS:000358147500181
J	Wu, H; Clay, K; Thompson, SS; Hennen-Bierwagen, TA; Andrews, BJ; Zechmann, B; Gibbon, BC				Wu, Hao; Clay, Kasi; Thompson, Stephanie S.; Hennen-Bierwagen, Tracie A.; Andrews, Bethany J.; Zechmann, Bernd; Gibbon, Bryan C.			Pullulanase and Starch Synthase III Are Associated with Formation of Vitreous Endosperm in Quality Protein Maize	PLOS ONE			English	Article							OPAQUE2 MODIFIER LOCI; DEBRANCHING ENZYME; MUTANT; IDENTIFICATION; GELATINIZATION; PURIFICATION; EXPRESSION; ENCODES; ZEINS; ZPU1	The opaque-2 (o2) mutation of maize increases lysine content, but the low seed density and soft texture of this type of mutant are undesirable. Lines with modifiers of the soft kernel phenotype (mo2) called "Quality Protein Maize" (QPM) have high lysine and kernel phenotypes similar to normal maize. Prior research indicated that the formation of vitreous endosperm in QPM might involve changes in starch granule structure. In this study, we focused on analysis of two starch biosynthetic enzymes that may influence kernel vitreousness. Analysis of recombinant inbred lines derived from a cross of W64Ao2 and K0326Y revealed that pullulanase activity had significant positive correlation with kernel vitreousness. We also found that decreased Starch Synthase III abundance may decrease the pullulanase activity and average glucan chain length given the same Zpu1 genotype. Therefore, Starch Synthase III could indirectly influence the kernel vitreousness by affecting pullulanase activity and coordinating with pullulanase to alter the glucan chain length distribution of amylopectin, resulting in different starch structural properties. The glucan chain length distribution had strong positive correlation with the polydispersity index of glucan chains, which was positively associated with the kernel vitreousness based on nonlinear regression analysis. Therefore, we propose that pullulanase and Starch Synthase III are two important factors responsible for the formation of the vitreous phenotype of QPM endosperms.	[Wu, Hao; Clay, Kasi; Thompson, Stephanie S.] Baylor Univ, Dept Biol, Waco, TX 76798 USA; [Hennen-Bierwagen, Tracie A.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Andrews, Bethany J.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Zechmann, Bernd] Baylor Univ, Ctr Microscopy & Imaging, Waco, TX 76798 USA; [Gibbon, Bryan C.] Florida A&M Univ, Dept Biol Sci, Tallahassee, FL 32307 USA	Baylor University; Iowa State University; Texas A&M University System; Texas A&M University College Station; Baylor University; State University System of Florida; Florida A&M University	Gibbon, BC (corresponding author), Florida A&M Univ, Dept Biol Sci, Tallahassee, FL 32307 USA.	bryan.gibbon@famu.edu		Hennen-Bierwagen, Tracie/0000-0002-2269-4491; Zechmann, Bernd/0000-0002-7702-2588	USDA-NIFA [2010-65115-20375]; Baylor University URSA award	USDA-NIFA(United States Department of Agriculture (USDA)); Baylor University URSA award	This work was supported by USDA-NIFA grant 2010-65115-20375 and a Baylor University URSA award to BCG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beatty MK, 1999, PLANT PHYSIOL, V119, P255, DOI 10.1104/pp.119.1.255; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Bhan MK, 2003, BMJ-BRIT MED J, V326, P146, DOI 10.1136/bmj.326.7381.146; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; CROMWELL GL, 1967, J ANIM SCI, V26, P1325, DOI 10.2527/jas1967.2661325x; Dinges JR, 2001, PLANT PHYSIOL, V125, P1406, DOI 10.1104/pp.125.3.1406; Dinges JR, 2003, PLANT CELL, V15, P666, DOI 10.1105/tpc.007575; Fujita N, 2006, PLANT PHYSIOL, V140, P1070, DOI 10.1104/pp.105.071845; Gao M, 1998, PLANT CELL, V10, P399, DOI 10.1105/tpc.10.3.399; GEETHA KB, 1991, PLANT CELL, V3, P1207, DOI 10.1105/tpc.3.11.1207; Gibbon BC, 2003, P NATL ACAD SCI USA, V100, P15329, DOI 10.1073/pnas.2136854100; Gilbert RG, 2009, PURE APPL CHEM, V81, P779, DOI 10.1351/PAC-REC-08-05-02_erratum; Guo XM, 2013, PLANT PHYSIOL, V162, P1359, DOI 10.1104/pp.113.218941; Guo XM, 2012, PLANT PHYSIOL, V158, P917, DOI 10.1104/pp.111.191163; Gutierrez OA, 2002, CROP SCI, V42, P355, DOI 10.2135/cropsci2002.0355; Habben J. E., 1995, SEED DEV GERMINATION, P791; HANNAH LC, 1976, BIOCHEM GENET, V14, P547, DOI 10.1007/BF00485834; Hasjim J, 2009, J AGR FOOD CHEM, V57, P2049, DOI 10.1021/jf803406y; Hennen-Bierwagen TA, 2008, PLANT PHYSIOL, V146, P1892, DOI 10.1104/pp.108.116285; Holding DR, 2008, THEOR APPL GENET, V117, P157, DOI 10.1007/s00122-008-0762-y; Holding DR, 2007, PLANT CELL, V19, P2569, DOI 10.1105/tpc.107.053538; Holding DR, 2011, THEOR APPL GENET, V122, P783, DOI 10.1007/s00122-010-1486-3; Hsieh PC, 2000, J BACTERIOL, V182, P949, DOI 10.1128/JB.182.4.949-955.2000; Jane J, 1999, CEREAL CHEM, V76, P629, DOI 10.1094/CCHEM.1999.76.5.629; Jenkins PJ, 1997, J APPL POLYM SCI, V66, P225, DOI 10.1002/(SICI)1097-4628(19971010)66:2<225::AID-APP3>3.3.CO;2-3; Jeon JS, 2010, PLANT PHYSIOL BIOCH, V48, P383, DOI 10.1016/j.plaphy.2010.03.006; Jia M, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-60; KRUEGER BR, 1987, CEREAL CHEM, V64, P187; Lin QH, 2012, PLANT PHYSIOL, V158, P679, DOI 10.1104/pp.111.189704; Liu FS, 2012, J EXP BOT, V63, P1167, DOI 10.1093/jxb/err341; LOPES MA, 1995, MOL GEN GENET, V247, P603, DOI 10.1007/BF00290352; NELSON OE, 1962, BIOCHEM BIOPH RES CO, V9, P297, DOI 10.1016/0006-291X(62)90043-8; O'Shea MG, 1998, CARBOHYD RES, V307, P1, DOI 10.1016/S0008-6215(97)10085-4; Prasanna BM, 2001, CURR SCI INDIA, V81, P1308; Rogosic M, 1996, EUR POLYM J, V32, P1337, DOI 10.1016/S0014-3057(96)00091-2; SCHMIDT RJ, 1990, P NATL ACAD SCI USA, V87, P46, DOI 10.1073/pnas.87.1.46; SCHMIDT RJ, 1992, PLANT CELL, V4, P689, DOI 10.1105/tpc.4.6.689; Segal G, 2003, GENETICS, V165, P387; STEVENS DJ, 1971, STARKE, V23, P8, DOI 10.1002/star.19710230104; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vasal S. K., 1980, Improvement of quality traits of maize for grain and silage use., P37; Vasanthan T., 2012, STARCH BASED POLYM M, P33; Wu CY, 2002, ARCH BIOCHEM BIOPHYS, V406, P21, DOI 10.1016/S0003-9861(02)00412-5; Wu YR, 2010, P NATL ACAD SCI USA, V107, P12810, DOI 10.1073/pnas.1004721107; Young Vernon R., 1998, P205; YOUNG VR, 1971, J NUTR, V101, P1475, DOI 10.1093/jn/101.11.1475; Zhang XL, 2004, PLANT MOL BIOL, V54, P865, DOI 10.1007/s11103-004-0312-1; Zhu F, 2013, J AGR FOOD CHEM, V61, P12345, DOI 10.1021/jf403865n	48	5	5	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130856	10.1371/journal.pone.0130856	http://dx.doi.org/10.1371/journal.pone.0130856			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115014	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500103
J	Zhao, XF; Guan, ZC; Xu, ML; Shi, YC; Liao, HL; Sun, J				Zhao, Xiaofeng; Guan, Zhichuan; Xu, Minglei; Shi, Yucai; Liao, Hualin; Sun, Jia			The Influence of Casing-Sand Adhesion on Cementing Bond Strength	PLOS ONE			English	Article								In the petroleum industry, one of the most serious problems encountered during cementing is the failure at the bonding interface. Many measures including casing-sand adhesion have been developed to improve cementing bond strength. However, due to the lack of detailed study of the technique, many questions remain. The primary goal of this study is to investigate the influence of casing-sand adhesion on cementing bond strength, and to optimize parameters. An orthogonal experiment and a supplementary experiment were conducted. The results indicated that casing-sand adhesion can improve the cementing bond strength. The priority orders of key factors are: sand grain size, sand coverage, adhesive curing temperature and adhesive curing time. The optimal parameters recommended for application are: 1.6mm similar to 1.9mm sand grain size, 60%similar to 70% sand coverage, 30 degrees C curing temperature and 60 hours curing time.	[Zhao, Xiaofeng; Guan, Zhichuan; Shi, Yucai; Liao, Hualin] China Univ Petr, Coll Petr Engn, Qingdao, Shandong, Peoples R China; [Xu, Minglei] CNPC Bohai Drilling Engn Co Ltd, Res Inst Petr Engn, Tianjin, Peoples R China; [Sun, Jia] SINOPEC, Int Petr Serv Corp, Beijing, Peoples R China	China University of Petroleum; China National Petroleum Corporation; Sinopec	Guan, ZC (corresponding author), China Univ Petr, Coll Petr Engn, Qingdao, Shandong, Peoples R China.	guanzhch@upc.edu.cn			Fundamental Research Funds for the Central Universities [12CX06028A]; International Petroleum Service Corporation of SINOPEC; Research Institute of Petroleum Engineering of CNPC Bohai Drilling Co. ltd.	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); International Petroleum Service Corporation of SINOPEC; Research Institute of Petroleum Engineering of CNPC Bohai Drilling Co. ltd.	This study was supported by "the Fundamental Research Funds for the Central Universities" (NO. 12CX06028A), and the author XF. Z received the funding. But the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. International Petroleum Service Corporation of SINOPEC provided support in the form of salaries for author J.S and Research Institute of Petroleum Engineering of CNPC Bohai Drilling Co. ltd. provided support in the form of salaries for author ML.X, but these companies did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Cao HM, 1994, OIL DRILLING PRODUCT, V16, P45; CARTER LG, 1964, J PETROL TECHNOL, V16, P157, DOI 10.2118/764-PA; Chen SY., 2008, THESIS DAQING PETROL; Chen YZ, 1999, PETROLEUM DRILLING T, V27, P43, DOI [10.3969/j.issn.1001-0890.1999.03.011, DOI 10.3969/J.ISSN.1001-0890.1999.03.011]; Drilling technology research institute of Jilin oilfield, 2002, REPORT CASING SAND A; George E, 1964, SPRING M SW DISTR AP, P33; James BS, 1966, SPRING M MID CONT DI, P43; Li H., 2013, THESIS NE PETROLEUM; Song YW., 2007, COMPUTER DIGITAL ENG, V35, P53, DOI [10.3969/ j. issn. 1001- 4578.2007.05.013, DOI 10.3969/J.ISSN.1001-4578.2007.05.013]; Yang JY, 2001, PETROLEUM DRILLING T, V29, P48, DOI [10.3969/j.issn.1001-0890.2001.05.016, DOI 10.3969/J.ISSN.1001-0890.2001.05.016]	10	5	5	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130892	10.1371/journal.pone.0130892	http://dx.doi.org/10.1371/journal.pone.0130892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115343	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500106
J	Amarilla, LD; Anton, AM; Chiapella, JO; Manifesto, MM; Angulo, DF; Sosa, V				Amarilla, Leonardo D.; Anton, Ana M.; Chiapella, Jorge O.; Manifesto, Maria M.; Angulo, Diego F.; Sosa, Victoria			Munroa argentina, a Grass of the South American Transition Zone, Survived the Andean Uplift, Aridification and Glaciations of the Quaternary	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; ATACAMA DESERT; INTRASPECIFIC PHYLOGEOGRAPHY; DISJUNCT DISTRIBUTION; CLIMATE-CHANGE; EVOLUTIONARY; DIVERSIFICATION; CHLOROPLAST; INFERENCE; SOFTWARE	The South American Transition Zone (SATZ) is a biogeographic area in which not only orogeny (Andes uplift) and climate events (aridification) since the mid-Miocene, but also Quaternary glaciation cycles had an important impact on the evolutionary history of the local flora. To study this effect, we selected Munroa argentina, an annual grass distributed in the biogeographic provinces of Puna, Prepuna and Monte. We collected 152 individuals from 20 localities throughout the species' range, ran genetic and demographic analyses, and applied ecological niche modeling. Phylogenetic and population genetic analyses based on cpDNA and AFLP data identified three phylogroups that correspond to the previously identified subregions within the SATZ. Molecular dating suggests that M. argentina has inhabited the SATZ since approximately 3.4 (4.2-1.2) Ma and paleomodels predict suitable climate in these areas during the Interglacial period and the Last Glacial Maximum. We conclude that the current distribution of M. argentina resulted from the fragmentation of its once continuous range and that climate oscillations promoted ecological differences that favored isolation by creating habitat discontinuity.	[Amarilla, Leonardo D.; Anton, Ana M.; Chiapella, Jorge O.] Univ Nacl Cordoba, CONICET, IMBIV, RA-5000 Cordoba, Argentina; [Manifesto, Maria M.] INTA, Inst Recursos Biol, RA-1712 Castelar, Argentina; [Angulo, Diego F.; Sosa, Victoria] Inst Ecol AC, Biol Evolut, Xalapa 91070, Veracruz, Mexico	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Instituto Nacional de Tecnologia Agropecuaria (INTA); Instituto de Ecologia - Mexico	Sosa, V (corresponding author), Inst Ecol AC, Biol Evolut, Carretera Antigua Coatepec 351 El Haya, Xalapa 91070, Veracruz, Mexico.	victoria.sosa@inecol.mx	Sosa, Victoria/A-5798-2013; Chiapella, Jorge O./AAI-2433-2021; Angulo, Diego F./B-3152-2015	Sosa, Victoria/0000-0002-0584-1672; Chiapella, Jorge O./0000-0003-1686-1211; Angulo, Diego F./0000-0002-5678-4946	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Red Latinoamericana de Botanica; Andrew W. Mellon Foundation [RLB2011-P18]; CONACyT; MINCyT; Myndel Botanica Foundation	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Red Latinoamericana de Botanica; Andrew W. Mellon Foundation; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); MINCyT; Myndel Botanica Foundation	The Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), the Red Latinoamericana de Botanica and the Andrew W. Mellon Foundation Grant 2011 (RLB2011-P18) (LDA) provided funding, with additional funds from a Bilateral Cooperation Project CONACyT (VS)-MINCyT (AMA), and the Myndel Botanica Foundation (2011) (JOC).	Abbott RJ, 2000, SCIENCE, V289, P1343, DOI 10.1126/science.289.5483.1343; Alsos IG, 2007, SCIENCE, V316, P1606, DOI 10.1126/science.1139178; Amarilla LD, BOT J LINNE IN PRESS; Amarilla Leonardo D, 2013, Darwiniana, nueva serie, V1, P241, DOI 10.14522/darwiniana.2013.12.502; Antonelli A, 2011, TAXON, V60, P403, DOI 10.1002/tax.602010; Antonelli A, 2009, P NATL ACAD SCI USA, V106, P9749, DOI 10.1073/pnas.0811421106; ARROYO MTK, 1988, ANN MO BOT GARD, V75, P55, DOI 10.2307/2399466; Avila LJ, 2006, BIOL J LINN SOC, V89, P241, DOI 10.1111/j.1095-8312.2006.00666.x; Avise J.C., 2000, PHYLOGEOGRAPHY; Baranzelli MC, 2014, EVOL ECOL, V28, P751, DOI 10.1007/s10682-014-9694-y; Bell CD, 2005, ORG DIVERS EVOL, V5, P147, DOI 10.1016/j.ode.2004.10.014; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bouchenak-Khelladi Y, 2010, BOT J LINN SOC, V162, P543, DOI 10.1111/j.1095-8339.2010.01041.x; Bouchenak-Khelladi Y, 2009, GLOBAL CHANGE BIOL, V15, P2397, DOI 10.1111/j.1365-2486.2009.01860.x; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Cabrera AL, 1980, MONOGRAFIA GEN SECRE, V13; Carstens BC, 2007, EVOLUTION, V61, P1439, DOI 10.1111/j.1558-5646.2007.00117.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Folguera A, 2011, BIOL J LINN SOC, V103, P250, DOI 10.1111/j.1095-8312.2011.01687.x; Fu YX, 1997, GENETICS, V147, P915; Garzione CN, 2008, SCIENCE, V320, P1304, DOI 10.1126/science.1148615; Gonzalez F, 2014, J BIOGEOGR, V41, P380, DOI 10.1111/jbi.12198; Gregory-Wodzicki KM, 2000, GEOL SOC AM BULL, V112, P1091, DOI 10.1130/0016-7606(2000)112<1091:UHOTCA>2.0.CO;2; Guerrero PC, 2013, P NATL ACAD SCI USA, V110, P11469, DOI 10.1073/pnas.1308721110; Hartley AJ, 2002, GEOLOGY, V30, P43, DOI 10.1130/0091-7613(2002)030<0043:LPAFTA>2.0.CO;2; Hasumi H, 2004, K 1 COUPLED GCM MIRO; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holling J.T., 1981, LAST GREAT ICE SHEET, P179; HOORN C, 1993, PALAEOGEOGR PALAEOCL, V105, P267, DOI 10.1016/0031-0182(93)90087-Y; HOORN C, 1995, GEOLOGY, V23, P237, DOI 10.1130/0091-7613(1995)023<0237:ATAACF>2.3.CO;2; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; Hulton NRJ, 2002, QUATERNARY SCI REV, V21, P233, DOI 10.1016/S0277-3791(01)00103-2; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jabaily RS, 2010, AM J BOT, V97, P337, DOI 10.3732/ajb.0900107; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Jakob SS, 2006, MOL BIOL EVOL, V23, P1602, DOI 10.1093/molbev/msl018; Jakob SS, 2010, MOL ECOL, V19, P1423, DOI 10.1111/j.1365-294X.2010.04582.x; Jakob SS, 2009, MOL BIOL EVOL, V26, P907, DOI 10.1093/molbev/msp012; Kadereit JW, 2004, PHILOS T R SOC B, V359, P265, DOI 10.1098/rstb.2003.1389; Koch MA, 2006, MOL ECOL, V15, P825, DOI 10.1111/j.1365-294X.2005.02848.x; Lachmuth S, 2010, MOL ECOL, V19, P3952, DOI 10.1111/j.1365-294X.2010.04797.x; Le Quesne C, 2009, PALAEOGEOGR PALAEOCL, V281, P334, DOI 10.1016/j.palaeo.2008.01.039; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Luebert F, 2008, SYST BOT, V33, P390, DOI 10.1600/036364408784571635; MANTEL N, 1967, CANCER RES, V27, P209; Mendez MA, 2004, REV CHIL HIST NAT, V77, P559; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Miller MP, 1997, TOOLS POPULATION GEN; Morrone JJ, 2006, ANNU REV ENTOMOL, V51, P467, DOI 10.1146/annurev.ento.50.071803.130447; Morrone Juan J, 2014, Cladistics, V30, P202, DOI 10.1111/cla.12039; Nei M., 1987, MOL EVOLUTIONARY GEN; Ossa PG, 2013, J BIOGEOGR, V40, P2191, DOI 10.1111/jbi.12152; Palma RE, 2005, J BIOGEOGR, V32, P1931, DOI 10.1111/j.1365-2699.2005.01349.x; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson PM, 2010, MOL PHYLOGENET EVOL, V55, P580, DOI 10.1016/j.ympev.2010.01.018; Pfenninger M, 2002, EVOLUTION, V56, P1776, DOI 10.1111/j.0014-3820.2002.tb00191.x; Pirie MD, 2006, J BIOGEOGR, V33, P31, DOI 10.1111/j.1365-2699.2005.01388.x; Placzek C, 2009, ANN MO BOT GARD, V96, P386, DOI 10.3417/2008019; Popp M, 2011, P NATL ACAD SCI USA, V108, P6520, DOI 10.1073/pnas.1012249108; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2004, DOCUMENTATION STRUCT; RABASSA J, 1990, QUATERNARY SCI REV, V9, P153, DOI 10.1016/0277-3791(90)90016-4; Rambaut A., 2009, TRACER VERSION 1 5; Ramos VA, 2008, DEV QUATER SCI, V11, P57, DOI 10.1016/S1571-0866(07)10004-X; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ribas CC, 2007, P ROY SOC B-BIOL SCI, V274, P2399, DOI 10.1098/rspb.2007.0613; Romanutti AA, 2012, FLORA ARGENTINA PLAN, V3, P154; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schulz N, 2012, INT J CLIMATOL, V32, P1803, DOI 10.1002/joc.2395; Sersic AN, 2011, BIOL J LINN SOC, V103, P475, DOI 10.1111/j.1095-8312.2011.01656.x; Soltis DE, 1997, PLANT SYST EVOL, V206, P353, DOI 10.1007/BF00987957; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Swenson NG, 2006, J EVOLUTION BIOL, V19, P717, DOI 10.1111/j.1420-9101.2005.01066.x; TAJIMA F, 1989, GENETICS, V123, P597; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TAYLOR DW, 1991, PALAEOGEOGR PALAEOCL, V88, P69, DOI 10.1016/0031-0182(91)90015-J; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; TEMPLETON AR, 1992, GENETICS, V132, P619; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; Viruel J, 2012, J BIOGEOGR, V39, P1073, DOI 10.1111/j.1365-2699.2011.02658.x; von Hagen KB, 2003, EVOLUTION, V57, P2507, DOI 10.1111/j.0014-3820.2003.tb01495.x; Wall JD, 2001, MOL BIOL EVOL, V18, P1134, DOI 10.1093/oxfordjournals.molbev.a003884; Widmer A, 2001, TRENDS ECOL EVOL, V16, P267, DOI 10.1016/S0169-5347(01)02163-2; Williams JW, 2004, ECOL MONOGR, V74, P309, DOI 10.1890/02-4045; Winkworth RC, 2005, AM J BOT, V92, P653, DOI 10.3732/ajb.92.4.653; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054	99	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0128559	10.1371/journal.pone.0128559	http://dx.doi.org/10.1371/journal.pone.0128559			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110533	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800011
J	Chen, HL; Hsiao, WH; Lee, HC; Wu, SC; Cheng, JW				Chen, Heng-Li; Hsiao, Wen-Hsin; Lee, Hsiang-Chi; Wu, Suh-Chin; Cheng, Jya-Wei			Selection and Characterization of DNA Aptamers Targeting All Four Serotypes of Dengue Viruses	PLOS ONE			English	Article							IN-VITRO SELECTION; BORNE ENCEPHALITIS-VIRUS; DOMAIN-III; ENVELOPE PROTEIN; NEUTRALIZING ANTIBODIES; QUADRUPLEX STRUCTURE; BINDING; COMPLEX; GLYCOPROTEIN; EPITOPES	Dengue viruses (DENVs) are members of Flaviviridae family, which are associated with human disease. The envelope (E) protein plays an important role in viral infection. However, there is no effective antibody for clinical treatment due to antibody dependent enhancement of infection. In this study, using Systematic Evolution of Ligands by Exponential Enrichment (SELEX), we demonstrated the first aptamer (S15) that can bind to DENV-2 envelop protein domain III (ED3) with a high binding affinity. S15 was found to form a parallel quadruplex based on Quadfinder prediction, gel mobility assay and circular dichroism studies. Both the quadruplex structure and the sequence on 5'-end were necessary for the binding activity of S15. NMR titration experiments indicated that S15 bound to a highly conserved loop between beta(A) and beta(B) strands of ED3. Moreover, S15 can neutralize the infections by all four serotypes of DENVs. Our result provides a new opportunity in the development of DNA aptamers against DENVs in the future.	[Cheng, Jya-Wei] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 300, Taiwan; Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 300, Taiwan	National Tsing Hua University; National Tsing Hua University	Cheng, JW (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 300, Taiwan.	jwcheng@life.nthu.edu.tw	Wu, Suh-Chin/AAV-6233-2021		Ministry of Science and Technology, Taiwan	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work is supported by grants from Ministry of Science and Technology, Taiwan to SCW and JWC.	Alka, 2007, MED MICROBIOL IMMUN, V196, P227, DOI 10.1007/s00430-007-0043-4; BALAGURUMOORTHY P, 1992, NUCLEIC ACIDS RES, V20, P4061, DOI 10.1093/nar/20.15.4061; Bauer F, 2007, FEBS LETT, V581, P1555, DOI 10.1016/j.febslet.2007.03.012; Chen F, 2007, BIOCHEM BIOPH RES CO, V357, P743, DOI 10.1016/j.bbrc.2007.04.007; Chin JFL, 2007, MICROBES INFECT, V9, P1, DOI 10.1016/j.micinf.2006.09.009; Chu JJH, 2005, J GEN VIROL, V86, P405, DOI 10.1099/vir.0.80411-0; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Feng XZ, 1998, TALANTA, V47, P1223, DOI 10.1016/S0039-9140(98)00198-2; Fialova M, 2006, BIOCHEM BIOPH RES CO, V344, P50, DOI 10.1016/j.bbrc.2006.03.144; Gopinath SCB, 2007, ANAL BIOANAL CHEM, V387, P171, DOI 10.1007/s00216-006-0826-2; Gromowski GD, 2008, J VIROL, V82, P8828, DOI 10.1128/JVI.00606-08; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Hrobowski YM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-49; Huang J, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-7; Huang KC, 2008, PROTEINS, V70, P1116, DOI 10.1002/prot.21806; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382; MACAYA RF, 1993, P NATL ACAD SCI USA, V90, P3745, DOI 10.1073/pnas.90.8.3745; Mandl CW, 2000, J VIROL, V74, P9601, DOI 10.1128/JVI.74.20.9601-9609.2000; Mann D, 2005, BIOCHEM BIOPH RES CO, V338, P1928, DOI 10.1016/j.bbrc.2005.10.172; Martina BE, 2008, VACCINE, V26, P153, DOI 10.1016/j.vaccine.2007.10.055; Mashima T, 2009, NUCLEIC ACIDS RES, V37, P6249, DOI 10.1093/nar/gkp647; Matsui K, 2009, VIROLOGY, V384, P16, DOI 10.1016/j.virol.2008.11.013; McMinn PC, 1997, J GEN VIROL, V78, P2711, DOI 10.1099/0022-1317-78-11-2711; Michalowski D, 2008, NUCLEIC ACIDS RES, V36, P7124, DOI 10.1093/nar/gkn891; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Murphy MB, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng110; Phan AT, 2005, P NATL ACAD SCI USA, V102, P634, DOI 10.1073/pnas.0406278102; Pileur F, 2003, NUCLEIC ACIDS RES, V31, P5776, DOI 10.1093/nar/gkg748; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; Raviprakash K, 2008, J VIROL, V82, P6927, DOI 10.1128/JVI.02724-07; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7; Rujan IN, 2005, NUCLEIC ACIDS RES, V33, P2022, DOI 10.1093/nar/gki345; RUSSELL PK, 1967, J IMMUNOL, V99, P285; Sanchez IJ, 1996, J GEN VIROL, V77, P2541, DOI 10.1099/0022-1317-77-10-2541; Shangguan DH, 2008, ANAL CHEM, V80, P721, DOI 10.1021/ac701962v; Sim ACN, 2008, VACCINE, V26, P1145, DOI 10.1016/j.vaccine.2007.12.047; Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07; Tang JJ, 2007, BIOSENS BIOELECTRON, V22, P2456, DOI 10.1016/j.bios.2006.09.015; Thiel K, 2004, NAT BIOTECHNOL, V22, P649, DOI 10.1038/nbt0604-649; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Zhang ZS, 2007, J VIROL METHODS, V143, P125, DOI 10.1016/j.jviromet.2007.02.012	49	20	22	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131240	10.1371/journal.pone.0131240	http://dx.doi.org/10.1371/journal.pone.0131240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110785	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800135
J	Dasgupta, S; Huang, IJ; McElroy, AE				Dasgupta, Subham; Huang, Irvin J.; McElroy, Anne E.			Hypoxia Enhances the Toxicity of Corexit EC9500A and Chemically Dispersed Southern Louisiana Sweet Crude Oil (MC-242) to Sheepshead Minnow (Cyprinodon variegatus) Larvae	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; INDUCED GENE-EXPRESSION; DEEP-WATER-HORIZON; FISH EMBRYOS; ZEBRAFISH; RESPONSES; SPILL	Oil exploration and production activities are common in the northern Gulf of Mexico as well as many other coastal and near coastal areas worldwide. Seasonal hypoxia is also a common feature in the Northern Gulf, and many other coastal areas, which is likely to increase in severity and extent with continuing anthropogenic nutrient inputs. Hypoxia has well established physiological effects on many organisms, and it has been shown to enhance the toxicity of polycyclic aromatic hydrocarbons (persistent components of petroleum) in fish. The goal of this study was to examine the combined effects of hypoxia and exposure to contaminants associated with oil spills. We evaluated the effects of short term (48 hr) exposures to Corexit EC9500A, water accommodated fractions (WAF), and chemically enhanced water accommodated fractions (CEWAF) prepared from Southern Louisiana Sweet Crude Oil (MC 242) on survival of sheepshead minnow (Cyprinodon variegatus) larvae held under normoxic (ambient air) or hypoxic (2 mg/L O-2) conditions. Results demonstrated that hypoxia significantly enhances mortality observed in response to Corexit or CEWAF solutions. In the latter case, significant interactions between the two stressors were also observed. Our data supports the need to further evaluate the combined stresses imparted by hypoxia and exposure to petroleum hydrocarbons and dispersants.	[Dasgupta, Subham; Huang, Irvin J.; McElroy, Anne E.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	McElroy, AE (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	Anne.McElroy@Stonybrook.edu			Gulf of Mexico Research Initiative(GOMRI) [108]	Gulf of Mexico Research Initiative(GOMRI)	Funding provided by Gulf of Mexico Research Initiative(GOMRI) 108, http://research.gulfresearchinitiative.org/research-awards/rfpiiinvestigator-grants/.	Adams J, 2014, ENVIRON TOXICOL CHEM, V33, P107, DOI 10.1002/etc.2397; Couillard CM, 2005, ENVIRON TOXICOL CHEM, V24, P1496, DOI 10.1897/04-267R.1; Di Giulio Richard T., 2008, P273, DOI 10.1201/9780203647295.ch6; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; EMMETT RL, 1991, DISTRIBUTION ABUNDAN, V2; Fleming CR, 2011, ECOTOXICOLOGY, V20, P1300, DOI 10.1007/s10646-011-0686-1; Fleming CR, 2009, COMP BIOCHEM PHYS C, V150, P383, DOI 10.1016/j.cbpc.2009.06.003; Gracey AY, 2001, P NATL ACAD SCI USA, V98, P1993, DOI 10.1073/pnas.98.4.1993; Hemmer MJ, 2011, ENVIRON TOXICOL CHEM, V30, P2244, DOI 10.1002/etc.619; Hendon LA, 2008, COMP BIOCHEM PHYS C, V147, P205, DOI 10.1016/j.cbpc.2007.09.011; Holm EK, 2011, DISPERSANTS OIL SPIL; Incardona JP, 2004, TOXICOL APPL PHARM, V196, P191, DOI 10.1016/j.taap.2003.11.026; Jonsson G, 2004, ENVIRON TOXICOL CHEM, V23, P1538, DOI 10.1897/03-173; LIEPELT A, 1995, AQUAT TOXICOL, V33, P177, DOI 10.1016/0166-445X(95)00016-W; Luna-Acosta A, 2011, WATER RES, V45, P4103, DOI 10.1016/j.watres.2011.05.011; Matson CW, 2008, CHEMOSPHERE, V74, P149, DOI 10.1016/j.chemosphere.2008.08.016; National Research Council, 1985, OIL SEA INP FAT EFF; National Research Council, 2005, UND OIL SPILL DISP E; Negreiros LA, 2011, COMP BIOCHEM PHYS C, V153, P408, DOI 10.1016/j.cbpc.2011.02.001; Nunnally CC, 2014, CONT SHELF RES, V85, P143, DOI 10.1016/j.csr.2014.06.006; Shang EHH, 2004, ENVIRON SCI TECHNOL, V38, P4763, DOI 10.1021/es0496423; Shi YL, 2013, J TOXICOL ENV HEAL A, V76, P827, DOI 10.1080/15287394.2013.821396; Turner RE, 2012, MAR POLLUT BULL, V64, P319, DOI 10.1016/j.marpolbul.2011.11.008; US Environmental Protection Agency, 2000, AMB AQ LIF WAT QUAL; Valentine DL, 2014, P NATL ACAD SCI USA, V111, P15906, DOI 10.1073/pnas.1414873111; van der Meer DLM, 2005, AM J PHYSIOL-REG I, V289, pR1512, DOI 10.1152/ajpregu.00089.2005; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; White HK, 2014, ENVIRON SCI TECH LET, V1, P295, DOI 10.1021/ez500168r; Whitehead A, 2013, INTEGR COMP BIOL, V53, P635, DOI 10.1093/icb/ict080; Wu DM, 2012, ENVIRON TOXICOL CHEM, V31, P754, DOI 10.1002/etc.1739; Wu RSS, 2002, MAR POLLUT BULL, V45, P35, DOI 10.1016/S0025-326X(02)00061-9; Yu RMK, 2008, AQUAT TOXICOL, V90, P235, DOI 10.1016/j.aquatox.2008.09.004	32	13	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0128939	10.1371/journal.pone.0128939	http://dx.doi.org/10.1371/journal.pone.0128939			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110918	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800017
J	Hu, X; Ren, J; Ren, XF; Huang, SS; Sabiel, SAI; Luo, MC; Nevo, E; Fu, CJ; Peng, JH; Sun, DF				Hu, Xin; Ren, Jing; Ren, Xifeng; Huang, Sisi; Sabiel, Salih A. I.; Luo, Mingcheng; Nevo, Eviatar; Fu, Chunjie; Peng, Junhua; Sun, Dongfa			Association of Agronomic Traits with SNP Markers in Durum Wheat (Triticum turgidum L. durum (Desf.))	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; WILD EMMER WHEAT; LINKAGE DISEQUILIBRIUM; GENETIC DIVERSITY; GRAIN-YIELD; CHROMOSOME 5A; POLYPLOID WHEAT; DIFFERENTIAL EXPRESSION; POPULATION-STRUCTURE	Association mapping is a powerful approach to detect associations between traits of interest and genetic markers based on linkage disequilibrium (LD) in molecular plant breeding. In this study, 150 accessions of worldwide originated durum wheat germplasm (Triticum turgidum spp. durum) were genotyped using 1,366 SNP markers. The extent of LD on each chromosome was evaluated. Association of single nucleotide polymorphisms (SNP) markers with ten agronomic traits measured in four consecutive years was analyzed under a mix linear model (MLM). Two hundred and one significant association pairs were detected in the four years. Several markers were associated with one trait, and also some markers were associated with multiple traits. Some of the associated markers were in agreement with previous quantitative trait loci (QTL) analyses. The function and homology analyses of the corresponding ESTs of some SNP markers could explain many of the associations for plant height, length of main spike, number of spikelets on main spike, grain number per plant, and 1000-grain weight, etc. The SNP associations for the observed traits are generally clustered in specific chromosome regions of the wheat genome, mainly in 2A, 5A, 6A, 7A, 1B, and 6B chromosomes. This study demonstrates that association mapping can complement and enhance previous QTL analyses and provide additional information for marker-assisted selection.	[Hu, Xin; Ren, Xifeng; Huang, Sisi; Sabiel, Salih A. I.; Sun, Dongfa] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Hubei, Peoples R China; [Ren, Jing] Dezhou Univ, Inst Biophys, Shandong Prov Key Lab Funct Macromol Biophys, Dezhou 253023, Shandong, Peoples R China; [Luo, Mingcheng] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Nevo, Eviatar] Univ Haifa, Inst Evolut, IL-31905 Haifa, Israel; [Fu, Chunjie; Peng, Junhua] China Natl Seed Grp Co Ltd, Ctr Sci & Technol, Wuhan 430206, Hunan, Peoples R China; [Sun, Dongfa] Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou 434025, Hubei, Peoples R China	Huazhong Agricultural University; Dezhou University; University of California System; University of California Davis; University of Haifa	Peng, JH (corresponding author), China Natl Seed Grp Co Ltd, Ctr Sci & Technol, Wuhan 430206, Hubei, Peoples R China.	jpeng@lamar.colostate.edu; sundongfa1@mail.hzau.edu.cn	Peng, Junhua/HHZ-2344-2022	Peng, Junhua/0000-0002-8428-3137; Luo, Ming-Cheng/0000-0002-9744-5887	"863" China High-Tech Research Program [2011AA10A106]; China National Science Foundation [31030055, 30870233]; China National Seed Group Co., Ltd.	"863" China High-Tech Research Program(National High Technology Research and Development Program of China); China National Science Foundation(National Natural Science Foundation of China (NSFC)); China National Seed Group Co., Ltd.	This study was supported by "863" China High-Tech Research Program (2011AA10A106) (DS), The China National Science Foundation (31030055 and 30870233) (JP). The China National Seed Group Co., Ltd. provided support in the form of salaries for authors [CF and JP], but did not have any additional role in the study design, data collection and analysis,	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Akhunov ED, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-702; Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; BLUM A, 1985, J EXP BOT, V36, P432, DOI 10.1093/jxb/36.3.432; BODMER WF, 1987, BIOESSAYS, V7, P41, DOI 10.1002/bies.950070109; Borner A, 1996, EUPHYTICA, V89, P69, DOI 10.1007/BF00015721; Borner A, 2002, THEOR APPL GENET, V105, P921, DOI 10.1007/s00122-002-0994-1; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Buckler E, 2007, NAT GENET, V39, P1056, DOI 10.1038/ng0907-1056; Cadalen T, 1998, THEOR APPL GENET, V96, P933, DOI 10.1007/s001220050823; Campbell BT, 2003, CROP SCI, V43, P1493, DOI 10.2135/cropsci2003.1493; Carvalho A, 2012, PLANT MOL BIOL REP, V30, P578, DOI 10.1007/s11105-011-0367-5; Chantret N, 2005, PLANT CELL, V17, P1033, DOI 10.1105/tpc.104.029181; Chantret N, 2000, THEOR APPL GENET, V100, P1217, DOI 10.1007/s001220051427; Chao SM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-727; Chao SM, 2009, MOL BREEDING, V23, P23, DOI 10.1007/s11032-008-9210-6; Chen XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044510; Cho RJ, 1999, NAT GENET, V23, P203, DOI 10.1038/13833; Choi IY, 2007, GENETICS, V176, P685, DOI 10.1534/genetics.107.070821; Cockram J, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-16; De Vita P, 2007, EUR J AGRON, V26, P39, DOI 10.1016/j.eja.2006.08.009; Deschamps S, 2010, MOL BREEDING, V25, P553, DOI 10.1007/s11032-009-9357-9; Dograr N, 2000, PLANT BREEDING, V119, P360, DOI 10.1046/j.1439-0523.2000.00497.x; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Edwards KJ, 2009, PLANT BIOTECHNOL J, V7, P375, DOI 10.1111/j.1467-7652.2009.00413.x; ELKELES A, 1995, PLANT MOL BIOL, V29, P109, DOI 10.1007/BF00019123; Eujayl I, 2002, THEOR APPL GENET, V104, P399, DOI 10.1007/s001220100738; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Gadaleta A, 2014, MOL BREEDING, V34, P1599, DOI 10.1007/s11032-014-0185-1; Ganal MW, 2009, CURR OPIN PLANT BIOL, V12, P211, DOI 10.1016/j.pbi.2008.12.009; Gonzalez-Hernandez JL, 2004, EUPHYTICA, V139, P217, DOI 10.1007/s10681-004-3157-4; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Huang XQ, 2003, THEOR APPL GENET, V106, P1379, DOI 10.1007/s00122-002-1179-7; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Incirli A, 2001, GENET RESOUR CROP EV, V48, P233, DOI 10.1023/A:1011244204655; IRISH VF, 1990, PLANT CELL, V2, P741, DOI 10.1105/tpc.2.8.741; Jana S, 1999, GENOME, V42, P562, DOI 10.1139/gen-42-4-562; Kato K, 2000, THEOR APPL GENET, V101, P1114, DOI 10.1007/s001220051587; Kato K, 1999, THEOR APPL GENET, V98, P472, DOI 10.1007/s001220051094; Kaufmann K, 2010, SCIENCE, V328, P85, DOI 10.1126/science.1185244; Kirigwi FM, 2007, MOL BREEDING, V20, P401, DOI 10.1007/s11032-007-9100-3; Kota R, 2008, FUNCT INTEGR GENOMIC, V8, P223, DOI 10.1007/s10142-007-0060-9; Kozlova SA, 2009, RUSS J GENET+, V45, P81, DOI 10.1134/S1022795409010116; KRESOVICH S, 1995, THEOR APPL GENET, V91, P206, DOI 10.1007/BF00220879; Laido G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095211; Li SS, 2007, MOL BREEDING, V20, P167, DOI 10.1007/s11032-007-9080-3; Li WL, 2002, EUPHYTICA, V125, P357, DOI 10.1023/A:1016069809977; Liu LiHua, 2010, Molecular Plant Breeding, V1, P5; Lynch M, 1999, GENETICS, V152, P1753; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; Matus IA, 2002, GENOME, V45, P1095, DOI 10.1139/G02-071; McCartney CA, 2005, GENOME, V48, P870, DOI 10.1139/g05-055; Murai K, 2003, PLANT CELL PHYSIOL, V44, P1255, DOI 10.1093/pcp/pcg171; NACHIT MM, 1992, THEOR APPL GENET, V83, P597, DOI 10.1007/BF00226903; Nasu S, 2002, DNA RES, V9, P163, DOI 10.1093/dnares/9.5.163; NEVO E, 1989, THEOR APPL GENET, V77, P421, DOI 10.1007/BF00305839; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Peng JH, 2009, GENETICA, V135, P95, DOI 10.1007/s10709-008-9262-x; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Peng JH, 2011, AUST J CROP SCI, V5, P1127; Pritchard JK, 2000, GENETICS, V155, P945; Pujar S, 1999, THEOR APPL GENET, V99, P868, DOI 10.1007/s001220051307; Rafalski A, 2004, TRENDS GENET, V20, P103, DOI 10.1016/j.tig.2003.12.002; Ren J, 2013, INT J MOL SCI, V14, P7061, DOI 10.3390/ijms14047061; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Shah MM, 1999, CROP SCI, V39, P1728, DOI 10.2135/cropsci1999.3961728x; Shultz RW, 2009, PLANT PHYSIOL, V150, P658, DOI 10.1104/pp.109.136614; Soleimani VD, 2002, THEOR APPL GENET, V104, P350, DOI 10.1007/s001220100714; Somers DJ, 2007, GENOME, V50, P557, DOI 10.1139/G07-031; Somers DJ, 2003, GENOME, V46, P431, DOI 10.1139/G03-027; Sourdille P, 2003, THEOR APPL GENET, V106, P530, DOI 10.1007/s00122-002-1044-8; Stein N, 2001, PLANT BREEDING, V120, P354, DOI 10.1046/j.1439-0523.2001.00615.x; Stevens R, 2002, J BIOL CHEM, V277, P32978, DOI 10.1074/jbc.M205125200; Stich B, 2005, THEOR APPL GENET, V111, P723, DOI 10.1007/s00122-005-2057-x; Stracke S, 2009, THEOR APPL GENET, V118, P259, DOI 10.1007/s00122-008-0896-y; Sun DF, 2011, EUPHYTICA, V178, P31, DOI 10.1007/s10681-010-0260-6; Sun QM, 2009, J INTEGR PLANT BIOL, V51, P423, DOI 10.1111/j.1744-7909.2009.00812.x; Sutka J, 1999, THEOR APPL GENET, V99, P199, DOI 10.1007/s001220051225; Thomas DC, 2005, AM J HUM GENET, V77, P337, DOI 10.1086/432962; Torki M, 1999, MOL GEN GENET, V261, P948, DOI 10.1007/s004380051042; Trebbi D, 2011, THEOR APPL GENET, V123, P555, DOI 10.1007/s00122-011-1607-7; Trevaskis B, 2003, P NATL ACAD SCI USA, V100, P13099, DOI 10.1073/pnas.1635053100; Vandepoele K, 2005, PLANT PHYSIOL, V139, P316, DOI 10.1104/pp.105.066290; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wang Y, 2008, PLANT BIOLOGY, V10, P548, DOI 10.1111/j.1438-8677.2008.00072.x; Weir BS, 1996, SINAUER ASS SUNDERL; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yang XH, 2010, THEOR APPL GENET, V121, P417, DOI 10.1007/s00122-010-1320-y; Yao J, 2009, GENETICA, V137, P67, DOI 10.1007/s10709-009-9351-5; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Zhang QS, 2010, PLANT PHYSIOL, V153, P555, DOI 10.1104/pp.110.157644; Zhang QS, 2005, PLANT PHYSIOL, V138, P131, DOI 10.1104/pp.104.057869; Zhang XK, 2008, CROP SCI, V48, P458, DOI 10.2135/cropsci2007.06.0355; Zhu CS, 2009, GENETICS, V182, P875, DOI 10.1534/genetics.108.098863; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	100	23	23	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130854	10.1371/journal.pone.0130854	http://dx.doi.org/10.1371/journal.pone.0130854			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110423	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800094
J	Muller-Dahlhaus, F; Lucke, C; Lu, MK; Arai, N; Herrmann, AFE; Ziemann, U				Mueller-Dahlhaus, Florian; Luecke, Caroline; Lu, Ming-Kuei; Arai, Noritoshi; Herrmann, Anna Fuhl Eva; Ziemann, Ulf			Augmenting LTP-Like Plasticity in Human Motor Cortex by Spaced Paired Associative Stimulation	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; HOMEOSTATIC-LIKE PLASTICITY; DEPRESSION-LIKE PLASTICITY; CORTICAL PLASTICITY; SYNAPTIC PLASTICITY; VISUAL-CORTEX; DEPENDENT CHANGES; IN-VIVO; METAPLASTICITY; MODULATION	Paired associative stimulation (PAS(LTP)) of the human primary motor cortex (M1) can induce LTP-like plasticity by increasing corticospinal excitability beyond the stimulation period. Previous studies showed that two consecutive PAS(LTP) protocols interact by homeostatic metaplasticity, but animal experiments provided evidence that LTP can be augmented by repeated stimulation protocols spaced by similar to 30min. Here we tested in twelve healthy selected PAS(LTP) responders the possibility that LTP-like plasticity can be augmented in the human M1 by systematically varying the interval between two consecutive PAS(LTP) protocols. The first PAS(LTP) protocol (PAS1) induced strong LTP-like plasticity lasting for 30-60min. The effect of a second identical PAS(LTP) protocol (PAS(2)) critically depended on the time between PAS(1) and PAS(2). At 10min, PAS(2) prolonged the PAS(1)-induced LTP-like plasticity. At 30min, PAS(2) augmented the LTP-like plasticity induced by PAS(1), by increasing both magnitude and duration. At 60min and 180min, PAS(2) had no effect on corticospinal excitability. The cumulative LTP-like plasticity after PAS(1) and PAS(2) at 30min exceeded significantly the effect of PAS(1) alone, and the cumulative PAS(1) and PAS(2) effects at 60min and 180min. In summary, consecutive PAS(LTP) protocols interact in human M1 in a time-dependent manner. If spaced by 30min, two consecutive PAS(LTP) sessions can augment LTP-like plasticity in human M1. Findings may inspire further research on optimized therapeutic applications of non-invasive brain stimulation in neurological and psychiatric diseases.	[Mueller-Dahlhaus, Florian; Luecke, Caroline; Lu, Ming-Kuei; Arai, Noritoshi; Ziemann, Ulf] Goethe Univ Frankfurt, Dept Neurol, D-60054 Frankfurt, Germany; [Mueller-Dahlhaus, Florian; Ziemann, Ulf] Univ Tubingen, Dept Neurol & Stroke, Tubingen, Germany; [Mueller-Dahlhaus, Florian; Ziemann, Ulf] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Lu, Ming-Kuei] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Herrmann, Anna Fuhl Eva] Goethe Univ Frankfurt, Inst Biostat & Math Modelling, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Goethe University Frankfurt	Ziemann, U (corresponding author), Goethe Univ Frankfurt, Dept Neurol, D-60054 Frankfurt, Germany.	ulf.ziemann@uni-tuebingen.de	Lu, Ming-Kuei/AAF-3338-2020; Lu, Ming-Kuei/M-2435-2013; Ziemann, Ulf/AAY-9125-2020	Lu, Ming-Kuei/0000-0002-2768-4399; Lu, Ming-Kuei/0000-0002-2768-4399; 				Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Cheyne JE, 2008, MOL CELL NEUROSCI, V37, P432, DOI 10.1016/j.mcn.2007.10.015; Clem RL, 2008, SCIENCE, V319, P101, DOI 10.1126/science.1143808; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Emond MR, 2010, J PHYSIOL-LONDON, V588, P1929, DOI 10.1113/jphysiol.2010.187229; Florian J, 2007, EUR J NEUROSCI, V25, P3461, DOI 10.1111/j.1460-9568.2007.05603.x; Fratello F, 2006, CLIN NEUROPHYSIOL, V117, P2667, DOI 10.1016/j.clinph.2006.07.315; Fricke K, 2011, J NEUROPHYSIOL, V105, P1141, DOI 10.1152/jn.00608.2009; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Gamboa OL, 2011, BRAIN STIMU IN PRESS; Goldsworthy MR, 2012, EUR J NEUROSCI, V35, P125, DOI 10.1111/j.1460-9568.2011.07924.x; Goldsworthy MR, 2014, CEREB CORTEX, DOI [10.1093/cercor/bht353, DOI 10.1093/CERC0R/BHT353]; Hamada M, 2008, J PHYSIOL-LONDON, V586, P3927, DOI 10.1113/jphysiol.2008.152793; Hamada M, 2014, J NEUROSCI, V34, P12837, DOI 10.1523/JNEUROSCI.1960-14.2014; Hamada M, 2012, J PHYSIOL-LONDON, V590, P2365, DOI 10.1113/jphysiol.2012.230540; Heidegger T, 2010, EUR J NEUROSCI, V32, P1215, DOI 10.1111/j.1460-9568.2010.07375.x; Hulme SR, 2013, TRENDS NEUROSCI, V36, P353, DOI 10.1016/j.tins.2013.03.007; Jung P, 2009, J NEUROSCI, V29, P5597, DOI 10.1523/JNEUROSCI.0222-09.2009; Kang JS, 2011, CEREB CORTEX, V21, P1203, DOI 10.1093/cercor/bhq204; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Lee MC, 2010, NEURON, V66, P859, DOI 10.1016/j.neuron.2010.05.015; Maggio N, 2014, NEUROSCIENCE, V281, P135, DOI 10.1016/j.neuroscience.2014.09.041; Mastroeni C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057957; Mockett Bruce G., 2008, Journal of Integrative Neuroscience, V7, P315, DOI 10.1142/S0219635208001782; Monte-Silva K, 2013, BRAIN STIMUL, V6, P424, DOI 10.1016/j.brs.2012.04.011; Monte-Silva K, 2010, J NEUROPHYSIOL, V103, P1735, DOI 10.1152/jn.00924.2009; Montgomery JM, 2004, TRENDS NEUROSCI, V27, P744, DOI 10.1016/j.tins.2004.10.006; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; Muller-Dahlhaus F, 2015, NEUROSCIENTIST, V21, P185, DOI 10.1177/1073858414526645; Muller-Dahlhaus JFM, 2008, EXP BRAIN RES, V187, P467, DOI 10.1007/s00221-008-1319-7; Muller-Dahlhaus Florian, 2010, Front Synaptic Neurosci, V2, P34, DOI 10.3389/fnsyn.2010.00034; Murakami T, 2012, J PHYSIOL-LONDON, V590, P5765, DOI 10.1113/jphysiol.2012.238519; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nitsche MA, 2007, J NEUROSCI, V27, P3807, DOI 10.1523/JNEUROSCI.5348-06.2007; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Philpot BD, 2007, NEURON, V53, P495, DOI 10.1016/j.neuron.2007.01.027; Potter-Nerger M, 2009, J NEUROPHYSIOL, V102, P3180, DOI 10.1152/jn.91046.2008; Quartarone A, 2005, BRAIN, V128, P1943, DOI 10.1093/brain/awh527; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rosenkranz K, 2007, J NEUROSCI, V27, P12058, DOI 10.1523/JNEUROSCI.2663-07.2007; Stefan K, 2004, J NEUROPHYSIOL, V92, P66, DOI 10.1152/jn.00383.2003; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Stefan K, 2006, CEREB CORTEX, V16, P376, DOI 10.1093/cercorbhi116; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Teo JTH, 2011, CEREB CORTEX, V21, P1627, DOI 10.1093/cercor/bhq231; Vlachos A, 2012, J NEUROSCI, V32, P17514, DOI 10.1523/JNEUROSCI.0409-12.2012; Wankerl K, 2010, J NEUROSCI, V30, P6197, DOI 10.1523/JNEUROSCI.4673-09.2010; Wolters A, 2003, J NEUROPHYSIOL, V89, P2339, DOI 10.1152/jn.00900.2002; Xu Z, 2009, J NEUROSCI, V29, P8764, DOI 10.1523/JNEUROSCI.1014-09.2009; Ziemann U, 2004, J NEUROSCI, V24, P1666, DOI 10.1523/JNEUROSCI.5016-03.2004; Ziemann U, 2008, BRAIN STIMUL, V1, P60, DOI 10.1016/j.brs.2007.08.003; Ziemann U, 2008, BRAIN STIMUL, V1, P164, DOI 10.1016/j.brs.2008.06.006	56	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131020	10.1371/journal.pone.0131020	http://dx.doi.org/10.1371/journal.pone.0131020			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110758	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800110
J	Presnyakova, D; Archer, W; Braun, DR; Flear, W				Presnyakova, Darya; Archer, Will; Braun, David R.; Flear, Wesley			Documenting Differences between Early Stone Age Flake Production Systems: An Experimental Model and Archaeological Verification	PLOS ONE			English	Article							EXTERIOR PLATFORM ANGLE; WESTERN CAPE PROVINCE; GESHER BENOT YAAQOV; OLORGESAILIE FORMATION; KAPTHURIN FORMATION; LITHIC TECHNOLOGY; HUMAN-EVOLUTION; RAW-MATERIAL; SITE; ASSEMBLAGES	This study investigates morphological differences between flakes produced via "core and flake" technologies and those resulting from bifacial shaping strategies. We investigate systematic variation between two technological groups of flakes using experimentally produced assemblages, and then apply the experimental model to the Cutting 10 Mid -Pleistocene archaeological collection from Elandsfontein, South Africa. We argue that a specific set of independent variables-and their interactions-including external platform angle, platform depth, measures of thickness variance and flake curvature should distinguish between these two technological groups. The role of these variables in technological group separation was further investigated using the Generalized Linear Model as well as Linear Discriminant Analysis. The Discriminant model was used to classify archaeological flakes from the Cutting 10 locality in terms of their probability of association, within either experimentally developed technological group. The results indicate that the selected independent variables play a central role in separating core and flake from bifacial technologies. Thickness evenness and curvature had the greatest effect sizes in both the Generalized Linear and Discriminant models. Interestingly the interaction between thickness evenness and platform depth was significant and played an important role in influencing technological group membership. The identified interaction emphasizes the complexity in attempting to distinguish flake production strategies based on flake morphological attributes. The results of the discriminant function analysis demonstrate that the majority of flakes at the Cutting 10 locality were not associated with the production of the numerous Large Cutting Tools found at the site, which corresponds with previous suggestions regarding technological behaviors reflected in this assemblage.	[Presnyakova, Darya] Univ Tubingen, Dept Early Prehistory & Quaternary Ecol, Schloss Hohentubingen, Tubingen, Germany; [Archer, Will; Braun, David R.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Braun, David R.] George Washington Univ, Ctr Adv Study Hominid Paleobiol, Washington, DC USA; [Braun, David R.; Flear, Wesley] Univ Cape Town, Dept Archaeol, ZA-7700 Rondebosch, South Africa	Eberhard Karls University of Tubingen; Max Planck Society; George Washington University; University of Cape Town	Presnyakova, D (corresponding author), Univ Tubingen, Dept Early Prehistory & Quaternary Ecol, Schloss Hohentubingen, Tubingen, Germany.	darya.presnyakova@uni-tuebingen.de		Archer, Will/0000-0003-1174-0605	Deutscher Akademischer Austauschdienst; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of University of Tubingen	Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tubingen	DP's work on this study was supported by the Deutscher Akademischer Austauschdienst. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen.	Adler DS, 2014, SCIENCE, V345, P1609, DOI 10.1126/science.1256484; Aiken L. S., 1991, MULTIPLE REGRESSION; Andrefsky W., 1986, LITHIC TECHNOL, V15, P48, DOI [10.1080/01977261.1986.11720867, DOI 10.1080/01977261.1986.11720867]; Andrefsky W, 2005, CAMB MAN ARCHAEOL, P201; [Anonymous], 2011, PALEOANTHROPOLOGY, DOI DOI 10.4207/PA.2011.ART61; Archer W, 2010, J ARCHAEOL SCI, V37, P201, DOI 10.1016/j.jas.2009.09.033; Ashton N. M., 1994, BIFACES PERSPECTIVE, V4, P182; Barsky D, 2011, J AFR ARCHAEOL, V9, P207, DOI 10.3213/2191-5784-10196; Beyene Y, 2004, SITES PREHISTORIQUES; Beyene Y, 2013, P NATL ACAD SCI USA, V110, P1584, DOI 10.1073/pnas.1221285110; Bleed P., 1997, ARCHEOLOGICAL PAPERS, V7, P95, DOI [10.1525/ap3a.1997.7.1.95, DOI 10.1525/AP3A.1997.7.1.95]; Blumenschine RJ, 2008, J ARCHAEOL SCI, V35, P76, DOI 10.1016/j.jas.2007.02.009; Boeda E., 1990, PAL O, V2, P43, DOI DOI 10.3406/PAL.1990.988; Bradbury A.P., 1998, MIDCONTINENTAL J ARC, V23, P263; Brantingham PJ, 2001, J ARCHAEOL SCI, V28, P747, DOI 10.1006/jasc.2000.0594; Braun DR, 2013, QUATERNARY SCI REV, V82, P145, DOI 10.1016/j.quascirev.2013.09.027; Braun DR, 2009, VERTEBR PALEOBIOL PA, P99, DOI 10.1007/978-1-4020-9060-8_9; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carbonell E, 1999, J ANTHROPOL ARCHAEOL, V18, P119, DOI 10.1006/jaar.1998.0331; Chazan M, 2008, J HUM EVOL, V55, P1, DOI 10.1016/j.jhevol.2008.01.004; Clark J.D., 1974, KALAMBO FALLS PREHIS, P71; CLARK JD, 1994, SCIENCE, V264, P1907, DOI 10.1126/science.8009220; CLARK JGD, 1968, WORLD PREHISTORY NEW; Clarkson C, 2013, J ARCHAEOL SCI, V40, P4348, DOI 10.1016/j.jas.2013.06.007; Cohen J., 1983, APPL MULTIPLE REGRES; CROMPTON RH, 1993, J HUM EVOL, V25, P175, DOI 10.1006/jhev.1993.1043; Dag D., 2001, LITHIC TECHNOL, V26, P105, DOI [10.1080/01977261.2001.11720981, DOI 10.1080/01977261.2001.11720981]; de la Torre I, 2004, CURR ANTHROPOL, V45, P439, DOI 10.1086/422079; De la Torre I, 2005, TECHNOLOGICAL STRATE; De La Torre I, 2013, J ARCHAEOL METHOD TH, V21, P781, DOI DOI 10.1007/S10816-013-9176-5; de la Torre I, 2008, J ANTHROPOL ARCHAEOL, V27, P244, DOI 10.1016/j.jaa.2007.12.001; de la Torre I, 2011, J HUM EVOL, V60, P768, DOI 10.1016/j.jhevol.2011.01.009; Deacon HJ., 1998, STONE AGE ARCHAEOLOG, P23; DEINO A, 1990, J GEOPHYS RES-SOLID, V95, P8453, DOI 10.1029/JB095iB06p08453; Delagnes A, 2005, J HUM EVOL, V48, P435, DOI 10.1016/j.jhevol.2004.12.005; Delagnes A, 2006, J ANTHROPOL ARCHAEOL, V25, P448, DOI 10.1016/j.jaa.2006.03.002; Dibble HL, 2009, J ARCHAEOL SCI, V36, P1945, DOI 10.1016/j.jas.2009.05.004; DIBBLE HL, 1981, J ARCHAEOL SCI, V8, P283, DOI 10.1016/0305-4403(81)90004-2; DIBBLE HL, 1995, J ARCHAEOL SCI, V22, P429, DOI 10.1006/jasc.1995.0042; Dibble HL, 1997, LITHIC TECHNOL, V22, P150, DOI [10.1080/01977261.1997.11754540, DOI 10.1080/01977261.1997.11754540]; Dobson AJ., 2008, INTRO GEN LINEAR MOD, DOI 10.1201/9780367807849; Dominguez-Rodrigo M, 2001, J HUM EVOL, V40, P289, DOI 10.1006/jhev.2000.0466; Eren MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029273; Feblot-Augustins J, 1999, PALEOANTHROPOLOGY, V2, P27; Feblot-Augustins J., 1997, ETUDES RECHERCHES AR, V75; FISH PR, 1978, AM ANTIQUITY, V43, P86, DOI 10.2307/279635; Foley R, 2003, EVOL ANTHROPOL, V12, P109, DOI 10.1002/evan.10108; Foley R, 1997, CAMB ARCHAEOL J, V7, P3, DOI 10.1017/S0959774300001451; Fox J., 2019, R COMPANION APPL REG, V.; Freckleton RP, 2011, BEHAV ECOL SOCIOBIOL, V65, P91, DOI 10.1007/s00265-010-1045-6; Gallotti R, 2010, AFR ARCHAEOL REV, V27, P291, DOI 10.1007/s10437-010-9083-z; Goren-Inbar N, 2008, J HUM EVOL, V55, P702, DOI 10.1016/j.jhevol.2008.07.005; Goren-Inbar N., 2006, AXE AGE ACHEULIAN TO, P111; Goren-Inbar N, 2011, J ARCHAEOL SCI, V38, P1901, DOI 10.1016/j.jas.2011.03.037; Harris JWK, 1997, KOOBI FORA RES PROJE, V5, P115; Hay R.L., 1976, GEOLOGY OLDUVAI GORG; HOWELL FC, 1961, SCI AM, V205, P118, DOI 10.1038/scientificamerican1061-118; Inizan Marie -Louise, 1999, PRE HIST PIERRE TAIL; Isaac G.Ll., 1997, KOOBI RES PROJECT, P262; Isaac GL, 1977, OLORGESAILIE ARCHAEO; Johnson CR, 2012, J ANTHROPOL ARCHAEOL, V31, P485, DOI 10.1016/j.jaa.2012.05.001; JONES PR, 1979, SCIENCE, V204, P835, DOI 10.1126/science.204.4395.835; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; Keeley L.H., 1980, EXPT DETERMINATION S; KEELEY LH, 1981, NATURE, V293, P464, DOI 10.1038/293464a0; Kimura Y, 1999, J HUM EVOL, V37, P807, DOI 10.1006/jhev.1999.0316; Klein RG, 1999, J HUM EVOL, V37, P153, DOI 10.1006/jhev.1999.0307; Klein RG, 2007, J HUM EVOL, V52, P164, DOI 10.1016/j.jhevol.2006.08.006; Kleindienst M. R., 1962, ACT 4 C PAN PREH ET, P81; Kleindienst MR, 1961, S AFRICAN ARCHAEOLOG, V16, P25; Kovarovic K, 2011, J ARCHAEOL SCI, V38, P3006, DOI 10.1016/j.jas.2011.06.028; Kuhn SL, 2013, J ARCHAEOL METHOD TH, V20, P194, DOI 10.1007/s10816-012-9146-3; Leakey L.S.B., 1936, STONE AGE AFRICA OUT; Leakey M. D., 1971, OLDUVAI GORGE EXCAVA; Lepre CJ, 2011, NATURE, V477, P82, DOI 10.1038/nature10372; Lin SC, 2013, AM ANTIQUITY, V78, P724, DOI 10.7183/0002-7316.78.4.724; Ludwig B.V., 1998, EARLY HUMAN BEHAV GL, P84; Lycett SJ, 2008, WORLD ARCHAEOL, V40, P295, DOI 10.1080/00438240802260970; Lycett SJ, 2010, WORLD ARCHAEOL, V42, P521, DOI 10.1080/00438243.2010.517667; Magnani M, 2014, J ARCHAEOL SCI, V46, P37, DOI 10.1016/j.jas.2014.02.029; McBrearty S, 1996, J HUM EVOL, V30, P563, DOI 10.1006/jhev.1996.0043; McNabb J, 2004, CURR ANTHROPOL, V45, P653, DOI 10.1086/423973; McPherron S., 2006, AXE AGE ACHEULIAN TO, P267; McPherron S. P., 1994, REDUCTION MODEL VARI; McPherron S. P., 1999, PREHISTOIRE EUROPEEN, V14, P9; McPherron S. P., 2003, PREHISTORIC BIFACES, P55; McPherron SP, 2000, J ARCHAEOL SCI, V27, P655, DOI 10.1006/jasc.1999.0467; Mundry R, 2007, ANIM BEHAV, V74, P965, DOI 10.1016/j.anbehav.2006.12.028; Norton CJ, 2006, J HUM EVOL, V51, P527, DOI 10.1016/j.jhevol.2006.07.004; Patterson DB, 2015, PALEOANTHROPOLOGY, pA23; Pelcin AW, 1997, J ARCHAEOL SCI, V24, P1107, DOI 10.1006/jasc.1996.0190; Pelcin AW, 1997, J ARCHAEOL SCI, V24, P749, DOI 10.1006/jasc.1996.0156; Pelegrin J., 2004, DOSSIERS ARCHELOGIE, V290, P26, DOI [10.1097/MD.0000000000000028, DOI 10.1097/MD.0000000000000028]; Potts R, 1999, J HUM EVOL, V37, P747, DOI 10.1006/jhev.1999.0344; RCore Team, 2020, R LANG ENV STAT COMP; Rezek Z, 2011, J ARCHAEOL SCI, V38, P1346, DOI 10.1016/j.jas.2011.01.014; RICHARD A. J., 2002, APPL MULTIVARIATE ST; Roche H, 2003, CR PALEVOL, V2, P663, DOI 10.1016/j.crpv.2003.06.001; Roche H., 1991, 25 ANS ETUDES TECHNO, P99; Roche H., 1988, AFR ARCHAEOL REV, V6, P27, DOI [DOI 10.1007/BF01117111, DOI 10.1007/BF01117111)]; ROE DA, 1964, P PREHIST SOC, V30, P245, DOI 10.1017/S0079497X00015140; Sampson C., 2006, AXE AGE ACHEULIAN TO, P75; Schick K., 2003, MULTIPLE APPROACHES, P1; Semaw S, 2000, J ARCHAEOL SCI, V27, P1197, DOI 10.1006/jasc.1999.0592; Sharon G, 2008, J ARCHAEOL SCI, V35, P1329, DOI 10.1016/j.jas.2007.09.004; Sharon G, 2010, QUATERN INT, V223, P226, DOI 10.1016/j.quaint.2009.11.023; Shea JJ, 2010, VERTEBR PALEOBIOL PA, P47, DOI 10.1007/978-90-481-9036-2_4; Shipton C, 2010, CAMB ARCHAEOL J, V20, P197, DOI 10.1017/S0959774310000235; Shott MJ., 1996, LITHIC TECHNOL, V21, P6, DOI [10.1080/01977261.1996.11754381, DOI 10.1080/01977261.1996.11754381]; Singer R.S., 1968, S AFR ARCHAEOL BULL, V23, P63, DOI DOI 10.2307/3888485; Tabachnick B.G., 2013, USING MULTIVARIATE S, V6th ed; Tryon C. A., 2005, AFR ARCHAEOL REV, V22, P199, DOI [10.1007/s10437-006-9002-5, DOI 10.1007/S10437-006-9002-5]; Turq A, 2013, J HUM EVOL, V65, P641, DOI 10.1016/j.jhevol.2013.07.014; Van Peer P, 2003, J HUM EVOL, V45, P187, DOI 10.1016/S0047-2484(03)00103-9; Venables WN., 2002, MODERN APPL STAT S 4; Villa P, 2001, QUATERN INT, V75, P113, DOI 10.1016/S1040-6182(00)00083-5; von Cramon-Taubadel N, 2008, AM J PHYS ANTHROPOL, V136, P108, DOI 10.1002/ajpa.20775; White M., 1995, LITHICS, V15, P1; White MJ., 2014, P PREHIST SOC, V64, P15, DOI [10.1017/S0079497X00002164, DOI 10.1017/S0079497X00002164]	119	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130732	10.1371/journal.pone.0130732	http://dx.doi.org/10.1371/journal.pone.0130732			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CL4OY	26111251	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800080
J	Tanase, MA; Ismail, I; Lowell, K; Karyanto, O; Santoro, M				Tanase, Mihai A.; Ismail, Ismail; Lowell, Kim; Karyanto, Oka; Santoro, Maurizio			Detecting and Quantifying Forest Change: The Potential of Existing C- and X-Band Radar Datasets	PLOS ONE			English	Article							PASS SAR INTERFEROMETRY; TOPOGRAPHY MISSION; TANDEM-X; BOREAL FOREST; INSAR DATA; HEIGHT; BIOMASS; SRTM; VALIDATION; VOLUME	This paper evaluates the opportunity provided by global interferometric radar datasets for monitoring deforestation, degradation and forest regrowth in tropical and semi-arid environments. The paper describes an easy to implement method for detecting forest spatial changes and estimating their magnitude. The datasets were acquired within space-borne high spatial resolutions radar missions at near-global scales thus being significant for monitoring systems developed under the United Framework Convention on Climate Change (UNFCCC). The approach presented in this paper was tested in two areas located in Indonesia and Australia. Forest change estimation was based on differences between a reference dataset acquired in February 2000 by the Shuttle Radar Topography Mission (SRTM) and TanDEM-X mission (TDM) datasets acquired in 2011 and 2013. The synergy between SRTM and TDM datasets allowed not only identifying changes in forest extent but also estimating their magnitude with respect to the reference through variations in forest height.	[Tanase, Mihai A.; Ismail, Ismail; Lowell, Kim] Univ Melbourne, Cooperat Res Ctr Spatial Informat, Melbourne, Vic, Australia; [Santoro, Maurizio] Gamma Remote Sensing AG, CH-3073 Gumlingen, Switzerland; [Ismail, Ismail; Karyanto, Oka] Gadjah Mada Univ, Fac Forestry, Yogyakarta, Indonesia	University of Melbourne; GAMMA Remote Sensing AG; Gadjah Mada University	Tanase, MA (corresponding author), Univ Melbourne, Cooperat Res Ctr Spatial Informat, Melbourne, Vic, Australia.	mihai@tma.ro	Tanase, Mihai/AAG-8049-2020	Tanase, Mihai A./0000-0002-0045-2299; , ismail/0000-0002-4639-7854	Gamma Remote Sensing	Gamma Remote Sensing	Gamma Remote Sensing provided support in the form of a salary for author MS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045022; Askne J, 2003, IEEE T GEOSCI REMOTE, V41, P1540, DOI 10.1109/TGRS.2003.813397; Askne JIH, 2013, REMOTE SENS-BASEL, V5, P5574, DOI 10.3390/rs5115574; Askne JIH, 2009, IEEE T GEOSCI REMOTE, V47, P513, DOI 10.1109/TGRS.2008.2009764; Askne JIH, 1997, IEEE T GEOSCI REMOTE, V35, P25, DOI 10.1109/36.551931; Bamler R, 1998, INVERSE PROBL, V14, pR1, DOI 10.1088/0266-5611/14/4/001; Brown CG, 2005, IEEE T GEOSCI REMOTE, V43, P1707, DOI 10.1109/TGRS.2005.851789; Castel T, 2000, REMOTE SENS ENVIRON, V73, P73, DOI 10.1016/S0034-4257(00)00083-3; DeFries R, 2007, ENVIRON SCI POLICY, V10, P385, DOI 10.1016/j.envsci.2007.01.010; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; *GOFC GOLD, 2010, SOURC METH PROC MON; Goldstein RM, 1998, GEOPHYS RES LETT, V25, P4035, DOI 10.1029/1998GL900033; HAGBERG JO, 1995, IEEE T GEOSCI REMOTE, V33, P331, DOI 10.1109/36.377933; Herold M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/1/014002; Hooijer A, 2012, BIOGEOSCIENCES, V9, P1053, DOI 10.5194/bg-9-1053-2012; Izzawati, 2006, IEEE T GEOSCI REMOTE, V44, P863, DOI 10.1109/TGRS.2006.870828; Kellndorfer J, 2004, REMOTE SENS ENVIRON, V93, P339, DOI 10.1016/j.rse.2004.07.017; Krieger G, 2007, IEEE T GEOSCI REMOTE, V45, P3317, DOI 10.1109/TGRS.2007.900693; Olander LP, 2008, REFERENCE SCENARIOS; ROY PS, 1991, INT J REMOTE SENS, V12, P2205, DOI 10.1080/01431169108955253; Saatchi SS, 2007, GLOBAL CHANGE BIOL, V13, P816, DOI 10.1111/j.1365-2486.2007.01323.x; Santoro M, 2005, IEEE T GEOSCI REMOTE, V43, P207, DOI 10.1109/TGRS.2004.841250; Simard M, 2006, PHOTOGRAMM ENG REM S, V72, P299, DOI 10.14358/PERS.72.3.299; Solberg Svein, 2014, Carbon Balance Manag, V9, P5; Solberg S, 2013, REMOTE SENS-BASEL, V5, P5449, DOI 10.3390/rs5115449; Solberg S, 2013, REMOTE SENS ENVIRON, V139, P60, DOI 10.1016/j.rse.2013.07.036; Solberg S, 2010, CAN J REMOTE SENS, V36, P68, DOI 10.5589/m10-025; Steininger MK, 2001, ENV CONSERVATION; Strozzi T, 2000, IEEE T GEOSCI REMOTE, V38, P766, DOI 10.1109/36.842005; Sun G, 2003, REMOTE SENS ENVIRON, V88, P401, DOI 10.1016/j.rse.2003.09.001; Tanase M, 2011, REMOTE SENS ENVIRON, V115, P2075, DOI 10.1016/j.rse.2011.04.009; Tanase MA, 2010, REMOTE SENS ENVIRON, V114, P2182, DOI 10.1016/j.rse.2010.04.021; Thirion-Lefevre L, 2007, IEEE T GEOSCI REMOTE, V45, P3172, DOI 10.1109/TGRS.2007.904921; Wagner F., 2003, IPCC GOOD PRACTICE G; Walker WS, 2007, REMOTE SENS ENVIRON, V106, P428, DOI 10.1016/j.rse.2006.09.007; WEGMULLER U, 1995, IEEE T GEOSCI REMOTE, V33, P1153, DOI 10.1109/36.469479; Werner C. L., 2002, Proceedings 4th European Conference on Synthetic Aperture Radar. EUSAR 2002, P353; Weydahl DJ, 2007, INT J REMOTE SENS, V28, P3513, DOI 10.1080/01431160600993447	39	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131079	10.1371/journal.pone.0131079	http://dx.doi.org/10.1371/journal.pone.0131079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111047	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800116
J	Young, T; Rohwer, A; van Schalkwyk, S; Volmink, J; Clarke, M				Young, Taryn; Rohwer, Anke; van Schalkwyk, Susan; Volmink, Jimmy; Clarke, Mike			Patience, Persistence and Pragmatism: Experiences and Lessons Learnt from the Implementation of Clinically Integrated Teaching and Learning of Evidence-Based Health Care - A Qualitative Study	PLOS ONE			English	Article							EVIDENCE-BASED MEDICINE; EDUCATION; BARRIERS	Background Clinically integrated teaching and learning are regarded as the best options for improving evidence-based healthcare (EBHC) knowledge, skills and attitudes. To inform implementation of such strategies, we assessed experiences and opinions on lessons learnt of those involved in such programmes. Methods and Findings We conducted semi-structured interviews with 24 EBHC programme coordinators from around the world, selected through purposive sampling. Following data transcription, a multidisciplinary group of investigators carried out analysis and data interpretation, using thematic content analysis. Successful implementation of clinically integrated teaching and learning of EBHC takes much time. Student learning needs to start in pre-clinical years with consolidation, application and assessment following in clinical years. Learning is supported through partnerships between various types of staff including the core EBHC team, clinical lecturers and clinicians working in the clinical setting. While full integration of EBHC learning into all clinical rotations is considered necessary, this was not always achieved. Critical success factors were pragmatism and readiness to use opportunities for engagement and including EBHC learning in the curriculum; patience; and a critical mass of the right teachers who have EBHC knowledge and skills and are confident in facilitating learning. Role modelling of EBHC within the clinical setting emerged as an important facilitator. The institutional context exerts an important influence; with faculty buy-in, endorsement by institutional leaders, and an EBHC-friendly culture, together with a supportive community of practice, all acting as key enablers. The most common challenges identified were lack of teaching time within the clinical curriculum, misconceptions about EBHC, resistance of staff, lack of confidence of tutors, lack of time, and negative role modelling. Conclusions Implementing clinically integrated EBHC curricula requires institutional support, a critical mass of the right teachers and role models in the clinical setting combined with patience, persistence and pragmatism on the part of teachers.	[Young, Taryn; Rohwer, Anke; Volmink, Jimmy] Univ Stellenbosch, Fac Med & Hlth Sci, Ctr Evidence Based Hlth Care, Cape Town, South Africa; [Young, Taryn; Volmink, Jimmy] South African Med Res Council, South African Cochrane Ctr, Cape Town, South Africa; [Young, Taryn] Univ Stellenbosch, Fac Med & Hlth Sci, Div Community Hlth, Cape Town, South Africa; [van Schalkwyk, Susan] Univ Stellenbosch, Fac Med & Hlth Sci, Ctr Hlth Profess Educ, Cape Town, South Africa; [Clarke, Mike] Queens Univ Belfast, All Ireland Hub Trials Methodol Res, Belfast, Antrim, North Ireland	Stellenbosch University; South African Medical Research Council; Stellenbosch University; Stellenbosch University; Queens University Belfast	Young, T (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Ctr Evidence Based Hlth Care, Cape Town, South Africa.	tyoung@sun.ac.za	van Schalkwyk, Susan/ABD-2638-2020; van Schalkwyk, Susan/AAA-2841-2021	van Schalkwyk, Susan/0000-0003-1596-6791; Young, Taryn/0000-0003-2406-081X	National Research Foundation of South Africa (UNIQUE) [86420]; Effective Health Care Research Consortium; UK Government Department for International Development; US President's Emergency Plan for AIDS relief (PEPFAR) through HRSA [T84HA21652]; Stellenbosch University Rural Medical Education Partnership Initiative (SURMEPI); UK Medical Research Council [G0901530]; Medical Research Council [G0901530] Funding Source: researchfish; Department for International Development (DFID) [201400] Funding Source: researchfish; MRC [G0901530] Funding Source: UKRI	National Research Foundation of South Africa (UNIQUE); Effective Health Care Research Consortium; UK Government Department for International Development; US President's Emergency Plan for AIDS relief (PEPFAR) through HRSA; Stellenbosch University Rural Medical Education Partnership Initiative (SURMEPI); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Department for International Development (DFID); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research is supported in part by the National Research Foundation of South Africa (UNIQUE GRANT NO 86420). TY and AR are supported in part by the Effective Health Care Research Consortium, which is funded by UKaid from the UK Government Department for International Development, www.evidence4health.org. SvS is supported by the US President's Emergency Plan for AIDS relief (PEPFAR) through HRSA under the terms of T84HA21652 and via the Stellenbosch University Rural Medical Education Partnership Initiative (SURMEPI). MC is Director of the All Ireland Hub for Trials Methodology Research, supported by the UK Medical Research Council (G0901530). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergh Anne-Marie, 2014, Evid Based Med, V19, P123, DOI 10.1136/eb-2014-101726; Bunniss S, 2010, MED EDUC, V44, P358, DOI 10.1111/j.1365-2923.2009.03611.x; Cheng HM, 2012, ANN ACAD MED SINGAP, V41, P4; Chinnock P, 2005, PLOS MED, V2, P367, DOI 10.1371/journal.pmed.0020107; Coppus Sjors F P J, 2007, BMC Med Educ, V7, P46, DOI 10.1186/1472-6920-7-46; Dans A L, 2000, ACP J Club, V133, pA11; Dawes Martin, 2005, BMC Med Educ, V5, P1; Denscombe M., 2010, GOOD RES GUIDE SMALL, V4; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Greenhalgh T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3725; Hammick M, 2007, MED TEACH, V29, P735, DOI 10.1080/01421590701682576; Hatala R, 2002, JAMA-J AM MED ASSOC, V288, P1110, DOI 10.1001/jama.288.9.1110; Ilic D, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-58; Ilic D, 2010, MED TEACH, V32, P443; Jackson Rod, 2006, Evid Based Med, V11, P35, DOI 10.1136/ebm.11.2.35; Khan Khalid S, 2006, BMC Med Educ, V6, P59, DOI 10.1186/1472-6920-6-59; Mattick K, 2006, J MED ETHICS, V32, P181, DOI 10.1136/jme.2005.014597; Mayosi BM, 2012, LANCET, V380, P2029, DOI 10.1016/S0140-6736(12)61814-5; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Rengerink KO, 2011, MED TEACH, V33, pe125, DOI 10.3109/0142159X.2011.542520; Rohwer A, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-77; Sackett DL, 2002, J CLIN EPIDEMIOL, V55, P1161, DOI 10.1016/S0895-4356(02)00521-8; Saldana J, 2012, CODING MANUAL QUALIT, VKindle Edition; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Stockler Martin R, 2009, Evid Based Med, V14, P98, DOI 10.1136/ebm.14.4.98-a; Straus SE, 2000, CAN MED ASSOC J, V163, P837; Straus SE, 2005, EVIDENCE BASED MED P; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Young T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086706	29	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131121	10.1371/journal.pone.0131121	http://dx.doi.org/10.1371/journal.pone.0131121			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OY	26110641	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800121
J	Zha, YF; Lu, XS; Wang, L; Yang, RQ; Ou, SX; Xing, D; Wang, DF				Zha, Yunfei; Lu, Xuesong; Wang, Li; Yang, Rongqian; Ou, Shanxing; Xing, Dong; Wang, Defeng			Nonrigid Registration Regularized by Shape Information: Application to Atlas Construction of Cardiac CT Images	PLOS ONE			English	Article							SEGMENTATION; ACCURACY	Cardiac atlases play an important role in the computer-aided diagnosis of cardiovascular diseases, in particular they need to deal with large and highly variable image datasets. In this paper, we propose a new nonrigid registration algorithm incorporating shape information, to produce comprehensive atlases. For one thing, the multiscale gradient orientation features of images are combined to form the construction of multifeature mutual information. Additionally, the shape information of multiple-objects in images is incorporated into the cost function for registration. We demonstrate the merits of the new registration algorithm on the 3D data sets of 15 patients. The experimental results show that the new registration algorithm can outperform the conventional intensity-based registration method. The obtained atlas can represent the cardiac structures more accurately.	[Zha, Yunfei; Xing, Dong] Wuhan Univ, Renmin Hosp, Dept Radiol, Wuhan 430060, Peoples R China; [Lu, Xuesong] South Cent Univ Nationalities, Coll Biomed Engn, Wuhan 430074, Peoples R China; [Wang, Li] Wuhan Univ, Renmin Hosp, Dept Infect Control, Wuhan 430060, Peoples R China; [Yang, Rongqian] S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510006, Guangdong, Peoples R China; [Ou, Shanxing] Guangzhou Gen Hosp, Dept Radiol, Guangzhou Mil Area Command, Guangzhou 510010, Guangdong, Peoples R China; [Wang, Defeng] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Res Ctr Med Image Comp, Shatin, Hong Kong, Peoples R China; [Wang, Defeng] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China	Wuhan University; South Central Minzu University; Wuhan University; South China University of Technology; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen	Yang, RQ (corresponding author), S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510006, Guangdong, Peoples R China.	bmeyrq@gmail.com; dfwang@cuhk.edu.hk	yang, rongqian/H-4416-2019		National Natural Science Foundation of China (NSFC) [61002046]; Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK 416712]; Innovation and Technology Commission of the Hong Kong Special Administrative Region, China [ITS/149/14FP]; Science, Technology and Innovation Commission of Shenzhen Municipality [CXZZ20140606164105361]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Innovation and Technology Commission of the Hong Kong Special Administrative Region, China; Science, Technology and Innovation Commission of Shenzhen Municipality	This work is supported by the National Natural Science Foundation of China (NSFC) funding (No. 61002046), and partially by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (No. CUHK 416712), a grant from the Innovation and Technology Commission of the Hong Kong Special Administrative Region, China (No. ITS/149/14FP), and a grant from The Science, Technology and Innovation Commission of Shenzhen Municipality (No. CXZZ20140606164105361). The authors would also like to thank Guangzhou General Hospital of Guangzhou Military Area Command for providing the images.	De Craene M, 2010, LECT NOTES COMPUT SC, V6364, P1, DOI 10.1007/978-3-642-15835-3_1; De Nigris D, 2012, IEEE T MED IMAGING, V31, P2343, DOI 10.1109/TMI.2012.2218116; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Frangi AF, 2002, IEEE T MED IMAGING, V21, P1151, DOI 10.1109/TMI.2002.804426; Guo YK, 2010, INT J CARDIOL, V139, P254, DOI 10.1016/j.ijcard.2008.10.031; Heinrich M., 2011, ANN BR MACH VIS ASS, V1, P1; Hoogendoorn C, 2013, IEEE T MED IMAGING, V32, P28, DOI 10.1109/TMI.2012.2230015; Hoogendoorn C, 2009, INT J COMPUT VISION, V85, P237, DOI 10.1007/s11263-009-0212-6; Hu SS, 2010, REPORT ON CARDIOVASC; Kirisli HA, 2010, MED PHYS, V37, P6279, DOI 10.1118/1.3512795; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Lorensen William E., 1987, P ACM SIGGRAPH, P163, DOI [10.1145/37401.37422, DOI 10.1145/37401.37422]; Marwan M, 2012, INT J CARDIOVAS IMAG, V28, P1173, DOI 10.1007/s10554-011-9907-1; Marwan M, 2010, EUR HEART J, V31, P2230, DOI 10.1093/eurheartj/ehq223; Neemuchwala H, 2005, SIGNAL PROCESS, V85, P277, DOI 10.1016/j.sigpro.2004.10.002; Perperidis D, 2005, LECT NOTES COMPUT SC, V3750, P402, DOI 10.1007/11566489_50; Perperidis D, 2004, PROC OF MEDICAL IMAG, P9; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; SCHROEDER WJ, 1992, COMP GRAPH, V26, P65, DOI 10.1145/142920.134010; Staring M, 2009, IEEE T MED IMAGING, V28, P1412, DOI 10.1109/TMI.2009.2016560; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Zhuang XH, 2010, IEEE T MED IMAGING, V29, P1612, DOI 10.1109/TMI.2010.2047112; ZIJDENBOS AP, 1994, IEEE T MED IMAGING, V13, P716, DOI 10.1109/42.363096	23	0	0	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130730	10.1371/journal.pone.0130730	http://dx.doi.org/10.1371/journal.pone.0130730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111054	gold, Green Published, Green Submitted			2022-12-27	WOS:000356933800078
J	Ekblom, O; Ekblom-Bak, E; Rosengren, A; Hallsten, M; Bergstrom, G; Borjesson, M				Ekblom, Orjan; Ekblom-Bak, Elin; Rosengren, Annika; Hallsten, Mattias; Bergstrom, Goran; Borjesson, Mats			Cardiorespiratory Fitness, Sedentary Behaviour and Physical Activity Are Independently Associated with the Metabolic Syndrome, Results from the SCAPIS Pilot Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; RISK-FACTORS; CARDIOMETABOLIC RISK; UNITED-STATES; ADULTS; TIME; METAANALYSIS; EXERCISE; WOMEN; MEN	Background Previous studies on the relation between lifestyle and the metabolic syndrome lack one or several aspects of the physical activity pattern in the analyses or cardiorespiratory fitness. Likewise, both uni- and triaxial accelerometry have been used, though, the predictive validity of these two modes has not been compared. Objectives The aims of the present study were firstly to investigate the independent relation between cardiorespiratory fitness and physical activity pattern to the metabolic syndrome (MetS) and secondly to examine the predictive validity of uni- and triaxial accelerometry, respectively. Methods Data was extracted from the SCAPIS pilot study (n=930, mean age 57.7 yrs). Physical activity pattern was assessed by accelerometry. Cardiorespiratory fitness was estimated using cycle ergometry. MetS was defined per the Adult Treatment Panel III from the National Cholesterol Education Program definition. Results Time spent sedentary (OR: 2.38, 95% CI: 1.54-4.24 for T3 vs T1), in light intensity (OR: 0.50, 95% CI: 0.28-0.90) and in moderate-to-vigorous activity (OR: 0.33, 95% CI: 0.18-0.61), as well as cardiorespiratory fitness (OR: 0.24, 95% CI: 0.12-0.48), were all independently related to the prevalence of MetS after adjustment for potential confounders, fitness and/or the other aspects of the physical activity pattern. In addition, we found that triaxial analyses were more discriminant, with ORs farther away from the reference group and additional significant ORs. Conclusion The finding that several aspects of the physical activity pattern reveal independent relations to the MetS makes new possible targets for behaviour change of interest, focusing on both exercise and everyday life. When assessing the risk status of a patient, it is advised that triaxial accelerometry is used.	[Ekblom, Orjan; Ekblom-Bak, Elin; Borjesson, Mats] Swedish Sch Sport & Hlth Sci, Astrand Lab Work Physiol, Stockholm, Sweden; [Rosengren, Annika; Hallsten, Mattias; Bergstrom, Goran] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Hallsten, Mattias; Bergstrom, Goran] Sahlgrens Univ Hosp, Sahlgrenska Ctr Cardiovasc & Metab Res, Wallenberg Lab, Gothenburg, Sweden; [Borjesson, Mats] Karolinska Univ Hosp, Stockholm, Sweden	Swedish School of Sport & Health Sciences; University of Gothenburg; Sahlgrenska University Hospital; Karolinska Institutet; Karolinska University Hospital	Ekblom, O (corresponding author), Swedish Sch Sport & Hlth Sci, Astrand Lab Work Physiol, Stockholm, Sweden.	orjan.ekblom@gih.se	Ekblom-Bak, Elin/AFR-0681-2022; Stefanadis, Christodoulos/ABH-2232-2020	Ekblom-Bak, Elin/0000-0002-3901-7833; Stefanadis, Christodoulos/0000-0001-5974-6454; Ekblom, Orjan/0000-0001-6058-4982; Rosengren, Annika/0000-0002-5409-6605	Swedish Heart and Lung Foundation; Knut and Alice Wallenberg Foundation; Swedish Research Council; VINNOVA; Sahlgrenska Academy at Gothenburg University; ALF/LUA in Western Sweden; FORTE (FORTE stands for Swedish Research Council for Health, Working Life and Welfare)	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); VINNOVA(Vinnova); Sahlgrenska Academy at Gothenburg University; ALF/LUA in Western Sweden; FORTE (FORTE stands for Swedish Research Council for Health, Working Life and Welfare)	SCAPIS is supported by the Swedish Heart and Lung Foundation, the Knut and Alice Wallenberg Foundation, the Swedish Research Council and VINNOVA. The SCAPIS pilot study also received funding from the Sahlgrenska Academy at Gothenburg University and strategic grants from ALF/LUA in Western Sweden. Elin Ekblom-Bak has received funding from FORTE (FORTE stands for Swedish Research Council for Health, Working Life and Welfare) and the Swedish Heart and Lung Foundation.	Aguilar-Farias N, 2014, J SCI MED SPORT, V17, P293, DOI 10.1016/j.jsams.2013.07.002; Atkin AJ, 2012, INT J EPIDEMIOL, V41, P1460, DOI 10.1093/ije/dys118; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Bouchard C, 2001, MED SCI SPORT EXER, V33, pS446, DOI 10.1097/00005768-200106001-00013; Celis-Morales CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036345; Christensen SE, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2458; Church T, 2009, OBESITY, V17, pS39, DOI 10.1038/oby.2009.387; Clarke J, 2014, MED SCI SPORT EXER, V46, P76, DOI 10.1249/MSS.0b013e31829f83a0; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dunkley AJ, 2012, DIABETES OBES METAB, V14, P616, DOI 10.1111/j.1463-1326.2012.01571.x; Earnest CP, 2013, MAYO CLIN PROC, V88, P259, DOI 10.1016/j.mayocp.2012.11.006; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Ekblom-Bak E, 2014, SCAND J MED SCI SPOR, V24, P319, DOI 10.1111/sms.12014; Ekblom-Bak E, 2014, BRIT J SPORT MED, V48, P233, DOI 10.1136/bjsports-2012-092038; Ekelund U, 2007, DIABETOLOGIA, V50, P1832, DOI 10.1007/s00125-007-0762-5; Green AN, 2014, EUR J APPL PHYSIOL, V114, P907, DOI 10.1007/s00421-014-2822-0; Hamer M, 2014, MED SCI SPORT EXER, V46, P1946, DOI 10.1249/MSS.0000000000000317; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; He D, 2014, ENDOCRINE, V46, P231, DOI 10.1007/s12020-013-0110-0; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Hong S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-481; Huang YJ, 2014, EUR J MED RES, V19, DOI 10.1186/2047-783X-19-22; Janssen I, 2012, INT J EPIDEMIOL, V41, P1132, DOI 10.1093/ije/dys038; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Kelly Louise A, 2013, BMC Med Phys, V13, P5, DOI 10.1186/1756-6649-13-5; Kim J, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-30; Lessard SJ, 2013, DIABETES, V62, P2717, DOI 10.2337/db13-0062; de Rezende LFM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105620; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Scuteri A., 2014, EUR J PREV CARDIOL; Shuval K, 2014, MAYO CLIN PROC, V89, P1052, DOI 10.1016/j.mayocp.2014.04.026; Thosar SS, 2012, MED SCI MONITOR, V18, pRA173, DOI 10.12659/MSM.883589; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Voulgari C, 2011, J AM COLL CARDIOL, V58, P1343, DOI 10.1016/j.jacc.2011.04.047; Welin L, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-403	38	42	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131586	10.1371/journal.pone.0131586	http://dx.doi.org/10.1371/journal.pone.0131586			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26120842	gold, Green Published			2022-12-27	WOS:000358150400125
J	Feresu, SA; Harlow, SD; Woelk, GB				Feresu, Shingairai A.; Harlow, Sioban D.; Woelk, Godfrey B.			Risk Factors for Low Birthweight in Zimbabwean Women: A Secondary Data Analysis	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; MALARIA INFECTION; PRETERM BIRTH; MATERNAL HIV; PREGNANCY; PREVALENCE; INFANTS; DETERMINANTS; MORTALITY; ANEMIA	Background Low birth weight (LBW) remains the main cause of mortality and morbidity in infants, and a problem in the care of pregnant women world-wide particularly in developing countries. The purpose of this study was to describe the socio-demographic, nutritional, reproductive, medical and obstetrical risk factors for delivering a live LBW infant at Harare Maternity Hospital, Zimbabwe. Methods A secondary data analysis from data obtained through a questionnaire and delivery records was conducted. Linear regression models with a complimentary log-log link function were used to estimate the relative risks for all LBW, term LBW and preterm LBW. Results The frequency of LBW was 16.7%. Lack of prenatal care (adjusted relative risk [ARR] 1.69, 95% CI 1.44, 1.98), mother's mid-arm circumference below 28.5 cm, (ARR 1.35, 95% CI 1.19, 1.54) and rural residence (ARR 1.22, 95% CI 1.04, 1.40) increased the risk of LBW. Eclampsia, anemia, and ante-partum hemorrhage, were associated with LBW (ARR 2.64, 95% CI 1.30, 5.35; ARR = 2.63, 95% CI 1.16, 5.97; and ARR = 2.39, 95% CI 1.55, 3.68), respectively. Malaria increased the risk of LBW (ARR = 1.89, 95% CI 1.21, 2.96). Prenatal care, infant sex, anemia, antepartum hemorrhage, premature rapture of membranes and preterm labor were associated with the three LBW categories. History of abortion or stillbirth, history of LBW, malaria, eclampsia, and placenta Previa, were associated with all LBW and preterm LBW, while pregnancy induced hypertension, and number of children alive were associated with all LBW and term LBW. Conclusions LBW frequency remains high and is associated with nutritive, reproductive, medical and obstetrical factors. Preterm LBW and term LBW have similar and also different risk factors. Understanding the role of different risk factors in these different LBW categories is important if the goal is to reduce LBW frequency, and its complications, in Zimbabwe.	[Feresu, Shingairai A.] Univ Pretoria, Sch Hlth Syst & Publ Hlth Epidemiol & Biostat, ZA-0002 Pretoria, South Africa; [Feresu, Shingairai A.] Univ Zimbabwe, Dept Community Med, Harare, Zimbabwe; [Feresu, Shingairai A.] Walden Univ, Coll Hlth Sci, Sch Hlth Sci, Minneapolis, MN USA; [Harlow, Sioban D.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Woelk, Godfrey B.] Elizabeth Glacier AIDS Fdn, Washington, DC USA	University of Pretoria; University of Zimbabwe; Walden University; University of Michigan System; University of Michigan	Feresu, SA (corresponding author), Univ Pretoria, Sch Hlth Syst & Publ Hlth Epidemiol & Biostat, ZA-0002 Pretoria, South Africa.	shinga.feresu@up.ac.za			W. K. Kellogg Foundation; University Of Michigan; University Of Zimbabwe; Medical Actuarial Research Foundation of Zimbabwe; Michael Gelfand Medical Research Foundation of Zimbabwe; Deusche Gesellschaft Fur Technische Zusammenarbeit (GTZ)	W. K. Kellogg Foundation; University Of Michigan(University of Michigan System); University Of Zimbabwe; Medical Actuarial Research Foundation of Zimbabwe; Michael Gelfand Medical Research Foundation of Zimbabwe; Deusche Gesellschaft Fur Technische Zusammenarbeit (GTZ)	The study was funded by the W. K. Kellogg Foundation, University Of Michigan, University Of Zimbabwe, Medical Actuarial Research Foundation of Zimbabwe, Michael Gelfand Medical Research Foundation of Zimbabwe, and Deusche Gesellschaft Fur Technische Zusammenarbeit (GTZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Muhammad Owais, 2011, J Ayub Med Coll Abbottabad, V23, P77; Akin Y, 2010, J PEDIAT, V20, px24; Anjum F, 2011, ANN KING EDWARD MED, V17, P223; Assefa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039957; BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; Ballot DE, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-11; Bellamy C, 2005, STATE WORLDS CHILDRE, P1; Bener Abdulbari, 2012, ISRN Obstet Gynecol, V2012, P540495; BISHOP CW, 1984, J AM DIET ASSOC, V84, P330; Bodeau-Livinec F, 2011, AM J TROP MED HYG, V85, P414, DOI 10.4269/ajtmh.2011.10-0599; Chifamba J, 2012, HIGH BLOOD PRESS CAR, V19, P123, DOI 10.2165/11632150-000000000-00000; Christensen R. H. B., 2015, ANAL ORDINAL DATA CU; Padilho PD, 2009, NUTR HOSP, V24, P207; Elhassan Elhassan M, 2010, BMC Res Notes, V3, P181, DOI 10.1186/1756-0500-3-181; Feresu S A, 2010, Cent Afr J Med, V56, P30; Feresu SA, 2004, INT J EPIDEMIOL, V33, P1194, DOI 10.1093/ije/dyh120; Feresu SA, 2004, PAEDIATR PERINAT EP, V18, P154, DOI 10.1111/j.1365-3016.2003.00539.x; Feresu Shingairai A, 2005, BMC Pregnancy Childbirth, V5, P9, DOI 10.1186/1471-2393-5-9; Friis H, 2004, AM J CLIN NUTR, V80, P178; Galvan J, 2001, Cent Afr J Med, V47, P87; Gibb DM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001217; Goldenberg RL, 1997, CLIN OBSTET GYNECOL, V40, P704, DOI 10.1097/00003081-199712000-00004; Goldenberg RL, 2007, AM J CLIN NUTR, V85, p584S, DOI 10.1093/ajcn/85.2.584S; Guyatt HL, 2004, CLIN MICROBIOL REV, V17, P760, DOI 10.1128/CMR.17.4.760-769.2004; Halileh S, 2008, MATERN CHILD HLTH J, V12, P606, DOI 10.1007/s10995-007-0226-z; Hill K, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P15; Kambarami R. A., 1998, Central African Journal of Medicine, V44, P229; Kodzi IA, 2013, DEMOGR RES, V28, P713, DOI 10.4054/DemRes.2013.28.25; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Majoko F M, 2004, Afr J Reprod Health, V8, P198, DOI 10.2307/3583404; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; Mmbando B P, 2008, Tanzan J Health Res, V10, P137; Ndirangu J, 2012, HUM REPROD, V27, P1846, DOI 10.1093/humrep/des090; Patra J, 2011, BJOG-INT J OBSTET GY, V118, P1411, DOI 10.1111/j.1471-0528.2011.03050.x; PIEGORSCH WW, 1992, AM STAT, V46, P94, DOI 10.2307/2684172; Prince CB, 2003, CALIFORNIA J HLTH PR, V1, P83; Ramakrishnan U, 2004, AM J CLIN NUTR, V79, P17; Roudbari M., 2007, Eastern Mediterranean Health Journal, V13, P838; Sanders J. A., 1996, Central African Journal of Medicine, V42, P323; Say Lale, 2006, Reprod Health, V3, P1, DOI 10.1186/1742-4755-3-1; Tabrizi FM, 2012, NUTR RES PRACT, V6, P132, DOI 10.4162/nrp.2012.6.2.132; Tachiweyika E, 2011, PAN AFRICAN MED J, V8, p[7, 1]; Takem EN, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.010; Ticconi C, 2005, INT J GYNECOL OBSTET, V88, P146, DOI 10.1016/j.ijgo.2004.11.018; Ticconi C, 2003, JAIDS-J ACQ IMM DEF, V34, P289, DOI 10.1097/00126334-200311010-00005; Valea I, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-71; Wardlaw T, 2004, LBW COUNTRY REGIONAL; WHO, 2005, WHO TECH REP SER, V931, P1; ZERFAS AJ, 1975, AM J CLIN NUTR, V28, P782, DOI 10.1093/ajcn/28.7.782	49	26	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129705	10.1371/journal.pone.0129705	http://dx.doi.org/10.1371/journal.pone.0129705			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114867	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500036
J	Galloway, AWE; Brett, MT; Holtgrieve, GW; Ward, EJ; Ballantyne, AP; Burns, CW; Kainz, MJ; Muller-Navarra, DC; Persson, J; Ravet, JL; Strandberg, U; Taipale, SJ; Alhgren, G				Galloway, Aaron W. E.; Brett, Michael T.; Holtgrieve, Gordon W.; Ward, Eric J.; Ballantyne, Ashley P.; Burns, Carolyn W.; Kainz, Martin J.; Mueller-Navarra, Doerthe C.; Persson, Jonas; Ravet, Joseph L.; Strandberg, Ursula; Taipale, Sami J.; Alhgren, Gunnel			A Fatty Acid Based Bayesian Approach for Inferring Diet in Aquatic Consumers	PLOS ONE			English	Article							ISOTOPE MIXING MODELS; FOOD-WEB MODELS; STABLE-ISOTOPES; FRESH-WATER; HERBIVOROUS ZOOPLANKTON; LAKE PHYTOPLANKTON; PRIOR INFORMATION; TROPHIC POSITION; DELTA-N-15; DAPHNIA	We modified the stable isotope mixing model MixSIR to infer primary producer contributions to consumer diets based on their fatty acid composition. To parameterize the algorithm, we generated a 'consumer-resource library' of FA signatures of Daphnia fed different algal diets, using 34 feeding trials representing diverse phytoplankton lineages. This library corresponds to the resource or producer file in classic Bayesian mixing models such as MixSIR or SIAR. Because this library is based on the FA profiles of zooplankton consuming known diets, and not the FA profiles of algae directly, trophic modification of consumer lipids is directly accounted for. To test the model, we simulated hypothetical Daphnia comprised of 80% diatoms, 10% green algae, and 10% cryptophytes and compared the FA signatures of these known pseudo-mixtures to outputs generated by the mixing model. The algorithm inferred these simulated consumers were comprised of 82% (63-92%) [median (2.5th to 97.5th percentile credible interval)] diatoms, 11% (4-22%) green algae, and 6% (0-25%) cryptophytes. We used the same model with published phytoplankton stable isotope (SI) data for delta C-13 and delta N-15 to examine how a SI based approach resolved a similar scenario. With SI, the algorithm inferred that the simulated consumer assimilated 52% (4-91%) diatoms, 23% (1-78%) green algae, and 18% (1-73%) cyanobacteria. The accuracy and precision of SI based estimates was extremely sensitive to both resource and consumer uncertainty, as well as the trophic fractionation assumption. These results indicate that when using only two tracers with substantial uncertainty for the putative resources, as is often the case in this class of analyses, the underdetermined constraint in consumer-resource SI analyses may be intractable. The FA based approach alleviated the underdetermined constraint because many more FA biomarkers were utilized (n < 20), different primary producers (e.g., diatoms, green algae, and cryptophytes) have very characteristic FA compositions, and the FA profiles of many aquatic primary consumers are strongly influenced by their diets.	[Galloway, Aaron W. E.] Univ Oregon, Oregon Inst Marine Biol, Charleston, OR 97420 USA; [Brett, Michael T.; Ravet, Joseph L.] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA; [Holtgrieve, Gordon W.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Ward, Eric J.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA 98112 USA; [Ballantyne, Ashley P.] Univ Montana, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA; [Burns, Carolyn W.] Univ Otago, Dept Zool, Dunedin 9054, New Zealand; [Kainz, Martin J.] WasserCluster Biol Stn Lunz, A-3293 Lunz Am See, Austria; [Mueller-Navarra, Doerthe C.] Univ Hamburg, Aquat Ecol, D-22609 Hamburg, Germany; [Persson, Jonas] Norwegian Inst Water Res NIVA, Integrated Water Resources Management, N-0349 Oslo, Norway; [Strandberg, Ursula] Univ Eastern Finland, Dept Biol, Joensuu 80101, Finland; [Taipale, Sami J.] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla 40014, Finland; [Alhgren, Gunnel] Uppsala Univ, Dept Ecol & Genet, Limnol, SE-75236 Uppsala, Sweden	University of Oregon; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; University of Montana System; University of Montana; University of Otago; University of Hamburg; Norwegian Institute for Water Research (NIVA); University of Eastern Finland; University of Jyvaskyla; Uppsala University	Galloway, AWE (corresponding author), Univ Oregon, Oregon Inst Marine Biol, Charleston, OR 97420 USA.	aaron.galloway@gmail.com; mtbrett@uw.edu	Kainz, Martin/AAG-6268-2021; Taipale, Sami/AAO-3492-2020		National Science Foundation [0925718, 0742559]; Office of Integrative Activities [1443108] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the National Science Foundation grants 0925718 and 0742559 to AWEG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TS, 2000, LIMNOL OCEANOGR, V45, P601, DOI 10.4319/lo.2000.45.3.0601; Ballantyne AP, 2011, BIOGEOSCIENCES, V8, P2689, DOI 10.5194/bg-8-2689-2011; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Brett MT, 2006, LIMNOL OCEANOGR, V51, P2428, DOI 10.4319/lo.2006.51.5.2428; Brett MT, 2014, MAR ECOL PROG SER, V514, P1, DOI 10.3354/meps11017; Brett MT, 2009, P NATL ACAD SCI USA, V106, P21197, DOI 10.1073/pnas.0904129106; Brett MT, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P115, DOI 10.1007/978-0-387-89366-2_6; BRETT MT, 1994, ECOLOGY, V75, P2243, DOI 10.2307/1940880; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; Bunn SE, 2013, LIMNOL OCEANOGR, V58, P765, DOI 10.4319/lo.2013.58.3.0765; Burns CW, 2011, FRESHWATER BIOL, V56, P889, DOI 10.1111/j.1365-2427.2010.02534.x; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cole JJ, 2011, P NATL ACAD SCI USA, V108, P1975, DOI 10.1073/pnas.1012807108; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; DEMOTT WR, 1988, LIMNOL OCEANOGR, V33, P397, DOI 10.4319/lo.1988.33.3.0397; Dethier MN, 2013, MAR ECOL PROG SER, V478, P1, DOI 10.3354/meps10310; Fry B, 2013, MAR ECOL PROG SER, V490, P291, DOI 10.3354/meps10536; Fry B, 2013, MAR ECOL PROG SER, V472, P1, DOI 10.3354/meps10168; Galloway AWE, 2014, MAR ECOL PROG SER, V507, P219, DOI 10.3354/meps10860; Galloway AWE, 2014, FRESHWATER BIOL, V59, P1902, DOI 10.1111/fwb.12394; Galloway AWE, 2012, J PHYCOL, V48, P956, DOI 10.1111/j.1529-8817.2012.01173.x; Graham CT, 2014, HYDROBIOLOGIA, V721, P45, DOI 10.1007/s10750-013-1636-0; Iverson SJ, 2004, ECOL MONOGR, V74, P211, DOI 10.1890/02-4105; KNISELY K, 1986, OECOLOGIA, V69, P86, DOI 10.1007/BF00399042; Martin-Creuzburg D, 2004, J CHEM ECOL, V30, P483, DOI 10.1023/B:JOEC.0000018624.94689.95; McCarthy MD, 2013, GEOCHIM COSMOCHIM AC, V103, P104, DOI 10.1016/j.gca.2012.10.037; Milke LM, 2006, AQUACULTURE, V260, P272, DOI 10.1016/j.aquaculture.2006.06.004; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Muller-Navarra DC, 2008, INT REV HYDROBIOL, V93, P489, DOI 10.1002/iroh.200711046; Nosrati K, 2014, GEODERMA, V217, P173, DOI 10.1016/j.geoderma.2013.12.002; Oechsler-Christensen B, 2012, J PLANKTON RES, V34, P161, DOI 10.1093/plankt/fbr090; Parnell AC, 2013, ENVIRONMETRICS, V24, P387, DOI 10.1002/env.2221; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Persson J, 2006, FRESHWATER BIOL, V51, P887, DOI 10.1111/j.1365-2427.2006.01540.x; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Piepho M, 2012, J PHYCOL, V48, P64, DOI 10.1111/j.1529-8817.2011.01103.x; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Prado P, 2012, MAR ECOL PROG SER, V462, P175, DOI 10.3354/meps09786; R Core Team, 2013, R A LANGUAGE AND ENV; Schlechtriem C, 2006, LIPIDS, V41, P397, DOI 10.1007/s11745-006-5111-9; Semmens BX, 2013, MAR ECOL PROG SER, V490, P285, DOI 10.3354/meps10535; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Strandberg U, 2014, LIPIDS, V49, P591, DOI 10.1007/s11745-014-3902-y; Taipale S, 2013, AQUAT MICROB ECOL, V71, P165, DOI 10.3354/ame01671; Taipale SJ, 2011, OIKOS, V120, P1674, DOI 10.1111/j.1600-0706.2011.19415.x; Vadeboncoeur Y, 2002, BIOSCIENCE, V52, P44, DOI 10.1641/0006-3568(2002)052[0044:PTLBTR]2.0.CO;2; Vuorio K, 2006, FRESHWATER BIOL, V51, P807, DOI 10.1111/j.1365-2427.2006.01529.x; Ward EJ, 2010, ENVIRON SCI TECHNOL, V44, P4645, DOI 10.1021/es100053v; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x	52	41	41	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129723	10.1371/journal.pone.0129723	http://dx.doi.org/10.1371/journal.pone.0129723			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114945	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500037
J	Brescia, MDG; Massarollo, PCB; Imakuma, ES; Mies, S				Guimaraes Brescia, Marilia D'Elboux; Bosco Massarollo, Paulo Celso; Imakuma, Ernesto Sasaki; Mies, Sergio			Prospective Randomized Trial Comparing Hepatic Venous Outflow and Renal Function after Conventional versus Piggyback Liver Transplantation	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; INFERIOR VENA-CAVA; SINGLE-CENTER EXPERIENCE; GENERALIZED ESTIMATING EQUATIONS; VENOVENOUS BYPASS; RISK-FACTORS; RIFLE CRITERIA; VASCULAR COMPLICATIONS; SELECTIVE USE; FAILURE	Background This randomized prospective clinical trial compared the hepatic venous outflow drainage and renal function after conventional with venovenous bypass (n = 15) or piggyback (n = 17) liver transplantation. Methods Free hepatic vein pressure (FHVP) and central venous pressure (CVP) measurements were performed after graft reperfusion. Postoperative serum creatinine (Cr) was measured daily on the first week and on the 14th, 21st and 28th postoperative days (PO). The prevalence of acute renal failure (ARF) up to the 28th PO was analyzed by RIFLE-AKIN criteria. A Generalized Estimating Equation (GEE) approach was used for comparison of longitudinal measurements of renal function. Results FHVP-CVP gradient > 3 mm Hg was observed in 26.7% (4/15) of the patients in the conventional group and in 17.6%(3/17) in the piggyback group (p = 0.68). Median FHVP-CVP gradient was 2 mm Hg (0-8 mmHg) vs. 3 mm Hg (0-7 mm Hg) in conventional and piggyback groups, respectively (p = 0.73). There is no statistically significant difference between the conventional (1/15) and the piggyback (2/17) groups regarding massive ascites development (p = 1.00). GEE estimated marginal mean for Cr was significantly higher in conventional than in piggyback group (2.14 +/- 0.26 vs. 1.47 +/- 0.15 mg/dL; p = 0.02). The conventional method presented a higher prevalence of severe ARF during the first 28 PO days (OR = 3.207; 95% CI, 1.010 to 10.179; p = 0.048). Conclusion Patients submitted to liver transplantation using conventional or piggyback methods present similar results regarding venous outflow drainage of the graft. Conventional with venovenous bypass technique significantly increases the harm of postoperative renal dysfunction.	[Guimaraes Brescia, Marilia D'Elboux; Bosco Massarollo, Paulo Celso; Imakuma, Ernesto Sasaki; Mies, Sergio] Univ Sao Paulo, Fac Med, Dept Cirurgia, Lab Anat Med Cirurg LIM 02, Sao Paulo, Brazil	Universidade de Sao Paulo	Brescia, MDG (corresponding author), Univ Sao Paulo, Fac Med, Dept Cirurgia, Lab Anat Med Cirurg LIM 02, Sao Paulo, Brazil.	mariliabrescia@hotmail.com	Massarollo, Paulo Celso Bosco/I-2283-2013; Mies, Sergio/AAP-4574-2021; Brescia, Marília/F-9982-2016; Massarollo, Paulo/AAS-3567-2020	Massarollo, Paulo Celso Bosco/0000-0001-6398-1027; Brescia, Marília/0000-0002-1988-8543; Massarollo, Paulo/0000-0001-6398-1027	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP [98/13664-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was financially supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br), FAPESP, Grant No. 98/13664-2 to PCBM.	Abdala E, 2007, LIVER TRANSPLANT, V13, P488, DOI 10.1002/lt.21085; Acosta F, 1999, TRANSPLANT P, V31, P2394, DOI 10.1016/S0041-1345(99)00397-8; Aucejo F, 2006, LIVER TRANSPLANT, V12, P808, DOI 10.1002/lt.20747; BELGHITI J, 1992, SURG GYNECOL OBSTET, V175, P271; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bilbao JI, 2000, CARDIOVASC INTER RAD, V23, P149, DOI 10.1007/s002709910031; Bittencourt PL, 2002, LIVER TRANSPLANT, V8, P34, DOI 10.1053/jlts.2002.29764; Cabezuelo JB, 2006, KIDNEY INT, V69, P1073, DOI 10.1038/sj.ki.5000216; Cabezuelo JB, 2003, TRANSPLANT P, V35, P1913, DOI 10.1016/S0041-1345(03)00598-0; Cabezuelo JB, 2002, TRANSPLANT P, V34, P254, DOI 10.1016/S0041-1345(01)02749-X; CALNE RY, 1968, BMJ-BRIT MED J, V4, P535, DOI 10.1136/bmj.4.5630.535; Cescon M, 2005, TRANSPL INT, V18, P318, DOI 10.1111/j.1432-2277.2004.00057.x; Chari RS, 1998, J AM COLL SURGEONS, V186, P683, DOI 10.1016/S1072-7515(98)00101-X; Chen J, 2011, TRANSPLANTATION, V91, P348, DOI 10.1097/TP.0b013e31820437da; Cirera I, 2000, LIVER TRANSPLANT, V6, P157, DOI 10.1002/lt.500060219; Darcy MD, 2007, TECH VASC INTERV RAD, V10, P240, DOI 10.1053/j.tvir.2007.09.018; Diggle PJ, 1994, ANALYSIS OF LONGITUD; Ducerf C, 1996, SURGERY, V120, P484, DOI 10.1016/S0039-6060(96)80067-5; Ferreira AC, 2010, CLIN TRANSPLANT, V24, P394, DOI 10.1111/j.1399-0012.2009.01087.x; Fonouni H, 2008, HPB, V10, P196, DOI 10.1080/13651820801953031; Friedman LM, 1998, FUNDAMENTALS OF CLIN, P233; Glanemann M, 2000, TRANSPLANT P, V32, P539, DOI 10.1016/S0041-1345(00)00880-0; Grande L, 1996, HEPATOLOGY, V23, P1418, DOI 10.1002/hep.510230618; Gurusamy KS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008258.pub2; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Iglesias JI, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-30; Ikeda O, 2010, JPN J RADIOL, V28, P520, DOI 10.1007/s11604-010-0463-8; Isern MRM, 2004, LIVER TRANSPLANT, V10, P425, DOI 10.1002/lt.20067; JONES R, 1992, TRANSPLANT P, V24, P189; Jovine E, 1997, TRANSPLANT INT, V10, P109, DOI 10.1007/PL00003824; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Khan S, 2006, TRANSPL INT, V19, P795, DOI 10.1111/j.1432-2277.2006.00331.x; Kluger MD, 2011, HPB, V13, P692, DOI 10.1111/j.1477-2574.2011.00348.x; Kundakci A, 2010, TRANSPL P, V42, P4171, DOI 10.1016/j.transproceed.2010.09.137; Leonardi LS, 2002, TRANSPLANT P, V34, P3336, DOI 10.1016/S0041-1345(02)03575-3; Levi DM, 2012, J AM COLL SURGEONS, V214, P691, DOI 10.1016/j.jamcollsurg.2011.12.039; Lewandowska L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107898; Lewandowska L, 2011, ANN TRANSPL, V16, P103; Lima EQ, 2003, RENAL FAILURE, V25, P553, DOI 10.1081/JDI-120022546; Margarit C, 1998, Transpl Int, V11 Suppl 1, pS248, DOI 10.1007/s001470050471; Massarollo PCB, 1998, TRANSPLANT P, V30, P2883, DOI 10.1016/S0041-1345(98)00854-9; Mehrabi A, 2009, LIVER TRANSPLANT, V15, P466, DOI 10.1002/lt.21705; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Miyamoto S, 2004, CLIN TRANSPLANT, V18, P686, DOI 10.1111/j.1399-0012.2004.00278.x; Moreno-Gonzalez E, 2003, TRANSPLANT P, V35, P1918, DOI 10.1016/S0041-1345(03)00600-6; Narciso RC, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-43; Navarro F, 1999, TRANSPLANTATION, V68, P646, DOI 10.1097/00007890-199909150-00009; Niemann CU, 2009, LIVER TRANSPLANT, V15, P1852, DOI 10.1002/lt.21938; Nishida S, 2006, HPB, V8, P182, DOI 10.1080/13651820500542135; O'Riordan A, 2007, AM J TRANSPLANT, V7, P168, DOI 10.1111/j.1600-6143.2006.01602.x; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Parrilla P, 1999, TRANSPLANTATION, V67, P1214, DOI 10.1097/00007890-199905150-00003; Pestana RC, 2013, TRANSPL P, V45, P2111, DOI 10.1016/j.transproceed.2012.11.007; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Reddy KA, 2005, LIVER TRANSPLANT, V11, P741, DOI 10.1002/lt.20482; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Robles R, 1999, TRANSPLANT P, V31, P2390, DOI 10.1016/S0041-1345(99)00395-4; Sakai T, 2010, TRANSPL INT, V23, P1247, DOI 10.1111/j.1432-2277.2010.01144.x; Baia CES, 2009, HEPATO-GASTROENTEROL, V56, P1445; Saner FH, 2012, LIVER INT, V32, P179, DOI 10.1111/j.1478-3231.2011.02563.x; SHAW BW, 1984, ANN SURG, V200, P524, DOI 10.1097/00000658-198410000-00013; Shokouh-Amiri MH, 2000, ANN SURG, V231, P814; Stieber AC, 1997, TRANSPLANTATION, V64, P654, DOI 10.1097/00007890-199708270-00019; TZAKIS A, 1989, ANN SURG, V210, P649, DOI 10.1097/00000658-198911000-00013; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F; Utsumi M, 2013, TRANSPL INT, V26, P842, DOI 10.1111/tri.12138; Wang SL, 2005, RADIOLOGY, V236, P352, DOI 10.1148/radiol.2361040327; Wojcicki M, 2009, TRANSPL P, V41, P3131, DOI 10.1016/j.transproceed.2009.07.092; Zhu M, 2010, TRANSPL P, V42, P3634, DOI 10.1016/j.transproceed.2010.08.059	70	11	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129923	10.1371/journal.pone.0129923	http://dx.doi.org/10.1371/journal.pone.0129923			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115520	gold, Green Published, Green Submitted			2022-12-27	WOS:000358147500043
J	Ho, CH; Chen, ZC; Chu, CC; Wang, JJ; Chiang, CY				Ho, Chung-Han; Chen, Zhih-Cherng; Chu, Chin-Chen; Wang, Jhi-Joung; Chiang, Chun-Yen			Temporal Trends of In-Hospital Mortality in Patients Treated with Intra-Aortic Balloon Pumping: A Nationwide Population Study in Taiwan, 1998-2008	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; INSURANCE RESEARCH DATABASE; CARDIOGENIC-SHOCK; COUNTERPULSATION; MANAGEMENT; OUTCOMES; RATES	Intra-aortic balloon pumping (IABP) is widely used for hemodynamic support in critical patients with cardiogenic shock (CS). We examined whether the in-hospital mortality of patients in Taiwan treated with IABP has recently declined. We used Taiwan's National Health Insurance Research Database to retrospectively review the in-hospital all-cause mortality of 9952 (7146 men [71.8%]) 18-year-old and older patients treated with IABP between 1998 and 2008. The mortality rate was 13.84% (n = 1377). The urbanization levels of the hospitals, and the number of days in the intensive care unit, of hospitalization, and of IABP treatment, and prior percutaneous coronary intervention (PCI) were associated with mortality. Seven thousand six hundred thirty-five patients (76.72%) underwent coronary artery bypass grafting (CABG) surgery, and 576 (5.79%) underwent high-risk PCI with IABP treatment. The number of patients treated with IABP significantly increased during this decade (p(trend) < 0.0001), the in-hospital all-cause mortality for patients treated with IABP significantly decreased (p(trend) = 0.0243), but the in-hospital all-cause mortality of patients who underwent CABG and PCI plus IABP did not decrease. In conclusion, the in-hospital mortality rate of IABP treatment decreased annually in Taiwan during the study period. However, high-risk patients who underwent coronary revascularization with IABP had a higher and unstable in-hospital mortality rate.	[Ho, Chung-Han; Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan; [Chen, Zhih-Cherng; Chiang, Chun-Yen] Chi Mei Med Ctr, Dept Internal Med, Div Cardiol, Tainan, Taiwan; [Chu, Chin-Chen; Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan; [Chen, Zhih-Cherng] Chia Nan Univ Pharm & Sci, Dept Pharm, Tainan, Taiwan	Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science	Chiang, CY (corresponding author), Chi Mei Med Ctr, Dept Internal Med, Div Cardiol, Tainan, Taiwan.	d930824@mail.chimei.org.tw		Chu, Chin-Chen/0000-0001-8745-239X; Ho, Chung-Han/0000-0001-5925-8477	Chi-Mei Medical Center [CMFHR10235]	Chi-Mei Medical Center	This study was supported by grants CMFHR10235 from Chi-Mei Medical Center and CHH received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaev A, 2005, JAMA-J AM MED ASSOC, V294, P448, DOI 10.1001/jama.294.4.448; Barron HV, 2001, AM HEART J, V141, P933, DOI 10.1067/mhj.2001.115295; Bignaini E, 2012, ANN CARD ANAESTH, V15, P274, DOI 10.4103/0971-9784.101871; Chen BK, 2014, INT J ENV RES PUB HE, V11, P1776, DOI 10.3390/ijerph110201776; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cohen M, 2003, EUR HEART J, V24, P1763, DOI 10.1016/j.ehj.2003.07.002; Curtis JP, 2012, CIRC-CARDIOVASC QUAL, V5, P21, DOI 10.1161/CIRCOUTCOMES.110.960385; Ferguson JJ, 2001, J AM COLL CARDIOL, V38, P1456, DOI 10.1016/S0735-1097(01)01553-4; Goldberg RJ, 2009, CIRCULATION, V119, P1211, DOI 10.1161/CIRCULATIONAHA.108.814947; Hemo E, 2014, J THORAC CARDIOV SUR, V148, P1869, DOI 10.1016/j.jtcvs.2013.12.063; Kapelios CJ, 2014, INT J CARDIOL, V172, P318, DOI 10.1016/j.ijcard.2014.01.098; Kulshreshtha A, 2014, PUBLIC HLTH REP, V129, P19; Landoni G, 2012, J CARDIOTHOR VASC AN, V26, P764, DOI 10.1053/j.jvca.2012.04.018; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Patel H, 2014, AM HEART J, V168, P363, DOI 10.1016/j.ahj.2014.02.015; Perera D, 2010, JAMA-J AM MED ASSOC, V304, P867, DOI 10.1001/jama.2010.1190; Sanborn TA, 2000, J AM COLL CARDIOL, V36, P1123, DOI 10.1016/S0735-1097(00)00875-5; Severi L, 2012, J CARDIOTHOR VASC AN, V26, P604, DOI 10.1053/j.jvca.2012.01.037; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Theologou T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004472.pub3; Thiele H, 2013, LANCET, V382, P1638, DOI 10.1016/S0140-6736(13)61783-3; Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410; Urban PM, 2004, AM J CARDIOL, V94, P181, DOI 10.1016/j.amjcard.2004.03.058; Zangrillo A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-014-0728-1	26	4	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131575	10.1371/journal.pone.0131575	http://dx.doi.org/10.1371/journal.pone.0131575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115413	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500172
J	Orlowski, G; Wuczynski, A; Karg, J				Orlowski, Grzegorz; Wuczynski, Andrzej; Karg, Jerzy			Effect of Brood Age on Nestling Diet and Prey Composition in a Hedgerow Specialist Bird, the Barred Warbler Sylvia nisoria	PLOS ONE			English	Article							SHRIKE LANIUS-COLLURIO; HABITAT PREFERENCES; INVERTEBRATE TAXA; FARMLAND BIRDS; FIELD MARGINS; ABUNDANCE; SELECTION; ENGLAND; FOOD; COMMUNITIES	The composition and quality of food provided to nestling birds influence their growth and development and offers key insight into the ecological requirements of birds. One bird species whose feeding ecology is poorly understood is the Barred Warbler (Sylvia nisoria), which utilizes semi-natural shrubby vegetation in agroecosystems. Because Barred Warbler nestlings vary greatly in body mass we hypothesised that diet and prey properties (size, diversity, taxonomic composition, and chitin content and resulting body hardness and digestibility) would differ as the nestlings aged. We quantified the diet based on faecal analysis, sampling faecal sacs from the nestlings pooled into three age classes: 2-3 days old, 46 d old, and 7-9 d old. Nestlings were provided a wide diversity of food and a strong relationship existed between food characteristics and nestling age. The youngest nestlings (2-3 d old) had the lowest values of each dietary characteristic (diversity, number and total biomass of prey, and individual prey weight), that were significantly lower than the oldest nestlings (7-9 d old). Nestlings aged 4-6 d exhibited intermediate dietary characteristics. Differences in dietary composition of the six major food types showed marked differences between the individual broods and age categories. Percentages of the number and biomass of soft-bodied prey were highest in the diet of 2-3 d and 4-6 d old nestlings, and decreased with increasing age, whereas the opposite trend was observed in the percentage of intermediately and heavily chitinised prey. Parent Barred Warblers probably preferentially select soft-bodied prey for the youngest nestlings, and satisfy the greater energy demands of the older ones by providing them with a greater variety of prey containing more chitin, as well as plant food. The provisioning of less-readily digestible prey to older nestlings suggests that as the quality of food decreases the quantity increases, implying that the youngest nestlings may be physiologically limited as regards their ability to digest more heavily chitinised prey.	[Orlowski, Grzegorz] Polish Acad Sci, Inst Agr & Forest Environm, Poznan, Poland; [Wuczynski, Andrzej] Polish Acad Sci, Inst Nat Conservat, Lower Silesian Field Stn, Wroclaw, Poland; [Karg, Jerzy] Univ Zielona Gora, Fac Biol Sci, Nat Conservat Dept, Zielona Gora, Poland	Polish Academy of Sciences; Polish Academy of Sciences; University of Zielona Gora	Wuczynski, A (corresponding author), Polish Acad Sci, Inst Nat Conservat, Lower Silesian Field Stn, Wroclaw, Poland.	a.wuczynski@pwr.edu.pl	Wuczyński, Andrzej/G-4372-2014; Wuczyński, Andrzej/AAB-1792-2020	Wuczyński, Andrzej/0000-0001-9577-3855; Wuczyński, Andrzej/0000-0001-9577-3855	Polish Ministry of Science and Higher Education [2P04F02329]; budget of the Institute of Nature Conservation PAS; University of Zielona Gora	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); budget of the Institute of Nature Conservation PAS; University of Zielona Gora	This study was supported by the Polish Ministry of Science and Higher Education (project 2P04F02329) and by the budget of the Institute of Nature Conservation PAS (AW) and the University of Zielona Gora. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ROCZ AKAD ROL POZ; Arnold KE, 2007, P ROY SOC B-BIOL SCI, V274, P2563, DOI 10.1098/rspb.2007.0687; Baldi A, 2011, IBIS, V153, P875, DOI 10.1111/j.1474-919X.2011.01169.x; BirdLife International, 2014, SPEC FACTSH SYLV NIS; BISHTON G, 1985, BIRD STUDY, V32, P113, DOI 10.1080/00063658509476865; BOCHENSKI Z, 1985, Acta Zoologica Cracoviensia, V29, P241; Brickle NW, 1999, BIRD STUDY, V46, P319, DOI 10.1080/00063659909461145; Buchanan GM, 2006, IBIS, V148, P615, DOI 10.1111/j.1474-919X.2006.00578.x; Caviedes-Vidal E, 2001, PHYSIOL BIOCHEM ZOOL, V74, P769, DOI 10.1086/322966; Chiu MC, 2009, ZOOL STUD, V48, P761; CODY ML, 1978, ECOL MONOGR, V48, P351, DOI 10.2307/2937239; CORBETT LK, 1989, J WILDLIFE MANAGE, V53, P343, DOI 10.2307/3801135; Cramp S, 1998, COMPLETE BIRDS W PAL; Cummins S, 2002, BIRD STUDY, V49, P139, DOI 10.1080/00063650209461258; Ewald J, 2014, 135 NECR; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Fuller RJ, 2001, AGR ECOSYST ENVIRON, V84, P79, DOI 10.1016/S0167-8809(00)00194-8; Garcia-Navas V, 2012, BIRD STUDY, V59, P236, DOI 10.1080/00063657.2012.662939; Gillings S, 1998, OECOLOGIA, V116, P120, DOI 10.1007/s004420050570; Glutz von Blotzheim UN, 2001, HDB VOGEL MITTELEURO, V14, DOI [10.1093/jhered/est069, DOI 10.1093/JHERED/EST069]; GOTZMAN JERZY, 1965, EKOL POLSKA SER A, V13, P1; GREEN RE, 1987, IBIS, V129, P511, DOI 10.1111/j.1474-919X.1987.tb08238.x; GREIGSMITH PW, 1983, BIRD STUDY, V30, P47, DOI 10.1080/00063658309476774; Hampe H, 1970, APUS, V2, P75; Hart JD, 2006, J APPL ECOL, V43, P81, DOI 10.1111/j.1365-2664.2005.01103.x; Hernandez A, 2005, FOLIA ZOOL, V54, P379; Hinsley SA, 2000, J ENVIRON MANAGE, V60, P33, DOI 10.1006/jema.2000.0360; Hogstad O, 2005, IBIS, V147, P77, DOI [10.1111/j.1474-919X.2004.00338.x, 10.1111/j.1474-919x.2004.00338]; Holland JM, 2012, ANN APPL BIOL, V160, P66, DOI 10.1111/j.1744-7348.2011.00521.x; Holland JM, 2006, ANN APPL BIOL, V148, P49, DOI 10.1111/j.1744-7348.2006.00039.x; JENNI L, 1990, IBIS, V132, P445, DOI 10.1111/j.1474-919X.1990.tb01062.x; Kragten S, 2011, BIRD CONSERV INT, V21, P1, DOI 10.1017/S0959270910000079; Krupa M, 2004, ACTA ORNITHOL, V39, P45; Lawler JJ, 2014, P NATL ACAD SCI USA, V111, P7492, DOI 10.1073/pnas.1405557111; Magrath M. J. L., 2004, P R SOC LOND B S, V271, P347; Marshall J, 2002, ADV AGROECOL, P219; Mengelkoch JM, 2004, CONDOR, V106, P423, DOI 10.1650/7341; Mitrus C, 2010, ANIM BIOL, V60, P319, DOI 10.1163/157075610X516529; Moreby SJ, 2000, BIRD STUDY, V47, P320, DOI 10.1080/00063650009461192; Moreby SJ, 2001, AGR ECOSYST ENVIRON, V86, P125, DOI 10.1016/S0167-8809(00)00279-6; Naef-Daenzer L, 2000, J AVIAN BIOL, V31, P206, DOI 10.1034/j.1600-048X.2000.310212.x; Orlowski G, 2008, LANDSCAPE URBAN PLAN, V86, P153, DOI 10.1016/j.landurbplan.2008.02.003; Orlowski G, 2014, ACTA ORNITHOL, V49, P107, DOI 10.3161/000164514X682931; Orlowski G, 2013, BIRD STUDY, V60, P475, DOI 10.1080/00063657.2013.839622; Orlowski G, 2011, CENT EUR J BIOL, V6, P1023, DOI 10.2478/s11535-011-0070-4; Orlowski G, 2011, ORNIS FENNICA, V88, P161; Payevsky Vladimir A., 1999, Avian Ecology and Behaviour, V2, P19; Polak Marcin, 2014, Ornis Polonica, V55, P22; Polak M, 2012, ANN ZOOL FENN, V49, P355, DOI 10.5735/086.049.0509; Radford AN, 2008, ETHOLOGY, V114, P907, DOI 10.1111/j.1439-0310.2008.01550.x; Ramsay SL, 2003, IBIS, V145, P227, DOI 10.1046/j.1474-919X.2003.00133.x; Sanderson FJ, 2009, AGR ECOSYST ENVIRON, V129, P37, DOI 10.1016/j.agee.2008.07.001; Shirihai H., 2001, SYLVIA WARBLERS IDEN; Slagsvold T, 2007, ANIM BEHAV, V73, P691, DOI 10.1016/j.anbehav.2006.05.021; SPJOTVOLL E, 1973, J AM STAT ASSOC, V68, P975, DOI 10.2307/2284534; StatSoft, 2006, STAT DAT AN SOFTW SY; Szymanski P, 2013, BIRD STUDY, V60, P484, DOI 10.1080/00063657.2013.840555; Vickery JA, 2009, AGR ECOSYST ENVIRON, V133, P1, DOI 10.1016/j.agee.2009.05.012; Waldenstrom Jonas, 2004, Ornis Svecica, V14, P107; WAUGH DR, 1978, THESIS U STIRLING; Wilson JD, 1999, AGR ECOSYST ENVIRON, V75, P13, DOI 10.1016/S0167-8809(99)00064-X; Wright J, 1998, J ANIM ECOL, V67, P620, DOI 10.1046/j.1365-2656.1998.00221.x; Wuczynski A, 2014, BIODIVERS CONSERV, V23, P999, DOI 10.1007/s10531-014-0649-y; Wuczynski A, 2011, AGR ECOSYST ENVIRON, V141, P202, DOI 10.1016/j.agee.2011.02.031	64	6	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131100	10.1371/journal.pone.0131100	http://dx.doi.org/10.1371/journal.pone.0131100			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114941	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500128
J	Cipolletta, E; Rusciano, MR; Maione, AS; Santulli, G; Sorriento, D; Del Giudice, C; Ciccarelli, M; Franco, A; Crola, C; Campiglia, P; Sala, M; Gomez-Monterrey, I; De Luca, N; Trimarco, B; Iaccarino, G; Illario, M				Cipolletta, Ersilia; Rusciano, Maria Rosaria; Maione, Angela Serena; Santulli, Gaetano; Sorriento, Daniela; Del Giudice, Carmine; Ciccarelli, Michele; Franco, Antonietta; Crola, Catherine; Campiglia, Pietro; Sala, Marina; Gomez-Monterrey, Isabel; De Luca, Nicola; Trimarco, Bruno; Iaccarino, Guido; Illario, Maddalena			Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; VASCULAR SMOOTH-MUSCLE; II INHIBITOR PROTEIN; INDEPENDENT ACTIVATION; UP-REGULATION; IN-VIVO; CALMODULIN; RAT; CALCIUM; EXPRESSION	Aims Activation of Ca2+/Calmodulin protein kinase II (CaMKII) is an important step in signaling of cardiac hypertrophy. The molecular mechanisms by which CaMKII integrates with other pathways in the heart are incompletely understood. We hypothesize that CaMKII association with extracellular regulated kinase (ERK), promotes cardiac hypertrophy through ERK nuclear localization. Methods and Results In H9C2 cardiomyoblasts, the selective CaMKII peptide inhibitor AntCaNtide, its penetratin conjugated minimal inhibitory sequence analog tat-CN17 beta, and the MEK/ERK inhibitor UO126 all reduce phenylephrine (PE)-mediated ERK and CaMKII activation and their interaction. Moreover, AntCaNtide or tat-CN17 beta pretreatment prevented PE induced CaMKII and ERK nuclear accumulation in H9C2s and reduced the hypertrophy responses. To determine the role of CaMKII in cardiac hypertrophy in vivo, spontaneously hypertensive rats were subjected to intramyocardial injections of AntCaNtide or tat-CN17 beta. Left ventricular hypertrophy was evaluated weekly for 3 weeks by cardiac ultrasounds. We observed that the treatment with CaMKII inhibitors induced similar but significant reduction of cardiac size, left ventricular mass, and thickness of cardiac wall. The treatment with CaMKII inhibitors caused a significant reduction of CaMKII and ERK phosphorylation levels and their nuclear localization in the heart. Conclusion These results indicate that CaMKII and ERK interact to promote activation in hypertrophy; the inhibition of CaMKII-ERK interaction offers a novel therapeutic approach to limit cardiac hypertrophy.	[Cipolletta, Ersilia; Ciccarelli, Michele; Iaccarino, Guido] Univ Salerno, Dept Med & Surg, I-84081 Baronissi, SA, Italy; [Rusciano, Maria Rosaria; Maione, Angela Serena; Crola, Catherine; De Luca, Nicola; Illario, Maddalena] Univ Naples Federico II, Dept Translat & Med Sci, Naples, Italy; [Santulli, Gaetano] Columbia Univ, New York Presbyterian Hosp Manhattan, Med Ctr, Coll Phys & Surg, New York, NY USA; [Sorriento, Daniela] Italian Natl Res Council CNR, IBB, Naples, Italy; [Del Giudice, Carmine; Franco, Antonietta; Trimarco, Bruno] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy; [Campiglia, Pietro; Sala, Marina] Univ Salerno, Dept Pharm, Fisciano, Italy; [Gomez-Monterrey, Isabel] Univ Naples Federico II, Dept Pharm, Naples, Italy	University of Salerno; University of Naples Federico II; Columbia University; NewYork-Presbyterian Hospital; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Istituto di Neuroscienze (IN-CNR); University of Naples Federico II; University of Salerno; University of Naples Federico II	Iaccarino, G (corresponding author), Univ Salerno, Dept Med & Surg, I-84081 Baronissi, SA, Italy.	giaccarino@unisa.it; illario@unina.it	Rusciano, Maria Rosaria/W-1958-2019; Santulli, Gaetano/I-9203-2016; Ciccarelli, Michele/K-2824-2016; Trimarco, Bruno BT/K-7851-2016; Iaccarino, Guido/D-4540-2009; Campiglia, Pietro/J-5625-2018; Ciccarelli, Michele/ABC-2826-2021; Del Giudice, Carmine/AFO-6296-2022; Maione, Angela Serena/H-3123-2018; Franco, Antonietta/AAP-5515-2021; IACCARINO, Guido/A-7702-2010	Santulli, Gaetano/0000-0001-7231-375X; Ciccarelli, Michele/0000-0003-2379-1960; Trimarco, Bruno BT/0000-0002-0701-6449; Iaccarino, Guido/0000-0002-8997-835X; Ciccarelli, Michele/0000-0003-2379-1960; Del Giudice, Carmine/0000-0002-7543-0609; Maione, Angela Serena/0000-0003-1460-7033; IACCARINO, Guido/0000-0002-8997-835X; DE LUCA, Nicola/0000-0002-9606-6586; Campiglia, Pietro/0000-0002-1069-2181	Fondazione Umberto Veronesi Fellowship	Fondazione Umberto Veronesi Fellowship(Fondazione Umberto Veronesi)	Ersilia Cipolletta was supported by a Fondazione Umberto Veronesi Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Anderson ME, 1998, J PHARMACOL EXP THER, V287, P996; BALTAS LG, 1995, FEBS LETT, V373, P71, DOI 10.1016/0014-5793(95)00981-E; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; BRAUN AP, 1995, J PHYSIOL-LONDON, V488, P37, DOI 10.1113/jphysiol.1995.sp020944; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chang BH, 2001, NEUROSCIENCE, V102, P767, DOI 10.1016/S0306-4522(00)00520-0; Ciccarelli M, 2008, BRIT J PHARMACOL, V153, P936, DOI 10.1038/sj.bjp.0707637; Ciccarelli M, 2011, CIRCULATION, V123, P1953, DOI 10.1161/CIRCULATIONAHA.110.988642; Cipolletta E, 2010, ENDOCRINOLOGY, V151, P2747, DOI 10.1210/en.2009-1248; Colomer JM, 2000, MOL ENDOCRINOL, V14, P1125, DOI 10.1210/me.14.8.1125; Colomer JM, 2003, MOL ENDOCRINOL, V17, P183, DOI 10.1210/me.2002-0350; Couchonnal LF, 2008, PHYSIOLOGY, V23, P151, DOI 10.1152/physiol.00043.2007; DAY RN, 1989, J BIOL CHEM, V264, P431; DRAZNIN B, 1987, DIABETES, V36, P174, DOI 10.2337/diabetes.36.2.174; EDMAN CF, 1994, BBA-MOL CELL RES, V1221, P89, DOI 10.1016/0167-4889(94)90221-6; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fujisawa H, 2001, J BIOCHEM-TOKYO, V129, P193, DOI 10.1093/oxfordjournals.jbchem.a002843; Gomez-Monterrey I, 2013, EUR J MED CHEM, V62, P425, DOI 10.1016/j.ejmech.2012.12.053; Hagemann D, 2001, MOL CELL BIOCHEM, V220, P69, DOI 10.1023/A:1010899724222; HE TC, 1995, J BIOL CHEM, V270, P11055, DOI 10.1074/jbc.270.19.11055; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; House SJ, 2007, AM J PHYSIOL-CELL PH, V292, pC2276, DOI 10.1152/ajpcell.00606.2006; Illario M, 2003, J BIOL CHEM, V278, P45101, DOI 10.1074/jbc.M305355200; Indolfi C, 2001, CIRC RES, V88, P319, DOI 10.1161/01.RES.88.3.319; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Kahl CR, 2004, J BIOL CHEM, V279, P15411, DOI 10.1074/jbc.M312543200; Kato T, 2000, CIRC RES, V87, P937, DOI 10.1161/01.RES.87.10.937; Kirchhefer U, 1999, CARDIOVASC RES, V42, P254, DOI 10.1016/S0008-6363(98)00296-X; Knoll R, 2011, EUR J HEART FAIL, V13, P811, DOI 10.1093/eurjhf/hfr071; Li BL, 2006, BBA-MOL CELL RES, V1763, P1275, DOI 10.1016/j.bbamcr.2006.09.029; Liang FQ, 2000, HYPERTENSION, V35, P188, DOI 10.1161/01.HYP.35.1.188; Little GH, 2009, J BIOL CHEM, V284, P24857, DOI 10.1074/jbc.M109.003186; Lu YM, 2010, BBA-GENE REGUL MECH, V1799, P429, DOI 10.1016/j.bbagrm.2010.02.004; Lu YM, 2009, CARDIOVASC THER, V27, P17, DOI 10.1111/j.1755-5922.2008.00068.x; Maier LS, 2012, ADV EXP MED BIOL, V740, P685, DOI 10.1007/978-94-007-2888-2_30; Maier LS, 2002, J MOL CELL CARDIOL, V34, P919, DOI 10.1006/jmcc.2002.2038; Mani SK, 2010, J MOL CELL CARDIOL, V48, P342, DOI 10.1016/j.yjmcc.2009.11.007; MAYER P, 1995, BASIC RES CARDIOL, V90, P372, DOI 10.1007/BF00788498; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Planavila A, 2005, CARDIOVASC RES, V65, P832, DOI 10.1016/j.cardiores.2004.11.011; Pleger ST, 2005, MOL THER, V12, P1120, DOI 10.1016/j.ymthe.2005.08.002; Proud CG, 2004, CARDIOVASC RES, V63, P403, DOI 10.1016/j.cardiores.2004.02.003; Regier N, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-57; Rusciano MR, 2012, TRANSL MED UNISA, V4, P66; Santulli G, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001081; Santulli G, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-41; Singer HA, 1997, J BIOL CHEM, V272, P9393; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Sorriento D, 2010, HYPERTENSION, V56, P696, DOI 10.1161/HYPERTENSIONAHA.110.155960; Staal J, 2004, IEEE T MED IMAGING, V23, P501, DOI 10.1109/TMI.2004.825627; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; Tombes RM, 2003, GENE, V322, P17, DOI 10.1016/j.gene.2003.08.023; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Watson LE, 2004, J AM SOC ECHOCARDIOG, V17, P161, DOI 10.1016/j.echo.2003.10.010; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhang T, 2004, RECENT PROG HORM RES, V59, P141, DOI 10.1210/rp.59.1.141; Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326	61	42	45	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130477	10.1371/journal.pone.0130477	http://dx.doi.org/10.1371/journal.pone.0130477			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110816	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800052
J	Saez, JE; Gomez, AV; Barrios, AP; Parada, GE; Galdames, L; Gonazlez, M; Andres, ME				Esteban Saez, Julian; Veronica Gomez, Andrea; Patricio Barrios, Alvaro; Eduardo Parada, Guillermo; Galdames, Leopoldo; Gonazlez, Marcela; Estela Andres, Maria			Decreased Expression of CoREST1 and CoREST2 Together with LSD1 and HDAC1/2 during Neuronal Differentiation	PLOS ONE			English	Article							HISTONE DEMETHYLASE; BRAIN-DEVELOPMENT; CORTICAL-NEURONS; STRUCTURAL BASIS; GENE; REST; COMPLEX; CELLS; SUBSTITUTES; PLASTICITY	CoREST (CoREST1, rcor1) transcriptional corepressor together with the histone demethylase LSD1 (KDM1A) and the histone deacetylases HDAC1/2 form LSD1-CoREST-HDAC (LCH) transcriptional complexes to regulate gene expression. CoREST1 belong to a family that also comprises CoREST2 (rcor2) and CoREST3 (rcor3). CoREST1 represses the expression of neuronal genes during neuronal differentiation. However, the role of paralogs CoREST2 and CoREST3 in this process is just starting to emerge. Here, we report the expression of all CoRESTs and partners LSD1 and HDAC1/2 in two models of neuronal differentiation: Nerve-Growth-Factor (NGF)-induced neuronal phenotype of PC12 cells, and in vitro maturation of embryonic rat cortical neurons. In both models, a concomitant and gradual decrease of LSD1, HDAC1, HDAC2, CoREST1, and CoREST2, but not CoREST3 was observed. As required by the study, full-length rat rcor1 gene was identified using in silico analysis of available rat genome. The work was also complemented by the analysis of rat RNA-seq databases. The analysis showed that all CoRESTs, including the identified four splicing variants of rat CoREST3, display a wide expression in adult tissues. Moreover, the analysis of RNA-seq databases showed that CoREST2 displays a higher expression than CoREST1 and CoREST3 in the mature brain. Immunofluorescent assays and immunoblots of adult rat brain showed that all CoRESTs are present in both glia and neurons. Regarding functional partnership, CoREST2 and CoREST3 interact with all LSD1 splicing variants. In conclusion, neuronal differentiation is accompanied by decreased expression of all core components of LCH complexes, but not CoREST3. The combination of the differential transcriptional repressor capacity of LCH complexes and variable protein levels of its different components should result in a finely tuned gene expression during neuronal differentiation and in the adult brain.	[Esteban Saez, Julian; Veronica Gomez, Andrea; Patricio Barrios, Alvaro; Eduardo Parada, Guillermo; Galdames, Leopoldo; Gonazlez, Marcela; Estela Andres, Maria] Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Cellular & Mol Biol, Santiago, Chile	Pontificia Universidad Catolica de Chile	Andres, ME (corresponding author), Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Cellular & Mol Biol, Alameda 340, Santiago, Chile.	mandres@bio.puc.cl		Parada, Guillermo/0000-0003-1018-9882	Chilean Governmental agency Fondecyt [1110352, 1150200]; Chilean Governmental agency MSI [P10/063-F]; Postdoctoral Fondecyt grant [3140475]	Chilean Governmental agency Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Chilean Governmental agency MSI; Postdoctoral Fondecyt grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was funded by the Chilean Governmental agencies Fondecyt grants No 1110352 and 1150200, and MSI P10/063-F (MEA). Postdoctoral Fondecyt grant No 3140475 (AVG).	Abrajano JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007936; Alarcon R, 2005, J BIOL CHEM, V280, P30406, DOI 10.1074/jbc.M414686200; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; [Anonymous], 2014, NUCL ACIDS RES; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Barrios AP, 2014, MOL CELL BIOL; Campos-Melo D, 2011, NEUROTOX RES, V20, P289, DOI 10.1007/s12640-011-9243-1; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Forneris F, 2007, J BIOL CHEM, V282, P20070, DOI 10.1074/jbc.C700100200; Fuentes P, 2012, CEREB CORTEX, V22, P1431, DOI 10.1093/cercor/bhr218; Gomez AV, 2008, MOL CELL, V31, P222, DOI 10.1016/j.molcel.2008.06.015; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hagelkruys A, 2014, DEVELOPMENT, V141, P604, DOI 10.1242/dev.100487; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MC, 2014, GENE DEV, V28, P2739, DOI 10.1101/gad.252692.114; Lee SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071455; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Qiao Y, 2014, J BIOL CHEM; Rosenbloom K. R., 2014, NUCL ACIDS RES; Rusconi F, 2014, CEREB CORTEX; Sanchez N, 2014, NEUROPHARMACOLOGY, V79, P559, DOI 10.1016/j.neuropharm.2014.01.008; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Toffolo E., 2013, J NEUROCHEM; Tontsch S, 2001, MECH DEVELOP, V108, P165, DOI 10.1016/S0925-4773(01)00477-4; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Upadhyay G, 2014, P NATL ACAD SCI US; Volvert ML, 2014, CELL REP, V7, P1168, DOI 10.1016/j.celrep.2014.03.075; Wang HM, 2004, J NEUROSCI, V24, P10963, DOI 10.1523/JNEUROSCI.3461-04.2004; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012; Yang P, 2011, STEM CELLS, V29, P791, DOI 10.1002/stem.634; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zeng WL, 2010, BIOCHEM BIOPH RES CO, V394, P1024, DOI 10.1016/j.bbrc.2010.03.115; Zhang F., 2014, INT J DISTRIB SENS N, V2014, P1, DOI DOI 10.1038/NCOMMS6815; Zibetti C, 2010, J NEUROSCI, V30, P2521, DOI 10.1523/JNEUROSCI.5500-09.2010	40	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131760	10.1371/journal.pone.0131760	http://dx.doi.org/10.1371/journal.pone.0131760			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111147	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800176
J	Mahmoodian, R; Hamdi, M; Hassan, MA; Akbari, A				Mahmoodian, Reza; Hamdi, M.; Hassan, M. A.; Akbari, Abolghasem			Mechanical and Chemical Characterization of a TiC/C System Synthesized Using a Focus Plasma Arc	PLOS ONE			English	Article							COMBUSTION SYNTHESIS; COMPOSITES; MICROSTRUCTURE; HYDROXYAPATITE; CERAMICS; TITANIUM; BEHAVIOR; POWDERS; PHASE	Titanium carbide-graphite (TiC/C) composite was successfully synthesized from Ti and C starting elemental powders using self-propagating high-temperature synthesis technique in an ultra-high plasma inert medium in a single stage. The TiC was exposed to a high-temperature inert medium to allow recrystallization. The product was then characterized using field emission scanning electron microscopy (FESEM) coupled with energy dispersive X-ray analysis (EDX), X-ray diffraction (XRD), Rietveld refinement, nanoindentation, and microhardness to determine the product's properties. The recorded micro-hardness of the product was 3660 HV, which is a 14% enhancement and makes is comparable to TiC materials.	[Mahmoodian, Reza; Hamdi, M.; Hassan, M. A.] Univ Malaya, Ctr Adv Mfg & Mat Proc AMMP, Dept Mech Engn, Kuala Lumpur 50603, Malaysia; [Mahmoodian, Reza] Azarin Kar Ind Co, Dept Res & Dev, Kerman 7635168361, Iran; [Akbari, Abolghasem] Univ Malaysia Pahang, Fac Civil Engn & Earth Resources, Pahang, Malaysia; [Hassan, M. A.] Assiut Univ, Dept Mech Engn, Assiut 71516, Egypt	Universiti Malaya; Universiti Malaysia Pahang; Egyptian Knowledge Bank (EKB); Assiut University	Mahmoodian, R (corresponding author), Univ Malaya, Ctr Adv Mfg & Mat Proc AMMP, Dept Mech Engn, Kuala Lumpur 50603, Malaysia.	mahmoodian.reza@gmail.com	Akbari, Abolghasem/N-1341-2014; Akbari, Abolghasem/L-5971-2019; Abd Shukor, Mohd Hamdi/B-9093-2010; Mahmoodian, Reza/C-7875-2009; Hassan, Mohsen A./J-9534-2012	Akbari, Abolghasem/0000-0003-4394-1970; Akbari, Abolghasem/0000-0003-4394-1970; Abd Shukor, Mohd Hamdi/0000-0003-2123-3041; Mahmoodian, Reza/0000-0001-5426-7665; Hassan, Mohsen A./0000-0001-8599-7732	Ministry of Higher Education, Malaysia [HIR-MOHE-16001-00-D000001]; BKP [BK064-2014]; UMRG [PR021B-13AET]; Azarin Kar Ind. Co.	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); BKP; UMRG; Azarin Kar Ind. Co.	The authors would like to acknowledge the University of Malaya for providing the necessary facilities and resources for this research. This research was fully funded by the Ministry of Higher Education, Malaysia with the high impact research (HIR) grant number of HIR-MOHE-16001-00-D000001, BKP grant (BK064-2014), UMRG (PR021B-13AET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author R. Mahmoodian was employed by Azarin Kar Ind. Co.. Author RM has not received any payment support from Azarin Kar Ind. Co. for this paper. The Azarin Kar Ind. Co. support was in form given space and using its equipment as courtesy. Azarin Kar Ind. Co. did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Amiriyan M, 2013, J CERAM PROCESS RES, V14, P288; Baradaran S, 2014, CARBON, V69, P32, DOI 10.1016/j.carbon.2013.11.054; Brazhkin VV, 2005, NATO SCI SER II-MATH, V200, P1; Carter CB, 2007, CERAMIC MATERIALS SC; Chen YH, 2013, INTERMETALLICS, V41, P58, DOI 10.1016/j.intermet.2013.05.001; Das K, 2002, J MATER SCI, V37, P3881, DOI 10.1023/A:1019699205003; Ding J, 2013, ADV APPL CERAM, V112, P131, DOI 10.1179/1743676112Y.0000000052; Friedrich A, 2011, MATERIALS, V4, P1648, DOI 10.3390/ma4101648; Hamedi MJ, 2011, OPT LASER ENG, V49, P557, DOI 10.1016/j.optlaseng.2010.12.002; Hassan M. A., 2015, Advanced Materials Research, V1105, P69, DOI 10.4028/www.scientific.net/AMR.1105.69; Hassan MA, 2014, SCI REP-UK, V4, DOI 10.1038/srep03724; Kaminska A, 2008, HIGH TEMP MATER P-US, V12, P121, DOI 10.1615/HighTempMatProc.v12.i1-2.100; Lin J, 2010, INT J REFRACT MET H, V28, P2, DOI 10.1016/j.ijrmhm.2009.07.012; Liu N, 2002, J EUR CERAM SOC, V22, P2409, DOI 10.1016/S0955-2219(02)00010-9; Mahmoodian R, 2013, JOM-US, V65, P80, DOI 10.1007/s11837-012-0498-7; Mahmoodian R, 2014, COMBUST SCI TECHNOL, V186, P737, DOI 10.1080/00102202.2013.878705; Mahmoodian R, 2014, COMPOS PART B-ENG, V59, P279, DOI 10.1016/j.compositesb.2013.12.016; Mahmoodian R, 2013, COMPOS PART B-ENG, V50, P187, DOI 10.1016/j.compositesb.2013.02.016; Mahmoodian R, 2012, HIGH TEMP MATER P-US, V16, P15, DOI 10.1615/HighTempMatProc.2012004708; Naderi S, 2015, MATER DESIGN, V67, P360, DOI 10.1016/j.matdes.2014.11.030; Nikbakht R, 2012, ACTA MATER, V60, P4041, DOI 10.1016/j.actamat.2012.04.017; Rahaei MB, 2012, POWDER TECHNOL, V217, P369, DOI 10.1016/j.powtec.2011.10.050; Shackelford JF, 2010, CRC MATERIALS SCIENC; Sigl LS, 1998, J EUR CERAM SOC, V18, P1521, DOI 10.1016/S0955-2219(98)00071-5; Sonnenburg K, 2009, PHYS CHEM CHEM PHYS, V11, P3300, DOI 10.1039/b822437d; Teber A, 2012, INT J REFRACT MET H, V30, P64, DOI 10.1016/j.ijrmhm.2011.06.013; Tjong SC, 2000, MAT SCI ENG R, V29, P49, DOI 10.1016/S0927-796X(00)00024-3; Tong LR, 2005, SCRIPTA MATER, V52, P1253, DOI 10.1016/j.scriptamat.2005.02.033; Veprek S, 2008, HDB CERAMIC HARD MAT, P104; Young RA, 1993, INTRODUCTION TO THE; Zhu C, 2013, ACTA MATER, V61, P2993, DOI 10.1016/j.actamat.2013.01.059	31	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130836	10.1371/journal.pone.0130836	http://dx.doi.org/10.1371/journal.pone.0130836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111217	gold, Green Published, Green Submitted			2022-12-27	WOS:000356933800092
J	McBreairty, LE; Robinson, JL; Furlong, KR; Brunton, JA; Bertolo, RF				McBreairty, Laura E.; Robinson, Jason L.; Furlong, Kayla R.; Brunton, Janet A.; Bertolo, Robert F.			Guanidinoacetate Is More Effective than Creatine at Enhancing Tissue Creatine Stores while Consequently Limiting Methionine Availability in Yucatan Miniature Pigs	PLOS ONE			English	Article							SKELETAL-MUSCLE; SUPPLEMENTATION; ACID; HOMOCYSTEINE; PERFORMANCE; ARGININE; METABOLISM; PROTEIN; INTERRELATIONSHIPS; PLASMA	Creatine (Cr) is an important high-energy phosphate buffer in tissues with a high energy demand such as muscle and brain and is consequently a highly consumed nutritional supplement. Creatine is synthesized via the S-adenosylmethionine (SAM) dependent methylation of guanidinoacetate (GAA) which is not regulated by a feedback mechanism. The first objective of this study was to determine the effectiveness of GAA at increasing tissue Cr stores. Because SAM is required for other methylation reactions, we also wanted to determine whether an increased creatine synthesis would lead to a lower availability of methyl groups for other methylated products. Three month-old pigs (n = 18) were fed control, GAA-or Cr-supplemented diets twice daily. On day 18 or 19, anesthesia was induced 1-3 hours post feeding and a bolus of [methyl-H-3] methionine was intravenously infused. After 30 minutes, the liver was analyzed for methyl-H-3 incorporation into protein, Cr, phosphatidylcholine (PC) and DNA. Although both Cr and GAA led to higher hepatic Cr concentration, only supplementation with GAA led to higher levels of muscle Cr (P < 0.05). Only GAA supplementation resulted in lower methyl-H-3 incorporation into PC and protein as well as lower hepatic SAM concentration compared to the controls, suggesting that Cr synthesis resulted in a limited methyl supply for PC and protein synthesis (P < 0.05). Although GAA is more effective than Cr at supporting muscle Cr accretion, further research should be conducted into the long term consequences of a limited methyl supply and its effects on protein and PC homeostasis.	[McBreairty, Laura E.; Robinson, Jason L.; Furlong, Kayla R.; Brunton, Janet A.; Bertolo, Robert F.] Mem Univ Newfoundland, Dept Biochem, St John, NF, Canada	Memorial University Newfoundland	Bertolo, RF (corresponding author), Mem Univ Newfoundland, Dept Biochem, St John, NF, Canada.	rbertolo@mun.ca		Brunton, Janet/0000-0002-3038-7870; Furlong, Kayla/0000-0001-7607-1751	Janeway Children's Hospital Foundation; Research and Development Corporation of Newfoundland and Labrador (RDC.org); Canadian Institute of Health Research [201103RNL]	Janeway Children's Hospital Foundation; Research and Development Corporation of Newfoundland and Labrador (RDC.org); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This research was funded by a Janeway Children's Hospital Foundation research grant awarded to RFB LEM JLR. Funding was also provided by The Research and Development Corporation of Newfoundland and Labrador (RDC.org) and the Canadian Institute of Health Research (http://www.cihr-irsc.gc.ca/e/193.html); grant number 201103RNL awarded to RFB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIC RE, 1972, POULTRY SCI, V51, P1098, DOI 10.3382/ps.0511098; Baker DH, 2009, AMINO ACIDS, V37, P29, DOI 10.1007/s00726-008-0198-3; Barber JJ, 2013, J STRENGTH COND RES, V27, P252, DOI 10.1519/JSC.0b013e318252f6b7; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bemben MG, 2005, SPORTS MED, V35, P107, DOI 10.2165/00007256-200535020-00002; Bender A, 2008, NUTR RES, V28, P172, DOI 10.1016/j.nutres.2008.01.001; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; Brault JJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1481, DOI 10.1152/ajpcell.00484.2002; Brosnan JT, 2009, J NUTR, V139, P1292, DOI 10.3945/jn.109.105411; Buchberger W, 2004, J SEP SCI, V27, P1309, DOI 10.1002/jssc.200401866; Chamruspollert M, 2002, BRIT J NUTR, V88, P655, DOI 10.1079/BJN2002732; da Silva RP, 2009, AM J PHYSIOL-ENDOC M, V296, pE256, DOI 10.1152/ajpendo.90547.2008; Deminice R, 2009, BRIT J NUTR, V102, P110, DOI 10.1017/S0007114508162985; Dilger RN, 2013, POULTRY SCI, V92, P171, DOI 10.3382/ps.2012-02425; Edison EE, 2007, AM J PHYSIOL-RENAL, V293, pF1799, DOI 10.1152/ajprenal.00356.2007; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gazzaneo MC, 2011, PEDIATR RES, V70, P253, DOI 10.1203/PDR.0b013e3182276cfa; GORDON A, 1995, CARDIOVASC RES, V30, P413, DOI 10.1016/0008-6363(95)00062-3; Green AL, 1996, AM J PHYSIOL-ENDOC M, V271, pE821, DOI 10.1152/ajpendo.1996.271.5.E821; GREENHAFF PL, 1994, AM J PHYSIOL, V266, pE725, DOI 10.1152/ajpendo.1994.266.5.E725; HARRIS RC, 1992, CLIN SCI, V83, P367, DOI 10.1042/cs0830367; Harris RC, 1997, RES VET SCI, V62, P58, DOI 10.1016/S0034-5288(97)90181-8; Hersch SM, 2006, NEUROLOGY, V66, P250, DOI 10.1212/01.wnl.0000194318.74946.b6; HOFFMAN DR, 1979, CAN J BIOCHEM CELL B, V57, P56, DOI 10.1139/o79-007; Horn M, 1998, J MOL CELL CARDIOL, V30, P277, DOI 10.1006/jmcc.1997.0590; Lamarre SG, 2010, J NUTR, V140, P1570, DOI 10.3945/jn.110.125476; Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200; LOIKE JD, 1988, P NATL ACAD SCI USA, V85, P807, DOI 10.1073/pnas.85.3.807; McBreairty LE, 2013, J NUTR, V143, P804, DOI 10.3945/jn.112.172593; MCGUIRE DM, 1984, J BIOL CHEM, V259, P2034; Michiels J, 2012, POULTRY SCI, V91, P402, DOI 10.3382/ps.2011-01585; Mora L, 2008, MEAT SCI, V79, P709, DOI 10.1016/j.meatsci.2007.11.002; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Ostojic SM, 2014, EUR J NUTR, V53, P1637, DOI 10.1007/s00394-014-0669-0; Ostojic SM, 2013, INT J MED SCI, V10, P141, DOI 10.7150/ijms.5125; Pena-Altamira E, 2005, BRAIN RES, V1058, P183, DOI 10.1016/j.brainres.2005.07.011; Ratnam S, 2006, AM J PHYSIOL-ENDOC M, V290, pE933, DOI 10.1152/ajpendo.00498.2005; Roshan VD, 2013, J SPORT MED PHYS FIT, V53, P232; Stead LM, 2006, AM J CLIN NUTR, V83, P5; Stead LM, 2001, AM J PHYSIOL-ENDOC M, V281, pE1095, DOI 10.1152/ajpendo.2001.281.5.E1095; Steenge GR, 2001, ARCH INTERN MED, V161, P1455, DOI 10.1001/archinte.161.11.1455; Syrotuik DG, 2004, J STRENGTH COND RES, V18, P610; Tachikawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032557; Ueland PM, 2000, AM J CLIN NUTR, V72, P324; VESTER B, 1991, EUR J CLIN CHEM CLIN, V29, P549; Walker J B, 1979, Adv Enzymol Relat Areas Mol Biol, V50, P177; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107	47	43	50	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131563	10.1371/journal.pone.0131563	http://dx.doi.org/10.1371/journal.pone.0131563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110793	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000356933800159
J	Montero-Castano, A; Vila, M				Montero-Castano, Ana; Vila, Montserrat			Direct and Indirect Influence of Non-Native Neighbours on Pollination and Fruit Production of a Native Plant	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; INVASIVE PLANT; GENETIC RELATEDNESS; POLLEN LIMITATION; MUSCARI-COMOSUM; MATING SYSTEM; EXOTIC PLANT; VISITATION; BIODIVERSITY; IMPACTS	Background Entomophilous non-native plants can directly affect the pollination and reproductive success of native plant species and also indirectly, by altering the composition and abundance of floral resources in the invaded community. Separating direct from indirect effects is critical for understanding the mechanisms underlying the impacts of non-native species on recipient communities. Objectives Our aims are: (a) to explore both the direct effect of the non-native Hedysarum coronarium and its indirect effect, mediated by the alteration of floral diversity, on the pollinator visitation rate and fructification of the native Leopoldia comosa and (b) to distinguish whether the effects of the non-native species were due to its floral display or to its vegetative interactions. Methods We conducted field observations within a flower removal experimental setup (i.e. non-native species present, absent and with its inflorescences removed) at the neighbourhood scale. Results Our study illustrates the complexity of mechanisms involved in the impacts of non-native species on native species. Overall, Hedysarum increased pollinator visitation rates to Leopoldia target plants as a result of direct and indirect effects acting in the same direction. Due to its floral display, Hedysarum exerted a direct magnet effect attracting visits to native target plants, especially those made by the honeybee. Indirectly, Hedysarum also increased the visitation rate of native target plants. Due to the competition for resources mediated by its vegetative parts, it decreased floral diversity in the neighbourhoods, which was negatively related to the visitation rate to native target plants. Hedysarum overall also increased the fructification of Leopoldia target plants, even though such an increase was the result of other indirect effects compensating for the observed negative indirect effect mediated by the decrease of floral diversity.	[Montero-Castano, Ana; Vila, Montserrat] CSIC, Agencia Estatal Consejo Super Invest Cient, EBD, Dept Ecol Integrat, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Montero-Castano, A (corresponding author), CSIC, Agencia Estatal Consejo Super Invest Cient, EBD, Dept Ecol Integrat, E-41080 Seville, Spain.	anamontero@ebd.csic.es	Vila, Montserrat/D-9339-2013; Montero, Ana/M-8541-2015	Vila, Montserrat/0000-0003-3171-8261; Montero, Ana/0000-0003-2631-0085	Spanish Ministerio de Economia y Competitividad, through the Severo Ochoa Program for Centres of Excellence in R+D+I [SEV-2012-0262]; Spanish Ministerio de Ciencia e Innovacion [CGL 2007-61165-BOS, CGL 2012-33801, CSD2008-00040]; Eurpean Union 7FP project STEP [244090-STEP-CP-FP]; JAE-Predoc fellowship of the Spanish National Research council(CSIC)	Spanish Ministerio de Economia y Competitividad, through the Severo Ochoa Program for Centres of Excellence in R+D+I; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Eurpean Union 7FP project STEP; JAE-Predoc fellowship of the Spanish National Research council(CSIC)	The Estacion Biologica de Donana recieves financial support from the Spanish Ministerio de Economia y Competitividad, through the Severo Ochoa Program for Centres of Excellence in R+D+I (SEV-2012-0262). Specific funding for this project was provided by the Spanish Ministerio de Ciencia e Innovacion projects REDESIN (CGL 2007-61165-BOS), FLORMAS (CGL 2012-33801) and MONTES (CSD2008-00040), and by the Eurpean Union 7FP project STEP (244090-STEP-CP-FP). AMC was supported by a JAE-Predoc fellowship of the Spanish National Research council(CSIC) (http://www.csic.es/web/guest/home;jsessionid=3BFBEC1AD1D38A6578170C6878D830C2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO DL, 1989, GENETICA, V78, P39; Alvarez ME, 2002, ECOL APPL, V12, P1434, DOI 10.1890/1051-0761(2002)012[1434:CLCOAP]2.0.CO;2; Brown BJ, 2001, OECOLOGIA, V129, P43, DOI 10.1007/s004420100700; Bustamante J., 1998, CULTIVO ZULLA MENORC; Bustamante J., 2007, ALTERNATIVA TRES HOJ; Carvalheiro LG, 2014, ECOL LETT, V17, P1389, DOI 10.1111/ele.12342; Chesson P, 2003, THEOR POPUL BIOL, V64, P345, DOI 10.1016/S0040-5809(03)00095-9; Chittka L, 2001, NATURE, V411, P653, DOI 10.1038/35079676; Crawley M.J., 2007, R BOOK; Cresswell JE, 2004, J APPL ECOL, V41, P539, DOI 10.1111/j.0021-8901.2004.00912.x; Dietzsch AC, 2011, OECOLOGIA, V167, P469, DOI 10.1007/s00442-011-1987-z; Dyer AR, 1999, ECOLOGY, V80, P2697, DOI 10.1890/0012-9658(1999)080[2697:EOCORA]2.0.CO;2; Ferrero V, 2013, BIOL INVASIONS, V15, P2347, DOI 10.1007/s10530-013-0457-4; Flores F, 1997, GENET RESOUR CROP EV, V44, P545, DOI 10.1023/A:1008682019883; Fraga P, 2004, CATALEG FLORA VASCUL; Fridley JD, 2003, J ECOL, V91, P396, DOI 10.1046/j.1365-2745.2003.00775.x; Garrido-Ramos MA, 1998, HEREDITY, V80, P724, DOI 10.1046/j.1365-2540.1998.00344.x; Ghazoul J, 2006, J ECOL, V94, P295, DOI 10.1111/j.1365-2745.2006.01098.x; Gomez-Aparicio L, 2008, J ECOL, V96, P447, DOI 10.1111/j.1365-2745.2007.01352.x; Gomez-Aparicio L, 2008, J ECOL, V96, P78, DOI 10.1111/j.1365-2745.2007.01317.x; Goodell K, 2010, INT J PLANT SCI, V171, P63, DOI 10.1086/647921; Goulson D, 2003, ANNU REV ECOL EVOL S, V34, P1, DOI 10.1146/annurev.ecolsys.34.011802.132355; Gross CL, 2001, BIOL CONSERV, V102, P89, DOI 10.1016/S0006-3207(01)00088-X; Hill PSM, 2001, ANIM BEHAV, V62, P729, DOI 10.1006/anbe.2001.1775; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; HURLBERT SH, 1978, ECOLOGY, V59, P67, DOI 10.2307/1936632; Huryn VMB, 1997, Q REV BIOL, V72, P275; Jakobsson A, 2009, OECOLOGIA, V160, P707, DOI 10.1007/s00442-009-1346-5; Johnson SD, 2003, ECOLOGY, V84, P2919, DOI 10.1890/02-0471; Jones FA, 2008, P ROY SOC B-BIOL SCI, V275, P2759, DOI 10.1098/rspb.2008.0894; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kandori I, 2009, OECOLOGIA, V159, P559, DOI 10.1007/s00442-008-1250-4; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Larson DL, 2006, BIOL CONSERV, V130, P148, DOI 10.1016/j.biocon.2005.12.009; Morales CL, 2009, ECOL LETT, V12, P716, DOI 10.1111/j.1461-0248.2009.01319.x; LAVERTY TM, 1992, OECOLOGIA, V89, P502, DOI 10.1007/BF00317156; Lazaro A, 2010, ECOL ENTOMOL, V35, P652, DOI 10.1111/j.1365-2311.2010.01223.x; Lazaro A, 2010, AM J BOT, V97, P760, DOI 10.3732/ajb.0900263; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Louati-Namouchi I, 2000, AGRONOMIE, V20, P655, DOI 10.1051/agro:2000157; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; McKinney AM, 2010, BIOL INVASIONS, V12, P2751, DOI 10.1007/s10530-009-9680-4; Memmott J, 2002, P ROY SOC B-BIOL SCI, V269, P2395, DOI 10.1098/rspb.2002.2174; MITCHELL RJ, 1994, AM NAT, V143, P870, DOI 10.1086/285637; Molina-Montenegro MA, 2008, OIKOS, V117, P1833, DOI 10.1111/j.0030-1299.2008.16896.x; Montero-Castano A, 2014, ACTA OECOL, V56, P1, DOI 10.1016/j.actao.2014.01.001; Morales CL, 2008, CRIT REV PLANT SCI, V27, P221, DOI 10.1080/07352680802205631; Ortells V, 1983, ELS ANGLICISMES MENO; Pollnac FW, 2009, WEED RES, V49, P242, DOI 10.1111/j.1365-3180.2009.00688.x; Potts SG, 2003, ECOLOGY, V84, P2628, DOI 10.1890/02-0136; R Development Core Team, 2001, R LANG ENV STAT COMP; REJON MR, 1985, BIOCHEM SYST ECOL, V13, P239; Roll J, 1997, CONSERV BIOL, V11, P738, DOI 10.1046/j.1523-1739.1997.96013.x; Satta A., 2000, Cahiers Options Mediterraneennes, V45, P373; Schnurr JL, 2004, ECOLOGY, V85, P741, DOI 10.1890/02-0644; SILANDER JA, 1985, OECOLOGIA, V66, P256, DOI 10.1007/BF00379863; Souto CP, 2002, AM J BOT, V89, P427, DOI 10.3732/ajb.89.3.427; Spigler RB, 2008, J ECOL, V96, P323, DOI 10.1111/j.1365-2745.2007.01335.x; Sulas L., 2000, Cahiers Options Mediterraneennes, V45, P147; TALAVERA S, 1988, Lagascalia, V15, P567; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Totland O, 2006, AM J BOT, V93, P868, DOI 10.3732/ajb.93.6.868; Tuomisto H, 2010, OECOLOGIA, V164, P853, DOI 10.1007/s00442-010-1812-0; Valdes B., 1987, FLORA VASCULAR ANDAL; Vamosi JC, 2006, P NATL ACAD SCI USA, V103, P956, DOI 10.1073/pnas.0507165103; Vila M, 2004, OIKOS, V105, P229, DOI 10.1111/j.0030-1299.2004.12682.x; Vila M, 2015, GLOBAL ECOL BIOGEOGR, V24, P139, DOI 10.1111/geb.12249; Vila M, 2009, P ROY SOC B-BIOL SCI, V276, P3887, DOI 10.1098/rspb.2009.1076; Waters SM, 2014, OIKOS, V123, P433, DOI 10.1111/j.1600-0706.2013.00643.x; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x; Wilcock C, 2002, TRENDS PLANT SCI, V7, P270, DOI 10.1016/S1360-1385(02)02258-6; Yagoubi N, 2000, AGRONOMIE, V20, P933, DOI 10.1051/agro:2000103; ZIMMERMAN M, 1988, AM NAT, V131, P723, DOI 10.1086/284815	75	6	6	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0128595	10.1371/journal.pone.0128595	http://dx.doi.org/10.1371/journal.pone.0128595			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110630	Green Published, gold			2022-12-27	WOS:000356933800012
J	Niess, C; Zacher, H				Niess, Christiane; Zacher, Hannes			Openness to Experience as a Predictor and Outcome of Upward Job Changes into Managerial and Professional Positions	PLOS ONE			English	Article							PERSONALITY-TRAIT DEVELOPMENT; CAREER SUCCESS; 5-FACTOR MODEL; PROPENSITY SCORE; LIFE-COURSE; DIVERGENT-THINKING; SOCIAL INVESTMENT; MEAN-LEVEL; WORK; MOBILITY	In industrial and organizational psychology, there is a long tradition of studying personality as an antecedent of work outcomes. Recently, however, scholars have suggested that personality characteristics may not only predict, but also change due to certain work experiences, a notion that is depicted in the dynamic developmental model (DDM) of personality and work. Upward job changes are an important part of employees' careers and career success in particular, and we argue that these career transitions can shape personality over time. In this study, we investigate the Big Five personality characteristics as both predictors and outcomes of upward job changes into managerial and professional positions. We tested our hypotheses by applying event history analyses and propensity score matching to a longitudinal dataset collected over five years from employees in Australia. Results indicated that participants' openness to experience not only predicted, but that changes in openness to experience also followed from upward job changes into managerial and professional positions. Our findings thus provide support for a dynamic perspective on personality characteristics in the context of work and careers.	[Niess, Christiane] Univ Cologne, Cologne Grad Sch Management Econ & Social Sci, D-50931 Cologne, Germany; [Zacher, Hannes] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands	University of Cologne; University of Groningen	Niess, C (corresponding author), Univ Cologne, Cologne Grad Sch Management Econ & Social Sci, Albertus Magnus Pl, D-50931 Cologne, Germany.	christiane.niess@gmail.com	Zacher, Hannes/X-1659-2018	Zacher, Hannes/0000-0001-6336-2947				Allison P.D., 1984, EVENT HIST ANAL REGR; [Anonymous], 2009, IZA DISCUSSION PAPER; Arthur M. B., 2001, BOUNDARYLESS CAREER; Arthur MB, 2005, J ORGAN BEHAV, V26, P177, DOI 10.1002/job.290; Australian Bureau of Statistics, 2013, ANZSCO AUSTR NZ STAN; BARON JN, 1986, ADMIN SCI QUART, V31, P561, DOI 10.2307/2392964; BARRICK MR, 1991, PERS PSYCHOL, V44, P1, DOI 10.1111/j.1744-6570.1991.tb00688.x; Bass B. M., 1990, BASS STOGDILLS HDB L; Biemann T, 2012, J VOCAT BEHAV, V81, P159, DOI 10.1016/j.jvb.2012.06.003; Boudreau JW, 2001, J VOCAT BEHAV, V58, P53, DOI 10.1006/jvbe.2000.1755; Caldwell R, 2002, PERS REV, V31, P693, DOI 10.1108/00483480210445971; CAPLAN RD, 1987, J VOCAT BEHAV, V31, P248, DOI 10.1016/0001-8791(87)90042-X; Carless SA, 2011, J VOCAT BEHAV, V78, P80, DOI 10.1016/j.jvb.2010.09.002; CASPI A, 1988, DEV PSYCHOL, V24, P824; Cohen J, 1977, STAT POWER ANAL BEHA, V2 2 ed, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; Connelly BS, 2013, PERS PSYCHOL, V66, P407, DOI 10.1111/peps.12020; Costa P. T., 1994, CAN PERSONALITY CHAN, P21, DOI [10.1037/10143-002, DOI 10.1037/10143-002]; Costa P.T., 1985, NEO PERSONALITY INVE; Cox D. R., 1984, ANAL SURVIVAL DATA; CROCKETT HJ, 1962, AM SOCIOL REV, V27, P191, DOI 10.2307/2089675; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; DIGMAN JM, 1989, J PERS, V57, P195, DOI 10.1111/j.1467-6494.1989.tb00480.x; DREHER GF, 1990, J APPL PSYCHOL, V75, P539, DOI 10.1037/0021-9010.75.5.539; Feist G J, 1998, Pers Soc Psychol Rev, V2, P290, DOI 10.1207/s15327957pspr0204_5; Feldman DC, 2007, J MANAGE, V33, P350, DOI 10.1177/0149206307300815; FRESE M, 1982, J OCCUP PSYCHOL, V55, P209, DOI 10.1111/j.2044-8325.1982.tb00095.x; GATTIKER UE, 1988, HUM RELAT, V41, P569, DOI 10.1177/001872678804100801; GOLDBERG LR, 1990, J PERS SOC PSYCHOL, V59, P1216, DOI 10.1037/0022-3514.59.6.1216; Gough H.G., 1990, MEASURES LEADERSHIP, P355; Harder VS, 2010, PSYCHOL METHODS, V15, P234, DOI 10.1037/a0019623; Ho DE, 2011, J STAT SOFTW, V42; Hofstede G., 2001, CULTURES CONSEQUENCE, V2nd, DOI DOI 10.1016/S0005-7967(02)00184-5; HOGAN R, 1994, AM PSYCHOL, V49, P493, DOI 10.1037/0003-066X.49.6.493; HOLLAND JL, 1959, J COUNS PSYCHOL, V6, P35, DOI 10.1037/h0040767; Hudson NW, 2012, J RES PERS, V46, P334, DOI 10.1016/j.jrp.2012.03.002; Ibarra H, 2007, HARVARD BUS REV, V85, P40; Jackson JJ, 2012, PSYCHOL SCI, V23, P270, DOI 10.1177/0956797611423545; Judge TA, 1999, PERS PSYCHOL, V52, P621, DOI 10.1111/j.1744-6570.1999.tb00174.x; Judge TA, 2002, J APPL PSYCHOL, V87, P530, DOI 10.1037//0021-9010.87.3.530; Judge TA, 2000, J APPL PSYCHOL, V85, P751, DOI 10.1037/0021-9010.85.5.751; Judge TA, 2002, J APPL PSYCHOL, V87, P765, DOI 10.1037/0021-9010.87.4.765; JUDGE TA, 1995, PERS PSYCHOL, V48, P485, DOI 10.1111/j.1744-6570.1995.tb01767.x; Judge TA, 2014, ACAD MANAGE IN PRESS; Judge TA, 2014, J APPL PSYCHOL, V99, P199, DOI 10.1037/a0034485; Kanfer R, 2001, J APPL PSYCHOL, V86, P837, DOI 10.1037//0021-9010.86.5.837; KOHN ML, 1978, AM J SOCIOL, V84, P24, DOI 10.1086/226739; KOHN ML, 1982, AM J SOCIOL, V87, P1257, DOI 10.1086/227593; Kristof-Brown AL, 2005, PERS PSYCHOL, V58, P281, DOI 10.1111/j.1744-6570.2005.00672.x; LePine JA, 2000, PERS PSYCHOL, V53, P563, DOI 10.1111/j.1744-6570.2000.tb00214.x; Li WD, 2014, J APPL PSYCHOL, V99, P948, DOI 10.1037/a0036169; MCCAULEY CD, 1994, J APPL PSYCHOL, V79, P544, DOI 10.1037/0021-9010.79.4.544; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P1258, DOI 10.1037/0022-3514.52.6.1258; Melamed T, 1996, J OCCUP ORGAN PSYCH, V69, P217, DOI 10.1111/j.2044-8325.1996.tb00612.x; Melbourne Institute of Applied Economic and Social Research, 2014, HILDA PUBL; Mitchell TR, 2001, ACAD MANAGE REV, V26, P530, DOI 10.2307/3560240; Moutafi J, 2007, BRIT J MANAGE, V18, P272, DOI 10.1111/j.1467-8551.2007.00511.x; Mumford MD, 1998, CREATIVITY RES J, V11, P151, DOI 10.1207/s15326934crj1102_5; Ng TWH, 2007, J OCCUP ORGAN PSYCH, V80, P363, DOI 10.1348/096317906X130582; Ng TWH, 2005, PERS PSYCHOL, V58, P367, DOI 10.1111/j.1744-6570.2005.00515.x; Ones DS, 2007, PERS PSYCHOL, V60, P995, DOI 10.1111/j.1744-6570.2007.00099.x; Peterson NG, 2001, PERS PSYCHOL, V54, P451, DOI 10.1111/j.1744-6570.2001.tb00100.x; PIEDMONT RL, 1991, J PERS SOC PSYCHOL, V60, P630, DOI 10.1037/0022-3514.60.4.630; Roberts BW, 2005, J RES PERS, V39, P166, DOI 10.1016/j.jrp.2004.08.002; Roberts BW, 2003, J PERS SOC PSYCHOL, V84, P582, DOI 10.1037/0022-3514.84.3.582; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Salthouse TA, 2006, PERSPECT PSYCHOL SCI, V1, P68, DOI 10.1111/j.1745-6916.2006.00005.x; SAUCIER G, 1994, J PERS ASSESS, V63, P506, DOI 10.1207/s15327752jpa6303_8; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; SCHNEIDER B, 1987, PERS PSYCHOL, V40, P437, DOI 10.1111/j.1744-6570.1987.tb00609.x; Seibert SE, 2001, J VOCAT BEHAV, V58, P1, DOI 10.1006/jvbe.2000.1757; SIMS RR, 1983, ACAD MANAGE REV, V8, P501, DOI 10.2307/257838; Sonnentag S, 2012, ORGAN PSYCHOL REV, V2, P361, DOI 10.1177/2041386612442079; Specht J, 2011, J PERS SOC PSYCHOL, V101, P862, DOI 10.1037/a0024950; Steiner PM, 2010, PSYCHOL METHODS, V15, P250, DOI 10.1037/a0018719; Stumpf S. A., 1981, ACAD MANAGE REV, V6, P539, DOI DOI 10.5465/AMR.1981.4285668; Tellegen A., 1982, BRIEF MANUAL MULTIDI; Tett RP, 2000, J RES PERS, V34, P397, DOI 10.1006/jrpe.2000.2292; Tharenou P, 1997, AUST PSYCHOL, V32, P19, DOI 10.1080/00050069708259614; Van Vianen AEM, 2003, INT J SELECT ASSESS, V11, P253, DOI 10.1111/j.0965-075X.2003.00249.x; Vinson GA, 2007, INT J SELECT ASSESS, V15, P118, DOI 10.1111/j.1468-2389.2007.00375.x; Wille B, 2014, J APPL PSYCHOL, V99, P262, DOI 10.1037/a0034917; Wille B, 2010, J VOCAT BEHAV, V76, P547, DOI 10.1016/j.jvb.2010.01.007; Wooden M, 2007, ECON REC, V83, P208, DOI 10.1111/j.1475-4932.2007.00395.x; Woods SA, 2013, J ORGAN BEHAV, V34, pS7, DOI 10.1002/job.1863; Yukl G., 1998, LEADERSHIP ORG; Zacher H., 2012, INT J DEV SCI, V6, P177, DOI DOI 10.3233/DEV-2012-12111; Zimmerman RD, 2008, PERS PSYCHOL, V61, P309, DOI 10.1111/j.1744-6570.2008.00115.x	88	37	38	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131115	10.1371/journal.pone.0131115	http://dx.doi.org/10.1371/journal.pone.0131115			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OY	26110527	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800119
J	Sonnevend, A; Ghazawi, AA; Hashmey, R; Jamal, W; Rotimi, VO; Shibl, AM; Al-Jardani, A; Al-Abri, SS; Tariq, WUZ; Weber, S; Pal, T				Sonnevend, Agnes; Ghazawi, Akela A.; Hashmey, Rayhan; Jamal, Wafaa; Rotimi, Vincent O.; Shibl, Atef M.; Al-Jardani, Amina; Al-Abri, Seif S.; Tariq, Waheed U. Z.; Weber, Stefan; Pal, Tibor			Characterization of Carbapenem-Resistant Enterobacteriaceae with High Rate of Autochthonous Transmission in the Arabian Peninsula	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; SULTANATE-OF-OMAN; KLEBSIELLA-PNEUMONIAE; MOLECULAR CHARACTERIZATION; SAUDI-ARABIA; ESCHERICHIA-COLI; GLOBAL SPREAD; OXA-48; RIYADH; NDM-1	To establish the role of local transmission versus possible pathogen import due to previous foreign exposure in infections caused by carbapenem non-susceptible Enterobacteriaceae in the Arabian Peninsula, 200 independent isolates collected in 16 hospitals of Saudi Arabia, Kuwait, Oman and the United Arab Emirates were studied. All strains were multidrug resistant; 42.5% of them also qualified as extremely drug resistant. The frequency of various carbapenemases varied according to the participating countries, but in the collection, as a whole, bla(NDM)-1 was the most frequently encountered carbapenemase gene (46.5%) followed by bla(OXA-48-like) gene (32.5%). A comparatively high rate (8.9%) of multi-clonal strains carrying both bla(NDM) and bla(OXA-48-like) genes in the United Arab Emirates, representing the most resistant subgroup, was encountered. No KPC-expressing isolates were detected. Three major clones of blaNDM-1 carrying Klebsiella pneumoniae of ST152 (n = 22, Saudi Arabia), ST14 (n = 7, United Arab Emirates) and ST147 types (n = 9, Oman) were identified, the latter two clones carrying similar, but not identical HI1b incompatibility type plasmids of > 170kb. While from 78.6% of the cases with documented foreign hospitalization blaNDM positive strains were isolated, these strains formed only 25.6% of all the isolates expressing this enzyme. In fact, 56.8% of the NDM, 75.7% of OXA-48-like and 90.9% of VIM positive strains were recovered from patients without documented foreign exposure, neither in the form of travel or prior hospitalization abroad, suggesting a high rate of autochthonous infections. This, considering the extensive links of these countries to the rest of the world, predicts that trends in the local epidemiology of carbapenem resistant strains may increasingly affect the spread of these pathogens on the global scale. These results call for improved surveillance of carbapenem resistant Enterobacteriaceae in the countries of the Arabian Peninsula.	[Sonnevend, Agnes; Ghazawi, Akela A.; Pal, Tibor] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Med Microbiol & Immunol, Al Ain, U Arab Emirates; [Hashmey, Rayhan] Tawam Hosp, Dept Med, Al Ain, U Arab Emirates; [Jamal, Wafaa; Rotimi, Vincent O.] Kuwait Univ, Fac Med, Dept Microbiol, Kuwait, Kuwait; [Shibl, Atef M.] King Saud Univ, Coll Pharm, Dept Pharmaceut, Riyadh, Saudi Arabia; [Shibl, Atef M.] Alfaisal Univ, Coll Med, Dept Pathol & Pharmacol, Riyadh, Saudi Arabia; [Al-Jardani, Amina] Cent Publ Hlth Labs, Minist Hlth, Muscat, Oman; [Al-Abri, Seif S.] Royal Hosp, Dept Med, Muscat, Oman; [Tariq, Waheed U. Z.] Tawam Hosp, Dept Lab Med, Al Ain, U Arab Emirates; [Weber, Stefan] Sheikh Khalifa Med City, Dept Pathol & Lab Med, Abu Dhabi, U Arab Emirates	United Arab Emirates University; Kuwait University; King Saud University; Alfaisal University; The Royal Hospital, Sultanate of Oman	Pal, T (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Med Microbiol & Immunol, Al Ain, U Arab Emirates.	tpal@uaeu.ac.ae	Sonnevend, Agnes/M-7740-2016; Pal, Tibor/AAX-5789-2020	Sonnevend, Agnes/0000-0002-7065-1736; Pal, Tibor/0000-0002-1815-1937	MERCK/MSD [50193]; College of Medicine and Health Sciences (UAE University) [NP15-30]; UAE University-National Research Research Foundation [31M08531M085]	MERCK/MSD(Merck & Company); College of Medicine and Health Sciences (UAE University); UAE University-National Research Research Foundation	1. MERCK/MSD (http://www.merck.ae/en/index.html) provided a grant (No. 50193) to TP as PI with AS, RH, WJ, VOR, AMS, AA-J, SA-A as coinvestigators. 2. College of Medicine and Health Sciences (UAE University) (http://www.cmhs.uaeu.ac.ae/en/) provided a grant (NP15-30) to TP. 3. UAE University-National Research Research Foundation (http://www.uaeu.ac.ae/en/dvcrgs/research/) provided a grant (31M085) to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn C, 2015, INT J INFECT DIS, V30, P36, DOI 10.1016/j.ijid.2014.11.008; Al Qadheeb NS, 2010, ANN SAUDI MED, V30, P404, DOI 10.4103/0256-4947.67087; Al-Agamy MH, 2013, DIAGN MICR INFEC DIS, V76, P214, DOI 10.1016/j.diagmicrobio.2013.02.006; Balkhy HH, 2012, EUR J CLIN MICROBIOL, V31, P1901, DOI 10.1007/s10096-011-1519-0; Berrazeg M, 2014, Euro Surveill, V19, DOI 10.2807/1560-7917.ES2014.19.20.20809; Clinical Laboratory Standards Institute (CLSI), 2014, PERF STAND ANT SUSC; Dash N, 2014, MICROB DRUG RESIST, V20, P52, DOI 10.1089/mdr.2013.0040; Dashti A, 2011, BMC P S6, V5, P027; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Dortet L, 2012, CLIN MICROBIOL INFEC, V18, pE144, DOI 10.1111/j.1469-0691.2012.03796.x; Dortet L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/249856; Dortet L, 2014, J ANTIMICROB CHEMOTH, V69, P623, DOI 10.1093/jac/dkt433; EUCAST, 2014, EUCAST CLIN BREAKP T; Garbati MA, 2013, J INFECT DEV COUNTR, V7, P713, DOI 10.3855/jidc.2851; Gottig S, 2013, J ANTIMICROB CHEMOTH, V68, P1737, DOI 10.1093/jac/dkt088; Jamal W, 2012, INT J ANTIMICROB AG, V39, P183, DOI 10.1016/j.ijantimicag.2011.10.002; Jamal W, 2013, J MED MICROBIOL, V62, P1239, DOI 10.1099/jmm.0.059915-0; Johnson AP, 2013, J MED MICROBIOL, V62, P499, DOI 10.1099/jmm.0.052555-0; Koh TH, 2010, LANCET INFECT DIS, V10, P828, DOI [10.1016/S1473-3099(10)70275-9, 10.1016/S1473-3099(10)70274-7]; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Marie MA, 2013, MICROBIOL IMMUNOL, V57, P805, DOI 10.1111/1348-0421.12104; Mathers AJ, 2013, J CLIN MICROBIOL, V51, P680, DOI 10.1128/JCM.02580-12; Memish ZA, 2015, MICROB DRUG RESIST, V21, P307, DOI 10.1089/mdr.2014.0121; Nordmann P, 2014, CLIN MICROBIOL INFEC, V20, P821, DOI 10.1111/1469-0691.12719; Nordmann P, 2012, EMERG INFECT DIS, V18, P1503, DOI 10.3201/eid1809.120355; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Poirel L, 2012, J ANTIMICROB CHEMOTH, V67, P2051, DOI 10.1093/jac/dks167; Poirel L, 2012, J ANTIMICROB CHEMOTH, V67, P1597, DOI 10.1093/jac/dks121; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P5403, DOI 10.1128/AAC.00585-11; Poirel L, 2011, J ANTIMICROB CHEMOTH, V66, P304, DOI 10.1093/jac/dkq428; Potron A, 2013, EUROSURVEILLANCE, V18, P9, DOI 10.2807/1560-7917.ES2013.18.31.20549; Potron A, 2011, ANTIMICROB AGENTS CH, V55, P4896, DOI 10.1128/AAC.00481-11; Rahman M, 2014, INT J ANTIMICROB AG, V44, P30, DOI 10.1016/j.ijantimicag.2014.03.003; Schwaber MJ, 2011, CLIN INFECT DIS, V52, P848, DOI 10.1093/cid/cir025; Shibl A, 2013, INT J INFECT DIS, V17, pE1130, DOI 10.1016/j.ijid.2013.06.016; Sonnevend A, 2012, CLIN MICROBIOL INFEC, V18, pE494, DOI 10.1111/1469-0691.12051; Sonnevend A, 2015, J ANTIMICROB CHEMOTH, V70, P1592, DOI 10.1093/jac/dku576; Sonnevend A, 2013, J MED MICROBIOL, V62, P1044, DOI 10.1099/jmm.0.059014-0; Sonnevend A, 2013, J MED MICROBIOL, V62, P582, DOI 10.1099/jmm.0.055681-0; UAEinteract, 2013, QATAR HAV HIGH EXP R; World Health Organization, ANT RES GLOB REP SUR; Zaman TU, 2014, INT J INFECT DIS, V28, P186, DOI 10.1016/j.ijid.2014.05.021; Zowawi HM, 2014, ANTIMICROB AGENTS CH, V58, P3085, DOI [10.1128/AAC.02050-13, 10.1128/AAC.]; Zowawi HM, 2013, CLIN MICROBIOL REV, V26, P361, DOI 10.1128/CMR.00096-12	44	57	57	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131372	10.1371/journal.pone.0131372	http://dx.doi.org/10.1371/journal.pone.0131372			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110660	Green Submitted, gold, Green Published			2022-12-27	WOS:000356933800146
J	Wu, A; Wang, JY; Jia, CX				Wu, Andrew; Wang, Jing-Yu; Jia, Cun-Xian			Religion and Completed Suicide: a Meta-Analysis	PLOS ONE			English	Article							PROTECTIVE FACTOR; RISK-FACTORS; BEHAVIORS; SPIRITUALITY; ADOLESCENTS; INVOLVEMENT; DEPRESSION; HEALTH; SAMPLE; MALES	Introduction Suicide is a major public health concern and a leading cause of death around the world. How religion influences the risk of completed suicide in different settings across the world requires clarification in order to best inform suicide prevention strategies. Methods A meta-analysis using search results from Pubmed and Web of Science databases was conducted following PRISMA protocol and using the keywords "religion" or "religious" or "religiosity" or "spiritual" or "spirituality" plus "suicide" or "suicidality" or "suicide attempt". Random and fixed effects models were used to generate pooled ORs and I-2 values. Sub-analyses were conducted among the following categories: young age (<45yo), older age (>= 45yo), western culture, eastern culture, and religious homogeneity. Results Nine studies that altogether evaluated 2339 suicide cases and 5252 comparison participants met all selection criteria and were included in the meta-analysis. The meta-analysis suggested an overall protective effect of religiosity from completed suicide with a pooled OR of 0.38 (95% CI: 0.21-0.71) and I-2 of 91%. Sub-analyses similarly revealed significant protective effects for studies performed in western cultures (OR = 0.29, 95% CI: 0.18-0.46), areas with religious homogeneity (OR = 0.18, 95% CI: 0.13-0.26), and among older populations (OR = 0.42, 95% CI: 0.21-0.84). High heterogeneity of our meta-analysis was attributed to three studies in which the methods varied from the other six. Conclusion Religion plays a protective role against suicide in a majority of settings where suicide research is conducted. However, this effect varies based on the cultural and religious context. Therefore, public health professionals need to strongly consider the current social and religious atmosphere of a given population when designing suicide prevention strategies.	[Wu, Andrew] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Wang, Jing-Yu; Jia, Cun-Xian] Shandong Univ, Sch Publ Hlth, Dept Epidemiol, Jinan 250100, Peoples R China; [Jia, Cun-Xian] Shandong Univ, Ctr Suicide Prevent Res, Jinan 250100, Peoples R China	Vanderbilt University; Shandong University; Shandong University	Jia, CX (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol, Jinan 250100, Peoples R China.	jiacunxian@sdu.edu.cn			Distinguished Scholar Cultivation Program Fund from Shandong University School of Public Health [JC201301]	Distinguished Scholar Cultivation Program Fund from Shandong University School of Public Health	This work was supported by the Distinguished Scholar Cultivation Program Fund from Shandong University School of Public Health (JC201301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding support does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Almasi K, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-45; Amit BH, 2014, EUR PSYCHIAT, V29, P509, DOI 10.1016/j.eurpsy.2014.04.005; [Anonymous], 2012, MENTAL HLTH SUICIDE; [Anonymous], 2014, ECONOMIST; [Anonymous], 2014, SUICIDE FACT SHEET; [Anonymous], 2014, PREVENTING SUICIDE G; [Anonymous], 2013, FACTS AND FIGURES; Balint L, 2014, J AFFECT DISORDERS, V155, P180, DOI 10.1016/j.jad.2013.10.047; Bando DH, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-124; Bonelli Raphael, 2012, Depress Res Treat, V2012, P962860, DOI 10.1155/2012/962860; Bussu A, 2013, J SOCIO-ECON, V42, P67, DOI 10.1016/j.socec.2012.11.013; Caribe AC, 2012, J NERV MENT DIS, V200, P863, DOI 10.1097/NMD.0b013e31826b6d05; Carli V, 2014, NORD J PSYCHIAT, V68, P44, DOI 10.3109/08039488.2013.767934; Colucci E, 2008, SUICIDE LIFE-THREAT, V38, P229, DOI 10.1521/suli.2008.38.2.229; Corcoran JJ, 2015, SELFLESSNESS SINFULN; Cotton S, 2006, J ADOLESCENT HEALTH, V38, P472, DOI 10.1016/j.jadohealth.2005.10.005; Crabtree S., RELIGIOSITY HIGHEST; Crabtree Steve, RELIG PROVIDES EMOTI; Dima-Cozma C, 2012, J STUDY RELIG IDEOL, V11, P31; Duberstein PR, 2004, PSYCHOL MED, V34, P1331, DOI 10.1017/S0033291704002600; Ellison CG, 1997, SOC FORCES, V76, P273, DOI 10.2307/2580326; Faria Neice Müller Xavier, 2006, Cad. Saúde Pública, V22, P2611, DOI 10.1590/S0102-311X2006001200011; Fellingham GW, 2000, BRIGHAM YOUNG U STUD, V39, P173; Florenzano R, 2014, ASIA-PAC PSYCHIAT, V6, P23, DOI 10.1111/appy.12102; Gearing RE, 2009, J RELIG HEALTH, V48, P332, DOI 10.1007/s10943-008-9181-2; Helliwell JF, 2004, PHILOS T R SOC B, V359, P1435, DOI 10.1098/rstb.2004.1522; Hilton SC, 2002, AM J EPIDEMIOL, V155, P413, DOI 10.1093/aje/155.5.413; Hooghe M, 2011, SUICIDE LIFE-THREAT, V41, P453, DOI 10.1111/j.1943-278X.2011.00047.x; Inglehart R., 2004, HUMAN BELIEFS VALUES; Kannan K, 2010, SAJP-S AFR J PSYCHI, V16, P138; Klein SD, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13102; Koenig Harold G, 2012, ISRN Psychiatry, V2012, P278730, DOI 10.5402/2012/278730; Koenig HG, 2014, J PSYCHOSOM RES, V77, P135, DOI 10.1016/j.jpsychores.2014.05.002; Koenig HG, 2009, CAN J PSYCHIAT, V54, P283, DOI 10.1177/070674370905400502; Krentzman AR, 2010, ALCOHOLISM CLIN EXPT, V34; Kunst AE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-969; Kurihara T, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-327; Langille DB, 2012, SOC PSYCH PSYCH EPID, V47, P1549, DOI 10.1007/s00127-011-0461-x; Li X, 2009, PSYCHOGERIATRICS, V9, P62, DOI 10.1111/j.1479-8301.2009.00269.x; Mandhouj O, 2014, INT J OFFENDER THER, V58, P821, DOI 10.1177/0306624X13491715; Marion MS, 2003, SUICIDE LIFE-THREAT, V33, P33, DOI 10.1521/suli.33.1.33.22780; Nisbet PA, 2000, J NERV MENT DIS, V188, P543, DOI 10.1097/00005053-200008000-00011; Nkansah-Amankra S, 2012, J AFFECT DISORDERS, V139, P40, DOI 10.1016/j.jad.2011.12.027; Polanco-Roman L, 2014, PSYCHIAT RES, V220, P927, DOI 10.1016/j.psychres.2014.09.017; Robinson JA, 2012, DEPRESS ANXIETY, V29, P983, DOI 10.1002/da.21978; Sisask M, 2010, ARCH SUICIDE RES, V14, P44, DOI 10.1080/13811110903479052; Tsoh J, 2005, AM J GERIAT PSYCHIAT, V13, P562, DOI 10.1176/appi.ajgp.13.7.562; Vijayakumar L, 2005, CRISIS, V26, P112, DOI 10.1027/0227-5910.26.3.112; Wang MC, 2013, DEATH STUD, V37, P228, DOI 10.1080/07481187.2011.623215; Wells GA., 2015, NEWCASTLE OTTAWA SCA; WIN-Gallup International, 2012, GLOB IND REL ATH; Yan T., 2003, J POPULATION RES, V27, P73; Yang F, 2014, WILL CHINA BECOME WO; Zhang J, 2004, ACTA PSYCHIAT SCAND, V110, P430, DOI 10.1111/j.1600-0447.2004.00388.x; Zhang J, 2010, PSYCHOL MED, V40, P581, DOI 10.1017/S0033291709990808; Zhang J, 2011, SOC SCI MED, V72, P2003, DOI 10.1016/j.socscimed.2011.03.048	56	72	73	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131715	10.1371/journal.pone.0131715	http://dx.doi.org/10.1371/journal.pone.0131715			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OY	26110867	Green Submitted, gold, Green Published			2022-12-27	WOS:000356933800173
J	Chiu, EC; Lee, Y; Lai, KY; Kuo, CJ; Lee, SC; Hsieh, CL				Chiu, En-Chi; Lee, Yen; Lai, Kuan-Yu; Kuo, Chian-Jue; Lee, Shu-Chun; Hsieh, Ching-Lin			Construct Validity of the Chinese Version of the Activities of Daily Living Rating Scale III in Patients with Schizophrenia	PLOS ONE			English	Article							FUNCTIONAL REMISSION; PERFORMANCE; SKILLS	Background The Chinese version of the Activities of Daily Living Rating Scale III (ADLRS-III), which has 10 domains, is commonly used for assessing activities of daily living (ADL) in patients with schizophrenia. However, construct validity (i.e., unidimensionality) for each domain of the ADLRS-III is unknown, limiting the explanations of the test results. Purpose This main purpose of this study was to examine unidimensionality of each domain in the ADLRS-III. We also examined internal consistency and ceiling/floor effects in patients with schizophrenia. Methods From occupational therapy records, we obtained 304 self-report data of the ADLRS-III. Confirmatory factor analysis (CFA) was conducted to examine the 10 one-factor structures. If a domain showed an insufficient model fit, exploratory factor analysis (EFA) was performed to investigate the factor structure and choose one factor representing the original construct. Internal consistency was examined using Cronbach's alpha (alpha). Ceiling and floor effects were determined by the percentage of patients with the maximum and minimum scores in each domain, respectively. Results CFA analyses showed that 4 domains (i.e., leisure, picture recognition, literacy ability, communication tools use) had sufficient model fits. These 4 domains had acceptable internal consistency (alpha = 0.79-0.87) and no ceiling/floor effects, except the leisure domain which had a ceiling effect. The other 6 domains showed insufficient model fits. The EFA results showed that these 6 domains were two-factor structures. Conclusion The results supported unidimensional constructs of the leisure, picture recognition, literacy ability, and communication tool uses domains. The sum scores of these 4 domains can be used to represent their respective domain-specific functions. Regarding the 6 domains with insufficient model fits, we have explained the two factors of each domain and chosen one factor to represent its original construct. Future users may use the items from the chosen factors to assess domain-specific functions in patients with schizophrenia.	[Chiu, En-Chi; Lee, Shu-Chun; Hsieh, Ching-Lin] Natl Taiwan Univ, Coll Med, Sch Occupat Therapy, Taipei 10764, Taiwan; [Lee, Yen] Univ Wisconsin, Dept Educ Psychol, Madison, WI 53706 USA; [Lai, Kuan-Yu; Kuo, Chian-Jue; Lee, Shu-Chun] Taipei City Hosp, Taipei City Psychiat Ctr, Taipei, Taiwan; [Kuo, Chian-Jue] Taipei Med Univ, Sch Med, Dept Psychiat, Taipei, Taiwan; [Kuo, Chian-Jue] Taipei Med Univ Hosp, Psychiat Res Ctr, Taipei, Taiwan; [Hsieh, Ching-Lin] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan	National Taiwan University; University of Wisconsin System; University of Wisconsin Madison; Taipei City Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University Hospital	Lee, SC (corresponding author), Natl Taiwan Univ, Coll Med, Sch Occupat Therapy, Taipei 10764, Taiwan.	A1057@tpech.gov.tw	Hsieh, Ching-Lin/G-6057-2011; Lee, Yen/HHN-1719-2022	Hsieh, Ching-Lin/0000-0001-9468-9969; Lee, Shu-Chun/0000-0002-8007-0409	Taipei City Government [63]	Taipei City Government	This study was supported by a research grant from the Taipei City Government (No. 63).	Bellack AS, 2007, SCHIZOPHRENIA BULL, V33, P805, DOI 10.1093/schbul/sbl035; Bond TG, 2007, APPL RASCH MODEL FDN; Bowie CR, 2006, AM J PSYCHIAT, V163, P418, DOI 10.1176/appi.ajp.163.3.418; Campo JA, 2004, ACTA NEUROPSYCHIATR, V16, P138, DOI 10.1111/j.0924-2708.2004.00065.x; CASANOVA JS, 1976, AM J OCCUP THER, V30, P101; Chou SC, 2002, INT J QUAL HEALTH C, V14, P49, DOI 10.1093/intqhc/14.1.49; CHU TF, 2004, J TAIWAN OCCUP THER, V22, P1; Chu TF., 1997, ACTIVITIES DAILY LIV; Cintron JA, 2005, J ANXIETY DISORD, V19, P51, DOI 10.1016/j.janxdis.2003.10.007; Culler KH., 1993, WILLARD SPACKMANS OC, P206; Cureton E.E., 1983, FACTOR ANAL APPL APP; Fischer EP, 2002, PSYCHIAT SERV, V53, P724, DOI 10.1176/appi.ps.53.6.724; Forero CG, 2009, STRUCT EQU MODELING, V16, P625, DOI 10.1080/10705510903203573; Haigh EAP, 2011, ASSESSMENT, V18, P11, DOI 10.1177/1073191110386342; Hair J., 2010, MULTIVARIATE DATA AN, V7; Harvey PD, 2014, J CLIN PSYCHIAT, V75, P15, DOI 10.4088/JCP.13049su1c.03; Harvey PD, 2013, SCHIZOPHR RES, V147, P86, DOI 10.1016/j.schres.2013.02.018; Holmes WC, 1997, QUAL LIFE RES, V6, P561, DOI 10.1023/A:1018464200708; Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R; Huang C, 2009, INT J GERIATR PSYCH, V24, P1166, DOI 10.1002/gps.2241; Karow A, 2012, EUR PSYCHIAT, V27, P401, DOI 10.1016/j.eurpsy.2011.01.012; Lam WW, 2012, HLTH EXPECT; Liu YC, 2011, PERCEPT MOTOR SKILL, V112, P703, DOI 10.2466/02.09.13.PMS.112.3.703-710; Llorca PM, 2009, SCHIZOPHR RES, V113, P218, DOI 10.1016/j.schres.2009.04.029; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Minrdila D., 2010, INT J DIGIT SOC, V1, P60; Mosey AC, 1976, ACTIVITIES THERAPY; Nunnally J., 1978, PSYCHOMETRIC THEORY; Patterson TL, 2001, SCHIZOPHRENIA BULL, V27, P235, DOI 10.1093/oxfordjournals.schbul.a006870; Riazi A, 2002, J NEUROL NEUROSUR PS, V73, P701, DOI 10.1136/jnnp.73.6.701; Rogers JC, 1998, WILLARD SPACKMANS OC, P185; Semkovska M, 2004, SCHIZOPHR RES, V69, P289, DOI 10.1016/j.schres.2003.07.005; Siegert RJ, 2010, J REHABIL MED, V42, P302, DOI 10.2340/16501977-0511; Stuart GW, 1987, REHABIL PSYCHIAT NUR, V23, P320; Su CY, 2007, AM J OCCUP THER, V61, P108, DOI 10.5014/ajot.61.1.108; Wang RH, 2012, J NURS RES, V20, P122, DOI 10.1097/jnr.0b013e318254eb47; Wu HW, 2010, J TAIWAN OCCUP THER, V6, P25; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	38	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130702	10.1371/journal.pone.0130702	http://dx.doi.org/10.1371/journal.pone.0130702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1BL	26121246	Green Submitted, Green Published, gold			2022-12-27	WOS:000358150400056
J	Jacquin, S; Rincheval, V; Mignotte, B; Richard, S; Humbert, M; Mercier, O; Londono-Vallejo, A; Fadel, E; Eddahibi, S				Jacquin, S.; Rincheval, V.; Mignotte, B.; Richard, S.; Humbert, M.; Mercier, O.; Londono-Vallejo, A.; Fadel, E.; Eddahibi, S.			Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in Rats	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; PATHWAY; ACTIVATION; PROMOTES	Objective Pulmonary artery smooth muscle cells (PA-SMCs) in pulmonary arterial hypertension (PAH) show similarities to cancer cells. Due to the growth-suppressive and pro-apoptotic effects of p53 and its inactivation in cancer, we hypothesized that the p53 pathway could be altered in PAH. We therefore explored the involvement of p53 in the monocrotaline (MCT) rat model of pulmonary hypertension (PH) and the pathophysiological consequences of p53 inactivation in response to animal treatment with pifithrin-a (PFT, an inhibitor of p53 activity). Methods and Results PH development was assessed by pulmonary arterial pressure, right ventricular hypertrophy and arterial wall thickness. The effect of MCT and PFT on lung p53 pathway expression was evaluated by western blot. Fourteen days of daily PFT treatment (2.2 mg/kg/day), similar to a single injection of MCT (60 mg/kg), induced PH and aggravated MCT-induced PH. In the first week after MCT administration and prior to PH development, p53, p21 and MDM2 protein levels were significantly reduced; whereas PFT administration effectively altered the protein level of p53 targets. Anti-apoptotic and pro-proliferative effects of PFT were revealed by TUNEL and MTT assays on cultured human PA-SMCs treated with 50 mu M PFT. Conclusions Pharmacological inactivation of p53 is sufficient to induce PH with a chronic treatment by PFT, an effect related to its anti-apoptotic and pro-proliferative properties. The p53 pathway was down-regulated during the first week in the rat MCT model. These in vivo experiments implicate the p53 pathway at the initiation stages of PH pathogenesis.	[Jacquin, S.; Humbert, M.] Ctr Chirurg Marie Lannelongue, INSERM, U999, Le Plessis Robinson, France; [Rincheval, V.; Mignotte, B.] Univ Versailles St Quentin En Yvelines, Lab Genet & Biol Cellulaire, Montigny Le Bretonneux, France; [Jacquin, S.; Richard, S.; Eddahibi, S.] Univ Arnaud Villeneuve, Ctr Hosp, INSERM, U1046, Montpellier, France; [Londono-Vallejo, A.] Inst Curie, UMR3244, Telomeres & Canc Lab, Labeled Ligue Contre Canc, Paris, France; [Mercier, O.; Fadel, E.] Ctr Chirurg Marie Lannelongue, Le Plessis Robinson, France	Hopital Marie Lannelongue; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Hopital Marie Lannelongue	Eddahibi, S (corresponding author), Univ Arnaud Villeneuve, Ctr Hosp, INSERM, U1046, Montpellier, France.	saadia.eddahibi@inserm.fr	Humbert, Marc/ABD-5112-2021; Mignotte, Bernard/A-3499-2009; Humbert, Marc/AAC-8459-2019; Londono-Vallejo, Arturo/ABH-5555-2020; Richard, Sylvain/C-9695-2016	Mignotte, Bernard/0000-0002-8512-8518; Humbert, Marc/0000-0003-0703-2892; Londono-Vallejo, Arturo/0000-0003-3535-7563; Mercier, Olaf/0000-0002-4760-6267; Richard, Sylvain/0000-0001-9460-6705	Agence National de la Recherche [ANR-08-GENOPAT- 004]	Agence National de la Recherche(French National Research Agency (ANR))	This work was supported by grants from the Agence National de la Recherche (ANR-08-GENOPAT- 004 to S.E., A.L.-V. and M.H.), Leg Poix (Chancellerie de Paris) and CORDDIM (Domaine d'Interet Majeur: Cardiovasculaire Obesite Rein Diabete, Region lle de France). The "Telomeres and Cancer" laboratory is a team labeled "Ligue Contre le Cancer". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnot S, 2007, INT J CLIN PRACT, V61, P19, DOI 10.1111/j.1742-1241.2007.01618.x; Archer SL, 2008, AM J PHYSIOL-HEART C, V294, pH570, DOI 10.1152/ajpheart.01324.2007; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Eddahibi S, 2006, CIRCULATION, V113, P1857, DOI 10.1161/CIRCULATIONAHA.105.591321; Eddahibi S, 2001, J CLIN INVEST, V108, P1141, DOI 10.1172/JCI12805; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; McMurtry MS, 2005, J CLIN INVEST, V115, P1479, DOI 10.1172/JCI23203; MEYRICK B, 1980, AM J PHYSIOL, V239, pH692, DOI 10.1152/ajpheart.1980.239.5.H692; Mizuno S, 2011, AM J PHYSIOL-LUNG C, V300, pL753, DOI 10.1152/ajplung.00286.2010; Mouraret N, 2013, CIRCULATION, V127, P1664, DOI 10.1161/CIRCULATIONAHA.113.002434; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Rai PR, 2008, AM J RESP CRIT CARE, V178, P558, DOI 10.1164/rccm.200709-1369PP; ROSENBERG HC, 1988, AM J PHYSIOL, V255, pH1484, DOI 10.1152/ajpheart.1988.255.6.H1484; Sakao S, 2011, INT J CARDIOL, V147, P4, DOI 10.1016/j.ijcard.2010.07.003; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Voelkel NF, 1998, CHEST, V114, p225S, DOI 10.1378/chest.114.3_Supplement.225S; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675	22	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131940	10.1371/journal.pone.0131940	http://dx.doi.org/10.1371/journal.pone.0131940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121334	Green Published, Green Submitted, gold			2022-12-27	WOS:000358150400183
J	Jones, PM; George, AM				Jones, Peter M.; George, Anthony M.			The Nucleotide-Free State of the Multidrug Resistance ABC Transporter LmrA: Sulfhydryl Cross-Linking Supports a Constant Contact, Head-to-Tail Configuration of the Nucleotide-Binding Domains	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; HUMAN P-GLYCOPROTEIN; ATP-BINDING; TRANSMEMBRANE SEGMENTS; CONFORMATIONAL-CHANGES; CYSTIC-FIBROSIS; SUBUNIT INTERACTIONS; STRUCTURAL MODEL; CATALYTIC CYCLE; NBD DIMER	ABC transporters are integral membrane pumps that are responsible for the import or export of a diverse range of molecules across cell membranes. ABC transporters have been implicated in many phenomena of medical importance, including cystic fibrosis and multidrug resistance in humans. The molecular architecture of ABC transporters comprises two transmembrane domains and two ATP-binding cassettes, or nucleotide-binding domains (NBDs), which are highly conserved and contain motifs that are crucial to ATP binding and hydrolysis. Despite the improved clarity of recent structural, biophysical, and biochemical data, the seemingly simple process of ATP binding and hydrolysis remains controversial, with a major unresolved issue being whether the NBD protomers separate during the catalytic cycle. Here chemical cross-linking data is presented for the bacterial ABC multidrug resistance (MDR) transporter LmrA. These indicate that in the absence of nucleotide or substrate, the NBDs come into contact to a significant extent, even at 4 degrees C, where ATPase activity is abrogated. The data are clearly not in accord with an inward-closed conformation akin to that observed in a crystal structure of V. cholerae MsbA. Rather, they suggest a head-to-tail configuration 'sandwich' dimer similar to that observed in crystal structures of nucleotide-bound ABC NBDs. We argue the data are more readily reconciled with the notion that the NBDs are in proximity while undergoing intra-domain motions, than with an NBD 'Switch' mechanism in which the NBD monomers separate in between ATP hydrolysis cycles.	[Jones, Peter M.; George, Anthony M.] Univ Technol Sydney, Sch Life Sci, Broadway, NSW 2007, Australia	University of Technology Sydney	George, AM (corresponding author), Univ Technol Sydney, Sch Life Sci, POB 123,Broadway, Broadway, NSW 2007, Australia.	tony.george@uts.edu.au		George, Anthony/0000-0003-4691-8960	University of Technology Sydney [0921e]	University of Technology Sydney	This work was supported by research grant 0921e from The University of Technology Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200; Ambudkar SV, 2006, FEBS LETT, V580, P1049, DOI 10.1016/j.febslet.2005.12.051; Bianchet MA, 1997, J BIOENERG BIOMEMBR, V29, P503, DOI 10.1023/A:1022443209010; Campbell JD, 2005, FEBS LETT, V579, P4193, DOI 10.1016/j.febslet.2005.06.027; Campbell JD, 2004, BIOPHYS J, V87, P3703, DOI 10.1529/biophysj.104.046870; Campbell JD, 2003, BIOCHEMISTRY-US, V42, P3666, DOI 10.1021/bi027337t; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Damas JM, 2011, PROTEIN SCI, V20, P1220, DOI 10.1002/pro.650; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; Daus ML, 2007, J BIOL CHEM, V282, P22387, DOI 10.1074/jbc.M701979200; DOIGE CA, 1993, ANNU REV MICROBIOL, V47, P291, DOI 10.1146/annurev.micro.47.1.291; Furukawa-Hagiya T, 2013, J PHYS CHEM B, V117, P83, DOI 10.1021/jp308315w; George AM, 1996, ARCH BIOCHEM BIOPHYS, V333, P66, DOI 10.1006/abbi.1996.0365; Gottesman MM, 2009, NAT BIOTECHNOL, V27, P546, DOI 10.1038/nbt0609-546; Grote M, 2008, BIOPHYS J, V95, P2924, DOI 10.1529/biophysj.108.132456; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hunke S, 2000, J BIOL CHEM, V275, P15526, DOI 10.1074/jbc.275.20.15526; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Ivetac A, 2007, BIOCHEMISTRY-US, V46, P2767, DOI 10.1021/bi0622571; Jones PM, 2007, J BIOL CHEM, V282, P22793, DOI 10.1074/jbc.M700809200; Jones PM, 2014, Q REV BIOPHYS, V47, P189, DOI 10.1017/S0033583514000031; Jones PM, 2013, CRIT REV BIOCHEM MOL, V48, P39, DOI 10.3109/10409238.2012.735644; Jones PM, 2012, J PHYS CHEM A, V116, P3004, DOI 10.1021/jp211139s; Jones PM, 2011, BIOPHYS J, V100, P3025, DOI 10.1016/j.bpj.2011.05.028; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Jones PM, 2009, PROTEINS, V75, P387, DOI 10.1002/prot.22250; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; Jones PM, 2002, P NATL ACAD SCI USA, V99, P12639, DOI 10.1073/pnas.152439599; Kos V, 2009, CELL MOL LIFE SCI, V66, P3111, DOI 10.1007/s00018-009-0064-9; LEENHOUTS KJ, 1990, APPL ENVIRON MICROB, V56, P2726, DOI 10.1128/AEM.56.9.2726-2735.1990; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loo TW, 2000, J BIOL CHEM, V275, P5253, DOI 10.1074/jbc.275.8.5253; Lubelski J, 2007, MICROBIOL MOL BIOL R, V71, P463, DOI 10.1128/MMBR.00001-07; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Moeller A, 2015, STRUCTURE, V23, P450, DOI 10.1016/j.str.2014.12.013; O'Mara ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091916; Oliveira ASF, 2010, J PHYS CHEM B, V114, P5486, DOI 10.1021/jp905735y; Orelle C, 2010, P NATL ACAD SCI USA, V107, P20293, DOI 10.1073/pnas.1006544107; POWER BE, 1992, GENE, V113, P95, DOI 10.1016/0378-1119(92)90674-E; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; Rosen B P, 1979, Methods Enzymol, V56, P233; Rothnie A, 2005, FEBS LETT, V579, P3984, DOI 10.1016/j.febslet.2005.06.030; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; Serohijos AWR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000008; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Siarheyeva A, 2007, BIOCHEMISTRY-US, V46, P3075, DOI 10.1021/bi062109a; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; Sim HM, 2013, BIOCHEMISTRY-US, V52, P7327, DOI 10.1021/bi4007786; Oliveira AS, 2011, PROTEINS, V79, P1977, DOI 10.1002/prot.23023; van Veen HW, 2000, EMBO J, V19, P2503, DOI 10.1093/emboj/19.11.2503; van Veen HW, 1998, BBA-BIOENERGETICS, V1365, P31, DOI 10.1016/S0005-2728(98)00039-5; VanVeen HW, 1996, P NATL ACAD SCI USA, V93, P10668, DOI 10.1073/pnas.93.20.10668; Velamakanni S, 2008, MOL PHARMACOL, V73, P12, DOI 10.1124/mol.108.038299; Verhalen B, 2011, J BIOL CHEM, V286, P10476, DOI 10.1074/jbc.M110.193151; Vigano C, 2000, J BIOL CHEM, V275, P10962, DOI 10.1074/jbc.275.15.10962; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wen PC, 2008, BIOPHYS J, V95, P5100, DOI 10.1529/biophysj.108.139444; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yu HB, 1999, BIOCHEMISTRY-US, V38, P12033, DOI 10.1021/bi9909492; Zoghbi ME, 2012, J BIOL CHEM, V287, P4157, DOI 10.1074/jbc.M111.318378; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	69	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131505	10.1371/journal.pone.0131505	http://dx.doi.org/10.1371/journal.pone.0131505			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26120849	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400116
J	Mu, GY; Liu, Y; Wang, LM				Mu, Guangyu; Liu, Ying; Wang, Limin			Considering the Spatial Layout Information of Bag of Features (BoF) Framework for Image Classification	PLOS ONE			English	Article								The spatial pooling method such as spatial pyramid matching (SPM) is very crucial in the bag of features model used in image classification. SPM partitions the image into a set of regular grids and assumes that the spatial layout of all visual words obey the uniform distribution over these regular grids. However, in practice, we consider that different visual words should obey different spatial layout distributions. To improve SPM, we develop a novel spatial pooling method, namely spatial distribution pooling (SDP). The proposed SDP method uses an extension model of Gauss mixture model to estimate the spatial layout distributions of the visual vocabulary. For each visual word type, SDP can generate a set of flexible grids rather than the regular grids from the traditional SPM. Furthermore, we can compute the grid weights for visual word tokens according to their spatial coordinates. The experimental results demonstrate that SDP outperforms the traditional spatial pooling methods, and is competitive with the state-of-the-art classification accuracy on several challenging image datasets.	[Mu, Guangyu; Liu, Ying; Wang, Limin] Jilin Univ Finance & Econ, Dept Management Sci & Informat Engn, Changchun, Peoples R China	Jilin University of Finance & Economics	Mu, GY (corresponding author), Jilin Univ Finance & Econ, Dept Management Sci & Informat Engn, Changchun, Peoples R China.	guangyumu@126.com			National Nature Science Foundation of China [61402193, 61202306]; Nature Science Foundation of Jilin Provincial science and technology Department [20130101072JC]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Jilin Provincial science and technology Department	YL was supported by National Nature Science Foundation of China 61402193 (http://www.nsfc.gov.cn/). LM was supported by National Nature Science Foundation of China 61202306 (http://www.nsfc.gov.cn/). GY was supported by Nature Science Foundation of Jilin Provincial science and technology Department 20130101072JC (http://kjt.jl.gov.cn/kjt/4/tindex.shtml).	[Anonymous], 2012, IEEE C COMP VIS PATT; Berg AC, 2005, PROC CVPR IEEE, P26; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Bo L., 2013, IEEE C COMP VIS PATT; Bo L, 2011, NEURAL INFORM PROCES; Boiman O., 2008, IEEE C COMP VIS PATT; Chang C.-C., LIBSVM LIB SUPPORT V; Csurka G, 2004, WORKSH STAT LEARN CO; Dalal N., 2005, IEEE COMPUTER SOC C, V1, P886, DOI DOI 10.1109/CVPR.2005.177; Fei-Fei L., 2004, IEEE C COMP VIS PATT; Felzenszwalb PF, 2010, IEEE T PATTERN ANAL, V32, P1627, DOI 10.1109/TPAMI.2009.167; Griffin G., CALTECH 256 OBJECT C; Jia Y, 2012, IEEE C COMP VIS PATT; Jurie F, 2005, IEEE I CONF COMP VIS, P604; Kobayashi T, 2013, IEEE C COMP VIS PATT; Kulkami N, 2011, IEEE C COMP VIS PATT; Lazebnik S, 2005, IEEE I CONF COMP VIS, P832, DOI 10.1109/ICCV.2005.10; Lazebnik S., 2006, 2006 IEEE COMP SOC C, P2169; Liu X, 2007, INT C IM VID RETR; Nister D, 2005, P 2006 IEEE COMP SOC, P2161; O'Hara S, 2011, ARXIV11013354CSCV; Pandey M., 2011, INT C COMP VIS; Parizi S. N., 2012, IEEE C COMP VIS PATT; Perronnin F., 2007, IEEE C COMP VIS PATT; Philbin J, 2007, IEEE C COMP VIS PATT; Quattoni A, 2009, IEEE C COMP VIS PATT; Sanchez J, 2013, INT J COMPUT VISION, V105, P222, DOI 10.1007/s11263-013-0636-x; Scherer D., 2010, INT C ART NEUR NETW; Sharma G, 2012, PROC CVPR IEEE, P3506, DOI 10.1109/CVPR.2012.6248093; Sivic J, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1470, DOI 10.1109/iccv.2003.1238663; Wang JJ, 2010, PROC CVPR IEEE, P3360, DOI 10.1109/CVPR.2010.5540018; Xie L, 2010, IEEE T PATTERN ANAL, V32, P1627; Yang J., 2009, IEEE C COMP VIS PATT; Yang L., 2008, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/DYSPAN.2008.47; Zhang B, 2015, INT C AC SPEECH SIGN; Zhang H, 2006, IEEE C COMP VIS PATT	37	1	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131164	10.1371/journal.pone.0131164	http://dx.doi.org/10.1371/journal.pone.0131164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121038	gold, Green Submitted, Green Published			2022-12-27	WOS:000358150400081
J	Savio-Galimberti, E; Knollmann, BC				Savio-Galimberti, Eleonora; Knollmann, Bjoern C.			Channel Activity of Cardiac Ryanodine Receptors (RyR2) Determines Potency and Efficacy of Flecainide and R-Propafenone against Arrhythmogenic Calcium Waves in Ventricular Cardiomyocytes	PLOS ONE			English	Article							CA2+ WAVES; ANTIARRHYTHMIC-DRUGS; RELEASE CHANNELS; SUDDEN-DEATH; TACHYCARDIA; ARRHYTHMIAS; SENSITIVITY; INHIBITION; MECHANISMS; CARVEDILOL	Flecainide blocks ryanodine receptor type 2 (RyR2) channels in the open state, suppresses arrhythmogenic Ca2+ waves and prevents catecholaminergic polymorphic ventricular tachycardia (CPVT) in mice and humans. We hypothesized that differences in RyR2 activity induced by CPVT mutations determines the potency of open-state RyR2 blockers like flecainide (FLEC) and R-propafenone (RPROP) against Ca2+ waves in cardiomyocytes. Using confocal microscopy, we studied Ca2+ sparks and waves in isolated saponin-permeabilized ventricular myocytes from two CPVT mouse models (Casq2(-/-), RyR2-R4496C(+/-)), wild-type (c57bl/6, WT) mice, and WT rabbits (New Zealand white rabbits). Consistent with increased RyR2 activity, Ca2+ spark and wave frequencies were significantly higher in CPVT compared to WT mouse myocytes. We next obtained concentration-response curves of Ca2+ wave inhibition for FLEC, RPROP (another open-state RyR2 blocker), and tetracaine (TET) (a state-independent RyR2 blocker). Both FLEC and RPROP inhibited Ca2+ waves with significantly higher potency (lower IC50) and efficacy in CPVT compared to WT. In contrast, TET had similar potency in all groups studied. Increasing RyR2 activity of permeabilized WT myocytes by exposure to caffeine (150 mu M) increased the potency of FLEC and RPROP but not of TET. RPROP and FLEC were also significantly more potent in rabbit ventricular myocytes that intrinsically exhibit higher Ca2+ spark rates than WT mouse ventricular myocytes. In conclusion, RyR2 activity determines the potency of open-state blockers FLEC and RPROP for suppressing arrhythmogenic Ca2+ waves in cardiomyocytes, a mechanism likely relevant to antiarrhythmic drug efficacy in CPVT.	[Savio-Galimberti, Eleonora; Knollmann, Bjoern C.] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA; [Savio-Galimberti, Eleonora; Knollmann, Bjoern C.] Vanderbilt Univ, Sch Med, Oates Inst Expt Therapeut, Dept Med, Nashville, TN 37212 USA; [Savio-Galimberti, Eleonora] Vanderbilt Univ, Sch Med, Div Cardiovasc Med, Dept Med, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Knollmann, BC (corresponding author), Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA.	bjorn.knollmann@vanderbilt.edu		Savio-Galimberti, Eleonora/0000-0001-9974-6213	National Institutes of Health (NIH) [HL88635, HL71670]; American Heart Association (AHA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071670, R01HL124935, R01HL088635] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health (NIH) grants HL88635 and HL71670 (BCK). American Heart Association (AHA) Innovative Research Grant (BCK).	[Anonymous], 1989, NEW ENGL J MED, V321, P406; Bannister ML, 2015, CIRC RES; Bers D, 2001, SARCOPLASMIC RETICUL, P161; Brunton L., 2011, GOODMAN GILMANS PHAR; Chen WQ, 2014, NAT MED, V20, P184, DOI 10.1038/nm.3440; Chopra N, 2013, CARDIOVASC RES, V98, P187, DOI 10.1093/cvr/cvt023; Eisner DA, 2009, J MOL CELL CARDIOL, V46, P474, DOI 10.1016/j.yjmcc.2008.12.005; ENDO M, 1977, PHYSIOL REV, V57, P71, DOI 10.1152/physrev.1977.57.1.71; FABIATO A, 1985, FED PROC, V44, P2970; FABIATO A, 1983, AM J PHYSIOL, V245, pC1; FABIATO A, 1982, FED PROC, V41, P2238; Fernandez-Velasco M, 2009, CIRC RES, V104, P201, DOI 10.1161/CIRCRESAHA.108.177493; Galimberti ES, 2011, J MOL CELL CARDIOL, V51, P760, DOI 10.1016/j.yjmcc.2011.07.002; Hilliard FA, 2010, J MOL CELL CARDIOL, V48, P293, DOI 10.1016/j.yjmcc.2009.10.005; Hoeker GS, 2009, AM J PHYSIOL-HEART C, V297, pH1235, DOI 10.1152/ajpheart.01320.2008; Hollingworth S, 2001, J GEN PHYSIOL, V118, P653, DOI 10.1085/jgp.118.6.653; Hwang HS, 2014, CIRC RES, V114, P1114, DOI 10.1161/CIRCRESAHA.114.303391; Hwang HS, 2011, CIRC-ARRHYTHMIA ELEC, V4, P128, DOI 10.1161/CIRCEP.110.959916; Kang GX, 2010, CIRC RES, V107, P512, DOI 10.1161/CIRCRESAHA.110.221481; Knollmann BC, 2011, NAT MED, V17, P923, DOI 10.1038/nm.2441; Knollmann BC, 2006, J CLIN INVEST, V116, P2510, DOI 10.1172/JCI29128; Laver DR, 2011, J MOL CELL CARDIOL, V51, P357, DOI 10.1016/j.yjmcc.2011.05.009; Liu HJ, 2002, J GEN PHYSIOL, V120, P39, DOI 10.1085/jgp.20028558; Liu N, 2011, CIRC RES, V109, P291, DOI 10.1161/CIRCRESAHA.111.247338; MEISSNER G, 1987, J BIOL CHEM, V262, P3065; Meli AC, 2011, CIRC RES, V109, P281, DOI 10.1161/CIRCRESAHA.111.244970; Nyegaard M, 2012, AM J HUM GENET, V91, P703, DOI 10.1016/j.ajhg.2012.08.015; Pitch E, 2007, AM J PHYSIOL, V293, P1073; Postma AV, 2002, CIRC RES, V91, pE21, DOI 10.1161/01.RES.0000038886.18992.6B; Priori SG, 2001, CIRCULATION, V103, P196; QU YS, 1995, P NATL ACAD SCI USA, V92, P11839, DOI 10.1073/pnas.92.25.11839; ROUSSEAU E, 1986, BIOPHYS J, V50, P1009, DOI 10.1016/S0006-3495(86)83543-3; ROUSSEAU E, 1987, AM J PHYSIOL, V253, pC364, DOI 10.1152/ajpcell.1987.253.3.C364; Roux-Buisson N, 2012, HUM MOL GENET, V21, P2759, DOI 10.1093/hmg/dds104; Shannon TR, 2003, CIRC RES, V93, P592, DOI 10.1161/01.RES.0000093399.11734.B3; Sikkel MB, 2013, CARDIOVASC RES, V98, P286, DOI 10.1093/cvr/cvt012; Suetomi T, 2011, CIRCULATION, V124, P682, DOI 10.1161/CIRCULATIONAHA.111.023259; Trafford AW, 1998, CARDIOVASC RES, V37, P710, DOI 10.1016/S0008-6363(97)00266-6; van der Werf C, 2011, J AM COLL CARDIOL, V57, P2244, DOI 10.1016/j.jacc.2011.01.026; Watanabe H, 2013, HEART RHYTHM, V10, P542, DOI 10.1016/j.hrthm.2012.12.035; Watanabe H, 2009, NAT MED, V15, P380, DOI 10.1038/nm.1942; Xu XJ, 2010, BIOCHEM BIOPH RES CO, V394, P660, DOI 10.1016/j.bbrc.2010.03.046; Zhao YT, 2015, SCI CHINA LIFE SCI, V58, P54, DOI 10.1007/s11427-014-4778-z; Zhou Q, 2011, NAT MED, V17, P1003, DOI 10.1038/nm.2406	44	23	24	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131179	10.1371/journal.pone.0131179	http://dx.doi.org/10.1371/journal.pone.0131179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121139	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400082
J	Jung, EM; da Silva, NPB; Jung, W; Farkas, S; Stroszczynski, C; Rennert, J				Jung, Ernst Michael; da Silva, Natascha Platz Batista; Jung, Wolfgang; Farkas, Stefan; Stroszczynski, Christian; Rennert, Janine			Is Strain Elastography (IO-SE) Sufficient for Characterization of Liver Lesions before Surgical Resection-Or Is Contrast Enhanced Ultrasound (CEUS) Necessary?	PLOS ONE			English	Article							INTRAOPERATIVE ULTRASONOGRAPHY; COLORECTAL-CANCER; EFSUMB GUIDELINES; CLINICAL-USE; METASTASES; RECOMMENDATIONS; SONOGRAPHY; PRINCIPLES; SURGERY	Aim To evaluate the diagnostic accuracy of IO-SE in comparison to IO-CEUS for the differentiation between malignant and benign liver lesions. Material and Methods In a retrospective diagnostic study IO-CEUS and SE examinations of 49 liver lesions were evaluated and compared to histopathological examinations. Ultrasound was performed using a multifrequency linear probe (6-9 MHz). The loops of CEUS were evaluated up to 5 min. The qualitative characterization of IO-SE was based on a color coding system (blue = hard, red = soft). Stiffness of all lesions was quantified by a specific scaling of 0-6 (0 = low, 6 = high) using 7 ROIs (2 central, 5 peripheral). Results All malignant lesions displayed a characteristic portal venous washout and could be diagnosed correctly by IO-CEUS. 3/5 benign lesions could not be characterized properly either by IO-CEUS or IO-SE prior to resection. Thus for IO-CEUS sensitivity, specificity, positive and negative predictive value and accuracy were 100%, 40%, 94%, 100% and 94%. Lesion sizes were between 8 and 59 mm in diameter. Regarding the IO-SE, malignant lesions showed a marked variability. In qualitative analysis, 31 of the malignant lesions were blue colored denoting overall induration. Thirteen malignant lesions showed an inhomogenous color pattern with partial indurations. Two of the benign lesions also displayed overall induration. The other benign lesions showed an inhomogenous color mapping. Calculated sensitivity of the SE was 70.5%, specificity 60%, PPV 94%, NPV 18.75%, and accuracy 69%. Conclusion IO-CEUS is useful for localization and characterization of liver lesions prior to surgical resection whereas IO-SE provided correct characterization only for a limited number of lesions.	[Jung, Ernst Michael; da Silva, Natascha Platz Batista; Stroszczynski, Christian; Rennert, Janine] Univ Hosp Regensburg, Dept Radiol, Regensburg, Germany; [Farkas, Stefan] Univ Hosp Regensburg, Dept Surg, Regensburg, Germany; [Jung, Wolfgang] Univ Saarland, Dept Mat Res, D-66123 Saarbrucken, Germany	University of Regensburg; University of Regensburg; Saarland University	Rennert, J (corresponding author), Univ Hosp Regensburg, Dept Radiol, Regensburg, Germany.	jarennert@yahoo.de	Farkas, Stefan/AAG-5843-2020					Bamber J, 2013, ULTRASCHALL MED, V34, P169, DOI 10.1055/s-0033-1335205; Claudon M, 2013, ULTRASOUND MED BIOL, V39, P187, DOI 10.1016/j.ultrasmedbio.2012.09.002; Conlon Rosie, 2003, Eur J Ultrasound, V16, P211, DOI 10.1016/S0929-8266(02)00075-7; Cosgrove D, 2013, ULTRASCHALL MED, V34, P238, DOI 10.1055/s-0033-1335375; Dietrich CF, 2012, ULTRASCHALL MED, V33, pS3, DOI 10.1055/s-0032-1312897; Fioole B, 2008, EUR J RADIOL, V67, P169, DOI 10.1016/j.ejrad.2007.03.017; Fischer T, 2013, ROFO-FORTSCHR RONTG, V185, P816, DOI 10.1055/s-0033-1335939; Greis C, 2011, RADIOLOGE, V51, P456, DOI 10.1007/s00117-010-2099-1; Jung EM, 2007, WORLD J GASTROENTERO, V13, P6356, DOI 10.3748/wjg.13.6356; Leen E, 2006, ANN SURG, V243, P236, DOI 10.1097/01.sla.0000197708.77063.07; Loss M, 2012, CLIN HEMORHEOL MICRO, V50, P65, DOI 10.3233/CH-2011-1444; Nakano H, 2008, WORLD J GASTROENTERO, V14, P3207, DOI 10.3748/wjg.14.3207; Takahashi M, 2012, BRIT J SURG, V99, P1271, DOI 10.1002/bjs.8844; Torzilli G, 2005, J GASTROINTEST SURG, V9, P1148, DOI 10.1016/j.gassur.2005.08.016; Wege AK, 2012, CLIN HEMORHEOL MICRO, V52, P93, DOI 10.3233/CH-2012-1587; Weskott HP, 2013, LIMITATIONS CE IOUS, P103; Wiggermann P, 2012, ULTRASCHALL MED, V33, P170, DOI 10.1055/s-0031-1281904; Wildi SM, 2008, J CLIN ULTRASOUND, V36, P20, DOI 10.1002/jcu.20408; Zacherl J, 2002, WORLD J SURG, V26, P550, DOI 10.1007/s00268-001-0266-2	19	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0123737	10.1371/journal.pone.0123737	http://dx.doi.org/10.1371/journal.pone.0123737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114286	Green Published, gold			2022-12-27	WOS:000358147500005
J	Takagi, T; Katagiri, H; Kim, Y; Suehara, Y; Kubota, D; Akaike, K; Ishii, M; Mukaihara, K; Okubo, T; Murata, H; Takahashi, M; Kaneko, K; Saito, T				Takagi, Tatsuya; Katagiri, Hirohisa; Kim, Yongji; Suehara, Yoshiyuki; Kubota, Daisuke; Akaike, Keisuke; Ishii, Midori; Mukaihara, Kenta; Okubo, Taketo; Murata, Hideki; Takahashi, Mitsuru; Kaneko, Kazuo; Saito, Tsuyoshi			Skeletal Metastasis of Unknown Primary Origin at the Initial Visit: A Retrospective Analysis of 286 Cases	PLOS ONE			English	Article							OCCULT CARCINOMA; BONE METASTASES; CANCER; PREDICTOR; ADENOCARCINOMA; MILLENNIUM; SEARCH; TUMOR	Background Skeletal metastasis is a common metastatic event for several carcinomas, and the treatment for skeletal metastasis of unknown primary (SMUP) are a critical issue in cancer therapy. Making a diagnosis of the primary site is the most crucial step in the treatment of SMUP; however, the procedures are sometimes difficult and time-consuming, and the primary site often remains unknown. Therefore, to establish optimal diagnostic strategies and elucidate the overall survival rates of SMUP, we conducted this retrospective study. Methods We retrospectively analyzed the clinical data for 286 SMUP cases from a total of 2,641 patients with skeletal metastases who were treated between 2002 and 2014 at our initiations. Results The primary sites were identified in 254/ 286 patients (88.8%), while 32 (11.2%) primary sites were not detected by our diagnostic strategies. Lung cancer was identified in 72 (25.2%) cases, and was the most frequently observed primary lesion. The median survival time of the SMUP patients was 20.0 months, while the median survival times of solitary bone metastasis cases and multi-bone metastasis cases were 39.0 months and 16.0 months, respectively. The median survival times of prostate cancer cases was over 120 months, that of patients with primary lung cancers was 9.0 months and the median survival time of cases who were finally diagnosed with an unknown primary was 11.0 months. Conclusions We believe that our study would contribute to establishing an optimal strategy for diagnosing the primary site in SMUP patients, and our data provide definite indications for the survival times for different SMUP situations.	[Takagi, Tatsuya; Kim, Yongji; Suehara, Yoshiyuki; Kubota, Daisuke; Akaike, Keisuke; Ishii, Midori; Mukaihara, Kenta; Okubo, Taketo; Kaneko, Kazuo] Juntendo Univ, Sch Med, Dept Orthopaed Surg, Tokyo 113, Japan; [Takagi, Tatsuya; Katagiri, Hirohisa; Murata, Hideki; Takahashi, Mitsuru] Shizuoka Canc Ctr, Dept Orthopaed Surg, Shizuoka, Japan; [Saito, Tsuyoshi] Juntendo Univ, Sch Med, Dept Human Pathol, Tokyo 113, Japan	Juntendo University; Shizuoka Cancer Center; Juntendo University	Suehara, Y (corresponding author), Juntendo Univ, Sch Med, Dept Orthopaed Surg, Tokyo 113, Japan.	ysuehara@juntendo.ac.jp			Ministry of Education, Science, Sports and Culture, Tokyo, Japan [26670286, 25861342, 15H04964]; Grants-in-Aid for Scientific Research [26893267] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for General Scientific Research from the Ministry of Education, Science, Sports and Culture (no. 26670286 to Tsuyoshi Saito as well as both no. 25861342 and no. 15H04964 to Yoshiyuki Suehara), Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON MG, 1991, INT ORTHOP, V15, P373, DOI 10.1007/BF00186882; Destombe C, 2007, JOINT BONE SPINE, V74, P85, DOI 10.1016/j.jbspin.2006.05.009; Didolkar MS, 1977, ANN SURG, V186, P625; Freedland SJ, 2008, EUR UROL, V53, P758, DOI 10.1016/j.eururo.2007.08.047; Hirohisa Katagiri MT, 1999, CANCER, V86, P533; Katagiri H, 2014, CANCER MED-US, V3, P1359, DOI 10.1002/cam4.292; MCMILLAN JH, 1982, RADIOLOGY, V143, P143, DOI 10.1148/radiology.143.1.7063718; Murakami S, 2002, DIGEST SURG, V19, P9, DOI 10.1159/000051999; NOTTEBAERT M, 1989, INT ORTHOP, V13, P119, DOI 10.1007/BF00266372; NYSTROM JS, 1977, SEMIN ONCOL, V4, P53; Partin AW, 2001, UROLOGY, V58, P843, DOI 10.1016/S0090-4295(01)01441-8; PUI CH, 1988, BLOOD, V71, P1135; Roobol MJ, 2009, EUR UROL, V56, P584, DOI 10.1016/j.eururo.2009.07.018; ROODMAN ST, 1988, TRANSPLANTATION, V45, P1050, DOI 10.1097/00007890-198806000-00010; ROUGRAFF BT, 1993, J BONE JOINT SURG AM, V75A, P1276, DOI 10.2106/00004623-199309000-00003; Schroder FH, 2014, LANCET, DOI [10.1016/s0140-6736(14), DOI 10.1016/S0140-6736(14)]; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; SHIH LY, 1992, J SURG ONCOL, V51, P109, DOI 10.1002/jso.2930510209; Shimada H, 2014, MOL CLIN ONCOL, V2, P875, DOI 10.3892/mco.2014.326; SIMON MA, 1986, CANCER, V58, P1088, DOI 10.1002/1097-0142(19860901)58:5<1088::AID-CNCR2820580518>3.0.CO;2-9; STEWART JF, 1979, BRIT MED J, V1, P1530, DOI 10.1136/bmj.1.6177.1530; TISI E, 1992, CANCER, V69, P2458, DOI 10.1002/1097-0142(19920515)69:10<2458::AID-CNCR2820691013>3.0.CO;2-5; Ugras N, 2014, ACTA ORTHOP BELG, V80, P139; VEGH Z, 1989, Orvosi Hetilap, V130, P1871	24	25	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129428	10.1371/journal.pone.0129428	http://dx.doi.org/10.1371/journal.pone.0129428			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115010	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500025
J	Yang, SP; Peng, AN; Wei, S; Wu, J; Zhao, JZ; Zhang, YM; Wang, J; Lu, Y; Yu, YZ; Zhang, B				Yang, Shaoping; Peng, Anna; Wei, Sheng; Wu, Jing; Zhao, Jinzhu; Zhang, Yiming; Wang, Jing; Lu, Yuan; Yu, Yuzhen; Zhang, Bin			Pre-Pregnancy Body Mass Index, Gestational Weight Gain, and Birth Weight: A Cohort Study in China	PLOS ONE			English	Article							RISK-FACTORS; PREGNANT-WOMEN; PRETERM BIRTH; MACROSOMIA; CONSEQUENCES; INFANTS; TRENDS	Objective To assess whether pre-pregnancy body mass index (BMI) modify the relationship between gestational weight gain (GWG) and child birth weight (specifically, presence or absence of low birth weight (LBW) or presence of absence of macrosomia), and estimates of the relative risk of macrosomia and LBW based on pre-pregnancy BMI were controlled in Wuhan, China. Methods From June 30, 2011 to June 30, 2013. All data was collected and available from the perinatal health care system. Logistic regression models were used to estimate the independent association among pregnancy weight gain, LBW, normal birth weight, and macrosomia within different pre-pregnancy BMI groups. We built different logistic models for the 2009 Institute of Medicine (IOM) Guidelines and Chinese-recommended GWG which was made from this sample. The Chinese-recommended GWG was derived from the quartile values (25th-75th percentiles) of weight gain at the time of delivery in the subjects which comprised our sample. Results For LBW children, using the recommended weight gain of the IOM and Chinese women as a reference, the OR for a pregnancy weight gain below recommendations resulted in a positive relationship for lean and normal weight women, but not for overweight and obese women. For macrosomia, considering the IOM's recommended weight gain as a reference, the OR magnitude for pregnancy weight gain above recommendations resulted in a positive correlation for all women. The OR for a pregnancy weight gain below recommendations resulted in a negative relationship for normal BMI and lean women, but not for overweight and obese women based on the IOM recommendations, significant based on the recommended pregnancy weight gain for Chinese women. Of normal weight children, 56.6% were above the GWG based on IOM recommendations, but 26.97% of normal weight children were above the GWG based on Chinese recommendations. Conclusions A GWG above IOM recommendations might not be helpful for Chinese women. We need unified criteria to classify adult BMI and to expand the sample size to improve representation and to elucidate the relationship between GWG and related outcomes for developing a Chinese GWG recommendation.	[Yang, Shaoping; Peng, Anna; Zhao, Jinzhu; Zhang, Yiming; Zhang, Bin] Wuhan Women & Children Hlth Care Ctr, Dept Primary Guidance, Wuhan, Hubei Province, Peoples R China; [Wei, Sheng; Wu, Jing] Huazhong Univ Sci & Technol, Tongji Med Coll, Key Lab Environm & Hlth, Minist Educ,Sch Publ Hlth, Wuhan 430074, Peoples R China; [Wei, Sheng; Wu, Jing] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Wang, Jing; Lu, Yuan; Yu, Yuzhen] Maternal & Children Hlth Care Dept Dist Wuhan, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhang, B (corresponding author), Wuhan Women & Children Hlth Care Ctr, Dept Primary Guidance, Wuhan, Hubei Province, Peoples R China.	mchwhzb@aliyun.com	Zhang, Yiming/HGB-7344-2022					Al-Hinai Mustafa, 2013, Sultan Qaboos Univ Med J, V13, P386; Asplund CA, 2008, ANN FAM MED, V6, P550, DOI 10.1370/afm.903; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Borkowski W, 2008, GINEKOL POL, V79, P415; da Fonseca MRCC, 2014, CIENC SAUDE COLETIVA, V19, P1401, DOI 10.1590/1413-81232014195.17022013; Chen Y, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-242; Cheng YKY, 2013, INT J GYNECOL OBSTET, V120, P249, DOI 10.1016/j.ijgo.2012.10.019; Communication UDo, 2009, TRACKING PROGR CHILD; Davis RR, 2012, MATERN CHILD HLTH J, V16, P119, DOI 10.1007/s10995-010-0713-5; Dietz PM, 2009, AM J OBSTET GYNECOL, V201, DOI [10.1016/ j. ajog. 2009.04.051, DOI 10.1016/J.AJ0G.2009.04.051]; El Fekih Chiraz, 2011, Tunis Med, V89, P553; Ezegwui HU, 2011, NIGER J CLIN PRACT, V14, P322, DOI 10.4103/1119-3077.86777; Gu SY, 2012, J BIOMED RES, V26, P235, DOI 10.7555/JBR.26.20120037; Han Z, 2011, INT J EPIDEMIOL, V40, P65, DOI 10.1093/ije/dyq195; Henriksen T, 2008, ACTA OBSTET GYN SCAN, V87, P134, DOI 10.1080/00016340801899289; Hinkle SN, 2010, AM J CLIN NUTR, V92, P644, DOI 10.3945/ajcn.2010.29726; Institute of Medicine, 2009, WEIGHT GAIN PREGN RE; Lertbunnaphong Tripop, 2012, Journal of the Medical Association of Thailand, V95, P853; Li GH, 2014, PAEDIATR PERINAT EP, V28, P345, DOI 10.1111/ppe.12133; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082310; Li S, 2013, OBESITY, V21, P178, DOI 10.1002/oby.20238; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Richardson C, 2014, AM J PERINAT, V31, P927, DOI 10.1055/s-0033-1363769; Salihu HM, 2009, EUR J OBSTET GYN R B, V144, P119, DOI 10.1016/j.ejogrb.2009.02.047; Shrestha I, 2010, Nepal Med Coll J, V12, P106; Sclowitz IKT, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-20; Tomic V, 2007, BOSNIAN J BASIC MED, V7, P271, DOI 10.17305/bjbms.2007.3058; Viswanathan M, 2008, EDUC ASIA PAC REG-IS, V12, P1, DOI 10.1007/978-1-4020-5769-4; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Wong W, 2000, J AM DIET ASSOC, V100, P791, DOI 10.1016/S0002-8223(00)00230-3; Yadav H, 2014, J OBSTET GYNAECOL RE, V40, P439, DOI 10.1111/jog.12209	31	34	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130101	10.1371/journal.pone.0130101	http://dx.doi.org/10.1371/journal.pone.0130101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115015	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500051
J	Yuan, Q; Song, LW; Cavallone, D; Moriconi, F; Cherubini, B; Colombatto, P; Oliveri, F; Coco, BA; Ricco, G; Bonino, F; Shih, JWK; Xia, NS; Brunetto, MR				Yuan, Quan; Song, Liu-Wei; Cavallone, Daniela; Moriconi, Francesco; Cherubini, Beatrice; Colombatto, Piero; Oliveri, Filippo; Coco, Barbara Agata; Ricco, Gabriele; Bonino, Ferruccio; Shih, James Wai Kuo; Xia, Ning-Shao; Brunetto, Maurizia Rossana			Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease	PLOS ONE			English	Article							NATURAL-HISTORY; SURFACE-ANTIGEN; IGM; HBC; INFECTION; HBSAG; MANAGEMENT; GENOTYPE; CARRIERS; VALUES	Non invasive immunologic markers of virus-induced liver disease are unmet needs. We tested the clinical significance of quantitative total and IgM-anti-HBc in well characterized chronic-HBsAg-carriers. Sera (212) were obtained from 111 HBsAg-carriers followed-up for 52 months (28-216) during different phases of chronic-HBV-genotype-D-infection: 10 HBeAg-positive, 25 inactive-carriers (HBV-DNA <= 2000IU/ml, ALT<30U/L), 66 HBeAg-negative-CHB-patients and 10 with HDV-super-infection. In 35 patients treated with Peg-IFN +/- nucleos(t) ide-analogues (NUCs) sera were obtained at baseline, end-of-therapy and week-24-off-therapy and in 22 treated with NUCs (for 60 months, 42-134m) at baseline and end-of-follow-up. HBsAg and IgM-anti-HBc were measured by Architect-assays (Abbott, USA); total-anti-HBc by double-antigen-sandwich-immune-assay (Wantai, China); HBV-DNA by COBAS-TaqMan (Roche, Germany). Total-anti-HBc were detectable in all sera with lower levels in HBsAg-carriers without CHB (immune-tolerant, inactive and HDV-superinfected, median 3.26, range 2.26-4.49 Log(10) IU/ml) versus untreated-CHB (median 4.68, range 2.76-5.54 Log(10) IU/ml), p<0.0001. IgM-anti-HBc positive using the chronic-hepatitis-cut-off" (0.130-S/CO) were positive in 102 of 212 sera (48.1%). Overall total-anti-HBc and IgM-anti-HBc correlated significantly (p<0.001, r=0.417). Total-anti-HBc declined significantly in CHB patients with response to Peg-IFN (p<0.001) and in NUC-treated patients (p<0.001); the lowest levels (median 2.68, range 2.12-3.08 Log(10) IU/ml) were found in long-term responders who cleared HBsAg subsequently. During spontaneous and therapy-induced fluctuations of CHB (remissions and reactivations) total-and IgM-anti-HBc correlated with ALT (p<0.001, r=0.351 and p=0.008, r=0.185 respectively). Total-anti-HBc qualifies as a useful marker of HBV-induced-liver-disease that might help to discriminate major phases of chronic HBV infection and to predict sustained response to antivirals.	[Yuan, Quan; Song, Liu-Wei; Shih, James Wai Kuo; Xia, Ning-Shao] Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen, Peoples R China; [Cavallone, Daniela; Moriconi, Francesco; Cherubini, Beatrice; Colombatto, Piero; Oliveri, Filippo; Coco, Barbara Agata; Ricco, Gabriele; Brunetto, Maurizia Rossana] Univ Hosp Pisa, Lab Mol Genet & Pathol Hepatitis Viruses, Hepatol Unit, Reference Ctr Tuscany Reg Chron Liver Dis & Canc, Pisa, Italy; [Bonino, Ferruccio] Univ Hosp Pisa, Gen Med Unit 2, Digest & Liver Dis, Pisa, Italy	Xiamen University; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Brunetto, MR (corresponding author), Univ Hosp Pisa, Lab Mol Genet & Pathol Hepatitis Viruses, Hepatol Unit, Reference Ctr Tuscany Reg Chron Liver Dis & Canc, Pisa, Italy.	brunettomaurizia@gmail.com	Ricco, Gabriele/K-1286-2018; Bonino, Ferruccio/C-6036-2018; Ricco, Gabriele/AAB-2673-2019; Cavallone, Daniela/AAB-2660-2019; Brunetto, Maurizia/AAU-2906-2020; yuan, quan/GZM-5597-2022; Oliveri, Filippo/GRX-9884-2022	Ricco, Gabriele/0000-0002-7916-5080; Bonino, Ferruccio/0000-0001-9942-0328; Ricco, Gabriele/0000-0002-7916-5080; Cavallone, Daniela/0000-0001-6718-9571; Brunetto, Maurizia/0000-0001-8364-9152; Oliveri, Filippo/0000-0002-9794-7203; Colombatto, Piero/0000-0002-5419-4109; Xia, Ningshao/0000-0003-0179-5266	Abbott; Abbvie; BMS; Gilead; Janssen; MSD; Novartis; Roche; Fujirebio	Abbott(Abbott Laboratories); Abbvie(AbbVie); BMS(Bristol-Myers Squibb); Gilead(Gilead Sciences); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); MSD; Novartis(Novartis); Roche(Roche Holding); Fujirebio	Maurizia Rossana Brunetto: invited speaker at meeting sponsored by Abbott, Abbvie, BMS, Gilead, Janssen, MSD, Novartis and Roche Daniela Cavallone, Francesco Moriconi, Piero Colombatto, Filippo Oliveri, Barbara Coco, Beatrice Cherubini: nothing to declare Ferruccio Bonino: invited speaker at meeting sponsored by Abbvie, BMS, Fujirebio, Gilead, Janssen, MSD and Roche. There are no patents, products in development or marketed products to declare and this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alexopoulou A, 2009, J MED VIROL, V81, P34, DOI 10.1002/jmv.21337; Bonino F, 2007, GUT, V56, P699, DOI 10.1136/gut.2005.089722; Bonino F, 2003, J HEPATOL, V39, pS160, DOI 10.1016/S0168-8278(03)00319-2; Brunetto MR, 2013, J HEPATOL, V59, P1153, DOI 10.1016/j.jhep.2013.07.017; Brunetto MR, 2010, GASTROENTEROLOGY, V139, P483, DOI 10.1053/j.gastro.2010.04.052; Brunetto MR, 2002, J HEPATOL, V36, P263, DOI 10.1016/S0168-8278(01)00266-5; BRUNETTO MR, 1993, J HEPATOL, V19, P431, DOI 10.1016/S0168-8278(05)80554-9; Cacciola I, 2005, LIVER INT, V25, P555, DOI 10.1111/j.1478-3231.2005.01048.x; Colloredo G, 1999, J VIRAL HEPATITIS, V6, P429, DOI 10.1046/j.1365-2893.1999.00171.x; Colloredo G, 1996, J HEPATOL, V25, P644, DOI 10.1016/S0168-8278(96)80233-9; European Association For The Study Of The Liver, 2012, J HEPATOL, V57, P167, DOI DOI 10.1016/J.JHEP.2012.02.010; Fan Rong, 2015, GUT, DOI [10.1136/gutjnl-2014-308546, DOI 10.1136/GUTJNL-2014-308546]; Fattovich Giovanna, 2003, Journal of Hepatology, V39, pS50; FERRARI C, 1991, J CLIN INVEST, V88, P214, DOI 10.1172/JCI115280; Galli C, 2008, J MED VIROL, V80, P974, DOI 10.1002/jmv.21179; GERLICH WH, 1986, J CLIN MICROBIOL, V24, P288, DOI 10.1128/JCM.24.2.288-293.1986; Hadziyannis SJ, 2006, SEMIN LIVER DIS, V26, P130, DOI 10.1055/s-2006-939751; Han QJ, 2013, SEMIN IMMUNOPATHOL, V35, P23, DOI 10.1007/s00281-012-0331-y; HOOFNAGLE JH, 1985, DIGEST DIS SCI, V30, P1022, DOI 10.1007/BF01315598; Janssen HLA, 2012, GUT, V61, P641, DOI 10.1136/gutjnl-2011-301096; KRYGER P, 1982, HEPATOLOGY, V2, P50; Li A, 2010, CLIN VACCINE IMMUNOL, V17, P464, DOI 10.1128/CVI.00457-09; Marcellin P, 2013, HEPATOL INT, V7, P88, DOI 10.1007/s12072-012-9343-x; MARINOS G, 1994, HEPATOLOGY, V19, P303; MILICH DR, 1986, SCIENCE, V234, P1398, DOI 10.1126/science.3491425; Milich DR, 1997, P NATL ACAD SCI USA, V94, P14648, DOI 10.1073/pnas.94.26.14648; MILICH DR, 1987, NATURE, V329, P547, DOI 10.1038/329547a0; Rodella A, 2006, J CLIN VIROL, V37, P206, DOI 10.1016/j.jcv.2006.06.011; Song LW, 2015, CLIN MICROBIOL INFEC, V21, P197, DOI 10.1016/j.cmi.2014.10.002; Yuan Q, 2013, GUT, V62, P182, DOI 10.1136/gutjnl-2012-302656	30	101	105	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130209	10.1371/journal.pone.0130209	http://dx.doi.org/10.1371/journal.pone.0130209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115521	gold, Green Published, Green Submitted			2022-12-27	WOS:000358147500056
J	Friedrich, M; Meier, D; Schuster, I; Nellen, W				Friedrich, Michael; Meier, Doreen; Schuster, Isabelle; Nellen, Wolfgang			A Simple Retroelement Based Knock-Down System in Dictyostelium: Further Insights into RNA Interference Mechanisms	PLOS ONE			English	Article							HEAVY-CHAIN GENE; HOMOLOGOUS RECOMBINATION; MESSENGER-RNA; PLASMID DNA; DISCOIDEUM; EXPRESSION; ANTISENSE; SEQUENCE; PROTEIN; DIRS-1	We have previously shown that the most abundant Dictyostelium discoideum retroelement DIRS-1 is suppressed by RNAi mechanisms. Here we provide evidence that both inverted terminal repeats have strong promoter activity and that bidirectional expression apparently generates a substrate for Dicer. A cassette containing the inverted terminal repeats and a fragment of a gene of interest was sufficient to activate the RNAi response, resulting in the generation of similar to 21 nt siRNAs, a reduction of mRNA and protein expression of the respective endogene. Surprisingly, no transitivity was observed on the endogene. This was in contrast to previous observations, where endogenous siRNAs caused spreading on an artificial transgene. Knock-down was successful on seven target genes that we examined. In three cases a phenotypic analysis proved the efficiency of the approach. One of the target genes was apparently essential because no knock-out could be obtained; the RNAi mediated knock-down, however, resulted in a very slow growing culture indicating a still viable reduction of gene expression.	[Friedrich, Michael; Meier, Doreen; Schuster, Isabelle; Nellen, Wolfgang] Univ Kassel, Abt Genet, FB 10, D-34125 Kassel, Germany	Universitat Kassel	Nellen, W (corresponding author), Brawijaya Univ, Dept Biol, Malang, East Java, Indonesia.	nellen@uni-kassel.de			Deutsche Forschungsgemeinschaft [FOR 1082, Ne285/14-1]; Promotionsstipendium des Landes Hessen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Promotionsstipendium des Landes Hessen	This work was supported by the Deutsche Forschungsgemeinschaft, FOR 1082, Ne285/14-1 (http://gepris.dfg.de/gepris/projekt/65636347), WN Promotionsstipendium des Landes Hessen (https://wissenschaft.hessen.de/wissenschaft/wissenschaftlicher-nachwuchs/promotionsstipendien) to DM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZAWA H, 1995, J BIOL CHEM, V270, P10923, DOI 10.1074/jbc.270.18.10923; ANDRE E, 1989, J CELL BIOL, V108, P985, DOI 10.1083/jcb.108.3.985; Bloomfield G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r75; Boeckeler K, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-12; Boesler B, 2014, J BIOL CHEM, V289, P35124, DOI 10.1074/jbc.M114.612663; CAPPELLO J, 1985, CELL, V43, P105, DOI 10.1016/0092-8674(85)90016-9; CHUNG S, 1983, NUCLEIC ACIDS RES, V11, P4835, DOI 10.1093/nar/11.14.4835; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COHEN SM, 1984, MOL CELL BIOL, V4, P2332, DOI 10.1128/MCB.4.11.2332; CROWLEY TE, 1985, CELL, V43, P633, DOI 10.1016/0092-8674(85)90235-1; DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Dubin MJ, 2011, EUKARYOT CELL, V10, P352, DOI 10.1128/EC.00196-10; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Gaudet P, 2007, NAT PROTOC, V2, P1317, DOI 10.1038/nprot.2007.179; Glockner G, 2009, NUCLEIC ACIDS RES, V37, P1809, DOI 10.1093/nar/gkp017; GUNTAKA RV, 1993, MICROBIOL REV, V57, P511, DOI 10.1128/MMBR.57.3.511-521.1993; Hinas A, 2007, NUCLEIC ACIDS RES, V35, P6714, DOI 10.1093/nar/gkm707; KIKKAWA U, 1992, MOL CELL BIOL, V12, P5711, DOI 10.1128/MCB.12.12.5711; KLAVER B, 1994, J VIROL, V68, P3830, DOI 10.1128/JVI.68.6.3830-3840.1994; KNECHT DA, 1987, SCIENCE, V236, P1081, DOI 10.1126/science.3576221; KUSPA A, 1992, P NATL ACAD SCI USA, V89, P8803, DOI 10.1073/pnas.89.18.8803; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Martens H, 2002, MOL BIOL CELL, V13, P445, DOI 10.1091/mbc.01-04-0211; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Morita T, 2004, J CELL SCI, V117, P5759, DOI 10.1242/jcs.01499; Myers SA, 2006, MOL BIOL CELL, V17, P4564, DOI 10.1091/mbc.E05-10-0994; NELLEN W, 1993, TRENDS BIOCHEM SCI, V18, P419, DOI 10.1016/0968-0004(93)90137-C; Pak J, 2012, CELL, V151, P885, DOI 10.1016/j.cell.2012.10.022; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Parikh A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r35; Piednoel M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-621; Popova B, 2006, NUCLEIC ACIDS RES, V34, P773, DOI 10.1093/nar/gkj465; Rot G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-265; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shina MC, 2011, CELL MOL LIFE SCI, V68, P303, DOI 10.1007/s00018-010-0455-y; Spann TP, 1996, P NATL ACAD SCI USA, V93, P5003, DOI 10.1073/pnas.93.10.5003; Veltman DM, 2009, PLASMID, V61, P110, DOI 10.1016/j.plasmid.2008.11.003; WALLRAFF E, 1986, EMBO J, V5, P61, DOI 10.1002/j.1460-2075.1986.tb04178.x; WELINDER BS, 1986, J CHROMATOGR, V361, P357; Wiegand S, 2014, NUCLEIC ACIDS RES, V42, P3330, DOI 10.1093/nar/gkt1337; Wiegand S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064804; Wiegand S, 2011, GENOMICS, V97, P321, DOI 10.1016/j.ygeno.2011.02.001; WITKE W, 1987, EMBO J, V6, P4143, DOI 10.1002/j.1460-2075.1987.tb02760.x	44	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131271	10.1371/journal.pone.0131271	http://dx.doi.org/10.1371/journal.pone.0131271			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110905	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800139
J	Gordon, CL; Cheng, AC; Cameron, PU; Bailey, M; Crowe, SM; Mills, J				Gordon, Claire L.; Cheng, Allen C.; Cameron, Paul U.; Bailey, Michael; Crowe, Suzanne M.; Mills, John			Quantitative Assessment of Intra-Patient Variation in CD4+T Cell Counts in Stable, Virologically-Suppressed, HIV-Infected Subjects	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LYMPHOCYTE COUNTS; ANTIRETROVIRAL THERAPY; VARIABILITY; INDIVIDUALS; SUBSETS; DISEASE; COHORT; MEN	Objectives Counts of absolute CD4+ T lymphocytes (CD4+ T cells) are known to be highly variable in untreated HIV-infected individuals, but there are no data in virologically-suppressed individuals. We investigated CD4+ T cell variability in stable, virologically-suppressed, HIV-1 infected adults on combination antiretroviral therapy (cART). Methods From a large hospital database we selected patients with stable virological suppression on cART for >3 years with >10 CD4+ T cell measurements performed over a further >2 years; and a control group of 95 patients not on cART. Results We identified 161 HIV-infected patients on cART without active HCV or HBV infection, with stable virological suppression for a median of 6.4 years. Over the study period 88 patients had reached a plateau in their absolute CD4+ T cell counts, while 65 patients had increasing and 8 patients had decreasing absolute CD4+ T cell counts. In patients with plateaued CD4+ T cell counts, variability in absolute CD4+ T cell counts was greater than in percent CD4+ T cells (median coefficient of variation (CV) 16.6% [IQR 13.8-20.1%] and CV 9.6% [IQR 7.4-13.0%], respectively). Patients with increasing CD4+ T cell counts had greater variability in absolute CD4+ T cell counts than those with plateaued CD4 T cell counts (CV 19.5% [IQR 16.1-23.8%], p<0.001) while there was no difference in percent CD4+ T cell variability between the two groups. As previously reported, untreated patients had CVs significantly higher than patients on cART (CVs of 21.1% [IQR 17.2-32.0%], p<0.001 and 15.2%(IQR 10.7-20.0%), p<0.001, respectively). Age or sex did not affect the degree of CD4+ variation. Conclusions Adults with stable, virologically-suppressed HIV infection continue to have significant variations in individual absolute CD4+ T cell and percent CD4+ T cell counts; this variation can be of clinical relevance especially around CD4+ thresholds. However, the variation seen in individuals on cART is substantially less than in untreated subjects.	[Gordon, Claire L.; Cheng, Allen C.; Cameron, Paul U.; Crowe, Suzanne M.; Mills, John] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Cheng, Allen C.; Bailey, Michael; Mills, John] Monash Univ, Dept Epidemiol & Preventat Med, Melbourne, Vic, Australia; [Cameron, Paul U.; Crowe, Suzanne M.; Mills, John] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia; [Mills, John] Monash Univ, Dept Med, Cent Clin Sch, Melbourne, Vic, Australia	Florey Institute of Neuroscience & Mental Health; Monash University; Burnet Institute; Monash University	Crowe, SM (corresponding author), Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia.	crowe@burnet.edu.au	Bailey, Michael J/A-4499-2012	Bailey, Michael J/0000-0002-5551-1401; Cheng, Allen/0000-0003-3152-116X; Gordon, Claire/0000-0001-5172-4728; Cameron, Paul Urquhart/0000-0002-1906-6945	Australian National Health & Medical Research Council (NH&MRC) Principal Research Fellowship; NH&MRC Career Development Fellowship	Australian National Health & Medical Research Council (NH&MRC) Principal Research Fellowship; NH&MRC Career Development Fellowship	SMC is the recipient of an Australian National Health & Medical Research Council (NH&MRC) Principal Research Fellowship, and ACC is supported by an NH&MRC Career Development Fellowship. SMC, ACC, PUC, CLG and JM are or were employees of The Alfred Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHM, 2022, HIV MAN AUSTR GUID; Bergeron M, 2010, CYTOM PART B-CLIN CY, V78B, P41, DOI 10.1002/cyto.b.20487; Costiniuk CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028570; CROWE SM, 1991, J ACQ IMMUN DEF SYND, V4, P770; Ford N, 2014, AIDS, V28, P2003, DOI 10.1097/QAD.0000000000000406; Girard PM, 2013, AIDS, V27, P2759, DOI 10.1097/01.aids.0000432458.98851.c1; HOOVER DR, 1992, J ACQ IMMUN DEF SYND, V5, P794; HUGHES MD, 1994, J INFECT DIS, V169, P28, DOI 10.1093/infdis/169.1.28; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; LaPerriere A, 1997, INT J SPORTS MED, V18, pS56, DOI 10.1055/s-2007-972700; LAURENCE J, 1993, ANN INTERN MED, V119, P55, DOI 10.7326/0003-4819-119-1-199307010-00010; Maini MK, 1996, GENITOURIN MED, V72, P27; MALONE JL, 1990, J ACQ IMMUN DEF SYND, V3, P144; Massanella M, 2010, ANTIVIR THER, V15, P333, DOI 10.3851/IMP1531; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; RABOUD JM, 1995, J ACQ IMMUN DEF SYND, V10, pS67; Raboud JM, 1996, J INFECT DIS, V174, P191, DOI 10.1093/infdis/174.1.191; Rabson A, 1995, AIDS Clin Care, V7, P1; SAX PE, 1995, CLIN INFECT DIS, V21, P1121, DOI 10.1093/clinids/21.5.1121; TURNER BJ, 1994, ARCH INTERN MED, V154, P1561, DOI 10.1001/archinte.154.14.1561; VANROOD Y, 1991, CLIN EXP IMMUNOL, V86, P349; Vitoria M, 2013, CURR OPIN HIV AIDS, V8, P12, DOI 10.1097/COH.0b013e32835b8123; WHO, ANT THER HIV INF AD	23	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0125248	10.1371/journal.pone.0125248	http://dx.doi.org/10.1371/journal.pone.0125248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110761	Green Published, gold			2022-12-27	WOS:000356933800002
J	Lee, HJ; Kim, SK; Park, H; Kim, HB; Jeon, HS; Jung, YJ; Oh, E; Kim, HJ; Yun, JY; Jeon, BS; Park, KS				Lee, Hong Ji; Kim, Sang Kyong; Park, Hyeyoung; Kim, Han Byul; Jeon, Hyo Seon; Jung, Yu Jin; Oh, Eungseok; Kim, Hee Jin; Yun, Ji Young; Jeon, Beom S.; Park, Kwang Suk			Clinicians' Tendencies to Under-Rate Parkinsonian Tremors in the Less Affected Hand	PLOS ONE			English	Article							RATING-SCALE; DISEASE; QUANTIFICATION; RELIABILITY; MOVEMENT; UPDRS; KAPPA	The standard assessment method for tremor severity in Parkinson's disease is visual observation by neurologists using clinical rating scales. This is, therefore, a subjective rating that is dependent on clinical expertise. The objective of this study was to report clinicians' tendencies to under-rate Parkinsonian tremors in the less affected hand. This was observed through objective tremor measurement with accelerometers. Tremor amplitudes were measured objectively using tri-axis-accelerometers for both hands simultaneously in 53 patients with Parkinson's disease during resting and postural tremors. The videotaped tremor was rated by neurologists using clinical rating scales. The tremor measured by accelerometer was compared with clinical ratings. Neurologists tended to under-rate the less affected hand in resting tremor when the contralateral hand had severe tremor in Session I. The participating neurologists corrected this tendency in Session II after being informed of it. The under-rating tendency was then repeated by other uninformed neurologists in Session III. Kappa statistics showed high inter-rater agreements and high agreements between estimated scores derived from the accelerometer signals and the mean Clinical Tremor Rating Scale evaluated in every session. Therefore, clinicians need to be aware of this under-rating tendency in visual inspection of the less affected hand in order to make accurate tremor severity assessments.	[Lee, Hong Ji; Kim, Sang Kyong; Kim, Han Byul; Jeon, Hyo Seon] Seoul Natl Univ, Interdisciplinary Program Bioengn, Seoul, South Korea; [Park, Hyeyoung; Jeon, Beom S.] Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea; [Park, Hyeyoung; Jeon, Beom S.] Seoul Natl Univ Hosp, Movement Disorder Ctr, Seoul 110744, South Korea; [Jung, Yu Jin] Kyung Hee Univ Hosp Gangdong, Dept Neurol, Seoul, South Korea; [Oh, Eungseok] Chungnam Natl Univ Hosp, Dept Neurol, Daejeon, South Korea; [Kim, Hee Jin] Konkuk Univ Hosp, Dept Neurol, Seoul, South Korea; [Yun, Ji Young] Ewha Womans Univ, Mokdong Hosp, Dept Neurol, Seoul, South Korea; [Park, Kwang Suk] Seoul Natl Univ, Dept Biomed Engn, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Kyung Hee University; Kyung Hee University Hospital; Chungnam National University; Chungnam National University Hospital; Konkuk University; Konkuk University Medical Center; Ewha Womans University; Seoul National University (SNU)	Park, KS (corresponding author), Seoul Natl Univ, Dept Biomed Engn, Seoul, South Korea.	pks@bmsil.snu.ac.kr	Oh, Eungseok/AAL-8935-2020	Oh, Eungseok/0000-0003-2068-3235	Ministry of Health and Welfare [HI13C0455]; BK21 Plus Program through the National Research Foundation of Korea (NRF) - Ministry of Education [22A20130011025]	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); BK21 Plus Program through the National Research Foundation of Korea (NRF) - Ministry of Education	HJL, SKK, HYP, HBK, HSJ, BSJ, and KSP received grant support from the Ministry of Health and Welfare (No. HI13C0455) and BK21 Plus Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant numbers 22A20130011025) in the data collection. YJJ, ESO, HJK, and JYY received no specific funding for this work.	Bacher M., 1989, NEUROPHYSIOLOGY, V72, P176; BAIN PG, 1993, J NEUROL NEUROSUR PS, V56, P868, DOI 10.1136/jnnp.56.8.868; CALZETTI S, 1987, J NEUROL NEUROSUR PS, V50, P561, DOI 10.1136/jnnp.50.5.561; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Fahn S, 1993, MOVEMENT DISORD, V2, P271; Findley L.J., 1995, HDB TREMOR DISORDERS, P1; Giuffrida JP, 2009, MOVEMENT DISORD, V24, P723, DOI 10.1002/mds.22445; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Hoff JI, 2001, CLIN NEUROPHARMACOL, V24, P280, DOI 10.1097/00002826-200109000-00004; O'Suilleabhain PE, 2001, MOVEMENT DISORD, V16, P265, DOI 10.1002/mds.1064; Patel S, 2009, IEEE T INF TECHNOL B, V13, P864, DOI 10.1109/TITB.2009.2033471; Rajaraman V, 2000, CLIN NEUROPHYSIOL, V111, P338, DOI 10.1016/S1388-2457(99)00230-8; Rigas G, 2012, IEEE T INF TECHNOL B, V16, P478, DOI 10.1109/TITB.2011.2182616; Salarian A, 2007, IEEE T BIO-MED ENG, V54, P313, DOI 10.1109/TBME.2006.886670; Smeja M, 1999, J PSYCHOPHYSIOL, V13, P245, DOI 10.1027//0269-8803.13.4.245; Stacy MA, 2007, MOVEMENT DISORD, V22, P833, DOI 10.1002/mds.21412; van Someren EJW, 1998, IEEE T BIO-MED ENG, V45, P386, DOI 10.1109/10.661163; VANHILTEN JJ, 1993, CLIN NEUROPHARMACOL, V16, P36, DOI 10.1097/00002826-199302000-00004; Zwartjes DGM, 2010, IEEE T BIO-MED ENG, V57, P2778, DOI 10.1109/TBME.2010.2049573	21	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131703	10.1371/journal.pone.0131703	http://dx.doi.org/10.1371/journal.pone.0131703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110768	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800170
J	Nasef, NA; Mehta, S; Powell, P; Marlow, G; Wileman, T; Ferguson, LR				Nasef, Noha Ahmed; Mehta, Sunali; Powell, Penny; Marlow, Gareth; Wileman, Tom; Ferguson, Lynnette R.			Extracts of Feijoa Inhibit Toll-Like Receptor 2 Signaling and Activate Autophagy Implicating a Role in Dietary Control of IBD	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; IN-VITRO; POLYPHENOLS; TLR4; CD14	Background Inflammatory bowel disease (IBD) is a heterogeneous chronic inflammatory disease affecting the gut with limited treatment success for its sufferers. This suggests the need for better understanding of the different subtypes of the disease as well as nutritional interventions to compliment current treatments. In this study we assess the ability of a hydrophilic feijoa fraction (F3) to modulate autophagy a process known to regulate inflammation, via TLR2 using IBD cell lines. Method Mouse embryonic fibroblasts (MEF) deleted for ATG5, and two intestinal epithelial cells HCT15 and HCT116, were used to test the anti-inflammatory effect of F3 after stimulating the cells with a TLR2 specific ligand PAM3CSK4. Results F3 was able to reduce TLR2 specific inflammation and stimulate autophagy in MEFs and HCT15 cells but not in HCT116 cells. The anti-inflammatory effect was reduced in the MEF cells deleted for ATG5. In addition, the activation of autophagy by F3 was enhanced by PAM3CSK4. Conclusion F3 of feijoa can interact with cells via a TLR2 specific mechanism and reduce Nuclear factor kappa B (NF-kappa B) activation in part due to stimulation of autophagy. These results suggest that there is potential benefit in using feijoa extracts as part of dietary interventions to manage IBD in patients.	[Nasef, Noha Ahmed; Mehta, Sunali; Marlow, Gareth; Ferguson, Lynnette R.] Univ Auckland, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Powell, Penny; Wileman, Tom] UEA, Norwich Med Sch, Biomed Res Ctr, Norwich, Norfolk, England	University of Auckland; University of East Anglia	Ferguson, LR (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Auckland 1, New Zealand.	l.ferguson@auckland.ac.nz	Mehta, Sunali/O-8459-2019	Mehta, Sunali/0000-0002-1777-1245; Marlow, Gareth/0000-0002-7608-9086; Powell, Penny/0000-0002-5347-0490	Nutrigenomics New Zealand; Ministry of Business, Innovation and Employment (MBIE); Kate Edger Educational Charitable Trust	Nutrigenomics New Zealand; Ministry of Business, Innovation and Employment (MBIE)(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Kate Edger Educational Charitable Trust	LF and NAN were supported by Nutrigenomics New Zealand and the Ministry of Business, Innovation and Employment (MBIE) to perform the studies in this Manuscript. NAN was also funded by the Kate Edger Educational Charitable Trust for this study and manuscript preparation. The funders had no role in study design, data collection and analysis. Nutrigenomics New Zealand had a role in the decision to publish of this material but had no role in the preparation of the manuscript.	Abbas AK., 2012, CELL MOL IMMUNOL; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; De Cruz P, 2012, INFLAMM BOWEL DIS, DOI [10.1002/ibd.21751, DOI 10.1002/IBD.21751]; Del Rio D, 2010, NUTR METAB CARDIOVAS, V20, P1, DOI 10.1016/j.numecd.2009.05.015; Fiocchi C., 2013, DIG DIS, V30, P2; Frolova L, 2008, J HISTOCHEM CYTOCHEM, V56, P267, DOI 10.1369/jhc.7A7303.2007; Fukata M, 2009, INFLAMM BOWEL DIS, V15, P997, DOI 10.1002/ibd.20880; Gonzalez R, 2011, CRIT REV FOOD SCI, V51, P331, DOI 10.1080/10408390903584094; Hommes DW, 2009, J PEDIATR GASTR NUTR, V48, pS52, DOI 10.1097/MPG.0b013e3181a11785; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Huebner C, 2010, INFLAMM BOWEL DIS, V16, P282, DOI 10.1002/ibd.21043; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Li DS, 2006, CELL RES, V16, P855, DOI 10.1038/sj.cr.7310110; Li FX, 2005, CAN J GASTROENTEROL, V19, P567, DOI 10.1155/2005/943547; Li YY, 2011, INT J MOL MED, V27, P337, DOI 10.3892/ijmm.2011.596; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Nasef NA, 2014, NUTRIENTS, V6, P5265, DOI 10.3390/nu6115265; Priego S, 2008, MOL CANCER THER, V7, P3330, DOI 10.1158/1535-7163.MCT-08-0363; Ranoa DRE, 2013, J BIOL CHEM, V288, P9729, DOI 10.1074/jbc.M113.453266; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Scalbert A, 2002, BIOMED PHARMACOTHER, V56, P276, DOI 10.1016/S0753-3322(02)00205-6; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Seow Cynthia H, 2009, Curr Gastroenterol Rep, V11, P509; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shapiro H, 2007, GUT, V56, P426, DOI 10.1136/gut.2006.094599; Shin DM, 2010, CELL MICROBIOL, V12, P1648, DOI 10.1111/j.1462-5822.2010.01497.x; Sies H, 2010, ARCH BIOCHEM BIOPHYS, V501, P2, DOI 10.1016/j.abb.2010.04.006; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhao L, 2007, J BIOL CHEM, V282, P11618, DOI 10.1074/jbc.M608644200	34	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130910	10.1371/journal.pone.0130910	http://dx.doi.org/10.1371/journal.pone.0130910			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110654	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000356933800097
J	Shahi, MH; York, D; Gandour-Edwards, R; Withers, SS; Holt, R; Rebhun, RB				Shahi, Mehdi Hayat; York, Daniel; Gandour-Edwards, Regina; Withers, Sita S.; Holt, Roseline; Rebhun, Robert B.			BMI1 Is Expressed in Canine Osteosarcoma and Contributes to Cell Growth and Chemotherapy Resistance	PLOS ONE			English	Article							GROUP GENE BMI-1; STEM-CELLS; SELF-RENEWAL; CANCER; SENESCENCE; TUMOR; MYC	BMI1, a stem cell factor and member of the polycomb group of genes, has been shown to contribute to growth and chemoresistance of several human malignancies including primary osteosarcoma (OSA). Naturally occurring OSA in the dog represents a large animal model of human OSA, however the potential role of BMI1 in canine primary and metastatic OSA has not been examined. Immunohistochemical staining of canine primary and metastatic OSA tumors revealed strong nuclear expression of BMI1. An identical staining pattern was found in both primary and metastatic human OSA tissues. Canine OSA cell lines (Abrams, Moresco, and D17) expressed high levels of BMI1 compared with canine osteoblasts and knockdown or inhibition of BMI1 by siRNA or by small molecule BMI1-inhibitor PTC-209 demonstrated a role for BMI1 in canine OSA cell growth and resistance to carboplatin and doxorubicin chemotherapy. These findings suggest that inhibition of BMI1 in primary or metastatic OSA may improve response to chemotherapy and that the dog may serve as a large animal model to evaluate such therapy.	[Shahi, Mehdi Hayat; York, Daniel; Withers, Sita S.; Holt, Roseline; Rebhun, Robert B.] Univ Calif Davis, Sch Vet Med, Comparat Oncol Lab, Davis, CA 95616 USA; [Shahi, Mehdi Hayat; York, Daniel; Withers, Sita S.; Holt, Roseline; Rebhun, Robert B.] Univ Calif Davis, Sch Vet Med, Ctr Compan Anim Hlth, Davis, CA 95616 USA; [Gandour-Edwards, Regina] Univ Calif Davis, Ctr Comprehens Canc, Dept Pathol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Rebhun, RB (corresponding author), Univ Calif Davis, Sch Vet Med, Comparat Oncol Lab, Davis, CA 95616 USA.	rbrebhun@ucdavis.edu		Rebhun, Robert/0000-0002-8047-3494; Withers, Sita/0000-0002-4107-3877	Bernice Barbour Foundation; Center for Companion Animal Health-UC Davis School of Veterinary Medicine; NCRR [K01 RR031272]; Office of Research Infrastructure Programs [8K01OD011111-02]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR031272] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD011111] Funding Source: NIH RePORTER	Bernice Barbour Foundation; Center for Companion Animal Health-UC Davis School of Veterinary Medicine; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the Bernice Barbour Foundation, the Center for Companion Animal Health-UC Davis School of Veterinary Medicine, and NCRR K01 RR031272 (currently supported by the Office of Research Infrastructure Programs 8K01OD011111-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu-Roy U, 2013, CANCER LETT, V338, P158, DOI 10.1016/j.canlet.2012.05.028; Borys D, 2012, HUM PATHOL, V43, P1948, DOI 10.1016/j.humpath.2012.02.003; Cao LX, 2011, J CELL BIOCHEM, V112, P2729, DOI 10.1002/jcb.23234; Duan XP, 2004, CLIN EXP METASTAS, V21, P747, DOI 10.1007/s10585-005-0599-6; Fan C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-98; Fenger JM, 2014, ILAR J, V55, P69, DOI 10.1093/ilar/ilu009; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Fidler IJ, 2012, HUM VACC IMMUNOTHER, V8, P1141, DOI 10.4161/hv.19643; HARJU VT, 1990, BONE, V11, P247, DOI 10.1016/8756-3282(90)90077-C; He HT, 2014, ONCOL LETT, V7, P1352, DOI 10.3892/ol.2014.1935; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Khanna C, 2009, CLIN CANCER RES, V15, P5671, DOI 10.1158/1078-0432.CCR-09-0719; Kim MC, 2013, J VET SCI, V14, P481, DOI 10.4142/jvs.2013.14.4.481; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Legare ME, 2011, J CANCER, V2, P262, DOI 10.7150/jca.2.262; Maeda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043355; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Paoloni M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-625; Raaphorst FM, 2003, TRENDS IMMUNOL, V24, P522, DOI 10.1016/S1471-4906(03)00241-2; Sasaki H, 2010, ONCOL REP, V23, P677, DOI 10.3892/or_00000684; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Selmic LE, 2014, J VET INTERN MED, V28, P554, DOI 10.1111/jvim.12313; Seo KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042960; Shahi MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096593; Siddique HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060664; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; Skorupski KA, 2016, VET COMP ONCOL, V14, P81, DOI 10.1111/vco.12069; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Vissers JHA, 2012, J CELL SCI, V125, P3939, DOI 10.1242/jcs.107375; Wu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014648; Xie XK, 2013, MOL MED REP, V8, P168, DOI 10.3892/mmr.2013.1484	32	18	18	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131006	10.1371/journal.pone.0131006	http://dx.doi.org/10.1371/journal.pone.0131006			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110620	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800108
J	Van Dolah, FM; Neely, MG; McGeorge, LE; Balmer, BC; Ylitalo, GM; Zolman, ES; Speakman, T; Sinclair, C; Kellar, NM; Rosel, PE; Mullin, KD; Schwacke, LH				Van Dolah, Frances M.; Neely, Marion G.; McGeorge, Lauren E.; Balmer, Brian C.; Ylitalo, Gina M.; Zolman, Eric S.; Speakman, Todd; Sinclair, Carrie; Kellar, Nicholas M.; Rosel, Patricia E.; Mullin, Keith D.; Schwacke, Lori H.			Seasonal Variation in the Skin Transcriptome of Common Bottlenose Dolphins (Tursiops truncatus) from the Northern Gulf of Mexico	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; GENE-EXPRESSION; BLUBBER; EPIDERMIS; RECEPTOR; ENZYMES; BIOPSY; GROWTH; ALPHA	As long-lived predators that integrate exposures across multiple trophic levels, cetaceans are recognized as sentinels for the health of marine ecosystems. Their utility as sentinels requires the establishment of baseline health parameters. Because cetaceans are protected, measurements obtained with minimal disruption to free ranging animals are highly desirable. In this study we investigated the utility of skin gene expression profiling to monitor health and contaminant exposure in common bottlenose dolphins (Tursiops truncatus). Remote integument biopsies were collected in the northern Gulf of Mexico prior to the Deep-water Horizon oil spill (May 2010) and during summer and winter for two years following oil contamination (2010-2011). A bottlenose dolphin microarray was used to characterize the skin transcriptomes of 94 individuals from three populations: Barataria Bay, Louisiana, Chandeleur Sound, Louisiana, and Mississippi Sound, Mississippi/Alabama. Skin transcriptomes did not differ significantly between populations. In contrast, season had a profound effect on gene expression, with nearly one-third of all genes on the array differing in expression between winter and the warmer seasons (moderated T-test; p<0.01, fold-change >= 1.5). Persistent organic pollutants (POPs) in blubber changed concurrently, reaching > two-fold higher concentrations in summer compared to winter, due to a seasonal decrease in blubber thickness and loss of stored lipid. However, global gene expression did not correlate strongly with seasonally changing contaminant concentrations, most likely because the refractory, lipid-stored metabolites are not substrates for phase I or II xenobiotic detoxification pathways. Rather, processes related to cell proliferation, motility, and differentiation dominated the differences in expression in winter and the warmer seasons. More subtle differences were seen between spring and summer (1.5% of genes differentially expressed). However, two presumed oil-exposed animals from spring presented gene expression profiles more similar to the summer animals (presumed exposed) than to other spring animals. Seasonal effects have not previously been considered in studies assessing gene expression in cetaceans, but clearly must be taken into account when applying transcriptomic analyses to investigate their contaminant exposure or health status.	[Van Dolah, Frances M.; Neely, Marion G.; McGeorge, Lauren E.; Balmer, Brian C.; Zolman, Eric S.; Speakman, Todd; Schwacke, Lori H.] NOAA, Natl Ocean Serv, Natl Ctr Coastal Ocean Sci, Charleston, SC 29405 USA; [Ylitalo, Gina M.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA 98112 USA; [Sinclair, Carrie; Mullin, Keith D.] NOAA, Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Pascagoula, MI USA; [Kellar, Nicholas M.] NOAA, Natl Marine Fisheries Serv, SW Fisheries Sci Ctr, La Jolla, CA USA; [Rosel, Patricia E.] NOAA, Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Lafayette, LA USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Van Dolah, FM (corresponding author), NOAA, Natl Ocean Serv, Natl Ctr Coastal Ocean Sci, Charleston, SC 29405 USA.	fran.vandolah@noaa.gov	Kellar, Nicholas/AAA-4606-2021	Rosel, Patricia/0000-0002-6481-3989; Balmer, Brian/0000-0001-9734-4042	Deepwater Horizon Natural Resource Damage Assessment	Deepwater Horizon Natural Resource Damage Assessment	This work was funded as part of the Deepwater Horizon Natural Resource Damage Assessment, conducted cooperatively by NOAA, other Federal and State Trustees, and British Petroleum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmer BC, 2015, SCI TOTAL ENVIRON, V527, P306, DOI 10.1016/j.scitotenv.2015.05.016; Baron JM, 2008, CURR MED CHEM, V15, P2258, DOI 10.2174/092986708785747535; Buckman AH, 2011, ENVIRON SCI TECHNOL, V45, P10194, DOI 10.1021/es201541j; Burczynski ME, 1999, CANCER RES, V59, P607; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ellisor D, 2013, SCI TOTAL ENVIRON, V463, P581, DOI 10.1016/j.scitotenv.2013.06.017; Gazel A, 2003, J INVEST DERMATOL, V121, P1459, DOI 10.1111/j.1523-1747.2003.12611.x; Geraci J.R., 1986, P3; Godard-Codding CAJ, 2011, ENVIRON HEALTH PERSP, V119, P337, DOI 10.1289/ehp.0901809; Gorgone AM, 2008, J WILDLIFE MANAGE, V72, P926, DOI 10.2193/2007-202; HICKS BD, 1985, J INVEST DERMATOL, V85, P60, DOI 10.1111/1523-1747.ep12275348; Hu T, 2010, TOXICOL IN VITRO, V24, P1450, DOI 10.1016/j.tiv.2010.03.013; Kellar NM, 2009, MAR MAMMAL SCI, V25, P507, DOI 10.1111/j.1748-7692.2009.00291.x; Kellar NM, 2006, MAR MAMMAL SCI, V22, P1, DOI 10.1111/j.1748-7692.2006.00001.x; Kucklick J, 2011, ENVIRON SCI TECHNOL, V45, P4270, DOI 10.1021/es1042244; Li XW, 2014, BIOCHEM BIOPH RES CO, V445, P469, DOI 10.1016/j.bbrc.2014.02.011; Mancia A, 2014, MAR ENVIRON RES, V100, P57, DOI 10.1016/j.marenvres.2014.03.007; Mancia A, 2010, ESTUAR COAST, V33, P919, DOI 10.1007/s12237-010-9287-0; Mantel A, 2012, J INVEST DERMATOL, V132, P1103, DOI 10.1038/jid.2011.412; Marin YE, 2009, EXP DERMATOL, V18, P611, DOI 10.1111/j.1600-0625.2008.00839.x; MASER E, 1995, BIOCHEM PHARMACOL, V49, P421, DOI 10.1016/0006-2952(94)00330-O; Mattson MC, 2006, MAR MAMMAL SCI, V22, P654, DOI 10.1111/j.1748-7692.2006.00057.x; Meagher EM, 2008, J COMP PHYSIOL B, V178, P529, DOI 10.1007/s00360-007-0245-5; MENON GK, 1986, CELL TISSUE RES, V244, P385; Meyer W, 2004, MAR BIOL, V144, P841, DOI 10.1007/s00227-003-1256-8; Montie EW, 2008, AQUAT TOXICOL, V86, P397, DOI 10.1016/j.aquatox.2007.12.004; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Mouton M, 2012, NEW APPROACHES STUDY, DOI [10.5772/2731, DOI 10.5772/2731]; Nakano M, 2009, DRUG METAB DISPOS, V37, P2119, DOI 10.1124/dmd.109.028530; National Oceanic and Atmospheric Administation, 2014, ENV RESP MAN APPL DE; Nuutila K, 2012, WOUND REPAIR REGEN, V20, P830, DOI 10.1111/j.1524-475X.2012.00831.x; Panti C, 2011, ECOTOXICOLOGY, V20, P1791, DOI 10.1007/s10646-011-0713-2; Pavek P, 2008, CURR DRUG METAB, V9, P129, DOI 10.2174/138920008783571774; Reif JS, 2006, JAVMA-J AM VET MED A, V228, P104, DOI 10.2460/javma.228.1.104; Rosel PE, 2009, MOL ECOL, V18, P5030, DOI 10.1111/j.1365-294X.2009.04413.x; Rosel PE, 2003, CONSERV GENET, V4, P647, DOI 10.1023/A:1025666212967; Samuel AM, 2004, CAN J ZOOL, V82, P1933, DOI 10.1139/Z05-001; Schwacke LH, 2014, ENVIRON SCI TECHNOL, V48, P93, DOI 10.1021/es403610f; Schwacke LH, 2012, P ROY SOC B-BIOL SCI, V279, P48, DOI 10.1098/rspb.2011.0665; Schwacke LH, 2010, ENVIRON RES, V110, P548, DOI 10.1016/j.envres.2010.05.003; Sellas AB, 2005, CONSERV GENET, V6, P715, DOI 10.1007/s10592-005-9031-7; Sinclair C, 2015, NMFSSEFSC670 NOAA; Tabuchi M, 2006, ENVIRON HEALTH PERSP, V114, P1024, DOI 10.1289/ehp.8661; Tang NJ, 2008, TOXICOL LETT, V177, P182, DOI 10.1016/j.toxlet.2008.01.011; Timar KK, 2007, MOL IMMUNOL, V44, P2578, DOI 10.1016/j.molimm.2006.12.014; Urian KW, 1996, J MAMMAL, V77, P394, DOI 10.2307/1382814; van Eijl S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041721; Vukelic S, 2011, J BIOL CHEM, V286, P10265, DOI 10.1074/jbc.M110.188268; Wells R.S., 2004, ECOHEALTH, V1, P246, DOI [10.1007/s10393-004-0094-6, DOI 10.1007/S10393-004-0094-6]; Wilson JY, 2007, TOXICOL SCI, V97, P111, DOI 10.1093/toxsci/kfm031; Yordy JE, 2010, ENVIRON TOXICOL CHEM, V29, P1263, DOI 10.1002/etc.152; Yordy JE, 2010, ENVIRON SCI TECHNOL, V44, P4789, DOI 10.1021/es1004158; Zabka TS, 2003, ANAT REC PART A, V273A, P636, DOI 10.1002/ar.a.10077	53	17	19	6	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130934	10.1371/journal.pone.0130934	http://dx.doi.org/10.1371/journal.pone.0130934			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110790	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800099
J	Yamamoto, N; Matsuki, Y; Yokoyama, H; Matsuki, H				Yamamoto, Naomichi; Matsuki, Yuuki; Yokoyama, Hiromichi; Matsuki, Hideaki			Relationships among Indoor, Outdoor, and Personal Airborne Japanese Cedar Pollen Counts	PLOS ONE			English	Article							INHALABLE AEROSOL SAMPLER; EXPOSURE; POLLINOSIS; PREVALENCE; AEROALLERGENS; PARTICLES; HOMES; COLLECTOR; SPORES	Japanese cedar pollinosis (JCP) is an important illness caused by the inhalation of airborne allergenic cedar pollens, which are dispersed in the early spring throughout the Japanese islands. However, associations between pollen exposures and the prevalence or severity of allergic symptoms are largely unknown, due to a lack of understanding regarding personal pollen exposures in relation to indoor and outdoor concentrations. This study aims to examine the relationships among indoor, outdoor, and personal airborne Japanese cedar pollen counts. We conducted a 4-year monitoring campaign to quantify indoor, outdoor, and personal airborne cedar pollen counts, where the personal passive settling sampler that has been previously validated against a volumetric sampler was used to count airborne pollen grains. A total of 256 sets of indoor, outdoor, and personal samples (768 samples) were collected from 9 subjects. Medians of the seasonally-integrated indoor-to-outdoor, personal-to-outdoor, and personal-to-indoor ratios of airborne pollen counts measured for 9 subjects were 0.08, 0.10, and 1.19, respectively. A greater correlation was observed between the personal and indoor counts (r = 0.89) than between the personal and outdoor counts (r = 0.71), suggesting a potential inaccuracy in the use of outdoor counts as a basis for estimating personal exposures. The personal pollen counts differed substantially among the human subjects (49% geometric coefficient of variation), in part due to the variability in the indoor counts that have been found as major determinants of the personal pollen counts. The findings of this study highlight the need for pollen monitoring in proximity to human subjects to better understand the relationships between pollen exposures and the prevalence or severity of pollen allergy.	[Yamamoto, Naomichi] Seoul Natl Univ, Dept Environm Hlth Sci, Seoul, South Korea; [Matsuki, Yuuki] Tokai Univ Oiso Hosp, Oiso, Kanagawa, Japan; [Yokoyama, Hiromichi] Kanagawa Univ Human Serv, Dept Nutr, Yokosuka, Kanagawa, Japan; [Matsuki, Hideaki] Tokai Univ, Dept Nursing, Isehara, Kanagawa, Japan	Seoul National University (SNU); Tokai University	Yamamoto, N (corresponding author), Seoul Natl Univ, Dept Environm Hlth Sci, 1 Gwanak Ro, Seoul, South Korea.	nyamamoto@snu.ac.kr	Yamamoto, Naomichi/D-4099-2014	Yamamoto, Naomichi/0000-0002-5969-5500				Berger U, 2014, CURR OPIN ALLERGY CL, V14, P200, DOI 10.1097/ACI.0000000000000060; Brasche S, 2005, INT J HYG ENVIR HEAL, V208, P247, DOI 10.1016/j.ijheh.2005.03.003; Burr ML, 2003, CLIN EXP ALLERGY, V33, P1675, DOI 10.1111/j.1365-2222.2003.01816.x; CHARPIN D, 1993, CLIN EXP ALLERGY, V23, P435, DOI 10.1111/j.1365-2222.1993.tb00350.x; Craven BA, 2006, J FLUID ENG-T ASME, V128, P1251, DOI 10.1115/1.2353274; Delaunay JJ, 2007, ANN ALLERG ASTHMA IM, V98, P553, DOI 10.1016/S1081-1206(10)60734-X; DURHAM OC, 1946, J ALLERGY, V17, P79, DOI 10.1016/0021-8707(46)90025-1; Fiorina A, 1997, ALLERGY, V52, P1026, DOI 10.1111/j.1398-9995.1997.tb02426.x; Graham JAH, 2000, ANN ALLERG ASTHMA IM, V84, P599, DOI 10.1016/S1081-1206(10)62410-6; Honda K, 2013, ALLERGOL INT, V62, P375, DOI 10.2332/allergolint.12-OA-0526; Hugg T, 2007, AEROBIOLOGIA, V23, P119, DOI 10.1007/s10453-007-9057-z; Jantunen J, 2009, AEROBIOLOGIA, V25, P193, DOI 10.1007/s10453-009-9124-8; KAWASHIMA S, 1995, GRANA, V34, P142, DOI 10.1080/00173139509430003; Kenny LC, 1997, ANN OCCUP HYG, V41, P135, DOI 10.1016/S0003-4878(96)00034-8; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Lee T, 2006, INDOOR AIR, V16, P37, DOI 10.1111/j.1600-0668.2005.00396.x; LEUSCHNER RM, 1979, CLIN ALLERGY, V9, P175, DOI 10.1111/j.1365-2222.1979.tb01539.x; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; McDonagh A, 2014, J AEROSOL SCI, V75, P94, DOI 10.1016/j.jaerosci.2014.05.007; Minami Y., 2010, J JAPAN RHINOL SOC, V49, P481, DOI [10.7248/jjrhi.49.481, DOI 10.7248/JJRHI.49.481]; Mitakakis TZ, 2000, CLIN EXP ALLERGY, V30, P1733, DOI 10.1046/j.1365-2222.2000.00966.x; Nishihata S., 2010, Clinical and Experimental Allergy Reviews, V10, P8; Okamoto Yoshitaka, 2009, Allergology International, V58, P155, DOI 10.2332/allergolint.08-RAI-0074; Okuda M, 2005, RHINOLOGY, V43, P29; Okuda M, 2003, ANN ALLERG ASTHMA IM, V91, P288, DOI 10.1016/S1081-1206(10)63532-6; Ozasa Kotaro, 2008, Allergol Int, V57, P175, DOI 10.2332/allergolint.O-07-513; Peel RG, 2014, ANN AGR ENV MED, V21, P745, DOI 10.5604/12321966.1129927; Peel RG, 2013, ANN ALLERG ASTHMA IM, V111, P548, DOI 10.1016/j.anai.2013.09.002; Raulf M, 2014, ALLERGY, V69, P1280, DOI 10.1111/all.12456; Riediker M, 2000, J INVEST ALLERG CLIN, V10, P200; Saito Y, 2014, P JPN ACAD B-PHYS, V90, P203, DOI 10.2183/pjab.90.203; Sakashita M, 2010, INT ARCH ALLERGY IMM, V151, P255, DOI 10.1159/000242363; Schwietz LA, 2000, ANN ALLERG ASTHMA IM, V84, P87, DOI 10.1016/S1081-1206(10)62746-9; Sterling DA, 1998, ANN ALLERG ASTHMA IM, V80, P279, DOI 10.1016/S1081-1206(10)62971-7; Tormo-Molina R, 2009, INT J ENV RES PUB HE, V6, P3169, DOI 10.3390/ijerph6123169; Yamada T, 2014, J ALLERGY CLIN IMMUN, V133, P632, DOI 10.1016/j.jaci.2013.11.002; Yamamoto N, 2007, J EXPO SCI ENV EPID, V17, P637, DOI 10.1038/sj.jes.7500549; Yamamoto N, 2006, J AEROSOL SCI, V37, P1442, DOI 10.1016/j.jaerosci.2006.05.002; Yamamoto N, 2011, J AEROSOL SCI, V42, P499, DOI 10.1016/j.jaerosci.2011.05.004; Yamamoto N, 2010, BUILD ENVIRON, V45, P792, DOI 10.1016/j.buildenv.2009.08.002; Yang W, 2011, J EXPO SCI ENV EPID, V21, P310, DOI 10.1038/jes.2010.23; Yoshida K, 2013, ALLERGY, V68, P757, DOI 10.1111/all.12164	42	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131710	10.1371/journal.pone.0131710	http://dx.doi.org/10.1371/journal.pone.0131710			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110813	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800171
J	Feng, HJ; Guo, LX; Wang, GK; Sun, JL; Pan, ZO; He, SP; Zhu, HQ; Sun, J; Du, XM				Feng, Hongjie; Guo, Lixue; Wang, Gaskin; Sun, Junling; Pan, Zhaoe; He, Shoupu; Zhu, Heqin; Sun, Jie; Du, Xiongming			The Negative Correlation between Fiber Color and Quality Traits Revealed by QTL Analysis	PLOS ONE			English	Article							COTTON GOSSYPIUM-HIRSUTUM; BACKCROSS-SELF APPROACH; EST-DERIVED MICROSATELLITES; UPLAND COTTON; SEGREGATION DISTORTION; ALLOTETRAPLOID COTTON; MOLECULAR DISSECTION; BARBADENSE COTTON; SSR MARKERS; INTERSPECIFIC VARIATION	Naturally existing colored cotton was far from perfection due to having genetic factors for lower yield, poor fiber quality and monotonous color. These factors posed a challenge to colored cotton breeding and innovation. To identify novel quantitative trait loci (QTL) for fiber color along with understanding of correlation between fiber color and quality in colored cotton, a RIL and two F-2 populations were generated from crosses among Zong128 (Brown fiber cotton) and two white fiber cotton lines which were then analyzed in four environments. Two stable and major QTLs (qLC-7-1, qFC-7-1) for fiber lint and fuzz color were detected accounting for 16.01%-59.85% of the phenotypic variation across multiple generations and environments. Meanwhile, some minor QTLs were also identified on chromosomes 5, 14, 21 and 24 providing low phenotypic variation (<5%) from only F2 populations, not from the RILs population. Especially, a multiple-effect locus for fiber color and quality has been detected between flanking markers NAU1043 and NAU3654 on chromosome 7 (A genome) over multiple environments. Of which, qLC-7-1, qFC-7-1 were responsible for positive effects and improved fiber color in offsprings. Meanwhile, the QTLs (qFL-7-1, qFU-7-1, qFF-7-1, qFE-7-1, and qFS-7-1) for fiber quality had negative effects and explained 2.19%-8.78% of the phenotypic variation. This multiple-effect locus for fiber color and quality may reveal the negative correlation between the two types of above traits, so paving the way towards cotton genetic improvement.	[Feng, Hongjie; Guo, Lixue; Wang, Gaskin; Sun, Junling; Pan, Zhaoe; He, Shoupu; Zhu, Heqin; Du, Xiongming] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, South Korea; [Feng, Hongjie; Guo, Lixue; Sun, Jie] Shihezi Univ, Xinjiang Prod & Construct Grp, Key Lab Oasis Ecoagr, Coll Agr, Shihezi, Peoples R China	Shihezi University	Sun, J (corresponding author), Shihezi Univ, Xinjiang Prod & Construct Grp, Key Lab Oasis Ecoagr, Coll Agr, Shihezi, Peoples R China.	sunjie@shzu.edu.cn; dujeffrey8848@hotmail.com	Du, Xiongming/AAI-9999-2020; Shoupu, He/AAR-5173-2021	Shoupu, He/0000-0001-8434-5484; Sun, Jie/0000-0002-8068-8102; Feng, Hongjie/0000-0001-8039-3227	National Key Technology R & D Program of China [2013BAD01B03]; National High Technology Research and Development Program (863 Program) [2011AA10A102]	National Key Technology R & D Program of China(National Key Technology R&D Program); National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China)	Funding: The authors appreciate the support of the National Key Technology R & D Program of China (Grant number 2013BAD01B03), and National High Technology Research and Development Program (863 Program) (Grant number 2011AA10A102).	Ahuja SL, 2009, EUPHYTICA, V169, P303, DOI 10.1007/s10681-009-9939-y; [Anonymous], 1984, AGRON ABROAD COTTON, V3, P172; Chee P, 2005, THEOR APPL GENET, V111, P757, DOI 10.1007/s00122-005-2063-z; Chee PW, 2005, THEOR APPL GENET, V111, P772, DOI 10.1007/s00122-005-2062-0; Chen Li, 2008, Acta Agronomica Sinica, V34, P1199, DOI 10.3724/SP.J.1006.2008.01199; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Dickerson D. K., 1999, NATURALLY COLORED CO; Draye X, 2005, THEOR APPL GENET, V111, P764, DOI 10.1007/s00122-005-2061-1; Dutt Y, 2004, PLANT BREEDING, V123, P145, DOI 10.1046/j.1439-0523.2003.00938.x; Feng HJ, 2011, PLANT BREEDING, V130, P450, DOI 10.1111/j.1439-0523.2010.01842.x; Frelichowski JE, 2006, MOL GENET GENOMICS, V275, P479, DOI 10.1007/s00438-006-0106-z; Guo WZ, 2007, GENETICS, V176, P527, DOI 10.1534/genetics.107.070375; Guo YF, 2008, EUPHYTICA, V161, P361, DOI 10.1007/s10681-007-9585-1; Han ZG, 2004, MOL GENET GENOMICS, V272, P308, DOI 10.1007/s00438-004-1059-8; Han ZG, 2006, THEOR APPL GENET, V112, P430, DOI 10.1007/s00122-005-0142-9; Hua SJ, 2009, CROP SCI, V49, P983, DOI 10.2135/cropsci2008.06.0371; Iqbal MJ, 2001, THEOR APPL GENET, V103, P547, DOI 10.1007/PL00002908; KOHEL RJ, 1985, CROP SCI, V25, P793, DOI 10.2135/cropsci1985.0011183X0025000500017x; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Lacape JM, 2005, CROP SCI, V45, P123, DOI 10.2135/cropsci2005.0123a; Li Wu, 2007, Journal of Genetics and Genomics, V34, P634, DOI 10.1016/S1673-8527(07)60072-1; Liu S, 2000, J HERED, V91, P326, DOI 10.1093/jhered/91.4.326; Mei M, 2004, THEOR APPL GENET, V108, P280, DOI 10.1007/s00122-003-1433-7; Nguyen TB, 2004, THEOR APPL GENET, V109, P167, DOI 10.1007/s00122-004-1612-1; Park YH, 2005, MOL GENET GENOMICS, V274, P428, DOI 10.1007/s00438-005-0037-0; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Rakshit A, 2010, J GENET, V89, P155, DOI 10.1007/s12041-010-0055-5; Reddy O. U. K., 2001, Journal of Cotton Science, V5, P103; Rong JK, 2004, GENETICS, V166, P389, DOI 10.1534/genetics.166.1.389; Shen XL, 2007, EUPHYTICA, V155, P371, DOI 10.1007/s10681-006-9338-6; Shen XL, 2005, MOL BREEDING, V15, P169, DOI 10.1007/s11032-004-4731-0; Shi YZ, 2002, COTTON SCI, V14, P242; Sun DL, 2009, INT J PLANT SCI, V170, P76, DOI 10.1086/593037; Taylor DR, 2003, GENETICA, V117, P27, DOI 10.1023/A:1022308414864; Ulloa M, 2005, J HERED, V96, P132, DOI 10.1093/jhered/esi020; Ulloa M, 2002, THEOR APPL GENET, V104, P200, DOI 10.1007/s001220100739; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; VOORRIPS RE, 2006, MAPCHART 2 2 SOFTWAR; Vreeland Jr JM, 1987, INT DEV RES CTR REPO, V10, P4; Wang BH, 2007, CROP SCI, V47, P1384, DOI 10.2135/cropsci2006.10.0647; Wang BH, 2006, EUPHYTICA, V152, P367, DOI 10.1007/s10681-006-9224-2; Wang K, 2006, THEOR APPL GENET, V113, P73, DOI 10.1007/s00122-006-0273-7; Xu Y, 1997, MOL GEN GENET, V253, P535, DOI 10.1007/s004380050355; Yan Q, 2011, 12 NAT PLANT GEN C P, P108; ZENG ZB, 1994, GENETICS, V136, P1457; Zhan SH, 2008, CHINESE AGR SCI B, V24, P146; Zhang J, 2002, THEOR APPL GENET, V105, P1166, DOI 10.1007/s00122-002-1100-4; Zhang ZS, 2009, MOL BREEDING, V24, P49, DOI 10.1007/s11032-009-9271-1	48	15	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0129490	10.1371/journal.pone.0129490	http://dx.doi.org/10.1371/journal.pone.0129490			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121363	Green Published, Green Submitted, gold			2022-12-27	WOS:000358150400021
J	Hagi, TT; Klemensberger, S; Bereiter, R; Nietzsche, S; Cosgarea, R; Flury, S; Lussi, A; Sculean, A; Eick, S				Haegi, Tobias T.; Klemensberger, Sabrina; Bereiter, Riccarda; Nietzsche, Sandor; Cosgarea, Raluca; Flury, Simon; Lussi, Adrian; Sculean, Anton; Eick, Sigrun			A Biofilm Pocket Model to Evaluate Different Non-Surgical Periodontal Treatment Modalities in Terms of Biofilm Removal and Reformation, Surface Alterations and Attachment of Periodontal Ligament Fibroblasts	PLOS ONE			English	Article							SUBGINGIVAL PLAQUE REMOVAL; ROOT SUBSTANCE REMOVAL; ER-YAG LASER; IN-VITRO; ANTIBACTERIAL ACTIVITY; ULTRASONIC SYSTEM; CHLORHEXIDINE; EFFICACY; ERYTHRITOL; THERAPY	Background and Aim There is a lack of suitable in vitro models to evaluate various treatment modalities intending to remove subgingival bacterial biofilm. Consequently, the aims of this in vitro-study were: a) to establish a pocket model enabling mechanical removal of biofilm and b) to evaluate repeated non-surgical periodontal treatment with respect to biofilm removal and reformation, surface alterations, tooth hard-substance-loss, and attachment of periodontal ligament (PDL) fibroblasts. Material and Methods Standardized human dentin specimens were colonized by multi-species biofilms for 3.5 days and subsequently placed into artificially created pockets. Non-surgical periodontal treatment was performed as follows: a) hand-instrumentation with curettes (CUR), b) ultrasonication (US), c) subgingival air-polishing using erythritol (EAP) and d) subgingival air-polishing using erythritol combined with chlorhexidine digluconate (EAP-CHX). The reduction and recolonization of bacterial counts, surface roughness (Ra and Rz), the caused tooth substance-loss (thickness) as well as the attachment of PDL fibroblasts were evaluated and statistically analyzed by means of ANOVA with Post-Hoc LSD. Results After 5 treatments, bacterial reduction in biofilms was highest when applying EAP-CHX (4 log10). The lowest reduction was found after CUR (2 log10). Additionally, substance-loss was the highest when using CUR (128 +/- 40 mu m) in comparison with US (14 +/- 12 mu m), EAP (6 +/- 7 mu m) and EAP-CHX (11 +/- 10) mu m). Surface was roughened when using CUR and US. Surfaces exposed to US and to EAP attracted the highest numbers of PDL fibroblasts. Conclusion The established biofilm model simulating a periodontal pocket combined with interchangeable placements of test specimens with multi-species biofilms enables the evaluation of different non-surgical treatment modalities on biofilm removal and surface alterations. Compared to hand instrumentation the application of ultrasonication and of air-polishing with erythritol prevents from substance-loss and results in a smooth surface with nearly no residual biofilm that promotes the reattachment of PDL fibroblasts.	[Haegi, Tobias T.; Klemensberger, Sabrina; Bereiter, Riccarda; Cosgarea, Raluca; Sculean, Anton; Eick, Sigrun] Univ Bern, Sch Dent Med, Dept Periodontol, Bern, Switzerland; [Nietzsche, Sandor] Univ Hosp Jena, Ctr Elect Microscopy, Jena, Germany; [Cosgarea, Raluca] Univ Cluj Napoca, Dept Prosthet Dent, Cluj Napoca, Romania; [Cosgarea, Raluca] Univ Marburg, Dept Periodontol, Marburg, Germany; [Flury, Simon; Lussi, Adrian] Univ Bern, Dept Prevent Restorat & Pediat Dent, Bern, Switzerland	University of Bern; Friedrich Schiller University of Jena; Babes Bolyai University from Cluj; Technical University of Cluj Napoca; Philipps University Marburg; University of Bern	Eick, S (corresponding author), Univ Bern, Sch Dent Med, Dept Periodontol, Bern, Switzerland.	sigrun.eick@zmk.unibe.ch	Cosgarea, Raluca/GQQ-0229-2022	Cosgarea, Raluca/0000-0003-2148-9645	Electro Medical System, Nyon, Switzerland	Electro Medical System, Nyon, Switzerland	The study was supported by a research grant from Electro Medical System, Nyon, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apatzidou Danae A, 2010, Dent Clin North Am, V54, P1, DOI 10.1016/j.cden.2009.08.006; Artigas J, 2014, SCI TOTAL ENVIRON, V468, P326, DOI 10.1016/j.scitotenv.2013.08.074; Axelsson P, 2004, J CLIN PERIODONTOL, V31, P749, DOI 10.1111/j.1600-051X.2004.00563.x; BADERSTEN A, 1984, J CLIN PERIODONTOL, V11, P114, DOI 10.1111/j.1600-051X.1984.tb00839.x; Belibasakis GN, 2014, J PERIODONTOL, V85, P343, DOI 10.1902/jop.2013.130167; Breschi L, 2010, DENT MATER, V26, P320, DOI 10.1016/j.dental.2009.11.153; Brusca SB, 2014, CURR OPIN RHEUMATOL, V26, P101, DOI 10.1097/BOR.0000000000000008; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Morandini ACD, 2011, BRAZ ORAL RES, V25, P157, DOI 10.1590/S1806-83242011000200010; de Mendonca AC, 2008, PHOTOMED LASER SURG, V26, P91, DOI 10.1089/pho.2007.2129; Drago L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107813; Drisko CH, 2001, PERIODONTOL 2000, V25, P77, DOI 10.1034/j.1600-0757.2001.22250106.x; Eick S, 2013, PHOTODIAGN PHOTODYN, V10, P156, DOI 10.1016/j.pdpdt.2012.12.001; Eick S, 2012, CLIN ORAL INVEST, V16, P735, DOI 10.1007/s00784-011-0567-2; Flemmig TF, 1998, J CLIN PERIODONTOL, V25, P158, DOI 10.1111/j.1600-051X.1998.tb02422.x; Flemmig TF, 2012, J PERIODONTOL, V83, P444, DOI 10.1902/jop.2011.110367; Hagi TT, 2015, QUINTESSENCE INT, V46, P31, DOI 10.3290/j.qi.a32817; Hagi Tobias T, 2013, Quintessence Int, V44, P753, DOI 10.3290/j.qi.a30606; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Hashino E, 2013, MOL ORAL MICROBIOL, V28, P435, DOI 10.1111/omi.12037; Henderson B, 2010, PERIODONTOL 2000, V54, P78, DOI 10.1111/j.1600-0757.2009.00331.x; Hughes F J, 1992, Eur J Prosthodont Restor Dent, V1, P63; Khademi AA, 2014, J RES PHARM PRACT, V3, P19, DOI 10.4103/2279-042X.132705; Khalefa M, 2013, J OROFAC ORTHOP, V74, P370, DOI 10.1007/s00056-013-0168-6; Khosravi M, 2004, J CLIN PERIODONTOL, V31, P160, DOI 10.1111/j.0303-6979.2004.00458.x; Kirst ME, 2015, APPL ENVIRON MICROB, V81, P783, DOI 10.1128/AEM.02712-14; Kishida M, 2004, J PERIODONTAL RES, V39, P111, DOI 10.1111/j.1600-0765.2004.00715.x; Lang Niklaus P, 2003, Oral Health Prev Dent, V1, P7; Locht C, 2012, BACTERIAL PATHOGENESIS: MOLECULAR AND CELLULAR MECHANISMS, P1; MEYER K, 1977, J CLIN PERIODONTOL, V4, P77, DOI 10.1111/j.1600-051X.1977.tb01887.x; Millhouse E, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-80; Moene R, 2010, J PERIODONTOL, V81, P79, DOI 10.1902/jop.2009.090394; Muller N, 2014, J CLIN PERIODONTOL, V41, P883, DOI 10.1111/jcpe.12289; Muller P, 2007, EUR J ORAL SCI, V115, P77, DOI 10.1111/j.1600-0722.2007.00418.x; NEWMAN MG, 1990, J PERIODONTOL, V61, P427, DOI 10.1902/jop.1990.61.7.427; Petersilka GJ, 2003, J PERIODONTOL, V74, P307, DOI 10.1902/jop.2003.74.3.307; Petersilka GJ, 2003, J CLIN PERIODONTOL, V30, P165, DOI 10.1034/j.1600-051X.2003.300204.x; RITZ L, 1991, J CLIN PERIODONTOL, V18, P643, DOI 10.1111/j.1600-051X.1991.tb00104.x; Sahrmann P, 2014, J PERIODONTOL, V85, P1107, DOI 10.1902/jop.2014.130629; Schmidlin RR, 2001, J CLIN PERIODONTOL, V28, P1058; Schwarz F, 2003, LASER SURG MED, V33, P140, DOI 10.1002/lsm.10201; TEW JG, 1985, INFECT IMMUN, V49, P487, DOI 10.1128/IAI.49.3.487-493.1985; Thurnheer T, 2014, CLIN ORAL INVEST, V18, P1779, DOI 10.1007/s00784-013-1157-2; Tsaousoglou P, 2014, J MED MICROBIOL, V63, P284, DOI 10.1099/jmm.0.065441-0; Tunkel J, 2002, J CLIN PERIODONTOL, V29, P72, DOI 10.1034/j.1600-051X.29.s3.4.x; Van Dyke TE, 2014, J PERIODONTOL, V85, P509, DOI 10.1902/jop.2014.130701; Wennstrom JL, 2011, J CLIN PERIODONTOL, V38, P820, DOI 10.1111/j.1600-051X.2011.01751.x; ZAPPA U, 1991, J PERIODONTOL, V62, P750, DOI 10.1902/jop.1991.62.12.750; Zaugg LK, 2014, DENT TRAUMATOL, V30, P326, DOI 10.1111/edt.12077	49	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131056	10.1371/journal.pone.0131056	http://dx.doi.org/10.1371/journal.pone.0131056			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121365	gold, Green Submitted, Green Published			2022-12-27	WOS:000358150400075
J	Steinmann, N; Corona, M; Neumann, P; Dainat, B				Steinmann, Nadja; Corona, Miguel; Neumann, Peter; Dainat, Benjamin			Overwintering Is Associated with Reduced Expression of Immune Genes and Higher Susceptibility to Virus Infection in Honey Bees	PLOS ONE			English	Article							DEFORMED WING VIRUS; DIVISION-OF-LABOR; APIS-MELLIFERA; JUVENILE-HORMONE; VARROA-DESTRUCTOR; VITELLOGENIN; PROPHENOLOXIDASE; PROTEIN; TRANSMISSION; INVERTEBRATE	The eusocial honey bee, Apis mellifera, has evolved remarkable abilities to survive extreme seasonal differences in temperature and availability of resources by dividing the worker caste into two groups that differ in physiology and lifespan: summer and winter bees. Most of the recent major losses of managed honey bee colonies occur during the winter, suggesting that winter bees may have compromised immune function and higher susceptibility to diseases. We tested this hypothesis by comparing the expression of eight immune genes and naturally occurring infection levels of deformed wing virus (DWV), one of the most widespread viruses in A. mellifera populations, between summer and winter bees. Possible interactions between immune response and physiological activity were tested by measuring the expression of vitellogenin and methyl farnesoate epoxidase, a gene coding for the last enzyme involved in juvenile hormone biosynthesis. Our data show that high DWV loads in winter bees correlate with reduced expression of genes involved in the cellular immune response and physiological activity and high expression of humoral immune genes involved in antibacterial defense compared with summer bees. This expression pattern could reflect evolutionary adaptations to resist bacterial pathogens and economize energy during the winter under a pathogen landscape with reduced risk of pathogenic viral infections. The outbreak of Varroa destructor infestation could have overcome these adaptations by promoting the transmission of viruses. Our results suggest that reduced cellular immune function during the winter may have increased honey bee's susceptibility to DWV. These results contribute to our understanding of honey bee colony losses in temperate regions.	[Steinmann, Nadja; Dainat, Benjamin] Agroscope Swiss Bee Res Ctr Liebefeld, CH-3003 Bern, Switzerland; [Steinmann, Nadja; Neumann, Peter] Univ Bern, Vetsuisse Fac, Inst Bee Hlth, CH-3001 Bern, Switzerland; [Steinmann, Nadja; Neumann, Peter] Univ Bern, Fac Med, CH-3001 Bern, Switzerland; [Corona, Miguel] USDA ARS, Bee Res Lab, Beltsville, MD 20705 USA; [Dainat, Benjamin] Swiss Bee Hlth Serv, CH-3003 Bern, Switzerland	Swiss Federal Research Station Agroscope; University of Bern; University of Bern; University of Geneva; United States Department of Agriculture (USDA)	Dainat, B (corresponding author), Agroscope Swiss Bee Res Ctr Liebefeld, Schwarzenburgstr 161, CH-3003 Bern, Switzerland.	benjamin.dainat@gmail.com	Dainat, Benjamin/AFN-8922-2022; Neumann, Peter/C-9964-2015	Dainat, Benjamin/0000-0002-1740-7136; Neumann, Peter/0000-0001-5163-5215; Corona, Miguel/0000-0002-2582-5397	Swiss Federal Veterinary Office [1.11.02]	Swiss Federal Veterinary Office	This study was partially funded by the Swiss Federal Veterinary Office grant 1.11.02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study did not receive any further additional funding.	Amdam GV, 2004, EXP GERONTOL, V39, P767, DOI 10.1016/j.exger.2004.02.010; Amdam GV, 2003, J THEOR BIOL, V223, P451, DOI 10.1016/S0022-5193(03)00121-8; Amdam GV, 2002, J THEOR BIOL, V216, P209, DOI 10.1006/jtbi.2002.2545; Ament SA, 2008, P NATL ACAD SCI USA, V105, P4226, DOI 10.1073/pnas.0800630105; Aurori CM, 2014, J GERONTOL A-BIOL, V69, P633, DOI 10.1093/gerona/glt134; Bailey L., 1991, HONEY BEE PATHOLOGY; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; Bomtorin AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086923; Bull JC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003083; Chen YP, 2006, APPL ENVIRON MICROB, V72, P606, DOI 10.1128/AEM.72.1.606-611.2006; Chen YP, 2005, APPL ENVIRON MICROB, V71, P436, DOI 10.1128/AEM.71.1.436-441.2005; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; COXFOSTER DL, 1994, J INSECT PHYSIOL, V40, P235, DOI 10.1016/0022-1910(94)90047-7; Dainat B, 2013, J INVERTEBR PATHOL, V112, P278, DOI 10.1016/j.jip.2012.12.009; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; DEMIRANDA JR, 2013, J APICULT RES, V52, DOI DOI 10.3896/IBRA.1.52.4.22; Di Prisco G, 2011, VIRUSES-BASEL, V3, P2425, DOI 10.3390/v3122425; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; FLURI P, 1977, EXPERIENTIA, V33, P1240, DOI 10.1007/BF01922354; FLURI P, 1982, J INSECT PHYSIOL, V28, P61, DOI 10.1016/0022-1910(82)90023-3; Free J. B., 1959, Proceedings of the Royal Entomological Society of London (A), V34, P141; Gatschenberger H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066415; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gregorc A, 2012, J INSECT PHYSIOL, V58, P1042, DOI 10.1016/j.jinsphys.2012.03.015; Gregory PG, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.7; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Hartfelder K, 1998, CURR TOP DEV BIOL, V40, P45, DOI 10.1016/S0070-2153(08)60364-6; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; HUANG ZY, 1995, J COMP PHYSIOL B, V165, P18, DOI 10.1007/BF00264682; IMDORF A, 2003, APIACTA, V38, P258; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Lourenco AP, 2005, INSECT BIOCHEM MOLEC, V35, P541, DOI 10.1016/j.ibmb.2005.01.013; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Mattila HR, 2007, ECOL ENTOMOL, V32, P496, DOI 10.1111/j.1365-2311.2007.00904.x; MERZ R, 1979, REV SUISSE ZOOL, V86, P663, DOI 10.5962/bhl.part.82329; Mockel N, 2011, J GEN VIROL, V92, P370, DOI 10.1099/vir.0.025940-0; Navajas M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-301; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Neumann P, 2012, TRENDS PARASITOL, V28, P353, DOI 10.1016/j.pt.2012.06.004; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; RIDDIFORD LM, 1970, SCIENCE, V167, P287, DOI 10.1126/science.167.3916.287; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Ruijter JM, 2013, METHODS, V59, P32, DOI 10.1016/j.ymeth.2012.08.011; Ryabov EV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004230; Schmid-Hempel P., 1998, Parasites in social insects.; Shelby KS, 2006, J INSECT SCI, V6, DOI 10.1673/2006_06_13.1; Shiao SH, 2001, INSECT MOL BIOL, V10, P315, DOI 10.1046/j.0962-1075.2001.00268.x; Simone M, 2009, EVOLUTION, V63, P3016, DOI 10.1111/j.1558-5646.2009.00772.x; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; STRAND MR, 1995, ANNU REV ENTOMOL, V40, P31, DOI 10.1146/annurev.en.40.010195.000335; Tentcheva D, 2006, APIDOLOGIE, V37, P41, DOI 10.1051/apido:2005057; Velthuis H. H. W., 1990, Social insects: an evolutionary approach to castes and reproduction., P231; Winston M., 1987, The biology of the honey bee.; Yang X, 2007, PARASITOLOGY, V134, P405, DOI 10.1017/S0031182006000710; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102	69	56	59	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0129956	10.1371/journal.pone.0129956	http://dx.doi.org/10.1371/journal.pone.0129956			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121358	gold, Green Published, Green Submitted			2022-12-27	WOS:000358150400030
J	Wilson, RL; Buckberry, S; Spronk, F; Laurence, JA; Leemaqz, S; O'Leary, S; Bianco-Miotto, T; Du, J; Anderson, PH; Roberts, CT				Wilson, Rebecca L.; Buckberry, Sam; Spronk, Fleur; Laurence, Jessica A.; Leemaqz, Shalem; O'Leary, Sean; Bianco-Miotto, Tina; Du, Jing; Anderson, Paul H.; Roberts, Claire T.			Vitamin D Receptor Gene Ablation in the Conceptus Has Limited Effects on Placental Morphology, Function and Pregnancy Outcome	PLOS ONE			English	Article							25-HYDROXYVITAMIN D; D DEFICIENCY; CALCIUM TRANSFER; SKELETAL-MUSCLE; FETAL-GROWTH; EXPRESSION; MICE; VDR; 1,25-DIHYDROXYVITAMIN-D; 1-ALPHA-HYDROXYLASE	Vitamin D deficiency has been implicated in the pathogenesis of several pregnancy complications attributed to impaired or abnormal placental function, but there are few clues indicating the mechanistic role of vitamin D in their pathogenesis. To further understand the role of vitamin D receptor (VDR)-mediated activity in placental function, we used heterozygous Vdr ablated C57Bl6 mice to assess fetal growth, morphological parameters and global gene expression in Vdr null placentae. Twelve Vdr(+/-) dams were mated at 10-12 weeks of age with Vdr(+/-) males. At day 18.5 of the 19.5 day gestation in our colony, females were euthanised and placental and fetal samples were collected, weighed and subsequently genotyped as either Vdr(+/+), Vdr(+/-) or Vdr(-/-). Morphological assessment of placentae using immunohistochemistry was performed and RNA was extracted and subject to microarray analysis. This revealed 25 genes that were significantly differentially expressed between Vdr(+/+) and Vdr(-/-) placentae. The greatest difference was a 6.47-fold change in expression of Cyp24a1 which was significantly lower in the Vdr(-/-) placentae (P<0.01). Other differentially expressed genes in Vdr(-/-) placentae included those involved in RNA modification (Snord123), autophagy (Atg4b), cytoskeletal modification (Shroom4), cell signalling (Plscr1, Pex5) and mammalian target of rapamycin (mTOR) signalling (Deptor and Prr5). Interrogation of the upstream sequence of differentially expressed genes identified that many contain putative vitamin D receptor elements (VDREs). Despite the gene expression differences, this did not contribute to any differences in overall placental morphology, nor was function affected as there was no difference in fetal growth as determined by fetal weight near term. Given our dams still expressed a functional VDR gene, our results suggest that cross-talk between the maternal decidua and the placenta, as well as maternal vitamin D status, may be more important in determining pregnancy outcome than conceptus expression of VDR.	[Wilson, Rebecca L.; Buckberry, Sam; Spronk, Fleur; Laurence, Jessica A.; Leemaqz, Shalem; O'Leary, Sean; Bianco-Miotto, Tina; Du, Jing; Roberts, Claire T.] Robinson Res Inst, Adelaide, SA, Australia; [Wilson, Rebecca L.; Buckberry, Sam; Spronk, Fleur; Laurence, Jessica A.; Leemaqz, Shalem; O'Leary, Sean; Roberts, Claire T.] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia; [Bianco-Miotto, Tina] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia; [Anderson, Paul H.] Univ S Australia, Div Hlth Sci, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Du, Jing] Shanghai Inst Planned Parenthood Res, Shanghai, Peoples R China	Robinson Research Institute; University of Adelaide; University of Adelaide; University of South Australia	Roberts, CT (corresponding author), Robinson Res Inst, Adelaide, SA, Australia.	claire.roberts@adelaide.edu.au	Bianco-Miotto, Tina/C-4808-2008; Buckberry, Sam/H-5774-2019; Du, Jing/AAY-4092-2021; Anderson, Paul H/F-4198-2013; O'Leary, Sean/R-1528-2016	Bianco-Miotto, Tina/0000-0002-8431-5338; Buckberry, Sam/0000-0003-2388-6046; Du, Jing/0000-0002-6767-2763; Anderson, Paul H/0000-0002-8685-3252; O'Leary, Sean/0000-0001-8454-9815; Roberts, Claire/0000-0002-9250-2192; Leemaqz, Shalem/0000-0003-4616-8426	National Health and Medical Research Council Project grant [GNT1020754]; NHMRC Senior Research Fellowship [GNT1020749]; NHMRC Career Development Fellowship [GNT1034698]; Cook Medical Adelaide Fellowship through Robinson Research Institute; Australian Postgraduate Award	National Health and Medical Research Council Project grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Cook Medical Adelaide Fellowship through Robinson Research Institute; Australian Postgraduate Award(Australian Government)	This work was supported by a National Health and Medical Research Council Project grant awarded to CTR and PHA (GNT1020754). CTR is supported by a NHMRC Senior Research Fellowship (GNT1020749). PHA is supported by a NHMRC Career Development Fellowship (GNT1034698). JD was the recipient of a Cook Medical Adelaide Fellowship awarded through the Robinson Research Institute. RLW and SB are both supported by Australian Postgraduate Awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajafari F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1169; Albay Ricardo III, 2009, BMC Physiology, V9, P4, DOI 10.1186/1472-6793-9-4; Anderson P H, 2003, Clin Biochem Rev, V24, P13; Ardawi MSM, 1997, EUR J ENDOCRINOL, V137, P402, DOI 10.1530/eje.0.1370402; Baker AM, 2010, J CLIN ENDOCR METAB, V95, P5105, DOI 10.1210/jc.2010-0996; Berghold VM, 2015, HISTOCHEM CELL BIOL, V143, P381, DOI 10.1007/s00418-014-1294-y; Bodnar LM, 2007, J CLIN ENDOCR METAB, V92, P3517, DOI 10.1210/jc.2007-0718; Bodnar LM, 2010, J NUTR, V140, P999, DOI 10.3945/jn.109.119636; Bodnar LM, 2009, J NUTR, V139, P1157, DOI 10.3945/jn.108.103168; Burton GJ, 2004, J SOC GYNECOL INVEST, V11, P342, DOI 10.1016/j.jsgi.2004.03.003; Chan SY, 2015, PLACENTA, V36, P403, DOI 10.1016/j.placenta.2014.12.021; Cho GJ, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.015; Cross JC, 1998, ANN NY ACAD SCI, V857, P23, DOI 10.1111/j.1749-6632.1998.tb10104.x; De Laine KM, 2013, AUST NZ J OBSTET GYN, V53, P353, DOI 10.1111/ajo.12052; Durk MR, 2014, J NEUROSCI, V34, P7091, DOI 10.1523/JNEUROSCI.2711-13.2014; Foster HA, 2014, J STEROID BIOCHEM, V139, P166, DOI 10.1016/j.jsbmb.2013.02.017; Girgis CM, 2014, ENDOCRINOLOGY, V155, P3227, DOI 10.1210/en.2014-1016; Girgis CM, 2014, ENDOCRINOLOGY, V155, P347, DOI 10.1210/en.2013-1205; Grant WB, 2009, DERM-ENDOCRINOL, V1, P223, DOI 10.4161/derm.1.4.9500; Haussler MR, 2011, BEST PRACT RES CL EN, V25, P543, DOI 10.1016/j.beem.2011.05.010; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hu LZ, 2014, J STEROID BIOCHEM, V144, P237, DOI 10.1016/j.jsbmb.2013.11.002; Jansson T, 2006, PLACENTA, V27, pS91, DOI 10.1016/j.placenta.2005.11.010; Javaid MK, MATERNAL VITAMIN D S; Johnstone CN, 2005, GENOMICS, V85, P338, DOI 10.1016/j.ygeno.2004.11.002; Jones G, 2012, ARCH BIOCHEM BIOPHYS, V523, P9, DOI 10.1016/j.abb.2011.11.003; Kato M, 2007, J IMMUNOL, V179, P6052, DOI 10.4049/jimmunol.179.9.6052; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kovacs CS, 2005, AM J PHYSIOL-ENDOC M, V289, pE133, DOI 10.1152/ajpendo.00354.2004; KUMAR R, 1979, J CLIN INVEST, V63, P342, DOI 10.1172/JCI109308; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Lam NN, 2014, J STEROID BIOCHEM, V144, P128, DOI 10.1016/j.jsbmb.2014.01.002; Leffelaar ER, 2010, BRIT J NUTR, V104, P108, DOI 10.1017/S000711451000022X; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Lisse TS, 2011, CELL CYCLE, V10, P1888, DOI 10.4161/cc.10.12.15620; Liu NQ, 2013, ENDOCRINOLOGY, V154, P2270, DOI 10.1210/en.2012-2270; Liu NQ, 2011, J IMMUNOL, V186, P5968, DOI 10.4049/jimmunol.1003332; Ma R, 2012, AM J PHYSIOL-ENDOC M, V303, pE928, DOI 10.1152/ajpendo.00279.2012; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Moon RJ, 2015, EUR J ENDOCRINOL, V173, pR69, DOI 10.1530/EJE-14-0826; Murphy VE, 2006, ENDOCR REV, V27, P141, DOI 10.1210/er.2005-0011; Ni W, 2014, HYPERTENSION, V64, DOI 10.1161/HYPERTENSIONAHA.114.03971; Nunn C, 2006, SEMIN CELL DEV BIOL, V17, P390, DOI 10.1016/j.semcdb.2006.04.001; Ormsby RT, 2014, J STEROID BIOCHEM, V144, P110, DOI 10.1016/j.jsbmb.2013.09.016; Panda DK, 2004, J BIOL CHEM, V279, P16754, DOI 10.1074/jbc.M310271200; Papapetrou PD, 2010, HORM-INT J ENDOCRINO, V9, P136, DOI 10.14310/horm.2002.1263; Perez-Ferre N, 2012, ENDOCR PRACT, V18, P676, DOI 10.4158/EP12025.OR; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Pospechova K, 2009, MOL CELL ENDOCRINOL, V299, P178, DOI 10.1016/j.mce.2008.12.003; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Rezende VB, 2012, MOL BIOL REP, V39, P10903, DOI 10.1007/s11033-012-1988-y; Roberts CT, 2003, PLACENTA, V24, pS94, DOI 10.1053/plac.2002.0949; Roos S, 2009, BIOCHEM SOC T, V37, P295, DOI 10.1042/BST0370295; Sablok A, 2015, CLIN ENDOCRINOL, V83, P536, DOI 10.1111/cen.12751; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; St-Arnaud R, 2012, VITAMIN D, P43; Tamblyn JA, 2015, J ENDOCRINOL, V224, pR107, DOI 10.1530/JOE-14-0642; Turner AG, 2014, J STEROID BIOCHEM, V144, P114, DOI 10.1016/j.jsbmb.2013.10.003; Wagner CL, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.10.888; Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Young BE, 2014, FASEB J, V28, P2029, DOI 10.1096/fj.13-246736; Zehnder D, 2002, AM J PATHOL, V161, P105, DOI 10.1016/S0002-9440(10)64162-4; Zhu K, 2014, J BONE MINER RES, V29, P1088, DOI 10.1002/jbmr.2138	67	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131287	10.1371/journal.pone.0131287	http://dx.doi.org/10.1371/journal.pone.0131287			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121239	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000358150400092
J	Yang, H; Huang, XC; Zeng, ZJ; Zhang, WC; Liu, CL; Fang, SM; Huang, LS; Chen, CY				Yang, Hui; Huang, Xiaochang; Zeng, Zhijun; Zhang, Wanchang; Liu, Chenlong; Fang, Shaoming; Huang, Lusheng; Chen, Congying			Genome-Wide Association Analysis for Blood Lipid Traits Measured in Three Pig Populations Reveals a Substantial Level of Genetic Heterogeneity	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; SERUM-LIPIDS; APO-B; LOCI; VARIANTS; LINKAGE; PROFILE; LDLR	Serum lipids are associated with myocardial infarction and cardiovascular disease in humans. Here we dissected the genetic architecture of blood lipid traits by applying genome-wide association studies (GWAS) in 1,256 pigs from Laiwu, Erhualian and Duroc x (Landrace x Yorkshire) populations, and a meta-analysis of GWAS in more than 2,400 pigs from five diverse populations. A total of 22 genomic loci surpassing the suggestive significance level were detected on 11 pig chromosomes (SSC) for six blood lipid traits. Meta-analysis of GWAS identified 5 novel loci associated with blood lipid traits. Comparison of GWAS loci across the tested populations revealed a substantial level of genetic heterogeneity for porcine blood lipid levels. We further evaluated the causality of nine polymorphisms nearby or within the APOB gene on SSC3 for serum LDL-C and TC levels. Of the 9 polymorphisms, an indel showed the most significant association with LDL-C and TC in Laiwu pigs. But the significant association was not identified in the White Duroc x Erhualian F-2 resource population, in which the QTL for LDL-C and TC was also detected on SSC3. This indicates that population-specific signals may exist for the SSC3 QTL. Further investigations are warranted to validate this assumption.	[Yang, Hui; Huang, Xiaochang; Zeng, Zhijun; Zhang, Wanchang; Liu, Chenlong; Fang, Shaoming; Huang, Lusheng; Chen, Congying] Jiangxi Agr Univ, Minist Agr China, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang 330045, Peoples R China	Jiangxi Agricultural University; Ministry of Agriculture & Rural Affairs	Huang, LS (corresponding author), Jiangxi Agr Univ, Minist Agr China, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang 330045, Peoples R China.	lushengHuang@hotmail.com; chcy75@hotmail.com	Chen, Congying/AFU-8515-2022; Chen, Congying/ABB-7384-2021; zeng, zhijun/AAE-1504-2019		Natural Science Foundation of China [31160225]; Jiangxi Provincial project [2010BQ01500]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangxi Provincial project	This study was supported by the Natural Science Foundation of China (31160225) and Jiangxi Provincial project for cultivating young scientists (2010BQ01500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bustan SA, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-157; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Benson MK, 2009, INDIAN J EXP BIOL, V47, P98; Burkhardt R, 2010, J CLIN INVEST, V120, P4410, DOI 10.1172/JCI44213; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Chasman DI, 2008, CIRC-CARDIOVASC GENE, V1, P21, DOI 10.1161/CIRCGENETICS.108.773168; Chen CY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-848; Chen RR, 2009, MAMM GENOME, V20, P386, DOI 10.1007/s00335-009-9190-9; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Druet T, 2010, GENETICS, V184, P789, DOI 10.1534/genetics.109.108431; Dumitrescu L, 2011, ANN HUM GENET, V75, P589, DOI 10.1111/j.1469-1809.2011.00664.x; Fang XD, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-16; Gallardo D, 2008, PHYSIOL GENOMICS, V35, P199, DOI 10.1152/physiolgenomics.90249.2008; Gottesman O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046419; Hayes BJ, 2008, J ANIM SCI, V86, P2089, DOI 10.2527/jas.2007-0733; Holleboom AG, 2011, CELL METAB, V14, P811, DOI 10.1016/j.cmet.2011.11.005; HUANG LS, 1988, J LIPID RES, V29, P63; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; KAYAMORI F, 1994, BIOSCI BIOTECH BIOCH, V58, P570, DOI 10.1271/bbb.58.570; Kwon DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107559; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Manunza A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-758; Mateus JC, 2004, ANIM GENET, V35, P305, DOI 10.1111/j.1365-2052.2004.01168.x; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nakazone MA, 2009, GENET MOL BIOL, V32, P227, DOI 10.1590/S1415-47572009005000028; Natarajan R, 2002, DIABETOLOGIA, V45, P125, DOI 10.1007/s125-002-8253-x; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Santa-Maria CA, 2013, CANCER RES, V73, DOI [10.1158/0008-5472. SABCS13-P1-08-11, DOI 10.1158/0008-5472]; Shen HQ, 2010, ARCH INTERN MED, V170, P1850, DOI 10.1001/archinternmed.2010.384; Steinhoff MS, 2014, PHYSIOL REV, V94, P265, DOI 10.1152/physrev.00031.2013; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Willer CJ, 2012, CURR OPIN LIPIDOL, V23, P98, DOI 10.1097/MOL.0b013e328350fad2; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wu Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003379; Xu SZ, 2003, GENETICS, V165, P2259; Zeng Z, 2014, ANIM GENET, V45, P665, DOI 10.1111/age.12183; Zhang Z, 2012, BIOINFORMATICS, V28, P2467, DOI 10.1093/bioinformatics/bts348; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	40	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131667	10.1371/journal.pone.0131667	http://dx.doi.org/10.1371/journal.pone.0131667			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121138	Green Submitted, Green Published, gold			2022-12-27	WOS:000358150400136
J	Cusick, KD; Fitzgerald, LA; Cockrell, AL; Biffinger, JC				Cusick, Kathleen D.; Fitzgerald, Lisa A.; Cockrell, Allison L.; Biffinger, Justin C.			Selection and Evaluation of Reference Genes for Reverse Transcription-Quantitative PCR Expression Studies in a Thermophilic Bacterium Grown under Different Culture Conditions	PLOS ONE			English	Article							REAL-TIME PCR; RT-PCR; HOUSEKEEPING GENES; IDENTIFICATION; QUANTIFICATION; REDUCTION; RNA; NORMALIZATION; VALIDATION; RADIATION	The phylum Deinococcus-Thermus is a deeply-branching lineage of bacteria widely recognized as one of the most extremophilic. Members of the Thermus genus are of major interest due to both their bioremediation and biotechnology potentials. However, the molecular mechanisms associated with these key metabolic pathways remain unknown. Reverse-transcription quantitative PCR (RT-qPCR) is a high-throughput means of studying the expression of a large suite of genes over time and under different conditions. The selection of a stably-expressed reference gene is critical when using relative quantification methods, as target gene expression is normalized to expression of the reference gene. However, little information exists as to reference gene selection in extremophiles. This study evaluated 11 candidate reference genes for use with the thermophile Thermus scotoductus when grown under different culture conditions. Based on the combined stability values from BestKeeper and NormFinder software packages, the following are the most appropriate reference genes when comparing: (1) aerobic and anaerobic growth: TSC_c19900, polA2, gyrA, gyrB; (2) anaerobic growth with varied electron acceptors: TSC_c19900, infA, pfk, gyrA, gyrB; (3) aerobic growth with different heating methods: gyrA, gap, gyrB; (4) all conditions mentioned above: gap, gyrA, gyrB. The commonly-employed rpoC does not serve as a reliable reference gene in thermophiles, due to its expression instability across all culture conditions tested here. As extremophiles exhibit a tendency for polyploidy, absolute quantification was employed to determine the ratio of transcript to gene copy number in a subset of the genes. A strong negative correlation was found to exist between ratio and threshold cycle (C-T) values, demonstrating that C-T changes reflect transcript copy number, and not gene copy number, fluctuations. Even with the potential for polyploidy in extremophiles, the results obtained via absolute quantification indicate that relative quantification is appropriate for RT-qPCR studies with this thermophile.	[Cusick, Kathleen D.; Cockrell, Allison L.] US Naval Res Lab, Natl Res Council Associateship, Washington, DC 20375 USA; [Fitzgerald, Lisa A.; Biffinger, Justin C.] US Naval Res Lab, Div Chem, Washington, DC 20375 USA	National Academies of Sciences, Engineering & Medicine; United States Department of Defense; United States Navy; Naval Research Laboratory; United States Department of Defense; United States Navy; Naval Research Laboratory	Cusick, KD (corresponding author), US Naval Res Lab, Natl Res Council Associateship, 4555 Overlook Ave SW, Washington, DC 20375 USA.	Kathleen_cusick.ctr@code6100.nrl.navy.mil	Cusick, Kathleen/AAZ-4174-2020	Cusick, Kathleen/0000-0001-7224-3472; , Lisa/0000-0002-2716-4908	Office of Naval Research/Naval Research Laboratory Nanoscience Institute BLK [614947]	Office of Naval Research/Naval Research Laboratory Nanoscience Institute BLK	Office of Naval Research/Naval Research Laboratory Nanoscience Institute BLK 6.1 funding, WU#614947, to JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Balkwill DL, 2004, EXTREMOPHILES, V8, P37, DOI 10.1007/s00792-003-0357-0; Berdygulova Z, 2011, J MOL BIOL, V405, P125, DOI 10.1016/j.jmb.2010.10.049; Bester PA, 2010, FEMS MICROBIOL LETT, V302, P182, DOI 10.1111/j.1574-6968.2009.01852.x; BROCK TD, 1969, J BACTERIOL, V98, P289, DOI 10.1128/JB.98.1.289-297.1969; Brudal Espen, 2013, BMC Res Notes, V6, P76, DOI 10.1186/1756-0500-6-76; Bruins ME, 2001, APPL BIOCHEM BIOTECH, V90, P155, DOI 10.1385/ABAB:90:2:155; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cason ED, 2012, CHEMOSPHERE, V86, P572, DOI 10.1016/j.chemosphere.2011.10.006; Costaglioli P, 2014, MOL CELL PROBE, V28, P10, DOI 10.1016/j.mcp.2013.09.003; Cusick KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112706; Eleaume H, 2004, J MICROBIOL METH, V59, P363, DOI 10.1016/j.mimet.2004.07.015; Florindo C, 2012, J MICROBIOL METH, V90, P220, DOI 10.1016/j.mimet.2012.05.011; Galisa PS, 2012, J MICROBIOL METH, V91, P1, DOI 10.1016/j.mimet.2012.07.005; Gounder K, 2011, BMC GENOMICS, V12, DOI [10.1186/1471-2164-12-12, DOI 10.1186/1471-2164-12-12]; HANSEN MT, 1978, J BACTERIOL, V134, P71, DOI 10.1128/JB.134.1.71-75.1978; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Ishitani R, 1996, J NEUROCHEM, V66, P928; Kieft TL, 1999, APPL ENVIRON MICROB, V65, P1214; Kumwenda B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-813; Lioliou EE, 2004, MICROB CELL FACT, V3, P1723; Liu JJ, 2013, J BIOSCI BIOENG, V116, P460, DOI 10.1016/j.jbiosc.2013.04.011; Lovdal T, 2014, MOL BIOTECHNOL, V56, P210, DOI 10.1007/s12033-013-9697-x; Lu HM, 2011, ARCH MICROBIOL, V193, P741, DOI 10.1007/s00203-011-0712-y; MINTON KW, 1994, MOL MICROBIOL, V13, P9, DOI 10.1111/j.1365-2958.1994.tb00397.x; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Nieto PA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-63; Ohtani N, 2010, J BACTERIOL, V192, P5499, DOI 10.1128/JB.00662-10; Oliverio AM, 2014, GENOME BIOL EVOL, V6, P482, DOI 10.1093/gbe/evu024; Opperman DJ, 2007, J APPL MICROBIOL, V103, P1907, DOI 10.1111/j.1365-2672.2007.03429.x; Pakchung AAH, 2006, ENVIRON CHEM, V3, P77, DOI 10.1071/EN05093; Pecoraro V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016392; Perez-Osorio AC, 2010, J BACTERIOL, V192, P2991, DOI 10.1128/JB.01598-09; Pfaffl M.W., 2004, A Z QUANT PCR, P87; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, BIOTECHNOL LETT, V23, P275, DOI 10.1023/A:1005658330108; Rajpurohit YS, 2010, MOL MICROBIOL, V77, P1470, DOI 10.1111/j.1365-2958.2010.07301.x; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ritalahti KM, 2006, APPL ENVIRON MICROB, V72, P2765, DOI 10.1128/AEM.72.4.2765-2774.2006; Serrano M, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-36; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; Stenico V, 2014, ANAEROBE, V27, P34, DOI 10.1016/j.anaerobe.2014.03.004; Sturzenbaum SR, 2001, COMP BIOCHEM PHYS B, V130, P281, DOI 10.1016/S1096-4959(01)00440-7; Takle GW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-50; Theis T, 2007, J MICROBIOL METH, V70, P355, DOI 10.1016/j.mimet.2007.05.011; Thomas F, 2011, J MICROBIOL METH, V84, P61, DOI 10.1016/j.mimet.2010.10.016; Vandecasteele SJ, 2001, J BACTERIOL, V183, P7094, DOI 10.1128/JB.183.24.7094-7101.2001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Zhao WJ, 2011, J IND MICROBIOL BIOT, V38, P1279, DOI 10.1007/s10295-010-0906-3; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	53	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131015	10.1371/journal.pone.0131015	http://dx.doi.org/10.1371/journal.pone.0131015			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115538	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500121
J	Frost, L; Baez, MAM; Harrilal, C; Garabedian, A; Fernandez-Lima, F; Leng, FF				Frost, Lorraine; Baez, Maria A. M.; Harrilal, Christopher; Garabedian, Alyssa; Fernandez-Lima, Francisco; Leng, Fenfei			The Dimerization State of the Mammalian High Mobility Group Protein AT-Hook 2 (HMGA2)	PLOS ONE			English	Article							AMYLOID FIBRIL FORMATION; SEDIMENTATION-VELOCITY; BETA; EXPRESSION; GENE; AGGREGATION; COMPLEX; BINDING; CANCER; DOMAIN	The mammalian high mobility group protein AT-hook 2 (HMGA2) is a chromosomal architectural transcription factor involved in cell transformation and oncogenesis. It consists of three positively charged "AT-hooks" and a negatively charged C-terminus. Sequence analyses, circular dichroism experiments, and gel-filtration studies showed that HMGA2, in the native state, does not have a defined secondary or tertiary structure. Surprisingly, using combined approaches of 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) chemical cross-linking, analytical ultracentrifugation, fluorescence resonance energy transfer (FRET), and mass spectrometry, we discovered that HMGA2 is capable of self-associating into homodimers in aqueous buffer solution. Our results showed that electrostatic interactions between the positively charged "AT-hooks" and the negatively charged C-terminus greatly contribute to the homodimer formation.	[Frost, Lorraine; Baez, Maria A. M.; Harrilal, Christopher; Garabedian, Alyssa; Fernandez-Lima, Francisco; Leng, Fenfei] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA; [Frost, Lorraine; Baez, Maria A. M.; Harrilal, Christopher; Garabedian, Alyssa; Fernandez-Lima, Francisco; Leng, Fenfei] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University	Leng, FF (corresponding author), Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA.	lengf@fiu.edu		Fernandez-Lima, Francisco/0000-0002-1283-4390	NIH [5SC1HD063059-04, 1R15GM109254-01A1, R00GM106414]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [SC1HD063059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM106414, R15GM109254] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants 5SC1HD063059-04 and 1R15GM109254-01A1 (to FL) and R00GM106414 (to FF-L).	Abe N, 1999, CANCER RES, V59, P1169; Alonso N, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv069; Anand A, 2000, NAT GENET, V24, P377, DOI 10.1038/74207; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P152, DOI 10.1016/S0968-0004(00)01777-1; Chen B, 2010, BIOCHEMISTRY-US, V49, P1590, DOI 10.1021/bi901881c; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; Cui TJ, 2007, BIOCHEMISTRY-US, V46, P13059, DOI 10.1021/bi701269s; Cui TJ, 2007, PROTEIN PEPTIDE LETT, V14, P87, DOI 10.2174/092986607779117281; Cui TJ, 2005, J MOL BIOL, V352, P629, DOI 10.1016/j.jmb.2005.07.048; Danielsson J, 2008, BIOCHEMISTRY-US, V47, P13428, DOI 10.1021/bi801040b; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Efanov A, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.46; Fedele M, 2001, CARCINOGENESIS, V22, P1583, DOI 10.1093/carcin/22.10.1583; Fernandez-Lima FA, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3665933; Fernandez-Lima F, 2011, INT J ION MOBIL SPEC, V14, P93, DOI 10.1007/s12127-011-0067-8; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Fonfria-Subiros E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037120; Foti D, 2003, MOL CELL BIOL, V23, P2720, DOI 10.1128/MCB.23.8.2720-2732.2003; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Goers J, 2003, PROTEIN SCI, V12, P702, DOI 10.1110/ps.0230903; Goodwin G, 1998, INT J BIOCHEM CELL B, V30, P761, DOI 10.1016/S1357-2725(98)00016-8; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hauke S, 2005, BBA-GENE STRUCT EXPR, V1729, P24, DOI 10.1016/j.bbaexp.2005.03.006; Hernandez DR, 2014, ANALYST, V139, P1913, DOI 10.1039/c3an02174b; Horikoshi M, 2013, NAT GENET, V45, P76, DOI 10.1038/ng.2477; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Kumar MS, 2014, NATURE, V505, P212, DOI 10.1038/nature12785; Lanza DCF, 2009, PROTEINS, V74, P104, DOI 10.1002/prot.22135; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P99; Ligon AH, 2000, GENE CHROMOSOME CANC, V28, P235, DOI 10.1002/1098-2264(200007)28:3<235::AID-GCC1>3.3.CO;2-Z; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Litvinovich SV, 1998, J MOL BIOL, V280, P245, DOI 10.1006/jmbi.1998.1863; McDaniel E. W., 1973, MOBILITY DIFFUSION I; Meyer B, 2007, MOL CARCINOG; Morishita A, 2013, CANCER RES, V73, P4289, DOI 10.1158/0008-5472.CAN-12-3848; Muller MH, 2013, ANTICANCER RES, V33, P3069; Padmanabhan S, 2001, J BIOL CHEM, V276, P41566, DOI 10.1074/jbc.M106352200; Pieprzyk J, 2014, BBA-PROTEINS PROTEOM, V1844, P1153, DOI 10.1016/j.bbapap.2014.03.010; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Reeves R, 2003, BIOCHEM CELL BIOL, V81, P185, DOI 10.1139/o03-044; Rogalla P, 1998, ANTICANCER RES, V18, P3327; Schenk ER, 2014, ANAL CHEM, V86, P2019, DOI 10.1021/ac403153m; Schenk ER, 2014, ANAL CHEM, V86, P1210, DOI 10.1021/ac403386q; SCHOENMAKERS EFPM, 1995, NAT GENET, V10, P436, DOI 10.1038/ng0895-436; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sigalov A, 2004, BIOCHEMISTRY-US, V43, P2049, DOI 10.1021/bi035900h; Sigalov AB, 2007, BIOCHIMIE, V89, P419, DOI 10.1016/j.biochi.2006.11.003; Simon SM, 2008, P NATL ACAD SCI USA, V105, P1152, DOI 10.1073/pnas.0706067105; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Sun M, 2013, P NATL ACAD SCI USA, V110, P9920, DOI 10.1073/pnas.1305172110; Thirumalai D, 2003, CURR OPIN STRUC BIOL, V13, P146, DOI 10.1016/S0959-440X(03)00032-0; Tjernberg L, 2002, J BIOL CHEM, V277, P43243, DOI 10.1074/jbc.M205570200; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; WHITLEY MZ, 1994, MOL CELL BIOL, V14, P6464, DOI 10.1128/MCB.14.10.6464; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; WOLFFE AP, 1994, SCIENCE, V264, P1100, DOI 10.1126/science.8178167; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yi MA, 2008, ANAL BIOCHEM, V374, P7, DOI 10.1016/j.ab.2007.10.023; Yie JM, 1999, EMBO J, V18, P3074, DOI 10.1093/emboj/18.11.3074; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	70	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130478	10.1371/journal.pone.0130478	http://dx.doi.org/10.1371/journal.pone.0130478			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114780	gold, Green Published, Green Submitted			2022-12-27	WOS:000358147500075
J	Martemyanov, VV; Pavlushin, SV; Dubovskiy, IM; Yushkova, YV; Morosov, SV; Chernyak, EI; Efimov, VM; Ruuhola, T; Glupov, VV				Martemyanov, Vyacheslav V.; Pavlushin, Sergey V.; Dubovskiy, Ivan M.; Yushkova, Yuliya V.; Morosov, Sergey V.; Chernyak, Elena I.; Efimov, Vadim M.; Ruuhola, Teija; Glupov, Victor V.			Asynchrony between Host Plant and Insects-Defoliator within a Tritrophic System: The Role of Herbivore Innate Immunity	PLOS ONE			English	Article							MOTH LYMANTRIA-DISPAR; NUCLEAR POLYHEDROSIS-VIRUS; EUROPEAN WHITE BIRCH; VERTICAL TRANSMISSION; HYDROLYZABLE TANNINS; SEASONAL-CHANGES; L. LEPIDOPTERA; BETULA-PENDULA; WINTER MOTH; PHENOLOGY	The effects of asynchrony in the phenology of spring-feeding insect-defoliators and their host plants on insects' fitness, as well as the importance of this effect for the population dynamics of outbreaking species of insects, is a widespread and well-documented phenomenon. However, the spreading of this phenomenon through the food chain, and especially those mechanisms operating this spreading, are still unclear. In this paper, we study the effect of seasonally declined leafquality (estimated in terms of phenolics and nitrogen content) on herbivore fitness, immune parameters and resistance against pathogen by using the silver birch Betula pendula-gypsy moth Lymantria dispar-nucleopolyhedrovirus as the tritrophic system. We show that a phenological mismatch induced by the delay in the emergence of gypsy moth larvae and following feeding on mature leaves has negative effects on the female pupal weight, on the rate of larval development and on the activity of phenoloxidase in the plasma of haemolymph. In addition, the larval susceptibility to exogenous nucleopolyhydrovirus infection as well as covert virus activation were both enhanced due to the phenological mismatch. The observed effects of phenological mismatch on insect-baculovirus interaction may partially explain the strong and fast fluctuations in the population dynamics of the gypsy moth that is often observed in the studied part of the defoliator area. This study also reveals some indirect mechanisms of effect related to host plant quality, which operate through the insect innate immune status and affect resistance to both exogenous and endogenous virus.	[Martemyanov, Vyacheslav V.; Pavlushin, Sergey V.; Dubovskiy, Ivan M.; Glupov, Victor V.] RAS, SB, Inst Systemat & Ecol Anim, Lab Insect Pathol, Novosibirsk, Russia; [Martemyanov, Vyacheslav V.] Natl Res Tomsk State Univ, Inst Biol, Tomsk, Russia; [Yushkova, Yuliya V.; Morosov, Sergey V.; Chernyak, Elena I.] RAS, SB, Novosibirsk Organ Chem Inst, Lab Ecol Res & Chromatog Anal, Novosibirsk, Russia; [Efimov, Vadim M.] RAS, SB, Inst Cytol & Genet, Lab Mol Genet Syst, Novosibirsk, Russia; [Ruuhola, Teija] Univ Eastern Finland, Dept Biol, Joensuu, Finland	Russian Academy of Sciences; Tomsk State University; Russian Academy of Sciences; Vorozhtsov Novosibirsk Institute of Organic Chemistry; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; University of Eastern Finland	Martemyanov, VV (corresponding author), RAS, SB, Inst Systemat & Ecol Anim, Lab Insect Pathol, Novosibirsk, Russia.	martemyanov79@yahoo.com	Glupov, Viktor/N-7706-2014; Dubovskiy, Ivan/B-8252-2008; Martemyanov, Vyacheslav/Q-7466-2016; Chernyak, Elena/S-9957-2017; Efimov, Vadim M./K-5806-2012; Efimov, Vadim/AAE-1158-2020; Pavlushin, Sergey/AAH-5329-2019	Dubovskiy, Ivan/0000-0001-9691-3960; Chernyak, Elena/0000-0002-1669-7864; Efimov, Vadim M./0000-0003-3035-8049; Efimov, Vadim/0000-0003-3035-8049; Pavlushin, Sergey/0000-0002-4210-0662	Federal Fundamental Scientific Research Programme [VI.51.1.5.]; Russian Foundation for Basic Research [12-04-01228-a]; government grant from the Russian Federation [MK-2984.2013.4]	Federal Fundamental Scientific Research Programme; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); government grant from the Russian Federation	The purchasing of supplies needed for this work was supported by the Federal Fundamental Scientific Research Programme for 2013-2020 (VI.51.1.5.) for VVG; The Russian Foundation for Basic Research (12-04-01228-a) for VVM; The government grant from the Russian Federation (MK-2984.2013.4) for IMD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakhvalov S. A., 2012, Voprosy Virusologii, V57, P35; Bakhvalov SA, 2002, RUSS J ECOL+, V33, P429, DOI 10.1023/A:1020959716580; Bakhvalov SA, 2010, FACTORS ECOLOGICAL M; Barbehenn R, 2008, J CHEM ECOL, V34, P748, DOI 10.1007/s10886-008-9478-3; Barbehenn RV, 2009, J INSECT PHYSIOL, V55, P297, DOI 10.1016/j.jinsphys.2008.12.001; Barbehenn RV, 2009, OECOLOGIA, V159, P777, DOI 10.1007/s00442-008-1268-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURAND JP, 1992, J VIROL METHODS, V36, P141, DOI 10.1016/0166-0934(92)90145-4; Burden JP, 2002, MOL ECOL, V11, P547, DOI 10.1046/j.0962-1083.2001.01439.x; Castro MEB, 2009, J INVERTEBR PATHOL, V102, P149, DOI 10.1016/j.jip.2009.07.011; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cory JS, 2006, TRENDS ECOL EVOL, V21, P278, DOI 10.1016/j.tree.2006.02.005; FEENY P, 1970, ECOLOGY, V51, P565, DOI 10.2307/1934037; Foster JR, 2013, FOREST ECOL MANAG, V287, P67, DOI 10.1016/j.foreco.2012.09.006; Haukioja E, 2003, OECOLOGIA, V136, P161, DOI 10.1007/s00442-003-1238-z; Haukioja E, 2002, ENTOMOL EXP APPL, V104, P125, DOI 10.1023/A:1021280106023; Hunter AF, 1999, J ANIM ECOL, V68, P1093, DOI 10.1046/j.1365-2656.1999.00356.x; HUNTER AF, 1992, OECOLOGIA, V89, P316, DOI 10.1007/BF00317408; Hunter AF, 2000, ECOLOGY, V81, P1248, DOI 10.2307/177205; HUNTER MD, 1993, OECOLOGIA, V94, P195, DOI 10.1007/BF00341317; Ibrahim MH, 2011, MOLECULES, V16, P5514, DOI 10.3390/molecules16075514; Ilyinykh AV, 2012, ZH OBSHCH BIOL, V73, P389; Ivashov AV, 2002, FOREST ECOL MANAG, V157, P7, DOI 10.1016/S0378-1127(00)00652-6; Johnson DM, 2006, ECOGRAPHY, V29, P367, DOI 10.1111/j.2006.0906-7590.04448.x; Kapari L, 2006, ECOLOGY, V87, P291, DOI 10.1890/05-0362; KEATING ST, 1989, J INVERTEBR PATHOL, V54, P165, DOI 10.1016/0022-2011(89)90026-8; KEATING ST, 1990, J CHEM ECOL, V16, P1445, DOI 10.1007/BF01014080; Klemola N, 2007, ENTOMOL EXP APPL, V123, P167, DOI 10.1111/j.1570-7458.2007.00533.x; Kukan B, 1999, J INVERTEBR PATHOL, V74, P103, DOI 10.1006/jipa.1999.4873; Lahtinen M, 2004, J CHEM ECOL, V30, P2257, DOI 10.1023/B:JOEC.0000048787.34388.dd; Laitinen ML, 2002, PHYSIOL PLANTARUM, V114, P450, DOI 10.1034/j.1399-3054.2002.1140315.x; Lee KP, 2006, P ROY SOC B-BIOL SCI, V273, P823, DOI 10.1098/rspb.2005.3385; Leonard D.E., 1981, B US DEP AGR, V1584, P9; Martemyanov VV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121917; Martemyanov VV, 2012, ARTHROPOD-PLANT INTE, V6, P507, DOI 10.1007/s11829-012-9202-7; Martemyanov VV, 2012, J CHEM ECOL, V38, P295, DOI 10.1007/s10886-012-0090-1; McNeil J, 2010, J INSECT PHYSIOL, V56, P1167, DOI 10.1016/j.jinsphys.2010.03.020; MORI K, 1992, LIEBIGS ANN CHEM, P485; Murillo R, 2011, J GEN VIROL, V92, P1061, DOI 10.1099/vir.0.028027-0; Mutikainen P, 2000, ECOLOGY, V81, P49, DOI 10.1890/0012-9658(2000)081[0049:HRIBPE]2.0.CO;2; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Narang N, 2001, EUR J ENTOMOL, V98, P189, DOI 10.14411/eje.2001.035; OURTH DD, 1993, COMP BIOCHEM PHYS B, V105, P719, DOI 10.1016/0305-0491(93)90111-H; Parry D, 1998, ENVIRON ENTOMOL, V27, P1368, DOI 10.1093/ee/27.6.1368; Pearse IS, 2011, ECOL ENTOMOL, V36, P635, DOI 10.1111/j.1365-2311.2011.01308.x; Plazonic A, 2009, MOLECULES, V14, P2466, DOI 10.3390/molecules14072466; PODGWAITE JD, 1986, ADV VIRUS RES, V31, P293, DOI 10.1016/S0065-3527(08)60266-3; Ponomarev VI, 2012, GYPSY MOTH T UROL W; Rantala MJ, 2006, J EVOLUTION BIOL, V19, P834, DOI 10.1111/j.1420-9101.2005.01048.x; Raymond B, 2007, BIOL CONTROL, V41, P237, DOI 10.1016/j.biocontrol.2007.02.005; Riipi M, 2002, OECOLOGIA, V130, P380, DOI 10.1007/s00442-001-0826-z; Rolff J., 2009, INSECT INFECT IMMUNI; Rousi M, 2005, TREE PHYSIOL, V25, P201, DOI 10.1093/treephys/25.2.201; Ruuhola T, 2003, CHEMOECOLOGY, V13, P95, DOI 10.1007/s00049-003-0232-6; Salminen JP, 2004, J CHEM ECOL, V30, P1693, DOI 10.1023/B:JOEC.0000042396.40756.b7; Salminen JP, 2002, Z NATURFORSCH C, V57, P248; Shelby KS, 2006, J INSECT SCI, P6; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Tikkanen OP, 2003, OECOLOGIA, V136, P244, DOI 10.1007/s00442-003-1267-7; Tropin IV, 1965, CONTROL CALCULATION; van Asch M, 2007, ANNU REV ENTOMOL, V52, P37, DOI 10.1146/annurev.ento.52.110405.091418; van Frankenhuyzen K., 2007, FIELD MANUAL TECHNIQ, V2nd edition, P481; Vilaplana L, 2010, EVOL ECOL, V24, P147, DOI 10.1007/s10682-009-9296-2; Zhang J, 2010, FOOD CHEM, V119, P1491, DOI 10.1016/j.foodchem.2009.09.031; Zhao PC, 2011, INSECT BIOCHEM MOLEC, V41, P645, DOI 10.1016/j.ibmb.2011.04.006	65	23	24	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130988	10.1371/journal.pone.0130988	http://dx.doi.org/10.1371/journal.pone.0130988			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115118	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500117
J	Ying, L; Zhu, ZW; Xu, ZY; He, TR; Li, EC; Guo, Z; Liu, F; Jiang, CM; Wang, Q				Ying, Li; Zhu, Ziwei; Xu, Zhiyun; He, Tianrui; Li, Encheng; Guo, Zhe; Liu, Fen; Jiang, Chunmeng; Wang, Qi			Cancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic Platform	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM-STRESS; CHEMOTHERAPY RESISTANCE; ACTIVATION; SENSITIVITY; EXPRESSION; CHAPERONE; PATHWAYS; STRATEGY; SYSTEM; LINES	Tumor stroma and growth factors provide a survival environment to tumor cells and can modulate their chemoresistance by dysregulating several signal pathways. In this study, we fabricated a three-dimensional (3D) microfluidic chip using polydimethylsiloxane (PDMS) to investigate the impact of hepatocyte growth factor (HGF) from cancer-associated fibroblasts (CAF) on the Met/PI3K/AKT activation, glucose regulatory protein (GRP78) expression and the paclitaxel-induced A549 cell apoptosis. With a concentration gradient generator, the assembled chip was able to reconstruct a tumor microenvironment in vitro. We found high levels of HGF in the supernatants of CAF and the CAF matrix from the supernatants of activated HFL1 fibroblasts or HGF enhanced the levels of Met, PI3K and AKT phosphorylation and GRP78 expression in A549 cells cultured in a 3D cell chamber, which was abrogated by anti-HGF. Inhibition of Met attenuated the CAF matrix-enhanced PI3K/AKT phosphorylation and GRP78 expression while inhibition of PI3K reduced GRP78 expression, but not Met phosphorylation in A549 cells. Inhibition of GRP78 failed to modulate the CAF matrixenhanced Met/PI3K/AKT phosphorylation in A549 cells. Furthermore, inhibition of PI3K or GRP78 enhanced spontaneous and paclitaxel-induced A549 cell apoptosis. Moreover, treatment with the CAF matrix inhibited spontaneous and medium or high dose of paclitaxel- induced A549 cell apoptosis. Inhibition of PI3K or GRP78 attenuated the CAF matrixmediated inhibition on paclitaxel-induced A549 cell apoptosis. Our data indicated that HGF in the CAF matrix activated the Met/PI3K/AKT and up-regulated GRP78 expression, promoting chemoresistance to paclitaxel-mediated apoptosis in A549 cells. Our findings suggest that the microfluidic system may represent an ideal platform for signaling research and drug screening.	[Ying, Li; Jiang, Chunmeng] Dalian Med Univ, Hosp 2, Dept Gastroenterol, Dailan, Peoples R China; [Zhu, Ziwei; Xu, Zhiyun; Li, Encheng; Guo, Zhe; Liu, Fen; Wang, Qi] Dalian Med Univ, Hosp 2, Dept Resp, Dailan, Peoples R China; [He, Tianrui] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China	Dalian Medical University; Dalian Medical University; Shanghai Jiao Tong University	Wang, Q (corresponding author), Dalian Med Univ, Hosp 2, Dept Resp, Dailan, Peoples R China.	wqdlmu@163.com			National High-tech R&D Program (973 Program) [2012CB822103]; National Natural Science Foundation of China [91129733, 81330060]	National High-tech R&D Program (973 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National High-tech R&D Program (973 Program, No. 2012CB822103) and National Natural Science Foundation of China (No. 91129733 and 81330060). Mrs QW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer M, 2010, INTEGR BIOL-UK, V2, P371, DOI 10.1039/c0ib00001a; Beaver LM, 2009, ENVIRON HEALTH PERSP, V117, P1896, DOI 10.1289/ehp.0900715; Brennen WN, 2012, MOL CANCER THER, V11, P257, DOI 10.1158/1535-7163.MCT-11-0340; Carraro A, 2008, BIOMED MICRODEVICES, V10, P795, DOI 10.1007/s10544-008-9194-3; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Franses JW, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001542; Fujiwara M, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-76; Gunn Richard M, 2008, J Chem Biol, V1, P49, DOI 10.1007/s12154-008-0008-0; Hao YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061754; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Huang B, 2008, BLOOD, V112, P1269, DOI 10.1182/blood-2008-03-147033; Huang CP, 2009, LAB CHIP, V9, P1740, DOI 10.1039/b818401a; Jagadeeswaran R, 2007, AM J PHYSIOL-LUNG C, V292, pL1488, DOI 10.1152/ajplung.00147.2006; Kinoshita K, 2010, INT J ONCOL, V37, P869, DOI 10.3892/ijo_00000738; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee E, 2006, CANCER RES, V66, P7849, DOI 10.1158/0008-5472.CAN-06-1660; Lee PJ, 2006, BIOTECHNOL BIOENG, V94, P5, DOI 10.1002/bit.20745; Liu LY, 2010, LAB CHIP, V10, P1807, DOI 10.1039/c003509b; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Ng CP, 2008, BIOTECHNOL BIOENG, V99, P1490, DOI 10.1002/bit.21698; Perego P, 2010, BIOCHEM PHARMACOL, V80, P1459, DOI 10.1016/j.bcp.2010.07.030; Pfaffenbach KT, 2012, J CELL PHYSIOL, V227, P3803, DOI 10.1002/jcp.24090; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Radisky DC, 2008, CANCER BIOL THER, V7, P1348, DOI 10.4161/cbt.7.9.6850; Shimomura M, 2012, INT J ONCOL, V40, P995, DOI 10.3892/ijo.2011.1297; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Su SF, 2013, ONCOGENE, V32, P4694, DOI 10.1038/onc.2012.483; Tachibana K, 2012, LUNG CANCER, V75, P181, DOI 10.1016/j.lungcan.2011.07.008; Wang JR, 2011, ONCOL REP, V26, P1081, DOI 10.3892/or.2011.1405; Wang SY, 2009, J PHARMACEUT BIOMED, V49, P806, DOI 10.1016/j.jpba.2008.12.021; Wang YY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-372; Wey S, 2012, BLOOD, V119, P817, DOI 10.1182/blood-2011-06-357384; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wu MH, 2010, LAB CHIP, V10, P939, DOI 10.1039/b921695b; Yamada T, 2010, CLIN CANCER RES, V16, P174, DOI 10.1158/1078-0432.CCR-09-1204; Ying L, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-76; Zhao L, 2010, BIOMED MICRODEVICES, V12, P325, DOI 10.1007/s10544-009-9388-3	37	65	68	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129593	10.1371/journal.pone.0129593	http://dx.doi.org/10.1371/journal.pone.0129593			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115510	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500030
J	Agathangelidis, A; Scarfo, L; Barbaglio, F; Apollonio, B; Bertilaccio, MTS; Ranghetti, P; Ponzoni, M; Leone, G; De Pascali, V; Pecciarini, L; Ghia, P; Caligaris-Cappio, F; Scielzo, C				Agathangelidis, Andreas; Scarfo, Lydia; Barbaglio, Federica; Apollonio, Benedetta; Bertilaccio, Maria Teresa Sabrina; Ranghetti, Pamela; Ponzoni, Maurilio; Leone, Gabriella; De Pascali, Valeria; Pecciarini, Lorenza; Ghia, Paolo; Caligaris-Cappio, Federico; Scielzo, Cristina			Establishment and Characterization of PCL12, a Novel CD5(+) Chronic Lymphocytic Leukaemia Cell Line	PLOS ONE			English	Article							B-CELLS; CLL; ANERGY	Immortalized cell lines representative of chronic lymphocytic leukemia (CLL) can assist in understanding disease pathogenesis and testing new therapeutic agents. At present, very few representative cell lines are available. We here describe the characterization of a new cell line (PCL12) that grew spontaneously from the peripheral blood (PB) of a CLL patient with progressive disease and EBV infection. The CLL cell origin of PCL12 was confirmed after the alignment of its IGH sequence against the "original" clonotypic sequence. The IGH gene rearrangement was truly unmutated and no CLL-related cytogenetic or genetic lesions were detected. PCL12 cells express CD19, CD20, CD5, CD23, low levels of IgM and IgD and the poor-outcome-associated prognostic markers CD38, ZAP70 and TCL1. In accordance with its aggressive phenotype the cell line is inactive in terms of LYN and HS1 phosphorylation. BcR signalling pathway is constitutively active and anergic in terms of p-ERK and Calcium flux response to alpha-IgM stimulation. PCL12 cells strongly migrate in vitro in response to SDF-1 and form clusters. Finally, they grow rapidly and localize in all lymphoid organs when xenotrasplanted in Rag2(-/-)gamma c(-/-) mice. PCL12 represents a suitable preclinical model for testing pharmacological agents.	[Agathangelidis, Andreas; Barbaglio, Federica; Apollonio, Benedetta; Bertilaccio, Maria Teresa Sabrina; Ranghetti, Pamela; Caligaris-Cappio, Federico; Scielzo, Cristina] IRCCS San Raffaele Sci Inst, Unit Lymphoid Malignancies, Div Expt Oncol, Milan, Italy; [Scarfo, Lydia; Bertilaccio, Maria Teresa Sabrina; Ghia, Paolo; Caligaris-Cappio, Federico; Scielzo, Cristina] Univ Vita Salute San Raffaele, Milan, Italy; [Agathangelidis, Andreas; Scarfo, Lydia; Ghia, Paolo] IRCCS San Raffaele Sci Inst, Div Expt Oncol, Unit Cell Neoplasia B, Milan, Italy; [Scarfo, Lydia; Ponzoni, Maurilio; Leone, Gabriella; Ghia, Paolo; Caligaris-Cappio, Federico] IRCCS San Raffaele Sci Inst, Lymphoma Unit, Dept Oncohematol, Milan, Italy; [Ponzoni, Maurilio; Leone, Gabriella; De Pascali, Valeria; Pecciarini, Lorenza] IRCCS San Raffaele Sci Inst, Pathol Unit, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Scielzo, C (corresponding author), IRCCS San Raffaele Sci Inst, Unit Lymphoid Malignancies, Div Expt Oncol, Milan, Italy.	scielzo.cristina@hsr.it	Agathangelidis, Andreas/ABD-4262-2021; Ghia, Paolo/K-7138-2016; Pecciarini, Lorenza/GQI-3544-2022; Scielzo, Cristina/AAN-4258-2020	Agathangelidis, Andreas/0000-0002-8467-7945; Ghia, Paolo/0000-0003-3750-7342; Scielzo, Cristina/0000-0001-7988-2824; Apollonio, Benedetta/0000-0003-2414-5549; Scarfo', Lydia/0000-0002-0844-0989; Barbaglio, Federica/0000-0001-5528-2197	Associazione Italiana per la Ricerca sul Cancro AIRC [9965]; Associazione Italiana per la Ricerca sul Cancro AIRC (Triennial fellowship "Guglielmina Lucatello e Gino Mazzega")	Associazione Italiana per la Ricerca sul Cancro AIRC(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Ricerca sul Cancro AIRC (Triennial fellowship "Guglielmina Lucatello e Gino Mazzega")(Fondazione AIRC per la ricerca sul cancro)	This project was supported by the Associazione Italiana per la Ricerca sul Cancro AIRC (Investigator Grant and Special Program Molecular Clinical Oncology-5 per mille #9965). AA is the recipient of a fellowship by Associazione Italiana per la Ricerca sul Cancro AIRC (Triennial fellowship "Guglielmina Lucatello e Gino Mazzega").	Agathangelidis A, 2012, BLOOD, V119, P4467, DOI 10.1182/blood-2011-11-393694; Apollonio B, 2014, JOVE-J VIS EXP, DOI 10.3791/51942; Apollonio B, 2013, BLOOD, V121, P3879, DOI 10.1182/blood-2012-12-474718; AvilaCarino J, 1997, INT J CANCER, V70, P1, DOI 10.1002/(SICI)1097-0215(19970106)70:1<1::AID-IJC1>3.0.CO;2-1; Balatti V, 2015, P NATL ACAD SCI US; Baliakas P, 2015, LEUKEMIA, V29, P329, DOI 10.1038/leu.2014.196; Bertilaccio MTS, 2013, LEUKEMIA, V27, P534, DOI 10.1038/leu.2012.268; Bertilaccio MTS, 2010, BLOOD, V115, P1605, DOI 10.1182/blood-2009-05-223586; Burger JA, 2000, BLOOD, V96, P2655; Byrd JC, 2015, BLOOD, V125, P2497, DOI 10.1182/blood-2014-10-606038; Gaidano G, 2012, J CLIN INVEST, V122, P3432, DOI 10.1172/JCI64101; Gresch O, 2004, METHODS, V33, P151, DOI 10.1016/j.ymeth.2003.11.009; Hadzidimitriou A, 2009, BLOOD, V113, P403, DOI 10.1182/blood-2008-07-166868; Haferlach C, 2007, LEUKEMIA, V21, P2442, DOI 10.1038/sj.leu.2404935; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Klein E, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23035; Malcikova J, 2014, BRIT J HAEMATOL, V166, P621, DOI 10.1111/bjh.12893; Mockridge CI, 2007, BLOOD, V109, P4424, DOI 10.1182/blood-2006-11-056648; Myhrinder AL, 2013, LEUKEMIA LYMPHOMA, V54, P1769, DOI 10.3109/10428194.2013.764418; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Rasul E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106008; RICKINSON AB, 1982, CLIN EXP IMMUNOL, V50, P347; Rosen A, 2012, ONCOIMMUNOLOGY, V1, P18, DOI 10.4161/onci.1.1.18400; Sandes AF, 2013, CYTOMETRY B; Scott DW, 2014, NAT REV CANCER, V14, P517, DOI 10.1038/nrc3774; Simons A, 2013, CYTOGENETIC GENOME R; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Stevenson FK, 2014, SEMIN HEMATOL, V51, P158, DOI 10.1053/j.seminhematol.2014.05.003; ten Hacken E, 2013, BLOOD, V121, P2264, DOI 10.1182/blood-2012-09-457119; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764	30	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130195	10.1371/journal.pone.0130195	http://dx.doi.org/10.1371/journal.pone.0130195			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110819	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800039
J	Aitken, P; Franklin, RC; Lawlor, J; Mitchell, R; Watt, K; Furyk, J; Small, N; Lovegrove, L; Leggat, P				Aitken, Peter; Franklin, Richard Charles; Lawlor, Jenine; Mitchell, Rob; Watt, Kerrianne; Furyk, Jeremy; Small, Niall; Lovegrove, Leone; Leggat, Peter			Emergency Department Presentations following Tropical Cyclone Yasi	PLOS ONE			English	Article							HURRICANE KATRINA; DISASTERS; LOUISIANA; IMPACT; CARE	Introduction Emergency departments see an increase in cases during cyclones. The aim of this study is to describe patient presentations to the Emergency Department (ED) of a tertiary level hospital (Townsville) following a tropical cyclone (Yasi). Specific areas of focus include changes in: patient demographics (age and gender), triage categories, and classification of diseases. Methods Data were extracted from the Townsville Hospitals ED information system (EDIS) for three periods in 2009, 2010 and 2011 to coincide with formation of Cyclone Yasi (31 January 2011) to six days after Yasi crossed the coast line (8 February 2012). The analysis explored the changes in ICD10-AM 4-character classification and presented at the Chapter level. Results There was a marked increase in the number of patients attending the ED during Yasi, particularly those aged over 65 years with a maximum daily attendance of 372 patients on 4 Feb 2011. The most marked increases were in: Triage categories -4 and 5; and ICD categories -diseases of the skin and subcutaneous tissue (L00-L99), and factors influencing health care status (Z00-Z99). The most common diagnostic presentation across all years was injury (S00-T98). Discussion There was an increase in presentations to the ED of TTH, which peaked in the first 24 -48 hours following the cyclone and returned to normal over a five-day period. The changes in presentations were mostly an amplification of normal attendance patterns with some altered areas of activity. Injury patterns are similar to overseas experience.	[Aitken, Peter; Franklin, Richard Charles; Lawlor, Jenine; Mitchell, Rob; Watt, Kerrianne; Furyk, Jeremy; Leggat, Peter] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld 4811, Australia; [Aitken, Peter; Lawlor, Jenine; Mitchell, Rob; Furyk, Jeremy; Small, Niall; Lovegrove, Leone] Townsville Hosp, Emergency Dept, Townsville, Qld, Australia; [Franklin, Richard Charles] Royal Life Saving Soc, Sydney, NSW, Australia	James Cook University	Franklin, RC (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld 4811, Australia.	richard.franklin@jcu.edu.au	Watt, Kerrianne/G-2520-2010; Franklin, Richard Charles/H-1731-2012	Watt, Kerrianne/0000-0002-2275-081X; Franklin, Richard Charles/0000-0003-1864-4552; Furyk, Jeremy/0000-0002-9503-0928; Leggat, Peter/0000-0002-8749-014X; Mitchell, Rob/0000-0002-6422-3348	Queensland Government, Queensland Injury Prevention Council Capacity Building Grant	Queensland Government, Queensland Injury Prevention Council Capacity Building Grant	Associate Professor Richard Franklin is funded via a Queensland Government, Queensland Injury Prevention Council Capacity Building Grant.	ABS, 2011, 32180 ABS; [Anonymous], 1995, PREHOSP DISASTER MED; AON Benfield, 2012, DEC 2012 GLOB CAT RE; Arthur C, 2008, AUST J EMERG MANAG, V23, P14; Australian Government Bureau of Meteorology, TROP CYCL INT IMP CA; Australian Institute of Health and Welfare, 2013, HLTH SERV SER, V52; Brillman JC., 2005, BMC MED INFORM DECIS, V5, P4, DOI DOI 10.1186/1472-6947-5-4; Brunkard J, 2008, DISASTER MED PUBLIC, V2, P215, DOI 10.1097/DMP.0b013e31818aaf55; Bureau of Meteorology, 2011, SAV TROP CYCL YAS; Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P242; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P928; Centres for Disease Control and Prevention, 1993, MMWR-MORBID MORTAL W, V42, P9; Emergency Management Australia, 2014, EMA DIS DAT REP; Forrester MB, 2009, DISASTER MED PUBLIC, V3, P151, DOI 10.1097/DMP.0b013e3181b66c2a; Henderson-Sellers A, 1998, B AM METEOROL SOC, V79, P19, DOI 10.1175/1520-0477(1998)079<0019:TCAGCC>2.0.CO;2; International Federation of the Red Cross and Red Crescent Societies, 2001, WORLD DIS REP; Kessler RC, 2007, J GEN INTERN MED, V22, P1225, DOI 10.1007/s11606-007-0294-1; Knabb R.D., 2006, TROPICAL CYCLONE REP; Kopp JB, 2007, CLIN J AM SOC NEPHRO, V2, P814, DOI 10.2215/CJN.03481006; Lin CH, 2013, J EMERG MED, V45, P372, DOI 10.1016/j.jemermed.2013.02.002; McKinney N, 2011, INT J BIOMETEOROL, V55, P533, DOI 10.1007/s00484-010-0370-9; Mitchell R, ANN ACTM IN PRESS; Mokdad AH, 2005, PREV CHRONIC DIS; NHMRC and the Australian Vice Chancellors Committee, 2007, NAT STAT ETH COND RE; NOJI EK, 1993, J TROP MED HYG, V96, P370; Perez E, 1995, Prehosp Disaster Med, V10, P202; Rath B, 2011, PUBLIC HEALTH REP, V126, P853, DOI 10.1177/003335491112600611; Shultz JM, 2005, EPIDEMIOL REV, V27, P21, DOI 10.1093/epirev/mxi011; Sullivent EE, 2006, J SAFETY RES, V37, P213, DOI 10.1016/j.jsr.2006.03.001; Toole M, 1997, PUBLIC HLTH CONSEQUE; United Nations Development Programme, 2004, RED DIS RISK CHALL D; Watson JT, 2007, EMERG INFECT DIS, V13, P1, DOI 10.3201/eid1301.060779; Willams W., 2005, Morbidity and Mortality Weekly Report, V54, P1018	33	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131196	10.1371/journal.pone.0131196	http://dx.doi.org/10.1371/journal.pone.0131196			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111010	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000356933800127
J	Cao, BC				Cao, Bochen			Estimating the Effects of Obesity and Weight Change on Mortality Using a Dynamic Causal Model	PLOS ONE			English	Article							BODY-MASS INDEX; LARGE PROSPECTIVE COHORT; CIGARETTE-SMOKING; DIABETES-MELLITUS; UNITED-STATES; OLDER-ADULTS; AGED ADULTS; RISK-FACTOR; US ADULTS; ASSOCIATION	Background A well-known challenge in estimating the mortality risks of obesity is reverse causality attributable to illness-associated and smoking-associated weight loss. Given that the likelihood of chronic and acute illnesses rises with age, reverse causality is most threatening to estimates derived from elderly populations. Methods I analyzed data from 12,523 respondents over 50 years old from a nationally representative longitudinal dataset, the Health and Retirement Study (HRS). The effects of both baseline body weight and time-varying weight change on mortality are estimated, adjusting for demographic and socio-economic variables, as well as time-varying confounders including illness and smoking. Body weight is measured by body mass index (BMI). In survival models for mortality, illness and smoking were lagged to minimize bias from reverse causality in estimates of the effect of weight change. Furthermore, because illness both causes and is caused by changes in BMI, I used a marginal structural model (MSM) rather than standard adjustment to control confounding by this and other time-dependent factors. Results Overall, relative to normal weight, underweight and Class II/III at baseline are associated with hazard ratios that are 2.07 (95% confidence interval (CI): 1.28-3.37) and 1.82 (1.54-2.16) respectively, whereas overweight and Class I obesity do not significantly lower or raise the mortality risks. Furthermore, relative to stable weight change, all types of weight change lead to significantly increased risk of mortality. Specifically, large weight loss results in a mortality risk that is nearly 3.86 (3.26-4.58) times of staying in the stable weight range and small weight loss is about 1.81 (1.55-2.11) times riskier. In contrast, large weight gain and small weight gain are associated with hazard ratios that are 1.98 (1.67-2.35) and 1.20 (1.02-1.41) respectively. Conclusions Being underweight or severe obese at baseline is associated with excess mortality risk, and weight change tend to raise mortality risk. Both the confounding by illness and by smoking lead to overestimates of the effects of being underweight at baseline and of weight loss, but underestimates the effect of being obese at baseline.	Univ Penn, Ctr Populat Studies, Philadelphia, PA 19104 USA	University of Pennsylvania	Cao, BC (corresponding author), Univ Penn, Ctr Populat Studies, Philadelphia, PA 19104 USA.	caob@sas.upenn.edu			National Institute of Aging [R01AG040212]; NATIONAL INSTITUTE ON AGING [U01AG009740, R01AG040212] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institute of Aging Grant R01AG040212. The URL of the funder is (http://www.nia.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Allison DB, 1997, AM J EPIDEMIOL, V146, P339, DOI 10.1093/oxfordjournals.aje.a009275; Allison DB, 1999, OBES RES, V7, P342, DOI 10.1002/j.1550-8528.1999.tb00417.x; Alpert MA, 2014, PROG CARDIOVASC DIS, V56, P391, DOI 10.1016/j.pcad.2013.09.003; Arnold AM, 2010, J GERONTOL A-BIOL, V65, P63, DOI 10.1093/gerona/glp050; Bastien M, 2014, PROG CARDIOVASC DIS, V56, P369, DOI 10.1016/j.pcad.2013.10.016; CARNEY RM, 1984, NEW ENGL J MED, V310, P614, DOI 10.1056/NEJM198403083101002; Claessen H, 2012, EUR J EPIDEMIOL, V27, P215, DOI 10.1007/s10654-012-9669-7; Comoni-Huntley J, 1991, J CLIN EPIDEMIOL, V44; COOK DG, 1986, LANCET, V2, P1376; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Evans MF, 1997, CAN FAM PHYSICIAN, V43, P455; Ezzati M, 2006, J ROY SOC MED, V99, P250, DOI 10.1258/jrsm.99.5.250; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2011, AM J EPIDEMIOL, V173, P1, DOI 10.1093/aje/kwq341; Foy CG, 2005, DIABETES CARE, V28, P2501, DOI 10.2337/diacare.28.10.2501; French SA, 1995, AM J EPIDEMIOL, V142, P1306, DOI 10.1093/oxfordjournals.aje.a117598; Gelber RP, 2007, INT J OBESITY, V31, P1240, DOI 10.1038/sj.ijo.0803564; He JH, 2011, ANN EPIDEMIOL, V21, P517, DOI 10.1016/j.annepidem.2011.04.001; He JH, 2009, INT J ENV RES PUB HE, V6, P3115, DOI 10.3390/ijerph6123115; Hernan MA, 2006, J EPIDEMIOL COMMUN H, V60, P578, DOI 10.1136/jech.2004.029496; HRS (2010) Health and Retirement Study public use dataset, 2010, U01AG009740 HRS NIA; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Lantz PM, 2010, SOC SCI MED, V70, P1558, DOI 10.1016/j.socscimed.2010.02.003; Lavie CJ, 2012, J AM COLL CARDIOL, V60, P1374, DOI 10.1016/j.jacc.2012.05.037; Manson JE, 2000, AM J MED, V109, P538, DOI 10.1016/S0002-9343(00)00568-4; MANSON JE, 1987, JAMA-J AM MED ASSOC, V257, P353, DOI 10.1001/jama.257.3.353; Mehta NK, 2009, DEMOGRAPHY, V46, P851, DOI 10.1353/dem.0.0077; Mehta NK, 2011, OXFORD HDB SOCIAL SC, P502; Mikkelsen KL, 1999, EPIDEMIOLOGY, V10, P671, DOI 10.1097/00001648-199911000-00005; Myrskyla M, 2009, EPIDEMIOLOGY, V20, P840, DOI 10.1097/EDE.0b013e3181b5f520; Newman AB, 2001, J AM GERIATR SOC, V49, P1309, DOI 10.1046/j.1532-5415.2001.49258.x; Preston SH, 2013, EPIDEMIOLOGY, V24, P158, DOI 10.1097/EDE.0b013e3182770217; RAND, 2011, RAND HRS DAT VERS L; Reas DL, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-269; Rimm EB, 1995, AM J PUBLIC HEALTH, V83, P211; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Robins JM, 1998, 1997 P AM STAT ASS S, P1, DOI DOI 10.1097/EDE.0B013E318245847E; Singh PN, 2001, AM J EPIDEMIOL, V154, P963, DOI 10.1093/aje/154.10.963; Singh PN, 1998, EPIDEMIOLOGY, V9, P246, DOI 10.1097/00001648-199805000-00007; Somes GW, 2002, AM J EPIDEMIOL, V156, P132, DOI 10.1093/aje/kwf019; Stewart ST, 2009, NEW ENGL J MED, V361, P2252, DOI 10.1056/NEJMsa0900459; TAYBACK M, 1990, ARCH INTERN MED, V150, P1065, DOI 10.1001/archinte.150.5.1065; Wannamethee SG, 2001, DIABETES CARE, V24, P1590, DOI 10.2337/diacare.24.9.1590; WHO, 2000, OB PREV MAN GLOB EP; Will JC, 2001, INT J EPIDEMIOL, V30, P540, DOI 10.1093/ije/30.3.540; Willett W., 2012, NUTR EPIDEMIOLOGY; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607	49	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0129946	10.1371/journal.pone.0129946	http://dx.doi.org/10.1371/journal.pone.0129946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110432	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800034
J	Choudhuri, SP; Delay, RJ; Delay, ER				Choudhuri, Shreoshi Pal; Delay, Rona J.; Delay, Eugene R.			L-Amino Acids Elicit Diverse Response Patterns in Taste Sensory Cells: A Role for Multiple Receptors	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; RAT GUSTATORY PAPILLAE; REGIONAL EXPRESSION PATTERNS; MONOSODIUM GLUTAMATE; UMAMI TASTE; CHORDA TYMPANI; BEHAVIORAL DISCRIMINATION; GLOSSOPHARYNGEAL NERVES; ALLOSTERIC MODULATORS; MAMMALIAN SWEET	Umami, the fifth basic taste, is elicited by the L-amino acid, glutamate. A unique characteristic of umami taste is the response potentiation by 5' ribonucleotide monophosphates, which are also capable of eliciting an umami taste. Initial reports using human embryonic kidney (HEK) cells suggested that there is one broadly tuned receptor heterodimer, T1r1+T1r3, which detects L-glutamate and all other L-amino acids. However, there is growing evidence that multiple receptors detect glutamate in the oral cavity. While much is understood about glutamate transduction, the mechanisms for detecting the tastes of other L-amino acids are less well understood. We used calcium imaging of isolated taste sensory cells and taste cell clusters from the circumvallate and foliate papillae of C57BL/6J and T1r3 knockout mice to determine if other receptors might also be involved in detection of L-amino acids. Ratio-metric imaging with Fura-2 was used to study calcium responses to monopotassium L-glutamate, L-serine, L-arginine, and L-glutamine, with and without inosine 5' monophosphate (IMP). The results of these experiments showed that the response patterns elicited by L-amino acids varied significantly across taste sensory cells. L-amino acids other than glutamate also elicited synergistic responses in a subset of taste sensory cells. Along with its role in synergism, IMP alone elicited a response in a large number of taste sensory cells. Our data indicate that synergistic and non-synergistic responses to L-amino acids and IMP are mediated by multiple receptors or possibly a receptor complex.	[Choudhuri, Shreoshi Pal; Delay, Rona J.; Delay, Eugene R.] Univ Vermont, Dept Biol & Vermont Chemosensory Grp, Burlington, VT 05405 USA	University of Vermont	Delay, ER (corresponding author), Univ Vermont, Dept Biol & Vermont Chemosensory Grp, Burlington, VT 05405 USA.	Eugene.Delay@uvm.edu	Choudhuri, Shreoshi Pal/I-4251-2019		National Science Foundation [IOS-0951016 ERD]; Division Of Integrative Organismal Systems [0951016] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by the National Science Foundation - IOS-0951016 ERD (PI) RJD (Co-PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillie GL, 2013, MOL PHARMACOL, V83, P322, DOI 10.1124/mol.112.080879; BEAUCHAMP GK, 1983, ANN INTERN MED, V98, P763, DOI 10.7326/0003-4819-98-5-763; BEHE P, 1990, J GEN PHYSIOL, V96, P1061, DOI 10.1085/jgp.96.5.1061; Bellisle F, 1999, NEUROSCI BIOBEHAV R, V23, P423, DOI 10.1016/S0149-7634(98)00043-8; BELLISLE F, 1991, PHYSIOL BEHAV, V49, P869, DOI 10.1016/0031-9384(91)90196-U; BERTINO M, 1982, AM J CLIN NUTR, V36, P1134, DOI 10.1093/ajcn/36.6.1134; BOITANO S, 1992, SCIENCE, V258, P292, DOI 10.1126/science.1411526; Bystrova MF, 2010, J CELL SCI, V123, P972, DOI 10.1242/jcs.061879; Caicedo A, 2000, J NEUROSCI, V20, P7978; Cao Y, 2009, P NATL ACAD SCI USA, V106, P4006, DOI 10.1073/pnas.0808672106; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Chaudhari N, 1996, J NEUROSCI, V16, P3817; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Damak S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-96; Dando R, 2009, J PHYSIOL-LONDON, V587, P5899, DOI 10.1113/jphysiol.2009.180083; Delay ER, 2007, NEUROSCIENCE, V148, P266, DOI 10.1016/j.neuroscience.2007.05.045; Delay ER, 2000, CHEM SENSES, V25, P507, DOI 10.1093/chemse/25.5.507; Delay ER, 2006, CHEM SENSES, V31, P351, DOI 10.1093/chemse/bjj039; DEMET E, 1989, PSYCHIAT RES, V30, P231, DOI 10.1016/0165-1781(89)90014-0; Dess NK, 1998, BIOL PSYCHOL, V48, P103, DOI 10.1016/S0301-0511(98)00014-3; Dvoryanchikov G, 2011, J NEUROSCI, V31, P5782, DOI 10.1523/JNEUROSCI.5559-10.2011; Eschle BK, 2009, NEUROSCIENCE, V163, P1292, DOI 10.1016/j.neuroscience.2009.07.035; FABBI F, 1954, Arch Ohren Nasen Kehlkopfheilkd, V164, P543, DOI 10.1007/BF02105163; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; France B, 2008, ASIA PAC J CLIN NUTR, V17, P376; Gabriel AS, 2009, AM J CLIN NUTR, V90, p743S, DOI 10.3945/ajcn.2009.27462I; Gabriel AS, 2009, BIOCHEM BIOPH RES CO, V378, P414, DOI 10.1016/j.bbrc.2008.11.060; Gilbertson TA, 1997, AM J PHYSIOL-CELL PH, V272, pC1203, DOI 10.1152/ajpcell.1997.272.4.C1203; Gilbertson TA, 2001, J NEUROSCI, V21, P4931, DOI 10.1523/JNEUROSCI.21-13-04931.2001; He W, 2004, J NEUROSCI, V24, P7674, DOI 10.1523/JNEUROSCI.2441-04.2004; Hellekant G, 1997, J NEUROPHYSIOL, V77, P978, DOI 10.1152/jn.1997.77.2.978; Hiji Y, 1967, Nihon Seirigaku Zasshi, V29, P602; Hiji Y, 1967, Nihon Seirigaku Zasshi, V29, P274; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YJA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030662; Huang YJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025471; Huang YA, 2009, J NEUROSCI, V29, P13909, DOI 10.1523/JNEUROSCI.2351-09.2009; Huang YJ, 2005, CHEM SENSES, V30, pI39, DOI 10.1093/chemse/bjh102; Huang YJ, 2005, J NEUROSCI, V25, P843, DOI 10.1523/JNEUROSCI.4446-04.2005; KASAHARA T, 1987, PHYSIOL BEHAV, V39, P619, DOI 10.1016/0031-9384(87)90162-4; Kawai M, 2012, AMINO ACIDS, V43, P2349, DOI 10.1007/s00726-012-1315-x; Kaya N, 2004, AM J PHYSIOL-REG I, V286, pR649, DOI 10.1152/ajpregu.00572.2003; Kim MR, 2003, BIOCHEM BIOPH RES CO, V312, P500, DOI 10.1016/j.bbrc.2003.10.137; Kusakabe Y, 2005, CHEM SENSES, V30, pI23, DOI 10.1093/chemse/bjh094; Kusakabe Y, 1998, BBA-MOL CELL RES, V1403, P265, DOI 10.1016/S0167-4889(98)00062-7; Kusuhara Y, 2013, J PHYSIOL-LONDON, V591, P1967, DOI 10.1113/jphysiol.2012.236604; LEFLOCH JP, 1989, DIABETES CARE, V12, P173, DOI 10.2337/diacare.12.3.173; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Lin WH, 2003, J NEUROPHYSIOL, V89, P1434, DOI 10.1152/jn.00994.2002; Lin WH, 1999, J NEUROPHYSIOL, V82, P2061, DOI 10.1152/jn.1999.82.5.2061; Lu SG, 2003, NEUROSCI LETT, V351, P157, DOI 10.1016/j.neulet.2003.07.016; MAGA JA, 1983, CRC CR REV FOOD SCI, V18, P231, DOI 10.1080/10408398309527364; Maliphol AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079403; Maruyama Y, 2006, J NEUROSCI, V26, P2227, DOI 10.1523/JNEUROSCI.4329-05.2006; MATTES RD, 1984, J CHRON DIS, V37, P195, DOI 10.1016/0021-9681(84)90147-4; NAGAHAMA S, 1985, J GEN PHYSIOL, V85, P431, DOI 10.1085/jgp.85.3.431; Nagai T, 1998, J COMP NEUROL, V392, P199, DOI 10.1002/(SICI)1096-9861(19980309)392:2<199::AID-CNE4>3.0.CO;2-Y; Nagarajan S, 1996, J MED CHEM, V39, P4167, DOI 10.1021/jm960349q; Nakashima K, 2012, PHYSIOL BEHAV, V105, P709, DOI 10.1016/j.physbeh.2011.09.028; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Niki M, 2011, CELL MOL NEUROBIOL, V31, P1033, DOI 10.1007/s10571-011-9702-5; NINOMIYA Y, 1992, COMP BIOCHEM PHYS A, V101, P97; NINOMIYA Y, 1989, COMP BIOCHEM PHYS A, V92, P365; Ninomiya Y, 2000, J NUTR, V130, p950S, DOI 10.1093/jn/130.4.950S; NINOMIYA Y, 1993, NEUROSCI LETT, V163, P197, DOI 10.1016/0304-3940(93)90381-T; NINOMIYA Y, 1989, COMP BIOCHEM PHYS A, V92, P371; Ogura T, 2002, J NEUROPHYSIOL, V87, P2643, DOI 10.1152/jn.2002.87.6.2643; PRITCHARD TC, 1982, BRAIN RES, V253, P81, DOI 10.1016/0006-8993(82)90675-8; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; Sako N, 1999, NEUROSCI LETT, V261, P109, DOI 10.1016/S0304-3940(99)00019-1; Sako N, 2003, CHEM SENSES, V28, P261, DOI 10.1093/chemse/28.3.261; Sako N, 2000, PHYSIOL BEHAV, V71, P193, DOI 10.1016/S0031-9384(00)00342-5; San Gabriel A, 2005, CHEM SENSES, V30, pI25, DOI 10.1093/chemse/bjh095; SATO M, 1970, JPN J PHYSIOL, V20, P444; Sato T, 1997, CHEM SENSES, V22, P287, DOI 10.1093/chemse/22.3.287; SCHIFFMAN S, 1994, NUTR REV, V52, pS11; SCHIFFMAN SS, 1981, PHYSIOL BEHAV, V27, P51, DOI 10.1016/0031-9384(81)90298-5; Schiffman SS, 2000, J NUTR, V130, p927S, DOI 10.1093/jn/130.4.927S; Schwartz TW, 2007, TRENDS PHARMACOL SCI, V28, P366, DOI 10.1016/j.tips.2007.06.008; Schwartz TW, 2006, J RECEPT SIG TRANSD, V26, P107, DOI 10.1080/10799890600567570; STEINER JE, 1969, ISR J PSYCHIAT REL D, V7, P223; Taruno A, 2013, NATURE, V495, P223, DOI 10.1038/nature11906; Toda Y, 2013, J BIOL CHEM, V288, P36863, DOI 10.1074/jbc.M113.494443; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; Toyama K, 2008, BIOL PHARM BULL, V31, P1852, DOI 10.1248/bpb.31.1852; Toyono T, 2003, CELL TISSUE RES, V313, P29, DOI 10.1007/s00441-003-0740-2; Toyono T, 2002, ARCH HISTOL CYTOL, V65, P91, DOI 10.1679/aohc.65.91; Toyono T, 2007, CELL TISSUE RES, V328, P57, DOI 10.1007/s00441-006-0351-9; Vandenbeuch A, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-77; Wagner A, 2008, NEUROPSYCHOPHARMACOL, V33, P513, DOI 10.1038/sj.npp.1301443; Wifall TC, 2007, CHEM SENSES, V32, P161, DOI 10.1093/chemse/bjl043; Yamaguchi S, 2000, J NUTR, V130, p921S, DOI 10.1093/jn/130.4.921S; Yamamoto S, 2009, AM J CLIN NUTR, V90, p844S, DOI 10.3945/ajcn.2009.27462X; YAMAMOTO T, 1991, PHYSIOL BEHAV, V49, P919, DOI 10.1016/0031-9384(91)90204-2; YOSHII K, 1986, BRAIN RES, V367, P45, DOI 10.1016/0006-8993(86)91577-5; Zhang F, 2008, P NATL ACAD SCI USA, V105, P20930, DOI 10.1073/pnas.0810174106; Zhang Y, 2010, NEUROSCIENCE, V169, P1421, DOI 10.1016/j.neuroscience.2010.05.021; Zhao FL, 2005, P NATL ACAD SCI USA, V102, P11100, DOI 10.1073/pnas.0501988102; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	101	19	19	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130088	10.1371/journal.pone.0130088	http://dx.doi.org/10.1371/journal.pone.0130088			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110622	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800036
J	Hung, GY; Horng, JL; Yen, HJ; Lee, CY				Hung, Giun-Yi; Horng, Jiun-Lin; Yen, Hsiu-Ju; Lee, Chih-Ying			Infant Cancer in Taiwan: Incidence and Trends (1995-2009)	PLOS ONE			English	Article							GERM-CELL TUMORS; CHILDHOOD-CANCER; CHILDREN; SURVIVAL; RISK; HEPATOBLASTOMA; EPIDEMIOLOGY; REGISTRY; SYSTEM; JAPAN	Background Current information about cancer incidence patterns among infants in East Asia is rare. The objective of this study was to report the first population-based cancer surveillance of infants in Taiwan. Methods Cancer frequencies and incidence rates among subjects aged < 1 year for the period 1995-2009 were obtained from the Taiwan Cancer Registry. Types of cancers were grouped according to the International Classification of Childhood Cancer. Rates and trends were analyzed by sex and disease groups and further compared with that of other countries. Results A total of 900 infants were diagnosed with cancers, giving an incidence rate of 250.7 per million person-years from 1995 to 2009. The male-to-female incidence rate ratio was 1.22. Overall, leukemias (56.3 per million) were the most common cancer, followed by germ cell neoplasms (43.2) and neuroblastomas (41.8). The incidence increased by 2.5% annually during the 15-year study period and was predominantly contributed by male infants (3.5%). Compared with other countries, the rate of hepatoblastoma in Taiwan was second to that from Beijing (China) and 2 to 5 times greater compared with the US, France, the North of England and Osaka (Japan). The rates of germ cell neoplasms were 2 to 4 times greater in Taiwan. Conclusions The current data suggests that cancer incidence rate among male infants was rising in Taiwan. The factors associated with higher rates of hepatoblastoma and germ cell neoplasms warrant further investigation on similar ethnic groups of different areas to elucidate the potential environmental impacts while controlling for race.	[Hung, Giun-Yi; Yen, Hsiu-Ju; Lee, Chih-Ying] Taipei Vet Gen Hosp, Div Pediat Hematol & Oncol, Dept Pediat, Taipei, Taiwan; [Hung, Giun-Yi; Yen, Hsiu-Ju; Lee, Chih-Ying] Natl Yang Ming Univ, Sch Med, Dept Pediat, Taipei 112, Taiwan; [Horng, Jiun-Lin] Taipei Med Univ, Coll Med, Sch Med, Dept Anat & Cell Biol, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Medical University	Hung, GY (corresponding author), Taipei Vet Gen Hosp, Div Pediat Hematol & Oncol, Dept Pediat, Taipei, Taiwan.	gyhung@vghtpe.gov.tw						[Anonymous], 2013, MONTHL B INT STAT ST; [Anonymous], 2013, JOINP REGR PROGR VER; Baba S, 2010, CANCER SCI, V101, P787, DOI 10.1111/j.1349-7006.2009.01443.x; BIRCH JM, 1992, BRIT J CANCER, V66, pS2; Boyle P, 1991, CANC REGISTRATION PR, V95; Buckley J D, 1992, Br J Cancer Suppl, V18, pS8; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chiang CJ, 2015, JPN J CLIN ONCOL, V45, P291, DOI 10.1093/jjco/hyu211; Cotterill S, 2000, BRIT J CANCER, V83, P397, DOI 10.1054/bjoc.2000.1313; DeBaun MR, 1998, J PEDIATR-US, V132, P398, DOI 10.1016/S0022-3476(98)70008-3; GIARDIELLO FM, 1991, J PEDIATR-US, V119, P766, DOI 10.1016/S0022-3476(05)80297-5; Gurney JG, 1999, NIH PUB, p[99, 149]; Herzog C E, 2000, Oncologist, V5, P445, DOI 10.1634/theoncologist.5-6-445; Howlader N, 2013, SEER CANC STAT REV 1; Hung GY, 2014, CANCER-AM CANCER SOC, V120, P3545, DOI 10.1002/cncr.28903; Ikeda H, 1997, J PEDIATR-US, V130, P557, DOI 10.1016/S0022-3476(97)70239-7; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Lacour B, 2010, EUR J CANCER PREV, V19, P173, DOI 10.1097/CEJ.0b013e32833876c0; Liu Y, 2010, STRUCT CHEM, V21, P21, DOI 10.1007/s11224-009-9519-8; Orbach D, 2013, LANCET ONCOL, V14, pE609, DOI 10.1016/S1470-2045(13)70236-5; Poynter JN, 2010, CANCER-AM CANCER SOC, V116, P4882, DOI 10.1002/cncr.25454; Spector LG, 2009, PEDIATRICS, V124, P96, DOI 10.1542/peds.2008-3069; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Stiller CA, 2004, ONCOGENE, V23, P6429, DOI 10.1038/sj.onc.1207717; Tsou Kuo-Inn, 2003, Acta Paediatrica Taiwanica, V44, P349; Tsubono Y, 2004, NEW ENGL J MED, V350, P2010, DOI 10.1056/NEJM200405063501922; Wang HW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-132; Yang L, 2014, CHINESE J CANCER RES, V26, P285, DOI 10.3978/j.issn.1000-9604.2014.06.09	28	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130444	10.1371/journal.pone.0130444	http://dx.doi.org/10.1371/journal.pone.0130444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110595	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800048
J	Kuan, CS; Chan, CL; Yew, SM; Toh, YF; Khoo, JS; Chong, J; Lee, KW; Tan, YC; Yee, WY; Ngeow, YF; Ng, KP				Kuan, Chee Sian; Chan, Chai Ling; Yew, Su Mei; Toh, Yue Fen; Khoo, Jia-Shiun; Chong, Jennifer; Lee, Kok Wei; Tan, Yung-Chie; Yee, Wai-Yan; Ngeow, Yun Fong; Ng, Kee Peng			Genome Analysis of the First Extensively Drug-Resistant (XDR) Mycobacterium tuberculosis in Malaysia Provides Insights into the Genetic Basis of Its Biology and Drug Resistance	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; STREPTOMYCIN RESISTANCE; EFFLUX PUMP; COMPENSATORY MUTATIONS; LOW-LEVEL; STRAINS; IDENTIFICATION; BIOSYNTHESIS; CHINA; KATG	The outbreak of extensively drug-resistant tuberculosis (XDR-TB) has become an increasing problem in many TB-burdened countries. The underlying drug resistance mechanisms, including the genetic variation favored by selective pressure in the resistant population, are partially understood. Recently, the first case of XDR-TB was reported in Malaysia. However, the detailed genotype family and mechanisms of the formation of multiple drugs resistance are unknown. We sequenced the whole genome of the UM 1072388579 strain with a 2-kb insert-size library and combined with that from previously sequenced 500-bp-insert paired-end reads to produce an improved sequence with maximal sequencing coverage across the genome. In silico spoligotyping and phylogenetic analyses demonstrated that UM 1072388579 strain belongs to an ancestral-like, non-Beijing clade of East Asia lineage. This is supported by the presence of a number of lineage-specific markers, including fadD28, embA, nuoD and pks7. Polymorphism analysis showed that the drug-susceptibility profile is correlated with the pattern of resistance mutations. Mutations in drug-efflux pumps and the cell wall biogenesis pathway such as mmpL, pks and fadD genes may play an important role in survival and adaptation of this strain to its surrounding environment. In this work, fifty-seven putative promoter SNPs were identified. Among them, we identified a novel SNP located at -4 T allele of TetR/acrR promoter as an informative marker to recognize strains of East Asian lineage. Our work indicates that the UM 1072388579 harbors both classical and uncommon SNPs that allow it to escape from inhibition by many antibiotics. This study provides a strong foundation to dissect the biology and underlying resistance mechanisms of the first reported XDR M. tuberculosis in Malaysia.	[Kuan, Chee Sian; Chan, Chai Ling; Yew, Su Mei; Toh, Yue Fen; Chong, Jennifer; Ngeow, Yun Fong; Ng, Kee Peng] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Khoo, Jia-Shiun; Lee, Kok Wei; Tan, Yung-Chie; Yee, Wai-Yan] Codon Genom SB, Seri Kembangan, Selangor Darul, Malaysia	Universiti Malaya	Ng, KP (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	kpng@ummc.edu.my	NGEOW, YUN FONG/B-9237-2010	Ngeow, Yun Fong/0000-0002-1011-762X; Tan, Yung-Chie/0000-0001-6221-6630	High Impact Research MoE Grant from the Ministry of Education Malaysia [UM.C/625/1/HIR/MOHE/MED/31]; Codon Genomics SB	High Impact Research MoE Grant from the Ministry of Education Malaysia; Codon Genomics SB	This study was supported by High Impact Research MoE Grant UM.C/625/1/HIR/MOHE/MED/31 (Account no. H-20001-00-E000070) from the Ministry of Education Malaysia. Codon Genomics SB provided support in the form of salaries for authors JSK, KWL, YCT and WYY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Da Silva PEA, 2011, J ANTIMICROB CHEMOTH, V66, P1417, DOI 10.1093/jac/dkr173; Balganesh M, 2010, ANTIMICROB AGENTS CH, V54, P5167, DOI 10.1128/AAC.00610-10; Barnard A, 2004, CURR OPIN MICROBIOL, V7, P102, DOI 10.1016/j.mib.2004.02.011; Bifani PJ, 1996, JAMA-J AM MED ASSOC, V275, P452, DOI 10.1001/jama.275.6.452; Billman-Jacobe H, 1999, ANTIMICROB AGENTS CH, V43, P3011, DOI 10.1128/AAC.43.12.3011; Birch HL, 2008, MOL MICROBIOL, V69, P1191, DOI 10.1111/j.1365-2958.2008.06354.x; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Brandis G, 2013, J ANTIMICROB CHEMOTH, V68, P2493, DOI 10.1093/jac/dkt224; Brandis G, 2012, MOL MICROBIOL, V85, P142, DOI 10.1111/j.1365-2958.2012.08099.x; Brossier F, 2006, J CLIN MICROBIOL, V44, P3659, DOI 10.1128/JCM.01054-06; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cade CE, 2010, PROTEIN SCI, V19, P458, DOI 10.1002/pro.324; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Chuang PC, 2010, J CLIN MICROBIOL, V48, P4245, DOI 10.1128/JCM.00970-10; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Coll F, 2012, BIOINFORMATICS, V28, P2991, DOI 10.1093/bioinformatics/bts544; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cox HS, 2008, NEW ENGL J MED, V359, P2398, DOI 10.1056/NEJMc0805644; Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P2503, DOI 10.1128/AAC.00298-08; de Vos M, 2013, ANTIMICROB AGENTS CH, V57, P827, DOI 10.1128/AAC.01541-12; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747; Feuerriegel S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-90; Flores L, 2007, J CLIN MICROBIOL, V45, P3393, DOI 10.1128/JCM.00828-07; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Garcia P, 2009, APPL ENVIRON MICROB, V75, P7663, DOI 10.1128/AEM.01864-09; Gavalda S, 2009, J BIOL CHEM, V284, P19255, DOI 10.1074/jbc.M109.006940; Guio H, 2014, GENOME ANNOUNC, V2; Guo HL, 2006, J MED MICROBIOL, V55, P1527, DOI 10.1099/jmm.0.46718-0; Hasan R, 2010, EMERG INFECT DIS, V16, P1473, DOI 10.3201/eid1609.100280; HEYM B, 1993, J BACTERIOL, V175, P4255, DOI 10.1128/JB.175.13.4255-4259.1993; Hong WL, 2014, EXPERT OPIN THER TAR, V18, P691, DOI 10.1517/14728222.2014.902937; Ilina EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056577; Ioerger TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075245; Ioerger TR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-670; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; Jassal M, 2009, LANCET INFECT DIS, V9, P19, DOI 10.1016/S1473-3099(08)70260-3; Johansen SK, 2006, MOL CELL, V23, P173, DOI 10.1016/j.molcel.2006.05.044; Karuthedath Vellarikkal S, 2013, GENOME ANNOUNC, V1; Kozinska Monika, 2011, Pneumonol Alergol Pol, V79, P278; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lanzas F, 2013, J CLIN MICROBIOL, V51, P3277, DOI 10.1128/JCM.01122-13; Lin N, 2013, FEMS MICROBIOL LETT; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Michael JS, 2012, INDIAN J MED RES, V136, P599; Migliori GB, 2007, EMERG INFECT DIS, V13, P780, DOI 10.3201/eid1305.070200; Murase Y, 2010, EMERG INFECT DIS, V16, P948, DOI 10.3201/eid1606.091844; Nadalin F, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S8; Ng KP, 2014, INT J MYCOBACT, V3, P82, DOI 10.1016/j.ijmyco.2014.03.005; Ng KP, 2013, GENOME ANNOUNC, V1; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; O'Toole RF, 2014, GENOME ANNOUNC, V2; Okamoto S, 2007, MOL MICROBIOL, V63, P1096, DOI 10.1111/j.1365-2958.2006.05585.x; Pasca MR, 2004, ANTIMICROB AGENTS CH, V48, P3175, DOI 10.1128/AAC.48.8.3175-3178.2004; Pei H, 2011, FOLIA MICROBIOL, V56, P549, DOI 10.1007/s12223-011-0080-7; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Schroeder E. K., 2002, Current Pharmaceutical Biotechnology, V3, P197, DOI 10.2174/1389201023378328; Sekiguchi J, 2007, J CLIN MICROBIOL, V45, P179, DOI 10.1128/JCM.00750-06; Shi R, 2007, ANTIMICROB AGENTS CH, V51, P4515, DOI 10.1128/AAC.00416-07; Somerville W, 2005, J CLIN MICROBIOL, V43, P2996, DOI 10.1128/JCM.43.6.2996-2997.2005; Sowajassatakul A, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-165; Spies FS, 2011, J CLIN MICROBIOL, V49, P2625, DOI 10.1128/JCM.00168-11; Sreevatsan S, 1997, ANTIMICROB AGENTS CH, V41, P1677, DOI 10.1128/AAC.41.8.1677; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Sreevatsan S, 1996, ANTIMICROB AGENTS CH, V40, P1024, DOI 10.1128/AAC.40.4.1024; Su CC, 2007, BIOCHEM BIOPH RES CO, V361, P85, DOI 10.1016/j.bbrc.2007.06.175; Tang SJ, 2011, SCAND J INFECT DIS, V43, P280, DOI 10.3109/00365548.2010.548080; van Doorn HR, 2001, J CLIN MICROBIOL, V39, P1591, DOI 10.1128/JCM.39.4.1591-1594.2001; Verma JS, 2014, J ANTIMICROB CHEMOTH, V69, P2935, DOI 10.1093/jac/dku273; Wan KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029190; Wang H, 2001, ANTIMICROB AGENTS CH, V45, P1515, DOI 10.1128/AAC.45.5.1515-1521.2001; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang K, 2013, CURR MICROBIOL, V66, P222, DOI 10.1007/s00284-012-0215-3; Williams MJ, 2011, J BACTERIOL, V193, P98, DOI 10.1128/JB.00774-10; Xu C, 1996, J INFECT DIS, V174, P1127, DOI 10.1093/infdis/174.5.1127; Zaunbrecher MA, 2009, P NATL ACAD SCI USA, V106, P20004, DOI 10.1073/pnas.0907925106; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735; zur Wiesch PS, 2010, ANTIMICROB AGENTS CH, V54, P2085, DOI 10.1128/AAC.01460-09	88	18	19	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131694	10.1371/journal.pone.0131694	http://dx.doi.org/10.1371/journal.pone.0131694			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110649	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800169
J	Ichikawa, M; Sowa, Y; Iizumi, Y; Aono, Y; Sakai, T				Ichikawa, Masami; Sowa, Yoshihiro; Iizumi, Yosuke; Aono, Yuichi; Sakai, Toshiyuki			Resibufogenin Induces G1-Phase Arrest through the Proteasomal Degradation of Cyclin D1 in Human Malignant Tumor Cells	PLOS ONE			English	Article							HUMAN BREAST-CANCER; LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; BETA-CATENIN; PHOSPHORYLATION; HUACHANSU; EXPRESSION; INACTIVATION; CHEMOTHERAPY; GEMCITABINE	Huachansu, a traditional Chinese medicine prepared from the dried toad skin, has been used in clinical studies for various cancers in China. Resibufogenin is a component of huachansu and classified as bufadienolides. Resibufogenin has been shown to exhibit the anti-proliferative effect against cancer cells. However, the molecular mechanism of resibufogenin remains unknown. Here we report that resibufogenin induces G1-phase arrest with hypophosphorylation of retinoblastoma (RB) protein and down-regulation of cyclin D1 expression in human colon cancer HT-29 cells. Since the down-regulation of cyclin D1 was completely blocked by a proteasome inhibitor MG132, the suppression of cyclin D1 expression by resibufogenin was considered to be in a proteasome-dependentmanner. It is known that glycogen synthase kinase-3 beta (GSK-3 beta) induces the proteasomal degradation of cyclin D1. The addition of GSK-3 beta inhibitor SB216763 inhibited the reduction of cyclin D1 caused by resibufogenin. These effects on cyclin D1 by resibufogenin were also observed in human lung cancer A549 cells. These findings suggest that the anti-proliferative effect of resibufogenin may be attributed to the degradation of cyclin D1 caused by the activation of GSK-3 beta.	[Ichikawa, Masami; Sowa, Yoshihiro; Iizumi, Yosuke; Aono, Yuichi; Sakai, Toshiyuki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Targeting Canc Prevent, Kyoto, Japan	Kyoto Prefectural University of Medicine	Sowa, Y (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Targeting Canc Prevent, Kyoto, Japan.	ysowa@koto.kpu-m.ac.jp			Kyoto Prefectural University of Medicine	Kyoto Prefectural University of Medicine	This work was supported by research funding of Kyoto Prefectural University of Medicine. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Arber N, 1996, GASTROENTEROLOGY, V110, P669, DOI 10.1053/gast.1996.v110.pm8608874; Arico S, 2002, J BIOL CHEM, V277, P27613, DOI 10.1074/jbc.M201119200; BARTKOVA J, 1994, INT J CANCER, V58, P568, DOI 10.1002/ijc.2910580420; BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; Caputi M, 1999, AM J RESP CELL MOL, V20, P746, DOI 10.1165/ajrcmb.20.4.3366; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DICKSON C, 1995, CANCER LETT, V90, P43, DOI 10.1016/0304-3835(94)03676-A; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Halilovic E, 2010, CANCER RES, V70, P6804, DOI 10.1158/0008-5472.CAN-10-0409; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Meng Z, 2012, BRIT J CANCER, V107, P411, DOI 10.1038/bjc.2012.283; Meng ZQ, 2009, CANCER-AM CANCER SOC, V115, P5309, DOI 10.1002/cncr.24602; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; Qi FH, 2010, BIOSCI TRENDS, V4, P297; Qi J, 2014, EVID-BASED COMPL ALT, V2014, DOI DOI 10.1155/2014/312684; Qin TJ, 2008, WORLD J GASTROENTERO, V14, P5210, DOI 10.3748/wjg.14.5210; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Wang DL, 2010, MOL MED REP, V3, P717, DOI 10.3892/mmr_00000323; Wang L, 2011, ANTICANCER RES, V31, P2141; Xie RF, 2012, J ETHNOPHARMACOL, V141, P692, DOI 10.1016/j.jep.2011.12.018; Xie XF, 2013, MED HYPOTHESES, V81, P243, DOI 10.1016/j.mehy.2013.04.038	28	23	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0129851	10.1371/journal.pone.0129851	http://dx.doi.org/10.1371/journal.pone.0129851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121043	gold, Green Published, Green Submitted			2022-12-27	WOS:000358150400027
J	Tresaugues, L; Lundback, T; Welin, M; Flodin, S; Nyman, T; Silvander, C; Graslund, S; Nordlund, P				Tresaugues, Lionel; Lundback, Thomas; Welin, Martin; Flodin, Susanne; Nyman, Tomas; Silvander, Camilla; Graslund, Susanne; Nordlund, Par			Structural Basis for the Specificity of Human NUDT16 and Its Regulation by Inosine Monophosphate	PLOS ONE			English	Article							STRAND BREAK REPAIR; NUDIX HYDROLASES; ARABIDOPSIS-THALIANA; DECAPPING ENZYME; NUCLEOTIDE POOLS; MESSENGER-RNA; NMR SYSTEM; CRYSTALLOGRAPHY; DNA; PYROPHOSPHOHYDROLASE	Human NUDT16 is a member of the NUDIX hydrolase superfamily. After having been initially described as an mRNA decapping enzyme, recent studies conferred it a role as an "housecleaning" enzyme specialized in the removal of hazardous (deoxy) inosine diphosphate from the nucleotide pool. Here we present the crystal structure of human NUDT16 both in its apo-form and in complex with its product inosine monophosphate (IMP). NUDT16 appears as a dimer whose formation generates a positively charged trench to accommodate substrate-binding. Complementation of the structural data with detailed enzymatic and biophysical studies revealed the determinants of substrate recognition and particularly the importance of the substituents in position 2 and 6 on the purine ring. The affinity for the IMP product, harboring a carbonyl in position 6 on the base, compared to purine monophosphates lacking a H-bond acceptor in this position, implies a catalytic cycle whose rate is primarily regulated by the product-release step. Finally, we have also characterized a phenomenon of inhibition by the product of the reaction, IMP, which might exclude non-deleterious nucleotides from NUDT16-mediated hydrolysis regardless of their cellular concentration. Taken together, this study details structural and regulatory mechanisms explaining how substrates are selected for hydrolysis by human NUDT16.	[Tresaugues, Lionel; Welin, Martin; Flodin, Susanne; Nyman, Tomas; Silvander, Camilla; Graslund, Susanne; Nordlund, Par] Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, Stockholm, Sweden; [Tresaugues, Lionel; Nordlund, Par] Karolinska Inst, Dept Med Biochem & Biophys, Div Biophys, Stockholm, Sweden; [Lundback, Thomas] Karolinska Inst, Dept Med Biochem & Biophys, Sci Life Labs, Chem Biol Consortium Sweden, Solna, Sweden; [Nordlund, Par] Nanyang Technol Univ, Sch Biol Sci, Ctr Biomed Struct Biol, Singapore 639798, Singapore	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tresaugues, L (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, Stockholm, Sweden.	Lionel.Tresaugues@ki.se; Par.Nordlund@ki.se	Gräslund, Susanne/ABB-6339-2020; Lundbäck, Thomas/G-8076-2018	Lundbäck, Thomas/0000-0002-8145-7808; Graslund, Susanne/0000-0003-0077-8333	Swedish Research Council; Swedish Cancer Society; Knut and Alice Wallenberg Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Wellcome Trust	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Wellcome Trust(Wellcome TrustEuropean Commission)	The project was funded by a grant from the Swedish Research Council, the Swedish Cancer Society, the Knut and Alice Wallenberg Foundation, the Swedish Agency for Innovation Systems, and the Swedish Foundation for Strategic Research (P.N.). T. L. is part of Chemical Biology Consortium Sweden, which is funded by the Swedish Research Council. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, the Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolhassani N, 2010, NUCLEIC ACIDS RES, V38, P2891, DOI 10.1093/nar/gkp1250; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Canales J, 2008, BIOCHEM J, V413, P103, DOI 10.1042/BJ20071471; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gunawardana D, 2008, NUCLEIC ACIDS RES, V36, P203, DOI 10.1093/nar/gkm1002; HOLMES SL, 1979, CLIN CHIM ACTA, V97, P143, DOI 10.1016/0009-8981(79)90410-8; Iyama T, 2010, NUCLEIC ACIDS RES, V38, P4834, DOI 10.1093/nar/gkq249; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8241, DOI 10.1073/pnas.131009198; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Li Y, 2011, RNA, V17, P419, DOI 10.1261/rna.2439811; Lu GW, 2011, PROTEIN CELL, V2, P64, DOI 10.1007/s13238-011-1009-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Munoz FJ, 2006, PLANT CELL PHYSIOL, V47, P926, DOI 10.1093/pcp/pcj065; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MYRNES B, 1982, NUCLEIC ACIDS RES, V10, P3693, DOI 10.1093/nar/10.12.3693; Olejnik K, 2007, FEBS J, V274, P4877, DOI 10.1111/j.1742-4658.2007.06009.x; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Peculis BA, 2007, J BIOL CHEM, V282, P24792, DOI 10.1074/jbc.M704179200; Sakumi K, 2010, MUTAT RES-GEN TOX EN, V703, P43, DOI 10.1016/j.mrgentox.2010.06.009; Saraswat V, 2002, BIOCHEMISTRY-US, V41, P15566, DOI 10.1021/bi020552p; Scarsdale JN, 2006, STRUCTURE, V14, P331, DOI 10.1016/j.str.2005.11.010; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Simone PD, 2013, MUTAT RES-REV MUTAT, V753, P131, DOI 10.1016/j.mrrev.2013.08.001; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu WL, 2006, J BIOL CHEM, V281, P22794, DOI 10.1074/jbc.M603407200; Xu WL, 2004, J BIOL CHEM, V279, P24861, DOI 10.1074/jbc.M403272200; Yoshimura K, 2007, PLANT CELL PHYSIOL, V48, P1438, DOI 10.1093/pcp/pcm112	43	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131507	10.1371/journal.pone.0131507	http://dx.doi.org/10.1371/journal.pone.0131507			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121039	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400117
J	Valkonen, M; Wouters, IM; Taubel, M; Rintala, H; Lenters, V; Vasara, R; Genuneit, J; Braun-Fahrlander, C; Piarroux, R; von Mutius, E; Heederik, D; Hyvarinen, A				Valkonen, Maria; Wouters, Inge M.; Taeubel, Martin; Rintala, Helena; Lenters, Virissa; Vasara, Ritva; Genuneit, Jon; Braun-Fahrlaender, Charlotte; Piarroux, Renaud; von Mutius, Erika; Heederik, Dick; Hyvarinen, Anne			Bacterial Exposures and Associations with Atopy and Asthma in Children	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; 16S RIBOSOMAL-RNA; IN-HOUSE DUST; CHILDHOOD ASTHMA; EARLY-LIFE; ALLERGY; DIVERSITY; WHEEZE; ENVIRONMENTS; PREVALENCE	Background The increase in prevalence of asthma and atopic diseases in Western countries has been linked to aspects of microbial exposure patterns of people. It remains unclear which microbial aspects contribute to the protective farm effect. Objective The objective of this study was to identify bacterial groups associated with prevalence of asthma and atopy, and to quantify indoor exposure to some of these bacterial groups. Methods A DNA fingerprinting technique, denaturing gradient gel electrophoresis (DGGE), was applied to mattress dust samples of farm children and control children in the context of the GABRIEL Advanced study. Associations between signals in DGGE and atopy, asthma and other allergic health outcomes were analyzed. Quantitative DNA based assays (qPCR) for four bacterial groups were applied on the dust samples to seek quantitative confirmation of associations indicated in DNA fingerprinting. Results Several statistically significant associations between individual bacterial signals and also bacterial diversity in DGGE and health outcomes in children were observed. The majority of these associations showed inverse relationships with atopy, less so with asthma. Also, in a subsequent confirmation study using a quantitative method (qPCR), higher mattress levels of specifically targeted bacterial groups - Mycobacterium spp., Bifidobacteriaceae spp. and two different clusters of Clostridium spp. - were associated with a lower prevalence of atopy. Conclusion DNA fingerprinting proved useful in identifying bacterial signals that were associated with atopy in particular. These findings were quantitatively confirmed for selected bacterial groups with a second method. High correlations between the different bacterial exposures impede a clear attribution of protective effects to one specific bacterial group. More diverse bacterial flora in mattress dust may link to microbial exposure patterns that protect against development of atopic diseases.	[Valkonen, Maria; Taeubel, Martin; Rintala, Helena; Vasara, Ritva; Hyvarinen, Anne] Natl Inst Hlth & Welf, Dept Hlth Protect, Kuopio, Finland; [Valkonen, Maria] Univ Eastern Finland, Dept Environm Sci, Dept Environm Sci, Kuopio, Finland; [Wouters, Inge M.; Lenters, Virissa; Hyvarinen, Anne] Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands; [Genuneit, Jon] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Braun-Fahrlaender, Charlotte] Univ Basel, Basel, Switzerland; [Piarroux, Renaud] Aix Marseille Univ, UMR MD3, Marseilles, France; [von Mutius, Erika] Univ Munich, Munich, Germany	Finland National Institute for Health & Welfare; University of Eastern Finland; Utrecht University; Ulm University; University of Basel; UDICE-French Research Universities; Aix-Marseille Universite; University of Munich	Valkonen, M (corresponding author), Natl Inst Hlth & Welf, Dept Hlth Protect, Kuopio, Finland.	maria.valkonen@thl.fi	Genuneit, Jon/I-9323-2012; Täubel, Martin/P-7059-2019	Genuneit, Jon/0000-0001-5764-1528; Täubel, Martin/0000-0001-8082-1041; von Mutius, Erika/0000-0002-8893-4515; Wouters, Inge M./0000-0001-7834-9390; Hyvarinen, Anne/0000-0002-2823-0866; piarroux, renaud/0000-0002-4151-4134; Heederik, Dick/0000-0002-4550-1437	European Commission, GABRIEL [018996, LSH-2004-1.2.5-1]; Olvi foundation; Graduate School of Environmental Health	European Commission, GABRIEL; Olvi foundation; Graduate School of Environmental Health	This work was supported by the European Commission as part of GABRIEL, contract number 018996 under the Integrated Program LSH-2004-1.2.5-1; (http://ec.europa.eu/contracts_grants/grants_en.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Personal research grants from Olvi foundation (www.olvisaatio.fi) and Graduate School of Environmental Health (http://www.uef.fi/fi/sytyke) were contributed to MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boon N, 2002, FEMS MICROBIOL ECOL, V39, P101, DOI 10.1111/j.1574-6941.2002.tb00911.x; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Chrischilles E, 2004, J ALLERGY CLIN IMMUN, V113, P66, DOI 10.1016/j.jaci.2003.09.037; Dilly O, 2004, APPL ENVIRON MICROB, V70, P468, DOI 10.1128/AEM.70.1.468-474.2004; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Ege MJ, 2012, ALLERGY, V67, P1565, DOI 10.1111/all.12028; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Ege MJ, 2007, J ALLERGY CLIN IMMUN, V119, P1140, DOI 10.1016/j.jaci.2007.01.037; Eisenberg SWF, 2010, VET MICROBIOL, V143, P284, DOI 10.1016/j.vetmic.2009.11.033; Frei R, 2012, ALLERGY, V67, P451, DOI 10.1111/j.1398-9995.2011.02783.x; Genuneit J, 2011, PAEDIATR PERINAT EP, V25, P436, DOI 10.1111/j.1365-3016.2011.01223.x; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Heederik D, 2012, J ALLERGY CLIN IMMUN, V130, P44, DOI 10.1016/j.jaci.2012.01.067; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; James AL, 2010, EUR RESPIR J, V35, P273, DOI 10.1183/09031936.00194308; Karkkainen PM, 2010, J ENVIRON MONITOR, V12, P759, DOI 10.1039/b917937b; Lotz A, 2013, BIOMETRIE EPIDEMIOLO, V9; Lubin JH, 2004, ENVIRON HEALTH PERSP, V112, P1691, DOI 10.1289/ehp.7199; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Lumley T., 2020, SURVEY ANAL COMPLEX; Lynch SV, 2014, J ALLERGY CLIN IMMUN, V134, P593, DOI 10.1016/j.jaci.2014.04.018; Merchant JA, 2005, ENVIRON HEALTH PERSP, V113, P350, DOI 10.1289/ehp.7240; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Schram-Bijkerk D, 2005, CLIN EXP ALLERGY, V35, P1272, DOI 10.1111/j.1365-2222.2005.02339.x; Sordillo JE, 2010, CLIN EXP ALLERGY, V40, P902, DOI 10.1111/j.1365-2222.2010.03509.x; Taubel M, 2009, J ALLERGY CLIN IMMUN, V124, P834, DOI 10.1016/j.jaci.2009.07.045; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Waser M, 2004, CLIN EXP ALLERGY, V34, P389, DOI 10.1111/j.1365-2222.2004.01873.x; Wlasiuk G, 2012, CURR OPIN ALLERGY CL, V12, P461, DOI 10.1097/ACI.0b013e328357a3bc	31	30	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131594	10.1371/journal.pone.0131594	http://dx.doi.org/10.1371/journal.pone.0131594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121165	Green Published, Green Submitted, gold			2022-12-27	WOS:000358150400127
J	Boukal, DS; Ditrich, T; Kutcherov, D; Sroka, P; Dudova, P; Papacek, M				Boukal, David S.; Ditrich, Tomas; Kutcherov, Dmitry; Sroka, Pavel; Dudova, Pavla; Papacek, Miroslav			Analyses of Developmental Rate Isomorphy in Ectotherms: Introducing the Dirichlet Regression	PLOS ONE			English	Article							EQUIPROPORTIONAL DEVELOPMENT; TEMPERATURE-DEPENDENCE; LIFE-HISTORY; RESPONSES; PHOTOPERIOD; PLASTICITY; COLEOPTERA; ORGANISMS; GROWTH; LEVEL	Temperature drives development in insects and other ectotherms because their metabolic rate and growth depends directly on thermal conditions. However, relative durations of successive ontogenetic stages often remain nearly constant across a substantial range of temperatures. This pattern, termed ` developmental rate isomorphy' (DRI) in insects, appears to be widespread and reported departures from DRI are generally very small. We show that these conclusions may be due to the caveats hidden in the statistical methods currently used to study DRI. Because the DRI concept is inherently based on proportional data, we propose that Dirichlet regression applied to individual-level data is an appropriate statistical method to critically assess DRI. As a case study we analyze data on five aquatic and four terrestrial insect species. We find that results obtained by Dirichlet regression are consistent with DRI violation in at least eight of the studied species, although standard analysis detects significant departure from DRI in only four of them. Moreover, the departures from DRI detected by Dirichlet regression are consistently much larger than previously reported. The proposed framework can also be used to infer whether observed departures from DRI reflect life history adaptations to size-or stage-dependent effects of varying temperature. Our results indicate that the concept of DRI in insects and other ectotherms should be critically re-evaluated and put in a wider context, including the concept of ` equiproportional development' developed for copepods.	[Boukal, David S.] Univ South Bohemia, Dept Ecosyst Biol, Fac Sci, Ceske Budejovice, Czech Republic; [Boukal, David S.; Ditrich, Tomas; Sroka, Pavel; Dudova, Pavla] Czech Acad Sci, Dept Ecol & Biosystemat, Inst Entomol, Ctr Biol, Ceske Budejovice, Czech Republic; [Ditrich, Tomas; Papacek, Miroslav] Univ South Bohemia, Dept Biol, Fac Educ, Ceske Budejovice, Czech Republic; [Kutcherov, Dmitry] St Petersburg State Univ, Dept Entomol, Fac Biol, St Petersburg 199034, Russia; [Dudova, Pavla] Univ South Bohemia, Dept Zool, Fac Sci, Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Saint Petersburg State University; University of South Bohemia Ceske Budejovice	Boukal, DS (corresponding author), Univ South Bohemia, Dept Ecosyst Biol, Fac Sci, Ceske Budejovice, Czech Republic.	boukal@entu.cas.cz	Ditrich, Tomáš/B-2747-2013; Kutcherov, Dmitry/K-3149-2013; Boukal, David/H-4762-2014; Sroka, Pavel/H-4132-2014	Ditrich, Tomáš/0000-0002-3179-7716; Kutcherov, Dmitry/0000-0001-9161-1517; Boukal, David/0000-0001-8181-7458; Sroka, Pavel/0000-0003-4367-6564	Grant Agency of the Czech Republic [P505/2010/0096]; European Community's Seventh Framework Programme [PERG04-GA-2008-239543]; Grant Agency of the University of South Bohemia [GAJU 145/2013/P]; Russian Foundation for Basic Research [14-04-01156]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); European Community's Seventh Framework Programme(European Commission); Grant Agency of the University of South Bohemia; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The study was supported by Grant Agency of the Czech Republic (www.gacr.cz) project P505/2010/0096 awarded to DSB. The authors also acknowledge additional funding from the European Community's Seventh Framework Programme (cordis.europa.eu/mariecurie-actions/erg/home.html) under grant agreement nr. PERG04-GA-2008-239543 to DSB, Grant Agency of the University of South Bohemia to PS (www.jcu.cz/veda-a-vyzkum/grantova-agentura-ju, project GAJU 145/2013/P awarded to DSB), and the Russian Foundation for Basic Research (www.rfbr.ru/rffi/eng) grant number 14-04-01156 to DK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J., 2003, STAT ANAL COMPOSITIO; ATKINSON D, 1995, J THERM BIOL, V20, P61, DOI 10.1016/0306-4565(94)00028-H; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CAMPBELL A, 1974, J APPL ECOL, V11, P431, DOI 10.2307/2402197; CHOW GC, 1960, ECONOMETRICA, V28, P591, DOI 10.2307/1910133; CORKETT CJ, 1970, J MAR BIOL ASSOC UK, V50, P161, DOI 10.1017/S0025315400000680; CORKETT CJ, 1984, CRUSTACEANA S, V0007, P00150; Dell AI, 2014, J ANIM ECOL, V83, P70, DOI 10.1111/1365-2656.12081; Forster J, 2011, AM NAT, V178, P668, DOI 10.1086/662174; Fussmann KE, 2014, NAT CLIM CHANGE, V4, P206, DOI [10.1038/nclimate2134, 10.1038/NCLIMATE2134]; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; HART RC, 1990, HYDROBIOLOGIA, V206, P175, DOI 10.1007/BF00014085; Hart RC, 1998, HYDROBIOLOGIA, V380, P77, DOI 10.1023/A:1003486520147; Honek A, 2003, EUR J ENTOMOL, V100, P295, DOI 10.14411/eje.2003.046; Horne CR, 2015, ECOL LETT, V18, P327, DOI 10.1111/ele.12413; Huey RB, 2011, P NATL ACAD SCI USA, V108, P10377, DOI 10.1073/pnas.1107430108; Ikemoto T, 2000, ENVIRON ENTOMOL, V29, P671, DOI 10.1603/0046-225X-29.4.671; Jarosik V, 2004, P ROY SOC B-BIOL SCI, V271, pS219, DOI 10.1098/rsbl.2003.0145; Jarosik V, 2002, AM NAT, V160, P497, DOI 10.1086/342077; Klecka J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037741; Kuang XJ, 2012, INSECT SCI, V19, P121, DOI 10.1111/j.1744-7917.2011.01428.x; Kucherov DA, 2011, ENTOMOL REV, V91, P692; Kutcherov DA, 2011, J INSECT PHYSIOL, V57, P892, DOI 10.1016/j.jinsphys.2011.03.028; LUTZ PE, 1968, ECOLOGY, V49, P637, DOI 10.2307/1935529; Maier M. J, 2014, DIRICHLETREG DIRICHL; Miller TEX, 2011, TRENDS ECOL EVOL, V26, P457, DOI 10.1016/j.tree.2011.05.005; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Perdikis DC, 2003, PHYSIOL ENTOMOL, V28, P331, DOI 10.1111/j.1365-3032.2003.00356.x; Pham-Kanter G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108451; R Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; Shi PJ, 2010, ENVIRON ENTOMOL, V39, P2033, DOI 10.1603/EN10136; Sokal RR, 1995, BIOMETRY PRINCIPLES, V3, P1995; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; TRUDGILL DL, 1995, FUNCT ECOL, V9, P136; VANRIJN PCJ, 1995, B ENTOMOL RES, V85, P285, DOI 10.1017/S0007485300034386; Vucic-Pestic O, 2011, GLOBAL CHANGE BIOL, V17, P1301, DOI 10.1111/j.1365-2486.2010.02329.x; WARD JV, 1982, ANNU REV ENTOMOL, V27, P97, DOI 10.1146/annurev.en.27.010182.000525; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; [No title captured]	40	12	12	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129341	10.1371/journal.pone.0129341	http://dx.doi.org/10.1371/journal.pone.0129341			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114859	Green Submitted, gold, Green Published			2022-12-27	WOS:000358147500023
J	Essoh, C; Latino, L; Midoux, C; Blouin, Y; Loukou, G; Nguetta, SPA; Lathro, S; Cablanmian, A; Kouassi, AK; Vergnaud, G; Pourcel, C				Essoh, Christiane; Latino, Libera; Midoux, Cedric; Blouin, Yann; Loukou, Guillaume; Nguetta, Simon-Pierre A.; Lathro, Serge; Cablanmian, Arsher; Kouassi, Athanase K.; Vergnaud, Gilles; Pourcel, Christine			Investigation of a Large Collection of Pseudomonas aeruginosa Bacteriophages Collected from a Single Environmental Source in Abidjan, Cote d'Ivoire	PLOS ONE			English	Article							GENOMIC ANALYSIS; PHAGE THERAPY; PHI-KMV; SEQUENCE; VIRUSES; DIVERSITY; INFECTION; ESTABLISHMENT; INTEGRATION; RESISTANCE	Twenty two distinct bacteriophages were isolated from sewage water from five locations in the city of Abidjan, Cote d'Ivoire over a two-year period, using a collection of Pseudomonas aeruginosa strains with diverse genotypes. The phages were characterized by their virulence spectrum on a panel of selected P. aeruginosa strains from cystic fibrosis patients and by whole genome sequencing. Twelve virions representing the observed diversity were visualised by electron microscopy. The combined observations showed that 17 phages, distributed into seven genera, were virulent, and that five phages were related to temperate phages belonging to three genera. Some showed similarity with known phages only at the protein level. The vast majority of the genetic variations among virulent phages from the same genus resulted from seemingly non-random horizontal transfer events, inside a population of P. aeruginosa phages with limited diversity. This suggests the existence of a single environmental reservoir or ecotype in which continuous selection is taking place. In contrast, mostly point mutations were observed among phages potentially capable of lysogenisation. This is the first study of P. aeruginosa phage diversity in an African city and it shows that a large variety of phage species can be recovered in a limited geographical site at least when different bacterial strains are used. The relative temporal and spatial stability of the Abidjan phage population might reflect equilibrium in the microbial community from which they are released.	[Essoh, Christiane; Latino, Libera; Midoux, Cedric; Blouin, Yann; Pourcel, Christine] Univ Paris 11, CNRS, Univ Paris Saclay, CEA,Inst Integrat Biol Cell, F-91405 Orsay, France; [Loukou, Guillaume; Lathro, Serge; Cablanmian, Arsher; Kouassi, Athanase K.] Lab Natl Sante Publ, Abidjan, Cote Ivoire; [Loukou, Guillaume] Univ Felix Houphouet Boigny, Dept Sci Pharmaceut & Biol, Lab Bacteriol Virol, Abidjan, Cote Ivoire; [Nguetta, Simon-Pierre A.] Univ Felix Houphouet Boigny, Dept Biosci, Genet Lab, Abidjan, Cote Ivoire; [Vergnaud, Gilles] Univ Paris Saclay, ParisTech, ENSTA, Palaiseau, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Saclay	Pourcel, C (corresponding author), Univ Paris 11, CNRS, Univ Paris Saclay, CEA,Inst Integrat Biol Cell, F-91405 Orsay, France.	christine.pourcel@u-psud.fr	Vergnaud, Gilles/AAC-1162-2020; Vergnaud, Gilles/P-1304-2015; Pourcel, Christine/E-4949-2017	Vergnaud, Gilles/0000-0003-0913-194X; Vergnaud, Gilles/0000-0003-0913-194X; Pourcel, Christine/0000-0002-8951-466X; Midoux, Cedric/0000-0002-7964-0929; NGUETTA, Simon-Pierre/0000-0003-4802-627X	Vaincre la Mucoviscidose Agence Nationale de la Recherche [ANR-13-ASTR-0011-01]	Vaincre la Mucoviscidose Agence Nationale de la Recherche(French National Research Agency (ANR))	Vaincre la Mucoviscidose (http://www.vaincrelamuco.org/) Agence Nationale de la Recherche (www.agence-nationale-recherche.fr/) grant number ANR-13-ASTR-0011-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon Stephen T, 2011, Bacteriophage, V1, P66; Alemayehu D, 2012, MBIO, V3, DOI 10.1128/mBio.00029-12; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bae HW, 2012, J VIROL, V86, P9537, DOI 10.1128/JVI.01403-12; Blouin Y, 2014, EMERG INFECT DIS, V20, P21, DOI 10.3201/eid2001.130652; Boisvert S, 2010, J COMPUT BIOL, V17, P1519, DOI 10.1089/cmb.2009.0238; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Briers Yves, 2011, Bacteriophage, V1, P25, DOI 10.4161/bact.1.1.14868; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Cady KC, 2011, MICROBIOL-SGM, V157, P430, DOI 10.1099/mic.0.045732-0; Cady KC, 2012, J BACTERIOL, V194, P5728, DOI 10.1128/JB.01184-12; CAMERON JR, 1977, NUCLEIC ACIDS RES, V4, P1429, DOI 10.1093/nar/4.5.1429; Ceyssens PJ, 2008, VIROLOGY, V377, P233, DOI 10.1016/j.virol.2008.04.038; Ceyssens PJ, 2008, J BACTERIOL, V190, P1429, DOI 10.1128/JB.01441-07; Ceyssens PJ, 2006, J BACTERIOL, V188, P6924, DOI 10.1128/JB.00831-06; Ceyssens PJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-134; Ceyssens PJ, 2010, VIROLOGY, V405, P26, DOI 10.1016/j.virol.2010.06.011; Ceyssens PJ, 2010, FUTURE MICROBIOL, V5, P1041, DOI 10.2217/FMB.10.66; Ceyssens PJ, 2009, ENVIRON MICROBIOL, V11, P2874, DOI 10.1111/j.1462-2920.2009.02030.x; De Paepe M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00039; Debarbieux L, 2010, J INFECT DIS, V201, P1096, DOI 10.1086/651135; Diaz-Munoz SL, 2014, ADV APPL MICROBIOL, V89, P135, DOI 10.1016/B978-0-12-800259-9.00004-4; Drulis-Kawa Z, 2013, ARCH VIROL; Essoh C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060575; Fothergill JL, 2012, EUR RESPIR J, V40, P227, DOI 10.1183/09031936.00204411; Fukuda K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047742; Garbe J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-301; Garbe J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-102; Glukhov AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051163; Hatfull GF, 2011, CURR OPIN VIROL, V1, P298, DOI 10.1016/j.coviro.2011.06.009; Henry M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117163; Karumidze N, 2012, APPL MICROBIOL BIOT, V94, P1609, DOI 10.1007/s00253-012-4119-8; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim S, 2012, APPL ENVIRON MICROB, V78, P6380, DOI 10.1128/AEM.00648-12; Kropinski AM, 2009, ENVIRON MICROBIOL, V11, P2775, DOI 10.1111/j.1462-2920.2009.01970.x; Krylov V, 2013, VIRUSES-BASEL, V5, P15, DOI 10.3390/v5010015; Krylov VN, 2014, ADV VIRUS RES, V88, P227, DOI 10.1016/B978-0-12-800098-4.00005-2; KULAKOV LA, 1985, MOL GEN GENET, V200, P123, DOI 10.1007/BF00383324; Kulakov LA, 2009, VIROLOGY, V391, P1, DOI 10.1016/j.virol.2009.06.024; Kutateladze M, 2008, MED MALADIES INFECT, V38, P426, DOI 10.1016/j.medmal.2008.06.023; Kutter E, 2010, CURR PHARM BIOTECHNO, V11, P69, DOI 10.2174/138920110790725401; Kwan T, 2006, J BACTERIOL, V188, P1184, DOI 10.1128/JB.188.3.1184-1187.2006; Lammens E, 2009, J MICROBIOL METH, V77, P207, DOI 10.1016/j.mimet.2009.02.006; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Latino L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093777; Lavigne R, 2003, VIROLOGY, V312, P49, DOI 10.1016/S0042-6822(03)00123-5; Llanes C, 2013, J ANTIMICROB CHEMOTH, V68, P1763, DOI 10.1093/jac/dkt115; Lopes A, 2010, NUCLEIC ACIDS RES, V38, P3952, DOI 10.1093/nar/gkq096; Lu SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062933; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Miyata R, 2014, VIRUS RES, V189, P43, DOI 10.1016/j.virusres.2014.04.019; Morello E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016963; Morgan GJ, 2002, J MOL BIOL, V317, P337, DOI 10.1006/jmbi.2002.5437; Newton GJ, 2001, MOL MICROBIOL, V39, P1237, DOI 10.1046/j.1365-2958.2001.02311.x; Parsley LC, 2010, APPL ENVIRON MICROB, V76, P2673, DOI 10.1128/AEM.02520-09; Pawluk A, 2014, MBIO, V5, DOI 10.1128/mBio.00896-14; Romling U, 2005, ENVIRON MICROBIOL, V7, P1029, DOI 10.1111/j.1462-2920.2005.00780.x; Sepulveda-Robles O, 2012, APPL ENVIRON MICROB, V78, P4510, DOI 10.1128/AEM.00065-12; SNYDER L, 1995, MOL MICROBIOL, V15, P415, DOI 10.1111/j.1365-2958.1995.tb02255.x; Sobral D, 2012, EUR J CLIN MICROBIOL, V31, P2247, DOI 10.1007/s10096-012-1562-5; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Tan YL, 2007, CELL MICROBIOL, V9, P479, DOI 10.1111/j.1462-5822.2006.00804.x; Uchiyama J, 2012, ARCH VIROL, V157, P733, DOI 10.1007/s00705-011-1210-x; Vu-Thien H, 2007, J CLIN MICROBIOL, V45, P3175, DOI 10.1128/JCM.00702-07; Wang PW, 2004, J BACTERIOL, V186, P400, DOI 10.1128/JB.186.2.400-410.2004; Watanabe R, 2007, ANTIMICROB AGENTS CH, V51, P446, DOI 10.1128/AAC.00635-06; Weigel C, 2006, FEMS MICROBIOL REV, V30, P321, DOI 10.1111/j.1574-6976.2006.00015.x; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Weitz Joshua S, 2012, F1000 Biol Rep, V4, P17; Williamson KE, 2005, APPL ENVIRON MICROB, V71, P3119, DOI 10.1128/AEM.71.6.3119-3125.2005; Wittmann J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086935; Zegans ME, 2009, J BACTERIOL, V191, P210, DOI 10.1128/JB.00797-08; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	76	47	48	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130548	10.1371/journal.pone.0130548	http://dx.doi.org/10.1371/journal.pone.0130548			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115051	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500078
J	Goswami, C; Shimada, Y; Yoshimura, M; Mondal, A; Oda, S; Tanaka, T; Sakai, T; Sakata, I				Goswami, Chayon; Shimada, Yoshiaki; Yoshimura, Makoto; Mondal, Anupom; Oda, Sen-ichi; Tanaka, Toru; Sakai, Takafumi; Sakata, Ichiro			Motilin Stimulates Gastric Acid Secretion in Coordination with Ghrelin in Suncus murinus	PLOS ONE			English	Article							MIGRATING MOTOR COMPLEX; HOUSE MUSK SHREW; GROWTH-HORMONE SECRETAGOGUE; PHASE-III CONTRACTIONS; FOOD-INTAKE; MOTION SICKNESS; PLASMA MOTILIN; CONSCIOUS RATS; STOMACH; DOGS	Motilin and ghrelin constitute a peptide family, and these hormones are important for the regulation of gastrointestinal motility. In this study, we examined the effect of motilin and ghrelin on gastric acid secretion in anesthetized suncus (house musk shrew, Suncus murinus), a ghrelin-and motilin-producing mammal. We first established a gastric lumen-perfusion system in the suncus and confirmed that intravenous (i.v.) administration of histamine (1 mg/kg body weight) stimulated acid secretion. Motilin (0.1, 1.0, and 10 mu g/kg BW) stimulated the acid output in a dose-dependent manner in suncus, whereas ghrelin (0.1, 1.0, and 10 mu g/kg BW) alone did not induce acid output. Furthermore, in comparison with the vehicle administration, the co-administration of low-dose (1 mu g/kg BW) motilin and ghrelin significantly stimulated gastric acid secretion, whereas either motilin (1 mu g/kg BW) or ghrelin (1 mu g/kg BW) alone did not significantly induce gastric acid secretion. This indicates an additive role of ghrelin in motilin-induced gastric acid secretion. We then investigated the pathways of motilin/motilin and ghrelin-stimulated acid secretion using receptor antagonists. Treatment with YM 022 (a CCK-B receptor antagonist) and atropine (a muscarinic acetylcholine receptor antagonist) had no effect on motilin or motilin-ghrelin co-administrationinduced acid output. In contrast, famotidine (a histamine H-2 receptor antagonist) completely inhibited motilin-stimulated acid secretion and co-administration of motilin and ghrelin induced gastric acid output. This is the first report demonstrating that motilin stimulates gastric secretion in mammals. Our results also suggest that motilin and co-administration of motilin and ghrelin stimulate gastric acid secretion via the histamine-mediated pathway in suncus.	[Goswami, Chayon; Shimada, Yoshiaki; Yoshimura, Makoto; Mondal, Anupom; Sakai, Takafumi; Sakata, Ichiro] Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Area Regulatory Biol, Saitama 3388570, Japan; [Oda, Sen-ichi] Okayama Univ Sci, Dept Zool, Lab Anim Management & Resources, Okayama, Japan; [Tanaka, Toru] Josai Univ, Fac Pharmaceut Sci, Saitama, Japan	Saitama University; Okayama University of Science; Josai University	Sakata, I (corresponding author), Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Area Regulatory Biol, Saitama 3388570, Japan.	isakata@mail.saitama-u.ac.jp	Sakata, Ichiro/F-9194-2012	Sakata, Ichiro/0000-0002-6067-0407; Goswami, Chayon/0000-0002-2301-6692	Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; Bednarek MA, 2000, J MED CHEM, V43, P4370, DOI 10.1021/jm0001727; BROWN JC, 1973, CAN J BIOCHEM CELL B, V51, P533, DOI 10.1139/o73-066; Date Y, 2001, BIOCHEM BIOPH RES CO, V280, P904, DOI 10.1006/bbrc.2000.4212; Ding XQ, 1996, PHARMACOL TOXICOL, V79, P324, DOI 10.1111/j.1600-0773.1996.tb00017.x; Gielkens HAJ, 1998, ALIMENT PHARM THER, V12, P27; Haans JJL, 2006, NEUROGASTROENT MOTIL, V18, P637, DOI 10.1111/j.1365-2982.2006.00797.x; HALL KE, 1983, CAN J PHYSIOL PHARM, V61, P1289, DOI 10.1139/y83-186; He J, 2010, J MOL ENDOCRINOL, V44, P37, DOI 10.1677/JME-09-0095; HERSEY SJ, 1995, PHYSIOL REV, V75, P155, DOI 10.1152/physrev.1995.75.1.155; Ishida Y, 2009, PEPTIDES, V30, P982, DOI 10.1016/j.peptides.2009.01.006; ITOH Z, 1978, AM J DIG DIS, V23, P929, DOI 10.1007/BF01072469; ITOH Z, 1976, SCAND J GASTROENTERO, V11, P93; Itoh Z, 1997, PEPTIDES, V18, P593, DOI 10.1016/S0196-9781(96)00333-6; JANSSENS J, 1983, REGUL PEPTIDES, V6, P363, DOI 10.1016/0167-0115(83)90265-3; Javid FA, 2001, PHARMACOL BIOCHEM BE, V68, P761, DOI 10.1016/S0091-3057(01)00470-1; Kamegai J, 2000, ENDOCRINOLOGY, V141, P4797, DOI 10.1210/en.141.12.4797; KANAMORI Y, 1989, CELL TISSUE RES, V258, P365; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Masuda Y, 2000, BIOCHEM BIOPH RES CO, V276, P905, DOI 10.1006/bbrc.2000.3568; MATSUNAGA Y, 1994, REGUL PEPTIDES, V52, P61, DOI 10.1016/0167-0115(94)90022-1; Miura T, 2009, PEPTIDES, V30, P758, DOI 10.1016/j.peptides.2008.12.016; Mondal A, 2012, AM J PHYSIOL-GASTR L, V302, pG1207, DOI 10.1152/ajpgi.00379.2011; Murakami N, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740283; NAGAYA H, 1991, JPN J PHARMACOL, V55, P425, DOI 10.1254/jjp.55.425; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Nishida A, 1996, JPN J PHARMACOL, V71, P223, DOI 10.1254/jjp.71.223; Oda S., 1992, NEPAL ANN RES I ENV, V43, P239; Peeters TL, 2005, GUT, V54, P1638, DOI 10.1136/gut.2004.062604; Sakahara S, 2010, AM J PHYSIOL-REG I, V299, pR1106, DOI 10.1152/ajpregu.00278.2010; Sakurada T, 2010, J GASTROENTEROL, V45, P1111, DOI 10.1007/s00535-010-0269-6; Shimizu S, 2014, PEPTIDES, V51, P74, DOI 10.1016/j.peptides.2013.10.028; Suzuki A, 2012, PEPTIDES, V36, P29, DOI 10.1016/j.peptides.2012.04.019; Suzuki H, 1998, AM J PHYSIOL-GASTR L, V274, pG87, DOI 10.1152/ajpgi.1998.274.1.G87; Takeuchi K, 1999, ALIMENT PHARM THERAP, V13, P87; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tsutsui C, 2009, PEPTIDES, V30, P318, DOI 10.1016/j.peptides.2008.10.006; UENO S, 1988, LIFE SCI, V43, P413, DOI 10.1016/0024-3205(88)90520-6; VANTRAPPEN G, 1979, DIGEST DIS SCI, V24, P497, DOI 10.1007/BF01489315; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Yakabi K, 2006, DIGEST DIS SCI, V51, P1313, DOI 10.1007/s10620-005-9002-3; YAMAMOTO O, 1994, J PHARMACOL EXP THER, V271, P1471; YAMAMOTO O, 1994, AM J PHYSIOL, V267, pG129, DOI 10.1152/ajpgi.1994.267.1.G129; Yin JY, 2006, SCAND J GASTROENTERO, V41, P903, DOI 10.1080/00365520500527391; Zeng NX, 1999, J CLIN INVEST, V104, P1383, DOI 10.1172/JCI7537; Zheng J, 2009, NEUROGASTROENT MOTIL, V21, P78, DOI 10.1111/j.1365-2982.2008.01179.x	47	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131554	10.1371/journal.pone.0131554	http://dx.doi.org/10.1371/journal.pone.0131554			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115342	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500171
J	Chevrier, A; Cheyne, D; Graham, S; Schachar, R				Chevrier, Andre; Cheyne, Douglas; Graham, Simon; Schachar, Russell			Dissociating Two Stages of Preparation in the Stop Signal Task Using fMRI	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; EVENT-RELATED FMRI; SLOW BRAIN POTENTIALS; RESPONSE-INHIBITION; MOTOR PREPARATION; PREFRONTAL CORTEX; ERROR-DETECTION; PERFORMANCE; SACCADES; MONKEY	Often we must balance being prepared to act quickly with being prepared to suddenly stop. The stop signal task (SST) is widely used to study inhibitory control, and provides a measure of the speed of the stop process that is robust to changes in subjects' response strategy. Previous studies have shown that preparation affects inhibition. We used fMRI to separate activity that occurs after a brief (500 ms) warning stimulus (warning-phase) from activity that occurs during responses that follow (response-phase). Both of these phases could contribute to the preparedness to stop because they both precede stop signals. Warning stimuli activated posterior networks that signal the need for top-down control, whereas response phases engaged prefrontal and subcortical networks that implement top-down control. Regression analyses revealed that both of these phases affect inhibitory control in different ways. Warning-phase activity in the cerebellum and posterior cingulate predicted stop latency and accuracy, respectively. By contrast, response-phase activity in fronto-temporal areas and left striatum predicted go speed and stop accuracy, in pre-supplementary motor area affected stop accuracy, and in right striatum predicted stop latency and accuracy. The ability to separate hidden contributions to inhibitory control during warning-phases from those during response-phases can aid in the study of models of preparation and inhibitory control, and of disorders marked by poor top-down control.	[Chevrier, Andre] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Cheyne, Douglas] Univ Toronto, Inst Biomat & Biomed Engn, Dept Med Imaging, Toronto, ON, Canada; [Graham, Simon] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Schachar, Russell] Hosp Sick Children, Psychiat Res, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Schachar, R (corresponding author), Hosp Sick Children, Psychiat Res, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	russell.schachar@sickkids.ca		Schachar, Russell/0000-0002-2015-4395; Cheyne, Douglas/0000-0002-2663-498X	Canadian Institutes of Health Research [MOP 82796]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant to R.S. from the Canadian Institutes of Health Research (MOP 82796). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann H, 1996, J NEUROL NEUROSUR PS, V60, P94, DOI 10.1136/jnnp.60.1.94; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Bhaijiwalla M, 2014, BRAIN BEHAV IN PRESS; Bittner R.A., 2014, CEREB CORTEX; Boucher L, 2007, PSYCHOL REV, V114, P376, DOI 10.1037/0033-295X.114.2.376; BRUNIA CHM, 1993, PSYCHOPHYSIOLOGY, V30, P327, DOI 10.1111/j.1469-8986.1993.tb02054.x; BRUNIA CHM, 1988, ELECTROEN CLIN NEURO, V69, P234, DOI 10.1016/0013-4694(88)90132-0; Buch ER, 2006, EXP BRAIN RES, V169, P69, DOI 10.1007/s00221-005-0130-y; Burman KJ, 2011, CEREB CORTEX, V21, P1712, DOI 10.1093/cercor/bhq239; Cameron IGM, 2012, NEUROIMAGE, V60, P1156, DOI 10.1016/j.neuroimage.2012.01.057; Chevrier A, 2010, NEUROIMAGE, V53, P664, DOI 10.1016/j.neuroimage.2010.06.056; Chevrier AD, 2007, HUM BRAIN MAPP, V28, P1347, DOI 10.1002/hbm.20355; Chikazoe J, 2009, J NEUROSCI, V29, P15870, DOI 10.1523/JNEUROSCI.3645-09.2009; Connolly JD, 2002, NAT NEUROSCI, V5, P1345, DOI 10.1038/nn969; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; GEMBA H, 1984, BRAIN RES, V306, P207, DOI 10.1016/0006-8993(84)90370-6; GOLDMANRAKIC PS, 1987, CIBA F SYMP, V132, P187; Grol MJ, 2006, J NEUROSCI, V26, P117, DOI 10.1523/JNEUROSCI.2786-05.2006; Hu S, 2012, HUM BRAIN MAPP, V33, P2785, DOI 10.1002/hbm.21399; Jaffard M, 2008, NEUROIMAGE, V42, P1196, DOI 10.1016/j.neuroimage.2008.05.041; Jennings JR, 2005, PSYCHOL BULL, V131, P434, DOI 10.1037/0033-2909.131.3.434; Khonsari RH, 2007, NEUROREPORT, V18, P1797, DOI 10.1097/WNR.0b013e3282f1a986; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Li CSR, 2005, EXP BRAIN RES, V167, P305, DOI 10.1007/s00221-005-0110-2; Logan Gordon D., 1994, P189; Mars RB, 2008, CORTEX, V44, P507, DOI 10.1016/j.cortex.2007.07.002; Mnatsakanian EV, 2002, BRAIN TOPOGR, V15, P87, DOI 10.1023/A:1021416406992; Morein-Zamir S., 2014, HUM BRAIN MAPP; Mulligan RC, 2011, PSYCHIAT RES-NEUROIM, V194, P119, DOI 10.1016/j.pscychresns.2011.02.003; Nigg JT, 2005, DEV PSYCHOPATHOL, V17, P785, DOI 10.1017/S0954579405050376; Ollinger JM, 2001, SEPARATING PROCESSES, DOI [10.1006/nimg.2000.0710, DOI 10.1006/NIMG.2000.0710]; Postle BR, 2000, BRAIN RES PROTOC, V5, P57, DOI 10.1016/S1385-299X(99)00053-7; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Schwerdtfeger RMH, 2013, NEUROIMAGE-CLIN, V2, P63, DOI 10.1016/j.nicl.2012.10.006; Smittenaar P, 2013, J NEUROSCI, V33, P18087, DOI 10.1523/JNEUROSCI.2167-13.2013; van Veen V, 2008, J COGNITIVE NEUROSCI, V20, P1952, DOI 10.1162/jocn.2008.20146; VANBOXTEL GJM, 1994, BIOL PSYCHOL, V38, P37, DOI 10.1016/0301-0511(94)90048-5; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P153, DOI 10.1097/00004728-199801000-00028; Yakusheva TA, 2007, NEURON, V54, P973, DOI 10.1016/j.neuron.2007.06.003	41	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130992	10.1371/journal.pone.0130992	http://dx.doi.org/10.1371/journal.pone.0130992			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110429	gold, Green Published, Green Submitted			2022-12-27	WOS:000356933800106
J	De Trez, C; Katsandegwaza, B; Caljon, G; Magez, S				De Trez, Carl; Katsandegwaza, Brunette; Caljon, Guy; Magez, Stefan			Experimental African Trypanosome Infection by Needle Passage or Natural Tsetse Fly Challenge Thwarts the Development of Collagen-Induced Arthritis in DBA/1 Prone Mice via an Impairment of Antigen Specific B Cell Autoantibody Titers	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; II COLLAGEN; HYGIENE HYPOTHESIS; ALLERGIC DISEASES; AUTOIMMUNE; SUSCEPTIBILITY; SUPPRESSION; ANTIBODIES; INDUCTION; STRAINS	Collagen-induced arthritis is a B cell-mediated autoimmune disease. Recently published studies have demonstrated that in some rare cases pathogens can confer protection from autoimmunity. Trypanosoma brucei parasites are tsetse fly transmitted extracellular protozoans causing sleeping sickness disease in humans and Nagana in livestock in sub-Saharan endemic areas. In the past, we demonstrated that trypanosome infections impair B cell homeostasis and abolish vaccine-induced protection against unrelated antigens. Hence, here we hypothesized that trypanosome infection can affect the onset of CIA by specifically dampening specific B-cell responses and type II collagen antibody titers in DBA/1 prone mice. We observed a substantial delay in the onset of collagen-induced arthritis in T. brucei-infected DBA/1mice that correlates with a drastic decrease of type II collagen titers of the different IgG isotypes in the serum. Treatment of infected mice with Berenil, a trypanocidal drug, restored the development of CIA-associated clinical symptoms. Interestingly, these data were confirmed by the challenge of immunized DBA/1 prone mice with T. brucei-infected tsetse flies. Together, these results demonstrate that T. brucei infection is impairing the maintenance of the antigen specific plasma B cell pool driving the development of CIA in DBA/1 prone mice.	[De Trez, Carl; Katsandegwaza, Brunette; Magez, Stefan] Vrije Univ Brussel, Res Unit Cellular & Mol Immunol, Brussels, Belgium; [De Trez, Carl; Katsandegwaza, Brunette; Magez, Stefan] VIB, Dept Biol Struct, Brussels, Belgium; [Caljon, Guy] Inst Trop Med Antwerp ITM, Dept Biomed Sci, Unit Vet Protozool, Antwerp, Belgium; [Caljon, Guy] Vrije Univ Brussel, Unit Cellular & Mol Immunol, Brussels, Belgium; [Caljon, Guy] VIB, Lab Myeloid Cell Immunol, Brussels, Belgium	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Institute of Tropical Medicine (ITM); Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	De Trez, C (corresponding author), Vrije Univ Brussel, Res Unit Cellular & Mol Immunol, Brussels, Belgium.	cdetrez@vub.ac.be	Caljon, Guy/E-1310-2017; Magez, Stefan/D-9497-2014; Magez, Stefan/AAC-5682-2021	Caljon, Guy/0000-0002-4870-3202; Magez, Stefan/0000-0003-3760-7968; Magez, Stefan/0000-0003-3760-7968; De Trez, Carl/0000-0002-3899-1968	Fonds voor Wetenschappelijk Onderzoek (FWO) via a "Krediet aan Navorsers" [1517313N/KN251]; Belgian Federal Science Policy Office via "Interuniversity Attraction Poles" [7-41]	Fonds voor Wetenschappelijk Onderzoek (FWO) via a "Krediet aan Navorsers"; Belgian Federal Science Policy Office via "Interuniversity Attraction Poles"	This work was supported by Fonds voor Wetenschappelijk Onderzoek (FWO) via a "Krediet aan Navorsers" grant # 1517313N/KN251 and Belgian Federal Science Policy Office via "Interuniversity Attraction Poles" grant # 7-41.	Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Bhattacharya P, 2014, CLIN IMMUNOL, V153, P187, DOI 10.1016/j.clim.2014.04.014; Bockstal V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002089; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Brand DD, 1996, J IMMUNOL, V157, P5178; Chu CQ, 2007, ARTHRITIS RHEUM, V56, P1145, DOI 10.1002/art.22453; Corthay A, 1999, INT IMMUNOL, V11, P1065, DOI 10.1093/intimm/11.7.1065; Drennan MB, 2005, J IMMUNOL, V175, P2501, DOI 10.4049/jimmunol.175.4.2501; Elshabrawy HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050366; Farooq SM, 2014, J CELL MOL MED, V18, P2512, DOI 10.1111/jcmm.12376; Farooq SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048635; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; GREENWOO.BM, 1968, LANCET, V2, P380; HOLMDAHL R, 1985, CLIN EXP IMMUNOL, V62, P639; JANOSSY G, 1981, LANCET, V2, P839; Magez S, 2009, FUTURE MICROBIOL, V4, P1075, DOI 10.2217/FMB.09.65; Martinez FD, 2001, RESPIR RES, V2, P129, DOI 10.1186/rr48; Mattsson L, 2000, CLIN EXP IMMUNOL, V122, P477, DOI 10.1046/j.1365-2249.2000.01384.x; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Panayi GS, 2005, RHEUMATOLOGY, V44, pII3, DOI 10.1093/rheumatology/keh616; Radwanska M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000078; RURANGIRWA FR, 1979, INFECT IMMUN, V26, P822, DOI 10.1128/IAI.26.3.822-826.1979; Svensson L, 1998, CLIN EXP IMMUNOL, V111, P521; Wilson MS, 2004, CLIN REV ALLERG IMMU, V26, P35, DOI 10.1385/CRIAI:26:1:35; Yanaba K, 2007, J IMMUNOL, V179, P1369, DOI 10.4049/jimmunol.179.2.1369	26	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130431	10.1371/journal.pone.0130431	http://dx.doi.org/10.1371/journal.pone.0130431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110416	gold, Green Published, Green Submitted			2022-12-27	WOS:000356933800046
J	Haas, B; Grenier, D				Haas, Bruno; Grenier, Daniel			Isolation, Characterization and Biological Properties of Membrane Vesicles Produced by the Swine Pathogen Streptococcus suis	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; OUTER-MEMBRANE; PORPHYROMONAS-GINGIVALIS; STATISTICAL-MODEL; KAPPA-B; VIRULENCE; PROTEIN; GENE; SEROTYPE-2; CELLS	Streptococcus suis, more particularly serotype 2, is a major swine pathogen and an emerging zoonotic agent worldwide that mainly causes meningitis, septicemia, endocarditis, and pneumonia. Although several potential virulence factors produced by S. suis have been identified in the last decade, the pathogenesis of S. suis infections is still not fully understood. In the present study, we showed that S. suis produces membrane vesicles (MVs) that range in diameter from 13 to 130 nm and that appear to be coated by capsular material. A proteomic analysis of the MVs revealed that they contain 46 proteins, 9 of which are considered as proven or suspected virulence factors. Biological assays confirmed that S. suis MVs possess active subtilisin-like protease (SspA) and DNase (SsnA). S. suis MVs degraded neutrophil extracellular traps, a property that may contribute to the ability of the bacterium to escape the host defense response. MVs also activated the nuclear factorkappa B (NF-.B) signaling pathway in both monocytes and macrophages, inducing the secretion of pro-inflammatory cytokines, which may in turn contribute to increase the permeability of the blood brain barrier. The present study brought evidence that S. suis MVs may play a role as a virulence factor in the pathogenesis of S. suis infections, and given their composition be an excellent candidate for vaccine development.	[Haas, Bruno; Grenier, Daniel] Univ Laval, Fac Med Dent, GREB, Quebec City, PQ, Canada; [Grenier, Daniel] FRQNT, CRIPA, St Hyacinthe, PQ, Canada	Laval University	Grenier, D (corresponding author), Univ Laval, Fac Med Dent, GREB, Quebec City, PQ, Canada.	Daniel.Grenier@greb.ulaval.ca		Haas, Bruno/0000-0002-8277-9657	Natural Sciences and Engineering Research Council of Canada (NSERC) [194703-2009]; Swine and Poultry Infectious Disease Research Center (CRIPA)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Swine and Poultry Infectious Disease Research Center (CRIPA)	This study was funded by Discovery grant 194703-2009 to DG from the Natural Sciences and Engineering Research Council of Canada (NSERC). BH is the recipient of a scholarship from the Swine and Poultry Infectious Disease Research Center (CRIPA).	Acevedo R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00121; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132; Bonifait L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-47; Bonifait L, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-42; Brassard J, 2004, VET MICROBIOL, V102, P87, DOI 10.1016/j.vetmic.2004.05.008; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brown L, 2014, MOL MICROBIOL, V93, P183, DOI 10.1111/mmi.12650; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Collins BS, 2011, DISCOV MED, V11, P7; COLLINS SJ, 1979, J EXP MED, V149, P969, DOI 10.1084/jem.149.4.969; de Buhr N, 2014, MICROBIOL-SGM, V160, P385, DOI 10.1099/mic.0.072199-0; Deatherage BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11; DORWARD DW, 1990, APPL ENVIRON MICROB, V56, P1960, DOI 10.1128/AEM.56.6.1960-1962.1990; DORWARD DW, 1989, J BACTERIOL, V171, P2499, DOI 10.1128/jb.171.5.2499-2505.1989; Esgleas M, 2008, MICROBIOL-SGM, V154, P2668, DOI 10.1099/mic.0.2008/017145-0; Ferrando ML, 2010, MICROBIOL-SGM, V156, P2818, DOI 10.1099/mic.0.037960-0; Fontaine MC, 2004, INFECT IMMUN, V72, P774, DOI 10.1128/IAI.72.2.774-781.2004; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Gottschalk M., 2012, DIS SWINE, P841; GOTTSCHALK MG, 1995, MICROBIOL-SGM, V141, P189, DOI 10.1099/00221287-141-1-189; Gurung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027958; Haas Bruno, 2014, BMC Res Notes, V7, P424, DOI 10.1186/1756-0500-7-424; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; Hu QY, 2010, MICROB PATHOGENESIS, V48, P103, DOI 10.1016/j.micpath.2009.11.005; Jiang YL, 2014, INT J MED MICROBIOL, V304, P431, DOI 10.1016/j.ijmm.2014.02.006; Jun SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071751; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim DK, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20384; Kim GH, 2014, CURR PROTEIN PEPT SC, V15, P719, DOI 10.2174/1573403X10666140505163121; Kim JH, 2015, SEMIN CELL DEV BIOL, V40, P97, DOI 10.1016/j.semcdb.2015.02.006; Kim MR, 2012, ALLERGY, V67, P1271, DOI 10.1111/all.12001; KNOX KW, 1966, J BACTERIOL, V92, P1206, DOI 10.1128/JB.92.4.1206-1217.1966; Koedel U, 2002, LANCET INFECT DIS, V2, P721, DOI 10.1016/S1473-3099(02)00450-4; Kong MY, 2005, GEOL SOC AM BULL, V117, P244, DOI 10.1130/B25000.1; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; LEDUC A, 1995, ANAEROBE, V1, P129, DOI 10.1006/anae.1995.1008; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Lee J, 2013, ANTIMICROB AGENTS CH, V57, P2589, DOI 10.1128/AAC.00522-12; Lee JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073196; Liao SM, 2014, J BACTERIOL, V196, P2355, DOI 10.1128/JB.01493-14; Lun SC, 2003, MICROB PATHOGENESIS, V34, P27, DOI 10.1016/S0882-4010(02)00192-4; MacDonald IA, 2012, RES MICROBIOL, V163, P607, DOI 10.1016/j.resmic.2012.10.020; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Olaya-Abril A, 2014, J PROTEOMICS, V106, P46, DOI 10.1016/j.jprot.2014.04.023; Rivera J, 2010, P NATL ACAD SCI USA, V107, P19002, DOI 10.1073/pnas.1008843107; Schooling SR, 2006, J BACTERIOL, V188, P5945, DOI 10.1128/JB.00257-06; Schrempf H, 2011, MICROB BIOTECHNOL, V4, P286, DOI 10.1111/j.1751-7915.2011.00251.x; Seele J, 2013, J BACTERIOL, V195, P930, DOI 10.1128/JB.01875-12; Segura M, 2009, J INFECT DIS, V199, P4, DOI 10.1086/594371; Shao ZQ, 2011, FEMS MICROBIOL LETT, V314, P174, DOI 10.1111/j.1574-6968.2010.02162.x; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; SMITH HE, 1992, INFECT IMMUN, V60, P2361, DOI 10.1128/IAI.60.6.2361-2367.1992; Soult MC, 2013, J SURG RES, V184, P458, DOI 10.1016/j.jss.2013.05.035; Vanrobaeys M, 1999, MICROBIOL-SGM, V145, P335, DOI 10.1099/13500872-145-2-335; Varela NP, 2013, ANIM HEALTH RES REV, V14, P68, DOI 10.1017/S1466252313000029; Veith PD, 2014, J PROTEOME RES, V13, P2420, DOI 10.1021/pr401227e; Winter J, 2014, INFECT IMMUN, V82, P1372, DOI 10.1128/IAI.01443-13	60	32	35	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130528	10.1371/journal.pone.0130528	http://dx.doi.org/10.1371/journal.pone.0130528			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110524	gold, Green Submitted, Green Published			2022-12-27	WOS:000356933800059
J	Kot, J; Sicko, Z; Doboszynski, T				Kot, Jacek; Sicko, Zdzislaw; Doboszynski, Tadeusz			The Extended Oxygen Window Concept for Programming Saturation Decompressions Using Air and Nitrox	PLOS ONE			English	Article							BUBBLE FORMATION MODEL; DIRECT ASCENT; SICKNESS; GAS; HUMANS; TISSUE; PROBABILITY; COMPRESSION; DYNAMICS; TRIMIX	Saturation decompression is a physiological process of transition from one steady state, full saturation with inert gas at pressure, to another one: standard conditions at surface. It is defined by the borderline condition for time spent at a particular depth (pressure) and inert gas in the breathing mixture (nitrogen, helium). It is a delicate and long lasting process during which single milliliters of inert gas are eliminated every minute, and any disturbance can lead to the creation of gas bubbles leading to decompression sickness (DCS). Most operational procedures rely on experimentally found parameters describing a continuous slow decompression rate. In Poland, the system for programming of continuous decompression after saturation with compressed air and nitrox has been developed as based on the concept of the Extended Oxygen Window (EOW). EOW mainly depends on the physiology of the metabolic oxygen window-also called inherent unsaturation or partial pressure vacancy-but also on metabolism of carbon dioxide, the existence of water vapor, as well as tissue tension. Initially, ambient pressure can be reduced at a higher rate allowing the elimination of inert gas from faster compartments using the EOW concept, and maximum outflow of nitrogen. Then, keeping a driving force for long decompression not exceeding the EOW allows optimal elimination of nitrogen from the limiting compartment with half-time of 360 min. The model has been theoretically verified through its application for estimation of risk of decompression sickness in published systems of air and nitrox saturation decompressions, where DCS cases were observed. Clear dose-reaction relation exists, and this confirms that any supersaturation over the EOW creates a risk for DCS. Using the concept of the EOW, 76 man-decompressions were conducted after air and nitrox saturations in depth range between 18 and 45 meters with no single case of DCS. In summary, the EOW concept describes physiology of decompression after saturation with nitrogen-based breathing mixtures.	[Kot, Jacek; Sicko, Zdzislaw; Doboszynski, Tadeusz] Med Univ Gdansk, Inst Maritime & Trop Med, Natl Ctr Hyperbar Med, Powstania Styczniowego, Gdynia, Poland	Fahrenheit Universities; Medical University Gdansk	Kot, J (corresponding author), Med Univ Gdansk, Inst Maritime & Trop Med, Natl Ctr Hyperbar Med, Powstania Styczniowego, Gdynia, Poland.	jkot@gumed.edu.pl	Kot, Jacek/I-5284-2012	Kot, Jacek/0000-0001-5604-8407	Polish State Committee of Science [4PO5B09208]	Polish State Committee of Science	Supported was provided by the Polish State Committee of Science, grant no. 4PO5B09208, for conducting experiments.	[Anonymous], 2013, 31 DMAC; [Anonymous], 1987, WMF85 PWS; [Anonymous], 1978, 17 UND MED SOC WORKS; Barnard EEP, 1976, 5 S UND PHYS; BARRY PD, 1984, UNDERSEA BIOMED RES, V11, P387; Behnke AR, 1951, DECOMPRESSION SICKNE, P53, DOI 10.1007/978-3-662-02409-6_4; Behnke AR, 1967, T 3 MAR TECHN SOC C; BENNETT PB, 1981, UNDERSEA BIOMED RES, V8, P85; BENNETT PB, 1982, UNDERSEA BIOMED RES, V9, P335; BERGHAGE T E, 1976, Undersea Biomedical Research, V3, P387; Blatteau JE, 2012, 1206 I RECH BIOM ARM; Blatteau JE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060639, 10.1371/journal.pone.0067681]; Boycott AE, 1908, J HYG-CAMBRIDGE, V8, P342, DOI 10.1017/S0022172400003399; Brubakk AO, 2014, COMPR PHYSIOL, V4, P1229, DOI 10.1002/cphy.c130048; BUHLMANN AA, 1967, J APPL PHYSIOL, V23, P458, DOI 10.1152/jappl.1967.23.4.458; Buhlmann AA, 1983, DEKOMPRESSION DEKOMP; Buhlmann AA, 1969, PHYSIOLOGY MEDICINE, P357; Buhlmann AA, 1975, PHYSL MED DIVING COM, P348; Clark JM, 2003, BENNETT ELLIOTTS PHY, V5th, P358; CONKIN J, 1992, AVIAT SPACE ENVIR MD, V63, P819; CONKIN J, 1992, AVIAT SPACE ENVIR MD, V63, P965; Des Grange M, 1957, NEDURR557; Doboszynski T, 1984, Bull Inst Marit Trop Med Gdynia, V35, P21; Doboszynski T, 1983, K NAUK 25 LEC WOJSK, P339; ECKENHOFF RG, 1986, UNDERSEA BIOMED RES, V13, P305; ECKENHOFF RG, 1990, J APPL PHYSIOL, V69, P914, DOI 10.1152/jappl.1990.69.3.914; ECKENHOFF RG, 1985, UNDERSEA BIOMED RES, V12, P41; EYPASCH E, 1995, BRIT MED J, V311, P619, DOI 10.1136/bmj.311.7005.619; Flook V, 2004, HUMANS IN SUBMARINES, V2004; Flook V, 2004, 214 UK HLTH SAF EX; Flynn ET, 1999, UNDERSEA HYPERBAR M, V26, P46; Gerth WA, 1997, UNDERSEA HYPERBAR M, V24, P275; Gulyar SA, 1977, ORGANIZM CHELOVEKA P; Hamilton RW, 1988, 881B NURP US DEP COM; Hempleman H.V., 1993, PHYSL MED DIVING, P342; Hempleman HV, 1969, PHYSL MED DIVING COM, P291; HENNESSY TR, 1977, PROC R SOC SER B-BIO, V197, P299, DOI 10.1098/rspb.1977.0072; Hennessy TR, 1978, P S EFF PRESS; HILLS BA, 1969, CLIN SCI, V36, P185; HILLS BA, 1977, DECOMPRESSION SICKNE; Hills BA, 1966, THERMODYNAMIC KINETI; Hugon J, 2014, UNDERSEA HYPERBAR M, V41, P531; Imbert JP, 1988, 88277 COMEX SERV; Imbert JP, 1994, GPCO203321 STOLT COM; Jones HB, 1951, DECOMPRESSION SICKNE, P278; Latson GW, 2000, 1100 NEDU TR; Le Pechon JC, 1981, 7 ANN C EUBS 21 24 J, P205; MCCALLUM RI, 1968, BRIT J IND MED, V25, P4; Momsen CB, 1942, 242 NEDU; Nishi RY, 1973, DIGITAL COMPUTATION; Olszanski R, 1997, Bull Inst Marit Trop Med Gdynia, V48, P75; Olszanski R, 2001, BLOOD COAGUL FIBRIN, V12, P269, DOI 10.1097/00001721-200106000-00007; Olszanski R, 2010, AVIAT SPACE ENVIR MD, V81, P585, DOI 10.3357/ASEM.2626.2010; Petersen K, 2009, 200901 NMRC; Petersen K, 2010, AVIAT SPACE ENVIR MD, V81, P639, DOI 10.3357/ASEM.2681.2010; Popova J, 2006, UNDERSEA HYPERBAR M, V33, P211; Risberg J, 2008, PROCEDURES SATURATIO; SCHREINER H. R., 1967, INT J BIOMETEOROL, V11, P301, DOI 10.1007/BF01426653; Schreiner HR, 1968, REV SUBAQU PHYSIOL H, V1, P28; Shi Z Y, 2000, J Physiol Anthropol Appl Human Sci, V19, P101, DOI 10.2114/jpa.19.101; Shi Z Y, 1998, Appl Human Sci, V17, P249, DOI 10.2114/jpa.17.249; Sicko Z, 1995, 21 ANN M EUBS HELS F, P172; Sicko Z, 1996, INT JOINT M HYP UND, P487; Sicko Z, 1998, INTERPRETATION RELAT, P231; Smith R. E., 1944, BULL MYTH BIOPHYS, V6, P125, DOI 10.1007/BF02478243; Survanshi SS, 1994, UNDERSEA HYPERB ME S, V21, P60; THALMANN E D, 1984, Undersea Biomedical Research, V11, P17; Thalmann ED, 1997, UNDERSEA HYPERBAR M, V24, P255; U.S. Navy, 2008, US NAV DIV MAN REV; Van Liew HD, 2005, UNDERSEA HYPERBAR M, V32, P409; Van Liew HD, 2005, UNDERSEA HYPERBAR M, V32, P375; VANLIEW HD, 1993, AVIAT SPACE ENVIR MD, V64, P859; Vann R.D., 1993, PHYSL MED DIVING, V4th, P376; Vann RD, 1985, E M US JAP COOP PROG, P77; Vann RD, 1984, 3RD P ANN CAN OC TEC, P175; Vann RD, 1986, P 8 M US JAP COOP PR; WATT DG, 1979, AVIAT SPACE ENVIR MD, V50, P571; Wienke B. R., 1989, Transport Theory, Invariant Imbedding and Integral Equations. Proceedings in Honor of G.M. Wing's 65th Birthday, P179; WIENKE BR, 1989, INT J BIOMED COMPUT, V24, P227, DOI 10.1016/0020-7101(89)90019-6; WIENKE BR, 1989, UNDERSEA BIOMED RES, V16, P53; WIENKE BR, 1992, COMPUT BIOL MED, V22, P389, DOI 10.1016/0010-4825(92)90039-P; WIENKE BR, 1990, INT J BIOMED COMPUT, V25, P193, DOI 10.1016/0020-7101(90)90009-J; WIENKE BR, 1990, INT J BIOMED COMPUT, V26, P237, DOI 10.1016/0020-7101(90)90048-Y; Workman RD, 1965, CALCULATION DECOMPRE; Yarborough OD, 1937, CALCULATION DECOMPRE; YOUNT DE, 1979, AVIAT SPACE ENVIR MD, V50, P44; YOUNT DE, 1986, AVIAT SPACE ENVIR MD, V57, P149; Zal'tsman GL, 1965, EFFECT GAS MEDIUM PR, P28; [No title captured]	89	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130835	10.1371/journal.pone.0130835	http://dx.doi.org/10.1371/journal.pone.0130835			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111113	gold, Green Submitted, Green Published			2022-12-27	WOS:000356933800091
J	Meng, QQ; Xin, L; Liu, WY; Lin, H; Tian, B; Wang, LW; Li, ZS				Meng, Qianqian; Xin, Lei; Liu, Wenyu; Lin, Han; Tian, Bo; Wang, Luowei; Li, Zhaoshen			Diagnosis and Treatment of Autoimmune Pancreatitis in China: A Systematic Review	PLOS ONE			English	Article							STEROID-THERAPY; CONSENSUS; CRITERIA; MULTICENTER; GUIDELINES; EXPERIENCE; SUBTYPES; TYPE-1	Aims To provide comprehensive data on the diagnosis and treatment of autoimmune pancreatitis (AIP) patients in China. Design A systematic review. Methods All clinical studies concerning AIP from China published between January 2006 and June 2014 were retrospectively reviewed and analyzed. Results A total of 26 original articles involving 706 AIP patients were included with an estimated proportion of type 2 AIP as 4.7%. In the 706 AIP patients, the range of mean/median age was 48.6-67.0 years old and the male to female ratio was 4.47:1. The common presentations included obstructive jaundice (pooled rate: 63.4%, 95% CI: 55.4%-71.0%) and abdominal symptoms (pooled rate: 62.3%, 95%CI: 52.4%-71.7%). Biliary involvement was the most common extrapancreatic manifestations, especially the lower part of the common bile duct (pooled rate: 62.3%, 95%CI: 49.9%-73.9%). According to the imaging examinations, 53.8% and 41.6% patients were classified into focal-type and diffuse-type, respectively. Notably, upstream pancreatic duct dilatation was found in parts of patients (pooled rate: 13.8%, 95%CI: 6.6%-23.1%). The levels of serum IgG4 were elevated in most patients (pooled rate: 86.0%, 95%CI: 74.2%-94.6%). Nearly three tenths AIP patients received surgery (pooled rate: 29.7%, 95%CI: 18.1%-42.8%) due to mimicked malignancy. Steroid treatment was given to 78.4% patients (95%CI: 65.3%-89.1%) with a pooled remission rate of 96.2% (95%CI: 94.0%-97.9%). The pooled relapse rate was 13.8% (95%CI: 7.2%-22.0%) with the mean follow-up time ranging from 12 to 45 months. Conclusion Type 1 is the predominant type of Chinese AIP patients and the clinical features, diagnostic modalities and therapeutic regimen were similar with those in other countries. Knowledge of AIP should be more widespread to avoid unnecessary surgery.	[Meng, Qianqian; Xin, Lei; Lin, Han; Tian, Bo; Wang, Luowei; Li, Zhaoshen] Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Liu, Wenyu] Second Mil Med Univ, Changhai Hosp, Dept Gen Surg, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Wang, LW (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China.	wangluoweimd@126.com; zhaoshenli@hotmail.com		Wang, Luowei/0000-0002-6647-786X	National Science Foundation of Shanghai [12ZR1438800]	National Science Foundation of Shanghai	This study was supported by National Science Foundation of Shanghai (Grant No. 12ZR1438800, http://www.stcsm.gov.cn/, [LWW]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chari ST, 2006, CLIN GASTROENTEROL H, V4, P1010, DOI 10.1016/j.cgh.2006.05.017; Chari ST, 2010, PANCREAS, V39, P549, DOI 10.1097/MPA.0b013e3181e4d9e5; Frulloni L, 2009, AM J GASTROENTEROL, V104, P2288, DOI 10.1038/ajg.2009.327; Hart PA, 2015, GASTROENTEROLOGY, V149, P39, DOI 10.1053/j.gastro.2015.03.010; Hart PA, 2013, GUT, V62, P1771, DOI 10.1136/gutjnl-2012-303617; Hart PA, 2013, GUT, V62, P1607, DOI 10.1136/gutjnl-2012-302886; Hirano K, 2010, GASTROINTEST ENDOSC, V71, P85, DOI 10.1016/j.gie.2009.08.008; Ishikawa T, 2012, WORLD J GASTROENTERO, V18, P3883, DOI 10.3748/wjg.v18.i29.3883; Kamisawa T, 2009, GUT, V58, P1504, DOI 10.1136/gut.2008.172908; Kamisawa T, 2008, SCAND J GASTROENTERO, V43, P609, DOI 10.1080/00365520701731263; Kamisawa T, 2014, J GASTROENTEROL, V49, P961, DOI 10.1007/s00535-014-0945-z; Kamisawa T, 2011, PANCREAS, V40, P809, DOI 10.1097/MPA.0b013e3182258a15; Kanno A, 2012, GASTROINTEST ENDOSC, V76, P594, DOI 10.1016/j.gie.2012.05.014; Kanno A, 2012, PANCREAS, V41, P835, DOI 10.1097/MPA.0b013e3182480c99; Kim KP, 2006, WORLD J GASTROENTERO, V12, P2487, DOI 10.3748/wjg.v12.i16.2487; Liu B, 2013, WORLD J GASTROENTERO, V19, P569, DOI 10.3748/wjg.v19.i4.569; Members of the Criteria Committee for Autoimmune Pancreatitis of the Japan Pancreas Society, 2002, J JPN PANCREAS SOC S, V17, P585; Okazaki K, 2012, PANCREAS, V41, P1341, DOI 10.1097/MPA.0b013e3182706ed5; Otsuki M, 2008, J GASTROENTEROL, V43, P403, DOI 10.1007/s00535-008-2205-6; Sah Raghuwansh P, 2012, Curr Gastroenterol Rep, V14, P95, DOI 10.1007/s11894-012-0246-8; Sah RP, 2010, GASTROENTEROLOGY, V139, P140, DOI 10.1053/j.gastro.2010.03.054; SARLES H, 1961, AM J DIG DIS, V6, P688, DOI 10.1007/BF02232341; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Song TJ, 2012, J GASTROEN HEPATOL, V27, P700, DOI 10.1111/j.1440-1746.2011.06934.x; Song TJ, 2010, AM J GASTROENTEROL, V105, P1655, DOI 10.1038/ajg.2009.689; Song Y, 2008, WORLD J GASTROENTERO, V14, P601, DOI 10.3748/wjg.14.601; Wang LW, 2009, PANCREAS, V38, P248, DOI 10.1097/MPA.0b013e31818f6ac1; Watanabe T, 2014, PANCREAS, V43, P255, DOI 10.1097/01.mpa.0000437323.52598.20; Xin L, 2014, HEPATOB PANCREAT DIS, V13, P642, DOI 10.1016/S1499-3872(14)60263-0; YOSHIDA K, 1995, DIGEST DIS SCI, V40, P1561, DOI 10.1007/BF02285209; Zhang Min-Min, 2011, J Interv Gastroenterol, V1, P182; Zhang XG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044808	32	16	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130466	10.1371/journal.pone.0130466	http://dx.doi.org/10.1371/journal.pone.0130466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110658	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800050
J	Rajaei, M; Haghjoo, MS; Miyaneh, EK				Rajaei, Mehri; Haghjoo, Mostafa S.; Miyaneh, Eynollah Khanjari			Ambiguity in Social Network Data for Presence, Sensitive-Attribute, Degree and Relationship Privacy Protection	PLOS ONE			English	Article								Maintaining privacy in network data publishing is a major challenge. This is because known characteristics of individuals can be used to extract new information about them. Recently, researchers have developed privacy methods based on k-anonymity and l-diversity to prevent re-identification or sensitive label disclosure through certain structural information. However, most of these studies have considered only structural information and have been developed for undirected networks. Furthermore, most existing approaches rely on generalization and node clustering so may entail significant information loss as all properties of all members of each group are generalized to the same value. In this paper, we introduce a framework for protecting sensitive attribute, degree (the number of connected entities), and relationships, as well as the presence of individuals in directed social network data whose nodes contain attributes. First, we define a privacy model that specifies privacy requirements for the above private information. Then, we introduce the technique of Ambiguity in Social Network data (ASN) based on anatomy, which specifies how to publish social network data. To employ ASN, individuals are partitioned into groups. Then, ASN publishes exact values of properties of individuals of each group with common group ID in several tables. The lossy join of those tables based on group ID injects uncertainty to reconstruct the original network. We also show how to measure different privacy requirements in ASN. Simulation results on real and synthetic datasets demonstrate that our framework, which protects from four types of private information disclosure, preserves data utility in tabular, topological and spectrum aspects of networks at a satisfactory level.	[Rajaei, Mehri; Haghjoo, Mostafa S.; Miyaneh, Eynollah Khanjari] Iran Univ Sci & Technol, Dept Comp Engn, Tehran, Iran; [Haghjoo, Mostafa S.] PayameNoor Univ, Kish Int Branch, Kish, Iran	Iran University Science & Technology	Rajaei, M (corresponding author), Iran Univ Sci & Technol, Dept Comp Engn, Tehran, Iran.	mrajaei@iust.ac.ir	Khanjari, Eynollah/S-9545-2018; Rajaei, Mehri/J-8876-2019; Torkaman Rahmani, Adel/S-9542-2018	Khanjari, Eynollah/0000-0002-2304-1804; Rajaei, Mehri/0000-0003-2526-8612; Lane, Michael/0000-0001-6534-4902				Backstrom L., 2007, P 16 INT C WORLD WID, P181, DOI DOI 10.1145/1242572.1242598; Barbaro M., 2006, NEW YORK TIMES, V9, P8; Bhagat S, 2009, P 35 INT C VER LARG; Bonchi F, 2011, P ICDE 11; Campan A, 2008, P 13 INT C EXT DAT T; Cheng J., 2010, P ACM SIGMOD INT C M; Cormode G, 2010, VLDB J, V19; Dwork C, 2006, LECT NOTES COMPUT SC, V4052, P1; Dwork C, 2006, LECT NOTES COMPUT SC, V3876, P265, DOI 10.1007/11681878_14; Fung B. C., 2010, ACM COMPUT SURV, V42, P4; Gehrke J, 2011, LECT NOTES COMPUT SC, V6597, P432, DOI 10.1007/978-3-642-19571-6_26; Hay M, 2007, 0719 UM AMH; Hay M, 2010, VLDB J, V19, P797, DOI 10.1007/s00778-010-0210-x; Hay M, 2009, IEEE DATA MINING, P169, DOI 10.1109/ICDM.2009.11; Karwa V, 2014, ACM T DATABASE SYST, V39, DOI 10.1145/2611523; Kasiviswanathan SP, 2013, LECT NOTES COMPUT SC, V7785, P457, DOI 10.1007/978-3-642-36594-2_26; Kleinberg JM, 2007, P 13 ACM SIGKDD INT, P4, DOI 10.1145/1281192.1281195; Liu K., 2008, P 2008 ACM SIGMOD IN, P93, DOI DOI 10.1145/1376616.1376629; Machanavajjhala A., 2007, ACM T KNOWL DISCOV D, V1; Medforth N, 2011, P ICDM; Milani Fard A, 2012, EDBT; Milani Fard A, 2013, WORLD WIDE WED J, V16; Nissim K, 2007, ACM S THEORY COMPUT, P75, DOI 10.1145/1250790.1250803; Samarati P., 1998, Proceedings of the Seventeenth ACM SIGACT-SIGMOD-SIGART Symposium on Principles of Database Systems. PODS 1998, DOI 10.1145/275487.275508; Samarati P, TECHNICAL REPORT; Srivastava J., 2008, TUT 8 SIAM INT C DAT; Tai C, 2011, PROC 17 ACM SIGKDDIN, DOI 10.1145/2020408.2020599; Tai CH, 2014, IEEE T KNOWL DATA EN, V26, P235, DOI 10.1109/TKDE.2013.40; Task C, 2012, ADV SOCIAL NETWORKS; Wang H, 2010, J COMPUT SCI TECH-CH, V25, P401, DOI 10.1007/s11390-010-9333-1; Wentao W, 2010, P 13 INT C EXT DAT T, P111, DOI DOI 10.1007/978-3-642-10494-7_6; Wu L, 2010, P ICDM; Wu X, 2009, INVITED BOOK CHAPTER; Xiao X., 2006, P 32 INT C VERY LARG, P139; Ying X., 2008, P SIAM INT C DAT MIN, DOI DOI 10.1137/1.9781611972788.67; Ying XW, 2011, KNOWL INF SYST, V28, P645, DOI 10.1007/s10115-010-0353-5; Yuan MX, 2013, IEEE T KNOWL DATA EN, V25, P633, DOI 10.1109/TKDE.2011.259; Yuan MX, 2010, PROC VLDB ENDOW, V4, P141, DOI 10.14778/1921071.1921080; Zhang Qiu-yu, 2007, Proceedings International Conference on Informatics and Control Technologies 2006, P116; Zhou B, 2011, KNOWL INF SYST, V28, P47, DOI 10.1007/s10115-010-0311-2; Zhou B, 2008, PROC INT CONF DATA, P506, DOI 10.1109/ICDE.2008.4497459; Zou L., 2009, P VLDB ENDOWMENT, P946, DOI [10.14778/1687627.1687734, DOI 10.14778/1687627.1687734]	42	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130693	10.1371/journal.pone.0130693	http://dx.doi.org/10.1371/journal.pone.0130693			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110762	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800074
J	Takayama, T; Okamoto, S; Hisamatsu, T; Naganuma, M; Matsuoka, K; Mizuno, S; Bessho, R; Hibi, T; Kanai, T				Takayama, Tetsuro; Okamoto, Susumu; Hisamatsu, Tadakazu; Naganuma, Makoto; Matsuoka, Katsuyoshi; Mizuno, Shinta; Bessho, Rieko; Hibi, Toshifumi; Kanai, Takanori			Computer-Aided Prediction of Long-Term Prognosis of Patients with Ulcerative Colitis after Cytoapheresis Therapy	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORK; MONOCYTE ADSORPTIVE APHERESIS; LOWER-GASTROINTESTINAL HEMORRHAGE; GRANULOCYTE/MONOCYTE APHERESIS; LEUKOCYTAPHERESIS; OPTIMIZATION; EXPERIENCE; INFECTION; IMPACT; VIRUS	Cytoapheresis (CAP) therapy is widely used in ulcerative colitis (UC) patients with moderate to severe activity in Japan. The aim of this study is to predict the need of operation after CAP therapy of UC patients on an individual level using an artificial neural network system (ANN). Ninety UC patients with moderate to severe activity were treated with CAP. Data on the patients' demographics, medication, clinical activity index (CAI) and efficacy of CAP were collected. Clinical data were divided into training data group and validation data group and analyzed using ANN to predict individual outcomes. The sensitivity and specificity of predictive expression by ANN were 0.96 and 0.97, respectively. Events of admission, operation, and use of immunomodulator, and efficacy of CAP were significantly correlated to the outcome. Requirement of operation after CAP therapy was successfully predicted by using ANN. This newly established ANN strategy would be used as powerful support of physicians in the clinical practice.	[Takayama, Tetsuro; Hisamatsu, Tadakazu; Mizuno, Shinta; Bessho, Rieko; Kanai, Takanori] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol,Shinjuk Ku, Tokyo, Japan; [Takayama, Tetsuro] Predict Med Inst, Minato Ku, Tokyo, Japan; [Takayama, Tetsuro] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan; [Takayama, Tetsuro] Wata Clin, Katsushika ku, Tokyo, Japan; [Okamoto, Susumu] Kyorin Univ, Sch Med, Dept Gen Med, Mitaka, Tokyo 181, Japan; [Naganuma, Makoto] Keio Univ, Sch Med, Ctr Diagnost & Therapeut Endoscopy, Shinjuku Ku, Tokyo, Japan; [Matsuoka, Katsuyoshi] Tokyo Med & Dent Univ, Grad Sch, Dept Adv Therapeut Gastrointestinal Dis, Bunkyo Ku, Tokyo, Japan; [Mizuno, Shinta] Saiseikai Cent Hosp, Dept Internal Med, Minato Ku, Tokyo, Japan; [Hibi, Toshifumi] Kitasato Univ, Kitasato Inst Hosp, Ctr Adv IBD Res & Treatment, Minato Ku, Tokyo, Japan	Keio University; Tokai University; Kyorin University; Keio University; Tokyo Medical & Dental University (TMDU); Tokyo Saiseikai Central Hospital; Kitasato University	Kanai, T (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol,Shinjuk Ku, Tokyo, Japan.	takagast@z2.keio.jp	Matsuoka, Katsuyoshi/AAB-1580-2022	Matsuoka, Katsuyoshi/0000-0002-2950-7660; Kanai, Takanori/0000-0002-1466-4532	KORP project grant from Otsuka Pharmaceutical, Inc.	KORP project grant from Otsuka Pharmaceutical, Inc.	This work was supported all by a KORP project grant from Otsuka Pharmaceutical, Inc. (to TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAXT WG, 1995, LANCET, V346, P1135, DOI 10.1016/S0140-6736(95)91804-3; BAXT WG, 1991, ANN INTERN MED, V115, P843, DOI 10.7326/0003-4819-115-11-843; CROSS SS, 1995, LANCET, V346, P1075, DOI 10.1016/S0140-6736(95)91746-2; Das A, 2003, LANCET, V362, P1261, DOI 10.1016/S0140-6736(03)14568-0; Das A, 2007, EUR J GASTROEN HEPAT, V19, P1064, DOI 10.1097/MEG.0b013e3282f198f7; Grossi E, 2007, DIGEST LIVER DIS, V39, P278, DOI 10.1016/j.dld.2006.10.003; Grossi E, 2007, EUR J GASTROEN HEPAT, V19, P1046, DOI 10.1097/MEG.0b013e3282f198a0; Hanai H, 2004, DIGESTION, V70, P36, DOI 10.1159/000080079; Hanai H, 2003, CLIN GASTROENTEROL H, V1, P28, DOI 10.1053/jcgh.2003.50005; Haydon GH, 1998, J VIRAL HEPATITIS, V5, P255, DOI 10.1046/j.1365-2893.1998.00108.x; Haydon GH, 1998, EUR J GASTROEN HEPAT, V10, P485, DOI 10.1097/00042737-199806000-00009; Hibi T, 2009, DIGEST LIVER DIS, V41, P570, DOI 10.1016/j.dld.2008.11.020; Hirose H, 2011, COMPUT BIOL MED, V41, P1051, DOI 10.1016/j.compbiomed.2011.09.005; Huang RSP, 2015, ANN CLIN LAB SCI, V45, P181; Kanke K, 2004, DIGEST LIVER DIS, V36, P811, DOI 10.1016/j.dld.2004.08.004; Ligor T, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/2/027106; Maiellaro PA, 2004, CURR PHARM DESIGN, V10, P2101, DOI 10.2174/1381612043384240; Naganuma M, 2004, INFLAMM BOWEL DIS, V10, P251, DOI 10.1097/00054725-200405000-00012; Ogata H, 2006, GUT, V55, P1255, DOI 10.1136/gut.2005.081794; Pace F, 2007, EUR J GASTROEN HEPAT, V19, P1043, DOI 10.1097/MEG.0b013e3282f198e5; RACHMILEWITZ D, 1989, BMJ-BRIT MED J, V298, P82, DOI 10.1136/bmj.298.6666.82; Sakuraba A, 2009, AM J GASTROENTEROL, V104, P2990, DOI 10.1038/ajg.2009.453; Sands BE, 2008, GASTROENTEROLOGY, V135, P400, DOI 10.1053/j.gastro.2008.04.023; Sangi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121569; Saniabadi AR, 2007, TRANSFUS APHER SCI, V37, P191, DOI 10.1016/j.transci.2007.08.003; Stylianou N, 2015, BURNS, V41, P925, DOI 10.1016/j.burns.2015.03.016; Suzuki Y, 2004, DIGEST DIS SCI, V49, P565, DOI 10.1023/B:DDAS.0000026299.43792.ae; Takagaki K, 2010, J PHARM SCI-US, V99, P4201, DOI 10.1002/jps.22135; Takayama K, 2000, J CONTROL RELEASE, V68, P175, DOI 10.1016/S0168-3659(00)00248-0; Takayama K, 2003, ADV DRUG DELIVER REV, V55, P1217, DOI 10.1016/S0169-409X(03)00120-0; Takayama Tetsuro, 2013, J Crohns Colitis, V7, pe49, DOI 10.1016/j.crohns.2012.05.005; Takayama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027223; Takayama T, 2009, EUR J GASTROEN HEPAT, V21, P1279, DOI 10.1097/MEG.0b013e32832a4eae; Yamamoto T, 2007, DIGEST LIVER DIS, V39, P626, DOI 10.1016/j.dld.2007.04.007; Yamamoto T, 2004, ALIMENT PHARM THER, V20, P783, DOI 10.1111/j.1365-2036.2004.02189.x; Yamamoto T, 2006, INFLAMM BOWEL DIS, V12, P719, DOI 10.1097/00054725-200608000-00008	36	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131197	10.1371/journal.pone.0131197	http://dx.doi.org/10.1371/journal.pone.0131197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111148	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800128
J	Vorobyeva, AG; Stanton, M; Godinat, A; Lund, KB; Karateev, GG; Francis, KP; Allen, E; Gelovani, JG; McCormack, E; Tangney, M; Dubikovskaya, EA				Vorobyeva, Anzhelika G.; Stanton, Michael; Godinat, Aurelien; Lund, Kjetil B.; Karateev, Grigory G.; Francis, Kevin P.; Allen, Elizabeth; Gelovani, Juri G.; McCormack, Emmet; Tangney, Mark; Dubikovskaya, Elena A.			Development of a Bioluminescent Nitroreductase Probe for Preclinical Imaging	PLOS ONE			English	Article							ESCHERICHIA-COLI; MYELOPEROXIDASE ACTIVITY; PRODRUG THERAPY; LIVING SUBJECTS; BREAST-CANCER; METRONIDAZOLE; ACTIVATION; CHEMILUMINESCENCE; RESISTANCE; SUBSTRATE	Bacterial nitroreductases (NTRs) have been widely utilized in the development of novel antibiotics, degradation of pollutants, and gene-directed enzyme prodrug therapy (GDEPT) of cancer that reached clinical trials. In case of GDEPT, since NTR is not naturally present in mammalian cells, the prodrug is activated selectively in NTR-transformed cancer cells, allowing high efficiency treatment of tumors. Currently, no bioluminescent probes exist for sensitive, non-invasive imaging of NTR expression. We therefore developed a "NTR caged luciferin" (NCL) probe that is selectively reduced by NTR, producing light proportional to the NTR activity. Here we report successful application of this probe for imaging of NTR in vitro, in bacteria and cancer cells, as well as in vivo in mouse models of bacterial infection and NTR-expressing tumor xenografts. This novel tool should significantly accelerate the development of cancer therapy approaches based on GDEPT and other fields where NTR expression is important.	[Vorobyeva, Anzhelika G.; Godinat, Aurelien; Karateev, Grigory G.; Dubikovskaya, Elena A.] Swiss Fed Inst Technol, Inst Chem Sci & Engn, Sch Basic Sci, CH-1015 Lausanne, Switzerland; [Stanton, Michael; Tangney, Mark] Natl Univ Ireland Univ Coll Cork, Cork Canc Res Ctr, Cork, Ireland; [Lund, Kjetil B.; McCormack, Emmet] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Lund, Kjetil B.; McCormack, Emmet] Haukeland Hosp, Dept Internal Med, Hematol Sect, N-5021 Bergen, Norway; [Francis, Kevin P.] PerkinElmer, Hopkinton, MA USA; [Allen, Elizabeth] Swiss Fed Inst Technol, Swiss Inst Expt Canc Res ISREC, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Gelovani, Juri G.] Wayne State Univ, Coll Engn, Dept Biomed Engn, Detroit, MI USA; [Gelovani, Juri G.] Wayne State Univ, Sch Med, Detroit, MI USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University College Cork; University of Bergen; University of Bergen; Haukeland University Hospital; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Wayne State University; Wayne State University	Dubikovskaya, EA (corresponding author), Swiss Fed Inst Technol, Inst Chem Sci & Engn, Sch Basic Sci, CH-1015 Lausanne, Switzerland.	elena.dubikovskaya@epfl.ch	Cormack, Emmet Mc/D-2922-2012; Hamblin, Mike/AAB-2511-2022; Hamblin, Michael R/H-2758-2019; Vorobyeva, Anzhelika/P-4018-2018; Godinat, Aurélien/A-4570-2017	Cormack, Emmet Mc/0000-0002-7621-4625; Hamblin, Michael R/0000-0001-6431-4605; Godinat, Aurélien/0000-0002-6068-2512; Vorobyeva, Anzhelika/0000-0002-4778-3909; Goun, Elena/0000-0002-4214-0656; Tangney, Mark/0000-0002-6314-1260	Intrace Medical, SA (Switzerland), Industrial grant [8421]; Bergen Research Foundation; Norwegian Cancer Society; Western regional health board of Norway; Science Foundation Ireland/Enterprise Ireland [12/TIDA/B2437]; Irish Health Research Board PhD Scholars Programme in Cancer Biology [HRA_POR/2010/138]; Irish Cancer Society [PCI12TAN]; European Commission Seventh Framework Programme [PIAP-GA-2013-612219-VIP]; PerkinElmer	Intrace Medical, SA (Switzerland), Industrial grant; Bergen Research Foundation; Norwegian Cancer Society(Norwegian Cancer Society); Western regional health board of Norway; Science Foundation Ireland/Enterprise Ireland(Science Foundation Ireland); Irish Health Research Board PhD Scholars Programme in Cancer Biology; Irish Cancer Society; European Commission Seventh Framework Programme(European Commission); PerkinElmer	This work was supported by Intrace Medical, SA (Switzerland), Industrial grant 8421 to EAD, Bergen Research Foundation, Norwegian Cancer Society and the Western regional health board of Norway to EM, Science Foundation Ireland/Enterprise Ireland (12/TIDA/B2437), the Irish Health Research Board PhD Scholars Programme in Cancer Biology and grant HRA_POR/2010/138 and the Irish Cancer Society (PCI12TAN), the European Commission Seventh Framework Programme (PIAP-GA-2013-612219-VIP) to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PerkinElmer provided support in the form of a salary for author KPF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ando Y, 2008, NAT PHOTONICS, V2, P44, DOI 10.1038/nphoton.2007.251; Ando Y, 2007, PHOTOCHEM PHOTOBIOL, V83, P1205, DOI 10.1111/j.1751-1097.2007.00140.x; Bhaumik S, 2012, GENE THER, V19, P295, DOI 10.1038/gt.2011.101; Branchini BR, 1999, BIOCHEMISTRY-US, V38, P13223, DOI 10.1021/bi991181o; Bryant LR, 2013, PERS CONTIN PHILOS, P55; Celli CM, 2006, BIOCHEM PHARMACOL, V72, P366, DOI 10.1016/j.bcp.2006.04.029; Cellitti SE, 2012, STRUCTURE, V20, P101, DOI 10.1016/j.str.2011.11.001; Cohen AS, 2010, J AM CHEM SOC, V132, P8563, DOI 10.1021/ja101766r; Cronin M, 2012, CANCER GENE THER, V19, P731, DOI 10.1038/cgt.2012.59; Cronin M, 2014, MOL THER, V22, P1188, DOI 10.1038/mt.2014.23; Cronin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030940; Cui L, 2011, ORG LETT, V13, P928, DOI 10.1021/ol102975t; Dragulescu-Andrasi A, 2009, BIOCONJUGATE CHEM, V20, P1660, DOI 10.1021/bc9002508; Godinat A, 2013, ACS CHEM BIOL, V8, P987, DOI 10.1021/cb3007314; Goun EA, 2006, CHEMBIOCHEM, V7, P1497, DOI 10.1002/cbic.200600171; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Henkin AH, 2012, ACS CHEM BIOL, V7, P1884, DOI 10.1021/cb300194b; Hickson J, 2010, CELL DEATH DIFFER, V17, P1003, DOI 10.1038/cdd.2009.205; James AL, 2001, LETT APPL MICROBIOL, V33, P403, DOI 10.1046/j.1472-765X.2001.01021.x; Jenks PJ, 2002, INT J ANTIMICROB AG, V19, P1, DOI 10.1016/S0924-8579(01)00468-X; Krohn KA, 2008, J NUCL MED, V49, p129S, DOI 10.2967/jnumed.107.045914; Leblond F, 2010, J PHOTOCH PHOTOBIO B, V98, P77, DOI 10.1016/j.jphotobiol.2009.11.007; Li Z, 2013, CHEM COMMUN, V49, P5859, DOI 10.1039/c3cc42610f; Li Z, 2013, ANAL CHEM, V85, P3926, DOI 10.1021/ac400750r; Liu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012024; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; McBain AJ, 1998, J MED MICROBIOL, V47, P407, DOI 10.1099/00222615-47-5-407; McCormack E, 2013, CANCER RES, V73, P1276, DOI 10.1158/0008-5472.CAN-12-2649; Mercier C, 2013, J APPL MICROBIOL, V115, P1012, DOI 10.1111/jam.12294; Miura K, 1997, BIOL PHARM BULL, V20, P110; Oliveira I.A.M., 2010, NITROREDUCTASES ENZY; Pal D, 2009, ANTIMICROB AGENTS CH, V53, P458, DOI 10.1128/AAC.00909-08; Patel P, 2009, MOL THER, V17, P1292, DOI 10.1038/mt.2009.80; Patterson S, 2014, TRENDS PARASITOL, V30, P289, DOI 10.1016/j.pt.2014.04.003; PREKEGES JL, 1991, BIOCHEM PHARMACOL, V42, P2387, DOI 10.1016/0006-2952(91)90245-Z; Prescher JA, 2010, CURR OPIN CHEM BIOL, V14, P80, DOI 10.1016/j.cbpa.2009.11.001; Prosser GA, 2010, BIOCHEM PHARMACOL, V79, P678, DOI 10.1016/j.bcp.2009.10.008; Razgulin A, 2011, CHEM SOC REV, V40, P4186, DOI 10.1039/c1cs15035a; Scabini M, 2011, APOPTOSIS, V16, P198, DOI 10.1007/s10495-010-0553-1; Sekar TV, 2014, THERANOSTICS, V4, P460, DOI 10.7150/thno.8077; Sellmyer MA, 2013, P NATL ACAD SCI USA, V110, P8567, DOI 10.1073/pnas.1218336110; Shah K, 2005, MOL THER, V11, P926, DOI 10.1016/j.ymthe.2005.01.017; Shi YM, 2013, ANALYST, V138, P1952, DOI 10.1039/c3an36807f; Sisson G, 2002, ANTIMICROB AGENTS CH, V46, P2116, DOI 10.1128/AAC.46.7.2116-2123.2002; Stanton M, 2015, CURR GENE THER, V15, P277, DOI 10.2174/1566523215666150126122712; Van de Bittner GC, 2010, P NATL ACAD SCI USA, V107, P21316, DOI 10.1073/pnas.1012864107; Viviani VR, 2014, BIOCHEMISTRY-US, V53, P5208, DOI 10.1021/bi500160m; Wehrman TS, 2006, NAT METHODS, V3, P295, DOI 10.1038/NMETH868; WHITE EH, 1970, ACCOUNTS CHEM RES, V3, P54, DOI 10.1021/ar50026a003; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Xu G, 2001, CLIN CANCER RES, V7, P3314; Yao H, 2007, ANGEW CHEM INT EDIT, V46, P7031, DOI 10.1002/anie.200701931; Zenno S, 1996, J BIOCHEM-TOKYO, V120, P736; Zenno S, 1996, J BACTERIOL, V178, P4508, DOI 10.1128/jb.178.15.4508-4514.1996; Zhang N, 2013, NAT MED, V19, P500, DOI 10.1038/nm.3110	56	32	32	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131037	10.1371/journal.pone.0131037	http://dx.doi.org/10.1371/journal.pone.0131037			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110789	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800111
J	Li, CH; Wang, Y; Li, YX; Jiang, CH; Yang, XJ; Wu, ZX				Li, Chuanhui; Wang, Yang; Li, Youxiang; Jiang, Chuhan; Yang, Xinjian; Wu, Zhongxue			Clinical and Angioarchitectural Risk Factors Associated with Intracranial Hemorrhage in Dural Arteriovenous Fistulas: A Single-Center Retrospective Study	PLOS ONE			English	Article							SPONTANEOUS INTRACEREBRAL HEMORRHAGE; VENOUS DRAINAGE; CLASSIFICATION; MALFORMATIONS; EMBOLIZATION; HYPERTENSION; ONYX	Purpose To investigate which clinical and angioarchitectural features were associated with the occurrence of intracranial hemorrhage in patients with intracranial dural arteriovenous fistulas (DAVFs). Materials and Methods We retrospectively reviewed the clinical and angioarchitectural features of 236 consecutive patients diagnosed with DAVF in our department from April 2009 to November 2013. Two groups of patients, with or without intracranial hemorrhage as clinical presentation at the initial diagnosis, were analysed to identify the differences in clinical and angioarchitectural features in univariate analysis. A multivariate logistic regression model was also developed to assess the independent contribution of the potential risk factors. Associations were considered significant for p<0.05. Results Fifty-six patients (23.7%) presented with intracranial hemorrhage at the initial diagnosis of DAVF. In univariate analysis, male patients (p = 0.002), patients with medical history of smoking (p<0.001) or alcohol consumption (p = 0.022), and DAVFs located at the tentorium (p = 0.010), frontalbasal (p = 0.007), foramen magnum (p = 0.043) or cerebral convexity (p<0.001) were associated with an increased risk of intracranial hemorrhage. A higher risk of hemorrhagic occurrence was also observed in DAVFs with superficial cortical venous drainage (p<0.001), deep venous drainage (p = 0.003), occluded venous sinus (p<0.032), or higher Borden type (p<0.001). A multivariate logistic regression model showed that intracranial hemorrhage in patients with DAVFs was correlated with higher Borden classification (OR 5.880; 95% CI, 3.370- 10.257; p<0.001). Conclusion Venous drainage pattern was the only independent risk factor of intracranial hemorrhage in our patients with intracranial DAVF. The other potential risk factors may be confounding factors in predicting intracranial hemorrhage.	Capital Med Univ, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, Beijing, Peoples R China; [Yang, Xinjian] Capital Med Univ, Beijing Tiantan Hosp, Beijing, Peoples R China	Beijing Neurosurgical Institute; Capital Medical University; Capital Medical University	Yang, XJ (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, 6 Tiantan Xili, Beijing, Peoples R China.	yang-xj@163.net; 252694812@qq.com		Yang, Xinjian/0000-0001-7306-0125	National Science Foundation of China [81220108007, 81371314, 81171079]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China (grant nos. 81220108007, 81371314, and 81171079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AWAD IA, 1990, J NEUROSURG, V72, P839, DOI 10.3171/jns.1990.72.6.0839; BORDEN JA, 1995, J NEUROSURG, V82, P166, DOI 10.3171/jns.1995.82.2.0166; BROTT T, 1986, STROKE, V17, P1078, DOI 10.1161/01.STR.17.6.1078; BROWN RD, 1994, J NEUROSURG, V81, P531, DOI 10.3171/jns.1994.81.4.0531; Chung SJ, 2002, CEREBROVASC DIS, V13, P79, DOI 10.1159/000047755; Daniels DJ, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.4.FOCUS1335; Davies MA, 1996, J NEUROSURG, V85, P830, DOI 10.3171/jns.1996.85.5.0830; Duffau H, 1999, J NEUROSURG, V90, P78, DOI 10.3171/jns.1999.90.1.0078; Hamada Y, 1997, NEUROSURGERY, V40, P452, DOI 10.1097/00006123-199703000-00005; Hiramatsu M, 2014, NEUROL MED-CHIR, V54, P63, DOI 10.2176/nmc.st.2013-0172; Jiang P, 2012, NEUROL INDIA, V60, P94, DOI 10.4103/0028-3886.93612; JUVELA S, 1995, STROKE, V26, P1558, DOI 10.1161/01.STR.26.9.1558; Kawaguchi T, 2000, NEUROL MED-CHIR, V40, P366, DOI 10.2176/nmc.40.366; Li CH, 2014, J NEUROINTERV SURG, V6, P115, DOI 10.1136/neurintsurg-2012-010641; Lucas CD, 2006, SURG NEUROL, V66, pS2, DOI 10.1016/j.surneu.2006.02.040; Peng TM, 2014, J CLIN NEUROSCI, V21, P769, DOI 10.1016/j.jocn.2013.07.024; Piippo A, 2013, J NEUROSURG, V118, P923, DOI 10.3171/2012.11.JNS111604; Puffer RC, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2011.12.FOCUS11323; SASAKI H, 1988, ACTA NEUROCHIR, V90, P117, DOI 10.1007/BF01560564; Singh V, 2008, NEUROSURGERY, V62, P628, DOI 10.1227/01.neu.0000317311.69697.fc; Suh DC, 2005, STROKE, V36, P1134, DOI 10.1161/01.STR.0000166194.82027.63; Tsai LK, 2004, J NEUROL NEUROSUR PS, V75, P1639, DOI 10.1136/jnnp.2003.026583; Willinsky R, 1999, AM J NEURORADIOL, V20, P1031; Zhou JF, 2003, BIOMED ENVIRON SCI, V16, P295	24	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131235	10.1371/journal.pone.0131235	http://dx.doi.org/10.1371/journal.pone.0131235			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26120845	gold, Green Published, Green Submitted			2022-12-27	WOS:000358150400089
J	Mani, RJ; Metcalf, JA; Clinkenbeard, KD				Mani, Rinosh J.; Metcalf, Jessica Abbey; Clinkenbeard, Kenneth D.			Amblyomma americanum as a Bridging Vector for Human Infection with Francisella tularensis	PLOS ONE			English	Article							MALE DERMACENTOR-ANDERSONI; MOUNTAIN-SPOTTED-FEVER; LONE-STAR TICK; BORRELIA-BURGDORFERI; ANAPLASMA-MARGINALE; TULAREMIA; MISSOURI; ARKANSAS; EPIDEMIOLOGY; TRANSMISSION	The gamma-proteobacterium Francisella tularensis causes seasonal tick-transmitted tularemia outbreaks in natural rabbit hosts and incidental infections in humans in the south-central United States. Although Dermacentor variabilis is considered a primary vector for F. tularensis, Amblyomma americanum is the most abundant tick species in this endemic region. A systematic study of F. tularensis colonization of A. americanum was undertaken to better understand its potential to serve as an overwintering reservoir for F. tularensis and as a bridging vector for human infections. Colony-reared A. americanum were artificially fed F. tularensis subspecies holarctica strain LVS via glass capillaries and colonization levels determined. Capillary-fed larva and nymph were initially infected with 104 CFU/tick which declined prior to molting for both stages, but rebounded post-molting in nymphs and persisted in 53% at 103 to 108 CFU/nymph at 168 days post-capillary feeding (longest sampling time in the study). In contrast, only 18% of adults molted from colonized nymphs maintained LVS colonization at 101 to 105 CFU/adult at 168 days post-capillary feeding (longest sampling time). For adults, LVS initially colonized the gut and disseminated to salivary glands by 24 h and had an ID50 of <5CFU in mice. Francisella tularensis infected the ovaries of gravid females, but transmission to eggs was infrequent and transovarial transmission to hatched larvae was not observed. The prolonged persistence of F. tularensis in A. americanum nymphs supports A. americanum as an overwintering reservoir for F. tularensis from which seasonal epizootics may originate; however, although the rapid dissemination of F. tularensis from gut to salivary glands in adults A. americanum is compatible with intermittent feeding adult males acting as bridging vectors for incidental F. tularensis infections of humans, acquisition of F. tularensis by adults may be unlikely based on adult feeding preference for larger mammals which are not involved in maintenance of sylvatic tularemia.	[Mani, Rinosh J.; Metcalf, Jessica Abbey; Clinkenbeard, Kenneth D.] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA; [Mani, Rinosh J.] Oklahoma Anim Dis Diagnost Lab, Stillwater, OK USA	Oklahoma State University System; Oklahoma State University - Stillwater	Mani, RJ (corresponding author), Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA.	rinosh.mani@okstate.edu			Center for Veterinary Health Sciences, Oklahoma State University	Center for Veterinary Health Sciences, Oklahoma State University	The study was funded by the Center for Veterinary Health Sciences, Oklahoma State University.	Assal NR, 1968, J OKLA STATE MED ASS, V61, P120; BELL JF, 1945, J INFECT DIS, V76, P83, DOI 10.1093/infdis/76.2.83; Brown HE, 2011, AM J TROP MED HYG, V84, P411, DOI 10.4269/ajtmh.2011.10-0593; CALHOUN EL, 1954, AM J TROP MED HYG, V3, P360, DOI 10.4269/ajtmh.1954.3.360; CALHOUN EL, 1955, AM J TROP MED HYG, V4, P310, DOI 10.4269/ajtmh.1955.4.310; Coburn J, 2015, APPL ENVIRON MICROB, V81, P386, DOI 10.1128/AEM.02917-14; Eisen L, 2007, J MED ENTOMOL, V44, P389, DOI 10.1603/0022-2585(2007)44[389:ACFRRO]2.0.CO;2; Goodman J., 2005, TICK BORNE DIS HUMAN; HOPLA C E, 1960, South Med J, V53, P92, DOI 10.1097/00007611-196001000-00020; Hopla C.E., 1974, Advances vet Sci comp Med, V18, P25; HOPLA C. E., 1953, JOUR KANSAS ENT SOC, V26, P72; HOPLA CE, 1955, AM J HYG, V61, P371, DOI 10.1093/oxfordjournals.aje.a119761; HOPLA CE, 1953, AM J HYG, V58, P101, DOI 10.1093/oxfordjournals.aje.a119585; JAWORSKI DC, 1995, J INSECT PHYSIOL, V41, P369, DOI 10.1016/0022-1910(94)00107-R; Jellison WL, 1974, TULAREMIA IN N AM; Katavolos P, 1998, J INFECT DIS, V177, P1422, DOI 10.1086/517829; KOCAN KM, 1992, AM J VET RES, V53, P499; KOCAN KM, 1993, AM J VET RES, V54, P107; Kollars TM, 2000, EXP APPL ACAROL, V24, P631, DOI 10.1023/A:1026566301325; Kollars TM, 2000, J PARASITOL, V86, P1156, DOI 10.1645/0022-3395(2000)086[1156:HAASAO]2.0.CO;2; Kugeler KJ, 2009, CLIN INFECT DIS, V48, P863, DOI 10.1086/597261; Lennette EH, 1964, GEN PRINCIPLES UNDER; Maier TM, 2004, APPL ENVIRON MICROB, V70, P7511, DOI 10.1128/AEM.70.12.7511-7519.2004; Mani RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035441; MCCAHAN GR, 1962, AM J HYG, V75, P335, DOI 10.1093/oxfordjournals.aje.a120254; Petersen JM, 2010, FUTURE MICROBIOL, V5, P649, DOI 10.2217/FMB.10.17; Petersen JM, 2009, VET RES, V40, DOI 10.1051/vetres:2008045; PHILIP C. B., 1934, Public Health Reports, V49, P386, DOI 10.2307/4581119; PIESMAN J, 1987, J CLIN MICROBIOL, V25, P557, DOI 10.1128/JCM.25.3.557-558.1987; PIESMAN J, 1990, AM J TROP MED HYG, V42, P352, DOI 10.4269/ajtmh.1990.42.352; Sonenshine DE., 1991, BIOL TICKS; Spencer RR, 1923, PUBLIC HEALTH REP, V38, P333, DOI 10.2307/4576667; Versage JL, 2003, J CLIN MICROBIOL, V41, P5492, DOI 10.1128/JCM.41.12.5492-5499.2003	33	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130513	10.1371/journal.pone.0130513	http://dx.doi.org/10.1371/journal.pone.0130513			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121137	gold, Green Published, Green Submitted			2022-12-27	WOS:000358150400046
J	Tarkia, M; Saraste, A; Stark, C; Vahasilta, T; Savunen, T; Strandberg, M; Saunavaara, V; Tolvanen, T; Teuho, J; Teras, M; Metsala, O; Rinne, P; Heinonen, I; Savisto, N; Pietila, M; Saukko, P; Roivainen, A; Knuuti, J				Tarkia, Miikka; Saraste, Antti; Stark, Christoffer; Vahasilta, Tommi; Savunen, Timo; Strandberg, Marjatta; Saunavaara, Virva; Tolvanen, Tuula; Teuho, Jarmo; Teras, Mika; Metsala, Olli; Rinne, Petteri; Heinonen, Ilkka; Savisto, Nina; Pietila, Mikko; Saukko, Pekka; Roivainen, Anne; Knuuti, Juhani			[F-18]FDG Accumulation in Early Coronary Atherosclerotic Lesions in Pigs	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; F-18-FDG UPTAKE; ARTERY-DISEASE; MYOCARDIAL-INFARCTION; PLAQUE INFLAMMATION; LOW-CARBOHYDRATE; HIGH-FAT; PET/CT; F-18-FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE	Objective Inflammation is an important contributor to atherosclerosis progression. A glucose analogue F-18-fluorodeoxyglucose ([F-18]FDG) has been used to detect atherosclerotic inflammation. However, it is not known to what extent [F-18]FDG is taken up in different stages of atherosclerosis. We aimed to study the uptake of [F-18]FDG to various stages of coronary plaques in a pig model. Methods First, diabetes was caused by streptozotocin injections (50 mg/kg for 3 days) in farm pigs (n = 10). After 6 months on high-fat diet, pigs underwent dual-gated cardiac PET/CT to measure [F-18]FDG uptake in coronary arteries. Coronary segments (n = 33) were harvested for ex vivo measurement of radioactivity and autoradiography (ARG). Results Intimal thickening was observed in 16 segments and atheroma type plaques in 10 segments. Compared with the normal vessel wall, ARG showed 1.7 +/- 0.7 times higher [F-18]FDG accumulation in the intimal thickening and 4.1 +/- 2.3 times higher in the atheromas (P = 0.004 and P = 0.003, respectively). Ex vivo mean vessel-to-blood ratio was higher in segments with atheroma than those without atherosclerosis (2.6 +/- 1.2 vs. 1.3 +/- 0.7, P = 0.04). In vivo PET imaging showed the highest target-to-background ratio (TBR) of 2.7. However, maximum TBR was not significantly different in segments without atherosclerosis (1.1 +/- 0.5) and either intimal thickening (1.2 +/- 0.4, P = 1.0) or atheroma (1.6 +/- 0.6, P = 0.4). Conclusions We found increased uptake of [F-18]FDG in coronary atherosclerotic lesions in a pig model. However, uptake in these early stage lesions was not detectable with in vivo PET imaging. Further studies are needed to clarify whether visible [F-18]FDG uptake in coronary arteries represents more advanced, highly inflamed plaques.	[Tarkia, Miikka; Saraste, Antti; Saunavaara, Virva; Tolvanen, Tuula; Teuho, Jarmo; Teras, Mika; Metsala, Olli; Rinne, Petteri; Heinonen, Ilkka; Savisto, Nina; Roivainen, Anne; Knuuti, Juhani] Univ Turku, Turku PET Ctr, Turku, Finland; [Tarkia, Miikka; Saraste, Antti; Saunavaara, Virva; Tolvanen, Tuula; Teuho, Jarmo; Teras, Mika; Metsala, Olli; Rinne, Petteri; Heinonen, Ilkka; Savisto, Nina; Roivainen, Anne; Knuuti, Juhani] Turku Univ Hosp, FIN-20520 Turku, Finland; [Stark, Christoffer; Vahasilta, Tommi; Savunen, Timo] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Saraste, Antti; Stark, Christoffer; Vahasilta, Tommi; Savunen, Timo; Strandberg, Marjatta; Pietila, Mikko] Turku Univ Hosp, Ctr Heart, FIN-20520 Turku, Finland; [Saraste, Antti; Stark, Christoffer; Vahasilta, Tommi; Savunen, Timo; Strandberg, Marjatta; Pietila, Mikko] Univ Turku, Turku, Finland; [Saukko, Pekka] Univ Turku, Dept Forens Med, Turku, Finland; [Saraste, Antti] Univ Turku, Inst Clin Med, Turku, Finland	University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; University of Turku	Tarkia, M (corresponding author), Univ Turku, Turku PET Ctr, Turku, Finland.	miikka.tarkia@tyks.fi	Knuuti, Juhani/AAA-7472-2019; Rinne, Petteri/N-7099-2019; Saunavaara, Virva/M-5594-2016	Knuuti, Juhani/0000-0003-3156-9593; Saunavaara, Virva/0000-0001-7858-5924; Teuho, Jarmo/0000-0001-9401-0725; Roivainen, Anne/0000-0002-4006-7977	Tekes - Finnish Funding Agency for Technology and Innovation; Finnish Cultural Foundation; Finnish Foundation for Cardiovascular Research; Turku University Hospital; Varsinais-Suomi Regional fund; Academy of Finland; University of Turku; Abo Akademi University; University of Turku Graduate School Drug Research Doctoral Programme	Tekes - Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Foundation for Cardiovascular Research; Turku University Hospital; Varsinais-Suomi Regional fund; Academy of Finland(Academy of Finland); University of Turku; Abo Akademi University; University of Turku Graduate School Drug Research Doctoral Programme	The study was funded by Tekes - the Finnish Funding Agency for Technology and Innovation and the Finnish Cultural Foundation; Finnish Foundation for Cardiovascular Research; Turku University Hospital; Finnish Cultural Foundation, Varsinais-Suomi Regional fund and it was conducted in the Finnish Centre of Excellence in Cardiovascular and Metabolic Disease supported by the Academy of Finland, University of Turku, Turku University Hospital and Abo Akademi University. Miikka Tarkia is a PhD student supported by the University of Turku Graduate School Drug Research Doctoral Programme.	Alexanderson E, 2008, J NUCL CARDIOL, V15, P841, DOI [10.1016/j.nuclcard.2008.06.014, 10.1007/BF03007367]; Bucerius J, 2014, EUR J NUCL MED MOL I, V41, P369, DOI 10.1007/s00259-013-2569-6; Chatzizisis YS, 2008, CIRCULATION, V117, P993, DOI 10.1161/CIRCULATIONAHA.107.695254; Cheng VY, 2012, J NUCL MED, V53, P575, DOI 10.2967/jnumed.111.097550; Dunphy MPS, 2005, J NUCL MED, V46, P1278; Gerrity RG, 2001, DIABETES, V50, P1654, DOI 10.2337/diabetes.50.7.1654; Kajander S, 2010, CIRCULATION, V122, P603, DOI 10.1161/CIRCULATIONAHA.109.915009; Kokki T, 2010, J NUCL CARDIOL, V17, P71, DOI 10.1007/s12350-009-9163-0; Laitinen I, 2009, EUR J NUCL MED MOL I, V36, P73, DOI 10.1007/s00259-008-0919-6; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Nesterov SV, 2009, EUR J NUCL MED MOL I, V36, P1594, DOI 10.1007/s00259-009-1143-8; Orbay H, 2013, THERANOSTICS, V3, P894, DOI 10.7150/thno.5506; Rissanen TT, 2013, AM J PHYSIOL-HEART C, V305, pH1297, DOI 10.1152/ajpheart.00561.2013; Rogers IS, 2010, JACC-CARDIOVASC IMAG, V3, P388, DOI 10.1016/j.jcmg.2010.01.004; Rudd JHF, 2010, J AM COLL CARDIOL, V55, P2527, DOI 10.1016/j.jacc.2009.12.061; Saam T, 2010, EUR J NUCL MED MOL I, V37, P1203, DOI 10.1007/s00259-010-1432-2; Sahni D, 2008, INDIAN J MED RES, V127, P564; Silvola JMU, 2011, JACC-CARDIOVASC IMAG, V4, P1294, DOI 10.1016/j.jcmg.2011.07.009; Tawakol A, 2006, J AM COLL CARDIOL, V48, P1818, DOI 10.1016/j.jacc.2006.05.076; Teramoto N, 2011, J NUCL MED, V52, P761, DOI 10.2967/jnumed.110.084848; Teras M, 2010, EUR J NUCL MED MOL I, V37, P505, DOI 10.1007/s00259-009-1252-4; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Williams G, 2008, AM J ROENTGENOL, V190, pW151, DOI 10.2214/AJR.07.2409; Williams G, 2009, NUCL MED COMMUN, V30, P287, DOI 10.1097/MNM.0b013e328328bfc3; Wykrzykowska J, 2009, J NUCL MED, V50, P563, DOI 10.2967/jnumed.108.055616; Zhang Zhuangyu, 2006, BMC Nucl Med, V6, P3, DOI 10.1186/1471-2385-6-3	26	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131332	10.1371/journal.pone.0131332	http://dx.doi.org/10.1371/journal.pone.0131332			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26120829	Green Published, Green Submitted, gold			2022-12-27	WOS:000358150400098
J	Tizioto, PC; Kim, J; Seabury, CM; Schnabel, RD; Gershwin, LJ; Van Eenennaam, AL; Toaff-Rosenstein, R; Neibergs, HL; Taylor, JF				Tizioto, Polyana C.; Kim, JaeWoo; Seabury, Christopher M.; Schnabel, Robert D.; Gershwin, Laurel J.; Van Eenennaam, Alison L.; Toaff-Rosenstein, Rachel; Neibergs, Holly L.; Taylor, Jeremy F.		Bovine Resp Dis Complex Coordinate	Immunological Response to Single Pathogen Challenge with Agents of the Bovine Respiratory Disease Complex: An RNA-Sequence Analysis of the Bronchial Lymph Node Transcriptome	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; TOLL-LIKE RECEPTORS; EXPRESSION ANALYSIS; PATHWAYS; CATTLE; CALVES; CELLS; SEQ; FEEDLOTS; TOPHAT	Susceptibility to bovine respiratory disease (BRD) is multi-factorial and is influenced by stress in conjunction with infection by both bacterial and viral pathogens. While vaccination is broadly used in an effort to prevent BRD, it is far from being fully protective and cases diagnosed from a combination of observed clinical signs without any attempt at identifying the causal pathogens are usually treated with antibiotics. Dairy and beef cattle losses from BRD are profound worldwide and genetic studies have now been initiated to elucidate host loci which underlie susceptibility with the objective of enabling molecular breeding to reduce disease prevalence. In this study, we employed RNA sequencing to examine the bronchial lymph node transcriptomes of controls and beef cattle which had individually been experimentally challenged with bovine respiratory syncytial virus, infectious bovine rhinotracheitis, bovine viral diarrhea virus, Pasteurella multocida, Mannheimia haemolytica or Mycoplasma bovis to identify the genes that are involved in the bovine immune response to infection. We found that 142 differentially expressed genes were located in previously described quantitative trait locus regions associated with risk of BRD. Mutations affecting the expression or amino acid composition of these genes may affect disease susceptibility and could be incorporated into molecular breeding programs. Genes involved in innate immunity were generally found to be differentially expressed between the control and pathogen-challenged animals suggesting that variation in these genes may lead to a heritability of susceptibility that is pathogen independent. However, we also found pathogen-specific expression profiles which suggest that host genetic variation for BRD susceptibility is pathogen dependent.	[Tizioto, Polyana C.] Embrapa Southeast Livestock, Sao Carlos, SP, Brazil; [Tizioto, Polyana C.; Kim, JaeWoo; Schnabel, Robert D.; Taylor, Jeremy F.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Seabury, Christopher M.] Texas A&M Univ, Coll Vet Med, Dept Vet Pathol, College Stn, TX 77843 USA; [Gershwin, Laurel J.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Van Eenennaam, Alison L.; Toaff-Rosenstein, Rachel] Univ Calif Davis, Coll Agr, Dept Anim Sci, Davis, CA 95616 USA; [Neibergs, Holly L.] Washington State Univ, Coll Vet Med, Dept Anim Sci, Pullman, WA 99164 USA	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Missouri System; University of Missouri Columbia; Texas A&M University System; Texas A&M University College Station; University of California System; University of California Davis; University of California System; University of California Davis; Washington State University	Taylor, JF (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.	taylorjerr@missouri.edu	Van Eenennaam, Alison L/G-3481-2011	Van Eenennaam, Alison L/0000-0003-1562-162X	Agriculture and Food Research Initiative competitive grant from the United States Department of Agriculture National Institute of Food and Agriculture [2011-68004-30367]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil [12/01502-7]	Agriculture and Food Research Initiative competitive grant from the United States Department of Agriculture National Institute of Food and Agriculture; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This project was supported by Agriculture and Food Research Initiative competitive grant number 2011-68004-30367 from the United States Department of Agriculture National Institute of Food and Agriculture (http://www.csrees.usda.gov/). PCT was supported by scholarship #12/01502-7 from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alvarez B, 2011, CURR OPIN PULM MED, V17, P172, DOI 10.1097/MCP.0b013e3283455c0b; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Chapple RH, 2013, PHYSIOL GENOMICS, V45, P301, DOI 10.1152/physiolgenomics.00128.2012; Civelek M, 2014, NAT REV GENET, V15, P34, DOI 10.1038/nrg3575; Claussnitzer M, 2014, CELL, V156, P343, DOI 10.1016/j.cell.2013.10.058; COLLIE DDS, 1992, BRIT VET J, V148, P33, DOI 10.1016/0007-1935(92)90064-8; Cusack PMV, 2003, AUST VET J, V81, P480, DOI 10.1111/j.1751-0813.2003.tb13367.x; Decaro N, 2008, J VET DIAGN INVEST, V20, P28, DOI 10.1177/104063870802000105; Delmastro-Greenwood MM, 2013, AM J CLIN EXP IMMUNO, V2, P30; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Edwards TA, 2010, VET CLIN N AM-FOOD A, V26, P273, DOI 10.1016/j.cvfa.2010.03.005; Ellis JA, 2001, VET CLIN N AM-FOOD A, V17, P535, DOI 10.1016/S0749-0720(15)30005-0; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Gagea MI, 2006, J VET DIAGN INVEST, V18, P18, DOI 10.1177/104063870601800104; Gershwin LJ, 1998, VACCINE, V16, P1225, DOI 10.1016/S0264-410X(98)80123-0; Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Huan TX, 2013, ARTERIOSCL THROM VAS, V33, P1427, DOI 10.1161/ATVBAHA.112.300112; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Jones C, 2010, VET CLIN N AM-FOOD A, V26, P303, DOI 10.1016/j.cvfa.2010.04.007; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lacy P, 2011, BLOOD, V118, P9, DOI 10.1182/blood-2010-08-265892; LASKEY J, 1988, EXP CELL RES, V176, P87, DOI 10.1016/0014-4827(88)90123-1; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lunnon K, 2012, J ALZHEIMERS DIS, V30, P685, DOI 10.3233/JAD-2012-111592; McGuirk SM, 2008, VET CLIN N AM-FOOD A, V24, P139, DOI 10.1016/j.cvfa.2007.10.003; Miles Delbert G., 2009, Animal Health Research Reviews, V10, P101, DOI 10.1017/S1466252309990090; Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706; Neibergs HL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1164; Preiss S, 2008, J VIRAL HEPATITIS, V15, P888, DOI 10.1111/j.1365-2893.2008.01001.x; Reghunathan R, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-2; Rice J. A., 2007, Animal Health Research Reviews, V8, P117, DOI 10.1017/S1466252307001375; Salinas GF, 2013, ANN RHEUM DIS, V72, P1037, DOI 10.1136/annrheumdis-2011-201270; Salojin K, 2007, J LEUKOCYTE BIOL, V81, P860, DOI 10.1189/jlb.1006639; SiSSon S., 1914, ANATOMY DOMESTIC ANI, VSecond; Snowder GD, 2006, J ANIM SCI, V84, P1999, DOI 10.2527/jas.2006-046; Srikumaran Subramaniam, 2007, Animal Health Research Reviews, V8, P215, DOI 10.1017/S1466252307001326; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valbuena G, 2003, AM J PATHOL, V163, P1357, DOI 10.1016/S0002-9440(10)63494-3; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Wickramarachchi DC, 2010, AUTOIMMUNITY, V43, P64, DOI 10.3109/08916930903374634; Xagorari Angeliki, 2008, Open Microbiol J, V2, P49, DOI 10.2174/1874285800802010049; Zhang XY, 2009, CELL MICROBIOL, V11, P1624, DOI 10.1111/j.1462-5822.2009.01353.x; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102; Zhou L, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-308	55	35	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131459	10.1371/journal.pone.0131459	http://dx.doi.org/10.1371/journal.pone.0131459			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121276	Green Submitted, Green Published, gold			2022-12-27	WOS:000358150400110
J	Bhanothu, V; Lakshmi, V; Theophilus, JP; Rozati, R; Badhini, P; Vijayalaxmi, B				Bhanothu, Venkanna; Lakshmi, Vemu; Theophilus, Jane P.; Rozati, Roya; Badhini, Prabhakar; Vijayalaxmi, Boda			Investigation of Toll-Like Receptor-2 (2258G/A) and Interferon Gamma (+874T/A) Gene Polymorphisms among Infertile Women with Female Genital Tuberculosis	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; GENOME-WIDE ASSOCIATION; NATURAL-KILLER-CELLS; UTERINE NK CELLS; MYCOBACTERIUM-TUBERCULOSIS; IFN-GAMMA; REPRODUCTIVE-TRACT; CYTOKINE/CHEMOKINE PRODUCTION; EXTRAPULMONARY TUBERCULOSIS; ENDOMETRIAL TUBERCULOSIS	Background Toll-like receptor 2 (TLR2) and interferon-gamma (IFN-gamma) coordinate with a diverse array of cellular programs through the transcriptional regulation of immunologically relevant genes and play an important role in immune system, reproductive physiology and basic pathology. Alterations in the functions of TLR2 2258G (guanine)/A, IFN-gamma (+874T/A) and signalling molecules that result from polymorphisms are often associated with susceptibility or resistance, which may, in turn, establish the innate host response to various infectious diseases. Presently, we proposed to investigate the risk of common single nucleotide polymorphism (SNP) of TLR2 and IFN-gamma genes, for their effect on infertility in women with female genital tuberculosis (FGTB) and healthy women as controls. Methodology/Principal Findings Genotyping of TLR2 and IFN-gamma gene polymorphisms was performed by amplification refractory mutation system multi-gene/multi-primer polymerase chain reaction followed by restriction fragment length polymorphism in 175 FGTB patients and 100 healthy control women (HCW). The TLR2 polymorphism [adenine (A) allele] was observed in 57.7 and 58.0% of FGTB patients and HCW, respectively. The IFN-gamma (+874T/A) polymorphism (A allele) was significant in 74.3 and 71.0% of FGTB patients and HCW, respectively, while the odds ratios for the AA and TA genotypes for predisposition of FGTB were found to be 0.304 and 1.650 in HCW, respectively. The SNP of TLR2 was not associated with FGTB but the SNP of IFN-gamma was found to be associated with mycobacteria infections and to induce infertility. Conclusions/Significance At present, we hypothesize that infertile women with FGTB and HCW without tuberculosis (TB) have identical frequency of TLR variants, which may be adequate in the production of IFN-gamma in response to Mycobacterium tuberculosis infections. Thus, the study appears to be the first of its kind reporting a mutation in the IFN-gamma gene [+874 T (thymine) to A] responsible for susceptibility to TB infections and further inducing infertility.	[Bhanothu, Venkanna; Theophilus, Jane P.] Osmania Univ, Univ Coll Sci, Dept Zool, Hyderabad, Telangana State, India; [Lakshmi, Vemu] Nizams Inst Med Sci, Dept Microbiol, Hyderabad, Telangana State, India; [Rozati, Roya; Vijayalaxmi, Boda] Owaisi Hosp & Res Ctr, Dept Obstet & Gynecol, Hyderabad, Telangana State, India; [Badhini, Prabhakar] Osmania Univ, Dept Genet, Univ Coll Sci, Hyderabad, Telangana State, India	Osmania University; Nizam's Institute of Medical Sciences; Osmania University	Bhanothu, V (corresponding author), Osmania Univ, Univ Coll Sci, Dept Zool, Hyderabad, Telangana State, India.	venkanna_82@yahoo.co.uk	Bhanothu, Venkanna/AAN-8183-2020; Bhanothu, Venkanna/J-2164-2019	Bhanothu, Venkanna/0000-0002-2591-3426; 	UGC-BSR Scheme, UGC, Government of India	UGC-BSR Scheme, UGC, Government of India	We are thankful to Prof. Bannoth Reddya Naik, Dept of Zoology, National Service Scheme (NSS) Coordinator, OU, Hyderabad for his valuable guidance. We are thankful to the Centre for Quality Control and Quantitative Methods, University College of Science, Osmania University, Hyderabad for providing the consultative services in data analysis and required software packages. We are also grateful to UGC-BSR Scheme, UGC, Government of India for providing research fellowship in sciences for meritorious students. We are also thankful to anonymous reviewers for their supportive comments.	Abrahams VM, 2005, PLACENTA, V26, P540, DOI 10.1016/j.placenta.2004.08.010; Ain R, 2003, DEV BIOL, V260, P176, DOI 10.1016/S0012-1606(03)00210-0; Amjadi F, 2014, IRAN J REPROD MED, V12, P28; Ashkar AA, 2001, SEMIN IMMUNOL, V13, P235, DOI 10.1006/smim.2000.0319; Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259; Azad AK, 2012, INFECT IMMUN, V80, P3343, DOI 10.1128/IAI.00443-12; Banerjee S, 2005, J CLIN ENDOCR METAB, V90, P944, DOI 10.1210/jc.2004-1113; Bansal C, 2012, INDIAN J MED SPEC, V3, P91, DOI 10.7713/ijms.2012.0020; Ben Youssef L B, 1985, J Gynecol Obstet Biol Reprod (Paris), V14, P59; Bhanothu V, 2014, EUR J CLIN MICROBIOL, V33, P1937, DOI 10.1007/s10096-014-2164-1; Bhanothu V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098005; Bhanothu Venkanna, 2013, AM J MED BIOL RES, V1, P1; Bhanu NV, 2005, J MED MICROBIOL, V54, P927, DOI 10.1099/jmm.0.45943-0; Biswas Debasis, 2009, BMC Res Notes, V2, P162, DOI 10.1186/1756-0500-2-162; Bochud PY, 2003, J IMMUNOL, V170, P3451, DOI 10.4049/jimmunol.170.7.3451; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Chakrabarti A. K., 1998, Indian Journal of Tuberculosis, V45, P101; Chen L, 2012, WORLD J GASTROENTERO, V18, P6856, DOI 10.3748/wjg.v18.i46.6856; Chowdhury N N, 1996, J Indian Med Assoc, V94, P345; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Corr SC, 2009, J INNATE IMMUN, V1, P350, DOI 10.1159/000200774; Cotter TW, 1997, INFECT IMMUN, V65, P2145, DOI 10.1128/IAI.65.6.2145-2152.1997; Daher S, 2003, J REPROD IMMUNOL, V58, P69, DOI 10.1016/S0165-0378(02)00059-1; Dalgic N, 2011, HUM IMMUNOL, V72, P440, DOI 10.1016/j.humimm.2011.02.001; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Dam P, 2006, GYNECOL OBSTET INVES, V61, P223, DOI 10.1159/000091498; Darville T, 2003, J IMMUNOL, V171, P6187, DOI 10.4049/jimmunol.171.11.6187; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; Eriksson M, 2006, J IMMUNOL, V176, P6219, DOI 10.4049/jimmunol.176.10.6219; Fazeli A, 2005, HUM REPROD, V20, P1372, DOI 10.1093/humrep/deh775; Figueroa-Damian R, 2001, ARCH MED RES, V32, P66, DOI 10.1016/S0188-4409(00)00266-6; FigueroaDamian R, 1996, INT J FERTIL MENOP S, V41, P430; Fluhr H, 2009, FERTIL STERIL, V91, P2131, DOI 10.1016/j.fertnstert.2008.04.015; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Fricke I, 2006, J IMMUNOL, V176, P5173, DOI 10.4049/jimmunol.176.9.5173; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Ganoza CA, 2008, J MED MICROBIOL, V57, P1094, DOI 10.1099/jmm.0.2008/001339-0; Gautam JK, 2006, J BIOL CHEM, V281, P30132, DOI 10.1074/jbc.M602057200; Girling JE, 2007, IMMUNOL CELL BIOL, V85, P481, DOI 10.1038/sj.icb.7100086; GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90; Guide SV, 2002, INFECT DIS CLIN N AM, V16, P163, DOI 10.1016/S0891-5520(03)00051-5; Gungorduk Kemal, 2007, Infect Dis Obstet Gynecol, V2007, P27028; HARAPAN H, 2013, EGYPT J MED HUM GEN, V14, P1, DOI DOI 10.1016/J.EJMHG.2012.08.003; Hart BE, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/415057; Henao MI, 2006, TUBERCULOSIS, V86, P11, DOI 10.1016/j.tube.2005.03.001; Heywood Shirley, 1999, Papua New Guinea Medical Journal, V42, P63; Hill AVS, 2001, ANNU REV GENOM HUM G, V2, P373, DOI 10.1146/annurev.genom.2.1.373; Jahromi BN, 2001, INT J GYNECOL OBSTET, V75, P269, DOI 10.1016/S0020-7292(01)00494-5; Jana N, 1999, NEW ENGL J MED, V341, P645, DOI 10.1056/NEJM199908263410903; Jindal UN, 2012, HUM REPROD, V27, P1368, DOI 10.1093/humrep/des076; Kassim I., 2004, SHERRIS MED MICROBIO, V4th; Kent PT, 1985, GUIDE LEVEL 3 LAB; Khan Nawaz, 2005, Journal of Postgraduate Medical Institute, V19, P97; Koga K, 2010, AM J REPROD IMMUNOL, V63, P587, DOI 10.1111/j.1600-0897.2010.00848.x; Kothari A, 2006, EUR J OBSTET GYN R B, V126, P48, DOI 10.1016/j.ejogrb.2005.07.025; LEVIN M, 1995, LANCET, V345, P79, DOI 10.1016/S0140-6736(95)90059-4; Lio D, 2002, EUR J IMMUNOGENET, V29, P371, DOI 10.1046/j.1365-2370.2002.00327.x; Lopes MQP, 2013, CURRENT ISSUES DIAGN, P79; Lopez-Maderuelo D, 2003, AM J RESP CRIT CARE, V167, P970, DOI 10.1164/rccm.200205-438BC; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Mahasirimongkol S, 2012, J HUM GENET, V57, P363, DOI 10.1038/jhg.2012.35; Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694; MARANA R, 1991, INT J FERTIL, V36, P104; Mares M, 2009, Roum Arch Microbiol Immunol, V68, P171; Morre SA, 2003, J INFECT DIS, V187, P341, DOI 10.1086/346044; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; MURRAY HW, 1991, INFECT IMMUN, V59, P4684, DOI 10.1128/IAI.59.12.4684-4686.1991; National Committee for Clinical Laboratory Standards, 2001, APPR GUID PROT LAB W; NAZ RK, 1995, J REPROD IMMUNOL, V29, P105, DOI 10.1016/0165-0378(95)00936-F; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703; Ojo BA, 2008, TROP DOCT, V38, P3, DOI 10.1258/td.2007.052090; Oliveira-Nascimento L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00079; Pacheco AG, 2008, HUM GENET, V123, P477, DOI 10.1007/s00439-008-0497-5; Pant SD, 2008, DEV BIOLOGICALS, V132, P247, DOI 10.1159/000317167; Parikh FR, 1997, FERTIL STERIL, V67, P497, DOI 10.1016/S0015-0282(97)80076-3; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Patni S, 2007, BJOG-INT J OBSTET GY, V114, P1326, DOI 10.1111/j.1471-0528.2007.01488.x; Platt JS, 1998, J LEUKOCYTE BIOL, V64, P393, DOI 10.1002/jlb.64.3.393; Png E, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-5; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1; Quayle AJ, 2002, J REPROD IMMUNOL, V57, P61, DOI 10.1016/S0165-0378(02)00019-0; Qureshi R. N., 2001, JPMA Journal of the Pakistan Medical Association, V51, P16; Rajamaheshwari N., 2009, IND J MED MICROBIO, V27, P361, DOI 10.4103/0255-0857.55461; Raut VS, 2001, INT J GYNECOL OBSTET, V72, P165, DOI 10.1016/S0020-7292(00)00328-3; Reeta Mani, 2003, Indian Journal of Tuberculosis, V50, P161; Reiling N, 2002, J IMMUNOL, V169, P3480, DOI 10.4049/jimmunol.169.7.3480; Rodrigues M. N., 2013, Open Journal of Animal Sciences, V3, P138, DOI 10.4236/ojas.2013.32021; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Rossouw M, 2003, LANCET, V361, P1871, DOI 10.1016/S0140-6736(03)13491-5; Roth A, 2010, P NATL ACAD SCI USA, V107, P19502, DOI 10.1073/pnas.1008178107; SAITO S, 1993, INT IMMUNOL, V5, P559, DOI 10.1093/intimm/5.5.559; Samuels DC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003929; Sanchez E, 2004, TISSUE ANTIGENS, V63, P54, DOI 10.1111/j.1399-0039.2004.00162.x; Satge D, 2013, ANAL SOMATIC MUTATIO, DOI [10.1002/9780470015902.a0024465, DOI 10.1002/9780470015902.A0024465]; Schaefer TM, 2004, IMMUNOLOGY, V112, P428, DOI 10.1111/j.1365-2567.2004.01898.x; Scherban M, 2008, EUR J SEXOL SEXUA S1, V17, pS163; Seaward AVC, 2010, HUM REPROD, V25, P2829, DOI 10.1093/humrep/deq236; Selvaraj P, 2010, TUBERCULOSIS, V90, P306, DOI 10.1016/j.tube.2010.08.001; Sharma JB, 2010, INT J GYNECOL OBSTET, V109, P242, DOI 10.1016/j.ijgo.2010.01.011; Sheehan D, 1980, THEORY PRACTICE HIST, P235; Shimada M, 2008, DEVELOPMENT, V135, P2001, DOI 10.1242/dev.020461; SIMON HB, 1977, AM J MED, V63, P410, DOI 10.1016/0002-9343(77)90279-0; Singh G.K, 2013, J NOBEL MED COLL, V2, P9, DOI DOI 10.4172/2324-9110.1000114; Singh S, 2010, TROP DOCT, V40, P125, DOI 10.1258/td.2009.090423; SKERRETT SJ, 1994, AM J RESP CRIT CARE, V149, P50, DOI 10.1164/ajrccm.149.1.8111597; Sreeramareddy CT, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-8; Swiderek WP, 2006, FOLIA MICROBIOL, V51, P647, DOI 10.1007/BF02931633; TB CARE I, 2014, INT STAND TUB CAR IS; Thangappah RBP, 2011, INDIAN J MED RES, V134, P40; Ting LM, 1999, J IMMUNOL, V163, P3898; Tripathy SN, 2002, INT J GYNECOL OBSTET, V76, P159, DOI 10.1016/S0020-7292(01)00525-2; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; VARMA TR, 1991, INT J GYNECOL OBSTET, V35, P1, DOI 10.1016/0020-7292(91)90056-B; Venkanna B., 2012, INT J CURR RES REV, V4, P130; Wang QL, 2001, INFECT IMMUN, V69, P2270, DOI 10.1128/IAI.69.4.2270-2276.2001; Wang Xingping, 2007, Journal of Genetics and Genomics, V34, P406, DOI 10.1016/S1673-8527(07)60044-7; Weigert K., 1904, Z WISS MIKROSK, V2, P1; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Witkin SS, 2010, J REPROD IMMUNOL, V84, P171, DOI 10.1016/j.jri.2009.11.005; Wochrle T, 2008, CYTOKINE, V41, P322, DOI 10.1016/j.cyto.2007.12.006; Woods DC, 2009, REPRODUCTION, V137, P987, DOI 10.1530/REP-08-0320; World Health Organization (Country Office for India), 2014, STAND TB CAR IND STC; Wu Q, 2007, AM J PHYSIOL-LUNG C, V292, pL1064, DOI 10.1152/ajplung.00301.2006; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351; Zhang JH, 2007, INT IMMUNOPHARMACOL, V7, P588, DOI 10.1016/j.intimp.2006.12.014; Zhang LP, 2009, ANIM BIOTECHNOL, V20, P87, DOI 10.1080/10495390902873096; Zhang Z, 2006, CELL MOL LIFE SCI, V63, P2901, DOI 10.1007/s00018-006-6189-1	135	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130273	10.1371/journal.pone.0130273	http://dx.doi.org/10.1371/journal.pone.0130273			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114934	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500063
J	Jones, SP; Franco, NF; Varney, B; Sundaram, G; Brown, DA; de Bie, J; Lim, CK; Guillemin, GJ; Brew, BJ				Jones, Simon P.; Franco, Nunzio F.; Varney, Bianca; Sundaram, Gayathri; Brown, David A.; de Bie, Josien; Lim, Chai K.; Guillemin, Gilles J.; Brew, Bruce J.			Expression of the Kynurenine Pathway in Human Peripheral Blood Mononuclear Cells: Implications for Inflammatory and Neurodegenerative Disease	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE ACTIVITY; QUINOLINIC ACID; T-CELL; DENDRITIC CELLS; TRYPTOPHAN-METABOLISM; MULTIPLE-SCLEROSIS; HUMAN MACROPHAGES; 3-HYDROXYKYNURENINE; INHIBITION; INTERFERON	The kynurenine pathway is a fundamental mechanism of immunosuppression and peripheral tolerance. It is increasingly recognized as playing a major role in the pathogenesis of a wide variety of inflammatory, neurodegenerative and malignant disorders. However, the temporal dynamics of kynurenine pathway activation and metabolite production in human immune cells is currently unknown. Here we report the novel use of flow cytometry, combined with ultra high-performance liquid chromatography and gas chromatography-mass spectrometry, to sensitively quantify the intracellular expression of three key kynurenine pathway enzymes and the main kynurenine pathway metabolites in a time-course study. This is the first study to show that up-regulation of indoleamine 2,3-dioxygenase (IDO-1), kynurenine 3-monoxygenase (KMO) and quinolinate phosphoribosyltransferase (QPRT) is lacking in lymphocytes treated with interferon gamma. In contrast, peripheral monocytes showed a significant elevation of kynurenine pathway enzymes and metabolites when treated with interferon gamma. Expression of IDO-1, KMO and QPRT correlated significantly with activation of the kynurenine pathway (kynurenine: tryptophan ratio), quinolinic acid concentration and production of the monocyte derived, pro-inflammatory immune response marker: neopterin. Our results also describe an original and sensitive methodological approach to quantify kynurenine pathway enzyme expression in cells. This has revealed further insights into the potential role of these enzymes in disease processes.	[Jones, Simon P.; Franco, Nunzio F.; Varney, Bianca; Sundaram, Gayathri; Brown, David A.; Guillemin, Gilles J.; Brew, Bruce J.] St Vincents Ctr Appl Med Res, Peter Duncan Neurosci Res Unit, Sydney, NSW, Australia; [Jones, Simon P.; Brown, David A.; Brew, Bruce J.] UNSW, Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia; [de Bie, Josien; Lim, Chai K.; Guillemin, Gilles J.] Macquarie Univ, Fac Med & Hlth Sci, Neuroinflammat Grp, Sydney, NSW 2109, Australia; [Brew, Bruce J.] St Vincents Hosp, Dept Neurol, Sydney, NSW 2010, Australia	University of New South Wales Sydney; Macquarie University; St Vincents Hospital Sydney	Jones, SP (corresponding author), St Vincents Ctr Appl Med Res, Peter Duncan Neurosci Res Unit, Sydney, NSW, Australia.	simon.jones@unsw.edu.au	Lim, Edwin/R-5001-2019; Guillemin, Gilles J/C-3878-2015; Sundaram, Gayathri/AAN-3599-2020	Lim, Edwin/0000-0003-3526-8405; Guillemin, Gilles J/0000-0001-8105-4470; Varney, Bianca/0000-0002-0611-6018; Sundaram, Gayathri/0000-0001-8610-1598; Brown, David/0000-0003-1382-9419; brew, bruce/0000-0003-0622-1392	Peter Duncan Neurosciences Research Unit; Multiple Sclerosis Research Australia (MSRA) [11010]; Australian Research Council (ARC) [FT120100397]; National Health and Medical Research Council (NHMRC); Ramaciotti establishment grant; Macquarie University; UHPLC and GC-MS	Peter Duncan Neurosciences Research Unit; Multiple Sclerosis Research Australia (MSRA); Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Ramaciotti establishment grant; Macquarie University; UHPLC and GC-MS	This work was funded by the Peter Duncan Neurosciences Research Unit (BJB), Multiple Sclerosis Research Australia (MSRA) Grant number 11010 (BJB) http://www.msra.org.au/, Australian Research Council (ARC) Future Fellowship number FT120100397 (GJG) http://www.arc.gov.au/, National Health and Medical Research Council (NHMRC) Project Grant and Fellowship (DAB) http://www.nhmrc.gov.au/, a Ramaciotti establishment grant, and a Macquarie University infrastructure grant funded the UHPLC and GC-MS equipment used in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball HJ, 2007, GENE, V396, P203, DOI 10.1016/j.gene.2007.04.010; Belladonna ML, 2006, J IMMUNOL, V177, P130, DOI 10.4049/jimmunol.177.1.130; Braidy N, 2009, INT J TRYPTOPHAN RES, V2, P61; CARLIN JM, 1989, J LEUKOCYTE BIOL, V45, P29, DOI 10.1002/jlb.45.1.29; CARLIN JM, 1987, J IMMUNOL, V139, P2414; Catherine U, 2003, NATURE MED; Chen YQ, 2009, INT J TRYPTOPHAN RES, V2, P1; Chen YQ, 2010, NEUROTOX RES, V18, P132, DOI 10.1007/s12640-009-9129-7; Chiarugi A, 2001, J NEUROIMMUNOL, V120, P190, DOI 10.1016/S0165-5728(01)00418-0; Connor TJ, 2008, NEUROSCI LETT, V441, P29, DOI 10.1016/j.neulet.2008.06.007; Croitoru-Lamoury J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014698; Dai W, 1990, REGULATION INDOLEAMI; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Fujigaki S, 1998, ARCH BIOCHEM BIOPHYS, V358, P329, DOI 10.1006/abbi.1998.0861; Goldstein LE, 2000, BIOCHEMISTRY-US, V39, P7266, DOI 10.1021/bi992997s; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Guidetti P, 2003, ADV EXP MED BIOL, V527, P137; Guidetti P, 1999, EUR J NEUROSCI, V11, P3857, DOI 10.1046/j.1460-9568.1999.00806.x; Guillemin GJ, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-16; Guillemin GJ, 2005, NEUROPATH APPL NEURO, V31, P395, DOI 10.1111/j.1365-2990.2005.00655.x; Guillemin GJ, 2005, GLIA, V49, P15, DOI 10.1002/glia.20090; Guillemin GJ, 2003, NEUROREPORT, V14, P2311, DOI 10.1097/00001756-200312190-00005; Guillemin GJ, 2001, J INTERF CYTOK RES, V21, P1097, DOI 10.1089/107999001317205231; Guillemin GJ, 2001, J NEUROCHEM, V78, P842, DOI 10.1046/j.1471-4159.2001.00498.x; Guillemin GJ, 2012, FEBS J; JHAMANDAS K, 1990, BRAIN RES, V529, P185, DOI 10.1016/0006-8993(90)90826-W; Kerr SJ, 1998, AIDS, V12, P355, DOI 10.1097/00002030-199804000-00003; Kwidzinski E, 2005, FASEB J, V19, P1347, DOI 10.1096/fj.04-3228fje; Colin-Gonzalez AL, 2013, NEUROTOXICOLOGY, V34, P189, DOI 10.1016/j.neuro.2012.11.007; Lee GK, 2002, IMMUNOLOGY, V107, P452, DOI 10.1046/j.1365-2567.2002.01526.x; Lim C.K., 2007, INT C SERIES, V1304; Liu H, 2007, J MOL BIOL, V373, P755, DOI 10.1016/j.jmb.2007.08.043; Madeleine W, 2014, PLOS ONE, V9; Mandi Y, 2012, J NEURAL TRANSM, V119, P197, DOI 10.1007/s00702-011-0681-y; McIlroy D, 2005, J LEUKOCYTE BIOL, V78, P794, DOI 10.1189/jlb.0105029; Mellor AL, 2004, INT IMMUNOL, V16, P1391, DOI 10.1093/intimm/dxh140; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Miller CL, 2004, NEUROBIOL DIS, V15, P618, DOI 10.1016/j.nbd.2003.12.015; Moffett JR, 1997, EXP NEUROL, V144, P287, DOI 10.1006/exnr.1996.6365; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Munn DH, 1998, SCIENCE, P281; MUSSO T, 1994, BLOOD, V83, P1408; Noakes R, 2015, INT J TRYPTOPHAN RES, V8, P7, DOI [10.4137/IJTR.S19985, 10.4137/1JTR.S19985]; Opitz CA, 2011, NATURE; OZAKI Y, 1987, BIOCHEM BIOPH RES CO, V144, P1147, DOI 10.1016/0006-291X(87)91431-8; Pilotte L, 2012, P NATL ACAD SCI USA, V109, P2497, DOI 10.1073/pnas.1113873109; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Rahman A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006344; Sahm F, 2013, CANCER RES, V73, P3225, DOI 10.1158/0008-5472.CAN-12-3831; Sakurai K, 2002, J NEUROIMMUNOL, V129, P186, DOI 10.1016/S0165-5728(02)00176-5; SALTER M, 1985, BIOCHEM J, V229, P499, DOI 10.1042/bj2290499; SHIMIZU T, 1978, J BIOL CHEM, V253, P4700; Stone TW, 2007, EUR J NEUROSCI, V25, P2656, DOI 10.1111/j.1460-9568.2007.05540.x; Stone TW, 2007, J NEUROSCI RES, V85, P1077, DOI 10.1002/jnr.21212; Stone TW, 2013, BRIT J PHARMACOL, V169, P1211, DOI 10.1111/bph.12230; STONE TW, 1993, PHARMACOL REV, V45, P309; STONE TW, 1981, EUR J PHARMACOL, V72, P411, DOI 10.1016/0014-2999(81)90587-2; Sundaram G, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0204-5; Takikawa O, 2005, BIOCHEM BIOPH RES CO, V338, P12, DOI 10.1016/j.bbrc.2005.09.032; Tan L, 2012, J NEUROL SCI, V323, P1, DOI 10.1016/j.jns.2012.08.005; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Vecsei L, 2013, NAT REV DRUG DISCOV, V12, P64, DOI 10.1038/nrd3793; Vidal C, 2015, STEM CELLS, V33, P111, DOI 10.1002/stem.1836; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; WERNERFELMAYER G, 1989, BIOCHIM BIOPHYS ACTA, V1012, P140, DOI 10.1016/0167-4889(89)90087-6; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Yan YP, 2010, J IMMUNOL, V185, P5953, DOI 10.4049/jimmunol.1001628; YASUI H, 1986, P NATL ACAD SCI USA, V83, P6622, DOI 10.1073/pnas.83.17.6622; Zunszain PA, 2012, NEUROPSYCHOPHARMACOL, V37, P939, DOI 10.1038/npp.2011.277	74	81	82	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131389	10.1371/journal.pone.0131389	http://dx.doi.org/10.1371/journal.pone.0131389			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114426	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500149
J	Miranda, PJ; Delgobo, M; Marino, GF; Paludo, KS; Baptista, MD; Pinto, SED				Miranda, Pedro Jeferson; Delgobo, Murilo; Marino, Giovani Favero; Paludo, Katia Sabrina; Baptista, Murilo da Silva; de Souza Pinto, Sandro Ely			The Oral Tolerance as a Complex Network Phenomenon	PLOS ONE			English	Article							REGULATORY T-CELLS; TGF-BETA; IMMUNE TOLERANCE; CUTTING EDGE; INDUCTION; MICE; ABSENCE; IL-10; FOXP3; EXPRESSION	The phenomenon of oral tolerance refers to a local and systemic state of tolerance induced in the gut after its exposure to innocuous antigens. Recent findings have shown the interrelationship between cellular and molecular components of oral tolerance, but its representation through a network of interactions has not been investigated. Our work aims at identifying the causal relationship of each element in an oral tolerance network, and also to propose a phenomenological model that's capable of predicting the stochastic behavior of this network when under manipulation. We compared the changes of a "healthy" network caused by "knock-outs" (KOs) in two approaches: an analytical approach by the Perron Frobenius theory; and a computational approach, which we describe within this work in order to find numerical results for the model. Both approaches have shown the most relevant immunological components for this phenomena, that happens to corroborate the empirical results from animal models. Besides explain in a intelligible fashion how the components interacts in a complex manner, we also managed to describe and quantify the importance of KOs that hasn't been empirically tested.	[Miranda, Pedro Jeferson; de Souza Pinto, Sandro Ely] Univ Estadual Ponta Grossa, Dept Phys, Ponta Grossa, Parana, Brazil; [Delgobo, Murilo; Marino, Giovani Favero] Univ Estadual Ponta Grossa, Dept Biol, Ponta Grossa, Parana, Brazil; [Baptista, Murilo da Silva] Univ Aberdeen, SUPA, Inst Complex Syst & Math Biol, Aberdeen, Scotland; [Paludo, Katia Sabrina] Univ Estadual Ponta Grossa, Dept Struct Biol Mol & Genet, Ponta Grossa, Parana, Brazil	Universidade Estadual de Ponta Grossa; Universidade Estadual de Ponta Grossa; University of Aberdeen; Universidade Estadual de Ponta Grossa	Pinto, SED (corresponding author), Univ Estadual Ponta Grossa, Dept Phys, Ponta Grossa, Parana, Brazil.	desouzapinto@gmail.com		Pinto, Sandro/0000-0002-3534-3893; Miranda, Pedro Jeferson/0000-0002-3593-9478; Delgobo, Murilo/0000-0003-4010-1909	Engineering and Physical Sciences Research Council (EPSRC) - UK [EP/I032606/1]; Higher Education Personnel Training Coordination (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) CAPES; EPSRC [EP/I032606/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I032606/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC) - UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Higher Education Personnel Training Coordination (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) CAPES; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	MSB acknowledges the Engineering and Physical Sciences Research Council (EPSRC) - UK grant EP/I032606/1. PJM and MD received regular scholarships from the Brazilian the following agency: Higher Education Personnel Training Coordination (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) CAPES http://www.fisica.uepg.br:7080/ppgfisica/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus CL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000103; Andolfi G, 2012, MOL THER, V20, P1778, DOI 10.1038/mt.2012.71; Anishchenko VS., 2002, NONLINEAR DYNAMICS C; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Batten M, 2008, J IMMUNOL, V180, P2752, DOI 10.4049/jimmunol.180.5.2752; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Bottinger EP, 1997, KIDNEY INT, V51, P1355, DOI 10.1038/ki.1997.185; Brandtzaeg P, 1998, NUTR REV, V56, pS5; Burg D, 2009, J THEOR BIOL, V259, P751, DOI 10.1016/j.jtbi.2009.04.010; Burt TD, 2013, AM J REPROD IMMUNOL, V69, P346, DOI 10.1111/aji.12083; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; CELADA F, 1992, IMMUNOL TODAY, V13, P56, DOI 10.1016/0167-5699(92)90135-T; Chang SY, 2010, GASTROENTEROLOGY, V138, P1468, DOI 10.1053/j.gastro.2009.11.006; Chao DL, 2004, J THEOR BIOL, V228, P227, DOI 10.1016/j.jtbi.2003.12.011; DEBOER RJ, 1991, J THEOR BIOL, V149, P381, DOI 10.1016/S0022-5193(05)80313-3; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Einstein A, 1905, ANN PHYS, V17; Fasano A, 2011, PHYSIOL REV, V91, P151, DOI 10.1152/physrev.00003.2008; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Gonnella PA, 2004, J AUTOIMMUN, V23, P193, DOI 10.1016/j.jaut.2004.08.001; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Huang GH, 2013, J IMMUNOL, V191, P650, DOI 10.4049/jimmunol.1300398; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Karlsson MR, 2010, ALLERGY, V65, P561, DOI 10.1111/j.1398-9995.2009.02225.x; Komarova NL, 2007, J THEOR BIOL, V249, P766, DOI 10.1016/j.jtbi.2007.09.013; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Menard S, 2010, MUCOSALIMMUNOLOGY, P1; Miron N, 2012, CLIN EXP IMMUNOL, V167, P405, DOI 10.1111/j.1365-2249.2011.04523.x; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Muphy KM, 2012, JANEWAYS IMMUNOBIOLO; Nagatani K, 2011, IMMUNOBIOLOGY, V216, P416, DOI 10.1016/j.imbio.2010.06.008; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Pabst O, 2012, MUCOSAL IMMUNOLOGY, P1; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Pearson C, 2012, TRENDS IMMUNOL, V33, P289, DOI 10.1016/j.it.2012.04.004; Pearson JE, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001058; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Pot C, 2010, J INTERF CYTOK RES, V30, P381, DOI 10.1089/jir.2010.0047; Reynolds LA, 2012, J IMMUNOL, V189, P1113, DOI 10.4049/jimmunol.1200991; Ribeiro LC, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031911; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Scott CL, 2011, TRENDS IMMUNOL, V32, P412, DOI 10.1016/j.it.2011.06.003; Semmrich M, 2012, MUCOSAL IMMUNOL, V5, P150, DOI 10.1038/mi.2011.61; Seneta E., 1981, NONNEGATIVE MATRICES; Shevach EM, 2008, J CLIN IMMUNOL, V28, P640, DOI 10.1007/s10875-008-9240-1; Soderqvist T, 2003, TROUBLED LIFE N JERN; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Suarez-Alvarez B, 2013, EPIGENETICS-US, V8, P694, DOI 10.4161/epi.25201; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sutherland DB, 2012, CURR OPIN IMMUNOL, V24, P261, DOI 10.1016/j.coi.2012.03.005; Thakar J, 2007, PLOS COMPUT BIOL, V3, P1022, DOI 10.1371/journal.pcbi.0030109; Thakar J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002345; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Welty NE, 2013, J EXP MED, V210, P2011, DOI 10.1084/jem.20130728; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Zhang BJ, 2008, CELL MOL IMMUNOL, V5, P325, DOI 10.1038/cmi.2008.40; Zhao M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-46	61	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130762	10.1371/journal.pone.0130762	http://dx.doi.org/10.1371/journal.pone.0130762			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115356	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500093
J	Saito, PTM; Nakamura, RYM; Amorim, WP; Papa, JP; de Rezende, PJ; Falcao, AX				Saito, Priscila T. M.; Nakamura, Rodrigo Y. M.; Amorim, Willian P.; Papa, Joao P.; de Rezende, Pedro J.; Falcao, Alexandre X.			Choosing the Most Effective Pattern Classification Model under Learning-Time Constraint	PLOS ONE			English	Article							CLASSIFIERS; TESTS; PERFORMANCE; LIBRARY; AREA	Nowadays, large datasets are common and demand faster and more effective pattern analysis techniques. However, methodologies to compare classifiers usually do not take into account the learning-time constraints required by applications. This work presents a methodology to compare classifiers with respect to their ability to learn from classification errors on a large learning set, within a given time limit. Faster techniques may acquire more training samples, but only when they are more effective will they achieve higher performance on unseen testing sets. We demonstrate this result using several techniques, multiple datasets, and typical learning-time limits required by applications.	[Saito, Priscila T. M.] Univ Tecnol Fed Parana, Dept Comp, Cornelio Procopio, Brazil; [Nakamura, Rodrigo Y. M.] Big Data Brazil, Sao Paulo, SP, Brazil; [Amorim, Willian P.] Univ Fed Mato Grosso do Sul, Inst Comp, Campo Grande, Brazil; [Papa, Joao P.] Sao Paulo State Univ, Dept Comp, Bauru, Brazil; [de Rezende, Pedro J.; Falcao, Alexandre X.] Univ Estadual Campinas, Inst Comp, Campinas, SP, Brazil	Universidade Tecnologica Federal do Parana; Universidade Federal de Mato Grosso do Sul; Universidade Estadual Paulista; Universidade Estadual de Campinas	Saito, PTM (corresponding author), Univ Tecnol Fed Parana, Dept Comp, Cornelio Procopio, Brazil.	psaito@utfpr.edu.br	Falcão, Alexandre X/F-8361-2012; Saito, Priscila T. M./E-8159-2013; Papa, Joao Paulo/ABC-6283-2020; Papa, Joao P/C-4849-2012; de Rezende, Pedro J./B-2888-2011	Saito, Priscila T. M./0000-0002-4870-4766; Papa, Joao Paulo/0000-0002-6494-7514; Papa, Joao P/0000-0002-6494-7514; de Rezende, Pedro J./0000-0002-9529-4253; Falcao, Alexandre/0000-0002-2914-5380	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [303182/2011-3, 477692/2012-5, 552559/2010-5, 481556/2009-5, 303673/2010-9, 470571/2013-6, 306166/2014-3, 311140/2014-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) [01-P-01965/2012]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/14058-5, 2012/18768-0, 2007/52015-0, 2013/20387-7, 2014/16250-9]; Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (Fundect-MS)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (Fundect-MS)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (http://www.cnpq.br/), grant numbers 303182/2011-3 (JPP), 477692/2012-5 (PJR), 552559/2010-5 (AXF, PTMS), 481556/2009-5 (AXF), 303673/2010-9 (AXF), 303182/2011-3 (JPP), 470571/2013-6 (JPP), 306166/2014-3 (JPP), and 311140/2014-9 (PJR). This work was also supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) (http://www.capes.gov.br/), grant number 01-P-01965/2012 (AXF); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (http://www.fapesp.br/), grant numbers 2011/14058-5 (JPP, RYMN), 2012/18768-0 (JPP), 2007/52015-0 (PJR), 2013/20387-7 (JPP), and 2014/16250-9 (JPP); and Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (Fundect-MS) (http://fundect.ledes.net/, WPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, the authors would also like to emphasize that Big Data Brazil is the current company of one of the coauthors (RN). However, the results of this present paper refer to the activities that were developed by the author in his master's degree. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Alpaydin E, 1999, NEURAL COMPUT, V11, P1885, DOI 10.1162/089976699300016007; Amancio DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094137; Batista G.E., 2004, ACM SIGKDD EXPLOR NE, V6, P20, DOI 10.1145/1007730.1007735; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Bouckaert RR, 2004, LECT NOTES ARTIF INT, V3056, P3; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Chang CC, 2001, IEEE IJCNN, P1031, DOI 10.1109/IJCNN.2001.939502; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Connect-4, 2012, CONN 4 DAT UCI MACH; Cortes C, 2004, ADV NEUR IN, V16, P313; Covertype, 2012, COV DAT UCI MACH LEA; CRAMER H., 1946, Mathematical methods of statistics.; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; Demsar J, 2006, J MACH LEARN RES, V7, P1; Dietterich TG, 1998, NEURAL COMPUT, V10, P1895, DOI 10.1162/089976698300017197; Duarte MF, 2004, J PARALLEL DISTR COM, V64, P826, DOI 10.1016/j.jpdc.2004.03.020; Dzeroski S, 2004, MACH LEARN, V54, P255, DOI 10.1023/B.MAC.0000015881.36452.6e; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Ferri C., 2002, P 19 INT C MACHINE L, P139; Flach P. A., 2011, P 28 INT C INT C MAC, P657; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Hanczar B, 2012, IEEE ACM T COMPUT BI, V9, P1379, DOI 10.1109/TCBB.2012.21; Hand DJ, 2009, MACH LEARN, V77, P103, DOI 10.1007/s10994-009-5119-5; Herschtal Alan, 2004, P 21 INT C MACH LEAR, P49; Huang J, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P553; Irsoy O, 2012, IEEE ACM T COMPUT BI, V99, P1; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; JARDINE N, 1971, INFORM STORAGE RET, V7, P217, DOI 10.1016/0020-0271(71)90051-9; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Kuncheva L, 1996, CONE TORUS DATASET A; Li H.T., 2008, INT WORKSH EARTH OBS, V1, P1, DOI DOI 10.1117/1.2943286; Li N, 2013, IEEE T PATTERN ANAL, V35, P1370, DOI 10.1109/TPAMI.2012.172; Ling C. X., 2003, IJCAI 2003, V18, P519, DOI DOI 10.5555/1630659.1630736; Liyun Li, 2009, Proceedings of the 2009 Ninth IEEE International Conference on Data Mining (ICDM 2009), P268, DOI 10.1109/ICDM.2009.46; Musicant D.R., 2003, FLAIRS C, P356; Nadeau C, 2003, MACH LEARN, V52, P239, DOI 10.1023/A:1024068626366; Nemenyi P., 1963, DISTRIBUTION FREE MU; Ojala M, 2010, J MACH LEARN RES, V11, P1833; Pao TL, 2008, IEICE T INF SYST, VE91D, P1074, DOI 10.1093/ietisy/e91-d.4.1074; Papa JP, 2009, INT J IMAG SYST TECH, V19, P120, DOI 10.1002/ima.20188; Papa JP, 2012, PATTERN RECOGN, V45, P512, DOI 10.1016/j.patcog.2011.07.013; Parker C., 2011, Proceedings of the 2011 IEEE 11th International Conference on Data Mining (ICDM 2011), P517, DOI 10.1109/ICDM.2011.21; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Raeder T., 2010, Proceedings 2010 10th IEEE International Conference on Data Mining (ICDM 2010), P421, DOI 10.1109/ICDM.2010.110; RAGHAVAN VV, 1989, ACM T INFORM SYST, V7, P205, DOI 10.1145/65943.65945; Rijsbergen C.J.V, 1979, INFORM RETRIEVAL; Salzberg SL, 1997, DATA MIN KNOWL DISC, V1, P317, DOI 10.1023/A:1009752403260; Soria D, 2008, SEVENTH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS, PROCEEDINGS, P619, DOI 10.1109/ICMLA.2008.97; Souza A, 2013, PROC SPIE, V8671, DOI 10.1117/12.2000310; Spina TV, 2012, INT J PATTERN RECOGN, V26, DOI 10.1142/S0218001412650016; Suzuki CTN, 2013, I S BIOMED IMAGING, P460; Valizadegan Hamed, 2009, ADV NEURAL INFORM PR, P1883; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Xu J., 2008, P 31 ANN INT ACM SIG, P107, DOI DOI 10.1145/1390334.1390355; Yisong Yue, 2007, 30th Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P271	58	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129947	10.1371/journal.pone.0129947	http://dx.doi.org/10.1371/journal.pone.0129947			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114552	gold, Green Published, Green Submitted			2022-12-27	WOS:000358147500046
J	Schmidt, GV; Mellerup, A; Christiansen, LE; Stahl, M; Olsen, JE; Angen, O				Schmidt, Gunilla Veslemoy; Mellerup, Anders; Christiansen, Lasse Engbo; Stahl, Marie; Olsen, John Elmerdahl; Angen, Oystein			Sampling and Pooling Methods for Capturing Herd Level Antibiotic Resistance in Swine Feces using qPCR and CFU Approaches	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; ESCHERICHIA-COLI STRAINS; TIME PCR ASSAYS; ANTIMICROBIAL RESISTANCE; SALMONELLA-ENTERICA; GENES; PREVALENCE; BACTERIA; PIGS; ENTEROBACTERIACEAE	The aim of this article was to define the sampling level and method combination that captures antibiotic resistance at pig herd level utilizing qPCR antibiotic resistance gene quantification and culture-based quantification of antibiotic resistant coliform indicator bacteria. Fourteen qPCR assays for commonly detected antibiotic resistance genes were developed, and used to quantify antibiotic resistance genes in total DNA from swine fecal samples that were obtained using different sampling and pooling methods. In parallel, the number of antibiotic resistant coliform indicator bacteria was determined in the same swine fecal samples. The results showed that the qPCR assays were capable of detecting differences in antibiotic resistance levels in individual animals that the coliform bacteria colony forming units (CFU) could not. Also, the qPCR assays more accurately quantified antibiotic resistance genes when comparing individual sampling and pooling methods. qPCR on pooled samples was found to be a good representative for the general resistance level in a pig herd compared to the coliform CFU counts. It had significantly reduced relative standard deviations compared to coliform CFU counts in the same samples, and therefore differences in antibiotic resistance levels between samples were more readily detected. To our knowledge, this is the first study to describe sampling and pooling methods for qPCR quantification of antibiotic resistance genes in total DNA extracted from swine feces.	[Schmidt, Gunilla Veslemoy; Mellerup, Anders; Stahl, Marie; Angen, Oystein] Tech Univ Denmark, Natl Vet Inst, Frederiksberg C, Denmark; [Christiansen, Lasse Engbo] Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark; [Olsen, John Elmerdahl] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark	Technical University of Denmark; Technical University of Denmark; University of Copenhagen	Schmidt, GV (corresponding author), Tech Univ Denmark, Natl Vet Inst, Frederiksberg C, Denmark.	gunillavbn@hotmail.com	Olsen, John Elmerdahl/N-9271-2019	Christiansen, Lasse Engbo/0000-0001-5019-1931; Olsen, John Elmerdahl/0000-0001-6225-6587	Strategic Research Council, Ministry for Food Agriculture and Fisheries; Faculty of Life Sciences, University of Copenhagen	Strategic Research Council, Ministry for Food Agriculture and Fisheries; Faculty of Life Sciences, University of Copenhagen	The work included in this article was supported by a grant from the Strategic Research Council, Ministry for Food Agriculture and Fisheries and the Faculty of Life Sciences, University of Copenhagen. The research has primarily been conducted in Section for Bacteriology, Pathology and Parasitology, National Veterinary Institute, Technical University of Denmark, in collaboration with Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen.	Aarestrup FM, 1999, INT J ANTIMICROB AG, V12, P279, DOI 10.1016/S0924-8579(99)90059-6; Agerso Y, 2012, J ANTIMICROB CHEMOTH, V67, P582, DOI 10.1093/jac/dkr507; Alali WQ, 2009, FOODBORNE PATHOG DIS, V6, P917, DOI 10.1089/fpd.2009.0271; Aminov RI, 2002, APPL ENVIRON MICROB, V68, P1786, DOI 10.1128/AEM.68.4.1786-1793.2002; Angen O, 2011, J DAIRY SCI, V94, P5750, DOI 10.3168/jds.2011-4197; Angen O, 1998, VET MICROBIOL, V63, P39, DOI 10.1016/S0378-1135(98)00222-3; Archambault M, 2006, MICROB DRUG RESIST, V12, P192, DOI 10.1089/mdr.2006.12.192; Baraniak A, 2002, ANTIMICROB AGENTS CH, V46, P151, DOI 10.1128/AAC.46.1.151-159.2002; Bibbal D, 2007, APPL ENVIRON MICROB, V73, P4785, DOI 10.1128/AEM.00252-07; Birkett CI, 2007, J MED MICROBIOL, V56, P52, DOI 10.1099/jmm.0.46909-0; Bockelmann U, 2009, APPL ENVIRON MICROB, V75, P154, DOI 10.1128/AEM.01649-08; Broens EM, 2011, VET MICROBIOL, V147, P440, DOI 10.1016/j.vetmic.2010.07.021; Byrne-Bailey KG, 2009, ANTIMICROB AGENTS CH, V53, P696, DOI 10.1128/AAC.00652-07; Caprioli A, 2000, INT J ANTIMICROB AG, V14, P295, DOI 10.1016/S0924-8579(00)00140-0; Chanawong A, 2001, J ANTIMICROB CHEMOTH, V48, P839, DOI 10.1093/jac/48.6.839; Chee-Sanford JC, 2009, J ENVIRON QUAL, V38, P1086, DOI 10.2134/jeq2008.0128; Chen CY, 2003, J MICROBIOL METH, V55, P475, DOI 10.1016/S0167-7012(03)00194-5; Chen J, 2007, APPL ENVIRON MICROB, V73, P4407, DOI 10.1128/AEM.02799-06; Costa D, 2008, VET MICROBIOL, V127, P97, DOI 10.1016/j.vetmic.2007.08.004; DANMAP,, 2021, US ANT AG OCC ANT RE; De Leener E, 2004, MICROB DRUG RESIST, V10, P341, DOI 10.1089/mdr.2004.10.341; Dunlop RH, 1999, EPIDEMIOL INFECT, V122, P485, DOI 10.1017/S0950268899002411; Falk PG, 1998, MICROBIOL MOL BIOL R, V62, P1157, DOI 10.1128/MMBR.62.4.1157-1170.1998; Fluit AC, 2001, CLIN MICROBIOL REV, V14, P836, DOI 10.1128/CMR.14.4.836-871.2001; Fodevareministeriet, 2012, 404 BEK FOD; Garofalo C, 2007, INT J FOOD MICROBIOL, V113, P75, DOI 10.1016/j.ijfoodmicro.2006.07.015; Gniadkowski M, 1998, ANTIMICROB AGENTS CH, V42, P827, DOI 10.1128/AAC.42.4.827; Guardabassi L, 2000, J MED MICROBIOL, V49, P929, DOI 10.1099/0022-1317-49-10-929; Hammerum AM, 2006, INT J FOOD MICROBIOL, V106, P235, DOI 10.1016/j.ijfoodmicro.2005.06.023; Harris S, 1997, BRIT J BIOMED SCI, V54, P166; Hasman H, 2005, J ANTIMICROB CHEMOTH, V56, P115, DOI 10.1093/jac/dki190; Heritage J, 1999, J ANTIMICROB CHEMOTH, V44, P309, DOI 10.1093/jac/44.3.309; Holzel CS, 2010, J APPL MICROBIOL, V108, P1642, DOI 10.1111/j.1365-2672.2009.04570.x; Jacoby GA, BETA LACTAMASE CLASS; Kazimierczak KA, 2009, APPL ENVIRON MICROB, V75, P1717, DOI 10.1128/AEM.02206-08; Knapp CW, 2010, ENVIRON POLLUT, V158, P1506, DOI 10.1016/j.envpol.2009.12.020; Koike S, 2007, APPL ENVIRON MICROB, V73, P4813, DOI 10.1128/AEM.00665-07; Li XZ, 2007, VET MICROBIOL, V121, P197, DOI 10.1016/j.vetmic.2007.01.015; McGowan JE, 2001, EMERG INFECT DIS, V7, P286, DOI 10.3201/eid0702.010228; Moodley A, 2009, ANTIMICROB AGENTS CH, V53, P1709, DOI 10.1128/AAC.01014-08; Munoz-Zanzi CA, 2000, J VET DIAGN INVEST, V12, P195, DOI 10.1177/104063870001200301; Munoz-Zanzi C, 2006, PREV VET MED, V74, P309, DOI 10.1016/j.prevetmed.2005.12.006; Navarro F, 2001, J ANTIMICROB CHEMOTH, V48, P383, DOI 10.1093/jac/48.3.383; Saenz Y, 2004, ANTIMICROB AGENTS CH, V48, P3996, DOI 10.1128/AAC.48.10.3996-4001.2004; Schwarz S, 2001, INT J ANTIMICROB AG, V17, P431, DOI 10.1016/S0924-8579(01)00297-7; Skov MN, 1999, J APPL MICROBIOL, V86, P695, DOI 10.1046/j.1365-2672.1999.00715.x; Smith MS, 2004, APPL ENVIRON MICROB, V70, P7372, DOI 10.1128/AEM.70.12.7372-7377.2004; Sunde M, 1998, MICROB DRUG RESIST, V4, P289, DOI 10.1089/mdr.1998.4.289; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van den Bogaard AE, 2000, INT J ANTIMICROB AG, V14, P327, DOI 10.1016/S0924-8579(00)00145-X; Wegener HC, 2003, EMERG INFECT DIS, V9, P774; *WHO, 2002, WHOCDSCSRDRS20015; Yu ZT, 2005, APPL ENVIRON MICROB, V71, P6926, DOI 10.1128/AEM.71.11.6926-6933.2005	53	21	21	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131672	10.1371/journal.pone.0131672	http://dx.doi.org/10.1371/journal.pone.0131672			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114765	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500178
J	Shi, K; Yang, ZG; Chen, J; Zhang, G; Xu, HY; Guo, YK				Shi, Ke; Yang, Zhi-gang; Chen, Jing; Zhang, Ge; Xu, Hua-yan; Guo, Ying-kun			Assessment of Double Outlet Right Ventricle Associated with Multiple Malformations in Pediatric Patients Using Retrospective ECG-Gated Dual-Source Computed Tomography	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; SOURCE CT; TRANSTHORACIC ECHOCARDIOGRAPHY; CORONARY-ANGIOGRAPHY; IMAGE QUALITY; PERFORMANCE; ANOMALIES; ARTERY	Purpose To evaluate the feasibility and diagnostic accuracy of retrospective electrocardiographically (ECG)-gated dual-source computed tomography (DSCT) for the assessment of double outlet right ventricle (DORV) and associated multiple malformations in pediatric patients. Materials and Methods Forty-seven patients < 10 years of age with DORV underwent retrospective ECG-gated DSCT. The location of the ventricular septal defect (VSD), alignment of the two great arteries, and associated malformations were assessed. The feasibility of retrospective ECG-gated DSCT in pediatric patients was assessed, the image quality of DSCT and the agreement of the diagnosis of associated malformations between DSCT and transthoracic echocardiography (TTE) were evaluated, the diagnostic accuracies of DSCT and TTE were referred to surgical results, and the effective doses were calculated. Results Apart from DORV, 109 associated malformations were confirmed postoperatively. There was excellent agreement (kappa = 0.90) for the diagnosis of associated malformations between DSCT and TTE. However, DSCT was superior to TTE in demonstrating paracardiac anomalies (sensitivity, coronary artery anomalies: 100% vs. 80.00%, anomalies of great vessels: 100% vs. 88.57%, separate thoracic and abdominal anomalies: 100% vs. 76.92%, respectively). Combined with TTE, DSCT can achieve excellent diagnostic performance in intracardiac anomalies (sensitivity, 91.30% vs. 100%). The mean image quality score was 3.70 +/- 0.46 (kappa = 0.76). The estimated mean effective dose was < 1 mSv (0.88 +/- 0.34 mSv). Conclusions Retrospective ECG-gated DSCT is a better diagnostic tool than TTE for pediatric patients with complex congenital heart disease such as DORV. Combined with TTE, it may reduce or even obviate the use of invasive cardiac catheterization, and thus expose the patients to a much lower radiation dose.	[Shi, Ke; Yang, Zhi-gang; Chen, Jing; Zhang, Ge; Xu, Hua-yan] Sichuan Univ, West China Hosp, Dept Radiol, Chengdu 610041, Sichuan, Peoples R China; [Yang, Zhi-gang; Xu, Hua-yan] Sichuan Univ, West China Hosp, Natl Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Guo, Ying-kun] Sichuan Univ, West China Univ Hosp 2, Dept Radiol, Chengdu 610041, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Yang, ZG (corresponding author), Sichuan Univ, West China Hosp, Dept Radiol, 37 Guo Xue Xiang, Chengdu 610041, Sichuan, Peoples R China.	yangzg666@163.com; gykpanda@163.com						[Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; Beier UH, 2006, CATHETER CARDIO INTE, V68, P441, DOI 10.1002/ccd.20817; Belli E, 1999, EUR J CARDIO-THORAC, V15, P747, DOI 10.1016/S1010-7940(99)00100-1; Bishnoi RN, 2014, CARDIOL YOUNG, V24, P732, DOI 10.1017/S1047951113001005; Chen SJ, 2008, J FORMOS MED ASSOC, V107, P371, DOI 10.1016/S0929-6646(08)60102-3; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; Deng W, 2010, INT J CARDIOL, V145, P633, DOI 10.1016/j.ijcard.2010.09.077; Faggioni L, 2012, AM J ROENTGENOL, V199, P1220, DOI 10.2214/AJR.11.8122; Flohr TG, 2006, EUR RADIOL, V16, P256, DOI 10.1007/s00330-005-2919-2; Hirai N, 2008, RADIOLOGY, V248, P424, DOI 10.1148/radiol.2482071804; Huda W, 2010, PHYS MED BIOL, V55, P3675, DOI 10.1088/0031-9155/55/13/007; Jin KN, 2010, INT J CARDIOVAS IMAG, V26, P63, DOI 10.1007/s10554-009-9579-2; Lai WW, 2006, J AM SOC ECHOCARDIOG, V19, P1413, DOI 10.1016/j.echo.2006.09.001; Lell M, 2009, EUR RADIOL, V19, P2576, DOI 10.1007/s00330-009-1558-4; LEV M, 1972, J THORAC CARDIOV SUR, V64, P271; Li X, 2011, RADIOLOGY, V259, P862, DOI 10.1148/radiol.11101900; Mahnken AH, 2011, EUR J RADIOL, V77, P443, DOI 10.1016/j.ejrad.2009.07.037; McCollough CH, 2007, RADIOLOGY, V243, P775, DOI 10.1148/radiol.2433061165; National Research Council of the National Academies NRC, 2006, HLTH RISKS EXP LOW L; Nie P, 2012, EUR RADIOL, V22, P2057, DOI 10.1007/s00330-012-2479-1; Stolzmann P, 2008, EUR RADIOL, V18, P592, DOI 10.1007/s00330-007-0786-8; Stolzmann P, 2011, EUR J RADIOL, V79, P85, DOI 10.1016/j.ejrad.2009.12.016; Sun ZH, 2012, EUR J RADIOL, V81, pE94, DOI 10.1016/j.ejrad.2011.01.070; Vitiello R, 1998, J AM COLL CARDIOL, V32, P1433, DOI 10.1016/S0735-1097(98)00396-9; Walsh R, 2011, PEDIATR RADIOL, V41, P1526, DOI 10.1007/s00247-011-2256-3; Walters H L 3rd, 2000, Ann Thorac Surg, V69, pS249, DOI 10.1016/S0003-4975(99)01247-3; Wang TL, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-130; Yu FF, 2013, J CARDIOVASC COMPUT, V7, P383, DOI 10.1016/j.jcct.2013.11.004	28	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130987	10.1371/journal.pone.0130987	http://dx.doi.org/10.1371/journal.pone.0130987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115034	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500116
J	Takenaka, C; Miyajima, H; Yoda, Y; Imazato, H; Yamamoto, T; Gomi, S; Ohshima, Y; Kagawa, K; Sasaki, T; Kawamata, S				Takenaka, Chiemi; Miyajima, Hiroshi; Yoda, Yusuke; Imazato, Hideo; Yamamoto, Takako; Gomi, Shinichi; Ohshima, Yasuhiro; Kagawa, Kenichi; Sasaki, Tetsuji; Kawamata, Shin			Controlled Growth and the Maintenance of Human Pluripotent Stem Cells by Cultivation with Defined Medium on Extracellular Matrix-Coated Micropatterned Dishes	PLOS ONE			English	Article							TRIALS; LINES	Here, we introduce a new serum-free defined medium (SPM) that supports the cultivation of human pluripotent stem cells (hPSCs) on recombinant human vitronectin-N (rhVNT-N)coated dishes after seeding with either cell clumps or single cells. With this system, there was no need for an intervening sequential adaptation process after moving hPSCs from feeder layer-dependent conditions. We also introduce a micropatterned dish that was coated with extracellular matrix by photolithographic technology. This procedure allowed the cultivation of hPSCs on 199 individual rhVNT-N-coated small round spots (1 mm in diameter) on each 35-mm polystyrene dish (termed "patterned culture"), permitting the simultaneous formation of 199 uniform high-density small-sized colonies. This culture system supported controlled cell growth and maintenance of undifferentiated hPSCs better than dishes in which the entire surface was coated with rhVNT-N (termed "non-patterned cultures"). Non-patterned cultures produced variable, unrestricted cell proliferation with non-uniform cell growth and uneven densities in which we observed downregulated expression of some self-renewal-related markers. Comparative flow cytometric studies of the expression of pluripotency-related molecules SSEA-3 and TRA-1-60 in hPSCs from non-patterned cultures and patterned cultures supported this concept. Patterned cultures of hPSCs allowed sequential visual inspection of every hPSC colony, giving an address and number in patterned culture dishes. Several spots could be sampled for quality control tests of production batches, thereby permitting the monitoring of hPSCs in a single culture dish. Our new patterned culture system utilizing photolithography provides a robust, reproducible and controllable cell culture system and demonstrates technological advantages for the mass production of hPSCs with process quality control.	[Takenaka, Chiemi; Imazato, Hideo; Yamamoto, Takako; Kawamata, Shin] Fdn Biomed Res & Innovat, R&D Ctr Cell Therapy, Chuo Ku, Kobe, Hyogo 6500043, Japan; [Miyajima, Hiroshi; Sasaki, Tetsuji] Kyokuto Pharmaceut Ind Co Ltd, Prod Dev Div, Kamitezuna Takahagi, Ibaraki 3180004, Japan; [Yoda, Yusuke; Gomi, Shinichi; Ohshima, Yasuhiro; Kagawa, Kenichi] Tokyo Electron Ltd, Technol Dev Ctr, Minato Ku, Tokyo 1076325, Japan	Institute for Biomedical Research & Innovation (IBRI); Tokyo Electron Ltd	Kawamata, S (corresponding author), Fdn Biomed Res & Innovat, R&D Ctr Cell Therapy, Chuo Ku, TRI 308,1-5-4 Minatojima Minamimachi, Kobe, Hyogo 6500043, Japan.	kawamata@fbri.org		kawamata, shin/0000-0001-5148-1949; Yamamoto, Takako/0000-0002-1877-0359	JST (Japan Science and Technology Agency); Kyokuto Pharmaceutical Industrial Co., Ltd.; Tokyo Electron Limited	JST (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)); Kyokuto Pharmaceutical Industrial Co., Ltd.; Tokyo Electron Limited	This work was partly supported by JST (Japan Science and Technology Agency) for safety tests in regenerative medicine 2011-2015 (http://www.jst.go.jp/shincho/en/index.html). Kyokuto Pharmaceutical Industrial Co., Ltd., and Tokyo Electron Limited provided support in the form of salaries for authors HM, TS, YY, SG, YO and KK retrospectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 1997, Adverse Drug React Toxicol Rev, V16, P113; [Anonymous], 2014, ASIA JAPAN WATCH; [Anonymous], 2006, GEOGRAPHICAL BSE RIS; Beers J, 2012, NAT PROTOC, V7, P2029, DOI 10.1038/nprot.2012.130; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Cyranoski D, 2013, NATURE, V494, P413, DOI 10.1038/494413a; Meng GL, 2012, STEM CELLS DEV, V21, P2036, DOI 10.1089/scd.2011.0489; Miyazaki T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2231; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Nishishita N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038389; Reardon S, 2014, NATURE, V513, P287, DOI 10.1038/513287a; Rodin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4195; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Song W, 2011, J NANOMATER, V2011, DOI 10.1155/2011/265251; Strauss S, 2010, NAT BIOTECHNOL, V28, P989, DOI 10.1038/nbt1010-989; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tano K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110496; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145	20	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129855	10.1371/journal.pone.0129855	http://dx.doi.org/10.1371/journal.pone.0129855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115194	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500040
J	Hagen, M; Lescher, S; Gerhardt, A; Lahner, M; Felber, S; Hennig, EM				Hagen, Marco; Lescher, Stephanie; Gerhardt, Andreas; Lahner, Matthias; Felber, Stephan; Hennig, Ewald M.			Shank Muscle Strength Training Changes Foot Behaviour during a Sudden Ankle Supination	PLOS ONE			English	Article							CHRONIC INSTABILITY; EVERTOR STRENGTH; TRICEPS SURAE; EXERCISE; SPRAIN; STIFFNESS; JOINT; PROPRIOCEPTION; METAANALYSIS; STIMULATION	Background The peroneal muscles are the most effective lateral stabilisers whose tension braces the ankle joint complex against excessive supination. The purpose of this study was to identify the morphological and biomechanical effects of two machine-based shank muscle training methods. Methods Twenty-two healthy male recreationally active sports students performed ten weeks of single-set high resistance strength training with 3 training sessions per week. The subjects conducted subtalar pronator/supinator muscle training (ST) with the right leg by using a custom-made apparatus; the left foot muscles were exercised with machine-based talocrural plantar and dorsiflexor training (TT). Muscle strength (MVIC), muscle volume and foot biomechanics (rearfoot motion, ground reaction forces, muscle reaction times) during a sudden ankle supination were recorded before and after the intervention. Results Compared to TT, ST resulted in significantly higher pronator (14% vs. 8%, P<0.01) and supinator MVIC (25% vs. 12%, P<0.01). During sudden foot inversions, both ST and TT resulted in reduced supination velocity (-12%; P<0.01). The muscle reaction onset time was faster after the training in peroneus longus (PL) (P<0.01). Muscle volume of PL (P<0.01) and TA (P<0.01) increased significantly after both ST and TT. Conclusion After both ST and TT, the ankle joint complex is mechanically more stabilised against sudden supinations due to the muscle volume increase of PL and TA. As the reduced supination velocities indicate, the strength training effects are already present during free-fall. According to a sudden ankle supination in standing position, both machine-based dorsiflexor and pronator strength training is recommended for enhancing the mechanical stability of the ankle.	[Hagen, Marco; Gerhardt, Andreas; Hennig, Ewald M.] Univ Duisburg Essen, Inst Sport & Movement Sci, Biomech Lab, Essen, Germany; [Lescher, Stephanie] Goethe Univ Frankfurt, Inst Neuroradiol, D-60054 Frankfurt, Germany; [Lahner, Matthias] Ruhr Univ Bochum, St Josef Hosp, Dept Orthopaed Sports Surg, Bochum, Germany; [Felber, Stephan] Stiftungsklinikum Mittelrhein Koblenz, Inst Diagnost & Intervent Radiol Neuroradiol & Nu, Koblenz, Germany	University of Duisburg Essen; Goethe University Frankfurt; Ruhr University Bochum	Hagen, M (corresponding author), Univ Duisburg Essen, Inst Sport & Movement Sci, Biomech Lab, Essen, Germany.	marco.hagen@uni-due.de		Tritt, Stephanie/0000-0003-1428-8618; Hennig, Ewald/0000-0002-2799-8590	University of Duisburg Essen	University of Duisburg Essen	The University of Duisburg Essen received funding for basic research in machine-based strength training from Kieser Training, Switzerland (www.kieser-training.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albracht K, 2013, EUR J APPL PHYSIOL, V113, P1605, DOI 10.1007/s00421-012-2585-4; Arnold BL, 2009, J ATHL TRAINING, V44, P653, DOI 10.4085/1062-6050-44.6.653; Atherton PJ, 2005, FASEB J, V19, P786, DOI 10.1096/fj.04-2179fje; BARRETT J, 1995, SPORTS MED, V20, P277, DOI 10.2165/00007256-199520040-00005; Bawa P, 2002, EXERC SPORT SCI REV, V30, P59, DOI 10.1097/00003677-200204000-00003; BERG HE, 1993, ACTA PHYSIOL SCAND, V148, P379, DOI 10.1111/j.1748-1716.1993.tb09573.x; Blackburn JT, 2008, J ATHL TRAINING, V43, P29, DOI 10.4085/1062-6050-43.1.29; Brauner T, 2009, P 22 C INT SOC BIOM, P178; BRUNS J, 1990, Beitraege zur Orthopaedie und Traumatologie, V37, P597; Docherty CL, 1998, J ATHL TRAINING, V33, P310; Doherty C, 2014, SPORTS MED, V44, P123, DOI 10.1007/s40279-013-0102-5; EDDS MV, 1950, J COMP NEUROL, V93, P259, DOI 10.1002/cne.900930207; Edington CJ, 1990, BIOMECHANICS DISTANC, P135; Eils E, 2001, MED SCI SPORT EXER, V33, P1991, DOI 10.1097/00005768-200112000-00003; FELLOWS SJ, 1989, EXP BRAIN RES, V77, P135; Folland JP, 2007, SPORTS MED, V37, P145, DOI 10.2165/00007256-200737020-00004; Fong DTP, 2007, SPORTS MED, V37, P73, DOI 10.2165/00007256-200737010-00006; Freriks B, 1999, EUROPEAN RECOMMENDAT, V8, P13; Gabriel DA, 2006, SPORTS MED, V36, P133, DOI 10.2165/00007256-200636020-00004; Gardiner P, 2006, J APPL PHYSIOL, V101, P1228, DOI 10.1152/japplphysiol.00482.2006; Gribble PA, 2013, J ORTHOP SPORT PHYS, V43, P585, DOI 10.2519/jospt.2013.0303; Hagen M, 2010, P 2 INT FOOT ANKL BI, P24; Hagen M, 2013, P BIOM S GERM SOC SP, P29; Han K, 2011, J SPORT REHABIL, V20, P157, DOI 10.1123/jsr.20.2.157; Hartsell HD, 1999, BRIT J SPORT MED, V33, P255, DOI 10.1136/bjsm.33.4.255; HAY JG, 1992, STRENGTH POWER SPORT, P197; Hertel J, 2002, J ATHL TRAINING, V37, P364; Herzog Walter, 2012, Mol Cell Biomech, V9, P175; HILL DK, 1968, J PHYSIOL-LONDON, V199, P637, DOI 10.1113/jphysiol.1968.sp008672; HOUSTON ME, 1983, EUR J APPL PHYSIOL O, V51, P25, DOI 10.1007/BF00952534; Hubal MJ, 2005, MED SCI SPORT EXER, V37, P964, DOI 10.1249/01.mss.0000170469.90461.5f; HUTTON RS, 1973, J NEUROPHYSIOL, V36, P1090, DOI 10.1152/jn.1973.36.6.1090; Isman R., 1967, B PROSTHET RES, V11, P97; KAMEN G, 1984, INT J SPORTS MED, V5, P26, DOI 10.1055/s-2008-1025876; Kaminski TW, 2003, BRIT J SPORT MED, V37, P410, DOI 10.1136/bjsm.37.5.410; Klein P, 1996, J BIOMECH, V29, P21, DOI 10.1016/0021-9290(95)00025-9; Konradsen L, 2002, J Electromyogr Kinesiol, V12, P199, DOI 10.1016/S1050-6411(02)00021-4; Konradsen L, 1997, AM J SPORT MED, V25, P54, DOI 10.1177/036354659702500110; Mattacola CG, 2002, J ATHL TRAINING, V37, P413; Melchiorri G, 2011, J ELECTROMYOGR KINES, V21, P954, DOI 10.1016/j.jelekin.2011.07.015; Milani TL, 2000, SPORTVERLETZ SPORTSC, V14, P115, DOI 10.1055/s-2000-7871; Munn J, 2005, J APPL PHYSIOL, V99, P1880, DOI 10.1152/japplphysiol.00559.2005; Podzielny S, 1997, CLIN BIOMECH, V12, P253, DOI 10.1016/S0268-0033(96)00066-6; Sale DG, 1991, PHYSL TESTING HIGH P, P21; SAMORAJSKI T, 1975, J COMP NEUROL, V159, P553, DOI 10.1002/cne.901590407; SHAPIRO MS, 1994, AM J SPORT MED, V22, P78, DOI 10.1177/036354659402200114; Shultz SJ, 2012, AM J SPORT MED, V40, P2836, DOI 10.1177/0363546512461744; STACOFF A, 1992, MED SCI SPORT EXER, V24, P695; Timmons JA, 2011, J APPL PHYSIOL, V110, P846, DOI 10.1152/japplphysiol.00934.2010; TROPP H, 1986, INT J SPORTS MED, V7, P291, DOI 10.1055/s-2008-1025777; Willems T, 2002, J ATHL TRAINING, V37, P487; Wright IC, 2000, J BIOMECH, V33, P513, DOI 10.1016/S0021-9290(99)00218-3	52	2	2	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130290	10.1371/journal.pone.0130290	http://dx.doi.org/10.1371/journal.pone.0130290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110847	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800040
J	Lee, MJ; Kim, N; Choe, JY; Khwarg, SI; Jeon, YK; Choung, HK; Kim, JE				Lee, Min Joung; Kim, Namju; Choe, Ji-Young; Khwarg, Sang In; Jeon, Yoon Kyung; Choung, Ho-Kyung; Kim, Ji Eun			Clinicopathological Analysis of Ocular Adnexal Extranodal Marginal Zone B-Cell Lymphoma with IgG4-Positive Cells	PLOS ONE			English	Article							IGG4-RELATED SYSTEMIC-DISEASE; MALT LYMPHOMA; TISSUE LYMPHOMA; ORBITAL INFLAMMATION; PSITTACI INFECTION; CHLAMYDIA-PSITTACI; INVOLVEMENT; THERAPY; MODEL; KOREA	This study aims to analyze clinical and pathologicalcharacteristics of ocular adnexal extranodal marginal zone B-celllymphoma (EMZL) accompanying IgG4-positive cells. Fifty patients with a diagnosis of primary non-conjunctival ocular adnexal EMZL were enrolled in this study. The number of IgG4-positive cells and the ratio of IgG/IgG4 were evaluated by immunohistochemistry in the biopsy specimens. The patients were divided into two groups based on the absolute number and the ratio of IgG4-positive cells (IgG4-posivite vs IgG4-negative groups). The demographic data, clinical staging at diagnosis, histopathological characteristics, and response to initial treatment were comparatively analyzed between the 2 groups. Five (10%) of 50 patients were defined as IgG4-positive group, and all the cases showed characteristic histological features such as extensive plasma cell infiltration and dense fibrosis. Most of these patients (4 of 5 patients) had lymphoma of the lacrimal gland. The patients from the IgG4-positive group showed a lower response rate to initial treatment (87.5 vs 33%, p = 0.03) than IgG4-negative group with a median follow-up period of 38 months. A part of the ocular adnexal EMZLs were accompanied with IgG4-positive cells. Significantly, most IgG4-positive ocular adnexal EMZLs occurred in the lacrimal gland, and can be related with a more frequent treatment failure.	[Lee, Min Joung] Hallym Univ, Sacred Heart Hosp, Dept Ophthalmol, Anyang, South Korea; [Kim, Namju] Seoul Natl Univ, Bundang Hosp, Dept Ophthalmol, Seungnam, South Korea; [Choe, Ji-Young] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Seungnam, South Korea; [Khwarg, Sang In] Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul 110744, South Korea; [Jeon, Yoon Kyung] Seoul Natl Univ Hosp, Dept Pathol, Seoul 110744, South Korea; [Choung, Ho-Kyung] Seoul Natl Univ, Boramae Hosp, Dept Ophthalmol, Seoul, South Korea; [Kim, Ji Eun] Seoul Natl Univ, Boramae Hosp, Dept Pathol, Seoul, South Korea	Hallym University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Choung, HK (corresponding author), Seoul Natl Univ, Boramae Hosp, Dept Ophthalmol, Seoul, South Korea.	hokyung214@gmail.com; npol181@snu.ac.kr	Kim, Ji Eun/J-5440-2012	Kim, Ji Eun/0000-0002-2156-9875	Seoul National University Hospital Research Fund [04-2005-0270]	Seoul National University Hospital Research Fund	This study was supported by a grant no 04-2005-0270 from the Seoul National University Hospital Research Fund (SIK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew N, 2013, ACTA OPHTHALMOL, V91, P694, DOI 10.1111/j.1755-3768.2012.02526.x; Batra R, 2012, OPHTHAL PLAST RECONS, V28, pE70, DOI 10.1097/IOP.0b013e31822d7f9b; Bi YW, 2012, HAEMATOL-HEMATOL J, V97, P926, DOI 10.3324/haematol.2010.036798; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Cheuk W, 2008, AM J SURG PATHOL, V32, P1159, DOI 10.1097/PAS.0b013e31816148ad; Choung HK, 2012, INVEST OPHTH VIS SCI, V53, P1928, DOI 10.1167/iovs.11-7668; Collina F, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-8; Coupland SE, 2009, ARCH PATHOL LAB MED, V133, P1262, DOI 10.1043/1543-2165-133.8.1262; Coupland SE, 2004, GRAEF ARCH CLIN EXP, V242, P130, DOI 10.1007/s00417-003-0831-5; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Ferreri AJM, 2008, ANN ONCOL, V19, P835, DOI 10.1093/annonc/mdm513; Ferry JA, 1996, AM J CLIN PATHOL, V105, P31; Go H, 2012, HISTOPATHOLOGY, V60, P296, DOI 10.1111/j.1365-2559.2011.04089.x; Gruenberger B, 2008, ACTA ONCOL, V47, P355, DOI 10.1080/02841860701630283; Kanari H, 2010, INT ARCH ALLERGY IMM, V152, P47, DOI 10.1159/000312125; Kim TM, 2010, CANCER SCI, V101, P1199, DOI 10.1111/j.1349-7006.2010.01502.x; Kubota T, 2008, AM J OPHTHALMOL, V145, P1002, DOI 10.1016/j.ajo.2008.01.006; Kubota T, 2010, J CLIN PATHOL, V63, P1059, DOI 10.1136/jcp.2010.082156; Masaki Y, 2011, J CLIN EXP HEMATOP, V51, P13, DOI 10.3960/jslrt.51.13; Oyama T, 2011, JPN J OPHTHALMOL, V55, P304, DOI 10.1007/s10384-011-0003-9; Pasquali T, 2011, ORBIT, V30, P258, DOI 10.3109/01676830.2011.593677; Paulus YM, 2012, OCUL IMMUNOL INFLAMM, V20, P375, DOI 10.3109/09273948.2012.709574; Sagaert X, 2007, LEUKEMIA, V21, P389, DOI 10.1038/sj.leu.2404517; Sagaert X, 2010, NAT REV GASTRO HEPAT, V7, P336, DOI 10.1038/nrgastro.2010.58; Sah RP, 2011, CURR OPIN RHEUMATOL, V23, P108, DOI 10.1097/BOR.0b013e3283413469; Sato Y, 2008, PATHOL INT, V58, P465, DOI 10.1111/j.1440-1827.2008.02257.x; Stefanovic A, 2009, BLOOD, V114, P501, DOI 10.1182/blood-2008-12-195453; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Strehl JD, 2011, J CLIN PATHOL, V64, P237, DOI 10.1136/jcp.2010.085613; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; van de Schans SAM, 2011, AUTOIMMUN REV, V10, P228, DOI 10.1016/j.autrev.2010.11.001; Wallace ZS, 2012, SURV OPHTHALMOL, V57, P26, DOI 10.1016/j.survophthal.2011.07.004; Yamamoto M, 2012, MOD RHEUMATOL, V22, P414, DOI 10.1007/s10165-011-0520-x; Yamamoto M, 2012, INTERNAL MED, V51, P349, DOI 10.2169/internalmedicine.51.6782; Yoo C, 2007, AM J HEMATOL, V82, P821, DOI 10.1002/ajh.20962	35	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131458	10.1371/journal.pone.0131458	http://dx.doi.org/10.1371/journal.pone.0131458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111022	gold, Green Published, Green Submitted			2022-12-27	WOS:000356933800151
J	Nater, UM; La Marca, R; Erni, K; Ehlert, U				Nater, Urs M.; La Marca, Roberto; Erni, Katja; Ehlert, Ulrike			Alpha-Amylase Activity in Blood Increases after Pharmacological, But Not Psychological, Activation of the Adrenergic System	PLOS ONE			English	Article							ACUTE-PANCREATITIS; SALIVARY AMYLASE; BULIMIA-NERVOSA; SERUM; STRESS; HYPERAMYLASEMIA; ISOENZYMES; RESPONSES; EXERCISE; PLASMA	Background & Aim Alpha-amylase in both blood and saliva has been used as a diagnostic parameter. While studies examining alpha-amylase activity in saliva have shown that it is sensitive to physiological and psychological challenge of the adrenergic system, no challenge studies have attempted to elucidate the role of the adrenergic system in alpha-amylase activity in blood. We set out to examine the impact of psychological and pharmacological challenge on alpha-amylase in blood in two separate studies. Methods In study 1, healthy subjects were examined in a placebo-controlled, double-blind paradigm using yohimbine, an alpha2-adrenergic antagonist. In study 2, subjects were examined in a standardized rest-controlled psychosocial stress protocol. Alpha-amylase activity in blood was repeatedly measured in both studies. Results Results of study 1 showed that alpha-amylase in blood is subject to stronger increases after injection of yohimbine compared to placebo. In study 2, results showed that there was no significant effect of psychological stress compared to rest. Conclusions Alpha-amylase in blood increases after pharmacological activation of the adrenergic pathways suggesting that sympathetic receptors are responsible for these changes. Psychological stress, however, does not seem to have an impact on alpha-amylase in blood. Our findings provide insight into the mechanisms underlying activity changes in alpha-amylase in blood in healthy individuals.	[Nater, Urs M.] Univ Marburg, Dept Psychol, D-35032 Marburg, Germany; [La Marca, Roberto; Erni, Katja; Ehlert, Ulrike] Univ Zurich, Dept Psychol, Zurich, Switzerland	Philipps University Marburg; University of Zurich	Nater, UM (corresponding author), Univ Marburg, Dept Psychol, D-35032 Marburg, Germany.	nater@uni-marburg.de	Nater, Urs/Q-5208-2019	Nater, Urs/0000-0002-2430-5090; La Marca, Roberto/0000-0003-1975-0285				Benifla M, 2003, J CLIN GASTROENTEROL, V37, P169, DOI 10.1097/00004836-200308000-00015; Bosch JA, 2003, PSYCHOSOM MED, V65, P245, DOI 10.1097/01.PSY.0000058376.50240.2D; Chatterton RT, 1997, J CLIN ENDOCR METAB, V82, P2503, DOI 10.1210/jc.82.8.2503; DAVIDSON GP, 1978, PEDIATR RES, V12, P967, DOI 10.1203/00006450-197810000-00003; DUBICK MA, 1987, GUT, V28, P330, DOI 10.1136/gut.28.3.330; Ehlert U, 2006, J CLIN ENDOCR METAB, V91, P5130, DOI 10.1210/jc.2006-0461; ELLIS C, 1982, DIGEST DIS SCI, V27, P897, DOI 10.1007/BF01316573; GILLARD BK, 1983, CLIN CHEM, V29, P1119; GWIRTSMAN HE, 1989, J CLIN PSYCHIAT, V50, P196; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; KRONVALL P, 1992, BIOL PSYCHIAT, V32, P156, DOI 10.1016/0006-3223(92)90018-U; Lankisch PG, 1999, GUT, V44, P542, DOI 10.1136/gut.44.4.542; LEVITT MD, 1980, NEW ENGL J MED, V302, P670, DOI 10.1056/NEJM198003203021206; Medaille C, 2004, VET CLIN PATH, V33, P155, DOI 10.1111/j.1939-165X.2004.tb00366.x; Nagy A, 2001, J PHYSIOL-PARIS, V95, P141, DOI 10.1016/S0928-4257(01)00018-3; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Nater UM, 2006, PSYCHONEUROENDOCRINO, V31, P49, DOI 10.1016/j.psyneuen.2005.05.010; Nater UM, 2005, INT J PSYCHOPHYSIOL, V55, P333, DOI 10.1016/j.ijpsycho.2004.09.009; NEXO E, 1988, SCAND J CLIN LAB INV, V48, P269, DOI 10.3109/00365518809167494; OLSEN PS, 1988, DIGESTION, V41, P34, DOI 10.1159/000199729; PIEPERBIGELOW C, 1990, GASTROENTEROL CLIN N, V19, P793; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; SCHEUTZEL P, 1991, Z GASTROENTEROL, V29, P339; Smotkin J, 2002, J CLIN GASTROENTEROL, V34, P459, DOI 10.1097/00004836-200204000-00018; SRAMEK JJ, 1995, PROG NEURO-PSYCHOPH, V19, P85, DOI 10.1016/0278-5846(94)00107-S; van Stegeren A, 2006, PSYCHONEUROENDOCRINO, V31, P137, DOI 10.1016/j.psyneuen.2005.05.012; Vissers RJ, 1999, J EMERG MED, V17, P1027, DOI 10.1016/S0736-4679(99)00136-5; Walsh NP, 1999, J SPORT SCI, V17, P129, DOI 10.1080/026404199366226; WARSHAW AL, 1988, AM J SURG, V155, P453, DOI 10.1016/S0002-9610(88)80112-0; Yadav D, 2002, AM J GASTROENTEROL, V97, P1309, DOI 10.1016/S0002-9270(02)04122-9; ZAKOWSKI JJ, 1985, CRC CR REV CL LAB SC, V21, P283, DOI 10.3109/10408368509165786	31	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130449	10.1371/journal.pone.0130449	http://dx.doi.org/10.1371/journal.pone.0130449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110636	Green Published, Green Accepted, gold			2022-12-27	WOS:000356933800049
J	Ottiger, B; Vanbellingen, T; Gabriel, C; Huberle, E; Koenig-Bruhin, M; Plugshaupt, T; Bohlhalter, S; Nyffeler, T				Ottiger, Beatrice; Vanbellingen, Tim; Gabriel, Claudia; Huberle, Elisabeth; Koenig-Bruhin, Monica; Plugshaupt, Tobias; Bohlhalter, Stephan; Nyffeler, Thomas			Validation of the New Lucerne ICF Based Multidisciplinary Observation Scale (LIMOS) for Stroke Patients	PLOS ONE			English	Article							INTERNATIONAL CLASSIFICATION; HEALTH ICF; CORE SETS; DISABILITY; REHABILITATION; CARE; QUESTIONNAIRE	Background Valid and multidisciplinary assessment of a stroke patient's ability to perform activities of daily living is very important to define individual goals and to plan targeted rehabilitation. Until today, there is no observation scale that relies on International Classification of Functioning, Disability and Health (ICF). The aim of the present study was to develop and evaluate the reliability and validity of a new multidisciplinary observation scale for stroke patients, shortly called LIMOS, which is based on ICF. Methods In a first phase, LIMOS was defined, using a Delphi approach, by an expert panel and a pilot testing was conducted in a small group of stroke patients (n = 10) to investigate feasibility and practicability. In a second phase, LIMOS was assessed for its reliability (internal consistency and test-retest reliability) and validity in a large cohort of stroke patients (n = 102). For convergent validity, the correlation between total scores of the LIMOS and the Functional Independence Measure (FIM) was assessed. Results LIMOS consisted of seven ICF chapters incorporating 45 domains. A high internal consistency (=0.98) of LIMOS was found. Furthermore, good test-retest reliability at item and subscale level was found. Principal component analysis revealed that among the seven ICF chapters, four components could be found: (1) interpersonal activities, mobility and self-care, (2) communication, (3) knowledge and general tasks, and (4) domestic life. Significant associations were found between LIMOS and the FIM indicating good convergent validity. Conclusions The new LIMOS is a reliable and valid observation scale for stroke patients based on ICF, which can be used by a multidisciplinary team working in a neurorehabilitation setting.	[Ottiger, Beatrice; Vanbellingen, Tim; Gabriel, Claudia; Huberle, Elisabeth; Koenig-Bruhin, Monica; Plugshaupt, Tobias; Bohlhalter, Stephan; Nyffeler, Thomas] Luzerner Kantonsspital, Neurol & Neurorehabil Ctr, Luzern, Switzerland	Lucerne Cantonal Hospital	Nyffeler, T (corresponding author), Luzerner Kantonsspital, Neurol & Neurorehabil Ctr, Luzern, Switzerland.	thomas.nyffeler@luks.ch		Vanbellingen, Tim/0000-0002-0884-2005; Bohlhalter, Stephan/0000-0002-0723-8164; Nyffeler, Thomas/0000-0003-2504-8935	Swiss National Science Foundation [320030_140696]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (Grant Number 320030_140696).	Baker K, 2011, STROKE, V42, P1787, DOI 10.1161/STROKEAHA.110.608505; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Cieza A, 2004, J REHABIL MED, V36, P9, DOI 10.1080/16501960410015353; Desrosiers J, 2003, ARCH GERONTOL GERIAT, V37, P157, DOI 10.1016/S0167-4943(03)00044-X; Evans A, 2002, STROKE, V33, P449, DOI 10.1161/hs0202.102364; Farin E, 2007, J REHABIL MED, V39, P537, DOI 10.2340/16501977-0083; Fleiss JL., 1986, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923.ch1, DOI 10.1002/9781118032923.CH1, DOI 10.1002/9781118032923]; Frank M, 2010, EUR NEUROL, V63, P227, DOI 10.1159/000279491; Garin O, 2010, HEALTH QUAL LIFE OUT, V19, P8, DOI DOI 10.1186/1477-7525-8-51.PUBMED:20482853; Glassel A, 2010, CAN J OCCUP THER, V77, P289, DOI 10.2182/cjot.2010.77.5.5; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Grill E, 2006, AM J PHYS MED REHAB, V85, P640, DOI 10.1097/01.phm.0000228537.17239.7f; Huber E, 2011, J REHABIL MED, V43, P1650; Kwakkel G, 2014, TXB NEURAL REPAIR RE; Kwon S, 2004, STROKE, V35, P918, DOI 10.1161/01.STR.0000119385.56094.32; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Lin Jau-Hong, 2004, Kaohsiung Journal of Medical Sciences, V20, P287; Miller EL, 2010, STROKE, V41, P2402, DOI 10.1161/STR.0b013e3181e7512b; Muller M, 2011, J REHABIL MED, V43, P92, DOI 10.2340/16501977-0622; Noonan V, 2009, BIOMED CENTRAL LTD, V7, P43; Nyein K, 1999, CLIN REHABIL, V13, P56, DOI 10.1191/026921599701532135; Persoon A, 2011, ISRN NURSING; Post MWM, 2008, J REHABIL MED, V40, P620, DOI 10.2340/16501977-0223; Rentsch HP, 2003, DISABIL REHABIL, V25, P411, DOI 10.1080/0963828031000069717; Stucki G, 2004, J REHABIL MED, V36, P5, DOI 10.1080/16501960410022300; Weimar C, 2002, STROKE, V33, P2053, DOI 10.1161/01.STR.0000022808.21776.BF; WHO, 2001, WHO INT CLASS FUNCT	27	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130925	10.1371/journal.pone.0130925	http://dx.doi.org/10.1371/journal.pone.0130925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110769	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800098
J	Roda, D; Castillo, J; Telechea-Fernandez, M; Gil, A; Lopez-Rodas, G; Franco, L; Gonzalez-Rodriguez, P; Rosello, S; Perez-Fidalgo, JA; Garcia-Trevijano, ER; Cervantes, A; Zaragoza, R				Roda, Desamparados; Castillo, Josefa; Telechea-Fernandez, Marcelino; Gil, Anabel; Lopez-Rodas, Gerardo; Franco, Luis; Gonzalez-Rodriguez, Patricia; Rosello, Susana; Alejandro Perez-Fidalgo, J.; Garcia-Trevijano, Elena R.; Cervantes, Andres; Zaragoza, Rosa			EGF-Induced Acetylation of Heterogeneous Nuclear Ribonucleoproteins Is Dependent on KRAS Mutational Status in Colorectal Cancer Cells	PLOS ONE			English	Article							K-RAS MUTATIONS; MAMMARY-GLAND; CODON 61; CETUXIMAB; RESISTANCE; ADENOCARCINOMA; APOPTOSIS; PATHWAYS; THERAPY; KINASE	KRAS mutational status is considered a negative predictive marker of the response to anti-EGFR therapies in colorectal cancer (CRC) patients. However, conflicting data exist regarding the variable response to EGFR-targeted therapy. The effects of oncogenic KRAS on downstream targets were studied in cell lines with different KRAS mutations. Cells harboring a single KRAS(G13D) allele showed the most tumorigenic profile, with constitutive activation of the downstream pathway, rendering them EGF-unresponsive. Conversely, KRAS(A146T) cells showed a full EGF-response in terms of signal transduction pathways, cell proliferation, migration or adhesion. Moreover, the global acetylome of CRC cells was also dependent on KRAS mutational status. Several hnRNP family members were identified within the 36 acetylated-proteins. Acetylation status is known to be involved in the modulation of EGF-response. In agreement with results presented herein, hnRNPA1 and L acetylation was induced in response to EGF in KRAS(A146T) cells, whereas acetyl-hnRNPA1 and L levels remained unchanged after growth factor treatment in KRASG13D unresponsive cells. Our results showed that hnRNPs induced-acetylation is dependent on KRAS mutational status. Nevertheless hnRNPs acetylation might also be the point where different oncogenic pathways converge.	[Roda, Desamparados; Castillo, Josefa; Telechea-Fernandez, Marcelino; Gil, Anabel; Rosello, Susana; Alejandro Perez-Fidalgo, J.; Cervantes, Andres; Zaragoza, Rosa] Univ Valencia, INCLIVA Biomed Res Inst, Dept Haematol & Med Oncol, Valencia, Spain; [Lopez-Rodas, Gerardo; Franco, Luis; Gonzalez-Rodriguez, Patricia; Garcia-Trevijano, Elena R.] Univ Valencia, INCLIVA Biomed Res Inst, Dept Biochem & Mol Biol, Valencia, Spain	University of Valencia; University of Valencia	Cervantes, A (corresponding author), Univ Valencia, INCLIVA Biomed Res Inst, Dept Haematol & Med Oncol, Valencia, Spain.	Andres.cervantes@uv.es	Ruiz García-Trevijano, Elena R./ABE-1014-2021; Keranen, Susana Rosello/E-7734-2015; González-Rodríguez, Patricia/AAA-1492-2022; Perez-Fidalgo, Alejandro/P-2944-2014; Cervantes, Andres/J-8713-2013; LOPEZ-RODAS, GERARDO/I-1349-2015	Ruiz García-Trevijano, Elena R./0000-0002-3985-1270; Keranen, Susana Rosello/0000-0003-3915-4130; Perez-Fidalgo, Alejandro/0000-0003-3568-4345; Cervantes, Andres/0000-0003-3806-3691; Zaragoza, Rosa/0000-0001-8280-5838; LOPEZ-RODAS, GERARDO/0000-0001-8367-653X; Castillo Aliaga, Josefa/0000-0002-4092-0085; Franco, Luis/0000-0001-9610-6448	Spanish government, Ministerio de Economia y Competitividad and FEDER [FIS PI09/02480, PI12/02767, FIS PI12/02394, FIS PI12/02110]; Generalitat Valenciana [PROMETEO 2013-005]; Ministerio de Ciencia e Innovacion (Rio Hortega Program); Sociedad Espanola Oncologia Medica (SEOM); Spanish Association Against Cancer (AECC, Provincial Board of Baleares)	Spanish government, Ministerio de Economia y Competitividad and FEDER; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Ministerio de Ciencia e Innovacion (Rio Hortega Program); Sociedad Espanola Oncologia Medica (SEOM); Spanish Association Against Cancer (AECC, Provincial Board of Baleares)	This work was supported in part by grants from Spanish government, Ministerio de Economia y Competitividad and FEDER grants (FIS PI09/02480 and PI12/02767 to AC; FIS PI12/02394 to ERGT and FIS PI12/02110 to GLR) and Generalitat Valenciana (PROMETEO 2013-005 to AC). DR held a fellowship from Ministerio de Ciencia e Innovacion (Rio Hortega Program) and from Sociedad Espanola Oncologia Medica (SEOM); MTM is a pre-doctoral fellow from Generalitat Valenciana (Prometeo) and AG is a recipient of postdoctoral fellowship from Spanish Association Against Cancer (AECC, Provincial Board of Baleares).	Arnandis T, 2012, CELL DEATH DIFFER, V19, P1536, DOI 10.1038/cdd.2012.46; Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Chen LC, 2009, ONCOGENE, V28, P1904, DOI 10.1038/onc.2009.55; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Ciardiello F, 2014, ANN ONCOL, V25, P1756, DOI 10.1093/annonc/mdu230; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Emonds E, 2010, WORLD J GASTROENTERO, V16, P1970, DOI 10.3748/wjg.v16.i16.1970; Er TK, 2014, CANCER LETT, V343, P1, DOI 10.1016/j.canlet.2013.09.012; Gryder BE, 2012, FUTURE MED CHEM, V4, P505, DOI [10.4155/FMC.12.3, 10.4155/fmc.12.3]; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hartman DJ, 2012, INT J CANCER, V131, P1810, DOI 10.1002/ijc.27461; Hayashi H, 2008, GENES CELLS, V13, P941, DOI 10.1111/j.1365-2443.2008.01218.x; Imamura Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-135; Jeannot V, 2014, INT J CANCER, V134, P2560, DOI 10.1002/ijc.28594; Jung JW, 2005, CANCER LETT, V225, P199, DOI 10.1016/j.canlet.2004.11.029; Kalikaki A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104902; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; LaBonte MJ, 2011, CANCER RES, V71, P3635, DOI 10.1158/0008-5472.CAN-10-2430; Liu L, 2010, BIOCHEM BIOPH RES CO, V392, P190, DOI 10.1016/j.bbrc.2010.01.011; Loupakis F, 2009, BRIT J CANCER, V101, P715, DOI 10.1038/sj.bjc.6605177; Ma YL, 2009, J PROTEOME RES, V8, P4525, DOI 10.1021/pr900365e; Parikh N, 2012, MOL CANCER RES, V10, P845, DOI 10.1158/1541-7786.MCR-12-0089; Sanchez-Quiles V, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009126; Smith G, 2010, BRIT J CANCER, V102, P693, DOI 10.1038/sj.bjc.6605534; Smith G, 2005, LIMMA LINEAR MODELS; Tan Gong-Jun, 2013, World J Biol Chem, V4, P91, DOI 10.4331/wjbc.v4.i4.91; Tyner JW, 2009, BLOOD, V113, P1749, DOI 10.1182/blood-2008-04-152157; Ushigome M, 2005, INT J ONCOL, V26, P635; Van Cutsem E, 2014, ANN ONCOL, V25, P1, DOI 10.1093/annonc/mdu260; Van Schaeybroeck S, 2011, CANCER RES, V71, P1071, DOI 10.1158/0008-5472.CAN-10-0714; Wang HL, 2010, ADV ANAT PATHOL, V17, P23, DOI 10.1097/PAP.0b013e3181c6962f; Yuen HF, 2012, BIOSCIENCE REP, V32, P413, DOI 10.1042/BSR20120050; Zaragoza R, 2005, BIOCHEM J, V391, P581, DOI 10.1042/BJ20050507	39	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130543	10.1371/journal.pone.0130543	http://dx.doi.org/10.1371/journal.pone.0130543			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110767	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800062
J	Torun, A; Szymanska, E; Castanon, I; Wolinska-Niziol, L; Bartosik, A; Jastrzebski, K; Mietkowska, M; Gonzalez-Gaitan, M; Miaczynska, M				Torun, Anna; Szymanska, Ewelina; Castanon, Irinka; Wolinska-Niziol, Lidia; Bartosik, Anna; Jastrzebski, Kamil; Mietkowska, Magdalena; Gonzalez-Gaitan, Marcos; Miaczynska, Marta			Endocytic Adaptor Protein Tollip Inhibits Canonical Wnt Signaling	PLOS ONE			English	Article							WNT/BETA-CATENIN PATHWAY; BETA-CATENIN; INTRACELLULAR TRAFFICKING; MOLECULAR-MECHANISM; NEGATIVE REGULATOR; CYCLIN D1; EXPRESSION; ACTIVATION; AUTOPHAGY; UBIQUITIN	Many adaptor proteins involved in endocytic cargo transport exhibit additional functions in other cellular processes which may be either related to or independent from their trafficking roles. The endosomal adaptor protein Tollip is an example of such a multitasking regulator, as it participates in trafficking and endosomal sorting of receptors, but also in interleukin/Toll/NF-kappa B signaling, bacterial entry, autophagic clearance of protein aggregates and regulation of sumoylation. Here we describe another role of Tollip in intracellular signaling. By performing a targeted RNAi screen of soluble endocytic proteins for their additional functions in canonical Wnt signaling, we identified Tollip as a potential negative regulator of this pathway in human cells. Depletion of Tollip potentiates the activity of beta-catenin/TCF-dependent transcriptional reporter, while its overproduction inhibits the reporter activity and expression of Wnt target genes. These effects are independent of dynamin-mediated endocytosis, but require the ubiquitin-binding CUE domain of Tollip. In Wnt-stimulated cells, Tollip counteracts the activation of beta-catenin and its nuclear accumulation, without affecting its total levels. Additionally, under conditions of ligand-independent signaling, Tollip inhibits the pathway after the stage of beta-catenin stabilization, as observed in human cancer cell lines, characterized by constitutive beta-catenin activity. Finally, the regulation of Wnt signaling by Tollip occurs also during early embryonic development of zebrafish. In summary, our data identify a novel function of Tollip in regulating the canonical Wnt pathway which is evolutionarily conserved between fish and humans. Tollip-mediated inhibition of Wnt signaling may contribute not only to embryonic development, but also to carcinogenesis. Mechanistically, Tollip can potentially coordinate multiple cellular pathways of trafficking and signaling, possibly by exploiting its ability to interact with ubiquitin and the sumoylation machinery.	[Torun, Anna; Szymanska, Ewelina; Wolinska-Niziol, Lidia; Bartosik, Anna; Jastrzebski, Kamil; Mietkowska, Magdalena; Miaczynska, Marta] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland; [Castanon, Irinka; Gonzalez-Gaitan, Marcos] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; University of Geneva	Miaczynska, M (corresponding author), Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland.	miaczynska@iimcb.gov.pl	Szymanska, Ewelina/HDN-3845-2022; Jastrzebski, Kamil/AAB-3994-2021	Miaczynska, Marta/0000-0003-0031-5267; Gonzalez-Gaitan, Marcos/0000-0002-6295-7321; Szymanska, Ewelina/0000-0001-7994-0764; Jastrzebski, Kamil/0000-0001-6481-1759; Wolinska-Niziol, Lidia/0000-0002-5540-9845	MAESTRO Grant from National Science Center [UMO-2011/02/A/NZ3/00149]; short-term EMBO fellowship; Parent-Bridge Program of Foundation for Polish Scienc; EU under European Regional Development Fund [POMOST/2011-3/11]; EU FP7 Grant FishMed GA [316125]; Foundation for Polish Science; European Union - Regional Development Fund; Departement d'Instruction Publique of the Canton of Geneva; SNSF; SystemsX epiPhysX grant; ERC; NCCR Frontiers in Genetics and Chemical Biology programs; Swiss Contribution to Enlarged European Union (PolishSwiss Research Programme) [PSPB-094/2010];  [N N301 296437]	MAESTRO Grant from National Science Center; short-term EMBO fellowship; Parent-Bridge Program of Foundation for Polish Scienc; EU under European Regional Development Fund; EU FP7 Grant FishMed GA; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union - Regional Development Fund(European Commission); Departement d'Instruction Publique of the Canton of Geneva; SNSF(Swiss National Science Foundation (SNSF)); SystemsX epiPhysX grant; ERC(European Research Council (ERC)European Commission); NCCR Frontiers in Genetics and Chemical Biology programs; Swiss Contribution to Enlarged European Union (PolishSwiss Research Programme); 	This work was supported by grant number N N301 296437 and a MAESTRO Grant (UMO-2011/02/A/NZ3/00149) from the National Science Center to M. Miaczynska (www.ncn.gov.pl). AT received a short-term EMBO fellowship (www.embo.org). ES was supported by the Parent-Bridge Program of Foundation for Polish Science, co-financed from the EU under the European Regional Development Fund (POMOST/2011-3/11; www.fnp.org.pl); LWN and AB by the EU FP7 Grant FishMed GA No. 316125 (http://fishmed.iimcb.gov.pl). KJ was supported by the Foundation for Polish Science within the International PhD Project 'Studies of nucleic acids and proteins from basic to applied research', co-financed from the European Union - Regional Development Fund. Work in the lab of MGG was supported by the Departement d'Instruction Publique of the Canton of Geneva (www.ge.ch/dip), SNSF (www.snf.ch/en/Pages/default.aspx), the SystemsX epiPhysX grant (www.systemsx.ch), ERC advanced grants (Sara and Morphogen; http://erc.europa.eu), the NCCR Frontiers in Genetics and Chemical Biology programs (www.snf.ch/en/funding/programmes/national-centres-of-competence-in-research-nccr/Pages/default.aspx) and a grant from Switzerland through the Swiss Contribution to the Enlarged European Union (PolishSwiss Research Programme project PSPB-094/2010; www.swiss.opi.org.pl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JW, 2009, BIOCHEM BIOPH RES CO, V379, P160, DOI 10.1016/j.bbrc.2008.12.043; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Andersson ER, 2012, CELL MOL LIFE SCI, V69, P1755, DOI 10.1007/s00018-011-0877-1; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Ankem G, 2011, BIOCHEM J, V435, P597, DOI 10.1042/BJ20102160; Bellipanni G, 2006, DEVELOPMENT, V133, P1299, DOI 10.1242/dev.02295; Brissoni B, 2006, CURR BIOL, V16, P2265, DOI 10.1016/j.cub.2006.09.062; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Cao H, 2000, J CELL SCI, V113, P1993; Capelluto DGS, 2012, MICROBES INFECT, V14, P140, DOI 10.1016/j.micinf.2011.08.018; Choi HK, 2011, MOL CELL, V43, P203, DOI 10.1016/j.molcel.2011.05.027; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Ciarrocchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004404; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Erter CE, 2001, DEVELOPMENT, V128, P3571; Forget MA, 2007, BRIT J CANCER, V96, P646, DOI 10.1038/sj.bjc.6603579; Furthauer M, 1997, DEVELOPMENT, V124, P4253; Gagliardi M, 2008, TRAFFIC, V9, P1, DOI 10.1111/j.1600-0854.2007.00662.x; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Hashimoto H, 2000, DEV BIOL, V217, P138, DOI 10.1006/dbio.1999.9537; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jia ZQ, 2014, CELL SIGNAL, V26, P2299, DOI 10.1016/j.cellsig.2014.07.028; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Katoh Y, 2004, J BIOL CHEM, V279, P24435, DOI 10.1074/jbc.M400059200; Kim I, 2013, J CELL BIOL, V200, P419, DOI 10.1083/jcb.201206096; Kim JH, 2006, NAT CELL BIOL, V8, P631, DOI 10.1038/ncb1415; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Laszlo B, 2010, FEBS J, V277, P4348, DOI 10.1111/j.1742-4658.2010.07864.x; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Li T, 2004, MOL IMMUNOL, V41, P85, DOI 10.1016/j.molimm.2004.03.009; Lo YLS, 2009, MAMM GENOME, V20, P305, DOI 10.1007/s00335-009-9188-3; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maitra U, 2013, ARTERIOSCL THROM VAS, V33, P24, DOI 10.1161/ATVBAHA.112.300049; Major MB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000037; Mitra S, 2013, J BIOL CHEM, V288, P25780, DOI 10.1074/jbc.M113.484170; Montero JA, 2003, CURR BIOL, V13, P1279, DOI 10.1016/S0960-9822(03)00505-0; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Pan WJ, 2008, SCIENCE, V321, P1350, DOI 10.1126/science.1160741; Perrimon N, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005975; Petherick KJ, 2013, EMBO J, V32, P1903, DOI 10.1038/emboj.2013.123; Pilecka I, 2007, EUR J CELL BIOL, V86, P533, DOI 10.1016/j.ejcb.2007.04.004; Pimentel-Nunes P, 2012, J CLIN PATHOL, V65, P302, DOI 10.1136/jclinpath-2011-200567; Pyrzynska B, 2009, MOL ONCOL, V3, P321, DOI 10.1016/j.molonc.2009.06.001; Rashid S, 2009, J BIOL CHEM, V284, P18115, DOI 10.1074/jbc.M109.007237; Royle SJ, 2011, TRAFFIC, V12, P791, DOI 10.1111/j.1600-0854.2011.01184.x; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Scholpp S, 2004, CURR BIOL, V14, P1834, DOI 10.1016/j.cub.2004.09.084; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P843; Shimizu T, 2005, DEV BIOL, V279, P125, DOI 10.1016/j.ydbio.2004.12.007; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sparks AB, 1998, CANCER RES, V58, P1130; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tanneberger K, 2011, EMBO J, V30, P1433, DOI 10.1038/emboj.2011.28; Tauriello DVF, 2010, CELL CYCLE, V9, P3700, DOI 10.4161/cc.9.18.13204; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Visvikis O, 2011, TRAFFIC, V12, P579, DOI 10.1111/j.1600-0854.2011.01174.x; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Wu MY, 2014, ONCOL REP, V32, P513, DOI 10.3892/or.2014.3266; Wu XT, 2013, BIOCHEM SOC T, V41, P1489, DOI 10.1042/BST20130185; Yamakami M, 2003, J BIOL CHEM, V278, P52865, DOI 10.1074/jbc.M306740200; Yamamoto H, 2003, EMBO J, V22, P2047, DOI 10.1093/emboj/cdg204; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Yamashina K, 2006, J BIOCHEM, V139, P305, DOI 10.1093/jb/mvj033; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Yang CK, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-12; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Zhu L, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.388009	88	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130818	10.1371/journal.pone.0130818	http://dx.doi.org/10.1371/journal.pone.0130818			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110841	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800088
J	Xu, WJ; Xing, T; Zhao, MM; Yin, XH; Xia, GM; Wang, MC				Xu, Wenjing; Xing, Tian; Zhao, Mingming; Yin, Xunhao; Xia, Guangmin; Wang, Mengcheng			Synonymous Codon Usage Bias in Plant Mitochondrial Genes Is Associated with Intron Number and Mirrors Species Evolution	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; DNA METHYLATION; NUCLEOTIDE SUBSTITUTION; HORNWORT CHLOROPLASTS; MOLECULAR EVOLUTION; GENOMES; SELECTION; EXPRESSION; PATTERN; SHOWS	Synonymous codon usage bias (SCUB) is a common event that a non-uniform usage of codons often occurs in nearly all organisms. We previously found that SCUB is correlated with both intron number and exon position in the plant nuclear genome but not in the plastid genome; SCUB in both nuclear and plastid genome can mirror the evolutionary specialization. However, how about the rules in the mitochondrial genome has not been addressed. Here, we present an analysis of SCUB in the mitochondrial genome, based on 24 plant species ranging from algae to land plants. The frequencies of NNA and NNT (A- and T-ending codons) are higher than those of NNG and NNC, with the strongest preference in bryophytes and the weakest in land plants, suggesting an association between SCUB and plant evolution. The preference for NNA and NNT is more evident in genes harboring a greater number of introns in land plants, but the bias to NNA and NNT exhibits even among exons. The pattern of SCUB in the mitochondrial genome differs in some respects to that present in both the nuclear and plastid genomes.	[Xu, Wenjing; Xing, Tian; Zhao, Mingming; Yin, Xunhao; Xia, Guangmin; Wang, Mengcheng] Shandong Univ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Minist Educ, Jinan 250100, Shandong, Peoples R China	Shandong University	Wang, MC (corresponding author), Shandong Univ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Minist Educ, 27 Shandanan Rd, Jinan 250100, Shandong, Peoples R China.	wangmc@sdu.edu.cn			Natural Science Foundation of China [31171175]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (31171175) (http://isisn.nsfc.gov.cn/egrantweb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlert D, 2009, MOL GENET GENOMICS, V282, P17, DOI 10.1007/s00438-009-0440-z; Akashi H, 2001, CURR OPIN GENET DEV, V11, P660, DOI 10.1016/S0959-437X(00)00250-1; Akashi H, 1998, CURR OPIN GENET DEV, V8, P688, DOI 10.1016/S0959-437X(98)80038-5; Bellizzi D, 2013, DNA RES, V20, P537, DOI 10.1093/dnares/dst029; Bernardi G, 2000, GENE, V241, P3, DOI 10.1016/S0378-1119(99)00485-0; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; CARDON LR, 1994, P NATL ACAD SCI USA, V91, P3799, DOI 10.1073/pnas.91.9.3799; Casjens S, 1998, ANNU REV GENET, V32, P339, DOI 10.1146/annurev.genet.32.1.339; Chateigner-Boutin AL, 2011, WIRES RNA, V2, P493, DOI 10.1002/wrna.72; Chen JQ, 2009, MOL BIOL EVOL, V26, P1523, DOI 10.1093/molbev/msp063; Coulombe-Huntington J, 2007, GENOME RES, V17, P23, DOI 10.1101/gr.5703406; Dzitoyeva S, 2012, NEUROBIOL AGING, V33, P2881, DOI 10.1016/j.neurobiolaging.2012.02.006; Fawcett JA, 2012, MOL BIOL EVOL, V29, P849, DOI 10.1093/molbev/msr254; Finster S, 2012, LAND PLANT RNA EDITI; Gabrielsen TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019132; Guo FB, 2009, DNA RES, V16, P91, DOI 10.1093/dnares/dsp001; Guo WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117075; Henze K, 2003, NATURE, V426, P127, DOI 10.1038/426127a; Henze K, 2001, TRENDS GENET, V17, P383, DOI 10.1016/S0168-9525(01)02312-5; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Kim HT, 2014, MOL CELLS, V37, P372, DOI 10.14348/molcells.2014.2296; Kugita M, 2003, NUCLEIC ACIDS RES, V31, P2417, DOI 10.1093/nar/gkg327; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; MCCLELLAND M, 1982, NUCLEIC ACIDS RES, V10, P7865, DOI 10.1093/nar/10.23.7865; Nabel CS, 2012, ACS CHEM BIOL, V7, P20, DOI 10.1021/cb2002895; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Pitsch NT, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-133; POLLACK Y, 1984, NUCLEIC ACIDS RES, V12, P4811, DOI 10.1093/nar/12.12.4811; Qi YY, 2015, EVOL BIOINFORM, V11, P65, DOI 10.4137/EBO.S22566; Qin Z, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-56; Rebelo AP, 2009, NUCLEIC ACIDS RES, V37, P6701, DOI 10.1093/nar/gkp727; REIS RJS, 1983, J BIOL CHEM, V258, P9078; Rodriguez-Trelles F, 2006, ANNU REV GENET, V40, P47, DOI 10.1146/annurev.genet.40.110405.090625; Roy SW, 2005, P NATL ACAD SCI USA, V102, P1986, DOI 10.1073/pnas.0408355101; Sharpton TJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r24; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Simkova H, 1998, PLANT CELL REP, V17, P220, DOI 10.1007/s002990050382; Singh ND, 2005, GENETICS, V169, P709, DOI 10.1534/genetics.104.032250; Sloan DB, 2010, J MOL EVOL, V70, P479, DOI 10.1007/s00239-010-9346-y; Suzuki H, 2005, FEBS LETT, V579, P6499, DOI 10.1016/j.febslet.2005.10.032; Sverdlov AV, 2004, GENE, V338, P85, DOI 10.1016/j.gene.2004.05.027; Takenaka M, 2008, MITOCHONDRION, V8, P35, DOI 10.1016/j.mito.2007.09.004; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Tian DC, 2008, NATURE, V455, P105, DOI 10.1038/nature07175; Vanyushin BF, 2011, BBA-GENE REGUL MECH, V1809, P360, DOI 10.1016/j.bbagrm.2011.04.006; Sanchez-Puerta MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098353; Wang B, 2011, J INTEGR PLANT BIOL, V53, P324, DOI 10.1111/j.1744-7909.2011.01033.x; Wang MC, 2008, SOIL BIOL BIOCHEM, V40, P778, DOI 10.1016/j.soilbio.2007.10.012; Wang ZX, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-153; WARD BL, 1981, CELL, V25, P793, DOI 10.1016/0092-8674(81)90187-2; WOLFE KH, 1989, J MOL EVOL, V29, P208, DOI 10.1007/BF02100204; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Yoshinaga K, 1996, NUCLEIC ACIDS RES, V24, P1008, DOI 10.1093/nar/24.6.1008; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang W, 2008, MOL GENET GENOMICS, V280, P351, DOI 10.1007/s00438-008-0370-1; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhou HQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107319	60	7	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131508	10.1371/journal.pone.0131508	http://dx.doi.org/10.1371/journal.pone.0131508			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110418	gold, Green Submitted, Green Published			2022-12-27	WOS:000356933800154
J	Boonnate, P; Waraasawapati, S; Hipkaeo, W; Pethlert, S; Sharma, A; Selmi, C; Prasongwattana, V; Cha'on, U				Boonnate, Piyanard; Waraasawapati, Sakda; Hipkaeo, Wiphawi; Pethlert, Supattra; Sharma, Amod; Selmi, Carlo; Prasongwattana, Vitoon; Cha'on, Ubon			Monosodium Glutamate Dietary Consumption Decreases Pancreatic beta-Cell Mass in Adult Wistar Rats	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; CHINESE ADULTS; BRAIN-LESIONS; OBESITY; MICE; PREVALENCE; METABOLISM; OVERWEIGHT; NUTRITION; FIBROSIS	Background The amount of dietary monosodium glutamate (MSG) is increasing worldwide, in parallel with the epidemics of metabolic syndrome. Parenteral administration of MSG to rodents induces obesity, hyperglycemia, hyperlipidemia, insulin resistance, and type 2 diabetes. However, the impact of dietary MSG is still being debated. We investigated the morphological and functional effects of prolonged MSG consumption on rat glucose metabolism and on pancreatic islet histology. Methods Eighty adult male Wistar rats were randomly subdivided into 4 groups, and test rats in each group were supplemented with MSG for a different duration (1, 3, 6, or 9 months, n=20 for each group). All rats were fed ad libitum with a standard rat chow and water. Ten test rats in each group were provided MSG 2 mg/g body weight/day in drinking water and the 10 remaining rats in each group served as non-MSG treated controls. Oral glucose tolerance tests (OGTT) were performed and serum insulin measured at 9 months. Animals were sacrificed at 1, 3, 6, or 9 months to examine the histopathology of pancreatic islets. Results MSG-treated rats had significantly lower pancreatic beta-cell mass at 1, 6 and 9 months of study. Islet hemorrhages increased with age in all groups and fibrosis was significantly more frequent in MSG-treated rats at 1 and 3 months. Serum insulin levels and glucose tolerance in MSG-treated and untreated rats were similar at all time points we investigated. Conclusion Daily MSG dietary consumption was associated with reduced pancreatic beta-cell mass and enhanced hemorrhages and fibrosis, but did not affect glucose homeostasis. We speculate that high dietary MSG intake may exert a negative effect on the pancreas and such effect might become functionally significant in the presence or susceptibility to diabetes or NaCl; future experiments will take these crucial cofactors into account.	[Boonnate, Piyanard; Pethlert, Supattra; Sharma, Amod; Prasongwattana, Vitoon; Cha'on, Ubon] Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand; [Waraasawapati, Sakda] Khon Kaen Univ, Fac Med, Dept Pathol, Khon Kaen, Thailand; [Hipkaeo, Wiphawi] Khon Kaen Univ, Fac Med, Dept Anat, Khon Kaen, Thailand; [Selmi, Carlo] Humanitas Clin & Res Ctr, Rheumatol & Clin Immunol, Milan, Italy; [Selmi, Carlo] Univ Calif Davis, Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA	Khon Kaen University; Khon Kaen University; Khon Kaen University; University of California System; University of California Davis	Cha'on, U (corresponding author), Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand.	ubocha@kku.ac.th	sharma, amod/ABT-8672-2022; Selmi, Carlo/ABG-4899-2021; Sharma, Amod/AAA-3679-2022	Selmi, Carlo/0000-0002-0323-0376; Sharma, Amod/0000-0002-2860-7790	Research and Technology affairs division, Khon Kaen University, Incubation research project [MIH-2554-M-11]; NRU-KKU; Invitation Research Fund from the Faculty of Medicine [I55227]	Research and Technology affairs division, Khon Kaen University, Incubation research project; NRU-KKU; Invitation Research Fund from the Faculty of Medicine	This work was supported by The Research and Technology affairs division, Khon Kaen University, Incubation research project (UC), MIH-2554-M-11, NRU-KKU (UC, PB) and Invitation Research Fund from the Faculty of Medicine (I55227; UC, PB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AREES EA, 1970, SCIENCE, V170, P549, DOI 10.1126/science.170.3957.549; Beyreuther K, 2007, EUR J CLIN NUTR, V61, P304, DOI 10.1038/sj.ejcn.1602526; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Chevassus H, 2002, BRIT J CLIN PHARMACO, V53, P641, DOI 10.1046/j.1365-2125.2002.01596.x; Franco CCD, 2014, CELL PHYSIOL BIOCHEM, V34, P1920, DOI 10.1159/000366390; Dembele K, 2009, CELL BIOL TOXICOL, V25, P141, DOI 10.1007/s10565-008-9067-9; Di Cairano ES, 2011, J BIOL CHEM, V286, P14007, DOI 10.1074/jbc.M110.183517; Ferrannini E, 2014, METABOLISM, V63, P1217, DOI 10.1016/j.metabol.2014.05.012; Gammelsaeter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022960; He K, 2008, OBESITY, V16, P1875, DOI 10.1038/oby.2008.274; He K, 2011, AM J CLIN NUTR, V93, P1328, DOI 10.3945/ajcn.110.008870; Hong OK, 2007, J CELL BIOCHEM, V101, P665, DOI 10.1002/jcb.21222; Hull R, 2005, DIABETOLOGIA, V48, P1350, DOI 10.1007/s00125-005-1772-9; Imaoka M, 2007, TOXICOL PATHOL, V35, P388, DOI 10.1080/01926230701230304; Insawang T, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-50; Islam MS, 2009, METHOD FIND EXP CLIN, V31, P249, DOI 10.1358/mf.2009.31.4.1362513; KADUK B, 1987, HEPATO-GASTROENTEROL, V34, P108; Katsuda Y, 2014, EXP ANIM TOKYO, V63, P121, DOI 10.1538/expanim.63.121; Katsuda Y, 2014, ANIM SCI J, V85, P588, DOI 10.1111/asj.12191; Kim JY, 2010, J BIOL CHEM, V285, P37251, DOI 10.1074/jbc.M110.142315; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Li L, 2001, ENDOCRINOLOGY, V142, P5379, DOI 10.1210/en.142.12.5379; Malta A, 2014, J ENDOCRINOL, V221, P285, DOI 10.1530/JOE-13-0473; Mozaffari MS, 2006, ADV EXP MED BIOL, V583, P173; Nagata M, 2006, EXP ANIM TOKYO, V55, P109, DOI 10.1538/expanim.55.109; Nakanishi Y, 2008, J AUTOIMMUN, V30, P42, DOI 10.1016/j.jaut.2007.11.016; Nakayama D, 2003, OBES RES, V11, P87, DOI 10.1038/oby.2003.14; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reinehr R, 2004, PANCREAS, V28, P129, DOI 10.1097/00006676-200403000-00003; Sasaki Y, 2011, EUR J PHARMACOL, V662, P1, DOI 10.1016/j.ejphar.2011.04.051; Sasaki Y, 2009, LIFE SCI, V85, P490, DOI 10.1016/j.lfs.2009.07.017; Schwitzgebel VM, 2014, J DIABETES INVEST, V5, P121, DOI 10.1111/jdi.12197; Sharma A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075546; Shi ZM, 2011, J HYPERTENS, V29, P846, DOI 10.1097/HJH.0b013e328344da8e; Shi ZM, 2010, BRIT J NUTR, V104, P457, DOI 10.1017/S0007114510000760; Simeone DM, 2006, AM J PHYSIOL-ENDOC M, V291, pE1305, DOI 10.1152/ajpendo.00561.2005; STEGINK LD, 1973, J NUTR, V103, P1146, DOI 10.1093/jn/103.8.1146; Topp BB, 2004, DIABETOLOGIA, V47, P1602, DOI 10.1007/s00125-004-1493-5; Hien VTT, 2013, PUBLIC HEALTH NUTR, V16, P922, DOI 10.1017/S1368980012003552; Walker R, 2000, J NUTR, V130, p1049S, DOI 10.1093/jn/130.4.1049S; Wang X, 2014, DIABETES METAB SYNDR, V7, P531, DOI 10.2147/DMSO.S69891; Yin GS, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/493828	44	24	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131595	10.1371/journal.pone.0131595	http://dx.doi.org/10.1371/journal.pone.0131595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121281	Green Submitted, Green Published, gold			2022-12-27	WOS:000358150400128
J	Liu, WW; Yi, ZZ; Xu, DP; Clamp, JC; Li, JQ; Lin, XF; Song, WB				Liu, Weiwei; Yi, Zhenzhen; Xu, Dapeng; Clamp, John C.; Li, Jiqiu; Lin, Xiaofeng; Song, Weibo			Two New Genera of Planktonic Ciliates and Insights into the Evolution of the Family Strombidiidae (Protista, Ciliophora, Oligotrichia)	PLOS ONE			English	Article							NOV COMB.; MORPHOLOGY; PROTOZOA; PHYLOGENY; SPIROTRICHEA; TAXONOMY	Oligotrich ciliates are common marine microplankters, but their biodiversity and evolutionary relationships have not been well-documented. Morphological descriptions and small subunit rRNA gene sequences of two new species representing two new strombidiid genera, Sinistrostrombidium cupiformum gen. nov., sp. nov. and Antestrombidium agathae gen. nov., sp. nov. are presented, and their taxonomy and molecular phylogeny are analyzed. Sinistrostrombidium gen. nov. is characterized by a sinistrally spiraled girdle kinety and a longitudinal ventral kinety. Antestrombidium gen. nov. is distinguished by tripartite somatic kineties (circular and ventral kineties plus dextrally spiraled girdle kinety). Sinistrostrombidium and Antestrombidium branched separately from one another in phylogenetic trees, clustering with different clades of strombidiids. The new genera added to the diversities of ciliary patterns and small subunit rRNA gene sequences in strombidiids leads to presentation of a new hypothesis about evolution of the 12 known strombidiid genera, based on ciliary pattern and partly supported by molecular evidence. In addition, our new morphological and molecular analyses support establishment of a new order Lynnellida ord. nov., characterized by an open adoral zone of membranelles without differentiation of anterior and ventral membranelles, for Lynnella, but we remain unable to assign the genus to a subclass with confidence.	[Liu, Weiwei; Yi, Zhenzhen; Li, Jiqiu; Lin, Xiaofeng] S China Normal Univ, Key Lab Ecol & Environm Sci Guangdong Higher Educ, Lab Protozool, Guangzhou, Guangdong, Peoples R China; [Liu, Weiwei; Song, Weibo] Ocean Univ China, Inst Evolut & Marine Biodivers, Lab Protozool, Qingdao, Peoples R China; [Liu, Weiwei] Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China; [Xu, Dapeng] Xiamen Univ, Inst Marine Microbes & Ecosphere, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Clamp, John C.] N Carolina Cent Univ, Dept Biol, Durham, NC USA	South China Normal University; Ocean University of China; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Xiamen University; University of North Carolina; North Carolina Central University	Lin, XF (corresponding author), S China Normal Univ, Key Lab Ecol & Environm Sci Guangdong Higher Educ, Lab Protozool, Guangzhou, Guangdong, Peoples R China.	xlin@scnu.edu.cn; wsong@ouc.edu.cn			National Natural Science Foundation of China [31222050, 31172060, 31201696, 31430077, 31471973, 31111120437]; Outstanding Young Teachers Program of Higher Education in Guangdong [Yq2013052]; International Research Coordination Network for Biodiversity of Ciliates; U.S. National Science Foundation (oDEB) [31111120437]; Division Of Environmental Biology [1136580] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Young Teachers Program of Higher Education in Guangdong; International Research Coordination Network for Biodiversity of Ciliates; U.S. National Science Foundation (oDEB); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support was provided by the National Natural Science Foundation of China (projects numbers: 31222050, 31172060, 31201696, 31430077, 31471973), Research Fund for the Outstanding Young Teachers Program of Higher Education in Guangdong (Yq2013052), and the International Research Coordination Network for Biodiversity of Ciliates funded jointly by the U.S. National Science Foundation (oDEB) and the National Natural Science Foundation of China (project number: 31111120437). http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list; http://www.gdhed.edu.cn/publicfiles/business/htmlfiles/gdjyt/tzgg/201402/205392. html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatha S, 2004, ACTA PROTOZOOL, V43, P201; Agatha S, 2004, ZOOLOGY, V107, P153, DOI 10.1016/j.zool.2004.02.003; Agatha S, 2003, EUR J PROTISTOL, V39, P245, DOI 10.1078/0932-4739-00915; Agatha S, 2014, ACTA PROTOZOOL, V53, P77, DOI 10.4467/16890027AP.14.008.1445; Agatha S, 2012, J EUKARYOT MICROBIOL, V59, P325, DOI 10.1111/j.1550-7408.2012.00623.x; Agatha S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022466; Agatha S, 2011, EUR J PROTISTOL, V47, P51, DOI 10.1016/j.ejop.2010.09.001; Claparede E., 1859, MEM I NATN GENEV, V6, P261, DOI DOI 10.5962/BHL.TITLE.29753; DALE T, 1987, J PLANKTON RES, V9, P871, DOI 10.1093/plankt/9.5.871; Fenchel T, 2008, J EXP MAR BIOL ECOL, V366, P99, DOI 10.1016/j.jembe.2008.07.013; Gao S, 2009, SYST BIODIVERS, V7, P235, DOI 10.1017/S1477200009002989; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Li JM, 2013, EUKARYOT CELL, V12, P430, DOI 10.1128/EC.00270-12; Liu W, 2015, ZOOL J LINN IN PRESS; Liu WW, 2013, INT J SYST EVOL MICR, V63, P4805, DOI 10.1099/ijs.0.052878-0; Liu WW, 2011, SYST BIODIVERS, V9, P247, DOI 10.1080/14772000.2011.605812; Liu WW, 2011, J EUKARYOT MICROBIOL, V58, P43, DOI 10.1111/j.1550-7408.2010.00519.x; Liu WW, 2009, J EUKARYOT MICROBIOL, V56, P459, DOI 10.1111/j.1550-7408.2009.00425.x; Lynn D.H., 2008, CILIATED PROTOZOA CH, DOI 10.1016/B978-0-08-018752-5.50010-0; McManus GB, 2010, J EUKARYOT MICROBIOL, V57, P369, DOI 10.1111/j.1550-7408.2010.00485.x; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Nylander JAA., 2004, MRMODELTEST 2 2; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Petz Wolfgang, 1995, Stapfia, V40, P1; PIERCE RW, 1992, REV AQUAT SCI, V6, P139; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Song W.B., 2009, FREE LIVING CILIATES; Song WB, 1998, J MAR BIOL ASSOC UK, V78, P767, DOI 10.1017/S0025315400044775; Song WB, 2000, EUR J PROTISTOL, V36, P327, DOI 10.1016/S0932-4739(00)80010-3; Song W, 2013, INT J SYST EVOL MICR, V63, P1179, DOI 10.1099/ijs.0.048314-0; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; WILBERT N, 1975, Mikrokosmos, V64, P171; Xu Da-Peng, 2011, Acta Zootaxonomica Sinica, V36, P502; Xu DP, 2006, J NAT HIST, V40, P1287, DOI 10.1080/00222930600913925; Xu DP, 2013, J EUKARYOT MICROBIOL, V60, P192, DOI 10.1111/jeu.12023; Xu D, 2012, J EUKARYOT MICROBIOL, V59, P351, DOI 10.1111/j.1550-7408.2012.00625.x	42	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131726	10.1371/journal.pone.0131726	http://dx.doi.org/10.1371/journal.pone.0131726			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121340	Green Published, Green Submitted, gold			2022-12-27	WOS:000358150400147
J	Rouquette-Jazdanian, AK; Kortum, RL; Li, WM; Merrill, RK; Nguyen, PH; Samelson, LE; Sommers, CL				Rouquette-Jazdanian, Alexandre K.; Kortum, Robert L.; Li, Wenmei; Merrill, Robert K.; Nguyen, Phan H.; Samelson, Lawrence E.; Sommers, Connie L.			miR-155 Controls Lymphoproliferation in LAT Mutant Mice by Restraining T-Cell Apoptosis via SHIP-1/mTOR and PAK1/FOXO3/BIM Pathways	PLOS ONE			English	Article							FAMILY-MEMBER BIM; FOXO TRANSCRIPTION FACTORS; P21-ACTIVATED PROTEIN-KINASES; INDUCE APOPTOSIS; GENETIC-EVIDENCE; PROSTATE-CANCER; ERK ACTIVATION; BREAST-CANCER; MOUSE MODEL; BCL-2	Linker for Activation of T cells (LAT) is an adapter protein that is essential for T cell function. Knock-in mice with a LAT mutation impairing calcium flux develop a fatal CD4(+) lymphoproliferative disease. miR-155 is a microRNA that is correlated with hyperproliferation in a number of cancers including lymphomas and leukemias and is overexpressed in mutant LAT T cells. To test whether miR-155 was merely indicative of T cell activation or whether it contributes to lymphoproliferative disease in mutant LAT mice, we interbred LAT mutant and miR-155-deficient mice. miR-155 deficiency markedly inhibited lymphoproliferative disease by stimulating BIM-dependent CD4+ T cell apoptosis, even though ERK activation and T cell proliferation were increased in double mutant CD4(+) T cells. Bim/Bcl2l11 expression is activated by the forkhead transcription factor FOXO3. Using miR-155-deficient, LAT mutant T cells as a discovery tool, we found two connected pathways that impact the nuclear translocation and activation of FOXO3 in T cells. One pathway is mediated by the inositide phosphatase SHIP-1 and the serine/threonine kinases AKT and PDK1. The other pathway involves PAK1 and JNK kinase activation. We define crosstalk between the two pathways via the kinase mTOR, which stabilizes PAK1. This study establishes a role for PAK1 in T cell apoptosis, which contrasts to its previously identified role in T cell proliferation. Furthermore, miR-155 regulates the delicate balance between PAK1-mediated proliferation and apoptosis in T cells impacting lymphoid organ size and function.	[Rouquette-Jazdanian, Alexandre K.; Kortum, Robert L.; Li, Wenmei; Merrill, Robert K.; Nguyen, Phan H.; Samelson, Lawrence E.; Sommers, Connie L.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Sommers, CL (corresponding author), NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	sommersc@mail.nih.gov		ROUQUETTE-JAZDANIAN, Alexandre K./0000-0003-2646-0040	Intramural Research Program of the National Cancer Institute Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010304] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Cancer Institute Center for Cancer Research (to LES). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Allen JE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004828; Babar IA, 2012, P NATL ACAD SCI USA, V109, pE1695, DOI 10.1073/pnas.1201516109; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Balagopalan L, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005512; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Bouillet P, 2009, NAT REV IMMUNOL, V9, P514, DOI 10.1038/nri2570; Brown JL, 1996, CURR BIOL, V6, P598, DOI 10.1016/S0960-9822(02)00546-8; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chinnadurai G, 2008, ONCOGENE, V27, pS114, DOI 10.1038/onc.2009.49; Cubillos-Ruiz JR, 2012, CANCER RES, V72, P1683, DOI 10.1158/0008-5472.CAN-11-3160; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Dudda JC, 2013, IMMUNITY, V38, P742, DOI 10.1016/j.immuni.2012.12.006; Elton TS, 2013, GENE, V532, P1, DOI 10.1016/j.gene.2012.12.009; Enders A, 2003, J EXP MED, V198, P1119, DOI 10.1084/jem.20030411; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Frost JA, 1996, MOL CELL BIOL, V16, P3707, DOI 10.1128/mcb.16.7.3707; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Fuller DM, 2012, J IMMUNOL, V189, P4005, DOI 10.4049/jimmunol.1201380; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gioeli D, 2011, MOL CANCER THER, V10, P1581, DOI 10.1158/1535-7163.MCT-10-1033; Harris CA, 2001, J BIOL CHEM, V276, P37754; Herold MJ, 2013, EMBO REP, V14, P992, DOI 10.1038/embor.2013.152; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Hoang B, 2012, J BIOL CHEM, V287, P21796, DOI 10.1074/jbc.M111.304626; Horn S, 2004, LEUKEMIA, V18, P1839, DOI 10.1038/sj.leu.2403529; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Irvin BJ, 2000, MOL CELL BIOL, V20, P9149, DOI 10.1128/MCB.20.24.9149-9161.2000; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Kortum RL, 2013, TRENDS IMMUNOL, V34, P259, DOI 10.1016/j.it.2013.02.004; Kortum RL, 2013, J IMMUNOL, V190, P147, DOI 10.4049/jimmunol.1201458; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Lynch CJ, 2001, J NUTR, V131, p861S, DOI 10.1093/jn/131.3.861S; Martini M, 2014, ANN MED, V46, P372, DOI 10.3109/07853890.2014.912836; Mitsiades CS, 2004, CURR CANCER DRUG TAR, V4, P235, DOI 10.2174/1568009043333032; Miyaji M, 2009, P NATL ACAD SCI USA, V106, P14502, DOI 10.1073/pnas.0903894106; Neilsen PM, 2013, ONCOGENE, V32, P2992, DOI 10.1038/onc.2012.305; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Pelicano H, 2003, J BIOL CHEM, V278, P37832, DOI 10.1074/jbc.M301546200; POLVERINO A, 1995, J BIOL CHEM, V270, P26067, DOI 10.1074/jbc.270.44.26067; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Rather MI, 2013, J BIOL CHEM, V288, P608, DOI 10.1074/jbc.M112.425736; Riaz M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3415; Rouquette-Jazdanian AK, 2012, MOL CELL, V48, P298, DOI 10.1016/j.molcel.2012.08.011; Seddiki N, 2014, IMMUNOLOGY, V142, P32, DOI 10.1111/imm.12227; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Sommers CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066709; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Tili E, 2013, IMMUNOL REV, V253, P167, DOI 10.1111/imr.12050; Tu H, 1999, MOL CELL BIOL, V19, P602; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Vadlakonda L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00165; Walsh K, 2013, CLIN CANCER RES, V19, P1106, DOI 10.1158/1078-0432.CCR-12-1060; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Yablonski D, 1998, EMBO J, V17, P5647, DOI 10.1093/emboj/17.19.5647; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016841; Yang Y, 2009, NEOPLASIA, V11, P313, DOI 10.1593/neo.81358; Yoshii S, 2001, MOL CELL BIOL, V21, P6796, DOI 10.1128/MCB.21.20.6796-6807.2001; Zambon AC, 2011, J BIOL CHEM, V286, P33260, DOI 10.1074/jbc.M111.268979; Zeng H, 2013, CURR OPIN IMMUNOL, V25, P347, DOI 10.1016/j.coi.2013.05.002; Zonari E, 2013, BLOOD, V122, P243, DOI 10.1182/blood-2012-08-449306	73	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131823	10.1371/journal.pone.0131823	http://dx.doi.org/10.1371/journal.pone.0131823			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121028	Green Submitted, gold, Green Published			2022-12-27	WOS:000358150400162
J	Davis, MA; Douglas, MR; Webb, CT; Collyer, ML; Holycross, AT; Painter, CW; Kamees, LK; Douglas, ME				Davis, Mark A.; Douglas, Marlis R.; Webb, Colleen T.; Collyer, Michael L.; Holycross, Andrew T.; Painter, Charles W.; Kamees, Larry K.; Douglas, Michael E.			Nowhere to Go but Up: Impacts of Climate Change on Demographics of a Short-Range Endemic (Crotalus willardi obscurus) in the Sky-Islands of Southwestern North America	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; SPATIAL ECOLOGY; NATURAL-HISTORY; GENETIC RESCUE; WESTERN US; FOREST; RATTLESNAKES; CONSERVATION; VIABILITY; PROGRAM	Biodiversity elements with narrow niches and restricted distributions (i.e., 'short range endemics,' SREs) are particularly vulnerable to climate change. The New Mexico Ridge-nosed Rattlesnake (Crotalus willardi obscurus, CWO), an SRE listed under the U.S. Endangered Species Act within three sky islands of southwestern North America, is constrained at low elevation by drought and at high elevation by wildfire. We combined long-term recapture and molecular data with demographic and niche modeling to gauge its climate-driven status, distribution, and projected longevity. The largest population (Animas) is numerically constricted (N = 151), with few breeding adults (N-b = 24) and an elevated inbreeding coefficient (Delta F = 0.77; 100 years). Mean home range (0.07km(2)) is significantly smaller compared to other North American rattlesnakes, and movements are within, not among sky islands. Demographic values, when gauged against those displayed by other endangered/Red-Listed reptiles [e.g., Loggerhead Sea Turtle (Caretta caretta)], are either comparable or markedly lower. Survival rate differs significantly between genders (female<male) and life history stages (juvenile<adult) while a steadily declining population trajectory (r = -0.20 +/- 0.03) underscores the shallow predicted-time-to-extinction (17.09 +/- 2.05 years). Core habitat is receding upwards in elevation and will shift 750km NW under conservative climate estimates. While survival is significantly impacted by wildfire at upper elevations, the extinction vortex is driven by small population demographics, a situation comparable to that of the European Adder (Vipera berus), a conservation icon in southern Sweden. Genetic rescue, a management approach successfully employed in similar situations, is ill advised in this situation due to climate-driven habitat change in the sky islands. CWO is a rare organism in a unique environment, with a conserved niche and a predisposition towards extinction. It is a bellwether for the eventual climate-driven collapse of the Madrean pine-oak ecosystem, one of Earth's three recognized megadiversity centers.	[Davis, Mark A.; Webb, Colleen T.] Colorado State Univ, Dept Biol, Ft Collins, CO USA; [Douglas, Marlis R.; Douglas, Michael E.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; [Collyer, Michael L.] Western Kentucky Univ, Dept Biol, Bowling Green, KY 42101 USA; [Holycross, Andrew T.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Painter, Charles W.] New Mexico Dept Game & Fish, Santa Fe, NM USA; [Kamees, Larry K.] Univ Texas El Paso, Dept Biol, El Paso, TX 79968 USA	Colorado State University; University of Arkansas System; University of Arkansas Fayetteville; Western Kentucky University; Arizona State University; Arizona State University-Tempe; New Mexico Department of Game and Fish; University of Texas System; University of Texas El Paso	Davis, MA (corresponding author), Univ Illinois, Illinois Nat Hist Survey, Champaign, IL 61820 USA.	davis63@illinois.edu	Douglas, Michael/T-1761-2019	Douglas, Michael/0000-0001-9670-7825; Davis, Mark/0000-0001-9034-9430	Wallace Research Foundation; Animas Foundation; Malpai Borderlands Group; Arizona Game and Fish Department (AGFD); Nongame Branch; AGFD Nongame Check-off Fund; New Mexico Department of Game and Fish (NMDGF); Endangered Species Program; New Mexico Department of Game and Fish Share-with-Wildlife Fund; Arizona Game and Fish Department Heritage Fund [I95048, I98011]; U. S. Forest Service Rocky Mountain Research Station; US Fish and Wildlife Service (USFWS)	Wallace Research Foundation; Animas Foundation; Malpai Borderlands Group; Arizona Game and Fish Department (AGFD); Nongame Branch; AGFD Nongame Check-off Fund; New Mexico Department of Game and Fish (NMDGF); Endangered Species Program; New Mexico Department of Game and Fish Share-with-Wildlife Fund; Arizona Game and Fish Department Heritage Fund; U. S. Forest Service Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service); US Fish and Wildlife Service (USFWS)(US Fish & Wildlife Service)	Financial support was provided by the Wallace Research Foundation (www.wallacefoundation.org); Animas Foundation; Malpai Borderlands Group (http://www.malpaiborderlandsgroup.org/); Arizona Game and Fish Department (AGFD; http://www.azgfd.gov/) Nongame Branch; AGFD Nongame Check-off Fund; New Mexico Department of Game and Fish (NMDGF; http://www.wildlife.state.nm.us/) Endangered Species Program; New Mexico Department of Game and Fish Share-with-Wildlife Fund; Arizona Game and Fish Department Heritage Fund (I95048, I98011); U. S. Forest Service Rocky Mountain Research Station; (http://www.fs.fed.us/rmrs/) and US Fish and Wildlife Service (USFWS; http://www.fws.gov/) Section 6 funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F, 2013, CONSERV GENET, V2nd; Amarasekare P, 2013, J ANIM ECOL, V82, P1240, DOI 10.1111/1365-2656.12112; Baillargeon S., 2007, J STAT SOFTW, V19, P1, DOI [DOI 10.18637/JSS.V019.I05, 10.18637/jss.v019.i05]; Beebe TJC, 2008, INTRO MOL ECOLOGY; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Bijlsma R, 2000, J EVOLUTION BIOL, V13, P502, DOI 10.1046/j.1420-9101.2000.00177.x; Botts EA, 2013, GLOBAL ECOL BIOGEOGR, V22, P567, DOI 10.1111/geb.12027; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Brown DE, 1994, BIOTIC COMMUNITIES S, P59; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Clark JR, 2013, BIOSCIENCE, V63, P924, DOI 10.1525/bio.2013.63.12.4; Clark RW, 2011, BIOL CONSERV, V144, P886, DOI 10.1016/j.biocon.2010.12.001; CORMACK RM, 1964, BIOMETRIKA, V51, P429, DOI 10.1093/biomet/51.3-4.429; D'Amen M, 2013, GLOBAL ECOL BIOGEOGR, V22, P93, DOI 10.1111/j.1466-8238.2012.00774.x; Davis MA, 2008, THESIS COLORADO STAT; Degregorio BA, 2011, HERPETOLOGICA, V67, P71, DOI 10.1655/09-049R1.1; Dillon GK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00271.1; Dirnbock T, 2011, GLOBAL CHANGE BIOL, V17, P990, DOI 10.1111/j.1365-2486.2010.02266.x; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dubey S, 2011, ECOL EVOL, V1, P218, DOI 10.1002/ece3.25; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; ESRI, 2011, ARCGIS DESKT REL 10; Falk DA, 2013, USDA P, VP-67; Ficetola GF, 2014, INT J GEOGR INF SCI, V28, P1723, DOI 10.1080/13658816.2014.891222; Flannigan MD, 2000, SCI TOTAL ENVIRON, V262, P221, DOI 10.1016/S0048-9697(00)00524-6; Frankham R., 2002, INTRO CONSERVATION G, DOI 10.1017/CBO9780511808999; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; Frankham R, 2011, CONSERV BIOL, V25, P465, DOI 10.1111/j.1523-1739.2011.01662.x; Gilpin M, 1986, CONSERVATION BIOL SC, P13; GREENE HW, 1994, AM ZOOL, V34, P48; Hart KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103453; Harvey MS, 2011, INVERTEBR SYST, V25, P1, DOI 10.1071/IS11011; Heber S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043113; Hedrick PW, 2014, CONSERV GENET, V15, P1111, DOI 10.1007/s10592-014-0604-1; Herrick GI, 2013, CONSERV LETT, V6, P238, DOI 10.1111/j.1755-263X.2012.00305.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hogg JT, 2006, P ROY SOC B-BIOL SCI, V273, P1491, DOI 10.1098/rspb.2006.3477; Holycross AT, 2007, BIOL CONSERV, V134, P142, DOI 10.1016/j.biocon.2006.07.020; Holycross AT, 2001, COPEIA, P473; Holycross AT, 2002, THESIS ARIZONA STATE; Hopken MW, 2013, MOL ECOL, V22, P956, DOI 10.1111/mec.12156; Hoss SK, 2010, J HERPETOL, V44, P110, DOI 10.1670/08-277.1; Hurteau MD, 2014, FOREST ECOL MANAG, V327, P280, DOI 10.1016/j.foreco.2013.08.007; Hyslop NL, 2012, POPUL ECOL, V54, P145, DOI 10.1007/s10144-011-0292-3; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Kamees LK, 2006, THESIS U TEXAS EL PA; Lacy RC, 2014, VORTEX STOACHASTIC S; Lacy Robert C., 2000, Ecological Bulletins, V48, P39; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lindo Z, 2012, GLOBAL CHANGE BIOL, V18, P2448, DOI 10.1111/j.1365-2486.2012.02725.x; Luiselli L, 2011, ECOL RES, V26, P745, DOI 10.1007/s11284-011-0828-1; MACARTNEY JM, 1988, J HERPETOL, V22, P61, DOI 10.2307/1564357; Madsen T, 1999, NATURE, V402, P34, DOI 10.1038/46941; Madsen T, 2004, BIOL CONSERV, V120, P145, DOI 10.1016/j.biocon.2004.01.022; Madsen T, 1996, BIOL CONSERV, V75, P113, DOI 10.1016/0006-3207(95)00067-4; Madsen T, 2011, HERPETOL CONSERV BIO, V6, P72; Merila J, 2012, BIOESSAYS, V34, P811, DOI 10.1002/bies.201200054; Mitton JB, 2012, AM NAT, V179, pE163, DOI 10.1086/665007; Morais AR, 2013, BIOL CONSERV, V166, P98, DOI 10.1016/j.biocon.2013.06.010; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Parker JM, 2007, J HERPETOL, V36, P598; Pe'er G, 2013, CONSERV BIOL, V27, P644, DOI 10.1111/cobi.12076; Pearman PB, 2010, ECOGRAPHY, V33, P990, DOI 10.1111/j.1600-0587.2010.06443.x; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pledger S, 2003, BIOMETRICS, V59, P786, DOI 10.1111/j.0006-341X.2003.00092.x; Ponder WF, 2002, INVERTEBR SYST, V16, P571, DOI 10.1071/IT01043; Prival DB, 2002, J HERPETOL, V36, P598, DOI 10.1670/0022-1511(2002)036[0598:NHOANP]2.0.CO;2; R Core Team, 2012, R FDN STAT COMP; Reed RN, 2002, SOUTHWEST NAT, V47, P30, DOI 10.2307/3672799; REINERT HK, 1988, COPEIA, P964, DOI 10.2307/1445720; Schoennagel T, 2011, FRONT ECOL ENVIRON, V9, P271, DOI 10.1890/090199; Schuett GW, 2013, J ZOOL, V289, P101, DOI 10.1111/j.1469-7998.2012.00969.x; SECOR SM, 1994, COPEIA, P631; Smith CF, 2009, HERPETOL MONOGR, V23, P45, DOI 10.1655/08-026.1; Smith LJ, 2001, SOUTHWEST NAT, V46, P54, DOI 10.2307/3672373; Stephens SL, 2013, SCIENCE, V342, P41, DOI 10.1126/science.1240294; Stephens SL, 2005, ECOL APPL, V15, P532, DOI 10.1890/04-0545; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; U. S. Fish and Wildlife Service, 1978, FED REGISTER, V43, P34476; Waldron JL, 2006, ANIM CONSERV, V9, P414, DOI 10.1111/j.1469-1795.2006.00050.x; Wallace BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024510; Walter H, 1983, VEGETATION EARTH ECO; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2013, CONSERV BIOL, V27, P1137, DOI 10.1111/cobi.12180; Waples RS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1339; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Warshall P, 1995, USDA ROCKY, V264, P6; Watsell AR, 2011, COPEIA, V2011, P29; Webb JK, 1997, BIOL CONSERV, V82, P203, DOI 10.1016/S0006-3207(97)00032-3; Weber M. G., 1997, Environmental Reviews, V5, P145, DOI 10.1139/a97-008; Weeks AR, 2011, EVOL APPL, V4, P709, DOI 10.1111/j.1752-4571.2011.00192.x; Westemeier RL, 1998, SCIENCE, V282, P1695, DOI 10.1126/science.282.5394.1695; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Whitaker PB, 2003, HERPETOL MONOGR, V17, P130, DOI 10.1655/0733-1347(2003)017[0130:ARSOMA]2.0.CO;2; Williams AP, 2010, P NATL ACAD SCI USA, V107, P21289, DOI 10.1073/pnas.0914211107; Williams J, 2013, FOREST ECOL MANAG, V294, P4, DOI 10.1016/j.foreco.2012.06.030; Wilson GA, 2003, GENETICS, V163, P1177; Wootton JT, 2013, ECOLOGY, V94, P2117, DOI 10.1890/12-1828.1	105	16	16	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131067	10.1371/journal.pone.0131067	http://dx.doi.org/10.1371/journal.pone.0131067			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114622	Green Published, gold			2022-12-27	WOS:000358147500125
J	Moghadam, NN; Holmstrup, M; Manenti, T; Mouridsen, MB; Pertoldi, C; Loeschcke, V				Moghadam, Neda Nasiri; Holmstrup, Martin; Manenti, Tommaso; Mouridsen, Marie Brandt; Pertoldi, Cino; Loeschcke, Volker			The Role of Storage Lipids in the Relation between Fecundity, Locomotor Activity, and Lifespan of Drosophila melanogaster Longevity-Selected and Control Lines	PLOS ONE			English	Article							FATTY-ACID-METABOLISM; EXTENDED LONGEVITY; ORGANISMAL PERFORMANCE; CALORIE RESTRICTION; STRESS RESISTANCE; INSULIN-RECEPTOR; MORTALITY-RATES; BODY STORES; TRADE-OFF; AGE	The contribution of insect fat body to multiple processes, such as development, metamorphosis, activity, and reproduction results in trade-offs between life history traits. In the present study, age-induced modulation of storage lipid composition in Drosophila melanogaster longevity-selected (L) and non-selected control (C) lines was studied and the correlation between total body fat mass and lifespan assessed. The trade-offs between fecundity, locomotor activity, and lifespan were re-evaluated from a lipid-related metabolic perspective. Fewer storage lipids in the L lines compared to the C lines supports the impact of body fat mass on extended lifespan. The higher rate of fecundity and locomotor activity in the L lines may increase the lipid metabolism and enhance the lipolysis of storage lipids, reducing fat reserves. The correlation between neutral lipid fatty acids and fecundity, as well as locomotor activity, varied across age groups and between the L and C lines. The fatty acids that correlated with egg production were different from the fatty acids that correlated with locomotor activity. The present study suggests that fecundity and locomotor activity may positively affect the lifespan of D. melanogaster through the inhibition of fat accumulation.	[Moghadam, Neda Nasiri; Manenti, Tommaso; Mouridsen, Marie Brandt; Loeschcke, Volker] Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark; [Holmstrup, Martin] Aarhus Univ, Dept Biosci, DK-8600 Silkeborg, Denmark; [Pertoldi, Cino] Aalborg Zoo, DK-9000 Aalborg, Denmark; [Pertoldi, Cino] Aalborg Univ, Dept 18, Sect Environm Engn, DK-9000 Aalborg, Denmark	Aarhus University; Aarhus University; Aalborg University	Moghadam, NN (corresponding author), Aarhus Univ, Dept Biosci, Ny Munkegade 114, DK-8000 Aarhus C, Denmark.	neda.nasiri@biology.au.dk	Dietz, Rune/F-9154-2015; Holmstrup, Martin/E-8731-2017; Loeschcke, Volker/J-2527-2013; Pertoldi, Cino/I-1746-2012	Dietz, Rune/0000-0001-9652-317X; Holmstrup, Martin/0000-0001-8395-6582; Loeschcke, Volker/0000-0003-1450-0754; Pertoldi, Cino/0000-0002-4644-8981	Faculty of Science and Technology Aarhus University; Natural Science Research Council [09-065925, 111065536]	Faculty of Science and Technology Aarhus University; Natural Science Research Council	This work was supported by a PhD grant from the Faculty of Science and Technology Aarhus University to NNM and a frame grant from the Natural Science Research Council (09-065925 and 111065536) to VL.	Ackerman D, 2012, BIOESSAYS, V34, P466, DOI 10.1002/bies.201100189; Aguila JR, 2007, J EXP BIOL, V210, P956, DOI 10.1242/jeb.001586; Anand AN, 2008, J INSECT PHYSIOL, V54, P1404, DOI 10.1016/j.jinsphys.2008.08.001; Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005; Arking R, 2002, AGEING RES REV, V1, P209, DOI 10.1016/S1568-1637(01)00010-1; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Barnes AI, 2008, P ROY SOC B-BIOL SCI, V275, P1675, DOI 10.1098/rspb.2008.0139; Barzilai N, 1999, J GERONTOL A-BIOL, V54, pB98, DOI 10.1093/gerona/54.3.B98; Blaak EE, 2000, ANN MED, V32, P380, DOI 10.3109/07853890008995942; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bluher M, 2008, OBESITY FACTS, V1, P176, DOI 10.1159/000145930; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Bubliy OA, 2005, J EVOLUTION BIOL, V18, P789, DOI 10.1111/j.1420-9101.2005.00928.x; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Corona G, 2009, INT J ANDROL, V32, P587, DOI 10.1111/j.1365-2605.2008.00951.x; De Loof A, 2011, J INSECT PHYSIOL, V57, P1, DOI 10.1016/j.jinsphys.2010.08.018; Djawdan M, 1996, PHYSIOL ZOOL, V69, P1176, DOI 10.1086/physzool.69.5.30164252; DOWLING NJE, 1986, J GEN MICROBIOL, V132, P1815; DOWNER RGH, 1976, AM ZOOL, V16, P733; Everitt A, 2010, AUSTRALAS J AGEING, V29, P14; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; Flatt T, 2009, BBA-GEN SUBJECTS, V1790, P951, DOI 10.1016/j.bbagen.2009.07.010; Fougeron AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026899; Gems D, 1998, GENETICS, V150, P129; Ghazi A, 2013, GENESIS, V51, P1, DOI 10.1002/dvg.22345; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; GILBERT LI, 1974, J LIPID RES, V15, P439; Girardot F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-69; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; GREEN PR, 1979, ARCH INT PHYSIOL BIO, V87, P485, DOI 10.3109/13813457909070512; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hansen M, 2013, CELL METAB, V17, P10, DOI 10.1016/j.cmet.2012.12.003; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Kammer AE, 1978, INSECT FLIGHT METABO, P133; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Kates M, 1986, LAB TECHNIQUES BIOCH, V3; KEITH AD, 1967, COMP BIOCHEM PHYSIOL, V21, P587, DOI 10.1016/0010-406X(67)90455-0; KIYOMOTO RK, 1970, LIPIDS, V5, P617, DOI 10.1007/BF02531340; Kloting N, 2005, EXP GERONTOL, V40, P878, DOI 10.1016/j.exger.2005.07.004; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Lane SJ, 2014, J EXP BIOL, V217, P1437, DOI 10.1242/jeb.095646; Lapierre LR, 2011, CURR BIOL, V21, P1507, DOI 10.1016/j.cub.2011.07.042; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Lorenz MW, 2004, ARCH INSECT BIOCHEM, V56, P110, DOI 10.1002/arch.20002; Lushchak OV, 2012, J GERONTOL A-BIOL, V67, P118, DOI 10.1093/gerona/glr184; Magwere T, 2006, J GERONTOL A-BIOL, V61, P136, DOI 10.1093/gerona/61.2.136; Magwere T, 2004, J GERONTOL A-BIOL, V59, P3; Marden JH, 2003, P NATL ACAD SCI USA, V100, P3369, DOI 10.1073/pnas.0634985100; MCFARLANE JE, 1968, COMP BIOCHEM PHYSIOL, V24, P377, DOI 10.1016/0010-406X(68)90989-4; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Min KJ, 2007, EXP GERONTOL, V42, P247, DOI 10.1016/j.exger.2006.10.009; Minois N, 2001, EXP GERONTOL, V36, P1137, DOI 10.1016/S0531-5565(00)00263-1; Moghadam NN, 2013, EXP GERONTOL, V48, P1362, DOI 10.1016/j.exger.2013.08.018; Papamandjaris AA, 1998, LIFE SCI, V62, P1203, DOI 10.1016/S0024-3205(97)01143-0; Parisi Michael, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-198; Parkes TL, 1999, NEUROBIOL AGING, V20, P531, DOI 10.1016/S0197-4580(99)00086-X; Pfeiffenberger Cory, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5518; Picard F, 2005, INT J OBESITY, V29, pS36, DOI 10.1038/sj.ijo.0802912; POUGH FH, 1989, PHYSIOL ZOOL, V62, P199, DOI 10.1086/physzool.62.2.30156169; Rattan SIS, 2006, FREE RADICAL RES, V40, P1230, DOI 10.1080/10715760600911303; Redinger RN, 2009, TRANSL RES, V154, P52, DOI 10.1016/j.trsl.2009.05.003; Ross RE, 2000, J INSECT PHYSIOL, V46, P1477, DOI 10.1016/S0022-1910(00)00072-X; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sarup P, 2011, AGE, V33, P69, DOI 10.1007/s11357-010-9162-8; SCHNEIDER M, 1994, INSECT BIOCHEM MOLEC, V24, P883, DOI 10.1016/0965-1748(94)90017-5; Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; SOHAL RS, 1986, EXP GERONTOL, V21, P509, DOI 10.1016/0531-5565(86)90003-3; Sturmey RG, 2009, REPROD DOMEST ANIM, V44, P50, DOI 10.1111/j.1439-0531.2009.01402.x; Suarez RK, 2000, PHYSIOL BIOCHEM ZOOL, V73, P765, DOI 10.1086/318112; Van Dooremalen C, 2011, J INSECT PHYSIOL, V57, P285, DOI 10.1016/j.jinsphys.2010.11.018; van Dooremalen C, 2010, J INSECT PHYSIOL, V56, P178, DOI 10.1016/j.jinsphys.2009.10.002; Vermeulen CJ, 2006, MECH AGEING DEV, V127, P610, DOI 10.1016/j.mad.2006.02.004; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wit J, 2013, EXP GERONTOL, V48, P349, DOI 10.1016/j.exger.2013.01.008; Zajitschek F, 2013, AGE, V35, P1193, DOI 10.1007/s11357-012-9445-3; Zhu C, 2010, INT J MOL SCI, V11, P4814, DOI 10.3390/ijms11124814; Zhu M, 2007, EXP GERONTOL, V42, P733, DOI 10.1016/j.exger.2007.05.011; Ziegler R, 2006, INSECT BIOCHEM MOLEC, V36, P264, DOI 10.1016/j.ibmb.2006.01.014; Zwaan B, 1996, EVOLUTION, V50, P475, DOI 10.2307/2410820	82	17	17	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130334	10.1371/journal.pone.0130334	http://dx.doi.org/10.1371/journal.pone.0130334			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115349	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500067
J	Murayama, T; Kurebayashi, N; Yamazawa, T; Oyamada, H; Suzuki, J; Kanemaru, K; Oguchi, K; Iino, M; Sakurai, T				Murayama, Takashi; Kurebayashi, Nagomi; Yamazawa, Toshiko; Oyamada, Hideto; Suzuki, Junji; Kanemaru, Kazunori; Oguchi, Katsuji; Iino, Masamitsu; Sakurai, Takashi			Divergent Activity Profiles of Type 1 Ryanodine Receptor Channels Carrying Malignant Hyperthermia and Central Core Disease Mutations in the Amino-Terminal Region	PLOS ONE			English	Article							CA2+-INDUCED CA2+ RELEASE; SKELETAL-MUSCLE; CALCIUM-RELEASE; RYR1 MUTATIONS; POSTULATED ROLE; SUDDEN-DEATH; IDENTIFICATION; PATHOGENESIS; SENSITIVITY; HALOTHANE	The type 1 ryanodine receptor (RyR1) is a Ca2+ release channel in the sarcoplasmic reticulum of skeletal muscle and is mutated in several diseases, including malignant hyperthermia (MH) and central core disease (CCD). Most MH and CCD mutations cause accelerated Ca2+ release, resulting in abnormal Ca2+ homeostasis in skeletal muscle. However, how specific mutations affect the channel to produce different phenotypes is not well understood. In this study, we have investigated 11 mutations at 7 different positions in the amino (N)-terminal region of RyR1 (9 MH and 2 MH/CCD mutations) using a heterologous expression system in HEK293 cells. In live-cell Ca2+ imaging at room temperature (similar to 25 degrees C), cells expressing mutant channels exhibited alterations in Ca2+ homeostasis, i.e., an enhanced sensitivity to caffeine, a depletion of Ca2+ in the ER and an increase in resting cytoplasmic Ca2+. RyR1 channel activity was quantitatively evaluated by [H-3] ryanodine binding and three parameters (sensitivity to activating Ca2+, sensitivity to inactivating Ca2+ and attainable maximum activity, i.e., gain) were obtained by fitting analysis. The mutations increased the gain and the sensitivity to activating Ca2+ in a site-specific manner. The gain was consistently higher in both MH and MH/CCD mutations. Sensitivity to activating Ca2+ was markedly enhanced in MH/CCD mutations. The channel activity estimated from the three parameters provides a reasonable explanation to the pathological phenotype assessed by Ca2+ homeostasis. These properties were also observed at higher temperatures (similar to 37 degrees C). Our data suggest that divergent activity profiles may cause varied disease phenotypes by specific mutations. This approach should be useful for diagnosis and treatment of diseases with mutations in RyR1.	[Murayama, Takashi; Kurebayashi, Nagomi; Sakurai, Takashi] Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Pharmacol, Tokyo 1138421, Japan; [Yamazawa, Toshiko] Jikei Univ, Sch Med, Dept Mol Physiol, Tokyo 1058461, Japan; [Oyamada, Hideto; Oguchi, Katsuji] Showa Univ, Sch Med, Dept Pharmacol, Tokyo 1428555, Japan; [Suzuki, Junji; Kanemaru, Kazunori; Iino, Masamitsu] Univ Tokyo, Grad Sch Med, Dept Pharmacol, Tokyo 1130033, Japan	Juntendo University; Jikei University; Showa University; University of Tokyo	Murayama, T (corresponding author), Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Pharmacol, Tokyo 1138421, Japan.	takashim@juntendo.ac.jp		Suzuki, Junji/0000-0003-1648-5471	Japan Society for the Promotion of Science (JSPS) [24590330, 24590331, 25136718, 25460303]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25221304]; Vehicle Racing Commemorative Foundation; Institute of Seizon Life Sciences; MEXT-supported Program for the Strategic Research Foundation at Private Universities; Grants-in-Aid for Scientific Research [15H05648, 15K08243] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation; Institute of Seizon Life Sciences; MEXT-supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (24590330 to TM, 24590331 and 25136718 to NK, and 25460303 to TY) by Japan Society for the Promotion of Science (JSPS), a Grant-in-Aid for Scientific Research (25221304 to MI) by The Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Vehicle Racing Commemorative Foundation (http://www.vecof.or.jp/) (to NK), the Institute of Seizon & Life Sciences (http://seizon.umin.jp/) (to NK), and MEXT-supported Program for the Strategic Research Foundation at Private Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila G, 2003, J GEN PHYSIOL, V121, P277, DOI 10.1085/jgp.200308791; Avila G, 2001, P NATL ACAD SCI USA, V98, P4215, DOI 10.1073/pnas.071048198; Avila G, 2001, J GEN PHYSIOL, V118, P277, DOI 10.1085/jgp.118.3.277; Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Brini M, 2005, J BIOL CHEM, V280, P15380, DOI 10.1074/jbc.M410421200; Carpenter D, 2009, BRIT J ANAESTH, V103, P538, DOI 10.1093/bja/aep204; Chelu MG, 2004, TRENDS CARDIOVAS MED, V14, P227, DOI 10.1016/j.tcm.2004.06.003; Chelu MG, 2006, FASEB J, V20, P329, DOI 10.1096/fj.05-4497fje; CHU A, 1990, MOL PHARMACOL, V37, P735; Dirksen RT, 2004, BIOPHYS J, V87, P3193, DOI 10.1529/biophysj.104.049447; Dirksen RT, 2002, TRENDS CARDIOVAS MED, V12, P189, DOI 10.1016/S1050-1738(02)00163-9; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Eltit JM, 2013, FASEB J, V27, P991, DOI 10.1096/fj.12-218354; ENDO M, 1977, PHYSIOL REV, V57, P71, DOI 10.1152/physrev.1977.57.1.71; Endo M, 2009, PHYSIOL REV, V89, P1153, DOI 10.1152/physrev.00040.2008; Feng W, 2011, MOL PHARMACOL, V79, P420, DOI 10.1124/mol.110.067959; Fiege M, 2002, ANESTHESIOLOGY, V97, P345, DOI 10.1097/00000542-200208000-00010; FRANZINIARMSTRONG C, 1994, ANNU REV PHYSIOL, V56, P509, DOI 10.1146/annurev.ph.56.030194.002453; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hopkins PM, 2000, BRIT J ANAESTH, V85, P118, DOI 10.1093/bja/85.1.118; Jiang DW, 2008, J BIOL CHEM, V283, P20813, DOI 10.1074/jbc.M801944200; Kimlicka L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2501; Lanner JT, 2012, NAT MED, V18, P244, DOI 10.1038/nm.2598; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Lynch PJ, 1997, ANESTHESIOLOGY, V86, P620, DOI 10.1097/00000542-199703000-00014; Manno C, 2013, J PHYSIOL-LONDON, V591, P4439, DOI 10.1113/jphysiol.2013.259572; MEISSNER G, 1992, MOL CELL BIOCHEM, V114, P119; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Monnier N, 2005, HUM MUTAT, V26, P413, DOI 10.1002/humu.20231; Murayama T, 2005, AM J PHYSIOL-CELL PH, V288, pC1222, DOI 10.1152/ajpcell.00415.2004; Murayama T, 2004, AM J PHYSIOL-CELL PH, V287, pC36, DOI 10.1152/ajpcell.00395.2003; Murayama T, 2000, BIOPHYS J, V78, P1810, DOI 10.1016/S0006-3495(00)76731-2; Murayama T, 2002, TRENDS CARDIOVAS MED, V12, P305, DOI 10.1016/S1050-1738(02)00179-2; Murayama T, 2007, BIOCHEM J, V402, P349, DOI 10.1042/BJ20061040; Murayama T, 2011, J BIOL CHEM, V286, P35571, DOI 10.1074/jbc.M111.255240; Murayama T, 2011, PROG BIOPHYS MOL BIO, V105, P134, DOI 10.1016/j.pbiomolbio.2010.10.003; Nakano M., 2014, SHOWA U J MED SCI, V26, P27, DOI DOI 10.15369/SUJMS.26.27; OGAWA Y, 1994, CRIT REV BIOCHEM MOL, V29, P229, DOI 10.3109/10409239409083482; Quane KA, 1997, BRIT J ANAESTH, V79, P332, DOI 10.1093/bja/79.3.332; RIOS E, 1991, PHYSIOL REV, V71, P849, DOI 10.1152/physrev.1991.71.3.849; Rios E, 2010, J PHYSIOL SCI, V60, P81, DOI 10.1007/s12576-009-0069-z; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Robinson RL, 2002, HUM MUTAT, V20, P88, DOI 10.1002/humu.10098; Sato K, 2013, ANESTHESIOLOGY, V119, P111, DOI 10.1097/ALN.0b013e31828cebfe; Sato K, 2010, ANESTHESIOLOGY, V112, P1350, DOI 10.1097/ALN.0b013e3181d69283; SCHNEIDER MF, 1994, ANNU REV PHYSIOL, V56, P463, DOI 10.1146/annurev.ph.56.030194.002335; Sutko JL, 1996, PHYSIOL REV, V76, P1027, DOI 10.1152/physrev.1996.76.4.1027; Suzuki J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5153; Tong JF, 1999, J BIOL CHEM, V274, P693, DOI 10.1074/jbc.274.2.693; Tong JF, 1997, J BIOL CHEM, V272, P26332, DOI 10.1074/jbc.272.42.26332; Treves S, 2008, CURR OPIN PHARMACOL, V8, P319, DOI 10.1016/j.coph.2008.01.005; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Yang T, 2006, ANESTHESIOLOGY, V105; Yang TZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1591, DOI 10.1152/ajpcell.00133.2006; Yang TZ, 2003, J BIOL CHEM, V278, P25722, DOI 10.1074/jbc.M302165200; Yarotskyy V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077633; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	59	23	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130606	10.1371/journal.pone.0130606	http://dx.doi.org/10.1371/journal.pone.0130606			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115329	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500080
J	Ohno, S; Hasegawa, K; Horie, M				Ohno, Seiko; Hasegawa, Kanae; Horie, Minoru			Gender Differences in the Inheritance Mode of RYR2 Mutations in Catecholaminergic Polymorphic Ventricular Tachycardia Patients	PLOS ONE			English	Article							DEATH	Catecholaminergic polymorphic ventricular tachycardia (CPVT) is one of the causes of sudden cardiac death in young people and results from RYR2 mutations in similar to 60% of CPVT patients. The inheritance of the RYR2 mutations follows an autosomal dominant trait, however, de novo mutations are often identified during familial analysis. In 36 symptomatic CPVT probands with RYR2 mutations, we genotyped their parents and confirmed the origin of the respective mutation. In 26 sets of proband and both parents (trio), we identified 17 de novomutations (65.4%), seven from their mothers and only two mutations were inherited from their fathers. Among nine sets of proband and mother, five mutations were inherited from mothers. Four other mutations were of unknown origin. The inheritance of RYR2 mutations was significantly more frequent from mothers (n = 12, 34.3%) than fathers (n = 2, 5.7%) (P = 0.013). The mean ages of onset were not significantly different in probands between de novo mutations and those from mothers. Thus, half of the RYR2 mutations in our cohort were de novo, and most of the remaining mutations were inherited from mothers. These data would be useful for family analysis and risk stratification of the disease.	[Ohno, Seiko; Hasegawa, Kanae; Horie, Minoru] Shiga Univ Med Sci, Cardiovasc & Resp Dept, Otsu, Shiga 52021, Japan; [Ohno, Seiko] Shiga Univ Med Sci, Ctr Epidemiol Res Asia, Otsu, Shiga 52021, Japan; [Ohno, Seiko] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Hasegawa, Kanae] Univ Fukui, Fac Med Sci, Dept Cardiovasc Med, Eiheiji, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Kyoto University; University of Fukui	Horie, M (corresponding author), Shiga Univ Med Sci, Cardiovasc & Resp Dept, Otsu, Shiga 52021, Japan.	horie@belle.shiga-med.ac.jp	Horie, Minoru/ABG-7128-2020		Japan Society for the Promotion of Science (KAKENHI) [24591575]; Ministry of Health, Labour, and Welfare, Japan; Takeda Science foundation; Naito foundation; Japanese Circulation Society	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science foundation(Takeda Science Foundation (TSF)); Naito foundation(Naito Memorial Foundation); Japanese Circulation Society(Japanese Circulation Society)	This study was supported by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (KAKENHI) (to S.O. 24591575), by a grant for Cardiovascular Diseases from the Ministry of Health, Labour, and Welfare, Japan (to M.H.), by a Research Grant from Takeda Science foundation (to S.O.), by a Research Grant from the Naito foundation (to S.O.), and by a translational Research Grant from the Japanese Circulation Society (to M.H.).	Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; George CH, 2006, CIRC RES, V98, P88, DOI 10.1161/01.RES.0000199296.70534.7c; Hayashi M, 2009, CIRCULATION, V119, P2426, DOI 10.1161/CIRCULATIONAHA.108.829267; Kawamura M, 2013, CIRC J, V77, P1705, DOI 10.1253/circj.CJ-12-1460; Lahat H, 2001, AM J HUM GENET, V69, P1378, DOI 10.1086/324565; Nyegaard M, 2012, AM J HUM GENET, V91, P703, DOI 10.1016/j.ajhg.2012.08.015; Ohno S, 2014, EUROPACE, V16, P1646, DOI 10.1093/europace/eut382; Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8; Priori SG, 2001, CIRCULATION, V103, P196; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; Roux-Buisson N, 2012, HUM MOL GENET, V21, P2759, DOI 10.1093/hmg/dds104; Tester DJ, 2006, HEART RHYTHM, V3, P800, DOI 10.1016/j.hrthm.2006.03.025; van der Werf C, 2012, CIRC-ARRHYTHMIA ELEC, V5, P748, DOI 10.1161/CIRCEP.112.970517; van der Werf C, 2011, J AM COLL CARDIOL, V57, P2244, DOI 10.1016/j.jacc.2011.01.026; Watanabe H, 2009, NAT MED, V15, P380, DOI 10.1038/nm.1942	15	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131517	10.1371/journal.pone.0131517	http://dx.doi.org/10.1371/journal.pone.0131517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114861	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500166
J	Przyborowski, K; Wojewoda, M; Sitek, B; Zakrzewska, A; Kij, A; Wandzel, K; Zoladz, JA; Chlopicki, S				Przyborowski, Kamil; Wojewoda, Marta; Sitek, Barbara; Zakrzewska, Agnieszka; Kij, Agnieszka; Wandzel, Krystyna; Zoladz, Jerzy Andrzej; Chlopicki, Stefan			Effects of 1-Methylnicotinamide (MNA) on Exercise Capacity and Endothelial Response in Diabetic Mice	PLOS ONE			English	Article							INDUCED PROSTACYCLIN RELEASE; NITRIC-OXIDE FORMATION; PULMONARY-HYPERTENSION; SINGLE BOUT; HEALTHY-MEN; IN-VIVO; NICOTINAMIDE; PLASMA; YOUNG; RATS	1-Methylnicotinamide (MNA), which was initially considered to be a biologically inactive endogenous metabolite of nicotinamide, has emerged as an anti-thrombotic and anti-inflammatory agent with the capacity to release prostacyclin (PGI(2)). In the present study, we characterized the effects of MNA on exercise capacity and the endothelial response to exercise in diabetic mice. Eight-week-old db/db mice were untreated or treated with MNA for 4 weeks (100 mg.kg(-1)), and their exercise capacity as well as NO-and PGI(2)-dependent response to endurance running were subsequently assessed. MNA treatment of db/db mice resulted in four-fold and three-fold elevation of urine concentrations of MNA and its metabolites (Met-2PY + Met-4PY), respectively (P<0.01), but did not affect HbA(1c) concentration, fasting glucose concentration or lipid profile. However, insulin sensitivity was improved (P<0.01). In MNA-treated db/db mice, the time to fatigue for endurance exercise was significantly prolonged (P<0.05). Post-exercise Delta 6-keto-PGF(1 alpha) (difference between mean concentration in the sedentary and exercised groups) tended to increase, and post-exercise leukocytosis was substantially reduced in MNA-treated animals. In turn, the post-exercise fall in plasma concentration of nitrate was not affected by MNA. In conclusion, we demonstrated for the first time that MNA improves endurance exercise capacity in mice with diabetes, and may also decrease the cardiovascular risk of exercise.	[Przyborowski, Kamil; Wojewoda, Marta; Sitek, Barbara; Zakrzewska, Agnieszka; Kij, Agnieszka; Wandzel, Krystyna; Chlopicki, Stefan] Jagiellonian Univ, JCET, Krakow, Poland; [Kij, Agnieszka] Jagiellonian Univ, Coll Med, Dept Pharmacokinet & Phys Pharm, Krakow, Poland; [Zoladz, Jerzy Andrzej] Univ Sch Phys Educ, Fac Rehabil, Dept Muscle Physiol, Krakow, Poland; [Chlopicki, Stefan] Jagiellonian Univ, Coll Med, Dept Expt Pharmacol, Krakow, Poland	Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Chlopicki, S (corresponding author), Jagiellonian Univ, JCET, Krakow, Poland.	stefan.chlopicki@jcet.eu		Przyborowski, Kamil/0000-0002-8526-945X; Zoladz, Jerzy A./0000-0002-1143-5590; Chlopicki, Stefan/0000-0002-2878-3858; Smeda, Marta/0000-0002-0219-2574	European Union from the resources of the European Regional Development Fund under the Innovative Economy Programme [POIG.01.01.02-00-069/09]	European Union from the resources of the European Regional Development Fund under the Innovative Economy Programme	European Union from the resources of the European Regional Development Fund under the Innovative Economy Programme (grant coordinated by JCET-UJ, No. POIG.01.01.02-00-069/09). Prof. SC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama K, 2000, J NEURAL TRANSM, V107, P985, DOI 10.1007/s007020070047; Bartsch P, 1999, LANCET, V354, P1747, DOI 10.1016/S0140-6736(99)90259-3; Bartus M, 2008, PHARMACOL REP, V60, P127; Blumberg FC, 2002, CHEST, V121, P1566, DOI 10.1378/chest.121.5.1566; BOGER RH, 1995, J APPL PHYSIOL, V78, P1832, DOI 10.1152/jappl.1995.78.5.1832; Bryniarski K, 2008, EUR J PHARMACOL, V578, P332, DOI 10.1016/j.ejphar.2007.09.011; Brzozowski T, 2008, J PHARMACOL EXP THER, V326, P105, DOI 10.1124/jpet.108.136457; BUGIARDINI R, 1986, AM J CARDIOL, V58, P453, DOI 10.1016/0002-9149(86)90014-7; Chlopicki S, 2007, BRIT J PHARMACOL, V152, P230, DOI 10.1038/sj.bjp.0707383; Chlopicki S, 2012, PHARMACOL REP, V64, P369; Feng DL, 1999, BRIT J SPORT MED, V33, P401, DOI 10.1136/bjsm.33.6.401; HANSEN JB, 1991, EUR J APPL PHYSIOL O, V62, P157, DOI 10.1007/BF00643735; Huang A, 2012, AM J PHYSIOL-REG I, V302, pR674, DOI 10.1152/ajpregu.00699.2011; Jones AM, 2014, APPL PHYSIOL NUTR ME, V39, P1019, DOI 10.1139/apnm-2014-0036; Jungersten L, 1997, J APPL PHYSIOL, V82, P760, DOI 10.1152/jappl.1997.82.3.760; Kakanis MW, 2010, EXERC IMMUNOL REV, V16, P119; Karamouzis M, 2001, PROSTAG LEUKOTR ESS, V64, P259, DOI 10.1054/plef.2001.0269; KOIVISTO VA, 1989, DIABETES CARE, V12, P609, DOI 10.2337/diacare.12.9.609; Lamprecht M, 2013, J APPL PHYSIOL, V115, P57, DOI 10.1152/japplphysiol.00187.2013; Larsen PJ, 2008, DIABETES OBES METAB, V10, P301, DOI 10.1111/j.1463-1326.2008.00865.x; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Nunes-Silva A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096464; Peake JM, 2005, MED SCI SPORT EXER, V37, P737, DOI 10.1249/01.MSS.0000161804.05399.3B; Rassaf T, 2007, BRIT J SPORT MED, V41, P669, DOI 10.1136/bjsm.2007.035758; Rhind SG, 1999, J APPL PHYSIOL, V87, P1178; RICHARDSON RS, 1995, J CLIN INVEST, V96, P1916, DOI 10.1172/JCI118237; RITTER JM, 1983, LANCET, V1, P317; Schmeisser K, 2013, NAT CHEM BIOL, V9, P693, DOI [10.1038/nchembio.1352, 10.1038/NCHEMBIO.1352]; St Croix CM, 1999, AM J RESP CRIT CARE, V159, P1125, DOI 10.1164/ajrccm.159.4.9806144; STANULOVIC M, 1971, ARCH BIOCHEM BIOPHYS, V145, P27, DOI 10.1016/0003-9861(71)90005-1; Watala C, 2009, PHARMACOL REP, V61, P86, DOI 10.1016/S1734-1140(09)70010-6; Wax D, 1999, CHEST, V116, P914, DOI 10.1378/chest.116.4.914; Zoladz JA, 2009, PHYSIOL RES, V58, P229, DOI 10.33549/physiolres.931403; Zoladz JA, 2010, PHARMACOL REP, V62, P494, DOI 10.1016/S1734-1140(10)70305-4	34	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130908	10.1371/journal.pone.0130908	http://dx.doi.org/10.1371/journal.pone.0130908			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115505	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500108
J	Ramsay, H; Barnett, JH; Miettunen, J; Mukkala, S; Maki, P; Liuhanen, J; Murray, GK; Jarvelin, MR; Ollila, H; Paunio, T; Veijola, J				Ramsay, Hugh; Barnett, Jennifer H.; Miettunen, Jouko; Mukkala, Sari; Maeki, Pirjo; Liuhanen, Johanna; Murray, Graham K.; Jarvelin, Marjo-Riitta; Ollila, Hanna; Paunio, Tiina; Veijola, Juha			Association between Dopamine Receptor D2 (DRD2) Variations rs6277 and rs1800497 and Cognitive Performance According to Risk Type for Psychosis: A Nested Case Control Study in a Finnish Population Sample	PLOS ONE			English	Article							WORKING-MEMORY; NEUROCOGNITIVE DEFICITS; C957T POLYMORPHISM; YOUNG-PEOPLE; OULU BRAIN; SCHIZOPHRENIA; ATTENTION; GENES; SUSCEPTIBILITY; AVAILABILITY	Background There is limited research regarding the association between genes and cognitive intermediate phenotypes in those at risk for psychotic disorders. Methods We measured the association between established psychosis risk variants in dopamine D2 receptor (DRD2) and cognitive performance in individuals at age 23 years and explored if associations between cognition and these variants differed according to the presence of familial or clinical risk for psychosis. The subjects of the Oulu Brain and Mind Study were drawn from the general population-based Northern Finland 1986 Birth Cohort (NFBC 1986). Using linear regression, we compared the associations between cognitive performance and two candidate DRD2 polymorphisms (rs6277 and rs1800497) between subjects having familial (n=61) and clinical (n=45) risk for psychosis and a random sample of participating NFBC 1986 controls (n=74). Cognitive performance was evaluated using a comprehensive battery of tests at follow-up. Results Principal components factor analysis supported a three-factor model for cognitive measures. The minor allele of rs6277 was associated with poorer performance on a verbal factor (p=0.003) but this did not significantly interact with familial or clinical risk for psychosis. The minor allele of rs1800497 was associated with poorer performance on a psychomotor factor (p=0.038), though only in those at familial risk for psychotic disorders (interaction p=0.049). Conclusion The effect of two DRD2 SNPs on cognitive performance may differ according to risk type for psychosis, suggesting that cognitive intermediate phenotypes differ according to the type (familial or clinical) risk for psychosis.	[Ramsay, Hugh; Miettunen, Jouko; Veijola, Juha] Univ Oulu, Dept Psychiat, Ctr Clin Neurosci, Oulu, Finland; [Ramsay, Hugh] Hlth Serv Execut, Dublin, Ireland; [Barnett, Jennifer H.; Murray, Graham K.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Barnett, Jennifer H.] Cambridge Cognit Ltd, Cambridge, England; [Miettunen, Jouko] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Miettunen, Jouko] Univ Oulu, Med Res Ctr Oulu, Oulu, Finland; [Miettunen, Jouko] Oulu Univ Hosp, Oulu, Finland; [Mukkala, Sari; Maeki, Pirjo; Veijola, Juha] Oulu Univ Hosp, Dept Psychiat, Oulu, Finland; [Maeki, Pirjo] Middle Ostrobothnia Cent Hosp, Dept Psychiat, Kiuru, Finland; [Maeki, Pirjo] Joint Municipal Author Wellbeing Raahe Dist, Mental Hlth Serv, Raahe Dist, Finland; [Maeki, Pirjo] Basic Hlth Care Dist Kallio, Mental Hlth Serv, Kallio, Finland; [Maeki, Pirjo] Northern Ostrobothnia Hosp Dist, Visala Hosp, Oulu, Finland; [Liuhanen, Johanna; Ollila, Hanna; Paunio, Tiina] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Helsinki, Finland; [Liuhanen, Johanna; Ollila, Hanna; Paunio, Tiina] Inst Mol Med, Helsinki, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Dept Publ Hlth Sci & Gen Practice, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Fac Med, London, England; [Paunio, Tiina] Univ Helsinki, Inst Clin Med, Dept Psychiat, Helsinki, Finland; [Paunio, Tiina] Helsinki Univ Cent Hosp, Helsinki, Finland	University of Oulu; University of Cambridge; University of Oulu; University of Oulu; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; Imperial College London; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Ramsay, H (corresponding author), Univ Oulu, Dept Psychiat, Ctr Clin Neurosci, Oulu, Finland.	drhughramsay@gmail.com	Ollila, Hanna M/I-8552-2017; Ollila, Hanna M/GQA-6308-2022; Miettunen, Jouko/AAC-4334-2019	Ollila, Hanna M/0000-0002-5302-6429; Ollila, Hanna M/0000-0002-5302-6429; Miettunen, Jouko/0000-0003-0575-2669; Murray, Graham/0000-0001-8296-1742; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Liuhanen, Johanna/0000-0002-1153-1013	Cambridge Cognition Ltd.; MRC [G0701911] Funding Source: UKRI; Medical Research Council [G0701911] Funding Source: researchfish	Cambridge Cognition Ltd.; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Cambridge Cognition Ltd. provided support in the form of salaries for author Jennifer H. Barnett but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Aalto S, 2005, J NEUROSCI, V25, P2471, DOI 10.1523/JNEUROSCI.2097-04.2005; Allen AJ, 2009, SCHIZOPHR RES, V109, P24, DOI 10.1016/j.schres.2009.01.016; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Benton AL, 1976, MULTILINGUAL APHASIA; Berryhill ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055862; Betcheva ET, 2009, J HUM GENET, V54, P98, DOI 10.1038/jhg.2008.14; Bolton JL, 2010, BEHAV GENET, V40, P630, DOI 10.1007/s10519-010-9372-y; Bora E, 2014, ACTA PSYCHIAT SCAND; Cannon TD, 2008, ARCH GEN PSYCHIAT, V65, P28, DOI 10.1001/archgenpsychiatry.2007.3; Carrion RE, 2011, AM J PSYCHIAT, V168, P806, DOI 10.1176/appi.ajp.2011.10081209; Chien YL, 2013, J HUM GENET, V58, P229, DOI 10.1038/jhg.2012.157; Cohen J.E., 1988, STAT POWER ANAL BEHA; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; Doll BB, 2011, J NEUROSCI, V31, P6188, DOI 10.1523/JNEUROSCI.6486-10.2011; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; First M. B., 1997, STRUCTURED CLIN INTE; Frank MJ, 2011, NEUROPSYCHOPHARMACOL, V36, P133, DOI 10.1038/npp.2010.96; Fusar-Poli P, 2010, ARCH GEN PSYCHIAT, V67, P683, DOI 10.1001/archgenpsychiatry.2010.77; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Granon S, 2000, J NEUROSCI, V20, P1208, DOI 10.1523/JNEUROSCI.20-03-01208.2000; Green MF, 2004, SCHIZOPHR RES, V72, P1, DOI 10.1016/j.schres.2004.09.006; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Green MF, 1996, AM J PSYCHIAT, V153, P321; Gur RE, 2007, SCHIZOPHRENIA BULL, V33, P49, DOI 10.1093/schbul/sbl055; Hawkins KA, 2004, SCHIZOPHR RES, V67, P115, DOI 10.1016/j.schres.2003.08.007; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Hirvonen MM, 2009, SYNAPSE, V63, P907, DOI 10.1002/syn.20672; JARVELIN MR, 1993, BRIT J OBSTET GYNAEC, V100, P310, DOI 10.1111/j.1471-0528.1993.tb12971.x; Jukuri T, 2013, SCHIZOPHR RES, V143, P239, DOI 10.1016/j.schres.2012.11.020; Kapur S, 1999, AM J PSYCHIAT, V156, P286; Kelleher I, 2012, SCHIZOPHR BULL EPUB; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Lencz T, 2006, BIOL PSYCHIAT, V59, P863, DOI 10.1016/j.biopsych.2005.09.005; Mattay VS, 2000, NEUROIMAGE, V12, P268, DOI 10.1006/nimg.2000.0610; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McAllister TW, 2005, AM J PSYCHIAT, V162, P1749, DOI 10.1176/appi.ajp.162.9.1749; McGlashan T, 2001, STRUCTURED INTERVIEW; Mukkala S, 2011, J CLIN EXP NEUROPSYC, V33, P385, DOI 10.1080/13803395.2010.524148; Neville MJ, 2004, HUM MUTAT, V23, P540, DOI 10.1002/humu.20039; Niendam TA, 2007, SCHIZOPHRENIA BULL, V33, P772, DOI 10.1093/schbul/sbm020; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rodriguez-Jimenez R, 2006, NEUROPSYCHOBIOLOGY, V54, P166, DOI 10.1159/000098652; SAHAKIAN B, 1989, BRIT J PSYCHIAT, V154, P797, DOI 10.1192/bjp.154.6.797; SAHAKIAN BJ, 1988, BRAIN, V111, P695, DOI 10.1093/brain/111.3.695; Sakurai H, 2012, SCHIZOPHR B, V1-11, DOI 10.1093/schbul/sbr131; Savitz J, 2006, GENES BRAIN BEHAV, V5, P311, DOI 10.1111/j.1601-183X.2005.00163.x; Seidman LJ, 2010, ARCH GEN PSYCHIAT, V67, P578, DOI 10.1001/archgenpsychiatry.2010.66; Soderqvist S, 2013, J COGN NEUROSCI; Torres-Reyna O, GETTING STARTED FACT; TRITES R, 1989, GROOVED PEGBOARD; Trites R., 1989, GROOVED PEGBOARD INS; Veijola J, 2013, EARLY INTERV PSYCHIA, V7, P146, DOI 10.1111/j.1751-7893.2012.00360.x; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D., 2010, WAIS 4 WECHSLER ADUL; White MJ, 2009, BEHAV GENET, V39, P285, DOI 10.1007/s10519-008-9255-7; Wood SJ, 2003, PSYCHOL MED, V33, P1239, DOI 10.1017/S0033291703008067; Xu HY, 2007, SCHIZOPHR RES, V90, P104, DOI 10.1016/j.schres.2006.10.001	60	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0127602	10.1371/journal.pone.0127602	http://dx.doi.org/10.1371/journal.pone.0127602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114663	Green Published, gold			2022-12-27	WOS:000358147500009
J	Robertson, GS; Bolton, M; Morrison, P; Monaghan, P				Robertson, Gail S.; Bolton, Mark; Morrison, Paul; Monaghan, Pat			Variation in Population Synchrony in a Multi-Species Seabird Community: Response to Changes in Predator Abundance	PLOS ONE			English	Article							GULLS LARUS DOMINICANUS; TERNS STERNA-MAXIMA; SPATIAL SYNCHRONY; BREEDING SUCCESS; SANDWICH TERNS; SOUTHERN-OCEAN; ROSEATE TERNS; DYNAMICS; COMMON; FLUCTUATIONS	Ecologically similar sympatric species, subject to typical environmental conditions, may be expected to exhibit synchronous temporal fluctuations in demographic parameters, while populations of dissimilar species might be expected to show less synchrony. Previous studies have tested for synchrony in different populations of single species, and those including data from more than one species have compared fluctuations in only one demographic parameter. We tested for synchrony in inter-annual changes in breeding population abundance and productivity among four tern species on Coquet Island, northeast England. We also examined how manipulation of one independent environmental variable (predator abundance) influenced temporal changes in ecologically similar and dissimilar tern species. Changes in breeding abundance and productivity of ecologically similar species (Arctic Sterna paradisaea, Common S. hirundo and Roseate Terns S. dougallii) were synchronous with one another over time, but not with a species with different foraging and breeding behaviour (Sandwich Terns Thalasseus sandvicensis). With respect to changes in predator abundance, there was no clear pattern. Roseate Tern abundance was negatively correlated with that of large gulls breeding on the island from 1975 to 2013, while Common Tern abundance was positively correlated with number of large gulls, and no significant correlations were found between large gull and Arctic and Sandwich Tern populations. Large gull abundance was negatively correlated with productivity of Arctic and Common Terns two years later, possibly due to predation risk after fledging, while no correlation with Roseate Tern productivity was found. The varying effect of predator abundance is most likely due to specific differences in the behaviour and ecology of even these closely-related species. Examining synchrony in multi-species assemblages improves our understanding of how whole communities react to long-term changes in the environment and suggests that changes in predator abundance may differentially affect populations of sympatric seabird species.	[Robertson, Gail S.; Monaghan, Pat] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Bolton, Mark; Morrison, Paul] Royal Soc Protect Birds, Ctr Conservat Sci, Sandy SG19 2DL, Beds, England	University of Glasgow; Royal Society for Protection of Birds	Robertson, GS (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland.	g.robertson.2@research.gla.ac.uk	Monaghan, Pat/E-6810-2015	Bolton, Mark/0000-0001-5605-687X	Natural Environment Research Council (NERC); Royal Society for the Protection of Birds (RSPB) through a NERC CASE studentship [NE/I528369/1]	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society for the Protection of Birds (RSPB) through a NERC CASE studentship	This work was funded by the Natural Environment Research Council (NERC; www.nerc.ac.uk/) and Royal Society for the Protection of Birds (RSPB; www.rspb.org.uk/) through a NERC CASE studentship to the University of Glasgow (award number NE/I528369/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Booth Vivienne, 2010, Conservation Evidence, V7, P39; Bryant R, 1999, WATERBIRDS, V22, P392, DOI 10.2307/1522115; Buntgen U, 2008, CLIM DYNAM, V31, P615, DOI 10.1007/s00382-008-0390-x; Buonaccorsi JP, 2001, ECOLOGY, V82, P1668, DOI 10.2307/2679809; Burger J, 1988, J APPL ECOL, V15, P697; Butler PG, 2010, QUATERNARY SCI REV, V29, P1614, DOI 10.1016/j.quascirev.2009.07.010; Cabot D., 2013, TERNS; CHATFIELD C, 1989, ANAL TIME SERIES; Cook E. R., 1981, Tree-Ring Bulletin, V41, P45; Courtney P.A., 1983, Colonial Waterbirds, V6, P107, DOI 10.2307/1520977; CRAWFORD RJM, 1995, IBIS, V137, P329, DOI 10.1111/j.1474-919X.1995.tb08029.x; DUNN EK, 1975, J ANIM ECOL, V44, P743, DOI 10.2307/3716; Frederiksen M, 2004, GLOBAL CHANGE BIOL, V10, P1214, DOI 10.1111/j.1529-8817.2003.00794.x; Furness RW, 2000, MAR ECOL PROG SER, V202, P253, DOI 10.3354/meps202253; Gaston AJ, 2003, AUK, V120, P362, DOI 10.1642/0004-8038(2003)120[0362:SFOTMU]2.0.CO;2; Gaston AJ, 2009, ENVIRON REV, V17, P267, DOI 10.1139/A09-013; Hansen BB, 2013, SCIENCE, V339, P313, DOI 10.1126/science.1226766; Hawkins BA, 1998, AM NAT, V152, P480, DOI 10.1086/286184; HOPKINS CD, 1972, AUK, V89, P583; IMS RA, 1990, OIKOS, V57, P381, DOI 10.2307/3565968; Inchausti P, 2003, J AVIAN BIOL, V34, P170, DOI 10.1034/j.1600-048X.2003.03031.x; JNCC, 2012, SEAB POP TRENDS CAUS; Jones HP, 2008, CONSERV BIOL, V22, P16, DOI 10.1111/j.1523-1739.2007.00859.x; Kerlin DH, 2007, OIKOS, V116, P2007, DOI 10.1111/j.2007.0030-1299.16145.x; Korpimaki E, 1996, BIOSCIENCE, V46, P754, DOI 10.2307/1312851; Lahoz-Monfort JJ, 2013, ECOLOGY, V94, P3, DOI 10.1890/12-0500.1; Lahoz-Monfort JJ, 2011, METHODS ECOL EVOL, V2, P116, DOI 10.1111/j.2041-210X.2010.00050.x; LAWLER SP, 1989, ANIM BEHAV, V38, P1039, DOI 10.1016/S0003-3472(89)80142-3; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Loison A, 2002, J APPL STAT, V29, P289, DOI 10.1080/02664760120108665; Morrison P., 2007, Conservation Evidence, V4, P1; Morrison P., 2006, CONSERV EVIDENCE, V3, P84; Nisbet I.C.T., 1984, Colonial Waterbirds, V7, P117, DOI 10.2307/1521090; NISBET ICT, 1972, BIRD BANDING, V43, P97, DOI 10.2307/4511853; Oro D, 1996, CONDOR, V98, P848, DOI 10.2307/1369868; PAINE RT, 1990, AUK, V107, P1; Paradis E, 2000, ECOLOGY, V81, P2112, DOI 10.1890/0012-9658(2000)081[2112:SSIPOB]2.0.CO;2; PEARSON TH, 1968, J ANIM ECOL, V37, P521, DOI 10.2307/3073; Peltonen M, 2002, ECOLOGY, V83, P3120, DOI 10.1890/0012-9658(2002)083[3120:SSIFIO]2.0.CO;2; Perrow MR, 2011, J FIELD ORNITHOL, V82, P68, DOI 10.1111/j.1557-9263.2010.00309.x; Phillips RA, 1999, J APPL ECOL, V36, P218, DOI 10.1046/j.1365-2664.1999.00391.x; Piatt JF, 2007, MAR ECOL PROG SER, V352, P221, DOI 10.3354/meps07078; POLLARD E, 1991, OIKOS, V60, P7, DOI 10.2307/3544985; Quintana F, 1998, AUK, V115, P1068, DOI 10.2307/4089525; R Development Core Team, 2014, R LANG ENV STAT COMP; Raimondo S, 2004, OIKOS, V107, P462, DOI 10.1111/j.0030-1299.2004.13449.x; Raimondo S, 2004, ECOL ENTOMOL, V29, P96, DOI 10.1111/j.0307-6946.2004.00579.x; Ramos JA, 2002, MAR ECOL PROG SER, V243, P271, DOI 10.3354/meps243271; RANTA E, 1995, P ROY SOC B-BIOL SCI, V262, P113, DOI 10.1098/rspb.1995.0184; RANTA E, 1995, J ANIM ECOL, V64, P767, DOI 10.2307/5855; Robertson GS, 2014, AUK, V131, P434, DOI 10.1642/AUK-13-243.1; Rock JC, 2007, WATERBIRDS, V30, P579, DOI 10.1675/1524-4695(2007)030[0579:DCAACT]2.0.CO;2; SAFINA C, 1990, J FIELD ORNITHOL, V61, P331; Sandvik H, 2008, ECOGRAPHY, V31, P73, DOI 10.1111/j.2007.0906-7590.05090.x; Schroeder ID, 2009, MAR ECOL PROG SER, V393, P211, DOI 10.3354/meps08103; Shealer DA, 1998, CONDOR, V100, P131, DOI 10.2307/1369904; Snow DW, 1998, BIRDS W PALEARCTIC, V1; Sokal R. R, 1981, BIOMETRY; Swanson BJ, 1999, OIKOS, V86, P265, DOI 10.2307/3546444; TAYLOR IR, 1983, ORNIS SCAND, V14, P90, DOI 10.2307/3676011; THOMAS G J, 1972, Biological Conservation, V4, P117, DOI 10.1016/0006-3207(72)90012-2; Trathan PN, 2007, PHILOS T R SOC B, V362, P2351, DOI 10.1098/rstb.2006.1953; UTTLEY J, 1989, ORNIS SCAND, V20, P273, DOI 10.2307/3676491; Veen J., 1977, BEHAVIOUR, V20, P1, DOI DOI 10.2307/30039178; Whittam RM, 1999, CAN J ZOOL, V77, P851, DOI 10.1139/cjz-77-6-851; Williams CK, 2003, ECOLOGY, V84, P2654, DOI 10.1890/03-0038; Yorio P, 1997, IBIS, V139, P536, DOI 10.1111/j.1474-919X.1997.tb04670.x	68	7	7	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131543	10.1371/journal.pone.0131543	http://dx.doi.org/10.1371/journal.pone.0131543			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115174	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000358147500170
J	Le, TD; Zhang, JP; Liu, L; Li, JY				Thuc Duy Le; Zhang, Junpeng; Liu, Lin; Li, Jiuyong			Ensemble Methods for MiRNA Target Prediction from Expression Data	PLOS ONE			English	Article							CAUSAL REGULATORY RELATIONSHIPS; INFERRING MICRORNA; CANCER; MECHANISMS; DISCOVERY; NETWORKS; RESOURCE; GENOMICS; MODULES; MODELS	Background microRNAs ( miRNAs) are short regulatory RNAs that are involved in several diseases, including cancers. Identifying miRNA functions is very important in understanding disease mechanisms and determining the efficacy of drugs. An increasing number of computational methods have been developed to explore miRNA functions by inferring the miRNA- mRNA regulatory relationships from data. Each of the methods is developed based on some assumptions and constraints, for instance, assuming linear relationships between variables. For such reasons, computational methods are often subject to the problem of inconsistent performance across different datasets. On the other hand, ensemble methods integrate the results from individual methods and have been proved to outperform each of their individual component methods in theory. Results In this paper, we investigate the performance of some ensemble methods over the commonly used miRNA target prediction methods. We apply eight different popular miRNA target prediction methods to three cancer datasets, and compare their performance with the ensemble methods which integrate the results from each combination of the individual methods. The validation results using experimentally confirmed databases show that the results of the ensemble methods complement those obtained by the individual methods and the ensemble methods perform better than the individual methods across different datasets. The ensemble method, Pearson+ IDA+ Lasso, which combines methods in different approaches, including a correlation method, a causal inference method, and a regression method, is the best performed ensemble method in this study. Further analysis of the results of this ensemble method shows that the ensemble method can obtain more targets which could not be found by any of the single methods, and the discovered targets are more statistically significant and functionally enriched. The source codes, datasets, miRNA target predictions by all methods, and the ground truth for validation are available in the Supplementary materials.	[Thuc Duy Le; Liu, Lin; Li, Jiuyong] Univ S Australia, Sch Informat Technol & Math Sci, Adelaide, SA 5001, Australia; [Zhang, Junpeng] Dali Univ, Sch Engn, Dali, Peoples R China	University of South Australia; Dali University	Le, TD (corresponding author), Univ S Australia, Sch Informat Technol & Math Sci, Adelaide, SA 5001, Australia.	thuc.le@unisa.edu.au; jiuyong.li@unisa.edu.au	Zhang, Junpeng/E-4737-2013; Li, Jiuyong/A-8134-2008; Le, Thuc Duy D/G-8444-2019; Li, Jiuyong/AAY-2706-2020; Liu, Lin/ABD-1224-2020	Zhang, Junpeng/0000-0001-6127-9701; Li, Jiuyong/0000-0002-9023-1878; Le, Thuc Duy D/0000-0002-9732-4313; Li, Jiuyong/0000-0002-9023-1878; Liu, Lin/0000-0003-2843-5738	Australian Research Council Discovery Project [DP130104090]; Applied Basic Research Foundation of Science and Technology of Yunnan Province [2013FD038]	Australian Research Council Discovery Project(Australian Research Council); Applied Basic Research Foundation of Science and Technology of Yunnan Province	This work has been partially supported by Australian Research Council Discovery Project DP130104090, (JL and LL), and the Applied Basic Research Foundation of Science and Technology of Yunnan Province, No. 2013FD038 (JZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Enright AJ, 2004, GENOME BIOL, V5; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Joung JG, 2007, BIOINFORMATICS, V23, P1141, DOI 10.1093/bioinformatics/btm045; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Le TD, 2014, BRIEFINGS BIOINFORMA; Le TD, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-92; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku182; Liu B, 2009, BMC BIOINFORMATICS, V19, P1; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu YM, 2011, BIOINFORMATICS, V27, P2406, DOI 10.1093/bioinformatics/btr410; Maathuis MH, 2010, NAT METHODS, V7, P247, DOI 10.1038/nmeth0410-247; Maathuis MH, 2009, ANN STAT, V37, P3133, DOI 10.1214/09-AOS685; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Muniategui A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030766; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Pio G, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S1-S4; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Riaz M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3415; Rubinstein R., 1999, METHODOL COMPUT APPL, V1, P127, DOI DOI 10.1023/A:1010091220143; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Shirdel EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017429; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sokilde R, 2011, MOL CANCER THER, V10, P375, DOI 10.1158/1535-7163.MCT-10-0605; Speed T, 2011, SCIENCE, V334, P1502, DOI 10.1126/science.1215894; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Le TD, 2013, BIOINFORMATICS, V29, P765, DOI 10.1093/bioinformatics/btt048; Tran DH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S5; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Zhang JP, 2014, J BIOMED INFORM, V52, P438, DOI 10.1016/j.jbi.2014.08.005; Zhang JP, 2014, BIOINFORMATICS, V30, P3070, DOI 10.1093/bioinformatics/btu489; Zhang Y, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-127; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	61	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131627	10.1371/journal.pone.0131627	http://dx.doi.org/10.1371/journal.pone.0131627			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114448	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000358147500175
J	Anderson, AS; Marques, TA; Shoo, LP; Williams, SE				Anderson, Alexander S.; Marques, Tiago A.; Shoo, Luke P.; Williams, Stephen E.			Detectability in Audio-Visual Surveys of Tropical Rainforest Birds: The Influence of Species, Weather and Habitat Characteristics	PLOS ONE			English	Article							AUSTRALIAN WET TROPICS; POPULATION-DENSITIES; MEASUREMENT ERROR; CLIMATE-CHANGE; POINT COUNTS; ABUNDANCE; CONSERVATION; BIODIVERSITY; RELIABILITY; DETECTIONS	Indices of relative abundance do not control for variation in detectability, which can bias density estimates such that ecological processes are difficult to infer. Distance sampling methods can be used to correct for detectability, but in rainforest, where dense vegetation and diverse assemblages complicate sampling, information is lacking about factors affecting their application. Rare species present an additional challenge, as data may be too sparse to fit detection functions. We present analyses of distance sampling data collected for a diverse tropical rainforest bird assemblage across broad elevational and latitudinal gradients in North Queensland, Australia. Using audio and visual detections, we assessed the influence of various factors on Effective Strip Width (ESW), an intuitively useful parameter, since it can be used to calculate an estimate of density from count data. Body size and species exerted the most important influence on ESW, with larger species detectable over greater distances than smaller species. Secondarily, wet weather and high shrub density decreased ESW for most species. ESW for several species also differed between summer and winter, possibly due to seasonal differences in calling behavior. Distance sampling proved logistically intensive in these environments, but large differences in ESW between species confirmed the need to correct for detection probability to obtain accurate density estimates. Our results suggest an evidence-based approach to controlling for factors influencing detectability, and avenues for further work including modeling detectability as a function of species characteristics such as body size and call characteristics. Such models may be useful in developing a calibration for non-distance sampling data and for estimating detectability of rare species.	[Anderson, Alexander S.; Williams, Stephen E.] James Cook Univ, Coll Marine Environm Sci, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia; [Marques, Tiago A.] Univ St Andrews, Res Unit Wildlife Populat Assessment, Ctr Res Ecol & Environm Modeling, The Observ, St Andrews, Fife, Scotland; [Shoo, Luke P.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	James Cook University; University of St Andrews; University of Queensland	Anderson, AS (corresponding author), James Cook Univ, Coll Marine Environm Sci, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia.	alexander.anderson@my.jcu.edu.au	Marques, Tiago A/A-5530-2010; Williams, Stephen E/A-7250-2008; Shoo, Luke P/A-2715-2009; Marques, Tiago A./M-3253-2019	Marques, Tiago A/0000-0002-2581-1972; Williams, Stephen E/0000-0002-2510-7408; Marques, Tiago A./0000-0002-2581-1972	Australian Government's National Environmental Research Program; Stuart Leslie Bird Research Award from Birds Australia; Earthwatch Institute; Marine and Tropical Sciences Research Facility (MTSRF); Fundacao Nacional para a Ciencia e Tecnologia, Portugal - FCT [PEst-OE/MAT/UI0006/2011]	Australian Government's National Environmental Research Program(Australian Government); Stuart Leslie Bird Research Award from Birds Australia; Earthwatch Institute; Marine and Tropical Sciences Research Facility (MTSRF); Fundacao Nacional para a Ciencia e Tecnologia, Portugal - FCT	This research was funded by the Australian Government's National Environmental Research Program, the Stuart Leslie Bird Research Award from Birds Australia (http://www.birdsaustralia.com.au/), the Earthwatch Institute (http://www.earthwatch.org/australia/), the Marine and Tropical Sciences Research Facility (MTSRF: http://www.rrrc.org.au/mtsrf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, TAM was partially sponsored by national funds through the Fundacao Nacional para a Ciencia e Tecnologia, Portugal - FCT under the project (PEst-OE/MAT/UI0006/2011).	Alldredge MW, 2007, J WILDLIFE MANAGE, V71, P2759, DOI 10.2193/2006-161; Alldredge MW, 2007, ECOL APPL, V17, P948, DOI 10.1890/06-0685; Alldredge MW, 2007, J APPL ECOL, V44, P281, DOI 10.1111/j.1365-2664.2006.01271.x; Anderson AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069393; Anderson AS, 2012, SCH MARINE TROPICAL; Bachler E, 2007, IBIS, V149, P693, DOI 10.1111/j.1474-919X.2007.00689.x; Barabesi L, 2013, ENVIRON ECOL STAT, V20, P215, DOI 10.1007/s10651-012-0216-1; BART J, 1984, AUK, V101, P307, DOI 10.1093/auk/101.2.307; Beier P, 2002, CONSERV BIOL, V16, P1097, DOI 10.1046/j.1523-1739.2002.01003.x; Bell H, 1983, EMU, V82, P256, DOI [10.1071/MU9820256s, DOI 10.1071/MU9820256S]; BELL HL, 1982, EMU, V82, P24, DOI 10.1071/MU9820024; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Borchers D, 2010, J AGR BIOL ENVIR ST, V15, P346, DOI 10.1007/s13253-010-0021-y; Boulinier T, 1998, ECOLOGY, V79, P1018, DOI 10.2307/176597; BRACKENBURY JH, 1979, J EXP BIOL, V78, P163; Brewster JP, 2009, J FIELD ORNITHOL, V80, P178, DOI 10.1111/j.1557-9263.2009.00220.x; Buckland S., 2004, ADV DISTANCE SAMPLIN; Buckland S.T., 2001, pi; Buckland ST, 2008, BIRD CONSERV INT, V18, pS91, DOI 10.1017/S0959270908000294; Buckland ST, 2006, AUK, V123, P345, DOI 10.1642/0004-8038(2006)123[345:PSFSRM]2.0.CO;2; BURNHAM KP, 1984, J WILDLIFE MANAGE, V48, P1248, DOI 10.2307/3801785; BURNHAM KP, 1980, WILDLIFE MONOGR, P7; Cassey P, 2007, NEW ZEAL J ECOL, V31, P223; Collier TC, 2010, J ACOUST SOC AM, V128, P182, DOI 10.1121/1.3425729; CROME F H J, 1975, Australian Wildlife Research, V2, P155; Dawson DK, 2009, J APPL ECOL, V46, P1201, DOI 10.1111/j.1365-2664.2009.01731.x; Diefenbach DR, 2007, AUK, V124, P96, DOI 10.1642/0004-8038(2007)124[96:IAFDIE]2.0.CO;2; Dobkin DS, 1998, J FIELD ORNITHOL, V69, P430; Dutson Guy, 2009, P1; EMLEN JT, 1992, J FIELD ORNITHOL, V63, P26; EMLEN JT, 1971, AUK, V88, P323, DOI 10.2307/4083883; EMLEN JT, 1977, AUK, V94, P455; Gale GA, 2009, AUK, V126, P439, DOI 10.1525/auk.2009.08087; GRANHOLM SL, 1983, CONDOR, V85, P243, DOI 10.2307/1367261; Harris JBC, 2007, AVIAN CONSERV ECOL, V2; Hilbert D, 2010, THREATS ECOSYSTEMS W, P1; Houlder D, 2000, ANUCLIM 5 0 FENNER C; Hulme MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054597; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Johnson DH, 2008, J WILDLIFE MANAGE, V72, P857, DOI 10.2193/2007-294; Karr J.R., 1981, Studies in Avian Biology, P548; Laurance SGW, 2004, ECOL APPL, V14, P1344, DOI 10.1890/03-5194; Lindenmayer DB, 2009, EMU, V109, P100, DOI 10.1071/MU08029; Mac Nally R, 1999, BIOL CONSERV, V95, P7, DOI 10.1016/S0006-3207(00)00017; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; Marchant S., 1990, HDB AUSTR NZ ANTARCT, V1; Marques FFC, 2003, BIOMETRICS, V59, P924, DOI 10.1111/j.0006-341X.2003.00107.x; Marques TA, 2010, BIOMETRICS, V66, P1247, DOI 10.1111/j.1541-0420.2009.01381.x; Marques TALO, 2007, INCORPORATING MEASUR; Marques TA, 2007, AUK, V124, P1229, DOI 10.1642/0004-8038(2007)124[1229:IEOBDU]2.0.CO;2; Marques TA, 2013, BIOL REV, V88, P287, DOI 10.1111/brv.12001; Martin J, 2007, CONSERV BIOL, V21, P472, DOI 10.1111/j.1523-1739.2006.00613.x; Mennill DJ, 2006, J ACOUST SOC AM, V119, P2832, DOI 10.1121/1.2184988; Moura NG, 2013, BIOL CONSERV, V167, P339, DOI 10.1016/j.biocon.2013.08.023; Nichols JD, 2000, AUK, V117, P393, DOI 10.1642/0004-8038(2000)117[0393:ADOAFE]2.0.CO;2; Norvell RE, 2003, AUK, V120, P1013, DOI 10.1642/0004-8038(2003)120[1013:ASCORA]2.0.CO;2; ORNELAS JF, 1993, CONDOR, V95, P422, DOI 10.2307/1369365; Pacific K, 2008, AUK, V125, P998, DOI 10.1525/auk.2008.111008; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; Perry JJ, 2012, EMU, V112, P261, DOI 10.1071/MU12007; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Pohlman CL, 2007, BIOTROPICA, V39, P62, DOI 10.1111/j.1744-7429.2006.00238.x; Ralph C. J, 1981, ESTIMATING NUMBERS T, V6; Risely K, 2011, BREEDING BIRD SURVEY, P1; Rosenstock SS, 2002, AUK, V119, P46, DOI 10.1642/0004-8038(2002)119[0046:LCTCPA]2.0.CO;2; Schieck J, 1997, CONDOR, V99, P179, DOI 10.2307/1370236; Scott J. M., 1981, STUD AVIAN BIOL, V6, P334; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Selmi S, 2003, J FIELD ORNITHOL, V74, P349, DOI 10.1648/0273-8570-74.4.349; Shoo LP, 2005, GLOBAL CHANGE BIOL, V11, P1469, DOI 10.1111/j.1365-2486.2005.00995.x; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Shoo LP, 2009, EMU, V109, P288, DOI 10.1071/MU08062; Simons TR, 2009, ENVIRON ECOL STAT SE, V3, P237, DOI 10.1007/978-0-387-78151-8_10; Sodhi NS, 2004, ANNU REV ECOL EVOL S, V35, P323, DOI 10.1146/annurev.ecolsys.35.112202.130209; Sutter GC, 2000, J FIELD ORNITHOL, V71, P110, DOI 10.1648/0273-8570-71.1.110; Taulman JF, 2013, SOUTHEAST NAT, V12, P457, DOI 10.1656/058.012.0301; Team R. D. C, 2011, R LANG ENV STAT COMP; Thill RE, 2005, BREEDING BIRDS EVEN; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas L., 2002, ENCY ENV, V1, P544, DOI [10.2307/2532812, DOI 10.2307/2532812]; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; WAIDE RB, 1988, AUK, V105, P296, DOI 10.2307/4087493; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Watson DM, 2004, WILDLIFE RES, V31, P1, DOI 10.1071/WR03022; WEBB LJ, 1959, J ECOL, V47, P551, DOI 10.2307/2257290; Whitaker DM, 1997, CAN J FOREST RES, V27, P1159, DOI 10.1139/x97-069; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Williams SE, 2002, ECOLOGY, V83, P1317, DOI 10.1890/0012-9658(2002)083[1317:SSSDAH]2.0.CO;2; Williams SE, 2008, DIVERS DISTRIB, V14, P69, DOI 10.1111/j.1472-4642.2007.00418.x; Williams SE, 2010, AUSTRAL ECOL, V35, P650, DOI 10.1111/j.1442-9993.2009.02073.x; WILSON DM, 1985, CONDOR, V87, P69, DOI 10.2307/1367132; Wilson RR, 2000, J FIELD ORNITHOL, V71, P345, DOI 10.1648/0273-8570-71.2.345	92	33	36	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0128464	10.1371/journal.pone.0128464	http://dx.doi.org/10.1371/journal.pone.0128464			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110433	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000356933800010
J	Fielder, H; Brotherton, P; Hosking, J; Hopkins, JJ; Ford-Lloyd, B; Maxted, N				Fielder, Hannah; Brotherton, Peter; Hosking, Julian; Hopkins, John J.; Ford-Lloyd, Brian; Maxted, Nigel			Enhancing the Conservation of Crop Wild Relatives in England	PLOS ONE			English	Article							GENETIC-RESOURCES; FOOD; INVENTORIES	Humans require resilient, rapidly renewable and sustainable supplies of food and many other plant-derived supplies. However, the combined effects of climate change and population growth compromise the provision of these supplies particularly in respect to global food security. Crop wild relatives (CWR) contain higher genetic diversity than crops and harbour traits that can improve crop resilience and yield through plant breeding. However, in common with most countries, CWR are poorly conserved in England. There is currently no provision for long-term CWR conservation in situ, and comprehensive ex situ collection and storage of CWR is also lacking. However, there is a commitment to achieve their conservation in England's Biodiversity Strategy and the UK has international commitments to do so as part of the Global Plant Conservation Strategy. Here, we identify a series of measures that could enhance the conservation of English CWR, thereby supporting the achievement of these national and international objectives. We provide an inventory of 148 priority English CWR, highlight hotspots of CWR diversity in sites including The Lizard Peninsula, the Dorset coast and Cambridgeshire and suggest appropriate sites for the establishment of a complementary network of genetic reserves. We also identify individual in situ and ex situ priorities for each English CWR. Based on these analyses, we make recommendations whose implementation could provide effective, long-term conservation of English CWR whilst facilitating their use in crop improvement.	[Fielder, Hannah; Ford-Lloyd, Brian; Maxted, Nigel] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Brotherton, Peter] Nat England, Peterborough, Cambs, England; [Hosking, Julian] Riverside Chambers, Nat England, Taunton, Somerset, England; [Hopkins, John J.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	University of Birmingham; University of Exeter	Fielder, H (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	hannahfielder88@gmail.com			EU Seventh Framework Programme; PGR Secure "Characterization of biodiversity resources for wild crop relatives to improve crops by breeding" [266394]	EU Seventh Framework Programme; PGR Secure "Characterization of biodiversity resources for wild crop relatives to improve crops by breeding"	The authors acknowledge the EU Seventh Framework Programme funded project, PGR Secure "Characterization of biodiversity resources for wild crop relatives to improve crops by breeding" (Grant agreement no. 266394) for providing the financial support for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, CHIN STRAT PLANT CON; [Anonymous], 2010, COP OUT BIOD LOSS RI; [Anonymous], 1997, PLANT GENETIC CONSER; Berlingeri C, 2012, GENET RESOUR CROP EV, V59, P655, DOI 10.1007/s10722-011-9709-2; Boon C, 2011, FLORA BEDFORDSHIRE; Braithwaite M.E., 2006, CHANGE BRIT FLORA 19; Brehm JM, 2008, GENET RESOUR CROP EV, V55, P779, DOI 10.1007/s10722-007-9283-9; Brehm JM, 2010, BIODIVERS CONSERV, V19, P2715, DOI 10.1007/s10531-010-9871-4; Brown A. H. D., 1995, P75; Brown A. H. D., 1991, Genetics and conservation of rare plants.., P99; BSBI, 2013, BSBI DISTR DAT; Cheffings C. M., 2005, SPECIES STATUS, V7, P1; DEFRA, 2011, BIOD 2020 STRAT ENGL; Defra, 2010, AGR UK 2010; Dias S, 2012, AGROBIODIVERSITY CONSERVATION: SECURING THE DIVERSITY OF CROP WILD RELATIVES AND LANDRACES, P270, DOI 10.1079/9781845938512.0270; Lozano F, 2012, BIODIVERS CONSERV, V21, P1937, DOI 10.1007/s10531-012-0286-2; Dulloo ME, 2008, CONSERVING PLANT GENETIC DIVERSITY IN PROTECTED AREAS: POPULATION MANAGEMENT OF CROP WILD RELATIVES, P23, DOI 10.1079/9781845932824.0023; ESRI, 2011, ARCGIS DESKT REL 10; EU, 2011, EU BIOD STRAT 2020; FAOSTAT, 2013, AGR CROP PROD DAT; Fitzgerald H., 2013, 121 MTT; Frankel O.H., 1995, CONSERVATION PLANT B; Franks JR, 1999, LAND USE POLICY, V16, P81, DOI 10.1016/S0264-8377(98)00038-6; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gonzalez-Orozco CE, 2012, CONSERV GENET, V13, P1269, DOI 10.1007/s10592-012-0370-x; GOODMAN RM, 1987, SCIENCE, V236, P48, DOI 10.1126/science.236.4797.48; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; Heywood V.H., 1995, FLORA MEDITERRANEAN, V5, P375; Hijmans R.J., 2012, DIVA GIS; Hopkins JJ, 2011, NATURAL ENGLAND RES, V037; Idohou R, 2013, GENET RESOUR CROP EV, V60, P1337, DOI 10.1007/s10722-012-9923-6; Iriondo JM, 2012, AGROBIODIVERSITY CONSERVATION: SECURING THE DIVERSITY OF CROP WILD RELATIVES AND LANDRACES, P72, DOI 10.1079/9781845938512.0072; Jackson A, 1995, BRIT WILDLIFE, V6, P273; Kell SP, 2012, AGROBIODIVERSITY CONSERVATION: SECURING THE DIVERSITY OF CROP WILD RELATIVES AND LANDRACES, P218, DOI 10.1079/9781845938512.0218; Kell S. P., 2008, P69; Kell SP., 2005, CATALOGUE CROP WILD; Khoury CK, 2013, CROP SCI, V53, P1496, DOI 10.2135/cropsci2012.10.0585; King H, 2007, CONSERVATION EVIDENC, V4, P73; King H., 2007, CONSERV EVID, V4, P69; Lakew B, 2011, FIELD CROP RES, V120, P161, DOI 10.1016/j.fcr.2010.09.011; Lewer R. P., 1987, Proceedings of the the Sixth Conference, Australian Association of Animal Breeding and Genetics, University of Western Australia, Perth, WA, Australia, 9-11 February 1987., P139; MAFF, 1995, UK COUNTR REP FAO; Brehm JM, 2012, AGROBIODIVERSITY CONSERVATION: SECURING THE DIVERSITY OF CROP WILD RELATIVES AND LANDRACES, P193, DOI 10.1079/9781845938512.0193; Maxted N, 2008, CONSERVING PLANT GENETIC DIVERSITY IN PROTECTED AREAS: POPULATION MANAGEMENT OF CROP WILD RELATIVES, P1, DOI 10.1079/9781845932824.0001; Maxted N, 2003, BIOL CONSERV, V113, P411, DOI 10.1016/S0006-3207(03)00123-X; Maxted N., 2008, P3, DOI 10.1079/9781845930998.0003; Maxted N, 1997, GENET RESOUR CROP EV, V44, P337, DOI 10.1023/A:1008643206054; Maxted N., 2009, ESTABLISHMENT NETWOR; Maxted N., 2004, SYSTEMATIC ECOGEOGRA; Maxted N, 2013, RESOURCE BOOK PREPAR; Maxted N, 2008, DIVERS DISTRIB, V14, P1018, DOI 10.1111/j.1472-4642.2008.00512.x; Maxted N, 2007, BIOL CONSERV, V140, P142, DOI 10.1016/j.biocon.2007.08.006; Maxted N, 2006, BIODIVERS CONSERV, V15, P2673, DOI 10.1007/s10531-005-5409-6; Maxted N, 2012, CROP SCI, V52, P774, DOI 10.2135/cropsci2011.08.0415; Munerati O, 1932, IND SACCARIFERA ITAL, V25, P303; Natural England, 2014, PUBL MAPS DAT; Panella L, 2014, NATL CROP WILD RELAT; Parra-Quijano M., 2008, P249, DOI 10.1079/9781845930998.0249; Phillips J, 2014, GENET RESOUR CROP EV, V61, P817, DOI 10.1007/s10722-013-0076-z; Planta Europa, 2008, SUST FUT EUR EUR STR; Porter JR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P485; PwC, 2013, CROP WILD REL VAL RE; Ramirez-Villegas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013497; Rebelo A.G., 1994, STRELITZIA, P231; Scheldeman X., 2010, TRAINING MANUAL SPAT; Scholten M., 2008, P120; Skot L, 2007, GENETICS, V177, P535, DOI 10.1534/genetics.107.071522; Stace C., 1997, NEW FLORA BRIT ISLES; Stace C., 2003, VICE COUNTY CENSUS C; Stace C.A., 2010, STACE, V3rd Edn; Stroh P.A., 2014, VASCULAR PLANT RED L; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Teso M. L. R., 2013, NATL STRATEGY CONSER; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; United Nations, 2011, WORLD POP PROSP; USDA ARS National Genetic Resources Program, 2012, NAT GEN RES PROGR; Vincent H, 2013, BIOL CONSERV, V167, P265, DOI 10.1016/j.biocon.2013.08.011; Walker KJ, 2003, WATSONIA, V26, P291; World Bank, 2008, INT TRADE CLIMATE CH; Zeven A.C, 1975, DICT CULTIVATED PLAN	80	39	42	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130804	10.1371/journal.pone.0130804	http://dx.doi.org/10.1371/journal.pone.0130804			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110773	gold, Green Published, Green Submitted			2022-12-27	WOS:000356933800086
J	Kubli, DA; Cortez, MQ; Moyzis, AG; Najor, RH; Lee, Y; Gustafsson, AB				Kubli, Dieter A.; Cortez, Melissa Q.; Moyzis, Alexandra G.; Najor, Rita H.; Lee, Youngil; Gustafsson, Asa B.			PINK1 Is Dispensable for Mitochondrial Recruitment of Parkin and Activation of Mitophagy in Cardiac Myocytes	PLOS ONE			English	Article							CELL-DEATH; PINK1/PARKIN-MEDIATED MITOPHAGY; DAMAGED MITOCHONDRIA; MITOFUSIN 2; AUTOPHAGY; BNIP3; UBIQUITIN; PROTEIN; DYSFUNCTION; INDUCTION	Myocyte function and survival relies on the maintenance of a healthy population of mitochondria. The PINK1/Parkin pathway plays an important role in clearing defective mitochondria via autophagy in cells. However, how the PINK1/Parkin pathway regulates mitochondrial quality control and whether it coordinates with other mitophagy pathways are still unclear. Therefore, the objective of this study was to investigate the effect of PINK1-deficiency on mitochondrial quality control in myocytes. Using PINK1-deficient ( PINK1-/-) mice, we found that Parkin is recruited to damaged cardiac mitochondria in hearts after treatment with the mitochondrial uncoupler FCCP or after a myocardial infarction even in the absence of PINK1. Parkin recruitment to depolarized mitochondria correlates with increased ubiquitination of mitochondrial proteins and activation of mitophagy in PINK1-/-myocytes. In addition, induction of mitophagy by the atypical BH3-only protein BNIP3 is unaffected by lack of PINK1. Overall, these data suggest that Parkin recruitment to depolarized cardiac mitochondria and subsequent activation of mitophagy is independent of PINK1. Moreover, alternative mechanisms of Parkin activation and pathways of mitophagy remain functional in PINK1-/-myocytes and could compensate for the PINK1 deficiency.	[Kubli, Dieter A.; Cortez, Melissa Q.; Moyzis, Alexandra G.; Najor, Rita H.; Lee, Youngil; Gustafsson, Asa B.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Gustafsson, AB (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	asag@ucsd.edu	Lee, Youngil/AAX-2787-2021	Lee, Youngil/0000-0003-3819-2469	U.S. Public Health Service [HL087023, HL101217, HL085577]; American Heart Association Established Investigator Award [14EIA18970095]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101217, P01HL085577, R01HL087023, T32HL007444] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); American Heart Association Established Investigator Award(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by U.S. Public Health Service Grants HL087023, HL101217, HL085577, and an American Heart Association Established Investigator Award 14EIA18970095.	Andres AM, 2014, ANTIOXID REDOX SIGN, V21, P1960, DOI 10.1089/ars.2013.5416; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Billia F, 2011, P NATL ACAD SCI USA, V108, P9572, DOI 10.1073/pnas.1106291108; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Dorn GW, 2010, J CARDIOVASC TRANSL, V3, P374, DOI 10.1007/s12265-010-9174-x; Gatica D, 2015, CIRC RES, V116, P456, DOI 10.1161/CIRCRESAHA.114.303788; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, AUTOPHAGY, V6, P871, DOI 10.4161/auto.6.7.13286; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Hammerling BC, 2014, J MOL CELL CARDIOL, V75, P122, DOI 10.1016/j.yjmcc.2014.07.013; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Hoshino A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3308; Huang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020975; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kim KY, 2011, J CLIN INVEST, V121, P3701, DOI 10.1172/JCI44736; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Kubli Dieter A, 2013, Commun Integr Biol, V6, pe24511, DOI 10.4161/cib.24511; Kubli DA, 2013, J BIOL CHEM, V288, P915, DOI 10.1074/jbc.M112.411363; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Lee Y, 2011, AM J PHYSIOL-HEART C, V301, pH1924, DOI 10.1152/ajpheart.00368.2011; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Regula KM, 2002, CIRC RES, V91, P226, DOI 10.1161/01.RES.0000029232.42227.16; Rikka S, 2011, CELL DEATH DIFFER, V18, P721, DOI 10.1038/cdd.2010.146; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zheng XD, 2014, EMBO J, V33, P1621, DOI 10.15252/embj.201489185	43	59	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130707	10.1371/journal.pone.0130707	http://dx.doi.org/10.1371/journal.pone.0130707			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110811	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800075
J	Branco, AF; Pereira, SP; Gonzalez, S; Gusev, O; Rizvanov, AA; Oliveira, PJ				Branco, Ana F.; Pereira, Susana P.; Gonzalez, Susana; Gusev, Oleg; Rizvanov, Albert A.; Oliveira, Paulo J.			Gene Expression Profiling of H9c2 Myoblast Differentiation towards a Cardiac-Like Phenotype	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE KINASE; CELL-LINE; RAT-HEART; IN-VITRO; MITOCHONDRIAL; CARDIOMYOBLASTS; MUSCLE; DOXORUBICIN; RECEPTOR; PATHWAYS	H9c2 myoblasts are a cell model used as an alternative for cardiomyocytes. H9c2 cells have the ability to differentiate towards a cardiac phenotype when the media serum is reduced in the presence of all-trans-retinoic acid (RA), creating multinucleated cells with low proliferative capacity. In the present study, we performed for the first time a transcriptional analysis of the H9c2 cell line in two differentiation states, i.e. embryonic cells and differentiated cardiac-like cells. The results show that RA-induced H9c2 differentiation increased the expression of genes encoding for cardiac sarcomeric proteins such as troponin T, or calcium transporters and associated machinery, including SERCA2, ryanodine receptor and phospholamban as well as genes associated with mitochondrial energy production including respiratory chain complexes subunits, mitochondrial creatine kinase, carnitine palmitoyltransferase I and uncoupling proteins. Undifferentiated myoblasts showed increased gene expression of pro-survival proteins such as Bcl-2 as well as cell cycle-regulating proteins. The results indicate that the differentiation of H9c2 cells lead to an increase of transcripts and protein levels involved in calcium handling, glycolytic and mitochondrial metabolism, confirming that H9c2 cell differentiation induced by RA towards a more cardiac-like phenotype involves remodeled mitochondrial function. PI3K, PDK1 and p-CREB also appear to be involved on H9c2 differentiation. Furthermore, complex analysis of differently expressed transcripts revealed significant up-regulation of gene expression related to cardiac muscle contraction, dilated cardiomyopathy and other pathways specific for the cardiac tissue. Metabolic and gene expression remodeling impacts cell responses to different stimuli and determine how these cells are used for biochemical assays.	[Branco, Ana F.; Pereira, Susana P.; Oliveira, Paulo J.] Univ Coimbra, Ctr Neurosci & Cell Biol, CNC, Cantanhede, Portugal; [Branco, Ana F.] Univ Coimbra, Dept Life Sci, Coimbra, Portugal; [Gonzalez, Susana] Spanish Natl Cardiovasc Res Ctr CNIC, Stem Cell Aging Grp, Madrid, Spain; [Gusev, Oleg; Rizvanov, Albert A.] Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia	Universidade de Coimbra; Universidade de Coimbra; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Kazan Federal University	Rizvanov, AA (corresponding author), Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia.	Albert.Rizvanov@kpfu.ru; pauloliv@ci.uc.pt	Pereira, Susana P./E-7628-2013; Branco, Ana/AGP-5286-2022; Gonzalez, Susana/I-3154-2015; Gusev, Oleg/D-9383-2011; Oliveira, Paulo J./H-1980-2011; Oliveira, Paulo J./AAQ-8943-2020; Rizvanov, Albert/H-4486-2013	Pereira, Susana P./0000-0002-1168-2444; Branco, Ana/0000-0002-0415-3560; Gonzalez, Susana/0000-0002-7443-6195; Gusev, Oleg/0000-0002-6203-9758; Oliveira, Paulo J./0000-0002-5201-9948; Oliveira, Paulo J./0000-0002-5201-9948; Rizvanov, Albert/0000-0002-9427-5739	Foundation for Science and Technology [PTDC/SAU-TOX/110952/2009, PTDC/SAU-TOX/117912/2010, PTDC/DTP-FTO/1180/2012, PEst-C/SAU/LA0001/2013-2014, SFRH/BD/64247/2009]; FEDER/Compete and National Budget; QREN [4832, CENTRO-07-ST24-FEDER-002008]; Program of Competitive Growth of Kazan Federal University;  [SFRH/BD/41384/2007]	Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FEDER/Compete and National Budget; QREN; Program of Competitive Growth of Kazan Federal University(Ministry of Education and Science, Russian FederationProject 5-100, Ministry of Education and Science, Russian Federation); 	Funding: The present work was supported by the Foundation for Science and Technology, research grants PTDC/SAU-TOX/110952/2009, PTDC/SAU-TOX/117912/2010 and PTDC/DTP-FTO/1180/2012 to PJO, and PEst-C/SAU/LA0001/2013-2014 to the CNC, co-funded by FEDER/Compete and National Budget. SPP is supported by a PhD fellowship from the Foundation for Science and Technology (SFRH/BD/64247/2009). The work was also supported by QREN project #4832 "Stem cell-based platforms for Regenerative and Therapeutic Medicine" reference CENTRO-07-ST24-FEDER-002008. Ana Branco and Susana Pereira were supported by Ph.D. fellowships SFRH/BD/41384/2007 and SFRH/BD/64247/2009, respectively. Oleg Gusev and Albert A. Rizvanov were supported by Program of Competitive Growth of Kazan Federal University. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; BOHM M, 1991, CIRC RES, V68, P689, DOI 10.1161/01.RES.68.3.689; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branco AF, 2013, INT J BIOCHEM CELL B, V45, P2379, DOI 10.1016/j.biocel.2013.08.006; Branco AF, 2012, CARDIOVASC TOXICOL, V12, P326, DOI 10.1007/s12012-012-9177-8; Branco AF, 2011, CARDIOVASC TOXICOL, V11, P191, DOI 10.1007/s12012-011-9111-5; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Chung S, 2010, J MOL CELL CARDIOL, V48, P725, DOI 10.1016/j.yjmcc.2009.12.014; Comelli M, 2011, MITOCHONDRION, V11, P315, DOI 10.1016/j.mito.2010.12.007; De Angelis A, 2010, CIRCULATION, V121, P276, DOI 10.1161/CIRCULATIONAHA.109.895771; di Giacomo V, 2010, DIFFERENTIATION, V80, P204, DOI 10.1016/j.diff.2010.06.002; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; KIMES BW, 1976, EXP CELL RES, V98, P367, DOI 10.1016/0014-4827(76)90447-X; Kuzmenkin A, 2009, FASEB J, V23, P4168, DOI 10.1096/fj.08-128546; Lee JK, 1999, BIOCHEM BIOPH RES CO, V254, P657, DOI 10.1006/bbrc.1998.0113; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Menard C, 1999, J BIOL CHEM, V274, P29063, DOI 10.1074/jbc.274.41.29063; Molina CE, 2012, J AM COLL CARDIOL, V59, P2182, DOI 10.1016/j.jacc.2012.01.060; Pagano M, 2004, J CELL PHYSIOL, V198, P408, DOI 10.1002/jcp.10420; Peifer C, 2008, CHEMMEDCHEM, V3, P1810, DOI 10.1002/cmdc.200800195; Pereira SL, 2011, CARDIOVASC TOXICOL, V11, P180, DOI 10.1007/s12012-011-9112-4; Sardao VA, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-11; Sardao VA, 2009, CANCER CHEMOTH PHARM, V64, P811, DOI 10.1007/s00280-009-0932-x; Sardao VA, 2009, CELL BIOL TOXICOL, V25, P227, DOI 10.1007/s10565-008-9070-1; SCHOPF G, 1986, BIOCHIM BIOPHYS ACTA, V884, P319, DOI 10.1016/0304-4165(86)90180-7; Schrauwen P, 2003, FASEB J, V17, P2272, DOI 10.1096/fj.03-0515fje; Schrauwen P, 2002, J EXP BIOL, V205, P2275; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Watkins SJ, 2011, IN VITRO CELL DEV-AN, V47, P125, DOI 10.1007/s11626-010-9368-1; Wu PF, 2000, ARCH BIOCHEM BIOPHYS, V381, P1, DOI 10.1006/abbi.2000.1946; Xu QH, 2002, J BIOL CHEM, V277, P41693, DOI 10.1074/jbc.M207095200; Xu YX, 2014, TRENDS BIOCHEM SCI, V39, P268, DOI 10.1016/j.tibs.2014.04.004; Yu XY, 2010, EXP CELL RES, V316, P2903, DOI 10.1016/j.yexcr.2010.07.004	37	80	80	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0129303	10.1371/journal.pone.0129303	http://dx.doi.org/10.1371/journal.pone.0129303			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121149	Green Published, gold			2022-12-27	WOS:000358150400019
J	Cho, EJ; Lee, JH; Cho, Y; Lee, YB; Yoo, JJ; Lee, M; Lee, DH; Yu, SJ; Kim, YJ; Yoon, JH; Lee, HS				Cho, Eun Ju; Lee, Jeong-Hoon; Cho, Yuri; Lee, Yun Bin; Yoo, Jeong-Ju; Lee, Minjong; Lee, Dong Hyeon; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan; Lee, Hyo-Suk			Comparison of the Efficacy of Entecavir and Tenofovir in Nucleos(T)ide Analogue-Experienced Chronic Hepatitis B Patients	PLOS ONE			English	Article							PRIOR EXPOSURE; LAMIVUDINE; FAILURE; RESISTANCE; LEVEL; NAIVE; HBV	The efficacy of entecavir (ETV) and tenofovir (TDF) for the treatment of nucleos(t)ide analogue (NA)-experienced chronic hepatitis B (CHB) patients has been little studied. Here, we compare the efficacy of both ETV and TDF in NA-experienced CHB patients without detectable genotypic resistance. This retrospective cohort study included consecutive NA-experienced patients who had neither current nor previous genotypic resistance and had received ETV or TDF for at least 6 months. Overall, 202 patients (146 patients in the ETV group and 56 in the TDF group) were analyzed. The cumulative probabilities of complete virologic suppression (CVS) at month 12 were 76.1% in the ETV group and 95.0% in the TDF group (P<0.001), respectively. The TDF-treated group achieved CVS more rapidly than the ETV group for both Hepatitis B e antigen (HBeAg)-negative and -positive patients (P = 0.006 and < 0.001, respectively), and for those with both low (< 2,000 IU/mL) and high (>= 2,000 IU/mL) HBV DNA levels (P = 0.01 and 0.002, respectively). TDF group had an increased probability of achieving CVS (hazard ratio, 2.242; 95% confidence interval, 1.587-3.165; P = 0.001), after adjustment for HBV DNA level, the presence of HBeAg, and a history of CVS during prior treatment. During the treatment period, 23 patients (15.8%) in the ETV group developed virologic breakthrough, compared to none in the TDF group. The cumulative probabilities of developing virologic breakthrough and ETV-resistance at month 24 were 9.7% and 5.3%, respectively. In conclusion, TDF is preferable to ETV for achieving CVS in NA-experienced CHB patients without genotypic resistance.	[Cho, Eun Ju; Lee, Jeong-Hoon; Cho, Yuri; Yoo, Jeong-Ju; Lee, Minjong; Lee, Dong Hyeon; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan; Lee, Hyo-Suk] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Cho, Eun Ju; Lee, Jeong-Hoon; Cho, Yuri; Yoo, Jeong-Ju; Lee, Minjong; Lee, Dong Hyeon; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan; Lee, Hyo-Suk] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Lee, Yun Bin] CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Songnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Pochon Cha University	Lee, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	pindra@empal.com	Lee, Jeong-Hoon/Q-1055-2018	Lee, Jeong-Hoon/0000-0002-0315-2080; Yoo, Jeong-Ju/0000-0002-7802-0381; Kim, Yoon Jun/0000-0001-9141-7773; Yoon, Jung-Hwan/0000-0002-9128-3610; Cho, Eun Ju/0000-0002-2677-3189; Lee, Yun Bin/0000-0002-3193-9745; , minjong/0000-0002-3159-5444; Yu, Su Jong/0000-0001-8888-7977	Seoul National University Hospital Research Fund [30-2014-0070]	Seoul National University Hospital Research Fund	This study was supported by the Seoul National University Hospital Research Fund (Grant No. 30-2014-0070) (http://www.snuh.org/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baran B, 2013, ANTIMICROB AGENTS CH, V57, P1790, DOI 10.1128/AAC.02600-12; Chevaliez S, 2010, J CLIN MICROBIOL, V48, P3641, DOI 10.1128/JCM.01306-10; Curtis LH, 2007, MED CARE, V45, pS103, DOI 10.1097/MLR.0b013e31806518ac; Dogan UB, 2012, TURK J GASTROENTEROL, V23, P247, DOI 10.4318/tjg.2012.0380; Guzelbulut F, 2012, HEPATO-GASTROENTEROL, V59, P477, DOI 10.5754/hge11426; Heinze G, 2001, BIOMETRICS, V57, P114, DOI 10.1111/j.0006-341X.2001.00114.x; Ke WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098865; Lee JH, 2014, ANTIMICROB AGENTS CH, V58, P1730, DOI 10.1128/AAC.02483-13; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Lok AS, 2007, HEPATOLOGY, V46, P254, DOI 10.1002/hep.21698; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Margeridon-Thermet S, 2013, ANTIMICROB AGENTS CH, V57, P343, DOI 10.1128/AAC.01601-12; Nguyen NH, 2015, J GASTROEN HEPATOL, V30, P43, DOI 10.1111/jgh.12728; Pageaux GP, 2014, J HEPATOL, V60, pS430, DOI 10.1016/S0168-8278(14)61221-6; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Patterson SJ, 2011, GUT, V60, P247, DOI 10.1136/gut.2010.223206; Petersen J, 2014, J HEPATOL, V60, pS51, DOI 10.1016/S0168-8278(14)60124-0; Reijnders JGP, 2010, J HEPATOL, V52, P493, DOI 10.1016/j.jhep.2010.01.012; van Bommel F, 2010, HEPATOLOGY, V51, P73, DOI 10.1002/hep.23246; van Bommel F, 2006, HEPATOLOGY, V44, P318, DOI 10.1002/hep.21253; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zoulim F, 2012, J HEPATOL, V56, pS112, DOI 10.1016/S0168-8278(12)60012-9	22	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130392	10.1371/journal.pone.0130392	http://dx.doi.org/10.1371/journal.pone.0130392			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121361	gold, Green Submitted, Green Published			2022-12-27	WOS:000358150400039
J	Eguchi, H; Wada, K; Higuchi, Y; Yoneoka, D; Smith, DR				Eguchi, Hisashi; Wada, Koji; Higuchi, Yoshiyuki; Yoneoka, Daisuke; Smith, Derek R.			Work Content and Serious Mental Illness among Middle-Aged Men: Results from a 6-Year Longitudinal Study in Japan	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; SOCIOECONOMIC-FACTORS; HEALTH INEQUALITIES; OCCUPATIONAL CLASS; STRESS MODELS; RISK; POPULATION; DEPRESSION; COHORT; METAANALYSIS	Objective The present study aimed to determine prospective associations between work content after a working life of more than 20 years and serious mental illness among Japanese men aged 50 to 59 years, using a nationwide population-based survey. Methods Data were extracted from a national longitudinal survey of middle-aged and elderly persons previously conducted by the Ministry of Health, Labour and Welfare in Japan. We analyzed data across 10 work content categories for Japanese men who had been working in the same job type or industry for over 20 years. As part pf the survey, participants completed the Kessler (K) 6 scale each year to determine their level of psychological distress (with scores >= 13 indicating serious mental illness). Cox discrete time proposal hazard regression analysis was used to examine potential associations between work content and serious mental illness from 2005 to 2010. Further adjustments were made for other sociodemographic characteristics and lifestyle factors. Results The current study involved a total of 11,942 participants with a mean (+/- standard deviation [SD]) of follow-up was 3.4 (+/- 2.0) years, during which time 892 participants (7.5%) had been classified as having a new-onset serious mental illness. Men who had worked in service jobs and in manufacturing jobs at baseline were more likely to develop serious mental illness than those in managerial jobs (hazard ratio 1.37, 1.30, 95% confidence intervals 1.04-1.80, 1.02-1.65) after adjustment for confounding variables. Conclusion These findings suggest that Japanese men aged 50 to 59 years who have worked in service and manufacturing jobs after a working life of over 20 years have an increased risk of serious mental illness during follow-up. Identifying the most at-risk work content category after a working life of over 20 years would be an essential part of providing more effective interventions for psychological distress among Japanese men in this age group.	[Eguchi, Hisashi] Kitasato Univ, Sch Med, Dept Publ Hlth, Minato, Kanagawa, Japan; [Wada, Koji] Int Hlth Cooperat, Natl Ctr Global Hlth & Med, Tokyo, Japan; [Higuchi, Yoshiyuki] Fukuoka Univ Educ, Dept Hlth & Phys Educ, Fukuoka 81141, Japan; [Yoneoka, Daisuke] Grad Univ Adv Studies, Dept Stat Sci, Sch Adv Sci, Hayama, Kanagawa, Japan; [Smith, Derek R.] Univ Newcastle, Fac Hlth & Med, Sch Hlth Sci, Ourimbah, NSW, Australia	Kitasato University; National Center for Global Health & Medicine - Japan; Fukuoka University Education; Graduate University for Advanced Studies - Japan; University of Newcastle	Wada, K (corresponding author), Int Hlth Cooperat, Natl Ctr Global Hlth & Med, Tokyo, Japan.	kwada-sgy@umin.ac.jp	Yoneoka, Daisuke/A-9336-2016	Yoneoka, Daisuke/0000-0002-3525-5092; Smith, Derek/0000-0002-8202-2523	Japan Society for the Promotion of Science, KAKENHI [25460812]	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science, KAKENHI Grant-in-Aid for Scientific Research C, Grant Number 25460812. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosma H, 1998, AM J PUBLIC HEALTH, V88, P68, DOI 10.2105/AJPH.88.1.68; Brunner EJ, 2004, J EPIDEMIOL COMMUN H, V58, P1019, DOI 10.1136/jech.2003.016881; Chien IC, 2013, J PSYCHOSOM RES, V75, P270, DOI 10.1016/j.jpsychores.2013.06.003; Fukuda Yoshiharu, 2012, Environmental Health and Preventive Medicine, V17, P10, DOI 10.1007/s12199-011-0212-3; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Hackett ML, 2005, STROKE, V36, P1330, DOI 10.1161/01.STR.0000165928.19135.35; Hirokawa K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002690; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; Inoue A, 2010, J OCCUP HEALTH, V52, P227, DOI 10.1539/joh.O10002; Inoue K, 2000, OCCUP ENVIRON MED, V57, P284; Kachi Y, 2014, SCAND J WORK ENV HEA, V40, P465, DOI 10.5271/sjweh.3442; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kawaharada M, 2007, IND HEALTH, V45, P247, DOI 10.2486/indhealth.45.247; Kawakami N, 2004, J EPIDEMIOL, V14, P204, DOI 10.2188/jea.14.204; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kondo N, 2008, J EPIDEMIOL COMMUN H, V62, P869, DOI 10.1136/jech.2007.070334; Lamar J, 2000, BRIT MED J, V321, P528, DOI 10.1136/bmj.321.7260.528; Lester D, 1992, Int J Soc Psychiatry, V38, P314, DOI 10.1177/002076409203800411; MARMOT MG, 1989, BRIT MED J, V299, P1547, DOI 10.1136/bmj.299.6715.1547; Martikainen P, 2004, SOC SCI MED, V59, P1287, DOI 10.1016/j.socscimed.2004.01.005; Mendenhall E, 2014, DIABETES RES CLIN PR, V103, P276, DOI 10.1016/j.diabres.2014.01.001; Ministry of Health Labour and Welfare Japan, 2013, WHITE PAPER ON THE L; Ministry of Health Labour and Welfare Japan, 2013, SURV IND ACC; Ministry of Health Labour and Welfare Japan, 2009, MORT STAT ACC ADV EF; Ministry of Health Labour and Welfare Japan, 2014, LONG SURV MIDDL AG E; Ministry of Internal Affairs and Communications Japan, 2009, JAP STAND CLASS OCC; Netterstrom B, 2008, EPIDEMIOL REV, V30, P118, DOI 10.1093/epirev/mxn004; Patrick Donald L, 2003, J Natl Cancer Inst, V95, P1110; Richardson DB, 2010, OCCUP ENVIRON MED, V67, P67, DOI 10.1136/oem.2008.044834; Roerecke M, 2014, INT J EPIDEMIOL; Rosenbaum S, 2014, J CLIN PSYCHIAT, V75, P964, DOI 10.4088/JCP.13r08765; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Siegrist J, 2004, SOC SCI MED, V58, P1463, DOI 10.1016/S0277-9536(03)00349-6; Smith DR, 2009, PUBLIC HEALTH, V123, P196, DOI 10.1016/j.puhe.2008.12.003; Stansfeld SA, 2013, PSYCHOL MED, V43, P961, DOI 10.1017/S0033291712001821; Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443, DOI 10.5271/sjweh.1050; Stansfeld SA, 2011, SOC PSYCH PSYCH EPID, V46, P101, DOI 10.1007/s00127-009-0173-7; Takeda Y, 2006, PUBLIC HEALTH, V120, P966, DOI 10.1016/j.puhe.2006.06.006; Taylor G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1151; Trevisol DJ, 2011, J HYPERTENS, V29, P179, DOI 10.1097/HJH.0b013e328340d76f; Tsutsumi A, 2007, PSYCHOTHER PSYCHOSOM, V76, P177, DOI 10.1159/000099845; Ueda K, 2003, LANCET, V361, P882, DOI 10.1016/S0140-6736(03)12696-7; Wada K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1191; Wei JK, 2014, AM J CARDIOL, V114, P187, DOI 10.1016/j.amjcard.2014.04.022; Wieclaw J, 2005, SCAND J WORK ENV HEA, V31, P343, DOI 10.5271/sjweh.917; Wilhelm K, 2004, SOC PSYCH PSYCH EPID, V39, P866, DOI 10.1007/s00127-004-0869-7	46	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131203	10.1371/journal.pone.0131203	http://dx.doi.org/10.1371/journal.pone.0131203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1BL	26121355	gold, Green Published, Green Submitted			2022-12-27	WOS:000358150400084
J	Li, WJ; Zhang, YC; Li, FY; Li, XY; Li, P; Jia, XY; Chen, HD; Ji, HJ				Li, Weijian; Zhang, Yuchi; Li, Fengying; Li, Xinyu; Li, Ping; Jia, Xiaoyu; Chen, Haide; Ji, Haojie			Out of Lust or Jealousy: The Effects of MateRelated Motives on Study-Time Allocation to Faces Varying in Attractiveness	PLOS ONE			English	Article							EVOLUTIONARY PSYCHOLOGY; INDIVIDUAL-DIFFERENCES; ROMANTIC MOTIVES; SELF-REGULATION; MEMORY; ATTUNEMENT; RESPONSES; PEACOCKS; PEOPLES	Although a growing number of empirical studies have revealed that activating mate-related motives might exert a specific set of consequences for human cognition and behaviors, such as attention and memory, little is known about whether mate-related motives affect self-regulated learning. The present study examined the effects of mate-related motives (mate-search and mate-guarding) on study-time allocation to faces varying in attractiveness. In two experiments, participants in mate-related priming conditions (Experiment 1: mate-search; Experiment 2: mate-guarding) or control conditions studied 20 female faces (10 highly attractive, 10 less attractive) during a self-paced study task, and then were given a yes/no face recognition task. The finding of Experiment 1 showed that activating a mate-search motive led the male participants to allocate more time to highly attractive female faces (i.e., perceived potential mates) than to less attractive ones. In Experiment 2, female participants in the mate-guarding priming condition spent more time studying highly attractive female faces (i.e., perceived potential rivals) than less attractive ones, compared to participants in the control condition. These findings illustrate the highly specific consequences of mate-related motives on study-time allocation, and highlight the value of exploring human cognition and motivation within evolutionary and self-regulated learning frameworks.	[Li, Weijian; Zhang, Yuchi; Li, Fengying; Li, Xinyu; Li, Ping; Ji, Haojie] Zhejiang Normal Univ, Inst Psychol, Jinhua, Zhejiang, Peoples R China; [Jia, Xiaoyu] Zhejiang Univ, Dept Psychol & Behav Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Yuchi; Chen, Haide] Beijing Normal Univ, Inst Dev Psychol, Beijing 100875, Peoples R China	Zhejiang Normal University; Zhejiang University; Beijing Normal University	Li, XY (corresponding author), Zhejiang Normal Univ, Inst Psychol, Jinhua, Zhejiang, Peoples R China.	xyli@zjnu.cn	Zhang, Yuchi/AAV-3193-2020; Jia, Xiaoyu/GZM-5563-2022	Jia, Xiaoyu/0000-0003-0830-6285; Li, Xinyu/0000-0002-3828-0971	National Nature Science Foundation of China [31170999]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (Grant No. 31170999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel R, 2013, MEM COGNITION, V41, P416, DOI 10.3758/s13421-012-0267-4; Ariel R, 2009, J EXP PSYCHOL GEN, V138, P432, DOI 10.1037/a0015928; Badcock C., 2000, EVOLUTIONARY PSYCHOL; BANDURA A, 1991, ORGAN BEHAV HUM DEC, V50, P248, DOI 10.1016/0749-5978(91)90022-L; Bell R, 2012, J EXP PSYCHOL LEARN, V38, P457, DOI 10.1037/a0026017; Bjork RA, 2013, ANNU REV PSYCHOL, V64, P417, DOI 10.1146/annurev-psych-113011-143823; Buckner JC, 2009, AM J ORTHOPSYCHIAT, V79, P19, DOI 10.1037/a0014796; BUSS DM, 1991, ANNU REV PSYCHOL, V42, P459, DOI 10.1146/annurev.ps.42.020191.002331; Caporael LR, 2001, ANNU REV PSYCHOL, V52, P607, DOI 10.1146/annurev.psych.52.1.607; Castel AD, 2013, PSYCHOL AGING, V28, P232, DOI 10.1037/a0030678; Confer JC, 2010, EVOL HUM BEHAV, V31, P348, DOI 10.1016/j.evolhumbehav.2010.04.002; Dunbar R. I. M., 2007, OXFORD HDB EVOLUTION; Dunlosky J, 1997, J GERONTOL B-PSYCHOL, V52, pP178, DOI 10.1093/geronb/52B.4.P178; Dunlosky J, 2011, J EXP PSYCHOL LEARN, V37, P899, DOI 10.1037/a0023064; Dunlosky J, 2011, PSYCHOL LEARN MOTIV, V54, P103, DOI 10.1016/B978-0-12-385527-5.00004-8; Efklides A, 2011, EDUC PSYCHOL-US, V46, P6, DOI 10.1080/00461520.2011.538645; Gao XB, 2009, NEUROCOMPUTING, V72, P3742, DOI 10.1016/j.neucom.2009.06.001; Greitemeyer T, 2013, J RISK RES, V16, P19, DOI 10.1080/13669877.2012.713388; Griskevicius V, 2006, J PERS SOC PSYCHOL, V91, P281, DOI 10.1037/0022-3514.91.2.281; Griskevicius V, 2006, J PERS SOC PSYCHOL, V91, P63, DOI 10.1037/0022-3514.91.1.63; Hahn AC, 2014, NEUROSCI BIOBEHAV R, V46, P591, DOI 10.1016/j.neubiorev.2014.08.015; Jost J T, 1998, Pers Soc Psychol Rev, V2, P137, DOI 10.1207/s15327957pspr0202_6; Karremans JC, 2011, COGNITION, V121, P422, DOI 10.1016/j.cognition.2011.07.008; Kenrick DT, 2010, CURR DIR PSYCHOL SCI, V19, P63, DOI 10.1177/0963721409359281; Koranyi N, 2012, J EXP SOC PSYCHOL, V48, P186, DOI 10.1016/j.jesp.2011.06.012; Kurman J, 2004, SEX ROLES, V50, P725, DOI 10.1023/B:SERS.0000027573.36376.69; Li FY, 2015, PSYCHON B REV, V22, P1007, DOI 10.3758/s13423-014-0762-7; Maner JK, 2007, J PERS SOC PSYCHOL, V93, P389, DOI 10.1037/0022-3514.93.3.389; Maner JK, 2007, EVOL HUM BEHAV, V28, P28, DOI 10.1016/j.evolhumbehav.2006.05.006; Maner JK, 2013, EVOL HUM BEHAV, V34, P412, DOI 10.1016/j.evolhumbehav.2013.07.005; Maner JK, 2012, J PERS SOC PSYCHOL, V103, P70, DOI 10.1037/a0028172; Marzi T, 2010, BIOL PSYCHOL, V84, P192, DOI 10.1016/j.biopsycho.2010.01.013; Massar K, 2010, PERS INDIV DIFFER, V49, P634, DOI 10.1016/j.paid.2010.05.037; MAZZONI G, 1993, J EXP PSYCHOL GEN, V122, P47, DOI 10.1037/0096-3445.122.1.47; Metcalfe J, 2010, BEHAV PROCESS, V83, P213, DOI 10.1016/j.beproc.2009.12.011; Metcalfe J, 2009, CURR DIR PSYCHOL SCI, V18, P159, DOI 10.1111/j.1467-8721.2009.01628.x; NELSON TO, 1988, J EXP PSYCHOL LEARN, V14, P676, DOI 10.1037/0278-7393.14.4.676; Nomi JS, 2013, COGNITION EMOTION, V27, P141, DOI 10.1080/02699931.2012.679917; Pelegrina S, 1999, LEARN INDIVID DIFFER, V11, P401, DOI 10.1016/S1041-6080(99)80011-9; Pfluger LS, 2012, EVOL HUM BEHAV, V33, P708, DOI 10.1016/j.evolhumbehav.2012.05.005; Reder LM., 1996, IMPLICIT MEMORY META, P45, DOI DOI 10.1037/A0034030; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Ritter SM, 2010, J EXP SOC PSYCHOL, V46, P631, DOI 10.1016/j.jesp.2010.02.010; Schaller M, 2011, CURR DIR PSYCHOL SCI, V20, P99, DOI 10.1177/0963721411402596; SIMPSON JA, 1991, J PERS SOC PSYCHOL, V60, P870, DOI 10.1037/0022-3514.60.6.870; Son LK, 2010, ADAPT BEHAV, V18, P132, DOI 10.1177/1059712309344776; Sundie JM, 2011, J PERS SOC PSYCHOL, V100, P664, DOI 10.1037/a0021669; Tullis JG, 2011, J MEM LANG, V64, P109, DOI 10.1016/j.jml.2010.11.002; Vaillancourt T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0080; Watier NN, 2011, ACTA PSYCHOL, V138, P143, DOI 10.1016/j.actpsy.2011.05.017; ZIMMERMAN BJ, 1986, CONTEMP EDUC PSYCHOL, V11, P307, DOI 10.1016/0361-476X(86)90027-5	51	4	6	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0132207	10.1371/journal.pone.0132207	http://dx.doi.org/10.1371/journal.pone.0132207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1BL	26121131	Green Submitted, Green Published, gold			2022-12-27	WOS:000358150400199
J	Poulet, C; Wettwer, E; Grunnet, M; Jespersen, T; Fabritz, L; Matschke, K; Knaut, M; Ravens, U				Poulet, Claire; Wettwer, Erich; Grunnet, Morten; Jespersen, Thomas; Fabritz, Larissa; Matschke, Klaus; Knaut, Michael; Ravens, Ursula			Late Sodium Current in Human Atrial Cardiomyocytes from Patients in Sinus Rhythm and Atrial Fibrillation	PLOS ONE			English	Article							LONG QT SYNDROME; CHRONIC HEART-FAILURE; ANTIANGINAL AGENT; THERAPEUTIC TARGET; DRUG TARGET; RANOLAZINE; CHANNEL; ARRHYTHMIAS; MODEL; PATHOPHYSIOLOGY	Slowly inactivating Na+ channels conducting "late" Na+ current (I-Na,I-late) contribute to ventricular arrhythmogenesis under pathological conditions. I-Na,I-late was also reported to play a role in chronic atrial fibrillation (AF). The objective of this study was to investigate I-Na,I-late in human right atrial cardiomyocytes as a putative drug target for treatment of AF. To activate Na+ channels, cardiomyocytes fromtransgenic mice which exhibit I-Na,I-late (.KPQ), and right atrial cardiomyocytes frompatients in sinus rhythm (SR) and AF were voltage clamped at room temperature by 250-ms long test pulses to -30 mV from a holding potential of -80 mV with a 100-ms pre-pulse to -110 mV (protocol I). I-Na,I-late at -30 mV was not discernible as deviation from the extrapolated straight line IV-curve between -110 mV and -80 mV in human atrial cells. Therefore, tetrodotoxin (TTX, 10 mu M) was used to define persistent inward current after 250 ms at -30 mV as I-Na,I-late. TTX-sensitive current was 0.27 +/- 0.06 pA/pF in ventricular cardiomyocytes from.KPQ mice, and amounted to 0.04 +/- 0.01 pA/pF and 0.09 +/- 0.02 pA/pF in SR and AF human atrial cardiomyocytes, respectively. With protocol II (holding potential -120 mV, pre-pulse to -80 mV) TTX-sensitive I-Na,I-late was always larger than with protocol I. Ranolazine (30 mu M) reduced I-Na,I-late by 0.02 +/- 0.02 pA/pF in SR and 0.09 +/- 0.02 pA/pF in AF cells. At physiological temperature (37 degrees C), however, I-Na,I-late became insignificant. Plateau phase and upstroke velocity of action potentials (APs) recorded with sharp microelectrodes in intact human trabeculae were more sensitive to ranolazine in AF than in SR preparations. Sodium channel subunits expressionmeasured with qPCR was high for SCN5A with no difference between SR and AF. Expression of SCN8A and SCN10A was low in general, and lower in AF than in SR. In conclusion, We confirm for the first time a TTX-sensitive current (I-Na,I-late) in right atrial cardiomyocytes from SR and AF patients at roomtemperature, but not at physiological temperature. While our study provides evidence for the presence of I-Na,I-late in human atria, the potential of such current as a target for the treatment of AF remains to be demonstrated.	[Poulet, Claire; Wettwer, Erich; Ravens, Ursula] Tech Univ Dresden, Fac Med, Dept Pharmacol & Toxicol, Dresden, Germany; [Grunnet, Morten; Jespersen, Thomas] Univ Copenhagen, Danish Arrhythmia Res Ctr, Copenhagen, Denmark; [Fabritz, Larissa] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Matschke, Klaus; Knaut, Michael] Heart Ctr Dresden, Clin Cardiac Surg, Dresden, Germany	Technische Universitat Dresden; University of Copenhagen; University of Birmingham; Technische Universitat Dresden	Ravens, U (corresponding author), Tech Univ Dresden, Fac Med, Dept Pharmacol & Toxicol, Dresden, Germany.	Ursula.Ravens@tu-dresden.de		Fabritz, Larissa/0000-0002-9241-1733; Jespersen, Thomas/0000-0001-6575-360X	Bundesministerium fur Bildung unf Forschung [BMBF 01GI0204]; European Union [FP7-Health-F2-2010-261057]	Bundesministerium fur Bildung unf Forschung; European Union(European Commission)	This work was supported by Bundesministerium fur Bildung unf Forschung BMBF 01GI0204 (http://www.gesundheitsforschung-bmbf.de/de/345.php), and European Union FP7-Health-F2-2010-261057 (http://www.eutraf.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antzelevitch C, 2004, CIRCULATION, V110, P904, DOI 10.1161/01.CIR.0000139333.83620.5D; Antzelevitch C, 2011, HEART RHYTHM, V8, P1281, DOI 10.1016/j.hrthm.2011.03.045; Benito B, 2008, HEART RHYTHM, V5, P1434, DOI 10.1016/j.hrthm.2008.07.013; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Berecki G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015772; Blana A, 2010, HEART RHYTHM, V7, P1862, DOI 10.1016/j.hrthm.2010.08.016; Burashnikov A, 2007, CIRCULATION, V116, P1449, DOI 10.1161/CIRCULATIONAHA.107.704890; Carmeliet E, 1998, PROG BIOPHYS MOL BIO, V70, P1, DOI 10.1016/S0079-6107(98)00002-9; Chambers JC, 2010, NAT GENET, V42, P149, DOI 10.1038/ng.516; COHEN CJ, 1984, CIRC RES, V54, P636, DOI 10.1161/01.RES.54.6.636; Despa S, 2013, J MOL CELL CARDIOL, V61, P2, DOI 10.1016/j.yjmcc.2013.04.011; Dobrev D, 2000, CIRCULATION, V102, P692, DOI 10.1161/01.CIR.102.6.692; Effinor PT, 2008, HEART RHYTHM, V5, P99, DOI [10.1016/j.hrthm.2007.09.015, 10.1016/j.hrthm.2008.01.014]; Fabritz L, 2010, CARDIOVASC RES, V87, P60, DOI 10.1093/cvr/cvq029; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Guerra PG, 1998, DRUGS, V56, P767, DOI 10.2165/00003495-199856050-00003; ISENBERG G, 1984, J PHYSIOL-LONDON, V357, P127, DOI 10.1113/jphysiol.1984.sp015493; Lemoine MD, 2011, CARDIOVASC RES, V92, P67, DOI 10.1093/cvr/cvr166; Makielski JC, 2006, BRIT J PHARMACOL, V148, P4, DOI 10.1038/sj.bjp.0706713; Maltsev VA, 2006, CARDIOVASC RES, V69, P116, DOI 10.1016/j.cardiores.2005.08.015; Maltsev VA, 2008, PROG BIOPHYS MOL BIO, V96, P421, DOI 10.1016/j.pbiomolbio.2007.07.010; Maltsev VA, 2007, EUR J HEART FAIL, V9, P219, DOI 10.1016/j.ejheart.2006.08.007; Miles RH, 2011, AM J CARDIOL, V108, P673, DOI 10.1016/j.amjcard.2011.04.017; Murdock David K, 2009, Indian Pacing Electrophysiol J, V9, P260; Nattel S, 2012, EUR HEART J, V33, P1870, DOI 10.1093/eurheartj/ehs079; Nuyens D, 2001, NAT MED, V7, P1021, DOI 10.1038/nm0901-1021; Olesen MS, 2012, CIRC-CARDIOVASC GENE, V5, P450, DOI 10.1161/CIRCGENETICS.111.962597; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Poulet C, 2014, CARDIOVASC RES, V103, DOI 10.1093/cvr/cvu091.60; Poulet C, 2011, J MOL CELL CARDIOL, V50, P357, DOI 10.1016/j.yjmcc.2010.10.011; Rajamani S, 2008, J CARDIOVASC PHARM, V51, P581, DOI 10.1097/FJC.0b013e3181799690; REUTER H, 1969, SCIENCE, V163, P399, DOI 10.1126/science.163.3865.399; Saint DA, 2008, BRIT J PHARMACOL, V153, P1133, DOI 10.1038/sj.bjp.0707492; Scheuer T, 2011, SEMIN CELL DEV BIOL, V22, P160, DOI 10.1016/j.semcdb.2010.10.002; Scirica BM, 2007, CIRCULATION, V116, P1647, DOI 10.1161/CIRCULATIONAHA.107.724880; Sicouri S, 2013, HEART RHYTHM, V10, P1036, DOI 10.1016/j.hrthm.2013.03.023; Soltysinska E, 2009, PFLUG ARCH EUR J PHY, V459, P11, DOI 10.1007/s00424-009-0718-3; Sossalla S, 2012, PHARMACOL THERAPEUT, V133, P311, DOI 10.1016/j.pharmthera.2011.11.003; Sossalla S, 2010, J AM COLL CARDIOL, V55, P2330, DOI 10.1016/j.jacc.2009.12.055; Szel T, 2011, EUR J PHARMACOL, V662, P31, DOI 10.1016/j.ejphar.2011.04.042; Tan JG, 2011, BIOCHEM BIOPH RES CO, V407, P788, DOI 10.1016/j.bbrc.2011.03.101; Toussaint D, 2011, N-S ARCH PHARMACOL, V383, P61; Undrovinas AI, 1999, CELL MOL LIFE SCI, V55, P494, DOI 10.1007/s000180050306; Undrovinas Albertas I, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS169; Wettwer E, 2004, CIRCULATION, V110, P2299, DOI 10.1161/01.CIR.0000145155.60288.71; Xi YT, 2009, EUR J HEART FAIL, V11, P749, DOI 10.1093/eurjhf/hfp092; Yang T, 2012, CIRC RES, V111, P322, DOI 10.1161/CIRCRESAHA.112.265173; Zaza A, 2008, PHARMACOL THERAPEUT, V119, P326, DOI 10.1016/j.pharmthera.2008.06.001; Zimmer T, 2008, PROG BIOPHYS MOL BIO, V98, P120, DOI 10.1016/j.pbiomolbio.2008.10.005	49	46	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131432	10.1371/journal.pone.0131432	http://dx.doi.org/10.1371/journal.pone.0131432			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121051	Green Published, Green Submitted, gold			2022-12-27	WOS:000358150400108
J	Sun, YJ; Fan, W; Zheng, HL; Zhang, YX; Li, FT; Chen, W				Sun, Yongjun; Fan, Wei; Zheng, Huaili; Zhang, Yuxin; Li, Fengting; Chen, Wei			Evaluation of Dewatering Performance and Fractal Characteristics of Alum Sludge	PLOS ONE			English	Article							WATER-TREATMENT SLUDGE; MOISTURE DISTRIBUTION; WASTE-WATER; POTENTIAL IMPLICATIONS; COMPLEX EQUILIBRIA; BIOLOGICAL-FLUIDS; POLYMER DOSAGE; FLOC; POLYACRYLAMIDE; METABOLISM	The dewatering performance and fractal characteristics of alum sludge from a drinking-water treatment plant were investigated in this study. Variations in residual turbidity of supernatant, dry solid content (DS), specific resistance to filtration (SRF), floc size, fractal dimension, and zeta potential were analyzed. Sludge dewatering efficiency was evaluated by measuring both DS and SRF. Results showed that the optimum sludge dewatering efficiency was achieved at 16 mg.L-1 flocculant dosage and pH 7. Under these conditions, the maximum DS was 54.6%, and the minimum SRF was 0.61 x 10(10) m.kg(-1). Floc-size measurements demonstrated that high flocculant dosage significantly improved floc size. Correlation analysis further revealed a strong correlation between fractal dimension and floc size after flocculation. A strong correlation also existed between floc size and zeta potential, and flocculants with a higher cationic degree had a larger correlation coefficient between floc size and zeta potential. In the flocculation process, the main flocculation mechanisms involved adsorption bridging under an acidic condition, and a combination between charge neutralization and adsorption-bridging interaction under neutral and alkaline conditions.	[Sun, Yongjun; Fan, Wei; Zheng, Huaili; Chen, Wei] Chongqing Univ, State Minist Educ, Key Lab Gorges Reservoir Reg Ecoenvironm 3, Chongqing 630044, Peoples R China; [Sun, Yongjun; Zheng, Huaili] Chongqing Univ, Natl Ctr Int Res Low Carbon, Chongqing 630044, Peoples R China; [Zhang, Yuxin] Chongqing Univ, Coll Mat Sci & Engn, Natl Key Lab Fundamental Sci Micro Nanodevices &, Chongqing 630044, Peoples R China; [Li, Fengting] Tongji Univ, Coll Environm Sci & Engn, Minist Educ, Key Lab Yangtze River Water Environm,State Key La, Shanghai 200092, Peoples R China	Chongqing University; Chongqing University; Chongqing University; Tongji University	Sun, YJ (corresponding author), Chongqing Univ, State Minist Educ, Key Lab Gorges Reservoir Reg Ecoenvironm 3, Chongqing 630044, Peoples R China.	sunyongjun008@163.com; zhl@cqu.edu.cn	LI, feng/HIR-1703-2022; Zhang, Yu Xin/D-1524-2009	Zhang, Yu Xin/0000-0003-4698-5645; sun, Yongjun/0000-0002-5266-3645	National Natural Science Foundation of China [21177164]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (Project No. 21177164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthon G, 2002, COORDIN CHEM REV, V228, P319, DOI 10.1016/S0010-8545(02)00021-8; Bourgeois JC, 2004, WATER RES, V38, P1173, DOI 10.1016/j.watres.2003.11.018; Chakraborti RK, 2000, ENVIRON SCI TECHNOL, V34, P3969, DOI 10.1021/es990818o; Chu CP, 1999, J ENVIRON ENG-ASCE, V125, P340, DOI 10.1061/(ASCE)0733-9372(1999)125:4(340); Chu W, 1999, WATER RES, V33, P3019, DOI 10.1016/S0043-1354(99)00010-X; COLIN F, 1995, WATER RES, V29, P2000, DOI 10.1016/0043-1354(94)00274-B; Dayde S, 2003, J INORG BIOCHEM, V97, P104, DOI 10.1016/S0162-0134(03)00244-7; De Gregorio C, 2010, CHEM ENG J, V165, P607, DOI 10.1016/j.cej.2010.10.004; Desroches S, 2000, J INORG BIOCHEM, V81, P301, DOI 10.1016/S0162-0134(00)00072-6; Dong YJ, 2011, WATER RES, V45, P3871, DOI 10.1016/j.watres.2011.04.042; Gmachowski L, 2010, COLLOID SURFACE A, V363, P119, DOI 10.1016/j.colsurfa.2010.04.027; Guan QQ, 2014, IND ENG CHEM RES, V53, P5624, DOI 10.1021/ie404116k; Huang C, 2002, J ENVIRON ENG-ASCE, V128, P1121, DOI 10.1061/(ASCE)0733-9372(2002)128:12(1121); Jin B, 2004, CHEM ENG J, V98, P115, DOI 10.1016/j.cej.2003.05.002; Kameswari KSB, 2013, CLEAN TECHNOL ENVIR, V15, P945, DOI 10.1007/s10098-012-0561-7; Lee KE, 2012, CHEM ENG J, V203, P370, DOI 10.1016/j.cej.2012.06.109; Li T, 2012, J ENVIRON SCI, V24, P1917, DOI 10.1016/S1001-0742(11)61041-3; Parsons SA, 1999, ENVIRON TECHNOL, V20, P979, DOI 10.1080/09593332008616893; Razah M, 2007, SEP PURIF TECHNOL, V55, P300, DOI 10.1016/j.seppur.2006.12.004; Shao LM, 2009, J ENVIRON SCI-CHINA, V21, P83, DOI 10.1016/S1001-0742(09)60015-2; Sotero-Santos RB, 2005, WATER RES, V39, P3909, DOI 10.1016/j.watres.2005.06.030; Sotero-Santos RB, 2007, CHEMOSPHERE, V68, P628, DOI 10.1016/j.chemosphere.2007.02.049; Sun YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111036; TSANG KR, 1990, WATER SCI TECHNOL, V22, P135, DOI 10.2166/wst.1990.0108; Vaxelaire J, 2004, WATER RES, V38, P2215, DOI 10.1016/j.watres.2004.02.021; Venturini-Soriano M, 1998, J INORG BIOCHEM, V71, P135, DOI 10.1016/S0162-0134(98)10045-4; Venturini-Soriano M, 2001, J INORG BIOCHEM, V85, P143, DOI 10.1016/S0162-0134(01)00206-9; Verrelli DI, 2010, WATER RES, V44, P1542, DOI 10.1016/j.watres.2009.10.036; Verrelli DI, 2009, COLLOID SURFACE A, V348, P14, DOI 10.1016/j.colsurfa.2009.06.013; VESILIND PA, 1994, WATER ENVIRON RES, V66, P4, DOI 10.2175/WER.66.1.2; Wang YL, 2012, COLLOID SURFACE A, V402, P152, DOI 10.1016/j.colsurfa.2012.03.043; Wang YL, 2009, J ENVIRON SCI-CHINA, V21, P41, DOI 10.1016/S1001-0742(09)60009-7; Wilen BM, 2003, WATER RES, V37, P3632, DOI 10.1016/S0043-1354(03)00291-4; Wu CC, 1997, COLLOID SURFACE A, V122, P89; Wu CC, 2003, ADV ENVIRON RES, V7, P617, DOI 10.1016/S1093-0191(02)00048-5; Yang Z, 2013, J HAZARD MATER, V254, P36, DOI 10.1016/j.jhazmat.2013.03.053; Yang Z, 2012, WATER RES, V46, P107, DOI 10.1016/j.watres.2011.10.024; Zhang ZQ, 2010, WATER RES, V44, P3087, DOI 10.1016/j.watres.2010.02.033; Zhao YQ, 2003, CHEM ENG J, V92, P227, DOI 10.1016/S1385-8947(02)00253-X; Zhao YQ, 2004, SEP PURIF TECHNOL, V35, P71, DOI 10.1016/S1383-5866(03)00132-1; Zheng HL, 2014, SEP PURIF TECHNOL, V123, P35, DOI 10.1016/j.seppur.2013.12.018; Zheng HL, 2014, IND ENG CHEM RES, V53, P2572, DOI 10.1021/ie403635y; Zheng HL, 2013, CHEM ENG J, V234, P318, DOI 10.1016/j.cej.2013.08.098; Zhou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098159; Zhu GC, 2012, DESALINATION, V285, P315, DOI 10.1016/j.desal.2011.10.019; Zhu JR, 2013, DESALIN WATER TREAT, V51, P2791, DOI 10.1080/19443994.2012.749579	46	14	14	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130683	10.1371/journal.pone.0130683	http://dx.doi.org/10.1371/journal.pone.0130683			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121132	Green Submitted, Green Published, gold			2022-12-27	WOS:000358150400055
J	Tada, H; Koide, M; Ara, W; Shibata, Y; Funabashi, T; Suyama, K; Goto, T; Takahashi, T				Tada, Hirobumi; Koide, Mayu; Ara, Wakana; Shibata, Yusuke; Funabashi, Toshiya; Suyama, Kumiko; Goto, Takahisa; Takahashi, Takuya			Estrous Cycle-Dependent Phasic Changes in the Stoichiometry of Hippocampal Synaptic AMPA Receptors in Rats	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SOCIAL-ISOLATION; BARREL CORTEX; PLASTICITY; SYNAPSES; EXPERIENCE; TRAFFICKING; SUBUNIT; DELIVERY; BEHAVIOR	Cognitive function can be affected by the estrous cycle. However, the effect of the estrous cycle on synaptic functions is poorly understood. Here we show that in female rats, inhibitory-avoidance (IA) task (hippocampus-dependent contextual fear-learning task) drives GluA2-lacking Ca2+-permeable AMPA receptors (CP-AMPARs) into the hippocampal CA3-CA1 synapses during all periods of the estrous cycle except the proestrous period, when estrogen levels are high. In addition, IA task failed to drive CP-AMPARs into the CA3-CA1 synapses of ovariectomized rats only when estrogen was present. Thus, changes in the stoichiometry of AMPA receptors during learning depend on estrogen levels. Furthermore, the induction of long-term potentiation (LTP) after IA task was prevented during the proestrous period, while intact LTP is still expressed after IA task during other period of the estrous cycle. Consistent with this finding, rats conditioned by IA training failed to acquire hippocampus-dependent Y-maze task during the proestrous period. On the other hand, during other estrous period, rats were able to learn Y-maze task after IA conditioning. These results suggest that high estrogen levels prevent the IA learning-induced delivery of CP-AMPARs into hippocampal CA3-CA1 synapses and limit synaptic plasticity after IA task, thus preventing the acquisition of additional learning.	[Tada, Hirobumi; Koide, Mayu; Ara, Wakana; Shibata, Yusuke; Funabashi, Toshiya; Suyama, Kumiko; Takahashi, Takuya] Yokohama City Univ, Grad Sch Med, Dept Physiol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Funabashi, Toshiya] St Marianna Univ, Sch Med, Dept Physiol, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan; [Koide, Mayu; Goto, Takahisa] Yokohama City Univ, Grad Sch Med, Dept Anesthesiol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	Yokohama City University; Saint Marianna University; Yokohama City University	Takahashi, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Physiol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	takahast@yokohama-cu.ac.jp	Tada, Hirobumi/ABB-7665-2020		Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/Minds) [14029040]; Special Coordination Funds for Promoting Science and Technology [11800122]; Strategic Research Program for Brain Sciences [09150699]; KAKENHI [23590286, 24700382]; Grants-in-Aid for Scientific Research [15K15041, 26500017] Funding Source: KAKEN	Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/Minds); Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Research Program for Brain Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded in part by The Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/Minds) (14029040), Special Coordination Funds for Promoting Science and Technology (11800122), the Strategic Research Program for Brain Sciences (09150699), KAKENHI (23590286, 24700382).	Andreen L, 2009, PSYCHONEUROENDOCRINO, V34, P1121, DOI 10.1016/j.psyneuen.2009.02.003; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Fortin DA, 2010, J NEUROSCI, V30, P11565, DOI 10.1523/JNEUROSCI.1746-10.2010; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; HAMPSON E, 1990, BRAIN COGNITION, V14, P26, DOI 10.1016/0278-2626(90)90058-V; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Jitsuki S, 2011, NEURON, V69, P780, DOI 10.1016/j.neuron.2011.01.016; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Mitsushima D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3760; Mitsushima D, 2011, P NATL ACAD SCI USA, V108, P12503, DOI 10.1073/pnas.1104558108; Miyahara T, 2012, J PLANT PHYSIOL, V169, P1321, DOI 10.1016/j.jplph.2012.05.004; Miyazaki T, 2013, EUR J NEUROSCI, V37, P1602, DOI 10.1111/ejn.12188; Miyazaki T, 2012, J CLIN INVEST, V122, P2690, DOI 10.1172/JCI63060; Miyazaki T, 2012, BRAIN RES, V1435, P1, DOI 10.1016/j.brainres.2011.11.033; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Tada H, 2013, NEUROSCIENCE, V248, P664, DOI 10.1016/j.neuroscience.2013.06.040; Tada H, 2010, J BIOL CHEM, V285, P3840, DOI 10.1074/jbc.M109.046284; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Warren SG, 1995, BRAIN RES, V703, P26, DOI 10.1016/0006-8993(95)01059-9; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Yuen GS, 2011, BRAIN RES, V1379, P44, DOI 10.1016/j.brainres.2010.07.067	27	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131359	10.1371/journal.pone.0131359	http://dx.doi.org/10.1371/journal.pone.0131359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121335	Green Submitted, Green Published, gold			2022-12-27	WOS:000358150400102
J	Yang, M; Xu, DP; Liu, Y; Guo, XD; Li, WS; Guo, CN; Zhang, HP; Gao, YJ; Mao, YL; Zhao, JM				Yang, Mei; Xu, Dongping; Liu, Yuan; Guo, Xiaodong; Li, Wenshu; Guo, Chaonan; Zhang, Hongping; Gao, Yinjie; Mao, Yuanli; Zhao, Jingmin			Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; EPITHELIUM-DERIVED FACTOR; GROWTH-FACTOR 21; RECEPTOR ANTAGONIST; FIBROSIS; OBESITY; STEATOSIS; SPECTRUM; OSTEOPROTEGERIN; CYTOKERATIN-18	Background Non-alcoholic steatoheaptitis (NASH), the critical stage of non-alcoholic fatty liver disease (NAFLD), is of chronic progression and can develop cirrhosis even hepatocellular carcinoma (HCC). However, non-invasive biomarkers for NASH diagnosis remain poorly applied in clinical practice. Our study aims at testing the accuracy of the combination of cytokeratin-18 M30 fragment (CK-18-M30), fibroblast growth factor 21 (FGF-21), interleukin 1 receptor antagonist (IL-1Ra), pigment epithelium-derived factor (PEDF) and osteoprotegerin (OPG) in diagnosing NAFLD and NASH. Methods 179 patients with biopsy-proven NAFLD were enrolled as training group, 91 age-and gender-matched healthy subjects were recruited at the same time as controls. 63 other NAFLD patients were separately collected as validation group. 45 alcoholic fatty liver disease (AFLD) patients, 50 hepatitis B virus (HBV) patients, 52 hepatitis C virus (HCV) patients were also included. Serum biomarker levels were measured by enzyme-linked immunosorbent assay. Results Serum levels of CK-18-M30, FGF-21, IL-1Ra and PEDF increased, while OPG decreased in a stepwise fashion in controls, non-NASH NAFLD patients and NASH patients (P < 0.01). The area under receiver-operating characteristics curve to diagnose NASH was 0.86 for CK-18-M30, 0.89 for FGF-21, 0.89 for IL-1Ra, 0.89 for PEDF and 0.89 for OPG. CK-18-M30 had 70% negative predictive value (NPV) and 79% positive predictive value (PPV) to diagnose NASH. A 5-step approach measuring CK-18-M30 followed by FGF21, IL-1Ra, PEDF and OPG gradually improved the NPV to 76% and PPV to 85%, which reached 80% and 76% respectively in the validation cohort. Conclusion Compared to single biomarker, stepwise combination of CK-18-M30, FGF-21, IL-1Ra, PEDF and OPG can further improve the accuracy in diagnosing NASH.	[Yang, Mei; Liu, Yuan; Guo, Xiaodong; Guo, Chaonan; Zhang, Hongping; Gao, Yinjie; Zhao, Jingmin] Beijing 302 Hosp, Dept Pathol & Hepatol, Beijing, Peoples R China; [Xu, Dongping] Beijing 302 Hosp, Liver Failure Med Ctr, Inst Infect Dis, Beijing, Peoples R China; [Li, Wenshu] Beijing 302 Hosp, Ctr Clin Trial, Beijing, Peoples R China; [Mao, Yuanli] Beijing 302 Hosp, Ctr Clin Lab, Beijing, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital	Zhao, JM (corresponding author), Beijing 302 Hosp, Dept Pathol & Hepatol, Beijing, Peoples R China.	jmzhao302@163.com			Clinical High-tech Key Project [2010jxgs099]; Research Found of Capital Medical Development [2014-2-5032]; Chinese Foundation for Hepatitis Prevention and Control-WBE Liver Fibrosis Foundation [CFHPC20131020]	Clinical High-tech Key Project; Research Found of Capital Medical Development; Chinese Foundation for Hepatitis Prevention and Control-WBE Liver Fibrosis Foundation	The work was supported by: 1. Clinical High-tech Key Project (Grant No. 2010jxgs099); 2. Research Found of Capital Medical Development (Grant No. 2014-2-5032), website: http://www.bjhbkj.com/; 3. Chinese Foundation for Hepatitis Prevention and Control-WBE Liver Fibrosis Foundation (Grant No. CFHPC20131020), website: http://www.cfhpc.org/home/Details/787. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MH, 2012, J OBES, V2012, DOI 10.1155/2012/483135; Alberti A, 2003, J HEPATOL, V38, pS104, DOI 10.1016/S0168-8278(03)00008-4; An JJ, 2007, YONSEI MED J, V48, P765, DOI 10.3349/ymj.2007.48.5.765; Bell LN, 2010, HEPATOLOGY, V51, P111, DOI 10.1002/hep.23271; Bianchi L, 2001, J HEPATOL, V35, P290, DOI 10.1016/S0168-8278(01)00155-6; Chen C, 2010, J CLIN ENDOCR METAB, V95, P5074, DOI 10.1210/jc.2010-0727; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Farrell GC, 2013, NAT REV GASTRO HEPAT, V10, P307, DOI 10.1038/nrgastro.2013.34; Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association, 2006, CHIN J LIVER DIS, V14, P164; Feldstein AE, 2009, HEPATOLOGY, V50, P1072, DOI 10.1002/hep.23050; Fitzpatrick E, 2010, J PEDIATR GASTR NUTR, V51, P500, DOI 10.1097/MPG.0b013e3181e376be; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Greenfield V, 2008, CURR OPIN GASTROEN, V24, P320, DOI 10.1097/MOG.0b013e3282fbccf2; Gurgen S, 2014, HUM EXP TOXICOL; Kashi MR, 2008, SEMIN LIVER DIS, V28, P396, DOI 10.1055/s-0028-1091984; Kim WR, 2002, HEPATOLOGY, V36, P227, DOI 10.1053/jhep.2002.34734; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kumar KS, 2000, MAYO CLIN PROC, V75, P733; Lebensztejn DM, 2011, ACTA BIOCHIM POL, V58, P563; Liver Disease and Metabolic Disorders Research Group (preparing) Chinese Society of Endocrinology, 2010, CLIN J ENDOCRINOL ME, V26, P531; Lonardo A, 2004, GASTROENTEROLOGY, V126, P586, DOI 10.1053/j.gastro.2003.11.020; Lonardo A, 2013, CURR PHARM DESIGN, V19, P5177, DOI 10.2174/1381612811319290003; Mao TH, 2011, SAUDI MED J, V32, P769; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Meier CA, 2002, J CLIN ENDOCR METAB, V87, P1184, DOI 10.1210/jc.87.3.1184; Musso G, 2013, CURR PHARM DESIGN, V19, P5297, DOI 10.2174/1381612811319290010; Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777; Pihlajamaki J, 2012, J HEPATOL, V56, P663, DOI 10.1016/j.jhep.2011.10.005; Polyzos SA, 2009, CURR MOL MED, V9, P299, DOI 10.2174/156652409787847191; Sanyal Arun J, 2011, Hepatology, V54, P344, DOI 10.1002/hep.24376; Shen JY, 2012, J HEPATOL, V56, P1363, DOI 10.1016/j.jhep.2011.12.025; Sherman Morris, 2007, Can J Gastroenterol, V21 Suppl C, p5C; Szalay F, 2003, J HEPATOL, V38, P395, DOI 10.1016/S0168-8278(02)00435-X; Tabuchi M, 2010, J NUTR SCI VITAMINOL, V56, P271, DOI 10.3177/jnsv.56.271; Tamimi TIAR, 2011, J HEPATOL, V54, P1224, DOI 10.1016/j.jhep.2010.08.023; Vos MB, 2008, J PEDIATR GASTR NUTR, V47, P481, DOI 10.1097/MPG.0b013e31817e2bfb; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Wong VWS, 2010, GUT, V59, P969, DOI 10.1136/gut.2009.205088; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yamagishi SI, 2010, CURR MED CHEM, V17, P1995, DOI 10.2174/092986710791233670; Yilmaz Y, 2012, ALIMENT PHARM THER, V36, P345, DOI 10.1111/j.1365-2036.2012.05196.x; Yilmaz Y, 2012, CLIN CHIM ACTA, V414, P154, DOI 10.1016/j.cca.2012.08.005; Yilmaz Y, 2011, CLIN CHIM ACTA, V412, P2296, DOI 10.1016/j.cca.2011.08.025; Yilmaz Y, 2010, SCAND J CLIN LAB INV, V70, P541, DOI 10.3109/00365513.2010.524933; Younossi ZM, 2008, OBES SURG, V18, P1430, DOI 10.1007/s11695-008-9506-y	50	46	48	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131664	10.1371/journal.pone.0131664	http://dx.doi.org/10.1371/journal.pone.0131664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121037	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400135
J	De Wit, R; Gautret, P; Bettarel, Y; Roques, C; Marliere, C; Ramonda, M; Thanh, TN; Quang, HT; Bouvier, T				De Wit, Rutger; Gautret, Pascale; Bettarel, Yvan; Roques, Cecile; Marliere, Christian; Ramonda, Michel; Thuy Nguyen Thanh; Huy Tran Quang; Bouvier, Thierry			Viruses Occur Incorporated in Biogenic High-Mg Calcite from Hypersaline Microbial Mats	PLOS ONE			English	Article							MARINE VIRUSES; NANOBACTERIA; CARBONATE; LAKE; PRECIPITATION; VARIABILITY; CHIPRANA; WATER; MINERALIZATION; CALCIFICATION	Using three different microscopy techniques (epifluorescence, electronic and atomic force microscopy), we showed that high-Mg calcite grains in calcifying microbial mats from the hypersaline lake "La Salada de Chiprana", Spain, contain viruses with a diameter of 50-80 nm. Energy-dispersive X-ray spectrometer analysis revealed that they contain nitrogen and phosphorus in a molar ratio of similar to 9, which is typical for viruses. Nucleic acid staining revealed that they contain DNA or RNA. As characteristic for hypersaline environments, the concentrations of free and attached viruses were high (>10(10) viruses per g of mat). In addition, we showed that acid treatment (dissolution of calcite) resulted in release of viruses into suspension and estimated that there were similar to 15 x 109 viruses per g of calcite. We suggest that virus-mineral interactions are one of the possible ways for the formation of nano-sized structures often described as "nanobacteria" and that viruses may play a role in initiating calcification.	[De Wit, Rutger; Bettarel, Yvan; Roques, Cecile; Bouvier, Thierry] Univ Montpellier, CNRS, IRD, Ifremer,Ctr Marine Biodivers Exploitat & Conserva, F-34095 Montpellier, France; [Gautret, Pascale] Univ Orleans, ISTO, UMR 7327, F-45071 Orleans, France; [Gautret, Pascale] CNRS, ISTO, UMR 7327, F-45071 Orleans, France; [Gautret, Pascale] Bur Rech Geol & Minieres, ISTO, UMR 7327, F-45060 Orleans, France; [Marliere, Christian] Univ Paris 11, CNRS, ISMO, F-91405 Orsay, France; [Ramonda, Michel] Univ Montpellier, Ctr Technol Montpellier, DRED Serv Communs Recherche, F-34095 Montpellier, France; [Thuy Nguyen Thanh; Huy Tran Quang] Natl Inst Hyg & Epidemiol, Dept Virol, Lab Ultrastruct, Nanobiomed Grp, Hanoi 1000, Vietnam	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Bureau de Recherches Geologiques et Minieres (BRGM); Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; CNRS - National Institute for Earth Sciences & Astronomy (INSU); Bureau de Recherches Geologiques et Minieres (BRGM); Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; CNRS - National Institute for Earth Sciences & Astronomy (INSU); Bureau de Recherches Geologiques et Minieres (BRGM); Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; CNRS - National Institute for Earth Sciences & Astronomy (INSU); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Universite de Montpellier; National Institute of Hygiene & Epidemiology (NIHE)	De Wit, R (corresponding author), Univ Montpellier, CNRS, IRD, Ifremer,Ctr Marine Biodivers Exploitat & Conserva, Pl Eugene Bataillon,Case 093, F-34095 Montpellier, France.	rutger.de-wit@umontpellier.fr	Huy, Tran Quang/W-7843-2018; Bouvier, Thierry/A-1895-2013; Bettarel, Yvan/L-2691-2017; RAMONDA, Michel/C-2948-2019; Gautret, Pascale/P-1881-2016	Huy, Tran Quang/0000-0003-2812-3937; Bettarel, Yvan/0000-0001-7155-3364; Gautret, Pascale/0000-0002-8580-6892; bouvier, thierry/0000-0002-7151-5680	Agence national de la recherche (ANR) [ANR-05-BLAN-0061]	Agence national de la recherche (ANR)(French National Research Agency (ANR))	This study was financially supported by the Agence national de la recherche (ANR), project: Mecanismes de precipitation de carbonate de calcium dans les biofilms photosynthetiques (CYANOCARBO), http://www.agence-nationale-recherche.fr/en/about-anr/about-the-french-national-research-agency/, Grant No ANR-05-BLAN-0061. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi G, 2006, GEOLOGY, V34, P1017, DOI 10.1130/G22986A.1; Auguet JC, 2006, MICROB ECOL, V51, P197, DOI 10.1007/s00248-005-0043-0; Benzerara K, 2003, P NATL ACAD SCI USA, V100, P7438, DOI 10.1073/pnas.0832464100; Benzerara K, 2006, J INVEST MED, V54, P367, DOI 10.2310/6650.2006.06016; Benzerara K, 2006, P NATL ACAD SCI USA, V103, P9440, DOI 10.1073/pnas.0603255103; Berquand A, 2003, SURF SCI, V523, P125, DOI 10.1016/S0039-6028(02)02455-X; Bettarel Y, 2005, AQUAT MICROB ECOL, V40, P103, DOI 10.3354/ame040103; Bettarel Y, 2006, APPL ENVIRON MICROB, V72, P5274, DOI 10.1128/AEM.00863-06; Bettarel Y, 2011, FEMS MICROBIOL ECOL, V76, P360, DOI 10.1111/j.1574-6941.2011.01054.x; Bettarel Y, 2010, FEMS MICROBIOL LETT, V311, P113, DOI 10.1111/j.1574-6968.2010.02074.x; Bodiguel H, 2004, REV SCI INSTRUM, V75, P2529, DOI 10.1063/1.1771495; Bontognali TRR, 2008, GEOLOGY, V36, P663, DOI 10.1130/G24755A.1; Bosak T, 2005, J SEDIMENT RES, V75, P190, DOI 10.2110/jsr.2005.015; Braissant O, 2003, J SEDIMENT RES, V73, P485, DOI 10.1306/111302730485; Brum JR, 2013, ISME J, V7, P1738, DOI 10.1038/ismej.2013.67; Brum JR, 2005, AQUAT MICROB ECOL, V41, P247, DOI 10.3354/ame041247; Camoin GF, 1999, SEDIMENT GEOL, V126, P271, DOI 10.1016/S0037-0738(99)00045-7; CHEKROUN K. B., 2004, J SEDIMENT RES, V74, P868, DOI DOI 10.1306/050504740868; Ciftcioglu N, 1999, KIDNEY INT, V56, P1893, DOI 10.1046/j.1523-1755.1999.00755.x; Cisar JO, 2000, P NATL ACAD SCI USA, V97, P11511, DOI 10.1073/pnas.97.21.11511; Cleveland JP, 1998, APPL PHYS LETT, V72, P2613, DOI 10.1063/1.121434; Cotner JB, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00132; Danovaro R, 2001, APPL ENVIRON MICROB, V67, P1384, DOI 10.1128/AEM.67.3.1384-1387.2001; Danovaro R, 2008, NATURE, V454, P1084, DOI 10.1038/nature07268; Daughney CJ, 2004, MAR CHEM, V91, P101, DOI 10.1016/j.marchem.2004.06.003; De Wit R, 2013, AQUAT CONSERV, V23, P532, DOI 10.1002/aqc.2319; Defarge C, 1996, J SEDIMENT RES, V66, P935; Desnues C, 2008, NATURE, V452, P340, DOI 10.1038/nature06735; Dupraz C, 2004, SEDIMENTOLOGY, V51, P745, DOI 10.1111/j.1365-3091.2004.00649.x; Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005; Dyall-Smith M, 2003, RES MICROBIOL, V154, P309, DOI 10.1016/S0923-2508(03)00076-7; Eissler Y, 2009, J PHYCOL, V45, P787, DOI 10.1111/j.1529-8817.2009.00705.x; Filippini M, 2006, APPL ENVIRON MICROB, V72, P4893, DOI 10.1128/AEM.00319-06; FOLK RL, 1993, J SEDIMENT PETROL, V63, P990, DOI 10.1306/D4267C67-2B26-11D7-8648000102C1865D; Folk RL, 1999, SEDIMENT GEOL, V126, P47, DOI 10.1016/S0037-0738(99)00031-7; Folk RL, 1998, ALPE ADRIA MICROBIOL, V7, P87; Fuhrman JA, 1995, LIMNOL OCEANOGR, V40, P1236, DOI 10.4319/lo.1995.40.7.1236; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Glud RN, 2004, LIMNOL OCEANOGR, V49, P2073, DOI 10.4319/lo.2004.49.6.2073; Glunk C, 2011, SEDIMENTOLOGY, V58, P720, DOI 10.1111/j.1365-3091.2010.01180.x; Goldberg M, 1996, PROG HISTOCHEM CYTOC, V31, P1; Griffin DW, 2013, ASTROBIOLOGY, V13, P774, DOI 10.1089/ast.2012.0959; GuixaBoixareu N, 1996, AQUAT MICROB ECOL, V11, P215, DOI 10.3354/ame011215; Hamilton A, 2000, MICROBIOL TODAY, V27, P182; Jonkers HM, 2003, FEMS MICROBIOL ECOL, V44, P175, DOI 10.1016/S0168-6496(02)00464-6; Jover LF, 2014, NAT REV MICROBIOL, V12, P519, DOI 10.1038/nrmicro3289; Kajander EO, 1998, P NATL ACAD SCI USA, V95, P8274, DOI 10.1073/pnas.95.14.8274; Kirkland BL, 1999, GEOLOGY, V27, P347, DOI 10.1130/0091-7613(1999)027<0347:AOFNLO>2.3.CO;2; Koch AL, 1997, MICROBIOL MOL BIOL R, V61, P305, DOI 10.1128/.61.3.305-318.1997; Kyle JE, 2008, GEOMICROBIOL J, V25, P338, DOI 10.1080/01490450802402703; Laidler JR, 2013, J VIROL, V87, P13927, DOI 10.1128/JVI.02825-13; Laidler JR, 2010, ASTROBIOLOGY, V10, P569, DOI 10.1089/ast.2010.0463; Losic D, 2006, J NANOSCI NANOTECHNO, V6, P982, DOI 10.1166/jnn.2006.174; Ludwig R, 2005, LIMNOL OCEANOGR, V50, P1836, DOI 10.4319/lo.2005.50.6.1836; Maniloff J, 1997, SCIENCE, V276, P1776; Martel J, 2008, P NATL ACAD SCI USA, V105, P5549, DOI 10.1073/pnas.0711744105; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; Nagasaki K, 2004, APPL ENVIRON MICROB, V70, P704, DOI 10.1128/AEM.70.2.704-711.2004; Niederberger M, 2006, PHYS CHEM CHEM PHYS, V8, P3271, DOI 10.1039/b604589h; Ohnesorge FM, 1997, BIOPHYS J, V73, P2183, DOI 10.1016/S0006-3495(97)78250-X; Orange F, 2011, BIOGEOSCIENCES, V8, P1465, DOI 10.5194/bg-8-1465-2011; Oren A, 1997, EXTREMOPHILES, V1, P143, DOI 10.1007/s007920050027; Pacton M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5298; Pedley M, 2009, SEDIMENTOLOGY, V56, P511, DOI 10.1111/j.1365-3091.2008.00983.x; Pedone VA, 1996, GEOLOGY, V24, P763, DOI 10.1130/0091-7613(1996)024<0763:FOACBN>2.3.CO;2; Peng X, 2013, GEOBIOLOGY, V11, P511, DOI 10.1111/gbi.12052; Perri E, 2013, J SEDIMENT RES, V83, P896, DOI 10.2110/jsr.2013.65; Prince JS, 2013, J MARINE BIOL; Psenner R, 1997, SCIENCE, V276, P1776; Raoult D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040041; Rice G, 2001, P NATL ACAD SCI USA, V98, P13341, DOI 10.1073/pnas.231170198; Russo F, 2006, SEDIMENT GEOL, V185, P267, DOI 10.1016/j.sedgeo.2005.12.017; Santos F, 2007, ENVIRON MICROBIOL, V9, P1711, DOI 10.1111/j.1462-2920.2007.01289.x; Schedl A, 1998, J GEOL, V106, P211, DOI 10.1086/516017; Schieber J, 2003, GEOLOGY, V31, P717, DOI 10.1130/G19663.1; Siegesmund MA, 2008, J PHYCOL, V44, P1572, DOI 10.1111/j.1529-8817.2008.00604.x; Spadafora A, 2010, SEDIMENTOLOGY, V57, P27, DOI 10.1111/j.1365-3091.2009.01083.x; Sprachta S, 2001, PALAEOGEOGR PALAEOCL, V175, P103, DOI 10.1016/S0031-0182(01)00388-1; Stedman Kenneth, 2005, Astrobiology, V5, P441, DOI 10.1089/ast.2005.5.441; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2010, MANUAL AQUATIC VIRAL, P145, DOI [DOI 10.4319/MAVE.2010.978-0-9845591-0-7, DOI 10.4319/MAVE.2010.978-0-9845591-0-7.145]; Tomaru Y, 2009, APPL ENVIRON MICROB, V75, P2375, DOI 10.1128/AEM.02580-08; Trichet Jean, 1995, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V14, P203; Urbano P, 2007, PLOS PATHOG, V3, P567, DOI 10.1371/journal.ppat.0030055; Uwins PJR, 1998, AM MINERAL, V83, P1541, DOI 10.2138/am-1998-11-1242; Valero-Garces BL, 2000, AMBIO, V29, P344, DOI 10.1639/0044-7447(2000)029[0344:ROASLE]2.0.CO;2; Vasconcelos C, 1997, J SEDIMENT RES, V67, P378; Velimirov B., 2001, MICROBES ENVIRON, V16, P67, DOI [10.1264/jsme2.2001.67, DOI 10.1264/JSME2.2001.67]; VIDONDO B, 1993, HYDROBIOLOGIA, V267, P113, DOI 10.1007/BF00018794; Vittori M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058968; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001	91	16	16	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130552	10.1371/journal.pone.0130552	http://dx.doi.org/10.1371/journal.pone.0130552			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115121	Green Published, gold			2022-12-27	WOS:000358147500079
J	He, K; McCord, MC; Hartnett, KA; Aizenman, E				He, Kai; McCord, Meghan C.; Hartnett, Karen A.; Aizenman, Elias			Regulation of Pro-Apoptotic Phosphorylation of Kv2.1 K+ Channels	PLOS ONE			English	Article							GATED POTASSIUM CHANNELS; NEURONAL APOPTOSIS; DEPENDENT MODULATION; ACTIVATION; SRC; KINASE; CURRENTS; LOCALIZATION; EXCITABILITY; ENHANCEMENT	Caspase activity during apoptosis is inhibited by physiological concentrations of intracellular K+. To enable apoptosis in injured cortical and hippocampal neurons, cellular loss of this cation is facilitated by the insertion of Kv2.1 K+ channels into the plasma membrane via a Zn2+/CaMKII/SNARE-dependent process. Pro-apoptotic membrane insertion of Kv2.1 requires the dual phosphorylation of the channel by Src and p38 at cytoplasmic N- and C-terminal residues Y124 and S800, respectively. In this study, we investigate if these phosphorylation sites are mutually co-regulated, and whether putative N-and C-terminal interactions, possibly enabled by Kv2.1 intracellular cysteine residues C73 and C710, influence the phosphorylation process itself. Studies were performed with recombinant wild type and mutant Kv2.1 expressed in Chinese hamster ovary (CHO) cells. Using immunoprecipitated Kv2.1 protein and phospho-specific antibodies, we found that an intact Y124 is required for p38 phosphorylation of S800, and, importantly, that Src phosphorylation of Y124 facilitates the action of the p38 at the S800 residue. Moreover, the actions of Src on Kv2.1 are substantially decreased in the non-phosphorylatable S800A channel mutant. We also observed that mutations of either C73 or C710 residues decreased the p38 phosphorylation at S800 without influencing the actions of Src on tyrosine phosphorylation of Kv2.1. Surprisingly, however, apoptotic K+ currents were suppressed only in cells expressing the Kv2.1(C73A) mutant but not in those transfected with Kv2.1(C710A), suggesting a possible structural alteration in the C-terminal mutant that facilitates membrane insertion. These results show that intracellular N-terminal domains critically regulate phosphorylation of the C-terminal of Kv2.1, and vice versa, suggesting possible new avenues for modifying the apoptotic insertion of these channels during neurodegenerative processes.	[He, Kai; McCord, Meghan C.; Hartnett, Karen A.; Aizenman, Elias] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Aizenman, E (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, E1456 BST,3500 Terrace St, Pittsburgh, PA 15261 USA.	redox@pitt.edu		Aizenman, Elias/0000-0001-9610-4194	National Institutes of Health [R01 NS043277, NS0432795]; American Heart Association fellowship [11PRE7230022]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association fellowship(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health grants R01 NS043277 and NS0432795 and by American Heart Association fellowship 11PRE7230022. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair B, 2008, BIOPHYS J, V94, P2106, DOI 10.1529/biophysj.107.118562; Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; Aras MA, 2011, ANTIOXID REDOX SIGN, V15, P2249, DOI 10.1089/ars.2010.3607; Barone FC, 2001, J PHARMACOL EXP THER, V296, P312; Cotella D, 2012, J NEUROSCI, V32, P4133, DOI 10.1523/JNEUROSCI.6153-11.2012; Deutsch E, 2012, MOL BIOL CELL, V23, P2917, DOI 10.1091/mbc.E12-01-0047; Frey MR, 2004, J BIOL CHEM, V279, P44513, DOI 10.1074/jbc.M406253200; Grizel A, 2014, J NEUROIMMUNE PHARM, V9, P727, DOI 10.1007/s11481-014-9565-x; Guan DX, 2013, J PHYSIOL-LONDON, V591, P4807, DOI 10.1113/jphysiol.2013.257253; He K, 2006, J PHARMACOL EXP THER, V317, P1320, DOI 10.1124/jpet.106.103044; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; HWANG PM, 1993, J NEUROSCI, V13, P1569; Ju M, 2003, J BIOL CHEM, V278, P12769, DOI 10.1074/jbc.M212973200; Knoch ME, 2008, GLIA, V56, P89, DOI 10.1002/glia.20592; Liu PW, 2014, J NEUROSCI, V34, P4991, DOI 10.1523/JNEUROSCI.1925-13.2014; Malin SA, 2002, J NEUROSCI, V22, P10094; McCord MC, 2013, P NATL ACAD SCI USA, V110, P13988, DOI 10.1073/pnas.1306238110; McLaughlin B, 2001, J NEUROSCI, V21, P3303, DOI 10.1523/JNEUROSCI.21-10-03303.2001; Misonou H, 2005, J NEUROSCI, V25, P11184, DOI 10.1523/JNEUROSCI.3370-05.2005; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Mohapatra DP, 2007, BIOCHEM SOC T, V35, P1064, DOI 10.1042/BST0351064; Mohapatra DP, 2008, J NEUROSCI, V28, P4982, DOI 10.1523/JNEUROSCI.0186-08.2008; Mohapatra DP, 2009, CHANNELS, V3, P46, DOI 10.4161/chan.3.1.7655; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Murakoshi H, 1997, MOL PHARMACOL, V52, P821, DOI 10.1124/mol.52.5.821; Norris CA, 2012, J NEUROSCI, V32, P8865, DOI 10.1523/JNEUROSCI.0937-12.2012; Pal S, 2003, J NEUROSCI, V23, P4798; Pal SK, 2006, CELL DEATH DIFFER, V13, P661, DOI 10.1038/sj.cdd.4401792; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Redman PT, 2007, P NATL ACAD SCI USA, V104, P3568, DOI 10.1073/pnas.0610159104; Redman PT, 2009, J PHYSIOL-LONDON, V587, P4393, DOI 10.1113/jphysiol.2009.176321; Schwetz TA, 2011, J BIOL CHEM, V286, P4123, DOI 10.1074/jbc.M110.171322; Shah NH, 2014, TRANSL STROKE RES, V5, P38, DOI 10.1007/s12975-013-0297-7; Shepherd AJ, 2014, PLOS ONE, V8; Shepherd AJ, 2012, J NEUROSCI, V32, P17725, DOI 10.1523/JNEUROSCI.3029-12.2012; Sobko A, 1998, EMBO J, V17, P4723, DOI 10.1093/emboj/17.16.4723; Speca DJ, 2014, GENES BRAIN BEHAV, V13, P394, DOI 10.1111/gbb.12120; Thobe BM, 2006, AM J PHYSIOL-CELL PH, V291, pC476, DOI 10.1152/ajpcell.00076.2006; Tiran Z, 2003, J BIOL CHEM, V278, P17509, DOI 10.1074/jbc.M212766200; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; Wei JF, 2008, J CELL PHYSIOL, V217, P544, DOI 10.1002/jcp.21530; Wray D, 2009, EUR BIOPHYS J BIOPHY, V38, P285, DOI 10.1007/s00249-008-0354-4; Wu XL, 2013, J BIOL CHEM, V288, P4128, DOI 10.1074/jbc.M112.440933; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114; Yu SP, 1998, J NEUROSCI RES, V52, P612, DOI 10.1002/(SICI)1097-4547(19980601)52:5<612::AID-JNR13>3.0.CO;2-3	45	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129498	10.1371/journal.pone.0129498	http://dx.doi.org/10.1371/journal.pone.0129498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115091	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000358147500026
J	Lee, J; Fricke, F; Warnken, U; Schnolzer, M; Kopitz, J; Gebert, J				Lee, Jennifer; Fricke, Fabia; Warnken, Uwe; Schnoelzer, Martina; Kopitz, Juergen; Gebert, Johannes			Reconstitution of TGFBR2-Mediated Signaling Causes Upregulation of GDF-15 in HCT116 Colorectal Cancer Cells	PLOS ONE			English	Article							BETA SUPERFAMILY MEMBER; TGF-BETA; MICROSATELLITE INSTABILITY; GENE; EXPRESSION; CYTOKINE; MIC-1; MUTATIONS; RECEPTOR	Although inactivating frameshift mutations in the Transforming growth factor beta receptor type 2 (TGFBR2) gene are considered as drivers of microsatellite unstable (MSI) colorectal tumorigenesis, consequential alterations of the downstream target proteome are not resolved completely. Applying a click-it chemistry protein labeling approach combined with mass spectrometry in a MSI colorectal cancer model cell line, we identified 21 de novo synthesized proteins differentially expressed upon reconstituted TGFBR2 expression. One candidate gene, the TGF-beta family member Growth differentiation factor-15 (GDF-15), exhibited TGFBR2-dependent transcriptional upregulation causing increased intracellular and extracellular protein levels. As a new TGFBR2 target gene it may provide a link between the TGF-beta branch and the BMP/GDF branch of SMAD-mediated signaling.	[Lee, Jennifer; Fricke, Fabia; Kopitz, Juergen; Gebert, Johannes] Univ Heidelberg Hosp, Inst Pathol, Dept Appl Tumor Biol, Heidelberg, Germany; [Lee, Jennifer; Fricke, Fabia; Kopitz, Juergen; Gebert, Johannes] German Canc Res Ctr, Canc Early Detect, Heidelberg, Germany; [Warnken, Uwe; Schnoelzer, Martina] German Canc Res Ctr, Funct Proteome Anal, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Gebert, J (corresponding author), Univ Heidelberg Hosp, Inst Pathol, Dept Appl Tumor Biol, Heidelberg, Germany.	johannes.gebert@med.uni-heidelberg.de			Deutsche Forschungsgemeinschaft [GE592/6-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Financial support was provided by Deutsche Forschungsgemeinschaft (GE592/6-2) to JK and JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Baek SJ, 2002, CARCINOGENESIS, V23, P425, DOI 10.1093/carcin/23.3.425; Baek SJ, 2001, MOL PHARMACOL, V59, P901, DOI 10.1124/mol.59.4.901; Ballikaya S, 2014, MOL CELL PROTEOMICS, V13, P3446, DOI 10.1074/mcp.M113.036665; Bauskin AR, 2010, J INTERF CYTOK RES, V30, P389, DOI 10.1089/jir.2009.0052; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Brown DA, 2003, CLIN CANCER RES, V9, P2642; D'Souza RCJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004856; Fairlie WD, 2001, J BIOL CHEM, V276, P16911, DOI 10.1074/jbc.M010000200; FRIEDMAN E, 1995, CANCER EPIDEM BIOMAR, V4, P549; Hua XX, 1999, P NATL ACAD SCI USA, V96, P13130, DOI 10.1073/pnas.96.23.13130; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Kane MF, 1997, CANCER RES, V57, P808; Lee J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057074; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Mehta RS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju016; Munoz NM, 2008, GROWTH FACTORS, V26, P254, DOI 10.1080/08977190802291667; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; PARSONS R, 1995, CANCER RES, V55, P5548; PERTOVAARA L, 1989, MOL CELL BIOL, V9, P1255, DOI 10.1128/MCB.9.3.1255; SCHROY P, 1990, CANCER RES, V50, P261; SIMON KE, 1995, CELL GROWTH DIFFER, V6, P1261; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wang CY, 2014, BIOCHEM J, V460, P35, DOI 10.1042/BJ20140155; Wang XY, 2013, BIOCHEM PHARMACOL, V85, P597, DOI 10.1016/j.bcp.2012.11.025	29	7	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131506	10.1371/journal.pone.0131506	http://dx.doi.org/10.1371/journal.pone.0131506			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114631	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500164
J	Li, MY; Wang, YY; Cai, JQ; Zhang, CB; Wang, KY; Cheng, W; Liu, YW; Zhang, W; Jiang, T				Li, Ming-Yang; Wang, Yin-Yan; Cai, Jin-Quan; Zhang, Chuan-Bao; Wang, Kuan-Yu; Cheng, Wen; Liu, Yan-Wei; Zhang, Wei; Jiang, Tao			Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas	PLOS ONE			English	Article							CODON 132 MUTATION; IDH1 MUTATIONS; DIFFUSE GLIOMAS; ASTROCYTOMAS; SURVIVAL; OLIGODENDROGLIOMAS; OLIGOASTROCYTOMAS; TEMOZOLOMIDE; TUMORS; CLASSIFICATION	Isocitrate dehydrogenase 1 gene mutations are found in most World Health Organization grade II and III gliomas and secondary glioblastomas. Isocitrate dehydrogenase 1 mutations are known to have prognostic value in high-grade gliomas. However, their prognostic significance in low-grade gliomas remains controversial. We determined the predictive and prognostic value of isocitrate dehydrogenase 1 status in low-grade gliomas. The association of isocitrate dehydrogenase 1 status with clinicopathological and genetic factors was also evaluated. Clinical information and genetic data including isocitrate dehydrogenase 1 mutation, O 6-methylguanine DNA methyltransferase promoter methylation, 1p/19q chromosome loss, and TP53 mutation of 417 low-grade gliomas were collected from the Chinese Glioma Genome Atlas database. Kaplan-Meier and Cox proportional hazards regression analyses were performed to evaluate the prognostic effect of clinical characteristics and molecular biomarkers. Isocitrate dehydrogenase 1 mutation was identified as an independent prognostic factor for overall, but not progression-free, survival. Notably, isocitrate dehydrogenase 1 mutation was found to be a significant prognostic factor in patients with oligodendrogliomas, but not in patients with astrocytomas. Furthermore, O 6-methylguanine DNA methyltransferase promoter methylation (p = 0.017) and TP53 mutation (p < 0.001), but not 1p/19q loss (p = 0.834), occurred at a higher frequency in isocitrate dehydrogenase 1-mutated tumors than in isocitrate dehydrogenase 1 wild-type tumors. Younger patient age (p = 0.041) and frontal lobe location (p = 0.010) were significantly correlated with isocitrate dehydrogenase 1 mutation. Chemotherapy did not provide a survival benefit in patients with isocitrate dehydrogenase 1-mutated tumors. Isocitrate dehydrogenase 1 mutation was an independent prognostic factor in low-grade gliomas, whereas it showed no predictive value for chemotherapy response. Isocitrate dehydrogenase 1 mutation was highly associated with O 6-methylguanine DNA methyltransferase promoter methylation and TP53 mutation.	[Li, Ming-Yang; Wang, Yin-Yan; Zhang, Wei; Jiang, Tao] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Li, Ming-Yang; Wang, Yin-Yan; Zhang, Chuan-Bao; Liu, Yan-Wei; Jiang, Tao] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [Cai, Jin-Quan] Harbin Med Univ, Dept Neurosurg, Affiliated Hosp 2, Harbin, Peoples R China; [Wang, Kuan-Yu] Dalian Med Univ, Dept Neurosurg, Affiliated Hosp 1, Dalian, Liao Ning Provi, Peoples R China; [Cheng, Wen] China Med Univ, Hosp 1, Dept Neurosurg, Shenyang, Peoples R China; [Zhang, Wei] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Jiang, Tao] Ctr Brain Tumor, Beijing Inst Brain Disorders, Beijing, Peoples R China	Capital Medical University; Beijing Neurosurgical Institute; Capital Medical University; Harbin Medical University; Dalian Medical University; China Medical University	Jiang, T (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.	taojiang1964@163.com	Wang, Yinyan/AAJ-1160-2020; jiang, tao/GWC-7108-2022; Li, Mingyang/C-2324-2018	Li, Mingyang/0000-0003-1766-7867	Beijing Science and Technology Plan [Z131100006113018]; National Science Foundation of China [91229121, 81201993]	Beijing Science and Technology Plan; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Beijing Science and Technology Plan (No. Z131100006113018) and National Science Foundation of China (No. 91229121 and No. 81201993). The funders had the key role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Boots-Sprenger SHE, 2013, MODERN PATHOL, V26, P922, DOI 10.1038/modpathol.2012.166; Dubbink HJ, 2009, NEUROLOGY, V73, P1792, DOI 10.1212/WNL.0b013e3181c34ace; Gorlia T, 2008, LANCET ONCOL, V9, P29, DOI 10.1016/S1470-2045(07)70384-4; Gorovets D, 2012, CLIN CANCER RES, V18, P2490, DOI 10.1158/1078-0432.CCR-11-2977; Gupta R, 2011, J CLIN PATHOL, V64, P835, DOI 10.1136/jclinpath-2011-200227; Hartmann C, 2011, CLIN CANCER RES, V17, P4588, DOI 10.1158/1078-0432.CCR-10-3194; Houillier C, 2010, NEUROLOGY, V75, P1560, DOI 10.1212/WNL.0b013e3181f96282; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Kim YH, 2010, AM J PATHOL, V177, P2708, DOI 10.2353/ajpath.2010.100680; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Maintz D, 1997, J NEUROPATH EXP NEUR, V56, P1098, DOI 10.1097/00005072-199710000-00003; Okamoto Y, 2004, ACTA NEUROPATHOL, V108, P49, DOI 10.1007/s00401-004-0861-z; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peraud A, 2002, CLIN CANCER RES, V8, P1117; Qi ST, 2012, CANCER SCI, V103, P269, DOI 10.1111/j.1349-7006.2011.02134.x; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Smith JS, 2000, J CLIN ONCOL, V18, P636, DOI 10.1200/JCO.2000.18.3.636; van den Bent MJ, 2010, CLIN CANCER RES, V16, P1597, DOI 10.1158/1078-0432.CCR-09-2902; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Wick W, 2012, LANCET ONCOL, V13, P707, DOI 10.1016/S1470-2045(12)70164-X; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yan W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030339; Zhang CB, 2014, J CANCER RES CLIN, V140, P45, DOI 10.1007/s00432-013-1519-9	24	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130872	10.1371/journal.pone.0130872	http://dx.doi.org/10.1371/journal.pone.0130872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115094	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500104
J	Nurse, ES; Karoly, PJ; Grayden, DB; Freestone, DR				Nurse, Ewan S.; Karoly, Philippa J.; Grayden, David B.; Freestone, Dean R.			A Generalizable Brain-Computer Interface (BCI) Using Machine Learning for Feature Discovery	PLOS ONE			English	Article							MOTOR IMAGERY; EEG; CLASSIFICATION; PLASTICITY	This work describes a generalized method for classifying motor-related neural signals for a brain-computer interface (BCI), based on a stochastic machine learning method. The method differs from the various feature extraction and selection techniques employed in many other BCI systems. The classifier does not use extensive a-priori information, resulting in reduced reliance on highly specific domain knowledge. Instead of pre-defining features, the time-domain signal is input to a population of multi-layer perceptrons (MLPs) in order to perform a stochastic search for the best structure. The results showed that the average performance of the new algorithm outperformed other published methods using the Berlin BCI IV (2008) competition dataset and was comparable to the best results in the Berlin BCI II (2002-3) competition dataset. The new method was also applied to electroencephalography (EEG) data recorded from five subjects undertaking a hand squeeze task and demonstrated high levels of accuracy with a mean classification accuracy of 78.9% after five-fold cross-validation. Our new approach has been shown to give accurate results across different motor tasks and signal types as well as between subjects.	[Nurse, Ewan S.; Karoly, Philippa J.; Grayden, David B.; Freestone, Dean R.] Univ Melbourne, Dept Elect & Elect Engn, NeuroEngn Lab, Melbourne, Vic 3010, Australia; [Nurse, Ewan S.; Karoly, Philippa J.; Grayden, David B.; Freestone, Dean R.] Univ Melbourne, Ctr Neural Engn, Melbourne, Vic 3010, Australia; [Karoly, Philippa J.; Freestone, Dean R.] Univ Melbourne, St Vincents Hosp Melbourne, Dept Med, Fitzroy, Vic 3065, Australia; [Freestone, Dean R.] Columbia Univ, Dept Stat, New York, NY 10027 USA	University of Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; Columbia University	Nurse, ES (corresponding author), Univ Melbourne, Dept Elect & Elect Engn, NeuroEngn Lab, Melbourne, Vic 3010, Australia.	enurse@student.unimelb.edu.au	Karoly, Philippa/ABC-9135-2021; Karoly, Philippa Jane/AAG-1544-2020; Grayden, David B/L-5782-2018; Nurse, Ewan/J-7600-2016	Karoly, Philippa/0000-0002-9879-5854; Karoly, Philippa Jane/0000-0002-9879-5854; Grayden, David B/0000-0002-5497-7234; Nurse, Ewan/0000-0001-8981-0074; Freestone, Dean/0000-0003-2411-5358	Victorian Life Sciences Computation Initiative (VLSCI), an initiative of the Victorian Government; Australian-American Fulbright Commission	Victorian Life Sciences Computation Initiative (VLSCI), an initiative of the Victorian Government; Australian-American Fulbright Commission	This research was supported by the Victorian Life Sciences Computation Initiative (VLSCI), an initiative of the Victorian Government hosted by the University of Melbourne, Australia. Dr. Freestone acknowledges the support of the Australian-American Fulbright Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai O, 2007, CLIN NEUROPHYSIOL, V118, P2637, DOI 10.1016/j.clinph.2007.08.025; Baranauskas G, 2014, WHAT LIMITS PERFORMA; Blankertz B, 2002, ADV NEUR IN, V14, P157; Chai RF, 2012, IEEE IJCNN, DOI 10.1109/IJCNN.2012.6252499; Chai RF, 2012, IEEE ENG MED BIO, P5266, DOI 10.1109/EMBC.2012.6347182; Chambers LD., 1998, PRACTICAL HANDBOOK O; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Dal Seno B, 2008, NEUR NETW 2008 IJCNN; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Herman P, 2008, IEEE T NEUR SYS REH, V16, P317, DOI 10.1109/TNSRE.2008.926694; Koessler L, 2009, NEUROIMAGE, V46, P64, DOI 10.1016/j.neuroimage.2009.02.006; Krishna S, 2011, 12 INT S QUAL EL DES, P1; Krusienski DJ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025002; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Lule D, 2007, NEUROREHAB NEURAL RE, V21, P518, DOI 10.1177/1545968307300698; McClelland J. L., 1986, PARALLEL DISTRIBUTED, V2; Moller MF, 1993, NEURAL NETWORKS; Mourino J, 2000, IEEE INNSENNS INT JO, V3, P3632; Ng BSW, 2013, CEREB CORTEX, V23, P389, DOI 10.1093/cercor/bhs031; Nijholt A, 2008, IEEE INTELL SYST, V23, P72, DOI 10.1109/MIS.2008.41; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 2001, P IEEE, V89, P1123, DOI 10.1109/5.939829; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Schiff SJ, 2012, COMPUT NEUROSCI-MIT, P1; Tangermann M, 2012, REV BCI COMPETITION; Tessitore A, 2006, BRAIN RES BULL, V69, P489, DOI 10.1016/j.brainresbull.2006.01.013; Thomas E, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/031001; Waldert S, 2009, J PHYSIOL-PARIS, V103, P244, DOI 10.1016/j.jphysparis.2009.08.007; Wang Dan, 2013, Int J Inf Educ Technol, V3, P505, DOI 10.7763/IJIET.2013.V3.326; Wang YJ, 2004, IEEE T BIO-MED ENG, V51, P1081, DOI 10.1109/TBME.2004.826697; Wolpaw JR, 2010, FRONT COLLECT, P29, DOI 10.1007/978-3-642-02091-9_2; Wulsin DF, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036015; Yang JH, 2012, ARTIF INTELL MED, V55, P117, DOI 10.1016/j.artmed.2012.02.001; Zander TO, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025005	36	24	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131328	10.1371/journal.pone.0131328	http://dx.doi.org/10.1371/journal.pone.0131328			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114954	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500141
J	Perez-Ornelas, F; Mendoza, O; Melin, P; Castro, JR; Rodriguez-Diaz, A; Castillo, O				Perez-Ornelas, Felicitas; Mendoza, Olivia; Melin, Patricia; Castro, Juan R.; Rodriguez-Diaz, Antonio; Castillo, Oscar			Fuzzy Index to Evaluate Edge Detection in Digital Images	PLOS ONE			English	Article							MODULAR NEURAL-NETWORKS; PATTERN-RECOGNITION; LOGIC; SETS; CLASSIFICATION; ALGORITHM	In literature, we can find different metrics to evaluate the detected edges in digital images, like Pratt's figure of merit (FOM), Jaccard's index (JI) and Dice's coefficient (DC). These metrics compare two images, the first one is the reference edges image, and the second one is the detected edges image. It is important to mention that all existing metrics must binarize images before their evaluation. Binarization step causes information to be lost because an incomplete image is being evaluated. In this paper, we propose a fuzzy index (FI) for edge evaluation that does not use a binarization step. In order to process all detected edges, images are represented in their fuzzy form and all calculations are made with fuzzy sets operators and fuzzy Euclidean distance between both images. Our proposed index is compared to the most used metrics using synthetic images, with good results.	[Perez-Ornelas, Felicitas; Mendoza, Olivia; Castro, Juan R.; Rodriguez-Diaz, Antonio] Autonomous Univ Baja California, Sch Engn, Tijuana, Baja California, Mexico; [Melin, Patricia; Castillo, Oscar] Tijuana Inst Technol, Div Grad Studies, Tijuana, Baja California, Mexico	Universidad Autonoma de Baja California	Mendoza, O (corresponding author), Autonomous Univ Baja California, Sch Engn, Tijuana, Baja California, Mexico.	omendoza@uabc.edu.mx	Melin, Patricia/B-3611-2013; Mendoza, Olivia/L-8069-2013; Rodríguez-Díaz, Antonio/G-4983-2011; Castillo, Oscar/I-5578-2019	Melin, Patricia/0000-0001-5798-1426; Rodríguez-Díaz, Antonio/0000-0003-3920-6834; Castillo, Oscar/0000-0002-7385-5689; Castro, Juan R./0000-0003-1188-1862; Mendoza, Olivia/0000-0002-9321-2322	Consejo Nacional de Ciencia y Tecnolgia (CONACYT)	Consejo Nacional de Ciencia y Tecnolgia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Nacional de Ciencia y Tecnolgia (CONACYT). www.conacyt.mx.	ABDOU IE, 1979, P IEEE, V67, P753, DOI 10.1109/PROC.1979.11325; Barrenechea E, 2011, IEEE T FUZZY SYST, V19, P819, DOI 10.1109/TFUZZ.2011.2146260; Bustince H, 2007, INFORM SCIENCES, V177, P906, DOI 10.1016/j.ins.2006.07.021; Bustince H, 2010, PATTERN RECOGN, V43, P3188, DOI 10.1016/j.patcog.2010.04.005; Bustince H, 2009, FUZZY SET SYST, V160, P1819, DOI 10.1016/j.fss.2008.08.005; Castillo O, 2010, FUZZY SET SYST, V161, P1, DOI 10.1016/j.fss.2009.10.023; Castro JR, 2007, FUZZ SYST C 2007 FUZ, P23; Castro JR, 2009, INFORM SCIENCES, V179, P2175, DOI 10.1016/j.ins.2008.10.016; Dongrui W, 2011, FUZZY SYSTEMS IEEE T, V19, P179; Galar M, 2011, IEEE T IMAGE PROCESS, V20, P1949, DOI 10.1109/TIP.2011.2107525; Gonzalez C, 2013, ADV TYP 2 FUZZ LOG S; Gonzalez CI, 2013, IFSA WORLD C NAFIPS; Lopes NV, 2010, IEEE T IMAGE PROCESS, V19, P199, DOI 10.1109/TIP.2009.2032349; Lopez-Molina C, 2013, PATTERN RECOGN, V46, P1125, DOI 10.1016/j.patcog.2012.10.027; MathWorks, 2015, MATL DOC 2015; Melin P, 2012, STUD COMPUT INTELL, V389, P1, DOI 10.1007/978-3-642-24139-0; Melin P, 2005, NEUR NETW 2005 IJCNN; Melin P, 2014, IEEE T FUZZY SYST, V22, P1515, DOI 10.1109/TFUZZ.2013.2297159; Melin P, 2014, APPL SOFT COMPUT, V21, P568, DOI 10.1016/j.asoc.2014.04.017; Melin P, 2013, EXPERT SYST APPL, V40, P5413, DOI 10.1016/j.eswa.2013.03.020; Melin P, 2012, STUD FUZZ SOFT COMP, V271, P179; Melin P, 2012, INFORM SCIENCES, V197, P1, DOI 10.1016/j.ins.2012.02.027; Melin P, 2011, IEEE T SYST MAN CY A, V41, P1001, DOI 10.1109/TSMCA.2010.2104318; Melin P, 2010, EXPERT SYST APPL, V37, P8527, DOI 10.1016/j.eswa.2010.05.023; Mendel J. M., 2010, P INT C FUZZ SYST, P1; Mendoza O, 2007, NEUR NETW 2007 IJCNN; Mendoza O, 2007, NEW METHOD EDGE DETE; Mendoza O, 2007, FUZZ INF PROC SOC 20; Mendoza O, 2010, NEUR NETW IJCNN 2010, P18; Mendoza O, 2010, STUD COMPUT INTELL, V312, P389, DOI 10.1007/978-3-642-15111-8_24; Mendoza O, 2009, INT J INTELL SYST, V24, P1115, DOI 10.1002/int.20378; Mendoza O, 2009, APPL SOFT COMPUT, V9, P1377, DOI 10.1016/j.asoc.2009.06.007; Mendoza O, 2009, INFORM SCIENCES, V179, P2078, DOI 10.1016/j.ins.2008.11.018; Moreno J.M.D., 1998, INTRO TOPOLOGIA ESPA; Pagola M, 2013, IEEE T FUZZY SYST, V21, P230, DOI 10.1109/TFUZZ.2012.2209885; Pratt WK, 2001, DIGITAL IMAGE PROCES; Prieto MS, 2003, IEEE T PATTERN ANAL, V25, P1265, DOI 10.1109/TPAMI.2003.1233900; Shattuck DW, 2009, NEUROIMAGE, V45, P431, DOI 10.1016/j.neuroimage.2008.10.066; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	39	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131161	10.1371/journal.pone.0131161	http://dx.doi.org/10.1371/journal.pone.0131161			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115362	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500132
J	Rams-Baron, M; Dulski, M; Mrozek-Wilczkiewicz, A; Korzec, M; Cieslik, W; Spaczynska, E; Bartczak, P; Ratuszna, A; Polanski, J; Musiol, R				Rams-Baron, Marzena; Dulski, Mateusz; Mrozek-Wilczkiewicz, Anna; Korzec, Mateusz; Cieslik, Wioleta; Spaczynska, Ewelina; Bartczak, Piotr; Ratuszna, Alicja; Polanski, Jaroslaw; Musiol, Robert			Synthesis of New Styrylquinoline Cellular Dyes, Fluorescent Properties, Cellular Localization and Cytotoxic Behavior	PLOS ONE			English	Article							ELECTRONIC EXCITATION-ENERGIES; CONTINUUM SOLVATION MODELS; EFFECTIVE CORE POTENTIALS; LINEAR-RESPONSE METHODS; AB-INITIO; 8-HYDROXYQUINOLINE DERIVATIVES; SPECTROSCOPIC CHARACTERIZATION; MOLECULAR CALCULATIONS; QUINOLINE; DFT	New styrylquinoline derivatives with their photophysical constants are described. The synthesis was achieved via Sonogashira coupling using the newly developed heterogeneous nano-Pd/Cu catalyst system, which provides an efficient synthesis of high purity products. The compounds were tested in preliminary fluorescent microscopy studies to in order to identify their preferable cellular localization, which appeared to be in the lipid cellular organelles. The spectroscopic properties of the compounds were measured and theoretical TD-DFT calculations were performed. A biological analysis of the quinolines that were tested consisted of cytotoxicity assays against normal human fibroblasts and colon adenocarcinoma cells. All of the compounds that were studied appeared to be safe and indifferent to cells in a high concentration range. The presented results suggest that the quinoline compounds that were investigated in this study may be valuable structures for development as fluorescent dyes that could have biological applications.	[Rams-Baron, Marzena; Mrozek-Wilczkiewicz, Anna; Ratuszna, Alicja] Univ Silesia, Chelkowski Inst Phys A, PL-40007 Katowice, Poland; [Rams-Baron, Marzena; Dulski, Mateusz; Mrozek-Wilczkiewicz, Anna; Ratuszna, Alicja] Silesian Ctr Educ & Interdisciplinary Res, PL-41500 Chorzow, Poland; [Korzec, Mateusz; Cieslik, Wioleta; Spaczynska, Ewelina; Bartczak, Piotr; Polanski, Jaroslaw; Musiol, Robert] Univ Silesia, Inst Chem, PL-40006 Katowice, Poland; [Dulski, Mateusz] Univ Silesia, Inst Mat Sci, PL-41500 Chorzow, Poland	University of Silesia in Katowice; University of Silesia in Katowice; University of Silesia in Katowice	Musiol, R (corresponding author), Univ Silesia, Inst Chem, Szkolna 9, PL-40006 Katowice, Poland.	robert.musiol@us.edu.pl	Cieślik, Wioleta/AAH-6820-2021; Korzec, Mateusz/AAQ-1180-2020; Bartczak, Piotr/V-9520-2018; Musioł, Robert/J-4790-2019	Cieślik, Wioleta/0000-0001-6371-9061; Korzec, Mateusz/0000-0002-8658-1031; Bartczak, Piotr/0000-0002-2035-8654; Dulski, Mateusz/0000-0001-8686-1853; Mrozek-Wilczkiewicz, Anna/0000-0003-2228-1475; Polanski, Jaroslaw/0000-0001-7361-2671; Musiol, Robert/0000-0002-6219-7369	NCN-National center [2014/13/D/NZ7/00322, 2012/07/N/NZ7/02110, 2013/09/B/NZ700423, DEC-2012/07/N/ST5/02221]; National Research and Development Center (NCBiR) Grant ORGANOMET [PBS2/A5/40/2014]; PL-Grid Infrastructure	NCN-National center; National Research and Development Center (NCBiR) Grant ORGANOMET; PL-Grid Infrastructure	This study was supported by NCN-National center for science grants 2014/13/D/NZ7/00322 (AMW), 2012/07/N/NZ7/02110 (WC), 2013/09/B/NZ700423 (RM) and DEC-2012/07/N/ST5/02221 (MD); National Research and Development Center (NCBiR) Grant ORGANOMET no: PBS2/A5/40/2014. This research was supported in part by PL-Grid Infrastructure.	Berlman I. B, 1971, HDB FLUORESCENCE SPE; Cammi R, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1867373; CIESLIK W, 2012, INT B PHARM SCI, V1, P3; Cieslik W, 2012, BIOORGAN MED CHEM, V20, P6960, DOI 10.1016/j.bmc.2012.10.027; Cinar R, 2013, ORG BIOMOL CHEM, V11, P2597, DOI 10.1039/c3ob27270b; Corni S, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2039077; Cossi M, 1996, CHEM PHYS LETT, V255, P327, DOI 10.1016/0009-2614(96)00349-1; Cossi M, 2000, J CHEM PHYS, V112, P2427, DOI 10.1063/1.480808; Dulski M, 2013, SPECTROCHIM ACTA A, V104, P315, DOI 10.1016/j.saa.2012.11.072; Foresman JB, 1996, J PHYS CHEM-US, V100, P16098, DOI 10.1021/jp960488j; Frisch G. W., 2013, GAUSSIAN 09; HAY PJ, 1985, J CHEM PHYS, V82, P299, DOI [10.1063/1.448975, 10.1063/1.448800, 10.1063/1.448799]; Improta R, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2222364; Korzec M, 2014, J CATAL, V313, P1, DOI 10.1016/j.jcat.2014.02.008; Machura B, 2013, POLYHEDRON, V51, P263, DOI 10.1016/j.poly.2012.12.028; Machura B, 2012, POLYHEDRON, V33, P388, DOI 10.1016/j.poly.2011.11.051; Mrozek-Wilczkiewicz A, 2014, ACS MED CHEM LETT, V5, P336, DOI 10.1021/ml400422a; Mrozek-Wilczkiewicz A, 2010, BIOORGAN MED CHEM, V18, P2664, DOI 10.1016/j.bmc.2010.02.025; Musiol R, 2006, BIOORGAN MED CHEM, V14, P3592, DOI 10.1016/j.bmc.2006.01.016; Musiol R, 2010, CURR MED CHEM, V17, P1960, DOI 10.2174/092986710791163966; Musiol R, 2006, MONATSH CHEM, V137, P1211, DOI 10.1007/s00706-006-0513-1; Musiol R, 2013, CURR PHARM DESIGN, V19, P1835, DOI 10.2174/1381612811319100008; Nosova EV, 2011, RUSS CHEM B+, V60, P942, DOI 10.1007/s11172-011-0148-1; Pillai S, 2012, J FLUORESC, V22, P1021, DOI 10.1007/s10895-012-1039-z; Podeszwa B, 2007, BIOORG MED CHEM LETT, V17, P6138, DOI 10.1016/j.bmcl.2007.09.040; Rosania GR, 2003, J AM CHEM SOC, V125, P1130, DOI 10.1021/ja027587x; Serda M, 2012, BIOORG MED CHEM LETT, V22, P5527, DOI 10.1016/j.bmcl.2012.07.030; Solomon VR, 2011, CURR MED CHEM, V18, P1488; Staderini M, 2013, ACS MED CHEM LETT, V4, P225, DOI 10.1021/ml3003605; Tomasi J, 1999, J MOL STRUC-THEOCHEM, V464, P211, DOI 10.1016/S0166-1280(98)00553-3; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; Wu Y, 2004, CHINA PART, V2, P19, DOI [DOI 10.1016/S1672-2515(07)60015-3, 10.1016/S1672-2515(07)60015-3]; Yamaguchi Y, 2008, J AM CHEM SOC, V130, P13867, DOI 10.1021/ja8040493	33	22	22	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131210	10.1371/journal.pone.0131210	http://dx.doi.org/10.1371/journal.pone.0131210			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114446	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500136
J	Schneider-Gold, C; Bellenberg, B; Prehn, C; Krogias, C; Schneider, R; Klein, J; Gold, R; Lukas, C				Schneider-Gold, Christiane; Bellenberg, Barabara; Prehn, Christian; Krogias, Christos; Schneider, Ruth; Klein, Jan; Gold, Ralf; Lukas, Carsten			Cortical and Subcortical Grey and White Matter Atrophy in Myotonic Dystrophies Type 1 and 2 Is Associated with Cognitive Impairment, Depression and Daytime Sleepiness	PLOS ONE			English	Article							TEMPORAL-LOBE ATROPHY; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; RATING-SCALE; BRAIN; ABNORMALITIES; VOLUME; MYOPATHY; MRI	Objectives Central nervous system involvement is one important clinical aspect of myotonic dystrophy type 1 and 2 (DM1 and DM2). We assessed CNS involvement DM1 and DM2 by 3T MRI and correlated clinical and neuocognitive symptoms with brain volumetry and voxel-based morphometry (VBM). Methods 12 patients with juvenile or classical DM1 and 16 adult DM2 patients underwent 3T MRI, a thorough neurological and neuropsychological examination and scoring of depression and daytime sleepiness. Volumes of brain, ventricles, cerebellum, brainstem, cervical cord, lesion load and VBM results of the patient groups were compared to 33 matched healthy subjects. Results Clinical symptoms were depression (more pronounced in DM2), excessive daytime sleepiness (more pronounced in DM1), reduced attention and flexibility of thinking, and deficits of short-term memory and visuo-spatial abilities in both patient groups. Both groups showed ventricular enlargement and supratentorial GM and WM atrophy, with prevalence for more GM atrophy and involvement of the motor system in DM1 and more WM reduction and affection of limbic structures in DM2. White matter was reduced in DM1 in the splenium of the corpus callosum and in left-hemisphericWM adjacent to the pre- and post-central gyrus. In DM2, the bilateral cingulate gyrus and subgyral medio-frontal and primary somato-sensory WM was affected. Significant structural-functional correlations of morphological MRI findings (global volumetry and VBM) with clinical findings were found for reduced flexibility of thinking and atrophy of the left secondary visual cortex in DM1 and of distinct subcortical brain structures in DM2. In DM2, depression was associated with brainstem atrophy, Daytime sleepiness correlated with volume decrease in the middle cerebellar peduncles, pons/midbrain and the right medio-frontal cortex. Conclusion GM and WM atrophy was significant in DM1 and DM2. Specific functional-structural associations related morphological changes to cognitive impairment, depression and daytime sleepiness, partly indicating involvement of complex neuronal networks.	[Schneider-Gold, Christiane; Prehn, Christian; Krogias, Christos; Schneider, Ruth; Gold, Ralf] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany; [Bellenberg, Barabara; Lukas, Carsten] Ruhr Univ Bochum, St Josef Hosp, Dept Radiol, Bochum, Germany; [Klein, Jan] Inst Med Image Comp, Fraunhofer MEVIS, Bremen, Germany	Ruhr University Bochum; Ruhr University Bochum	Schneider-Gold, C (corresponding author), Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany.	christiane.schneider-gold@ruhr-uni-bochum.de	Lukas, Carsten/A-9767-2015; Krogias, Christos/AAL-8540-2020; Bellenberg, Barbara/ABI-6463-2020	Lukas, Carsten/0000-0002-8562-9697; Bellenberg, Barbara/0000-0001-7484-6787; Schneider-Gold, Christiane/0000-0002-9232-201X; Klein, Jan/0000-0001-9421-3549	FoRUM grant of the Ruhr-University of Bochum [F701-2010]	FoRUM grant of the Ruhr-University of Bochum	The project was funded by a FoRUM grant (F701-2010) of the Ruhr-University of Bochum to CSG and CL.	Allen RP, 2009, SLEEP MED, V10, P1097, DOI 10.1016/j.sleep.2008.10.007; Antonini G, 2004, J NEUROL NEUROSUR PS, V75, P1611, DOI 10.1136/jnnp.2003.032417; Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bernal B., 2008, BRODMANNS INTERACTIV; Bugiardini E, 2014, NEUROMUSCULAR DISORD, V24, P445, DOI 10.1016/j.nmd.2014.01.013; Caso F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104697; Dang-Vu TT, 2007, SLEEP MED, V8, P349, DOI 10.1016/j.sleep.2007.03.006; Day John W, 2005, Curr Neurol Neurosci Rep, V5, P55, DOI 10.1007/s11910-005-0024-1; Eichler L, 2011, AM J NEURORADIOL, V32, P890, DOI 10.3174/ajnr.A2387; Franc DT, 2012, NEUROMUSCULAR DISORD, V22, P483, DOI 10.1016/j.nmd.2012.01.003; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Giesel FL, 2006, AM J NEURORADIOL, V27, P1454; Hahn HK, 2004, METHOD INFORM MED, V43, P376; Harting C, 2000, WECHSLER MEMORY SCAL; Horn W, 1983, LEISTUNGSPRUFSYSTEME, V2; Jack CR, 1998, NEUROLOGY, V51, P993, DOI 10.1212/WNL.51.4.993; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kamsteeg EJ, 2012, EUR J HUM GENET, V20, P1203, DOI 10.1038/ejhg.2012.108; Kassubek J, 2003, NEUROSCI LETT, V348, P73, DOI 10.1016/S0304-3940(03)00740-7; Krogias C, 2015, J NEUROL, V262, P365, DOI 10.1007/s00415-014-7566-6; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Lukas C, 2004, NEURORADIOLOGY, V46, P906, DOI 10.1007/s00234-004-1282-3; Lukas C, 2011, PSYCHIAT RES-NEUROIM, V193, P123, DOI 10.1016/j.pscychresns.2011.01.008; Lukas Carsten, 2009, Ther Adv Neurol Disord, V2, P42, DOI 10.1177/1756285609343480; Mathieu J, 2001, NEUROLOGY, V56, P336, DOI 10.1212/WNL.56.3.336; Meola G, 1999, NEUROLOGY, V53, P1042, DOI 10.1212/WNL.53.5.1042; Michelsen KA, 2008, PROG BRAIN RES, V172, P233, DOI 10.1016/S0079-6123(08)00912-6; Minnerop M, 2011, BRAIN, V134, P3527, DOI 10.1093/brain/awr299; Minnerop M, 2008, J NEUROL, V255, P1904, DOI 10.1007/s00415-008-0997-1; Mitsuoka T, 2003, CLIN NEUROPHYSIOL, V114, P99, DOI 10.1016/S1388-2457(02)00325-5; Olivieri MP, 1997, J PEPT RES, V50, P436; Ota M, 2006, NEUROSCI LETT, V407, P234, DOI 10.1016/j.neulet.2006.08.077; Oyamada R, 2006, NEUROPATHOLOGY, V26, P107, DOI 10.1111/j.1440-1789.2006.00662.x; Peric S, 2015, J NEUROL, V262, P142, DOI 10.1007/s00415-014-7545-y; Piantoni G, 2013, J NEUROSCI, V33, P227, DOI 10.1523/JNEUROSCI.2030-12.2013; Romeo V, 2010, J NEUROL, V257, P1246, DOI 10.1007/s00415-010-5498-3; Romigi A, 2011, EUR J NEUROL, V18, P1139, DOI 10.1111/j.1468-1331.2011.03352.x; Schmahmann JD, 2010, NEUROPSYCHOL REV, V20, P236, DOI 10.1007/s11065-010-9142-x; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Serra L, 2014, JAMA NEUROL, V71, P603, DOI 10.1001/jamaneurol.2014.130; Stocco A, 2010, PSYCHOL REV, V117, P541, DOI 10.1037/a0019077; Vielhaber S, 2006, MUSCLE NERVE, V34, P145, DOI 10.1002/mus.20565; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Weber YG, 2010, NEUROLOGY, V74, P1108, DOI 10.1212/WNL.0b013e3181d8c35f; Whitwell JL, 2001, AM J NEURORADIOL, V22, P1483; Wozniak JR, 2014, J NEUROL SCI, V341, P73, DOI 10.1016/j.jns.2014.04.005; Wozniak JR, 2013, J NEUROL, V260, P1122, DOI 10.1007/s00415-012-6771-4; Wozniak JR, 2011, NEUROMUSCULAR DISORD, V21, P89, DOI 10.1016/j.nmd.2010.11.013	49	46	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130352	10.1371/journal.pone.0130352	http://dx.doi.org/10.1371/journal.pone.0130352			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114298	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500070
J	Wawrusiewicz-Kurylonek, N; Telejko, B; Kuzmicki, M; Sobota, A; Lipinska, D; Pliszka, J; Raczkowska, B; Kuc, P; Urban, R; Szamatowicz, J; Kretowski, A; Laudanski, P; Gorska, M				Wawrusiewicz-Kurylonek, Natalia; Telejko, Beata; Kuzmicki, Mariusz; Sobota, Angelika; Lipinska, Danuta; Pliszka, Justyna; Raczkowska, Beata; Kuc, Pawel; Urban, Remigiusz; Szamatowicz, Jacek; Kretowski, Adam; Laudanski, Piotr; Gorska, Maria			Increased Maternal and Cord Blood Betatrophin in Gestational Diabetes	PLOS ONE			English	Article							ANGIOPOIETIN-LIKE PROTEIN; MESSENGER-RNA EXPRESSION; BROWN-FAT; IRISIN; SERUM; GLUCOSE; PLASMA; IDENTIFICATION; LIPASIN; OBESITY	Aim The aim of the study was to compare maternal and cord blood levels of betatrophin - a new peptide potentially controlling beta cell growth - as well as in its mRNA expression in subcutaneous adipose tissue, visceral adipose tissue and placental tissue obtained from pregnant women with normal glucose tolerance (NGT) and gestational diabetes (GDM). Methods Serum betatrophin and irisin concentrations were measured by ELISA in 93 patients with GDM and 97 women with NGT between 24 and 28 week of gestation. Additionally, maternal and cord blood betatrophin and irisin, as well as their genes (C19orf80 and Fndc5) expression were evaluated in 20 patients with GDM and 20 women with NGT at term. Results In both groups, serum betatrophin concentrations were significantly higher in the patients with GDM than in the controls (1.91 [1.40-2.60] ng/ml vs 1.63 [1.21-2.22] ng/ml, p=0.03 and 3.45 [2.77-6.53] ng/ml vs 2.78 [2.16-3.65] ng/ml, p=0.03, respectively). Cord blood betatrophin levels were also higher in the GDM than in the NGT group (20.43 [12.97-28.80] ng/ml vs 15.06 [10.11-21.36] ng/ml, p=0.03). In both groups betatrophin concentrations in arterial cord blood were significantly higher than in maternal serum (p=0.0001). Serum irisin levels were significantly lower in the patients with GDM (1679 [1308-2171] ng/ml) than in the healthy women between 24 and 28 week of pregnancy (1880 [1519-2312] ng/ml, p=0.03). Both C19orf80 and Fndc5 mRNA expression in fat and placental tissue did not differ significantly between the groups studied. Conclusions Our results suggest that an increase in maternal and cord blood betatrophin might be a compensatory mechanism for enhanced insulin demand in GDM.	[Wawrusiewicz-Kurylonek, Natalia; Telejko, Beata; Lipinska, Danuta; Pliszka, Justyna; Raczkowska, Beata; Kretowski, Adam; Gorska, Maria] Med Univ Bialystok, Dept Endocrinol Diabetol & Internal Med, Bialystok, Poland; [Kuzmicki, Mariusz; Sobota, Angelika; Szamatowicz, Jacek] Med Univ Bialystok, Dept Gynecol, Bialystok, Poland; [Kuc, Pawel; Urban, Remigiusz; Laudanski, Piotr] Med Univ Bialystok, Dept Perinatol, Bialystok, Poland	Medical University of Bialystok; Medical University of Bialystok; Medical University of Bialystok	Kuzmicki, M (corresponding author), Med Univ Bialystok, Dept Gynecol, Bialystok, Poland.	mkuzmicki@op.pl	Kretowski, Adam/U-6299-2018; Wawrusiewicz-Kurylonek, Natalia/AAB-3385-2020; Wawrusiewicz-Kurylonek, Natalia/AAB-2666-2020; Wawrusiewicz-Kurylonek, Natalia/AHD-2486-2022; Kuc, Pawel/HGB-5361-2022; Szamatowicz, Jacek/T-6569-2018	Kretowski, Adam/0000-0002-4522-4978; Wawrusiewicz-Kurylonek, Natalia/0000-0002-1087-8154; Wawrusiewicz-Kurylonek, Natalia/0000-0002-1087-8154; Kuzmicki, Mariusz/0000-0002-7482-9394; Laudanski, Piotr/0000-0001-8955-8198; Szamatowicz, Jacek/0000-0001-8632-7829	State Committee for Scientific Research [N N407 141937]	State Committee for Scientific Research(Polish State Committee for Scientific Research)	The study was supported by the State Committee for Scientific Research (grant No. N N407 141937).	Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Buchanan TA, 2007, DIABETES CARE, V30, pS105, DOI 10.2337/dc07-s201; Chen X, 2015, J CLIN ENDOCR METAB, V100, pE96, DOI 10.1210/jc.2014-2300; Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy, 2013, DIAGN CRIT CLASS HYP; Ebert T, 2014, J CLIN ENDOCR METAB, V99, pE2510, DOI 10.1210/jc.2013-4349; Ebert T, 2014, CYTOKINE, V65, P153, DOI 10.1016/j.cyto.2013.11.009; Espes D, 2015, DIABETIC MED, V32, P1172, DOI 10.1111/dme.12731; Espes D, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/323407; Fenzl A, 2014, DIABETOLOGIA, V57, P1204, DOI 10.1007/s00125-014-3208-x; Fu ZY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05013; Fu ZY, 2013, BIOCHEM BIOPH RES CO, V430, P1126, DOI 10.1016/j.bbrc.2012.12.025; Gomez-Ambrosi J, 2014, J CLIN ENDOCR METAB, V99, pE2004, DOI 10.1210/jc.2014-1568; Gusarova V, 2014, CELL, V159, P691, DOI 10.1016/j.cell.2014.09.027; Hu H, 2014, DIABETES CARE, V37, P2718, DOI 10.2337/dc14-0602; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Jiao Y, 2014, DIABETES, V63, P1283, DOI 10.2337/db13-1435; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Kuzmicki M, 2014, GYNECOL ENDOCRINOL, V30, P636, DOI 10.3109/09513590.2014.920006; Kuzmicki M, 2013, EUR J ENDOCRINOL, V168, P419, DOI 10.1530/EJE-12-0654; Kuzmicki M, 2012, GYNECOL ENDOCRINOL, V28, P841, DOI 10.3109/09513590.2012.683055; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Piya MK, 2014, AM J PHYSIOL-ENDOC M, V306, pE512, DOI 10.1152/ajpendo.00308.2013; Quagliarini F, 2012, P NATL ACAD SCI USA, V109, P19751, DOI 10.1073/pnas.1217552109; Ren G, 2012, AM J PHYSIOL-ENDOC M, V303, pE334, DOI 10.1152/ajpendo.00084.2012; Retnakaran R, 2009, DIABETIC MED, V26, P1198, DOI 10.1111/j.1464-5491.2009.02841.x; Telejko B, 2010, EXP CLIN ENDOCR DIAB, V118, P87, DOI 10.1055/s-0029-1238313; Telejko B, 2010, DIABETES RES CLIN PR, V87, P176, DOI 10.1016/j.diabres.2009.10.018; Tokumoto S, 2015, DIABETIC MED, V32, P653, DOI 10.1111/dme.12696; Wang Y, 2013, P NATL ACAD SCI USA, V110, P16109, DOI 10.1073/pnas.1315292110; Yamada H, 2015, ENDOCR J; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Yuksel MA, 2014, DIABETES RES CLIN PR, V104, P171, DOI 10.1016/j.diabres.2013.12.025; Zhang R, 2012, BIOCHEM BIOPH RES CO, V424, P786, DOI 10.1016/j.bbrc.2012.07.038; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106	35	37	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131171	10.1371/journal.pone.0131171	http://dx.doi.org/10.1371/journal.pone.0131171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115519	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500134
J	Goyal, R; Longo, LD				Goyal, Ravi; Longo, Lawrence D.			Metabolic Profiles in Ovine Carotid Arteries with Developmental Maturation and Long-Term Hypoxia	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; GENE-EXPRESSION; GROWTH RESTRICTION; ANTENATAL HYPOXIA; AGING PROCESS; FETAL; PRETERM; NICOTINAMIDE; RESPONSES; CELLS	Background Long-term hypoxia (LTH) is an important stressor related to health and disease during development. At different time points from fetus to adult, we are exposed to hypoxic stress because of placental insufficiency, high-altitude residence, smoking, chronic anemia, pulmonary, and heart disorders, as well as cancers. Intrauterine hypoxia can lead to fetal growth restriction and long-term sequelae such as cognitive impairments, hypertension, cardiovascular disorders, diabetes, and schizophrenia. Similarly, prolonged hypoxic exposure during adult life can lead to acute mountain sickness, chronic fatigue, chronic headache, cognitive impairment, acute cerebral and/or pulmonary edema, and death. Aim LTH also can lead to alteration in metabolites such as fumarate, 2-oxoglutarate, malate, and lactate, which are linked to epigenetic regulation of gene expression. Importantly, during the intrauterine life, a fetus is under a relative hypoxic environment, as compared to newborn or adult. Thus, the changes in gene expression with development from fetus to newborn to adult may be as a consequence of underlying changes in the metabolic profile because of the hypoxic environment along with developmental maturation. To examine this possibility, we examined the metabolic profile in carotid arteries from near-term fetus, newborn, and adult sheep in both normoxic and long-term hypoxic acclimatized groups. Results Our results demonstrate that LTH differentially regulated glucose metabolism, mitochondrial metabolism, nicotinamide cofactor metabolism, oxidative stress and antioxidants, membrane lipid hydrolysis, and free fatty acid metabolism, each of which may play a role in genetic-epigenetic regulation.	[Goyal, Ravi; Longo, Lawrence D.] Loma Linda Univ, Ctr Perinatal Biol, Dept Basic Sci, Sch Med, Loma Linda, CA 92350 USA	Loma Linda University	Goyal, R (corresponding author), Loma Linda Univ, Ctr Perinatal Biol, Dept Basic Sci, Sch Med, Loma Linda, CA 92350 USA.	rgoyal@llu.edu			National Institute of Health [HD003708, HD031226]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD081283] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The studies were supported by National Institute of Health, Grant No. HD003708 and HD031226. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht E, 2014, METABOLOMICS, V10, P141, DOI 10.1007/s11306-013-0565-2; Ali YO, 2011, J BIOL CHEM, V286, P19089, DOI 10.1074/jbc.M111.219295; Ballabh P, 2004, PEDIATR RES, V56, P117, DOI 10.1203/01.PDR.0000130472.30874.FF; Bartelds B, 2004, AM J PHYSIOL-HEART C, V286, pH2243, DOI 10.1152/ajpheart.00864.2003; Bartelds B, 1998, AM J PHYSIOL-HEART C, V274, pH1962, DOI 10.1152/ajpheart.1998.274.6.H1962; Bassan H, 2009, CLIN PERINATOL, V36, P737, DOI 10.1016/j.clp.2009.07.014; Baze MM, 2010, PHYSIOL GENOMICS, V41, P275, DOI 10.1152/physiolgenomics.00075.2009; BROWN JK, 1974, DEV MED CHILD NEUROL, V16, P567; Cao RS, 2014, CELL PHYSIOL BIOCHEM, V34, P1427, DOI 10.1159/000366348; DIECKHOFF D, 1969, PFLUG ARCH EUR J PHY, V310, P75, DOI 10.1007/BF00586876; EASTMAN NJ, 1954, AM J OBSTET GYNECOL, V67, P701, DOI 10.1016/0002-9378(54)90098-8; Evens AM, 2010, J CLIN ONCOL, V28, P1017, DOI 10.1200/JCO.2009.24.1893; FANOS V, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/720514; Geiger K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026465; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Gonzalez-Rodriguez PJ, 2014, NEUROBIOL DIS, V65, P172, DOI 10.1016/j.nbd.2014.01.020; Goyal R, 2014, PHYSIOL GENOMICS, V46, P725, DOI 10.1152/physiolgenomics.00073.2014; Goyal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082200; Goyal R, 2012, PEDIATR RES, V72, P137, DOI 10.1038/pr.2012.57; Goyal R, 2010, AM J PHYSIOL-REG I, V299, pR1377, DOI 10.1152/ajpregu.00344.2010; Heather LC, 2011, J MOL CELL CARDIOL, V50, P598, DOI 10.1016/j.yjmcc.2011.01.007; HEISTAD DD, 1978, J CLIN INVEST, V62, P761, DOI 10.1172/JCI109187; HERTER FP, 1961, CANCER RES, V21, P31; Huang D, 2014, ACTA BIOCH BIOPH SIN, V46, P214, DOI 10.1093/abbs/gmt148; Ichiki T, 2014, TRENDS CARDIOVAS MED, V24, P197, DOI 10.1016/j.tcm.2014.03.004; Jun JC, 2012, AM J PHYSIOL-ENDOC M, V303, pE377, DOI 10.1152/ajpendo.00641.2011; KAMITOMO M, 1994, AM J PHYSIOL, V266, pR1778, DOI 10.1152/ajpregu.1994.266.6.R1778; Kehrer M, 2005, PEDIATR RES, V58, P927, DOI 10.1203/01.PDR.0000182579.52820.C3; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; Kraut JA, 2014, NEW ENGL J MED, V371, P2309, DOI 10.1056/NEJMra1309483; Latham T, 2012, NUCLEIC ACIDS RES, V40, P4794, DOI 10.1093/nar/gks066; Lee SJ, 2009, J PHYSIOL-LONDON, V587, P2033, DOI 10.1113/jphysiol.2009.166983; LeMieux M, 2013, ADV NUTR, V4, P548, DOI 10.3945/an.113.004267; LONGO LD, 1987, ENVIRON HEALTH PERSP, V74, P93, DOI 10.2307/3430439; Longo LD, 1997, BRIT J OBSTET GYNAEC, V104, P652, DOI 10.1111/j.1471-0528.1997.tb11974.x; LONGO LD, 1993, AM J PHYSIOL, V264, pR65, DOI 10.1152/ajpregu.1993.264.1.R65; LONGO LD, 1991, SEMIN PERINATOL, V15, P49; de Lemos ML, 2013, INT J BIOCHEM CELL B, V45, P1377, DOI 10.1016/j.biocel.2013.04.011; Mashina SY, 2006, B EXP BIOL MED+, V142, P169, DOI 10.1007/s10517-006-0318-6; Moore LG, 2003, HIGH ALT MED BIOL, V4, P141, DOI 10.1089/152702903322022767; MULLIGAN JC, 1980, J PEDIATR-US, V96, P903, DOI 10.1016/S0022-3476(80)80575-0; Mulvihill MM, 2014, AM J PHYSIOL-ENDOC M, V307, pE237, DOI 10.1152/ajpendo.00228.2014; Muratsubaki H., 2003, Archives of Physiology and Biochemistry, V111, P449, DOI 10.3109/13813450312331342319; Murdoch, 1997, J Travel Med, V4, P90, DOI 10.1111/j.1708-8305.1997.tb00786.x; NAEYE RL, 1987, AM J DIS CHILD, V141, P50, DOI 10.1001/archpedi.1987.04460010050022; Nelson KB, 2003, PEDIATR RES, V53, P600, DOI 10.1203/01.PDR.0000056802.22454.AB; Nelson KB, 2003, NEW ENGL J MED, V349, P1765, DOI 10.1056/NEJMsb035364; Nicholson JK, 2012, NATURE, V491, P384, DOI 10.1038/nature11708; Norman JT, 1999, EXP NEPHROL, V7, P463; Papamatheakis DG, 2013, CURR VASC PHARMACOL, V11, P616, DOI 10.2174/1570161111311050006; Ream M, 2008, AM J PHYSIOL-REG I, V295, pR583, DOI 10.1152/ajpregu.00771.2007; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P118, DOI 10.1111/j.1471-0528.2006.01150.x; Romero R, 2002, AM J OBSTET GYNECOL, V187, P1299, DOI 10.1067/mob.2002.128319; Romero R, 2010, J MATERN-FETAL NEO M, V23, P1344, DOI 10.3109/14767058.2010.482618; Rueda-Clausen CF, 2009, CARDIOVASC RES, V81, P713, DOI 10.1093/cvr/cvn341; Salminen A, 2014, AGEING RES REV, V16, P45, DOI 10.1016/j.arr.2014.05.004; Salminen A, 2014, CELL SIGNAL, V26, P1598, DOI 10.1016/j.cellsig.2014.03.030; Schurr A, 2002, NEUROCHEM INT, V41, P1, DOI 10.1016/S0197-0186(01)00142-5; Serra-Perez A, 2010, J BIOL CHEM, V285, P18217, DOI 10.1074/jbc.M110.101048; Shen CC, 2004, J BIOMED SCI, V11, P472, DOI [10.1159/000077897, 10.1007/BF02256096]; Shetty PK, 2014, NEUROBIOL DIS, V62, P469, DOI 10.1016/j.nbd.2013.10.025; Shinitzky M, 2000, EUR J BIOCHEM, V267, P2547, DOI 10.1046/j.1432-1327.2000.01265.x; SZYMONOWICZ W, 1990, PEDIATR RES, V28, P361, DOI 10.1203/00006450-199010000-00012; Tong DL, 2012, PHARMACOLOGY, V90, P11, DOI 10.1159/000338628; Wang ZH, 2009, AM J PHYSIOL-HEART C, V296, pH1321, DOI 10.1152/ajpheart.00440.2008; Williams JM, 2006, J APPL PHYSIOL, V100, P225, DOI 10.1152/japplphysiol.00221.2005	67	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130739	10.1371/journal.pone.0130739	http://dx.doi.org/10.1371/journal.pone.0130739			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110419	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800082
J	Li, FF; Zhou, J; Zhao, DD; Yan, P; Li, X; Han, Y; Li, XS; Wang, GY; Yu, KJ; Liu, SL				Li, Fei-Feng; Zhou, Jing; Zhao, Dan-Dan; Yan, Peng; Li, Xia; Han, Ying; Li, Xian-Shu; Wang, Gui-Yu; Yu, Kai-Jiang; Liu, Shu-Lin			Characterization of SMAD3 Gene Variants for Possible Roles in Ventricular Septal Defects and Other Congenital Heart Diseases	PLOS ONE			English	Article							CELLS; MICROENVIRONMENT; DIFFERENTIATION; OSTEOARTHRITIS; MUTATIONS; PHENOTYPE; ANEURYSMS; INSIGHTS; LEFTY	Background Nodal/TGF signaling pathway has an important effect at early stages of differentiation of human embryonic stem cells in directing them to develop into different embryonic lineages. SMAD3 is a key intracellular messenger regulating factor in the Nodal/TGF signaling pathway, playing important roles in embryonic and, particularly, cardiovascular system development. The aim of this work was to find evidence on whether SMAD3 variations might be associated with ventricular septal defects (VSD) or other congenital heart diseases (CHD). Methods We sequenced the SMAD3 gene for 372 Chinese Han CHD patients including 176 VSD patients and evaluated SNP rs2289263, which is located before the 5'UTR sequence of the gene. The statistical analyses were conducted using Chi-Square Tests as implemented in SPSS (version 13.0). The Hardy-Weinberg equilibrium test of the population was carried out using the online software OEGE. Results Three heterozygous variants in SMAD3gene, rs2289263, rs35874463 and rs17228212, were identified. Statistical analyses showed that the rs2289263 variant located before the 5'UTR sequence of SMAD3 gene was associated with the risk of VSD (P value = 0.013 < 0.05). Conclusions The SNP rs2289263 in the SMAD3 gene is associated with VSD in Chinese Han populations.	[Li, Fei-Feng; Zhao, Dan-Dan; Li, Xia; Han, Ying; Liu, Shu-Lin] Harbin Med Univ, Genom Res Ctr, State Prov Key Lab Biopharmaceut Engn China 1, Harbin, Peoples R China; [Zhou, Jing; Yu, Kai-Jiang] Harbin Med Univ, Affiliated Hosp 2, Intens Care Unit, Harbin, Peoples R China; [Yan, Peng; Wang, Gui-Yu] Harbin Med Univ, Affiliated Hosp 2, Dept Colorectal Surg, Harbin, Peoples R China; [Li, Xian-Shu] Daqing Peoples Hosp, Daqing, Peoples R China; [Liu, Shu-Lin] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada	Harbin Medical University; Harbin Medical University; Harbin Medical University; University of Calgary	Wang, GY (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Colorectal Surg, Harbin, Peoples R China.	guiywang@gmail.com; drkaijiang@163.com; slliu@ucalgary.ca			Heilongjiang Innovation Research Foundation for Graduate Studies [YJSCX2014-10HYD]; Heilongjiang Provincial Educational Department [12541431]; Pharmacy College of Harbin Medical University; National Natural Science Foundation of China [NSFC81271786, 81110378, 30970119, 81030029]	Heilongjiang Innovation Research Foundation for Graduate Studies; Heilongjiang Provincial Educational Department; Pharmacy College of Harbin Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from Heilongjiang Innovation Research Foundation for Graduate Studies (YJSCX2014-10HYD), a grant from the Heilongjiang Provincial Educational Department (12541431), a grant from Pharmacy College of Harbin Medical University to FFL; and grants of National Natural Science Foundation of China (NSFC81271786, 81110378, 30970119, 81030029) to SLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Arthur HM, 2011, BIRTH DEFECTS RES A, V91, P423, DOI 10.1002/bdra.20794; Barroso-delJesus A, 2011, FASEB J, V25, P1497, DOI 10.1096/fj.10-172221; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Costa FF, 2009, EPIGENOMICS-UK, V1, P387, DOI 10.2217/EPI.09.25; Deng X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104535; Dolk H, 2011, CIRCULATION, V123, P841, DOI 10.1161/CIRCULATIONAHA.110.958405; Dvash T, 2007, STEM CELLS, V25, P465, DOI 10.1634/stemcells.2006-0179; Erol O, 2014, J TURK-GER GYNECOL A, V15, P96, DOI 10.5152/jtgga.2014.0012; Fahed AC, 2013, CIRC RES, V112, P707, DOI 10.1161/CIRCRESAHA.112.300853; Gelb BD, 2013, CURR OPIN PEDIATR, V25, P561, DOI 10.1097/MOP.0b013e3283648826; Gong W, 2001, J Med Genet, V38, pE45, DOI 10.1136/jmg.38.12.e45; Gramley F, 2010, INT J CARDIOL, V143, P405, DOI 10.1016/j.ijcard.2009.03.110; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Jiang LY, 2013, RHEUMATOL INT, V33, P1763, DOI 10.1007/s00296-012-2593-z; Kebed KY, 2014, MAYO CLIN PROC, V89, P1143, DOI 10.1016/j.mayocp.2014.04.024; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Malchenko S, 2010, J CELL PHYSIOL, V225, P390, DOI 10.1002/jcp.22280; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Richards AA, 2010, CURR CARDIOL REV, V6, P91, DOI 10.2174/157340310791162703; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schuldiner M, 2003, METHOD ENZYMOL, V365, P446; Sharma Mukti, 2013, Med J Armed Forces India, V69, P241, DOI 10.1016/j.mjafi.2012.11.013; Tabibzadeh S, 2006, STEM CELLS, V24, P1998, DOI 10.1634/stemcells.2006-0075; Tan ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036590; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; van der Bom T, 2011, NAT REV CARDIOL, V8, P50, DOI 10.1038/nrcardio.2010.166; van der Linde D, 2012, J AM COLL CARDIOL, V60, P397, DOI 10.1016/j.jacc.2011.12.052; van Driel LMJW, 2008, EUR HEART J, V29, P1424, DOI 10.1093/eurheartj/ehn170; van Weerd JH, 2011, CARDIOVASC RES, V91, P203, DOI 10.1093/cvr/cvr138; Verheugt CL, 2010, EUR HEART J, V31, P1220, DOI 10.1093/eurheartj/ehq032; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141	38	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131542	10.1371/journal.pone.0131542	http://dx.doi.org/10.1371/journal.pone.0131542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110764	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800158
J	Raj, M; Paul, M; Sudhakar, A; Varghese, AA; Haridas, AC; Kabali, C; Kumar, RK				Raj, Manu; Paul, Mary; Sudhakar, Abish; Varghese, Anu Alphonse; Haridas, Aareesh Chittulliparamb; Kabali, Conrad; Kumar, Raman Krishna			Micro-Economic Impact of Congenital Heart Surgery: Results of a Prospective Study from a Limited-Resource Setting	PLOS ONE			English	Article							RISK ADJUSTMENT; COSTS; DISEASES	Introduction The microeconomic impact of surgery for congenital heart disease is unexplored, particularly in resource limited environments. We sought to understand the direct and indirect costs related to congenital heart surgery and its impact on Indian households from a family perspective. Methods Baseline and first follow-up data of 644 consecutive children admitted for surgery for congenital heart disease (March 2013 - July 2014) in a tertiary referral hospital in Central Kerala, South India was collected prospectivelyfrom parents through questionnaires using a semi-structured interview schedule. Results The median age was 8.2 months (IQR: 3.0-36.0 months). Most families belonged to upper middle (43.0%) and lower middle (35.7%) socioeconomic class. Only 3.9% of families had some form of health insurance. The median expense for the admission and surgery was INR 201898 (IQR: 163287-266139) [I$ 11989 (IQR: 9696-15804)], which was 0.93 (IQR: 0.52-1.49) times the annual family income of affected patients. Median loss of man-days was 35 (IQR: 24-50) and job-days was 15 (IQR: 11-24). Surgical risk category and hospital stay duration significantly predicted higher costs. One in two families reported overwhelming to high financial stress during admission period for surgery. Approximately half of the families borrowed money during the follow up period after surgery. Conclusion Surgery for congenital heart disease results in significant financial burden for majority of families studied. Efforts should be directed at further reductions in treatment costs without compromising the quality of care together with generating financial support for affected families.	[Raj, Manu; Paul, Mary; Sudhakar, Abish; Varghese, Anu Alphonse; Haridas, Aareesh Chittulliparamb; Kumar, Raman Krishna] Amrita Inst Med Sci & Res Ctr, Dept Pediat Cardiol, Kochi, Kerala, India; [Kabali, Conrad] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi; University of Toronto	Raj, M (corresponding author), Amrita Inst Med Sci & Res Ctr, Dept Pediat Cardiol, Kochi, Kerala, India.	drmanuraj@gmail.com	Paul, Mary/AAA-2722-2021; Kabali, Conrad/AAX-7718-2021; Raj, Manu/U-7187-2019; Kabali, Conrad/AAW-6681-2021	Raj, Manu/0000-0001-7130-3437; Kabali, Conrad/0000-0002-0553-0305; Kumar, Raman Krishna/0000-0003-4343-0951; Sudhakar, Abish/0000-0001-7978-6445	Indian Council of Medical Research [5/4/1-23/11NCD-II]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was funded by the Indian Council of Medical Research grant No. 5/4/1-23/11NCD-II (www.icmr.nic.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, INT J POSTCOLONIAL S, V4, DOI DOI 10.1029/2001WR000759; Connor JA, 2005, PEDIATRICS, V116, P689, DOI 10.1542/peds.2004-2071; Connor JA, 2010, J PEDIATR HEALTH CAR, V24, P318, DOI 10.1016/j.pedhc.2009.09.002; Dallal GE, 2015, CONFIDENCE INTERVALS; Engelgau M, 2011, J HEALTH COMMUN, V16, P75, DOI 10.1080/10810730.2011.601394; Fernandes Alfredo Manoel da Silva, 2004, Arq. Bras. Cardiol., V83, P18, DOI 10.1590/S0066-782X2004001300003; Jenkins KJ, 2002, J THORAC CARDIOV SUR, V123, P110, DOI 10.1067/mtc.2002.119064; Kumar Neeta, 2012, Indian J Public Health, V56, P103, DOI 10.4103/0019-557X.96988; Kumar RK, 2008, HEART, V94, P984, DOI 10.1136/hrt.2007.139360; Kumar RK, 2014, ANN PEDIAT CARDIOL, V7, P1, DOI 10.4103/0974-2069.126537; Lawoko S, 2003, QUAL LIFE RES, V12, P655, DOI 10.1023/A:1025114331419; Lawrence EJ, 2013, CIRC-CARDIOVASC QUAL, V6, P201, DOI 10.1161/CIRCOUTCOMES.111.000066; Pasquali SK, 2014, ANN THORAC SURG, V98, P1660, DOI 10.1016/j.athoracsur.2014.06.032; Pasquali SK, 2014, PEDIATRICS, V133, pE553, DOI 10.1542/peds.2013-2870; Pasquali SK, 2011, CIRC-CARDIOVASC QUAL, V4, P306, DOI 10.1161/CIRCOUTCOMES.110.958959; Raucci FJ, 2014, AM J CARDIOL, V114, P1740, DOI 10.1016/j.amjcard.2014.09.006; Reddy SN, 2014, ANN PEDIAT CARDIO S1, V7, P541; Talwar S, 2008, CARDIOL YOUNG, V18, P363, DOI 10.1017/S1047951108002448; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; World Health Organization, 2009, WHO GUID ID EC CONS	20	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131348	10.1371/journal.pone.0131348	http://dx.doi.org/10.1371/journal.pone.0131348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110639	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800145
J	Warren, KJ; Olson, MM; Thompson, NJ; Cahill, ML; Wyatt, TA; Yoon, KJ; Loiacono, CM; Kohut, ML				Warren, Kristi J.; Olson, Molly M.; Thompson, Nicholas J.; Cahill, Mackenzie L.; Wyatt, Todd A.; Yoon, Kyoungjin J.; Loiacono, Christina M.; Kohut, Marian L.			Exercise Improves Host Response to Influenza Viral Infection in Obese and Non-Obese Mice through Different Mechanisms	PLOS ONE			English	Article							DIET-INDUCED OBESITY; T-CELL RESPONSES; DENDRITIC CELLS; CARDIORESPIRATORY FITNESS; POSITIVE FEEDBACK; PHYSICAL-ACTIVITY; CLONAL EXPANSION; CUTTING EDGE; RISK-FACTOR; TNF-ALPHA	Obesity has been associated with greater severity of influenza virus infection and impaired host defense. Exercise may confer health benefits even when weight loss is not achieved, but it has not been determined if regular exercise improves immune defense against influenza A virus (IAV) in the obese condition. In this study, diet-induced obese mice and lean control mice exercised for eight weeks followed by influenza viral infection. Exercise reduced disease severity in both obese and non-obese mice, but the mechanisms differed. Exercise reversed the obesity-associated delay in bronchoalveolar-lavage (BAL) cell infiltration, restored BAL cytokine and chemokine production, and increased ciliary beat frequency and IFN alpha-related gene expression. In non-obese mice, exercise treatment reduced lung viral load, increased Type-I-IFN-related gene expression early during infection, but reduced BAL inflammatory cytokines and chemokines. In both obese and non-obese mice, exercise increased serum anti-influenza virus specific IgG2c antibody, increased CD8+ T cell percentage in BAL, and reduced TNF alpha by influenza viral NP-peptide-responding CD8+ T cells. Overall, the results suggest that exercise "restores" the immune response of obese mice to a phenotype similar to non-obese mice by improving the delay in immune activation. In contrast, in non-obese mice exercise treatment results in an early reduction in lung viral load and limited inflammatory response.	[Warren, Kristi J.; Yoon, Kyoungjin J.; Kohut, Marian L.] Iowa State Univ, Immunobiol Program, Ames, IA 50011 USA; [Olson, Molly M.; Thompson, Nicholas J.; Cahill, Mackenzie L.; Kohut, Marian L.] Iowa State Univ, Coll Human Sci, Dept Kinesiol, Ames, IA USA; [Wyatt, Todd A.] VA Nebraska Western Iowa Hlth Care Syst, Res Serv, Dept Vet Affairs, Med Ctr, Omaha, NE USA; [Wyatt, Todd A.] Univ Nebraska, Med Ctr, Sleep & Allergy Div, Pulm Crit Care, Omaha, NE 68182 USA; [Loiacono, Christina M.] USDA, Natl Vet Serv Labs, APHIS, Ames, IA 50010 USA; [Yoon, Kyoungjin J.] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA	Iowa State University; Iowa State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska Medical Center; United States Department of Agriculture (USDA); Iowa State University	Kohut, ML (corresponding author), Iowa State Univ, Immunobiol Program, Ames, IA 50011 USA.	mkohut@iastate.edu		Thompson, Nicholas/0000-0002-5426-4883	National Institute of Allergy and Infectious Diseases at the National Institute of Health [R01 AI 059455-A2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059455] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases at the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institute of Allergy and Infectious Diseases at the National Institute of Health [R01 AI 059455-A2] awarded to MLK.	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Allen-Gipson DS, 2004, J AEROSOL MED, V17, P107, DOI 10.1089/0894268041457138; Anderson RV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012902; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; BELL RR, 1995, J NUTR, V125, P2356, DOI 10.1093/jn/125.9.2356; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; Davis JM, 1997, J APPL PHYSIOL, V83, P1461, DOI 10.1152/jappl.1997.83.5.1461; Desai KH, 1997, AM J PHYSIOL-HEART C, V272, pH1053, DOI 10.1152/ajpheart.1997.272.2.H1053; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Easterbrook JD, 2011, INFLUENZA OTHER RESP, V5, P418, DOI 10.1111/j.1750-2659.2011.00254.x; Eckel RH, 1997, CIRCULATION, V96, P3248, DOI 10.1161/01.CIR.96.9.3248; Eliakim A, 2006, AUTOIMMUNITY, V39, P137, DOI 10.1080/08916930600597326; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Farrell SW, 2007, OBESITY, V15, P3140, DOI 10.1038/oby.2007.374; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Ferguson RD, 2013, VITAM HORM, V93, P51, DOI 10.1016/B978-0-12-416673-8.00010-1; Gaidhu MP, 2010, AM J PHYSIOL-CELL PH, V298, pC961, DOI 10.1152/ajpcell.00547.2009; Gardner EM, 2011, ANNU REV NUTR, V31, P353, DOI 10.1146/annurev-nutr-081810-160812; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Heer AK, 2007, J IMMUNOL, V178, P2182, DOI 10.4049/jimmunol.178.4.2182; Huttunen R, 2013, J HOSP INFECT, V85, P8, DOI 10.1016/j.jhin.2013.06.012; ILBACK NG, 1984, INFECT IMMUN, V45, P498; Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09; Karisson EA, 2010, J IMMUNOL, V184, P3127, DOI 10.4049/jimmunol.0903220; Karlsson EA, 2010, EXP BIOL MED, V235, P1412, DOI 10.1258/ebm.2010.010227; Karlsson EA, 2010, J NUTR, V140, P1691, DOI 10.3945/jn.110.123653; Kim TS, 2014, IMMUNITY, V40, P400, DOI 10.1016/j.immuni.2014.02.004; Kohut ML, 2009, J INFECT DIS, V200, P1434, DOI 10.1086/606014; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Le Bon A, 2006, J IMMUNOL, V176, P4682, DOI 10.4049/jimmunol.176.8.4682; Lee DC, 2009, BRIT J SPORT MED, V43, P49, DOI 10.1136/bjsm.2008.054536; Louie JK, 2011, CLIN INFECT DIS, V52, P301, DOI 10.1093/cid/ciq152; Lowder T, 2006, EXERC IMMUNOL REV, V12, P97; Mancuso P, 2010, J APPL PHYSIOL, V108, P722, DOI 10.1152/japplphysiol.00781.2009; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Marois I, 2012, J LEUKOCYTE BIOL, V92, P107, DOI 10.1189/jlb.1011490; McAuley PA, 2013, DIABETES CARE; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; Mitsutake S, 2012, FEBS LETT, V586, P1300, DOI 10.1016/j.febslet.2012.03.032; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; O'Brien KB, 2012, J INFECT DIS, V205, P252, DOI 10.1093/infdis/jir729; Prakash A, 2005, J BIOL CHEM, V280, P18651, DOI 10.1074/jbc.M501289200; Radigan KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108138; Schwerbrock NMJ, 2009, J NUTR, V139, P1588, DOI 10.3945/jn.109.108027; Sheridan PA, 2012, INT J OBESITY, V36, P1072, DOI 10.1038/ijo.2011.208; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; Smith AG, 2009, IMMUNOLOGY, V126, P268, DOI 10.1111/j.1365-2567.2008.02895.x; Steinberger J, 2003, CIRCULATION, V107, P1448, DOI 10.1161/01.CIR.0000060923.07573.F2; Sui XM, 2007, JAMA-J AM MED ASSOC, V298, P2507, DOI 10.1001/jama.298.21.2507; Swallow JG, 1998, J APPL PHYSIOL, V84, P69, DOI 10.1152/jappl.1998.84.1.69; Thomas LA, 2005, BRAIN BEHAV IMMUN, V19, P377, DOI 10.1016/j.bbi.2005.04.002; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Veckman V, 2006, VIROLOGY, V345, P96, DOI 10.1016/j.virol.2005.09.043; Viasus D, 2011, CLIN MICROBIOL INFEC, V17, P738, DOI 10.1111/j.1469-0691.2010.03362.x; Warren K, 2013, J APPL PHYSIOL, V114, P1413, DOI 10.1152/japplphysiol.01355.2012; WEBER DJ, 1985, JAMA-J AM MED ASSOC, V254, P3187, DOI 10.1001/jama.254.22.3187; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045; Xu LM, 2004, J IMMUNOL, V173, P721, DOI 10.4049/jimmunol.173.2.721; Zhang AJX, 2013, J INFECT DIS, V207, P1270, DOI 10.1093/infdis/jit031	60	31	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0129713	10.1371/journal.pone.0129713	http://dx.doi.org/10.1371/journal.pone.0129713			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110868	gold, Green Submitted, Green Published			2022-12-27	WOS:000356933800028
J	Yang, BL; Lu, YP; Zhang, A; Zhou, AZ; Zhang, L; Zhang, LR; Gao, LM; Zang, YH; Tang, XH; Sun, LY				Yang, BL; Lu, YP; Zhang, A; Zhou, AZ; Zhang, L; Zhang, LR; Gao, LM; Zang, YH; Tang, XH; Sun, LY			Doxycycline Induces Apoptosis and Inhibits Proliferation and Invasion of Human Cervical Carcinoma Stem Cells	PLOS ONE			English	Article							CANCER STATISTICS; CD133(+) CELLS; BREAST-TUMORS; EXPRESSION	Background Cancer stem cells (CSCs) are proposed to be responsible for high recurrence rate in cervical carcinoma. Reagents that can suppress the proliferation and differentiation of CSCs would provide new opportunities to fight against tumor recurrence. Doxycycline has been reported as a potential anti-cancer compound. However, few studies investigated its inhibitory effect against cervical cancer stem cells. Methods HeLa cells were cultured in cancer stem cell conditional media in a poly-hema-treated dish. In this non-adhesive culture system, HeLa cells were treated with cisplatin until some cells survived and formed spheroids, which were then collected and injected into the immunodeficient mice. Cisplatin was administered every three days for five times. The tumor xenografts with CSC enrichment were cultured in cancer stem cell specific medium again to form tumorsphere, which we called HeLa-CSCs. Expression of cancer stem cell markers in HeLa-CSCs was measured by flow cytometry and qPCR. HeLa-CSCs were then treated with doxycycline. Proliferation and differentiation rates were determined by the size of spheres formed in vitro and tumor formed in vivo. Results We developed a new strategy to selectively enrich CSCs from human cervical carcinoma cell line HeLa, and these HeLa-CSCs are CD133+/CD49f+ cell populations with significantly enhanced expression of stem cell markers. When these HeLa-CSCs were treated with doxycycline, the colony formation, proliferation, migration and invasion, and differentiation were all suppressed. Meanwhile, stem cell markers SOX-2, OCT-4, NANOG, NOTCH and BMI-1 decreased in doxycycline treated cells, so as the surface markers CD133 and CD49f. Furthermore, proliferation markers Ki67 and PCNA were also decreased by doxycycline treatment in the in vivo xenograft mouse model. Conclusions Cancer stem cells are enriched from sphere-forming and chemoresistant HeLa-derived tumor xenografts in immunodeficient mice. Doxycycline inhibits proliferation, invasion, and differentiation, and also induces apoptosis of these HeLa-CSCs in vitro and in vivo.	[Yang, BL] People Hosp Pudong New Area, Dept Gynecol & Obstet, Shanghai 20299, Peoples R China		Yang, BL (corresponding author), People Hosp Pudong New Area, Dept Gynecol & Obstet, Shanghai 20299, Peoples R China.	binlieyang@126.com			Pudong New District Health Systems Personnel Training Plan [PWR1210-04]	Pudong New District Health Systems Personnel Training Plan	This research was supported by the Pudong New District Health Systems Personnel Training Plan (NO. PWR1210-04). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababneh N, 2013, NUCLEIC ACID THER, V23, P401, DOI 10.1089/nat.2013.0423; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Cantile M, 2013, TUMORI J, V99, pe245, DOI [10.1177/030089161309900523, 10.1700/1377.15325]; Charafe-Jauffret E, 2013, CANCER RES, V73, P7290, DOI 10.1158/0008-5472.CAN-12-4704; Chung SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083971; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Fuller Jennifer, 2006, Sci Aging Knowledge Environ, V2006, ppe12, DOI 10.1126/sageke.2006.9.pe12; Gu W, 2011, CANCER GENE THER, V18, P897, DOI 10.1038/cgt.2011.58; Hadnagy A, 2006, EXP CELL RES, V312, P3701, DOI 10.1016/j.yexcr.2006.08.030; Kim CF, 2008, CELL STEM CELL, V3, P147, DOI 10.1016/j.stem.2008.07.012; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Li HH, 2013, INT J BIOL MARKER, V28, pE357, DOI 10.5301/jbm.5000048; Mohseny AB, 2011, LAB INVEST, V91, P1195, DOI 10.1038/labinvest.2011.72; Mouratidis PXE, 2007, INT J CANCER, V120, P743, DOI 10.1002/ijc.22303; Organista-Nava J, 2014, TUMOR BIOL, V35, P1727, DOI 10.1007/s13277-013-1321-y; Sagar J, 2010, ANTI-CANCER AGENT ME, V10, P556, DOI 10.2174/187152010793498645; Sagar J, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-2; Schieber MS, 2013, CANCER CELL, V23, P265, DOI 10.1016/j.ccr.2013.02.021; Sekeroglu ZA, 2012, DRUG CHEM TOXICOL, V35, P334, DOI 10.3109/01480545.2011.621954; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Son K, 2009, ANTICANCER RES, V29, P3995; Sun Hao-cun, 2007, Zhonghua Zhongliu Zazhi, V29, P500; Tang H, 2013, GENE THER, V20, P770, DOI 10.1038/gt.2012.96; Uchida S, 2005, INVEST OPHTH VIS SCI, V46, P1620, DOI 10.1167/iovs.04-0288; Wang KF, 2013, ONCOL LETT, V6, P1673, DOI 10.3892/ol.2013.1607; Wang QM, 2015, MOL CARCINOGEN, V54, P449, DOI 10.1002/mc.22113; Wang Y, 2008, CELL STEM CELL, V2, P297, DOI 10.1016/j.stem.2008.03.014; Wei Xu-Dong, 2013, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V48, P578; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Wu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089841; Yang ZJ, 2007, CANCER CELL, V11, P3, DOI 10.1016/j.ccr.2006.12.007; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	33	30	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0129138	10.1371/journal.pone.0129138	http://dx.doi.org/10.1371/journal.pone.0129138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111245	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800020
J	Zhou, JLX; Fan, LCX; Li, XY; Calvet, JP; Li, XG				Zhou, Julie X.; Fan, Lucy X.; Li, Xiaoyan; Calvet, James P.; Li, Xiaogang			TNF alpha Signaling Regulates Cystic Epithelial Cell Proliferation through Akt/mTOR and ERK/MAPK/Cdk2 Mediated Id2 Signaling	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; NF-KAPPA-B; MAMMARY-GLAND DEVELOPMENT; OSTEOCLAST DIFFERENTIATION; RECEPTOR ACTIVATOR; INHIBITORY FACTOR; MESSENGER-RNA; MTOR PATHWAY; LIGAND; GROWTH	Tumor necrosis factor alpha (TNF alpha) is present in cyst fluid and promotes cyst growth in autosomal dominant polycystic kidney disease (ADPKD). However, the cross-talk between TNF alpha and PKD associated signaling pathways remains elusive. In this study, we found that stimulation of renal epithelial cells with TNF alpha or RANKL (receptor activator of NF-kappa B ligand), a member of the TNF alpha cytokine family, activated either the PI3K pathway, leading to AKT and mTOR mediated the increase of Id2 protein, or MAPK and Cdk2 to induce Id2 nuclear translocation. The effects of TNF alpha/RANKL on increasing Id2 protein and its nuclear translocation caused significantly decreased mRNA and protein levels of the Cdk inhibitor p21, allowing increased cell proliferation. TNF alpha levels increase in cystic kidneys in response to macrophage infiltration and thus might contribute to cyst growth and enlargement during the progression of disease. As such, this study elucidates a novel mechanism for TNF alpha signaling in regulating cystic renal epithelial cell proliferation in ADPKD.	[Zhou, Julie X.; Fan, Lucy X.; Li, Xiaoyan; Li, Xiaogang] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66160 USA; [Zhou, Julie X.; Fan, Lucy X.; Li, Xiaoyan; Calvet, James P.; Li, Xiaogang] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66160 USA; [Calvet, James P.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Li, Xiaogang] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Li, XG (corresponding author), Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66160 USA.	xli3@kumc.edu			National Institutes of Health grant [R01DK084097]; KUMC Kidney Institute internal grant; PKD Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084097] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KUMC Kidney Institute internal grant; PKD Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	X. Li acknowledges supports from National Institutes of Health grant R01DK084097 and from a KUMC Kidney Institute internal grant, J.P. Calvet acknowledges support from the PKD Foundation.	Bukanov NO, 2006, NATURE, V444, P949, DOI 10.1038/nature05348; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Chen L, 2015, J CLIN INVEST, V125, P2399, DOI 10.1172/JCI80467; Distefano G, 2009, MOL CELL BIOL, V29, P2359, DOI 10.1128/MCB.01259-08; Edelstein CL, 2008, CLIN J AM SOC NEPHRO, V3, P1219, DOI 10.2215/CJN.05611207; Fan LX, 2013, J AM SOC NEPHROL, V24, P2010, DOI 10.1681/ASN.2013020176; Fan LX, 2012, KIDNEY INT, V81, P76, DOI 10.1038/ki.2011.296; GARDNER KD, 1991, KIDNEY INT, V39, P718, DOI 10.1038/ki.1991.87; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hotokezaka H, 2007, J CELL BIOCHEM, V101, P122, DOI 10.1002/jcb.21167; Igarashi P, 2007, J AM SOC NEPHROL, V18, P1371, DOI 10.1681/ASN.2007030299; Inoue J, 2007, CANCER SCI, V98, P268, DOI 10.1111/j.1349-7006.2007.00389.x; Jankiewicz M, 2006, MOL ENDOCRINOL, V20, P2369, DOI 10.1210/me.2006-0071; Karihaloo A, 2011, J AM SOC NEPHROL, V22, P1809, DOI 10.1681/ASN.2011010084; Kartsogiannis V, 1999, BONE, V25, P525, DOI 10.1016/S8756-3282(99)00214-8; Kim NS, 2011, MOL CELL BIOL, V31, P4775, DOI 10.1128/MCB.05646-11; Kim NS, 2006, MOL CELL BIOL, V26, P1002, DOI 10.1128/MCB.26.3.1002-1013.2006; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Li XG, 2005, NAT CELL BIOL, V7, P1202, DOI 10.1038/ncb1326; Li XG, 2008, NAT MED, V14, P863, DOI 10.1038/nm1783; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Mabuchi S, 2004, CLIN CANCER RES, V10, P7645, DOI 10.1158/1078-0432.CCR-04-0958; Matsumura ME, 2002, J BIOL CHEM, V277, P7293, DOI 10.1074/jbc.M108986200; NAKAMURA T, 1993, J AM SOC NEPHROL, V4, P1064; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Norton JD, 1998, TRENDS CELL BIOL, V8, P58, DOI 10.1016/S0962-8924(97)01183-5; Polivka J, 2014, PHARMACOL THERAPEUT, V142, P164, DOI 10.1016/j.pharmthera.2013.12.004; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Vielhauer V, 2007, SEMIN NEPHROL, V27, P286, DOI 10.1016/j.semnephrol.2007.02.004; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Wierod L, 2007, CELL PROLIFERAT, V40, P475, DOI 10.1111/j.1365-2184.2007.00451.x; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhou X, 2014, HUM MOL GENET, V23, P1644, DOI 10.1093/hmg/ddt556; Zhou X, 2013, J CLIN INVEST, V123, P3084, DOI 10.1172/JCI64401; Zou W, 2005, J CELL PHYSIOL, V202, P371, DOI 10.1002/jcp.20127	40	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131043	10.1371/journal.pone.0131043	http://dx.doi.org/10.1371/journal.pone.0131043			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110849	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800113
J	Hubble, K; Bowen, KL; Moore, SC; van Goozen, SHM				Hubble, Kelly; Bowen, Katharine L.; Moore, Simon C.; van Goozen, Stephanie H. M.			Improving Negative Emotion Recognition in Young Offenders Reduces Subsequent Crime	PLOS ONE			English	Article							FACIAL AFFECT RECOGNITION; ANTISOCIAL-BEHAVIOR; FEARFUL EXPRESSIONS; CONDUCT DISORDER; PSYCHOPATHY; DEFICITS; OUTCOMES; CHILD; DEPRESSION; REGRESSION	Background Children with antisocial behaviour show deficits in the perception of emotional expressions in others that may contribute to the development and persistence of antisocial and aggressive behaviour. Current treatments for antisocial youngsters are limited in effectiveness. It has been argued that more attention should be devoted to interventions that target neuropsychological correlates of antisocial behaviour. This study examined the effect of emotion recognition training on criminal behaviour. Methods Emotion recognition and crime levels were studied in 50 juvenile offenders. Whilst all young offenders received their statutory interventions as the study was conducted, a subgroup of twenty-four offenders also took part in a facial affect training aimed at improving emotion recognition. Offenders in the training and control groups were matched for age, SES, IQ and lifetime crime level. All offenders were tested twice for emotion recognition performance, and recent crime data were collected after the testing had been completed. Results Before the training there were no differences between the groups in emotion recognition, with both groups displaying poor fear, sadness and anger recognition. After the training fear, sadness and anger recognition improved significantly in juvenile offenders in the training group. Although crime rates dropped in all offenders in the 6 months following emotion testing, only the group of offenders who had received the emotion training showed a significant reduction in the severity of the crimes they committed. Conclusions The study indicates that emotion recognition can be relatively easily improved in youths who engage in serious antisocial and criminal behavior. The results suggest that improved emotion recognition has the potential to reduce the severity of reoffending.	[Hubble, Kelly; Bowen, Katharine L.; van Goozen, Stephanie H. M.] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales; [Moore, Simon C.] Cardiff Univ, Sch Dent, Violence Res Grp, Cardiff CF10 3AX, S Glam, Wales; [van Goozen, Stephanie H. M.] Leiden Univ, Dept Clin Child & Adolescent Studies, Leiden, Netherlands	Cardiff University; Cardiff University; Leiden University; Leiden University - Excl LUMC	van Goozen, SHM (corresponding author), Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales.	vangoozens@cardiff.ac.uk		Hubble, Kelly/0000-0002-9280-6268; Moore, Simon/0000-0001-5495-4705	Economic and Social Research Council [1085185] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Andershed H., 2002, PSYCHOPATHS CURRENT, P131, DOI DOI 10.1037/T07576-000; [Anonymous], 2001, BRIT MED J, DOI DOI 10.1136/BMJ.323.7306.191; Bardone AM, 1998, J AM ACAD CHILD PSY, V37, P594, DOI 10.1097/00004583-199806000-00009; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Best M, 2002, P NATL ACAD SCI USA, V99, P8448, DOI 10.1073/pnas.112604099; Blair RJR, 2005, DEV PSYCHOPATHOL, V17, P865, DOI 10.1017/S0954579405050418; Blair RJR, 2004, PERS INDIV DIFFER, V37, P1111, DOI 10.1016/j.paid.2003.10.008; Blair RJR, 2001, J ABNORM CHILD PSYCH, V29, P491, DOI 10.1023/A:1012225108281; Bolte S, 2006, BEHAV NEUROSCI, V120, P211, DOI 10.1037/0735-7044.120.1.211; Bowen KL, 2014, J PSYCHOPATHOL BEHAV, V36, P60, DOI 10.1007/s10862-013-9368-z; Butler S, 2011, J AM ACAD CHILD PSY, V50, P1220, DOI 10.1016/j.jaac.2011.09.017; COX DR, 1972, J R STAT SOC B, V34, P187; Dadds MR, 2006, BRIT J PSYCHIAT, V189, P280, DOI 10.1192/bjp.bp.105.018150; Dadds MR, 2011, J CHILD PSYCHOL PSYC, V52, P238, DOI 10.1111/j.1469-7610.2010.02323.x; Dadds MR, 2012, PSYCHIAT RES, V199, P201, DOI 10.1016/j.psychres.2012.04.033; Dawel A, 2012, NEUROSCI BIOBEHAV R, V36, P2288, DOI 10.1016/j.neubiorev.2012.08.006; de Vries SLA, 2015, J CHILD PSYCHOL PSYC, V56, P108, DOI 10.1111/jcpp.12320; Fairchild G, 2009, J CHILD PSYCHOL PSYC, V50, P627, DOI 10.1111/j.1469-7610.2008.02020.x; Farrington D. P., 2002, EVIDENCE BASED CRIME; Farrington DP, 2007, SAVING CHILDREN FROM; Fombonne E, 2001, BRIT J PSYCHIAT, V179, P210, DOI 10.1192/bjp.179.3.210; Glass SJ, 2006, J ABNORM PSYCHOL, V115, P815, DOI 10.1037/0021-843X.115.4.815; Golan O, 2010, J AUTISM DEV DISORD, V40, P269, DOI 10.1007/s10803-009-0862-9; Huesmann L Rowell, 2002, Crim Behav Ment Health, V12, P185, DOI 10.1002/cbm.496; Kosson DS, 2002, EMOTION, V2, P398, DOI 10.1037//1528-3542.2.4.398; Leist Tatyana, 2009, Clin Child Psychol Psychiatry, V14, P237, DOI 10.1177/1359104508100887; Losel F, 2003, ANN AM ACAD POLIT SS, V587, P84, DOI 10.1177/0002716202250793; Marsh AA, 2008, NEUROSCI BIOBEHAV R, V32, P454, DOI 10.1016/j.neubiorev.2007.08.003; Neumann D, 2015, J HEAD TRAUMA REHAB, V30, pE12, DOI 10.1097/HTR.0000000000000054; Odgers CL, 2007, ARCH GEN PSYCHIAT, V64, P476, DOI 10.1001/archpsyc.64.4.476; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Penton-Voak IS, 2013, PSYCHOL SCI, V24, P688, DOI 10.1177/0956797612459657; Ross A., 2011, PREVENTION AND REDUC; Sato Wataru, 2009, Child Adolesc Psychiatry Ment Health, V3, P27, DOI 10.1186/1753-2000-3-27; Schonenberg M, 2013, J PERS DISORD, V27, P496, DOI 10.1521/pedi_2013_27_100; Schonenberg M., 2013, PSYCHOL MED, V1, P1; Tracy JL, 2014, CLIN PSYCHOL SCI, V2, P371, DOI 10.1177/2167702614537627; Van Goozen SHM, 2008, DEV PSYCHOPATHOL, V20, P941, DOI 10.1017/S095457940800045X; Wechsler D., 2011, WASI 2 WECHSLER ABBR	39	44	44	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0132035	10.1371/journal.pone.0132035	http://dx.doi.org/10.1371/journal.pone.0132035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1BL	26121148	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000358150400190
J	Kahan, BC; Rehal, S; Cro, S				Kahan, Brennan C.; Rehal, Sunita; Cro, Suzie			Blinded Outcome Assessment Was Infrequently Used and Poorly Reported in Open Trials	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIALS; EMPIRICAL-EVIDENCE; OBSERVER BIAS; IMPACT	Objective Unblinded outcome assessment can lead to biased estimates of treatment effect in randomised trials. We reviewed published trials to assess how often blinded assessment is used, and whether its use varies according to the type of outcome or assessor. Design and setting A review of parallel group, individually randomised phase III trials published in four general medical journals (BMJ, Journal of the American Medical Association, The Lancet, and New England Journal of Medicine) in 2010. Main outcome measures Whether assessment of the primary outcome was blinded, and whether this differed according to outcome or assessor type. Results We identified 258 eligible trials. Of these, 106 (41%) were reported as double-blind, and 152 (59%) as partially or fully open-label (that is, they included some groups who were unblinded, such as patients, those delivering the intervention, or those in charge of medical care). Of the 152 open trials, 125 required outcome assessment. Of these 125 trials, only 26% stated that outcome assessment was blinded; 51% gave no information on whether assessment was blinded or not. Furthermore, 18% of trials did not state who performed the assessment. The choice of outcome type (e.g. instrument measured, rated, or naturally occurring event) did not appear to influence whether blinded assessment was performed (range 24-32% for the most common outcome types). However, the choice of outcome assessor did influence blinding; independent assessors were blinded much more frequently (71%) than participant (5%) or physician (24%) assessors. Despite this, open trials did not use independent assessors any more frequently than double-blind trials (17% vs. 18% respectively). Conclusions Blinding of outcome assessors is infrequently used and poorly reported. Increased use of independent assessors could increase the frequency of blinded assessment.	[Kahan, Brennan C.] Queen Mary Univ London, Pragmat Clin Trials Unit, London, England; [Rehal, Sunita; Cro, Suzie] UCL, MRC Clin Trials Unit, London, England	University of London; Queen Mary University London; Medical Research Council Clinical Trials Unit; University of London; University College London	Kahan, BC (corresponding author), Queen Mary Univ London, Pragmat Clin Trials Unit, London, England.	b.kahan@qmul.ac.uk		Rehal, Sunita/0000-0002-2578-5778	Medical Research Council [MC_UU_12023/29] Funding Source: researchfish; MRC [MC_UU_12023/29] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bello S, 2014, J CLIN EPIDEMIOL, V67, P1059, DOI 10.1016/j.jclinepi.2014.05.007; Boutron I, 2004, J CLIN EPIDEMIOL, V57, P543, DOI 10.1016/j.jclinepi.2003.12.010; Boutron I, 2007, PLOS MED, V4, P370, DOI 10.1371/journal.pmed.0040061; Dechartres A, 2009, J CLIN EPIDEMIOL, V62, P695, DOI 10.1016/j.jclinepi.2008.09.011; FISHER S, 1993, J NERV MENT DIS, V181, P345, DOI 10.1097/00005053-199306000-00002; Haahr MT, 2006, CLIN TRIALS, V3, P360, DOI 10.1177/1740774506069153; Hrobjartsson A, 2014, INT J EPIDEMIOLOGY; Hrobjartsson A, 2014, INT J EPIDEMIOL, V43, P1272, DOI 10.1093/ije/dyu115; Hrobjartsson A, 2013, CAN MED ASSOC J, V185, pE201, DOI 10.1503/cmaj.120744; Hrobjartsson A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1119; Kahan BC, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-456; Kahan BC, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5840; Karanicolas PJ, 2008, J BONE JOINT SURG AM, V90A, P1026, DOI 10.2106/JBJS.G.00963; Karanicolas PJ, 2009, J CLIN EPIDEMIOL, V62, P214, DOI 10.1016/j.jclinepi.2008.05.006; Linde K, 2007, PAIN, V128, P264, DOI 10.1016/j.pain.2006.12.006; Liu CJ, 2011, AM J PHYS MED REHAB, V90, P190, DOI 10.1097/PHM.0b013e31820174b3; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Montori VM, 2002, J CLIN EPIDEMIOL, V55, P787, DOI 10.1016/S0895-4356(02)00446-8; NOSEWORTHY JH, 1994, NEUROLOGY, V44, P16, DOI 10.1212/WNL.44.1.16; Poolman RW, 2007, J BONE JOINT SURG AM, V89A, P550, DOI 10.2106/JBJS.F.00683; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	22	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131926	10.1371/journal.pone.0131926	http://dx.doi.org/10.1371/journal.pone.0131926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26120839	Green Published, Green Submitted, gold			2022-12-27	WOS:000358150400179
J	Kobis, NC; van Prooijen, JW; Righetti, F; Van Lange, PAM				Kobis, Nils C.; van Prooijen, Jan-Willem; Righetti, Francesca; Van Lange, Paul A. M.			"Who Doesn't?"-The Impact of Descriptive Norms on Corruption	PLOS ONE			English	Article							PEOPLE; TRUST	Corruption poses one of the major societal challenges of our time. Considerable advances have been made in understanding corruption on a macro level, yet the psychological antecedents of corrupt behavior remain largely unknown. In order to explain why some people engage in corruption while others do not, we explored the impact of descriptive social norms on corrupt behavior by using a novel behavioral measure of corruption. We conducted three studies to test whether perceived descriptive norms of corruption (i.e. the belief about the prevalence of corruption in a specific context) influence corrupt behavior. The results indicated that descriptive norms highly correlate with corrupt behavior-both when measured before (Study 1) or after (Study 2) the behavioral measure of corruption. Finally, we adopted an experimental design to investigate the causal effect of descriptive norms on corruption (Study 3). Corrupt behavior in the corruption game significantly drops when participants receive short anti-corruption descriptive norm primes prior to the game. These findings indicate that perceived descriptive norms can impact corrupt behavior and, possibly, could offer an explanation for inter-personal and inter-cultural variation in corrupt behavior in the real world. We discuss implications of these findings and draw avenues for future research.	[Kobis, Nils C.; van Prooijen, Jan-Willem; Righetti, Francesca; Van Lange, Paul A. M.] Vrije Univ Amsterdam, Dept Social & Org Psychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Kobis, NC (corresponding author), Vrije Univ Amsterdam, Dept Social & Org Psychol, Amsterdam, Netherlands.	n.c.kobis@vu.nl	Köbis, Nils/B-6354-2018	Köbis, Nils/0000-0002-0608-7333; Van Lange, Paul/0000-0001-7774-6984; van Prooijen, Jan-Willem/0000-0001-6236-0819	Netherlands Organization for Scientific Research [NWO] [406-12-003]	Netherlands Organization for Scientific Research [NWO](Netherlands Organization for Scientific Research (NWO))	The first author is financially supported by a Research Talent Grant of the Netherlands Organization for Scientific Research [NWO grant number 406-12-003], http://www.nwo.nl/en/funding/our-funding-instruments/magw/research-talent/research-talent.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acemoglu D., 2012, FOREIGN POLICY, P85; Amundsen Inge., 2000, RES CORRUPTION POLIC, P51; Anand V, 2004, ACAD MANAGE EXEC, V18, P39, DOI 10.5465/AME.2004.13837437; Ariely D., 2012, HONEST TRUTH DISHONE; Ashforth BE, 2003, RES ORGAN BEHAV, V25, P1, DOI 10.1016/S0191-3085(03)25001-2; Bardhan P, 1997, J ECON LIT, V35, P1320; Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066x.54.7.462; BICCHIERI C, 1995, RATION SOC, V7, P201, DOI 10.1177/1043463195007002007; Bicchieri C, 2009, J BEHAV DECIS MAKING, V22, P191, DOI 10.1002/bdm.621; Bryan C, 2012, J EXP PSYCHOL GEN, V142, P1, DOI [10.1037/a0028649, DOI 10.1037/A0028649]; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; Cialdini RB., 2006, INFLUENCE PSYCHOL PE; Darley JM., 2005, BROOKLYN LAW R, V70, P1177; de Sardan JPO, 1999, J MOD AFR STUD, V37, P25, DOI 10.1017/S0022278X99002992; Dong B, 2012, J ECON PSYCHOL, V33, P609, DOI 10.1016/j.joep.2011.12.001; Dungan J, 2014, J INTERDISC ECON, V26, P97, DOI 10.1177/0260107914540832; Elster J., 1989, CEMENT SOC SURVEY SO; Haidt J., 2010, HDB SOCIAL PSYCHOL, P797, DOI DOI 10.1002/9780470561119.SOCPSY002022; Heidenheimer A.J., 1989, POLITICAL CORRUPTION; Hellman J. S., 2000, MEASURING GOVERNANCE; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hogg MA, 2008, SOC PERSONAL PSYCHOL, V2, P1269, DOI 10.1111/j.1751-9004.2008.00099.x; JONES TM, 1991, ACAD MANAGE REV, V16, P366, DOI 10.2307/258867; Karklins Rasma, 2005, SYSTEM MADE ME DO IT; Kerr NL, 1997, J EXP SOC PSYCHOL, V33, P211, DOI 10.1006/jesp.1996.1319; Kosfeld M, 1997, CORRUPTION COOPERATI; Kurer O, 2005, POLIT STUD-LONDON, V53, P222, DOI 10.1111/j.1467-9248.2005.00525.x; Lambsdorff J. G., 2004, NEW I EC CORRUPTION; Lambsdorff JG, 2011, INT REV LAW ECON, V31, P116, DOI 10.1016/j.irle.2011.04.002; Lee-Chai Annette Y., 2001, USE ABUSE POWER MULT; MAURO P, 1995, Q J ECON, V110, P681, DOI 10.2307/2946696; Mazar N, 2011, PSYCHOL SCI, V22, P843, DOI 10.1177/0956797611412389; Mazar N, 2008, J MARKETING RES, V45, P633, DOI 10.1509/jmkr.45.6.633; Mungiu-Pippidi A, 2006, J DEMOCR, V17, P86, DOI 10.1353/jod.2006.0050; Myint U., 2000, ASIA PACIFIC DEV J, V7, P33, DOI DOI 10.1007/S12117-997-1155-3; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Nolan JM, 2008, PERS SOC PSYCHOL B, V34, P913, DOI 10.1177/0146167208316691; Olken BA, 2012, ANNU REV ECON, V4, P479, DOI 10.1146/annurev-economics-080511-110917; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Persson A, 2013, GOVERNANCE, V26, P449, DOI 10.1111/j.1468-0491.2012.01604.x; PHILLIPS DP, 1974, AM SOCIOL REV, V39, P340, DOI 10.2307/2094294; RENO RR, 1993, J PERS SOC PSYCHOL, V64, P104, DOI 10.1037/0022-3514.64.1.104; Rose-Ackerman S, 2006, INTERNATIONAL HANDBOOK ON THE ECONOMICS OF CORRUPTION, pXIV; Rothstein B, 2000, J THEOR POLIT, V12, P477, DOI 10.1177/0951692800012004007; Rothstein B, 2011, CORRUPTION KILLING F, P58; Rothstein B, 2009, RATION SOC, V21, P81, DOI 10.1177/1043463108099349; Schultz PW, 2007, PSYCHOL SCI, V18, P429, DOI 10.1111/j.1467-9280.2007.01917.x; Thaler R.H., 2021, NUDGE FINAL EDITION; Treisman D, 2000, J PUBLIC ECON, V76, P399, DOI 10.1016/S0047-2727(99)00092-4; Wenzel M, 2004, J ECON PSYCHOL, V25, P213, DOI 10.1016/S0167-4870(02)00168-X; Widmalm Stein, 2008, DECENTRALISATION COR	51	58	60	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131830	10.1371/journal.pone.0131830	http://dx.doi.org/10.1371/journal.pone.0131830			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1BL	26121127	Green Published, gold			2022-12-27	WOS:000358150400163
J	Subramanian, VS; Ghosal, A; Kapadia, R; Nabokina, SM; Said, HM				Subramanian, Veedamali S.; Ghosal, Abhisek; Kapadia, Rubina; Nabokina, Svetlana M.; Said, Hamid M.			Molecular Mechanisms Mediating the Adaptive Regulation of Intestinal Riboflavin Uptake Process	PLOS ONE			English	Article							VITAMIN STATUS; FUNCTIONAL-CHARACTERIZATION; IDENTIFICATION; DEFICIENCY; EXPRESSION; CELLS; B-2; MUTATIONS; INJURY; ACID	The intestinal absorption process of vitamin B2 (riboflavin, RF) is carrier-mediated, and all three known human RF transporters, i.e., hRFVT-1, -2, and -3 (products of the SLC52A1, 2 & 3 genes, respectively) are expressed in the gut. We have previously shown that the intestinal RF uptake process is adaptively regulated by substrate level, but little is known about the molecular mechanism(s) involved. Using human intestinal epithelial NCM460 cells maintained under RF deficient and over-supplemented (OS) conditions, we now show that the induction in RF uptake in RF deficiency is associated with an increase in expression of the hRFVT-2 & -3 (but not hRFVT-1) at the protein and mRNA levels. Focusing on hRFVT-3, the predominant transporter in the intestine, we also observed an increase in the level of expression of its hnRNA and activity of its promoter in the RF deficiency state. An increase in the level of expression of the nuclear factor Sp1 (which is important for activity of the SLC52A3 promoter) was observed in RF deficiency, while mutating the Sp1/GC site in the SLC52A3 promoter drastically decreased the level of induction in SLC52A3 promoter activity in RF deficiency. We also observed specific epigenetic changes in the SLC52A3 promoter in RF deficiency. Finally, an increase in hRFVT-3 protein expression at the cell surface was observed in RF deficiency. Results of these investigations show, for the first time, that transcriptional and post-transcriptional mechanisms are involved in the adaptive regulation of intestinal RF uptake by the prevailing substrate level.	[Subramanian, Veedamali S.; Ghosal, Abhisek; Kapadia, Rubina; Nabokina, Svetlana M.; Said, Hamid M.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Said, Hamid M.] Univ Calif Irvine, Dept Physiol Biophys, Irvine, CA 92717 USA; [Subramanian, Veedamali S.; Ghosal, Abhisek; Kapadia, Rubina; Nabokina, Svetlana M.; Said, Hamid M.] VAMC, Long Beach, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Said, HM (corresponding author), Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA.	hmsaid@uci.edu			Department of Veterans Affairs and the National Institutes of Health [DK-58057, DK-56061]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058057, R01DK056061, R37DK056061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018071] Funding Source: NIH RePORTER	Department of Veterans Affairs and the National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by grants from the Department of Veterans Affairs and the National Institutes of Health (DK-58057 and DK-56061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydemir F, 2009, J NUTR, V139, P434, DOI 10.3945/jn.108.094052; BETZ AL, 1994, ACTA NEUROCHIR, P314; BONJOUR JP, 1980, INT J VITAM NUTR RES, V50, P425; Bosch AM, 2011, J INHERIT METAB DIS, V34, P159, DOI 10.1007/s10545-010-9242-z; Cooperman J.M., 1984, HDB VITAMINS NUTR BI, P299; D'Addario C, 2011, FASEB J, V25, P1069, DOI 10.1096/fj.10-168534; Elferink CJ, 1996, BIOTECHNIQUES, V20, P470; FERNANDEZBANARES F, 1989, AM J GASTROENTEROL, V84, P744; Ghosal A, 2015, AM J PHYSIOL-CELL PH, V308, pC189, DOI 10.1152/ajpcell.00342.2014; Green P, 2010, AM J HUM GENET, V86, P485, DOI 10.1016/j.ajhg.2010.02.006; Ho G, 2011, HUM MUTAT, V32, pE1976, DOI 10.1002/humu.21399; Iwanaga K, 2007, TRANSPLANTATION, V83, P747, DOI 10.1097/01.tp.0000256283.06469.d4; Johnson JO, 2012, BRAIN, V135, P2875, DOI 10.1093/brain/aws161; Jorgensen TN, 2014, NEUROCHEM INT, V73, P107, DOI 10.1016/j.neuint.2014.01.005; Kodentsova V. M., 1994, Voprosy Meditsinskoi Khimii, V40, P33; Kumar CK, 1998, AM J PHYSIOL-RENAL, V274, pF104, DOI 10.1152/ajprenal.1998.274.1.F104; KUROKI F, 1993, DIGEST DIS SCI, V38, P1614, DOI 10.1007/BF01303168; Law LK, 2009, CLIN CHIM ACTA, V404, P95, DOI 10.1016/j.cca.2009.02.015; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu DD, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0422-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazur-Bialy AI, 2013, BRIT J NUTR, V110, P509, DOI 10.1017/S0007114512005351; Naggar H, 2005, CURR EYE RES, V30, P35, DOI 10.1080/02713680490894559; Nakano E, 2011, DIGEST DIS SCI, V56, P1007, DOI 10.1007/s10620-010-1374-3; Rivilin R. S., 2010, RIBOFLAVIN ENCYCLOPE, P691; ROSENTHAL WS, 1973, AM J CLIN NUTR, V26, P858, DOI 10.1093/ajcn/26.8.858; Said H. M., 2015, SLESENGER FORDTRAN G, P1765; Said H. M., 2011, MODERN NUTR HLTH DIS, V11, P325; Said HM, 2011, BIOCHEM J, V437, P357, DOI 10.1042/BJ20110326; Said HM, 2000, AM J PHYSIOL-CELL PH, V278, pC270, DOI 10.1152/ajpcell.2000.278.2.C270; SAID HM, 1994, AM J PHYSIOL, V266, pG15, DOI 10.1152/ajpgi.1994.266.1.G15; SAID HM, 1993, GASTROENTEROLOGY, V105, P1294, DOI 10.1016/0016-5085(93)90131-U; Said HM, 2005, J PHYSIOL-LONDON, V566, P369, DOI 10.1113/jphysiol.2005.085811; Sanches SC, 2014, FOOD CHEM TOXICOL, V67, P65, DOI 10.1016/j.fct.2014.02.013; Schramm M, 2014, EUR J IMMUNOL, V44, P728, DOI 10.1002/eji.201343940; Seekamp A, 1999, INFLAMMATION, V23, P449, DOI 10.1023/A:1021965026580; Srinivasan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078853; Subramanian VS, 2013, AM J PHYSIOL-CELL PH, V305, pC539, DOI 10.1152/ajpcell.00089.2013; Subramanian VS, 2013, AM J PHYSIOL-GASTR L, V304, pG741, DOI 10.1152/ajpgi.00018.2013; Subramanian VS, 2011, BBA-BIOMEMBRANES, V1808, P3016, DOI 10.1016/j.bbamem.2011.08.004; Tanaka K, 2005, NEUROSCI LETT, V378, P70, DOI 10.1016/j.neulet.2004.12.030; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Tumer E, 2013, J BIOL CHEM, V288, P33813, DOI 10.1074/jbc.M113.482760; Yao Y, 2010, J NUTR, V140, P1220, DOI 10.3945/jn.110.122911; Yonezawa A, 2013, MOL ASPECTS MED, V34, P693, DOI 10.1016/j.mam.2012.07.014; Zhu M, 2014, J HUM GENET, V59, P256, DOI 10.1038/jhg.2014.10	46	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131698	10.1371/journal.pone.0131698	http://dx.doi.org/10.1371/journal.pone.0131698			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121134	Green Published, gold			2022-12-27	WOS:000358150400145
J	Technow, F; Messina, CD; Totir, LR; Cooper, M				Technow, Frank; Messina, Carlos D.; Totir, L. Radu; Cooper, Mark			Integrating Crop Growth Models with Whole Genome Prediction through Approximate Bayesian Computation	PLOS ONE			English	Article							RECOMBINANT INBRED LINES; ROOT-SYSTEM ARCHITECTURE; QUANTITATIVE TRAIT LOCI; SEQUENTIAL MONTE-CARLO; ZEA-MAYS L.; LEAF GROWTH; WATER-DEFICIT; MAIZE YIELD; ENVIRONMENT INTERACTIONS; ECOPHYSIOLOGICAL MODEL	Genomic selection, enabled by whole genome prediction (WGP) methods, is revolutionizing plant breeding. Existing WGP methods have been shown to deliver accurate predictions in the most common settings, such as prediction of across environment performance for traits with additive gene effects. However, prediction of traits with non-additive gene effects and prediction of genotype by environment interaction (GxE), continues to be challenging. Previous attempts to increase prediction accuracy for these particularly difficult tasks employed prediction methods that are purely statistical in nature. Augmenting the statistical methods with biological knowledge has been largely overlooked thus far. Crop growth models (CGMs) attempt to represent the impact of functional relationships between plant physiology and the environment in the formation of yield and similar output traits of interest. Thus, they can explain the impact of GxE and certain types of non-additive gene effects on the expressed phenotype. Approximate Bayesian computation (ABC), a novel and powerful computational procedure, allows the incorporation of CGMs directly into the estimation of whole genome marker effects in WGP. Here we provide a proof of concept study for this novel approach and demonstrate its use with synthetic data sets. We show that this novel approach can be considerably more accurate than the benchmark WGP method GBLUP in predicting performance in environments represented in the estimation set as well as in previously unobserved environments for traits determined by non-additive gene effects. We conclude that this proof of concept demonstrates that using ABC for incorporating biological knowledge in the form of CGMs into WGP is a very promising and novel approach to improving prediction accuracy for some of the most challenging scenarios in plant breeding and applied genetics.	[Technow, Frank; Totir, L. Radu] DuPont Pioneer, Breeding Technol, Johnston, IA 50131 USA; [Messina, Carlos D.; Cooper, Mark] DuPont Pioneer, Trait Characterizat & Dev, Johnston, IA USA	DuPont; Pioneer Hi-Bred International, Inc.; DuPont; Pioneer Hi-Bred International, Inc.	Technow, F (corresponding author), DuPont Pioneer, Breeding Technol, Johnston, IA 50131 USA.	Frank.Technow@pioneer.com	Technow, Frank/AAC-4994-2019; Cooper, Mark/AAG-8551-2019	Technow, Frank/0000-0002-2497-3136; Cooper, Mark/0000-0002-9418-3359				ALLARD R. W., 1964, CROP SCI, V4, P503; [Anonymous], 2015, NAT GENET, V47, P99, DOI 10.1038/ng.3213; [Anonymous], 2014, R LANG ENV STAT COMP; Bengtsson T., 2008, PROBAB STAT, V2, P316, DOI DOI 10.1214/193940307000000518; Bogard M, 2014, J EXP BOT, V65, P5849, DOI 10.1093/jxb/eru328; Brun F, 2006, WORKING WITH DYNAMIC; Burgueno J, 2012, CROP SCI, V52, P707, DOI 10.2135/cropsci2011.06.0299; Buyya R, 2008, HPCC 2008: 10TH IEEE INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE COMPUTING AND COMMUNICATIONS, PROCEEDINGS, P5, DOI 10.1109/HPCC.2008.172; Chapman S, 2003, AGRON J, V95, P99, DOI 10.2134/agronj2003.0099; Chapman SC, 2000, AUST J AGR RES, V51, P209, DOI 10.1071/AR99021; Chenu K, 2008, PLANT CELL ENVIRON, V31, P378, DOI 10.1111/j.1365-3040.2007.01772.x; Chenu K, 2009, GENETICS, V183, P1507, DOI 10.1534/genetics.109.105429; Combs E, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2012.11.0030; COOPER M, 1994, THEOR APPL GENET, V88, P561, DOI 10.1007/BF01240919; Cooper M, 2014, J EXP BOT, V65, P6191, DOI 10.1093/jxb/eru064; Cooper M, 2014, CROP PASTURE SCI, V65, P311, DOI 10.1071/CP14007; Cooper Mark, 2002, In Silico Biology, V2, P151; Cooper M, 2009, CURR OPIN PLANT BIOL, V12, P231, DOI 10.1016/j.pbi.2009.01.006; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; CURRY GL, 1978, J THEOR BIOL, V74, P397, DOI 10.1016/0022-5193(78)90222-9; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; de Dorlodot S, 2007, TRENDS PLANT SCI, V12, P474, DOI 10.1016/j.tplants.2007.08.012; Dong ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043450; Elings A, 2000, AGRON J, V92, P436, DOI 10.2134/agronj2000.923436x; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Erbe M, 2012, J DAIRY SCI, V95, P4114, DOI 10.3168/jds.2011-5019; Eta-Ndu JT, 1999, CROP SCI, V39, P346; Fernie AR, 2009, TRENDS GENET, V25, P39, DOI 10.1016/j.tig.2008.10.010; Gelfand AE, 1999, J AM STAT ASSOC, V94, P247, DOI 10.2307/2669699; Gianola D, 2013, GENETICS, V194, P573, DOI 10.1534/genetics.113.151753; Guo M, 2014, J EXP BOT, V65, P249, DOI 10.1093/jxb/ert370; Guo ZG, 2012, THEOR APPL GENET, V124, P261, DOI 10.1007/s00122-011-1702-9; Habben JE, 2014, PLANT BIOTECHNOL J, V12, P685, DOI 10.1111/pbi.12172; Habier D, 2013, GENETICS, V194, P597, DOI 10.1534/genetics.113.152207; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hammer G, 2006, TRENDS PLANT SCI, V11, P587, DOI 10.1016/j.tplants.2006.10.006; Hammer GL, 2010, J EXP BOT, V61, P2185, DOI 10.1093/jxb/erq095; Hammer GL, 2009, CROP SCI, V49, P299, DOI 10.2135/cropsci2008.03.0152; Handley LJL, 2011, BIOCONTROL, V56, P409, DOI 10.1007/s10526-011-9386-2; Heslot N, 2014, THEOR APPL GENET, V127, P463, DOI 10.1007/s00122-013-2231-5; Heslot N, 2012, CROP SCI, V52, P146, DOI 10.2135/cropsci2011.06.0297; Hickey JM, 2014, CROP SCI, V54, P1476, DOI 10.2135/cropsci2013.03.0195; Holland J. B., 2001, Plant Breeding Reviews, V21, P27; Holzworth DP, 2014, ENVIRON MODELL SOFTW, V62, P327, DOI 10.1016/j.envsoft.2014.07.009; Howard R, 2014, G3-GENES GENOM GENET, V4, P1027, DOI 10.1534/g3.114.010298; Jarquin D, 2014, THEOR APPL GENET, V127, P595, DOI 10.1007/s00122-013-2243-1; Karkkainen HP, 2012, GENETICS, V191, P969, DOI 10.1534/genetics.112.139014; Keating BA, 2003, EUR J AGRON, V18, P267, DOI 10.1016/S1161-0301(02)00108-9; Keurentjes JJB, 2009, CURR OPIN PLANT BIOL, V12, P223, DOI 10.1016/j.pbi.2008.12.003; Liebisch F, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0048-8; Liepe J, 2014, NAT PROTOC, V9, P439, DOI 10.1038/nprot.2014.025; Liepe J, 2010, BIOINFORMATICS, V26, P1797, DOI 10.1093/bioinformatics/btq278; Loffler CM, 2005, CROP SCI, V45, P1708, DOI 10.2135/cropsci2004.0370; Lopes JS, 2010, INFECT GENET EVOL, V10, P826, DOI 10.1016/j.meegid.2009.10.010; Araus JL, 2014, TRENDS PLANT SCI, V19, P52, DOI 10.1016/j.tplants.2013.09.008; Lund MS, 2014, LIVEST SCI, V166, P101, DOI 10.1016/j.livsci.2014.05.008; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Marjoram P, 2014, HEREDITY, V112, P79, DOI 10.1038/hdy.2013.52; Marjoram P, 2003, P NATL ACAD SCI USA, V100, P15324, DOI 10.1073/pnas.0306899100; MCGARRAHAN JP, 1984, AGRON J, V76, P518, DOI 10.2134/agronj1984.00021962007600040004x; MEGHJI MR, 1984, CROP SCI, V24, P545, DOI 10.2135/cropsci1984.0011183X002400030028x; MELCHINGER AE, 1994, THEOR APPL GENET, V88, P343, DOI 10.1007/BF00223643; Messina C, 2009, CROP PHYSIOLOGY: APPLICATIONS FOR GENETIC IMPROVEMENT AND AGRONOMY, P235, DOI 10.1016/B978-0-12-374431-9.00010-4; Messina CD, 2011, J EXP BOT, V62, P855, DOI 10.1093/jxb/erq329; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen T, 2010, GENETICS, V185, P623, DOI 10.1534/genetics.110.116590; Mikel MA, 2006, CROP SCI, V46, P1193, DOI 10.2135/cropsci2005.10-0371; Montes JM, 2011, FIELD CROP RES, V121, P268, DOI 10.1016/j.fcr.2010.12.017; MUCHOW RC, 1988, FIELD CROP RES, V18, P17, DOI 10.1016/0378-4290(88)90056-1; MUCHOW RC, 1990, AGRON J, V82, P338, DOI 10.2134/agronj1990.00021962008200020033x; MUCHOW RC, 1990, FIELD CROP RES, V23, P145, DOI 10.1016/0378-4290(90)90109-O; Neild RE, 1987, REP NCH 40; Nielsen RL, 2002, AGRON J, V94, P549; Ober U, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002685; PASSIOURA JB, 1983, AGR WATER MANAGE, V7, P265, DOI 10.1016/0378-3774(83)90089-6; Peters GW, 2012, STAT COMPUT, V22, P1209, DOI 10.1007/s11222-012-9315-y; Pilalis E, 2011, BIOTECHNOL BIOENG, V108, P1673, DOI 10.1002/bit.23107; Ponciano JM, 2012, SYST BIOL, V61, P955, DOI 10.1093/sysbio/sys055; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Renton M, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr006; Resende MFR, 2012, NEW PHYTOL, V193, P617, DOI 10.1111/j.1469-8137.2011.03895.x; Reymond M, 2003, PLANT PHYSIOL, V131, P664, DOI 10.1104/pp.013839; Richey FD, 1942, SCIENCE, V96, P280, DOI 10.1126/science.96.2490.280; Riedelsheimer C, 2012, P NATL ACAD SCI USA, V109, P8872, DOI 10.1073/pnas.1120813109; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Rincent R, 2012, GENETICS, V192, P715, DOI 10.1534/genetics.112.141473; Robert C, 2007, THE BAYESIAN CHOICE; Sadegh M, 2014, WATER RESOUR RES, V50, P6767, DOI 10.1002/2014WR015386; Saha R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021784; Schulz-Streeck T, 2013, PLANT BREEDING, V132, P532, DOI 10.1111/pbr.12105; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Simons M, 2014, J EXP BOT, V65, P5657, DOI 10.1093/jxb/eru227; Singh M, 1999, THEOR APPL GENET, V99, P988, DOI 10.1007/s001220051406; Sisson SA, 2007, P NATL ACAD SCI USA, V104, P1760, DOI 10.1073/pnas.0607208104; Slafer GA, 2003, ANN APPL BIOL, V142, P117, DOI 10.1111/j.1744-7348.2003.tb00237.x; Sun XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050604; Tardieu F, 2005, AUST J AGR RES, V56, P937, DOI 10.1071/AR05156; Tavare S, 1997, GENETICS, V145, P505; Technow F, 2013, HYPRED SIMULATION OF; Technow F, 2013, THEOR APPL GENET, V126, P1133, DOI 10.1007/s00122-013-2041-9; Technow F, 2013, G3-GENES GENOM GENET, V3, P197, DOI 10.1534/g3.112.004630; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; van Ittersum MK, 2003, EUR J AGRON, V18, P201, DOI 10.1016/S1161-0301(02)00106-5; Wallach D, 2012, AGRON J, V104, P1274, DOI 10.2134/agronj2012.0038; Wang EL, 2013, ENVIRON MODELL SOFTW, V46, P50, DOI 10.1016/j.envsoft.2013.02.009; Welcker C, 2007, J EXP BOT, V58, P339, DOI 10.1093/jxb/erl227; Windhausen VS, 2012, G3-GENES GENOM GENET, V2, P1427, DOI 10.1534/g3.112.003699; Wolf DP, 1997, CROP SCI, V37, P763, DOI 10.2135/cropsci1997.0011183X003700030012x; Xu SZ, 2007, BIOMETRICS, V63, P513, DOI 10.1111/j.1541-0420.2006.00711.x; Yang WZ, 2012, GENETICS, V190, P1491, DOI 10.1534/genetics.111.131540; Yin XY, 2000, AGRON J, V92, P114, DOI 10.2134/agronj2000.921114x; Yin XY, 2005, J EXP BOT, V56, P967, DOI 10.1093/jxb/eri090; Yin XY, 2004, TRENDS PLANT SCI, V9, P426, DOI 10.1016/j.tplants.2004.07.007; Zhang X, 2015, HEREDITY, V114, P291, DOI 10.1038/hdy.2014.99	114	112	113	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130855	10.1371/journal.pone.0130855	http://dx.doi.org/10.1371/journal.pone.0130855			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121133	gold, Green Submitted, Green Published			2022-12-27	WOS:000358150400064
J	Chang, YS; Owen, JP; Pojman, NJ; Thieu, T; Bukshpun, P; Wakahiro, MLJ; Berman, JI; Roberts, TPL; Nagarajan, SS; Sherr, EH; Mukherjee, P				Chang, Yi Shin; Owen, Julia P.; Pojman, Nicholas J.; Thieu, Tony; Bukshpun, Polina; Wakahiro, Mari L. J.; Berman, Jeffrey I.; Roberts, Timothy P. L.; Nagarajan, Srikantan S.; Sherr, Elliott H.; Mukherjee, Pratik			White Matter Changes of Neurite Density and Fiber Orientation Dispersion during Human Brain Maturation	PLOS ONE			English	Article							TENSOR IMAGING DTI; DIFFUSION MRI; IN-VIVO; MICROSTRUCTURAL CORRELATIONS; TISSUE MICROSTRUCTURE; SPATIAL STATISTICS; NERVE-FIBERS; LIFE-SPAN; CHILDHOOD; ADULTHOOD	Diffusion tensor imaging (DTI) studies of human brain development have consistently shown widespread, but nonlinear increases in white matter anisotropy through childhood, adolescence, and into adulthood. However, despite its sensitivity to changes in tissue microstructure, DTI lacks the specificity to disentangle distinct microstructural features of white and gray matter. Neurite orientation dispersion and density imaging (NODDI) is a recently proposed multi-compartment biophysical model of brain microstructure that can estimate non-collinear properties of white matter, such as neurite orientation dispersion index (ODI) and neurite density index (NDI). In this study, we apply NODDI to 66 healthy controls aged 7-63 years to investigate changes of ODI and NDI with brain maturation, with comparison to standard DTI metrics. Using both region-of-interest and voxel-wise analyses, we find that NDI exhibits striking increases over the studied age range following a logarithmic growth pattern, while ODI rises following an exponential growth pattern. This novel finding is consistent with well-established age-related changes of FA over the lifespan that show growth during childhood and adolescence, plateau during early adulthood, and accelerating decay after the fourth decade of life. Our results suggest that the rise of FA during the first two decades of life is dominated by increasing NDI, while the fall in FA after the fourth decade is driven by the exponential rise of ODI that overcomes the slower increases of NDI. Using partial least squares regression, we further demonstrate that NODDI better predicts chronological age than DTI. Finally, we show excellent test-retest reliability of NODDI metrics, with coefficients of variation below 5% in all measured regions of interest. Our results support the conclusion that NODDI reveals biologically specific characteristics of brain development that are more closely linked to the microstructural features of white matter than are the empirical metrics provided by DTI.	[Chang, Yi Shin; Owen, Julia P.; Nagarajan, Srikantan S.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Owen, Julia P.; Nagarajan, Srikantan S.; Mukherjee, Pratik] Univ Calif San Francisco, Program Bioengineering, San Francisco, CA 94143 USA; [Pojman, Nicholas J.; Thieu, Tony; Bukshpun, Polina; Wakahiro, Mari L. J.; Sherr, Elliott H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Berman, Jeffrey I.; Roberts, Timothy P. L.] Univ Penn, Dept Radiol, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Mukherjee, P (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	pratik.mukherjee@ucsf.edu		Roberts, Timothy/0000-0001-7320-4870; Mukherjee, Pratik/0000-0001-7473-7409	Simons Foundation [220843]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD086984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008871] Funding Source: NIH RePORTER	Simons Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a grant from the Simons Foundation (SFARI Award #220843 to ES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P97, DOI 10.1002/wics.51; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Bach M, 2014, NEUROIMAGE, V100, P358, DOI 10.1016/j.neuroimage.2014.06.021; Bevington PR, 1969, DATA REDUCTION ERROR; De Santis S, 2014, NEUROIMAGE, V89, P35, DOI 10.1016/j.neuroimage.2013.12.003; Feldman ML, 1998, J NEUROCYTOL, V27, P605, DOI 10.1023/A:1006926428699; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Flynn SW, 2003, MOL PSYCHIATR, V8, P811, DOI 10.1038/sj.mp.4001337; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Horowitz A, 2015, BRAIN STRUCT FUNCT, V220, P1777, DOI 10.1007/s00429-014-0871-0; Huang H, 2006, NEUROIMAGE, V33, P27, DOI 10.1016/j.neuroimage.2006.06.009; HUTTENLOCHER PR, 1987, HUM NEUROBIOL, V6, P1; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Imperati D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023437; Inglese Matilde, 2004, Top Magn Reson Imaging, V15, P355, DOI 10.1097/01.rmr.0000168069.12985.15; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kunz N, 2014, NEUROIMAGE, V96, P288, DOI 10.1016/j.neuroimage.2014.03.057; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Li YO, 2012, HUM BRAIN MAPP, V33, P1431, DOI 10.1002/hbm.21292; Marner L, 2003, J COMP NEUROL, V462, P144, DOI 10.1002/cne.10714; Metzler-Baddeley C, 2012, NEUROIMAGE, V59, P1394, DOI 10.1016/j.neuroimage.2011.08.043; Mishra V, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00721; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Mukherjee P, 2001, RADIOLOGY, V221, P349, DOI 10.1148/radiol.2212001702; Paus T, 2010, HORM BEHAV, V57, P63, DOI 10.1016/j.yhbeh.2009.08.004; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Paz-Alonso P.M., 2013, OXFORD HDB HIGHER CO; Peters A, 2003, J COMP NEUROL, V460, P238, DOI 10.1002/cne.10639; Qiu DQ, 2008, NEUROIMAGE, V41, P223, DOI 10.1016/j.neuroimage.2008.02.023; Richardson EPJ, 1982, HISTOL HISTOPATHOL, P146; Sandell JH, 2001, J COMP NEUROL, V429, P541, DOI 10.1002/1096-9861(20010122)429:4<541::AID-CNE3>3.0.CO;2-5; Seber GAF, 1989, NONLINEAR REGRESSION, P197; Simmonds DJ, 2014, NEUROIMAGE, V92, P356, DOI 10.1016/j.neuroimage.2013.12.044; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sugiyama I, 2002, J NEUROSCI RES, V70, P309, DOI 10.1002/jnr.10386; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Tariq M, 2013, P INT SOC MAGN RES M; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wahl M, 2010, NEUROIMAGE, V51, P531, DOI 10.1016/j.neuroimage.2010.02.072; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; White NS, 2013, HUM BRAIN MAPP, V34, P327, DOI 10.1002/hbm.21454; White NS, 2009, HUM BRAIN MAPP, V30, P3696, DOI 10.1002/hbm.20799; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3; Yeatman JD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5932; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	52	94	94	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0123656	10.1371/journal.pone.0123656	http://dx.doi.org/10.1371/journal.pone.0123656			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115451	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500003
J	Cussen, VA; Mench, JA				Cussen, Victoria A.; Mench, Joy A.			The Relationship between Personality Dimensions and Resiliency to Environmental Stress in Orange-Winged Amazon Parrots (Amazona amazonica), as Indicated by the Development of Abnormal Behaviors	PLOS ONE			English	Article							BORN STRIPED MICE; FEATHER PICKING; INDIVIDUAL-DIFFERENCES; STEREOTYPIC BEHAVIOR; COPING STYLES; ENRICHMENT; TEMPERAMENT; WELFARE; EXPLORATION; ANIMALS	Parrots are popular companion animals, but are frequently relinquished because of behavioral problems, including abnormal repetitive behaviors like feather damaging behavior and stereotypy. In addition to contributing to pet relinquishment, these behaviors are important as potential indicators of diminished psychological well-being. While abnormal behaviors are common in captive animals, their presence and/or severity varies between animals of the same species that are experiencing the same environmental conditions. Personality differences could contribute to this observed individual variation, as they are known risk factors for stress sensitivity and affective disorders in humans. The goal of this study was to assess the relationship between personality and the development and severity of abnormal behaviors in captive-bred orange-winged Amazon parrots (Amazona amazonica). We monitored between-individual behavioral differences in enrichment-reared parrots of known personality types before, during, and after enrichment deprivation. We predicted that parrots with higher scores for neurotic-like personality traits would be more susceptible to enrichment deprivation and develop more abnormal behaviors. Our results partially supported this hypothesis, but also showed that distinct personality dimensions were related to different forms of abnormal behavior. While neuroticism-like traits were linked to feather damaging behavior, extraversion-like traits were negatively related to stereotypic behavior. More extraverted birds showed resiliency to environmental stress, developing fewer stereotypies during enrichment deprivation and showing lower levels of these behaviors following re-enrichment. Our data, together with the results of the few studies conducted on other species, suggest that, as in humans, certain personality types render individual animals more susceptible or resilient to environmental stress. Further, this susceptibility/resiliency can have a long-term effect on behavior, as evidenced by behavioral changes that persisted despite re-enrichment. Ours is the first study evaluating the relationship between personality dimensions, environment, and abnormal behaviors in an avian species.	[Cussen, Victoria A.; Mench, Joy A.] Univ Calif Davis, Ctr Anim Welf, Davis, CA 95616 USA; [Mench, Joy A.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Mench, JA (corresponding author), Univ Calif Davis, Ctr Anim Welf, Davis, CA 95616 USA.	jamench@ucdavis.edu			W.K. Kellogg Endowment; Psittacine Research Project; Jastro Shields Research Fellowship; Kratzer; Ogasawara; Vohra Scholarship; Hart Fellowship; Cole Fellowship; Goss Fellowship	W.K. Kellogg Endowment; Psittacine Research Project; Jastro Shields Research Fellowship; Kratzer; Ogasawara; Vohra Scholarship; Hart Fellowship; Cole Fellowship; Goss Fellowship	This research was supported by the W.K. Kellogg Endowment and the Psittacine Research Project; V.A.C. was also supported by the Jastro Shields Research Fellowship, Kratzer, Ogasawara, Vohra Scholarship, and the Hart, Cole, Goss Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Kratzer, Ogasawara, Vohra Scholarship is an internal scholarship, formerly call the Avian Sciences Faculty Scholarship. It was renamed to honor emeriti faculty, and is not commercial.	Amaral OB, 2008, PHYSIOL BEHAV, V93, P388, DOI 10.1016/j.physbeh.2007.09.009; Carere C, 2010, CURR ZOOL, V56, P728, DOI 10.1093/czoolo/56.6.728; Cussen VA, 2014, ANIM COGN, V17, P901, DOI 10.1007/s10071-013-0723-y; Cussen VA, 2014, ANIM BEHAV, V89, P123, DOI 10.1016/j.anbehav.2013.12.022; Dallaire JA, 2012, APPL ANIM BEHAV SCI, V142, P98, DOI 10.1016/j.applanim.2012.09.012; Fox RA, 2010, ETHOLOGY, V116, P59, DOI 10.1111/j.1439-0310.2009.01713.x; Freeman HD, 2010, AM J PRIMATOL, V72, P653, DOI 10.1002/ajp.20833; Garner JP, 2006, APPL ANIM BEHAV SCI, V96, P153, DOI 10.1016/j.applanim.2005.09.009; Garner JP, 2002, BEHAV BRAIN RES, V136, P83, DOI 10.1016/S0166-4328(02)00111-0; Gartner MC, 2013, APPL ANIM BEHAV SCI, V144, P1, DOI 10.1016/j.applanim.2012.11.010; Gosling SD, 2002, J RES PERS, V36, P607, DOI 10.1016/S0092-6566(02)00511-1; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Gottlieb DH, 2013, AM J PRIMATOL, V75, P995, DOI 10.1002/ajp.22161; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; Gross AN, 2012, BEHAV BRAIN RES, V234, P61, DOI 10.1016/j.bbr.2012.06.007; Hansen SW, 2006, APPL ANIM BEHAV SCI, V99, P172, DOI 10.1016/j.applanim.2005.10.005; Ijichi CL, 2013, ANIM BEHAV, V85, P1145, DOI 10.1016/j.anbehav.2013.03.033; Japyassu HF, 2014, BEHAV PROCESS, V109, P40, DOI 10.1016/j.beproc.2014.09.016; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; Jones MA, 2011, APPL ANIM BEHAV SCI, V135, P138, DOI 10.1016/j.applanim.2011.08.015; Jones MA, 2010, APPL ANIM BEHAV SCI, V123, P70, DOI 10.1016/j.applanim.2009.12.009; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Mason G, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P325, DOI [10.1079/9780851990040.0325, 10.1079/9780851990040.0000]; Mason G, 2007, APPL ANIM BEHAV SCI, V102, P163, DOI 10.1016/j.applanim.2006.05.041; Mason GJ, 2004, ANIM WELFARE, V13, pS57; Meehan CL, 2004, DEV PSYCHOBIOL, V44, P209, DOI 10.1002/dev.20007; Meehan CL, 2003, APPL ANIM BEHAV SCI, V81, P73, DOI 10.1016/S0168-1591(02)00238-1; Meehan CL, 2003, APPL ANIM BEHAV SCI, V80, P71, DOI 10.1016/S0168-1591(02)00192-2; Mettke-Hofmann C, 2002, ETHOLOGY, V108, P249, DOI 10.1046/j.1439-0310.2002.00773.x; Minderman J, 2009, BEHAV ECOL, V20, P830, DOI 10.1093/beheco/arp067; Nettle D, 2006, AM PSYCHOL, V61, P622, DOI 10.1037/0003-066X.61.6.622; NEWBERRY RC, 1995, APPL ANIM BEHAV SCI, V44, P229, DOI 10.1016/0168-1591(95)00616-Z; Powell SB, 2000, DEV PSYCHOBIOL, V37, P100, DOI 10.1002/1098-2302(200009)37:2<100::AID-DEV5>3.3.CO;2-Y; Schuett W, 2011, ANIM BEHAV, V81, P609, DOI 10.1016/j.anbehav.2010.12.006; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Swaisgood R, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P256, DOI 10.1079/9780851990040.0256; Tilly SLC, 2010, ANIM BEHAV, V80, P363, DOI 10.1016/j.anbehav.2010.06.008; van Zeeland YRA, 2013, APPL ANIM BEHAV SCI, V148, P218, DOI 10.1016/j.applanim.2013.08.004; van Zeeland YRA, 2009, APPL ANIM BEHAV SCI, V121, P75, DOI 10.1016/j.applanim.2009.09.006; VanHoek CS, 1997, ZOO BIOL, V16, P161; Weinstein TAR, 2008, ANIM BEHAV, V76, P455, DOI 10.1016/j.anbehav.2008.01.024; Zuur Alain F., 2009, P1	43	22	22	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0126170	10.1371/journal.pone.0126170	http://dx.doi.org/10.1371/journal.pone.0126170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114423	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500006
J	Grobelak, A; Napora, A				Grobelak, Anna; Napora, Anna			The Chemophytostabilisation Process of Heavy Metal Polluted Soil	PLOS ONE			English	Article							BIOAVAILABILITY; AMENDMENTS; IMMOBILIZATION; STABILIZATION; CADMIUM; COMPOST; ZN; PB; CU	Industrial areas are characterised by soil degradation processes that are related primarily to the deposition of heavy metals. Areas contaminated with metals are a serious source of risk due to secondary pollutant emissions and metal leaching and migration in the soil profile and into the groundwater. Consequently, the optimal solution for these areas is to apply methods of remediation that create conditions for the restoration of plant cover and ensure the protection of groundwater against pollution. Remediation activities that are applied to large-scale areas contaminated with heavy metals should mainly focus on decreasing the degree of metal mobility in the soil profile and metal bioavailability to levels that are not phytotoxic. Chemophytostabilisation is a process in which soil amendments and plants are used to immobilise metals. The main objective of this research was to investigate the effects of different doses of organic amendments (after aerobic sewage sludge digestion in the food industry) and inorganic amendments (lime, superphosphate, and potassium phosphate) on changes in the metals fractions in soils contaminated with Cd, Pb and Zn during phytostabilisation. In this study, the contaminated soil was amended with sewage sludge and inorganic amendments and seeded with grass (tall fescue) to increase the degree of immobilisation of the studied metals. The contaminated soil was collected from the area surrounding a zinc smelter in the Silesia region of Poland (pH 5.5, Cd 12 mg kg(-1), Pb 1100 mg kg(-1), Zn 700 mg kg(-1)). A plant growth experiment was conducted in a growth chamber for 5 months. Before and after plant growth, soil subsamples were subjected to chemical and physical analyses. To determine the fractions of the elements, a sequential extraction method was used according to Zeien and Brummer. Research confirmed that the most important impacts on the Zn, Cd and Pb fractions included the combined application of sewage sludge from the food industry and the addition of lime and potassium phosphate. Certain doses of inorganic additives decreased the easily exchangeable fraction from 50% to 1%. The addition of sewage sludge caused a decrease in fraction I for Cd and Pb. In combination with the use of inorganic additives, a mobile fraction was not detected and an easily mobilisable fraction was reduced by half. For certain combinations of metals, the concentrations were detected up to a few percent. The application of sewage sludge resulted in a slight decrease in a mobile (water soluble and easily exchangeable metals) fraction of Zn, but when inorganic additives were applied, this fraction was not detected. The highest degree of immobilisation of the tested heavy metals relative to the control was achieved when using both sewage	[Grobelak, Anna; Napora, Anna] Czestochowa Tech Univ, Inst Environm Engn, PL-42200 Czestochowa, Poland	Technical University Czestochowa	Grobelak, A (corresponding author), Czestochowa Tech Univ, Inst Environm Engn, PL-42200 Czestochowa, Poland.	agrobelak@is.pcz.czest.pl		Grobelak, Anna/0000-0003-1972-9734	National Science Centre [DEC-2011/03/N/NZ9/02034]; University Internal Grant [BS/PB-401-304/11]	National Science Centre(National Science Centre, Poland); University Internal Grant	The project was supported by National Science Centre grants DEC-2011/03/N/NZ9/02034 and University Internal Grant BS/PB-401-304/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkorta I., 2004, Reviews in Environmental Science and Bio/Technology, V3, P55, DOI 10.1023/B:RESB.0000040057.45006.34; Alvarenga P, 2009, CHEMOSPHERE, V74, P1292, DOI 10.1016/j.chemosphere.2008.11.063; Basta NT, 1999, J ENVIRON QUAL, V28, P633, DOI 10.2134/jeq1999.00472425002800020029x; Blaylock MJ, 2000, PHYTOREMEDIATION OF TOXIC METALS, P53; Bolan NS, 2003, PLANT SOIL, V256, P231, DOI 10.1023/A:1026288021059; Calace N, 2006, ANN CHIM-ROME, V96, P131, DOI 10.1002/adic.200690013; Cao XD, 2009, J HAZARD MATER, V164, P555, DOI 10.1016/j.jhazmat.2008.08.034; Evangelou MWH, 2007, CHEMOSPHERE, V68, P989, DOI 10.1016/j.chemosphere.2007.01.062; Flis J, 2011, GEOCHIM COSMOCHIM AC, V75, P1858, DOI 10.1016/j.gca.2011.01.021; Grobelak A, 2013, ROCZ OCHR SR, V15, P1982; Gupta SK, 2000, PHYTOREMEDIATION OF CONTAMINATED SOIL AND WATER, P303; Kabata-Pendias Alina, 2010, P1; Kacprzak M, 2010, J ENV STUD, V2, P73; Kacprzak M., 2011, INZYNIERIA EKOLOGICZ, V25, P99; Kacprzak M, 2014, DESALIN WATER TREAT, V52, P3955, DOI 10.1080/19443994.2014.887492; Kacprzak M, 2014, INT J PHYTOREMEDIAT, V16, P593, DOI 10.1080/15226514.2013.798625; Kumpiene J, 2008, WASTE MANAGE, V28, P215, DOI 10.1016/j.wasman.2006.12.012; Kyziol-Komosinska J, 2011, ARCH ENVIRON PROT, V37, P3; Mc Gowen SL, 2007, J ENVIRON QUAL, V30, P493; McIntyre T, 2003, ADV BIOCHEM ENG BIOT, V78, P97; Mench M, 2003, PLANT SOIL, V249, P187, DOI 10.1023/A:1022566431272; Naidu R, 2008, DEV SOIL SCI, V32, P1; Navari-Izzo F, 2010, HDB PLANT CROP STRES, P635; Neczaj E, 2012, GLOBAL NEST J, V14, P141; Neuschl C, 2009, THESIS HUMBOLDT U BE, P1; Padmavathiamma P., 2009, WATER AIR SOIL POLLU, V9, P253, DOI [10.1007/s11267-009-9214-1, DOI 10.1007/S11267-009-9214-1]; Park JH, 2011, J HAZARD MATER, V185, P549, DOI 10.1016/j.jhazmat.2010.09.082; Paulose B, 2007, ENVIRON POLLUT, V146, P19, DOI 10.1016/j.envpol.2006.06.016; Perez-de-Mora A, 2006, SOIL BIOL BIOCHEM, V38, P327, DOI 10.1016/j.soilbio.2005.05.010; Prasad M.N.V., 2006, TRACE ELEMENTS ENV B, P405; Qi YB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097327; Raicevic S, 2005, J HAZARD MATER, V117, P41, DOI 10.1016/j.jhazmat.2004.07.024; Reeves RD, 2007, PLANT SOIL, V293, P107, DOI 10.1007/s11104-007-9192-x; Simon L, 2005, ENVIRON GEOCHEM HLTH, V27, P289, DOI 10.1007/s10653-004-5977-5; Stanczyk-Mazanek E, 2010, J ENV STUD, V2, P221; Violante A, 2010, J SOIL SCI PLANT NUT, V10, P268, DOI 10.4067/S0718-95162010000100005; Wuana RA, 2011, ISRN ECOL, V2011, P1, DOI [10.5402/2011/402647, DOI 10.5402/2011/402647]; Zhang XF, 2010, BIORESOURCE TECHNOL, V101, P2063, DOI 10.1016/j.biortech.2009.11.065; Zimmerman Amanda Jo, 2010, Int J Anal Chem, V2010, P387803, DOI 10.1155/2010/387803	39	26	26	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129538	10.1371/journal.pone.0129538	http://dx.doi.org/10.1371/journal.pone.0129538			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115341	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500028
J	Malagoni, AM; Lamberti, N; Carrabre, JE; Litmanen, H; Jeannier, P; Zhukovskaja, L; Dal Follo, D; Zambon, C; Resch, N; Manfredini, F				Malagoni, Anna Maria; Lamberti, Nicola; Carrabre, James E.; Litmanen, Hannu; Jeannier, Pierre; Zhukovskaja, Larisa; Dal Follo, Donatella; Zambon, Christel; Resch, Nicole; Manfredini, Fabio			Planning the International Competition Schedules for the Health of Elite Athletes: A 21-Year Retrospective Study Evaluating the Effectiveness and Economic Impact in an Olympic Sport	PLOS ONE			English	Article							IMMUNE-ENDOCRINE RESPONSES; ORGANIZATIONAL STRESS; WORLD-CUP; PLAYERS; PERFORMANCE; LOAD; FOOTBALLERS; RECOVERY; INJURIES; SEASON	Background The increased number of trips and competitions scheduled in the international agonistic calendars meets commercial demands while acting as a source of stress for the athletes. A model, developed in biathlons to monitor the so-called competition load, revealed an upward trend over time. The aim of this study was to evaluate, in a 21-year period, the effects of the International Biathlon Union's rescheduling of the competitive calendars to control the competition load, as well as its stability over time and the economic impact of this intervention. Methods For each season competition, the load factors from the international agonistic calendar (number of venues/events, competition days/distance) were considered, and the athletes' daily and maximal stress scores were calculated. The calendar rescheduling, which started in 2001, involved the length of competitions, number of resting days and frequency of travels. Data from the period pre (1994-2000) and post (2001-2007) the intervention, as well as follow-up (2008-2015), were compared and analyzed in relation to the federation's budget. Results The competition load and athletes' daily stress score progressively increased pre, plateaued post and remained stable in follow-up. Their annual variations within the final two periods were significantly lower than in the pre period, in spite of the higher average values. The maximal stress score decreased over time. The direct correlation between most of the competition load factors with the economic budget present in pre was lost in post and follow- up. Similarly, the athletes' daily stress score had a stable trend in post and follow-up, while budget continued to increase. Conclusions The management of an athlete's potential source of stress by an international federation stabilized the competition load over time, but it did not affect the budget. Furthermore, it uncoupled the relationship between the athlete's effort and federation income.	[Malagoni, Anna Maria; Carrabre, James E.; Litmanen, Hannu; Jeannier, Pierre; Zhukovskaja, Larisa; Dal Follo, Donatella; Resch, Nicole; Manfredini, Fabio] Int Biathlon Union, Salzburg, Austria; [Lamberti, Nicola; Zambon, Christel; Manfredini, Fabio] Univ Ferrara, Dept Biomed Sci & Surg Specialties, I-44100 Ferrara, Italy	University of Ferrara	Malagoni, AM (corresponding author), Int Biathlon Union, Salzburg, Austria.	mlgnmr@unife.it	Lamberti, Nicola/P-6955-2019; Manfredini, Fabio/ABG-2372-2020; Malagoni, Anna Maria/K-4974-2016	Lamberti, Nicola/0000-0001-5763-3069; Manfredini, Fabio/0000-0001-9476-6434; Malagoni, Anna Maria/0000-0002-3362-4691				Ekstrand J, 2004, BRIT J SPORT MED, V38, P493, DOI 10.1136/bjsm.2003.009134; Fletcher D, 2003, SPORT PSYCHOL, V17, P175, DOI 10.1123/tsp.17.2.175; Florenes TW, 2012, SCAND J MED SCI SPOR, V22, P58, DOI 10.1111/j.1600-0838.2010.01147.x; Gomes RV, 2013, BIOL SPORT, V30, P173, DOI 10.5604/20831862.1059169; Hartwig TB, 2009, J SPORT SCI, V27, P1087, DOI 10.1080/02640410903096611; Manfredini F, 2002, INT J SPORTS MED, V23, P348, DOI 10.1055/s-2002-33140; Manfredini R, 1998, BRIT J SPORT MED, V32, P101, DOI 10.1136/bjsm.32.2.101; Merode A De, 1999, HARMONISATION METHOD, P1; Noblet AJ, 2002, J APPL SPORT PSYCHOL, V14, P1, DOI 10.1080/10413200209339007; Nunes JA, 2014, J STRENGTH COND RES, V28, P2973, DOI 10.1519/JSC.0000000000000499; SHIROM A, 1982, J OCCUP BEHAV, V3, P21, DOI 10.1002/job.4030030104; Silva JR, 2014, APPL PHYSIOL NUTR ME, V39, P432, DOI 10.1139/apnm-2013-0180; Visnes H, 2013, SCAND J MED SCI SPOR, V23, P607, DOI 10.1111/j.1600-0838.2011.01430.x; Woodman T, 2001, J APPL SPORT PSYCHOL, V13, P207, DOI 10.1080/104132001753149892	14	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130338	10.1371/journal.pone.0130338	http://dx.doi.org/10.1371/journal.pone.0130338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1AM	26115423	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500068
J	Rocher, S; Jean, M; Castonguay, Y; Belzile, F				Rocher, Solen; Jean, Martine; Castonguay, Yves; Belzile, Francois			Validation of Genotyping-By-Sequencing Analysis in Populations of Tetraploid Alfalfa by 454 Sequencing	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA; GENETIC DIVERSITY; GENOME; SATIVA; SELECTION; MARKERS; MAP	Genotyping-by-sequencing (GBS) is a relatively low-cost high throughput genotyping technology based on next generation sequencing and is applicable to orphan species with no reference genome. A combination of genome complexity reduction and multiplexing with DNA barcoding provides a simple and affordable way to resolve allelic variation between plant samples or populations. GBS was performed on ApeKI libraries using DNA from 48 genotypes each of two heterogeneous populations of tetraploid alfalfa (Medicago sativa spp.sativa): the synthetic cultivar Apica (ATF0) and a derived population (ATF5) obtained after five cycles of recurrent selection for superior tolerance to freezing (TF). Nearly 400 million reads were obtained from two lanes of an Illumina HiSeq 2000 sequencer and analyzed with the Universal Network-Enabled Analysis Kit (UNEAK) pipeline designed for species with no reference genome. Following the application of whole dataset-level filters, 11,694 single nucleotide polymorphism (SNP) loci were obtained. About 60% had a significant match on the Medicago truncatula syntenic genome. The accuracy of allelic ratios and genotype calls based on GBS data was directly assessed using 454 sequencing on a subset of SNP loci scored in eight plant samples. Sequencing depth in this study was not sufficient for accurate tetraploid allelic dosage, but reliable genotype calls based on diploid allelic dosage were obtained when using additional quality filtering. Principal Component Analysis of SNP loci in plant samples revealed that a small proportion (<5%) of the genetic variability assessed by GBS is able to differentiate ATF0 and ATF5. Our results confirm that analysis of GBS data using UNEAK is a reliable approach for genome-wide discovery of SNP loci in outcrossed polyploids.	[Rocher, Solen; Castonguay, Yves] Agr & Agroalimentaire Canada, Ctr Rech & Dev Sols & Grandes Cultures, Quebec City, PQ, Canada; [Jean, Martine; Belzile, Francois] Univ Laval, Dept Phytol, Quebec City, PQ, Canada; [Jean, Martine; Belzile, Francois] Univ Laval, Inst Biol Integrat & Syst, Quebec City, PQ, Canada	Agriculture & Agri Food Canada; Laval University; Laval University	Castonguay, Y (corresponding author), Agr & Agroalimentaire Canada, Ctr Rech & Dev Sols & Grandes Cultures, Quebec City, PQ, Canada.	Yves.castonguay@AGR.GC.CA		Belzile, Francois/0000-0001-6893-4529; Rocher, Solen/0000-0002-7054-8149	competitive grant of Agriculture and Agri-Food Canada; "Centre Seve" of the "Fonds de recherche du Qubec - Nature et technologies"; Natural Sciences and Engineering Research Council of Canada	competitive grant of Agriculture and Agri-Food Canada; "Centre Seve" of the "Fonds de recherche du Qubec - Nature et technologies"; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This project was supported by a competitive grant of Agriculture and Agri-Food Canada to YC and by a grant from the "Centre Seve" of the "Fonds de recherche du Qubec - Nature et technologies" to YC and FB. The participation of SR to this project was supported by a Natural Sciences and Engineering Research Council of Canada visiting fellowship in Canadian federal government laboratories. The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beissinger TM, 2013, GENETICS, V193, P1073, DOI 10.1534/genetics.112.147710; Byrne S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057438; Castonguay Y, 2006, ADV AGRON, V90, P203, DOI 10.1016/S0065-2113(06)90006-6; Castonguay Y, 2010, THEOR APPL GENET, V120, P1611, DOI 10.1007/s00122-010-1280-2; Castonguay Y, 2009, CROP SCI, V49, P809, DOI 10.2135/cropsci2008.09.0539; Choi HK, 2004, P NATL ACAD SCI USA, V101, P15289, DOI 10.1073/pnas.0402251101; Choi HK, 2004, GENETICS, V166, P1463, DOI 10.1534/genetics.166.3.1463; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Dube MP, 2013, THEOR APPL GENET, V126, P823, DOI 10.1007/s00122-012-2020-6; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Falke KC, 2007, THEOR APPL GENET, V114, P765, DOI 10.1007/s00122-006-0443-7; Flajoulot S, 2005, THEOR APPL GENET, V111, P1420, DOI 10.1007/s00122-005-0074-4; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; He JF, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00484; Julier B, 2014, QUANTITATIVE TRAITS, P229; Kopecky D, 2014, BIOTECHNOL ADV, V32, P190, DOI 10.1016/j.biotechadv.2013.11.010; Li XH, 2014, G3-GENES GENOM GENET, V4, P1971, DOI 10.1534/g3.114.012245; Li XH, 2011, THEOR APPL GENET, V123, P667, DOI 10.1007/s00122-011-1617-5; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Matthews PD, 2013, BREW SCI, V66, P185; MICHAUD R, 1983, CAN J PLANT SCI, V63, P547, DOI 10.4141/cjps83-066; Nagl N, 2011, INT J MOL SCI, V12, P5449, DOI 10.3390/ijms12085449; Poland JA, 2012, PLANT GENOME-US, V5, P92, DOI 10.3835/plantgenome2012.05.0005; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Remus-Borel W, 2010, THEOR APPL GENET, V120, P1163, DOI 10.1007/s00122-009-1243-7; Russelle MP, 2001, AM SCI, V89, P252, DOI 10.1511/2001.3.252; Schilling MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095292; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Tang HB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-312; Uitdewilligen JGAML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062355; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Veronesi F, 2010, HANDB PLANT BREED, V5, P395, DOI 10.1007/978-1-4419-0760-8_17	32	17	18	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131918	10.1371/journal.pone.0131918	http://dx.doi.org/10.1371/journal.pone.0131918			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115486	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500185
J	Share, BL; Naughton, GA; Obert, P; Peat, JK; Aumand, EA; Kemp, JG				Share, Bianca L.; Naughton, Geraldine A.; Obert, Philippe; Peat, Jennifer K.; Aumand, Elizabeth A.; Kemp, Justin G.			Effects of a Multi-Disciplinary Lifestyle Intervention on Cardiometabolic Risk Factors in Young Women with Abdominal Obesity: A Randomised Controlled Trial	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; WEIGHT; OVERWEIGHT; MANAGEMENT; CHILDREN; OUTCOMES; PROFILE; TRENDS	Background Young women are under-represented in cardiovascular disease research, with obesity and cardiometabolic risk factor interventions generally targeting older adults. Furthermore, appropriate study designs for young women remain uncertain. This study aimed to assess the impact of a 12 week multi-disciplinary lifestyle intervention on cardiometabolic risk factors in premenopausal women with abdominal obesity. Methods Women aged 18-30 y with abdominal obesity [waist circumference (WC) >= 80 cm] were randomised to a 12 week lifestyle intervention (n = 26) of physical activity, nutrition education and cognitive behavioural therapy, or a wait-list control group (n = 17). Both groups completed anthropometric, biochemical, nutrition and fitness testing, at pre (0 weeks) and post (12 weeks), with intervention participants completed follow-up testing at 24 weeks. Results Results from a linear mixed model showed no between-group differences, other than increased physical activity in the intervention group, at post. In the intervention group alone, positive within-group changes were observed in WC, waist-hip-ratio (WHR), waist-height-ratio (WHtR), resting heart rate, blood pressure, predicted VO2max, and total energy intake. Most changes were maintained at 24 weeks post-intervention. Similar within-group improvements were observed in control participants in WC, WHR, WHtR, and systolic blood pressure but no changes were detected in physical activity and nutrition. Conclusions Cardiometabolic risk factors were decreased as a result of a lifestyle intervention in young women with abdominal obesity. It is difficult to describe observations in the control group without greater understanding of the behaviour of wait-list participants.	[Share, Bianca L.; Naughton, Geraldine A.; Obert, Philippe; Aumand, Elizabeth A.; Kemp, Justin G.] Australian Catholic Univ, Sch Exercise Sci, Melbourne, Vic, Australia; [Peat, Jennifer K.] Australian Catholic Univ, Fac Hlth Sci, Sydney, NSW, Australia; [Naughton, Geraldine A.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Obert, Philippe] Univ Avignon, LAPEC, EA4278, Avignon, France	Australian Catholic University; Australian Catholic University; Murdoch Children's Research Institute; Avignon Universite	Share, BL (corresponding author), Australian Catholic Univ, Sch Exercise Sci, Melbourne, Vic, Australia.	bianca.share@acu.edu.au	Naughton, Geraldine/M-4094-2017	Naughton, Geraldine/0000-0002-0534-1627; Kemp, Justin/0000-0003-4930-3806				Abadie B, 2000, J EXERCISE PHYSL ONL, P1; Adamson L, 2007, WOMENS WEIGHT FINDIN; Alberti KG, 2009, HARMONIZING METABOLI, DOI DOI 10.1161/CIRCULATI0NAHA.109.192644; Australian Bureau of Statistics, 2013, AUSTR HLTH SURV UPD, DOI [10.1016/j.ijrobp.2011.02.008, DOI 10.1016/J.IJROBP.2011.02.008]; Baucom DH, 2003, BEHAV THER, V34, P179, DOI 10.1016/S0005-7894(03)80012-6; Bray GA, 2015, OBESITY, V23, P2, DOI 10.1002/oby.20964; Brooks G. A., 1996, Exercise physiology: human bioenergetics and its applications.; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; BRUCE RA, 1973, AM HEART J, V85, P546, DOI 10.1016/0002-8703(73)90502-4; Chang MW, 2010, J NUTR EDUC BEHAV, V42, pS11, DOI 10.1016/j.jneb.2010.01.010; Cleland VJ, 2011, J SCI MED SPORT, V14, P496, DOI 10.1016/j.jsams.2011.04.006; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crist Laura A, 2012, Prev Chronic Dis, V9, pE68; DECI EL, 1985, J RES PERS, V19, P109, DOI 10.1016/0092-6566(85)90023-6; Department of Health and Ageing, 2005, NAT PHYS ACT GUID AU; Donnelly JE, 2003, ARCH INTERN MED, V163, P1343, DOI 10.1001/archinte.163.11.1343; Elliott SA, 2002, BEHAV RES THER, V40, P1047, DOI 10.1016/S0005-7967(01)00082-1; Emaus A, 2008, MED SCI SPORT EXER, V40, P1022, DOI 10.1249/MSS.0b013e318167411f; Gokee-LaRose J, 2009, INT J OBESITY, V33, P1374, DOI 10.1038/ijo.2009.185; Gokee-LaRose J, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-10; Gravetter J. F., 2012, RES METHODS BEHAV SC; Griffin HJ, 2013, ASIA PAC J CLIN NUTR, V22, P235, DOI 10.6133/apjcn.2013.22.2.16; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Health and Social Care Information Centre, 2011, HLTH SURV ENGL SUMM; Hutchesson MJ, 2013, J ACAD NUTR DIET, V113, P795, DOI 10.1016/j.jand.2013.01.015; Irving BA, 2008, MED SCI SPORT EXER, V40, P1863, DOI 10.1249/MSS.0b013e3181801d40; Jensterle M, 2008, INT J GYNECOL OBSTET, V102, P137, DOI 10.1016/j.ijgo.2008.03.017; Kemmler W, 2009, MED SCI SPORT EXER, V41, P297, DOI 10.1249/MSS.0b013e31818844b7; Kosmala W, 2008, J CLIN ENDOCR METAB, V93, P3748, DOI 10.1210/jc.2008-1017; Lang Astrid, 2006, Eur J Cardiovasc Nurs, V5, P102, DOI 10.1016/j.ejcnurse.2005.11.002; LaRose JG, 2012, OBESITY, V20, P2314, DOI 10.1038/oby.2012.30; Lucke J, 2007, WOMENS HEALTH, V3, P423, DOI 10.2217/17455057.3.4.423; MacLean PS, 2015, OBESITY, V23, P7, DOI 10.1002/oby.20967; Magarey A, 2011, INT J PEDIATR OBES, V6, P2, DOI 10.3109/17477161003728469; Martin C.A., 2005, IND COMMER TRAIN, V37, P39, DOI DOI 10.1108/00197850510699965; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miller W C, 2001, Obes Rev, V2, P37, DOI 10.1046/j.1467-789x.2001.00023.x; National Health and Medical Reserach Council, 2005, DIET GUID AUSTR GUID; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pearson TA, 2003, CIRCULATION, V107, P499; Peat J., 2005, MED STAT GUIDE DATA; Peat JK., 2002, HLTH SCI RES HDB QUA; Perri MG, 2014, OBESITY, V22, P3, DOI 10.1002/oby.20672; Robertson RJ, 2004, PERCIEVED EXERTION P; SALLIS JF, 1993, MED SCI SPORT EXER, V25, P99, DOI 10.1249/00005768-199301000-00014; Stewart S, 2008, AUSTR FAT BOMB REP L; Thomson RL, 2008, J CLIN ENDOCR METAB, V93, P3373, DOI 10.1210/jc.2008-0751; Wadden TA, 2014, OBESITY, V22, P5, DOI 10.1002/oby.20662; Wake M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3092; Waters L, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-120; World Health Organization, 2006, GLOB DAT BOD MASS IN	52	20	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130270	10.1371/journal.pone.0130270	http://dx.doi.org/10.1371/journal.pone.0130270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1AM	26114854	gold, Green Published, Green Submitted			2022-12-27	WOS:000358147500062
J	van Elk, M				van Elk, Michiel			Perceptual Biases in Relation to Paranormal and Conspiracy Beliefs	PLOS ONE			English	Article							CONTEXT-SENSITIVITY; ILLUSORY FACE; SCHIZOTYPY; BELIEVERS; PRECEDENCE; IDEATION; AGENCY; PRONE	Previous studies have shown that one's prior beliefs have a strong effect on perceptual decision-making and attentional processing. The present study extends these findings by investigating how individual differences in paranormal and conspiracy beliefs are related to perceptual and attentional biases. Two field studies were conducted in which visitors of a paranormal conducted a perceptual decision making task (i.e. the face / house categorization task; Experiment 1) or a visual attention task (i.e. the global / local processing task; Experiment 2). In the first experiment it was found that skeptics compared to believers more often incorrectly categorized ambiguous face stimuli as representing a house, indicating that disbelief rather than belief in the paranormal is driving the bias observed for the categorization of ambiguous stimuli. In the second experiment, it was found that skeptics showed a classical 'global-to-local' interference effect, whereas believers in conspiracy theories were characterized by a stronger 'local-to-global interference effect'. The present study shows that individual differences in paranormal and conspiracy beliefs are associated with perceptual and attentional biases, thereby extending the growing body of work in this field indicating effects of cultural learning on basic perceptual processes.	[van Elk, Michiel] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [van Elk, Michiel] Univ Amsterdam, Amsterdam Brain & Cognit Ctr, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	van Elk, M (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	m.vanelk@uva.nl			Netherlands Organization for Scientific Research (NWO) [016.135.135]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by a VENI grant no. 016.135.135 to the first author from the Netherlands Organization for Scientific Research (NWO).	Barrett JL, 2000, TRENDS COGN SCI, V4, P29, DOI 10.1016/S1364-6613(99)01419-9; Barrett JL, 2011, PSYCHOLOGIST, V24, P252; Bedwell JS, 2009, SCHIZOPHR RES, V108, P158, DOI 10.1016/j.schres.2008.11.020; Blackmore SJ, 1993, EUR J PARAPSYCHOL, V10; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Brugger P, 1997, Cogn Neuropsychiatry, V2, P251, DOI 10.1080/135468097396270; Brugger P., 2001, HAUNTINGS POLTERGEIS, P195; Colzato LS, 2010, COGNITION, V117, P87, DOI 10.1016/j.cognition.2010.07.003; Colzato LS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003679; Corlett PR, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.053.2009; Darwin H, 2011, PERS INDIV DIFFER, V50, P1289, DOI 10.1016/j.paid.2011.02.027; Douglas KM, 2011, BRIT J SOC PSYCHOL, V50, P544, DOI 10.1111/j.2044-8309.2010.02018.x; Douglas KM, THINKING RE IN PRESS; Fyfe S, 2008, CORTEX, V44, P1316, DOI 10.1016/j.cortex.2007.07.009; Galdos M, 2011, SCHIZOPHRENIA BULL, V37, P1179, DOI 10.1093/schbul/sbq029; Gervais WM, 2012, SCIENCE, V336, P493, DOI 10.1126/science.1215647; Gianotti LRR, 2001, PSYCHIAT CLIN NEUROS, V55, P595, DOI 10.1046/j.1440-1819.2001.00911.x; GOERTZEL T, 1994, POLIT PSYCHOL, V15, P731, DOI 10.2307/3791630; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goodarzi MA, 2000, SCHIZOPHR RES, V45, P115, DOI 10.1016/S0920-9964(99)00173-5; Gosselin F, 2003, PSYCHOL SCI, V14, P505, DOI 10.1111/1467-9280.03452; Goulding A, 2005, PERS INDIV DIFFER, V38, P1069, DOI 10.1016/j.paid.2004.07.006; Goulding A, 2004, PERS INDIV DIFFER, V37, P157, DOI 10.1016/j.paid.2003.08.008; GUTHRIE S, 1980, CURR ANTHROPOL, V21, P181, DOI 10.1086/202429; Guthrie Stewart, 1993, FACES CLOUDS NEW THE; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; Hergovich A, 2003, PERS INDIV DIFFER, V34, P195, DOI 10.1016/S0191-8869(02)00022-3; Howell G. T., 2012, TUTOR QUANT METHODS, V8, P1, DOI DOI 10.20982/TQMP.08.1.P001; Imhoff R, 2014, EUR J PERSONALITY, V28, P25, DOI 10.1002/per.1930; KIMCHI R, 1992, PSYCHOL BULL, V112, P24, DOI 10.1037/0033-2909.112.1.24; Kramer R M, 1998, Pers Soc Psychol Rev, V2, P251, DOI 10.1207/s15327957pspr0204_3; Krummenacher P, 2010, J COGNITIVE NEUROSCI, V22, P1670, DOI 10.1162/jocn.2009.21313; Leman P. J., 2007, SOC PSYCHOL REV, V9, P18; Leman PJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00378; Lindeman M, 2007, J RES PERS, V41, P731, DOI 10.1016/j.jrp.2006.06.009; Lindeman M, 2013, SOC COGN AFFECT NEUR, V8, P943, DOI 10.1093/scan/nss096; Masuda T, 2000, INT J PSYCHOL, V35, P258; Masuda T, 2001, J PERS SOC PSYCHOL, V81, P922, DOI 10.1037//0022-3514.81.5.922; MILLER J, 1981, J EXP PSYCHOL HUMAN, V7, P1161, DOI 10.1037/0096-1523.7.6.1161; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Newheiser AK, 2011, PERS INDIV DIFFER, V51, P1007, DOI 10.1016/j.paid.2011.08.011; Nisbett RE, 2005, TRENDS COGN SCI, V9, P467, DOI 10.1016/j.tics.2005.08.004; Pennycook G, 2012, COGNITION, V123, P335, DOI 10.1016/j.cognition.2012.03.003; RAWLINGS D, 1984, PERS INDIV DIFFER, V5, P657, DOI 10.1016/0191-8869(84)90113-2; Reed P, 2008, J BEHAV THER EXP PSY, V39, P276, DOI 10.1016/j.jbtep.2007.07.005; Riekki T, 2013, APPL COGNITIVE PSYCH, V27, P150, DOI 10.1002/acp.2874; Rieth CA, 2011, I-PERCEPTION, V2, P458, DOI 10.1068/i0421; Stieger S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00297; Sugimori E, 2011, CONSCIOUS COGN, V20, P688, DOI 10.1016/j.concog.2010.12.014; Swami V, 2014, COGNITION, V133, P572, DOI 10.1016/j.cognition.2014.08.006; Tobacyk Jerome., 2004, INT J TRANSPERSONAL, V23, P94, DOI [DOI 10.24972/IJTS.2004.23.1.94, DOI 10.1037/T14015-000]; van Elk M., 2014, RELIG BRAIN BEHAV; van Elk M, 2013, CONSCIOUS COGN, V22, P1041, DOI 10.1016/j.concog.2013.07.004; Van Prooijen JW, 2013, EUR J SOC PSYCHOL, V43, P109, DOI 10.1002/ejsp.1922; Vercammen A, 2008, PSYCHOL MED, V38, P1177, DOI 10.1017/S0033291707002437; Whitson JA, 2008, SCIENCE, V322, P115, DOI 10.1126/science.1159845; WILLIAMS LM, 1991, PERS INDIV DIFFER, V12, P1339, DOI 10.1016/0191-8869(91)90210-3; Wood MJ, 2012, SOC PSYCHOL PERS SCI, V3, P767, DOI 10.1177/1948550611434786	58	38	38	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130422	10.1371/journal.pone.0130422	http://dx.doi.org/10.1371/journal.pone.0130422			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1AM	26114604	Green Published, gold			2022-12-27	WOS:000358147500073
J	Wei, SJ; Du, ZL; Gao, F; Ke, X; Li, J; Liu, JX; Zhou, YJ				Wei, Shanjun; Du, Zhenlin; Gao, Fei; Ke, Xiang; Li, Jing; Liu, Jianxiu; Zhou, Yijun			Global Transcriptome Profiles of 'Meyer' Zoysiagrass in Response to Cold Stress	PLOS ONE			English	Article							ALLENE OXIDE SYNTHASE; GENE-EXPRESSION; FREEZING TOLERANCE; LOW-TEMPERATURE; DIFFERENTIAL EXPRESSION; CHLOROPHYLL BREAKDOWN; PHOSPHATASE GENE; CHILLING STRESS; JASMONIC ACID; ARABIDOPSIS	A long green period is essential for a turfgrass species with high ornamental value and a wide area of use. Zoysiagrasses (Zoysia spp. Willd.) are perennial turfgrass species popular in tropical, subtropical and temperate zones, possessing many properties necessary to be economically useful turfgrass. They do not have a long green period because of cold sensitivity. A main focus in zoysiagrass research is to develop cold tolerant cultivars. Understanding the cold response in zoysiagrass is a fundamental area of research. In the present study, 'Meyer' zoysiagrass (Zoysia japonica), a widely cultivated variety in the genus, is used. We employed RNA-Seq to investigate genome-wide gene expression profiles in leaves under cold stress (4 degrees C). Using the Illumina sequencing platform, we obtained approximately 206 million high-quality paired-end reads from three libraries (0 h, 2 h, and 72 h cold treatment at 4 degrees C). After de novo assembly and quantitative assessment, 46,412 unigenes were generated with an average length of 998 bp and an N50 of 1,522 bp. A total of 25,644 (55.2%) unigenes were annotated by alignment with public protein databases including NR, SwissProt, KEGG and KOG. Differentially expressed genes (DEGs) were investigated using the RPKM method. A total of 756 DEGs were identified between 0h and 2h-cold treatment, with 522 up-regulated and 234 down-regulated; and 5327 DEGs were identified between 0h and 72h-cold treatment, with 2453 up-regulated and 2874 down-regulated. The expression profile of 15 DEGs selected randomly was confirmed with qRT-PCR. The results suggest that cold stress can induce desiccation and oxidative stress, inhibit photosynthesis and substance transport. In response to the stress, genes involved in proline synthesis, in starch hydrolysis, in methionine and ascorbic acid metabolism, in SOD activity, and in DREBs response pathway were up-regulated. GA metabolism, ABA and JA stimulus response were affected under cold exposure. This is the first transcriptome sequencing of Z. japonica, providing a large set of sequence data as well as gene expression profiles under cold stress. It will improve our current understanding of the cold response of zoysiagrass and be beneficial in breeding research.	[Wei, Shanjun; Gao, Fei; Ke, Xiang; Li, Jing; Zhou, Yijun] Minzu Univ China, Coll Life Environm Sci, Beijing, Peoples R China; [Du, Zhenlin] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Liu, Jianxiu] Jiangsu Prov & Chinese Acad Sci, Nanjing, Jiangsu, Peoples R China	Minzu University of China; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Liu, JX (corresponding author), Jiangsu Prov & Chinese Acad Sci, 1 Qianhu Houcun, Nanjing, Jiangsu, Peoples R China.	turfunit@aliyun.com; queenzhou@263.net	Gao, Fei/I-5768-2019	Gao, Fei/0000-0003-3600-4970	National Natural Science Foundation of China [31100507]; Fundamental Research Funds for the Central Universities; 111 Project [B08044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 111 Project(Ministry of Education, China - 111 Project)	This research project was supported by National Natural Science Foundation of China (31100507), The Fundamental Research Funds for the Central Universities, and 111 Project (B08044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DJ, 2001, TRENDS PLANT SCI, V6, P36, DOI 10.1016/S1360-1385(00)01808-2; Atkinson NJ, 2013, PLANT PHYSIOL, V162, P2028, DOI 10.1104/pp.113.222372; Badawi M, 2007, MOL GENET GENOMICS, V277, P533, DOI 10.1007/s00438-006-0206-9; Bakker H, 2008, CARBOHYD RES, V343, P2148, DOI 10.1016/j.carres.2008.01.010; Barah P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-722; Baud S, 2004, J EXP BOT, V55, P397, DOI 10.1093/jxb/erh047; Beard JB, 1973, TURFGRASS SCIENCE AN; Borovskii GB, 2002, RUSS J PLANT PHYSL+, V49, P229, DOI 10.1023/A:1014857708301; Breton G, 2003, PLANT PHYSIOL, V132, P64, DOI 10.1104/pp.102.015255; Buttner M, 2007, THE MONOSACCHARIDE T, V581, P2318; Cai HW, 2005, THEOR APPL GENET, V112, P158, DOI 10.1007/s00122-005-0118-9; Carvallo MA, 2011, J EXP BOT, V62, P3807, DOI 10.1093/jxb/err066; Chaumont F, 2014, PLANT PHYSIOL, V164, P1600, DOI 10.1104/pp.113.233791; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Chinthapalli B, 2003, J EXP BOT, V54, P707, DOI 10.1093/jxb/erg078; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CRESPI MD, 1991, PLANT PHYSIOL, V96, P887, DOI 10.1104/pp.96.3.887; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Du H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00397; Du YC, 1999, PLANT CELL ENVIRON, V22, P317, DOI 10.1046/j.1365-3040.1999.00415.x; Engelke M.C., 2003, TURFGRASS BIOL GENET, P271; Froehlich JE, 2001, PLANT PHYSIOL, V125, P306, DOI 10.1104/pp.125.1.306; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Ganeshan S, 2008, J EXP BOT, V59, P2393, DOI 10.1093/jxb/ern112; Ge LF, 2008, PLANTA, V228, P191, DOI 10.1007/s00425-008-0729-x; Guo HL, 2012, BREEDING SCI, V62, P320, DOI 10.1270/jsbbs.62.320; Ha SB, 2002, BIOSCI BIOTECH BIOCH, V66, P2719, DOI 10.1271/bbb.66.2719; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hoshida H, 2000, PLANT MOL BIOL, V43, P103, DOI 10.1023/A:1006408712416; Hu T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1147; Jain D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-24; Kaur S, 2009, J AGRON CROP SCI, V195, P393, DOI 10.1111/j.1439-037X.2009.00383.x; Kim BG, 2007, PLANT J, V52, P473, DOI 10.1111/j.1365-313X.2007.03249.x; Kim SH, 2015, PLANT PHYSIOL BIOCH, V87, P84, DOI 10.1016/j.plaphy.2014.12.020; Knox AK, 2008, PLANT MOL BIOL, V67, P257, DOI 10.1007/s11103-008-9316-6; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Lee JY, 2003, PLANT PHYSIOL, V132, P517, DOI 10.1104/pp.103.020511; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li LH, 2012, PLANT PHYSIOL BIOCH, V58, P46, DOI 10.1016/j.plaphy.2012.06.009; Liu SX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003790; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao Pei Sheng, 2009, Grassland Science, V55, P1, DOI 10.1111/j.1744-697X.2009.00129.x; Matsuba K, 1997, PLANT CELL ENVIRON, V20, P268, DOI 10.1046/j.1365-3040.1997.d01-55.x; Matsumura T, 1997, PLANT PHYSIOL, V114, P653, DOI 10.1104/pp.114.2.653; Nandi D, 2005, TOXICOLOGY, V211, P26, DOI 10.1016/j.tox.2005.02.013; Patton AJ, 2007, CROP SCI, V47, P2162, DOI 10.2135/cropsci2006.11.0739; Patton AJ, 2007, CROP SCI, V47, P2170, DOI 10.2135/cropsci2006.12.0784; Pauwels L, 2009, TRENDS PLANT SCI, V14, P87, DOI 10.1016/j.tplants.2008.11.005; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Peng YH, 2008, PLANT CELL ENVIRON, V31, P1275, DOI 10.1111/j.1365-3040.2008.01840.x; Pramanik MHR, 2005, PLANT MOL BIOL, V58, P751, DOI 10.1007/s11103-005-7404-4; Pruzinska A, 2003, P NATL ACAD SCI USA, V100, P15259, DOI 10.1073/pnas.2036571100; RITCHIE SW, 1994, PLANT MOL BIOL, V26, P679, DOI 10.1007/BF00013753; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez PL, 1998, FEBS LETT, V421, P185, DOI 10.1016/S0014-5793(97)01558-5; ROGERS RA, 1977, CROP SCI, V17, P727, DOI 10.2135/cropsci1977.0011183X001700050013x; Sakuraba Y, 2013, BIOCHEM BIOPH RES CO, V430, P32, DOI 10.1016/j.bbrc.2012.11.050; Sattler SE, 2006, PLANT CELL, V18, P3706, DOI 10.1105/tpc.106.044065; Srivastava AC, 2008, PLANT PHYSIOL, V148, P200, DOI 10.1104/pp.108.124776; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Stumpe M, 2006, PLANT J, V47, P883, DOI 10.1111/j.1365-313X.2006.02843.x; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tanaka N, 2004, PLANT BIOTECHNOL J, V2, P507, DOI 10.1111/j.1467-7652.2004.00097.x; Terol J, 2006, GENE, V371, P279, DOI 10.1016/j.gene.2005.12.014; Thomashow MF, 1998, PLANT PHYSIOL, V118, P1, DOI 10.1104/pp.118.1.1; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Toyofuku K, 2000, PLANT CELL PHYSIOL, V41, P940, DOI 10.1093/pcp/pcd016; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Vettakkorumakankav NN, 1999, PLANT CELL PHYSIOL, V40, P542, DOI 10.1093/oxfordjournals.pcp.a029575; Wang JR, 2014, INT J MOL SCI, V15, P203, DOI 10.3390/ijms15010203; Weber A, 2000, PLANT CELL, V12, P787, DOI 10.1105/tpc.12.5.787; Wormit A, 2006, PLANT CELL, V18, P3476, DOI 10.1105/tpc.106.047290; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; Xuan JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075705; Yamauchi Y, 2004, PLANT CELL, V16, P367, DOI 10.1105/tpc.018143; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Yaneshita M, 1999, THEOR APPL GENET, V98, P751, DOI 10.1007/s001220051131; Yaneva I, 1996, J PLANT PHYSIOL, V149, P211, DOI 10.1016/S0176-1617(96)80197-0; Zhang CJ, 2011, PLANT CELL REP, V30, P389, DOI 10.1007/s00299-010-0939-0; Zhang Q, 2009, J AM SOC HORTIC SCI, V134, P322, DOI 10.21273/JASHS.134.3.322; Zhen Y, 2008, MOL BIOL EVOL, V25, P2547, DOI 10.1093/molbev/msn196; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	86	31	36	6	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131153	10.1371/journal.pone.0131153	http://dx.doi.org/10.1371/journal.pone.0131153			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115186	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500131
J	Hengl, T; Heuvelink, GBM; Kempen, B; Leenaars, JGB; Walsh, MG; Shepherd, KD; Sila, A; MacMillan, RA; de Jesus, JM; Tamene, L; Tondoh, JE				Hengl, Tomislav; Heuvelink, Gerard B. M.; Kempen, Bas; Leenaars, Johan G. B.; Walsh, Markus G.; Shepherd, Keith D.; Sila, Andrew; MacMillan, Robert A.; de Jesus, Jorge Mendes; Tamene, Lulseged; Tondoh, Jerome E.			Mapping Soil Properties of Africa at 250 m Resolution: Random Forests Significantly Improve Current Predictions	PLOS ONE			English	Article							SURVEILLANCE; MODELS; CARBON	80% of arable land in Africa has low soil fertility and suffers from physical soil problems. Additionally, significant amounts of nutrients are lost every year due to unsustainable soil management practices. This is partially the result of insufficient use of soil management knowledge. To help bridge the soil information gap in Africa, the Africa Soil Information Service (AfSIS) project was established in 2008. Over the period 2008-2014, the AfSIS project compiled two point data sets: the Africa Soil Profiles (legacy) database and the AfSIS Sentinel Site database. These data sets contain over 28 thousand sampling locations and represent the most comprehensive soil sample data sets of the African continent to date. Utilizing these point data sets in combination with a large number of covariates, we have generated a series of spatial predictions of soil properties relevant to the agricultural management-organic carbon, pH, sand, silt and clay fractions, bulk density, cation-exchange capacity, total nitrogen, exchangeable acidity, Al content and exchangeable bases (Ca, K, Mg, Na). We specifically investigate differences between two predictive approaches: random forests and linear regression. Results of 5-fold cross-validation demonstrate that the random forests algorithm consistently outperforms the linear regression algorithm, with average decreases of 15-75% in Root Mean Squared Error (RMSE) across soil properties and depths. Fitting and running random forests models takes an order of magnitude more time and the modelling success is sensitive to artifacts in the input data, but as long as quality-controlled point data are provided, an increase in soil mapping accuracy can be expected. Results also indicate that globally predicted soil classes (USDA Soil Taxonomy, especially Alfisols and Mollisols) help improve continental scale soil property mapping, and are among the most important predictors. This indicates a promising potential for transferring pedological knowledge from data rich countries to countries with limited soil data.	[Hengl, Tomislav; Heuvelink, Gerard B. M.; Kempen, Bas; Leenaars, Johan G. B.; de Jesus, Jorge Mendes] ISRIC World Soil Informat, Wageningen, Netherlands; [Walsh, Markus G.] Columbia Univ, Earth Inst, New York, NY 10027 USA; [Walsh, Markus G.] Selian Agr Res Inst, Arusha, Tanzania; [Shepherd, Keith D.; Sila, Andrew; Tondoh, Jerome E.] World Agroforestry Ctr, Nairobi, Kenya; [MacMillan, Robert A.] LandMapper Environm Solut Inc, Edmonton, AB, Canada; [Tamene, Lulseged] Ctr Int Agr Trop, Lilongwe, Malawi	Columbia University; CGIAR; World Agroforestry (ICRAF)	Hengl, T (corresponding author), ISRIC World Soil Informat, Wageningen, Netherlands.	tom.hengl@wur.nl	Tamene, Lulseged/GPC-7434-2022; Heuvelink, Gerard/AAD-5916-2022; Hengl, Tomislav/AAE-9320-2019	Tamene, Lulseged/0000-0002-4846-2330; Heuvelink, Gerard/0000-0003-0959-9358; Hengl, Tomislav/0000-0002-9921-5129; Leenaars, Johan G.B./0000-0003-1091-7114; Kempen, Bas/0000-0002-2841-0058; Mendes de Jesus, Jorge Samuel/0000-0001-9890-067X; Sila, Andrew/0000-0002-3991-8770	Bill and Melinda Gates Foundation (BMGF); Alliance for a Green Revolution in Africa (AGRA); Columbia Global Centers (CGC); Earth Institute of Columbia University (EI); World Agroforestry Centre (ICRAF); ISRIC-World Soil Information; Dutch government	Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); Alliance for a Green Revolution in Africa (AGRA); Columbia Global Centers (CGC); Earth Institute of Columbia University (EI); World Agroforestry Centre (ICRAF); ISRIC-World Soil Information; Dutch government	The AfSIS project has been funded by the Bill and Melinda Gates Foundation (BMGF) and the Alliance for a Green Revolution in Africa (AGRA) and is supported by close scientific, operational and implementation partnerships with the Columbia Global Centers (CGC), the Earth Institute of Columbia University (EI), the World Agroforestry Centre (ICRAF), and ISRIC-World Soil Information. The Bill & Melinda Gates Foundation is a non-profit-making organization founded by Bill and Melinda Gates. ISRIC is a non-profit-making organization, core-funded by the Dutch government, with a mandate to serve the international community as custodian of global soil information and to increase awareness and understanding of the role of soils in major global issues. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2010, ADV WATER RESOUR, V33, P69, DOI 10.1016/j.advwatres.2009.10.008; Alliance for a Green Revolution in Africa (AGRA), 2014, AFR AGR STAT REP; Ballabio C, 2014, ASA CSSA SSSA INTERN; Bivand R.S., 2013, APPL SPATIAL DATA AN, DOI 10.1007/978-1-4614-7618-4; Boettinger J., 2010, PROGR SOIL SCI, V2; Bohner J, 2008, SAGA SECONDS OUT, V19; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown PE, 2015, J STAT SOFTW, V63; Brus DJ, 2011, EUR J SOIL SCI, V62, P394, DOI 10.1111/j.1365-2389.2011.01364.x; Bui EN, 2006, ECOL MODEL, V191, P431, DOI 10.1016/j.ecolmodel.2005.05.021; Christensen R., 2001, LINEAR MODELS MULTIV; de Brogniez D, 2014, EUROPEAN J SOIL SCI; Dewitte O, 2013, GEODERMA, V211, P138, DOI 10.1016/j.geoderma.2013.07.007; Durana PJ, 2008, PROFILES HIST US SOI, P315, DOI DOI 10.1002/9780470376959.APP1; FAO Economic and Social Development Department, 2002, WORLD AGR 2015 2030; Grunwald S, 2011, SOIL SCI SOC AM J, V75, P1201, DOI 10.2136/sssaj2011.0025; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Henderson BL, 2005, GEODERMA, V124, P383, DOI 10.1016/j.geoderma.2004.06.007; Hengl T, 2013, INT J APPL EARTH OBS, V22, P127, DOI 10.1016/j.jag.2012.02.005; Hengl T, 2015, GSIF GLOBAL SOIL INF; Hengl T, 2007, COMPUT GEOSCI-UK, V33, P1301, DOI 10.1016/j.cageo.2007.05.001; Hengl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105992; Heuvelink G, 2010, 4 GLOB WORKSH DIG SO, P24; Jun C, 2014, NATURE, V514, P434, DOI 10.1038/514434c; Kamau M, 2012, RUFORUM 3 BIENN C 24; Knaus J, 2009, R J, V1, P54; Kuhn M., 2013, PACKAGEAPPLIEDPREDIC, DOI DOI 10.1007/978-1-4614-6849-3; Leenaars J, 2014, 201401 ISRIC; Malone BP, 2009, GEODERMA, V154, P138, DOI 10.1016/j.geoderma.2009.10.007; Mansuy N, 2014, GEODERMA, V235, P59, DOI 10.1016/j.geoderma.2014.06.032; McBratney A.B., 2011, HDB SOIL SCI, P1; Nocita M, 2015, GLOBAL CHANGE BIOL, V21, P10, DOI 10.1111/gcb.12632; ODEH IOA, 1995, GEODERMA, V67, P215, DOI 10.1016/0016-7061(95)00007-B; Odgers NP, 2012, GEODERMA, V189, P153, DOI 10.1016/j.geoderma.2012.05.026; Palm CA, 2009, P 9 INT C E SE AS FE; Pebesma E, 2011, COMPUT GEOSCI-UK, V37, P343, DOI 10.1016/j.cageo.2010.03.019; Rabus B, 2003, ISPRS J PHOTOGRAMM, V57, P241, DOI 10.1016/S0924-2716(02)00124-7; Sachs J, 2010, NATURE, V466, P558, DOI 10.1038/466558a; Sanchez PA, 2009, SCIENCE, V325, P680, DOI 10.1126/science.1175084; Sexton JO, 2013, INT J DIGIT EARTH, V6, P427, DOI 10.1080/17538947.2013.786146; Shepherd K.D., 2010, 19 WORLD C SOIL SCI; Shepherd KD, 2007, J NEAR INFRARED SPEC, V15, P1, DOI 10.1255/jnirs.716; Shepherd KD, 2015, AGR SYST, V132, P93, DOI 10.1016/j.agsy.2014.09.002; Sila A, 2015, SOIL SPEC SOIL SPECT; Statnikov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-319; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; The Montpellier Panel, 2014, NO ORD MATT CONS RES; Vagen T, 2010, AFSIS TECHNICAL SPEC; Van Ranst E., 2010, B S ANCES DACAD MIE, V56, P147; Walsh MG, 2006, LDSF GUIDE FIELD SAM; Wysocki DA, 2005, GEODERMA, V126, P167, DOI 10.1016/j.geoderma.2004.11.012	53	423	433	11	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0125814	10.1371/journal.pone.0125814	http://dx.doi.org/10.1371/journal.pone.0125814			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110833	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800004
J	Rhodes, DM; Smith, SA; Holcombe, M; Qwarnstrom, EE				Rhodes, David M.; Smith, Sarah A.; Holcombe, Mike; Qwarnstrom, Eva E.			Computational Modelling of NF-kappa B Activation by IL-1RI and Its Co-Receptor TILRR, Predicts a Role for Cytoskeletal Sequestration of I kappa B alpha in Inflammatory Signalling	PLOS ONE			English	Article							DEGRADATION; LOOP	The transcription factor NF-kappa B (nuclear factor kappa B) is activated by Toll-like receptors and controlled by mechanotransduction and changes in the cytoskeleton. In this study we combine 3-D predictive protein modelling and in vitro experiments with in silico simulations to determine the role of the cytoskeleton in regulation of NF-kappa B. Simulations used a comprehensive agent-based model of the NF-kappa B pathway, which includes the type 1 IL-1 receptor (IL-1R1) complex and signalling intermediates, as well as cytoskeletal components. Agent based modelling relies on in silico reproductions of systems through the interactions of its components, and provides a reliable tool in investigations of biological processes, which require spatial considerations and involve complex formation and translocation of regulatory components. We show that our model faithfully reproduces the multiple steps comprising the NF-kappa B pathway, and provides a framework from which we can explore novel aspects of the system. The analysis, using 3-D predictive protein modelling and in vitro assays, demonstrated that the NF-kappa B inhibitor, I kappa B alpha is sequestered to the actin/spectrin complex within the cytoskeleton of the resting cell, and released during IL-1 stimulation, through a process controlled by the IL-1RI co-receptor TILRR (Toll-like and IL-1 receptor regulator). In silico simulations using the agent-based model predict that the cytoskeletal pool of I kappa B alpha is released to adjust signal amplification in relation to input levels. The results suggest that the process provides a mechanism for signal calibration and enables efficient, activation-sensitive regulation of NF-kappa B and inflammatory responses.	[Rhodes, David M.; Smith, Sarah A.; Qwarnstrom, Eva E.] Univ Sheffield, Sch Med, Dept Cardiovasc Sci, Sheffield S10 2TN, S Yorkshire, England; [Rhodes, David M.; Holcombe, Mike] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield	Qwarnstrom, EE (corresponding author), Univ Sheffield, Sch Med, Dept Cardiovasc Sci, Sheffield S10 2TN, S Yorkshire, England.	e.qwarnstrom@sheffield.ac.uk		Qwarnstrom, Eva/0000-0003-4417-8663	UK government, Biotechnology and Biological Sciences Research Council UK [BB/J009687/1]; BBSRC [BB/J009687/1] Funding Source: UKRI; MRC [MC_PC_13076] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C515798/1, BB/J009687/1] Funding Source: researchfish; British Heart Foundation [PG/11/103/29219] Funding Source: researchfish	UK government, Biotechnology and Biological Sciences Research Council UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	The study was supported by a grant from the UK government, Biotechnology and Biological Sciences Research Council UK; http://www.bbsrc.ac.uk/home/home.aspx. Grant number BB/J009687/1 to EEQ and MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abagyan R, 2006, TRENDS BIOCHEM SCI, V31, P76, DOI 10.1016/j.tibs.2005.12.006; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baltimore D, 2011, NAT IMMUNOL, V12, P683, DOI 10.1038/ni.2072; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bowe RA, 2014, MOL BIOL CELL, V25, P184, DOI 10.1091/mbc.E13-06-0306; Carlotti F, 1999, J BIOL CHEM, V274, P37941, DOI 10.1074/jbc.274.53.37941; Carlotti F, 2000, J BIOL CHEM, V275, P41028, DOI 10.1074/jbc.M006179200; Davis CN, 2006, P NATL ACAD SCI USA, V103, P2953, DOI 10.1073/pnas.0510802103; Di Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052337; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Greenough C, RALTR2008022; Kanarek N, 2012, IMMUNOL REV, V246, P77, DOI 10.1111/j.1600-065X.2012.01098.x; Lamboy JA, 2011, P NATL ACAD SCI USA, V108, P10178, DOI 10.1073/pnas.1102226108; Legrand-Poels S, 2007, J CELL SCI, V120, P1299, DOI 10.1242/jcs.03424; Mammoto A, 2012, J CELL SCI, V125, P1, DOI [10.1242/jcs.105999, DOI 10.1242/JCS.105999]; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Pogson M, 2006, BIOSYSTEMS, V85, P37, DOI 10.1016/j.biosystems.2006.02.004; Pogson M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002367; Richmond P, 2010, BRIEF BIOINFORM, V11, P334, DOI 10.1093/bib/bbp073; Sriswasdi S, 2014, P NATL ACAD SCI USA, V111, P1801, DOI 10.1073/pnas.1317620111; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yang L, 2003, J BIOL CHEM, V278, P30881, DOI 10.1074/jbc.M212216200; Zhang X, 2012, J BIOL CHEM, V287, P12348, DOI 10.1074/jbc.C111.321711; Zhang X, 2010, J BIOL CHEM, V285, P7222, DOI 10.1074/jbc.M109.073429; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zheng LL, 2014, J CELL SCI, V127, P1306, DOI 10.1242/jcs.143255	31	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0129888	10.1371/journal.pone.0129888	http://dx.doi.org/10.1371/journal.pone.0129888			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110282	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000356933800033
J	Shen, J; Gopalakrishnan, V; Lee, JE; Fang, SY; Zhao, H				Shen, Jie; Gopalakrishnan, Vancheswaran; Lee, Jeffrey E.; Fang, Shenying; Zhao, Hua			Mitochondrial DNA Copy Number in Peripheral Blood and Melanoma Risk	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OXIDATIVE STRESS; MALIGNANT-MELANOMA; PANCREATIC-CANCER; VARIANTS; SUSCEPTIBILITY; PIGMENTATION; EPIDEMIOLOGY; GENETICS; SURVIVAL	Mitochondrial DNA (mtDNA) copy number in peripheral blood has been suggested as risk modifier in various types of cancer. However, its influence on melanoma risk is unclear. We evaluated the association between mtDNA copy number in peripheral blood and melanoma risk in 500 melanoma cases and 500 healthy controls from an ongoing melanoma study. The mtDNA copy number was measured using real-time polymerase chain reaction. Overall, mean mtDNA copy number was significantly higher in cases than in controls (1.15 vs 0.99, P<0.001). Increased mtDNA copy number was associated with a 1.45-fold increased risk of melanoma (95% confidence interval: 1.12-1.97). Significant joint effects between mtDNA copy number and variables related to pigmentation and history of sunlight exposure were observed. This study supports an association between increased mtDNA copy number and melanoma risk that is independent on the known melanoma risk factors (pigmentation and history of sunlight exposure).	[Shen, Jie; Gopalakrishnan, Vancheswaran; Zhao, Hua] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Lee, Jeffrey E.; Fang, Shenying] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Zhao, H (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	hzhao2@mdanderson.org	Gopalakrishnan, Vancheswaran/S-9550-2019	Gopalakrishnan, Vancheswaran/0000-0002-8704-035X; Fang, Shenying/0000-0002-0604-793X	NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ardestani Shidrokh, 2013, J Mol Signal, V8, P12, DOI 10.1186/1750-2187-8-12; Bataille V, 2013, CURR ONCOL REP, V15, P526, DOI 10.1007/s11912-013-0342-4; Boulton SJ, 2015, FASEB J, V29, P346, DOI 10.1096/fj.14-261982; Burgeiro A, 2013, EUR J PHARMACOL, V705, P109, DOI 10.1016/j.ejphar.2013.02.035; Crimi M, 2008, INT J NANOMED, V3, P51; Dong J, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.12.020; Erdei E, 2010, EXPERT REV ANTICANC, V10, P1811, DOI [10.1586/era.10.170, 10.1586/ERA.10.170]; Erdmann F, 2013, INT J CANCER, V132, P385, DOI 10.1002/ijc.27616; Fang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085642; Forsea AM, 2014, BRIT J DERMATOL, V171, P179, DOI 10.1111/bjd.12923; Gerstenblith MR, 2010, PIGM CELL MELANOMA R, V23, P587, DOI 10.1111/j.1755-148X.2010.00730.x; Gupte A, 2009, CANCER TREAT REV, V35, P32, DOI 10.1016/j.ctrv.2008.07.004; Han Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/825065; Hawkes JE, 2013, J DERMATOL SCI, V69, P30, DOI 10.1016/j.jdermsci.2012.09.016; Hofmann JN, 2014, CARCINOGENESIS, V35, P1028, DOI 10.1093/carcin/bgt495; Hosgood HD, 2010, CARCINOGENESIS, V31, P847, DOI 10.1093/carcin/bgq045; Hosnijeh FS, 2014, BLOOD, V124, P530, DOI 10.1182/blood-2013-10-532085; Huang B, 2014, CANCER EPIDEM BIOMAR, V23, P2357, DOI 10.1158/1055-9965.EPI-14-0297; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; Hyland PL., 2014, J CARCINOG MUTAGEN, V2014, pS006; Jenkins NC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/908797; Jiao Q, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/426028; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Kim SH, 2014, BIOCHEM BIOPH RES CO, V451, P246, DOI 10.1016/j.bbrc.2014.07.105; Kocarnik JM, 2014, J INVEST DERMATOL, V134, P2049, DOI 10.1038/jid.2014.53; Lan Q, 2008, BLOOD, V112, P4247, DOI 10.1182/blood-2008-05-157974; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; Liao LM, 2011, CANCER EPIDEM BIOMAR, V20, P1944, DOI 10.1158/1055-9965.EPI-11-0379; Liu CS, 2003, FREE RADICAL RES, V37, P1307, DOI 10.1080/10715760310001621342; Liu HL, 2013, CARCINOGENESIS, V34, P885, DOI 10.1093/carcin/bgs407; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lucas RM, 2008, INT J EPIDEMIOL, V37, P654, DOI 10.1093/ije/dyn017; Lynch SM, 2011, CANCER PREV RES, V4, P1912, DOI 10.1158/1940-6207.CAPR-11-0002; Maccioni L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-325; Mallet JD, 2014, PHOTOCHEM PHOTOBIOL, V90, P15, DOI 10.1111/php.12161; Mathers CD, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-36; Mayer JE, 2014, J AM ACAD DERMATOL, V71, DOI [10.1016/j.jaad.2014.05.045, 10.1016/j.jaad.2014.05.046]; Meng SS, 2012, PIGM CELL MELANOMA R, V25, P612, DOI 10.1111/j.1755-148X.2012.01023.x; Nourazarian AR, 2014, ASIAN PAC J CANCER P, V15, P4745, DOI 10.7314/APJCP.2014.15.12.4745; O'Sullivan NA, 2014, AUSTRALAS J DERMATOL, V55, P99, DOI 10.1111/ajd.12145; Pani G, 2010, CANCER METAST REV, V29, P351, DOI 10.1007/s10555-010-9225-4; Pavlides S, 2012, ANTIOXID REDOX SIGN, V16, P1264, DOI 10.1089/ars.2011.4243; Pena-Chilet M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-160; Pho LN, 2010, GIORN ITAL DERMAT V, V145, P37; Plym A, 2014, ACTA ONCOL, V53, P688, DOI 10.3109/0284186X.2013.854928; Qian J, 2013, PIGM CELL MELANOMA R, V26, P392, DOI 10.1111/pcmr.12069; Rendleman J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-279; Saretzki G, 2014, CURR PHARM DESIGN, V20, P6386, DOI 10.2174/1381612820666140630095606; Shen J, 2010, MITOCHONDRION, V10, P62, DOI 10.1016/j.mito.2009.09.004; Simons AL, 2009, J CANCER RES THER, V5, P2, DOI 10.4103/0973-1482.55133; Smit NPM, 2008, PHOTOCHEM PHOTOBIOL, V84, P550, DOI 10.1111/j.1751-1097.2007.00242.x; Stefanaki I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055712; Takeuchi H, 2004, ANN NY ACAD SCI, V1022, P50, DOI 10.1196/annals.1318.009; Thyagarajan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065968; Thyagarajan B, 2012, CANCER EPIDEM BIOMAR, V21, P1574, DOI 10.1158/1055-9965.EPI-12-0138-T; Usher-Smith JA, 2014, CANCER EPIDEM BIOMAR, V23, P1450, DOI 10.1158/1055-9965.EPI-14-0295; van den Hurk K, 2012, BBA-REV CANCER, V1826, P89, DOI 10.1016/j.bbcan.2012.03.011; VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122; Wei QY, 2003, J NATL CANCER I, V95, P308, DOI 10.1093/jnci/95.4.308; Wu L, 2014, CANCER EPIDEM BIOMAR, V23, P1121, DOI 10.1158/1055-9965.EPI-13-0627; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213; Zhang XJ, 2012, J DERMATOL SCI, V66, P89, DOI 10.1016/j.jdermsci.2012.02.017	62	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131649	10.1371/journal.pone.0131649	http://dx.doi.org/10.1371/journal.pone.0131649			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110424	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800166
J	Shringarpure, SS; Carroll, A; De La Vega, FM; Bustamante, CD				Shringarpure, Suyash S.; Carroll, Andrew; De La Vega, Francisco M.; Bustamante, Carlos D.			Inexpensive and Highly Reproducible Cloud-Based Variant Calling of 2,535 Human Genomes	PLOS ONE			English	Article								Population scale sequencing of whole human genomes is becoming economically feasible; however, data management and analysis remains a formidable challenge for many research groups. Large sequencing studies, like the 1000 Genomes Project, have improved our understanding of human demography and the effect of rare genetic variation in disease. Variant calling on datasets of hundreds or thousands of genomes is time-consuming, expensive, and not easily reproducible given the myriad components of a variant calling pipeline. Here, we describe a cloud-based pipeline for joint variant calling in large samples using the Real Time Genomics population caller. We deployed the population caller on the Amazon cloud with the DNAnexus platform in order to achieve low-cost variant calling. Using our pipeline, we were able to identify 68.3 million variants in 2,535 samples from Phase 3 of the 1000 Genomes Project. By performing the variant calling in a parallel manner, the data was processed within 5 days at a compute cost of $7.33 per sample (a total cost of $18,590 for completed jobs and $21,805 for all jobs). Analysis of cost dependence and running time on the data size suggests that, given near linear scalability, cloud computing can be a cheap and efficient platform for analyzing even larger sequencing studies in the future.	[Shringarpure, Suyash S.; De La Vega, Francisco M.; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Carroll, Andrew] DNAnexus, Mountain View, CA 94040 USA; [De La Vega, Francisco M.] Real Time Genom Inc, San Bruno, CA 94066 USA	Stanford University	Bustamante, CD (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	cdbustam@stanford.edu		Bustamante, Carlos D./0000-0002-4187-7920	NIH [U01HG005715]; Real Time Genomics, Inc.; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG005715] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Real Time Genomics, Inc.; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded in part by NIH grant U01HG005715. Compute and storage was donated by DNAnexus. Real Time Genomics, Inc. provided support in the form of salaries for author FDV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	Afgan E, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S12-S4; Allcock W., 2005, PROC ACM IEEE C SUPE, P54, DOI DOI 10.1109/SC.2005.72; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Cleary JG, 2014, J COMPUT BIOL, V21, P405, DOI 10.1089/cmb.2014.0029; de Alfonso C, 2013, FUTURE GENER COMP SY, V29, P704, DOI 10.1016/j.future.2012.08.014; Evani US, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S6-S19; Griffith R., 2009, SCIENCE, P07, DOI [10.1145/1721654.1721672, DOI 10.1145/1721654.1721672]; Gupta A, 2013, INT CONF CLOUD COMP, P306, DOI 10.1109/CloudCom.2013.47; Han E, 2014, MOL BIOL EVOL, V31, P723, DOI 10.1093/molbev/mst229; Huang ZY, 2013, IEEE GLOB CONF SIG, P49, DOI 10.1109/GlobalSIP.2013.6736809; Karczewski KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084860; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maraj Arianit, 2013, Proceedings of the 2013 55th International Symposium. ELMAR-2013, P239; Reid JG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-30; Schatz MC, 2009, BIOINFORMATICS, V25, P1363, DOI 10.1093/bioinformatics/btp236; Wilks C, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau093; Woitaszek Matthew, 2010, Proceedings of the 2010 IEEE 10th International Conference on Computer and Information Technology (CIT 2010), P210, DOI 10.1109/CIT.2010.72	19	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0129277	10.1371/journal.pone.0129277	http://dx.doi.org/10.1371/journal.pone.0129277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110529	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800023
J	de Melo, ISV; dos Santos, AF; de Lemos, TLG; Goulart, MOF; Santana, AEG				Vieira de Melo, Ingrid Sofia; dos Santos, Aldenir Feitosa; Gomes de Lemos, Telma Leda; Fonseca Goulart, Marilia Oliveira; Goulart Santana, Antonio Euzebio			Oncocalyxone A Functions As an Anti-Glycation Agent In Vitro	PLOS ONE			English	Article							AUXEMMA-ONCOCALYX; END-PRODUCTS; DIABETIC COMPLICATIONS; ANTIGLYCATION; CORDIACHROMES; ANTIOXIDANT; ENDPRODUCTS; FRACTION; PLANT; TAUB	Advanced glycation endproducts (AGE) are the result of post-translational changes to proteins, which ultimately compromise their structure and/or function. The identification of methods to prevent the formation of these compounds holds great promise in the development of alternative therapies for diseases such as diabetes. Plants used in traditional medicine are often rich sources of anti-glycation agents. Therefore, in this study, we investigated the anti-glycation activity of one such compound, Oncocalyxone A (Onco A). Using spectrofluorimetric techniques, we determined that Onco A inhibits AGE formation in a concentration-dependent manner. Its IC50 value (87.88 +/- 3.08 mu M) was almost two times lower than the standard anti-glycation compound aminoguanidine (184.68 +/- 4.85 mu M). The excellent anti-glycation activity of Onco A makes it an exciting candidate for the treatment of diseases associated with excessive accumulation of AGE. However, additional studies are necessary to identify its mechanism of action, as well as the in vivo response in suitable model organisms.	[Vieira de Melo, Ingrid Sofia; Fonseca Goulart, Marilia Oliveira; Goulart Santana, Antonio Euzebio] Univ Fed Alagoas, Inst Quim & Biotecnol, BR-57072970 Maceio, AL, Brazil; [Vieira de Melo, Ingrid Sofia] Inst Fed Alagoas, Dept Agroind, BR-57820000 Murici, AL, Brazil; [dos Santos, Aldenir Feitosa] Univ Estadual Alagoas, Dept Quim, BR-57312270 Arapiraca, AL, Brazil; [Gomes de Lemos, Telma Leda] Univ Fed Ceara, Dept Quim Organ & Inorgan, BR-60451970 Fortaleza, Ceara, Brazil	Universidade Federal de Alagoas; Instituto Federal de Alagoas (IFAL); Universidade Federal do Ceara	Santana, AEG (corresponding author), Univ Fed Alagoas, Inst Quim & Biotecnol, Cidade Univ,BR 101 Km 14, BR-57072970 Maceio, AL, Brazil.	aegs@qui.ufal.br	Goulart, Marilia/A-1199-2013; Sant'Ana, Antonio/AAP-6955-2021; de Lemos, Telma Leda Gomes/T-5750-2019; FEITOSA DOS SANTOS, ALDENIR/C-6916-2019	Goulart, Marilia/0000-0001-9860-3667; de Lemos, Telma Leda Gomes/0000-0002-7031-860X; FEITOSA DOS SANTOS, ALDENIR/0000-0001-6049-9446; Santana, Antonio/0000-0002-3750-438X				Barreto ACH, 2013, INT J MOL SCI, V14, P18269, DOI 10.3390/ijms140918269; Beaulieu LP, 2010, PHYTOTHER RES, V24, P741, DOI 10.1002/ptr.3025; Bodiga VL, 2014, HEART FAIL REV, V19, P49, DOI 10.1007/s10741-013-9374-y; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; Choudhary MI, 2011, SCI CHINA CHEM, V54, P1926, DOI 10.1007/s11426-011-4436-2; Costa CD, 2012, J BRAZIL CHEM SOC, V23, P1174, DOI 10.1590/S0103-50532012000600024; Elosta A, 2012, CURR DIABETES REV, V8, P92, DOI 10.2174/157339912799424528; Ferreira MAD, 2008, BRIT J PHARMACOL, V154, P1216, DOI 10.1038/bjp.2008.199; Ferreira MAD, 2004, PHYTOMEDICINE, V11, P315, DOI 10.1078/0944711041495227; Ferreira MAD, 2003, BIOL PHARM BULL, V26, P595, DOI 10.1248/bpb.26.595; Khan KM, 2010, LETT DRUG DES DISCOV, V7, P188, DOI 10.2174/157018010790596597; Khan KM, 2009, BIOORGAN MED CHEM, V17, P7795, DOI 10.1016/j.bmc.2009.09.028; Magadula J. J., 2014, European Journal of Medicinal Plants, V4, P1336, DOI 10.9734/EJMP/2014/10812; Muhammad N, 2013, J ENZYM INHIB MED CH, V28, P997, DOI 10.3109/14756366.2012.702344; Ono Y, 1998, DIABETES RES CLIN PR, V41, P131, DOI 10.1016/S0168-8227(98)00074-6; Park HY, 2010, ARCH PHARM RES, V33, P1159, DOI 10.1007/s12272-010-0804-2; Pessoa C, 2004, ARKIVOC, P89, DOI 10.3998/ark.5550190.0005.612; Pessoa O.D., 1993, NAT PROD LETT, V2, P145; PESSOA ODL, 1995, PHYTOCHEMISTRY, V40, P1777, DOI 10.1016/0031-9422(95)00397-P; Ramkissoon JS, 2013, ASIAN PAC J TROP MED, V6, P561, DOI 10.1016/S1995-7645(13)60097-8; Saraswat M, 2009, BRIT J NUTR, V101, P1714, DOI 10.1017/S0007114508116270; Sivagnanam I, 2013, INT J PHARM PHARM SC, V5, P630; Vasconcelos SML, 2007, QUIM NOVA, V30, P1323, DOI 10.1590/S0100-40422007000500046; Wu CH, 2005, J AGR FOOD CHEM, V53, P3167, DOI 10.1021/jf048550u; Yamagishi S, 1998, DIABETOLOGIA, V41, P1435, DOI 10.1007/s001250051089; Yamaguchi F, 2000, J AGR FOOD CHEM, V48, P180, DOI 10.1021/jf990845y	26	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131222	10.1371/journal.pone.0131222	http://dx.doi.org/10.1371/journal.pone.0131222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110531	gold, Green Published, Green Submitted			2022-12-27	WOS:000356933800131
J	Wos, G; Willi, Y				Wos, Guillaume; Willi, Yvonne			Temperature-Stress Resistance and Tolerance along a Latitudinal Cline in North American Arabidopsis lyrata	PLOS ONE			English	Article							EVOLUTIONARY DYNAMICS; FREEZING TOLERANCE; PLANT-RESISTANCE; RESPONSES; BENEFITS; GROWTH; COSTS; ENVIRONMENTS; ADAPTATION; STRATEGIES	The study of latitudinal gradients can yield important insights into adaptation to temperature stress. Two strategies are available: resistance by limiting damage, or tolerance by reducing the fitness consequences of damage. Here we studied latitudinal variation in resistance and tolerance to frost and heat and tested the prediction of a trade-off between the two strategies and their costliness. We raised plants of replicate maternal seed families from eight populations of North American Arabidopsis lyrata collected along a latitudinal gradient in climate chambers and exposed them repeatedly to either frost or heat stress, while a set of control plants grew under standard conditions. When control plants reached maximum rosette size, leaf samples were exposed to frost and heat stress, and electrolyte leakage (PEL) was measured and treated as an estimate of resistance. Difference in maximum rosette size between stressed and control plants was used as an estimate of tolerance. Northern populations were more frost resistant, and less heat resistant and less heat tolerant, but-unexpectedly-they were also less frost tolerant. Negative genetic correlations between resistance and tolerance to the same and different thermal stress were generally not significant, indicating only weak trade-offs. However, tolerance to frost was consistently accompanied by small size under control conditions, which may explain the non-adaptive latitudinal pattern for frost tolerance. Our results suggest that adaptation to frost and heat is not constrained by trade-offs between them. But the cost of frost tolerance in terms of plant size reduction may be important for the limits of species distributions and climate niches.	[Wos, Guillaume; Willi, Yvonne] Univ Neuchatel, Evolutionary Bot, Inst Biol, CH-2000 Neuchatel, Switzerland	University of Neuchatel	Wos, G (corresponding author), Univ Neuchatel, Evolutionary Bot, Inst Biol, CH-2000 Neuchatel, Switzerland.	guillaume.wos@unine.ch	Wos, Guillaume/G-4598-2019	Wos, Guillaume/0000-0001-9826-4159	Swiss National Science Foundation [PP00P3-123396/1]; Fondation Pierre Mercier pour la Science, Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Pierre Mercier pour la Science, Lausanne	The authors were supported by the Swiss National Science Foundation (PP00P3-123396/1 to YW) and the Fondation Pierre Mercier pour la Science, Lausanne (to YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2004, ECOL LETT, V7, P1199, DOI 10.1111/j.1461-0248.2004.00680.x; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Blodner C, 2007, PLANT CELL ENVIRON, V30, P165, DOI 10.1111/j.1365-3040.2006.01615.x; Carr DE, 2006, HEREDITY, V96, P29, DOI 10.1038/sj.hdy.6800743; CHAPIN FS, 1981, ARCTIC ALPINE RES, V13, P83; Conover DO, 2009, ANN NY ACAD SCI, V1168, P100, DOI 10.1111/j.1749-6632.2009.04575.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; De Frenne P, 2013, J ECOL, V101, P784, DOI 10.1111/1365-2745.12074; Dexter ST, 1930, PLANT PHYSIOL, V5, P215, DOI 10.1104/pp.5.2.215; El-Keblawy A, 1999, INT J PLANT SCI, V160, P331, DOI 10.1086/314136; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; FINEBLUM WL, 1995, NATURE, V377, P517, DOI 10.1038/377517a0; Griffin PC, 2014, ECOL LETT, V17, P484, DOI 10.1111/ele.12248; Gurvich DE, 2002, GLOBAL CHANGE BIOL, V8, P1139, DOI 10.1046/j.1365-2486.2002.00540.x; Hedrick PW, 2006, ANNU REV ECOL EVOL S, V37, P67, DOI 10.1146/annurev.ecolsys.37.091305.110132; HOFFMANN AA, 1994, TRENDS ECOL EVOL, V9, P223, DOI 10.1016/0169-5347(94)90248-8; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; LANDE R, 1979, EVOLUTION, V33, P234, DOI [10.2307/2407380, 10.1111/j.1558-5646.1979.tb04678.x]; Li B, 1998, OECOLOGIA, V115, P293, DOI 10.1007/s004420050519; Mauricio R, 1997, ECOLOGY, V78, P1301, DOI 10.1890/0012-9658(1997)078[1301:VITDSO]2.0.CO;2; Mauricio R, 2000, EVOL ECOL, V14, P491, DOI 10.1023/A:1010909829269; Nunez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541, DOI 10.1146/annurev.ecolsys.38.091206.095822; Paccard A, 2013, J EVOLUTION BIOL, V26, P2331, DOI 10.1111/jeb.12220; Paccard A, 2014, OECOLOGIA, V175, P577, DOI 10.1007/s00442-014-2932-8; Quilot-Turion B, 2013, ANN BOT-LONDON, V111, P957, DOI 10.1093/aob/mct055; Rasband W, IMAGEJ; Riihimaki M, 2004, AM J BOT, V91, P1036, DOI 10.3732/ajb.91.7.1036; Ritz C, 2005, J STAT SOFTW, V12, P1; Roff Derek A., 1992; Roy BA, 2000, EVOLUTION, V54, P51, DOI 10.1111/j.0014-3820.2000.tb00007.x; Sandring S, 2007, J EVOLUTION BIOL, V20, P558, DOI 10.1111/j.1420-9101.2006.01260.x; Schmickl R, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-98; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; SIMMS EL, 1987, AM NAT, V130, P570, DOI 10.1086/284731; SIMMS EL, 1994, EVOLUTION, V48, P1973, DOI 10.1111/j.1558-5646.1994.tb02227.x; Stearns S.C., 1992, pi; Suter L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080819; Valverde PL, 2003, J EVOLUTION BIOL, V16, P127, DOI 10.1046/j.1420-9101.2003.00482.x; VANDERMEIJDEN E, 1988, OIKOS, V51, P355, DOI 10.2307/3565318; Weinig C, 2003, EVOLUTION, V57, P1270, DOI 10.1111/j.0014-3820.2003.tb00335.x; Willi Y, 2010, J EVOLUTION BIOL, V23, P2123, DOI 10.1111/j.1420-9101.2010.02073.x; Willi Y, 2013, EVOLUTION, V67, P806, DOI 10.1111/j.1558-5646.2012.01818.x; Zhen Y, 2008, NEW PHYTOL, V177, P419, DOI 10.1111/j.1469-8137.2007.02262.x; Zuther E, 2012, PLANT CELL ENVIRON, V35, P1860, DOI 10.1111/j.1365-3040.2012.02522.x	44	19	19	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131808	10.1371/journal.pone.0131808	http://dx.doi.org/10.1371/journal.pone.0131808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110428	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800178
J	Yang, H; Peng, YF; Ni, HM; Li, Y; Shi, YH; Ding, WX; Fan, J				Yang, Hua; Peng, Yuan-Fei; Ni, Hong-Min; Li, Yuan; Shi, Ying-Hong; Ding, Wen-Xing; Fan, Jia			Basal Autophagy and Feedback Activation of Akt Are Associated with Resistance to Metformin-Induced Inhibition of Hepatic Tumor Cell Growth	PLOS ONE			English	Article							PROTEIN-KINASE; LIVER-CANCER; HEPATOCELLULAR-CARCINOMA; MTOR COMPLEX; STRESS; RISK; PHOSPHORYLATION; METAANALYSIS; PROTEASOME; MECHANISM	While accumulating evidence has shown that the use of the diabetic drug metformin may be beneficial against various tumors in some epidemiological studies, a few studies failed to show the same beneficial effects. The molecular and cellular mechanisms for these conflicting observations are not clear. In this study, we compared the inhibitory effects of cell growth by metformin on several hepatic tumor cell lines: SMMC-7721, HCC-97L, HCC-LM3 and HepG2. While metformin inhibited cell growth in all these cells, we found that SMMC-7721, HCC-97L and HCC-LM3 cells were more resistant than HepG2 cells. Mechanistically, we found that metformin inhibited mTOR in all these hepatic tumor cells. However, SMMC7721 cells had higher levels of basal autophagy and mTORC2-mediated feedback activation of Akt than HepG2 cells, which may render SMMC-7721 cells to be more resistant to metformin-induced inhibition of cell growth. Similarly, HCC-97L and HCC-LM3 cells also had higher feedback activation of AKT than HepG2 cells, which may also account for their resistance to metformin-induced inhibition of cell growth. Therefore, the various basal autophagy and mTOR activity in different cancer cells may contribute to the controversial findings on the use of metformin in inhibition of cancers in humans.	[Yang, Hua; Peng, Yuan-Fei; Shi, Ying-Hong; Fan, Jia] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Shanghai 200032, Peoples R China; [Yang, Hua; Ni, Hong-Min; Li, Yuan; Ding, Wen-Xing] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA	Fudan University; University of Kansas; University of Kansas Medical Center	Ding, WX (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA.	wxding@kumc.edu; fan.jia@zs-hospital.sh.cn	Shi, Ying-Hong/B-7063-2017; Li, Yuan/J-7786-2019; Fan, Jia/C-6689-2017	Li, Yuan/0000-0002-3171-8053; 	National Institute on Alcohol Abuse and Alcoholism (NIAAA) [R01 AA020518]; National Institute of Diabetes and Digestive and Kidney [R01 DK102142]; National Center for Research Resources [5P20RR021940-07]; National Institute of General Medical Sciences [8 P20 GM103549-07]; Institutional Development Award (IDeA) from National Institute of General Medical Sciences of National Institutes of Health [P20 GM103418]; National Natural Science Foundation of China [81030038, 81272389]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103549, P20GM103418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA020518, R01AA020518] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Diabetes and Digestive and Kidney(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Institutional Development Award (IDeA) from National Institute of General Medical Sciences of National Institutes of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported in part by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) funds R01 AA020518 (W.X.D), National Institute of Diabetes and Digestive and Kidney R01 DK102142 (W.X.D) and by grants from the National Center for Research Resources (5P20RR021940-07) and the National Institute of General Medical Sciences (8 P20 GM103549-07), an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (P20 GM103418), as well as National Natural Science Foundation of China (No. 81030038, 81272389, J.F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; Ding WX, 2009, MOL CANCER THER, V8, P2036, DOI 10.1158/1535-7163.MCT-08-1169; Ding WX, 2004, HEPATOLOGY, V40, P403, DOI 10.1002/hep.20310; Forner A, 2012, LANCET; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hagberg KW, 2014, BRIT J CANCER, V111, P1710, DOI 10.1038/bjc.2014.447; HUNDAL HS, 1992, ENDOCRINOLOGY, V131, P1165, DOI 10.1210/en.131.3.1165; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Li Y, 2003, J CANCER RES CLIN, V129, P43, DOI 10.1007/s00432-002-0396-4; Liao C, 2000, HEPATOLOGY, V32, P721, DOI 10.1053/jhep.2000.17967; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Thorgeirsson SS, 2006, J HEPATOL, V44, P798, DOI 10.1016/j.jhep.2006.01.008; Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86; Tsilidis KK, 2014, DIABETES CARE, V37, P2522, DOI 10.2337/dc14-0584; Williams JA, 2013, PHARM RES-DORDR, V30, P2279, DOI 10.1007/s11095-013-1139-8; Zhang ZJ, 2014, AM J EPIDEMIOL, V180, P11, DOI 10.1093/aje/kwu124; Zhang ZJ, 2012, J CLIN ENDOCR METAB, V97, P2347, DOI 10.1210/jc.2012-1267; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	29	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130953	10.1371/journal.pone.0130953	http://dx.doi.org/10.1371/journal.pone.0130953			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111001	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800102
J	Deng, XZ; Michaelson, D; Tchieu, J; Cheng, J; Rothenstein, D; Feldman, R; Lee, SG; Fuller, J; Haimovitz-Friedman, A; Studer, L; Powell, S; Fuks, Z; Hubbard, EJA; Kolesnick, R				Deng, Xinzhu; Michaelson, David; Tchieu, Jason; Cheng, Jin; Rothenstein, Diana; Feldman, Regina; Lee, Sang-gyu; Fuller, John; Haimovitz-Friedman, Adriana; Studer, Lorenz; Powell, Simon; Fuks, Zvi; Hubbard, E. Jane Albert; Kolesnick, Richard			Targeting Homologous Recombination in Notch-Driven C-elegans Stem Cell and Human Tumors	PLOS ONE			English	Article							STRAND BREAK REPAIR; CAENORHABDITIS-ELEGANS; DNA-DAMAGE; GERM-LINE; PATHWAY; DEATH; ACTIVATION; LIN-12; GLP-1; PROLIFERATION	Mammalian NOTCH1-4 receptors are all associated with human malignancy, although exact roles remain enigmatic. Here we employ glp-1(ar202), a temperature-sensitive gain-of-function C. elegans NOTCH mutant, to delineate NOTCH-driven tumor responses to radiotherapy. At <= 20 degrees C, glp-1(ar202) is wild-type, whereas at 25 degrees C it forms a germline stem cell/progenitor cell tumor reminiscent of human cancer. We identify a NOTCH tumor phenotype in which all tumor cells traffic rapidly to G2/M post-irradiation, attempt to repair DNA strand breaks exclusively via homology-driven repair, and when this fails die by mitotic death. Homology-driven repair inactivation is dramatically radiosensitizing. We show that these concepts translate directly to human cancer models.	[Deng, Xinzhu; Cheng, Jin; Rothenstein, Diana; Feldman, Regina; Lee, Sang-gyu; Fuller, John; Kolesnick, Richard] Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, New York, NY 10021 USA; [Michaelson, David; Hubbard, E. Jane Albert] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Stem Cell Biol, Skirball Inst Biomol Med,Dept Cell Biol, New York, NY USA; [Tchieu, Jason; Studer, Lorenz] Mem Sloan Kettering Canc Ctr, Ctr Stem Cell Biol, New York, NY 10021 USA; [Haimovitz-Friedman, Adriana; Powell, Simon; Fuks, Zvi] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; New York University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Kolesnick, R (corresponding author), Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, 1275 York Ave, New York, NY 10021 USA.	r-kolesnick@ski.mskcc.org	Studer, Lorenz/ABH-1491-2021; Tchieu, Jason/AAG-1551-2020	Studer, Lorenz/0000-0003-0741-7987; Tchieu, Jason/0000-0002-9793-9836; Cheng, Jin/0000-0002-4364-9657; Hubbard, E. Jane Albert/0000-0001-5893-7232	NCI NIH HHS [P30 CA016087, R01 CA169306, P30 CA008748] Funding Source: Medline; NIGMS NIH HHS [R01 GM 061706, R01 GM061706] Funding Source: Medline; NIH HHS [P40 OD010440] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA169306, P30CA016087, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061706] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; Altman DG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d2090; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; BEDFORD JS, 1978, RADIAT RES, V76, P573, DOI 10.2307/3574806; Berry LW, 1997, DEVELOPMENT, V124, P925; BRENNER S, 1974, GENETICS, V77, P71; Chin GM, 2001, GENE DEV, V15, P522, DOI 10.1101/gad.864101; Clejan I, 2006, GENETICS, V173, P1301, DOI 10.1534/genetics.106.058628; Deng XZ, 2004, NAT GENET, V36, P906, DOI 10.1038/ng1396; DEWEY WC, 1971, P NATL ACAD SCI USA, V68, P667, DOI 10.1073/pnas.68.3.667; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Feng H, 1999, NAT CELL BIOL, V1, P486, DOI 10.1038/70272; Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; GREENWALD IS, 1983, CELL, V34, P435, DOI 10.1016/0092-8674(83)90377-X; Hayashi M, 2007, PLOS GENET, V3, P2068, DOI 10.1371/journal.pgen.0030191; Hua GQ, 2012, GASTROENTEROLOGY, V143, P1266, DOI 10.1053/j.gastro.2012.07.106; Hubbard EJA, 2007, DEV DYNAM, V236, P3343, DOI 10.1002/dvdy.21335; Joshi PM, 2010, DEV DYNAM, V239, P1539, DOI 10.1002/dvdy.22296; Kershner AM, 2014, P NATL ACAD SCI USA, V111, P3739, DOI 10.1073/pnas.1401861111; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lemmens BBLG, 2011, CHROMOSOMA, V120, P1, DOI 10.1007/s00412-010-0296-3; Lobry C, 2014, BLOOD, V123, P2451, DOI 10.1182/blood-2013-08-355818; McAuliffe SM, 2012, P NATL ACAD SCI USA, V109, pE2939, DOI 10.1073/pnas.1206400109; Michaelson D, 2010, DEVELOPMENT, V137, P671, DOI 10.1242/dev.042523; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Morgan SE, 1997, CANCER RES, V57, P3386; Morgan WF, 2012, RADIAT RES, V178, pAV223, DOI 10.1667/RRAV19.1; Moser BA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000622; NEWMAN AP, 1995, DEVELOPMENT, V121, P263; Nomiya T, 2013, J RADIAT RES, V54, P1161, DOI 10.1093/jrr/rrt075; OKUNIEFF P, 1995, INT J RADIAT ONCOL, V33, P961, DOI 10.1016/0360-3016(95)02142-0; Palomero T, 2006, LEUKEMIA, V20, P1279, DOI 10.1038/sj.leu.2404258; Pepper ASR, 2003, DEV BIOL, V259, P336, DOI 10.1016/S0012-1606(03)00203-3; Pepper ASR, 2003, GENETICS, V163, P115; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Rodriguez A, 2001, J VIROL, V75, P4482, DOI 10.1128/JVI.75.10.4482-4489.2001; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Stergiou L, 2004, CELL DEATH DIFFER, V11, P21, DOI 10.1038/sj.cdd.4401340; Stiernagle Theresa, 2006, WormBook, P1; Surova O, 2013, ONCOGENE, V32, P3789, DOI 10.1038/onc.2012.556; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Wang JL, 2012, ADV EXP MED BIOL, V727, P174, DOI 10.1007/978-1-4614-0899-4_13; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Xue D, 1996, GENE DEV, V10, P1073, DOI 10.1101/gad.10.9.1073; YOCHEM J, 1989, CELL, V58, P553, DOI 10.1016/0092-8674(89)90436-4	53	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0127862	10.1371/journal.pone.0127862	http://dx.doi.org/10.1371/journal.pone.0127862			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26120834	Green Published, gold			2022-12-27	WOS:000358150400008
J	Grenier, D; Chen, HQ; Ben Lagha, A; Fournier-Larente, J; Morin, MP				Grenier, Daniel; Chen, Huangqin; Ben Lagha, Amel; Fournier-Larente, Jade; Morin, Marie-Pierre			Dual Action of Myricetin on Porphyromonas gingivalis and the Inflammatory Response of Host Cells: A Promising Therapeutic Molecule for Periodontal Diseases	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; ORAL-HEALTH; IRON; POLYPHENOLS; FLAVONOIDS; CYTOKINE; INTERLEUKIN-6; FIBROBLASTS; PERSPECTIVE; MECHANISMS	Periodontitis that affects the underlying structures of the periodontium, including the alveolar bone, is a multifactorial disease, whose etiology involves interactions between specific bacterial species of the subgingival biofilm and the host immune components. In the present study, we investigated the effects of myricetin, a flavonol largely distributed in fruits and vegetables, on growth and virulence properties of Porphyromonas gingivalis as well as on the P. gingivalis-induced inflammatory response in host cells. Minimal inhibitory concentration values of myricetin against P. gingivalis were in the range of 62.5 to 125 mu g/ml. The iron-chelating activity of myricetin may contribute to the antibacterial activity of this flavonol. Myricetin was found to attenuate the virulence of P. gingivalis by reducing the expression of genes coding for important virulence factors, including proteinases (rgpA, rgpB, and kgp) and adhesins (fimA, hagA, and hagB). Myricetin dose-dependently prevented NF-kappa B activation in a monocyte model. Moreover, it inhibited the secretion of IL-6, IL-8 and MMP-3 by P. gingivalis-stimulated gingival fibroblasts. In conclusion, our study brought clear evidence that the flavonol myricetin exhibits a dual action on the periodontopathogenic bacterium P. gingivalis and the inflammatory response of host cells. Therefore, myricetin holds promise as a therapeutic agent for the treatment/prevention of periodontitis.	Univ Laval, Fac Dent, Oral Ecol Res Grp, Quebec City, PQ, Canada; [Chen, Huangqin] Hubei Univ Sci & Technol, Dept Stomatol, Xianning City, Hubei Province, Peoples R China	Laval University; Hubei University of Science & Technology	Grenier, D (corresponding author), Univ Laval, Fac Dent, Oral Ecol Res Grp, Quebec City, PQ, Canada.	Daniel.Grenier@greb.ulaval.ca			Laboratoire de Controle Microbiologique [2014-15]	Laboratoire de Controle Microbiologique	This work was funded by Laboratoire de Controle Microbiologique 2014-15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albandar JM, 2011, J PERIODONTOL, V82, P337, DOI 10.1902/jop.2011.100638; Anaya-Bergman C, 2015, MOL ORAL MICROBIOL, V30, P39, DOI 10.1111/omi.12066; Azelmat J, 2015, ARCHS ORAL IN PRESS; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Banerjee A, 2015, BRIT J HAEMATOL, V168, P576, DOI 10.1111/bjh.13151; Bartold PM, 2013, PERIODONTOL 2000, V62, P203, DOI 10.1111/j.1600-0757.2012.00450.x; BARUA PK, 1990, ORAL MICROBIOL IMMUN, V5, P263; Berezow AB, 2011, PERIODONTOL 2000, V55, P36, DOI 10.1111/j.1600-0757.2010.00350.x; Boelaert JR, 1996, ACTA CLIN BELG, V51, P213, DOI 10.1080/22953337.1996.11718513; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Cai LN, 1996, J NAT PROD, V59, P987, DOI 10.1021/np960451q; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; de Souza JAC, 2012, J APPL ORAL SCI, V20, P128, DOI 10.1590/S1678-77572012000200002; Dashper SG, 2009, J BACTERIOL, V191, P1044, DOI 10.1128/JB.01270-08; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; EMERY T, 1971, BIOCHEMISTRY-US, V10, P1483, DOI 10.1021/bi00784a033; Enersen M, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.20265; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Gutierrez-Venegas G, 2013, MICROBIOL IMMUNOL, V57, P849, DOI 10.1111/1348-0421.12103; Hakkinen SH, 1999, J AGR FOOD CHEM, V47, P2274, DOI 10.1021/jf9811065; Hinz B, 2013, PERIODONTOL 2000, V63, P14, DOI 10.1111/prd.12030; Ide M, 2014, BRIT DENT J, V217, P467, DOI 10.1038/sj.bdj.2014.903; Ide R, 2007, J PERIODONTOL, V78, P2120, DOI 10.1902/jop.2007.070193; Jain S, 2010, PERIODONTOL 2000, V54, P53, DOI 10.1111/j.1600-0757.2009.00333.x; Jin HT, 2014, FITOTERAPIA, V94, P55, DOI 10.1016/j.fitote.2014.01.017; Karlsson E, 2009, INT J DENT HYG, V7, P23, DOI 10.1111/j.1601-5037.2008.00332.x; Kato H, 2014, ARCH ORAL BIOL, V59, P167, DOI 10.1016/j.archoralbio.2013.11.008; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kitano S, 2001, JPN J PHARMACOL, V85, P84, DOI 10.1254/jjp.85.84; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Lopez NJ, 2000, J PERIODONTOL, V71, P948, DOI 10.1902/jop.2000.71.6.948; MEIKLE MC, 1994, J PERIODONTAL RES, V29, P118, DOI 10.1111/j.1600-0765.1994.tb01100.x; Messa E, 2010, HAEMATOL-HEMATOL J, V95, P1308, DOI 10.3324/haematol.2009.016824; Moon JH, 2013, J MED MICROBIOL, V62, P1307, DOI 10.1099/jmm.0.053553-0; MORI A, 1987, PHYTOCHEMISTRY, V26, P2231, DOI 10.1016/S0031-9422(00)84689-0; Mysak J, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/476068; O'Brien-Simpson NM, 2004, PERIODONTOL 2000, V35, P101, DOI 10.1111/j.0906-6713.2004.003559.x; Ong KC, 1997, GEN PHARMACOL-VASC S, V29, P121, DOI 10.1016/S0306-3623(96)00421-1; Otomo-Corgel Joan, 2012, J Evid Based Dent Pract, V12, P20, DOI 10.1016/S1532-3382(12)70006-4; Palaska I, 2013, EUR J PHARMACOL, V720, P77, DOI 10.1016/j.ejphar.2013.10.047; Papanicolaou DA, 1998, ANN INTERN MED, V128, P127, DOI 10.7326/0003-4819-128-2-199801150-00009; Petti S, 2009, J DENT, V37, P413, DOI 10.1016/j.jdent.2009.02.003; Preshaw PM, 2004, J CLIN PERIODONTOL, V31, P697, DOI 10.1111/j.1600-051X.2004.00558.x; Puupponen-Pimia R, 2001, J APPL MICROBIOL, V90, P494, DOI 10.1046/j.1365-2672.2001.01271.x; Rajagopalan S, 1996, J CLIN INVEST, V98, P2572, DOI 10.1172/JCI119076; Sapna G, 2014, ORAL DIS, V20, P538, DOI 10.1111/odi.12159; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Survay NS, 2011, J KOREAN SOC APPL BI, V54, P1, DOI 10.3839/jksabc.2011.001; Takashiba S, 2003, J PERIODONTOL, V74, P103, DOI 10.1902/jop.2003.74.1.103; Varoni EM, 2012, CURR MED CHEM, V19, P1706; Wang PL, 2003, BIOCHEM BIOPH RES CO, V305, P970, DOI 10.1016/S0006-291X(03)00821-0; Wei YB, 2014, BIOL TRACE ELEM RES, V161, P223, DOI 10.1007/s12011-014-0099-0; WOOLDRIDGE KG, 1993, FEMS MICROBIOL REV, V12, P325, DOI 10.1016/0168-6445(93)90011-W	55	26	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131758	10.1371/journal.pone.0131758	http://dx.doi.org/10.1371/journal.pone.0131758			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121135	Green Published, Green Submitted, gold			2022-12-27	WOS:000358150400154
J	Leonard, CA; Lee, WY; Tailor, P; Salo, PT; Kubes, P; Krawetz, RJ				Leonard, Catherine A.; Lee, Woo-Yong; Tailor, Pankaj; Salo, Paul T.; Kubes, Paul; Krawetz, Roman J.			Allogeneic Bone Marrow Transplant from MRL/MpJ Super-Healer Mice Does Not Improve Articular Cartilage Repair in the C57BI/6 Strain	PLOS ONE			English	Article							POSTTRAUMATIC ARTHRITIS; REGENERATION; CELLS; SKIN; OSTEOARTHRITIS; MECHANISMS; DEFECTS; C57BL/6; ORIGIN; HEART	Background Articular cartilage has been the focus of multiple strategies to improve its regenerative/repair capacity. The Murphy Roths Large (MRL/MpJ) "super-healer" mouse demonstrates an unusual enhanced regenerative capacity in many tissues and provides an opportunity to further study endogenous cartilage repair. The objective of this study was to test whether the super-healer phenotype could be transferred from MRL/MpJ to non-healer C57BI/6 mice by allogeneic bone marrow transplant. Methodology The healing of 2mm ear punches and full thickness cartilage defects was measured 4 and 8 weeks after injury in control C57BI/6 and MRL/MpJ "super-healer" mice, and in radiation chimeras reconstituted with bone marrow from the other mouse strain. Healing was assessed using ear hole diameter measurement, a 14 point histological scoring scale for the cartilage defect and an adapted version of the Osteoarthritis Research Society International scale for assessment of osteoarthritis in mouse knee joints. Principal Findings Normal and chimeric MRL mice showed significantly better healing of articular cartilage and ear wounds along with less severe signs of osteoarthritis after cartilage injury than the control strain. Contrary to our hypothesis, however, bone marrow transplant from MRL mice did not confer improved healing on the C57BI/6 chimeras, either in regards to ear wound healing or cartilage repair. Conclusion and Significance The elusive cellular basis for the MRL regenerative phenotype still requires additional study and may possibly be dependent on additional cell types external to the bone marrow.	[Leonard, Catherine A.; Tailor, Pankaj; Salo, Paul T.; Krawetz, Roman J.] Univ Calgary, Dept Surg, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada; [Lee, Woo-Yong; Kubes, Paul] Univ Calgary, Dept Physiol & Pharmacol, Calvin Phoebe & Joan Snyder Inst Chron Dis, Calgary, AB, Canada	University of Calgary; University of Calgary	Krawetz, RJ (corresponding author), Univ Calgary, Dept Surg, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada.	rkrawetz@ucalgary.ca			Pfizer; Alberta Innovates-Health Solutions (team grant in osteoarthritis); Canadian Institutes for Health Research (Institute of Musculoskeletal Health and Arthritis)	Pfizer(Pfizer); Alberta Innovates-Health Solutions (team grant in osteoarthritis); Canadian Institutes for Health Research (Institute of Musculoskeletal Health and Arthritis)	This study was supported by research grants from Pfizer, Alberta Innovates-Health Solutions (team grant in osteoarthritis), and Canadian Institutes for Health Research (Institute of Musculoskeletal Health and Arthritis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anraku Y, 2009, J BONE MINER METAB, V27, P272, DOI 10.1007/s00774-009-0038-x; Barry F, 2013, NAT REV RHEUMATOL, V9, P584, DOI 10.1038/nrrheum.2013.109; Bedelbaeva K, 2004, CLONING STEM CELLS, V6, P352, DOI 10.1089/clo.2004.6.352; Bedelbaeva K, 2010, P NATL ACAD SCI USA, V107, P5845, DOI 10.1073/pnas.1000830107; Carvalho-Tavares J, 2000, CIRC RES, V87, P1141, DOI 10.1161/01.RES.87.12.1141; Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519; Colwell AS, 2006, WOUND REPAIR REGEN, V14, P81, DOI 10.1111/j.1524-475X.2005.00092.x; Diekman BO, 2013, CELL TRANSPLANT, V22, P1395, DOI 10.3727/096368912X653264; Fathke C, 2004, STEM CELLS, V22, P812, DOI 10.1634/stemcells.22-5-812; Fitzgerald J, 2008, OSTEOARTHR CARTILAGE, V16, P1319, DOI 10.1016/j.joca.2008.03.014; Fukada S, 2002, J CELL SCI, V115, P1285; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Grisel P, 2008, CARDIOVASC PATHOL, V17, P14, DOI 10.1016/j.carpath.2007.01.007; Hayakawa J, 2003, INT J HEMATOL, V77, P456, DOI 10.1007/BF02986613; Heber-Katz E, 2004, PHILOS T ROY SOC B, V359, P785, DOI 10.1098/rstb.2004.1468; Heydeman A, 1998, FRONT BIOL, V7, P522; Jinks C, 2007, RHEUMATOLOGY, V46, P877, DOI 10.1093/rheumatology/kem013; Kench JA, 1999, CLIN IMMUNOL, V92, P300, DOI 10.1006/clim.1999.4754; KITAGAWA H, 1993, IMMUNOBIOLOGY, V188, P99, DOI 10.1016/S0171-2985(11)80490-0; Kurth TB, 2011, ARTHRITIS RHEUM-US, V63, P1289, DOI 10.1002/art.30234; Lewis JS, 2013, ARTHRITIS RHEUM-US, V65, P660, DOI 10.1002/art.37796; Mak J, 2015, MAGN RESON IMAGING, V33, P690, DOI 10.1016/j.mri.2015.01.001; Miyashima S, 1996, J IMMUNOL, V156, P79; Rai MF, 2014, MATRIX BIOL, V39, P50, DOI 10.1016/j.matbio.2014.08.011; Rai MF, 2013, G3-GENES GENOM GENET, V3, P1881, DOI 10.1534/g3.113.007302; Rai MF, 2012, ARTHRITIS RHEUM-US, V64, P2300, DOI 10.1002/art.34396; SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009; Tolba RH, 2010, WOUND REPAIR REGEN, V18, P662, DOI 10.1111/j.1524-475X.2010.00631.x; Ueno M, INVEST OPHTHALMOL VI, V46, P4097; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Ward BD, 2008, ARTHRITIS RHEUM-US, V58, P744, DOI 10.1002/art.23288	31	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131661	10.1371/journal.pone.0131661	http://dx.doi.org/10.1371/journal.pone.0131661			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26120841	gold, Green Published, Green Submitted			2022-12-27	WOS:000358150400134
J	Bosschem, I; Bayry, J; De Bruyne, E; Van Deun, K; Smet, A; Vercauteren, G; Ducatelle, R; Haesebrouck, F; Flahou, B				Bosschem, Iris; Bayry, Jagadeesh; De Bruyne, Ellen; Van Deun, Kim; Smet, Annemieke; Vercauteren, Griet; Ducatelle, Richard; Haesebrouck, Freddy; Flahou, Bram			Effect of Different Adjuvants on Protection and Side-Effects Induced by Helicobacter suis Whole-Cell Lysate Vaccination	PLOS ONE			English	Article							REGULATORY T-CELLS; PYLORI INFECTION; IMMUNE-RESPONSE; POSTIMMUNIZATION GASTRITIS; BACTERIAL-COLONIZATION; ORAL IMMUNIZATION; UREASE; MICE; CCR4; CLASSIFICATION	Helicobacter suis (H. suis) is a widespread porcine gastric pathogen, which is also of zoonotic importance. The first goal of this study was to investigate the efficacy of several vaccine adjuvants (CpG-DNA, Curdlan, Freund's Complete and Incomplete, Cholera toxin), administered either subcutaneously or intranasally along with H. suis whole-cell lysate, to protect against subsequent H. suis challenge in a BALB/c infection model. Subcutaneous immunization with Freund's complete (FC)/lysate and intranasal immunization with Cholera toxin (CT)/lysate were shown to be the best options for vaccination against H. suis, as determined by the amount of colonizing H. suis bacteria in the stomach, although adverse effects such as post-immunization gastritis/pseudo-pyloric metaplasia and increased mortality were observed, respectively. Therefore, we decided to test alternative strategies, including sublingual vaccine administration, to reduce the unwanted side-effects. A CCR4 antagonist that transiently inhibits the migration of regulatory T cells was also included as a new adjuvant in this second study. Results confirmed that immunization with CT (intranasally or sublingually) is among the most effective vaccination protocols, but increased mortality was still observed. In the groups immunized subcutaneously with FC/lysate and CCR4 antagonist/lysate, a significant protection was observed. Compared to the FC/lysate immunized group, gastric pseudo-pyloric metaplasia was less severe or even absent in the CCR4 antagonist/lysate immunized group. In general, an inverse correlation was observed between IFN-gamma, IL-4, IL-17, KC, MIP-2 and LIX mRNA expression and H. suis colonization density, whereas lower IL-10 expression levels were observed in partially protected animals.	[Bosschem, Iris; De Bruyne, Ellen; Van Deun, Kim; Smet, Annemieke; Vercauteren, Griet; Ducatelle, Richard; Haesebrouck, Freddy; Flahou, Bram] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [Bayry, Jagadeesh] Inst Natl Sante & Rech Med, Unite 1138, Paris, France; [Bayry, Jagadeesh] Ctr Rech Cordeliers, Equipe Immunopathol & Therapeut Immunointervent, Paris, France; [Bayry, Jagadeesh] Univ Paris 06, Sorbonne Univ, UMR S 1138, Paris, France; [Bayry, Jagadeesh] Univ Paris 05, Sorbonne Paris Cite, UMR S 1138, Paris, France	Ghent University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Bosschem, I (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	Iris.Bosschem@ugent.be; Freddy.Haesebrouck@ugent.be; Bram.Flahou@ugent.be	Bayry, Jagadeesh/A-6589-2011; Haesebrouck, Freddy/M-3857-2014; Smet, Annemieke/M-9295-2017	Bayry, Jagadeesh/0000-0003-0498-9808; Haesebrouck, Freddy/0000-0002-1709-933X; Smet, Annemieke/0000-0002-1271-6191	agency for Innovation by Science and Technology [090996]; Research Fund of Ghent University, Ghent, Belgium [GOA01G00408]	agency for Innovation by Science and Technology; Research Fund of Ghent University, Ghent, Belgium(Ghent University)	This work was supported by a grant from the agency for Innovation by Science and Technology (http://www.iwt.be/IWT grant 090996 received by KVD) and by a grant from the Research Fund of Ghent University, Ghent, Belgium (https://www.ugent.be/nl/onderzoek/financiering/bof/goa/overzicht.htm Grant no. GOA01G00408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderl F, 2014, WORLD J GASTROENTERO, V20, P11939, DOI 10.3748/wjg.v20.i34.11939; Andre S, 2009, AM J PATHOL, V174, P1575, DOI 10.2353/ajpath.2009.080987; Baele M, 2008, INT J SYST EVOL MICR, V58, P1350, DOI 10.1099/ijs.0.65133-0; Banerjee S, 2002, GUT, V51, P634, DOI 10.1136/gut.51.5.634; Bayry J, 2008, P NATL ACAD SCI USA, V105, P10221, DOI 10.1073/pnas.0803453105; Bayry J, 2014, TRENDS PHARMACOL SCI, V35, P163, DOI 10.1016/j.tips.2014.02.003; Blanchard TG, 2010, ADV M C M, P167, DOI 10.1079/9781845935948.0167; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; CORTHESYTHEULAZ I, 1995, GASTROENTEROLOGY, V109, P115, DOI 10.1016/0016-5085(95)90275-9; Cox JC, 1997, VACCINE, V15, P248, DOI 10.1016/S0264-410X(96)00183-1; Davies MN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008084; De Bruyne E, 2012, VET MICROBIOL, V160, P449, DOI 10.1016/j.vetmic.2012.06.031; Delyria ES, 2009, GASTROENTEROLOGY, V136, P247, DOI 10.1053/j.gastro.2008.09.017; Ermak TH, 1998, J EXP MED, V188, P2277, DOI 10.1084/jem.188.12.2277; Flahou B, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-75; Flahou B, 2009, VACCINE, V27, P1416, DOI 10.1016/j.vaccine.2008.12.031; Garhart CA, 2002, INFECT IMMUN, V70, P3529, DOI 10.1128/IAI.70.7.3529-3538.2002; Goto T, 1999, INFECT IMMUN, V67, P2531, DOI 10.1128/IAI.67.5.2531-2539.1999; Guy B, 1998, VACCINE, V16, P850, DOI 10.1016/S0264-410X(97)00258-2; Guy B, 1999, VACCINE, V17, P1130, DOI 10.1016/S0264-410X(98)00332-6; Haesebrouck F, 2009, CLIN MICROBIOL REV, V22, P202, DOI 10.1128/CMR.00041-08; Hellemans A, 2007, VET REC, V161, P189, DOI 10.1136/vr.161.6.189; Higashi Takehiro, 2010, Allergology International, V59, P161, DOI 10.2332/allergolint.09-OA-0103; Ismail HF, 2003, J IMMUNOL, V170, P3782, DOI 10.4049/jimmunol.170.7.3782; Jiang WW, 2003, INFECT IMMUN, V71, P40, DOI 10.1128/IAI.71.1.40-46.2003; Kao JY, 2010, GASTROENTEROLOGY, V138, P1046, DOI 10.1053/j.gastro.2009.11.043; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsumoto Y, 2005, HELICOBACTER, V10, P407, DOI 10.1111/j.1523-5378.2005.00349.x; Morihara F, 2007, J MED MICROBIOL, V56, P847, DOI 10.1099/jmm.0.47061-0; Nystrom J, 2006, MICROBES INFECT, V8, P442, DOI 10.1016/j.micinf.2005.07.010; O'Rourke JL, 2004, INT J SYST EVOL MICR, V54, P2203, DOI 10.1099/ijs.0.63117-0; Pere H, 2011, BLOOD, V118, P4853, DOI 10.1182/blood-2011-01-329656; Raghavan S, 2003, INFECT IMMUN, V71, P7014, DOI 10.1128/IAI.71.12.7014-7022.2003; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Stolte M, 2001, CAN J GASTROENTEROL, V15, P591, DOI 10.1155/2001/367832; Sutton P, 2007, FEMS IMMUNOL MED MIC, V50, P213, DOI 10.1111/j.1574-695X.2006.00206.x; Svennerholm AM, 2007, FEMS IMMUNOL MED MIC, V50, P146, DOI 10.1111/j.1574-695X.2007.00237.x; Vermoote M, 2013, VACCINE, V31, P3250, DOI 10.1016/j.vaccine.2013.05.047; Xie Y, 2007, WORLD J GASTROENTERO, V13, P1547, DOI 10.3748/wjg.v13.i10.1547	39	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131364	10.1371/journal.pone.0131364	http://dx.doi.org/10.1371/journal.pone.0131364			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115373	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500145
J	Chase, L; Rabe, MJ				Chase, Loren; Rabe, Michael J.			Reducing Lead on the Landscape: Anticipating Hunter Behavior in Absence of a Free Nonlead Ammunition Program	PLOS ONE			English	Article							EXPOSURE; SHOT; DEER	Lead is a neurotoxin that has been documented to affect many forms of wildlife, and has been identified as a limiting factor in a population of California Condors in Northern Arizona. The Arizona Game and Fish Department provides vouchers for free nonlead ammunition to hunters selected to hunt within the distribution of California Condors, with the intention of having fewer lead-laden offal piles available to California Condors. Although wildlife agencies may reasonably assume voucher programs motivate hunters into choosing nonlead ammunition, the lead reduction efforts attributable to the voucher program has not been empirically quantified. Our intention was to compare a control group of hunters to a treatment group of hunters within California Condor occupied areas. Both groups received educational materials regarding the deleterious effects of lead, but the treatment group also received a voucher for a free initial box of ammunition. About half of the control group used nonlead ammunition, compared to about three-fourths of the treatment group. Prominent barriers to adoption of nonlead ammunition included a general difficulty of obtaining it, obtaining it in the desired caliber, and its costliness. Frequently mentioned motivations for using nonlead was the exhortation to use it by the Department, and the desire to aid California Condor recovery by hunters. The disparate compliance rates found herein confirm and quantify the success of nonlead ammunition voucher programs, but underscore the importance of working to increase the supply of nonlead ammunition with the end of facilitating its procurement and reducing its cost.	[Chase, Loren] Arizona Game & Fish Dept, Social Sci Res Program, Phoenix, AZ 85086 USA; [Rabe, Michael J.] Arizona Game & Fish Dept, Nongame Branch, Wildlife Management Div, Phoenix, AZ USA		Chase, L (corresponding author), Arizona Game & Fish Dept, Social Sci Res Program, Phoenix, AZ 85086 USA.	lchase@azgfd.gov	Chase, Loren/J-6088-2019	Chase, Loren/0000-0002-8424-0225				AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 1980, UNDERSTANDING ATTITU; Avery D, 2009, INGESTION LEAD SPENT, P161, DOI DOI 10.4080/ILSA.2009.0115; Bedrosian B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051978; Blus LJ, 1999, ECOTOXICOLOGY, V8, P125, DOI 10.1023/A:1008918819661; BRENNAN LA, 1991, WILDLIFE SOC B, V19, P544; Chase L, 2012, REDUCING LEAD LANDSC; Church ME, 2006, ENVIRON SCI TECHNOL, V40, P6143, DOI 10.1021/es060765s; Craighead D, 2008, J WILDLIFE MANAGE, V72, P240, DOI 10.2193/2007-120; Dillman D.A., 2014, INTERNET PHONE MAIL, V4th ed.; DITERS RW, 1978, J WILDLIFE DIS, V14, P187, DOI 10.7589/0090-3558-14.2.187; Epps CW, 2014, CONDOR, V116, P429, DOI 10.1650/CONDOR-14-78.1; Fair JM, 2002, ECOTOXICOLOGY, V11, P199, DOI 10.1023/A:1015474832239; Ferrandis P, 2008, ENVIRON SCI TECHNOL, V42, P6271, DOI 10.1021/es800215y; Finkelstein ME, 2012, P NATL ACAD SCI USA, V109, P11449, DOI 10.1073/pnas.1203141109; Friend Milton, 2009, P34; Green RE, 2009, INGESTION LEAD SPENT, P240, DOI [10.4080/ilsa.2009.0101, DOI 10.4080/ILSA.2009.0101]; Green RE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004022; Grund Marrett D., 2010, Human-Wildlife Interactions, V4, P257; Haig SM, 2014, CONDOR, V116, P408, DOI 10.1650/CONDOR-14-36.1; Harmata AR, 2013, J WILDLIFE DIS, V49, P114, DOI 10.7589/2012-01-004; Hunt WG, 2006, WILDLIFE SOC B, V34, P167, DOI 10.2193/0091-7648(2006)34[167:BFIDRI]2.0.CO;2; Hunt W Grainger, 2009, J Avian Med Surg, V23, P145, DOI 10.1647/2007-035.1; Hunt WG, 2007, CALIFORNIA CONDORS 2, P109; Kelly TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017656; Larsen RT, 2007, WEST N AM NATURALIST, V67, P152, DOI 10.3398/1527-0904(2007)67[152:GSPACO]2.0.CO;2; Parish, 2009, INGESTION LEAD SPENT, P341, DOI DOI 10.4080/ILSA.2009.0309; Petty R. E., 1986, COMMUN PERSUATION, P1; Pokras MA, 2008, ECOHEALTH, V5, P379, DOI 10.1007/s10393-008-0177-x; Prukop J, 2005, WILDLIFE SOC B, V33, P374, DOI 10.2193/0091-7648(2005)33[374:IMOTVO]2.0.CO;2; Putnam RD., 2000, BOWLING ALONE COLLAP; Responsive Management, 2003, HUNT KNOWL ATT THREA; Rideout BA, 2012, J WILDLIFE DIS, V48, P95, DOI 10.7589/0090-3558-48.1.95; Samuel MD, 2000, J WILDLIFE MANAGE, V64, P947, DOI 10.2307/3803203; Schroeder SA, 2012, J WILDLIFE MANAGE, V76, P1528, DOI 10.1002/jwmg.420; Seng PT, 2006, NONLEAD AMMUNITION P; Snyder NFR., 2000, CALIFORNIA CONDOR SA; Sullivan KA, 2009, CALIFORNIA CONDORS 2, P109; Thomas VG, 2013, AMBIO, V42, P737, DOI 10.1007/s13280-012-0361-7; Trinogga A, 2013, SCI TOTAL ENVIRON, V443, P226, DOI 10.1016/j.scitotenv.2012.10.084; USFWS, 2013, US FISH WILDL SERV C; USFWS, 1996, FED REGISTER, V67, P54044; Vaske, 2007, PUBLIC KNOWLEDGE PER; Vaske J., 2008, SURVEY RES ANAL APPL; Walters JR, 2010, AUK, V127, P969, DOI 10.1525/auk.2010.127.4.969; Wright TD, 2007, SUMMARY SCI AMMUNITI	46	8	8	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0128355	10.1371/journal.pone.0128355	http://dx.doi.org/10.1371/journal.pone.0128355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114878	gold, Green Published, Green Submitted			2022-12-27	WOS:000358147500011
J	Di Muccio, T; Scalone, A; Bruno, A; Marangi, M; Grande, R; Armignacco, O; Gradoni, L; Gramiccia, M				Di Muccio, Trentina; Scalone, Aldo; Bruno, Antonella; Marangi, Massimo; Grande, Romualdo; Armignacco, Orlando; Gradoni, Luigi; Gramiccia, Marina			Epidemiology of Imported Leishmaniasis in Italy: Implications for a European Endemic Country	PLOS ONE			English	Article							WORLD CUTANEOUS LEISHMANIASIS; OLD-WORLD; VISCERAL LEISHMANIASIS; GEOGRAPHICAL-DISTRIBUTION; ISOENZYME ANALYSIS; CHANGING PATTERN; UNITED-KINGDOM; 1ST REPORT; INFANTUM; IDENTIFICATION	In the past decade, the number of imported leishmaniasis cases has increased in countries of Western Europe. The trend is associated with increasing travels, ecotourism activity, military operations and immigration. While in endemic countries leishmaniasis is usually well diagnosed, accurate patient history and parasite identification are necessary to distinguish between autochthonous and imported cases. This is particularly important, as new Leishmania species/genotypesmay be introduced and transmitted by local phlebotomine vectors without appropriate surveillance, with unpredictable consequences. We report on the surveillance of imported leishmaniasis performed by the LeishmaniaIdentification Reference Centre of Rome from 1986 through 2012, involving health care centres from 16/20 Italian regions. Suspected imported cases were analyzed and conclusions were based on clinical, epidemiological and diagnostic findings. Over the years, different parasite identification methods were employed, including MultiLocus Enzyme Electrophoresis and molecular techniques combining disease diagnosis (SSU rDNA nested-PCR) and Leishmania typing (nuclear repetitive sequence and ITS-1 PCR-RFLPs). A total of 105 imported cases were recorded (annual range: 0-20) of which 36 were visceral (VL) (16 HIV-coinfections) and 69 cutaneous (CL) cases; 85 cases (52 CL) were fromthe OldWorld and 20 (17 CL) fromthe NewWorld. Eight Leishmania species were identified, of which 7 were exotic to Italy. VL importation until 1995 was associated with the spread ofMediterranean Leishmania-HIV co-infections in early 1990s. Following the introduction of HAART treatment, such cases became occasional in Italians but relatively frequent among immigrants. In contrast, a steady increase of CL cases was observed from different areas of the Old and NewWorlds, that in recent years includedmainly immigrants ` visiting friends and relatives' and Italian tourists. This positive trend likely depends on better diagnosis and reporting; however, we suspect that many CL cases remained unrecognized. Given the relatively low incidence of leishmaniasis importation, the risk of introduction of exotic parasites appears limited, although the detection of anthroponotic species requires attention.	[Di Muccio, Trentina; Scalone, Aldo; Gradoni, Luigi; Gramiccia, Marina] Ist Super Sanita, Unit Vector Borne Dis & Int Hlth, MIPI Dept, I-00161 Rome, Italy; [Bruno, Antonella] IRCCS Policlin San Matteo, Parasitol Lab, Unit Microbiol & Virol, Pavia, Italy; [Marangi, Massimo] St Andrea Hosp, Infect Dis Unit, Dept Med Sci, Rome, Italy; [Grande, Romualdo] Luigi Sacco Univ Hosp, Unit Clin Microbiol Virol & Bioemergencies Diag, Milan, Italy; [Armignacco, Orlando] Belcolle Hosp, Infect Dis Unit, Viterbo, Italy	Istituto Superiore di Sanita (ISS); IRCCS Fondazione San Matteo; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; University of Milan; Luigi Sacco Hospital	Gramiccia, M (corresponding author), Ist Super Sanita, Unit Vector Borne Dis & Int Hlth, MIPI Dept, Viale Regina Elena 299, I-00161 Rome, Italy.	marina.gramiccia@iss.it	GRAMICCIA, MARINA/C-4969-2016; Grande, Romualdo/GVS-6291-2022; Gradoni, Luigi/C-4962-2016; DI MUCCIO, TRENTINA/C-4967-2016	Grande, Romualdo/0000-0002-3136-5091; DI MUCCIO, TRENTINA/0000-0001-6452-8902	EU grant [FP7-261504]	EU grant(European Commission)	This study was funded by EU grant FP7-261504 "Biology and control of vector-borne infections in Europe" (EDENext) and is catalogued by the EDENext Steering Committee as EDENext000 (http://www.edenext.eu). MG received the funding. The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MZ, 2009, MICROBES INFECT, V11, P707, DOI 10.1016/j.micinf.2009.04.009; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Antinori S, 2005, CLIN MICROBIOL INFEC, V11, P343, DOI 10.1111/j.1469-0691.2004.01046.x; Antoniou M, 2013, EUROSURVEILLANCE, V18, P54, DOI 10.2807/1560-7917.ES2013.18.30.20540; Antoniou M, 2008, LANCET INFECT DIS, V8, P6, DOI 10.1016/S1473-3099(07)70297-9; Azmi K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-121; Bart A, 2013, EUROSURVEILLANCE, V18, P14, DOI 10.2807/1560-7917.ES2013.18.30.20544; Beltrame A, 2008, J TRAVEL MED, V15, P358, DOI 10.1111/j.1708-8305.2008.00220.x; Boite MC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001888; Botilde Y, 2006, INFECT GENET EVOL, V6, P440, DOI 10.1016/j.meegid.2006.02.003; Chicharro C, 2013, EUROSURVEILLANCE, V18, P22, DOI 10.2807/1560-7917.ES2013.18.30.20545; Cruz I., 2002, T R SOC TROP MED HYG, V96, pS185, DOI DOI 10.1016/S0035-9203(02)90074-X; CUPOLILLO E, 1994, AM J TROP MED HYG, V50, P296, DOI 10.4269/ajtmh.1994.50.296; Dujardin JC, 2008, EMERG INFECT DIS, V14, P1013, DOI 10.3201/eid1407.071589; El Baidouri F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002255; El Hajj L, 2004, INT J DERMATOL, V43, P120, DOI 10.1111/j.1365-4632.2004.01991.x; El Tai NO, 2000, T ROY SOC TROP MED H, V94, P575, DOI 10.1016/S0035-9203(00)90093-2; Evans D.A., 1987, P52; Franco AO, 2011, PARASITOLOGY, V138, P1878, DOI 10.1017/S003118201100148X; FRANK C, 1993, T ROY SOC TROP MED H, V87, P184, DOI 10.1016/0035-9203(93)90482-6; Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331; Gkolfinopoulou K, 2013, Euro Surveill, V18, P20532, DOI 10.2807/1560-7917.ES2013.18.29.20532; GRADONI L, 1993, T ROY SOC TROP MED H, V87, P94, DOI 10.1016/0035-9203(93)90441-R; Gradoni L, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.30.20539; Gramiccia M, 2013, EUROSURVEILLANCE, V18, P29, DOI 10.2807/1560-7917.ES2013.18.29.20535; Gramiccia M, 2003, ANN TROP MED PARASIT, V97, P65, DOI 10.1179/000349803225002543; GRAMICCIA M, 1989, T ROY SOC TROP MED H, V83, P76, DOI 10.1016/0035-9203(89)90713-X; Gramiccia M, 2007, ECOL CONT VECTOR-BOR, V1, P75; Harms G, 2003, EMERG INFECT DIS, V9, P872; Harms G, 2011, INT J DERMATOL, V50, P1336, DOI 10.1111/j.1365-4632.2011.04987.x; Herbinger KH, 2011, TROP MED INT HEALTH, V16, P1457, DOI 10.1111/j.1365-3156.2011.02840.x; Herremans T, 2010, INT HEALTH, V2, P42, DOI 10.1016/j.inhe.2009.12.005; Khatri M, 2008, J AM ACAD DERMATOL, V61, P15; Kuhls K, 2005, MICROBES INFECT, V7, P1224, DOI 10.1016/j.micinf.2005.04.009; Kuhls K, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000261; Kuhls K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001155; Lachaud L, 2013, EUROSURVEILLANCE, V18, P38; Lawn SD, 2004, QJM-INT J MED, V97, P781, DOI 10.1093/qjmed/hch127; Malik ANJ, 2006, EMERG INFECT DIS, V12, P1257, DOI 10.3201/eid1708.050486; Marfurt J, 2003, DIAGN MICR INFEC DIS, V46, P115, DOI 10.1016/S0732-8893(03)00040-3; Mersini K., 2011, P 7 INT S PHLEB SAND, P147; Michel G, 2011, ACTA TROP, V119, P69, DOI 10.1016/j.actatropica.2011.05.012; Minodier P, 1997, J CLIN MICROBIOL, V35, P2551, DOI 10.1128/JCM.35.10.2551-2555.1997; Morizot G, 2007, AM J TROP MED HYG, V76, P48; Nimri Laila, 2002, Kinetoplastid Biology and Disease, V1, pUnpaginated, DOI 10.1186/1475-9292-1-7; Pavli A, 2010, INT J INFECT DIS, V14, pE1032, DOI 10.1016/j.ijid.2010.06.019; Perez-Ayala A, 2009, J TRAVEL MED, V16, P395, DOI 10.1111/j.1708-8305.2009.00341.x; Poeppl W, 2013, TRAVEL MED INFECT DI, V11, P90, DOI 10.1016/j.tmaid.2013.03.002; PORTUS M, 1989, Revista Iberica de Parasitologia, V49, P287; Portus M, 1986, LEISHMANIA TAXONOMIE, P433; PRATLONG F, 1989, ANN PARASIT HUM COMP, V64, P506, DOI 10.1051/parasite/1989646506; PRATLONG F, 1995, J INFECT DIS, V172, P323, DOI 10.1093/infdis/172.1.323; Pratlong F, 2004, J CLIN MICROBIOL, V42, P4077, DOI 10.1128/JCM.42.9.4077-4082.2004; Pratlong F, 2013, PARASITOLOGY, V140, P423, DOI 10.1017/S0031182012001825; Pratlong F, 2009, TROP MED INT HEALTH, V14, P1071, DOI 10.1111/j.1365-3156.2009.02336.x; Ravel C, 2006, INT J PARASITOL, V36, P1383, DOI 10.1016/j.ijpara.2006.06.019; RIOUX JA, 1990, ANN PARASIT HUM COMP, V65, P111, DOI 10.1051/parasite/1990653111; Rotureau B, 2006, J CLIN MICROBIOL, V44, P1120, DOI 10.1128/JCM.44.3.1120-1122.2006; SALIBA E, 1993, T ROY SOC TROP MED H, V87, P633, DOI 10.1016/0035-9203(93)90267-T; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Sisko-Kraljevic K, 2013, Euro Surveill, V18, P20533, DOI 10.2807/1560-7917.ES2013.18.29.20533; Van der Auwera G, 2014, J CLIN MICROBIOL, V52, P1098, DOI 10.1128/JCM.02936-13; VANEYS GJJM, 1992, MOL BIOCHEM PARASIT, V51, P133, DOI 10.1016/0166-6851(92)90208-2; Volf P, 2007, INT J PARASITOL, V37, P589, DOI 10.1016/j.ijpara.2007.02.002; Wall EC, 2012, AM J TROP MED HYG, V86, P115, DOI 10.4269/ajtmh.2012.10-0558; Weitzel T, 2005, EUR J CLIN MICROBIOL, V24, P471, DOI 10.1007/s10096-005-1363-1; World Health Organization (WHO), 2010, WHO WHO CONTR LEISHM; World Health Organization (WHO), 1990, WHO TECH REP SER, P793; Zeegelaar JE, 2005, CLIN EXP DERMATOL, V30, P1, DOI 10.1111/j.1365-2230.2004.01677.x	69	34	33	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129418	10.1371/journal.pone.0129418	http://dx.doi.org/10.1371/journal.pone.0129418			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114938	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500024
J	Yoo, MR; Gweon, HM; Park, AY; Cho, KE; Kim, JA; Youk, JH; Son, EJ				Yoo, Mi Ri; Gweon, Hye Mi; Park, Ah Young; Cho, Kyung Eun; Kim, Jeong-Ah; Youk, Ji Hyun; Son, Eun Ju			Repeat Diagnoses of Bethesda Category III Thyroid Nodules: What To Do Next?	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; UNDETERMINED SIGNIFICANCE; FOLLICULAR LESION; MALIGNANCY; CYTOLOGY; ATYPIA; ULTRASONOGRAPHY; MANAGEMENT; ULTRASOUND; BIOPSY	Objectives To assess the malignancy rates of thyroid nodules repeatedly classified as Bethesda category III on fine needle aspiration (FNA), and to suggest management guidelines for these lesions. Methods This is a retrospective study that included 395 thyroid nodules categorized as Bethesda III undergone either surgery or ultrasound (US) follow-up. There were 67 nodules classified a second time as Bethesda category III on repeat FNA. We compared malignancy rates, clinicopathologic and ultrasonographic characteristics between direct surgery and repeat FNA groups and between the initial and repeat Bethesda category III groups, each. And in the repeat Bethesda III group, clinicopathologic and US variables were compared between benign and malignant nodules. Results Incidence of concurrent cancer, underlying thyroiditis and positive BRAF mutation were significantly higher in 142 nodules with direct surgery than 243 nodules with repeat FNA (p < 0.05). Of the 395 nodules with Bethesda category III cytology on initial FNA, the malignancy rate was 59.5%. In 67 nodules with repeat Bethesda III classification, however, the malignancy rate was 73.1% (p < 0.05). However, none of the variables were significantly different between the initial Bethesda category III group and the repeat Bethesda category III group (p > 0.05). In the repeat Bethesda category III group, solid consistency, irregular/microlobulated margins, nonparallel shape, and number of suspicious findings or "suspicious malignant" US assessments were associated with a high malignancy rate (p < 0.05). On multivariate logistic regression analysis, the factor associated with malignancy in the repeat Bethesda category III group was irregular/microlobulated margin (odds ratio = 15.576; 95% CI, 2.097-115.6804, p = 0.007) with a sensitivity, specificity, positive and negative predictive values, and accuracy of 81.6%, 83.3%, 93.0%, 62.5% and 82.1%, respectively. Conclusion Thyroid nodules with repeated Bethesda category III classification and irregular/microlobulated margins on US are at increased risk of malignancy, and operative management should be considered as opposed to repeat FNA.	[Son, Eun Ju] Yonsei Univ, Coll Med, Dept Radiol, Gangnam Severance Hosp, Seoul, South Korea; Yonsei Univ, Coll Med, Res Inst Radiol Sci, Gangnam Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Son, EJ (corresponding author), Yonsei Univ, Coll Med, Dept Radiol, Gangnam Severance Hosp, Seoul, South Korea.	EJSONRD@yuhs.ac		Gweon, Hye Mi/0000-0002-3054-1532; Kim, Jeong-Ah/0000-0003-4949-4913; Son, Eun Ju/0000-0002-7895-0335	Yonsei University College of Medicine [6-2014-0125]	Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant of Yonsei University College of Medicine for 2014 (6-2014-0125).	Broome JT, 2014, WORLD J SURG, V38, P628, DOI 10.1007/s00268-013-2330-0; Carr R, 2013, ENDOCR PATHOL, V24, P62, DOI 10.1007/s12022-013-9240-4; Cibas ES, 2009, THYROID, V19, P1159, DOI 10.1089/thy.2009.0274; Faquin WC, 2010, DIAGN CYTOPATHOL, V38, P731, DOI 10.1002/dc.21292; Gweon HM, 2013, ANN SURG ONCOL, V20, P3083, DOI 10.1245/s10434-013-2990-x; Ho AS, 2014, THYROID, V24, P832, DOI 10.1089/thy.2013.0317; Kim DW, 2011, AM J NEURORADIOL, V32, P2136, DOI 10.3174/ajnr.A2686; Kim EK, 2002, AM J ROENTGENOL, V178, P687, DOI 10.2214/ajr.178.3.1780687; Kim GR, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/354612; Layfield LJ, 2009, DIAGN CYTOPATHOL, V37, P710, DOI 10.1002/dc.21093; Lee SW, 2013, RADIOLOGY, V266, P956, DOI 10.1148/radiol.12112710; Mehta RS, 2013, SURGERY, V154, P730, DOI 10.1016/j.surg.2013.05.015; Mendez W, 2008, ANN SURG ONCOL, V15, P2487, DOI 10.1245/s10434-008-0052-6; Rosario PW, 2014, THYROID, V24, P1115, DOI 10.1089/thy.2013.0650; VanderLaan PA, 2011, AM J CLIN PATHOL, V135, P770, DOI 10.1309/AJCP4P2GCCDNHFMY; Yassa L, 2007, CANCER CYTOPATHOL, V111, P508, DOI 10.1002/cncr.23116; Yoo WS, 2014, CLIN ENDOCRINOL, V80, P735, DOI 10.1111/cen.12348; Yoon JH, 2010, ANN SURG ONCOL, V17, P2147, DOI 10.1245/s10434-010-0992-5	18	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130138	10.1371/journal.pone.0130138	http://dx.doi.org/10.1371/journal.pone.0130138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115096	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500052
J	Azuma, T; Ishiuchi, H; Inoyama, T; Teranishi, Y; Yamaoka, M; Sato, T; Yamashita, N; Tanaka, H; Mino, Y				Azuma, Takashi; Ishiuchi, Hirotaka; Inoyama, Tomomi; Teranishi, Yusuke; Yamaoka, Misato; Sato, Takaji; Yamashita, Naoyuki; Tanaka, Hiroaki; Mino, Yoshiki			Detection of Peramivir and Laninamivir, New Anti-Influenza Drugs, in Sewage Effluent and River Waters in Japan	PLOS ONE			English	Article							INFLUENZA-A H1N1; WASTE-WATER; OSELTAMIVIR CARBOXYLATE; NEURAMINIDASE INHIBITOR; SEASONAL INFLUENZA; ENVIRONMENTAL FATE; ANTIVIRAL DRUGS; SURFACE WATERS; PHARMACEUTICALS; REMOVAL	This is the first report of the detection of two new anti-influenza drugs, peramivir (PER) and laninamivir (LAN), in Japanese sewage effluent and river waters. Over about 1 year from October 2013 to July 2014, including the influenza prevalence season in January and February 2014, we monitored for five anti-influenza drugs-oseltamivir (OS), oseltamivir carboxylate (OC), zanamivir (ZAN), PER, and LAN-in river waters and in sewage effluent flowing into urban rivers of the Yodo River system in Japan. The dynamic profiles of these anti-influenza drugs were synchronized well with that of the numbers of influenza patients treated with the drugs. The highest levels in sewage effluents and river waters were, respectively, 82 and 41 ng/L (OS), 347 and 125 ng/L (OC), 110 and 35 ng/L (ZAN), 64 and 11 ng/L (PER), and 21 and 9 ng/L (LAN). However, application of ozone treatment before discharge from sewage treatment plants was effective in reducing the levels of these anti-influenza drugs in effluent. The effectiveness of the ozone treatment and the drug dependent difference in susceptibility against ozone were further evidenced by ozonation of a STP effluent in a batch reactor. These findings should help to promote further environmental risk assessment of the generation of drug-resistant influenza viruses in aquatic environments.	[Azuma, Takashi; Ishiuchi, Hirotaka; Inoyama, Tomomi; Teranishi, Yusuke; Yamaoka, Misato; Sato, Takaji; Mino, Yoshiki] Osaka Univ Pharmaceut Sci, Takatsuki, Osaka, Japan; [Yamashita, Naoyuki; Tanaka, Hiroaki] Kyoto Univ, Res Ctr Environm Qual Management, Otsu, Shiga, Japan	Osaka University of Pharmaceutical Sciences; Kyoto University	Azuma, T (corresponding author), Osaka Univ Pharmaceut Sci, Takatsuki, Osaka, Japan.	t.azuma@gly.oups.ac.jp			Lake Biwa-Yodo River Water Quality Preservation Organization	Lake Biwa-Yodo River Water Quality Preservation Organization	This study was funded by the Lake Biwa-Yodo River Water Quality Preservation Organization (http://www.byq.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accinelli C, 2007, INT J ENVIRON AN CH, V87, P579, DOI 10.1080/03067310601151894; Accinelli C, 2012, BIORESOURCE TECHNOL, V120, P180, DOI 10.1016/j.biortech.2012.06.056; Accinelli C, 2010, CHEMOSPHERE, V79, P891, DOI 10.1016/j.chemosphere.2010.02.022; Achenbach JE, 2013, ANTIMICROB AGENTS CH, V57, P2171, DOI 10.1128/AAC.02126-12; [Anonymous], 2011, SPARC ON LIN CALC V4; [Anonymous], 2008, PROD MON TAM; Antoniou MG, 2013, SCI TOTAL ENVIRON, V456, P42, DOI 10.1016/j.scitotenv.2013.03.072; Azuma T, 2014, INT J ENVIRON AN CH, V94, P853, DOI 10.1080/03067319.2014.921290; Azuma T, 2013, CHEMOSPHERE, V93, P1672, DOI 10.1016/j.chemosphere.2013.05.025; Azuma T, 2012, ENVIRON SCI TECHNOL, V46, P12873, DOI 10.1021/es303203c; Bartels P, 2008, SCI TOTAL ENVIRON, V405, P215, DOI 10.1016/j.scitotenv.2008.06.032; Cass LMR, 1999, CLIN PHARMACOKINET, V36, P1, DOI 10.2165/00003088-199936001-00001; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P421; Chemical Abstracts Service SciFinder. American Chemical Society, SCIFINDER ONL DAT SU; Chen WY, 2014, ENVIRON POLLUT, V184, P377, DOI 10.1016/j.envpol.2013.09.019; Correia V, 2010, ANTIVIR RES, V86, P128, DOI 10.1016/j.antiviral.2010.01.002; Ellis JB, 2010, WATER SCI TECHNOL, V61, P879, DOI 10.2166/wst.2010.002; Escuret V, 2008, J CLIN VIROL, V41, P25, DOI 10.1016/j.jcv.2007.10.019; Fick J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000986; Ghosh GC, 2010, ENVIRON HEALTH PERSP, V118, P103, DOI 10.1289/ehp.0900930; GlaxoSmithKline, 2006, SAFETY DATA SHEET VE, V13, P1; Goncalves C, 2011, ENVIRON SCI TECHNOL, V45, P4307, DOI 10.1021/es1032629; He G, 1999, CLIN PHARMACOKINET, V37, P471, DOI 10.2165/00003088-199937060-00003; Hurt AC, 2007, ANTIVIR RES, V73, P228, DOI 10.1016/j.antiviral.2006.10.004; Hutchinson T, 2009, J LAW MED ETHICS, V37, P1; Infectious Disease Surveillance Center (Japan), 2015, INF DIS WEEKL REP ID; Ishizuka H, 2010, J CLIN PHARMACOL, V50, P1319, DOI 10.1177/0091270009356297; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jarhult JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024742; Kim IH, 2008, WATER SCI TECHNOL, V57, P195, DOI 10.2166/wst.2008.808; Kim I, 2011, OZONE-SCI ENG, V33, P150, DOI 10.1080/01919512.2011.549427; Kim I, 2010, WATER ENVIRON RES, V82, P294, DOI 10.2175/106143009X12487095236630; Kohno S, 2010, ANTIMICROB AGENTS CH, V54, P4568, DOI 10.1128/AAC.00474-10; Kumar V, 2009, CHEMOSPHERE, V77, P1440, DOI 10.1016/j.chemosphere.2009.08.052; Leknes H, 2012, SCI TOTAL ENVIRON, V414, P632, DOI 10.1016/j.scitotenv.2011.11.004; Li WX, 1998, ANTIMICROB AGENTS CH, V42, P647, DOI 10.1128/AAC.42.3.647; Lindegardh N, 2006, J PHARMACEUT BIOMED, V42, P430, DOI 10.1016/j.jpba.2006.04.028; Nutley N. J, 2005, ROCHE RES REPORT, P1; Okomo-Adhiambo M, 2010, VIRUSES-BASEL, V2, P2269, DOI 10.3390/v2102269; Okuda T, 2009, ENVIRON INT, V35, P815, DOI 10.1016/j.envint.2009.01.006; Osaka Prefectural Government (Japan), 2012, RIV DEV PROJ KANZ RI, P1; Osaka Prefecture Infectious Disease Surveillance Center (Japan), 2015, INF DIS WEEKL REP; Peng XZ, 2014, SCI TOTAL ENVIRON, V466, P755, DOI 10.1016/j.scitotenv.2013.07.062; Prasse C, 2010, ENVIRON SCI TECHNOL, V44, P1728, DOI 10.1021/es903216p; Renner R, 2007, ENVIRON SCI TECHNOL, V41, P7591; Rosal R, 2010, WATER RES, V44, P578, DOI 10.1016/j.watres.2009.07.004; Sacca ML, 2009, CHEMOSPHERE, V75, P28, DOI 10.1016/j.chemosphere.2008.11.060; Shionogi & Co. Ltd, 2010, RAP INTR DRIP INF PA; Shobugawa Y, 2012, J INFECT CHEMOTHER, V18, P858, DOI 10.1007/s10156-012-0428-1; Singer AC, 2007, ENVIRON HEALTH PERSP, V115, P102, DOI 10.1289/ehp.9574; Singer AC, 2011, ENVIRON HEALTH PERSP, V119, P1084, DOI 10.1289/ehp.1002757; Soderstrom H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006064; Straub JO, 2009, ECOTOX ENVIRON SAFE, V72, P1625, DOI 10.1016/j.ecoenv.2008.09.011; Takanami R., 2012, Journal of Water and Environment Technology, V10, P57, DOI 10.2965/jwet.2012.57; Tanaka A, 2010, JPN J CLIN EXP MED, V87, P1702; Ternes TA, 2003, WATER RES, V37, P1976, DOI 10.1016/S0043-1354(02)00570-5; Watanabe A, 2010, JPN J CLIN EXP MED, V87, P1707; Widmer N, 2010, CLIN PHARMACOKINET, V49, P741, DOI 10.2165/11534730-000000000-00000; Williams M.A., 1997, ANTIVIR RES, V34, P86; Yamashita M, 2009, ANTIMICROB AGENTS CH, V53, P186, DOI 10.1128/AAC.00333-08; Yoon S, 2014, J IND ENG CHEM, V20, P2914, DOI 10.1016/j.jiec.2013.11.028; Zonja B, 2014, J HAZARD MATER, V265, P296, DOI 10.1016/j.jhazmat.2013.10.008	62	14	15	6	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131412	10.1371/journal.pone.0131412	http://dx.doi.org/10.1371/journal.pone.0131412			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110817	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800148
J	Espino, GD; Soto, LA				de la Lanza Espino, Guadalupe; Soto, Luis A.			C:N:P Molar Ratios, Sources and C-14 Dating of Surficial Sediments from the NW Slope of Cuba	PLOS ONE			English	Article							ORGANIC-MATTER; SURFACE SEDIMENTS; NITROGEN; CARBON; GULF; PHOSPHORUS; BURIAL; AMMONIUM; PACIFIC; STRAITS	The surficial sediments recovered from 12 sites located near the channel axis of the Florida Straits and the lower slope off NW Cuba were analyzed for total organic carbon (TOC), nitrogen (TN), phosphorus (TP), elemental C:N:P ratios, C and N isotopic values, and C-14 dating. The depth profiles of TOC, TN, and TP (0-18 cm) displayed a downcore trend and a significant variation. The TOC values were low (0.15 to 0.62%; 66 to 516 mu mol g(-1)). Sites near the island's lower slope had lower TOC average concentrations (158-333 mu mol g(-1)) than those closer to the channel axis (averaging 341-516 mu mol g(-1); p < 0.05). The TN concentrations near the lower slope attained 0.11%(80 mu mol g(-1)), whereas, towards the channel axis, they decreased to 0.07% (55 mu mol g(-1); p<0.05). The C:N ratios ranged from 1.9 to 10.2. The mean molar C:N ratio (5.4) indicated a marine hemipelagic deposition. The TP was lower at sites near the lower slope (38.4 to 50.0 mu mol g(-1); 0.12% to 0.16%) than those near the channel axis (50.0 to 66 mu mol g(-1); 0.15 to 0.21%). C:P fluctuated from 7.7 to 14.1 in the surficial sediment layer. The bulk organic delta C-13(org) and delta N-15 values confirmed pelagic organic sources, and the C-14 dating revealed that the sediments were deposited during the Holocene (1000-5000 yr BP). We suggest that the hydrodynamic conditions in the Straits influence vertical and advective fluxes of particulate organic material trapped in the mixedlayer, which reduces the particulate matter flux to the seabed.	[de la Lanza Espino, Guadalupe] Univ Nacl Autonoma Mexico, Inst Biol, Mexico City, DF, Mexico; [Soto, Luis A.] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Espino, GD (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Mexico City, DF, Mexico.	lasg@cmarl.unam.mx			CESIGMA S.A. (Cuba); Universidad Nacional Autonoma de Mexico	CESIGMA S.A. (Cuba); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	The research cruise was funded by CESIGMA S.A. (Cuba), and the Universidad Nacional Autonoma de Mexico provided analytical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTABET MA, 1988, DEEP-SEA RES, V35, P535, DOI 10.1016/0198-0149(88)90130-6; Anadon R, 2002, DEEP-SEA RES PT II, V49, P883, DOI 10.1016/S0967-0645(01)00129-1; Calvert SE, 2004, ORG GEOCHEM, V35, P981, DOI 10.1016/j.orggeochem.2004.03.001; Carvalho FP, 2011, ICES J MAR SCI, V68, P427, DOI 10.1093/icesjms/fsr005; CESIGMA, 2002, EST LIN BAS AMB AR M; Cha HJ, 2005, MAR GEOL, V216, P127, DOI 10.1016/j.margeo.2005.02.001; Chambers AF, 2003, OFFSH NO CUB AAPG IN, p[25, 36]; Coogan AH, 1970, FIELD GUIDE SOME CAR, P141; Eberli G.P., 2000, P OCEAN DRILLING PRO, V166, P167, DOI [10.2973/odp.proc.sr.166.128.2000, DOI 10.2973/ODP.PROC.SR.166.128.2000]; ECHEVARRIARODRIGUEZ G, 1991, J PETROL GEOL, V14, P259, DOI 10.1111/j.1747-5457.1991.tb00311.x; Ezer T, 2003, J GEOPHYS RES, V108, P1; Freudenthal T, 2001, GEOCHIM COSMOCHIM AC, V65, P1795, DOI 10.1016/S0016-7037(01)00554-3; Fry B, 1989, DELTA13C MEASUREMENT, P196; GAUDETTE HE, 1974, J SEDIMENT PETROL, V44, P249; Gaumet F, 2002, OFFSHORE MAG, V62, P5; Goni MA, 1998, GEOCHIM COSMOCHIM AC, V62, P3055, DOI 10.1016/S0016-7037(98)00217-8; GRUNDMANIS V, 1982, GEOCHIM COSMOCHIM AC, V46, P1101, DOI 10.1016/0016-7037(82)90062-X; HEDGES JI, 1986, SCIENCE, V231, P1129, DOI 10.1126/science.231.4742.1129; Holm NG, 1978, CONTRIB MICROB GEOCH, V3, P1; Hu JF, 2006, MAR CHEM, V98, P274, DOI 10.1016/j.marchem.2005.03.008; Hurley RJ, 1964, SO STRAITS FLORIDA B, V14, P373; INGALL ED, 1990, GEOCHIM COSMOCHIM AC, V54, P373, DOI 10.1016/0016-7037(90)90326-G; Jackson M. L., 1969, SOIL CHEM ANAL ADV C, V2nd; JASPER JP, 1990, GEOCHIM COSMOCHIM AC, V54, P1117, DOI 10.1016/0016-7037(90)90443-O; Kabanova Yu, 1973, ACAD CIENCIAS CUBA S, V16, P1; Lopez-Veneroni D, 2014, ISOT ENV HEALT UNPUB; Lopez-Veneroni D, 1998, THESIS TEXAS A M U T, P666; Loring DH, 1977, 700 FISH MAR SERV; MACKO SA, 1984, NATURWISSENSCHAFTEN, V71, P374, DOI 10.1007/BF00410746; Magnier C, 2004, MAR PETROL GEOL, V21, P195, DOI 10.1016/j.marpetgeo.2003.11.009; MALLOY RJ, 1970, GEOL SOC AM BULL, V81, P1947, DOI 10.1130/0016-7606(1970)81[1947:GAGSSO]2.0.CO;2; MANGERUD J, 1974, Boreas (Oslo), V3, P109; MEYERS PA, 1994, CHEM GEOL, V114, P289, DOI 10.1016/0009-2541(94)90059-0; Mingram B, 2005, INT J EARTH SCI, V94, P1010, DOI 10.1007/s00531-005-0015-0; Morse JW, 2008, DEEP-SEA RES PT II, V55, P2563, DOI 10.1016/j.dsr2.2008.07.004; MULLER PJ, 1977, GEOCHIM COSMOCHIM AC, V41, P765, DOI 10.1016/0016-7037(77)90047-3; Munk W., 1970, GEOPHYS FLUID DYN, V1, P161, DOI [DOI 10.1080/03091927009365772, 10.1080/03091927009365772]; Oehlert AM, 2012, SEDIMENTOLOGY, V59, P319, DOI 10.1111/j.1365-3091.2011.01273.x; Okolodkov Yuri B., 2003, Hidrobiológica, V13, P207; Pinon JR, 2006, CUBAS ENERGY CRISI 3; Premuzic E.T., 1982, ORG GEOCHEM, V4, P63, DOI [10.1016/0146-6380(82)90009-2., DOI 10.1016/0146-6380(82)90009-2]; PROKOPENKO MG, 2006, P OC DRILL PROGR SCI, V0202; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; Rodriguez-Medina MA, 1989, THESIS U NACL AUTONO; Ruttenberg K.C., 1997, P OCEAN DRILLING PRO, V155, P505; Ruttenberg KC, 1997, MAR GEOL, V139, P123, DOI 10.1016/S0025-3227(96)00107-7; RUTTENBERG KC, 1993, GEOCHIM COSMOCHIM AC, V57, P991, DOI 10.1016/0016-7037(93)90035-U; Sanchez A, 2007, CIENC MAR, V33, P23, DOI 10.7773/cm.v33i1.1036; Santschi PH, 2008, DEEP-SEA RES PT II, V55, P2572, DOI 10.1016/j.dsr2.2008.07.005; Schneider B, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001871; Shigemitsu M, 2009, J OCEANOGR, V65, P541, DOI 10.1007/s10872-009-0046-4; Silva N, 2002, ESTUAR COAST SHELF S, V55, P763, DOI 10.1006/ecss.2001.0938; Soto LA, 2012, INTERCIENCIA, V37, P812; WILSON RD, 1974, SCIENCE, V184, P857, DOI 10.1126/science.184.4139.857	54	1	1	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0125562	10.1371/journal.pone.0125562	http://dx.doi.org/10.1371/journal.pone.0125562			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110791	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800003
J	Gangula, P; Ravella, K; Chukkapalli, S; Rivera, M; Srinivasan, S; Hale, A; Channon, K; Southerland, J; Kesavalu, L				Gangula, Pandu; Ravella, Kalpana; Chukkapalli, Sasanka; Rivera, Mercedes; Srinivasan, Shanthi; Hale, Ashley; Channon, Keith; Southerland, Janet; Kesavalu, Lakshmyya			Polybacterial Periodontal Pathogens Alter Vascular and Gut BH4/nNOS/NRF2-Phase II Enzyme Expression	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SYSTEMIC INFLAMMATION; NITRIC-OXIDE; DISEASE; INFECTION; ATHEROSCLEROSIS; IDENTIFICATION; ASSOCIATION; IMPAIRMENT; BACTEREMIA	Periodontal disease is a highly prevalent chronic inflammatory disease and is associated with complex microbial infection in the subgingival cavity. Recently, American Heart Association supported a century old association between periodontal disease and atherosclerotic vascular disease. We have recently shown that polybacterial periodontal infection led to aortic atherosclerosis and modulation of lipid profiles; however the underlying mechanism (s) has not been yet demonstrated. Altered nitric oxide (NO) synthesis and tetrahydrobiopterin (BH4), a cofactor for nitric oxide synthases (NOS) has long been shown to be associated with vascular dysfunction and gastrointestinal motility disorders. We sought to examine the mechanism of periodontal infection leading to altered vascular and gastrointestinal smooth muscle relaxation, focusing on the BH4/nNOS pathways. In addition, we also have investigated how the antioxidant system (NRF2-Phase II enzyme expression) in vascular and GI specimens is altered by oral infection. Eight week old male ApoE(null) mice were either sham-infected or infected orally for 16 weeks with a mixture of major periodontal bacteria Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia to induce experimental periodontitis. Serum, vascular (mesenteric), stomach, and colon specimens were collected at the end of periodontal pathogen infection. Bacterial infection induced significant (p<0.05) reductions in the levels of BH4, in ratio of BH4: BH2+B and also in nitric oxide levels compared to sham-infected controls. In addition, we identified a significant (p<0.05) reduction in eNOS dimerization, nNOS dimerization and protein expression of BH4 biosynthesis enzymes; GCH-1, DHFR and NRF2 & Phase II enzymes in infected mice versus controls in both mesenteric artery and colon tissues. However, we found no differences in nNOS/BH4 protein expression in stomach tissues of infected and sham-infected mice. This suggests that a polybacterial infection can cause significant changes in the vascular and colonic BH4/nNOS/NRF2 pathways which might lead to impaired vascular relaxation and colonic motility.	[Gangula, Pandu; Ravella, Kalpana] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA; [Gangula, Pandu; Southerland, Janet] Meharry Med Coll, Sch Dent, Nashville, TN 37208 USA; [Chukkapalli, Sasanka; Rivera, Mercedes; Kesavalu, Lakshmyya] Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL USA; [Srinivasan, Shanthi] Emory Univ, Div Digest Dis, Dept Med, Atlanta, GA 30322 USA; [Hale, Ashley; Channon, Keith] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England; [Kesavalu, Lakshmyya] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA	Meharry Medical College; Meharry Medical College; State University System of Florida; University of Florida; Emory University; University of Oxford; State University System of Florida; University of Florida	Gangula, P (corresponding author), Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA.	pgangula@mmc.edu; Kesavalu@dental.ufl.edu	Srinivasan, Shanthi/A-6133-2013; Southerland, Janet H/AAV-9643-2020	channon, keith/0000-0002-1043-4342	Meharry Translational Research Pilot Grant (MeTRC-NIH/NCRR) [1 U54RR026140-01]; NIH-National Institute of Diabetes and Digestive and Kidney Diseases [R21DKO76704]; NIH-National Institute of Dental and Craniofacial Research [R01DE020820]; British Heart Foundation [RG/12/5/29576] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020820] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007593, G12MD007586] Funding Source: NIH RePORTER	Meharry Translational Research Pilot Grant (MeTRC-NIH/NCRR); NIH-National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH-National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); British Heart Foundation(British Heart Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work has been supported by Meharry Translational Research Pilot Grant (MeTRC-NIH/NCRR; 1 U54RR026140-01: PG); NIH-National Institute of Diabetes and Digestive and Kidney Diseases [R21DKO76704 (PG)]; NIH-National Institute of Dental and Craniofacial Research [R01DE020820 (Dr. Kesavalu)].	Ali ZA, 2013, CIRCULATION, V128, pS50, DOI 10.1161/CIRCULATIONAHA.112.000249; Andriankaja OM, 2010, AUST DENT J, V55, P252, DOI 10.1111/j.1834-7819.2010.01231.x; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Brogden KA, 2002, POLYMICROBIAL DISEASES, P3; D'Aiuto F, 2004, J PERIODONTAL RES, V39, P236, DOI 10.1111/j.1600-0765.2004.00731.x; D'Aiuto F, 2004, J DENT RES, V83, P156, DOI 10.1177/154405910408300214; Dashper SG, 2011, J DENT RES, V90, P691, DOI 10.1177/0022034510385242; Eugenia MG, 2008, REPROD SCI, V15, P9, DOI [10.1177/1933719107312160, DOI 10.1177/1933719107312160]; Fiehn NE, 2005, J PERIODONTOL, V76, P731, DOI 10.1902/jop.2005.76.5.731; Figuero E, 2011, J PERIODONTOL, V82, P1469, DOI 10.1902/jop.2011.100719; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Gangula PR, 2011, NEUROGASTROENT MOTIL, V23, P773, DOI 10.1111/j.1365-2982.2011.01695.x; Gangula PRR, 2011, DIGEST DIS SCI, V56, P2520, DOI 10.1007/s10620-011-1735-6; Gangula PRR, 2010, NEUROGASTROENT MOTIL, V22, P1325, DOI 10.1111/j.1365-2982.2010.01588.x; Gangula PRR, 2010, AM J PHYSIOL-GASTR L, V298, pG692, DOI 10.1152/ajpgi.00450.2009; Gangula PRR, 2004, BIOL REPROD, V71, P1739, DOI 10.1095/biolreprod.104.031369; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Higashi Y, 2008, HYPERTENSION, V51, P446, DOI 10.1161/HYPERTENSIONAHA.107.101535; Higashi Y, 2009, ATHEROSCLEROSIS, V206, P604, DOI 10.1016/j.atherosclerosis.2009.03.037; Iwai T, 2009, J PERIODONTAL RES, V44, P689, DOI 10.1111/j.1600-0765.2008.01165.x; Kebschull M, 2010, J DENT RES, V89, P879, DOI 10.1177/0022034510375281; Kesavalu L, 2007, INFECT IMMUN, V75, P1704, DOI 10.1128/IAI.00733-06; Kozarov E, 2006, MICROBES INFECT, V8, P687, DOI 10.1016/j.micinf.2005.09.004; Kuramitsu HK, 2003, CRIT REV ORAL BIOL M, V14, P331, DOI 10.1177/154411130301400504; Lapu BR, 2007, AM J CARDIOL, V99, p7D; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lies B, 2014, NEUROGASTROENT MOTIL, V26, P901, DOI 10.1111/nmo.12367; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Mukhopadhyay S, 2011, FREE RADICAL BIO MED, V51, P619, DOI 10.1016/j.freeradbiomed.2011.04.044; Nibali L, 2007, J CLIN PERIODONTOL, V34, P931, DOI 10.1111/j.1600-051X.2007.01133.x; Nishihara T, 2004, PERIODONTOL 2000, V36, P14, DOI 10.1111/j.1600-0757.2004.03671.x; Oktay S, 2014, J PERIODONTOL, V7, P1; Paquette DW, 2007, PERIODONTOL 2000, V44, P113, DOI 10.1111/j.1600-0757.2006.00196.x; Paraskevas S, 2008, J CLIN PERIODONTOL, V35, P277, DOI 10.1111/j.1600-051X.2007.01173.x; Pussinen PJ, 2007, ATHEROSCLEROSIS, V193, P222, DOI 10.1016/j.atherosclerosis.2006.06.027; Ravella K, 2012, DIGEST DIS SCI, V57, P1504, DOI 10.1007/s10620-012-2070-2; Rivera MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057178; Savage A, 2009, J CLIN PERIODONTOL, V36, P458, DOI 10.1111/j.1600-051X.2009.01408.x; Slade GD, 1999, J PUBLIC HEALTH DENT, V59, P67, DOI 10.1111/j.1752-7325.1999.tb03237.x; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Southerland JH, 2012, ATHEROSCLEROSIS, V222, P196, DOI 10.1016/j.atherosclerosis.2012.01.026; Sugiyama S, 2012, J CLIN BIOCHEM NUTR, V51, P108, DOI 10.3164/jcbn.11-103; Takahashi T, 2003, J GASTROENTEROL, V38, P421, DOI 10.1007/s00535-003-1094-y; Trevisan M, 2010, MEDITERR J HEMATOL I, V2, DOI 10.4084/MJHID.2010.030; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wiebe C B, 2000, J Can Dent Assoc, V66, P594; Zelkha SA, 2010, PERIODONTOL 2000, V54, P207, DOI 10.1111/j.1600-0757.2010.00358.x	49	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0129885	10.1371/journal.pone.0129885	http://dx.doi.org/10.1371/journal.pone.0129885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111153	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800031
J	Li, RX; Cai, F; Pang, G; Shen, QR; Li, R; Chen, W				Li, Rui-Xia; Cai, Feng; Pang, Guan; Shen, Qi-Rong; Li, Rong; Chen, Wei			Solubilisation of Phosphate and Micronutrients by Trichoderma harzianum and Its Relationship with the Promotion of Tomato Plant Growth	PLOS ONE			English	Article							ASPERELLUM STRAIN T34; FUSARIUM-WILT; MICROORGANISMS; METABOLITES; ZINC; IRON	Trichoderma harzianum strain SQR-T037 is a biocontrol agent that has been shown to enhance the uptake of nutrients (macro-and microelements) by plants in fields. The objective of this study was to investigate the contribution of SQR-T037 to P and microelement (Fe, Mn, Cu and Zn) nutrition in tomato plants grown in soil and in hydroponic conditions. Inoculation with SQR-T037 significantly improved the biomass and nutrient uptake of tomato seedlings grown in a nutrient-limiting soil. So we investigated the capability of SQR-T037 to solubilise sparingly soluble minerals in vitro via four known mechanisms: acidification by organic acids, chelation by siderophores, redox by ferric reductase and hydrolysis by phytase. SQR-T037 was able to solubilise phytate, Fe2O3, CuO, and metallic Zn but not Ca-3(PO4)(2) or MnO2. Organic acids, including lactic acid, citric acid, tartaric acid and succinic acid, were detected by HPLC and LC/MS in two Trichoderma cultures. Additionally, we inoculated tomato seedlings with SQR-T037 using a hydroponic system with specific nutrient deficiencies (i.e., nutrient solutions deficient in P, Fe, Cu or Zn and supplemented with their corresponding solid minerals) to better study the effects of Trichoderma inoculation on plant growth and nutrition. Inoculated seedlings grown in Cu-deficient hydroponic conditions exhibited increases in dry plant biomass (92%) and Cu uptake (42%) relative to control plants. However, we did not observe a significant effect on seedling biomass in plants grown in the Fe-and Zn-deficient hydroponic conditions; by contrast, the biomass decreased by 82% in the P-deficient hydroponic condition. Thus, we demonstrated that Trichoderma SQR-T037 competed for P (phytate) and Zn with tomato seedlings by suppressing root development, releasing phytase and/or chelating minerals. The results of this study suggest that the induction of increased or suppressed plant growth occurs through the direct effect of T. harzianumon root development, in combination with indirect mechanisms, such as mineral solubilisation (including solubilisation via acidification, redox, chelation and hydrolysis).	[Li, Rui-Xia; Cai, Feng; Shen, Qi-Rong; Li, Rong; Chen, Wei] Nanjing Agr Univ, Jiangsu Key Lab, Nanjing, Jiangsu, Peoples R China; [Li, Rui-Xia; Cai, Feng; Shen, Qi-Rong; Li, Rong; Chen, Wei] Nanjing Agr Univ, Engn Ctr Solid Organ Waste Utilizat, Nanjing, Jiangsu, Peoples R China; [Cai, Feng; Pang, Guan; Shen, Qi-Rong; Li, Rong; Chen, Wei] Natl Engn Res Ctr Organ Based Fertilizers, Nanjing, Jiangsu, Peoples R China; [Li, Rui-Xia; Cai, Feng; Shen, Qi-Rong; Li, Rong; Chen, Wei] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University; Nanjing Agricultural University	Chen, W (corresponding author), Nanjing Agr Univ, Jiangsu Key Lab, Nanjing, Jiangsu, Peoples R China.	chenwei@njau.edu.cn	Shen, Qirong/AAB-6531-2020	Pang, Guan/0000-0002-5860-3483	National Key Technology R&D Program of the Ministry of Science and Technology [2013BAD20B05, L0201400202]; Priority Academic Program Development of the Jiangsu Higher Education Institutions (PAPD); 111 project [B12009]; Agricultural Ministry of China [201103004]; National Key Basic Research Program of China [2015CB150506]	National Key Technology R&D Program of the Ministry of Science and Technology(National Key Technology R&D Program); Priority Academic Program Development of the Jiangsu Higher Education Institutions (PAPD); 111 project(Ministry of Education, China - 111 Project); Agricultural Ministry of China(Ministry of Agriculture & Rural Affairs); National Key Basic Research Program of China(National Basic Research Program of China)	This research was supported by the National Key Technology R&D Program of the Ministry of Science and Technology (2013BAD20B05 and L0201400202), the Priority Academic Program Development of the Jiangsu Higher Education Institutions (PAPD), the 111 project (B12009), the Agricultural Ministry of China (201103004) and the National Key Basic Research Program of China (2015CB150506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams P, 2007, J APPL MICROBIOL, V103, P2240, DOI 10.1111/j.1365-2672.2007.03472.x; Adams P, 2007, MICROB ECOL, V54, P306, DOI 10.1007/s00248-006-9203-0; Altomare C, 1999, APPL ENVIRON MICROB, V65, P2926; Altomare C, 2011, SUSTAIN AGR REV, V7, P161, DOI 10.1007/978-94-007-1521-9_6; ANKE H, 1991, BIOL MET, V4, P176, DOI 10.1007/BF01141311; Atkins SD, 2003, APPL ENVIRON MICROB, V69, P4788, DOI 10.1128/AEM.69.8.4788-4793.2003; Benitez T, 2004, INT MICROBIOL, V7, P249; Cai F, 2015, PLANT SOIL, V388, P337, DOI 10.1007/s11104-014-2326-z; Cai F, 2013, PLANT PHYSIOL BIOCH, V73, P106, DOI 10.1016/j.plaphy.2013.08.011; de Santiago A, 2013, SOIL BIOL BIOCHEM, V57, P598, DOI 10.1016/j.soilbio.2012.06.020; de Santiago A, 2011, PLANT SOIL, V342, P97, DOI 10.1007/s11104-010-0670-1; Deubel A, 2005, SOIL BIOL, V3, P177; Ferandez LA, 2007, BIOL FERT SOILS, V43, P805, DOI 10.1007/s00374-007-0172-3; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Hervas A, 1998, BIOL CONTROL, V13, P166, DOI 10.1006/bcon.1998.0659; Huang XQ, 2011, APPL MICROBIOL BIOT, V91, P741, DOI 10.1007/s00253-011-3259-6; Machuca A, 2003, LETT APPL MICROBIOL, V36, P177, DOI 10.1046/j.1472-765X.2003.01290.x; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Menezes-Blackburn D, 2014, BIOL FERT SOILS, V50, P583, DOI 10.1007/s00374-013-0872-9; Nenwani V, 2010, J YEAST FUNGAL RES, V1, P9; OGNALAGA M, 1994, SOIL SCI SOC AM J, V58, P332, DOI 10.2136/sssaj1994.03615995005800020011x; Shen WS, 2008, PLANT SOIL, V306, P117, DOI 10.1007/s11104-007-9472-5; Vinale F, 2006, LETT APPL MICROBIOL, V43, P143, DOI 10.1111/j.1472-765X.2006.01939.x; Yedidia I, 2001, PLANT SOIL, V235, P235, DOI 10.1023/A:1011990013955	24	95	112	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130081	10.1371/journal.pone.0130081	http://dx.doi.org/10.1371/journal.pone.0130081			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110536	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800035
J	Scherer, K; Willer, K; Gromann, L; Birnbacher, L; Braig, E; Grandl, S; Sztrokay-Gaul, A; Herzen, J; Mayr, D; Hellerhoff, K; Pfeiffer, F				Scherer, Kai; Willer, Konstantin; Gromann, Lukas; Birnbacher, Lorenz; Braig, Eva; Grandl, Susanne; Sztrokay-Gaul, Aniko; Herzen, Julia; Mayr, Doris; Hellerhoff, Karin; Pfeiffer, Franz			Toward Clinically Compatible Phase-Contrast Mammography	PLOS ONE			English	Article							ENERGY	Phase-contrast mammography using laboratory X-ray sources is a promising approach to overcome the relatively low sensitivity and specificity of clinical, absorption-based screening. Current research is mostly centered on identifying potential diagnostic benefits arising from phase-contrast and dark-field mammography and benchmarking the latter with conventional state-of-the-art imaging methods. So far, little effort has been made to adjust this novel imaging technique to clinical needs. In this article, we address the key points for a successful implementation to a clinical routine in the near future and present the very first dose-compatible and rapid scan-time phase-contrast mammograms of both a freshly dissected, cancer-bearing mastectomy specimen and a mammographic accreditation phantom.	[Scherer, Kai; Willer, Konstantin; Gromann, Lukas; Birnbacher, Lorenz; Braig, Eva; Herzen, Julia; Pfeiffer, Franz] Tech Univ Munich, Dept Phys, Lehrstuhl Biomed Phys, D-80290 Munich, Germany; [Scherer, Kai; Willer, Konstantin; Gromann, Lukas; Birnbacher, Lorenz; Braig, Eva; Herzen, Julia; Pfeiffer, Franz] Tech Univ Munich, Inst Med Tech, D-80290 Munich, Germany; [Grandl, Susanne; Sztrokay-Gaul, Aniko; Hellerhoff, Karin] Univ Munich, Inst Clin Radiol, Munich, Germany; [Mayr, Doris] Univ Munich, Inst Pathol, D-80539 Munich, Germany	Technical University of Munich; University of Munich; Technical University of Munich; University of Munich; University of Munich	Scherer, K (corresponding author), Tech Univ Munich, Dept Phys, Lehrstuhl Biomed Phys, D-80290 Munich, Germany.	kai.scherer@tum.de			DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP); DFG Gottfried Wilhelm Leibniz program; European Research Council (ERC, FP7) [StG 240142]; Karlsruhe Nano Micro Facility (KNMF); Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT)	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP)(German Research Foundation (DFG)); DFG Gottfried Wilhelm Leibniz program(German Research Foundation (DFG)); European Research Council (ERC, FP7)(European Research Council (ERC)); Karlsruhe Nano Micro Facility (KNMF); Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT)	The authors acknowledge financial support through the DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP), the DFG Gottfried Wilhelm Leibniz program and the European Research Council (ERC, FP7, StG 240142). Part of this work was carried out with the support of the Karlsruhe Nano Micro Facility (KNMF, www.kit.edu/knmf), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT).	De Man B., 2007, P MEDICAL IMAGING 20, V6510, P65102; Donath T, 2009, J APPL PHYS, V106, DOI 10.1063/1.3208052; Hauser N, 2014, INVEST RADIOL, V49, P131, DOI 10.1097/RLI.0000000000000001; Hendrick RE, 1999, MAMMOGRAPHY QUALITY; Michel T, 2013, PHYS MED BIOL, V58, P2713, DOI 10.1088/0031-9155/58/8/2713; Perry N, 2008, ANN ONCOL, V19, P614, DOI 10.1093/annonc/mdm481; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Sarapata A, 2015, OPT EXPRESS, V23, P523, DOI 10.1364/OE.23.000523; Scherer K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093502; Stampanoni M, 2011, INVEST RADIOL, V46, P801, DOI 10.1097/RLI.0b013e31822a585f; Wang Y, 2007, J X-RAY SCI TECHNOL, V15, P169; Wang Z, 2013, J INSTRUM, V8, DOI 10.1088/1748-0221/8/07/C07011	12	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130776	10.1371/journal.pone.0130776	http://dx.doi.org/10.1371/journal.pone.0130776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110618	Green Published, gold			2022-12-27	WOS:000356933800084
J	Valente, TW; Palinkas, LA; Czaja, S; Chu, KH; Brown, CH				Valente, Thomas W.; Palinkas, Lawrence A.; Czaja, Sara; Chu, Kar-Hai; Brown, C. Hendricks			Social Network Analysis for Program Implementation	PLOS ONE			English	Article							PREVENTION PROGRAM; PEER-EDUCATION; TRANSLATION; SCIENCE; COALITIONS; INTERVENTION; PARTNERSHIPS; FRAMEWORK; EFFICACY; LEADERS	This paper introduces the use of social network analysis theory and tools for implementation research. The social network perspective is useful for understanding, monitoring, influencing, or evaluating the implementation process when programs, policies, practices, or principles are designed and scaled up or adapted to different settings. We briefly describe common barriers to implementation success and relate them to the social networks of implementation stakeholders. We introduce a few simple measures commonly used in social network analysis and discuss how these measures can be used in program implementation. Using the four stage model of program implementation (exploration, adoption, implementation, and sustainment) proposed by Aarons and colleagues [1] and our experience in developing multi-sector partnerships involving community leaders, organizations, practitioners, and researchers, we show how network measures can be used at each stage to monitor, intervene, and improve the implementation process. Examples are provided to illustrate these concepts. We conclude with expected benefits and challenges associated with this approach.	[Valente, Thomas W.; Chu, Kar-Hai] Univ So Calif, Sch Med, Prevent Med, Los Angeles, CA 90089 USA; [Palinkas, Lawrence A.] Univ So Calif, Sch Social Work, Los Angeles, CA 90089 USA; [Czaja, Sara] Univ Miami, Sch Med, Miami, FL USA; [Brown, C. Hendricks] Northwestern Univ, Sch Med, Chicago, IL USA	University of Southern California; University of Southern California; University of Miami; Northwestern University	Valente, TW (corresponding author), Univ So Calif, Sch Med, Prevent Med, Los Angeles, CA 90089 USA.	tvalente@usc.edu		Brown, C Hendricks/0000-0002-0294-2419	Center for Prevention Implementation Methodology (Ce-PIM) for Drug Abuse and HIV Sexual Risk Behavior from National Institute on Drug Abuse [P30-DA027828]; Office of Behavioral and Social Science Research (Brown, PI); NATIONAL INSTITUTE ON DRUG ABUSE [P30DA027828] Funding Source: NIH RePORTER	Center for Prevention Implementation Methodology (Ce-PIM) for Drug Abuse and HIV Sexual Risk Behavior from National Institute on Drug Abuse; Office of Behavioral and Social Science Research (Brown, PI); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by grant P30-DA027828 for the Center for Prevention Implementation Methodology (Ce-PIM) for Drug Abuse and HIV Sexual Risk Behavior from the National Institute on Drug Abuse and the Office of Behavioral and Social Science Research (Brown, PI).	Aarons GA, 2012, ADM POLICY MENT HLTH, V39, P331, DOI 10.1007/s10488-010-0302-3; Aarons GA, 2011, ADM POLICY MENT HLTH, V38, P4, DOI 10.1007/s10488-010-0327-7; [Anonymous], 2011, RES METHODS ANTHR; BACKER TE, 2003, EVALUATING COMMUNITY; Balas E A, 2000, Yearb Med Inform, P65; Barkin SL, 2012, PEDIATRICS, V130, P445, DOI 10.1542/peds.2011-3762; Bess KD, 2012, HEALTH EDUC BEHAV, V39, P526, DOI 10.1177/1090198111419656; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Borgatti S. P., 2006, Computational & Mathematical Organization Theory, V12, P21, DOI 10.1007/s10588-006-7084-x; Borgatti S.P., 2018, ANAL SOCIAL NETWORKS; Brown C. H., 2014, ADV PREVENTION SCI D; Brown CH, 2012, ADM POLICY MENT HLTH, V39, P301, DOI 10.1007/s10488-011-0387-3; Brown CH, 2013, JAIDS-J ACQ IMM DEF, V63, pS66; Brownson RC, 2015, AM J PREV MED, V48, P543, DOI 10.1016/j.amepre.2014.11.015; Buller DB, 1999, J NATL CANCER I, V91, P1491, DOI 10.1093/jnci/91.17.1491; Capurro D, 2014, J MED INTERNET RES, V16, P213, DOI 10.2196/jmir.2679; Chambers DA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-117; Chambers DA, 2012, AM J COMMUN PSYCHOL, V50, P282, DOI 10.1007/s10464-012-9528-4; Chu K, 2015, P 2015 48 HAW INT C; Coleman J. S., 1966, MED INNOVATION DIFFU; Conrad DA, 2003, MED CARE RES REV, V60, p95S, DOI 10.1177/1077558703259096; Cross W, 2014, PREV SCI, V47, pS251; Curran GM, 2012, MED CARE, V50, P217, DOI 10.1097/MLR.0b013e3182408812; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; ENNETT ST, 1994, AM J PUBLIC HEALTH, V84, P1394, DOI 10.2105/AJPH.84.9.1394; Everett MG, 2010, SOC NETWORKS, V32, P339, DOI 10.1016/j.socnet.2010.06.004; Feinberg Mark E, 2005, J Prim Prev, V26, P279, DOI 10.1007/s10935-005-5390-4; Fixsen D., 2005, IMPLEMENTATION RES S; Flay BR, 2005, PREV SCI, V6, P151, DOI 10.1007/s11121-005-5553-y; Flodgren G, 2010, COCHRANE COLLABORATI; Garfein RS, 2007, AIDS, V21, P1923, DOI 10.1097/QAD.0b013e32823f9066; Gesell SB, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-116; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Glasgow RE, 2003, AM J PUBLIC HEALTH, V93, P1261, DOI 10.2105/AJPH.93.8.1261; Glasgow RE, 2007, ANNU REV PUBL HEALTH, V28, P413, DOI 10.1146/annurev.publhealth.28.021406.144145; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Heckathorn DD, 2002, AIDS BEHAV, V6, P55; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Iyengar R, 2011, MARKET SCI, V30, P195, DOI 10.1287/mksc.1100.0566; Kadushin C., 2012, UNDERSTANDING SOCIAL; Kegler MC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-90; Kellam SG, 2012, ADM POLICY MENT HLTH, V39, P317, DOI 10.1007/s10488-011-0402-8; Kelly JA, 2006, BMJ-BRIT MED J, V333, P1098, DOI 10.1136/bmj.38992.478299.55; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; Moore S, 2005, AM J PUBLIC HEALTH, V95, P1330, DOI 10.2105/AJPH.2004.046094; Morris M, 2004, NETWORK EPIDEMIOLOGY; Neaigus A, 1998, Public Health Rep, V113 Suppl 1, P140; OConnell ME, 2009, PREVENTING MENTAL, EMOTIONAL, AND BEHAVIORAL DISORDERS AMONG YOUNG PEOPLE: PROGRESS AND POSSIBILITIES, P1; Palinkas L.A., 2012, TRANSLATION IMPLEMEN; Palinkas LA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-133; Palinkas LA, 2014, ADM POLICY MENT HLTH, V41, P74, DOI 10.1007/s10488-012-0437-5; Palinkas LA, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-113; PENTZ MA, 1989, JAMA-J AM MED ASSOC, V261, P3259, DOI 10.1001/jama.261.22.3259; Poduska J, 2012, ADM POLICY MENT HLTH, V39, P258, DOI 10.1007/s10488-011-0383-7; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Rohrbach LA, 2006, EVAL HEALTH PROF, V29, P302, DOI 10.1177/0163278706290408; Saint-Charles J, 2009, SOC NETWORKS, V31, P33, DOI 10.1016/j.socnet.2008.09.001; Saldana L, 2012, ADM POLICY MENT HLTH, V39, P419, DOI 10.1007/s10488-011-0363-y; Shin HS, 2014, OBESITY, V22, P1520, DOI 10.1002/oby.20731; Son J, 2008, SOC SCI RES, V37, P330, DOI 10.1016/j.ssresearch.2006.12.004; Soydan H., 2014, EVIDENCE BASED PRACT; Spoth R, 2013, PREV SCI, V14, P319, DOI 10.1007/s11121-012-0362-6; Stoebenau K, 2003, INT FAM PLAN PERSPEC, V29, P167, DOI 10.2307/3181045; Sussman S, 2006, EVAL HEALTH PROF, V29, P7, DOI 10.1177/0163278705284441; Valente T.W., 2002, EVALUATING HLTH PROM, P328; Valente TW, 2007, HEALTH EDUC BEHAV, V34, P881, DOI 10.1177/1090198106297855; Valente TW, 2007, ADDICTION, V102, P1804, DOI 10.1111/j.1360-0443.2007.01992.x; Valente TW, 2007, AM J PUBLIC HEALTH, V97, P880, DOI 10.2105/AJPH.2005.063644; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330; Valente TW, 2010, AM J PUBLIC HEALTH, V100, P1319, DOI 10.2105/AJPH.2009.171116; Valente TW, 1998, COMMUN RES, V25, P96, DOI 10.1177/009365098025001004; Valente TW, 2003, AM J PUBLIC HEALTH, V93, P1837, DOI 10.2105/AJPH.93.11.1837; Valente TW, 1995, NETWORK MODELS OF TH; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Wyman PA, 2010, AM J PUBLIC HEALTH, V100, P1653, DOI 10.2105/AJPH.2009.190025	76	146	148	17	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131712	10.1371/journal.pone.0131712	http://dx.doi.org/10.1371/journal.pone.0131712			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OY	26110842	gold, Green Submitted, Green Published			2022-12-27	WOS:000356933800172
J	Joo, YH; Han, KD; Park, KH				Joo, Young-Hoon; Han, Kyung-do; Park, Kyung Ho			Association of Hearing Loss and Tinnitus with Health-Related Quality of Life: The Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							IMPAIRMENT; AUDIOMETRY; MORTALITY; DISEASE; RISK	Background Hearing loss and tinnitus are global public health concerns. There have been some studies suggesting a relationship between hearing loss and tinnitus and impaired health-related quality of life (HRQoL), but there have been no large cross-sectional epidemiologic studies of a representative sample of the entire country population investigating this possible association. Objective The aim of this study was to investigate the relationship between hearing loss and tinnitus and HRQoL in South Korea using data from the Korea National Health and Nutrition Examination Surveys during 2010-2012. Methods Cross-sectional data of 11,266 adults who completed the Korea National Health and Nutrition Examination Surveys were analyzed. Subjects were divided into four groups as follows: normal hearing without tinnitus, normal hearing with tinnitus, hearing loss without tinnitus, and hearing loss with tinnitus. Results Among the population that was >= 19 years of age, the prevalence of unilateral hearing loss was 9.69% and that of tinnitus in the prior 12 months was 32.76%. The hearing loss with tinnitus group had the highest percentage of subjects who responded "some or extreme problems" in all five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) of HRQoL. After adjustment for age, gender, body mass index, smoking status, alcohol intake, regular exercise, house income, education level, diabetes, hypertension, and stress level, the HRQoL odds ratios (OR) were 1.47 (95% confidence interval [CI], 1.07-2.02) for mobility, 1.59 (95% CI, 1.07-2.37) for usual activity, and 1.84 (95% CI, 1.25-2.70) for anxiety/depression in the hearing loss with tinnitus group, compared with the normal hearing without tinnitus group. The ORs for the normal hearing with tinnitus group compared with the hearing loss without tinnitus group was increased in all five dimensions of HRQoL after adjustment for confounders. Conclusion Hearing loss with tinnitus has a considerable impact on HRQoL in the Korean population. In our study, the hearing loss without tinnitus group showed better a HRQoL than the normal hearing with tinnitus group.	[Joo, Young-Hoon; Park, Kyung Ho] Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea; [Han, Kyung-do] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Park, KH (corresponding author), Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	khpent@catholic.ac.kr	Joo, Young Hoon/AAU-7285-2020	Joo, Young Hoon/0000-0002-4662-1916				Allman BL, 2013, HEARING RES, V295, P1, DOI 10.1016/j.heares.2012.11.012; Bauch Christopher D, 2003, J Am Acad Audiol, V14, P181; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Carlsson PI, 2011, INT J AUDIOL, V50, P139, DOI 10.3109/14992027.2010.533705; Chia EM, 2007, EAR HEARING, V28, P187, DOI 10.1097/AUD.0b013e31803126b6; Cronlein T, 2007, PROG BRAIN RES, V166, P227, DOI 10.1016/S0079-6123(07)66021-X; Fransen E, 2003, EXP GERONTOL, V38, P353, DOI 10.1016/S0531-5565(03)00032-9; Huang Q, 2010, EUR ARCH OTO-RHINO-L, V267, P1179, DOI 10.1007/s00405-010-1270-7; Kim Yangho, 2013, J Prev Med Public Health, V46, P96, DOI 10.3961/jpmph.2013.46.2.96; Kleefstra N, 2008, DIABETES CARE, V31, P932, DOI 10.2337/dc07-2072; Larsson G, 2007, EUR J CANCER CARE, V16, P493, DOI 10.1111/j.1365-2354.2007.00781.x; Mahomed F, 2013, EAR HEARING, V34, P745, DOI 10.1097/01.aud.0000436255.53747.a4; Mattox DE, 2006, NEUROOTOLOGY, V12, P135; MEIKLE MB, 1984, OTOLARYNG HEAD NECK, V92, P689, DOI 10.1177/019459988409200617; Park HA, 2013, KOREAN J FAM MED, V34, P79, DOI 10.4082/kjfm.2013.34.2.79; Park SH, 2010, INT J CARDIOL, V139, P234, DOI 10.1016/j.ijcard.2008.10.011; Schenkeveld L, 2010, AM HEART J, V159, P471, DOI 10.1016/j.ahj.2009.12.012; Sindhusake Doungkamol, 2004, J Am Acad Audiol, V15, P269; Swanepoel D, 2010, TELEMED J E-HEALTH, V16, P557, DOI 10.1089/tmj.2009.0143; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; Turner Oliver, 2007, Ann Gen Psychiatry, V6, P26, DOI 10.1186/1744-859X-6-26; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	22	37	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131247	10.1371/journal.pone.0131247	http://dx.doi.org/10.1371/journal.pone.0131247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121026	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400090
J	Wang, AP; Li, XH; Yang, YM; Li, WQ; Zhang, W; Hu, CP; Zhang, Z; Li, YJ				Wang, Ai-ping; Li, Xiao-hui; Yang, Yong-mei; Li, Wen-qun; Zhang, Wang; Hu, Chang-ping; Zhang, Zheng; Li, Yuan-jian			A Critical Role of the mTOR/eIF2 alpha Pathway in Hypoxia-Induced Pulmonary Hypertension	PLOS ONE			English	Article							MUSCLE-CELL PROLIFERATION; ARTERIAL-HYPERTENSION; MAMMALIAN TARGET; G(1) ARREST; RAPAMYCIN; MTOR; INHIBITION; SURVIVAL; GROWTH; PHOSPHORYLATION	Enhanced proliferation of pulmonary arterial vascular smooth muscle cells (PASMCs) is a key pathological component of vascular remodeling in hypoxia-induced pulmonary hypertension (HPH). Mammalian targeting of rapamycin (mTOR) signaling has been shown to play a role in protein translation and participate in the progression of pulmonary hypertension. Eukaryotic translation initiation factor-2 alpha (eIF2 alpha) is a key factor in regulation of cell growth and cell cycle, but its role in mTOR signaling and PASMCs proliferation remains unknown. Pulmonary hypertension (PH) rat model was established by hypoxia. Rapamycin was used to treat rats as an mTOR inhibitor. Proliferation of primarily cultured rat PASMCs was induced by hypoxia, rapamycin and siRNA of mTOR and eIF2 alpha were used in loss-of-function studies. The expression and activation of eIF2 alpha, mTOR and c-myc were analyzed. Results showed that mTOR/eIF2 alpha signaling was significantly activated in pulmonary arteries from hypoxia exposed rats and PASMCs cultured under hypoxia condition. Treatment with mTOR inhibitor for 21 days attenuated vascular remodeling, suppressed mTOR and eIF2 alpha activation, inhibited c-myc expression in HPH rats. In hypoxia-induced PASMCs, rapamycin and knockdown of mTOR and eIF2 alpha by siRNA significantly abolished proliferation and increased c-myc expression. These results suggest a critical role of the mTOR/eIF2 alpha pathway in hypoxic vascular remodeling and PASMCs proliferation of HPH.	[Wang, Ai-ping; Li, Xiao-hui; Yang, Yong-mei; Li, Wen-qun; Zhang, Wang; Hu, Chang-ping; Zhang, Zheng; Li, Yuan-jian] Cent S Univ, Sch Pharmaceut Sci, Dept Pharmacol, Changsha 410078, Hunan, Peoples R China; [Wang, Ai-ping; Yang, Yong-mei] Univ South China, Sch Med, Dept Anat, Hengyang 421001, Peoples R China	Central South University; University of South China	Li, YJ (corresponding author), Cent S Univ, Sch Pharmaceut Sci, Dept Pharmacol, Changsha 410078, Hunan, Peoples R China.	yuan_jianli@sina.com	Li, Yuan/GXV-1310-2022		National Natural Science Foundation of China [81200035, 81273513, 81072638]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81200035 to X-H.L, No. 81273513 to Y-J.L, and No. 81072638 to C-P.H).	Anand P, 2006, J NUTR, V136, P27, DOI 10.1093/jn/136.1.27; Bennett RL, 2012, CELL CYCLE, V11, P407, DOI 10.4161/cc.11.2.18999; Bentley J Kelley, 2008, Proc Am Thorac Soc, V5, P89, DOI 10.1513/pats.200705-063VS; Bernard Sandra, 2006, V42, P329, DOI 10.1007/004; Chan SY, 2008, J MOL CELL CARDIOL, V44, P14, DOI 10.1016/j.yjmcc.2007.09.006; Dahal BK, 2010, AM J RESP CRIT CARE, V181, P158, DOI 10.1164/rccm.200811-1682OC; Eckerdt F, 2014, ONCOTARGET, V5, P8442, DOI 10.18632/oncotarget.2319; Evangelisti C, 2011, LEUKEMIA, V25, P781, DOI 10.1038/leu.2011.20; Goncharov DA, 2014, CIRCULATION, V129, P864, DOI 10.1161/CIRCULATIONAHA.113.004581; Goncharova EA, 2013, FASEB J, V27, P1796, DOI 10.1096/fj.12-222224; Goncharova EA, 2011, MOL CELL BIOL, V31, P2484, DOI 10.1128/MCB.01061-10; Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047; Houssaini A, 2013, AM J RESP CELL MOL, V48, P568, DOI 10.1165/rcmb.2012-0429OC; Hubbi ME, 2014, P NATL ACAD SCI USA, V111, pE3325, DOI 10.1073/pnas.1412840111; Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com; Karelina K, 2015, NEUROSCIENCE, V285, P292, DOI 10.1016/j.neuroscience.2014.10.053; Krymskaya VP, 2011, FASEB J, V25, P1922, DOI 10.1096/fj.10-175018; Li XW, 2012, EUR J PHARMACOL, V679, P117, DOI 10.1016/j.ejphar.2012.01.015; Li XH, 2010, VASC PHARMACOL, V53, P223, DOI 10.1016/j.vph.2010.09.002; Liu B, 2014, J CARDIOVASC PHARM, V63, P567, DOI 10.1097/FJC.0000000000000082; Liu TR, 2011, MOL CANCER THER, V10, P1460, DOI 10.1158/1535-7163.MCT-10-0925; Liu XF, 2013, BLOOD, V121, P3364, DOI 10.1182/blood-2012-09-456400; Liu Y, 2010, NEOPLASIA, V12, P61, DOI 10.1593/neo.91354; Masri FA, 2007, AM J PHYSIOL-LUNG C, V293, pL548, DOI 10.1152/ajplung.00428.2006; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Moss SC, 2010, J BIOL CHEM, V285, P11991, DOI 10.1074/jbc.M109.066621; Nuhrenberg TG, 2004, FASEB J, V18, P246, DOI 10.1096/fj.04-2431fje; Ogawa A, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.190; Ogawa A, 2009, AM J PHYSIOL-LUNG C, V297, pL666, DOI 10.1152/ajplung.90548.2008; Paddenberg R, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-15; Ricard N, 2014, CIRCULATION, V129, P1586, DOI 10.1161/CIRCULATIONAHA.113.007469; Sakao S, 2011, INT J CARDIOL, V147, P4, DOI 10.1016/j.ijcard.2010.07.003; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Shi X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.282; Sun LQ, 1999, J BIOL CHEM, V274, P17236, DOI 10.1074/jbc.274.24.17236; Tang ZH, 2008, CIRCULATION, V118, P764, DOI 10.1161/CIRCULATIONAHA.107.761932; Wang W, 2014, J CELL PHYSIOL, V229, P2117, DOI 10.1002/jcp.24670; Yang J, 2013, AM J PHYSIOL-LUNG C, V305, pL312, DOI 10.1152/ajplung.00054.2013; Zeng XC, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-261; Zhang PP, 2014, BIOCHEM BIOPH RES CO, V452, P53, DOI 10.1016/j.bbrc.2014.08.046	40	26	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130806	10.1371/journal.pone.0130806	http://dx.doi.org/10.1371/journal.pone.0130806			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26120832	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400062
J	Wells, AJ; Vink, R; Helps, SC; Knox, SJ; Blumbergs, PC; Turner, RJ				Wells, Adam J.; Vink, Robert; Helps, Stephen C.; Knox, Steven J.; Blumbergs, Peter C.; Turner, Renee J.			Elevated Intracranial Pressure and Cerebral Edema following Permanent MCA Occlusion in an Ovine Model	PLOS ONE			English	Article							ARTERY INFARCTION; DECOMPRESSIVE CRANIECTOMY; MALIGNANT INFARCTION; TENTORIUM CEREBELLI; HEMISPHERIC STROKE; BRAIN EDEMA; RATS; HEMICRANIECTOMY; MULTICENTER; GRADIENTS	Introduction Malignant middle cerebral artery (MCA) stroke has a disproportionately high mortality due to the rapid development of refractory space-occupying cerebral edema. Animal models are essential in developing successful anti-edema therapies; however to date poor clinical translation has been associated with the predominately used rodent models. As such, large animal gyrencephalic models of stroke are urgently needed. The aim of the study was to characterize the intracranial pressure (ICP) response to MCA occlusion in our recently developed ovine stroke model. Materials and Methods 30 adult female Merino sheep (n = 8-12/gp) were randomized to sham surgery, temporary or permanent proximal MCA occlusion. ICP and brain tissue oxygen were monitored for 24 hours under general anesthesia. MRI, infarct volume with triphenyltetrazolium chloride (TTC) staining and histology were performed. Results No increase in ICP, radiological evidence of ischemia within the MCA territory but without space-occupying edema, and TTC infarct volumes of 7.9+/-5.1% were seen with temporary MCAO. Permanent MCAO resulted in significantly elevated ICP, accompanied by 30% mortality, radiological evidence of space-occupying cerebral edema and TTC infarct volumes of 27.4+/-6.4%. Conclusions Permanent proximal MCAO in the sheep results in space-occupying cerebral edema, raised ICP and mortality similar to human malignant MCA stroke. This animal model may prove useful for pre-clinical testing of anti-edema therapies that have shown promise in rodent studies.	[Wells, Adam J.; Helps, Stephen C.; Turner, Renee J.] Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA 5005, Australia; [Wells, Adam J.] Royal Adelaide Hosp, Dept Neurosurg, Adelaide, SA 5000, Australia; [Vink, Robert] Univ S Australia, Fac Hlth Sci, Adelaide, SA 5000, Australia; [Knox, Steven J.] Royal Adelaide Hosp, Dept Radiol, Adelaide, SA 5000, Australia; [Blumbergs, Peter C.] South Australia Pathol, Tissue Pathol, Adelaide, SA 5000, Australia	University of Adelaide; Royal Adelaide Hospital; University of South Australia; Royal Adelaide Hospital	Turner, RJ (corresponding author), Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA 5005, Australia.	renee.turner@adelaide.edu.au	Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667	National Health and Medical Research Council [1017721]; Overseas Biomedical Post-doctoral Training Fellowship [519365]; Neurosurgical Research Foundation; Neurosurgical Society of Australasia	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Overseas Biomedical Post-doctoral Training Fellowship; Neurosurgical Research Foundation; Neurosurgical Society of Australasia	This study was supported by the National Health and Medical Research Council through Dora Lush Biomedical Postgraduate Fellowship (AJW; 1017721) and the Overseas Biomedical Post-doctoral Training Fellowship (RJT; 519365) and research scholarships from the Neurosurgical Research Foundation (AJW) and Neurosurgical Society of Australasia (AJW). The funding organizations played no role in design and conduct of the study; collection, management, analysis and interpretation of the data; or preparation, review or approval of the manuscript.	Arnaout OM, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.3.FOCUS1160; Berrouschot J, 1998, INTENS CARE MED, V24, P620, DOI 10.1007/s001340050625; Boltze J, 2008, J CEREBR BLOOD F MET, V28, P1951, DOI 10.1038/jcbfm.2008.89; BULL JWD, 1969, P ROY SOC MED, V62, P1301, DOI 10.1177/003591576906201242; Carhuapoma JR, 2002, J NEUROSURG ANESTH, V14, P299, DOI 10.1097/00008506-200210000-00005; Casals JB, 2011, COMPARATIVE MED, V61, P305; D'Ambrosio AL, 2002, SURG NEUROL, V58, P295, DOI 10.1016/S0090-3019(02)00817-0; DeVries AC, 2001, NEUROSCI BIOBEHAV R, V25, P325, DOI 10.1016/S0149-7634(01)00017-3; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; FORSTING M, 1995, STROKE, V26, P259, DOI 10.1161/01.STR.26.2.259; Gabrielian L, 2011, J NEUROTRAUM, V28, P2103, DOI 10.1089/neu.2011.1785; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Hudetz JA, 2010, J CARDIOTHOR VASC AN, V24, P131, DOI 10.1053/j.jvca.2009.05.008; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; KLINTWORTH GK, 1968, ANAT RECORD, V160, P635, DOI 10.1002/ar.1091600312; Koizumi J, 1986, JPN J STROKE, V8, P108; KOTWICA Z, 1991, RES EXP MED, V191, P99, DOI 10.1007/BF02576664; Li FH, 1997, J CEREBR BLOOD F MET, V17, P1132, DOI 10.1097/00004647-199710000-00016; Lin HC, 1997, VET SURG, V26, P247, DOI 10.1111/j.1532-950X.1997.tb01494.x; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; O'Brien MD, 1973, STROKE, V4, P201, DOI 10.1161/01.STR.4.2.201; O'Donnell ME, 2004, J CEREBR BLOOD F MET, V24, P1046, DOI 10.1097/01.WCB.0000130867.32663.90; Okada Y, 1983, J Neurosurg, V58, P500, DOI 10.3171/jns.1983.58.4.0500; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P26, DOI 10.1001/archneur.1984.04050130032017; Schifilliti D, 2010, CNS DRUGS, V24, P893, DOI 10.2165/11584760-000000000-00000; Schwab S, 1996, NEUROLOGY, V47, P393, DOI 10.1212/WNL.47.2.393; Serena J, 2005, STROKE, V36, P1921, DOI 10.1161/01.STR.0000177870.14967.94; SHAH V, 1993, HEPATOLOGY, V17, P1117, DOI 10.1002/hep.1840170627; Simard JM, 2010, STROKE, V41, P531, DOI 10.1161/STROKEAHA.109.572644; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Thrift AG, 2000, STROKE, V31, P2087, DOI 10.1161/01.STR.31.9.2087; Toyota S, 2002, STROKE, V33, P1383, DOI 10.1161/01.STR.0000015557.18508.DD; Treadwell SD, 2010, POSTGRAD MED J, V86, P235, DOI 10.1136/pgmj.2009.094292; Turner RJ, 2011, BRAIN RES, V1393, P84, DOI 10.1016/j.brainres.2011.03.066; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Walberer M, 2007, J NEUROSURG ANESTH, V19, P105, DOI 10.1097/ANA.0b013e31802c7e33; Wang David Z, 2011, Curr Treat Options Cardiovasc Med, V13, P225, DOI 10.1007/s11936-011-0121-1; Wells AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042157; YANO M, 1987, NEUROSURGERY, V21, P688, DOI 10.1227/00006123-198711000-00015	43	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130512	10.1371/journal.pone.0130512	http://dx.doi.org/10.1371/journal.pone.0130512			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121036	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400045
J	Zhao, K; Shao, B; Yang, DJ; Li, FQ; Zhu, JH				Zhao, Kai; Shao, Bing; Yang, Dajin; Li, Fengqin; Zhu, Jianghui			Natural Occurrence of Alternaria Toxins in Wheat-Based Products and Their Dietary Exposure in China	PLOS ONE			English	Article							MYCOTOXIN ALTERNARIOL	A total of 181 wheat flour and 142 wheat-based foods including dried noodle, steamed bread and bread collected in China were analyzed for alternariol (AOH), alternariol monomethyl ether (AME), tentoxin (TEN) and tenuazonic acid (TeA) by ultra-performance liquidchromatography-electrospray ionization-tandem mass spectrometry. TeA was the predominant toxin found in 99.4% wheat flour samples at levels ranging from 1.76 mu g/kg to 520 mu g/kg. TEN was another Alternaria toxin frequently detected in wheat flour samples (97.2%) at levels between 2.72 mu g/kg and 129 mu g/kg. AOH and AME were detected in 11 (6.1%) samples at levels ranging from 16.0 mu g/kg to 98.7 mu g/kg (AOH) and in 165 (91.2%) samples with a range between 0.320 mu g/kg and 61.8 mu g/kg (AME). AOH was quantified at higher levels than AME with the ratio of AOH/AME ranging from 1.0 to 3.7. Significant linear regressions of correlation in toxin concentrations were observed between AOH and AME, AME and TeA, TEN and TeA, AOH+AME and TeA. At an average and 95th percentile, dietary exposure to AOH and AME in the Chinese general population and different age subgroups exceeded the relevant threshold value of toxicological concern (TTC), with the highest exposure found in children which deserves human health concern. TEN and TeA seem unlikely to be health concerns for the Chinese via wheat-based products but attention should be paid to synergistic or additive effects of TeA with AOH, AME, TEN and a further assessment will be performed once more data on toxicity-guided fractionation of the four toxins are available. It is necessary to conduct a systemic surveillance of Alternaria toxins in raw and processed foods in order to provide the scientific basis for making regulations on these toxins in China.	[Zhao, Kai] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Beijing, Peoples R China; [Zhao, Kai; Yang, Dajin; Li, Fengqin; Zhu, Jianghui] China Natl Ctr Food Safety Risk Assessment, Key Lab Food Safety Risk Assessment, Beijing, Peoples R China; [Shao, Bing] Beijing Municipal Ctr Dis Control & Prevent, Dept Cent Lab, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Li, FQ (corresponding author), China Natl Ctr Food Safety Risk Assessment, Key Lab Food Safety Risk Assessment, Beijing, Peoples R China.	lifengqin@cfsa.net.cn	shao, bing/L-8793-2019	Yang, Dajin/0000-0001-7032-5642	National High-tech R&D Program (863 Program); Ministry of Science and Technology of the People's Republic of China [2012AA101603]	National High-tech R&D Program (863 Program)(National High Technology Research and Development Program of China); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was supported by the National High-tech R&D Program (863 Program), the Ministry of Science and Technology of the People's Republic of China Grant Number: 2012AA101603 (http://www.863.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkai-Golan R, 2008, MYCOTOXINS IN FRUITS AND VEGETABLES, P185, DOI 10.1016/B978-0-12-374126-4.00008-5; Bottalico A., 1992, ALTERNARIA BIOL PLAN, V3, P209; Brugger EM, 2006, TOXICOL LETT, V164, P221, DOI 10.1016/j.toxlet.2006.01.001; EFSA, 2012, EFSA J; EFSA Panel on Contaminants in the Food Chain (CONTAM), 2011, EFSA J; European Food Safety Authority (EFSA), 2010, EFSA J; Fehr M, 2009, MOL NUTR FOOD RES, V53, P441, DOI 10.1002/mnfr.200700379; Kada T, 1984, HDB MUTAGENICITY TES, P13; Kocher U, 2007, P 29 MYC WORKSH 2007; Kroes R, 2004, FOOD CHEM TOXICOL, V42, P65, DOI 10.1016/j.fct.2003.08.006; Lehmann L, 2006, FOOD CHEM TOXICOL, V44, P398, DOI 10.1016/j.fct.2005.08.013; Li FQ, 2000, J AGR FOOD CHEM, V48, P2920, DOI 10.1021/jf0000171; Li FQ, 2001, J FOOD PROTECT, V64, P567, DOI 10.4315/0362-028X-64.4.567; LIU GT, 1992, CHINESE MED J-PEKING, V105, P394; Logrieco A, 2009, WORLD MYCOTOXIN J, V2, P129, DOI 10.3920/WMJ2009.1145; Muller MEH, 2013, FOOD CONTROL, V34, P191, DOI 10.1016/j.foodcont.2013.04.018; Pfeiffer E., 2007, MYCOTOXIN RES, V27, P152, DOI DOI 10.1007/BF02951512; Siegel D, 2009, J CHROMATOGR A, V1216, P4582, DOI 10.1016/j.chroma.2009.03.063; Tiemann U, 2009, TOXICOL LETT, V186, P139, DOI 10.1016/j.toxlet.2009.01.014; Wollenhaupt K, 2008, TOXICOL LETT, V182, P57, DOI 10.1016/j.toxlet.2008.08.005; World Health Organization (WHO), 2009, PRINC METH RISK ASS, V68; Zhao K, 2015, J AGR FOOD CHEM, V63, P343, DOI 10.1021/jf5052738; ZHEN YZ, 1991, IARC SCI PUBL, V105, P253	23	35	39	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0132019	10.1371/journal.pone.0132019	http://dx.doi.org/10.1371/journal.pone.0132019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121047	Green Submitted, Green Published, gold			2022-12-27	WOS:000358150400189
J	Coccon, F; Zucchetta, M; Bossi, G; Borrotti, M; Torricelli, P; Franzoi, P				Coccon, Francesca; Zucchetta, Matteo; Bossi, Giulia; Borrotti, Matteo; Torricelli, Patrizia; Franzoi, Piero			A Land-Use Perspective for Birdstrike Risk Assessment: The Attraction Risk Index	PLOS ONE			English	Article							AIRCRAFT; AIRPORTS; POPULATIONS; COLLISIONS; AVIATION; RANKING; RAPTORS; URBAN; AURA	Collisions between aircraft and birds, birdstrikes, pose a serious threat to aviation safety. The occurrence of these events is influenced by land-uses in the surroundings of airports. Airports located in the same region might have different trends for birdstrike risk, due to differences in the surrounding habitats. Here we developed a quantitative tool that assesses the risk of birdstrike based on the habitats within a 13-km buffer from the airport. For this purpose, we developed Generalized Linear Models (GLMs) with binomial distribution to estimate the contribution of habitats to wildlife use of the study area, depending on season. These GLMs predictions were combined to the flight altitude of birds within the 13-km buffer, the airport traffic pattern and the severity indices associated with impacts. Our approach was developed at Venice Marco Polo International airport (VCE), located in northeast Italy and then tested at Treviso Antonio Canova International airport (TSF), which is 20 km inland. Results from the two airports revealed that both the surrounding habitats and the season had a significant influence to the pattern of risk. With regard to VCE, agricultural fields, wetlands and urban areas contributed most to the presence of birds in the study area. Furthermore, the key role of distance of land-uses from the airport on the probability of presence of birds was highlighted. The reliability of developed risk index was demonstrated since at VCE it was significantly correlated with bird strike rate. This study emphasizes the importance of the territory near airports and the wildlife use of its habitats, as factors in need of consideration for birdstrike risk assessment procedures. Information on the contribution of habitats in attracting birds, depending on season, can be used by airport managers and local authorities to plan specific interventions in the study area in order to lower the risk.	[Coccon, Francesca; Zucchetta, Matteo; Torricelli, Patrizia; Franzoi, Piero] Univ Ca Foscari Venice, Dept Environm Sci Informat & Stat, Venice, Italy; [Bossi, Giulia] CNR, IRPI, Natl Res Council Italy, Res Inst Geohydrol Protect, Padua, Italy; [Borrotti, Matteo] Univ Ca Foscari Venice, European Ctr Living Technol, Venice, Italy; [Borrotti, Matteo] CNR, IMAT, Natl Res Council Italy, Inst Appl Math & Informat Technol, Milan, Italy	Universita Ca Foscari Venezia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca per la Protezione Idrogeologica (IRPI-CNR); Universita Ca Foscari Venezia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Matematica Applicata e Tecnologie Informatiche "Enrico Magenes" (IMATI-CNR)	Coccon, F (corresponding author), Univ Ca Foscari Venice, Dept Environm Sci Informat & Stat, Venice, Italy.	francesca.coccon@unive.it	Bossi, Giulia/K-6449-2015	Bossi, Giulia/0000-0003-1486-403X; Zucchetta, Matteo/0000-0002-5431-6751; Franzoi, Piero/0000-0003-3686-8525	SAVE S.p.A.	SAVE S.p.A.	The study was partially funded by SAVE S.p.A. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 1993, BIRD MIGRATION; Allan J, 2006, RISK ANAL, V26, P723, DOI 10.1111/j.1539-6924.2006.00776.x; Allan J, 2000, IBSC25WPOS3; Allan JR, 2002, P NAT WILDL RES CTR; Anagnostopoulos A, 2003, 26 INT BIRD STRIK CO; [Anonymous], 2011, CIRCOLARE APT01 B PR; Authority CA, 2008, CIVIL AVIATION AUTHO, P772; Baxter A, 2003, PREDICTING BIRDSTRIK, P5; Baxter AT, 2006, WILDLIFE SOC B, V34, P1162, DOI 10.2193/0091-7648(2006)34[1162:UORTRS]2.0.CO;2; BELANT JL, 1993, CONDOR, V95, P817, DOI 10.2307/1369420; Bibby C, 1998, EXPEDITION FIELD TEC; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Blackwell BF, 2006, J RAPTOR RES, V40, P76, DOI 10.3356/0892-1016(2006)40[76:CORHBJ]2.0.CO;2; Blackwell BF, 2013, WILDL MANAGE CONSERV, P153; Blackwell BF, 2009, LANDSCAPE URBAN PLAN, V93, P1, DOI 10.1016/j.landurbplan.2009.07.005; Bon M, 2013, UCCELLI LAGUNA CITTA; BURGER J, 1983, ENVIRON CONSERV, V10, P115, DOI 10.1017/S0376892900012200; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cleary EC, 2005, WILDLIFE HAZARDMANAG; DeVault TL, 2013, WILDL MANAGE CONSERV, P1; DeVault TL, 2005, J WILDLIFE MANAGE, V69, P592; DeVault TL, 2012, ENVIRON MANAGE, V49, P517, DOI 10.1007/s00267-011-9803-4; Dolbeer RA, 2000, WILDLIFE SOC B, V28, P372; Dolbeer RA, 2011, WILDLIFE STRIKES CIV; Dolbeer RA., 2006, ICAO J, V61, P21; Dolbeer RA, 2006, J WILDLIFE MANAGE, V70, P1345, DOI 10.2193/0022-541X(2006)70[1345:HDOBRB]2.0.CO;2; Dolbeer Richard A., 2011, Human-Wildlife Interactions, V5, P235; Evans J, 2010, ETHOLOGY, V116, P588, DOI 10.1111/j.1439-0310.2010.01771.x; Giunchi D, 2007, WILDLIFE RES, V34, P306, DOI 10.1071/WR06153; Godin AJ, 1994, HDB PREVENTION CONTO, P56; Gregory RD, 2004, TECH ECOL CONSERVAT, P17; International Civil Aviation Organization, 2011, AIRP SERV MAN 3; International Civil Aviation Organization, 2002, 9184AN902 INT CIV AV; Kelly TA, 1999, J RAPTOR RES, V33, P59; Kelly T, 2006, ENVIRONM POLLUT SER, V10, P5, DOI 10.1007/1-4020-4504-2_1; Mallord JW, 2007, J APPL ECOL, V44, P185, DOI 10.1111/j.1365-2664.2006.01242.x; Martin JA, 2011, WILDLIFE RISK AVIATI; Meinertzhagen R., 1955, Ibis, V97, P81, DOI 10.1111/j.1474-919X.1955.tb03020.x; Montemaggiori Alessandro, 2009, Alula (Roma), V16, P420; Oost L, 2000, IBSC25WPRS9, V1; Richardson WJ, 2000, P INT BIRD STRIK COM; Shamoun-Baranes J, 2006, B AM METEOROL SOC, V87, P47, DOI 10.1175/BAMS-87-1-47; Soldatini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028920; Soldatini C, 2010, EUR J WILDLIFE RES, V56, P623, DOI 10.1007/s10344-009-0359-z; Sowden R, 2007, BIRD STRIK COMM US C; Thorpe J., 2003, P INT BIRD STRIK COM; Thorpe J, 2005, P INT BIRD STRIK COM; Vidal E, 1998, BIODIVERS CONSERV, V7, P1013, DOI 10.1023/A:1008805030578; Vuorisalo T, 2003, LANDSCAPE URBAN PLAN, V62, P69, DOI 10.1016/S0169-2046(02)00124-X; Wright S., 2008, WILDLIFE STRIKES CIV; Zakrajsek EJ, 2005, WILDLIFE SOC B, V33, P258, DOI 10.2193/0091-7648(2005)33[258:RTROWS]2.0.CO;2	51	16	17	5	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0128363	10.1371/journal.pone.0128363	http://dx.doi.org/10.1371/journal.pone.0128363			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114958	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500012
J	Domagalski, K; Pawlowska, M; Kozielewicz, D; Dybowska, D; Tretyn, A; Halota, W				Domagalski, Krzysztof; Pawlowska, Malgorzata; Kozielewicz, Dorota; Dybowska, Dorota; Tretyn, Andrzej; Halota, Waldemar			The Impact of IL28B Genotype and Liver Fibrosis on the Hepatic Expression of IP10, IFI27, ISG15, and MX1 and Their Association with Treatment Outcomes in Patients with Chronic Hepatitis C	PLOS ONE			English	Article							PEGYLATED INTERFERON-ALPHA; PLUS RIBAVIRIN THERAPY; GENE-EXPRESSION; VIROLOGICAL RESPONSE; VIRAL KINETICS; VIRUS; PEGINTERFERON; PROTEIN-10; PREDICTS	The strong impact of interleukin 28B (IL28B) polymorphisms on sustained virological response (SVR) after peginterferon and ribavirin treatment in patients with chronic hepatitis C (CHC) is well-known. We investigated IL28B variability and hepatic expression of IP10, IFI27, ISG15, and MX1 in CHC patients, the relation of each with their clinical characteristics, and how they associated with responses to combined therapy. Genotyping and gene expression analysis were conducted in a selected cohort of treatment-naive patients who underwent interferon and ribavirin treatment. Differential expression of IP10, IFI27, ISG15, and MX1 genes was assessed from pretreatment liver biopsies using quantitative PCR. Histopathological evaluation of liver specimens was performed on the basis of the Scheuer's modified scale. We showed that hepatic IFI27, ISG15, and MX1 expression was lower in the IL28B CC 12979860 and TT rs8099917 groups than in the CT-TT rs12979860 and TG-GG rs8099917 groups (P < 0.001). We found no differences in IP10 expression between the IL28B genotypes (P > 0.05); in contrast, IP10 expression was significantly affected by the progression of fibrosis (P = 0.007). We showed that the rs12979860 CC genotype was associated with successful treatment when compared to the rs12979860 CT-TT genotype (P = 0.004). Additionally, the expression levels of IP10, IFI27 and ISG15, but not MX1, were significantly higher in non-SVR patients than in SVR patients. The effect of variation in IL28B on the results of IFN-based treatment may be associated with changes in IFI27 and ISG15, but not with IP10. Silencing of IP10 is positive and independent from IL28B prediction of SVR, which is strongly associated with liver fibrosis in CHC patients.	[Domagalski, Krzysztof] Nicolaus Copernicus Univ, Ctr Modern Interdisciplinary Technol, Torun, Poland; [Pawlowska, Malgorzata; Kozielewicz, Dorota; Dybowska, Dorota; Halota, Waldemar] Nicolaus Copernicus Univ, Fac Med, Dept Infect Dis & Hepatol, Bydgoszcz, Poland; [Tretyn, Andrzej] Nicolaus Copernicus Univ, Dept Plant Physiol & Biotechnol, Torun, Poland	Nicolaus Copernicus University; Nicolaus Copernicus University; Nicolaus Copernicus University	Domagalski, K (corresponding author), Nicolaus Copernicus Univ, Ctr Modern Interdisciplinary Technol, Torun, Poland.	krydom@umk.pl	Dybowska, Dorota/B-6907-2016; TRETYN, Andrzej/E-7196-2014; Domagalski, Krzysztof/G-4668-2014; Pawlowska, Malgorzata/F-4209-2014	TRETYN, Andrzej/0000-0002-6278-5590; Domagalski, Krzysztof/0000-0002-9766-8730; Pawlowska, Malgorzata/0000-0002-6044-0425	Ministry of Science and Higher Education (MNiSW) [N402 584440]; Nicolaus Copernicus University (UMK) [MN-4/WL-SD]; Foundation For Infectious Disease Control	Ministry of Science and Higher Education (MNiSW)(Ministry of Science and Higher Education, Poland); Nicolaus Copernicus University (UMK); Foundation For Infectious Disease Control	This study was supported by the Ministry of Science and Higher Education (MNiSW grant no. N402 584440), Nicolaus Copernicus University (UMK, grant no. MN-4/WL-SD) and Foundation For Infectious Disease Control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalaei-Andabili SH, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.15895; Abe H, 2011, J HEPATOL, V54, P1094, DOI 10.1016/j.jhep.2010.09.019; Asahina Y, 2012, HEPATOLOGY, V55, P20, DOI 10.1002/hep.24623; Askarieh G, 2010, HEPATOLOGY, V51, P1523, DOI 10.1002/hep.23509; Asselah T, 2008, GUT, V57, P516, DOI 10.1136/gut.2007.128611; Asselah T, 2010, LIVER INT, V30, P1259, DOI 10.1111/j.1478-3231.2010.02283.x; Chayama K, 2011, J GASTROEN HEPATOL, V26, P83, DOI 10.1111/j.1440-1746.2010.06550.x; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Darling JM, 2011, HEPATOLOGY, V53, P14, DOI 10.1002/hep.24056; Diago M, 2006, GUT, V55, P374, DOI 10.1136/gut.2005.074062; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Domagalski K, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.13678; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Fensterl V, 2009, BIOFACTORS, V35, P14, DOI 10.1002/biof.6; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Jimenez-Sousa MA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-6; Konishi H, 2013, HEPATOL RES, V43, P1139, DOI 10.1111/hepr.12070; LAHIRI DK, 1992, J BIOCHEM BIOPH METH, V25, P193, DOI 10.1016/0165-022X(92)90014-2; Naggie S, 2012, HEPATOLOGY, V56, P444, DOI 10.1002/hep.25647; Onomoto K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019799; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Shirakawa H, 2008, HEPATOLOGY, V48, P1753, DOI 10.1002/hep.22543; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Younossi ZM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-25	30	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130899	10.1371/journal.pone.0130899	http://dx.doi.org/10.1371/journal.pone.0130899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115415	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500107
J	Higuera, PE; Abatzoglou, JT; Littell, JS; Morgan, P				Higuera, Philip E.; Abatzoglou, John T.; Littell, Jeremy S.; Morgan, Penelope			The Changing Strength and Nature of Fire-Climate Relationships in the Northern Rocky Mountains, USA, 1902-2008	PLOS ONE			English	Article							VEGETATION DISTRIBUTION; BURNED AREA; WESTERN US; FOREST; WILDFIRE; REGIME; PYROGEOGRAPHY; 20TH-CENTURY; VARIABILITY; REGRESSION	Time-varying fire-climate relationships may represent an important component of fire-regime variability, relevant for understanding the controls of fire and projecting fire activity under global-change scenarios. We used time-varying statistical models to evaluate if and how fire-climate relationships varied from 1902-2008, in one of the most flammable forested regions of the western U.S.A. Fire-danger and water-balance metrics yielded the best combination of calibration accuracy and predictive skill in modeling annual area burned. The strength of fire-climate relationships varied markedly at multi-decadal scales, with models explaining < 40% to 88% of the variation in annual area burned. The early 20th century (1902-1942) and the most recent two decades (1985-2008) exhibited strong fire-climate relationships, with weaker relationships for much of the mid 20th century (1943-1984), coincident with diminished burning, less fire-conducive climate, and the initiation of modern fire fighting. Area burned and the strength of fire-climate relationships increased sharply in the mid 1980s, associated with increased temperatures and longer potential fire seasons. Unlike decades with high burning in the early 20th century, models developed using fire-climate relationships from recent decades overpredicted area burned when applied to earlier periods. This amplified response of fire to climate is a signature of altered fire-climate-relationships, and it implicates non-climatic factors in this recent shift. Changes in fuel structure and availability following 40+ yr of unusually low fire activity, and possibly land use, may have resulted in increased fire vulnerability beyond expectations from climatic factors alone. Our results highlight the potential for non-climatic factors to alter fire-climate relationships, and the need to account for such dynamics, through adaptable statistical or processes-based models, for accurately predicting future fire activity.	[Higuera, Philip E.; Morgan, Penelope] Univ Idaho, Coll Nat Resources, Moscow, ID 83843 USA; [Abatzoglou, John T.] Univ Idaho, Dept Geog, Moscow, ID 83843 USA; [Littell, Jeremy S.] USGS, Alaska Climate Sci Ctr, Anchorage, AK USA	Idaho; University of Idaho; Idaho; University of Idaho; United States Department of the Interior; United States Geological Survey	Higuera, PE (corresponding author), Univ Idaho, Coll Nat Resources, Moscow, ID 83843 USA.	phiguera@uidaho.edu	Abatzoglou, John T/C-7635-2012; Higuera, Philip Edward/B-1330-2010; Abatzoglou, John T/ABE-6134-2020	Abatzoglou, John T/0000-0001-7599-9750; Higuera, Philip Edward/0000-0001-5396-9956; Abatzoglou, John T/0000-0001-7599-9750	U.S. National Science Foundation from the Office of International and Integrative Activities [0966472]; Rocky Mountain Research Station, Forest Service, U.S. Department of Agriculture Research [04-JV-11222048021]; USDA/USDI Joint Fire Science Program [03-1-1-07, 11-1-7-4]; Office Of The Director [1443108] Funding Source: National Science Foundation	U.S. National Science Foundation from the Office of International and Integrative Activities(National Science Foundation (NSF)); Rocky Mountain Research Station, Forest Service, U.S. Department of Agriculture Research; USDA/USDI Joint Fire Science Program(United States Department of Agriculture (USDA)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was supported in part by U.S. National Science Foundation (www.nsf.gov) grant 0966472 from the Office of International and Integrative Activities (PEH), the Rocky Mountain Research Station (www.fs.fed.us/rmrs), Forest Service, U.S. Department of Agriculture Research Joint Venture Agreement 04-JV-11222048021, USDA/USDI Joint Fire Science Program (www.firescience.gov) project 03-1-1-07 (PM), USDA/USDI Joint Fire Science Program poject 11-1-7-4 (JTA),	Abatzoglou JT, 2014, J HYDROMETEOROL, V15, P1900, DOI 10.1175/JHM-D-13-0167.1; Abatzoglou JT, 2013, INT J WILDLAND FIRE, V22, P1003, DOI 10.1071/WF13019; Adams JB, 2003, NATURE, V426, P274, DOI 10.1038/nature02101; Anderson RL, 1942, ANN MATH STAT, V13, P1, DOI 10.1214/aoms/1177731638; Baker WL., 2009, FIRE ECOLOGY ROCKY M; Barrett CM, 2013, ECOLOGY, V94, P389, DOI 10.1890/12-0840.1; Bowman DMJS, 2011, J BIOGEOGR, V38, P2223, DOI 10.1111/j.1365-2699.2011.02595.x; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Brunelle A, 2005, QUATERNARY SCI REV, V24, P2281, DOI 10.1016/j.quascirev.2004.11.010; Collins BM, 2006, CAN J FOREST RES, V36, P699, DOI 10.1139/X05-264; Collins BM, 2009, ECOSYSTEMS, V12, P114, DOI 10.1007/s10021-008-9211-7; Comer P., 2003, ECOLOGICAL SYSTEMS U; Compo GP, 2011, Q J ROY METEOR SOC, V137, P1, DOI 10.1002/qj.776; COOK ER, 1994, INT J CLIMATOL, V14, P379, DOI 10.1002/joc.3370140404; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; Deeming J.E., 1977, NATL FIRE DANGER RAT, VVolume 39, DOI [10.2737/INT-GTR-169, DOI 10.2737/INT-GTR-169]; Dillon GK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00271.1; Duffy PA, 2005, ECOL APPL, V15, P1317, DOI 10.1890/04-0739; Elsner MM, 2010, CLIMATIC CHANGE, V102, P225, DOI 10.1007/s10584-010-9855-0; Falk DA, 2011, FRONT ECOL ENVIRON, V9, P446, DOI 10.1890/100052; Fauria MM, 2011, WIRES CLIM CHANGE, V2, P99, DOI 10.1002/wcc.92; Flannigan MD, 2009, INT J WILDLAND FIRE, V18, P483, DOI 10.1071/WF08187; Gedalof Z, 2005, ECOL APPL, V15, P154, DOI 10.1890/03-5116; Gibson C. E., 2014, ATLAS DIGITAL POLYGO; Gibson CE, 2006, THESIS U IDAHO MOSCO; Girardin MP, 2009, GLOBAL CHANGE BIOL, V15, P2751, DOI 10.1111/j.1365-2486.2009.01869.x; Hessburg PF, 2003, FOREST ECOL MANAG, V178, P23, DOI 10.1016/S0378-1127(03)00052-5; Heyerdahl EK, 2008, ECOLOGY, V89, P705, DOI 10.1890/06-2047.1; Heyerdahl EK, 2008, INT J WILDLAND FIRE, V17, P40, DOI 10.1071/WF07024; Joly K, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00012.1; Kasischke ES, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025677; Kelly R, 2013, P NATL ACAD SCI USA, V110, P13055, DOI 10.1073/pnas.1305069110; Kolden CA, 2012, FOREST ECOL MANAG, V286, P38, DOI 10.1016/j.foreco.2012.08.020; Krawchuk MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005102; Lenihan JM, 2003, ECOL APPL, V13, P1667, DOI 10.1890/025295; Littell JS, 2010, CLIMATIC CHANGE, V102, P129, DOI 10.1007/s10584-010-9858-x; Littell JS, 2009, ECOL APPL, V19, P1003, DOI 10.1890/07-1183.1; Mann DH, 2012, ARCT ANTARCT ALP RES, V44, P319, DOI 10.1657/1938-4246-44.3.319; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Marlon JR, 2012, P NATL ACAD SCI USA, V109, pE535, DOI 10.1073/pnas.1112839109; McKenzie D, 2004, CONSERV BIOL, V18, P890, DOI 10.1111/j.1523-1739.2004.00492.x; McWethy DB, 2013, GLOBAL ECOL BIOGEOGR, V22, P900, DOI 10.1111/geb.12038; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Miller JD, 2012, ECOL APPL, V22, P184, DOI 10.1890/10-2108.1; Miller JD, 2009, ECOSYSTEMS, V12, P16, DOI 10.1007/s10021-008-9201-9; Morgan P, 2008, ECOLOGY, V89, P717, DOI 10.1890/06-2049.1; Morgan P, 2014, FIRE ECOL, V10, P14, DOI 10.4996/fireecology.1001014; Moritz MA, 2005, P NATL ACAD SCI USA, V102, P17912, DOI 10.1073/pnas.0508985102; Moritz MA, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00345.1; Naficy C, 2010, ECOL APPL, V20, P1851, DOI 10.1890/09-0217.1; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; National Research Council, 2006, SURF TEMP REC LAST 2; Neter J., 1996, APPL LINEAR REGRESSI; Pechony O, 2010, P NATL ACAD SCI USA, V107, P19167, DOI 10.1073/pnas.1003669107; Pfeiffer M, 2013, GEOSCI MODEL DEV, V6, P643, DOI 10.5194/gmd-6-643-2013; Pinol J, 1998, CLIMATIC CHANGE, V38, P345, DOI 10.1023/A:1005316632105; Pyne S, 1996, INTRO WILDLAND FIRE; RENKIN RA, 1992, CAN J FOREST RES, V22, P37, DOI 10.1139/x92-005; Rogers BM, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001695; Rupp TS, 2002, CLIMATIC CHANGE, V55, P213, DOI 10.1023/A:1020247405652; Spracklen DV, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010966; Stephenson NL, 1998, J BIOGEOGR, V25, P855, DOI 10.1046/j.1365-2699.1998.00233.x; Teske CC, 2012, FIRE ECOL, V8, P82, DOI 10.4996/fireecology.0802082; Toms JD, 2003, ECOLOGY, V84, P2034, DOI 10.1890/02-0472; Trouet V, 2009, THEOR APPL CLIMATOL, V95, P349, DOI 10.1007/s00704-008-0012-x; Veblen TT, 2011, AUSTRAL ECOL, V36, P891, DOI 10.1111/j.1442-9993.2010.02236.x; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Westerling AL, 2011, P NATL ACAD SCI USA, V108, P13165, DOI 10.1073/pnas.1110199108; Westerling AL, 2008, FOR SCI, V79, P107; Whitlock C, 2011, QUATERNARY RES, V75, P114, DOI 10.1016/j.yqres.2010.08.013; Wotton BM, 2010, INT J WILDLAND FIRE, V19, P253, DOI 10.1071/WF09002; Wotton BM, 2009, ENVIRON ECOL STAT, V16, P107, DOI 10.1007/s10651-007-0084-2; Yocom LL, 2010, ECOLOGY, V91, P1660, DOI 10.1890/09-0845.1	73	76	76	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0127563	10.1371/journal.pone.0127563	http://dx.doi.org/10.1371/journal.pone.0127563			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114580	gold, Green Published, Green Submitted			2022-12-27	WOS:000358147500008
J	Lu, HJ; Lin, JK; Chen, WS; Jiang, JK; Yang, SH; Lan, YT; Lin, CC; Liu, CA; Teng, HW				Lu, Hsueh-Ju; Lin, Jen-Kou; Chen, Wei-Shone; Jiang, Jeng-Kai; Yang, Shung-Haur; Lan, Yuan-Tzu; Lin, Chun-Chi; Liu, Chien-An; Teng, Hao-Wei			The Prognostic Role of Para-Aortic Lymph Nodes in Patients with Colorectal Cancer: Is It Regional or Distant Disease?	PLOS ONE			English	Article							RECTAL-CANCER; COMPUTED-TOMOGRAPHY; COLON-CANCER; CURATIVE RESECTION; OPERATIVE SALVAGE; METASTASIS; RECURRENCE; SIZE; SURGERY; CT	Introduction Visible para-aortic lymph nodes of >= 2 mm in size are common metastatic patterns of colorectal cancer (CRC) seen on imaging. Their prognostic value, however, remains inconclusive. We aimed to assess the prognostic role of visible para-aortic lymph nodes (PALNs). Methods Patients with confirmed pathologic diagnosis of CRC were enrolled. Correlations among clinicopathologic variables were analyzed using the chi(2) test. The Cox proportional hazards model was applied for univariate and multivariate analyses. Survival was estimated using the Kaplan-Meier method and log-rank test. A prognostic model for visible PALNs in CRC patients was established. Results In total, 4527 newly diagnosed CRC patients were enrolled. Patients with visible PALNs had inferior overall survival compared to those without visible PALNs (5-year overall survival, 67% vs. 76%, P = 0.015). Lymphovascular invasion (LVI) (hazard ratio = 1.865, P = 0.015); nodal disease (pN+) status (hazard ratio = 2.099, P = 0.006); elevated preoperative serum carcinoembryonic antigen (CEA) levels (hazard ratio = 2.263, P < 0.001); and visible PALNs >= 10 mm (hazard ratio = 1.638, P = 0.031) were independent prognostic factors for patients with visible PALNs. If each prognostic factor scored one point, 5-year overall survival of lower- (prognostic score 0-1), intermediate- (prognostic score 2), and high- (prognostic score 3-4) risk groups were, 78%. 54%, and 25% respectively (P < 0.001). Conclusions The prognostic model, which included LVI, pN+ status, preoperative serum CEA level, and the size of visible PALNs, could effectively distinguish the outcome of patients with visible PALNs.	[Lu, Hsueh-Ju] Show Chwan Mem Hosp, Div Hematol & Oncol, Changhua, Taiwan; [Lin, Jen-Kou; Chen, Wei-Shone; Jiang, Jeng-Kai; Yang, Shung-Haur; Lan, Yuan-Tzu; Lin, Chun-Chi] Taipei Vet Gen Hosp, Dept Surg, Div Colon & Rectum Surg, Taipei, Taiwan; [Liu, Chien-An] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Teng, Hao-Wei] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan; [Teng, Hao-Wei] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Lu, Hsueh-Ju; Lin, Jen-Kou; Chen, Wei-Shone; Jiang, Jeng-Kai; Yang, Shung-Haur; Lan, Yuan-Tzu; Lin, Chun-Chi; Liu, Chien-An; Teng, Hao-Wei] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Lu, Hsueh-Ju] Natl Yang Ming Univ, Program Mol Med, Sch Life Sci, Taipei 112, Taiwan	Show Chwan Memorial Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Teng, HW (corresponding author), Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan.	danny_teng@yahoo.com.tw	Lu, Hsueh Ju/AAS-8603-2021	Lu, Hsueh-Ju/0000-0003-2083-6481	Taiwan Clinical Oncology Research Foundation	Taiwan Clinical Oncology Research Foundation	This study was supported by the Taiwan Clinical Oncology Research Foundation.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Bipat S, 2004, RADIOLOGY, V232, P773, DOI 10.1148/radiol.2323031368; Bowne WB, 2005, DIS COLON RECTUM, V48, P897, DOI 10.1007/s10350-004-0881-8; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Choi J, 2015, WORLD J GASTROENTERO, V21, P556, DOI 10.3748/wjg.v21.i2.556; Choi PW, 2010, J SURG ONCOL, V101, P66, DOI 10.1002/jso.21421; Chok KSH, 2007, WORLD J SURG, V31, P1485, DOI 10.1007/s00268-007-9089-0; Committee on Classification of Regional Lymph Nodes of Japan Society of Clinical Oncology, 2003, Int J Clin Oncol, V8, P248; Dhar DK, 2005, J AM COLL SURGEONS, V200, P20, DOI 10.1016/j.jamcollsurg.2004.09.037; DORFMAN RE, 1991, RADIOLOGY, V180, P319, DOI 10.1148/radiology.180.2.2068292; Duffy MJ, 2001, CLIN CHEM, V47, P624; Fakih MG, 2006, ONCOLOGY-NY, V20, P579; Fujii S, 2010, HEPATO-GASTROENTEROL, V57, P472; Greene Frederick L, 2002, Bull Am Coll Surg, V87, P13; Ho TW, 2011, ANN SURG ONCOL, V18, P697, DOI 10.1245/s10434-010-1322-7; Huh JW, 2010, J GASTROINTEST SURG, V14, P1074, DOI 10.1007/s11605-010-1206-y; Iizasa T, 2006, ANN THORAC SURG, V82, P254, DOI 10.1016/j.athoracsur.2006.02.027; Jassem J, 2008, J CLIN ONCOL, V26, P1698, DOI 10.1200/JCO.2006.09.9887; Lan YT, 2014, AM J SURG, V207, P922, DOI 10.1016/j.amjsurg.2013.08.035; Lee MJ, 2009, WORLD J GASTROENTERO, V15, P4434, DOI 10.3748/wjg.15.4434; Liang JT, 2007, ANN SURG ONCOL, V14, P1980, DOI 10.1245/s10434-007-9368-x; Lou Z, 2013, WORLD J GASTROENTERO, V19, P389, DOI 10.3748/wjg.v19.i3.389; Markl B, 2012, MODERN PATHOL, V25, P1413, DOI 10.1038/modpathol.2012.92; Min BS, 2008, J SURG ONCOL, V97, P136, DOI 10.1002/jso.20926; Min BS, 2009, ANN SURG ONCOL, V16, P3271, DOI 10.1245/s10434-009-0692-1; Perez RO, 2009, DIS COLON RECTUM, V52, P1278, DOI 10.1007/DCR.0b013e3181a0af4b; Pomerri F, 2009, EJSO-EUR J SURG ONC, V35, P168, DOI 10.1016/j.ejso.2008.02.006; Rees M, 2008, ANN SURG, V247, P125, DOI 10.1097/SLA.0b013e31815aa2c2; Reese ES, 2013, CANCER MED-US, V2, P907, DOI 10.1002/cam4.143; Saokar A, 2010, CLIN IMAG, V34, P361, DOI 10.1016/j.clinimag.2009.07.004; Torabi M, 2004, J NUCL MED, V45, P1509; Yang L, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000266; Yeo SG, 2010, RADIOTHER ONCOL, V97, P307, DOI 10.1016/j.radonc.2010.05.021	33	6	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130345	10.1371/journal.pone.0130345	http://dx.doi.org/10.1371/journal.pone.0130345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115511	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500069
J	Peacock-Villada, A; Coljee, V; Danilowicz, C; Prentiss, M				Peacock-Villada, Alexandra; Coljee, Vincent; Danilowicz, Claudia; Prentiss, Mara			ssDNA Pairing Accuracy Increases When Abasic Sites Divide Nucleotides into Small Groups	PLOS ONE			English	Article							DNA	Accurate sequence dependent pairing of single-stranded DNA (ssDNA) molecules plays an important role in gene chips, DNA origami, and polymerase chain reactions. In many assays accurate pairing depends on mismatched sequences melting at lower temperatures than matched sequences; however, for sequences longer than similar to 10 nucleotides, single mismatches and correct matches have melting temperature differences of less than 3 degrees C. We demonstrate that appropriately grouping of 35 bases in ssDNA using abasic sites increases the difference between the melting temperature of correct bases and the melting temperature of mismatched base pairings. Importantly, in the presence of appropriately spaced abasic sites mismatches near one end of a long dsDNA destabilize the annealing at the other end much more effectively than in systems without the abasic sites, suggesting that the dsDNA melts more uniformly in the presence of appropriately spaced abasic sites. In sum, the presence of appropriately spaced abasic sites allows temperature to more accurately discriminate correct base pairings from incorrect ones.	[Peacock-Villada, Alexandra; Coljee, Vincent; Danilowicz, Claudia; Prentiss, Mara] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University	Danilowicz, C (corresponding author), Harvard Univ, Dept Phys, 17 Oxford St, Cambridge, MA 02138 USA.	danilow@fas.harvard.edu	Prentiss, Mara/AAU-2940-2021		NIH grant [NIH/NIGMS-R01-GM025326]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025326] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant NIH/NIGMS-R01-GM025326 to M.P. (http://www.nih.gov/).	Bar A, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/3/034110; Baumforth KRN, 1999, J CLIN PATHOL-MOL PA, V52, P1; Cisse II, 2012, NAT STRUCT MOL BIOL, V19, P623, DOI 10.1038/nsmb.2294; Gorreta F, 2012, METHODS MOL BIOL, V823, P89, DOI 10.1007/978-1-60327-216-2_7; HOWLEY PM, 1979, J BIOL CHEM, V254, P4876; Nangreave J, 2010, CURR OPIN CHEM BIOL, V14, P608, DOI 10.1016/j.cbpa.2010.06.182; Owczarzy R, 2008, BIOCHEMISTRY-US, V47, P5336, DOI 10.1021/bi702363u; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; SantaLucia J, 1996, BIOCHEMISTRY-US, V35, P3555, DOI 10.1021/bi951907q; WALLACE RB, 1979, NUCLEIC ACIDS RES, V6, P3543, DOI 10.1093/nar/6.11.3543; You Y, 2011, BIOPOLYMERS, V95, P472, DOI 10.1002/bip.21615	11	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130875	10.1371/journal.pone.0130875	http://dx.doi.org/10.1371/journal.pone.0130875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115175	gold, Green Published, Green Submitted			2022-12-27	WOS:000358147500105
J	Akelo, V; McLellan-Lemal, E; Toledo, L; Girde, S; Borkowf, CB; Ward, L; Ondenge, K; Ndivo, R; Lecher, SL; Mills, LA; Thomas, TK				Akelo, Victor; McLellan-Lemal, Eleanor; Toledo, Lauren; Girde, Sonali; Borkowf, Craig B.; Ward, Laura; Ondenge, Kenneth; Ndivo, Richard; Lecher, Shirley L.; Mills, Lisa A.; Thomas, Timothy K.			Determinants and Experiences of Repeat Pregnancy among HIV-Positive Kenyan Women-A Mixed-Methods Analysis	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INFECTED WOMEN; FERTILITY INTENTIONS; BIRTH OUTCOMES; PREVALENCE; DESIRE; MEN	Objective To identify factors associated with repeat pregnancy subsequent to an index pregnancy among women living with HIV (WLWH) in western Kenya who were enrolled in a 24-month phase-II clinical trial of triple-ART prophylaxis for prevention of mother-to-child transmission, and to contextualize social and cultural influences on WLWH's reproductive decision making. Methods A mixed-methods approach was used to examine repeat pregnancy within a 24 month period after birth. Counselor-administered questionnaires were collected from 500 WLWH. Forty women (22 with a repeat pregnancy; 18 with no repeat pregnancy) were purposively selected for a qualitative interview (QI). Simple and multiple logistic regression analyses were performed for quantitative data. Thematic coding and saliency analysis were undertaken for qualitative data. Results Eighty-eight (17.6%) women had a repeat pregnancy. Median maternal age was 23 years (range 15-43 years) and median gestational age at enrollment was 34 weeks. In multiple logistic regression analyses, living in the same compound with a husband (adjusted odds ratio (AOR): 2.33; 95% confidence interval (CI): 1.14, 4.75) was associated with increased odds of repeat pregnancy (p <= 0.05). Being in the 30-43 age group (AOR: 0.25; 95% CI: 0.07, 0.87), having talked to a partner about family planning (FP) use (AOR: 0.53; 95% CI: 0.29, 0.98), and prior usage of FP (AOR: 0.45; 95% CI: 0.25, 0.82) were associated with a decrease in odds of repeat pregnancy. QI findings centered on concerns about modern contraception methods (side effects and views that they 'ruined the womb') and a desire to have the right number of children. Religious leaders, family, and the broader community were viewed as reinforcing cultural expectations for married women to have children. Repeat pregnancy was commonly attributed to contraception failure or to lack of knowledge about post-delivery fertility. Conclusions In addition to cultural context, reproductive health programs for WLWH may need to address issues related to living circumstances and the possibility that reproductive-decision making may extend beyond the woman and her partner.	[Akelo, Victor; Ondenge, Kenneth; Ndivo, Richard] Kenya Govt Med Res Ctr, Kisumu, Kenya; [McLellan-Lemal, Eleanor; Toledo, Lauren; Girde, Sonali; Borkowf, Craig B.; Lecher, Shirley L.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Toledo, Lauren; Girde, Sonali] ICF Int, Atlanta, GA USA; [Ward, Laura; Mills, Lisa A.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Thomas, Timothy K.] Ctr Dis Control & Prevent, Kisumu, Kenya	Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health	Akelo, V (corresponding author), Kenya Govt Med Res Ctr, Kisumu, Kenya.	vakelo@kemricdc.org	McLellan-Lemal, Eleanor/J-9720-2012	McLellan-Lemal, Eleanor/0000-0002-1884-9315	Kenya Medical Research Institute (KEMRI); US Centers for Disease Control and Prevention (CDC)	Kenya Medical Research Institute (KEMRI); US Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for the study was provided by the Kenya Medical Research Institute (KEMRI) through a cooperative agreement with the US Centers for Disease Control and Prevention (CDC). The study design, data collection instruments, data collection, data analysis, decision to publish, and preparation of the manuscript were led by CDC and KEMRI staff based in Atlanta and at the KEMRI/CDC Field Station in Kisumu, Kenya. The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the CDC.	Akelo V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066593; Andia I, 2009, AM J PUBLIC HEALTH, V99, P340, DOI 10.2105/AJPH.2007.129528; [Anonymous], 2012, GLOB REP UNAIDS REP; Buetow S, 2010, J HEALTH SERV RES PO, V15, P123, DOI 10.1258/jhsrp.2009.009081; Bussmann H, 2007, JAIDS-J ACQ IMM DEF, V45, P269; Calvert C, 2015, TROP MED INT HEALTH, V20, P122, DOI 10.1111/tmi.12412; Chi Boi Kim, 2011, Anthropol Med, V18, P315, DOI 10.1080/13648470.2011.615909; Cliffe S, 2011, AIDS CARE, V23, P1093, DOI 10.1080/09540121.2011.554515; De la Cruz NG, 2011, AIDS BEHAV, V15, P1233, DOI 10.1007/s10461-010-9788-7; Finocchario-Kessler S, 2012, AIDS PATIENT CARE ST, V26, P700, DOI 10.1089/apc.2012.0232; Fram SM, 2013, QUAL REP, V18; French CE, 2012, JAIDS-J ACQ IMM DEF, V59, P287, DOI 10.1097/QAI.0b013e31823dbeac; Guest G., 2003, FIELD METHOD, V15, P186, DOI [10.1177/1525822X03251188, DOI 10.1177/1525822X03251188, 10.1177/1525822X03015002005, DOI 10.1177/1525822X03015002005]; Hernando V, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-194; Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149; Kawale P, 2014, AIDS CARE, V26, P769, DOI 10.1080/09540121.2013.855294; Kleinbaum David G., 2010, LOGISTIC REGRESSION; MacQueen K.M., 1998, CAM J, V10, P31, DOI [10.1177/1525822X980100020301, DOI 10.1177/1525822X980100020301, 10.1177/1525822x980100020301]; Myer L, 2007, AIDS PATIENT CARE ST, V21, P278, DOI 10.1089/apc.2006.0108; Ngugi EW, 2014, JAIDS-J ACQ IMM DEF, V66, pS75, DOI 10.1097/QAI.0000000000000107; O'Connor MK, 2008, QUAL INQ, V14, P28, DOI 10.1177/1077800407308907; Obare F, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-34; Oluoch Tom, 2011, Open AIDS J, V5, P125, DOI 10.2174/1874613601105010125; Owiti GO, 2012, LUO CO WIVES KENYA U; Schwartz SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036039; Smee N, 2011, WOMEN HEALTH ISS, V21, P222, DOI 10.1016/j.whi.2010.11.005; Sofolahan Y A, 2012, AIDS Res Treat, V2012, P478065, DOI 10.1155/2012/478065; Spangler SA, 2014, JAIDS-J ACQ IMM DEF, V67, pS235, DOI 10.1097/QAI.0000000000000376; Suryavanshi N, 2008, AIDS CARE, V20, P1111, DOI 10.1080/09540120701842753; Taylor S. J., 1984, INTRO QUALITATIVE RE; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; Todd CS, 2011, AIDS BEHAV, V15, P454, DOI 10.1007/s10461-010-9848-z; Tweya H, 2013, AIDS BEHAV, V17, P471, DOI 10.1007/s10461-012-0150-0; UNAIDS, 2010, REP GLOB AIDS EP; Wanyenze RK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-98; Westreich Daniel, 2012, Infect Dis Obstet Gynecol, V2012, P917059, DOI 10.1155/2012/917059; Zhdanova-Redman E., KENYA TRADITIONS DAI	37	7	7	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131163	10.1371/journal.pone.0131163	http://dx.doi.org/10.1371/journal.pone.0131163			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1BL	26120846	gold, Green Published			2022-12-27	WOS:000358150400080
J	Alsters, SIM; Goldstone, AP; Buxton, JL; Zekavati, A; Sosinsky, A; Yiorkas, AM; Holder, S; Klaber, RE; Bridges, N; van Haelst, MM; le Roux, CW; Walley, AJ; Walters, RG; Mueller, M; Blakemore, AIF				Alsters, Suzanne I. M.; Goldstone, Anthony P.; Buxton, Jessica L.; Zekavati, Anna; Sosinsky, Alona; Yiorkas, Andrianos M.; Holder, Susan; Klaber, Robert E.; Bridges, Nicola; van Haelst, Mieke M.; le Roux, Carel W.; Walley, Andrew J.; Walters, Robin G.; Mueller, Michael; Blakemore, Alexandra I. F.			Truncating Homozygous Mutation of Carboxypeptidase E (CPE) in a Morbidly Obese Female with Type 2 Diabetes Mellitus, Intellectual Disability and Hypogonadotrophic Hypogonadism	PLOS ONE			English	Article							EARLY-ONSET OBESITY; MELANOCYTE-STIMULATING HORMONE; MISSENSE MUTATION; FAT/FAT MICE; E GENE; DEFICITS; BRAIN; DYSFUNCTION; BEHAVIORS; PITUITARY	Carboxypeptidase E is a peptide processing enzyme, involved in cleaving numerous peptide precursors, including neuropeptides and hormones involved in appetite control and glucose metabolism. Exome sequencing of a morbidly obese female from a consanguineous family revealed homozygosity for a truncating mutation of the CPE gene (c.76_98del; p. E26RfsX68). Analysis detected no CPE expression in whole blood-derived RNA from the proband, consistent with nonsense-mediated decay. The morbid obesity, intellectual disability, abnormal glucose homeostasis and hypogonadotrophic hypogonadism seen in this individual recapitulates phenotypes in the previously described fat/fat and Cpe knockout mouse models, evidencing the importance of this peptide/hormone-processing enzyme in regulating body weight, metabolism, and brain and reproductive function in humans.	[Alsters, Suzanne I. M.; Buxton, Jessica L.; Yiorkas, Andrianos M.; le Roux, Carel W.; Blakemore, Alexandra I. F.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Diabet Endocrinol & Metab, Sect Invest Med, London, England; [Goldstone, Anthony P.] Hammersmith Hosp, Imperial Coll Healthcare NHS Trust, Imperial Ctr Endocrinol, London, England; [Goldstone, Anthony P.] Univ London Imperial Coll Sci Technol & Med, Ctr Neuropsychopharmacol & Computat, Cognit & Clin Neuroimaging Lab, Hammersmith Hosp,Dept Med,Div Brain Sci, London, England; [Goldstone, Anthony P.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC, Metab & Mol Imaging Grp,Clin Sci Ctr, London, England; [Buxton, Jessica L.] UCL, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, London, England; [Zekavati, Anna; Sosinsky, Alona; Mueller, Michael] Univ London Imperial Coll Sci Technol & Med, Fac Med, NIHR Imperial BRC Genom Facil, London, England; [Holder, Susan] Northwick Pk Hosp & Clin Res Ctr, North West London Hosp NHS Trust, Kennedy Galton Ctr, NW Thames Reg Genet Serv, Harrow HA1 3UJ, Middx, England; [Klaber, Robert E.] St Marys Hosp, Dept Paediat, Imperial Coll Healthcare NHS Trust, London, England; [Bridges, Nicola] Chelsea & Westminster Hosp, Dept Paediat Endocrinol, London, England; [van Haelst, Mieke M.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Med Genet, Utrecht, Netherlands; [le Roux, Carel W.] Univ Coll Dublin, Sch Med & Med Sci, Conway Inst, Diabet Complicat Res Ctr, Dublin 2, Ireland; [Walley, Andrew J.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Walters, Robin G.] Univ Oxford, Clin Trial Serv Unit, Nuffield Dept Populat Hlth, Oxford, England; [Walters, Robin G.] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit CTSU, Oxford, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London; University of London; University College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; University College Dublin; Imperial College London; University of Oxford; University of Oxford	Goldstone, AP (corresponding author), Hammersmith Hosp, Imperial Coll Healthcare NHS Trust, Imperial Ctr Endocrinol, London, England.	tony.goldstone@imperial.ac.uk; a.blakemore@imperial.ac.uk	Buxton, Jessica/L-9849-2019; Walters, Robin G/E-6069-2010	Walters, Robin G/0000-0002-9179-0321; Goldstone, Anthony/0000-0001-8179-7071	Medical Research Council; Biotechnology and Biological Sciences Research Council (BBSRC); National Institute for Health Research (NIHR); Integrative Mammalian Biology (IMB) Capacity Building Award [FP7-HEALTH-2009-241592 EuroCHIP]; NIHR Imperial Biomedical Research Centre Funding Scheme; Diabetes UK; Biomedical Research Centre; UK Medical Research Council; Wellcome Trust; NIHR Imperial BRC; MRC [MR/K014536/1] Funding Source: UKRI; Diabetes UK [08/0003775] Funding Source: researchfish; Medical Research Council [MR/K014536/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Integrative Mammalian Biology (IMB) Capacity Building Award; NIHR Imperial Biomedical Research Centre Funding Scheme; Diabetes UK(Diabetes UK); Biomedical Research Centre; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NIHR Imperial BRC; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Section of Investigative Medicine is funded by grants from the Medical Research Council, Biotechnology and Biological Sciences Research Council (BBSRC), National Institute for Health Research (NIHR), an Integrative Mammalian Biology (IMB) Capacity Building Award, an FP7-HEALTH-2009-241592 EuroCHIP grant, and is supported by the NIHR Imperial Biomedical Research Centre Funding Scheme. This work was also funded by a project grant from Diabetes UK to AB and RW, and Biomedical Research Centre awards to AB, RW, MVH and CLR. Authors AB and AG are each also funded by the UK Medical Research Council. JB is also funded by the Wellcome Trust. The Imperial Genomics Facility is funded by the NIHR Imperial BRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Asai M, 2013, SCIENCE, V341, P275, DOI 10.1126/science.1233000; BERTAGNA X, 1986, P NATL ACAD SCI USA, V83, P9719, DOI 10.1073/pnas.83.24.9719; Borman AD, 2014, HUM MUTAT, V35, P289, DOI 10.1002/humu.22482; Cawley NX, 2010, AM J PHYSIOL-ENDOC M, V299, pE189, DOI 10.1152/ajpendo.00516.2009; Cawley NX, 2004, ENDOCRINOLOGY, V145, P5807, DOI 10.1210/en.2004-0847; Challis BG, 2002, HUM MOL GENET, V11, P1997, DOI 10.1093/hmg/11.17.1997; Che FY, 2001, P NATL ACAD SCI USA, V98, P9971, DOI 10.1073/pnas.161542198; Chen H, 2001, HUM MUTAT, V18, P120, DOI 10.1002/humu.1161; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Doche ME, 2012, J CLIN INVEST, V122, P4732, DOI 10.1172/JCI62696; Farooqi IS, 2007, J CLIN ENDOCR METAB, V92, P3369, DOI 10.1210/jc.2007-0687; FRICKER LD, 1982, P NATL ACAD SCI-BIOL, V79, P3886, DOI 10.1073/pnas.79.12.3886; Fricker LD, 2007, ENDOCRINOLOGY, V148, P4185, DOI 10.1210/en.2007-0123; Friis-Hansen L, 2001, J ENDOCRINOL, V169, P595, DOI 10.1677/joe.0.1690595; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; HALL C, 1993, GENOMICS, V15, P461, DOI 10.1006/geno.1993.1093; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee YS, 2006, CELL METAB, V3, P135, DOI 10.1016/j.cmet.2006.01.006; Li P, 2014, INT J OBESITY, V38, P724, DOI 10.1038/ijo.2013.140; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; Pearce LR, 2013, CELL, V155, P765, DOI 10.1016/j.cell.2013.09.058; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Rodriguiz RM, 2013, INT J NEUROPSYCHOPH, V16, P1623, DOI 10.1017/S1461145713000059; Sapio MR, 2014, PROTEOM CLIN APPL, V8, P327, DOI 10.1002/prca.201300090; Schaaf CP, 2013, NAT GENET, V45, P1405, DOI 10.1038/ng.2776; Srinivasan S, 2004, ENDOCRINOLOGY, V145, P2023, DOI 10.1210/en.2003-1442; Utsunomiya N, 1998, DIABETOLOGIA, V41, P701, DOI 10.1007/s001250050971; Wang WG, 1998, ENDOCRINE, V9, P329, DOI 10.1385/ENDO:9:3:329; Wardlaw SL, 2011, EUR J PHARMACOL, V660, P213, DOI 10.1016/j.ejphar.2010.10.107; Wilkinson CW, 2006, PEPTIDES, V27, P453, DOI 10.1016/j.peptides.2005.05.029; Woronowicz A, 2008, HIPPOCAMPUS, V18, P1051, DOI 10.1002/hipo.20462; Zammit PS, 2008, DEV BIOL, V313, P420, DOI 10.1016/j.ydbio.2007.10.044; Zhang X, 2008, J NEUROCHEM, V107, P1596, DOI 10.1111/j.1471-4159.2008.05722.x	43	45	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131417	10.1371/journal.pone.0131417	http://dx.doi.org/10.1371/journal.pone.0131417			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26120850	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000358150400107
J	Bowles, TM; Hollander, AD; Steenwerth, K; Jackson, LE				Bowles, Timothy M.; Hollander, Allan D.; Steenwerth, Kerri; Jackson, Louise E.			Tightly-Coupled Plant-Soil Nitrogen Cycling: Comparison of Organic Farms across an Agricultural Landscape	PLOS ONE			English	Article							CROPPING SYSTEMS; SMALLHOLDER FARMS; NITRATE; MANAGEMENT; AVAILABILITY; AMMONIUM; TOMATO; CARBON; AGROECOSYSTEMS; RESPONSES	How farming systems supply sufficient nitrogen (N) for high yields but with reduced N losses is a central challenge for reducing the tradeoffs often associated with N cycling in agriculture. Variability in soil organic matter and management of organic farms across an agricultural landscape may yield insights for improving N cycling and for evaluating novel indicators of N availability. We assessed yields, plant-soil N cycling, and root expression of N metabolism genes across a representative set of organic fields growing Roma-type tomatoes (Solanum lycopersicum L.) in an intensively-managed agricultural landscape in California, USA. The fields spanned a three-fold range of soil carbon (C) and N but had similar soil types, texture, and pH. Organic tomato yields ranged from 22.9 to 120.1 Mg ha(-1) with a mean similar to the county average (86.1 Mg ha(-1)), which included mostly conventionally-grown tomatoes. Substantial variability in soil inorganic N concentrations, tomato N, and root gene expression indicated a range of possible tradeoffs between yields and potential for N losses across the fields. Fields showing evidence of tightly-coupled plant-soil N cycling, a desirable scenario in which high crop yields are supported by adequate N availability but low potential for N loss, had the highest total and labile soil C and N and received organic matter inputs with a range of N availability. In these fields, elevated expression of a key gene involved in root N assimilation, cytosolic glutamine synthetase GS1, confirmed that plant N assimilation was high even when inorganic N pools were low. Thus tightlycoupled N cycling occurred on several working organic farms. Novel combinations of N cycling indicators (i.e. inorganic N along with soil microbial activity and root gene expression for N assimilation) would support adaptive management for improved N cycling on organic as well as conventional farms, especially when plant-soil N cycling is rapid.	[Bowles, Timothy M.; Jackson, Louise E.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Hollander, Allan D.] Univ Calif Davis, Dept Environm Sci & Policy, Environm Informat Ctr, Davis, CA 95616 USA; [Steenwerth, Kerri] USDA ARS, Crops Pathol & Genet Res Unit, Davis, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Agriculture (USDA)	Bowles, TM (corresponding author), Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA.	timothy.bowles@gmail.com		Bowles, Timothy/0000-0002-4840-3787; Hollander, Allan/0000-0002-2647-8235	United States Department of Agriculture (USDA) Organic Agriculture Research and Extension Initiative (OREI) award [2009-01415]; National Science Foundation (NSF); ARS [ARS-0426234] Funding Source: Federal RePORTER	United States Department of Agriculture (USDA) Organic Agriculture Research and Extension Initiative (OREI) award; National Science Foundation (NSF)(National Science Foundation (NSF)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The funding came from a United States Department of Agriculture (USDA) Organic Agriculture Research and Extension Initiative (OREI) award number 2009-01415 to LEJ; http://www.nifa.usda.gov/funding/rfas/OREI.html. Additional funding came from a National Science Foundation (NSF) Graduate Research Fellowship to TMB; https://www.nsfgrfp.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CR, 2011, J ENVIRON MANAGE, V92, P1339, DOI 10.1016/j.jenvman.2010.11.019; Andrews SS, 2003, GEODERMA, V114, P187, DOI 10.1016/S0016-7061(03)00041-7; [Anonymous], 2009, MEAS CAL; Bernard SM, 2009, NEW PHYTOL, V182, P608, DOI 10.1111/j.1469-8137.2009.02823.x; Berry PM, 2002, SOIL USE MANAGE, V18, P248, DOI 10.1079/SUM2002129; Bommarco R, 2013, TRENDS ECOL EVOL, V28, P230, DOI 10.1016/j.tree.2012.10.012; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bowles TM, 2015, PLANT SOIL, V392, P175, DOI 10.1007/s11104-015-2412-x; Bowles TM, 2014, SOIL BIOL BIOCHEM, V68, P252, DOI 10.1016/j.soilbio.2013.10.004; Burger M, 2003, SOIL BIOL BIOCHEM, V35, P29, DOI 10.1016/S0038-0717(02)00233-X; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P1007, DOI 10.2136/sssaj1993.03615995005700040021x; Casagrande M, 2009, AGRON SUSTAIN DEV, V29, P565, DOI 10.1051/agro/2009015; Cavigelli MA, 2008, AGRON J, V100, P785, DOI 10.2134/agronj2006.0373; Cavigelli MA, 2013, RENEW AGR FOOD SYST, V28, P145, DOI 10.1017/S1742170512000439; Chirinda N, 2010, AGR ECOSYST ENVIRON, V139, P584, DOI 10.1016/j.agee.2010.10.001; Culman SW, 2012, SOIL SCI SOC AM J, V76, P494, DOI 10.2136/sssaj2011.0286; Culman SW, 2010, LANDSCAPE ECOL, V25, P1333, DOI 10.1007/s10980-010-9511-0; Cumming G, 2009, STAT MED, V28, P205, DOI 10.1002/sim.3471; Dale VH, 2007, ECOL ECON, V64, P286, DOI 10.1016/j.ecolecon.2007.05.009; Delmotte S, 2011, EUR J AGRON, V35, P223, DOI 10.1016/j.eja.2011.06.006; Di HJ, 2002, NUTR CYCL AGROECOSYS, V64, P237, DOI 10.1023/A:1021471531188; Dore T, 2008, AGRON SUSTAIN DEV, V28, P151, DOI 10.1051/agro:2007031; Drinkwater LE, 2007, ADV AGRON, V92, P163, DOI 10.1016/S0065-2113(04)92003-2; DRINKWATER LE, 1995, ECOL APPL, V5, P1098, DOI 10.2307/2269357; Drinkwater LE, 1998, NATURE, V396, P262, DOI 10.1038/24376; El Omari R, 2010, FUNCT PLANT BIOL, V37, P55, DOI 10.1071/FP09162; Elia A, 2012, EUR J AGRON, V40, P64, DOI 10.1016/j.eja.2012.02.001; Fessehazion MK, 2011, AGR ECOSYST ENVIRON, V141, P350, DOI 10.1016/j.agee.2011.03.018; Forster J.C., 1995, METHODS APPL SOIL MI, P79, DOI DOI 10.1016/B978-012513840-6/50023-9; Frank DA, 2009, ECOLOGY, V90, P1512, DOI 10.1890/08-0789.1; Gabriel D, 2009, J APPL ECOL, V46, P323, DOI 10.1111/j.1365-2664.2009.01624.x; Gattinger A, 2012, P NATL ACAD SCI USA, V109, P18226, DOI 10.1073/pnas.1209429109; Grandy AS, 2013, ADV AGROECOL, P113; Guthman Julie, 2019, WILTED PATHOGENS CHE; Hartz TK, 2009, HORTSCIENCE, V44, P1988, DOI 10.21273/HORTSCI.44.7.1988; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hochmuth GJ, 2003, HORTSCIENCE, V38, P999, DOI 10.21273/HORTSCI.38.5.999; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Hollander A. D., 2010, CALIFORNIA AUGMENTED; Hollander A.D., 2012, OSGEO J, V10, P26; Inselsbacher E, 2010, SOIL BIOL BIOCHEM, V42, P360, DOI 10.1016/j.soilbio.2009.11.019; Jackson LE, 2011, CLIMATIC CHANGE, V109, P407, DOI 10.1007/s10584-011-0306-3; Jackson LE, 2008, ANNU REV PLANT BIOL, V59, P341, DOI 10.1146/annurev.arplant.59.032607.092932; Kirchmann H, 2007, AGRON J, V99, P960, DOI 10.2134/agronj2006.0061; Kramer SB, 2006, P NATL ACAD SCI USA, V103, P4522, DOI 10.1073/pnas.0600359103; Krusekopf HH, 2002, HORTSCIENCE, V37, P520, DOI 10.21273/HORTSCI.37.3.520; MAGDOFF FR, 1984, SOIL SCI SOC AM J, V48, P1301, DOI 10.2136/sssaj1984.03615995004800060020x; Marriott EE, 2006, SOIL SCI SOC AM J, V70, P950, DOI 10.2136/sssaj2005.0241; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; Miller R., 1997, HDB REFERENCE METHOD, P115, DOI [10.1201/9781420049398.ch15, DOI 10.1201/9781420049398.CH15]; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Moldrup P, 2001, SOIL SCI SOC AM J, V65, P613, DOI 10.2136/sssaj2001.653613x; Ono F, 2000, PLANT BIOLOGY, V2, P17, DOI 10.1055/s-2000-297; Pang XP, 2000, SOIL SCI SOC AM J, V64, P247, DOI 10.2136/sssaj2000.641247x; Ponisio LC, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1396; Poudel DD, 2002, AGR ECOSYST ENVIRON, V90, P125, DOI 10.1016/S0167-8809(01)00196-7; Richter K, 2009, SHARPENING FOCUS YOL; RICK CM, 1988, ANNU REV GENET, V22, P281, DOI 10.1146/annurev.ge.22.120188.001433; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Ros GH, 2009, SOIL BIOL BIOCHEM, V41, P1029, DOI 10.1016/j.soilbio.2009.01.011; Ruzicka DR, 2012, PLANT SOIL, V350, P145, DOI 10.1007/s11104-011-0890-z; Ruzicka DR, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-75; Schachtman DP, 2007, ANNU REV PLANT BIOL, V58, P47, DOI 10.1146/annurev.arplant.58.032806.103750; Seufert V, 2012, NATURE, V485, P229, DOI 10.1038/nature11069; SMART DR, 1988, OECOLOGIA, V76, P336, DOI 10.1007/BF00377026; Soil Survey Staff. Natural Resources Conservation Service United States Department of Agriculture, 2011, SOIL SURV GEOGR SSUR; Stark JM, 1997, NATURE, V385, P61, DOI 10.1038/385061a0; Syswerda SP, 2012, AGR ECOSYST ENVIRON, V149, P10, DOI 10.1016/j.agee.2011.12.007; Tei F, 2002, EUR J AGRON, V18, P45, DOI 10.1016/S1161-0301(02)00096-5; Tittonell P, 2005, AGR ECOSYST ENVIRON, V110, P166, DOI 10.1016/j.agee.2005.04.003; Tittonell P, 2013, SOIL SCI SOC AM J, V77, P525, DOI 10.2136/sssaj2012.0250; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; von Wiren N, 2000, CURR OPIN PLANT BIOL, V3, P254, DOI 10.1016/S1369-5266(00)00073-X; Wallenstein MD, 2006, ECOL APPL, V16, P2143, DOI 10.1890/1051-0761(2006)016[2143:ECODCA]2.0.CO;2; WARING SA, 1964, NATURE, V201, P951, DOI 10.1038/201951a0; Williams A, 2013, APPL SOIL ECOL, V65, P1, DOI 10.1016/j.apsoil.2012.12.019; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Yolo County Crop Statistics, YOL COUNT CROP STAT	78	32	32	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131888	10.1371/journal.pone.0131888	http://dx.doi.org/10.1371/journal.pone.0131888			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121264	Green Submitted, gold, Green Published			2022-12-27	WOS:000358150400173
J	Nakazawa, T; Tateoka, K; Saito, Y; Abe, T; Yano, M; Yaegashi, Y; Narimatsu, H; Fujimoto, K; Nakata, A; Nakata, K; Someya, M; Hori, M; Hareyama, M; Sakata, K				Nakazawa, Takuya; Tateoka, Kunihiko; Saito, Yuichi; Abe, Tadanori; Yano, Masaki; Yaegashi, Yuji; Narimatsu, Hirokazu; Fujimoto, Kazunori; Nakata, Akihiro; Nakata, Kensei; Someya, Masanori; Hori, Masakazu; Hareyama, Masato; Sakata, Koichi			Analysis of Prostate Deformation during a Course of Radiation Therapy for Prostate Cancer	PLOS ONE			English	Article							CONFORMAL RADIOTHERAPY; SEMINAL-VESICLES; FIDUCIAL MARKERS; BEAM; POSITION; MOTION; CT	Purpose Accurate analysis of the correlation between deformation of the prostate and displacement of its center of gravity (CoG) is important for efficient radiation therapy for prostate cancer. In this study, we addressed this problem by introducing a new analysis approach. Method A planning computed tomography (CT) scan and 7 repeat cone-beam CT scans during the course of treatment were obtained for 19 prostate cancer patients who underwent three-dimensional conformal radiation therapy. A single observer contoured the prostate gland only. To evaluate the local deformation of the prostate, it was divided into 12 manually defined segments. Prostate deformation was calculated using in-house developed software. The correlation between the displacement of the CoG and the local deformation of the prostate was evaluated using multiple regression analysis. Results The mean value and standard deviation (SD) of the prostate deformation were 0.6 mm and 1.7 mm, respectively. For the majority of the patients, the local SD of the deformation was slightly lager in the superior and inferior segments. Multiple regression analysis revealed that the anterior-posterior displacement of the CoG of the prostate had a highly significant correlation with the deformations in the middle-anterior (p < 0.01) and middle-posterior (p < 0.01) segments of the prostate surface (R-2 = 0.84). However, there was no significant correlation between the displacement of the CoG and the deformation of the prostate surface in other segments. Conclusion Anterior-posterior displacement of the CoG of the prostate is highly correlated with deformation in its middle-anterior and posterior segments. In the radiation therapy for prostate cancer, it is necessary to optimize the internal margin for every position of the prostate measured using image-guided radiation therapy.	[Nakazawa, Takuya; Tateoka, Kunihiko; Saito, Yuichi; Abe, Tadanori; Yano, Masaki; Nakata, Akihiro; Nakata, Kensei; Someya, Masanori; Hori, Masakazu; Sakata, Koichi] Sapporo Med Univ, Grad Sch Med, Dept Radiat Oncol & Med Phys, Sapporo, Hokkaido, Japan; [Nakazawa, Takuya; Yaegashi, Yuji; Narimatsu, Hirokazu] Kushiro City Gen Hosp, Dept Radiol, Kushiro, Hokkaido, Japan; [Tateoka, Kunihiko; Fujimoto, Kazunori; Hareyama, Masato] Social Med Corp Teishinkai, Radiat Therapy Res Inst, Preparatory Off Proton Therapy Ctr, Sapporo, Hokkaido, Japan	Sapporo Medical University	Nakazawa, T (corresponding author), Sapporo Med Univ, Grad Sch Med, Dept Radiat Oncol & Med Phys, Sapporo, Hokkaido, Japan.	tnakazawa@sapmed.ac.jp	Someya, Masanori/HGE-7117-2022					BRAHME A, 1988, RADIOTHER ONCOL, V12, P129, DOI 10.1016/0167-8140(88)90167-3; Brock KK, 2010, INT J RADIAT ONCOL, V76, P583, DOI 10.1016/j.ijrobp.2009.06.031; De Crevoisier R, 2005, INT J RADIAT ONCOL, V62, P965, DOI 10.1016/j.ijrobp.2004.11.032; Dearnaley DP, 2005, BRIT J CANCER, V92, P488, DOI 10.1038/sj.bjc.6602301; Deurloo KEI, 2005, INT J RADIAT ONCOL, V61, P228, DOI 10.1016/j.ijrobp.2004.09.023; Letourneau D, 2005, RADIOTHER ONCOL, V75, P279, DOI 10.1016/j.radonc.2005.03.001; Mayyas E, 2013, MED PHYS, V40, DOI 10.1118/1.4794502; Nichol AM, 2007, INT J RADIAT ONCOL, V67, P48, DOI 10.1016/j.ijrobp.2006.08.021; Onishi Y, 2012, GUIDELINE RAD THERAP, P1; Rodriguez-Vila B, 2010, MED PHYS, V37, P1137, DOI 10.1118/1.3302916; Sanguineti G, 2003, RADIOTHER ONCOL, V66, P151, DOI 10.1016/S0167-8140(03)00031-8; Stroom JC, 1999, RADIOTHER ONCOL, V51, P237, DOI 10.1016/S0167-8140(99)00061-4; van der Wielen GJ, 2008, INT J RADIAT ONCOL, V72, P1604, DOI 10.1016/j.ijrobp.2008.07.023; Wen N, 2013, PHYS MED BIOL, V58, P7733, DOI 10.1088/0031-9155/58/21/7733; Wu J, 2001, RADIOTHER ONCOL, V61, P127, DOI 10.1016/S0167-8140(01)00452-2; Zellars RC, 2000, INT J RADIAT ONCOL, V47, P655, DOI 10.1016/S0360-3016(00)00469-7	16	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131822	10.1371/journal.pone.0131822	http://dx.doi.org/10.1371/journal.pone.0131822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26120840	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400161
J	Ramos, D; Chicaybam, G; de-Souza-Ferreira, E; Martinez, CG; Kurtenbach, E; Casimiro-Lopes, G; Galina, A				Ramos-Filho, Dionizio; Chicaybam, Gustavo; de-Souza-Ferreira, Eduardo; Martinez, Camila Guerra; Kurtenbach, Eleonora; Casimiro-Lopes, Gustavo; Galina, Antonio			High Intensity Interval Training (HIIT) Induces Specific Changes in Respiration and Electron Leakage in the Mitochondria of Different Rat Skeletal Muscles	PLOS ONE			English	Article							FATTY-ACID OXIDATION; GLUCOSE-TRANSPORT; EXERCISE; ADAPTATIONS; BIOGENESIS; EXPRESSION; RECOVERY; FIBERS; DISUSE	High intensity interval training (HIIT) is characterized by vigorous exercise with short rest intervals. Hydrogen peroxide (H2O2) plays a key role in muscle adaptation. This study aimed to evaluate whether HIIT promotes similar H2O2 formation via O-2 consumption (electron leakage) in three skeletal muscles with different twitch characteristics. Rats were assigned to two groups: sedentary (n=10) and HIIT (n=10, swimming training). We collected the tibialis anterior (TA-fast), gastrocnemius (GAST-fast/slow) and soleus (SOL-slow) muscles. The fibers were analyzed for mitochondrial respiration, H2O2 production and citrate synthase (CS) activity. A multi-substrate (glycerol phosphate (G3P), pyruvate, malate, glutamate and succinate) approach was used to analyze the mitochondria in permeabilized fibers. Compared to the control group, oxygen flow coupled to ATP synthesis, complex I and complex II was higher in the TA of the HIIT group by 1.5-, 3.0- and 2.7-fold, respectively. In contrast, oxygen consumed by mitochondrial glycerol phosphate dehydrogenase (mGPdH) was 30% lower. Surprisingly, the oxygen flow coupled to ATP synthesis was 42% lower after HIIT in the SOL. Moreover, oxygen flow coupled to ATP synthesis and complex II was higher by 1.4- and 2.7-fold in the GAST of the HIIT group. After HIIT, CS activity increased 1.3-fold in the TA, and H2O2 production was 1.3-fold higher in the TA at sites containing mGPdH. No significant differences in H2O2 production were detected in the SOL. Surprisingly, HIIT increased H2O2 production in the GAST via complex II, phosphorylation, oligomycin and antimycin by 1.6-, 1.8-, 2.2-, and 2.2-fold, respectively. Electron leakage was 3.3-fold higher in the TA with G3P and 1.8-fold higher in the GAST with multiple substrates. Unexpectedly, the HIIT protocol induced different respiration and electron leakage responses in different types of muscle.	[Ramos-Filho, Dionizio; Chicaybam, Gustavo; de-Souza-Ferreira, Eduardo; Galina, Antonio] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo Meis, Lab Bioenerget & Mitochondrial Physiol, Rio De Janeiro, RJ, Brazil; [Casimiro-Lopes, Gustavo] Univ Estado Rio De Janeiro, UERJ, Inst Phys Educ & Sports, Rio De Janeiro, RJ, Brazil; [Martinez, Camila Guerra; Kurtenbach, Eleonora] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Ramos, D (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo Meis, Lab Bioenerget & Mitochondrial Physiol, Rio De Janeiro, RJ, Brazil.	dionizioramos@gmail.com; galina@bioqmed.ufrj.br	Martinez, Camila G/S-4666-2018; Kurtenbach, Eleonora/L-4148-2016; Lopes, Gustavo Casimiro/C-5502-2008; Ramos-Filho, Dionizio/A-3687-2010	Martinez, Camila G/0000-0001-6116-9182; Kurtenbach, Eleonora/0000-0002-2141-518X; Lopes, Gustavo Casimiro/0000-0002-6329-3918; 				Acin-Perez R, 2014, BBA-BIOENERGETICS, V1837, P444, DOI 10.1016/j.bbabio.2013.12.009; Anderson EJ, 2006, AM J PHYSIOL-CELL PH, V290, pC844, DOI 10.1152/ajpcell.00402.2005; [Anonymous], 2012, METHOD MOL BIOL, V810, pR25; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Bronstad E, 2012, EUR RESPIR J, V40, P1130, DOI 10.1183/09031936.00193411; Casimiro-Lopes G, 2012, EUR J APPL PHYSIOL, V112, P3839, DOI 10.1007/s00421-012-2368-y; Cavalcanti-de-Albuquerque JPA, 2014, J APPL PHYSIOL, V116, P779, DOI 10.1152/japplphysiol.00121.2013; Ciolac EG, 2012, AM J CARDIOVASC DIS, V2, P102; Currie KD, 2013, APPL PHYSIOL NUTR ME, V38, P644, DOI 10.1139/apnm-2012-0354; Daussin FN, 2008, J APPL PHYSIOL, V104, P1436, DOI 10.1152/japplphysiol.01135.2007; Daussin FN, 2012, MED SCI SPORT EXER, V44, P217, DOI 10.1249/MSS.0b013e31822b0bd4; Delp MD, 1996, J APPL PHYSIOL, V80, P261, DOI 10.1152/jappl.1996.80.1.261; Gillen JB, 2013, OBESITY, V21, P2249, DOI 10.1002/oby.20379; Gomez-Cabrera MC, 2008, AM J CLIN NUTR, V87, P142, DOI 10.1093/ajcn/87.1.142; Gore M, 1998, CAN J PHYSIOL PHARM, V76, P1139, DOI 10.1139/cjpp-76-12-1139; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hoshino D, 2013, APPL PHYSIOL NUTR ME, V38, P326, DOI 10.1139/apnm-2012-0257; Isner-Horobeti ME, 2014, MUSCLE NERVE, V50, P803, DOI 10.1002/mus.24215; Kawanaka K, 1998, J APPL PHYSIOL, V84, P1852, DOI 10.1152/jappl.1998.84.6.1852; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Larsen S, 2011, DIABETOLOGIA, V54, P1427, DOI 10.1007/s00125-011-2098-4; Laughlin MH, 1984, AM J PHYSIOL-HEART C, V15, pH398; Little JP, 2009, J PHYSL, V588, pR1011; MEDBO JI, 1989, J APPL PHYSIOL, V67, P1881, DOI 10.1152/jappl.1989.67.5.1881; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Niklas P, 2010, EUR J APPL PHYSIOL, V110, P597, DOI 10.1007/s00421-010-1544-1; Nikolovski S, 1996, ACTA PHYSIOL SCAND, V157, P427, DOI 10.1046/j.1365-201X.1996.507273000.x; Orr AL, 2012, J BIOL CHEM, V287, P42921, DOI 10.1074/jbc.M112.397828; Picard M, 2008, AM J RESP CRIT CARE, V178, P1040, DOI 10.1164/rccm.200807-1005OC; Powers SK, 2012, AM J PHYSIOL-ENDOC M, V303, pE31, DOI 10.1152/ajpendo.00609.2011; Raja G, 2003, J EXP BIOL, V206, P2159, DOI 10.1242/jeb.00416; ROY RR, 1985, BRAIN RES, V337, P175, DOI 10.1016/0006-8993(85)91627-0; Sandstrom ME, 2006, J PHYSL, V575, pR25; Santiago APSA, 2008, BIOCHIMIE, V90, P1566, DOI 10.1016/j.biochi.2008.06.013; Serpiello FR, 2012, MED SCI SPORT EXER, V44, P827, DOI 10.1249/MSS.0b013e318240067e; Terada S, 2005, ACTA PHYSIOL SCAND, V184, P59, DOI 10.1111/j.1365-201X.2005.01423.x; Terada S, 2004, JPN J PHYSIOL, V54, P47, DOI 10.2170/jjphysiol.54.47; Terada S, 2001, J APPL PHYSIOL, V90, P2019, DOI 10.1152/jappl.2001.90.6.2019; THOMASON DB, 1990, J APPL PHYSIOL, V68, P1, DOI 10.1152/jappl.1990.68.1.1; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Tweedie C, 2011, AM J PHYSIOL-REG I, V300, pR544, DOI 10.1152/ajpregu.00250.2010; World Health Organization, GLOB HLTH RISKS MORT	44	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131766	10.1371/journal.pone.0131766	http://dx.doi.org/10.1371/journal.pone.0131766			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121248	Green Submitted, Green Published, gold			2022-12-27	WOS:000358150400155
J	Tempski, P; Santos, IS; Mayer, FB; Enns, SC; Perotta, B; Paro, HBMS; Gannam, S; Peleias, M; Garcia, VL; Baldassin, S; Guimaraes, KB; Silva, NR; da Cruz, EMTN; Tofoli, LF; Silveira, PSP; Martins, MA				Tempski, Patricia; Santos, Itamar S.; Mayer, Fernanda B.; Enns, Sylvia C.; Perotta, Bruno; Paro, Helena B. M. S.; Gannam, Silmar; Peleias, Munique; Garcia, Vera Lucia; Baldassin, Sergio; Guimaraes, Katia B.; Silva, Nilson R.; Navarro da Cruz, Emirene M. T.; Tofoli, Luis F.; Silveira, Paulo S. P.; Martins, Milton A.			Relationship among Medical Student Resilience, Educational Environment and Quality of Life	PLOS ONE			English	Article							INVENTORY; DEPRESSION; VALIDATION; REDUCTION; CONSTRUCT; ANXIETY; BURNOUT; SCHOOL	Context Resilience is a capacity to face and overcome adversities, with personal transformation and growth. In medical education, it is critical to understand the determinants of a positive, developmental reaction in the face of stressful, emotionally demanding situations. We studied the association among resilience, quality of life (QoL) and educational environment perceptions in medical students. Methods We evaluated data from a random sample of 1,350 medical students from 22 Brazilian medical schools. Information from participants included the Wagnild and Young's resilience scale (RS-14), the Dundee Ready Educational Environment Measure (DREEM), the World Health Organization Quality of Life questionnaire - short form (WHOQOL-BREF), the Beck Depression Inventory (BDI) and the State-Trait Anxiety Inventory (STAI). Results Full multiple linear regression models were adjusted for sex, age, year of medical course, presence of a BDI score >= 14 and STAI state or anxiety scores >= 50. Compared to those with very high resilience levels, individuals with very low resilience had worse QoL, measured by overall (beta=-0.89; 95% confidence interval =-1.21 to -0.56) and medical-school related (beta=-0.85; 95% CI=-1.25 to -0.45) QoL scores, environment (beta=-6.48; 95% CI=-10.01 to -2.95), psychological (beta=-22.89; 95% CI=-25.70 to -20.07), social relationships (beta=-14.28; 95% CI=-19.07 to -9.49), and physical health (beta=-10.74; 95% CI=-14.07 to -7.42) WHOQOL-BREF domain scores. They also had a worse educational environment perception, measured by global DREEM score (beta=-31.42; 95% CI=-37.86 to -24.98), learning (beta=-7.32; 95% CI=-9.23 to -5.41), teachers (beta=-5.37; 95% CI=-7.16 to -3.58), academic self-perception (beta=-7.33; 95% CI=-8.53 to -6.12), atmosphere (beta=-8.29; 95% CI=-10.13 to -6.44) and social self-perception (beta=-3.12; 95% CI=-4.11 to -2.12) DREEM domain scores. We also observed a dose-response pattern across resilience level groups for most measurements. Conclusions Medical students with higher resilience levels had a better quality of life and a better perception of educational environment. Developing resilience may become an important strategy to minimize emotional distress and enhance medical training.	[Tempski, Patricia; Mayer, Fernanda B.; Enns, Sylvia C.; Gannam, Silmar; Peleias, Munique; Martins, Milton A.] Univ Sao Paulo, Sch Med, Ctr Dev Med Educ, Sao Paulo, Brazil; [Tempski, Patricia] Evangel Med Sch Parana, Curitiba, Parana, Brazil; [Santos, Itamar S.; Perotta, Bruno; Martins, Milton A.] Univ Sao Paulo, Sch Med, Dept Med, Sao Paulo, Brazil; [Paro, Helena B. M. S.] Univ Fed Uberlandia, Dept Obstet & Gynecol, BR-38400 Uberlandia, MG, Brazil; [Garcia, Vera Lucia] State Univ Sao Paulo, Botucatu, SP, Brazil; [Baldassin, Sergio; Silva, Nilson R.] ABC Fdn, Sch Med, Santo Andre, Brazil; [Guimaraes, Katia B.] Sch Med Marilia, Marilia, Brazil; [Navarro da Cruz, Emirene M. T.] Sch Med Rio Preto, Sao Jose Do Rio Preto, Brazil; [Tofoli, Luis F.] Univ Estadual Campinas, Sch Med, Dept Psychiat, Campinas, Brazil; [Silveira, Paulo S. P.] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Uberlandia; Universidade Estadual Paulista; Faculdade de Medicina do ABC; Faculdade de Medicina de Marilia; Universidade Estadual de Campinas; Universidade de Sao Paulo	Martins, MA (corresponding author), Univ Sao Paulo, Sch Med, Ctr Dev Med Educ, Sao Paulo, Brazil.	mmartins@usp.br	Santos, Itamar S/K-7055-2012; Mayer, Fernanda Brenneisen/ABH-9750-2020; Martins, Milton A/L-7541-2017; Tófoli, Luís Fernando/F-9221-2012; Baldassin, Sergio P/L-9166-2016; Santos, Itamar/M-2208-2019; Garcia, Vera Lucia/H-3300-2012; Paro, Helena B M S/H-1330-2019	Santos, Itamar S/0000-0003-3212-8466; Tófoli, Luís Fernando/0000-0003-2262-8272; Baldassin, Sergio P/0000-0002-8954-3081; Santos, Itamar/0000-0003-3212-8466; Garcia, Vera Lucia/0000-0001-9821-7950; Paro, Helena B M S/0000-0001-6226-3074; Sergio Panse Silveira, Paulo/0000-0003-4110-1038; Mayer, Fernanda/0000-0002-4152-034X	CAPES (Brazilian Federal Agency for the Support and Evaluation of Graduate Education), Brazil; CNPq (National Council for Scientific Development), Brazil	CAPES (Brazilian Federal Agency for the Support and Evaluation of Graduate Education), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (National Council for Scientific Development), Brazil	This study was supported by CAPES (Brazilian Federal Agency for the Support and Evaluation of Graduate Education) and CNPq (National Council for Scientific Development), Brazil.	Atkinson PA, 2009, J PSYCHIATR MENT HLT, V16, P137, DOI 10.1111/j.1365-2850.2008.01341.x; Ball S, 2002, ACAD MED, V77, P911, DOI 10.1097/00001888-200209000-00023; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Biaggio AMB, 1979, MANUAL INVENTARIO AN; Bonanno GA, 2005, AM PSYCHOL, V60, P265, DOI 10.1037/0003-066X.60.3.265b; De Oliveira GR, 2005, MED TEACH, V27, P343, DOI 10.1080/01421590500046387; Dunn LB, 2008, ACAD PSYCHIATR, V32, P44, DOI 10.1176/appi.ap.32.1.44; Dyrbye LN, 2010, MED EDUC, V44, P1016, DOI 10.1111/j.1365-2923.2010.03754.x; Dyrbye LN, 2010, JAMA-J AM MED ASSOC, V304, P1173, DOI 10.1001/jama.2010.1318; Finkelstein C, 2007, MED EDUC, V41, P258, DOI 10.1111/j.1365-2929.2007.02685.x; Fleck MPA, 1999, REV BRAS PSIQUIATR, V21; Freire P, 2000, PEDAGOGY FREEDOM ETH; Gorenstein C, 1996, BRAZ J MED BIOL RES, V29, P453; Grotberg EH., 1997, ANN CONV INT COUNC P; Grotberg EH, 2008, RESILIENCIA DESCOBRI; Haglund MEM, 2009, ACAD MED, V84, P258, DOI 10.1097/ACM.0b013e31819381b1; Howe A, 2012, MED EDUC, V46, P349, DOI 10.1111/j.1365-2923.2011.04188.x; Jackson D, 2007, J ADV NURS, V60, P1, DOI 10.1111/j.1365-2648.2007.04412.x; Koenig TW, 2013, ACAD MED, V88, P603, DOI 10.1097/ACM.0b013e31828b3389; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Martin AJ, 2006, PSYCHOL SCHOOLS, V43, P267, DOI 10.1002/pits.20149; Maudsley RF, 2001, ACAD MED, V76, P432, DOI 10.1097/00001888-200105000-00011; Melillo A, 2001, RESILIENCIA DESCOBRI; Nagji A, 2013, TEACH LEARN MED, V25, P201, DOI 10.1080/10401334.2013.801774; Pai PG, 2014, J CLIN DIAGN RES, V8, P103, DOI [10.7860/JCDR/2014/5559.3944, 10.7860/JCDR/2014/5569.3944]; Park CL., 2013, EUROPEAN HLTH PSYCHO, V15, P40, DOI DOI 10.1037/A0018301; Paro HBMS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094133; Paro HBMS, 2010, MED EDUC, V44, P227, DOI 10.1111/j.1365-2923.2009.03587.x; Pesce Renata P., 2005, Cad. Saúde Pública, V21, P436, DOI 10.1590/S0102-311X2005000200010; Roff S, 1997, MED TEACH, V19, P295, DOI 10.3109/01421599709034208; Rutter M, 2012, DEV PSYCHOPATHOL, V24, P335, DOI 10.1017/S0954579412000028; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; Slavin SJ, 2014, ACAD MED, V89, P573, DOI 10.1097/ACM.0000000000000166; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stress Wolff T., 2007, MED EDUC, V28, P8; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Tempski P, 2009, MED ED; Tempski P, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-106; Tempski P, 2012, MED EDUC, V46, P345, DOI 10.1111/j.1365-2923.2011.04207.x; Testerman JK, 1996, ACAD MED, V71, pS43, DOI 10.1097/00001888-199610000-00040; Wagnild G., 2009, RESILIENCE SCALE USE; Wagnild G M, 1993, J Nurs Meas, V1, P165; Winnicott D. W., 1965, MATURATIONAL PROCESS; Zamirinejad S, 2014, ISSUES MENT HEALTH N, V35, P480, DOI 10.3109/01612840.2013.879628	45	92	96	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131535	10.1371/journal.pone.0131535	http://dx.doi.org/10.1371/journal.pone.0131535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1BL	26121357	gold, Green Published, Green Submitted			2022-12-27	WOS:000358150400120
J	Ackerly, DD; Cornwell, WK; Weiss, SB; Flint, LE; Flint, AL				Ackerly, David D.; Cornwell, William K.; Weiss, Stuart B.; Flint, Lorraine E.; Flint, Alan L.			A Geographic Mosaic of Climate Change Impacts on Terrestrial Vegetation: Which Areas Are Most at Risk?	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; LOGISTIC-REGRESSION; CALIFORNIA; FUTURE; VULNERABILITY; TEMPERATURE; PRECIPITATION; BIODIVERSITY; FINGERPRINT; CHALLENGES	Changes in climate projected for the 21st century are expected to trigger widespread and pervasive biotic impacts. Forecasting these changes and their implications for ecosystem services is a major research goal. Much of the research on biotic responses to climate change has focused on either projected shifts in individual species distributions or changes in biome distributions. Here, we introduce a novel application of multinomial logistic regression as a powerful approach to model vegetation distributions and potential responses to 21st century climate change. We modeled the distribution of 22 major vegetation types, most defined by a single dominant woody species, across the San Francisco Bay Area. Predictor variables included climate and topographic variables. The novel aspect of our model is the output: a vector of relative probabilities for each vegetation type in each location within the study domain. The model was then projected for 54 future climate scenarios, spanning a representative range of temperature and precipitation projections from the CMIP3 and CMIP5 ensembles. We found that sensitivity of vegetation to climate change is highly heterogeneous across the region. Surprisingly, sensitivity to climate change is higher closer to the coast, on lower insolation, north-facing slopes and in areas of higher precipitation. While such sites may provide refugia for mesic and cool-adapted vegetation in the face of a warming climate, the model suggests they will still be highly dynamic and relatively sensitive to climate-driven vegetation transitions. The greater sensitivity of moist and low insolation sites is an unexpected outcome that challenges views on the location and stability of climate refugia. Projections provide a foundation for conservation planning and land management, and highlight the need for a greater understanding of the mechanisms and time scales of potential climate-driven vegetation transitions.	[Ackerly, David D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Ackerly, David D.] Univ Calif Berkeley, Jepson Herbarium, Berkeley, CA 94720 USA; [Cornwell, William K.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Weiss, Stuart B.] Creekside Ctr Earth Observat, Menlo Pk, CA USA; [Flint, Lorraine E.; Flint, Alan L.] US Geol Survey, Div Water Resources, Sacramento, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of New South Wales Sydney; United States Department of the Interior; United States Geological Survey	Ackerly, DD (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	dackerly@berkeley.edu	Cornwell, William/I-4083-2019; Ackerly, David/A-1247-2009	Ackerly, David/0000-0002-1847-7398; Cornwell, Will/0000-0003-4080-4073	Gordon and Betty Moore Foundation; California Energy Commission	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); California Energy Commission	Support for this research was provided by the Gordon and Betty Moore Foundation, (www.moore.org) and the California Energy Commission, (www.energy.ca.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Ackerly DD, 2012, CEC5002011037; ADAM DP, 1983, SCIENCE, V219, P168, DOI 10.1126/science.219.4581.168; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Ashcroft MB, 2012, GLOBAL CHANGE BIOL, V18, P1866, DOI 10.1111/j.1365-2486.2012.02661.x; Augustin NH, 2001, J APPL ECOL, V38, P991, DOI 10.1046/j.1365-2664.2001.00653.x; AXELROD DI, 1981, AM NAT, V117, P847, DOI 10.1086/283775; Baldwin B.G., 2012, JEPSON MANUAL VASCUL, V2nd ed.; BAOSC, 2011, CONS LANDS NETW SAN; Blois JL, 2009, ANNU REV EARTH PL SC, V37, P181, DOI 10.1146/annurev.earth.031208.100055; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Calef MP, 2005, J BIOGEOGR, V32, P863, DOI 10.1111/j.1365-2699.2004.01185.x; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chornesky EA, 2015, BIOSCIENCE, V65, P247, DOI 10.1093/biosci/biu233; Cornwell WK, 2012, CEC5002012023; Corona P, 2008, PLANT BIOSYST, V142, P509, DOI 10.1080/11263500802410850; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Debella-Gilo M, 2009, CATENA, V77, P8, DOI 10.1016/j.catena.2008.12.001; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; Flint L.E., 2013, ECOL PROCESS, V2, P1, DOI [DOI 10.1186/2192-1709-2-25, 10.1186/2192-1709-2-25]; FLINT LE, 2012, ECOL PROCESS, V1, pNIL6, DOI DOI 10.1186/2192-1709-1-2; Fussel HM, 2006, CLIMATIC CHANGE, V75, P301, DOI 10.1007/s10584-006-0329-3; Gavin DG, 2014, NEW PHYTOL, V204, P37, DOI 10.1111/nph.12929; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hansen J, 2001, J GEOPHYS RES-ATMOS, V106, P23947, DOI 10.1029/2001JD000354; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Harrison S, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00095.1; Heller NE, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00313.1; Hijmans RJ, 2013, R PACKAGE VERSION; Hosmer DW, 2013, WILEY SER PROBAB ST, P89; Ionescu C, 2009, ENVIRON MODEL ASSESS, V14, P1, DOI 10.1007/s10666-008-9179-x; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Jansen E, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P433; Johnstone JA, 2010, P NATL ACAD SCI USA, V107, P4533, DOI 10.1073/pnas.0915062107; Jun C, 2014, NATURE, V514, P434, DOI 10.1038/514434c; Keating KA, 2004, J WILDLIFE MANAGE, V68, P774, DOI 10.2193/0022-541X(2004)068[0774:UAIOLR]2.0.CO;2; Keenan T, 2011, GLOBAL CHANGE BIOL, V17, P565, DOI 10.1111/j.1365-2486.2010.02254.x; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Klausmeyer KR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00044.1; Lawler JJ, 2015, CONSERV BIOL, V29, P618, DOI 10.1111/cobi.12505; Lenoir J, 2010, ECOGRAPHY, V33, P295, DOI 10.1111/j.1600-0587.2010.06279.x; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mbogga MS, 2010, J APPL ECOL, V47, P731, DOI 10.1111/j.1365-2664.2010.01830.x; Menard S., 2002, APPL LOGISTIC REGRES; Millington JDA, 2007, ECOSYSTEMS, V10, P562, DOI 10.1007/s10021-007-9020-4; Mosblech NAS, 2011, J BIOGEOGR, V38, P419, DOI 10.1111/j.1365-2699.2010.02436.x; Nakafuji DY, 2002, WIND PERFORMANCE REP; NRCS, 2006, SSURGOSTATSGO2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Pierce DW, 2013, CLIM DYNAM, V40, P839, DOI 10.1007/s00382-012-1337-9; Pontius RG, 2011, INT J REMOTE SENS, V32, P4407, DOI 10.1080/01431161.2011.552923; Quillet A, 2010, ENVIRON REV, V18, P333, DOI 10.1139/A10-016; R Core Team, 2021, R LANGUAGE ENV STAT; Rapacciuolo G, 2014, GLOBAL CHANGE BIOL, V20, P2841, DOI 10.1111/gcb.12638; Rodder D, 2011, GLOBAL ECOL BIOGEOGR, V20, P915, DOI 10.1111/j.1466-8238.2011.00659.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Russell WH, 2003, LANDSCAPE URBAN PLAN, V64, P201, DOI 10.1016/S0169-2046(02)00233-5; Scheiter S, 2013, NEW PHYTOL, V198, P957, DOI 10.1111/nph.12210; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; Stanton JC, 2012, METHODS ECOL EVOL, V3, P349, DOI 10.1111/j.2041-210X.2011.00157.x; Stephenson NL, 2011, SCIENCE, V334, DOI 10.1126/science.1205740; Stephenson NL, 1998, J BIOGEOGR, V25, P855, DOI 10.1046/j.1365-2699.1998.00233.x; STEPHENSON NL, 1990, AM NAT, V135, P649, DOI 10.1086/285067; Svenning JC, 2013, AM J BOT, V100, P1266, DOI 10.3732/ajb.1200469; Thrasher Bridget, 2013, Eos, Transactions American Geophysical Union, V94, P321; VANGARDINGEN P, 1991, ADV BOT RES, V18, P189, DOI 10.1016/S0065-2296(08)60023-3; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Warman L, 2009, LANDSCAPE ECOL, V24, P1, DOI 10.1007/s10980-008-9285-9; Weiss S, 2013, CLIMATE SCENARIOS SA; WILLIAMS K, 1987, OECOLOGIA, V72, P461, DOI 10.1007/BF00377580; Williams Stephen E, 2008, PLoS Biol, V6, P2621, DOI 10.1371/journal.pbio.0060325	81	35	35	3	157	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130629	10.1371/journal.pone.0130629	http://dx.doi.org/10.1371/journal.pone.0130629			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115485	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500082
J	Chen, LG; Zhan, Q; Ma, C; Liu, Q; Zhang, XF; Tian, X; Jiang, YL; Dong, YM; Chen, SY; Lu, JP				Chen, Luguang; Zhan, Qian; Ma, Chao; Liu, Qi; Zhang, Xuefeng; Tian, Xia; Jiang, Yuanliang; Dong, Yinmei; Chen, Shiyue; Lu, Jianping			Reproducibility of Middle Cerebral Artery Stenosis Measurements by DSA: Comparison of the NASCET and WASID Methods	PLOS ONE			English	Article							DIGITAL-SUBTRACTION-ANGIOGRAPHY; HIGH-RESOLUTION MRI; CAROTID STENOSIS; OCCLUSIVE DISEASE; GRADING METHODS; CT ANGIOGRAPHY; SEVERITY; STROKE; ECST; CC	Purpose To evaluate the intra-and inter-observer variability of the North American Symptomatic Carotid Endarterectomy Trial (NASCET) and Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) criteria for the evaluation of middle cerebral artery (MCA) stenosis using digital subtraction angiography (DSA). Materials and Methods DSA images of 114 cases with 131 stenotic MCAs were retrospectively analyzed. Two radiologists and a researcher measured the degree of MCA stenosis independently using both NASCET and WASID methods. To determine intra-observer agreement, all the observers reevaluated the degree of MCA stenosis 4 weeks later. The linear relation and coefficient of variation (CV) between the measurements made by the two methods were assessed by correlation coefficient and multi-factor analysis of variance (ANOVA), respectively. Intra-and inter-observer variability of the two methods was evaluated by intraclass correlation coefficient (ICC), Spearman's R value, Pearson correlation coefficient and Bland-Altman plots. Results Despite the fact that the degree of MCA stenosis measured by NASCET was lower than measured using the WASID method, there was good linear correlation between the measurements made by the two methods (for the mean measurements of the 3 observers, NASCET% = 0.891 x WASID% -1.89%; ICC, Spearman's R value and Pearson correlation were 0.874, 0.855, and 0.874, respectively). The CVs of both intra-and inter-observer measurements of MCA stenosis using WASID were significantly lower than that using NASCET confirmed by the multi-factor ANOVA results, which showed only the measurement methods of MCA stenosis had significant effects on the CVs both in intra-and inter-observer measurements (both P values < 0.001). Intra-observer measurements showed good or excellent agreement with respect to WASID and NASCET evaluation (ICC, 0.656 to 0.817 and 0.635 to 0.761, respectively). Good agreement for the WASID evaluation (ICC, 0.592 to 0.628) and for the NASCET evaluation (ICC, 0.529 to 0.568) was observed for interobserver measurements. Bland-Altman plots demonstrated that the WASID method had better reproducibility and intra-observer agreement than NASCET method for evaluating MCA stenosis. Conclusion Both NASCET and WASID methods have an acceptable level of agreement; however, the WASID method had better reproducibility for the evaluation of MCA stenosis, and thus the WASID method may serve as a standard for measuring the degree of MCA stenosis.	[Chen, Luguang; Zhan, Qian; Ma, Chao; Liu, Qi; Zhang, Xuefeng; Tian, Xia; Jiang, Yuanliang; Dong, Yinmei; Chen, Shiyue; Lu, Jianping] Second Mil Med Univ, Changhai Hosp Shanghai, Dept Radiol, Shanghai 200433, Peoples R China	Naval Medical University	Lu, JP (corresponding author), Second Mil Med Univ, Changhai Hosp Shanghai, Dept Radiol, 168 Changhai Rd, Shanghai 200433, Peoples R China.	cjr.lujianping@vip.163.com	Jiang, Yuanliang/AAO-6881-2020	Ma, Chao/0000-0002-2473-387X	1255 Academic Discipline Project of Shanghai Changhai Hospital [CH125520800]; Shanghai Shenkang, Shanghai, China [SHDC12013110, ChiCTR-DDT-14004284]	1255 Academic Discipline Project of Shanghai Changhai Hospital; Shanghai Shenkang, Shanghai, China	This work was supported by the 1255 Academic Discipline Project of Shanghai Changhai Hospital (CH125520800) and the Shanghai Shenkang Project SHDC12013110 (Clinical Research Registration Number: ChiCTR-DDT-14004284), Shanghai, China.	Bash S, 2005, AM J NEURORADIOL, V26, P1012; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Carvalho M, 2014, J STROKE CEREBROVASC, V23, P599, DOI 10.1016/j.jstrokecerebrovasdis.2013.06.006; ELIASZIW M, 1994, STROKE, V25, P2445, DOI 10.1161/01.STR.25.12.2445; Famakin BM, 2009, STROKE, V40, P1999, DOI 10.1161/STROKEAHA.108.546150; FOX AJ, 1993, RADIOLOGY, V186, P316, DOI 10.1148/radiology.186.2.8421726; Huang J, 2012, J NEURORADIOLOGY, V39, P342, DOI 10.1016/j.neurad.2011.11.005; Kern R, 2005, NEUROLOGY, V65, P859, DOI 10.1212/01.wnl.0000175983.76110.59; Kilickap G, 2012, INT J CARDIOVAS IMAG, V28, P1257, DOI 10.1007/s10554-011-9939-6; Liu Q, 2013, INT J CARDIOVAS IMAG, V29, P1491, DOI 10.1007/s10554-013-0237-3; Mazighi M, 2006, NEUROLOGY, V66, P1187, DOI 10.1212/01.wnl.0000208404.94585.b2; Nederkoorn PJ, 2002, J VASC SURG, V36, P806, DOI 10.1067/mva.2002.127529; ROTHWELL PM, 1994, STROKE, V25, P2435, DOI 10.1161/01.STR.25.12.2435; Saba L, 2010, EUR J RADIOL, V76, P42, DOI 10.1016/j.ejrad.2009.04.064; Samuels OB, 2000, AM J NEURORADIOL, V21, P643; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Staikov IN, 2000, J NEUROL, V247, P681, DOI 10.1007/s004150070110; Tang CW, 2011, AM J NEURORADIOL, V32, P911, DOI 10.3174/ajnr.A2409; Tarasow Eugeniusz, 2007, Med Sci Monit, V13 Suppl 1, P65; Turan TN, 2010, STROKE, V41, P1636, DOI 10.1161/STROKEAHA.110.584672; Wang YJ, 2014, STROKE, V45, P663, DOI 10.1161/STROKEAHA.113.003508; Zhu XJ, 2013, AM J NEURORADIOL, V34, P1717, DOI 10.3174/ajnr.A3573	22	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130991	10.1371/journal.pone.0130991	http://dx.doi.org/10.1371/journal.pone.0130991			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115309	Green Submitted, gold, Green Published			2022-12-27	WOS:000358147500118
J	Chen, SM; Chou, WC; Hu, LY; Hsiung, CN; Chu, HW; Huang, YL; Hsu, HM; Yu, JC; Shen, CY				Chen, Shiau-Mei; Chou, Wen-Cheng; Hu, Ling-Yueh; Hsiung, Chia-Ni; Chu, Hou-Wei; Huang, Yuan-Ling; Hsu, Huan-Ming; Yu, Jyh-Cherng; Shen, Chen-Yang			The Effect of MicroRNA-124 Overexpression on Anti-Tumor Drug Sensitivity	PLOS ONE			English	Article							BREAST-CANCER PROGRESSION; DNA-DAMAGE; HEPATOCELLULAR-CARCINOMA; MIR-124; REPAIR; ATMIN; PATHWAYS; TARGETS; DIFFERENTIATION; PROLIFERATION	MicroRNAs play critical roles in regulating various physiological processes, including growth and development. Previous studies have shown that microRNA-124 (miR-124) participates not only in regulation of early neurogenesis but also in suppression of tumorigenesis. In the present study, we found that overexpression of miR-124 was associated with reduced DNA repair capacity in cultured cancer cells and increased sensitivity of cells to DNA-damaging anti-tumor drugs, specifically those that cause the formation of DNA strand-breaks (SBs). We then examined which DNA repair-related genes, particularly the genes of SB repair, were regulated by miR-124. Two SB repair-related genes, encoding ATM interactor (ATMIN) and poly (ADP-ribose) polymerase 1 (PARP1), were strongly affected by miR-124 overexpression, by binding of miR-124 to the 3c-untranslated region of their mRNAs. As a result, the capacity of cells to repair DNA SBs, such as those resulting from homologous recombination, was significantly reduced upon miR-124 overexpression. A particularly important therapeutic implication of this finding is that overexpression of miR-124 enhanced cell sensitivity to multiple DNA-damaging agents via ATMIN- and PARP1-mediated mechanisms. The translational relevance of this role of miR-124 in anti-tumor drug sensitivity is suggested by the finding that increased miR-124 expression correlates with better breast cancer prognosis, specifically in patients receiving chemotherapy. These findings suggest that miR-124 could potentially be used as a therapeutic agent to improve the efficacy of chemotherapy with DNA-damaging agents.	[Chen, Shiau-Mei; Huang, Yuan-Ling; Shen, Chen-Yang] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chen, Shiau-Mei; Chou, Wen-Cheng; Hu, Ling-Yueh; Hsiung, Chia-Ni; Chu, Hou-Wei; Huang, Yuan-Ling; Shen, Chen-Yang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Hsu, Huan-Ming; Yu, Jyh-Cherng] Tri Serv Gen Hosp, Dept Surg, Taipei, Taiwan; [Shen, Chen-Yang] China Med Univ, Coll Publ Hlth, Taichong, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan; Tri-Service General Hospital; China Medical University Taiwan	Shen, CY (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	bmcys@ibms.sinica.edu.tw						Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chou WC, 2008, EMBO J, V27, P3140, DOI 10.1038/emboj.2008.229; Chu HW, 2014, HUM MOL GENET, V23, P355, DOI 10.1093/hmg/ddt426; Creighton CJ, 2008, RNA, V14, P2290, DOI 10.1261/rna.1188208; Curtin NJ, 2013, MOL ASPECTS MED, V34, P1217, DOI 10.1016/j.mam.2013.01.006; Curtin NJ, 2004, CLIN CANCER RES, V10, P881, DOI 10.1158/1078-0432.CCR-1144-3; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Greene SB, 2010, CURR DRUG TARGETS, V11, P1059; Gusev Y, 2008, METHODS, V44, P61, DOI 10.1016/j.ymeth.2007.10.005; Han ZB, 2013, CELL PHYSIOL BIOCHEM, V31, P823, DOI 10.1159/000350100; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hsiung CN, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0455-1; Hunt S, 2011, FEBS LETT, V585, P187, DOI 10.1016/j.febslet.2010.11.038; Kanu N, 2008, CELL CYCLE, V7, P3483, DOI 10.4161/cc.7.22.7044; Kanu N, 2007, EMBO J, V26, P2933, DOI 10.1038/sj.emboj.7601733; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lang QB, 2012, BIOCHEM BIOPH RES CO, V426, P247, DOI 10.1016/j.bbrc.2012.08.075; Liang YJ, 2013, CARCINOGENESIS, V34, P713, DOI 10.1093/carcin/bgs383; Liang YL, 2009, WORLD J SURG, V33, P661, DOI 10.1007/s00268-008-9840-1; Loizou JI, 2011, CANCER CELL, V19, P587, DOI 10.1016/j.ccr.2011.03.022; Lovat F, 2011, SEMIN ONCOL, V38, P724, DOI 10.1053/j.seminoncol.2011.08.006; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Lv ZH, 2013, MOL MED REP, V8, P345, DOI 10.3892/mmr.2013.1561; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Manakov SA, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00156; McNees CJ, 2005, EMBO J, V24, P2447, DOI 10.1038/sj.emboj.7600704; Moore Drew D, 2014, Cancer Treat Res, V162, P65, DOI 10.1007/978-3-319-07323-1_4; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Oka H, 2008, BIOCHEM BIOPH RES CO, V371, P225, DOI 10.1016/j.bbrc.2008.04.052; Ottaviani G, 2009, CANCER TREAT RES, V152, P421, DOI 10.1007/978-1-4419-0284-9_2; Papatheodorou I, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-66; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pierson J, 2008, J NEURO-ONCOL, V90, P1, DOI 10.1007/s11060-008-9624-3; Rastelli F, 2010, TUMORI J, V96, P875, DOI 10.1177/548.6505; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Smith LM, 2005, CLIN CANCER RES, V11, P8449, DOI 10.1158/1078-0432.CCR-05-1224; Wang P, 2014, ONCOGENE, V33, P514, DOI 10.1038/onc.2012.598; Wilting SM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-167; Wong KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019027; Xie BY, 2013, BIOINFORMATICS, V29, P638, DOI 10.1093/bioinformatics/btt014; Zhang TY, 2014, P NATL ACAD SCI USA, V111, P12091, DOI 10.1073/pnas.1400230111; Zhang TY, 2012, CELL REP, V2, P1498, DOI 10.1016/j.celrep.2012.11.002; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145	48	32	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0128472	10.1371/journal.pone.0128472	http://dx.doi.org/10.1371/journal.pone.0128472			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115122	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500014
J	Concepcion-Acevedo, J; Weiss, HN; Chaudhry, WN; Levin, BR				Concepcion-Acevedo, Jeniffer; Weiss, Howard N.; Chaudhry, Waqas Nasir; Levin, Bruce R.			Malthusian Parameters as Estimators of the Fitness of Microbes: A Cautionary Tale about the Low Side of High Throughput	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; COMPENSATORY EVOLUTION; BACTERIAL-POPULATIONS; STRUCTURED HABITATS; BIOLOGICAL COST; MUTATIONS; SELECTION; FREQUENCY	The maximum exponential growth rate, the Malthusian parameter (MP), is commonly used as a measure of fitness in experimental studies of adaptive evolution and of the effects of antibiotic resistance and other genes on the fitness of planktonic microbes. Thanks to automated, multi-well optical density plate readers and computers, with little hands-on effort investigators can readily obtain hundreds of estimates of MPs in less than a day. Here we compare estimates of the relative fitness of antibiotic susceptible and resistant strains of E. coli, Pseudomonas aeruginosa and Staphylococcus aureus based on MP data obtained with automated multi-well plate readers with the results from pairwise competition experiments. This leads us to question the reliability of estimates of MP obtained with these high throughput devices and the utility of these estimates of the maximum growth rates to detect fitness differences.	[Concepcion-Acevedo, Jeniffer; Chaudhry, Waqas Nasir; Levin, Bruce R.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Weiss, Howard N.] Georgia Inst Technol, Dept Math, Atlanta, GA 30332 USA; [Chaudhry, Waqas Nasir] Natl Univ Sci & Technol, Islamabad, Pakistan	Emory University; University System of Georgia; Georgia Institute of Technology; National University of Sciences & Technology - Pakistan	Levin, BR (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	blevin@emory.edu			US National Institutes of General Medical Science [GM098175]; Higher Education Commission Pakistan; Procter and Gamble	US National Institutes of General Medical Science; Higher Education Commission Pakistan(Higher Education Commission of Pakistan); Procter and Gamble(Procter & Gamble)	This research was supported by a grant from the US National Institutes of General Medical Science, GM098175 (BRL) and from the Higher Education Commission Pakistan (WNC). The Bioscreen TM plate reader was purchased with funds from a grant from Procter and Gamble. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscripts.	Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; Bacher JM, 2001, J BACTERIOL, V183, P5414, DOI 10.1128/JB.183.18.5414-5425.2001; Bjorkman J, 2000, DRUG RESIST UPDATE, V3, P237, DOI 10.1054/drup.2000.0147; Carlton BC, 1981, MANUAL METHODS GENER, P222; CHAO L, 1981, P NATL ACAD SCI-BIOL, V78, P6324, DOI 10.1073/pnas.78.10.6324; Dahlberg C, 2003, GENETICS, V165, P1641; DEAN AM, 1986, GENET RES, V48, P1, DOI 10.1017/S0016672300024587; Gallet R, 2012, GENETICS, V190, P175, DOI 10.1534/genetics.111.133454; Gravesen A, 2002, APPL ENVIRON MICROB, V68, P756, DOI 10.1128/AEM.68.2.756-764.2002; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Hall AR, 2011, EVOLUTION, V65, P2370, DOI 10.1111/j.1558-5646.2011.01302.x; Hall BG, 2014, MOL BIOL EVOL, V31, P232, DOI 10.1093/molbev/mst187; Jiang WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003844; Kugelberg E, 2005, J ANTIMICROB CHEMOTH, V55, P22, DOI 10.1093/jac/dkh505; Lang GI, 2011, GENETICS, V188, P647, DOI 10.1534/genetics.111.128942; Leiby N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001789; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Levin BR, 2000, GENETICS, V154, P985; LEVIN BR, 1988, PHILOS T R SOC B, V319, P459, DOI 10.1098/rstb.1988.0059; Lindsey HA, 2013, NATURE, V494, P463, DOI 10.1038/nature11879; Nagaev I, 2001, MOL MICROBIOL, V40, P433, DOI 10.1046/j.1365-2958.2001.02389.x; Novak M, 2009, ANTON LEEUW INT J G, V96, P267, DOI 10.1007/s10482-009-9342-7; Paulander W, 2009, GENETICS, V183, P539, DOI 10.1534/genetics.109.106104; Ramadhan AA, 2005, J CLIN PATHOL, V58, P744, DOI 10.1136/jcp.2004.024091; Reynolds MG, 2000, GENETICS, V156, P1471; Schrag SJ, 1996, NATURE, V381, P120, DOI 10.1038/381120b0; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Wei Y, 2011, P NATL ACAD SCI USA, V108, P4047, DOI 10.1073/pnas.1013499108	28	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0126915	10.1371/journal.pone.0126915	http://dx.doi.org/10.1371/journal.pone.0126915			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114477	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500007
J	Harman, NL; Bruce, IA; Kirkham, JJ; Tierney, S; Callery, P; O'Brien, K; Bennett, AMD; Chorbachi, R; Hall, PN; Harding-Bell, A; Parfect, VH; Rumsey, N; Sell, D; Sharma, R; Williamson, PR				Harman, Nicola L.; Bruce, Iain A.; Kirkham, Jamie J.; Tierney, Stephanie; Callery, Peter; O'Brien, Kevin; Bennett, Alex M. D.; Chorbachi, Raouf; Hall, Per N.; Harding-Bell, Anne; Parfect, Victoria H.; Rumsey, Nichola; Sell, Debbie; Sharma, Ravi; Williamson, Paula R.			The Importance of Integration of Stakeholder Views in Core Outcome Set Development: Otitis Media with Effusion in Children with Cleft Palate	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; MIDDLE-EAR DISEASE; TYMPANOSTOMY TUBE INSERTION; 1ST 3 YEARS; CLINICAL-TRIALS; LANGUAGE-DEVELOPMENT; VENTILATION TUBES; PRESCHOOL-CHILDREN; GLUE EAR; HEARING IMPAIRMENT	Background Approximately 75% of children with cleft palate (CP) have Otitis Media with Effusion (OME) histories. Evidence for the effective management of OME in these children is lacking. The inconsistency in outcome measurement in previous studies has led to a call for the development of a Core Outcome Set (COS). Despite the increase in the number of published COS, involvement of patients in the COS development process, and methods to integrate the views of patients and health professionals, to date have been limited. Methods and Findings A list of outcomes measured in previous research was identified through reviewing the literature. Opinion on the importance of each of these outcomes was then sought from key stakeholders: Ear, Nose and Throat (ENT) surgeons, audiologists, cleft surgeons, speech and language therapists, specialist cleft nurses, psychologists, parents and children. The opinion of health professionals was sought in a three round Delphi survey where participants were asked to score each outcome using a bespoke online system. Parents and children were also asked to score outcomes in a survey and provided an in-depth insight into having OME through semi-structured interviews. The results of the Delphi survey, interviews and parent/patient survey were brought together in a final consensus meeting with representation from all stakeholders. A final set of eleven outcomes reached the definition of "consensus in" to form the recommended COS: hearing; chronic otitis media (COM); OME; receptive language skills; speech development; psycho social development; acute otitis media (AOM); cholesteatoma; side effects of treatment; listening skills; otalgia. Conclusions We have produced a recommendation about the outcomes that should be measured, as a minimum, in studies of the management of OME in children with CP. The development process included input from key stakeholders and used novel methodology to integrate the opinion of healthcare professionals, parents and children.	[Harman, Nicola L.; Kirkham, Jamie J.; Williamson, Paula R.] Univ Liverpool, Dept Biostat, MRC North West Hub Trials Methodol Res, Liverpool L69 3BX, Merseyside, England; [Bruce, Iain A.] Cent Manchester Univ Hosp NHS Fdn Trust, Royal Manchester Childrens Hosp, Manchester, Lancs, England; [Tierney, Stephanie] Univ Warwick, Warwick Med Sch, Royal Coll, Nursing Res Inst, Warwick, England; [Callery, Peter] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England; [O'Brien, Kevin] Univ Manchester, Sch Dent, Healing Fdn, Cleft & Craniofacial Clin Res Ctr, Manchester, Lancs, England; [Bennett, Alex M. D.] NHS Lothian, ENT Dept, Edinburgh, Midlothian, Scotland; [Chorbachi, Raouf] Great Ormond St Hosp Sick Children, North Thames Cleft Serv, London WC1N 3JH, England; [Chorbachi, Raouf] Great Ormond St Hosp Sick Children, Dept Audiol Med Audiol Cochlear Implants, London WC1N 3JH, England; [Hall, Per N.; Harding-Bell, Anne; Parfect, Victoria H.] Cambridge Univ Hosp NHS Trust, Cleft Net East, Cambridge, England; [Rumsey, Nichola] Univ W England, Dept Hlth & Social Sci, Ctr Appearance Res, Bristol BS16 1QY, Avon, England; [Sell, Debbie] Great Ormond St Hosp Sick Children, North Thames Cleft Serv, Speech & Language Therapy, London, England; [Sharma, Ravi] Alder Hey Childrens NHS Fdn Trust, North West Isle Man & North Wales Cleft Lip & Pal, Liverpool, Merseyside, England	University of Liverpool; Royal Manchester Children's Hospital; University of Manchester; University of Warwick; University of Manchester; University of Manchester; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of West England; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Alder Hey Children's NHS Foundation Trust	Harman, NL (corresponding author), Univ Liverpool, Dept Biostat, MRC North West Hub Trials Methodol Res, Liverpool L69 3BX, Merseyside, England.	n.harman@liv.ac.uk	Bruce, Iain A/H-9508-2019; Kirkham, Jamie/AAD-4490-2019; Callery, Peter/F-2203-2010; Harman, Nicola/AAM-3474-2021; Williamson, Paula R/B-6425-2016	Bruce, Iain A/0000-0003-0831-4760; Kirkham, Jamie/0000-0003-2579-9325; Callery, Peter/0000-0002-9082-8084; Harman, Nicola/0000-0001-6958-6466; Williamson, Paula R/0000-0001-9802-6636; Sell, Debbie/0000-0002-2488-5881	National Institute for Health Research Health Technology Assessment Programme [09/167/02]; Healing Foundation [1078666, 3831398]; MRC North West Hub for Trials Methodology Research [G0800792]; MRC [MR/K025635/1, G0800792] Funding Source: UKRI; Medical Research Council [G0800792, MR/K025635/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10025] Funding Source: researchfish	National Institute for Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR)); Healing Foundation; MRC North West Hub for Trials Methodology Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the National Institute for Health Research Health Technology Assessment Programme (project number 09/167/02). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Health Technology Assessment Programme, National Institute for Health Research, National Health Service or the Department of Health. This study is also supported by the Healing Foundation (Registered Charity number 1078666 vertical bar Registered Company number 3831398). The development of the COMET Delphi software was funded by the MRC North West Hub for Trials Methodology Research (grant number G0800792). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACK NA, 1990, BRIT MED J, V300, P1551, DOI 10.1136/bmj.300.6739.1551; BOERS M, 1994, J RHEUMATOL, V21, P86; Broen PA, 1996, CLEFT PALATE-CRAN J, V33, P127, DOI 10.1597/1545-1569(1996)033<0127:COTHHO>2.3.CO;2; Browning GG, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001801.pub3; Casselbrant ML, 2009, INT J PEDIATR OTORHI, V73, P1718, DOI 10.1016/j.ijporl.2009.09.007; Chen JL, 2008, OTOL NEUROTOL, V29, P812, DOI 10.1097/MAO.0b013e318180a4e0; Civelek B, 2007, TURK J MED SCI, V37, P223; Clarke M, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-39; Cooney RM, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-17; Curtin G, 2009, ARCH OTOLARYNGOL, V135, P748, DOI 10.1001/archoto.2009.106; DEMPSTER JH, 1993, J LARYNGOL OTOL, V107, P284, DOI 10.1017/S0022215100122844; Devane D, 2007, BIRTH-ISS PERINAT C, V34, P164, DOI 10.1111/j.1523-536X.2006.00145.x; FIELLAUNIKOLAJSEN M, 1980, CLIN OTOLARYNGOL, V5, P424; Flynn T, 2009, INT J PEDIATR OTORHI, V73, P1441, DOI 10.1016/j.ijporl.2009.07.015; FRABLE MA, 1985, LARYNGOSCOPE, V95, P1044; FREELAND AP, 1981, BRIT J PLAST SURG, V34, P142, DOI 10.1016/S0007-1226(81)80081-1; Gargon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099111; GATES GA, 1989, ANN OTO RHINOL LARYN, V98, P2, DOI 10.1177/00034894890981S202; GOLDMAN JL, 1993, SOUTHERN MED J, V86, P1236, DOI 10.1097/00007611-199311000-00010; GORDON ASD, 1988, INT J PEDIATR OTORHI, V15, P149, DOI 10.1016/0165-5876(88)90066-3; Greig AVH, 1999, J LARYNGOL OTOL, V113, P1068, DOI 10.1017/S0022215100157913; Griffin GH, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003423.pub2; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P395, DOI 10.1016/j.jclinepi.2010.09.012; Hammaren-Malmi S, 2005, PEDIATRICS, V116, P185, DOI 10.1542/peds.2004-2253; Harman NL, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-70; Hormann K, 1991, Dtsch Z Mund Kiefer Gesichtschir, V15, P149; Hornigold R, 2008, CLIN OTOLARYNGOL, V33, P265, DOI 10.1111/j.1749-4486.2008.01670.x; HUBBARD TW, 1985, NEW ENGL J MED, V312, P1529, DOI 10.1056/NEJM198506133122401; John A, 2006, CLEFT PALATE-CRAN J, V43, P272, DOI 10.1597/04-141.1; Johnston LC, 2004, PEDIATRICS, V114, pE58, DOI 10.1542/peds.114.1.e58; Khanna D, 2008, ANN RHEUM DIS, V67, P703, DOI 10.1136/ard.2007.078923; Kirkham JJ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-324; Koivunen P, 2004, BMJ-BRIT MED J, V328, P487, DOI 10.1136/bmj.37972.678345.0D; Liu Lin, 2004, Zhonghua Er Bi Yan Hou Ke Za Zhi, V39, P216; Maheshwar AA, 2002, INT J PEDIATR OTORHI, V66, P55, DOI 10.1016/S0165-5876(02)00206-9; Mandel EM, 2002, PEDIATRICS, V110, P1071, DOI 10.1542/peds.110.6.1071; Mattila PS, 2003, ARCH OTOLARYNGOL, V129, P163, DOI 10.1001/archotol.129.2.163; MAW AR, 1983, BRIT MED J, V287, P1586, DOI 10.1136/bmj.287.6405.1586; Maw R, 1999, LANCET, V353, P960, DOI 10.1016/S0140-6736(98)05295-7; Mease PJ, 2008, ARTHRIT RHEUM-ARTHR, V59, P952, DOI 10.1002/art.23826; Merrick GD, 2007, BRIT J ORAL MAX SURG, V45, P527, DOI 10.1016/j.bjoms.2007.02.003; MOLLER P, 1981, ACTA OTO-LARYNGOL, V92, P521, DOI 10.3109/00016488109133291; MOLLER P, 1982, ACTA OTO-LARYNGOL, P158; Nguyen LHP, 2004, LARYNGOSCOPE, V114, P863, DOI 10.1097/00005537-200405000-00014; NICE, 2008, SURG MAN CHILDR OT M; Paradise JL, 2007, NEW ENGL J MED, V356, P248, DOI 10.1056/NEJMoa062980; Paradise JL, 2005, NEW ENGL J MED, V353, P576, DOI 10.1056/NEJMoa050406; Paradise JL, 2003, PEDIATRICS, V112, P265, DOI 10.1542/peds.112.2.265; PARADISE JL, 1974, PEDIATRICS, V53, P48; Paradise JL, 2001, NEW ENGL J MED, V344, P1179, DOI 10.1056/NEJM200104193441601; Paradise JL, 1999, JAMA-J AM MED ASSOC, V282, P945, DOI 10.1001/jama.282.10.945; PARADISE JL, 1990, JAMA-J AM MED ASSOC, V263, P2066, DOI 10.1001/jama.263.15.2066; Perera R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006285; Phua YS, 2009, INT J PEDIATR OTORHI, V73, P307, DOI 10.1016/j.ijporl.2008.10.026; Ponduri S, 2009, CLEFT PALATE-CRAN J, V46, P30, DOI 10.1597/07-219.1; POTSIC WP, 1979, CLEFT PALATE J, V16, P56; Prinsen CAC, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-247; RACH GH, 1991, CLIN OTOLARYNGOL, V16, P128, DOI 10.1111/j.1365-2273.1991.tb01960.x; Reiter R, 2009, CLEFT PALATE-CRAN J, V46, P598, DOI 10.1597/08-166.1; ROBSON AK, 1992, J LARYNGOL OTOL, V106, P788, DOI 10.1017/S0022215100120894; Rovers MM, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.3.e42; ROYDHOUSE N, 1980, ANN OTO RHINOL LARYN, V89, P312, DOI 10.1177/00034894800890S373; RYNNELDAGOO B, 1978, ANN OTO RHINOL LARYN, V87, P272, DOI 10.1177/000348947808700223; Sell D, 2009, INT J LANG COMM DIS, V44, P529, DOI 10.1080/13682820802196815; Shaw R, 2003, J CRANIO MAXILL SURG, V31, P316, DOI 10.1016/S1010-5182(03)00074-X; Sheahan P, 2002, CLIN OTOLARYNGOL, V27, P494, DOI 10.1046/j.1365-2273.2002.00607.x; Simpson SA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004163.pub2; Sinha I, 2008, PLOS MED, V5, P569, DOI 10.1371/journal.pmed.0050096; SMITH TL, 1994, OTOLARYNG HEAD NECK, V111, P423, DOI 10.1177/019459989411100406; Szabo C, 2010, INT J PEDIATR OTORHI, V74, P874, DOI 10.1016/j.ijporl.2010.04.016; Tanpowpong Kunchitthape, 2007, Journal of the Medical Association of Thailand, V90, P1866; Thomas CL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001935.pub2; Tierney S, 2013, INT J PEDIATR OTORHI, V77, P1742, DOI 10.1016/j.ijporl.2013.08.006; Tierney S, 2013, CLEFT PALATE CRANIOF; van den Aardweg MTA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007810.pub2; Williamson PR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-132; Zheng Qian, 2003, Hua Xi Kou Qiang Yi Xue Za Zhi, V21, P28; ZIELHUIS GA, 1989, LANCET, V1, P311	78	74	75	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129514	10.1371/journal.pone.0129514	http://dx.doi.org/10.1371/journal.pone.0129514			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115172	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500027
J	Hu, XL; Lu, L; Li, X; Wang, JH; Guo, M				Hu, Xiaoli; Lu, Ling; Li, Xin; Wang, Jianhua; Guo, Ming			Land Use/Cover Change in the Middle Reaches of the Heihe River Basin over 2000-2011 and Its Implications for Sustainable Water Resource Management	PLOS ONE			English	Article							FOR-GREEN POLICY; NORTH-WEST CHINA; COVER CHANGE; ARAL SEA; GRAIN; ENVIRONMENT; RESTORATION; XINJIANG; CROPLAND; PLATEAU	The Heihe River Basin (HRB) is a typical arid inland river basin in northwestern China. From the 1960s to the 1990s, the downstream flow in the HRB declined as a result of large, artificial changes in the distribution of water and land and a lack of effective water resource management. Consequently, the ecosystems of the lower reaches of the basin substantially deteriorated. To restore these degraded ecosystems, the Ecological Water Diversion Project (EWDP) was initiated by the Chinese government in 2000. The project led to agricultural and ecological changes in the middle reaches of the basin. In this study, we present three datasets of land use/cover in the middle reaches of the HRB derived from Landsat TM/ETM + images in 2000, 2007 and 2011. We used these data to investigate changes in land use/cover between 2000 and 2011 and the implications for sustainable water resource management. The results show that the most significant land use/cover change in the middle reaches of the HRB was the continuous expansion of farmland for economic interests. From 2000 to 2011, the farmland area increased by 12.01%. The farmland expansion increased the water resource stress; thus, groundwater was over-extracted and the ecosystem was degraded in particular areas. Both consequences are negative and potentially threaten the sustainability of the middle reaches of the HRB and the entire river basin. Local governments should therefore improve the management of water resources, particularly groundwater management, and should strictly control farmland reclamation. Then, water resources could be ecologically and socioeconomically sustained, and the balance between upstream and downstream water demands could be ensured. The results of this study can also serve as a reference for the sustainable management of water resources in other arid inland river basins.	[Hu, Xiaoli; Lu, Ling; Li, Xin; Wang, Jianhua; Guo, Ming] Chinese Acad Sci, Cold & Arid Regions Environm & Engn Res Inst, Lanzhou 730000, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Lu, L (corresponding author), Chinese Acad Sci, Cold & Arid Regions Environm & Engn Res Inst, 320 Donggang West Rd, Lanzhou 730000, Peoples R China.	luling@lzb.ac.cn	li, xin/HHS-9461-2022; Li, Xin/F-7473-2011; hu, xiaoli/B-7374-2018	Li, Xin/0000-0003-2999-9818; 	CAS Action Plan for West Development Project [KZCX2-XB3-15]; NSFC project [41101388, 91125001, 09XSH014]	CAS Action Plan for West Development Project; NSFC project(National Natural Science Foundation of China (NSFC))	The study was jointly supported by the CAS Action Plan for West Development Project (grant no. KZCX2-XB3-15) and the NSFC project (grant no. 41101388, 91125001 and 09XSH014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai XM, 2003, AGR SYST, V76, P1043, DOI 10.1016/S0308-521X(02)00028-8; Chang YS, 2011, PROCEDIA ENVIRON SCI, V10, P2385, DOI 10.1016/j.proenv.2011.09.371; Chase T. N., 1999, CLIM DYNAM, V16, P93, DOI DOI 10.1007/s003820050007; Cheng GD, 1996, B CHIN ACAD SCI, V10, P203; Cheng GD, 2014, NATL SCI REV, V1, P413, DOI 10.1093/nsr/nwu017; [程国栋 CHENG Guodong], 2006, [地学前缘, Earth science frontiers], V13, P3; DeFries R, 2004, HYDROL PROCESS, V18, P2183, DOI 10.1002/hyp.5584; [邓铭江 Deng Mingjiang], 2011, [冰川冻土, Journal of Glaciology and Geocryology], V33, P1363; Fang CL, 2007, WATER RESOUR MANAG, V21, P1613, DOI 10.1007/s11269-006-9117-0; Feng Q, 2005, ENVIRON GEOL, V48, P202, DOI 10.1007/s00254-005-1288-0; Feng ZM, 2005, LAND USE POLICY, V22, P301, DOI 10.1016/j.landusepol.2004.05.004; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; [高前兆 Gao Qianzhao], 2004, [水科学进展, Advances in Water Science], V15, P391; [盖迎春 Ge Yingchun], 2014, [地球科学进展, Advance in Earth Sciences], V29, P285; Giri C, 2013, INT J APPL EARTH OBS, V25, P30, DOI [10, 10.1016/j.jag.2013.03.005]; Ji XB, 2006, ENVIRON GEOL, V50, P793, DOI 10.1007/s00254-006-0251-z; Kilgour DM, 2001, ENVIRON RESOUR ECON, V18, P43, DOI 10.1023/A:1011100130736; Kloditz C, 1998, PHOTOGRAMM ENG REM S, V64, P127; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Li CZ, 2011, J NATURAL RESOURCES, V26, P354; [李娜 LI Na], 2008, [中国沙漠, Journal of Desert Research], V28, P223; Li X, 2001, J ARID ENVIRON, V48, P521, DOI 10.1006/jare.2000.0715; Li X, 2011, INT J DIGIT EARTH, V4, P347, DOI 10.1080/17538947.2011.558123; Liu H, 2005, J WATER RES PLAN MAN, V131, P420, DOI 10.1061/(ASCE)0733-9496(2005)131:6(420); Liu JY, 2003, SCI CHINA SER D, V46, P373; Liu JY, 2005, REMOTE SENS ENVIRON, V98, P442, DOI 10.1016/j.rse.2005.08.012; Liu YC, 1992, J ARID LAND RESOURCE, V6, P9; Long HL, 2006, LAND DEGRAD DEV, V17, P589, DOI 10.1002/ldr.736; Lu L, 2003, J ARID ENVIRON, V53, P395, DOI 10.1006/jare.2002.1032; Lu L, 2009, INT J REMOTE SENS, V30, P793, DOI 10.1080/01431160802438530; Luo GP, 2008, J ENVIRON MANAGE, V88, P775, DOI 10.1016/j.jenvman.2007.04.003; [蒙吉军 Meng Jijun], 2004, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V40, P922; Micklin P, 2007, ANNU REV EARTH PL SC, V35, P47, DOI 10.1146/annurev.earth.35.031306.140120; MICKLIN PP, 1988, SCIENCE, V241, P1170, DOI 10.1126/science.241.4870.1170; Qin C, 2010, GLOBAL PLANET CHANGE, V72, P192, DOI 10.1016/j.gloplacha.2010.04.005; Ran YH, 2010, INT J REMOTE SENS, V31, P391, DOI 10.1080/01431160902893451; Shi Y. F., 2003, CHIN QUAT SCI, V23, P152, DOI DOI 10.3321/j.issn:1001-7410.2003.02.005; Song XL, 2013, CHINA SEED IND, V1, P27; Turner BL, 2007, P NATL ACAD SCI USA, V104, P20666, DOI 10.1073/pnas.0704119104; Wang GX, 2007, HYDROL PROCESS, V21, P1370, DOI 10.1002/hyp.6308; [王根绪 WANG Genxu], 2006, [地理学报, Acta Geographica Sinica], V61, P339; Wang GX, 1999, J ARID ENVIRON, V43, P121, DOI 10.1006/jare.1999.0563; [王钧 WANG Jun], 2008, [地理科学, Scientia Geographica Sinica], V28, P83; Wang XH, 2008, CATENA, V72, P56, DOI 10.1016/j.catena.2007.04.003; Wang XH, 2007, LAND USE POLICY, V24, P417, DOI 10.1016/j.landusepol.2006.05.005; [魏智 WEI Zhi], 2008, [干旱区研究, Arid Zone Research], V25, P336; [肖生春 Xiao Shengchun], 2004, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V18, P57; Xie YC, 2014, INT J APPL EARTH OBS, V33, P181, DOI 10.1016/j.jag.2014.05.008; Yang B, 2012, HOLOCENE, V22, P773, DOI 10.1177/0959683611430411; Yang HF, 2014, CATENA, V115, P85, DOI 10.1016/j.catena.2013.11.020; Zhang B, 2004, AREAL RES DEV, V23, P112; Zhang JX, 2009, INT J APPL EARTH OBS, V11, P403, DOI 10.1016/j.jag.2009.07.004; Zhang YC, 2011, HYDROL PROCESS, V25, P3448, DOI 10.1002/hyp.8073; Zhou DC, 2012, ECOL INDIC, V23, P88, DOI 10.1016/j.ecolind.2012.03.021; Zhou DC, 2010, J ARID LAND, V2, P157, DOI 10.3724/SP.J.1227.2010.00157; 康兴成, 2002, [中国科学. D辑, 地球科学, Science in China], V32, P675	56	52	53	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0128960	10.1371/journal.pone.0128960	http://dx.doi.org/10.1371/journal.pone.0128960			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115484	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500017
J	Liu, Z; Ren, LD; Liu, CH; Xia, TS; Zha, XM; Wang, S				Liu, Zhao; Ren, Lidong; Liu, Chenghao; Xia, Tiansong; Zha, Xiaoming; Wang, Shui			Phenformin Induces Cell Cycle Change, Apoptosis, and Mesenchymal-Epithelial Transition and Regulates the AMPK/mTOR/p70s6k and MAPK/ERK Pathways in Breast Cancer Cells	PLOS ONE			English	Article							DIABETIC-PATIENTS; IN-VIVO; METFORMIN; BIGUANIDES; AMPK; INHIBITION; ACTIVATION; D1	Breast cancer remains a world-wide challenge, and additional anti-cancer therapies are still urgently needed. Emerging evidence has demonstrated the potent anti-tumor effect of biguanides, among which phenformin was reported to potentially be a more active anticancer agent than metformin. However, little attention has been given to the role of phenformin in breast cancer. In this study, we reveal the role of phenformin in cell death of the MCF7, ZR-75-1, MDA-MB-231 and SUM1315 breast cancer cell lines. The respective IC50 values of phenformin in MCF7, ZR-75-1, MDA-MB-231 and SUM1315 cells were 1.184 +/- 0.045 mM, 0.665 +/- 0.007 mM, 2.347 +/- 0.010 mM and 1.885 +/- 0.015 mM (mean +/- standard error). Phenformin induced cell cycle change and apoptosis in breast cancer cells via the AMPK/mTOR/p70s6k and MAPK/ERK pathways. Interestingly, phenformin induced MET (mesenchymal-epithelial transition) and decreased the migration rate in breast cancer cell lines. Furthermore, our results suggest that phenformin inhibits breast cancer cell metastasis after intracardiac injection into nude mice. Taken together, our study further confirms the potential benefit of phenformin in breast cancer treatment and provides novel mechanistic insight into its anti-cancer activity in breast cancer.	[Liu, Zhao; Ren, Lidong; Liu, Chenghao; Xia, Tiansong; Zha, Xiaoming; Wang, Shui] Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Zha, XM (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China.	njzhaxm@qq.com; ws0801@hotmail.com			National Natural Science Foundation of China [81270952, 81070684, 81071753, 81172502, 81202077, 81272916]; Natural Science Foundation of Jiangsu Province [BK2010581, BK2011853, BK2011855, BK20141023]; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU [IRT-008]; Priority Academic Program Development of Jiangsu higher Education Institutions (PAPD); Jiangsu Province Innovation Project for Graduate Student [CXZZ13-0585]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu higher Education Institutions (PAPD); Jiangsu Province Innovation Project for Graduate Student	This work was supported in part by the National Natural Science Foundation of China (81270952, 81070684, 81071753, 81172502, 81202077 and 81272916), the Natural Science Foundation of Jiangsu Province (BK2010581, BK2011853, BK2011855 and BK20141023), the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU (IRT-008), a project Funded by the Priority Academic Program Development of Jiangsu higher Education Institutions (PAPD), and Jiangsu Province Innovation Project for Graduate Student (CXZZ13-0585).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Appleyard MVCL, 2012, BRIT J CANCER, V106, P1117, DOI 10.1038/bjc.2012.56; Bayraktar S, 2012, CANCER-AM CANCER SOC, V118, P1202, DOI 10.1002/cncr.26439; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Berstein LM, 2011, BREAST CANCER RES TR, V128, P109, DOI 10.1007/s10549-010-1072-z; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Cantrell LA, 2010, GYNECOL ONCOL, V116, P92, DOI 10.1016/j.ygyno.2009.09.024; De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; El-Masry OS, 2012, ONCOL LETT, V3, P224, DOI 10.3892/ol.2011.458; Hadad SM, 2014, CLIN TRANSL ONCOL, V16, P746, DOI 10.1007/s12094-013-1144-8; Huang X, 2008, BIOCHEM J, V412, P211, DOI 10.1042/BJ20080557; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Fonseca EAI, 2011, LIFE SCI, V88, P846, DOI 10.1016/j.lfs.2011.03.005; Janzer A, 2014, P NATL ACAD SCI USA, V111, P10574, DOI 10.1073/pnas.1409844111; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung JY, 2004, NEUROSCI LETT, V371, P85, DOI 10.1016/j.neulet.2004.06.069; Lamouille S, 2012, J CELL SCI, V125, P1259, DOI 10.1242/jcs.095299; Lea MA, 2011, ANTICANCER RES, V31, P421; LUGARO G, 1968, EXPERIENTIA, V24, P794, DOI 10.1007/BF02144872; MCGUINNESS ME, 1993, ANN PHARMACOTHER, V27, P1183, DOI 10.1177/106002809302701004; Orrenius S, 2004, TOXICOL LETT, V149, P19, DOI 10.1016/j.toxlet.2003.12.017; Pollak M, 2013, J CLIN INVEST, V123, P3693, DOI 10.1172/JCI67232; Pollak M, 2010, CANCER PREV RES, V3, P1060, DOI 10.1158/1940-6207.CAPR-10-0175; Pollak MN, 2012, CANCER DISCOV, V2, P778, DOI 10.1158/2159-8290.CD-12-0263; Qu C, 2014, MOL CELL BIOCHEM, V386, P63, DOI 10.1007/s11010-013-1845-x; Queiroz EAIF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098207; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vincent EE, 2015, ONCOGENE, V34, P3627, DOI 10.1038/onc.2014.301; Wang J, 2015, CELL BIOCHEM BIOPHYS, V71, P513, DOI 10.1007/s12013-014-0283-z; Wang Y, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-8; WILCOCK C, 1990, BIOCHEM PHARMACOL, V39, P1831, DOI 10.1016/0006-2952(90)90136-9; Yuan P, 2013, P NATL ACAD SCI USA, V110, P18226, DOI 10.1073/pnas.1317577110	34	26	26	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131207	10.1371/journal.pone.0131207	http://dx.doi.org/10.1371/journal.pone.0131207			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114294	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500135
J	van der Bles, AM; Postmes, T; Meijer, RR				van der Bles, Anne Marthe; Postmes, Tom; Meijer, Rob R.			Understanding Collective Discontents: A Psychological Approach to Measuring Zeitgeist	PLOS ONE			English	Article							NATIONAL CHARACTER; MASS-MEDIA; COMMUNICATION; JUDGMENTS; OPTIMISM; CULTURE; AVERAGE; SELF; PERCEPTIONS; REFLECT	Over the last decade, several countries around the world developed a collective sense of doom and gloom: Their Zeitgeist could be characterized as one of decline. Paradoxically, in some countries, such as the Netherlands, this collective discontent with society seems to exist despite high levels of individual well-being. Current psychological research informs us about why individuals would feel unduly optimistic, but does not account for a collective sense of decline. The present research develops a novel operationalization of Zeitgeist, referred to as a general factor Z. We conceptualize Zeitgeist as a collective global-level evaluation of the state (and future) of society. Three studies confirm that perceptions of the same societal problems at the personal and collective level differed strongly. Across these studies we found support for a hypothesized latent factor Z, underlying collective-level perceptions of society. This Z-factor predicted people's interpretation of new information about society that was presented through news stories. These results provide a first step in operationalizing and (ultimately) understanding the concept of Zeitgeist: collectively shared ideas about society. Implications for policy are discussed.	[van der Bles, Anne Marthe; Postmes, Tom] Univ Groningen, Dept Social Psychol, Groningen, Netherlands; [Meijer, Rob R.] Univ Groningen, Dept Psychometr & Stat, Groningen, Netherlands	University of Groningen; University of Groningen	van der Bles, AM (corresponding author), Univ Groningen, Dept Social Psychol, Groningen, Netherlands.	a.m.van.der.bles@rug.nl	Postmes, Tom/A-9004-2010	Postmes, Tom/0000-0002-8029-7398				Alicke M. D., 2005, SELF SOCIAL JUDGMENT, P85, DOI DOI 10.1111/J.1559-1816.2011.00752.X; ALICKE MD, 1995, J PERS SOC PSYCHOL, V68, P804, DOI 10.1037/0022-3514.68.5.804; [Anonymous], PRACT ASSESS RES EVA; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bijl R, 2011, DE SOCIALE STAAT VAN; Boehnke K, 2001, J CROSS CULT PSYCHOL, V32, P241, DOI 10.1177/0022022101032002010; Boehnke K, 2007, J MARRIAGE FAM, V69, P778, DOI 10.1111/j.1741-3737.2007.00405.x; Brouwer D, 2013, PSYCHOL ASSESSMENT, V25, P136, DOI 10.1037/a0029228; Brown JD, 2012, PERS SOC PSYCHOL B, V38, P209, DOI 10.1177/0146167211432763; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Chambers JR, 2004, PSYCHOL BULL, V130, P813, DOI 10.1037/0033-2909.130.5.813; Chiu CY, 2010, PERSPECT PSYCHOL SCI, V5, P482, DOI 10.1177/1745691610375562; Dekker P, 2013, BURGERPERSPECTIEVEN; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Echterhoff G, 2009, PERSPECT PSYCHOL SCI, V4, P496, DOI 10.1111/j.1745-6924.2009.01161.x; Fiedler K, 2014, EUR J SOC PSYCHOL, V44, P657, DOI 10.1002/ejsp.2069; Fischer R, 2006, PERS SOC PSYCHOL B, V32, P1419, DOI 10.1177/0146167206291425; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Hardin C.D., 1996, HDB MOTIVATION COGNI, V3, P28; Hayes AF, 2013, COMMUN RES, V40, P439, DOI 10.1177/0093650211428608; Heine SJ, 2008, PSYCHOL SCI, V19, P309, DOI 10.1111/j.1467-9280.2008.02085.x; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; JENSEN AR, 1986, J VOCAT BEHAV, V29, P301, DOI 10.1016/0001-8791(86)90011-4; Katz E., 1955, PERSONAL INFLUENCE T; Lyons A, 2003, J PERS SOC PSYCHOL, V85, P989, DOI 10.1037/0022-3514.85.6.989; Markus A., 2014, MAPPING SOCIAL COHES; McCrae RR, 2006, CURR DIR PSYCHOL SCI, V15, P156, DOI 10.1111/j.1467-8721.2006.00427.x; McLeod JM, 1999, POLIT COMMUN, V16, P315, DOI 10.1080/105846099198659; Moore DA, 2007, J PERS SOC PSYCHOL, V92, P972, DOI 10.1037/0022-3514.92.6.972; Morton TA, 2001, COMMUN RES, V28, P602, DOI 10.1177/009365001028005002; NOELLENE.E, 1974, J COMMUN, V24, P43, DOI 10.1111/j.1460-2466.1974.tb00367.x; Pew Research Center, 2014, PEW RESEARCH GLOBAL; Postmes T, 1999, J PERS SOC PSYCHOL, V76, P320, DOI 10.1037/0022-3514.76.2.320; Postmes T., 2005, EUROPEAN REV SOCIAL, V16, P1, DOI [10.1080/10463280440000062, DOI 10.1080/10463280440000062]; Postmes T, 2013, BRIT J SOC PSYCHOL, V52, P597, DOI 10.1111/bjso.12006; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Russell DW, 2002, PERS SOC PSYCHOL B, V28, P1629, DOI 10.1177/014616702237645; Satorra A., 1994, LATENT VARIABLES ANA, P399, DOI DOI 10.2307/2291370; Schama S., 1987, THE EMBARRASSMENT OF; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Shteynberg G, 2009, J CROSS CULT PSYCHOL, V40, P46, DOI 10.1177/0022022108326196; Smith LGE, 2011, BRIT J SOC PSYCHOL, V50, P74, DOI 10.1348/014466610X500340; Stroebe K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120145; SVENSON O, 1981, ACTA PSYCHOL, V47, P143, DOI 10.1016/0001-6918(81)90005-6; Tabachnick B. G.., 2012, USING MULTIVARIATE S; Terracciano A, 2005, SCIENCE, V310, P96, DOI 10.1126/science.1117199; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; TYLER TR, 1984, J PERS SOC PSYCHOL, V47, P693, DOI 10.1037/0022-3514.47.4.693; van der Linden S, 2015, J ENVIRON PSYCHOL, V41, P112, DOI 10.1016/j.jenvp.2014.11.012; Wan C, 2007, J PERS SOC PSYCHOL, V92, P337, DOI 10.1037/0022-3514.92.2.337; WEINSTEIN ND, 1980, J PERS SOC PSYCHOL, V39, P806, DOI 10.1037/0022-3514.39.5.806; World Value Survey, 2012, WORLD VALUE SURVEY W; Zou X, 2009, J PERS SOC PSYCHOL, V97, P579, DOI 10.1037/a0016399	55	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130100	10.1371/journal.pone.0130100	http://dx.doi.org/10.1371/journal.pone.0130100			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1AM	26114943	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500050
J	Zeytuni, N; Cronin, S; Lefevre, CT; Arnoux, P; Baran, D; Shtein, Z; Davidov, G; Zarivach, R				Zeytuni, Natalie; Cronin, Samuel; Lefevre, Christopher T.; Arnoux, Pascal; Baran, Dror; Shtein, Zvi; Davidov, Geula; Zarivach, Raz			MamA as a Model Protein for Structure-Based Insight into the Evolutionary Origins of Magnetotactic Bacteria	PLOS ONE			English	Article							TPR-CONTAINING PROTEIN; MAGNETITE FORMATION; MAGNETOSOME; CRYSTALLIZATION; DENSITY	MamA is a highly conserved protein found in magnetotactic bacteria (MTB), a diverse group of prokaryotes capable of navigating according to magnetic fields - an ability known as magnetotaxis. Questions surround the acquisition of this magnetic navigation ability; namely, whether it arose through horizontal or vertical gene transfer. Though its exact function is unknown, MamA surrounds the magnetosome, the magnetic organelle embedding a biomineralised nanoparticle and responsible for magnetotaxis. Several structures for MamA from a variety of species have been determined and show a high degree of structural similarity. By determining the structure of MamA from Desulfovibrio magneticus RS-1 using X-ray crystallography, we have opened up the structure-sequence landscape. As such, this allows us to perform structural-and phylogenetic-based analyses using a variety of previously determined MamA from a diverse range of MTB species across various phylogenetic groups. We found that MamA has remained remarkably constant throughout evolution with minimal change between different taxa despite sequence variations. These findings, coupled with the generation of phylogenetic trees using both amino acid sequences and 16S rRNA, indicate that magnetotaxis likely did not spread via horizontal gene transfer and instead has a significantly earlier, primordial origin.	[Zeytuni, Natalie; Cronin, Samuel; Baran, Dror; Shtein, Zvi; Davidov, Geula; Zarivach, Raz] Ben Gurion Univ Negev, Natl Inst Biotechnol, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Lefevre, Christopher T.; Arnoux, Pascal] Aix Marseille Univ, CNRS, UMR Biol Vegetale & Microbiol Environm 7265, CEA,Lab Bioenerget Cellulaire, St Paul Les Durance, France	Ben Gurion University; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite	Zarivach, R (corresponding author), Ben Gurion Univ Negev, Natl Inst Biotechnol, Dept Life Sci, IL-84105 Beer Sheva, Israel.	zarivach@bgu.ac.il	ZARIVACH, RAZ/F-1671-2012; Lefevre, Christopher T/H-6072-2013; Zeytuni, Natalie/AAP-7850-2021	ZARIVACH, RAZ/0000-0001-6543-0296; Lefevre, Christopher T/0000-0002-1692-0245; Zeytuni, Natalie/0000-0002-5708-4095; ARNOUX, Pascal/0000-0003-4609-4893; Davidov, Geula/0000-0001-5153-4940	Israeli Ministry of Science, Technology and Space and EMBO; European Molecular Biology Organisation	Israeli Ministry of Science, Technology and Space and EMBO; European Molecular Biology Organisation	This research was made possible through grants from the Israeli Ministry of Science, Technology and Space and EMBO, the European Molecular Biology Organisation.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, DOI DOI 10.1093/NAR/GKQ399; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baud F, 1999, P NATL ACAD SCI USA, V96, P12494, DOI 10.1073/pnas.96.22.12494; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; DELONG EF, 1993, SCIENCE, V259, P803, DOI 10.1126/science.259.5096.803; Flies CB, 2005, APPL ENVIRON MICROB, V71, P2723, DOI 10.1128/AEM.71.5.2723-2731.2005; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Kolinko S, 2012, ENVIRON MICROBIOL, V14, P1709, DOI 10.1111/j.1462-2920.2011.02609.x; Komeili A, 2004, P NATL ACAD SCI USA, V101, P3839, DOI 10.1073/pnas.0400391101; Lefevre CT, 2013, TRENDS MICROBIOL, V21, P534, DOI 10.1016/j.tim.2013.07.005; Lefevre CT, 2013, ENVIRON MICROBIOL, V15, P2712, DOI 10.1111/1462-2920.12128; Lefevre CT, 2013, MICROBIOL MOL BIOL R, V77, P497, DOI 10.1128/MMBR.00021-13; Lefevre CT, 2013, ENVIRON MICROBIOL, V15, P2267, DOI 10.1111/1462-2920.12097; Lefevre CT, 2012, ISME J, V6, P440, DOI 10.1038/ismej.2011.97; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lower BH, 2013, J MOL MICROB BIOTECH, V23, P63, DOI 10.1159/000346543; Murat D, 2010, P NATL ACAD SCI USA, V107, P5593, DOI 10.1073/pnas.0914439107; Nakazawa H, 2009, GENOME RES, V19, P1801, DOI 10.1101/gr.088906.108; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Posfai M, 2006, EARTH PLANET SC LETT, V249, P444, DOI 10.1016/j.epsl.2006.06.036; SAKAGUCHI T, 1993, NATURE, V365, P47, DOI 10.1038/365047a0; Sakaguchi T, 2002, INT J SYST EVOL MICR, V52, P215, DOI 10.1099/00207713-52-1-215; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yamamoto D, 2010, P NATL ACAD SCI USA, V107, P9382, DOI 10.1073/pnas.1001870107; Zeytuni N, 2010, JOVE, P8; Zeytuni N, 2012, J STRUCT BIOL, V180, P479, DOI 10.1016/j.jsb.2012.08.001; Zeytuni N, 2011, P NATL ACAD SCI USA, V108, pE480, DOI 10.1073/pnas.1103367108; Zeytuni N, 2010, ACTA CRYSTALLOGR F, V66, P824, DOI 10.1107/S1744309110018300	38	11	11	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130394	10.1371/journal.pone.0130394	http://dx.doi.org/10.1371/journal.pone.0130394			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114501	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500072
J	Caceres, M; Ortiz, L; Recabarren, T; Romero, A; Colombo, A; Leiva-Salcedo, E; Varela, D; Rivas, J; Silva, I; Morales, D; Campusano, C; Almarza, O; Simon, F; Toledo, H; Park, KS; Trimmer, JS; Cerda, O				Caceres, Monica; Ortiz, Liliana; Recabarren, Tatiana; Romero, Anibal; Colombo, Alicia; Leiva-Salcedo, Elias; Varela, Diego; Rivas, Jose; Silva, Ian; Morales, Diego; Campusano, Camilo; Almarza, Oscar; Simon, Felipe; Toledo, Hector; Park, Kang-Sik; Trimmer, James S.; Cerda, Oscar			TRPM4 Is a Novel Component of the Adhesome Required for Focal Adhesion Disassembly, Migration and Contractility	PLOS ONE			English	Article							CATION CHANNEL TRPM4; CELL-MIGRATION; CALCIUM OSCILLATIONS; SIGNALING COMPLEXES; MICROARRAY ANALYSIS; BETA-PIX; ACTIVATION; EXPRESSION; ZEBRAFISH; MOTILITY	Cellular migration and contractility are fundamental processes that are regulated by a variety of concerted mechanisms such as cytoskeleton rearrangements, focal adhesion turnover, and Ca2+ oscillations. TRPM4 is a Ca2+-activated non-selective cationic channel (Ca2+-NSCC) that conducts monovalent but not divalent cations. Here, we used a mass spectrometry-based proteomics approach to identify putative TRPM4-associated proteins. Interestingly, the largest group of these proteins has actin cytoskeleton-related functions, and among these nine are specifically annotated as focal adhesion-related proteins. Consistent with these results, we found that TRPM4 localizes to focal adhesions in cells from different cellular lineages. We show that suppression of TRPM4 in MEFs impacts turnover of focal adhesions, serum-induced Ca2+ influx, focal adhesion kinase (FAK) and Rac activities, and results in reduced cellular spreading, migration and contractile behavior. Finally, we demonstrate that the inhibition of TRPM4 activity alters cellular contractility in vivo, affecting cutaneous wound healing. Together, these findings provide the first evidence, to our knowledge, for a TRP channel specifically localized to focal adhesions, where it performs a central role in modulating cellular migration and contractility.	[Caceres, Monica; Ortiz, Liliana; Recabarren, Tatiana; Romero, Anibal; Rivas, Jose; Silva, Ian; Morales, Diego; Campusano, Camilo; Almarza, Oscar; Toledo, Hector; Cerda, Oscar] Univ Chile, Fac Med, Inst Ciencias Biomed ICBM, Programa Biol Celular & Mol, Santiago, Chile; [Caceres, Monica; Park, Kang-Sik; Trimmer, James S.; Cerda, Oscar] Univ Calif Davis, Coll Biol Sci, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Recabarren, Tatiana; Colombo, Alicia] Univ Chile, Fac Med, Inst Ciencias Biomed ICBM, Programa Anat & Biol Desarrollo, Santiago, Chile; [Leiva-Salcedo, Elias] NICHD, Sect Cellular Signaling, Program Dev Biol, NIH, Bethesda, MD USA; [Varela, Diego] Univ Chile, Fac Med, Inst Ciencias Biomed ICBM, Programa Fisiopatol, Santiago, Chile; [Simon, Felipe] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Santiago, Chile; [Simon, Felipe] Univ Andres Bello, Fac Med, Santiago, Chile; [Simon, Felipe] Millennium Inst Immunol & Immunotherapy, Santiago, Chile; [Park, Kang-Sik] Kyung Hee Univ, Sch Med, Dept Physiol, Seoul, South Korea; [Trimmer, James S.] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	Universidad de Chile; University of California System; University of California Davis; Universidad de Chile; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Universidad de Chile; Universidad Andres Bello; Universidad Andres Bello; Kyung Hee University; University of California System; University of California Davis	Cerda, O (corresponding author), Univ Chile, Fac Med, Inst Ciencias Biomed ICBM, Programa Biol Celular & Mol, Santiago, Chile.	oscarcerda@med.uchile.cl	Park, Kang-Sik/AAK-2486-2020; Varela, Diego/AAG-7489-2019; Colombo, Alicia/I-3329-2013; Colombo, Alicia/AAD-5178-2021; Cerda, Oscar/N-3895-2018	Varela, Diego/0000-0002-9352-414X; Cerda, Oscar/0000-0003-2873-5722; Simon, Felipe/0000-0002-2653-9798; Morales, Diego/0000-0002-5834-3685; Almarza, Oscar/0000-0003-0460-3143	Fondecyt [11121239, 11140064, 1120240, 1121078, 1120126]; NIH [R01 NS042225]; Conicyt; Millennium Institute on Immunology and Immunotherapy [P09-016-F]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042225] Funding Source: NIH RePORTER	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Millennium Institute on Immunology and Immunotherapy; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded by Fondecyt 11121239 to OC, Fondecyt 11140064 to MC, and NIH R01 NS042225 to JST. A doctoral Fellowship from Conicyt supports AR. Fondecyt 1120240 funded DV. Fondecyt 1121078 and Millennium Institute on Immunology and Immunotherapy P09-016-F supported FS. Fondecyt 1120126 funded HT.	Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Ashida S, 2004, CANCER RES, V64, P5963, DOI 10.1158/0008-5472.CAN-04-0020; Barbet G, 2008, NAT IMMUNOL, V9, P1148, DOI 10.1038/ni.1648; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Bryja V, 2006, NAT PROTOC, V1, P2082, DOI 10.1038/nprot.2006.355; Cerda O, 2015, PFLUG ARCH EUR J PHY, V467, P1723, DOI 10.1007/s00424-014-1610-3; Cerda O, 2011, J BIOL CHEM, V286, P28738, DOI 10.1074/jbc.M111.251942; Chang FM, 2007, MOL BIOL CELL, V18, P253, DOI 10.1091/mbc.E06-03-0207; Cherubini A, 2005, MOL BIOL CELL, V16, P2972, DOI 10.1091/mbc.E04-10-0940; Clark K, 2008, EUR J CELL BIOL, V87, P631, DOI 10.1016/j.ejcb.2008.01.009; Dehart GW, 2008, P NATL ACAD SCI USA, V105, P7188, DOI 10.1073/pnas.0708044105; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Deramaudt TB, 2011, MOL BIOL CELL, V22, P964, DOI 10.1091/mbc.E10-08-0725; Easley CA, 2008, CELL MOTIL CYTOSKEL, V65, P662, DOI 10.1002/cm.20294; Echeverria C, 2015, J HYPERTENS, V33, P981, DOI 10.1097/HJH.0000000000000496; Echeverria C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094146; Fan RS, 2005, J BIOL CHEM, V280, P24212, DOI 10.1074/jbc.M500716200; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; Giannone G, 2002, J BIOL CHEM, V277, P26364, DOI 10.1074/jbc.M203952200; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Gonzales AL, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004732; Goswami C, 2007, J NEUROCHEM, V103, P1319, DOI 10.1111/j.1471-4159.2007.04846.x; Grinnell F, 2006, EXP CELL RES, V312, P86, DOI 10.1016/j.yexcr.2005.010.001; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Guinamard R, 2014, BRIT J PHARMACOL, V171, P1600, DOI 10.1111/bph.12582; Guinamard R, 2010, PHYSIOLOGY, V25, P155, DOI 10.1152/physiol.00004.2010; Heinrich C, 2010, ONCOGENE, V29, P1598, DOI 10.1038/onc.2009.456; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Ishida-Takagishi M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1861; Jean L, 2013, J CELL SCI, V126, P5585, DOI 10.1242/jcs.131060; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; Kastenhuber E, 2013, DEV DYNAM, V242, P1236, DOI 10.1002/dvdy.24020; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kobayashi T, 2010, CURR OPIN CELL BIOL, V22, P669, DOI 10.1016/j.ceb.2010.08.023; Kruse M, 2014, CURR OPIN PHARMACOL, V15, P68, DOI 10.1016/j.coph.2013.12.003; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Lee A, 2014, J NEUROSCI, V34, P15159, DOI 10.1523/JNEUROSCI.3275-14.2014; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; Liman E. R., 2007, TRP ION CHANNEL FUNC; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Narayan G, 2007, GENE CHROMOSOME CANC, V46, P373, DOI 10.1002/gcc.20418; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nishiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018410; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Piao HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121703; Pla AF, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00311; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rittie L, 2005, METH MOLEC MED, V117, P83; Rooney C, 2010, EMBO REP, V11, P292, DOI 10.1038/embor.2010.10; Rotty JD, 2012, J CELL BIOL, V197, P381, DOI 10.1083/jcb.201107078; Sarmiento D, 2015, MICROVASC RES, V98, P187, DOI 10.1016/j.mvr.2014.02.001; Shimizu T, 2009, CELL CALCIUM, V45, P226, DOI 10.1016/j.ceca.2008.10.005; Simon F, 2010, J BIOL CHEM, V285, P37150, DOI 10.1074/jbc.M110.155390; Singh J, 2006, CANCER LETT, V237, P298, DOI 10.1016/j.canlet.2005.06.008; Suguro M, 2006, CANCER SCI, V97, P868, DOI 10.1111/j.1349-7006.2006.00267.x; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tscharntke M, 2007, J CELL SCI, V120, P1480, DOI 10.1242/jcs.03426; Tsunoda S, 2001, J NEUROSCI, V21, P150, DOI 10.1523/JNEUROSCI.21-01-00150.2001; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wei CL, 2012, CURR OPIN CELL BIOL, V24, P254, DOI 10.1016/j.ceb.2011.12.002; Wong VW, 2012, NAT MED, V18, P148, DOI 10.1038/nm.2574; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; WOODS A, 1992, J CELL SCI, V101, P277; Xu SH, 2011, CURR BIOL, V21, P1960, DOI 10.1016/j.cub.2011.10.050; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200; Yoo SK, 2012, J CELL BIOL, V199, P225, DOI 10.1083/jcb.201203154; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200	78	44	44	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130540	10.1371/journal.pone.0130540	http://dx.doi.org/10.1371/journal.pone.0130540			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110647	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800061
J	Cho, W; Kang, JL; Park, YM				Cho, Wonkyoung; Kang, Jihee Lee; Park, Young Mi			Corticotropin-Releasing Hormone (CRH) Promotes Macrophage Foam Cell Formation via Reduced Expression of ATP Binding Cassette Transporter-1 (ABCA1)	PLOS ONE			English	Article							SCAVENGER RECEPTOR BI; CHOLESTEROL EFFLUX; ACCELERATES ATHEROSCLEROSIS; CAROTID ATHEROSCLEROSIS; CHRONIC STRESS; LXR-ALPHA; DISEASE; MICE; ACTIVATION; DEPRESSION	Atherosclerosis, the major pathology of cardiovascular disease, is caused by multiple factors involving psychological stress. Corticotropin-releasing hormone (CRH), which is released by neurosecretory cells in the hypothalamus, peripheral nerve terminals and epithelial cells, regulates various stress-related responses. Our current study aimed to verify the role of CRH in macrophage foam cell formation, the initial critical stage of atherosclerosis. Our quantitative real-time reverse transcriptase PCR (qRT-PCR), semi-quantitative reverse transcriptase PCR, and Western blot results indicate that CRH down-regulates ATP-binding cassette transporter-1 (ABCA1) and liver X receptor (LXR)-alpha, a transcription factor for ABCA1, in murine peritoneal macrophages and human monocyte-derived macrophages. Oil-red O (ORO) staining and intracellular cholesterol measurement of macrophages treated with or without oxidized LDL (oxLDL) and with or without CRH (10 nM) in the presence of apolipoprotein A1 (apoA1) revealed that CRH treatment promotes macrophage foam cell formation. The boron-dipyrromethene (BODIPY)-conjugated cholesterol efflux assay showed that CRH treatment reduces macrophage cholesterol efflux. Western blot analysis showed that CRH-induced down-regulation of ABCA1 is dependent on phosphorylation of Akt (Ser473) induced by interaction between CRH and CRH receptor 1(CRHR1). We conclude that activation of this pathway by CRH accelerates macrophage foam cell formation and may promote stress-related atherosclerosis.	[Cho, Wonkyoung; Park, Young Mi] Ewha Womans Univ, Coll Med, Dept Mol Med, Seoul, South Korea; [Cho, Wonkyoung; Park, Young Mi] Ewha Womans Univ, Global Top Res Grp 5, Seoul, South Korea; [Kang, Jihee Lee] Ewha Womans Univ, Coll Med, Dept Physiol, Tissue Injury Def Res Ctr, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University	Park, YM (corresponding author), Ewha Womans Univ, Coll Med, Dept Mol Med, Seoul, South Korea.	parkym@ewha.ac.kr			National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2012R1A1A1013250]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2010-0027945]	National Research Foundation of Korea (NRF) - Korean government (MSIP); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. NRF-2012R1A1A1013250), as well as the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2010-0027945).	Agelaki S, 2002, INFECT IMMUN, V70, P6068, DOI 10.1128/IAI.70.11.6068-6074.2002; Baigent SM, 2001, PEPTIDES, V22, P809, DOI 10.1016/S0196-9781(01)00395-3; Cavelier C, 2006, BBA-MOL CELL BIOL L, V1761, P655, DOI 10.1016/j.bbalip.2006.04.012; Chandras C, 2009, ENDOCRINOLOGY, V150, P4606, DOI 10.1210/en.2008-1810; Checkley S, 1996, BRIT MED BULL, V52, P597; Chen JH, 2012, INFLAMM RES, V61, P1299, DOI 10.1007/s00011-012-0529-4; Coste SC, 2002, TRENDS CARDIOVAS MED, V12, P176, DOI 10.1016/S1050-1738(02)00157-3; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; de la Llera-Moya M, 1999, J LIPID RES, V40, P575; Elenkov IJ, 1999, TRENDS ENDOCRIN MET, V10, P359, DOI 10.1016/S1043-2760(99)00188-5; Esler M, 2000, J CARDIOVASC PHARM, V35, pS1, DOI 10.1097/00005344-200000004-00001; FISHER LA, 1983, REGUL PEPTIDES, V5, P153, DOI 10.1016/0167-0115(83)90123-4; FORGEZ P, 1984, J LIPID RES, V25, P954; Geeraert B, 2007, J THROMB HAEMOST, V5, P2529, DOI 10.1111/j.1538-7836.2007.02786.x; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GRUNT M, 1993, AM J PHYSIOL, V264, pH1124, DOI 10.1152/ajpheart.1993.264.4.H1124; Harbuz MS, 1997, ANN NY ACAD SCI, V823, P214, DOI 10.1111/j.1749-6632.1997.tb48393.x; Hatch F T, 1968, Adv Lipid Res, V6, P1; Im E, 2010, GASTROENTEROLOGY, V138, P2457, DOI 10.1053/j.gastro.2010.02.055; Joyce CW, 2002, P NATL ACAD SCI USA, V99, P407, DOI 10.1073/pnas.012587699; Kellner-Weibel G, 2000, BIOCHEMISTRY-US, V39, P221, DOI 10.1021/bi991666c; Keresztes M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071902; Kumari M, 2003, STRESS, V6, P297, DOI 10.1080/10253890310001619461; LENZ HJ, 1985, AM J PHYSIOL, V249, pR85, DOI 10.1152/ajpregu.1985.249.1.R85; LEU SJC, 1992, CELL IMMUNOL, V143, P220, DOI 10.1016/0008-8749(92)90018-K; Li LJ, 2003, ARTERIOSCL THROM VAS, V23, P1204, DOI 10.1161/01.ATV.0000071349.30914.25; Ma L, 2012, J BIOL CHEM, V287, P40502, DOI 10.1074/jbc.M112.413245; MACCANNELL KL, 1984, GASTROENTEROLOGY, V87, P94; Morris MJ, 1997, HYPERTENSION, V29, P137, DOI 10.1161/01.HYP.29.1.137; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Park YM, 2012, LAB INVEST, V92, P1171, DOI 10.1038/labinvest.2012.74; Paterniti S, 2001, ARTERIOSCL THROM VAS, V21, P136, DOI 10.1161/01.ATV.21.1.136; Repnik U, 2003, J IMMUNOL METHODS, V278, P283, DOI 10.1016/S0022-1759(03)00231-X; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Sankaranarayanan S, 2011, J LIPID RES, V52, P2332, DOI 10.1194/jlr.D018051; SEASHOLTZ A F, 1991, Molecular and Cellular Neuroscience, V2, P266, DOI 10.1016/1044-7431(91)90054-R; Shively CA, 2009, NEUROSCI BIOBEHAV R, V33, P133, DOI 10.1016/j.neubiorev.2008.06.006; Silverstein Roy L, 2010, Trans Am Clin Climatol Assoc, V121, P206; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; Singh Raja B, 2002, Exp Clin Cardiol, V7, P40; Soumian S, 2005, VASC MED, V10, P109, DOI 10.1191/1358863x05vm593ra; Stewart RAH, 2003, EUR HEART J, V24, P2027, DOI 10.1016/j.ehj.2003.08.017; Szczepanska-Sadowska E, 2010, J PHYSIOL PHARMACOL, V61, P509; Tang CK, 2004, ACTA PHARMACOL SIN, V25, P581; Tang SL, 2012, ATHEROSCLEROSIS, V222, P344, DOI 10.1016/j.atherosclerosis.2012.03.005; Theoharides TC, 1998, ENDOCRINOLOGY, V139, P403, DOI 10.1210/en.139.1.403; Timmermans W, 2013, NEUROSCIENCE, V248, P626, DOI 10.1016/j.neuroscience.2013.05.043; Tsatsanis C, 2006, J IMMUNOL, V176, P1869, DOI 10.4049/jimmunol.176.3.1869; Tsatsanis C, 2005, FEBS LETT, V579, P4259, DOI 10.1016/j.febslet.2005.06.057; UDELSMAN R, 1986, PEPTIDES, V7, P465, DOI 10.1016/0196-9781(86)90016-1; Vaisman BL, 2012, J LIPID RES, V53, P158, DOI 10.1194/jlr.M018713; Venihaki M, 1997, ENDOCRINOLOGY, V138, P698, DOI 10.1210/en.138.2.698; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wolff B, 2005, HEART, V91, P460, DOI 10.1136/hrt.2003.031088; Wu YQ, 2009, ATHEROSCLEROSIS, V203, P360, DOI 10.1016/j.atherosclerosis.2008.05.059; Xu SW, 2010, CYTOTECHNOLOGY, V62, P473, DOI 10.1007/s10616-010-9290-0; Ye D, 2011, CURR DRUG TARGETS, V12, P647, DOI 10.2174/138945011795378522; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zoumakis E, 2001, GYNECOL ENDOCRINOL, V15, P98, DOI 10.1080/713602800	59	9	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130587	10.1371/journal.pone.0130587	http://dx.doi.org/10.1371/journal.pone.0130587			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110874	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800066
J	Garrido, MG; Muhlfriedel, RL; Beck, SC; Wallrapp, C; Seeliger, MW				Garrido, Marina Garcia; Muehlfriedel, Regine L.; Beck, Susanne C.; Wallrapp, Christine; Seeliger, Mathias W.			Scale Adjustments to Facilitate Two-Dimensional Measurements in OCT Images	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; CELL-BASED PRODUCTION; INFANTS; RETINA; MODELS; EYE	Purpose To address the problem of unequal scales for the measurement of two-dimensional structures in OCT images, and demonstrate the use of intra-ocular objects of known dimensions in the murine eye for the equal calibration of axes. Methods The first part of this work describes the mathematical foundation of major distortion effects introduced by X-Y scaling differences. Illustrations were generated with CorelGraph X3 software. The second part bases on image data obtained with a HRA2 Spectralis (Heidelberg Engineering) in SV129 wild-type mice. Subretinally and intravitreally implanted microbeads, alginate capsules with a diameter of 154 +/- 5 mu m containing GFP-marked mesenchymal stem cells (CellBeads), were used as intraocular objects for calibration. Results The problems encountered with two-dimensional measurements in cases of unequal scales are demonstrated and an estimation of the resulting errors is provided. Commonly, the Y axis is reliably calibrated using outside standards like histology or manufacturer data. We show here that intraocular objects like dimensionally stable spherical alginate capsules allow for a two-dimensional calibration of the acquired OCT raw images by establishing a relation between X and Y axis data. For our setup, a correction factor of about 3.3 was determined using both epiretinally and subretinally positioned beads (3.350 +/- 0.104 and 3.324 +/- 0.083, respectively). Conclusions In this work, we highlight the distortion-related problems in OCT image analysis induced by unequal X and Y scales. As an exemplary case, we provide data for a two-dimensional in vivo OCT image calibration in mice using intraocular alginate capsules. Our results demonstrate the need for a proper two-dimensional calibration of OCT data, and we believe that equal scaling will certainly improve the efficiency of OCT image analysis.	[Garrido, Marina Garcia; Muehlfriedel, Regine L.; Beck, Susanne C.; Seeliger, Mathias W.] Ctr Ophthalmol, Inst Ophthalm Res, Div Ocular Neurodegenerat, Tubingen, Germany; [Wallrapp, Christine] BTG Int Germany GmbH, Alzenau, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Garrido, MG (corresponding author), Ctr Ophthalmol, Inst Ophthalm Res, Div Ocular Neurodegenerat, Tubingen, Germany.	marina.garcia-garrido@med.uni-tuebingen.de			German Ministry of Education and Research (BMBF) [HOPE2 01GM1108A]; Deutsche Forschungsgemein schaft; Open Access Publishing Fund of University of Tuebingen; Heidelberg Engineering GmbH	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemein schaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tuebingen; Heidelberg Engineering GmbH	This work was supported by the German Ministry of Education and Research (BMBF, HOPE2 01GM1108A) and by the Deutsche Forschungsgemein schaft and Open Access Publishing Fund of University of Tuebingen. Dr. Susanne C Beck received a grant from Heidelberg Engineering GmbH. The funders provided support in the form of salaries for authors [SCB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This specific roles of these authors are articulated in the 'author contribution' section.	Agrawal A, 2012, BIOMED OPT EXPRESS, V3, P1116, DOI 10.1364/BOE.3.0011163; Anger EM, 2004, EXP EYE RES, V78, P1117, DOI 10.1016/j.exer.2004.01.011; Baxi J, 2014, J BIOMED OPT, V19, P21106, DOI [10.1117/1.JBO.19.2.021106, DOI 10.1117/1.JB0.19.2.021106]; Cook A, 2008, INVEST OPHTH VIS SCI, V49, P5199, DOI 10.1167/iovs.06-0114; Ferguson LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111203; Fischer MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055173; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Folgar FA, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.016014; Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892; Garcia Garrido M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100080, DOI 10.1371/J0URNAL.P0NE.0100080]; Gloesmann M, 2003, INVEST OPHTH VIS SCI, V44, P1696, DOI 10.1167/iovs.02-0654; Heile AMB, 2009, NEUROSCI LETT, V463, P176, DOI 10.1016/j.neulet.2009.07.071; Huang YJ, 1998, INVEST OPHTH VIS SCI, V39, P2405; Huber G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013403; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Krebs I, 2010, OPHTHALMOLOGY, V117, P1577, DOI 10.1016/j.ophtha.2010.04.032; Lozano DC, 2013, INVEST OPHTH VIS SCI, V54, P6446, DOI 10.1167/iovs.13-12575; Maldonado RS, 2010, INVEST OPHTH VIS SCI, V51, P2678, DOI 10.1167/iovs.09-4403; Odell D, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/692574; Patel NB, 2012, INVEST OPHTH VIS SCI, V53, P5788, DOI 10.1167/iovs.12-9937; Sadda SR, 2010, INVEST OPHTH VIS SCI, V51, P1071, DOI 10.1167/iovs.09-4325; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Sull AC, 2010, RETINA-J RET VIT DIS, V30, P235, DOI 10.1097/IAE.0b013e3181bd2c3b; Weber C, 2010, ADV BIOCHEM ENG BIOT, V123, P143, DOI 10.1007/10_2009_25; Wolf-Schnurrbusch UEK, 2009, INVEST OPHTH VIS SCI, V50, P3432, DOI 10.1167/iovs.08-2970; Zhang R, 2011, RETINA-J RET VIT DIS, V31, P785, DOI 10.1097/IAE.0b013e3181f27509; Zhang R, 2010, ACTA OPHTHALMOL, V88, pe348, DOI 10.1111/j.1755-3768.2009.01762.x	28	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131154	10.1371/journal.pone.0131154	http://dx.doi.org/10.1371/journal.pone.0131154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110792	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800123
J	Mancuso, R; Hernis, A; Agostini, S; Rovaris, M; Caputo, D; Fuchs, D; Clerici, M				Mancuso, Roberta; Hernis, Ambra; Agostini, Simone; Rovaris, Marco; Caputo, Domenico; Fuchs, Dietmar; Clerici, Mario			Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis	PLOS ONE			English	Article							REGULATORY T-CELLS; INTERFERON-GAMMA; CYTOKINE PRODUCTION; SERUM TRYPTOPHAN; 2,3-DIOXYGENASE; KYNURENINE; ACTIVATION; NEOPTERIN; PROFILES; MARKER	Background Interferon gamma (IFN-gamma) production induces the transcription of indoleamine 2,3 dioxygenase (IDO) resulting in the reduction of T-cell activation and proliferation through the depletion of tryptophan and the elicitation of Treg lymphocytes. IDO was shown to be involved in the pathogenesis of autoimmune diseases; we investigated whether changes in IDO gene expression and activity could be indicative of onset of relapse inmultiple sclerosis (MS) patients. Methods IDO and interferon-gamma (IFN-gamma) gene expression, serum IDO activity (Kynurenine/Tryptophan ratio) and serum neopterin concentration - a protein released by macrophages upon IFN-gamma stimulation - were measured in 51 individuals: 36 relapsing remitting (RR)-MS patients (21 in acute phase -AMS, 15 in stable phase -SMS) and 15 healthy controls (HC). PBMCs samples in AMS patients were collected before (BT-AMS) and during glucocorticoids-based therapy (DT-AMS). Results IDO expression was increased and IFN-gamma was decreased (p<0.001) in BT-AMS compared to SMS patients. Glucocorticoids-induced disease remission resulted in a significant reduction of IDO and IFN-gamma gene expression, IDO catalytic activity (p<0.001). Serum neopterin concentration followed the same trend as IDO expression and activity. Conclusions Measurement of IDO gene expression and activity in blood could be a useful marker to monitor the clinical course of RR-MS. Therapeutic interventions modulating IDO activity may be beneficial in MS.	[Mancuso, Roberta; Hernis, Ambra; Agostini, Simone; Rovaris, Marco; Caputo, Domenico; Clerici, Mario] Don C Gnocchi Fdn ONLUS, I-20100 Milan, Italy; [Fuchs, Dietmar] Med Univ Innsbruck, Div Biol Chem, Bioctr, A-6020 Innsbruck, Austria; [Clerici, Mario] Univ Milan, Dept Physiopathol & Transplantat, I-20090 Milan, Italy	IRCCS Fondazione Don Carlo Gnocchi Onlus; Medical University of Innsbruck; University of Milan	Mancuso, R (corresponding author), Don C Gnocchi Fdn ONLUS, Piazza Morandi 3, I-20100 Milan, Italy.	rmancuso@dongnocchi.it	Rovaris, Marco/AAA-6040-2020; Mancuso, Roberta/H-8986-2012; Agostini, Simone/L-7377-2015; Fuchs, Dietmar/AAL-8011-2021	Rovaris, Marco/0000-0001-9691-1957; Mancuso, Roberta/0000-0002-4449-3623; Agostini, Simone/0000-0002-6214-0645; Fuchs, Dietmar/0000-0003-1627-9563; Ambra, Hernis/0000-0001-9234-6452				AlberatiGiani D, 1996, J NEUROCHEM, V66, P996; Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Boasso A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002961; Campbell BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00012; Chen YQ, 2009, INT J TRYPTOPHAN RES, V2, P1; Clerici M, 2001, J NEUROIMMUNOL, V121, P88, DOI 10.1016/S0165-5728(01)00431-3; Fallarino F, 2009, J IMMUNOL, V183, P6303, DOI 10.4049/jimmunol.0901577; Ferrante P, 1998, J IMMUNOL, V160, P1514; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Frisullo G, 2007, CLIN IMMUNOL, V124, P284, DOI 10.1016/j.clim.2007.05.011; FUCHS D, 1990, J NEUROL, V237, P125, DOI 10.1007/BF00314679; Fujigaki S, 2001, EUR J IMMUNOL, V31, P2313, DOI 10.1002/1521-4141(200108)31:8<2313::AID-IMMU2313>3.0.CO;2-S; Heyes MP, 1996, BIOCHEM J, V320, P595, DOI 10.1042/bj3200595; Kahl KG, 2002, J NEUROL SCI, V200, P53, DOI 10.1016/S0022-510X(02)00136-3; KERMODE AG, 1990, BRAIN, V113, P1477, DOI 10.1093/brain/113.5.1477; Kwidzinski E, 2005, FASEB J, V19, P1347, DOI 10.1096/fj.04-3228fje; Lee GK, 2002, IMMUNOLOGY, V107, P452, DOI 10.1046/j.1365-2567.2002.01526.x; Liu XQ, 2009, CHINESE MED J-PEKING, V122, P3072, DOI 10.3760/cma.j.issn.0366-6999.2009.24.030; Macchiarulo A, 2009, AMINO ACIDS, V37, P219, DOI 10.1007/s00726-008-0137-3; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; MONACO F, 1979, J NEUROL NEUROSUR PS, V42, P640, DOI 10.1136/jnnp.42.7.640; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Murr C, 2002, CURR DRUG METAB, V3, P175, DOI 10.2174/1389200024605082; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rudzite V, 1996, ADV EXP MED BIOL, V398, P183; Sakurai K, 2002, J NEUROIMMUNOL, V129, P186, DOI 10.1016/S0165-5728(02)00176-5; Saresella M, 2008, FASEB J, V22, P3500, DOI 10.1096/fj.08-110650; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Stinissen P, 2008, EUR J IMMUNOL, V38, P1190, DOI 10.1002/eji.200838371; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Terentis AC, 2002, J BIOL CHEM, V277, P15788, DOI 10.1074/jbc.M200457200; THOMAS SR, 1994, J BIOL CHEM, V269, P14457; Venken K, 2008, IMMUNOLOGY, V123, P79, DOI 10.1111/j.1365-2567.2007.02690.x; Widner B, 1997, CLIN CHEM, V43, P2424	36	55	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130715	10.1371/journal.pone.0130715	http://dx.doi.org/10.1371/journal.pone.0130715			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110930	gold, Green Published, Green Submitted			2022-12-27	WOS:000356933800077
J	Prell, T; Hartung, V; Tietz, F; Penzlin, S; Ilse, B; Schweser, F; Deistung, A; Bokemeyer, M; Reichenbach, JR; Witte, OW; Grosskreutz, J				Prell, Tino; Hartung, Viktor; Tietz, Florian; Penzlin, Susanne; Ilse, Benjamin; Schweser, Ferdinand; Deistung, Andreas; Bokemeyer, Martin; Reichenbach, Juergen R.; Witte, Otto W.; Grosskreutz, Julian			Susceptibility-Weighted Imaging Provides Insight into White Matter Damage in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							CLINICAL-APPLICATIONS; IRON DEPOSITION; HUMAN BRAIN; CALCIUM; RECONSTRUCTION; COGNITION; CONTRAST; DISEASE; CORTEX; MRI	Background Amyotrophic lateral sclerosis (ALS) is a fatal, progressive neurodegenerative disorder, characterised by widespread white matter damage. There is growing evidence that disturbances in iron metabolism contribute to white matter alterations. Materials & Methods We analysed the data of susceptibility-weighted imaging (SWI) of white matter in a cohort of 27 patients with ALS and 30 healthy age-matched controls. Results Signal alterations were found on SWI in the corpus callosum; along the corticospinal tract (subcortical motor cortex, posterior limb of the internal capsule and brainstem levels) and in the subgyral regions of frontal, parietal, temporal, occipital and limbic lobes. Alterations of white matter in the corpus callosum correlated with disease severity as assessed by the revised ALS functional rating scale. Conclusion SWI is capable of indicating iron and myelin disturbances in white matter of ALS patients. The SWI patterns observed in this study suggest that widespread alterations due to iron disturbances occur in patients with ALS and correlate with disease severity.	[Prell, Tino; Tietz, Florian; Penzlin, Susanne; Witte, Otto W.; Grosskreutz, Julian] Jena Univ Hosp, Hans Berger Dept Neurol, D-07747 Jena, Germany; [Schweser, Ferdinand] SUNY Buffalo, Sch Med & Biomed Sci, Buffalo Neuroimaging Anal Ctr, Dept Neurol, Buffalo, NY 14260 USA; [Schweser, Ferdinand] SUNY Buffalo, Sch Med & Biomed Sci, MRI Clin & Translat Res Ctr, Buffalo, NY 14260 USA; [Deistung, Andreas; Reichenbach, Juergen R.] Jena Univ Hosp, Inst Diagnost & Intervent Radiol, Med Phys Grp, D-07743 Jena, Germany; [Bokemeyer, Martin] Jena Univ Hosp, Dept Neuroradiol, D-07747 Jena, Germany; [Hartung, Viktor] HELIOS Kreiskrankenhaus Gotha, Dept Radiol, D-99867 Gotha, Germany; [Ilse, Benjamin] Univ Gottingen, Dept Neurol, D-37075 Gottingen, Germany	Friedrich Schiller University of Jena; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Gottingen	Prell, T (corresponding author), Jena Univ Hosp, Hans Berger Dept Neurol, Erlanger Allee 101, D-07747 Jena, Germany.	tino.prell@med.uni-jena.de	Prell, Tino/AAE-5492-2020; Schweser, Ferdinand/Q-6932-2019; Grosskreutz, Julian/G-2293-2010; Deistung, Andreas/AAN-9412-2021; Witte, Otto/P-4127-2018; Reichenbach, Jürgen R./B-4333-2011	Prell, Tino/0000-0002-6423-3108; Schweser, Ferdinand/0000-0003-0399-9211; Grosskreutz, Julian/0000-0001-9525-1424; Witte, Otto/0000-0003-2101-4105; Reichenbach, Jürgen R./0000-0002-2640-0630; Hartung, Viktor/0000-0002-6273-9172; Deistung, Andreas/0000-0002-2427-1302	International Organization for Magnetic Resonance in Medicine (ISMRM); Friedrich Schiller University Jena; Interdisciplinary Center for Clinical Research (IZKF) in Jena, Germany; German Research Foundation (DFG); Thuringian Ministry for Education and Research; Federal Ministry for Research and Technology; European Union; BMBF (Bundesministerium fur Bildung und Forschung) grant (ERMCC-NDEG) of ERANET-NEURON program of European Union; University Hospital Jena	International Organization for Magnetic Resonance in Medicine (ISMRM); Friedrich Schiller University Jena; Interdisciplinary Center for Clinical Research (IZKF) in Jena, Germany; German Research Foundation (DFG)(German Research Foundation (DFG)); Thuringian Ministry for Education and Research; Federal Ministry for Research and Technology; European Union(European Commission); BMBF (Bundesministerium fur Bildung und Forschung) grant (ERMCC-NDEG) of ERANET-NEURON program of European Union; University Hospital Jena	Tino Prell received funding from IZKF grant from University Hospital Jena. Viktor Hartung reports no disclosures. Florian Tietz reports no disclosures. Susanne Penzlin reports no disclosures. Benjamin Ilse reports no disclosures. Ferdinand Schweser received funding from seed grants awarded by the International Organization for Magnetic Resonance in Medicine (ISMRM) and by the Friedrich Schiller University Jena. Andreas Deistung received funding from a seed grant awarded by the Interdisciplinary Center for Clinical Research (IZKF) in Jena, Germany. Martin Bokemeyer reports no disclosures. Jurgen R. Reichenbach received funding from the German Research Foundation (DFG, 2011-2015). Otto W. Witte received funding from the German Research Foundation (DFG, 2012-2015), Thuringian Ministry for Education and Research (2009-2012), Federal Ministry for Research and Technology, (2009-2015) (JenAge), Federal Ministry for Research and Technology (2009-15) (Bernstein Fokus), European Union (2006-10). Julian Grosskreutz received funding from a BMBF (the Bundesministerium fur Bildung und Forschung) grant (ERMCC-NDEG) in the framework of the ERANET-NEURON program of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042816; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Deistung A, 2008, RADIOGRAPHICS, V28, P639, DOI 10.1148/rg.283075715; Filippini N, 2010, NEUROLOGY, V75, P1645, DOI 10.1212/WNL.0b013e3181fb84d1; Grosskreutz J, 2010, CELL CALCIUM, V47, P165, DOI 10.1016/j.ceca.2009.12.002; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Haacke EM, 1997, HUM BRAIN MAPP, V5, P341, DOI 10.1002/(SICI)1097-0193(1997)5:5<341::AID-HBM2>3.0.CO;2-3; Hadzhieva M, 2014, NEUROPATH APPL NEURO, V40, P240, DOI 10.1111/nan.12096; Hecht MJ, 2005, NEURORADIOLOGY, V47, P805, DOI 10.1007/s00234-005-1421-5; ISHIKAWA K, 1993, ANN NEUROL, V33, P218, DOI 10.1002/ana.410330214; KASARSKIS EJ, 1995, J NEUROL SCI, V130, P203, DOI 10.1016/0022-510X(95)00037-3; Langkammer C, 2012, NEUROIMAGE, V59, P1413, DOI 10.1016/j.neuroimage.2011.08.045; Langkammer C, 2010, J MAGN RESON IMAGING, V31, P1339, DOI 10.1002/jmri.22185; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Lule D, 2007, J NEUROL, V254, P519, DOI 10.1007/s00415-006-0409-3; NOLL DC, 1991, IEEE T MED IMAGING, V10, P154, DOI 10.1109/42.79473; Ong BC, 2010, J MED IMAG RADIAT ON, V54, P435, DOI 10.1111/j.1754-9485.2010.02208.x; Poloni G, 2011, NEUROLOGIST, V17, P185, DOI 10.1097/NRL.0b013e31821a2643; Prell T, 2013, CELL CALCIUM, V54, P132, DOI 10.1016/j.ceca.2013.05.007; Rabinovici G D, 2007, Am J Alzheimers Dis Other Demen, V22, P474, DOI 10.1177/1533317507308779; Rauscher A, 2006, Z MED PHYS, V16, P240, DOI 10.1078/0939-3889-00322; Reichenbach JR, 1997, JMRI-J MAGN RESON IM, V7, P266, DOI 10.1002/jmri.1880070203; Reichenbach JR, 2001, NMR BIOMED, V14, P453, DOI 10.1002/nbm.722; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Sarro L, 2011, AM J NEURORADIOL, V32, P1866, DOI 10.3174/ajnr.A2658; Schuster C, 2014, NEUROBIOL AGING, V35, P240, DOI 10.1016/j.neurobiolaging.2013.07.020; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; SMITH MC, 1960, J NEUROL NEUROSUR PS, V23, P269, DOI 10.1136/jnnp.23.4.269; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; SWASH M, 1988, J NEUROL NEUROSUR PS, V51, P785, DOI 10.1136/jnnp.51.6.785; Tu S, 2013, CONSCIOUS COGN, V22, P479, DOI 10.1016/j.concog.2013.02.007; Turner MR, 2012, BIOMARK MED, V6, P319, DOI [10.2217/BMM.12.26, 10.2217/bmm.12.26]; Whitwell JL, 2012, BRAIN, V135, P794, DOI 10.1093/brain/aws001; Yan SQ, 2013, AGE, V35, P1927, DOI 10.1007/s11357-012-9487-6	34	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131114	10.1371/journal.pone.0131114	http://dx.doi.org/10.1371/journal.pone.0131114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110427	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800118
J	Svishcheva, GR; Belonogova, NM; Axenovich, TI				Svishcheva, Gulnara R.; Belonogova, Nadezhda M.; Axenovich, Tatiana I.			Region-Based Association Test for Familial Data under Functional Linear Models	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAITS; RARE VARIANTS; MIXED MODELS; GENETIC PATHWAY; DISEASE; STRATEGIES; REGRESSION; SAMPLES; COMMON	Region-based association analysis is a more powerful tool for gene mapping than testing of individual genetic variants, particularly for rare genetic variants. The most powerful methods for regional mapping are based on the functional data analysis approach, which assumes that the regional genome of an individual may be considered as a continuous stochastic function that contains information about both linkage and linkage disequilibrium. Here, we extend this powerful approach, earlier applied only to independent samples, to the samples of related individuals. To this end, we additionally include a random polygene effects in functional linear model used for testing association between quantitative traits and multiple genetic variants in the region. We compare the statistical power of different methods using Genetic Analysis Workshop 17 mini-exome family data and a wide range of simulation scenarios. Our method increases the power of regional association analysis of quantitative traits compared with burden-based and kernel-based methods for the majority of the scenarios. In addition, we estimate the statistical power of our method using regions with small number of genetic variants, and show that our method retains its advantage over burden-based and kernel-based methods in this case as well. The new method is implemented as the R-function 'famFLM' using two types of basis functions: the B-spline and Fourier bases. We compare the properties of the new method using models that differ from each other in the type of their function basis. The models based on the Fourier basis functions have an advantage in terms of speed and power over the models that use the B-spline basis functions and those that combine B-spline and Fourier basis functions.	[Svishcheva, Gulnara R.; Belonogova, Nadezhda M.; Axenovich, Tatiana I.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; [Axenovich, Tatiana I.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk 630090, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University	Axenovich, TI (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia.	aks@bionet.nsc.ru	Axenovich, Tatiana I/AAD-2595-2022; Svishcheva, Gulnara/AAD-2881-2022; Svishcheva, Gulnara/L-4010-2015	Axenovich, Tatiana I/0000-0002-4318-4458; Svishcheva, Gulnara/0000-0001-9478-267X; 	Russian Foundation for Basic Research [13-04-00272, 14-04-00126]; Federal Agency of Scientific Organizations [VI.53.2.2]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Federal Agency of Scientific Organizations	The study was supported by Russian Foundation for Basic Research, projects 13-04-00272 (GRS) and 14-04-00126 (TIA), Federal Agency of Scientific Organizations, project VI.53.2.2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy Laura, 2011, BMC Proc, V5 Suppl 9, pS2, DOI 10.1186/1753-6561-5-S9-S2; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Belonogova NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065395; Chen H, 2013, GENET EPIDEMIOL, V37, P196, DOI 10.1002/gepi.21703; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Fan RZ, 2014, GENET EPIDEMIOL, V38, P622, DOI 10.1002/gepi.21840; Fan RZ, 2013, GENET EPIDEMIOL, V37, P726, DOI 10.1002/gepi.21757; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Horvath L, 2012, INFERENCE FUNCTIONAL, DOI DOI 10.1007/978-1-4614-3655-3; Jiang D, 2014, GENET EPIDEMIOL, V38, P10, DOI 10.1002/gepi.21775; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kwee LC, 2008, AM J HUM GENET, V82, P386, DOI 10.1016/j.ajhg.2007.10.010; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li Lun, 2011, BMC Proc, V5 Suppl 9, pS117, DOI 10.1186/1753-6561-5-S9-S117; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/nmeth.1681, 10.1038/NMETH.1681]; Liu D, 2007, BIOMETRICS, V63, P1079, DOI 10.1111/j.1541-0420.2007.00799.x; Liu DW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-292; Luo L, 2012, J MED GENET, V49, P513, DOI 10.1136/jmedgenet-2012-100798; Luo L, 2011, GENOME RES, V21, P1099, DOI 10.1101/gr.115998.110; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Oualkacha K, 2013, GENET EPIDEMIOL, V37, P366, DOI 10.1002/gepi.21725; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; Ramsay JO, 2009, USE R, P1, DOI 10.1007/978-0-387-98185-7_1; Schifano ED, 2012, GENET EPIDEMIOL, V36, P797, DOI 10.1002/gepi.21676; Svishcheva GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099407; Svishcheva GR, 2012, NAT GENET, V44, P1166, DOI 10.1038/ng.2410; Vsevolozhskaya OA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105074; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Yang HC, 2008, GENETICS, V179, P1057, DOI 10.1534/genetics.107.084616; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	36	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0128999	10.1371/journal.pone.0128999	http://dx.doi.org/10.1371/journal.pone.0128999			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111046	Green Submitted, gold, Green Published			2022-12-27	WOS:000356933800018
J	Li, T; Wang, GL; Shi, BT; Liu, PX; Si, W; Wang, B; Jiang, L; Zhou, LJ; Xiu, JS; Liu, HG				Li, Tao; Wang, Gaoling; Shi, Bingtian; Liu, Peixin; Si, Wei; Wang, Bin; Jiang, Li; Zhou, Lunjiang; Xiu, Jinsheng; Liu, Henggui			Comprehensive Analysis and Characterization of Linear Antigenic Domains on HN Protein from Genotype VII Newcastle Disease Virus Using Yeast Surface Display System	PLOS ONE			English	Article							HEMAGGLUTININ-NEURAMINIDASE; F-PROTEIN; SACCHAROMYCES-CEREVISIAE; PHYLOGENETIC ANALYSIS; DIRECTED EVOLUTION; HUMAN-ANTIBODIES; FUSION; GLYCOPROTEIN; STRAINS; LIBRARY	Circulation of genotype VII Newcastle disease virus (NDV) has posed a great threat for the poultry industry worldwide. Antibodies against Hemagglutinin-neuraminidase (HN), a membrane protein of NDV with critical roles in NDV infection, have been reported to provide chickens protection from NDV infection. In this study, we comprehensively analyzed the in vivo antibody responses against the linear antigenic domains of the HN protein from genotype VII NDV using a yeast surface display system. The results revealed four distinct regions of HN, P1 (1-52aa), P2 (53-192aa), P3 (193-302aa) and P4 (303-571aa), respectively, according to their antigenic potency. Analysis by FACS and ELISA assay indicated P2 to be the dominant linear antigenic domain, with the immunogenic potency to protect the majority of chickens from NDV challenge. In contrast, the P1, P3 and P4 domains showed weak antigenicity in vivo and could not protect chickens from NDV challenge. These results provide important insight into the characteristic of humoral immune responses elicited by HN of NDV in vivo.	[Li, Tao; Wang, Gaoling; Liu, Peixin; Si, Wei; Wang, Bin; Jiang, Li; Liu, Henggui] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China; [Li, Tao; Wang, Bin; Xiu, Jinsheng] Fujian Agr & Forestry Univ, Coll Anim Sci, Fuzhou, Peoples R China; [Zhou, Lunjiang] Fujian Acad Agr Sci, Inst Anim Husb & Vet Med, Fuzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Fujian Agriculture & Forestry University; Fujian Academy of Agricultural Sciences	Xiu, JS (corresponding author), Fujian Agr & Forestry Univ, Coll Anim Sci, Fuzhou, Peoples R China.	xiujinsheng@163.com; lhg@hvri.ac.cn			State Key Laboratory of Veterinary Biotechnology Research Fund [SKLVBP201416]; Chinese Special Fund for Agro-scientific Research in the Public Interest [201303033]	State Key Laboratory of Veterinary Biotechnology Research Fund; Chinese Special Fund for Agro-scientific Research in the Public Interest	This research was supported by the State Key Laboratory of Veterinary Biotechnology Research Fund (SKLVBP201416) and the Chinese Special Fund for Agro-scientific Research in the Public Interest (201303033).	Aldous EW, 2003, AVIAN PATHOL, V32, P239, DOI 10.1080/030794503100009783; BallagiPordany A, 1996, ARCH VIROL, V141, P243, DOI 10.1007/BF01718397; Biswas M, 2012, J VIROL, V86, P12708, DOI 10.1128/JVI.00886-12; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Burns ML, 2014, APPL ENVIRON MICROB, V80, P5732, DOI 10.1128/AEM.01466-14; Cattoli G, 2010, VET MICROBIOL, V142, P168, DOI 10.1016/j.vetmic.2009.09.063; Cattoli G, 2011, J VET DIAGN INVEST, V23, P637, DOI 10.1177/1040638711407887; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Colby DW, 2004, METHOD ENZYMOL, V388, P348; COLLINS PL, 1980, J VIROL, V35, P682, DOI 10.1128/JVI.35.3.682-693.1980; Cornelissen LAHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044447; Estevez C, 2011, J GEN VIROL, V92, P544, DOI 10.1099/vir.0.027540-0; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Ferreira L, 2004, J GEN VIROL, V85, P1981, DOI 10.1099/vir.0.79877-0; Graff CP, 2004, PROTEIN ENG DES SEL, V17, P293, DOI 10.1093/protein/gzh038; IORIO RM, 1983, J VIROL, V48, P440, DOI 10.1128/JVI.48.2.440-450.1983; Iorio RM, 2009, FUTURE VIROL, V4, P335, DOI 10.2217/FVL.09.17; Jin Shi-qiang, 2012, Chinese Journal of Virology, V28, P394; Kim LM, 2008, J CLIN MICROBIOL, V46, P3303, DOI 10.1128/JCM.00644-08; Kim LM, 2007, J VIROL, V81, P12641, DOI 10.1128/JVI.00843-07; Kumar S, 2011, J VIROL, V85, P6521, DOI 10.1128/JVI.00367-11; Laserson U, 2014, P NATL ACAD SCI USA, V111, P4928, DOI 10.1073/pnas.1323862111; Lee JW, 2010, AVIAN DIS, V54, P53, DOI 10.1637/8965-062009-Reg.1; Li J, 2009, EUR J IMMUNOL, V39, P3498, DOI 10.1002/eji.200939532; Lindh E, 2012, J CLIN MICROBIOL, V50, P3664, DOI 10.1128/JCM.01427-12; Liu XF, 2003, ARCH VIROL, V148, P1387, DOI 10.1007/s00705-003-0014-z; Lomniczi B, 1998, ARCH VIROL, V143, P49, DOI 10.1007/s007050050267; Mahon PJ, 2011, J VIROL, V85, P12079, DOI 10.1128/JVI.05679-11; Maminiaina OF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013987; Melanson VR, 2006, J VIROL, V80, P623, DOI 10.1128/JVI.80.2.623-633.2006; Melanson VR, 2004, J VIROL, V78, P13053, DOI 10.1128/JVI.78.23.13053-13061.2004; NISHIKAWA K, 1986, J VIROL, V60, P987, DOI 10.1128/JVI.60.3.987-993.1986; Prodromou C, 2007, DRUG DISCOV TODAY, V12, P931, DOI 10.1016/j.drudis.2007.08.012; Radwan MM, 2013, VIRUS GENES, V47, P311, DOI 10.1007/s11262-013-0950-y; Siegel RW, 2004, J IMMUNOL METHODS, V286, P141, DOI 10.1016/j.jim.2004.01.005; Solomon P, 2012, VIRUS GENES, V44, P98, DOI 10.1007/s11262-011-0678-5; Steglich C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072530; Stone-Hulslander J, 1999, J VIROL, V73, P3630, DOI 10.1128/JVI.73.5.3630-3637.1999; Su BS, 2011, VET MICROBIOL, V151, P220, DOI 10.1016/j.vetmic.2011.02.047; Ujvari D, 2003, VIRUS RES, V96, P63, DOI 10.1016/S0168-1702(03)00173-4; Van Deventer JA, 2014, METHODS MOL BIOL, V1131, P151, DOI 10.1007/978-1-62703-992-5_10; Walter RJ, 2012, J PANCREAS, V13, P502, DOI 10.6092/1590-8577/977; Wang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099905; Wehmann E, 2003, AVIAN PATHOL, V32, P157, DOI 10.1080/0307945021000071623; Wong SK, 2009, ACTA VIROL, V53, P35, DOI 10.4149/av_2009_01_35; Xu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018016; Yuan P, 2005, STRUCTURE, V13, P803, DOI 10.1016/j.str.2005.02.019; Yuan P, 2011, P NATL ACAD SCI USA, V108, P14920, DOI 10.1073/pnas.1111691108; Zaitsev V, 2004, J VIROL, V78, P3733, DOI 10.1128/JVI.78.7.3733-3741.2004; Zuo T, 2011, J BIOL CHEM, V286, P33511, DOI 10.1074/jbc.M111.270553	50	7	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131723	10.1371/journal.pone.0131723	http://dx.doi.org/10.1371/journal.pone.0131723			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121247	Green Submitted, gold, Green Published			2022-12-27	WOS:000358150400146
J	Pontes, TB; Moreira-Nunes, CDA; Maues, JHD; Lamarao, LM; de Lemos, JAR; Montenegro, RC; Burbano, RMR				Pontes, Thais Brilhante; Aquino Moreira-Nunes, Caroline de Fatima; da Silva Maues, Jersey Heitor; Lamarao, Leticia Martins; Rodrigues de Lemos, Jose Alexandre; Montenegro, Raquel Carvalho; Rodriguez Burbano, Rommel Mario			The miRNA Profile of Platelets Stored in a Blood Bank and Its Relation to Cellular Damage from Storage	PLOS ONE			English	Article							BUFFY COAT; MICRORNA; TRANSFUSION; BIOGENESIS; EXPRESSION; RNA; INFLAMMATION; CONTRIBUTES; MECHANISMS; SENESCENCE	Millions of blood products are transfused each year, and many lives are directly affected by transfusion. Platelet concentrate (PC) is one of the main products derived from blood. Even under good storage conditions, PC is likely to suffer cell damage. The shape of platelets changes after 5 to 7 days of storage at 22 degrees C. Taking into consideration that some platelet proteins undergo changes in their shape and functionality during PC storage. Sixteen PC bags were collected and each PC bag tube was cut into six equal pieces to perform experiments with platelets from six different days of storage. Thus, on the first day of storage, 1/6 of the tube was used for miRNA extraction, and the remaining 5/6 was stored under the same conditions until extraction of miRNAs on each the following five days. Samples were sequenced on an Illumina Platform to demonstrate the most highly expressed miRNAs. Three miRNAs, mir127, mir191 and mir320a were validated by real-time quantitative PCR (RQ-PCR) in 100 PC bags tubes. Our method suggests, the use of the miRNAs mir127 and mir320a as biomarkers to assess the "validity period" of PC bags stored in blood banks for long periods. Thus, bags can be tested on the 5th day of storage for the relative expression levels of mir127 and mir320a. Thus, we highlight candidate miRNAs as biomarkers of storage damage that can be used as tools to evaluate the quality of stored PC. The use of miRNAs as biomarkers of damage is unprecedented and will contribute to improved quality of blood products for transfusions.	[Pontes, Thais Brilhante; Aquino Moreira-Nunes, Caroline de Fatima; da Silva Maues, Jersey Heitor; Montenegro, Raquel Carvalho; Rodriguez Burbano, Rommel Mario] Fed Univ Para, Inst Biol Sci, Lab Human Cytogenet, BR-66075110 Belem, PA, Brazil; [Lamarao, Leticia Martins; Rodrigues de Lemos, Jose Alexandre] Fdn Ctr Hemotherapy & Hematol Para HEMOPA, Lab Genet & Mol Biol, BR-66033000 Belem, PA, Brazil; [Rodrigues de Lemos, Jose Alexandre] Fed Univ Para, Inst Biol Sci, BR-66075110 Belem, PA, Brazil	Universidade Federal do Para; Universidade Federal do Para	Burbano, RMR (corresponding author), Fed Univ Para, Inst Biol Sci, Lab Human Cytogenet, BR-66075110 Belem, PA, Brazil.	rommel@ufpa.br	Lemos, José Alexandre R/M-8753-2016; Montenegro, Raquel/I-1260-2013; Aquino Moreira-Nunes, Caroline de Fátima/S-6409-2019; Burbano, Rommel R/C-4149-2012	Lemos, José Alexandre R/0000-0002-7595-2597; Montenegro, Raquel/0000-0002-3861-293X; Aquino Moreira-Nunes, Caroline de Fátima/0000-0001-5845-3481; Burbano, Rommel R/0000-0002-4872-234X; Maues, Jersey Heitor da S/0000-0001-5570-3158	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA); Centro de Hemoterapia e Hematologia do Estado do Para (HEMOPA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Centro de Hemoterapia e Hematologia do Estado do Para (HEMOPA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding: This paper was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, to RMRB), the Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA, to RMRB), the Centro de Hemoterapia e Hematologia do Estado do Para (HEMOPA, to CFAMN and LML) and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, TBP).	Abdelmohsen K, 2012, AGEING RES REV, V11, P491, DOI 10.1016/j.arr.2012.01.003; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bauersachs J, 2011, CIRC RES, V109, P334, DOI 10.1161/CIRCRESAHA.110.228676; Bontekoe IJ, 2014, VOX SANG, V107, P140, DOI 10.1111/vox.12140; BRUIL A, 1995, TRANSFUS MED REV, V9, P145, DOI 10.1016/S0887-7963(05)80053-7; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Carubbi C, 2014, SEMIN THROMB HEMOST, V40, P88, DOI 10.1055/s-0033-1363472; Chen JF, 2009, J CELL SCI, V122, P13, DOI 10.1242/jcs.041723; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Dangwal S, 2012, THROMB HAEMOSTASIS, V108, P599, DOI 10.1160/TH12-03-0211; Delobel J, 2010, INT J MOL SCI, V11, P4601, DOI 10.3390/ijms11114601; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edelstein Leonard C, 2012, Handb Exp Pharmacol, P435, DOI 10.1007/978-3-642-29423-5_17; Estebanell E, 2000, TRANSFUSION, V40, P535, DOI 10.1046/j.1537-2995.2000.40050535.x; Freedman Jane E, 2012, F1000Res, V1, P50, DOI 10.12688/f1000research.1-50.v1; Girardot M, 2010, BLOOD, V116, P437, DOI 10.1182/blood-2008-06-165985; Hogman C F, 1988, Acta Anaesthesiol Scand Suppl, V89, P4; Hussein K, 2009, PLATELETS, V20, P391, DOI 10.1080/09537100903114537; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kannan M, 2009, TRANSFUSION, V49, P1443, DOI 10.1111/j.1537-2995.2009.02140.x; Kato M, 2013, AGEING RES REV, V12, P429, DOI 10.1016/j.arr.2012.03.012; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Kumar M, 2011, J ALLERGY CLIN IMMUN, V128, P1077, DOI 10.1016/j.jaci.2011.04.034; Landi Evaldo P., 2003, Rev. Bras. Hematol. Hemoter., V25, P39, DOI 10.1590/S1516-84842003000100007; Landry P, 2009, NAT STRUCT MOL BIOL, V16, P961, DOI 10.1038/nsmb.1651; Lena AM, 2012, BIOCHEM BIOPH RES CO, V423, P509, DOI 10.1016/j.bbrc.2012.05.153; Leytin V, 2012, BLOOD REV, V26, P51, DOI 10.1016/j.blre.2011.10.002; Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P70, DOI 10.2450/2008.0038-07; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Ministerio da Saude (Brasil), 2014, INFORMATION BOOKLET; Murphy MF, 2001, BRIT J HAEMATOL, V113, P24; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; Nurden AT, 2011, THROMB HAEMOSTASIS, V105, pS13, DOI 10.1160/THS10-11-0720; Nuyttens BP, 2011, THROMB RES, V127, pS26, DOI 10.1016/S0049-3848(10)70151-1; Osman A., 2014, P 11 EUROPEAN C NOND, P1; Osman A, 2011, PLATELETS, V22, P433, DOI 10.3109/09537104.2011.560305; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Ple H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050746; Pope CA, 2004, ENVIRON HEALTH PERSP, V112, P339, DOI 10.1289/ehp.6588; Schubert P, 2010, BLOOD TRANSFUS-ITALY, V8, pS69, DOI 10.2450/2010.011S; Sharma S, 2011, AM FAM PHYSICIAN, V83, P719; Shrivastava M, 2009, TRANSFUS APHER SCI, V41, P105, DOI 10.1016/j.transci.2009.07.002; Thiele T, 2010, BLOOD TRANSFUS-ITALY, V8, pS16, DOI 10.2450/2010.004S; Vanni Denise Siqueira, 2007, J. Bras. Patol. Med. Lab., V43, P181, DOI 10.1590/S1676-24442007000300007; Vasconcelos E, 2003, TRANSFUS APHER SCI, V29, P13, DOI 10.1016/S1473-0502(03)00091-0; Viele M, 2000, MEDICAL IMMUNOLOGY, P215; Volk N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019391; Wang QZ, 2009, CURR CANCER DRUG TAR, V9, P572, DOI 10.2174/156800909788486731; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; Zubair AC, 2010, AM J HEMATOL, V85, P117, DOI 10.1002/ajh.21599	50	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0129399	10.1371/journal.pone.0129399	http://dx.doi.org/10.1371/journal.pone.0129399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121269	Green Published, Green Submitted, gold			2022-12-27	WOS:000358150400020
J	Uraki, S; Tameda, M; Sugimoto, K; Shiraki, K; Takei, Y; Nobori, T; Ito, M				Uraki, Satoko; Tameda, Masahiko; Sugimoto, Kazushi; Shiraki, Katsuya; Takei, Yoshiyuki; Nobori, Tsutomu; Ito, Masaaki			Substitution in Amino Acid 70 of Hepatitis C Virus Core Protein Changes the Adipokine Profile via Toll-Like Receptor 2/4 Signaling	PLOS ONE			English	Article							RIBAVIRIN COMBINATION THERAPY; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; GENOTYPE 1B; IMPORTANT PREDICTOR; HCV GENOTYPE; STEATOSIS; INTERFERON; INFLAMMATION; ASSOCIATION	Background & Aims It has been suggested that amino acid (aa) substitution at position 70 from arginine (70R) to glutamine (70Q) in the genotype 1b hepatitis C virus (HCV) core protein is associated with insulin resistance and worse prognosis. However, the precise mechanism is still unclear. The aim of this study was to investigate the impact of the substitution at position 70 in HCV core protein on adipokine production by murine and human adipocytes. Methods The influence of treatment with HCV core protein (70R or 70Q) on adipokine production by both 3T3-L1 and human adipocytes were examined with real-time PCR and enzyme-linked immunosorbent assay (ELISA), and triglyceride content was also analyzed. The effects of toll-like receptor (TLR) 2/4 inhibition on IL-6 production by 3T3-L1 induced by HCV core protein were examined. Results IL-6 production was significantly increased and adiponectin production was reduced without a change in triglyceride content by treatment with 70Q compared to 70R core protein in both murine and human adipocytes. IL-6 induction of 3T3-L1 cells treated by 70Q HCV core protein was significantly inhibited with anti-TLR2 antibody by 42%, and by TLR4 inhibitor by 40%. Conclusions Our study suggests that extracellular HCV core protein with substitution at position 70 enhanced IL-6 production and reduced adiponectin production from visceral adipose tissue, which can cause insulin resistance, hepatic steatosis, and ultimately development of HCC.	[Uraki, Satoko; Tameda, Masahiko; Sugimoto, Kazushi; Shiraki, Katsuya; Ito, Masaaki] Mie Univ, Sch Med, Dept Internal Med 1, Tsu, Mie 5148507, Japan; [Tameda, Masahiko; Sugimoto, Kazushi; Nobori, Tsutomu] Mie Univ, Sch Med, Dept Mol & Lab Med, Tsu, Mie 5148507, Japan; [Tameda, Masahiko; Sugimoto, Kazushi; Shiraki, Katsuya; Takei, Yoshiyuki] Mie Univ, Sch Med, Dept Gastroenterol & Hepatol, Tsu, Mie 5148507, Japan	Mie University; Mie University; Mie University	Sugimoto, K (corresponding author), Mie Univ, Sch Med, Dept Internal Med 1, Tsu, Mie 5148507, Japan.	kazushi@clin.medic.mie-u.ac.jp						Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Akuta N, 2006, J MED VIROL, V78, P83, DOI 10.1002/jmv.20507; Akuta N, 2009, J MED VIROL, V81, P452, DOI 10.1002/jmv.21400; Akuta N, 2007, HEPATOLOGY, V46, P1357, DOI 10.1002/hep.21836; Akuta N, 2009, J MED VIROL, V81, P1032, DOI 10.1002/jmv.21473; Asselah T, 2006, GUT, V55, P123, DOI 10.1136/gut.2005.069757; Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010; Bedossa P, 2007, HEPATOLOGY, V46, P380, DOI 10.1002/hep.21711; Bes-Houtmann S, 2007, HISTOCHEM CELL BIOL, V127, P131, DOI 10.1007/s00418-006-0230-1; Camma C, 2006, HEPATOLOGY, V43, P64, DOI 10.1002/hep.20983; Dolganiuc A, 2004, GASTROENTEROLOGY, V127, P1513, DOI 10.1053/j.gastro.2004.08.067; Durante-Mangoni E, 2006, ALIMENT PHARM THERAP, V24, P1349, DOI 10.1111/j.1365-2036.2006.03114.x; El-Shamy A, 2013, HEPATOLOGY, V58, P555, DOI 10.1002/hep.26205; Fartoux L, 2005, HEPATOLOGY, V41, P82, DOI 10.1002/hep.20519; Funaoka Y, 2011, J VIROL, V85, P5986, DOI 10.1128/JVI.02583-10; Gonzalez-Reimers E, 2009, ANN NUTR METAB, V55, P351, DOI 10.1159/000252351; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; Kadowaki K, 2006, J CLIN ENDOCR METAB, V91, P5090, DOI 10.1210/jc.2005-2846; KANTO T, 1995, J HEPATOL, V22, P440, DOI 10.1016/0168-8278(95)80107-3; Leandro G, 2006, GASTROENTEROLOGY, V130, P1636, DOI 10.1053/j.gastro.2006.03.014; Lehrke M, 2004, NAT MED, V10, P126, DOI 10.1038/nm0204-126; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lonardo A, 2004, GASTROENTEROLOGY, V126, P586, DOI 10.1053/j.gastro.2003.11.020; Meng GX, 2004, J CLIN INVEST, V113, P1473, DOI 10.1172/JCI200420762; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Moschen AR, 2010, GUT, V59, P1259, DOI 10.1136/gut.2010.214577; Moucari R, 2008, GASTROENTEROLOGY, V134, P416, DOI 10.1053/j.gastro.2007.11.010; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Poulain-Godefroy O, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/823486; Reddy KR, 1999, HEPATOLOGY, V30, P787, DOI 10.1002/hep.510300319; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Shintani Y, 2004, GASTROENTEROLOGY, V126, P840, DOI 10.1053/j.gastro.2003.11.056; Simons PJ, 2007, J ENDOCRINOL, V192, P289, DOI 10.1677/JOE-06-0047; Stepanova M, 2012, J VIRAL HEPATITIS, V19, P341, DOI 10.1111/j.1365-2893.2011.01554.x; Sugimoto K, 2003, HEPATOLOGY, V37, P590, DOI 10.1053/jhep.2003.50103; Tacke RS, 2011, J BIOL CHEM, V286, P10847, DOI 10.1074/jbc.M110.217653; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Zampino R, 2008, J VIRAL HEPATITIS, V15, P740, DOI 10.1111/j.1365-2893.2008.00994.x	45	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131346	10.1371/journal.pone.0131346	http://dx.doi.org/10.1371/journal.pone.0131346			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121241	gold, Green Published, Green Submitted			2022-12-27	WOS:000358150400101
J	Woodbury, MG; Sibbald, RG; Ostrow, B; Persaud, R; Lowe, JM				Woodbury, M. Gail; Sibbald, R. Gary; Ostrow, Brian; Persaud, Reneeka; Lowe, Julia M.			Tool for Rapid & Easy Identification of High Risk Diabetic Foot: Validation & Clinical Pilot of the Simplified 60 Second Diabetic Foot Screening Tool	PLOS ONE			English	Article							RELIABILITY; BURDEN; ULCERS	Background Most diabetic foot amputations are caused by ulcers on the skin of the foot i.e. diabetic foot ulcers. Early identification of patients at high risk for diabetic foot ulcers is crucial. The 'Simplified 60-Second Diabetic Foot Screening Tool' has been designed to rapidly detect high risk diabetic feet, allowing for timely identification and referral of patients needing treatment. This study aimed to determine the clinical performance and inter-rater reliability of 'Simplified 60 Second Diabetic Foot Screening Tool' in order to evaluate its applicability for routine screening. Methods and Findings The tool was independently tested by n=12 assessors with n=18 Guyanese patients with diabetes. Inter-rater reliability was assessed by calculating Cronbach's alpha for each of the assessment items. A minimum value of 0.60 was considered acceptable. Reliability scores of the screening tool assessment items were: 'monofilament test' 0.98; 'active ulcer' 0.97; 'previous amputation' 0.97; 'previous ulcer' 0.97; 'fixed ankle' 0.91; 'deformity' 0.87; 'callus' 0.87; 'absent pulses' 0.87; 'fixed toe' 0.80; 'blisters' 0.77; 'ingrown nail' 0.72; and 'fissures' 0.55. The item 'stiffness in the toe or ankle' was removed as it was observed in only 1.3% of patients. The item 'fissures' was also removed due to low inter-rater reliability. Clinical performance was assessed via a pilot study utilizing the screening tool on n=1,266 patients in an acute care setting in Georgetown, Guyana. In total, 48% of patients either had existing diabetic foot ulcers or were found to be at high risk for developing ulcers. Conclusions Clinicians in low and middle income countries such as Guyana can use the Simplified 60Second Diabetic Screening Tool to facilitate early detection and appropriate treatment of diabetic foot ulcers. Implementation of this screening tool has the potential to decrease diabetes related disability and mortality.	[Woodbury, M. Gail] Queens Univ, Kingston, ON, Canada; [Sibbald, R. Gary; Ostrow, Brian; Lowe, Julia M.] Univ Toronto, Toronto, ON, Canada; [Persaud, Reneeka] Suddie Hosp, Essequibo, Guyana	Queens University - Canada; University of Toronto	Sibbald, RG (corresponding author), Univ Toronto, Toronto, ON, Canada.	rgarysibbald@gmail.com	Ostrow, Brian/AAJ-3820-2021		Government of Canada through the Canadian International Development Agency: Canadian-Caribbean Co-operation Fund [530-0272-G015]; Government of Canada through the Canadian International Development Agency: Canadian Partnership Branch [S064802]	Government of Canada through the Canadian International Development Agency: Canadian-Caribbean Co-operation Fund; Government of Canada through the Canadian International Development Agency: Canadian Partnership Branch	Funding: Funding for this study was provided by the Government of Canada through the Canadian International Development Agency: Phase 1-Canadian-Caribbean Co-operation Fund, Project No. 530-0272-G015: "Technical Assistance for the Development of an enhanced diabetic foot program at GPHC in Guyana," Lead Organization Georgetown Public Hospital Corporation and Phase 2 - Canadian Partnership Branch, Project No. S064802: "Regionalization of Comprehensive Diabetes Care in Guyana-The Guyana Diabetic Foot Project-Phase 2", Lead Organization Canadian Association of General Surgeons. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abbas Zulfiqarali G, 2007, Int Wound J, V4, P305; Bharara M, 2009, INT WOUND J, V6, P2, DOI 10.1111/j.1742-481X.2009.00587.x; Boulton A J, 2000, J Fam Pract, V49, pS3; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Boulton AJM, 2008, DIABETES CARE, V31, P1679, DOI 10.2337/dc08-9021; Carreau L, 2013, OSTOMY WOUND MANAG, V59, P28; Central Ingelligence Agency, 2013, WORLD FACTB GUYAN; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; DONNER A, 1987, STAT MED, V6, P441, DOI 10.1002/sim.4780060404; Inlow S., 2004, WOUND CARE CANADA, V2, P10; International Council for Coaching Excellence, 2013, INT SPORT COACH FRAM, P1; Jeffcoate W, 2005, LANCET, V365, P1527, DOI 10.1016/S0140-6736(05)66437-9; Lavery LA, 2008, DIABETES CARE, V31, P154, DOI 10.2337/dc07-1302; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Murphy CA, 2012, ADV SKIN WOUND CARE, V25, P261, DOI 10.1097/01.ASW.0000415343.45178.91; Narayan KV, 2006, DIABETES PANDEMIC PO; Orsted HL, 2009, WOUND CARE CAN, V7, P40; Ostrow B, 2010, WCET, V30, P28; Pan-American Health Organization, 2009, GUYAN COUNTR COOP ST; Reiber G., 2001, DIABET FOOT, V71, P73; Reiber GE, 1998, AM J SURG, V176, p5S, DOI 10.1016/S0002-9610(98)00181-0; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Woodbury GM, 2009, WOUND CARE CAN, V7, P44; Wu SC, 2007, VASC HEALTH RISK MAN, V3, P65	25	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0125578	10.1371/journal.pone.0125578	http://dx.doi.org/10.1371/journal.pone.0125578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121258	Green Published, Green Submitted, gold			2022-12-27	WOS:000358150400002
J	Chen, SW; Liaw, JW; Chang, YJ; Chan, HL; Chiu, LY				Chen, Szi-Wen; Liaw, Jiunn-Woei; Chang, Ya-Ju; Chan, Hsiao-Lung; Chiu, Li-Yu			A Cycling Movement Based System for Real-Time Muscle Fatigue and Cardiac Stress Monitoring and Analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEART-RATE; MULTIPLE-SCLEROSIS; CONDUCTION-VELOCITY; PERCEIVED EXERTION; INTERVAL DYNAMICS; EMG SIGNAL; ELECTROMYOGRAPHY; FLUCTUATION; STROKE	In this study, we defined a new parameter, referred to as the cardiac stress index (CSI), using a nonlinear detrended fluctuation analysis (DFA) of heart rate (HR). Our study aimed to incorporate the CSI into a cycling based fatigue monitoring system developed in our previous work so the muscle fatigue and cardiac stress can be both continuously and quantitatively assessed for subjects undergoing the cycling exercise. By collecting electrocardiogram (ECG) signals, the DFA scaling exponent a was evaluated on the RR time series extracted from a windowed ECG segment. We then obtained the running estimate of a by shifting a one-minute window by a step of 20 seconds so the CSI, defined as the percentage of all the less-than-one a values, can be synchronously updated every 20 seconds. Since the rating of perceived exertion (RPE) scale is considered as a convenient index which is commonly used to monitor subjective perceived exercise intensity, we then related the Borg RPE scale value to the CSI in order to investigate and quantitatively characterize the relationship between exercise-induced fatigue and cardiac stress. Twenty-two young healthy participants were recruited in our study. Each participant was asked to maintain a fixed pedaling speed at a constant load during the cycling exercise. Experimental results showed that a decrease in DFA scaling exponent a or an increase in CSI was observed during the exercise. In addition, the Borg RPE scale and CSI were positively correlated, suggesting that the factors due to cardiac stress might also contribute to fatigue state during physical exercise. Since the CSI can effectively quantify the cardiac stress status during physical exercise, our system may be used in sports medicine, or used by cardiologists who carried out stress tests for monitoring heart condition in patients with heart diseases.	[Chen, Szi-Wen; Chan, Hsiao-Lung; Chiu, Li-Yu] Chang Gung Univ, Dept Elect Engn, Taoyuan, Taiwan; [Chen, Szi-Wen; Liaw, Jiunn-Woei; Chang, Ya-Ju; Chan, Hsiao-Lung] Chang Gung Univ, HARC, Taoyuan, Taiwan; [Liaw, Jiunn-Woei] Chang Gung Univ, Dept Mech Engn, Taoyuan, Taiwan; [Chang, Ya-Ju] Chang Gung Univ, Dept Phys, Coll Med, Taoyuan, Taiwan; [Chang, Ya-Ju] Chang Gung Univ, Coll Med, Grad Inst Rehabil Sci, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University	Chen, SW (corresponding author), Chang Gung Univ, Dept Elect Engn, Taoyuan, Taiwan.	chensw@mail.cgu.edu.tw; markliaw@mail.cgu.edu.tw		Chen, Szi-Wen/0000-0001-6171-0493	Taiwanese Ministry of Science and Technology (MOST) [102-2221-E-182-023]; Chang Gung Memorial Hospital (CGMH) [CMRPD2D0091, CMRPD3E0321]	Taiwanese Ministry of Science and Technology (MOST); Chang Gung Memorial Hospital (CGMH)(Chang Gung Memorial Hospital)	This research was supported by Taiwanese Ministry of Science and Technology (MOST) under the Grant 102-2221-E-182-023 and by Chang Gung Memorial Hospital (CGMH) under the Grant CMRPD2D0091 and CMRPD3E0321. The URLs of Taiwanese MOST and CGMH are http://www.most.gov.tw and http://www.cgmh.org.tw, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absil PA, 1999, PHYSICA A, V272, P235, DOI 10.1016/S0378-4371(99)00295-2; Acharya R. U., 2002, ITBM RBM, V23, P333, DOI DOI 10.1016/S1297-9562(02)90002-1; AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Amato MP, 2001, MULT SCLER J, V7, P340, DOI 10.1191/135245801681138059; ARENDTNIELSEN L, 1989, J CLIN NEUROPHYSIOL, V6, P173, DOI 10.1097/00004691-198904000-00004; BIGLANDRITCHIE B, 1992, J APPL PHYSIOL, V73, P2457, DOI 10.1152/jappl.1992.73.6.2457; BIGLANDRITCHIE B, 1981, J APPL PHYSIOL, V51, P1300, DOI 10.1152/jappl.1981.51.5.1300; BILODEAU M, 1991, EUR J APPL PHYSIOL O, V63, P24, DOI 10.1007/BF00760796; Bilodeau M, 2003, J ELECTROMYOGR KINES, V13, P83, DOI 10.1016/S1050-6411(02)00050-0; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brown DA, 2005, PHYS THER, V85, P159, DOI 10.1093/ptj/85.2.159; Chang YJ, 2008, SENSORS-BASEL, V8, P3643, DOI 10.3390/s8063643; Chang YJ, 2015, ARCH PHYS MED REHAB, V96, P1006, DOI 10.1016/j.apmr.2015.01.021; Chang YJ, 2011, J REHABIL RES DEV, V48, P555, DOI 10.1682/JRRD.2010.03.0038; Chen S-W, 2007, Journal of Medical Engineering & Technology, V31, P210, DOI 10.1080/03091900600747617; Chen SW, 2014, SENSORS-BASEL, V14, P12410, DOI 10.3390/s140712410; Cornforth DJ., 2014, INTERDISCIP J INF KN, V9, P193, DOI 10.28945/2085; de Groot MH, 2003, ARCH PHYS MED REHAB, V84, P1714, DOI 10.1053/S0003-9993(03)00346-0; DE LUCA CJ, 1993, MUSCLE NERVE, V16, P210, DOI 10.1002/mus.880160216; De Luca CJ, 1997, J APPL BIOMECH, V13, P135, DOI 10.1123/jab.13.2.135; Egana M, 2010, EUR J APPL PHYSIOL, V108, P649, DOI 10.1007/s00421-009-1254-8; Faulkner J A, 1990, Annu Rev Gerontol Geriatr, V10, P147; GARLAND SJ, 1991, J PHYSIOL-LONDON, V435, P547, DOI 10.1113/jphysiol.1991.sp018524; Herlofson K, 2003, ACTA NEUROL SCAND, V107, P1, DOI 10.1034/j.1600-0404.2003.02033.x; Huikuri HV, 2000, CIRCULATION, V101, P47, DOI 10.1161/01.CIR.101.1.47; Jones B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120338; JUEL C, 1988, ACTA PHYSIOL SCAND, V134, P209, DOI 10.1111/j.1748-1716.1988.tb08481.x; Karavirta L, 2009, MED SCI SPORT EXER, V41, P1436, DOI 10.1249/MSS.0b013e3181994a91; Katz-Leurer M, 2006, CLIN REHABIL, V20, P398, DOI 10.1191/0269215505cr960oa; Koufaki P, 2014, J REHABIL MED, V46, P348, DOI 10.2340/16501977-1278; Matthews S, 2012, INT J CARDIOL, V156, P337, DOI 10.1016/j.ijcard.2012.02.004; Merkelbach S, 2002, J NERV MENT DIS, V190, P388, DOI 10.1097/00005053-200206000-00007; Morley W, 2005, AGE AGEING, V34, P313, DOI 10.1093/ageing/afi082; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Peltola MA, 2004, ANN NONINVAS ELECTRO, V9, P127, DOI 10.1111/j.1542-474X.2004.92531.x; Peltola MA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00148; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Pikkujamsa SM, 1999, CIRCULATION, V100, P393, DOI 10.1161/01.CIR.100.4.393; Rodriguez E, 2007, PHYSICA A, V384, P429, DOI 10.1016/j.physa.2007.05.022; STAMFORD BA, 1976, ERGONOMICS, V19, P53, DOI 10.1080/00140137608931513; Tarkiainen TH, 2007, CLIN PHYSIOL FUNCT I, V27, P126, DOI 10.1111/j.1475-097X.2007.00726.x; Tulppo MP, 2001, AM J PHYSIOL-HEART C, V280, pH1081, DOI 10.1152/ajpheart.2001.280.3.H1081; van der Werf SP, 1998, J NEUROL SCI, V160, P164, DOI 10.1016/S0022-510X(98)00251-2; VIITASALO JT, 1978, ELECTROMYO CLIN NEUR, V18, P167	44	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130798	10.1371/journal.pone.0130798	http://dx.doi.org/10.1371/journal.pone.0130798			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115515	gold, Green Submitted, Green Published			2022-12-27	WOS:000358147500095
J	Geskin, A; Legowski, E; Chakka, A; Chandran, UR; Barmada, MM; LaFramboise, WA; Berg, J; Jacobson, RS				Geskin, Albert; Legowski, Elizabeth; Chakka, Anish; Chandran, Uma R.; Barmada, M. Michael; LaFramboise, William A.; Berg, Jeremy; Jacobson, Rebecca S.			Needs Assessment for Research Use of High-Throughput Sequencing at a Large Academic Medical Center	PLOS ONE			English	Article							DATA-MANAGEMENT; CLOUD; GENOME; BIOINFORMATICS; CHALLENGES; SEQ	Next Generation Sequencing (NGS) methods are driving profound changes in biomedical research, with a growing impact on patient care. Many academic medical centers are evaluating potential models to prepare for the rapid increase in NGS information needs. This study sought to investigate (1) how and where sequencing data is generated and analyzed, (2) research objectives and goals for NGS, (3) workforce capacity and unmet needs, (4) storage capacity and unmet needs, (5) available and anticipated funding resources, and (6) future challenges. As a precursor to informed decision making at our institution, we undertook a systematic needs assessment of investigators using survey methods. We recruited 331 investigators from over 60 departments and divisions at the University of Pittsburgh Schools of Health Sciences and had 140 respondents, or a 42% response rate. Results suggest that both sequencing and analysis bottlenecks currently exist. Significant educational needs were identified, including both investigator-focused needs, such as selection of NGS methods suitable for specific research objectives, and program-focused needs, such as support for training an analytic workforce. The absence of centralized infrastructure was identified as an important institutional gap. Key principles for organizations managing this change were formulated based on the survey responses. This needs assessment provides an in-depth case study which may be useful to other academic medical centers as they identify and plan for future needs.	[Geskin, Albert; Legowski, Elizabeth; Chakka, Anish; Chandran, Uma R.; LaFramboise, William A.; Jacobson, Rebecca S.] Univ Pittsburgh, Sch Med, Dept Biomed Informat, Pittsburgh, PA 15213 USA; [Chakka, Anish; Chandran, Uma R.; LaFramboise, William A.; Jacobson, Rebecca S.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Barmada, M. Michael; Berg, Jeremy; Jacobson, Rebecca S.] Univ Pittsburgh, Sch Med, Inst Personalized Med, Pittsburgh, PA USA; [Barmada, M. Michael] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jacobson, RS (corresponding author), Univ Pittsburgh, Sch Med, Dept Biomed Informat, Pittsburgh, PA 15213 USA.	rebeccaj@pitt.edu	Berg, Jeremy/GRY-6706-2022; PAN, ZEQIANG/X-6341-2018	Berg, Jeremy/0000-0002-2444-8139; Barmada, M Michael/0000-0002-3604-6460; Jacobson, Rebecca/0000-0002-5719-8340; Berg, Jeremy/0000-0003-3022-0963; Chakka, Anish Bhaswanth/0000-0002-1095-1817	University of Pittsburgh; UPMC through the Institute of Personalized Medicine; National Cancer Institute [P30CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER	University of Pittsburgh(University of Pittsburgh); UPMC through the Institute of Personalized Medicine; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded by University of Pittsburgh and UPMC through the Institute of Personalized Medicine. Additionally, this project used the UPCI Cancer Bioinformatics Services, which is supported in part by the National Cancer Institute award P30CA047904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2010, NAT METHODS, V7, P495, DOI 10.1038/nmeth0710-495; Bao RY, 2014, CANCER INFORM, V13, P67, DOI 10.4137/CIN.S13779; Bhuvaneshwar K, COMPUTATIONAL AND ST; Biesecker LG, 2014, NEW ENGL J MED, V370, P2418, DOI 10.1056/NEJMra1312543; Clarke L, 2012, NAT METHODS, V9, P1, DOI [10.1038/NMETH.1974, 10.1038/nmeth.1974]; Dudley JT, 2010, NAT BIOTECHNOL, V28, P1181, DOI 10.1038/nbt1110-1181; Dudley JT, 2010, GENOME MED, V2, DOI 10.1186/gm172; Dudley JT, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000589; Finotello F, 2015, BRIEF FUNCT GENOMICS, V14, P130, DOI 10.1093/bfgp/elu035; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Hayden EC, 2014, NATURE, V507, P294, DOI 10.1038/507294a; Heath AP, 2014, J AM MED INFORM ASSN, V21, P969, DOI 10.1136/amiajnl-2013-002155; Hey T, 2009, THE FOURTH PARADIGM; Howe D, 2008, NATURE, V455, P47, DOI 10.1038/455047a; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Lampa S, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-9; Lewitter F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000372; Lewitter F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000368; Liu B, 2014, J BIOMED INFORM, V49, P119, DOI 10.1016/j.jbi.2014.01.005; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Mardis E, 2014, DIS MODEL MECH, V7, P313, DOI 10.1242/dmm.015396; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Marx V, 2013, NAT METHODS, V10, P941, DOI 10.1038/nmeth.2654; Marx V, 2013, NATURE, V496, P253, DOI 10.1038/498255a; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Ng PC, 2010, METHODS MOL BIOL, V628, P215, DOI 10.1007/978-1-60327-367-1_12; Nowoczynksi P, 2012, PROCEEDINGS OF THE 1; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Pasquale F, 2014, STANFORD TECHNOLOGY; Rabbani B, 2014, J HUM GENET, V59, P5, DOI 10.1038/jhg.2013.114; Sboner A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-125; Schadt EE, 2010, NAT REV GENET, V11, P647, DOI 10.1038/nrg2857; Stein LD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-207; Technology E.C. H., 2013, NATURE, V507, P294; van Berkum Nynke L, 2010, J Vis Exp, DOI 10.3791/1869; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Welch L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003496; Wilson D, 2014, CLIENT SIDE ENCRYPTE	43	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131166	10.1371/journal.pone.0131166	http://dx.doi.org/10.1371/journal.pone.0131166			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115441	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000358147500133
J	Urena-Aranda, CA; Rojas-Soto, O; Martinez-Meyer, E; Yanez-Arenas, C; Ramirez, RL; de los Monteros, AE				Urena-Aranda, Cinthya A.; Rojas-Soto, Octavio; Martinez-Meyer, Enrique; Yanez-Arenas, Carlos; Landgrave Ramirez, Rosario; Espinosa de los Monteros, Alejandro			Using Range-Wide Abundance Modeling to Identify Key Conservation Areas for the Micro-Endemic Bolson Tortoise (Gopherus flavomarginatus)	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; BIOTIC INTERACTIONS; IMPROVE PREDICTION; MACROECOLOGY; SUITABILITY; PATTERNS; HABITAT; SCALES	A widespread biogeographic pattern in nature is that population abundance is not uniform across the geographic range of species: most occurrence sites have relatively low numbers, whereas a few places contain orders of magnitude more individuals. The Bolson tortoise Gopherus flavomarginatus is endemic to a small region of the Chihuahuan Desert in Mexico, where habitat deterioration threatens this species with extinction. In this study we combined field burrows counts and the approach for modeling species abundance based on calculating the distance to the niche centroid to obtain range-wide abundance estimates. For the Bolson tortoise, we found a robust, negative relationship between observed burrows abundance and distance to the niche centroid, with a predictive capacity of 71%. Based on these results we identified four priority areas for the conservation of this microendemic and threatened tortoise. We conclude that this approach may be a useful approximation for identifying key areas for sampling and conservation efforts in elusive and rare species.	[Urena-Aranda, Cinthya A.] Inst Ecol AC, Div Posgrad, Xalapa, Veracruz, Mexico; [Urena-Aranda, Cinthya A.; Rojas-Soto, Octavio; Espinosa de los Monteros, Alejandro] Inst Ecol AC, Biol Evolut, Xalapa, Veracruz, Mexico; [Martinez-Meyer, Enrique] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Mexico City 04510, DF, Mexico; [Landgrave Ramirez, Rosario] Inst Ecol AC, Ecol Func, Xalapa, Veracruz, Mexico	Instituto de Ecologia - Mexico; Instituto de Ecologia - Mexico; Universidad Nacional Autonoma de Mexico; Instituto de Ecologia - Mexico	de los Monteros, AE (corresponding author), Inst Ecol AC, Biol Evolut, Xalapa, Veracruz, Mexico.	alejandro.espinosa@inecol.mx	Rojas-Soto, Octavio/Q-6252-2018; Espinosa de los Monteros, Alejandro/Q-6207-2018; Yañez-Arenas, Carlos/X-6091-2018	Rojas-Soto, Octavio/0000-0002-0201-1454; Espinosa de los Monteros, Alejandro/0000-0002-7742-5977; Yañez-Arenas, Carlos/0000-0002-6299-275X; Martinez-Meyer, Enrique/0000-0003-1184-9264	Mexican Council of Science and Technology CONACyT [235792/213554]	Mexican Council of Science and Technology CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The Instituto de Ecologia, A.C. and its Graduate Studies office provided support during the studies of CAUA, who was awarded a Doctorate Scholarship by the Mexican Council of Science and Technology CONACyT (No. 235792/213554). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adest Gary A., 1989, Vida Silvestre Neotropical, V2, P7; Aguirre G, 1997, CONSERVATION RESTORA, P333; Aguirre G, 1995, P N AM TORT C SOC HE, P6; Urena-Aranda CA, 2012, AMPHIBIA-REPTILIA, V33, P45, DOI 10.1163/156853811X621508; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Auffenberg W., 1969, BIOL SCI CURRICULUM; Avery HW, 1997, CONSERVATION RSTORAT, P13; Barve N, 2008, TOOL PARTIAL ROC; Boarman WI, 2002, SENSITIVE ANIMALS PL, P1; Brown J. H., 1995, MACROECOLOGY; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Bury R.B., 1988, Annals of Carnegie Museum, V57, P5; Chefaoui RM, 2005, BIOL CONSERV, V122, P327, DOI 10.1016/j.biocon.2004.08.005; CORNET A F, 1988, P221; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Figueiredo MSL, 2009, DIVERS DISTRIB, V15, P117, DOI 10.1111/j.1472-4642.2008.00525.x; Gaston K.J., 1994, RARITY, P1; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; Gaston KJ, 1996, J ANIM ECOL, V65, P701, DOI 10.2307/5669; Gonzalez T.R., 2006, REPTILIA, V62, P26; Guo QF, 2000, J ECOL, V88, P551, DOI 10.1046/j.1365-2745.2000.00466.x; He FL, 2000, AM NAT, V156, P553, DOI 10.1086/303403; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hutchinson G. E., 1957, QUANTITATIVE BIOL, V22, P415, DOI DOI 10.1111/J.2008.0030-1299.16434.X; Hwang WH, 2011, METHODS ECOL EVOL, V2, P550, DOI 10.1111/j.2041-210X.2011.00105.x; Jimenez-Valverde A, 2009, ANN ZOOL FENN, V46, P451, DOI 10.5735/086.046.0606; Kazmaier RT, 2001, CONSERV BIOL, V15, P1091, DOI 10.1046/j.1523-1739.2001.0150041091.x; Krabbe MB, 2010, Q REV BIOL, V85, P31, DOI [10.1086/650265, DOI 10.1086/650265]; Kunin WE, 1998, SCIENCE, V281, P1513, DOI 10.1126/science.281.5382.1513; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Leathwick JR, 2002, BIODIVERS CONSERV, V11, P2177, DOI 10.1023/A:1021394628607; Lieberman S.S., 1988, Annals of Carnegie Museum, V57, P31; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Luoto M, 2001, ECOGRAPHY, V24, P601, DOI 10.1034/j.1600-0587.2001.d01-215.x; MAGUIRE B, 1973, AM NAT, V107, P213, DOI 10.1086/282827; Martinez-Meyer E, 2006, ORYX, V40, P411, DOI 10.1017/S0030605306001360; Martinez-Meyer E, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0637; MAUER BA, 1994, RES EXPLOR, V10, P306; Maurer B. A, 1994, GEOGRAPHICAL POPULAT; Maurer BA, 2002, ECOL LETT, V5, P223, DOI 10.1046/j.1461-0248.2002.00308.x; Meier ES, 2010, ECOGRAPHY, V33, P1038, DOI 10.1111/j.1600-0587.2010.06229.x; Morafka D.J., 1988, Annals of Carnegie Museum, V57, P47; Morafka D.J., 1982, N AM TORTOISES CONSE, P71; Morafka DJ, 1989, CONSERVATION BIOL TO, P10; Morafka DJ, 1978, BIOGEOGRAPHICAL ANAL, P159; Murray BR, 1998, J ANIM ECOL, V67, P567, DOI 10.1046/j.1365-2656.1998.00217.x; Oliver TH, 2012, J APPL ECOL, V49, P581, DOI 10.1111/j.1365-2664.2012.02138.x; Pearce J, 2001, BIOL CONSERV, V98, P33, DOI 10.1016/S0006-3207(00)00139-7; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rzedowski J., 1978, VEGETACION MEXICO; SEMARNAT, 2010, PROTECCION AMBIENTAL; Thuiller W, 2010, BIOL LETTERS, V6, P120, DOI 10.1098/rsbl.2009.0669; Torres NM, 2012, DIVERS DISTRIB, V18, P615, DOI 10.1111/j.1472-4642.2012.00892.x; Tosh CA, 2004, ANIM CONSERV, V7, P55, DOI 10.1017/S1367943003001112; Trevino E, 1997, CONSERVATION RESTORA, P417; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Williams RAJ, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-47; Yanez-Arenas C, 2012, OIKOS, V121, P2081, DOI 10.1111/j.1600-0706.2012.20350.x; Yu JP, 2000, J BIOGEOGR, V27, P131, DOI 10.1046/j.1365-2699.2000.00366.x	61	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131452	10.1371/journal.pone.0131452	http://dx.doi.org/10.1371/journal.pone.0131452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115482	gold, Green Published, Green Submitted			2022-12-27	WOS:000358147500160
J	Daiha, KD; Angeli, R; de Oliveira, SD; Almeida, RV				Daiha, Karina de Godoy; Angeli, Renata; de Oliveira, Sabrina Dias; Almeida, Rodrigo Volcan			Are Lipases Still Important Biocatalysts? A Study of Scientific Publications and Patents for Technological Forecasting	PLOS ONE			English	Article							BIODIESEL PRODUCTION; INDUSTRIAL; ENZYMES	The great potential of lipases is known since 1930 when the work of J. B. S. Haldane was published. After eighty-five years of studies and developments, are lipases still important biocatalysts? For answering this question the present work investigated the technological development of four important industrial sectors where lipases are applied: production of detergent formulations; organic synthesis, focusing on kinetic resolution, production of biodiesel, and production of food and feed products. The analysis was made based on research publications and patent applications, working as scientific and technological indicators, respectively. Their evolution, interaction, the major players of each sector and the main subject matters disclosed in patent documents were discussed. Applying the concept of technology life cycle, S-curves were built by plotting cumulative patent data over time to monitor the attractiveness of each technology for investment. The results lead to a conclusion that the use of lipases as biocatalysts is still a relevant topic for the industrial sector, but developments are still needed for lipase biocatalysis to reach its full potential, which are expected to be achieved within the third, and present, wave of biocatalysis.	[Daiha, Karina de Godoy; Almeida, Rodrigo Volcan] Univ Fed Rio de Janeiro, Dept Bioquim, Rio De Janeiro, Brazil; [Angeli, Renata] Ctr Univ Estadual Zona Oeste, Unidade Biol, Rio De Janeiro, Brazil; [de Oliveira, Sabrina Dias] Univ Fed Rio de Janeiro, Agencia Inovacao, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Centro Universitario Estadual da Zona Oeste; Universidade Federal do Rio de Janeiro	Daiha, KD (corresponding author), Univ Fed Rio de Janeiro, Dept Bioquim, Rio De Janeiro, Brazil.	karinadaiha@gmail.com; volcan@iq.ufrj.br	Almeida, Rodrigo/AAE-3019-2019; Almeida, Rodrigo/GZH-0682-2022; Almeida, Rodrigo V/I-4362-2013	Almeida, Rodrigo/0000-0002-0164-6044; Almeida, Rodrigo V/0000-0002-0164-6044	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Karina's scholarship was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. The other authors received no specific funding for this work.	Aravindan R., 2007, Indian Journal of Biotechnology, V6, P141; Bassegoda A, 2012, COMPUT STRUCT BIOTEC, V2, DOI 10.5936/csbj.201209005; Blaser HU, 2013, REND LINCEI-SCI FIS, V24, P213, DOI 10.1007/s12210-012-0220-2; Blue Sun Biodiesel, 2014, BLUE SUN MOST ADV BI; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Breuer M, 2004, ANGEW CHEM INT EDIT, V43, P788, DOI 10.1002/anie.200300599; Callan B, 1997, SCI PUBL POLICY, V24, P146; Chiu YJ, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/273530; Christopher LP, 2014, APPL ENERG, V119, P497, DOI 10.1016/j.apenergy.2014.01.017; DSM, 2015, ROYAL DSM INT ANN RE; Ernst H, 1997, SMALL BUS ECON, V9, P361, DOI 10.1023/A:1007921808138; Fjerbaek L, 2009, BIOTECHNOL BIOENG, V102, P1298, DOI 10.1002/bit.22256; Freedonia Group, 2014, WORLD ENZ REP; Garcia-Urdiales E, 2011, CHEM REV, V111, pPR110, DOI 10.1021/cr100330u; Gerken JM, 2014, R&D MANAGE, P1; Ghaly A. E., 2010, American Journal of Biochemistry and Biotechnology, V6, P54; Ghanem A, 2004, TETRAHEDRON-ASYMMETR, V15, P3331, DOI 10.1016/j.tetasy.2004.09.019; Gotor-Fernandez V, 2006, J MOL CATAL B-ENZYM, V40, P111, DOI 10.1016/j.molcatb.2006.02.010; Haldane J. B. S., 1930, MONOGRAPHS BIOCH ENZ, P102; Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016; Intepe G, 2012, WORLD ACAD SCI ENG T, V6, P11; Jaeger KE, 1998, TRENDS BIOTECHNOL, V16, P396, DOI 10.1016/S0167-7799(98)01195-0; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Kikkawa T, 2011, CHEM CHEM IND, V64, P559; KLIBANOV AM, 1989, TRENDS BIOCHEM SCI, V14, P141, DOI 10.1016/0968-0004(89)90146-1; Koskinen A., 1996, ENZYMATIC REACTIONS, DOI [10.1007/978-94-011-0611-5_11, DOI 10.1007/978-94-011-0611-5_11]; KPMG International, 2011, JAP CHEM IND FIND RI; Li Shuang, 2012, Comput Struct Biotechnol J, V2, pe201209017, DOI 10.5936/csbj.201209017; Liu CY, 2010, SCIENTOMETRICS, V82, P21, DOI 10.1007/s11192-009-0055-5; Liu JS, 2011, SOL ENERG MAT SOL C, V95, P3130, DOI 10.1016/j.solmat.2011.07.002; Liu WF, 2007, BIOTECHNOL ADV, V25, P369, DOI 10.1016/j.biotechadv.2007.03.002; MARGOLIN AL, 1993, ENZYME MICROB TECH, V15, P266, DOI 10.1016/0141-0229(93)90149-V; Matsuda T, 2009, TETRAHEDRON-ASYMMETR, V20, P513, DOI 10.1016/j.tetasy.2008.12.035; Meyer HP, 2013, CATAL SCI TECHNOL, V3, P29, DOI 10.1039/c2cy20350b; Meyer HP, 2013, BIOCATALYSIS GREEN C, P23; MEYER P, 1994, TECHNOL FORECAST SOC, V47, P89, DOI 10.1016/0040-1625(94)90042-6; Novozymes S/A, 2014, NOV REP; Otto R., 2014, RAPID GROWTH BIOPHAR; Palomo JM, 2012, CURR ORG SYNTH, V9, P791, DOI 10.2174/157017912803901628; Schafer T, 2005, BIOPOLYMERS, V7, P377; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Schulze B, 1999, CURR OPIN BIOTECH, V10, P609, DOI 10.1016/S0958-1669(99)00042-7; Sharma R, 2001, BIOTECHNOL ADV, V19, P627, DOI 10.1016/S0734-9750(01)00086-6; Tan TW, 2010, BIOTECHNOL ADV, V28, P628, DOI 10.1016/j.biotechadv.2010.05.012; Taylor M, 2012, INT J PROD ECON, V140, P541, DOI 10.1016/j.ijpe.2012.07.006; The Rockefeller University, 2013, LOG AN LOGL LAB 2; Trusheim MR, 2010, FRONTIERS HLTH POLIC, V13, P1, DOI DOI 10.2202/1558-9544.1200; Tufvesson P, 2011, BIOTECHNOL BIOENG, V108, P1479, DOI 10.1002/bit.23154; Viesel Fuel, 2014, ENY PROC OV; Watson WJW, 2012, GREEN CHEM, V14, P251, DOI 10.1039/c1gc15904f; Wenda S, 2011, GREEN CHEM, V13, P3007, DOI 10.1039/c1gc15579b; Wu CY, 2014, NATURE, V509, P427, DOI 10.1038/509427e; Zhang JJ, 2015, PHARM TECHNOLOGY SOU, V11	54	63	64	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131624	10.1371/journal.pone.0131624	http://dx.doi.org/10.1371/journal.pone.0131624			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111144	gold, Green Submitted, Green Published			2022-12-27	WOS:000356933800164
J	Fujita, T; Chiwaki, F; Takahashi, RU; Aoyagi, K; Yanagihara, K; Nishimura, T; Tamaoki, M; Komatsu, M; Komatsuzaki, R; Matsusaki, K; Ichikawa, H; Sakamoto, H; Yamada, Y; Fukagawa, T; Katai, H; Konno, H; Ochiya, T; Yoshida, T; Sasaki, H				Fujita, Takeshi; Chiwaki, Fumiko; Takahashi, Ryou-u; Aoyagi, Kazuhiko; Yanagihara, Kazuyoshi; Nishimura, Takao; Tamaoki, Masashi; Komatsu, Masayuki; Komatsuzaki, Rie; Matsusaki, Keisuke; Ichikawa, Hitoshi; Sakamoto, Hiromi; Yamada, Yasuhide; Fukagawa, Takeo; Katai, Hitoshi; Konno, Hiroyuki; Ochiya, Takahiro; Yoshida, Teruhiko; Sasaki, Hiroki			Identification and Characterization of CXCR4-Positive Gastric Cancer Stem Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; INITIATING CELLS; TGF-BETA; TUMOR HETEROGENEITY; SCIRRHOUS CARCINOMA; COLORECTAL-CANCER; METASTASIS; SURVIVAL; STOMACH; GROWTH	Diffuse-type solid tumors are often composed of a high proportion of rarely proliferating (i.e., dormant) cancer cells, strongly indicating the involvement of cancer stem cells (CSCs) Although diffuse-type gastric cancer (GC) patients have a poor prognosis due to high-frequent development of peritoneal dissemination (PD), it is limited knowledge that the PD-associated CSCs and efficacy of CSC-targeting therapy in diffuse-type GC. In this study, we established highly metastatic GC cell lines by in vivo selection designed for the enrichment of PD-associated GC cells. By microarray analysis, we found C-X-C chemokine receptor type 4 (CXCR4) can be a novel marker for highly metastatic CSCs, since CXCR4-positive cells can grow anchorage-independently, initiate tumors in mice, be resistant to cytotoxic drug, and produce differentiated daughter cells. In clinical samples, these CXCR4-positive cells were found from not only late metastasis stage (accumulated ascites) but also earlier stage (peritoneal washings). Moreover, treatment with transforming growth factor-beta enhanced the anti-cancer effect of docetaxel via induction of cell differentiation/asymmetric cell division of the CXCR4-positive gastric CSCs even in a dormant state. Therefore, differentiation inducers hold promise for obtaining the maximum therapeutic outcome from currently available anti-cancer drugs through re-cycling of CSCs.	[Fujita, Takeshi; Chiwaki, Fumiko; Aoyagi, Kazuhiko; Nishimura, Takao; Tamaoki, Masashi; Komatsu, Masayuki; Komatsuzaki, Rie; Sasaki, Hiroki] Natl Canc Ctr, Dept Translat Oncol, Tokyo, Japan; [Takahashi, Ryou-u; Ochiya, Takahiro] Natl Canc Ctr, Div Mol & Cellular Med, Tokyo, Japan; [Ichikawa, Hitoshi] Natl Canc Ctr, Dept Clin Genom, Tokyo, Japan; [Ichikawa, Hitoshi; Sakamoto, Hiromi; Yoshida, Teruhiko] Natl Canc Ctr, Dept Translat Oncol, Tokyo, Japan; [Yamada, Yasuhide] Natl Canc Ctr, Gastrointestinal Med Oncol, Tokyo, Japan; [Fukagawa, Takeo; Katai, Hitoshi] Natl Canc Ctr, Gastr Surg Div, Tokyo, Japan; [Yanagihara, Kazuyoshi] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Translat Res, Chiba, Japan; [Matsusaki, Keisuke] Kanamecho Hosp, Tokyo, Japan; [Konno, Hiroyuki] Hamamatsu Univ, Sch Med, Dept Surg 2, Shizuoka, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Hamamatsu University School of Medicine	Sasaki, H (corresponding author), Natl Canc Ctr, Dept Translat Oncol, Tokyo, Japan.	hksasaki@ncc.go.jp	Ochiya, Takahiro/AAH-7585-2019; Yamada, Yasuhide/AAH-9124-2020		National Institute of Biomedical Innovation [ID10-41]; Ministry of Health, Labour and Welfare of Japan [H22-007]; National Cancer Center Research and Development Fund [25-A-6, 26-A-3]; Foundation for Promotion of Cancer Research in Japan; Grants-in-Aid for Scientific Research [15K14389] Funding Source: KAKEN	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Foundation for Promotion of Cancer Research in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the National Institute of Biomedical Innovation (for the Advanced Research for Medical Products Mining Programme ID10-41), the Ministry of Health, Labour and Welfare of Japan (for the Third Comprehensive 10-Year Strategy for Cancer Control H22-007), National Cancer Center Research and Development Fund (25-A-6, 26-A-3). Drs T Fujita, M Tamaoki and T Nishimura are the recipients of a Research Resident Fellowship from the Foundation for Promotion of Cancer Research in Japan.	Bao W, 2011, GASTROENTEROLOGY, V141, P2076, DOI 10.1053/j.gastro.2011.08.050; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Blagosklonny MV, 2005, CELL CYCLE, V4, P1693, DOI 10.4161/cc.4.12.2259; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Campbell LL, 2007, CELL CYCLE, V6, P2332, DOI 10.4161/cc.6.19.4914; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dd Shipitsin M, 2007, CANCER CELL, V11, P259; Ehata S, 2011, ONCOGENE, V30, P1693, DOI 10.1038/onc.2010.546; Fujita T, 2013, CANCER SCI, V104, P214, DOI 10.1111/cas.12054; Fukagawa T, 2010, WORLD J SURG, V34, P563, DOI 10.1007/s00268-009-0355-1; Fukaya M, 2006, GASTROENTEROLOGY, V131, P14, DOI 10.1053/j.gastro.2006.05.008; Grichnik JM, 2006, J INVEST DERMATOL, V126, P142, DOI 10.1038/sj.jid.5700017; HEPPNER GH, 1983, CANCER METAST REV, V2, P5, DOI 10.1007/BF00046903; Hoshino Y, 2015, AM J PATHOL, V185, P1457, DOI 10.1016/j.ajpath.2015.01.011; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Japanese Gastric Cancer Association Registration Committee, 2006, Gastric Cancer, V9, P51; Kinugasa S, 1998, ONCOLOGY-BASEL, V55, P582, DOI 10.1159/000011916; Komuro A, 2009, JNCI-J NATL CANCER I, V101, P592, DOI 10.1093/jnci/djp058; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nakamura R, 2007, INT J CLIN ONCOL, V12, P291, DOI 10.1007/s10147-007-0683-9; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ohta H, 2009, BRIT J CANCER, V100, P389, DOI 10.1038/sj.bjc.6604846; Polyak K, 2006, NAT MED, V12, P296, DOI 10.1038/nm1379; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Saeki N, 2011, GASTROENTEROLOGY, V140, P892, DOI 10.1053/j.gastro.2010.10.058; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Taichman RS, 2002, CANCER RES, V62, P1832; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Vagenas K, 2007, J SURG RES, V139, P182, DOI 10.1016/j.jss.2006.10.005; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Yamaguchi H, 2009, CANCER RES, V69, P8594, DOI 10.1158/0008-5472.CAN-09-2305; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yanagihara K, 2005, CANCER SCI, V96, P323, DOI 10.1111/j.1349-7006.2005.00054.x; Yanagihara K, 2004, CANCER SCI, V95, P575, DOI 10.1111/j.1349-7006.2004.tb02489.x; YANAGIHARA K, 1991, CANCER RES, V51, P381; Yasumoto K, 2006, CANCER RES, V66, P2181, DOI 10.1158/0008-5472.CAN-05-3393	50	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130808	10.1371/journal.pone.0130808	http://dx.doi.org/10.1371/journal.pone.0130808			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110809	gold, Green Published, Green Submitted			2022-12-27	WOS:000356933800087
J	Huang, GL; Zhu, H; Shi, YX; Wu, WZ; Cai, HJ; Chen, XJ				Huang, Guanli; Zhu, Hua; Shi, Yixiong; Wu, Wenzhi; Cai, Huajie; Chen, Xiangjian			cir-ITCH Plays an Inhibitory Role in Colorectal Cancer by Regulating the Wnt/beta-Catenin Pathway	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; UBIQUITIN LIGASE ITCH; CIRCULAR RNAS; CHINESE POPULATIONS; IDENTIFICATION; TUMORIGENESIS; POLYMORPHISM; DEGRADATION; SPONGES; GROWTH	Noncoding RNAs (ncRNAs) are the dominant product of eukaryotic transcription. These products range from short microRNAs (miRNAs) to long intergenic noncoding RNAs (lincRNAs). Circular RNAs composed of exonic sequences represent an understudied form of ncRNA that was discovered more than 20 years ago. Using a TaqMan-based reverse transcriptase polymerase chain reaction assay, we analyzed the relationship between cir-ITCH expression and colorectal cancer (CRC) in a total of 45 CRCs and paired adjacent nontumor tissue samples. We found that cir-ITCH expression was typically down-regulated in CRC compared to the peritumoral tissue. This result, as well as several follow-up experiments, showed that cir-ITCH could increase the level of ITCH, which is involved in the inhibition of the Wnt/beta-catenin pathway. Therefore, our results showed that cir-ITCH plays a role in CRC by regulating the Wnt/beta-catenin pathway.	[Huang, Guanli] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg Oncol, Wenzhou, Zhejiang, Peoples R China; [Zhu, Hua] Wenzhou Med Univ, Affiliated Hosp 1, Dept Obstet, Wenzhou, Zhejiang, Peoples R China; [Zhu, Hua] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gynecol, Wenzhou, Zhejiang, Peoples R China; [Shi, Yixiong; Wu, Wenzhi] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Wenzhou, Zhejiang, Peoples R China; [Cai, Huajie; Chen, Xiangjian] Wenzhou Med Univ, Affiliated Hosp 1, Dept Endoscop Surg, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Chen, XJ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Endoscop Surg, Wenzhou, Zhejiang, Peoples R China.	wz1370666@126.com			Wenzhou Science and Technology Bureau Natural Science Foundation [Y20140700]	Wenzhou Science and Technology Bureau Natural Science Foundation	This work was supported by a grant from Wenzhou Science and Technology Bureau Natural Science Foundation (Y20140700 Dr. XC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Chastagner P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002735; Chen DL, 2014, HEPATOLOGY, V60, P598, DOI 10.1002/hep.27118; Chu CY, 2007, J CELL PHYSIOL, V213, P412, DOI 10.1002/jcp.21230; Danan M, 2012, NUCLEIC ACIDS RES, V40, P3131, DOI 10.1093/nar/gkr1009; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; He YJ, 2006, WORLD J GASTROENTERO, V12, P4981, DOI 10.3748/wjg.v12.i31.4981; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Jiang L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3225; Kubo N, 2010, BIOCHEM BIOPH RES CO, V403, P405, DOI 10.1016/j.bbrc.2010.11.043; Lehmann U, 2001, METHODS, V25, P409, DOI 10.1006/meth.2001.1263; Li F, 2015, ONCOTARGET; Li N, 2014, CARCINOGENESIS, V35, P2687, DOI 10.1093/carcin/bgu201; Li W, 2014, GASTROENTEROLOGY, V146, P1714, DOI 10.1053/j.gastro.2014.03.002; Liu YC, 2013, INT J BIOCHEM CELL B, V45, P2643, DOI 10.1016/j.biocel.2013.09.003; Luo XY, 2011, CANCER EPIDEM BIOMAR, V20, P1272, DOI 10.1158/1055-9965.EPI-11-0035; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Sampath D, 2009, BLOOD, V113, P3744, DOI 10.1182/blood-2008-09-178707; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Vincent HA, 2009, J MOL BIOL, V387, P570, DOI 10.1016/j.jmb.2009.01.068; Wei W, 2012, MOL CELL BIOL, V32, P3903, DOI 10.1128/MCB.00251-12; Wu H, 2015, ONCOGENE, V34, P4723, DOI 10.1038/onc.2014.400; Wu HC, 2015, MOL CARCINOGEN, V54, P102, DOI 10.1002/mc.22078; Wu HC, 2013, CARCINOGENESIS, V34, P2908, DOI 10.1093/carcin/bgt252; Ye Q, 2015, CARCINOGENESIS, V36, P318, DOI 10.1093/carcin/bgv003; Zhang N, 2013, ONCOGENE, V32, P5078, DOI 10.1038/onc.2012.526	31	233	260	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131225	10.1371/journal.pone.0131225	http://dx.doi.org/10.1371/journal.pone.0131225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110611	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800132
J	Ling, SSM; Khoo, LHB; Hwang, LA; Yeoh, KG; Ho, B				Ling, Samantha Shi Min; Khoo, Lawrence Han Boon; Hwang, Le-Ann; Yeoh, Khay Guan; Ho, Bow			Instrumental Role of Helicobacter pylori gamma-Glutamyl Transpeptidase in VacA- Dependent Vacuolation in Gastric Epithelial Cells	PLOS ONE			English	Article							PEPTIC-ULCER; GASTRODUODENAL DISEASES; HELA-CELLS; TOXIN; CYTOTOXIN; INFECTION; PROTEIN; COLONIZATION; PATHOGENESIS; EXPRESSION	Helicobacter pylori causes cellular vacuolation in host cells, a cytotoxic event attributed to vacuolating cytotoxin (VacA) and the presence of permeant weak bases such as ammonia. We report here the role of gamma-glutamyl transpeptidase (GGT), a constitutively expressed secretory enzyme of H. pylori, in potentiating VacA-dependent vacuolation formation in H. pylori-infected AGS and primary gastric cells. The enhancement is brought about by GGT hydrolysing glutamine present in the extracellular medium, thereby releasing ammonia which accentuates the VacA-induced vacuolation. The events of vacuolation in H. pylori wild type (WT)-and Delta ggt-infected AGS cells were first captured and visualized by real-time phase-contrast microscopy where WT was observed to induce more vacuoles than Delta ggt. By using semi-quantitative neutral red uptake assay, we next showed that Delta ggt induced significantly less vacuolation in AGS and primary gastric epithelial cells as compared to the parental strain (P<0.05) indicating that GGT potentiates the vacuolating effect of VacA. Notably, vacuolation induced by WT was significantly reduced in the absence of GGT substrate, glutamine (P<0.05) or in the presence of a competitive GGT inhibitor, serine-borate complex. Furthermore, the vacuolating ability of Delta ggt was markedly restored when co-incubated with purified recombinant GGT (rGGT), although rGGT itself did not induce vacuolation independently. Similarly, the addition of exogenous ammonium chloride as a source of ammonia also rescued the ability of Delta ggt to induce vacuolation. Additionally, we also show that monoclonal antibodies against GGT effectively inhibited GGT activity and successfully suppressed H. pylori-induced vacuolation. Collectively, our results clearly demonstrate that generation of ammonia by GGT through glutamine hydrolysis is responsible for enhancing VacA-dependent vacuolation. Our findings provide a new perspective on GGT as an important virulence factor and a promising target in the management of H. pylori-associated gastric diseases.	[Ling, Samantha Shi Min; Ho, Bow] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore; [Khoo, Lawrence Han Boon; Hwang, Le-Ann] Natl Univ Singapore, Inst Mol & Cell Biol, Monoclonal Antibody Unit, Singapore 117548, Singapore; [Yeoh, Khay Guan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore	Ho, B (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore.	bow_ho@nuhs.edu.sg	Khoo, Lawrence/GYD-6260-2022		Singapore National Medical Research Council [R182000180213]; National University of Singapore [N182000002091]; National University Health System [R182000264733]	Singapore National Medical Research Council(National Medical Research Council, Singapore); National University of Singapore(National University of Singapore); National University Health System	This work was supported by grants from Singapore National Medical Research Council [R182000180213], National University of Singapore [N182000002091] and National University Health System [R182000264733]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; BOS KD, 1985, CLIN CHIM ACTA, V152, P205, DOI 10.1016/0009-8981(85)90193-7; Busiello I, 2004, CELL MICROBIOL, V6, P255, DOI 10.1046/j.1462-5822.2004.00366.x; Chevalier C, 1999, MOL MICROBIOL, V31, P1359, DOI 10.1046/j.1365-2958.1999.01271.x; Chiozzi V, 2009, J PHYSIOL PHARMACOL, V60, P23; COVER TL, 1993, INFECT IMMUN, V61, P1427, DOI 10.1128/IAI.61.4.1427-1431.1993; COVER TL, 1992, J INFECT DIS, V166, P1073, DOI 10.1093/infdis/166.5.1073; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; COVER TL, 1991, INFECT IMMUN, V59, P1264, DOI 10.1128/IAI.59.4.1264-1270.1991; COVER TL, 1992, J BIOL CHEM, V267, P10570; Cover TL, 1996, ADV INTERNAL MED, V41, P85; de Bernard M, 1998, TOXICOL LETT, V99, P109, DOI 10.1016/S0378-4274(98)00140-4; Figura N, 1996, ALIMENT PHARM THER, V10, P79, DOI 10.1046/j.1365-2036.1996.22164009.x; FIOCCA R, 1994, SCAND J GASTROENTERO, V29, P11, DOI 10.3109/00365529409091404; Gong M, 2004, WORLD J GASTROENTERO, V10, P2994; Gong M, 2010, GASTROENTEROLOGY, V139, P564, DOI 10.1053/j.gastro.2010.03.050; HESSEY SJ, 1990, GUT, V31, P134, DOI 10.1136/gut.31.2.134; Hoffman PS, 2003, INFECT IMMUN, V71, P2534, DOI 10.1128/IAI.71.5.2534-2541.2003; KONISHI H, 1992, J MED MICROBIOL, V37, P118, DOI 10.1099/00222615-37-2-118; Leduc D, 2010, INFECT IMMUN, V78, P2782, DOI 10.1128/IAI.00149-10; Lip KM, 2006, J VIROL, V80, P941, DOI 10.1128/JVI.80.2.941-950.2006; MARSHALL BJ, 1984, LANCET, V1, P1311; MEGRAUD F, 1985, J CLIN MICROBIOL, V22, P1007, DOI 10.1128/JCM.22.6.1007-1010.1985; Morbiato L, 2001, FEBS LETT, V508, P479, DOI 10.1016/S0014-5793(01)03133-7; PAPINI E, 1994, P NATL ACAD SCI USA, V91, P9720, DOI 10.1073/pnas.91.21.9720; RICCI V, 1993, FEBS LETT, V334, P158, DOI 10.1016/0014-5793(93)81703-3; Ricci V, 1997, J PATHOL, V183, P453; Schmees C, 2007, GASTROENTEROLOGY, V132, P1820, DOI 10.1053/j.gastro.2007.02.031; Shanjana A, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-31; Shibayama K, 2003, MOL MICROBIOL, V47, P443, DOI 10.1046/j.1365-2958.2003.03305.x; Shibayama K, 2007, MOL MICROBIOL, V64, P396, DOI 10.1111/j.1365-2958.2007.05661.x; Smoot DT, 1996, GUT, V39, P795, DOI 10.1136/gut.39.6.795; Smoot Duane T., 2000, Methods in Cell Science, V22, P133, DOI 10.1023/A:1009846624044; Tan SM, 2004, J BACTERIOL, V186, P885, DOI 10.1128/JB.186.3.885-888.2004; TATE SS, 1978, P NATL ACAD SCI USA, V75, P4806, DOI 10.1073/pnas.75.10.4806; TELFORD JL, 1994, J EXP MED, V179, P1653, DOI 10.1084/jem.179.5.1653; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; TRICOTTET V, 1986, ULTRASTRUCT PATHOL, V10, P113, DOI 10.3109/01913128609014587; Yamasaki E, 2006, J BIOL CHEM, V281, P11250, DOI 10.1074/jbc.M509404200; Zheng PY, 2000, GUT, V47, P18, DOI 10.1136/gut.47.1.18	40	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131460	10.1371/journal.pone.0131460	http://dx.doi.org/10.1371/journal.pone.0131460			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111186	Green Submitted, gold, Green Published			2022-12-27	WOS:000356933800152
J	Liu, J; Zhu, L; Xie, GL; Bao, JF; Yu, Q				Liu, Jun; Zhu, Lin; Xie, Guang-liang; Bao, Jing-fang; Yu, Qing			Let-7 miRNAs Modulate the Activation of NF-kappa B by Targeting TNFAIP3 and Are Involved in the Pathogenesis of Lupus Nephritis	PLOS ONE			English	Article							MESANGIAL CELLS; EXPRESSION; MICRORNAS; ALPHA; A20; MOLECULES; VARIANTS; PATHWAY; DISEASE	TNFAIP3 is a ubiquitin-editing enzyme that negatively regulates multiple NF-kappa B signaling pathways and dysregulation of TNFAIP3 is related to systemic lupus erythematosus (SLE). Although there exists evidence indicating that microRNAs (miRNAs) modulate the expression of TNFAIP3, whether and how miRNAs regulate TNFAIP3 and contribute to lupus nephritis (LN) is still not well understood. In this study, we screened eleven selected miRNAs that potentially regulated TNFAIP3 expression by dual luciferase assay and found that Let-7 miRNAs repressed TNFAIP3 expression by targeting the 3'UTR of TNFAIP3 mRNA. Overexpression of Let-7 miRNAs led to increased phosphorylation and sustained degradation of I kappa B alpha and enhanced phosphorylation of p65 following TNF alpha stimulation and promoted SeV-induced production of cytokines in HEK293T cells. In addition, the expression of Let-7 miRNAs was significantly up-regulated, and TNFAIP3 level was remarkably down-regulated in samples from LN patients compared control samples. Our findings have uncovered Let-7-TNFAIP3-NF-kappa B pathway that is involved in LN and thus provided a potential target for therapeutic intervention.	[Liu, Jun; Zhu, Lin; Xie, Guang-liang; Bao, Jing-fang; Yu, Qing] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Nephrol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Yu, Q (corresponding author), Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Nephrol, Shanghai 200030, Peoples R China.	yuqingsh2014@sina.com			Shanghai Committee of Science and Technology Foundation [14411963300]	Shanghai Committee of Science and Technology Foundation	This research is funded by the Shanghai Committee of Science and Technology Foundation (http://www.stcsm.gov.cn/), and the funding number is 14411963300. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Arthritis Rheum, V60 Suppl 10, P1, DOI 10.1002/art.27423; Ashizawa M, 2003, AM J KIDNEY DIS, V42, P76, DOI 10.1016/S0272-6386(03)00411-6; Bronze-da-Rocha E, 2012, J CLIN IMMUNOL, V32, P721, DOI 10.1007/s10875-012-9665-4; Chafin CB, 2013, AUTOIMMUNITY, V46, P351, DOI 10.3109/08916934.2013.773976; DALCANTON A, 1995, KIDNEY INT, V48, P1687, DOI 10.1038/ki.1995.466; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; FUKATSU A, 1993, LAB INVEST, V69, P58; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Imaizumi T, 2015, CLIN EXP NEPHROL, V19, P75, DOI 10.1007/s10157-014-0956-3; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; Lewis E, 2005, LUPUS, V14, P31, DOI 10.1191/0961203305lu2056oa; Li D, 2012, J CLIN IMMUNOL, V32, P1287, DOI 10.1007/s10875-012-9764-2; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Lu J, 2012, NEPHROLOGY, V17, P346, DOI 10.1111/j.1440-1797.2012.01573.x; Maes OC, 2009, CURR GENOMICS, V10, P154, DOI 10.2174/138920209788185252; Mezzano S, 2004, NEPHROL DIAL TRANSPL, V19, P2505, DOI 10.1093/ndt/gfh207; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Wang CM, 2011, BIOCHEM BIOPH RES CO, V411, P586, DOI 10.1016/j.bbrc.2011.06.191; Wang DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031240; Wang SF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003750; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Xu J, 2013, ONCOGENE, V32, P976, DOI 10.1038/onc.2012.121; Yung S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/139365; Zheng L, 2008, J HISTOCHEM CYTOCHEM, V56, P517, DOI 10.1369/jhc.7A7368.2008; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681	30	44	47	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0121256	10.1371/journal.pone.0121256	http://dx.doi.org/10.1371/journal.pone.0121256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110642	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800001
J	Lochead, J; Schessner, J; Werner, T; Wolfl, S				Lochead, Julia; Schessner, Julia; Werner, Tobias; Woelfl, Stefan			Time-Resolved Cell Culture Assay Analyser (TReCCA Analyser) for the Analysis of On-Line Data: Data Integration-Sensor Correction-Time-Resolved IC50 Determination	PLOS ONE			English	Article							OXYGEN; CYTOTOXICITY; LINE	Time-resolved cell culture assays circumvent the need to set arbitrary end-points and reveal the dynamics of quality controlled experiments. However, they lead to the generation of large data sets, which can represent a complexity barrier to their use. We therefore developed the Time-Resolved Cell Culture Assay (TReCCA) Analyser program to perform standard cell assay analyses efficiently and make sophisticated in-depth analyses easily available. The functions of the program include data normalising and averaging, as well as smoothing and slope calculation, pin-pointing exact change time points. A time-resolved IC50/EC50 calculation provides a better understanding of drug toxicity over time and a more accurate drug to drug comparison. Finally the logarithmic sensor recalibration function, for sensors with an exponential calibration curve, homogenises the sensor output and enables the detection of low-scale changes. To illustrate the capabilities of the TReCCA Analyser, we performed on-line monitoring of dissolved oxygen in the culture media of the breast cancer cell line MCF-7 treated with different concentrations of the anti-cancer drug Cisplatin. The TReCCA Analyser is freely available at www.uni-heidelberg.de/fakultaeten/biowissenschaften/ipmb/biologie/woelfl/Research.html. By introducing the program, we hope to encourage more systematic use of time-resolved assays and lead researchers to fully exploit their data.	[Lochead, Julia; Schessner, Julia; Woelfl, Stefan] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Lochead, Julia; Werner, Tobias] Mannheim Univ Appl Sci, Inst Analyt Chem, Mannheim, Germany	Ruprecht Karls University Heidelberg	Werner, T (corresponding author), Mannheim Univ Appl Sci, Inst Analyt Chem, Mannheim, Germany.	t.werner@hs-mannheim.de; wolfl@uni-hd.de	Schessner, Julia Patricia/AFQ-4383-2022	Schessner, Julia Patricia/0000-0003-3361-9830	Albert and Anneliese Konanz foundation	Albert and Anneliese Konanz foundation	The authors thank PreSens Precision Sensing GmbH for the gift of material provided for the experimental work. PreSens Precision Sensing GmbH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors also thank the Albert and Anneliese Konanz foundation for the 2-year fellowship provided to JL. This work was done in the context of the cooperative HBIGS (Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology) graduate school "Disease models and drugs" of Heidelberg University and Mannheim University of Applied Sciences.	Akin M, 2011, BIOSENS BIOELECTRON, V26, P4532, DOI 10.1016/j.bios.2011.05.018; Amano T, 2003, ANAL BIOCHEM, V314, P1, DOI 10.1016/S0003-2697(02)00653-X; Arain S, 2006, SENSOR ACTUAT B-CHEM, V113, P639, DOI 10.1016/j.snb.2005.07.056; Beckers S, 2010, TOXICOL IN VITRO, V24, P686, DOI 10.1016/j.tiv.2009.04.018; CARRAWAY ER, 1991, ANAL CHEM, V63, P332, DOI 10.1021/ac00004a006; Dong K, 2009, BREAST CANCER RES TR, V113, P443, DOI 10.1007/s10549-008-9956-x; Fischer J, 2010, ACTA BIOMATER, V6, P1813, DOI 10.1016/j.actbio.2009.10.020; Gottfried E, 2011, CANCER CHEMOTH PHARM, V67, P117, DOI 10.1007/s00280-010-1294-0; Kensy F, 2005, BIOPROC BIOSYST ENG, V28, P75, DOI 10.1007/s00449-005-0010-7; KLIMANT I, 1995, ANAL CHEM, V67, P3160, DOI 10.1021/ac00114a010; Koster M, 2010, J PLANKTON RES, V32, P171, DOI 10.1093/plankt/fbp112; Lasko DR, 1996, BIOTECHNOL BIOENG, V52, P364, DOI 10.1002/(SICI)1097-0290(19961105)52:3<364::AID-BIT2>3.0.CO;2-I; Lawrence M, 2012, GWIDGETSRGTK2 TOOLKI; Lawrence M, 2011, CAIRODEVICE CAIRO BA; Lawrence M, 2010, J STAT SOFTW, V37, P1; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; O'Riordan TC, 2007, ANAL CHEM, V79, P9414, DOI 10.1021/ac701770b; Pogribny IP, 2010, INT J CANCER, V127, P1785, DOI 10.1002/ijc.25191; R Core Team, 2021, R LANGUAGE ENV STAT; Ritz C, 2005, J STAT SOFTW, V12, P1; Sebaugh JL, 2011, PHARM STAT, V10, P128, DOI 10.1002/pst.426; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Strecker R, 2011, COMP BIOCHEM PHYS C, V153, P318, DOI 10.1016/j.cbpc.2010.12.002; Verzani J, 2012, GWIDGETS API BUILDIN; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wilson GS, 2005, BIOSENS BIOELECTRON, V20, P2388, DOI 10.1016/j.bios.2004.12.003; Wolf P, 2011, TOXICOL IN VITRO, V25, P1889, DOI 10.1016/j.tiv.2011.05.031	27	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131233	10.1371/journal.pone.0131233	http://dx.doi.org/10.1371/journal.pone.0131233			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110644	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800133
J	Masuda, Y; Vaziri, ND; Li, S; Le, A; Hajighasemi-Ossareh, M; Robles, L; Foster, CE; Stamos, MJ; Al-Abodullah, I; Ricordi, C; Ichii, H				Masuda, Yuichi; Vaziri, Nosratola D.; Li, Shiri; Le, Aimee; Hajighasemi-Ossareh, Mohammad; Robles, Lourdes; Foster, Clarence E.; Stamos, Michael J.; Al-Abodullah, Ismail; Ricordi, Camillo; Ichii, Hirohito			The Effect of Nrf2 Pathway Activation on Human Pancreatic Islet Cells	PLOS ONE			English	Article							ANTIOXIDANT-RESPONSIVE ELEMENT; HEME OXYGENASE-1 GENE; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; KEAP1-NRF2-ARE PATHWAY; SUPEROXIDE-DISMUTASE; INSULIN-SECRETION; DIABETES-MELLITUS; SIGNALING PATHWAY; BETA-CELLS	Background Pancreatic islets are known to contain low level of antioxidants that renders them vulnerable to oxidative stress. Nrf2 is the master regulator of numerous genes, encoding antioxidant, detoxifying, and cytoprotective molecules. Activation of Nrf2 pathway induces up-regulation of numerous genes encoding antioxidant and phase II detoxifying enzymes and related proteins. However, little is known regarding the role of this pathway in human islet cells. The aim was to investigate the effect of Nrf2 activator (dh404, CDDO-9,11-dihydro-trifluoroethyl amide) on human islet cells. Methods Human islets were obtained from cadaveric donors. After dh404 treatment, Nrf2 translocation, mRNA expression, and protein abundance of its key target gene products were examined. The proportion of dh404-treated or non-treated viable islet beta cells was analyzed using flowcytemetry. The cytoprotective effects against oxidative stress and production of inflammatory mediators, and in vivo islet function after transplantation were determined. Results Nrf2 nuclear translocation was confirmed by con-focal microscope within 2 hours after treatment, which was associated with a dose-dependent increase in mRNA expression of antioxidants, including NQO1, HO-1, and GCLC. Enhanced HO-1 expression in dh404 treated islets was confirmed by Western Blot assay. Islet function after transplantation (2000 IEQ/mouse) to diabetic nude mice was not affected with or without dh404 treatment. After induction of oxidative stress with hydrogen peroxide (200 mu M) the proportion of dh404-treated viable islet cells was significantly higher in the dh404-treated than untreated islets (74% vs. 57%; P<0.05). Dh404 significantly decreased production of cytokines/chemokines including IL-1 beta, IL-6, IFN-gamma and MCP-1. Conclusion Treatment of human pancreatic islets with the potent synthetic Nrf2 activator, dh404, significantly increased expression of the key anti-oxidants enzymes, decreased inflammatory mediators in islets and conferred protection against oxidative stress in beta cells.	[Masuda, Yuichi; Li, Shiri; Le, Aimee; Hajighasemi-Ossareh, Mohammad; Robles, Lourdes; Foster, Clarence E.; Stamos, Michael J.; Ichii, Hirohito] Univ Calif Irvine, Dept Surg, Irvine, CA 92717 USA; [Vaziri, Nosratola D.] Univ Calif Irvine, Med, Irvine, CA 92717 USA; [Al-Abodullah, Ismail] City Hope Natl Med Ctr, Southern Calif Islet Cell Resources Ctr, Dept Diabet Endocrinol & Metab, Duarte, CA 91010 USA; [Al-Abodullah, Ismail] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; [Ichii, Hirohito] Univ Miami, Diabet Res Inst, Miami, FL USA	University of California System; University of California Irvine; University of California System; University of California Irvine; City of Hope; City of Hope; Beckman Research Institute of City of Hope; University of Miami	Ichii, H (corresponding author), Univ Calif Irvine, Dept Surg, Irvine, CA 92717 USA.	hichii@uci.edu	RICORDI, CAMILLO/AAA-4740-2019; Stamos, Michael Jerry/I-2465-2019; Foster, Clarence/AAD-8502-2019; Ichii, Hirohito/AAV-8256-2021	Stamos, Michael Jerry/0000-0003-2068-7391; Ricordi, Camillo/0000-0001-8092-7153	NIH-NCRR [UL1 TR000153, KL2 TR000147]; Juvenile Diabetes Research Foundation International [17-2011-609]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000153, KL2TR000147, KL2TR001416] Funding Source: NIH RePORTER	NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The work was supported by the following: HI: NIH-NCRR UL1 TR000153, KL2 TR000147; and HI: the Juvenile Diabetes Research Foundation International 17-2011-609.	Acharya JD, 2010, ISLETS, V2, P225, DOI 10.4161/isl.2.4.12219; Aminzadeh MA, 2014, XENOBIOTICA, V44, P570, DOI 10.3109/00498254.2013.852705; Azevedo-Martins AK, 2003, DIABETES, V52, P93, DOI 10.2337/diabetes.52.1.93; Aziz MTA, 2010, ANGIOLOGY, V61, P557, DOI 10.1177/0003319709356424; Balamurugan AN, 2009, PANCREAS, V38, P454, DOI 10.1097/MPA.0b013e318196c3e7; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Bouzakri K, 2011, DIABETES, V60, P1111, DOI 10.2337/db10-1178; Copple IM, 2008, TOXICOLOGY, V246, P24, DOI 10.1016/j.tox.2007.10.029; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; EIZIRIK DL, 1994, P NATL ACAD SCI USA, V91, P9253, DOI 10.1073/pnas.91.20.9253; Giudice A, 2006, BIOESSAYS, V28, P169, DOI 10.1002/bies.20359; Giudice A, 2010, METHODS MOL BIOL, V647, P37, DOI 10.1007/978-1-60761-738-9_3; GRANKVIST K, 1981, BIOCHEM J, V199, P393, DOI 10.1042/bj1990393; GRANKVIST K, 1981, BIOCHEM J, V200, P685, DOI 10.1042/bj2000685; GRANKVIST K, 1981, NATURE, V294, P158, DOI 10.1038/294158a0; Hotta M, 1998, J EXP MED, V188, P1445, DOI 10.1084/jem.188.8.1445; Ichii H, 2005, AM J TRANSPLANT, V5, P1635, DOI 10.1111/j.1600-6143.2005.00913.x; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kanitkar M, 2008, LIFE SCI, V82, P182, DOI 10.1016/j.lfs.2007.10.026; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kundu JK, 2010, PHARM RES-DORDR, V27, P999, DOI 10.1007/s11095-010-0096-8; Larsen CE, 2004, CURR OPIN IMMUNOL, V16, P660, DOI 10.1016/j.coi.2004.07.014; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Li S, 2015, CELL TRANSPLANT; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Li WJ, 2014, FEBS LETT, V588, P2115, DOI 10.1016/j.febslet.2014.04.046; Li YX, 2006, PANCREAS, V33, P280, DOI 10.1097/01.mpa.0000236735.39241.d0; Magesh S, 2012, MED RES REV, V32, P687, DOI 10.1002/med.21257; Nishikawa T, 2007, ANTIOXID REDOX SIGN, V9, P343, DOI 10.1089/ars.2006.1458; Pileggi A, 2005, CELL TRANSPLANT, V14, P85, DOI 10.3727/000000005783983160; Rabinovitch A, 1998, BIOCHEM PHARMACOL, V55, P1139, DOI 10.1016/S0006-2952(97)00492-9; Rabinovitch A, 1996, J CLIN ENDOCR METAB, V81, P3197, DOI 10.1210/jc.81.9.3197; Robertson RP, 2006, CURR OPIN PHARMACOL, V6, P615, DOI 10.1016/j.coph.2006.09.002; So HS, 2006, CELL DEATH DIFFER, V13, P1763, DOI 10.1038/sj.cdd.4401863; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Tang C, 2007, DIABETES, V56, P2722, DOI 10.2337/db07-0279; VAJKOCZY P, 1995, TRANSPLANTATION, V60, P123, DOI 10.1097/00007890-199507270-00002; Velmurugan GV, 2013, CARDIOVASC RES, V100, P143, DOI 10.1093/cvr/cvt125; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Wang HJ, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/141898; Wasserman WW, 1997, ARCH BIOCHEM BIOPHYS, V344, P387, DOI 10.1006/abbi.1997.0215; Yagishita Y, 2014, DIABETES, V63, P605, DOI 10.2337/db13-0909; Zhang JY, 2012, DIABETES RES CLIN PR, V97, P474, DOI 10.1016/j.diabres.2012.02.029	44	39	41	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131012	10.1371/journal.pone.0131012	http://dx.doi.org/10.1371/journal.pone.0131012			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110640	Green Published, gold			2022-12-27	WOS:000356933800109
J	Stauffer, BA; Miksis-Olds, J; Goes, JI				Stauffer, Beth A.; Miksis-Olds, Jennifer; Goes, Joaquim I.			Cold Regime Interannual Variability of Primary and Secondary Producer Community Composition in the Southeastern Bering Sea	PLOS ONE			English	Article							OSCILLATING CONTROL HYPOTHESIS; ANTARCTIC KRILL; EUPHAUSIA-SUPERBA; CLIMATE-CHANGE; SHELF; ECOSYSTEM; ABUNDANCE; COASTAL; INSTRUMENTS; PHAEOCYSTIS	Variability of hydrographic conditions and primary and secondary productivity between cold and warm climatic regimes in the Bering Sea has been the subject of much study in recent years, while interannual variability within a single regime and across multiple trophic levels has been less well-documented. Measurements from an instrumented mooring on the southeastern shelf of the Bering Sea were analyzed for the spring-to-summer transitions within the cold regime years of 2009-2012 to investigate the interannual variability of hydrographic conditions, primary producer biomass, and acoustically-derived secondary producer and consumer abundance and community structure. Hydrographic conditions in 2012 were significantly different than in 2009, 2010, and 2011, driven largely by increased ice extent and thickness, later ice retreat, and earlier stratification of the water column. Primary producer biomass was more tightly coupled to hydrographic conditions in 2012 than in 2009 or 2011, and shallow and mid-column phytoplankton blooms tended to occur independent of one another. There was a high degree of variability in the relationships between different classes of secondary producers and hydrographic conditions, evidence of significant intraconsumer interactions, and trade-offs between different consumer size classes in each year. Phytoplankton blooms stimulated different populations of secondary producers in each year, and summer consumer populations appeared to determine dominant populations in the subsequent spring. Overall, primary producers and secondary producers were more tightly coupled to each other and to hydrographic conditions in the coldest year compared to the warmer years. The highly variable nature of the interactions between the atmospherically-driven hydrographic environment, primary and secondary producers, and within food webs underscores the need to revisit how climatic regimes within the Bering Sea are defined and predicted to function given changing climate scenarios.	[Stauffer, Beth A.; Goes, Joaquim I.] Columbia Univ, Lamont Doherty Earth Observ, Dept Biol & Paleo Environm, Palisades, NY 10964 USA; [Miksis-Olds, Jennifer] Penn State Univ, Appl Res Lab, State Coll, PA 16803 USA	Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Stauffer, BA (corresponding author), Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA.	stauffer@louisiana.edu		Goes, Joaquim/0000-0002-9785-6985	National Aeronautics and Space Administration [NNX10AP10G, NNX11AP28G]; Office of Naval Research [N000140810391]	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Office of Naval Research(Office of Naval Research)	Funding for this project was provided to J.I. Goes and J. Miksis-Olds by the National Aeronautics and Space Administration, Awards NNX10AP10G and NNX11AP28G (http://www.nasa.gov/) and Office of Naval Research, Award N000140810391 (http://www.onr.navy.mil/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigo Kevin R., 2011, Journal of Geophysical Research: Oceans, V116, DOI 10.1029/2011JC007151; Atkinson A, 1997, MAR ECOL PROG SER, V160, P63, DOI 10.3354/meps160063; Aydin K, 2007, DEEP-SEA RES PT II, V54, P2501, DOI 10.1016/j.dsr2.2007.08.022; Baier CT, 2005, J PLANKTON RES, V27, P1113, DOI 10.1093/plankt/fbi078; Baier CT, 2003, J PLANKTON RES, V25, P771, DOI 10.1093/plankt/25.7.771; Brierley AS, 2006, LIMNOL OCEANOGR-METH, V4, P18, DOI 10.4319/lom.2006.4.18; Brown ZW, 2012, ICES J MAR SCI, V69, P1180, DOI 10.1093/icesjms/fss113; Brown ZW, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006766; Cetinic I, 2009, OPT EXPRESS, V17, P15420, DOI 10.1364/OE.17.015420; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Clough J, 2005, AQUAT MICROB ECOL, V39, P121, DOI 10.3354/ame039121; Codiga DL, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008473; Coyle KO, 2011, FISH OCEANOGR, V20, P139, DOI 10.1111/j.1365-2419.2011.00574.x; Coyle KO, 2008, DEEP-SEA RES PT II, V55, P1775, DOI 10.1016/j.dsr2.2008.04.029; Coyle KO, 2002, DEEP-SEA RES PT II, V49, P6009, DOI 10.1016/S0967-0645(02)00331-4; Davis P. J., 1975, INTERPOLATION APPROX; De Robertis A, 2010, CAN J FISH AQUAT SCI, V67, P1459, DOI 10.1139/F10-075; Dekshenieks MM, 2001, MAR ECOL PROG SER, V223, P61, DOI 10.3354/meps223061; Demer DA, 2003, ICES J MAR SCI, V60, P625, DOI 10.1016/S1054-3139(03)00063-8; Earp A, 2011, OPT EXPRESS, V19, P26768, DOI 10.1364/OE.19.026768; Emery W.J., 2001, DATA ANAL METHODS PH, P159, DOI DOI 10.1016/C2010-0-66362-0; Flynn KJ, 2008, HARMFUL ALGAE, V8, P129, DOI 10.1016/j.hal.2008.08.007; Fofonoff P, 1983, ALGORITHMS COMPUTATI; Gardner GA, 1982, CANADIAN SPECIAL PUB, V62, P536; Hunt GL, 2008, DEEP-SEA RES PT II, V55, P1919, DOI 10.1016/j.dsr2.2008.04.032; Hunt George L. Jr., 2010, P196; Hunt GL, 2011, ICES J MAR SCI, V68, P1230, DOI 10.1093/icesjms/fsr036; Hunt GL, 2002, DEEP-SEA RES PT II, V49, P5821, DOI 10.1016/S0967-0645(02)00321-1; Kunze E, 2006, SCIENCE, V313, P1768, DOI 10.1126/science.1129378; LITTLE EM, 1972, ARCTIC, V25, P28; Liu H, 2008, J PLANKTON RES, V30, P923, DOI 10.1093/plankt/fbn046; Lomas MW, 2012, DEEP-SEA RES PT II, V65-70, P126, DOI 10.1016/j.dsr2.2012.02.010; LORENZEN CARL J., 1966, DEEP SEA RES, V13, P223, DOI 10.1016/0011-7471(66)91102-8; Menke W., 2012, ENV DATA ANAL MATLAB; Miksis-Olds JL, 2013, PROGR OCEANOGRAPHY, V111, P38; Nakagawa Yoshizumi, 2002, Polar Bioscience, V15, P52; Nejstgaard JC, 2007, BIOGEOCHEMISTRY, V83, P147, DOI 10.1007/s10533-007-9098-y; Okkonen SR, 2004, DEEP-SEA RES PT II, V51, P1033, DOI 10.1016/j.dsr2.2003.08.005; OWEN RW, 1989, J MAR RES, V47, P197, DOI 10.1357/002224089785076415; Perez MA, NMFSAFSC141993 NOAA; Reiss CS, 2008, ICES J MAR SCI, V65, P497, DOI 10.1093/icesjms/fsn033; Sigler MF, 2014, DEEP-SEA RES PT II, V109, P71, DOI 10.1016/j.dsr2.2013.12.007; Smith P. E., 1985, EGG PRODUCTION METHO, V36, P27; Stabeno P, 2010, PROG OCEANOGR, V85, P180, DOI 10.1016/j.pocean.2010.02.010; Stabeno PJ, 2012, DEEP-SEA RES PT II, V65-70, P31, DOI 10.1016/j.dsr2.2012.02.020; Stabeno PJ, 2012, DEEP-SEA RES PT II, V65-70, P14, DOI 10.1016/j.dsr2.2012.02.019; Stabeno PJ, 2002, DEEP-SEA RES PT II, V49, P5931, DOI 10.1016/S0967-0645(02)00327-2; Stanton TK., 1998, P IEEE C REC ADV SON; Stauffer BA, 2014, DEEP-SEA RES PT II, V109, P57, DOI 10.1016/j.dsr2.2014.03.007; Turner JT, 2002, J PLANKTON RES, V24, P1185, DOI 10.1093/plankt/24.11.1185; Watkins JL, 2002, ICES J MAR SCI, V59, P1326, DOI 10.1006/jmsc.2002.1309; Zhang JL, 2012, DEEP-SEA RES PT II, V65-70, P58, DOI 10.1016/j.dsr2.2012.02.023	52	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131246	10.1371/journal.pone.0131246	http://dx.doi.org/10.1371/journal.pone.0131246			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110822	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800136
J	Sundaram, M; Willoughby, JR; Lichti, NI; Steele, MA; Swihart, RK				Sundaram, Mekala; Willoughby, Janna R.; Lichti, Nathanael I.; Steele, Michael A.; Swihart, Robert K.			Segregating the Effects of Seed Traits and Common Ancestry of Hardwood Trees on Eastern Gray Squirrel Foraging Decisions	PLOS ONE			English	Article							SCATTER-HOARDING RODENTS; PHYLOGENETIC-RELATIONSHIPS; SCIURUS-CAROLINENSIS; EVOLUTIONARY ECOLOGY; BIOLOGICAL TRAITS; ALIGNMENT METHODS; GREY SQUIRRELS; ACORN TANNINS; WOOD MOUSE; M-COFFEE	The evolution of specific seed traits in scatter-hoarded tree species often has been attributed to granivore foraging behavior. However, the degree to which foraging investments and seed traits correlate with phylogenetic relationships among trees remains unexplored. We presented seeds of 23 different hardwood tree species (families Betulaceae, Fagaceae, Juglandaceae) to eastern gray squirrels (Sciurus carolinensis), and measured the time and distance travelled by squirrels that consumed or cached each seed. We estimated 11 physical and chemical seed traits for each species, and the phylogenetic relationships between the 23 hardwood trees. Variance partitioning revealed that considerable variation in foraging investment was attributable to seed traits alone (27-73%), and combined effects of seed traits and phylogeny of hardwood trees (5-55%). A phylogenetic PCA (pPCA) on seed traits and tree phylogeny resulted in 2 "global" axes of traits that were phylogenetically autocorrelated at the family and genus level and a third "local" axis in which traits were not phylogenetically autocorrelated. Collectively, these axes explained 30-76% of the variation in squirrel foraging investments. The first global pPCA axis, which produced large scores for seed species with thin shells, low lipid and high carbohydrate content, was negatively related to time to consume and cache seeds and travel distance to cache. The second global pPCA axis, which produced large scores for seeds with high protein, low tannin and low dormancy levels, was an important predictor of consumption time only. The local pPCA axis primarily reflected kernel mass. Although it explained only 12% of the variation in trait space and was not autocorrelated among phylogenetic clades, the local axis was related to all four squirrel foraging investments. Squirrel foraging behaviors are influenced by a combination of phylogenetically conserved and more evolutionarily labile seed traits that is consistent with a weak or more diffuse coevolutionary relationship between rodents and hardwood trees rather than a direct coevolutionary relationship.	[Sundaram, Mekala; Willoughby, Janna R.; Lichti, Nathanael I.; Swihart, Robert K.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Steele, Michael A.] Wilkes Univ, Dept Biol, Wilkes Barre, PA 18766 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Wilkes University	Sundaram, M (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.	msundara@purdue.edu	Swihart, Robert K/D-2787-2016; Willoughby, Janna/L-2764-2013	Willoughby, Janna/0000-0002-0176-1878	Fred M. van Eck scholarship; Fred M. van Eck Foundation for Purdue University; John S. Wright Endowment	Fred M. van Eck scholarship; Fred M. van Eck Foundation for Purdue University; John S. Wright Endowment	This study was funded by a Fred M. van Eck scholarship awarded to MS by the Fred M. van Eck Foundation for Purdue University, and the John S. Wright Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeles J. G. C., 2005, Plant Molecular Biology Reporter, V23, P297, DOI 10.1007/BF02772760; Bonner FT, 1974, USDA FOREST SERV AGR, P269; Bonner FT, 2008, THE WOODY PLANT SEED; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Campbell V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-64; CARPENTER I. W., 1954, JOUR FOREST, V52, P269; Chen X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032890; ChungMacCoubrey AL, 1997, PHYSIOL ZOOL, V70, P270, DOI 10.1086/639595; Delgado MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092892; Desdevises Y, 2003, EVOLUTION, V57, P2647; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Diniz JAF, 2012, EVOLUTION, V66, P1079, DOI 10.1111/j.1558-5646.2011.01499.x; Forget PM, 2001, TRENDS ECOL EVOL, V16, P65, DOI 10.1016/S0169-5347(00)02072-3; Gernhard T, 2008, J THEOR BIOL, V253, P769, DOI 10.1016/j.jtbi.2008.04.005; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; HAGERMAN AE, 1987, J CHEM ECOL, V13, P437, DOI 10.1007/BF01880091; HERRERA CM, 1985, OIKOS, V44, P132, DOI 10.2307/3544054; Hopewell LJ, 2008, ETHOLOGY, V114, P1061, DOI 10.1111/j.1439-0310.2008.01554.x; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; JACOBS LF, 1992, ANIM BEHAV, V43, P522, DOI 10.1016/S0003-3472(05)80111-3; Jansen PA, 2004, ECOL MONOGR, V74, P569, DOI 10.1890/03-4042; Jansen PA, 2008, ECOGRAPHY, V31, P43, DOI 10.1111/j.2007.0906-7590.05156.x; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; JANZEN DH, 1980, EVOLUTION, V34, P611, DOI 10.1111/j.1558-5646.1980.tb04849.x; JOHNSON WC, 1993, OECOLOGIA, V94, P159, DOI 10.1007/BF00341312; Jombart T, 2010, BIOINFORMATICS, V26, P1907, DOI 10.1093/bioinformatics/btq292; Jombart T, 2010, J THEOR BIOL, V264, P693, DOI 10.1016/j.jtbi.2010.03.038; KELLY D, 1994, TRENDS ECOL EVOL, V9, P465, DOI 10.1016/0169-5347(94)90310-7; LEWIS AR, 1982, AM MIDL NAT, V107, P250, DOI 10.2307/2425376; Li RQ, 2004, INT J PLANT SCI, V165, P311, DOI 10.1086/381920; Lichti NI, 2014, ECOLOGY, V95, P1746, DOI 10.1890/13-1657.1; Lichti NI, 2012, IMPLICATIONS OF CONT; Manos Paul S., 2008, Madrono, V55, P181, DOI 10.3120/0024-9637-55.3.181; Manos PS, 2001, ANN MO BOT GARD, V88, P231, DOI 10.2307/2666226; Moore JE, 2007, ECOLOGY, V88, P2529, DOI 10.1890/07-0247.1; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; Oh SH, 2008, TAXON, V57, P434, DOI 10.2307/25066014; Parker Tommy S., 2008, Urban Ecosystems, V11, P243, DOI 10.1007/s11252-008-0060-0; ROBBINS CT, 1991, J MAMMAL, V72, P480, DOI 10.2307/1382130; Salminen JP, 2011, FUNCT ECOL, V25, P325, DOI 10.1111/j.1365-2435.2010.01826.x; Sambrook J., 2001, MOL CLONING LAB MANU; Santos T. N., 2012, P 23 ISPIM C, P1; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schnurr JL, 2002, OIKOS, V96, P402, DOI 10.1034/j.1600-0706.2002.960302.x; Shimada T, 2003, POPUL ECOL, V45, P7, DOI 10.1007/s10144-002-0134-4; Shimada T, 2006, J CHEM ECOL, V32, P1165, DOI 10.1007/s10886-006-9078-z; SMITH CC, 1972, ECOLOGY, V53, P82, DOI 10.2307/1935712; Steele MA, 2006, ANIM BEHAV, V71, P155, DOI 10.1016/j.anbehav.2005.05.005; Steele MA, 2001, J MAMMAL, V82, P35, DOI 10.1644/1545-1542(2001)082&lt;0035:CMBSME&gt;2.0.CO;2; STEELE MA, 1993, AM MIDL NAT, V130, P229, DOI 10.2307/2426123; Steele MA, 2008, CURR SCI INDIA, V95, P871; Theimer Tad C., 2005, P283, DOI 10.1079/9780851998060.0283; Vander Wall SB, 2001, BOT REV, V67, P74, DOI 10.1007/BF02857850; Vander Wall SB, 1990, FOOD HOARDING IN ANI; VANDERWALL SB, 1994, ECOLOGY, V75, P1911, DOI 10.2307/1941596; Wall S. B. vander, 2005, Seed fate: predation, dispersal and seedling establishment, P1, DOI 10.1079/9780851998060.0001; Wall SBV, 2010, PHILOS T R SOC B, V365, P989, DOI 10.1098/rstb.2009.0205; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Wang B, 2008, ACTA OECOL, V34, P379, DOI 10.1016/j.actao.2008.07.001; Wang B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040640; Wang Bo, 2012, SCI REP-UK, V2, P1, DOI DOI 10.1111/J.1600-0706.2012.20823.X; Wenny DG, 2001, EVOL ECOL RES, V3, P51; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Xiao ZS, 2010, BEHAV ECOL, V21, P169, DOI 10.1093/beheco/arp169; Xiao ZS, 2006, ACTA OECOL, V29, P205, DOI 10.1016/j.actao.2005.10.004; Xiao ZS, 2005, ACTA OECOL, V28, P221, DOI 10.1016/j.actao.2005.04.006; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zhang JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070449; ZHARKIKH A, 1994, J MOL EVOL, V39, P315, DOI 10.1007/BF00160155	72	24	26	3	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130942	10.1371/journal.pone.0130942	http://dx.doi.org/10.1371/journal.pone.0130942			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110828	Green Submitted, gold, Green Published			2022-12-27	WOS:000356933800100
J	Yao, X; Tian, Z				Yao, Xu; Tian, Zhong			Saturated, Monounsaturated and Polyunsaturated Fatty Acids Intake and Risk of Pancreatic Cancer: Evidence from Observational Studies	PLOS ONE			English	Article							NUTRITIONAL FACTORS; DIETARY-FAT; METAANALYSIS; CARCINOGENESIS; COHORT; MEAT; SUSCEPTIBILITY; PROTEIN; CANADA; DAIRY	Background Although the relationship between dietary monounsaturated fatty acids (MUFAs), polyunsaturated fatty acids (PUFAs), and saturated fatty acids (SFAs) intake and pancreatic cancer risk has been reported by several studies, the evidence is controversial. We firstly conducted this comprehensive meta-analysis to summarize the aforementioned evidence from observational studies. Methods The MEDLINE (PubMed), Embase, and ISI Web of Science databases were used to search for epidemiological studies of dietary SFA, MUFA, and PUFA and pancreatic cancer risk that were published until the end of June 2014. Random-or fixed-effects models were used to estimate the relative risks (RRs) and 95% confidence intervals (CIs). We also carried out subgroup, sensitivity, and publication bias analyses. Results We identified 13 case-control studies and 7 prospective studies which including 6270 pancreatic cancer cases in the meta-analysis of SFA, MUFA, and PUFA and risk of pancreatic cancer. The summary RR was 1.13 (95% CI = 0.94-1.35, I-2 = 70.7%) for SFA, 1.00 (95% CI = 0.87-1.14, I-2 = 43.4%) for MUFA, and 0.87 (95% CI = 0.75-1.00, I-2 = 55.3%) for PUFA for high versus low intake categories. We found no evidence of publication bias. Conclusion In summary, findings of this study supports an inverse association between diets high in PUFA and pancreatic cancer risk. Further large prospective studies are warranted to report the results stratified by the subtypes of MUFA and PUFA and adjust for other potential risk factors to eliminate residual confounding.	[Yao, Xu; Tian, Zhong] China Med Univ, Shengjing Hosp, Dept Gen Surg, Shenyang 110001, Peoples R China	China Medical University	Tian, Z (corresponding author), China Med Univ, Shengjing Hosp, Dept Gen Surg, Shenyang 110001, Peoples R China.	zhongt_sjhospital@126.com						APPEL MJ, 1990, CANCER LETT, V55, P239, DOI 10.1016/0304-3835(90)90125-H; APPEL MJ, 1994, CANCER RES, V54, P2113; Arem H, 2013, ANN EPIDEMIOL, V23, P571, DOI 10.1016/j.annepidem.2013.06.006; Aune D, 2012, ANN ONCOL, V23, P2536, DOI 10.1093/annonc/mds076; Aune D, 2012, ANN ONCOL, V23, P843, DOI 10.1093/annonc/mdr398; BAGHURST PA, 1991, AM J EPIDEMIOL, V134, P167, DOI 10.1093/oxfordjournals.aje.a116069; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Chan JM, 2007, CANCER CAUSE CONTROL, V18, P1153, DOI 10.1007/s10552-007-9054-0; Chu M, 1997, CARCINOGENESIS, V18, P315, DOI 10.1093/carcin/18.2.315; CLANDININ MT, 1993, ANN NY ACAD SCI, V683, P151, DOI 10.1111/j.1749-6632.1993.tb35701.x; DEMESQUITA HBB, 1990, INT J CANCER, V46, P435, DOI 10.1002/ijc.2910460319; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EVERHART J, 1995, JAMA-J AM MED ASSOC, V273, P1605, DOI 10.1001/jama.273.20.1605; FALCONER JS, 1994, BRIT J CANCER, V69, P826, DOI 10.1038/bjc.1994.161; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; GHADIRIAN P, 1995, CANCER EPIDEM BIOMAR, V4, P895; Guan HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092738; Guan HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075279; He K, 2013, AM J EPIDEMIOL, V177, P152, DOI 10.1093/aje/kws232; Heinen MM, 2009, INT J CANCER, V125, P1118, DOI 10.1002/ijc.24387; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HOWE GR, 1990, INT J CANCER, V45, P604, DOI 10.1002/ijc.2910450405; Jansen RJ, 2014, INT J CANCER, V134, P1935, DOI 10.1002/ijc.28525; Jing W, 2014, MOL CANCER THER, V13, P2127, DOI 10.1158/1535-7163.MCT-14-0175; KALAPOTHAKI V, 1993, CANCER CAUSE CONTROL, V4, P383, DOI 10.1007/BF00051342; Karim-Kos HE, 2008, EUR J CANCER, V44, P1345, DOI 10.1016/j.ejca.2007.12.015; Kipnis V, 2003, AM J EPIDEMIOL, V158, P14, DOI 10.1093/aje/kwg091; Klein AP, 2012, MOL CARCINOGEN, V51, P14, DOI 10.1002/mc.20855; Lin YS, 2005, J GASTROENTEROL, V40, P297, DOI 10.1007/s00535-004-1537-0; Lucenteforte E, 2010, EUR J CANCER, V46, P581, DOI 10.1016/j.ejca.2009.09.024; Michaud DS, 2003, AM J EPIDEMIOL, V157, P1115, DOI 10.1093/aje/kwg098; Nkondjock A, 2005, BRIT J CANCER, V92, P971, DOI 10.1038/sj.bjc.6602380; Nothlings U, 2005, JNCI-J NATL CANCER I, V97, P1458, DOI 10.1093/jnci/dji292; OLSEN GW, 1991, CANCER CAUSE CONTROL, V2, P291, DOI 10.1007/BF00051668; ROEBUCK BD, 1987, CANCER RES, V47, P1333; Shen QW, 2014, EUR J CANC PREV; Sievenpiper JL, 2002, CAN J DIET PRACT RES, V63, P20, DOI 10.3148/63.1.2002.20; Stolzenberg-Solomon RZ, 2002, AM J EPIDEMIOL, V155, P783, DOI 10.1093/aje/155.9.783; Storlien LH, 2000, BRIT J NUTR, V83, pS85; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thiebaut ACM, 2009, JNCI-J NATL CANCER I, V101, P1001, DOI 10.1093/jnci/djp168; Wells G, 2008, NEWCASTLE OTTAWA SCA; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Woutersen RA, 1999, MUTAT RES-GEN TOX EN, V443, P111, DOI 10.1016/S1383-5742(99)00014-9; Wu L, 2014, CANCER EPIDEM BIOMAR, V23, P1121, DOI 10.1158/1055-9965.EPI-13-0627; Xu B, 2013, ANN EPIDEMIOL, V23, P215, DOI 10.1016/j.annepidem.2012.12.016; ZATONSKI W, 1991, INT J CANCER, V48, P390, DOI 10.1002/ijc.2910480314; Zhang JJ, 2009, NUTR CANCER, V61, P457, DOI 10.1080/01635580902718941; Zou L, 2014, EUR J CANCER, V50, P193, DOI 10.1016/j.ejca.2013.08.014	51	17	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130870	10.1371/journal.pone.0130870	http://dx.doi.org/10.1371/journal.pone.0130870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110621	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800096
J	Samrat, NH; Ahmad, N; Choudhury, IA; Taha, Z				Samrat, Nahidul Hoque; Ahmad, Norhafizan; Choudhury, Imtiaz Ahmed; Taha, Zahari			Technical Study of a Standalone Photovoltaic-Wind Energy Based Hybrid Power Supply Systems for Island Electrification in Malaysia	PLOS ONE			English	Article							EQUIVALENT-CIRCUIT MODELS; SUSTAINABLE ENERGY; GENERATION SYSTEM; SIMULATION; BATTERY	Energy is one of the most important factors in the socioeconomic development of a country. In a developing country like Malaysia, the development of islands is mostly related to the availability of electric power. Power generated by renewable energy sources has recently become one of the most promising solutions for the electrification of islands and remote rural areas. But high dependency on weather conditions and the unpredictable nature of these renewable energy sources are the main drawbacks. To overcome this weakness, different green energy sources and power electronic converters need to be integrated with each other. This study presents a battery storage hybrid standalone photovoltaic-wind energy power supply system. In the proposed standalone hybrid system, a DC-DC buck-boost bidirectional converter controller is used to accumulates the surplus hybrid power in the battery bank and supplies this power to the load during the hybrid power shortage by maintaining the constant dc-link voltage. A three-phase voltage source inverter complex vector control scheme is used to control the load side voltage in terms of the voltage amplitude and frequency. Based on the simulation results obtained from MATLAB/Simulink, it has been found that the overall hybrid framework is capable of working under variable weather and load conditions.	[Samrat, Nahidul Hoque; Ahmad, Norhafizan; Choudhury, Imtiaz Ahmed] Univ Malaya, Fac Engn, Dept Mech Engn, CPDM, Kuala Lumpur 50603, Malaysia; [Taha, Zahari] Univ Malaysia Pahang, Fac Mfg Engn, Innovat Mfg Mechatron & Sports Lab iMAMS, Pekan 26600, Pahang, Malaysia	Universiti Malaya; Universiti Malaysia Pahang	Ahmad, N (corresponding author), Univ Malaya, Fac Engn, Dept Mech Engn, CPDM, Kuala Lumpur 50603, Malaysia.	norhafizan@um.edu.my	CHOUDHURY, IMTIAZ AHMED/B-5346-2010; Ahmad, Norhafizan/B-9358-2010	CHOUDHURY, IMTIAZ AHMED/0000-0001-7633-7492; Ahmad, Norhafizan/0000-0003-2725-9795	KeTTHA, Ministry of Energy, Green Technology and Water, Malaysia [53-02-03-1102]; University of Malaya High Impact Research (HIR) Grant [UM.C/625/1/HIR/MOHE/ENG/41]; Ministry of Higher Education (MOHE)	KeTTHA, Ministry of Energy, Green Technology and Water, Malaysia; University of Malaya High Impact Research (HIR) Grant; Ministry of Higher Education (MOHE)(Ministry of Higher Education & Scientific Research (MHESR))	This research is supported by the KeTTHA, Ministry of Energy, Green Technology and Water (53-02-03-1102), Malaysia, and the University of Malaya High Impact Research (HIR) Grant (UM.C/625/1/HIR/MOHE/ENG/41) sponsored by the Ministry of Higher Education (MOHE).	Aghaei M, 2013, PROCEEDINGS OF THE 2013 IEEE 7TH INTERNATIONAL POWER ENGINEERING AND OPTIMIZATION CONFERENCE (PEOCO2013), P203; Al-Maamori M.H., 2013, INT J MULTIDISCIP CU, P1; [Anonymous], 2014, 3KW WIND TURBINE; [Anonymous], 2013, GEOGRAPHY MALAYSIA; [Anonymous], 2013, LIST ISLANDS MALAYSI; Astrom K. J., 1995, PID CONTROLLERS THEO; Barote L, 2008, PROCEEDINGS OF THE 11TH INTERNATIONAL CONFERENCE ON OPTIMIZATION OF ELECTRICAL AND ELECTRONIC EQUIPMENT, VOL II A AND B, P407; Bhave AG, 1999, RENEW ENERG, V17, P355, DOI 10.1016/S0960-1481(98)00123-2; Bhende CN, 2011, IEEE T SUSTAIN ENERG, V2, P361, DOI 10.1109/TSTE.2011.2159253; Cetin E, 2010, ENERG BUILDINGS, V42, P1344, DOI 10.1016/j.enbuild.2010.03.003; Clifton J, 2010, ENERG POLICY, V38, P5272, DOI 10.1016/j.enpol.2010.05.036; Dahono P. A., 1995, Proceedings of 1995 International Conference on Power Electronics and Drive Systems (Cat. No.95TH8025), P571, DOI 10.1109/PEDS.1995.405006; Darus ZM, 2008, MATH COMPUT SCI ENG, P431; de Battista H, 2006, J POWER SOURCES, V155, P478, DOI 10.1016/j.jpowsour.2005.05.005; Delfino B, 2003, POW TECH C P 2003 IE, V2, P6; Fei Ding, 2010, CICED 2010 P, P1; Grenier D, 1997, IEEE T IND ELECTRON, V44, P680, DOI 10.1109/41.633471; Haque M.E., 2008, IEEE POW EN SOC GEN, P1, DOI [10.1109/PES.2008.4596245, DOI 10.1109/PES.2008.4596245]; Haque ME, 2008, P IEEE POW EN SOC GE; Hu XS, 2014, IEEE T IND INFORM, V10, P1948, DOI 10.1109/TII.2013.2284713; Hu XS, 2014, IEEE T INTELL TRANSP, V15, P1193, DOI 10.1109/TITS.2013.2294675; Hu XS, 2014, ENERGY, V64, P953, DOI 10.1016/j.energy.2013.11.061; Hu XS, 2013, J POWER SOURCES, V239, P449, DOI 10.1016/j.jpowsour.2013.03.157; Hu XS, 2013, SIMUL MODEL PRACT TH, V34, P1, DOI 10.1016/j.simpat.2013.01.001; Hu XS, 2012, J POWER SOURCES, V198, P359, DOI 10.1016/j.jpowsour.2011.10.013; Khan FI, 2005, RENEW ENERG, V30, P157, DOI 10.1016/j.renene.2004.05.009; Khan MJ, 2005, RENEW ENERG, V30, P421, DOI 10.1016/j.renene.2004.05.013; Krause P., 2013, ANAL ELECT MACHINERY, V3rd, DOI DOI 10.1109/9780470544167; Li S., 2011, STEM CELL TISSUE ENG; Lund H, 2006, RENEW ENERG, V31, P503, DOI 10.1016/j.renene.2005.04.008; Mahamudul H, 2013, INT J PHOTOENERGY, V2013, DOI 10.1155/2013/762946; Muljadi E, 1996, IEEE IND APPLIC SOC, P541, DOI 10.1109/IAS.1996.557087; Onar OC, 2006, J POWER SOURCES, V161, P707, DOI 10.1016/j.jpowsour.2006.03.055; Onar OC, 2008, J POWER SOURCES, V185, P1273, DOI 10.1016/j.jpowsour.2008.08.083; Ong HC, 2011, RENEW SUST ENERG REV, V15, P639, DOI 10.1016/j.rser.2010.09.043; Pandiarajan N, 2012, INT J PHOTOENERGY, V2012, DOI 10.1155/2012/410401; Rao ZH, 2011, RENEW SUST ENERG REV, V15, P4554, DOI 10.1016/j.rser.2011.07.096; Salas V, 2006, SOL ENERG MAT SOL C, V90, P1555, DOI 10.1016/j.solmat.2005.10.023; Samrat NH, 2014, SCI WORLD J, DOI 10.1155/2014/436376; Samrat NH, 2014, P IEEE 8 INT POW ENG; Shafie SM, 2011, RENEW SUST ENERG REV, V15, P4370, DOI 10.1016/j.rser.2011.07.113; Tremblay O, 2007, 2007 IEEE VEHICLE POWER AND PROPULSION CONFERENCE, VOLS 1 AND 2, P284; Uzunoglu M, 2009, RENEW ENERG, V34, P509, DOI 10.1016/j.renene.2008.06.009; Valenciaga F, 2005, IEEE T ENERGY CONVER, V20, P398, DOI 10.1109/TEC.2005.845524; Zhang L, 2015, J POWER SOURCES, V274, P899, DOI 10.1016/j.jpowsour.2014.10.170; Zhang L, 2014, ENERGIES, V7, P3204, DOI 10.3390/en7053204	46	8	9	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130678	10.1371/journal.pone.0130678	http://dx.doi.org/10.1371/journal.pone.0130678			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121032	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400054
J	Sanjurjo, A				Sanjurjo, Adam			Search, Memory, and Choice Error: An Experiment	PLOS ONE			English	Article							SHORT-TERM-MEMORY; WORKING-MEMORY; DECISION-MAKING; INFORMATION ACQUISITION; THEORETIC FOUNDATIONS; COGNITIVE-ABILITY; CONSUMER CHOICE; LOAD; QUALITY; MODEL	Multiple attribute search is a central feature of economic life: we consider much more than price when purchasing a home, and more than wage when choosing a job. An experiment is conducted in order to explore the effects of cognitive limitations on choice in these rich settings, in accordance with the predictions of a new model of search memory load. In each task, subjects are made to search the same information in one of two orders, which differ in predicted memory load. Despite standard models of choice treating such variations in order of acquisition as irrelevant, lower predicted memory load search orders are found to lead to substantially fewer choice errors. An implication of the result for search behavior, more generally, is that in order to reduce memory load (thus choice error) a limited memory searcher ought to deviate from the search path of an unlimited memory searcher in predictable waysa mechanism that can explain the systematic deviations from optimal sequential search that have recently been discovered in peoples' behavior. Further, as cognitive load is induced endogenously (within the task), and found to affect choice behavior, this result contributes to the cognitive load literature (in which load is induced exogenously), as well as the cognitive ability literature (in which cognitive ability is measured in a separate task). In addition, while the information overload literature has focused on the detrimental effects of the quantity of information on choice, this result suggests that, holding quantity constant, the order that information is observed in is an essential determinant of choice failure.	Univ Alicante, Fundamentos Anal Econ, E-03080 Alicante, Spain	Universitat d'Alacant	Sanjurjo, A (corresponding author), Univ Alicante, Fundamentos Anal Econ, E-03080 Alicante, Spain.	sanjurjo@ua.es			Spanish Ministerio de Ciencia y Tecnologia; Feder Funds [SEJ-2007-62656]; Spanish Ministry of Economics and Competition [ECO2012-34928]	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Feder Funds(European Commission); Spanish Ministry of Economics and Competition(Spanish Government)	Funding: Financial support from the Spanish Ministerio de Ciencia y Tecnologia and Feder Funds (SEJ-2007-62656) and the Spanish Ministry of Economics and Competition (ECO2012-34928, http://www.biodiversa.org/102) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred S, 2013, COGNITIVE LOAD STRAT; [Anonymous], 2011, J EC ED; Ariely D, 2000, J CONSUM RES, V27, P233, DOI 10.1086/314322; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Beach L.R., 1978, ACAD MANAGE REV, V3, P439, DOI [10.5465/AMR.1978.4305717, DOI 10.5465/AMR.1978.4305717]; Benjamin DJ, 2013, J EUR ECON ASSOC, V11, P1231, DOI 10.1111/jeea.12055; Bernheim BD, 2007, AM ECON REV, V97, P464, DOI 10.1257/aer.97.2.464; Bernheim BD, 2009, Q J ECON, V124, P51, DOI 10.1162/qjec.2009.124.1.51; Besedes T, REV EC STUDIES; Branas-Garza P, 2012, J ECON BEHAV ORGAN, V83, P254, DOI 10.1016/j.jebo.2012.05.018; Branas-Garza P, 2011, J ECON BEHAV ORGAN, V78, P25, DOI 10.1016/j.jebo.2010.12.005; Broder A, 2003, J EXP PSYCHOL LEARN, V29, P611, DOI 10.1037/0278-7393.29.4.611; Burks SV, 2009, P NATL ACAD SCI USA, V106, P7745, DOI 10.1073/pnas.0812360106; Burnham TC, 2009, J ECON BEHAV ORGAN, V72, P171, DOI 10.1016/j.jebo.2009.05.015; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; CAMERER CF, 1993, FRONTIERS OF GAME THEORY, P27; Caplin A, 2011, AM ECON REV, V101, P2899, DOI 10.1257/aer.101.7.2899; Cappelletti D, 2011, J ECON PSYCHOL, V32, P940, DOI 10.1016/j.joep.2011.08.001; Carpenter J, 2013, GAME ECON BEHAV, V80, P115, DOI 10.1016/j.geb.2013.02.012; CHEWNING EG, 1990, ACCOUNT ORG SOC, V15, P527, DOI 10.1016/0361-3682(90)90033-Q; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Cornelissen G, 2007, INT J RES MARK, V24, P278, DOI 10.1016/j.ijresmar.2007.05.001; Cornelissen G, 2011, PERS SOC PSYCHOL B, V37, P1080, DOI 10.1177/0146167211405996; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Crawford V, 2008, PERSPECTIVES FUTURE; Cueva-Herrero C, 2014, COGNITIVE IR REFLECT; Deck C, 2013, EFFECT COGNITIVE LOA; Devetag G, 2003, J ECON PSYCHOL, V24, P189, DOI 10.1016/S0167-4870(02)00202-7; Dohmen T, 2010, AM ECON REV, V100, P1238, DOI 10.1257/aer.100.3.1238; Duffy S, 2014, J BEHAV EXP ECON, V51, P47, DOI 10.1016/j.socec.2014.01.006; Gabaix X, 2006, AM ECON REV, V96, P1043, DOI 10.1257/aer.96.4.1043; GILBERT DT, 1988, J PERS SOC PSYCHOL, V54, P733, DOI 10.1037/0022-3514.54.5.733; Gill D, 2012, COGNITIVE ABILITY LE; Hinson JM, 2003, J EXP PSYCHOL LEARN, V29, P298, DOI 10.1037/0278-7393.29.2.298; Hinson JM, 2002, COGN AFFECT BEHAV NE, V2, P341, DOI 10.3758/CABN.2.4.341; JACOBY J, 1974, J MARKETING RES, V11, P63, DOI 10.2307/3150994; JOHNSON EJ, 1985, MANAGE SCI, V31, P395, DOI 10.1287/mnsc.31.4.395; Jones G, 2008, J ECON BEHAV ORGAN, V68, P489, DOI 10.1016/j.jebo.2008.06.010; Jones MT, 2014, J ECON BEHAV ORGAN, V106, P352, DOI 10.1016/j.jebo.2014.07.005; Klayman J, 1983, ADV PSYCHOL, V14, P401, DOI DOI 10.1016/S0166-4115(08)62246-3; KLEINMUNTZ DN, 1993, PSYCHOL SCI, V4, P221, DOI 10.1111/j.1467-9280.1993.tb00265.x; KOHN MG, 1974, J ECON THEORY, V9, P93, DOI 10.1016/0022-0531(74)90061-1; Krajbich I, 2010, NAT NEUROSCI, V13, P1292, DOI 10.1038/nn.2635; Lee BK, 2004, PSYCHOL MARKET, V21, P159, DOI 10.1002/mar.20000; LIPPMAN SA, 1976, ECON INQ, V14, P155, DOI 10.1111/j.1465-7295.1976.tb00386.x; MALHOTRA NK, 1982, J CONSUM RES, V8, P419, DOI 10.1086/208882; Milinski M, 1998, P NATL ACAD SCI USA, V95, P13755, DOI 10.1073/pnas.95.23.13755; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; MORGAN P, 1985, ECONOMETRICA, V53, P923, DOI 10.2307/1912661; Newell A., 1972, HUMAN PROBLEM SOLVIN; Palacios-Huerta I., 2003, EXPT EC, V6, P235, DOI DOI 10.1023/A:1026209001464; Payne J. W., 1993, ADAPTIVE DECISION MA; Putterman L, 2011, J PUBLIC ECON, V95, P1213, DOI 10.1016/j.jpubeco.2011.05.001; Reutskaja E, 2011, AM ECON REV, V101, P900, DOI 10.1257/aer.101.2.900; Roch SG, 2000, ORGAN BEHAV HUM DEC, V83, P185, DOI 10.1006/obhd.2000.2915; RUSSO JE, 1983, J EXP PSYCHOL LEARN, V9, P676, DOI 10.1037/0278-7393.9.4.676; Rydval O, 2011, CAUSAL EFFECT COGNIT; Samak AS, 2013, EXPT STUDY INFORM SE; Sanjurjo A, 2014, SEARCH MULTIPLE ATTR; Schram A, 2011, EUR ECON REV, V55, P799, DOI 10.1016/j.euroecorev.2011.01.001; Schulz JF, 2014, J ECON PSYCHOL, V41, P77, DOI 10.1016/j.joep.2012.08.007; Shi SW, 2013, MANAGE SCI, V59, P1009, DOI 10.1287/mnsc.1120.1625; Shiv B, 1999, J CONSUM RES, V26, P278, DOI 10.1086/209563; SHUGAN SM, 1980, J CONSUM RES, V7, P99, DOI 10.1086/208799; Simon HA, 1955, Q J ECON, V69, P99, DOI 10.2307/1884852; Smith EE, 1996, CEREB CORTEX, V6, P11, DOI 10.1093/cercor/6.1.11; Smith J. C., 2006, DECISION ANALYSIS, V3, P3, DOI DOI 10.1287/DECA.1050.0044; STIGLER GJ, 1961, J POLIT ECON, V69, P213, DOI 10.1086/258464; SWANN WB, 1990, J PERS SOC PSYCHOL, V59, P17, DOI 10.1037/0022-3514.59.1.17; van den Bos K, 2006, J EXP SOC PSYCHOL, V42, P273, DOI 10.1016/j.jesp.2005.04.003; Ward A, 2000, J PERS SOC PSYCHOL, V78, P753, DOI 10.1037/0022-3514.78.4.753	75	3	3	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0126508	10.1371/journal.pone.0126508	http://dx.doi.org/10.1371/journal.pone.0126508			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1BL	26121356	Green Submitted, Green Published, gold			2022-12-27	WOS:000358150400003
J	Son, JS; Khair, S; Pettet, DW; Ouyang, NT; Tian, XY; Zhang, YH; Zhu, W; Mackenzie, GG; Robertson, CE; Ir, D; Frank, DN; Rigas, B; Li, E				Son, Joshua S.; Khair, Shanawaj; Pettet, Donald W., III; Ouyang, Nengtai; Tian, Xinyu; Zhang, Yuanhao; Zhu, Wei; Mackenzie, Gerardo G.; Robertson, Charles E.; Ir, Diana; Frank, Daniel N.; Rigas, Basil; Li, Ellen			Altered Interactions between the Gut Microbiome and Colonic Mucosa Precede Polyposis in APC(Min/+) Mice	PLOS ONE			English	Article							FAMILIAL ADENOMATOUS POLYPOSIS; REAL-TIME PCR; HIGH-FAT-DIET; COLORECTAL-CANCER; INTESTINAL NEOPLASIA; GENE-EXPRESSION; BACTERIA; IDENTIFICATION; TUMORIGENESIS; MUTATIONS	Mutation of the adenomatous polyposis coli (APC gene), an early event in the adenoma-carcinoma sequence, is present in 70-80% of sporadic human colorectal adenomas and carcinomas. To test the hypothesis that mutation of the APC gene alters microbial interactions with host intestinal mucosa prior to the development of polyposis, culture-independent methods (targeted qPCR assays and Illumina sequencing of the 16S rRNA gene V1V2 hypervariable region) were used to compare the intestinal microbial composition of 30 six-week old C57BL/6 APC(Min/+) and 30 congenic wild type (WT) mice. The results demonstrate that similar to 12-14 week old APC(Min/+) mice with intestinal neoplasia, 6 week old APC(Min/+) mice with no detectable neoplasia, exhibit an increased relative abundance of Bacteroidetes spp in the colon. Parallel mouse RNA sequence analysis, conducted on a subset of proximal colonic RNA samples (6 APC(Min/+), 6 WT) revealed 130 differentially expressed genes (DEGs, fold change >= 2, FDR < 0.05). Hierarchical clustering of the DEGs was carried out by using 1-r dissimilarity measurement, where r stands for the Pearson correlation, and Ward minimum variance linkage, in order to reduce the number of input variables. When the cluster centroids (medians) were included along with APC genotype as input variables in a negative binomial (NB) regression model, four of seven mouse gene clusters, in addition to APC genotype, were significantly associated with the increased relative abundance of Bacteroidetes spp. Three of the four clusters include several downregulated genes encoding immunoglobulin variable regions and non-protein coding RNAs. These results support the concept that mutation of the APC gene alters colonic-microbial interactions prior to polyposis. It remains to be determined whether interventions directed at ameliorating dysbiosis in APC(Min/+) mice, such as through probiotics, prebiotics or antibiotics, could reduce tumor formation.	[Son, Joshua S.; Khair, Shanawaj; Pettet, Donald W., III; Ouyang, Nengtai; Rigas, Basil; Li, Ellen] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Tian, Xinyu; Zhang, Yuanhao; Zhu, Wei] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Mackenzie, Gerardo G.] SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; [Robertson, Charles E.; Ir, Diana; Frank, Daniel N.] Univ Colorado, Dept Med, Anschutz Med Campus, Aurora, CO USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Colorado System; University of Colorado Anschutz Medical Campus	Li, E (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.	ellen.li@stonybrookmedicine.edu	Mackenzie, Gerardo G/AAW-5114-2020	Khair, shanawaj/0000-0001-7902-5689; ROBERTSON, CHARLES/0000-0002-4136-4121	Simons Foundation [269010]	Simons Foundation	Funding: This work was supported by 269010 Simons Foundation (www.simonsfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; Belcheva A, 2014, CELL, V158, P288, DOI 10.1016/j.cell.2014.04.051; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brocardo M, 2008, J BIOL CHEM, V283, P5950, DOI 10.1074/jbc.M708775200; Campbell JH, 2012, ISME J, V6, P2033, DOI 10.1038/ismej.2012.54; Chen LC, 2004, CANCER RES, V64, P3694, DOI 10.1158/0008-5472.CAN-03-3264; Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743; Curran J.M., 2013, HOTELLING HOTELLINGS; Day SD, 2013, CYTOKINE, V64, P454, DOI 10.1016/j.cyto.2013.04.031; De Palma G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-63; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dove WF, 1997, CANCER RES, V57, P812; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074957; Hara N, 2012, J IMMUNOL, V189, P3805, DOI 10.4049/jimmunol.1201257; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Li E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026284; Li YH, 2012, CARCINOGENESIS, V33, P1231, DOI 10.1093/carcin/bgs137; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Mackenzie GG, 2010, GASTROENTEROLOGY, V139, P1320, DOI 10.1053/j.gastro.2010.06.044; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; McAlpine CA, 2006, INT J CANCER, V119, P2339, DOI 10.1002/ijc.22115; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Nadal I, 2009, INT J OBESITY, V33, P758, DOI 10.1038/ijo.2008.260; Nagalingam NA, 2011, INFLAMM BOWEL DIS, V17, P917, DOI 10.1002/ibd.21462; Nielsen A, 2015, GEN LINEAR MIXED MOD; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Ouyang N, 2012, PLOS ONE, V2; Paulsen JE, 2000, SCAND J GASTROENTERO, V35, P534; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Robertson SJ, 2013, GUT MICROBES, V4, P222, DOI 10.4161/gmic.24373; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Senda T, 2007, MED MOL MORPHOL, V40, P68, DOI 10.1007/s00795-006-0352-5; Serino M, 2012, GUT, V61, P543, DOI 10.1136/gutjnl-2011-301012; Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Sokal R.R., 1994, BIOMETRY PRINCIPLES; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; SWEETSER DA, 1988, P NATL ACAD SCI USA, V85, P9611, DOI 10.1073/pnas.85.24.9611; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Wasan HS, 1997, P NATL ACAD SCI USA, V94, P3308, DOI 10.1073/pnas.94.7.3308; Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13; Zhang TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030044	58	34	35	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0127985	10.1371/journal.pone.0127985	http://dx.doi.org/10.1371/journal.pone.0127985			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121046	Green Published, Green Submitted, gold			2022-12-27	WOS:000358150400009
J	Cadalbert, LC; Ghaffar, FN; Stevenson, D; Bryson, S; Vaz, FM; Gottlieb, E; Strathdee, D				Cadalbert, Laurence C.; Ghaffar, Farah Naz; Stevenson, David; Bryson, Sheila; Vaz, Frederic M.; Gottlieb, Eyal; Strathdee, Douglas			Mouse Tafazzin Is Required for Male Germ Cell Meiosis and Spermatogenesis	PLOS ONE			English	Article							BARTH-SYNDROME; PIRNA BIOGENESIS; MITOCHONDRIAL DYNAMICS; NUAGE FORMATION; EXPRESSION; MICE; GENE; CARDIOLIPIN; MODEL; MITOPLD	Barth syndrome is an X-linked mitochondrial disease, symptoms of which include neutropenia and cardiac myopathy. These symptoms are the most significant clinical consequences of a disease, which is increasingly recognised to have a variable presentation. Mutation in the Taz gene in Xq28 is thought to be responsible for the condition, by altering mitochondrial lipid content and mitochondrial function. Male chimeras carrying a targeted mutation of Taz on their X-chromosome were infertile. Testes from the Taz knockout chimeras were smaller than their control counterparts and this was associated with a disruption of the progression of spermatocytes through meiosis to spermiogenesis. Taz knockout ES cells also showed a defect when differentiated to germ cells in vitro. Mutant spermatocytes failed to progress past the pachytene stage of meiosis and had higher levels of DNA double strand damage and increased levels of endogenous retrotransposon activity. Altogether these data revealed a novel role for Taz in helping to maintain genome integrity in meiosis and facilitating germ cell differentiation. We have unravelled a novel function for the Taz protein, which should contribute to an understanding of how a disruption of the Taz gene results in the complex symptoms underlying Barth Syndrome.	[Cadalbert, Laurence C.; Ghaffar, Farah Naz; Stevenson, David; Bryson, Sheila; Strathdee, Douglas] Canc Res UK Beatson Inst, Transgen Technol Lab, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland; [Gottlieb, Eyal] Canc Res UK Beatson Inst, Cell Death & Metab Lab, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland; [Vaz, Frederic M.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands	Beatson Institute; Beatson Institute; University of Amsterdam; Academic Medical Center Amsterdam	Strathdee, D (corresponding author), Canc Res UK Beatson Inst, Transgen Technol Lab, Garscube Estate, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	d.strathdee@beatson.gla.ac.uk	Gottlieb, Eyal/G-6450-2010	Gottlieb, Eyal/0000-0002-9770-0956; Vaz, Frederic/0000-0002-9048-1041; Cadalbert, Laurence/0000-0003-1333-2146; Stevenson, David/0000-0001-9117-138X; Gilbey, Thomas/0000-0001-5677-3318; Ghaffar, Farah/0000-0001-6131-2604	Cancer Research UK; Barth Syndrome Foundation; Barth Syndrome Trust; Cancer Research UK [18278, 22311] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Barth Syndrome Foundation; Barth Syndrome Trust; Cancer Research UK(Cancer Research UK)	This work was supported by funding from Cancer Research UK (www.cancerresearchuk.org) and a grant from the Barth Syndrome Foundation (www.barthsyndrome.org) and the Barth Syndrome Trust (www.barthsyndrome.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; Aravin AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000764; Baba T, 2014, J BIOL CHEM, V289, P11497, DOI 10.1074/jbc.M113.531921; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Cadalbert L, 2005, CELL SIGNAL, V17, P1254, DOI 10.1016/j.cellsig.2005.01.003; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Castaneda J, 2014, EMBO J, V33, P1999, DOI 10.15252/embj.201386855; Clarke SLN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-23; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Dudek J, 2013, STEM CELL RES, V11, P806, DOI 10.1016/j.scr.2013.05.005; Gao Q, 2012, BMB REP, V45, P7, DOI 10.5483/BMBRep.2012.45.1.7; Gonzalez IL, 2005, AM J MED GENET A, V134A, P409, DOI 10.1002/ajmg.a.30661; Ha H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-545; Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009; Houtkooper RH, 2009, ANAL BIOCHEM, V387, P230, DOI 10.1016/j.ab.2009.01.032; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Huhta J, 2013, SEMIN FETAL NEONAT M, V18, P245, DOI 10.1016/j.siny.2013.05.003; Ipsaro JJ, 2012, NATURE, V491, P279, DOI 10.1038/nature11502; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Khuchua Z, 2006, CIRC RES, V99, P201, DOI 10.1161/01.RES.0000233378.95325.ce; Kiebish MA, 2013, J LIPID RES, V54, P1312, DOI 10.1194/jlr.M034728; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lee EJ, 2011, RNA, V17, P1090, DOI 10.1261/rna.2565011; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lucchinetti E, 2006, PHYSIOL GENOMICS, V25, P314, DOI 10.1152/physiolgenomics.00251.2005; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; McEwan C, 2003, TRANSGENIC RES, V12, P519, DOI 10.1023/A:1024273324890; Neuwald AF, 1997, CURR BIOL, V7, pR465; Nishimasu H, 2012, NATURE, V491, P284, DOI 10.1038/nature11509; Phoon CKL, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000455; Powers C, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00074; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Rao DD, 2009, CANCER GENE THER, V16, P807, DOI 10.1038/cgt.2009.53; Reynolds N, 2005, REPROD BIOMED ONLINE, V10, P72, DOI 10.1016/S1472-6483(10)60806-1; Saxena A, 2012, DIS MARKERS, V33, P261, DOI [10.1155/2012/396737, 10.3233/DMA-2012-0932]; Schachtner H, 2012, EUR J CELL BIOL, V91, P923, DOI 10.1016/j.ejcb.2012.04.002; Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007; Schlame M, 2012, NAT CHEM BIOL, V8, P862, DOI 10.1038/NCHEMBIO.1064; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756; Shidoji Y, 1999, BIOCHEM BIOPH RES CO, V264, P343, DOI 10.1006/bbrc.1999.1410; Shiromoto Y, 2013, RNA, V19, P803, DOI 10.1261/rna.038521.113; Shoji M, 2009, DEV CELL, V17, P775, DOI 10.1016/j.devcel.2009.10.012; Singh DK, 2012, RNA BIOL, V9, P1380, DOI 10.4161/rna.22402; Singh S, 2011, PHARM RES-DORDR, V28, P2996, DOI 10.1007/s11095-011-0608-1; Soper SFC, 2008, DEV CELL, V15, P285, DOI 10.1016/j.devcel.2008.05.015; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Soustek MS, 2011, HUM GENE THER, V22, P865, DOI 10.1089/hum.2010.199; St Laurent G, 2010, MECH AGEING DEV, V131, P299, DOI 10.1016/j.mad.2010.03.008; van der Weyden L, 2005, GENESIS, V41, P171, DOI 10.1002/gene.20111; Vangompel Michael J W, 2011, Spermatogenesis, V1, P36; Vinet L, 2008, AM J PHYSIOL-HEART C, V295, pH352, DOI 10.1152/ajpheart.01101.2007; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005; Whited K, 2013, HUM MOL GENET, V22, P483, DOI 10.1093/hmg/dds447; Xu MG, 2008, BIOL REPROD, V79, P51, DOI 10.1095/biolreprod.108.068072; Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Yang XSW-X, 2010, ADV BIOSCIENCE BIOTE, V1, P97; Yin DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027154	62	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131066	10.1371/journal.pone.0131066	http://dx.doi.org/10.1371/journal.pone.0131066			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114544	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500124
J	Chang, SF; Lin, SS; Yang, HC; Chou, YY; Gao, JI; Lu, SC				Chang, Shwu-Fen; Lin, Shih-Shan; Yang, Hui-Ching; Chou, Yuan-Yi; Gao, Jhen-I; Lu, Shao-Chun			LPS-Induced G-CSF Expression in Macrophages Is Mediated by ERK2, but Not ERK1	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; NITRIC-OXIDE SYNTHASE; BINDING PROTEIN-BETA; NF-KAPPA-B; GENE-EXPRESSION; INFLAMMATORY ARTHRITIS; INTERFERON-GAMMA; GRANULOCYTE; LIPOPOLYSACCHARIDE; CELLS	Granulocyte colony-stimulating factor (G-CSF) selectively stimulates proliferation and differentiation of neutrophil progenitors which play important roles in host defense against infectious agents. However, persistent G-CSF production often leads to neutrophilia and excessive inflammatory reactions. There is therefore a need to understand the mechanism regulating G-CSF expression. In this study, we showed that U0126, a MEK1/2 inhibitor, decreases lipopolysaccharide (LPS)-stimulated G-CSF promoter activity, mRNA expression and protein secretion. Using short hairpin RNA knockdown, we demonstrated that ERK2, and not ERK1, involves in LPS-induced G-CSF expression, but not LPS-regulated expression of TNF-alpha. Reporter assays showed that ERK2 and C/EBP beta synergistically activate G-CSF promoter activity. Further chromatin immunoprecipitation (ChIP) assays revealed that U0126 inhibits LPS-induced binding of NF-kappa B (p50/p65) and C/EBP beta to the G-CSF promoter, but not their nuclear protein levels. Knockdown of ERK2 inhibits LPS-induced accessibility of the G-CSF promoter region to DNase I, suggesting that chromatin remodeling may occur. These findings clarify that ERK2, rather than ERK1, mediates LPS-induced G-CSF expression in macrophages by remodeling chromatin, and stimulates C/EBP beta-dependent activation of the G-CSF promoter. This study provides a potential target for regulating G-CSF expression.	[Chang, Shwu-Fen] Taipei Med Univ, Grad Inst Med Sci, Sch Med, Taipei, Taiwan; [Lin, Shih-Shan; Yang, Hui-Ching; Chou, Yuan-Yi; Gao, Jhen-I; Lu, Shao-Chun] Natl Taiwan Univ, Coll Med, Dept Biochem & Mol Biol, Taipei 10764, Taiwan	Taipei Medical University; National Taiwan University	Lu, SC (corresponding author), Natl Taiwan Univ, Coll Med, Dept Biochem & Mol Biol, Taipei 10764, Taiwan.	lsc@ntu.edu.tw			Ministry of Science and Technology in Taiwan [SCL NSC96-2320-B002-022, SFC NSC 96-2320-B-038-028, SFC NSC 99-2320-B038-009-MY3]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	Grant of SCL NSC96-2320-B002-022 by Ministry of Science and Technology in Taiwan (www.most.gov.tw). Grant of SFC NSC 96-2320-B-038-028 by Ministry of Science and Technology in Taiwan (www.most.gov.tw). Grant of SFC NSC 99-2320-B038-009-MY3 by Ministry of Science and Technology in Taiwan (www.most.gov.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajenjo N, 2004, J BIOL CHEM, V279, P32813, DOI 10.1074/jbc.M313656200; AKASHI M, 1994, BLOOD, V83, P3182; Araki K, 2007, LIVER INT, V27, P716, DOI 10.1111/j.1478-3231.2007.01468.x; Bergmann M, 1998, J BIOL CHEM, V273, P6607, DOI 10.1074/jbc.273.12.6607; Brown CY, 1996, J BIOL CHEM, V271, P20108, DOI 10.1074/jbc.271.33.20108; Campbell IK, 2000, J LEUKOCYTE BIOL, V68, P144; Carlson SM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002010; Chen BC, 2001, BRIT J PHARMACOL, V134, P1055, DOI 10.1038/sj.bjp.0704334; Cho YC, 2015, J ETHNOPHARMACOL, V162, P140, DOI 10.1016/j.jep.2014.12.056; Chou SF, 2002, BIOCHEM BIOPH RES CO, V296, P48, DOI 10.1016/S0006-291X(02)00835-5; Chou YY, 2011, FEBS J, V278, P85, DOI 10.1111/j.1742-4658.2010.07929.x; Cockerill PN, 2011, FEBS J, V278, P2182, DOI 10.1111/j.1742-4658.2011.08128.x; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; El Kasmi KC, 2007, J IMMUNOL, V179, P7215, DOI 10.4049/jimmunol.179.11.7215; Endo Kazuya, 2005, Gastric Cancer, V8, P173, DOI 10.1007/s10120-005-0330-y; Eyles JL, 2006, NAT CLIN PRACT RHEUM, V2, P500, DOI 10.1038/ncprheum0291; Eyles JL, 2008, BLOOD, V112, P5193, DOI 10.1182/blood-2008-02-139535; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Hanlon M, 2001, J BIOL CHEM, V276, P38449, DOI 10.1074/jbc.M102165200; Hareng L, 2002, BIOL CHEM, V383, P1501, DOI 10.1515/BC.2002.172; Hu JB, 2001, J BIOL CHEM, V276, P287, DOI 10.1074/jbc.M004885200; Jin Y, 2015, J BIOL CHEM, V290, P2099, DOI 10.1074/jbc.M114.599985; Joshita S, 2009, INTERNAL MED, V48, P687, DOI 10.2169/internalmedicine.48.1900; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Kojima K, 2002, HISTOL HISTOPATHOL, V17, P1005, DOI 10.14670/HH-17.1005; Lee CH, 2013, ONCOL REP, V30, P419, DOI 10.3892/or.2013.2463; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Lu SC, 2007, BIOCHEM J, V402, P387, DOI 10.1042/BJ20061096; Makuta Y, 2003, BIOL PHARM BULL, V26, P1076, DOI 10.1248/bpb.26.1076; Nakamura H, 2000, CLIN EXP RHEUMATOL, V18, P713; NISHIZAWA M, 1990, MOL CELL BIOL, V10, P2002, DOI 10.1128/MCB.10.5.2002; NISHIZAWA M, 1990, J BIOL CHEM, V265, P5897; Rego D, 2011, J IMMUNOL, V186, P5443, DOI 10.4049/jimmunol.1003551; Roy SK, 2005, J BIOL CHEM, V280, P24462, DOI 10.1074/jbc.M413661200; Roy SK, 2002, P NATL ACAD SCI USA, V99, P7945, DOI 10.1073/pnas.122075799; Schwabe RF, 2005, FASEB J, V19, P1758, DOI 10.1096/fj.05-3736fje; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Wright HL, 2012, RHEUMATOLOGY, V51, P451, DOI 10.1093/rheumatology/ker338; Yang SH, 2001, MOL CELL BIOL, V21, P2802, DOI 10.1128/MCB.21.8.2802-2814.2001; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100	42	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129685	10.1371/journal.pone.0129685	http://dx.doi.org/10.1371/journal.pone.0129685			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114754	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500035
J	Chaturvedi, P; Chen, NX; O'Neill, K; McClintick, JN; Moe, SM; Janga, SC				Chaturvedi, Praneet; Chen, Neal X.; O'Neill, Kalisha; McClintick, Jeanette N.; Moe, Sharon M.; Janga, Sarath Chandra			Differential miRNA Expression in Cells and Matrix Vesicles in Vascular Smooth Muscle Cells from Rats with Kidney Disease	PLOS ONE			English	Article							LARGE GENE LISTS; OSTEOBLAST DIFFERENTIATION; MESSENGER-RNAS; IN-VITRO; CALCIFICATION; MICRORNAS; NETWORKS; TARGETS; CYTOSCAPE; MECHANISM	Vascular calcification is a complex process and has been associated with aging, diabetes, chronic kidney disease (CKD). Although there have been several studies that examine the role of miRNAs (miRs) in bone osteogenesis, little is known about the role of miRs in vascular calcification and their role in the pathogenesis of vascular abnormalities. Matrix vesicles (MV) are known to play in important role in initiating vascular smooth muscle cell (VSMC) calcification. In the present study, we performed miRNA microarray analysis to identify the dysregulated miRs between MV and VSMC derived from CKD rats to understand the role of post-transcriptional regulatory networks governed by these miRNAs in vascular calcification and to uncover the differential miRNA content of MV. The percentage of miRNA to total RNA was increased in MV compared to VSMC. Comparison of expression profiles of miRNA by microarray demonstrated 33 miRs to be differentially expressed with the majority (similar to 57%) of them down-regulated. Target genes controlled by differentially expressed miRNAs were identified utilizing two different complementary computational approaches Miranda and Targetscan to understand the functions and pathways that may be affected due to the production of MV from calcifying VSMC thereby contributing to the regulation of genes by miRs. We found several processes including vascular smooth muscle contraction, response to hypoxia and regulation of muscle cell differentiation to be enriched. Signaling pathways identified included MAP-kinase and wnt signaling that have previously been shown to be important in vascular calcification. In conclusion, our results demonstrate that miRs are concentrated in MV from calcifying VSMC, and that important functions and pathways are affected by the miRs dysregulation between calcifying VSMC and the MV they produce. This suggests that miRs may play a very important regulatory role in vascular calcification in CKD by controlling an extensive network of post-transcriptional targets.	[Chaturvedi, Praneet; Janga, Sarath Chandra] Indiana Univ Purdue Univ, Dept Biohlth Informat, Sch Informat & Comp, Indianapolis, IN 46202 USA; [Chen, Neal X.; O'Neill, Kalisha; McClintick, Jeanette N.; Moe, Sharon M.] Indiana Univ Sch Med, Dept Med, Div Nephrol, Indianapolis, IN 46202 USA; [Moe, Sharon M.] Roudebush VA Med Ctr, Indianapolis, IN USA; [Janga, Sarath Chandra] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, HITS 5021, Indianapolis, IN 46202 USA; [Janga, Sarath Chandra] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Janga, SC (corresponding author), Indiana Univ Purdue Univ, Dept Biohlth Informat, Sch Informat & Comp, Indianapolis, IN 46202 USA.	scjanga@iupui.edu	CHATURVEDI, PRANEET/S-3184-2019	Janga, Sarath Chandra/0000-0001-7351-6268	Office of Vice-President for Research at IUPUI in the form of an IU Collaborative Research Grant (IUCRG) grant; School of Informatics and Computing at Indiana University Purdue University Indianapolis (IUPUI) in the form of start-up funds	Office of Vice-President for Research at IUPUI in the form of an IU Collaborative Research Grant (IUCRG) grant; School of Informatics and Computing at Indiana University Purdue University Indianapolis (IUPUI) in the form of start-up funds	The authors acknowledge support from the Office of Vice-President for Research at IUPUI in the form of an IU Collaborative Research Grant (IUCRG) grant which facilitated this study. SCJ acknowledges support from the School of Informatics and Computing at Indiana University Purdue University Indianapolis (IUPUI) in the form of start-up funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2006, CIRC RES, V98, P727, DOI 10.1161/01.RES.0000216009.68958.e6; ANDERSON HC, 1988, RHEUM DIS CLIN N AM, V14, P303; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bhushan R, 2013, INT J BIOCHEM CELL B, V45, P696, DOI 10.1016/j.biocel.2012.12.008; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Chen M, 2014, INT J CARDIOL, V173, P65, DOI 10.1016/j.ijcard.2014.02.007; Chen NX, 2008, J BONE MINER RES, V23, P1798, DOI 10.1359/JBMR.080604; Chen NX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064558; Chen NX, 2010, AM J PHYSIOL-RENAL, V299, pF674, DOI 10.1152/ajprenal.00730.2009; Chen NX, 2002, KIDNEY INT, V62, P1724, DOI 10.1046/j.1523-1755.2002.00625.x; Cui RR, 2012, CARDIOVASC RES, V96, P320, DOI 10.1093/cvr/cvs258; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Janga SC, 2011, ADV EXP MED BIOL, V722, P59, DOI 10.1007/978-1-4614-0332-6_4; Mikhaylova L, 2007, CALCIFIED TISSUE INT, V81, P372, DOI 10.1007/s00223-007-9073-6; Moe SM, 2009, KIDNEY INT, V75, P176, DOI 10.1038/ki.2008.456; Moe SM, 2004, CIRC RES, V95, P560, DOI 10.1161/01.RES.0000141775.67189.98; Palmieri A, 2008, IMPLANT DENT, V17, P100, DOI 10.1097/ID.0b013e318166d182; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Vimalraj S, 2014, INT J BIOL MACROMOL, V66, P194, DOI 10.1016/j.ijbiomac.2014.02.030; Wang T, 2010, BIOCHEM BIOPH RES CO, V402, P186, DOI 10.1016/j.bbrc.2010.08.031; Wang W, 2003, J BIOL CHEM, V278, P3762, DOI 10.1074/jbc.M208868200; Wu TT, 2012, J BIOL CHEM, V287, P7503, DOI 10.1074/jbc.M111.292722; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409	31	29	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131589	10.1371/journal.pone.0131589	http://dx.doi.org/10.1371/journal.pone.0131589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115487	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500173
J	Choy, ATH; Chan, BP				Choy, Andrew Tsz Hang; Chan, Barbara Pui			A Structurally and Functionally Biomimetic Biphasic Scaffold for Intervertebral Disc Tissue Engineering	PLOS ONE			English	Article							PHOTOCHEMICAL CROSS-LINKING; MESENCHYMAL STEM-CELLS; ENCAPSULATED COLLAGEN MICROSPHERES; NUCLEUS PULPOSUS; CHONDROGENIC DIFFERENTIATION; MECHANICAL-PROPERTIES; ACELLULAR MATRIX; DEGENERATION; COMPRESSION; CONSTRUCTS	Tissue engineering offers high hopes for the treatment of intervertebral disc (IVD) degeneration. Whereas scaffolds of the disc nucleus and annulus have been extensively studied, a truly biomimetic and mechanically functional biphasic scaffold using naturally occurring extracellular matrix is yet to be developed. Here, a biphasic scaffold was fabricated with collagen and glycosaminoglycans (GAGs), two of the most abundant extracellular matrix components in the IVD. Following fabrication, the scaffold was characterized and benchmarked against native disc. The biphasic scaffold was composed of a collagen-GAG co-precipitate making up the nucleus pulposus-like core, and this was encapsulated in multiple lamellae of photochemically crosslinked collagen membranes comprising the annulus fibrosus-like lamellae. On mechanical testing, the height of our engineered disc recovered by similar to 82-89% in an annulus-independent manner, when compared with the 99% recovery exhibited by native disc. The annulus-independent nature of disc height recovery suggests that the fluid replacement function of the engineered nucleus pulposus core might mimic this hitherto unique feature of native disc. Biphasic scaffolds comprised of 10 annulus fibrosus-like lamellae had the best overall mechanical performance among the various designs owing to their similarity to native disc in most aspects, including elastic compliance during creep and recovery, and viscous compliance during recovery. However, the dynamic mechanical performance (including dynamic stiffness and damping factor) of all the biphasic scaffolds was similar to that of the native discs. This study contributes to the rationalized design and development of a biomimetic and mechanically viable biphasic scaffold for IVD tissue engineering.	[Choy, Andrew Tsz Hang; Chan, Barbara Pui] Univ Hong Kong, Dept Mech Engn, Tissue Engn Lab, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Chan, BP (corresponding author), Univ Hong Kong, Dept Mech Engn, Tissue Engn Lab, Hong Kong, Hong Kong, Peoples R China.	bpchan@hku.hk	Chan, Barbara Pui/AAM-7767-2020	Chan, BP/0000-0001-5419-2472	AO Spine (AOSPN) [SRN_2011_14]	AO Spine (AOSPN)	This work was supported by AO Spine (AOSPN) (grant number: SRN_2011_14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au-yeung KL, 2010, TISSUE ENG PART C-ME, V16, P93, DOI [10.1089/ten.tec.2008.0707, 10.1089/ten.TEC.2008.0707]; Barbir A, 2010, J BIOMECH, V43, P1067, DOI 10.1016/j.jbiomech.2009.12.005; Bowles RD, 2011, P NATL ACAD SCI USA, V108, P13106, DOI 10.1073/pnas.1107094108; Boxberger JI, 2009, J BIOMECH, V42, P1941, DOI 10.1016/j.jbiomech.2009.05.008; Chan BP, 2007, TISSUE ENG, V13, P73, DOI 10.1089/ten.2006.004; Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3; Chan BP, 2010, TISSUE ENG PART C-ME, V16, P225, DOI 10.1089/ten.tec.2008.0709; Chan BP, 2005, J BIOMED MATER RES A, V75A, P689, DOI 10.1002/jbm.a.30469; Chan OCM, 2008, J CONTROL RELEASE, V129, P135, DOI 10.1016/j.jconrel.2008.04.011; Cheng HW, 2009, TISSUE ENG PART C-ME, V15, P697, DOI [10.1089/ten.tec.2008.0635, 10.1089/ten.TEC.2008.0635]; Cheng HW, 2011, BIOMATERIALS, V32, P1526, DOI 10.1016/j.biomaterials.2010.10.021; Chik TK, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400192; Choy ATH, 2013, ACTA BIOMATER, V9, P4661, DOI 10.1016/j.actbio.2012.09.016; Costi JJ, 2008, SPINE, V33, P1731, DOI 10.1097/BRS.0b013e31817bb116; Costi JJ, 2011, EXPERT REV MED DEVIC, V8, P357, DOI [10.1586/erd.11.1, 10.1586/ERD.11.1]; Gadd MJ, 2011, P I MECH ENG H, V225, P335, DOI 10.1177/2041303310393410; Guerin H. A. L., 2006, SPINE TECHNOLOGY HDB, P35, DOI [10.1016/B978-012369390-7/50004-6, DOI 10.1016/B978-012369390-7/50004-6]; Hui TY, 2008, BIOMATERIALS, V29, P3201, DOI 10.1016/j.biomaterials.2008.04.001; Iatridis JC, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005164; Kwok CB, 2013, J BIOMED MATER RES A, V101, P1716, DOI 10.1002/jbm.a.34475; Li CH, 2011, TISSUE ENG PT A, V17, P777, DOI [10.1089/ten.tea.2010.0078, 10.1089/ten.TEA.2010.0078]; Meakin JR, 2001, CLIN BIOMECH, V16, P560, DOI 10.1016/S0268-0033(01)00042-0; Meakin JR, 2000, J BIOMECH, V33, P575, DOI 10.1016/S0021-9290(99)00215-8; Mizuno H, 2006, BIOMATERIALS, V27, P362, DOI 10.1016/j.biomaterials.2005.06.042; Mwale F, 2004, Eur Cell Mater, V8, P58; Nerurkar NL, 2010, SPINE, V35, P867, DOI 10.1097/BRS.0b013e3181d74414; Nesti LJ, 2008, TISSUE ENG PT A, V14, P1527, DOI 10.1089/ten.tea.2008.0215; O'Connell GD, 2011, J MECH BEHAV BIOMED, V4, P933, DOI 10.1016/j.jmbbm.2011.02.002; Park SH, 2012, TISSUE ENG PT A, V18, P447, DOI [10.1089/ten.tea.2011.0195, 10.1089/ten.TEA.2011.0195]; Sebastine IM, 2007, P ANN INT IEEE EMBS, P6401; Sen S, 2012, MECH MATER, V44, P93, DOI 10.1016/j.mechmat.2011.07.016; Shen FH, 2006, J AM ACAD ORTHOP SUR, V14, P477, DOI 10.5435/00124635-200608000-00005; URBAN JPG, 1988, SPINE, V13, P179, DOI 10.1097/00007632-198802000-00009; Urban JPG, 2000, AM ZOOL, V40, P53, DOI 10.1668/0003-1569(2000)040[0053:TNOTID]2.0.CO;2; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005; YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203; Yuan MT, 2013, BIOMATERIALS, V34, P3948, DOI 10.1016/j.biomaterials.2013.02.004; Yuan MT, 2011, SPINE J, V11, P947, DOI 10.1016/j.spinee.2011.07.004; Zhuang Y, 2011, BIOCHEM BIOPH RES CO, V407, P327, DOI 10.1016/j.bbrc.2011.03.015	39	25	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131827	10.1371/journal.pone.0131827	http://dx.doi.org/10.1371/journal.pone.0131827			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115332	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500183
J	Fang, BS; Jiang, W; Zhou, Q; Wang, SZ				Fang, Baishan; Jiang, Wei; Zhou, Qiang; Wang, Shizhen			Codon-Optimized NADH Oxidase Gene Expression and Gene Fusion with Glycerol Dehydrogenase for Bienzyme System with Cofactor Regeneration	PLOS ONE			English	Article							HETEROLOGOUS PROTEIN EXPRESSION; ESCHERICHIA-COLI; STREPTOCOCCUS-MUTANS; KLEBSIELLA-PNEUMONIAE; INITIATION CODON; TRANSLATION INITIATION; LACTOBACILLUS-BREVIS; MOLECULAR-CLONING; SEQUENCE-ANALYSIS; BIAS	NADH oxidases (NOXs) play an important role in maintaining balance of NAD(+)/NADH by catalyzing cofactors regeneration. The expression of nox gene from Lactobacillus brevis in Escherichia coliBL21 (BL21 (DE3)) was studied. Two strategies, the high AT-content in the region adjacent to the initiation codon and codon usage of the whole gene sequence consistent with the host, obtained the NOX activity of 59.9 U/mg and 73.3 U/mg (crude enzyme), with enhanced expression level of 2.0 and 2.5-folds, respectively. Purified NOX activity was 213.8 U/mg. Gene fusion of glycerol dehydrogenase (GDH) and NOX formed bifuctional multi-enzymes for bioconversion of glycerol coupled with coenzyme regeneration. Kinetic parameters of the GDH-NOX for each substrate, glycerol and NADH, were calculated as V-max(Glycerol) 20 mu M/min, K-m(Glycerol) 19.4 mM, V-max (NADH) 12.5 mu M/min and K-m ((NADH)) 51.3 mu M, respectively, which indicated the potential application of GDH-NOX for quick glycerol analysis and dioxyacetone biosynthesis.	[Fang, Baishan; Jiang, Wei; Zhou, Qiang; Wang, Shizhen] Xiamen Univ, Dept Chem & Biochem Engn, Coll Chem & Chem Engn, Xiamen 361005, Peoples R China; [Fang, Baishan; Jiang, Wei; Zhou, Qiang; Wang, Shizhen] Xiamen Univ, Key Lab Synthet Biotechnol Xiamen City, Xiamen 361005, Peoples R China; [Fang, Baishan] Xiamen Univ, Key Lab Chem Biol Fujian Prov, Xiamen 361005, Fujian, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Wang, SZ (corresponding author), Xiamen Univ, Dept Chem & Biochem Engn, Coll Chem & Chem Engn, Xiamen 361005, Peoples R China.	szwang@xmu.edu.cn			National Natural Science Foundation of China [41176111, 41306124]; State Key Program of the National Natural Science Foundation of China [21336009]; Fundamental Research Funds for the Central Universities [2013121029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No. 41176111, No. 41306124), the State Key Program of the National Natural Science Foundation of China (No. 21336009), and the Fundamental Research Funds for the Central Universities (No. 2013121029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON SGE, 1991, MOL BIOL EVOL, V8, P530; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Baca AM, 2000, INT J PARASITOL, V30, P113, DOI 10.1016/S0020-7519(00)00019-9; Burgess-Brown NA, 2008, PROTEIN EXPRES PURIF, V59, P94, DOI 10.1016/j.pep.2008.01.008; FORAGE RG, 1982, J BACTERIOL, V149, P413, DOI 10.1128/JB.149.2.413-419.1982; Geueke B, 2003, ENZYME MICROB TECH, V32, P205, DOI 10.1016/S0141-0229(02)00290-9; GOLDMAN E, 1995, J MOL BIOL, V245, P467, DOI 10.1006/jmbi.1994.0038; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Higuchi M, 1999, J BACTERIOL, V181, P5940, DOI 10.1128/JB.181.19.5940-5947.1999; HIGUCHI M, 1994, BIOSCI BIOTECH BIOCH, V58, P1603, DOI 10.1271/bbb.58.1603; HIGUCHI M, 1993, J GEN MICROBIOL, V139, P2343, DOI 10.1099/00221287-139-10-2343; Hong SY, 2006, BIOTECHNOL LETT, V28, P1857, DOI 10.1007/s10529-006-9166-8; Hummel W, 2003, BIOTECHNOL LETT, V25, P51, DOI 10.1023/A:1021730131633; JOHNSON EA, 1985, J BACTERIOL, V164, P479, DOI 10.1128/JB.164.1.479-483.1985; JOHNSON EA, 1987, J BACTERIOL, V169, P2050, DOI 10.1128/jb.169.5.2050-2054.1987; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kodumal SJ, 2004, P NATL ACAD SCI USA, V101, P15573, DOI 10.1073/pnas.0406911101; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lapenaite I, 2006, CRIT REV ANAL CHEM, V36, P13, DOI 10.1080/10408340500451973; Li N, 2002, AM J PHYSIOL-RENAL, V282, pF1111, DOI 10.1152/ajprenal.00218.2001; Li WG, 2011, PHYS RES INT, V2011, P1, DOI [10.1155/2011/791545, DOI 10.1155/2011/791545]; Lu P, 2008, APPL MICROBIOL BIOT, V79, P579, DOI 10.1007/s00253-008-1468-4; Marin Monica, 2008, Biotechnology Journal, V3, P1047, DOI 10.1002/biot.200800089; Matsumoto J, 1996, BIOSCI BIOTECH BIOCH, V60, P39, DOI 10.1271/bbb.60.39; Menzella HG, 2006, J IND MICROBIOL BIOT, V33, P22, DOI 10.1007/s10295-005-0038-3; Menzella HG, 2007, CHEM BIOL, V14, P143, DOI 10.1016/j.chembiol.2006.12.002; Menzella HG, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-15; Nishikubo T, 2005, J BIOTECHNOL, V120, P341, DOI 10.1016/j.jbiotec.2005.06.032; Pandey A, 2002, J ENZYM INHIB MED CH, V17, P49, DOI 10.1080/14756360290029510; PARK HJ, 1992, EUR J BIOCHEM, V205, P881, DOI 10.1111/j.1432-1033.1992.tb16853.x; Ruzheinikov SN, 2001, STRUCTURE, V9, P789, DOI 10.1016/S0969-2126(01)00645-1; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Sokic-Lazic D, 2010, ELECTROANAL, V22, P757, DOI 10.1002/elan.200980010; Stenstrom CM, 2002, GENE, V288, P1, DOI 10.1016/S0378-1119(02)00501-2; Stenstrom CM, 2001, GENE, V263, P273, DOI 10.1016/S0378-1119(00)00550-3; Thannickal VJ, 1995, J BIOL CHEM, V270, P30334, DOI 10.1074/jbc.270.51.30334; Trujillo M, 1997, PROTEIN ENG, V10, P567, DOI 10.1093/protein/10.5.567; Tufvesson P, 2013, ORG PROCESS RES DEV, V17, P1233, DOI 10.1021/op4001675; Vervoort EB, 2000, NUCLEIC ACIDS RES, V28, P2069, DOI 10.1093/nar/28.10.2069; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Wang John, 2008, International Journal of Information and Decision Sciences, V1, P1; Wang XX, 2010, PROTEIN EXPRES PURIF, V72, P101, DOI 10.1016/j.pep.2010.02.011; Warnholtz A, 1999, CIRCULATION, V99, P2027, DOI 10.1161/01.CIR.99.15.2027; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Welch M, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2008.0520.focus; Yadava A, 2003, INFECT IMMUN, V71, P4961, DOI 10.1128/IAI.71.9.4961-4969.2003; Zhang Y. S., 2006, J TIANJIN U SCI TECH, V21, P15; Zhou ZY, 2004, PROTEIN EXPRES PURIF, V34, P87, DOI 10.1016/j.pep.2003.11.006	48	8	8	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0128412	10.1371/journal.pone.0128412	http://dx.doi.org/10.1371/journal.pone.0128412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115038	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500013
J	Garcia-Recio, S; Pastor-Arroyo, EM; Marin-Aguilera, M; Almendro, V; Gascon, P				Garcia-Recio, Susana; Pastor-Arroyo, Eva M.; Marin-Aguilera, Mercedes; Almendro, Vanessa; Gascon, Pedro			The Transmodulation of HER2 and EGFR by Substance P in Breast Cancer Cells Requires c-Src and Metalloproteinase Activation	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; TACHYKININ RECEPTORS; TYROSINE KINASES; FAMILY KINASES; TRANSACTIVATION; PROGRESSION; EXPRESSION; PHOSPHORYLATION	Background Substance P (SP) is a pleiotropic cytokine/neuropeptide that enhances breast cancer (BC) aggressiveness by transactivating tyrosine kinase receptors like EGFR and HER2. We previously showed that SP and its cognate receptor NK-1 (SP/NK1-R) signaling modulates the basal phosphorylation of HER2 and EGFR in BC, increasing aggressiveness and drug resistance. In order to elucidate the mechanisms responsible for NK-1R-mediated HER2 and EGFR transactivation, we investigated the involvement of c-Src (a ligand-independent mediator) and of metalloproteinases (ligand-dependent mediators) in HER2/EGFR activation. Results and Discussion Overexpression of NK-1R in MDA-MB-231 and its chemical inhibition in SK-BR-3, BT-474 and MDA-MB-468 BC cells significantly modulated c-Src activation, suggesting that this protein is a mediator of NK-1R signaling. In addition, the c-Src inhibitor 4-(4'-phenoxyanilino)-6,7-dimethoxyquinazoline prevented SP-induced activation of HER2. On the other hand, SP-dependent phosphorylation of HER2 and EGFR decreased substantially in the presence of the MMP inhibitor 1-10, phenanthroline monohydrate, and the dual inhibition of both c-Src and MMP almost abolished the activation of HER2 and EGFR. Moreover, the use of these inhibitors demonstrated that this Src and MMP-dependent signaling is important to the cell viability and migration capacity of HER2+ and EGFR+ cell lines. Conclusion Our results indicate that the transactivation of HER2 and EGFR by the pro-inflammatory cytokine/neuropeptide SP in BC cells is a c-Src and MMP-dependent process.	[Garcia-Recio, Susana; Pastor-Arroyo, Eva M.; Marin-Aguilera, Mercedes; Almendro, Vanessa; Gascon, Pedro] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain; [Garcia-Recio, Susana; Pastor-Arroyo, Eva M.; Marin-Aguilera, Mercedes; Almendro, Vanessa; Gascon, Pedro] Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Gascon, Pedro] Univ Barcelona, Dept Med, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona	Garcia-Recio, S (corresponding author), Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain.	sugarcia@clinic.ub.es; gascon@clinic.ub.es	Recio, Susana Garcia/M-4723-2019; , Mercedes/A-4426-2014	Recio, Susana Garcia/0000-0003-3820-1679; , Mercedes/0000-0002-2205-3459	Fondo de Investigacion Sanitaria [PI08022]; Instituto de salud Carlos III-Subdirecion General de Evaluacion y Fomento de Investigacion; Fondo Europeo de Desarollo Regional; Union Europea; Una manera de hacer Europa; Fundacion Cellex; Redes Tematicas de Investigacion en Cancer (RTICC) [RD07/0020/2014]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Instituto de salud Carlos III-Subdirecion General de Evaluacion y Fomento de Investigacion; Fondo Europeo de Desarollo Regional; Union Europea; Una manera de hacer Europa; Fundacion Cellex(Foundation CELLEX); Redes Tematicas de Investigacion en Cancer (RTICC)	This work was supported by a grant from the Fondo de Investigacion Sanitaria (PI08022) (P. G.), Instituto de salud Carlos III-Subdirecion General de Evaluacion y Fomento de Investigacion, Fondo Europeo de Desarollo Regional, Union Europea, Una manera de hacer Europa (http://www.eng.isciii.es/), and by a grant from the Fundacion Cellex (P.G), by Redes Tematicas de Investigacion en Cancer (RTICC, RD07/0020/2014) (P.G) (http://www.rticc.org/). The work was carried out in part at the Esther Koplowitz Centre, Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almendro V, 2010, CURR DRUG TARGETS, V11, P1169, DOI 10.2174/138945010792006807; Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; Arthur DB, 2006, BIOCHEM BIOPH RES CO, V347, P678, DOI 10.1016/j.bbrc.2006.06.141; Belsches-Jablonski AP, 2001, ONCOGENE, V20, P1465, DOI 10.1038/sj.onc.1204205; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; Bost KL, 2004, FRONT BIOSCI-LANDMRK, V9, P3331, DOI 10.2741/1484; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Cabioglu N, 2005, CANCER RES, V65, P6493, DOI 10.1158/0008-5472.CAN-04-1303; Castagliuolo I, 2000, J BIOL CHEM, V275, P26545, DOI 10.1074/jbc.M003990200; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Delcourt N, 2007, TRENDS PHARMACOL SCI, V28, P602, DOI 10.1016/j.tips.2007.09.007; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Esteban F, 2009, HISTOPATHOLOGY, V54, P258, DOI 10.1111/j.1365-2559.2008.03193.x; Friess H, 2003, LAB INVEST, V83, P731, DOI 10.1097/01.LAB.0000067499.57309.F6; Garcia-Recio S, 2013, CANC RES IN PRESS; Garcia-Recio S, 2013, CANCER RES, V73, P6424, DOI 10.1158/0008-5472.CAN-12-4573; HENNIG IM, 1995, INT J CANCER, V61, P786, DOI 10.1002/ijc.2910610608; Hsieh M, 2007, MOL CELL BIOL, V27, P1914, DOI 10.1128/MCB.01919-06; Ishizawar RC, 2007, ONCOGENE, V26, P3503, DOI 10.1038/sj.onc.1210138; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; KAVELAARS A, 1994, J IMMUNOL, V153, P3691; MAGGI CA, 1995, GEN PHARMACOL-VASC S, V26, P911, DOI 10.1016/0306-3623(94)00292-U; Mancino M, 2011, BBA-REV CANCER, V1816, P105, DOI 10.1016/j.bbcan.2011.04.005; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Mayordomo C, 2012, J CELL PHYSIOL, V227, P1358, DOI 10.1002/jcp.22848; Munoz M, 2014, INT J ONCOL, V45, P1658, DOI 10.3892/ijo.2014.2565; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Olayioye MA, 1998, MOL CELL BIOL, V18, P5042, DOI 10.1128/MCB.18.9.5042; Page NM, 2005, PEPTIDES, V26, P1356, DOI 10.1016/j.peptides.2005.03.030; Palma C, 2000, LIFE SCI, V67, P985, DOI 10.1016/S0024-3205(00)00692-5; Palma C, 2006, CURR DRUG TARGETS, V7, P1043, DOI 10.2174/138945006778019282; Patacchini R, 2004, TRENDS PHARMACOL SCI, V25, P1, DOI 10.1016/j.tips.2003.11.005; PATSCHINSKY T, 1982, P NATL ACAD SCI-BIOL, V79, P973, DOI 10.1073/pnas.79.4.973; Pennefather JN, 2004, LIFE SCI, V74, P1445, DOI 10.1016/j.lfs.2003.09.039; Pierce KL, 2001, J BIOL CHEM, V276, P23155, DOI 10.1074/jbc.M101303200; Rivas MA, 2010, BREAST CANCER RES TR, V122, P111, DOI 10.1007/s10549-009-0546-3; Rosso M, 2008, TUMOR BIOL, V29, P245, DOI 10.1159/000152942; Singh D, 2000, P NATL ACAD SCI USA, V97, P388, DOI 10.1073/pnas.97.1.388; Stern DF, 2000, BREAST CANCER RES, V2, P176, DOI 10.1186/bcr51; Tian GC, 2001, BIOCHEMISTRY-US, V40, P7084, DOI 10.1021/bi0100586; VE US, 1931, J PHYSL, V72, P74; Williams R, 2007, AM J PHYSIOL-LUNG C, V292, pL430, DOI 10.1152/ajplung.00475.2005; Yamaguchi K, 2005, CANCER CHEMOTH PHARM, V56, P585, DOI 10.1007/s00280-005-1030-3; Yamaguchi Keisuke, 2005, Brain Tumor Pathol, V22, P1, DOI 10.1007/s10014-005-0178-1; Zhang Y, 2000, NAT IMMUNOL, V1, P392, DOI 10.1038/80826	47	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129661	10.1371/journal.pone.0129661	http://dx.doi.org/10.1371/journal.pone.0129661			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114632	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500034
J	Habib, R; Ansar, M; Mattheisen, M; Shahid, M; Ali, G; Ahmad, W; Betz, RC				Habib, Rabia; Ansar, Muhammad; Mattheisen, Manuel; Shahid, Muhammad; Ali, Ghazanfar; Ahmad, Wasim; Betz, Regina C.			A Novel Locus for Ectodermal Dysplasia of Hair, Nail and Skin Pigmentation Anomalies Maps to Chromosome 18p11.32-p11.31	PLOS ONE			English	Article							FRANCESCHETTI-JADASSOHN-SYNDROME; DERMATOPATHIA PIGMENTOSA RETICULARIS; MUTATIONS; GENE; FAMILY	Ectodermal dysplasias (EDs) are a large heterogeneous group of inherited disorders exhibiting abnormalities in ectodermally derived appendages such as hair, nails, teeth and sweat glands. EDs associated with reticulated pigmentation phenotype are rare entities for which the genetic basis and pathophysiology are not well characterized. The present study describes a five generation consanguineous Pakistani family segregating an autosomal recessive form of a novel type of ectodermal dysplasia. The affected members present with sparse and woolly hair, severe nail dystrophy and reticulate skin pigmentation. After exclusion of known gene loci related with other skin disorders, genome-wide linkage analysis was performed using Illumina HumanOmniExpress beadchip SNP arrays. We linked this form of ED to human chromosome 18p11.32-p11.31 flanked by the SNPs rs9284390 (0.113Mb) and rs4797100 (3.14 Mb). A maximum two-point LOD score of 3.3 was obtained with several markers along the disease interval. The linkage interval of 3.03 Mb encompassed seventeen functional genes. However, sequence analysis of all these genes did not discover any potentially disease causing-variants. The identification of this novel locus provides additional information regarding the mapping of a rare form of ED. Further research, such as the use of whole-genome sequencing, would be expected to reveal any pathogenic mutation within the disease locus.	[Habib, Rabia; Ansar, Muhammad; Shahid, Muhammad; Ali, Ghazanfar; Ahmad, Wasim] Quaid I Azam Univ, Fac Biol Sci, Dept Biochem, Islamabad, Pakistan; [Mattheisen, Manuel] Univ Bonn, Dept Genom Math, Bonn, Germany; [Habib, Rabia; Mattheisen, Manuel; Betz, Regina C.] Univ Bonn, Inst Human Genet, Bonn, Germany	Quaid I Azam University; University of Bonn; University of Bonn	Ahmad, W (corresponding author), Quaid I Azam Univ, Fac Biol Sci, Dept Biochem, Islamabad, Pakistan.	wahmad@qau.edu.pk	Ahmad, Wasim/GSD-8904-2022; Shahid, Muhammad/AAH-7843-2019; Ansar, Muhammad/H-5967-2011; Betz, Regina C/E-8591-2011; Ali, Ghazanfar/L-9277-2019; Mattheisen, Manuel/B-4949-2012; Habib, Rabia/AAF-3131-2021; Mattheisen, Manuel/S-3725-2019	Ansar, Muhammad/0000-0001-5891-7063; Betz, Regina C/0000-0001-5024-3623; Ali, Ghazanfar/0000-0002-6172-9503; Mattheisen, Manuel/0000-0002-8442-493X; Mattheisen, Manuel/0000-0002-8442-493X; Habib, Rabia/0000-0002-1886-9834	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	R.C.B. is the recipient of a Heisenberg Professorship from the German Research Foundation (DFG).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Fistaro SK, 2010, J DTSCH DERMATOL GES, V8, P187, DOI 10.1111/j.1610-0387.2009.07137.x; Habib R, 2011, GENE, V490, P26, DOI 10.1016/j.gene.2011.09.002; HEIMER WL, 1992, J AM ACAD DERMATOL, V26, P298, DOI 10.1016/0190-9622(92)70039-I; ITIN PH, 1993, J AM ACAD DERMATOL, V28, P942, DOI 10.1016/0190-9622(93)70135-G; Itin PH, 1998, DERMATOLOGY, V197, P281, DOI 10.1159/000018015; Kirwan M, 2008, CLIN GENET, V73, P103, DOI 10.1111/j.1399-0004.2007.00923.x; Lin ZM, 2012, AM J HUM GENET, V91, P906, DOI 10.1016/j.ajhg.2012.08.029; Lugassy J, 2006, AM J HUM GENET, V79, P724, DOI 10.1086/507792; Marneros AG, 2013, AM J HUM GENET, V92, P621, DOI 10.1016/j.ajhg.2013.03.002; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Petrof G, 2014, AM J HUM GENET, V95, P308, DOI 10.1016/j.ajhg.2014.08.001; Rozen S, 2000, Methods Mol Biol, V132, P365; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Seelow D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003874; Vachiramon V, 2011, CLIN EXP DERMATOL, V36, P459, DOI 10.1111/j.1365-2230.2011.04100.x; Whittock NV, 2000, J INVEST DERMATOL, V115, P694, DOI 10.1046/j.1523-1747.2000.00097.x	18	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129811	10.1371/journal.pone.0129811	http://dx.doi.org/10.1371/journal.pone.0129811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115030	gold, Green Published, Green Submitted			2022-12-27	WOS:000358147500038
J	Niu, MJ; Li, Z; Chang, GL; Kong, XJ; Hong, M; Zhang, QF				Niu, Mei-Ju; Li, Zhen; Chang, Guo-Liang; Kong, Xiang-Jin; Hong, Min; Zhang, Qing-fu			Crystal Structure, Cytotoxicity and Interaction with DNA of Zinc (II) Complexes with o-Vanillin Schiff Base Ligands	PLOS ONE			English	Article							FLUORESCENCE PROPERTIES; DNA/PROTEIN INTERACTION; MANGANESE COMPLEXES; COPPER-COMPLEXES; COBALT COMPLEXES; METAL-COMPLEXES; BINDING; ENANTIOMERS; SPECTRA	Two new zinc complexes, Zn(HL1)(2) (1) and [Zn-2(H2L2)(OAc)(2)](2) (2) [H2L1 = Schiff base derived from o-vanillin and (R)-(+)-2-amino-3-phenyl-1-propanol, H3L2 = Schiff base derived from o-vanillin and 2-amino-2-ethyl-1,3-propanediol], have been synthesized and characterized by single crystal X-ray diffraction, elemental analyses, TG analyses, solid fluorescence, IR, UV-Vis and circular dichroism spectra. The structural analysis shows that complex 1 has a right-handed double helical chain along the crystallographic b axis. A homochiral 3D supramolecular architecture has been further constructed by intermolecular C-H center dot center dot center dot pi, O-H center dot center dot center dot O and C-H center dot center dot center dot O interactions. Complex 2 includes two crystallographically independent binuclear zinc molecules. The two binuclear zinc molecules are isostructural. The 2-D sheet supramolecular structure was formed by intermolecular hydrogen bonding interaction. The fluorescence of ligands and complexes in DMF at room temperature are studied. The interactions of two complexes with calf thymus DNA (CT-DNA) are investigated using UV-Vis, CD and fluorescence spectroscopy. The results show that complex 1 exhibits higher interaction with CT-DNA than complex 2. In addition, in vitro cytotoxicity of the complexes towards four kinds of cancerous cell lines (A549, HeLa, HL-60 and K562) were assayed by the MTT method. Investigations on the structures indicated that the chirality and nuclearity of zinc complexes play an important role on cytotoxic activity.	[Niu, Mei-Ju; Li, Zhen; Chang, Guo-Liang; Kong, Xiang-Jin; Hong, Min; Zhang, Qing-fu] Liaocheng Univ, Sch Chem & Chem Engn, Liaocheng 252059, Shandong, Peoples R China; [Niu, Mei-Ju; Li, Zhen; Chang, Guo-Liang] Liaocheng Univ, Shandong Prov Key Lab Chem Energy Storage & Novel, Liaocheng 252059, Shandong, Peoples R China	Liaocheng University; Liaocheng University	Niu, MJ (corresponding author), Liaocheng Univ, Sch Chem & Chem Engn, Liaocheng 252059, Shandong, Peoples R China.	niumeiju@163.dom	Zhag, Qingfu/E-8090-2013; zhao, qiang/GWC-1298-2022	Zhag, Qingfu/0000-0002-5788-7023; 	Natural Science Foundation of Shandong Province [ZR2013BM017]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	The authors acknowledge the financial support of the Natural Science Foundation of Shandong Province (No. ZR2013BM017).	Al Rasbi NK, 2014, J PHOTOCH PHOTOBIO A, V285, P37, DOI 10.1016/j.jphotochem.2014.03.020; Aritake Y, 2012, POLYHEDRON, V31, P278, DOI 10.1016/j.poly.2011.09.025; Arjmand F, 2011, J PHOTOCH PHOTOBIO B, V103, P166, DOI 10.1016/j.jphotobiol.2011.03.001; BEKHEIT MM, 1986, SYN REACT INORG MET, V16, P1135, DOI 10.1080/00945718608071387; Che CM, 2003, COORDIN CHEM REV, V242, P97, DOI 10.1016/S0010-8545(03)00065-1; Cheng QR, 2011, POLYHEDRON, V30, P1171, DOI 10.1016/j.poly.2011.01.014; Consiglio G, 2010, INORG CHEM, V49, P5134, DOI 10.1021/ic100284r; Fu ZY, 2002, EUR J INORG CHEM, P2730; FUKUHARA C, 1987, J CHEM SOC DALTON, P1305, DOI 10.1039/dt9870001305; Gao EJ, 2012, RUSS J COORD CHEM+, V38, P386, DOI 10.1134/S1070328412050028; Gu ZG, 2013, POLYHEDRON, V51, P186, DOI 10.1016/j.poly.2012.12.027; Guo Q, 2013, SPECTROCHIM ACTA A, V106, P155, DOI 10.1016/j.saa.2012.12.089; Ingole PG, 2011, DESALINATION, V281, P413, DOI 10.1016/j.desal.2011.08.017; Khan NU, 2011, SPECTROCHIM ACTA A, V81, P199, DOI 10.1016/j.saa.2011.06.002; KOVACIC JE, 1967, SPECTROCHIM ACTA A-M, VA 23, P183, DOI 10.1016/0584-8539(67)80219-8; Li P, 2014, Z ANORG ALLG CHEM, V640, P2238, DOI 10.1002/zaac.201400051; Li P, 2014, J INORG BIOCHEM, V137, P101, DOI 10.1016/j.jinorgbio.2014.04.005; Lin WC, 2014, CHINESE J STRUC CHEM, V33, P591; McMillin DR, 1998, CHEM REV, V98, P1201, DOI 10.1021/cr9601167; Mishra M, 2014, SPECTROCHIM ACTA A, V132, P452, DOI 10.1016/j.saa.2014.05.007; Nair MS, 2012, J SAUDI CHEM SOC, V16, P83, DOI 10.1016/j.jscs.2010.11.002; Niu MJ, 2014, J COORD CHEM, V67, P81, DOI 10.1080/00958972.2013.876625; PERCY GC, 1972, J INORG NUCL CHEM, V34, P3357, DOI 10.1016/0022-1902(72)80230-6; Prabhakar M, 2005, INORG CHEM, V44, P2585, DOI 10.1021/ic048236h; Raman N, 2014, SPECTROCHIM ACTA A, V125, P404, DOI 10.1016/j.saa.2014.01.108; Roy P, 2009, POLYHEDRON, V28, P1133, DOI 10.1016/j.poly.2009.01.042; Shakir M, 2011, SPECTROCHIM ACTA A, V79, P1050; Tang YZ, 2009, INORG CHIM ACTA, V362, P1969, DOI 10.1016/j.ica.2008.09.032; TURK T, 1992, INORG CHEM, V31, P1854; Vijayalakshmi R, 2006, BIOORGAN MED CHEM, V14, P3300, DOI 10.1016/j.bmc.2005.12.049; Wen HR, 2012, INORG CHEM COMMUN, V20, P303, DOI 10.1016/j.inoche.2012.03.036; Wen JH, 2011, CHEM COMMUN, V47, P11330, DOI 10.1039/c1cc14107d; Ye Q, 2005, INORG CHEM, V44, P3618, DOI 10.1021/ic0500098; Yin HD, 2012, J ORGANOMET CHEM, V713, P11, DOI 10.1016/j.jorganchem.2012.03.027	34	21	21	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130922	10.1371/journal.pone.0130922	http://dx.doi.org/10.1371/journal.pone.0130922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114437	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500110
J	Shibasaki, N; Yamasaki, T; Kanno, T; Arakaki, R; Sakamoto, H; Utsunomiya, N; Inoue, T; Tsuruyama, T; Nakamura, E; Ogawa, O; Kamba, T				Shibasaki, Noboru; Yamasaki, Toshinari; Kanno, Toru; Arakaki, Ryuichiro; Sakamoto, Hiromasa; Utsunomiya, Noriaki; Inoue, Takahiro; Tsuruyama, Tatsuaki; Nakamura, Eijiro; Ogawa, Osamu; Kamba, Tomomi			Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; INTERLEUKIN-13 RECEPTOR; MESENCHYMAL TRANSITION; ANTIANGIOGENIC THERAPY; TARGET; MACROPHAGES; XENOGRAFTS; EXPRESSION; PROMOTES; SU11248	Vascular endothelial growth factor (VEGF) and mammalian target of rapamycin are well-known therapeutic targets for renal cell carcinoma (RCC). Sunitinib is an agent that targets VEGF receptors and is considered to be a standard treatment for metastatic or unresectable clear cell RCC (ccRCC). However, ccRCC eventually develops resistance to sunitinib in most cases, and the mechanisms underlying this resistance are not fully elucidated. In the present study, we established unique primary xenograft models, KURC1 (Kyoto University Renal Cancer 1) and KURC2, from freshly isolated ccRCC specimens. The KURC1 xenograft initially responded to sunitinib treatment, however finally acquired resistance. KURC2 retained sensitivity to sunitinib for over 6 months. Comparing gene expression profiles between the two xenograft models with different sensitivity to sunitinib, we identified interleukin 13 receptor alpha 2 (IL13RA2) as a candidate molecule associated with the acquired sunitinib-resistance in ccRCC. And patients with high IL13RA2 expression in immunohistochemistry in primary ccRCC tumor tends to have sunitinib-resistant metastatic site. Next, we showed that sunitinib-sensitive 786-O cells acquired resistance in vivo when IL13RA2 was overexpressed. Conversely, shRNA-mediated knockdown of IL13RA2 successfully overcame the sunitinib-resistance in Caki-1 cells. Histopathological analyses revealed that IL13RA2 repressed sunitinib-induced apoptosis without increasing tumor vasculature in vivo. To our knowledge, this is a novel mechanism of developing resistance to sunitinib in a certain population of ccRCC, and these results indicate that IL13RA2 could be one of potential target to overcome sunitinib resistance.	[Shibasaki, Noboru; Yamasaki, Toshinari; Kanno, Toru; Arakaki, Ryuichiro; Sakamoto, Hiromasa; Utsunomiya, Noriaki; Inoue, Takahiro; Ogawa, Osamu; Kamba, Tomomi] Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan; [Tsuruyama, Tatsuaki] Kyoto Univ, Grad Sch Med, Dept Diagnost Pathol, Kyoto, Japan; [Nakamura, Eijiro] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Lab Malignancy Control Res, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University	Kamba, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan.	kamba@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [23249073]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology No. 23249073.	Albiges L, 2012, J CLIN ONCOL, V30, P482, DOI 10.1200/JCO.2011.37.2516; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bhatt RS, 2010, MOL CANCER THER, V9, P2793, DOI 10.1158/1535-7163.MCT-10-0477; Brugarolas J, 2007, NEW ENGL J MED, V356, P185, DOI 10.1056/NEJMe068263; Caput D, 1996, J BIOL CHEM, V271, P16921, DOI 10.1074/jbc.271.28.16921; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Dabney R, 2014, TARGET ONCOL, V9, P183, DOI 10.1007/s11523-013-0303-8; Debinski W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077719; Escudier B, 2012, ANN ONCOL, V23, P65, DOI 10.1093/annonc/mds227; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Ferrara N, 2010, CURR OPIN HEMATOL, V17, P219, DOI 10.1097/MOH.0b013e3283386660; Fiebig HH, 2004, EUR J CANCER, V40, P802, DOI 10.1016/j.ejca.2004.01.009; Finke J, 2011, INT IMMUNOPHARMACOL, V11, P856, DOI 10.1016/j.intimp.2011.01.030; Flanigan Robert C, 2003, Curr Treat Options Oncol, V4, P385, DOI 10.1007/s11864-003-0039-2; Frey K, 2010, J UROLOGY, V184, P2540, DOI 10.1016/j.juro.2010.07.030; Gotink KJ, 2011, CLIN CANCER RES, V17, P7337, DOI 10.1158/1078-0432.CCR-11-1667; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; Hall B, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-45; Hammers HJ, 2010, MOL CANCER THER, V9, P1525, DOI 10.1158/1535-7163.MCT-09-1106; He H, 2010, PROSTATE, V70, P993, DOI 10.1002/pros.21133; Hsi LC, 2011, MOL CANCER THER, V10, P1149, DOI 10.1158/1535-7163.MCT-10-1064; Huang D, 2010, CANCER RES, V70, P1053, DOI 10.1158/0008-5472.CAN-09-3722; Huang D, 2010, CANCER RES, V70, P1063, DOI 10.1158/0008-5472.CAN-09-3965; Jin KT, 2010, CLIN TRANSL ONCOL, V12, P473, DOI 10.1007/s12094-010-0540-6; Kanno T, 2012, ONCOGENE, V31, P3098, DOI 10.1038/onc.2011.475; Kelly-Welch Ann, 2005, Sci STKE, V2005, pcm8, DOI 10.1126/stke.2932005cm8; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Meng FB, 2014, IUBMB LIFE, V66, P835, DOI 10.1002/iub.1336; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2006, JAMA-J AM MED ASSOC, V295, P2516, DOI 10.1001/jama.295.21.2516; Nakamura E, 2006, AM J PATHOL, V168, P574, DOI 10.2353/ajpath.2006.050867; Peterson JK, 2004, EUR J CANCER, V40, P837, DOI 10.1016/j.ejca.2004.01.003; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Schor-Bardach R, 2009, RADIOLOGY, V251, P731, DOI 10.1148/radiol.2521081059; Schueneman AJ, 2003, CANCER RES, V63, P4009; Sellers WR, 2011, CELL, V147, P26, DOI 10.1016/j.cell.2011.09.016; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sivanand S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003643; Suggitt M, 2005, CLIN CANCER RES, V11, P971; Terada N, 2010, CANCER RES, V70, P1606, DOI 10.1158/0008-5472.CAN-09-2984; Vasselli JR, 2003, P NATL ACAD SCI USA, V100, P6958, DOI 10.1073/pnas.1131754100; WEIDNER N, 1995, AM J PATHOL, V147, P9; Xin H, 2009, CANCER RES, V69, P2506, DOI 10.1158/0008-5472.CAN-08-4323; Yamasaki T, 2012, CANCER SCI, V103, P2027, DOI 10.1111/j.1349-7006.2012.02412.x; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028432, 10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953]; Zhau HE, 2008, CLIN EXP METASTAS, V25, P601, DOI 10.1007/s10585-008-9183-1	51	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130980	10.1371/journal.pone.0130980	http://dx.doi.org/10.1371/journal.pone.0130980			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114873	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500114
J	Wu, P; Wu, D; Li, LJ; Chai, Y; Huang, J				Wu, Pin; Wu, Dang; Li, Lijun; Chai, Ying; Huang, Jian			PD-L1 and Survival in Solid Tumors: A Meta-Analysis	PLOS ONE			English	Article							PROGRAMMED DEATH-1 LIGAND-1; COSTIMULATORY MOLECULE B7-H1; CELL LUNG-CANCER; CLINICAL-SIGNIFICANCE; INFILTRATING LYMPHOCYTES; ANTI-PD-L1 ANTIBODY; EXPRESSION; BLOCKADE; IMMUNOTHERAPY; CARCINOMA	Background Numerous agents targeting PD-L1/PD-1 check-point are in clinical development. However, the correlation between PD-L1expression and prognosis of solid tumor is still in controversial. Here, we elicit a systematic review and meta-analysis to investigate the potential value of PD-L1 in the prognostic prediction in human solid tumors. Methods Electronic databases were searched for studies evaluating the expression of PD-L1 and overall survival (OS) of patients with solid tumors. Odds ratios (ORs) from individual studies were calculated and pooled by using a random-effect model, and heterogeneity and publication bias analyses were also performed. Results A total of 3107 patients with solid tumor from 28 published studies were included in the meta-analysis. The median percentage of solid tumors with PD-L1 overexpression was 52.5%. PD-L1 overexpression was associated with worse OS at both 3 years (OR = 2.43, 95% confidence interval (CI) = 1.60 to 3.70, P < 0.0001) and 5 years (OR = 2.23, 95% CI = 1.40 to 3.55, P = 0.0008) of solid tumors. Among the tumor types, PD-L1 was associated with worse 3 year-OS of esophageal cancer, gastric cancer, hepatocellular carcinoma, and urothelial cancer, and 5 year-OS of esophageal cancer, gastric cancer and colorectal cancer. Conclusions These results suggest that expression of PD-L1 is associated with worse survival in solid tumors. However, the correlations between PD-L1 and prognosis are variant among different tumor types. More studies are needed to investigate the clinical value of PD-L1 expression in prognostic prediction and treatment option.	[Wu, Pin; Chai, Ying] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Thorac Surg, Hangzhou 310009, Zhejiang, Peoples R China; [Huang, Jian] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Surg Oncol, Hangzhou 310009, Zhejiang, Peoples R China; [Wu, Pin; Wu, Dang; Huang, Jian] Zhejiang Univ, Prov Key Lab Mol Biol Med Sci, Key Lab Canc Prevent & Intervent,Sch Med, Natl Minist Educ,Canc Inst,Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China; [Li, Lijun] Xixi Hosp Hangzhou, Hangzhou 310009, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Chai, Y (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Thorac Surg, Hangzhou 310009, Zhejiang, Peoples R China.	chaiy@126.com; drhuangjian@zju.edu.cn		Wu, Pin/0000-0002-0472-1425; Huang, Jian/0000-0003-3340-5007	Science and Technology Department of Zhejiang Province [2011c13034similar to1, 2013c03044-7]; Natural Science Foundation of Zhejiang Province [Z2100366, LY13H160016]	Science and Technology Department of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by grants from the Science and Technology Department of Zhejiang Province (2011c13034 similar to 1, to JH and 2013c03044-7, to YC); and Natural Science Foundation of Zhejiang Province (Z2100366, to JH and LY13H160016, to YC).	Blank C, 2004, CANCER RES, V64, P1140, DOI 10.1158/0008-5472.CAN-03-3259; Boorjian SA, 2008, CLIN CANCER RES, V14, P4800, DOI 10.1158/1078-0432.CCR-08-0731; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chen LJ, 2014, INT J CLIN EXP PATHO, V7, P6015; Chen Xiao-Ling, 2009, Ai Zheng, V28, P1328; Chen YB, 2012, TUMORI, V98, P751, DOI 10.1700/1217.13499; Cho YA, 2011, ORAL ONCOL, V47, P1148, DOI 10.1016/j.oraloncology.2011.08.007; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Deeks JJ HJ, 2006, COCHRANE HDB SYSTEMA, V425; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Gao Q, 2009, CLIN CANCER RES, V15, P971, DOI 10.1158/1078-0432.CCR-08-1608; Geng YT, 2015, INT J CLIN ONCOL, V20, P273, DOI 10.1007/s10147-014-0701-7; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hino R, 2010, CANCER-AM CANCER SOC, V116, P1757, DOI 10.1002/cncr.24899; Hou JY, 2014, EXP MOL PATHOL, V96, P284, DOI 10.1016/j.yexmp.2014.03.005; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Karim R, 2009, CLIN CANCER RES, V15, P6341, DOI 10.1158/1078-0432.CCR-09-1652; Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liu YW, 2013, J NEUROSCI, V33, P14231, DOI 10.1523/JNEUROSCI.5812-12.2013; Loos M, 2011, ANN THORAC SURG, V91, P1025, DOI 10.1016/j.athoracsur.2010.12.041; Perez-Gracia JL, 2014, CURR OPIN IMMUNOL, V27, P89, DOI 10.1016/j.coi.2014.01.002; Mansfield AS, 2014, J THORAC ONCOL, V9, P1036, DOI 10.1097/JTO.0000000000000177; Mittal D, 2014, CURR OPIN IMMUNOL, V27, P16, DOI 10.1016/j.coi.2014.01.004; Mu CY, 2011, MED ONCOL, V28, P682, DOI 10.1007/s12032-010-9515-2; Nakanishi J, 2007, CANCER IMMUNOL IMMUN, V56, P1173, DOI 10.1007/s00262-006-0266-z; Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shi SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076012; Strome SE, 2003, CANCER RES, V63, P6501; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Ukpo OC, 2013, HEAD NECK PATHOL, V7, P113, DOI 10.1007/s12105-012-0406-z; Velcheti V, 2014, LAB INVEST, V94, P107, DOI 10.1038/labinvest.2013.130; Wang YH, 2009, J HUAZHONG U SCI-MED, V29, P77, DOI 10.1007/s11596-009-0116-2; Wu CP, 2006, ACTA HISTOCHEM, V108, P19, DOI 10.1016/j.acthis.2006.01.003; Wu K, 2009, CANCER RES, V69, P8067, DOI 10.1158/0008-5472.CAN-09-0901; Xylinas E, 2014, EJSO-EUR J SURG ONC, V40, P121, DOI 10.1016/j.ejso.2013.08.023; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001; Yang CY, 2014, EUR J CANCER, V50, P1361, DOI 10.1016/j.ejca.2014.01.018; Zhang YX, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000515; Zhu JJ, 2014, HUM IMMUNOL, V75, P348, DOI 10.1016/j.humimm.2014.01.006	49	253	274	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131403	10.1371/journal.pone.0131403	http://dx.doi.org/10.1371/journal.pone.0131403			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114883	gold, Green Submitted, Green Published			2022-12-27	WOS:000358147500154
J	Alomair, OI; Brereton, IM; Smith, MT; Galloway, GJ; Kurniawan, ND				Alomair, Othman I.; Brereton, Ian M.; Smith, Maree T.; Galloway, Graham J.; Kurniawan, Nyoman D.			In vivo High Angular Resolution Diffusion-Weighted Imaging of Mouse Brain at 16.4 Tesla	PLOS ONE			English	Article							CORPUS-CALLOSUM; HIGH-FIELD; ANATOMICAL CHARACTERIZATION; FIBER TRACTOGRAPHY; WHITE-MATTER; RAT-BRAIN; RF PROBE; MRI; DEMYELINATION; ARTIFACTS	Magnetic Resonance Imaging (MRI) of the rodent brain at ultra-high magnetic fields (> 9.4 Tesla) offers a higher signal-to-noise ratio that can be exploited to reduce image acquisition time or provide higher spatial resolution. However, significant challenges are presented due to a combination of longer T-1 and shorter T-2/T-2* relaxation times and increased sensitivity to magnetic susceptibility resulting in severe local-field inhomogeneity artefacts from air pockets and bone/brain interfaces. The Stejskal-Tanner spin echo diffusion-weighted imaging (DWI) sequence is often used in high-field rodent brain MRI due to its immunity to these artefacts. To accurately determine diffusion-tensor or fibre-orientation distribution, high angular resolution diffusion imaging (HARDI) with strong diffusion weighting (b > 3000 s/mm(2)) and at least 30 diffusion-encoding directions are required. However, this results in long image acquisition times unsuitable for live animal imaging. In this study, we describe the optimization of HARDI acquisition parameters at 16.4T using a Stejskal-Tanner sequence with echo-planar imaging (EPI) readout. EPI segmentation and partial Fourier encoding acceleration were applied to reduce the echo time (TE), thereby minimizing signal decay and distortion artefacts while maintaining a reasonably short acquisition time. The final HARDI acquisition protocol was achieved with the following parameters: 4 shot EPI, b = 3000 s/mm(2), 64 diffusion-encoding directions, 125x150 mu m(2) in-plane resolution, 0.6 mm slice thickness, and 2h acquisition time. This protocol was used to image a cohort of adult C57BL/6 male mice, whereby the quality of the acquired data was assessed and diffusion tensor imaging (DTI) derived parameters were measured. High-quality images with high spatial and angular resolution, low distortion and low variability in DTI-derived parameters were obtained, indicating that EPI-DWI is feasible at 16.4T to study animal models of white matter (WM) diseases.	[Alomair, Othman I.; Brereton, Ian M.; Galloway, Graham J.; Kurniawan, Nyoman D.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Smith, Maree T.] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; [Alomair, Othman I.] King Saud Univ, Coll Appl Med Sci, Riyadh, Saudi Arabia	University of Queensland; University of Queensland; King Saud University	Kurniawan, ND (corresponding author), Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia.	n.kurniawan@uq.edu.au	Smith, Maree T/I-4005-2015; Kurniawan, Nyoman/D-9764-2011; Galloway, Graham/D-2009-2011; Brereton, Ian/E-6146-2011; Alomair, Othman/T-2733-2017	Smith, Maree T/0000-0003-2281-3734; Kurniawan, Nyoman/0000-0001-6340-182X; Galloway, Graham/0000-0002-0805-2775; Brereton, Ian/0000-0001-8813-6866; Alomair, Othman/0000-0001-9769-2514	Queensland State Government; Saudi Government Scholarship - King Saud University, Riyadh, Saudi Arabia	Queensland State Government; Saudi Government Scholarship - King Saud University, Riyadh, Saudi Arabia	The authors thank the Queensland State Government for support of the 16.4T through the Queensland NMR Network. Author Alomair acknowledges the Saudi Government Scholarship provided by King Saud University, Riyadh, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2012, MOUSE NERVOUS SYSTEM, P473, DOI 10.1016/B978-0-12-369497-3.10015-9; Aggarwal M, 2010, MAGN RESON MED, V64, P249, DOI 10.1002/mrm.22426; Ahrens ET, 2002, PROG NUCL MAG RES SP, V40, P275, DOI 10.1016/S0079-6565(02)00003-1; Alexander AL, 1997, MAGN RESON MED, V38, P1016, DOI 10.1002/mrm.1910380623; ANDERSON AW, 1994, MAGNET RESON MED, V32, P379, DOI 10.1002/mrm.1910320313; Anderson SA, 2007, NMR BIOMED, V20, P200, DOI 10.1002/nbm.1167; Andersson JLR, 2002, NEUROIMAGE, V16, P177, DOI 10.1006/nimg.2001.1039; Atkinson D, 2000, MAGN RESON MED, V44, P101, DOI 10.1002/1522-2594(200007)44:1<101::AID-MRM15>3.0.CO;2-S; Baloch S, 2009, CEREB CORTEX, V19, P675, DOI 10.1093/cercor/bhn112; Baltes C, 2009, NMR BIOMED, V22, P834, DOI 10.1002/nbm.1396; Bammer P, 1999, RADIOLOGY, V211, P799, DOI 10.1148/radiology.211.3.r99jn15799; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; Boretius S, 2007, J NEUROSCI METH, V161, P112, DOI 10.1016/j.jneumeth.2006.10.019; Brennan FH, 2013, NEUROIMAGE; Brockstedt S, 2000, MAGN RESON IMAGING, V18, P649, DOI 10.1016/S0730-725X(00)00159-4; Butts K, 1996, MAGNET RESON MED, V35, P763, DOI 10.1002/mrm.1910350518; de Figueiredo EHMSG, 2011, MAGN RESON IMAGING C, V19, P1, DOI 10.1016/j.mric.2010.10.005; DECRESPIGNY AJ, 1995, MAGN RESON MED, V33, P720, DOI 10.1002/mrm.1910330518; DELAPAZ RL, 1994, RADIOGRAPHICS, V14, P1045, DOI 10.1148/radiographics.14.5.7991813; Denic A, 2011, NEUROTHERAPEUTICS, V8, P3, DOI 10.1007/s13311-010-0002-4; Ferris CF, 2013, TRANSLATIONAL NEUROIMAGING: TOOLS FOR CNS DRUG DISCOVERY, DEVELOPMENT AND TREATMENT, P59, DOI 10.1016/B978-0-12-386945-6.00003-2; Fischer H., 1998, ECHO PLANAR IMAGING, P179; Frost R, 2012, MAGN RESON MED, V68, P441, DOI 10.1002/mrm.23242; Harsan LA, 2010, NMR BIOMED, V23, P884, DOI 10.1002/nbm.1496; Harsan LA, 2008, J NEUROSCI, V28, P14189, DOI 10.1523/JNEUROSCI.4453-08.2008; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Kim SG, 1996, MAGNET RESON MED, V35, P895, DOI 10.1002/mrm.1910350618; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Le Bihan D, 1995, DIFFUSION AND PERFUS; Le Bihan D, 2006, J MAGN RESON IMAGING, V24, P478, DOI 10.1002/jmri.20683; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Marzola P, 2003, EUR J RADIOL, V48, P165, DOI 10.1016/j.ejrad.2003.08.007; Moldrich RX, 2010, NEUROIMAGE, V51, P1027, DOI 10.1016/j.neuroimage.2010.03.035; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2001, MAGN RESON MED, V46, P18, DOI 10.1002/mrm.1155; Mori S, 2007, INTRODUCTION TO DIFF, P49; Mori S, 2014, INTRODUCTION TO DIFF, P27; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Muller HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053389; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Paxinos G, 2004, THE MOUSE BRAIN IN S; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Pipe J, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P11, DOI 10.1016/B978-0-12-374709-9.00002-X; Pohmann R, 2011, MAGN RESON MED, V66, P1572, DOI 10.1002/mrm.22949; Ratering D, 2008, MAGN RESON MED, V59, P1440, DOI 10.1002/mrm.21629; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; STEHLING MK, 1991, SCIENCE, V254, P43, DOI 10.1126/science.1925560; Sun SW, 2007, NEUROBIOL DIS, V28, P30, DOI 10.1016/j.nbd.2007.06.011; Sun SW, 2006, NEUROIMAGE, V32, P1195, DOI 10.1016/j.neuroimage.2006.04.212; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Tani Y, 2004, TOXICOL PATHOL, V32, P41, DOI 10.1080/01926230490260952; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; van de Ven RCG, 2007, MAGN RESON MED, V58, P390, DOI 10.1002/mrm.21313; Wang SL, 2008, STROKE, V39, P2348, DOI 10.1161/STROKEAHA.107.509927; Wu D, 2014, NEUROIMAGE, V91, P12, DOI 10.1016/j.neuroimage.2014.01.014; Wu D, 2013, NEUROIMAGE, V83, P18, DOI 10.1016/j.neuroimage.2013.06.012; Xie MQ, 2010, J NEUROPATH EXP NEUR, V69, P704, DOI 10.1097/NEN.0b013e3181e3de90; Xu JQ, 2008, NMR BIOMED, V21, P928, DOI 10.1002/nbm.1307; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhang JY, 2012, MAGN RESON MED, V67, P750, DOI 10.1002/mrm.23032; Zhang JY, 2012, TRENDS NEUROSCI, V35, P412, DOI 10.1016/j.tins.2012.04.010; Zhang Jiangyang, 2010, Imaging Med, V2, P623, DOI 10.2217/iim.10.60; Zhang JY, 2003, NEUROIMAGE, V20, P1639, DOI 10.1016/S1053-8119(03)00410-5; Zhou XHJ, 1998, MAGNET RESON MED, V39, P596, DOI 10.1002/mrm.1910390413	66	20	23	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130133	10.1371/journal.pone.0130133	http://dx.doi.org/10.1371/journal.pone.0130133			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110770	gold, Green Published, Green Submitted			2022-12-27	WOS:000356933800038
J	Tummers, QRJG; Hoogstins, CES; Peters, AAW; de Kroon, CD; Trimbos, JBMZ; van de Velde, CJH; Frangioni, JV; Vahrmeijer, AL; Gaarenstroom, KN				Tummers, Quirijn R. J. G.; Hoogstins, Charlotte E. S.; Peters, Alexander A. W.; de Kroon, Cor D.; Trimbos, J. Baptist M. Z.; van de Velde, Cornelis J. H.; Frangioni, John V.; Vahrmeijer, Alexander L.; Gaarenstroom, Katja N.			The Value of Intraoperative Near-Infrared Fluorescence Imaging Based on Enhanced Permeability and Retention of Indocyanine Green: Feasibility and False-Positives in Ovarian Cancer	PLOS ONE			English	Article							VASCULAR-PERMEABILITY; MACROMOLECULAR THERAPEUTICS; CYTOREDUCTIVE SURGERY; DRUG-DELIVERY; TUMOR; BREAST; CHEMOTHERAPY; INFECTION; CARCINOMA; DIAGNOSIS	Objective In ovarian cancer, two of the most important prognostic factors for survival are completeness of staging and completeness of cytoreductive surgery. Therefore, intra-operative visualization of tumor lesions is of great importance. Preclinical data already demonstrated tumor visualization in a mouse-model using near-infrared (NIR) fluorescence imaging and indocyanine green (ICG) as a result of enhanced permeability and retention (EPR). The aim of this study was to determine feasibility of intraoperative ovarian cancer metastases imaging using NIR fluorescence imaging and ICG in a clinical setting. Methods Ten patients suspected of ovarian cancer scheduled for staging or cytoreductive surgery were included. Patients received 20 mg ICG intravenously after opening the abdominal cavity. The mini-FLARE NIR fluorescence imaging system was used to detect NIR fluorescent lesions. Results 6 out of 10 patients had malignant disease of the ovary or fallopian tube, of which 2 had metastatic disease outside the pelvis. Eight metastatic lesions were detected in these 2 patients, which were all NIR fluorescent. However, 13 non-malignant lesions were also NIR fluorescent, resulting in a false-positive rate of 62%. There was no significant difference in tumor-to-background ratio between malignant and benign lesions (2.0 vs 2.0; P=0.99). Conclusions This is the first clinical trial demonstrating intraoperative detection of ovarian cancer metastases using NIR fluorescence imaging and ICG. Despite detection of all malignant lesions, a high false-positive rate was observed. Therefore, NIR fluorescence imaging using ICG based on the EPR effect is not satisfactory for the detection of ovarian cancer metastases. The need for tumor-specific intraoperative agents remains.	[Tummers, Quirijn R. J. G.; Hoogstins, Charlotte E. S.; van de Velde, Cornelis J. H.; Vahrmeijer, Alexander L.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Peters, Alexander A. W.; de Kroon, Cor D.; Trimbos, J. Baptist M. Z.; Gaarenstroom, Katja N.] Leiden Univ, Med Ctr, Dept Gynecol, Leiden, Netherlands; [Frangioni, John V.] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Dept Med, Boston, MA 02215 USA; [Frangioni, John V.] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA; [Frangioni, John V.] Curadel LLC, Worcester, MA USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Vahrmeijer, AL (corresponding author), Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands.	a.l.vahrmeijer@lumc.nl	Vahrmeijer, Alexander/AAG-3329-2022; Vahrmeijer, Alexander/AFK-4657-2022	Vahrmeijer, Alexander/0000-0001-9370-0011; Vahrmeijer, Alexander/0000-0001-9370-0011; Gaarenstroom, Katja/0000-0002-4702-1680	Dutch Cancer Society [UL2010-4732]; NIH [R01-CA-115296]; project MUSIS [030-202-04]; Curadel, LLC; NATIONAL CANCER INSTITUTE [R01CA115296] Funding Source: NIH RePORTER	Dutch Cancer Society(KWF Kankerbestrijding); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); project MUSIS; Curadel, LLC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Dutch Cancer Society grant UL2010-4732 and NIH grant R01-CA-115296. This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine; project MUSIS (grant 030-202-04). Curadel, LLC provided support in the form of salaries for author JVF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Alacam B, 2008, PHYS MED BIOL, V53, P837, DOI 10.1088/0031-9155/53/4/002; Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; Colombo N, 2006, CRIT REV ONCOL HEMAT, V60, P159, DOI 10.1016/j.critrevonc.2006.03.004; Fader AN, 2007, J CLIN ONCOL, V25, P2873, DOI 10.1200/JCO.2007.11.0932; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Griffiths C T, 1975, Natl Cancer Inst Monogr, V42, P101; Hagen A, 2009, OPT EXPRESS, V17, P17016, DOI 10.1364/OE.17.017016; HOSKINS WJ, 1994, AM J OBSTET GYNECOL, V170, P974, DOI 10.1016/S0002-9378(94)70090-7; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kimura T, 2007, GASTROINTEST ENDOSC, V66, P37, DOI 10.1016/j.gie.2007.01.009; Kosaka N, 2011, INT J CANCER, V129, P1671, DOI 10.1002/ijc.26113; Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Maeda H, 2013, CANCER SCI, V104, P779, DOI 10.1111/cas.12152; Maeda H, 2012, P JPN ACAD B-PHYS, V88, P53, DOI 10.2183/pjab.88.53; Mataki N, 2003, GASTROINTEST ENDOSC, V57, P336, DOI 10.1067/mge.2003.133; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Mieog JSD, 2011, ANN SURG ONCOL, V18, P2483, DOI 10.1245/s10434-011-1566-x; Ntziachristos V, 2000, P NATL ACAD SCI USA, V97, P2767, DOI 10.1073/pnas.040570597; Poellinger A, 2011, RADIOLOGY, V258, P409, DOI 10.1148/radiol.10100258; Schaafsma BE, 2011, J SURG ONCOL, V104, P323, DOI 10.1002/jso.21943; Trimbos B, 2010, J NATL CANCER I, V102, P982, DOI 10.1093/jnci/djq149; Tummers QRJG, 2014, EJSO-EUR J SURG ONC, V40, P850, DOI 10.1016/j.ejso.2014.02.225; Vahrmeijer AL, 2013, NAT REV CLIN ONCOL, V10, P507, DOI 10.1038/nrclinonc.2013.123; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; van der Vorst JR, 2014, HEAD NECK-J SCI SPEC, V36, P853, DOI 10.1002/hed.23384; van der Vorst JR, 2013, CANCER-AM CANCER SOC, V119, P3411, DOI 10.1002/cncr.28203; Vergote I, 1998, GYNECOL ONCOL, V71, P431, DOI 10.1006/gyno.1998.5213; Vergote Ignace, 2003, Current Opinion in Oncology, V15, P452, DOI 10.1097/00001622-200311000-00008	31	87	87	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0129766	10.1371/journal.pone.0129766	http://dx.doi.org/10.1371/journal.pone.0129766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110901	gold, Green Submitted, Green Published			2022-12-27	WOS:000356933800029
J	Wang, YW; Shan, XF; Liang, Z; Shan, YL; Huang, WX; Zhang, DZ; Zen, AZ; Zhou, X; Zhao, Y; Gong, XY; Xu, G; Zhang, XY; Chen, J; Huang, AL				Wang, Yuwei; Shan, Xuefeng; Liang, Zhi; Shan, Youlan; Huang, Wenxiang; Zhang, Dazhi; Zen, Aizhong; Zhou, Xin; Zhao, Yao; Gong, Xuyang; Xu, Ge; Zhang, Xiuyu; Chen, Juan; Huang, Ailong			Deep Sequencing Analysis of HBV Genotype Shift and Correlation with Antiviral Efficiency during Adefovir Dipivoxil Therapy	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; RESISTANCE; MUTATIONS; INFECTION; SELECTION; REVEALS	Background Viral genotype shift in chronic hepatitis B (CHB) patients during antiviral therapy has been reported, but the underlying mechanism remains elusive. Methods 38 CHB patients treated with ADV for one year were selected for studying genotype shift by both deep sequencing and Sanger sequencing method. Results Sanger sequencing method found that 7.9% patients showed mixed genotype before ADV therapy. In contrast, all 38 patients showed mixed genotype before ADV treatment by deep sequencing. 95.5% mixed genotype rate was also obtained from additional 200 treatment-naive CHB patients. Of the 13 patients with genotype shift, the fraction of the minor genotype in 5 patients (38%) increased gradually during the course of ADV treatment. Furthermore, responses to ADV and HBeAg seroconversion were associated with the high rate of genotype shift, suggesting drug and immune pressure may be key factors to induce genotype shift. Interestingly, patients with genotype C had a significantly higher rate of genotype shift than genotype B. In genotype shift group, ADV treatment induced a marked enhancement of genotype B ratio accompanied by a reduction of genotype C ratio, suggesting genotype C may be more sensitive to ADV than genotype B. Moreover, patients with dominant genotype C may have a better therapeutic effect. Finally, genotype shifts was correlated with clinical improvement in terms of ALT. Conclusions Our findings provided a rational explanation for genotype shift among ADV-treated CHB patients. The genotype and genotype shift might be associated with antiviral efficiency.	[Wang, Yuwei; Shan, Xuefeng; Gong, Xuyang; Xu, Ge; Chen, Juan; Huang, Ailong] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Chongqing, Peoples R China; [Liang, Zhi; Zhou, Xin] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Shan, Youlan; Zhang, Dazhi; Zhang, Xiuyu] Chongqing Med Univ, Affiliated Hosp 2, Dept Infect Dis, Chongqing, Peoples R China; [Huang, Wenxiang; Zen, Aizhong] Chongqing Med Univ, Affiliated Hosp 1, Dept Infect Dis, Chongqing, Peoples R China; [Zhao, Yao] Chongqing Med Univ, Childrens Hosp, Pediat Res Inst, Chongqing, Peoples R China; [Wang, Yuwei] Chongqing Hosp Tradit Chinese Med, Dept Lab Med, Chongqing, Peoples R China; [Shan, Xuefeng] Chongqing Med Univ, Affiliated Hosp 1, Dept Pharm, Chongqing, Peoples R China	Chongqing Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Chen, J (corresponding author), Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Chongqing, Peoples R China.	yixin_xinyuan@163.com; ahuang1964@163.com			National Science and Technology Major Project [2013ZX10002002, 2012ZX10002005]; National Natural Science Foundation of China [81101297]	National Science and Technology Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science and Technology Major Project (2013ZX10002002, 2012ZX10002005), and National Natural Science Foundation of China (81101297).	Buster EHCJ, 2011, J HEPATOL, V54, P395, DOI 10.1016/j.jhep.2010.07.052; Cao GW, 2009, WORLD J GASTROENTERO, V15, P5761, DOI 10.3748/wjg.15.5761; Chen BF, 2006, J GEN VIROL, V87, P39, DOI 10.1099/vir.0.81357-0; Dienstag JL, 2009, HEPATOLOGY, V49, pS112, DOI 10.1002/hep.22920; Erhardt A, 2005, GUT, V54, P1009, DOI 10.1136/gut.2004.060327; Fallot G, 2012, GUT, V61, P1197, DOI 10.1136/gutjnl-2011-300907; Friedt M, 1999, HEPATOLOGY, V29, P1252, DOI 10.1002/hep.510290418; Gerner PR, 1998, VIROLOGY, V245, P163, DOI 10.1006/viro.1998.9126; Gordon SC, 2013, HEPATOLOGY, V58, P505, DOI 10.1002/hep.26277; Hannoun C, 2002, J INFECT DIS, V186, P752, DOI 10.1086/342599; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Jardi R, 2008, J HEPATOL, V49, P695, DOI 10.1016/j.jhep.2008.03.030; Kao JH, 2005, HEPATOLOGY, V41, P216, DOI 10.1002/hep.20500; Kato H, 2002, HEPATOLOGY, V35, P922, DOI 10.1053/jhep.2002.32096; Kurbanov F, 2010, HEPATOL RES, V40, P14, DOI 10.1111/j.1872-034X.2009.00601.x; Law PTY, 2013, J HEPATOL, V58, P1165, DOI 10.1016/j.jhep.2013.01.032; Lin CL, 2011, J GASTROEN HEPATOL, V26, P123, DOI 10.1111/j.1440-1746.2010.06541.x; Liu Y, 2011, J VIRAL HEPATITIS, V18, pe29, DOI 10.1111/j.1365-2893.2010.01360.x; Mirandola S, 2012, ANTIVIR RES, V96, P422, DOI 10.1016/j.antiviral.2012.09.014; Ono A, 2012, J HEPATOL, V57, P508, DOI 10.1016/j.jhep.2012.04.037; Phung TBT, 2010, J MED VIROL, V82, P1327, DOI 10.1002/jmv.21775; Qin YL, 2011, J VIROL, V85, P10167, DOI 10.1128/JVI.00819-11; Raimondi S, 2010, J HEPATOL, V52, P441, DOI 10.1016/j.jhep.2009.12.014; Ramirez C, 2013, ANTIVIR RES, V98, P273, DOI 10.1016/j.antiviral.2013.03.007; Stoeck T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-72; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Zhao Y, 2010, J CLIN MICROBIOL, V48, P3690, DOI 10.1128/JCM.00741-10	28	4	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131337	10.1371/journal.pone.0131337	http://dx.doi.org/10.1371/journal.pone.0131337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110616	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800144
J	Chou, CM; Yu, FY; Yu, PL; Ho, JF; Bostock, RM; Chung, KR; Huang, JW; Lee, MH				Chou, Chien-Ming; Yu, Fang-Yi; Yu, Pei-Ling; Ho, Jia-Fang; Bostock, Richard M.; Chung, Kuang-Ren; Huang, Jenn-Wen; Lee, Miin-Huey			Expression of Five Endopolygalacturonase Genes and Demonstration that MfPG1 Overexpression Diminishes Virulence in the Brown Rot Pathogen Monilinia fructicola	PLOS ONE			English	Article							BOTRYTIS-CINEREA; COLLETOTRICHUM-GLOEOSPORIOIDES; SCLEROTINIA-SCLEROTIORUM; CATABOLITE REPRESSION; MEDIATED INTEGRATION; PEACH FRUIT; PH; CUTINASE; REDOX; REGULATOR	Monilinia fructicola is a devastating pathogen on stone fruits, causing blossom blight and fruit rot. Little is known about pathogenic mechanisms in M. fructicola and related Monilinia species. In this study, five endopolygalacturonase (endo-PG) genes were cloned and functionally characterized in M. fructicola. Quantitative reverse-transcriptase PCR (qRT-PCR) revealed that the five MfPG genes are differentially expressed during pathogenesis and in culture under various pH regimes and carbon and nitrogen sources. MfPG1 encodes the major endo-PG and is expressed to significantly higher levels compared to the other four MfPGs in culture and in planta. MfPG1 function during pathogenesis was evaluated by examining the disease phenotypes and gene expression patterns in M. fructicola MfPG1-overexpressing strains and in strains carrying the beta-glucuronidase (GUS) reporter gene fused with MfPG1 (MfPG1-GUS). The MFPG1-GUS reporter was expressed in situ in conidia and hyphae following inoculation of flower petals, and qRT-PCR analysis confirmed MfPG1 expression during pathogenesis. MfPG1-overexpressing strains produced smaller lesions and higher levels of reactive oxygen species (ROS) on the petals of peach and rose flowers than the wild-type strain, suggesting that MfPG1 affecting fungal virulence might be in part resulted from the increase of ROS in the Prunus-M. fructicola interactions.	[Chou, Chien-Ming; Yu, Fang-Yi; Yu, Pei-Ling; Ho, Jia-Fang; Chung, Kuang-Ren; Huang, Jenn-Wen; Lee, Miin-Huey] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan; [Yu, Fang-Yi; Yu, Pei-Ling; Ho, Jia-Fang; Bostock, Richard M.; Huang, Jenn-Wen; Lee, Miin-Huey] Natl Chung Hsing Univ, NCHU UCD Plant & Food Biotechnol Ctr, Taichung 40227, Taiwan; [Lee, Miin-Huey] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Bostock, Richard M.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; University of California System; University of California Davis	Lee, MH (corresponding author), Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan.	mhlee@nchu.edu.tw	Chung, Kuang-Ren/Q-1157-2019; YU, PEI-LING/M-1348-2019	Lee, Miin-Huey/0000-0001-8073-0916	National Science Council of Taiwan [97-2313-B-005-034-MY3, NSC 101-2313-B-005 -037-MY3, NSC-102-2911-I-005-301]; Ministry of Education, Taiwan; ATU plan; RMB; JWH	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan); ATU plan; RMB; JWH	Research was supported by grants (97-2313-B-005-034-MY3, NSC 101-2313-B-005 -037-MY3 and NSC-102-2911-I-005-301) from the National Science Council of Taiwan and by the Ministry of Education, Taiwan, under the ATU plan to MHL, RMB and JWH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan N, 2013, MOL PLANT MICROBE IN, V26, P1345, DOI 10.1094/MPMI-03-13-0080-R; Alkan N, 2013, ANTIOXID REDOX SIGN, V19, P1012, DOI 10.1089/ars.2012.5062; Aro N, 2005, FEMS MICROBIOL REV, V29, P719, DOI 10.1016/j.femsre.2004.11.006; Avallone S, 2002, INT J FOOD SCI TECH, V37, P191, DOI 10.1046/j.1365-2621.2002.00556.x; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bostock RM, 1999, PHYSIOL MOL PLANT P, V54, P37, DOI 10.1006/pmpp.1998.0189; Buzi A, 2003, J PLANT PATHOL, V85, P111; Byrde R.J.W., 1977, BROWN ROT FUNGI FRUI; Chiu CM, 2013, PLANT PATHOL, V62, P809, DOI 10.1111/ppa.12006; De Cal A, 2013, POSTHARVEST BIOL TEC, V86, P418, DOI 10.1016/j.postharvbio.2013.07.012; FraissinetTachet L, 1995, CURR GENET, V29, P96, DOI 10.1007/BF00313199; Gell I, 2007, J APPL MICROBIOL, V103, P2629, DOI 10.1111/j.1365-2672.2007.03495.x; Jurick Wayne M. II, 2012, Archives of Phytopathology and Plant Protection, V45, P1101, DOI 10.1080/03235408.2012.657893; Katoh H, 2007, PHYTOPATHOLOGY, V97, P557, DOI 10.1094/PHYTO-97-5-0557; Lee MH, 2006, CURR GENET, V49, P309, DOI 10.1007/s00294-006-0059-0; Lee MH, 2007, PHYTOPATHOLOGY, V97, P269, DOI 10.1094/PHYTO-97-3-0269; Lee MH, 2006, PHYTOPATHOLOGY, V96, P1072, DOI 10.1094/PHYTO-96-1072; Lee MH, 2010, MOL PLANT MICROBE IN, V23, P176, DOI 10.1094/MPMI-23-2-0176; Li RG, 2004, FUNGAL GENET BIOL, V41, P754, DOI 10.1016/j.fgb.2004.03.002; LU SW, 1994, P NATL ACAD SCI USA, V91, P12649, DOI 10.1073/pnas.91.26.12649; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Pellier AL, 2003, MOL MICROBIOL, V48, P639, DOI 10.1046/j.1365-2958.2003.03451.x; Perez-Garcia A, 2001, MOL PLANT MICROBE IN, V14, P316, DOI 10.1094/MPMI.2001.14.3.316; Poinssot B, 2003, MOL PLANT MICROBE IN, V16, P553, DOI 10.1094/MPMI.2003.16.6.553; Reignault P, 2008, EUR J PLANT PATHOL, V120, P1, DOI 10.1007/s10658-007-9184-y; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; ten Have A, 1998, MOL PLANT MICROBE IN, V11, P1009, DOI 10.1094/MPMI.1998.11.10.1009; vanderVlugtBergmans CJB, 1997, MOL PLANT MICROBE IN, V10, P21, DOI 10.1094/MPMI.1997.10.1.21; Wubben JP, 2000, CURR GENET, V37, P152, DOI 10.1007/s002940050022; Xu LS, 2013, MOL PLANT MICROBE IN, V26, P431, DOI 10.1094/MPMI-07-12-0177-R; Yakoby N, 2001, MOL PLANT MICROBE IN, V14, P988, DOI 10.1094/MPMI.2001.14.8.988; You BJ, 2007, MOL PLANT MICROBE IN, V20, P1149, DOI 10.1094/MPMI-20-9-1149; You BJ, 2009, ARCH MICROBIOL, V191, P615, DOI 10.1007/s00203-009-0489-4	33	19	22	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0132012	10.1371/journal.pone.0132012	http://dx.doi.org/10.1371/journal.pone.0132012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26120831	gold, Green Published, Green Submitted			2022-12-27	WOS:000358150400188
J	Groenendyk, DG; Ferre, TPA; Thorp, KR; Rice, AK				Groenendyk, Derek G.; Ferre, Ty P. A.; Thorp, Kelly R.; Rice, Amy K.			Hydrologic-Process-Based Soil Texture Classifications for Improved Visualization of Landscape Function	PLOS ONE			English	Article							CLUSTER-ANALYSIS; HYDRAULIC CONDUCTIVITY	Soils lie at the interface between the atmosphere and the subsurface and are a key component that control ecosystem services, food production, and many other processes at the Earth's surface. There is a long-established convention for identifying and mapping soils by texture. These readily available, georeferenced soil maps and databases are used widely in environmental sciences. Here, we show that these traditional soil classifications can be inappropriate, contributing to bias and uncertainty in applications from slope stability to water resource management. We suggest a new approach to soil classification, with a detailed example from the science of hydrology. Hydrologic simulations based on common meteorological conditions were performed using HYDRUS-1D, spanning textures identified by the United States Department of Agriculture soil texture triangle. We consider these common conditions to be: drainage from saturation, infiltration onto a drained soil, and combined infiltration and drainage events. Using a k-means clustering algorithm, we created soil classifications based on the modeled hydrologic responses of these soils. The hydrologic-process-based classifications were compared to those based on soil texture and a single hydraulic property, K-s. Differences in classifications based on hydrologic response versus soil texture demonstrate that traditional soil texture classification is a poor predictor of hydrologic response. We then developed a QGIS plugin to construct soil maps combining a classification with georeferenced soil data from the Natural Resource Conservation Service. The spatial patterns of hydrologic response were more immediately informative, much simpler, and less ambiguous, for use in applications ranging from trafficability to irrigation management to flood control. The ease with which hydrologic-process-based classifications can be made, along with the improved quantitative predictions of soil responses and visualization of landscape function, suggest that hydrologic-process-based classifications should be incorporated into environmental process models and can be used to define application-specific maps of hydrologic function.	[Groenendyk, Derek G.; Ferre, Ty P. A.] Univ Arizona, Hydrol & Water Resources, Tucson, AZ 85721 USA; [Thorp, Kelly R.] USDA ARS, United States Arid Land Agr Res Ctr, Maricopa, AZ USA; [Rice, Amy K.] Colorado Sch Mines, Hydrol Sci & Engn Program, Golden, CO 80401 USA	University of Arizona; United States Department of Agriculture (USDA); Colorado School of Mines	Groenendyk, DG (corresponding author), Univ Arizona, Hydrol & Water Resources, Tucson, AZ 85721 USA.	drockg@email.arizona.edu	BITOUN, RACHEL Elisabeth/AAC-9538-2021; Thorp, Kelly/C-2013-2009	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Thorp, Kelly/0000-0001-9168-875X; Ferre, Paul/0000-0002-5209-1798	Phoenix Chapter of Achievement Rewards for College Scientists Foundation (ARCS), Inc.; National Aeronautics and Space Administration (NASA) Research Opportunities in Space and Earth Sciences (ROSES) Terrestrial Ecology Program [NNH09ZDA001N]	Phoenix Chapter of Achievement Rewards for College Scientists Foundation (ARCS), Inc.; National Aeronautics and Space Administration (NASA) Research Opportunities in Space and Earth Sciences (ROSES) Terrestrial Ecology Program	Funding was provided by the Phoenix Chapter of the Achievement Rewards for College Scientists Foundation (ARCS), Inc., www.arcsfoundation.org, (DGG) and through the National Aeronautics and Space Administration (NASA) Research Opportunities in Space and Earth Sciences (ROSES) Terrestrial Ecology Program, Award #NNH09ZDA001N, http://cce.nasa.gov/terrestrial_ecology/index.html (DGG, KRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CW, 1999, SOIL SCI SOC AM J, V63, P142, DOI 10.2136/sssaj1999.03615995006300010021x; [Anonymous], WEB SOIL SURV INT; [Anonymous], 1927, GROUPING SOILS BASIS; Atterberg A., 1905, CHEM ZEITUNG, V29, P195; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; Boorman D. B., 1995, HYDROLOGY SOIL TYPES; Bormann H, 2010, GEODERMA, V157, P142, DOI 10.1016/j.geoderma.2010.04.005; Bormann H., 2007, ADV GEOSCI, V11, P7, DOI [10.5194/adgeo-11-7-2007, DOI 10.5194/ADGEO-11-7-2007]; DEQUEIROZ K, 1992, ANNU REV ECOL SYST, V23, P449, DOI 10.1146/annurev.ecolsys.23.1.449; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Everitt B., 1974, CLUSTER ANAL; Fredline E, 2000, ANN TOURISM RES, V27, P763, DOI 10.1016/S0160-7383(99)00103-6; FROHLICH C, 1990, GEOPHYS J INT, V100, P19, DOI 10.1111/j.1365-246X.1990.tb04564.x; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Hartigan J., 1975, CLUSTERING ALGORITHM; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; International Society of Soil Science, 1929, BIOL, V4, P215; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Jain AK., 1988, TECHNOMETRICS; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; MADRIGAL R, 1995, ANN TOURISM RES, V22, P86, DOI 10.1016/0160-7383(94)00070-9; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; MUALEM Y, 1976, WATER RESOUR RES, V12, P513, DOI 10.1029/WR012i003p00513; Nelson GC, 1997, AM J AGR ECON, V79, P80, DOI 10.2307/1243944; NORRIS JM, 1971, J SOIL SCI, V22, P69, DOI 10.1111/j.1365-2389.1971.tb01594.x; PUNJ G, 1983, J MARKETING RES, V20, P134, DOI 10.2307/3151680; Quantum GIS Development Team, 2014, QUANT GIS GEOGR INF; SAXTON KE, 1986, SOIL SCI SOC AM J, V50, P1031, DOI 10.2136/sssaj1986.03615995005000040039x; Schaap MG, 2001, J HYDROL, V251, P163, DOI 10.1016/S0022-1694(01)00466-8; Simnek J., 2006, HYDRUS SOFTWARE PACK, P1; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; Sokal RR, 1963, PRINCIPLES NUMERICAL; Twarakavi NKC, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR007939; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; WEBB RS, 1993, GLOBAL BIOGEOCHEM CY, V7, P97, DOI 10.1029/92GB01822; WEBSTER R, 1968, NATURE, V219, P680, DOI 10.1038/219680a0; Whitney M, 1911, 78 USDA; WILSON MF, 1985, J CLIMATOL, V5, P119, DOI 10.1002/joc.3370050202; Young FJ, 2000, SOIL SCI SOC AM J, V64, P989, DOI 10.2136/sssaj2000.643989x	39	41	41	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131299	10.1371/journal.pone.0131299	http://dx.doi.org/10.1371/journal.pone.0131299			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121466	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400094
J	Koubaa, A; Triki, M; Trabelsi, H; Masmoudi, L; Sahnoun, Z; Hakim, A				Koubaa, Abdessalem; Triki, Moez; Trabelsi, Hajer; Masmoudi, Liwa; Sahnoun, Zouhair; Hakim, Ahmed			Changes in Antioxidant Defense Capability and Lipid Profile after 12-Week Low-Intensity Continuous Training in Both Cigarette and Hookah Smokers: A Follow-Up Study	PLOS ONE			English	Article							POSTPRANDIAL OXIDATIVE STRESS; CONTINUOUS MODERATE EXERCISE; CORONARY-ARTERY-DISEASE; PHYSICAL-ACTIVITY; PLASMA ANTIOXIDANTS; MARATHON RUN; OLDER MEN; IN-VIVO; SMOKING; WOMEN	To examine the impact of low-intensity continuous training program on antioxidant defense capability and lipid profile in male cigarette or hookah smokers. Forty-three male adults participated in a 12-week continuous training program at an intensity of 40% of VO(2)max. All subjects were subjected to anthropometric, physical and biochemical tests before and after the training program. The increase of Glutathione reductase (GR) and Superoxide dismutase (SOD) is significant only for cigarette smokers (CS) and hookah smokers (HS) groups. The Malondialdehyde (MDA) decrease and a-tocopherol increase are significant only for HS group. GPx was increased in NS, CS and HS by 2.6% (p<0.01), 2% (p<0.05) and 1.7% (p<0.05) respectively. Likewise, significant improvements of high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and TC / HDL-C ratio were observed in three groups. En contrast no significant changes were recorded in triglycerides (TG). Also, significant reduction of total cholesterol (TC) for CS group (p<0.01) and HS groups (p<0.05). This continuous training program appears to have an important role in lipid levels improving and oxidative stress attenuation.	[Koubaa, Abdessalem; Sahnoun, Zouhair; Hakim, Ahmed] Sfax Med Fac SMF, Pharmacol Lab, Sfax 3029, Tunisia; [Koubaa, Abdessalem; Trabelsi, Hajer; Masmoudi, Liwa] Sfax Inst Sport & Phys Educ, Res Unit EM2S, Sfax 3000, Tunisia; [Triki, Moez] Univ Sousse, Ibn El Jazzar Med Fac, Lab Cardio Circulatory Resp & Hormonal Adaptat Mu, Sousse 4002, Tunisia	Universite de Sousse	Triki, M (corresponding author), Univ Sousse, Ibn El Jazzar Med Fac, Lab Cardio Circulatory Resp & Hormonal Adaptat Mu, 98-UR08-67,Ave Mohamed Karoui, Sousse 4002, Tunisia.	trikimoez27@yahoo.fr	Masmoudi, Liwa/ABE-4769-2021	Masmoudi, Liwa/0000-0002-9628-1585	laboratory of Pharmacology, Faculty of Medicine of Sfax, Tunisia	laboratory of Pharmacology, Faculty of Medicine of Sfax, Tunisia	This research was supported by a grant from the laboratory of Pharmacology, Faculty of Medicine of Sfax, Tunisia.	Alberg AJ, 2002, TOXICOLOGY, V180, P121, DOI 10.1016/S0300-483X(02)00386-4; ALESSIO HM, 1993, MED SCI SPORT EXER, V25, P218, DOI 10.1249/00005768-199302000-00010; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; American Association of Clinical Endocrinologists (AACE) Lipid Guidelines, 2000, ENDOCR PRACT, V6, P162; American College of Sports Medicine, 1986, GUID GRAD EX TEST EX, V3rd; Aslan R, 1998, T J MED SCI, V28, P411; Banz WJ, 2003, EXP BIOL MED, V228, P434, DOI 10.1177/153537020322800414; Ben Saad H, 2009, REV PNEUMOL CLIN, V65, P369, DOI 10.1016/j.pneumo.2009.08.010; Bergholm R, 1999, ATHEROSCLEROSIS, V145, P341, DOI 10.1016/S0021-9150(99)00089-1; BIJNEN FCH, 1994, B WORLD HEALTH ORGAN, V72, P1; Bloomer RJ, 2008, BRIT J NUTR, V99, P1055, DOI 10.1017/S0007114507844370; Bloomer RJ, 2006, MED SCI SPORT EXER, V38, P1436, DOI 10.1249/01.mss.0000227408.91474.77; Bloomer RJ, 2009, INT J ENV RES PUB HE, V6, P579, DOI 10.3390/ijerph6020579; Bloomer RJ, 2009, NICOTINE TOB RES, V11, P3, DOI 10.1093/ntr/ntn005; Bloomer RJ, 2004, CAN J APPL PHYSIOL, V29, P245, DOI 10.1139/h04-017; Burke A, 2003, PROG CARDIOVASC DIS, V46, P79, DOI 10.1016/S0033-0620(03)00076-8; Child RB, 1998, MED SCI SPORT EXER, V30, P1603, DOI 10.1097/00005768-199811000-00008; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Cobb CO, 2011, NICOTINE TOB RES, V13, P78, DOI 10.1093/ntr/ntq212; Coppoolse R, 1999, EUR RESPIR J, V14, P258, DOI 10.1034/j.1399-3003.1999.14b04.x; Covas MI, 2002, MED SCI SPORT EXER, V34, P814, DOI 10.1097/00005768-200205000-00014; CRISWELL D, 1993, MED SCI SPORT EXER, V25, P1135; Dietrich M, 2003, AM J CLIN NUTR, V77, P160, DOI 10.1093/ajcn/77.1.160; DILLARD CJ, 1978, J APPL PHYSIOL, V45, P927, DOI 10.1152/jappl.1978.45.6.927; Donnelly JE, 2000, INT J OBESITY, V24, P566, DOI 10.1038/sj.ijo.0801198; Elosua R, 2003, ATHEROSCLEROSIS, V167, P327, DOI 10.1016/S0021-9150(03)00018-2; EVELO CTA, 1992, EUR J APPL PHYSIOL O, V64, P354, DOI 10.1007/BF00636224; Franzoni F, 2005, AM J HYPERTENS, V18, P510, DOI 10.1016/j.amjhyper.2004.11.006; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Joseph LJO, 1999, METABOLISM, V48, P1474, DOI 10.1016/S0026-0495(99)90162-2; Kiter G, 2000, RESP MED, V94, P891, DOI 10.1053/rmed.2000.0859; Knishkowy B, 2005, PEDIATRICS, V116, pE113, DOI 10.1542/peds.2004-2173; Kong C, 2001, ATHEROSCLEROSIS, V156, P373, DOI 10.1016/S0021-9150(00)00664-X; Koubaa A, 2013, IJPSI, V2, P51; Kraus H, 1961, HYPOKINETIC DIS DIS; Liu ML, 1999, AM J PHYSIOL-ENDOC M, V276, pE1083, DOI 10.1152/ajpendo.1999.276.6.E1083; Lodovici M, 2000, FREE RADICAL BIO MED, V28, P13, DOI 10.1016/S0891-5849(99)00194-X; Ma J, 2000, AM J CLIN NUTR, V71, P774, DOI 10.1093/ajcn/71.3.774; MANNING J M, 1991, Medicine and Science in Sports and Exercise, V23, P1222; MENA P, 1991, INT J SPORTS MED, V12, P563, DOI 10.1055/s-2007-1024734; Moholdt TT, 2009, AM HEART J, V158, P1031, DOI 10.1016/j.ahj.2009.10.003; MORROW JD, 1995, NEW ENGL J MED, V332, P1198, DOI 10.1056/NEJM199505043321804; Mosher PE, 1998, ARCH PHYS MED REHAB, V79, P652, DOI 10.1016/S0003-9993(98)90039-9; MOTOYAMA M, 1995, EUR J APPL PHYSIOL, V70, P126, DOI 10.1007/BF00361539; Palaniappan U, 2001, J NUTR, V131, P1952, DOI 10.1093/jn/131.7.1952; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pialoux V, 2006, EUR J CLIN NUTR, V60, P1345, DOI 10.1038/sj.ejcn.1602462; POWERS SK, 1994, RESP PHYSIOL, V95, P227, DOI 10.1016/0034-5687(94)90118-X; Prabhakaran B, 1999, BRIT J SPORT MED, V33, P190, DOI 10.1136/bjsm.33.3.190; ROBERTSON JD, 1991, CLIN SCI, V80, P611, DOI 10.1042/cs0800611; Shaw I, 2008, CARDIOVASC J AFR, V19, P194; SHERMAN CB, 1991, CLIN CHEST MED, V12, P643; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P373, DOI 10.1056/NEJM199108083250601; Tiidus PM, 1996, AM J PHYSIOL-REG I, V271, pR832, DOI 10.1152/ajpregu.1996.271.4.R832; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; Wegge JK, 2004, METABOLISM, V53, P377, DOI 10.1016/j.metabol.2003.10.016; WITZTUM JL, 1994, LANCET, V344, P793, DOI 10.1016/S0140-6736(94)92346-9; Wozniak A, 2001, MED SCI SPORT EXER, V33, P1109; Yamaguchi Y, 2005, EUR J CLIN INVEST, V35, P186, DOI 10.1111/j.1365-2362.2005.01472.x; Zaher C, 2004, INT J TUBERC LUNG D, V8, P1423	62	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130563	10.1371/journal.pone.0130563	http://dx.doi.org/10.1371/journal.pone.0130563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121249	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400047
J	Lozada-Misa, P; Kerr, A; Raymundo, L				Lozada-Misa, Paula; Kerr, Alexander; Raymundo, Laurie			Contrasting Lesion Dynamics of White Syndrome among the scleractinian corals Porites spp	PLOS ONE			English	Article							REEF-BUILDING CORAL; DISEASE DYNAMICS; REGENERATION; ISLANDS; PLASTICITY; OUTBREAK; GROWTH; DAMAGE; RATES; SIZE	White syndrome (WS) is currently the most prevalent disease of scleractinian corals in the Indo-Pacific region, with an ability to exist in both epizootic and enzootic states. Here, we present results of an examination of WS lesion dynamics and show that potentially associated traits of host morphology (i.e., branching vs. massive), lesion size, and tissue deposition rate influence disease severity and recovery. Lesion healing rate was positively correlated with initial lesion size in both morphologies, but the rate at which lesions healed differed between morphologies. New lesions in branching Porites cylindrica appeared less frequently, were smaller and healed more quickly, but were more abundant than in closelyrelated massive Porites sp(p). The positive association between lesion size and healing rate was partly explained by geometry; branching limited lesion maximum size, and larger lesion margins contained more polyps producing new tissue, resulting in faster healing. However, massive colonies deposited tissue more slowly than branching colonies, resulting in slower recovery and more persistent lesions. Corallite size and density did not differ between species and did not, therefore, influence healing rate. We demonstrated multiple modes of pathogen transmission, which may be influenced by the greater potential for pathogen entrainment in branching vs. massive morphologies. We suggest that attributes such as colony morphology and species-specific growth rates require consideration as we expand our understanding of disease dynamics in colonial organisms such as coral.	[Lozada-Misa, Paula] NOAA, Pacific Isl Fisheries Sci Ctr, Coral Reef Ecosyst Div, Honolulu, HI USA; [Kerr, Alexander; Raymundo, Laurie] Univ Guam, Marine Lab, Mangilao, GU 96923 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Guam	Raymundo, L (corresponding author), Univ Guam, Marine Lab, Mangilao, GU 96923 USA.	ljraymundo@gmail.com	Raymundo, Laurie/AAE-5230-2020		Global Environment Facility/World Bank Coral Reef Targeted Research and Capacity Building for Management, Coral Disease Working Group; National Oceanographic and Atmospheric Administration Coral Reef Initiative for Guam [NA05NOS4261188, NA06NOS4260114]	Global Environment Facility/World Bank Coral Reef Targeted Research and Capacity Building for Management, Coral Disease Working Group; National Oceanographic and Atmospheric Administration Coral Reef Initiative for Guam	This work was supported by the Global Environment Facility/World Bank Coral Reef Targeted Research and Capacity Building for Management, Coral Disease Working Group (www.gefcoral.org) and the National Oceanographic and Atmospheric Administration Coral Reef Initiative for Guam: Project Numbers NA05NOS4261188 and NA06NOS4260114. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2010, DIS AQUAT ORGAN, V91, P1, DOI 10.3354/dao02247; Aeby GS, 2006, MAR ECOL PROG SER, V318, P103, DOI 10.3354/meps318103; Aeby GS, 2005, CORAL REEFS, V24, P481, DOI 10.1007/s00338-005-0493-3; Ainsworth TD, 2007, MAR BIOL, V151, P19, DOI 10.1007/s00227-006-0449-3; Ainsworth TD, 2007, APPL ENVIRON MICROB, V73, P981, DOI 10.1128/AEM.02172-06; [Anonymous], 1977, P 3 INT COR REEF S; Ban SS, 2013, CORAL REEFS, V32, P1, DOI 10.1007/s00338-012-0944-6; Bruno JF, 1997, ECOLOGY, V78, P2177, DOI 10.2307/2265954; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Burdick D, 2008, NOAA TECHNICAL MEMOR, V73, P1; Bythell J, 2004, CORAL HEALTH AND DISEASE, P351; COFFROTH MA, 1991, MAR BIOL, V109, P35, DOI 10.1007/BF01320229; Cole AJ, 2009, CORAL REEFS, V28, P965, DOI 10.1007/s00338-009-0519-3; Custodio HM, 1997, CORAL REEFS, V16, P267, DOI 10.1007/s003380050083; Dalton SJ, 2010, MAR FRESHWATER RES, V61, P342, DOI 10.1071/MF09060; Dalton SJ, 2006, CORAL REEFS, V25, P37, DOI 10.1007/s00338-005-0039-8; Gordis L, 1996, EPIDEMIOLOGY; HIGHSMITH RC, 1979, J EXP MAR BIOL ECOL, V37, P105, DOI 10.1016/0022-0981(79)90089-3; Lirman D, 2000, MAR ECOL PROG SER, V197, P209, DOI 10.3354/meps197209; McIlwain JL, 1997, MAR ECOL PROG SER, V155, P189, DOI 10.3354/meps155189; MEESTERS EH, 1994, MAR ECOL PROG SER, V112, P119, DOI 10.3354/meps112119; Meesters EH, 1997, MAR ECOL PROG SER, V146, P91, DOI 10.3354/meps146091; Muko S, 2000, B MAR SCI, V66, P225; Myers RL, 2009, DIS AQUAT ORGAN, V87, P97, DOI 10.3354/dao02139; Palmer CV, 2008, P ROY SOC B-BIOL SCI, V275, P2687, DOI 10.1098/rspb.2008.0335; Raymundo LJ, 2004, ECOL APPL, V14, P281, DOI 10.1890/02-5373; Raymundo LJ, 2008, CORAL DIS GUIDELINES; Redding JE, 2013, MAR POLLUT BULL, V73, P57, DOI 10.1016/j.marpolbul.2013.06.002; Rinkevich B, 2002, ISRAEL J ZOOL, V48, P71, DOI 10.1560/BCPA-UM3A-MKBP-HGL2; Roff G, 2006, CORAL REEFS, V25, P255, DOI 10.1007/s00338-006-0099-4; Snell J. L., 1997, INTRO PROBABILITY, P405; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Weil E, 2004, CORAL HEALTH AND DISEASE, P35; Williams GJ, 2011, CORAL REEFS, V30, P621, DOI 10.1007/s00338-011-0762-2; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Work TM, 2006, DIS AQUAT ORGAN, V70, P155, DOI 10.3354/dao070155; Work TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022869	38	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0129841	10.1371/journal.pone.0129841	http://dx.doi.org/10.1371/journal.pone.0129841			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26120844	gold, Green Published, Green Submitted			2022-12-27	WOS:000358150400026
J	Willems, B; Tao, SJ; Yu, TS; Huysseune, A; Witten, PE; Winkler, C				Willems, Bernd; Tao, Shijie; Yu, Tingsheng; Huysseune, Ann; Witten, Paul Eckhard; Winkler, Christoph			The Wnt Co-Receptor Lrp5 Is Required for Cranial Neural Crest Cell Migration in Zebrafish	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-5; BONE-DENSITY; EMBRYONIC-DEVELOPMENT; PHARYNGEAL DENTITION; G1/S TRANSITION; REITERATED WNT; BETA-CATENIN; EXPRESSION; SPECIFICATION; SCLEROSTIN	During vertebrate neurulation, cranial neural crest cells (CNCCs) undergo epithelial to mesenchymal transition (EMT), delaminate from the neural plate border, and migrate as separate streams into different cranial regions. There, they differentiate into distinct parts of the craniofacial skeleton. Canonical Wnt signaling has been shown to be essential for this process at different levels but the involved receptors remained unclear. Here we show that the frizzled co-receptor low-density-lipoprotein (LDL) receptor-related protein 5 (Lrp5) plays a crucial role in CNCC migration and morphogenesis of the cranial skeleton. Early during induction and migration of CNCCs, lrp5 is expressed ubiquitously but later gets restricted to CNCC derivatives in the ventral head region besides different regions in the CNS. A knock-down of lrp5 does not interfere with induction of CNCCs but leads to reduced proliferation of premigratory CNCCs. In addition, cell migration is disrupted as CNCCs are found in clusters at ectopic positions in the dorsomedial neuroepithelium after lrp5 knock-down and transient CRISPR/Cas9 gene editing. These migratory defects consequently result in malformations of the craniofacial skeleton. To date, Lrp5 has mainly been associated with bone homeostasis in mammals. Here we show that in zebrafish, lrp5 also controls cell migration during early morphogenetic processes and contributes to shaping the craniofacial skeleton.	[Willems, Bernd; Tao, Shijie; Yu, Tingsheng; Winkler, Christoph] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Willems, Bernd; Tao, Shijie; Yu, Tingsheng; Winkler, Christoph] Natl Univ Singapore, Ctr Bioimaging Sci CBIS, Singapore 117548, Singapore; [Huysseune, Ann; Witten, Paul Eckhard] Univ Ghent, Dept Biol, B-9000 Ghent, Belgium	National University of Singapore; National University of Singapore; Ghent University	Winkler, C (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbswcw@nus.edu.sg	Winkler, Christoph/G-4822-2012; Witten, Paul Eckhard/AAY-3113-2020	Winkler, Christoph/0000-0003-4688-6241; Witten, Paul Eckhard/0000-0002-2928-5762; Yu, Tingsheng/0000-0002-8106-7981	Agency for Science, Technology and Research (A-STAR) Singapore/Biomedical Research Council (BMRC) [07/1/21/19/544]; Ghent University [BOF08/GOA/019]; NUS graduate scholarships	Agency for Science, Technology and Research (A-STAR) Singapore/Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); Ghent University(Ghent University); NUS graduate scholarships	This work was supported by a grant from the Agency for Science, Technology and Research (A-STAR) Singapore/Biomedical Research Council (BMRC), grant number 07/1/21/19/544, to CW, and from Ghent University (grant number: BOF08/GOA/019) to AH and PEW. BW and TY receive NUS graduate scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Alexander C, 2011, DEVELOPMENT, V138, P5135, DOI 10.1242/dev.067801; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Berndt JD, 2006, DEVELOPMENT, V133, P3983, DOI 10.1242/dev.02583; Bezooijen RL, 2005, CYTOKINE GROWTH F R, V16, P319, DOI 10.1016/j.cytogfr.2005.02.005; Borday-Birraux V, 2006, EVOL DEV, V8, P130, DOI 10.1111/j.1525-142X.2006.00084.x; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Burstyn-Cohen T, 2004, DEVELOPMENT, V131, P5327, DOI 10.1242/dev.01424; Burstyn-Cohen T, 2002, DEV CELL, V3, P383, DOI 10.1016/S1534-5807(02)00221-6; Chen MY, 2009, J BIOL CHEM, V284, P35040, DOI 10.1074/jbc.M109.047456; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; de Melker AA, 2004, DEV DYNAM, V230, P708, DOI 10.1002/dvdy.20091; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Dorsky RI, 2000, BIOESSAYS, V22, P708, DOI 10.1002/1521-1878(200008)22:8<708::AID-BIES4>3.3.CO;2-E; Dorsky RI, 1999, MECH DEVELOP, V86, P147, DOI 10.1016/S0925-4773(99)00101-X; Dutton JR, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-105; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Galindo M, 2007, J MOL HISTOL, V38, P501, DOI 10.1007/s10735-007-9143-0; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hanken J, 2005, J ANAT, V207, P437, DOI 10.1111/j.1469-7580.2005.00481.x; Houston DW, 2002, MECH DEVELOP, V117, P337, DOI 10.1016/S0925-4773(02)00205-8; Huysseune A, 1998, ANAT EMBRYOL, V198, P289, DOI 10.1007/s004290050185; Huysseune A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00386; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kelsh RN, 2000, MECH DEVELOP, V93, P161, DOI 10.1016/S0925-4773(00)00250-1; Kimmel CB, 2001, J ANAT, V199, P105, DOI 10.1046/j.1469-7580.2001.19910105.x; Kimmel CB, 2001, DEV BIOL, V233, P239, DOI 10.1006/dbio.2001.0201; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kwee ML, 2005, J BONE MINER RES, V20, P1254, DOI 10.1359/JBMR.050303; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lewis JL, 2004, DEVELOPMENT, V131, P1299, DOI 10.1242/dev.01007; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Luo RS, 2001, DEV DYNAM, V220, P169, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1097>3.0.CO;2-1; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McNulty MS, 2012, GENE EXPR PATTERNS, V12, P228, DOI 10.1016/j.gep.2012.04.003; Piloto S, 2010, DEVELOPMENT, V137, P1981, DOI 10.1242/dev.048439; Raible DW, 2005, SEMIN CELL DEV BIOL, V16, P673, DOI 10.1016/j.semcdb.2005.06.008; Renn J, 2009, DEV DYNAM, V238, P241, DOI 10.1002/dvdy.21836; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rogers CD, 2012, WIRES DEV BIOL, V1, P52, DOI 10.1002/wdev.8; SaintJeannet JP, 1997, P NATL ACAD SCI USA, V94, P13713, DOI 10.1073/pnas.94.25.13713; Santagati F, 2003, NAT REV NEUROSCI, V4, P806, DOI 10.1038/nrn1221; Sasaki MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067522; See K, 2014, HUM MOL GENET, V23, P1754, DOI 10.1093/hmg/ddt567; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Vallin J, 2001, J BIOL CHEM, V276, P30350, DOI 10.1074/jbc.M103167200; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Wu JL, 2005, DEV BIOL, V279, P220, DOI 10.1016/j.ydbio.2004.12.016	54	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131768	10.1371/journal.pone.0131768	http://dx.doi.org/10.1371/journal.pone.0131768			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121341	gold, Green Published			2022-12-27	WOS:000358150400156
J	Lopez-Bru, D; Palazon-Bru, A; la Rosa, DMFD; Gil-Guillen, VF				Lopez-Bru, David; Palazon-Bru, Antonio; la Rosa, David Manuel Folgado-de; Gil-Guillen, Vicente Francisco			Scoring System for Mortality in Patients Diagnosed with and Treated Surgically for Differentiated Thyroid Carcinoma with a 20-Year Follow-Up	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; RISK SCORE; CANCER; SURVIVAL; PAPILLARY; THERAPY; DEATH; EUROPE	Background Differentiated thyroid carcinoma (DTC) is associated with an increased mortality. Few studies have constructed predictive models of all-cause mortality with a high discriminating power for patients with this disease that would enable us to determine which patients are more likely to die. Objective To construct a predictive model of all-cause mortality at 5, 10, 15 and 20 years for patients diagnosed with and treated surgically for DTC for use as a mobile application. Design We undertook a retrospective cohort study using data from 1984 to 2013. Setting All patients diagnosed with and treated surgically for DTC at a general university hospital covering a population of around 200,000 inhabitants in Spain. Participants The study involved 201 patients diagnosed with and treated surgically for DTC (174, papillary; 27, follicular). Exposures Age, gender, town, family history, type of surgery, type of cancer, histological subtype, micro-carcinoma, multicentricity, TNM staging system, diagnostic stage, permanent post-operative complications, local and regional tumor persistence, distant metastasis, and radioiodine therapy. Main outcome measure All-cause mortality. Methods A Cox multivariate regression model was constructed to determine which variables at diagnosis were associated with mortality. Using the model a risk table was constructed based on the sum of all points to estimate the likelihood of death. This was then incorporated into a mobile application. Results The mean follow-up was 8.8 +/- 6.7 years. All-cause mortality was 12.9%(95% confidence interval [CI]: 8.3- 17.6%). Predictive variables: older age, local tumor persistence and distant metastasis. The area under the ROC curve was 0.81 (95% CI: 0.72- 0.91, p< 0.001). Conclusion This study provides a practical clinical tool giving a simple and rapid indication (via a mobile application) of which patients with DTC are at risk of dying in 5, 10, 15 or 20 years. Nonetheless, caution should be exercised until validation studies have corroborated our results.	[Lopez-Bru, David] Gen Univ Hosp, Dept Otorhinolaryngol, Alicante, Spain; [Palazon-Bru, Antonio; la Rosa, David Manuel Folgado-de; Gil-Guillen, Vicente Francisco] Miguel Hernandez Univ, Dept Clin Med, Alicante, Spain; [Palazon-Bru, Antonio; Gil-Guillen, Vicente Francisco] Gen Univ Hosp, Res Unit, Alicante, Spain	General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; General University Hospital of Alicante	Palazon-Bru, A (corresponding author), Miguel Hernandez Univ, Dept Clin Med, Alicante, Spain.	antonio.pb23@gmail.com	Guillén, Vicente Francisco Gil/AAE-8201-2019	Palazon-Bru, Antonio/0000-0002-5959-9631; Gil-Guillen, Vicente F/0000-0003-3793-9786				AKSLEN LA, 1991, CANCER RES, V51, P1234; American Joint Committee on Cancer (AJCC), 2010, AJCC CANC STAGING MA, V7th; Colonna M, 2006, EUR J CANCER, V42, P2598, DOI 10.1016/j.ejca.2006.04.026; Cushing SL, 2004, LARYNGOSCOPE, V114, P2110, DOI 10.1097/01.mlg.0000149442.22393.e2; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Eichhorn W, 2003, THYROID, V13, P949, DOI 10.1089/105072503322511355; Eustatia-Rutten CFA, 2006, J CLIN ENDOCR METAB, V91, P313, DOI 10.1210/jc.2005-1322; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hay ID, 2010, WORLD J SURG, V34, P1192, DOI 10.1007/s00268-009-0364-0; Hay ID, 1993, SURGERY, V114, P1057; Herrero Zapatero E, 2009, TRATADO OTORRINOLARI, P3751, DOI [10.1016/j.adengl.2013.04.025, DOI 10.1016/J.ADENGL.2013.04.025]; Huang BY, 2011, ONCOLOGY-BASEL, V80, P123, DOI 10.1159/000328912; Huang CH, 2012, PEDIATR SURG INT, V28, P489, DOI 10.1007/s00383-012-3054-1; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; Links TP, 2005, ENDOCR-RELAT CANCER, V12, P273, DOI 10.1677/erc.1.00892; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; Mendelsohn AH, 2010, ARCH OTOLARYNGOL, V136, P1055, DOI 10.1001/archoto.2010.181; Ministerio de Sanidad y Politica Social, 2009, ESTR CANC SIST NAC S, DOI [10.1080/00207590500411179, DOI 10.1080/00207590500411179]; Palazon-Bru A, 2015, CURR MED RES OPIN, V31, P883, DOI 10.1185/03007995.2015.1030377; Ramirez-Prado D, 2015, INT J CLIN PRACT, V69, P474, DOI 10.1111/ijcp.12563; Rego-Iraeta A, 2009, THYROID, V19, P333, DOI 10.1089/thy.2008.0210; SALVESEN H, 1991, ACTA CHIR-EUR J SURG, V157, P521; Scheiden R, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-102; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Sebastian SO, 2000, ARCH SURG-CHICAGO, V135, P272, DOI 10.1001/archsurg.135.3.272; Storm HH, 2001, EUR J CANCER, V37, P775, DOI 10.1016/S0959-8049(01)00010-7; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Toniato A, 2011, UPDATES SURG-ITALY, V63, P115, DOI 10.1007/s13304-011-0060-0; Vorburger SA, 2009, ANN SURG ONCOL, V16, P2862, DOI 10.1245/s10434-009-0592-4; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yang LM, 2013, J CLIN ONCOL, V31, P468, DOI 10.1200/JCO.2012.42.4457	32	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0128620	10.1371/journal.pone.0128620	http://dx.doi.org/10.1371/journal.pone.0128620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115328	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500015
J	Milella, M; Mariotti, V; Belcastro, MG; Knusel, CJ				Milella, Marco; Mariotti, Valentina; Belcastro, Maria Giovanna; Knuesel, Christopher J.			Patterns of Irregular Burials in Western Europe (1st-5th Century AD)	PLOS ONE			English	Article							POPULATION	Background Irregular burials (IB-burials showing features that contrast with the majority of others in their geographic and chronological context) have been the focus of archaeological study because of their relative rarity and enigmatic appearance. Interpretations of IB often refer to supposed fear of the dead or to social processes taking place in time-specific contexts. However, a comprehensive and quantitative analysis of IB for various geographical contexts is still lacking, a fact that hampers any discussion of these burials on a larger scale. Methods Here, we collected a bibliographic dataset of 375 IB from both Britain and Continental Europe, altogether spanning a time period from the 1st to the 5th century AD. Each burial has been coded according to ten dichotomous variables, further analyzed by means of chi-squared tests on absolute frequencies, non-metric multidimensional scaling, and cluster analysis. Results Even acknowledging the limits of this study, and in particular the bias represented by the available literature, our results point to interesting patterns. Geographically, IB show a contrast between Britain and Continental Europe, possibly related to historical processes specific to these regions. Different types of IB (especially prone depositions and depositions with the cephalic extremity displaced) present a series of characteristics and associations between features that permit a more detailed conceptualization of these occurrences from a socio-cultural perspective that aids to elucidate their funerary meaning. Conclusions and Significance Altogether, the present work stresses the variability of IB, and the need to contextualize them in a proper archaeological and historical context. It contributes to the discussion of IB by providing a specific geographic and chronological frame of reference that supports a series of hypotheses about the cultural processes possibly underlying their occurrence.	[Milella, Marco] Univ Zurich, Anthropol Inst & Museum, CH-8057 Zurich, Switzerland; [Mariotti, Valentina; Belcastro, Maria Giovanna] Alma Mater Studiorum Univ Bologna, Dipartimento Sci Biol Geol & Ambientali, Lab Bioarcheol & Osteol Forense, I-40126 Bologna, Italy; [Mariotti, Valentina] Univ Aix Marseille, EFS Fac Med, Eth & Sante CNRS, Sect Nord,UMR ADES Anthropol Bioculturel 7268, F-13344 Marseille 15, France; [Belcastro, Maria Giovanna] Ctr Fermi, I-00184 Rome, Italy; [Knuesel, Christopher J.] Univ Bordeaux, PACEA, UMR5199, F-33615 Pessac, France	University of Zurich; University of Bologna; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux	Milella, M (corresponding author), Univ Zurich, Anthropol Inst & Museum, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	marco.milella@aim.uzh.ch	Milella, Marco/D-5070-2017	Milella, Marco/0000-0003-1027-6601; BELCASTRO, MARIA GIOVANNA/0000-0002-8932-8509				Agarwal S. C., 2011, SOCIAL BIOARCHAEOLOG; Alfaye Villa S., 2009, NAILS DEAD POLYSEMIC, P427; Alfaye Villa S, 2009, SIT TIBI TERRA GRAVI, P181; [Anonymous], 2014, ROUTLEDGE HDB BIOARC; [Anonymous], 2001, ARCHEOL PAPERS AM AN, DOI DOI 10.1525/AP3A.2001.10.1.80; Arcini C., 2009, CURR ANTHROPOL, V231, P30; Armit I., 2012, HEADHUNTING BODY IRO; Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; Belcastro M. G, 2010, SEPOLTURE ANOMALE IN; Belcastro MG, 2010, J HUM EVOL, V58, P522, DOI 10.1016/j.jhevol.2010.03.011; Bennike P., 1985, PALAEOPATHOLOGY DANI; BINFORD LR, 1971, AM ANTIQUITY, V36, P6, DOI 10.1017/S0081130000002525; Boylston A, 2000, J ARCHAEOL SCI, V27, P241, DOI 10.1006/jasc.1999.0451; Boylston A., 2000, HUMAN OSTEOLOGY ARCH, P357; Castella D, 2007, KORPERGRABER DES 1 3, P323; Charlier P., 2008, DEVIANT BURIAL ARCHA, P57; Collis J., 2003, CELTS ORIGINS MYTHS; Collis J., 1984, EUROPEAN IRON AGE; Cunliffe BW., 1997, THE ANCIENT CELTS; De Filippis Cappai C, 1997, IMAGO MORTIS LUOMO R; Dornan JL, 2002, J ARCHAEOL METHOD TH, V9, P303, DOI 10.1023/A:1021318432161; Duncan W. N., 2005, INTERACTING DEAD PER, P207; Evans J, 2006, J ARCHAEOL SCI, V33, P265, DOI 10.1016/j.jas.2005.07.011; Faull M. L., 1977, STUDIES CELTIC SURVI, P1; Frazer J. G., 1886, J ANTHR I GREAT BRIT, V15, P63; Geake H, 1992, AGE SUTTON HOO 7 CEN, P83; Gowland R.L., 2006, SOCIAL ARCHAEOLOGY F; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hodder I., 1985, ADV ARCHAEOLOGICAL M, V8, DOI DOI 10.1016/B978-0-12-003108-5.50006-3; Jaccard P., 1901, ETUDE COMP DISTRIBUT; James S., 1999, ATLANTIC CELTS ANCIE; JONES RFJ, 1987, WORLD ARCHAEOL, V19, P47, DOI 10.1080/00438243.1987.9980023; Knudson KJ, 2008, J ARCHAEOL RES, V16, P397, DOI 10.1007/s10814-008-9024-4; Knusel CJ, 2014, J SOC ARCHAEOL, V14, P26, DOI 10.1177/1469605313518869; Kruta V., 2003, GRANDE STORIA CELTI; Kuijt I, 1996, J ANTHROPOL ARCHAEOL, V15, P313, DOI 10.1006/jaar.1996.0012; Kyll N., 1964, TRIERER Z GESCH KUNS, V27, P168; Maioli MG, 2010, SEPOLTURE ANOMALE IN, P163; Mariotti V, PARCO ARCHEOLOGICO N; Mariotti V, 2014, J ARCHAEOL SCI, V49, P488, DOI 10.1016/j.jas.2014.05.037; Mariotti V, 2009, J HUM EVOL, V56, P340, DOI 10.1016/j.jhevol.2009.01.001; Milella M, 2009, PAGANI CRISTIANI FOR, V8, P111; Milella M, 2011, LINSEDIAMENTO ETRUSC, P99; Montgomery J., 2011, BIOARCHAEOLOGY HUMAN, P141; Murphy E., 2008, DEVIANT BURIAL ARCHA; Murphy E. M., 2008, DEVIANT BURIAL ARCHA, P91; Murphy Eileen, 2007, DEVIANT BURIAL ARCHA, P169; Pauli L, 1975, KELTISCHER VOLKSGLAU; Pettitt P, 2011, PALAEOLITHIC ORIGINS OF HUMAN BURIAL, P1; Philpott RA, 1991, BURIAL PRACTICES ROM, P43; Price J. L., 1981, B BRIT MUS NAT HIST, V35, P145; Raftery Barry, 1994, PAGAN CELTIC IRELAND; Reynolds Andrew, 2009, ANGLO SAXON DEVIANT; Rittershofer K-F, 1997, SONDERBESTATTUNGEN B; Schleifring J, 1999, FESTSCHRIFT GUNTER S, P625; SHAY T, 1985, J ANTHROPOL ARCHAEOL, V4, P221, DOI 10.1016/0278-4165(85)90004-2; Tempelmann-Maczynska M, 1989, ZRG GERM ABT, V106, P274; Van Gennep A, 1909, RITES PASSAGE; Warnke D, 1982, AUSGRABUNGEN FUNDE, V27; Watts D, 1998, RELIG LATE ROMAN BRI; Wilke G, 1933, BESTATUNG BAUCHLAGE, P449; Wilke G, 1931, MANNUS, V23, P202; Zipp K, 2011, ANTHR UNTERSUCHUNG K	64	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130616	10.1371/journal.pone.0130616	http://dx.doi.org/10.1371/journal.pone.0130616			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CN1AM	26115408	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000358147500081
J	Ping, XF; Tang, C				Ping, Xianfeng; Tang, Chao			An Atlas of Network Topologies Reveals Design Principles for Caenorhabditis elegans Vulval Precursor Cell Fate Patterning	PLOS ONE			English	Article							SIGNALING NETWORK; ROBUSTNESS; LIN-12/NOTCH; CROSSTALK; INDUCTION; EPISTASIS; PATHWAYS; NEMATODE; MOTIFS	The vulval precursor cell (VPC) fate patterning in Caenorhabditis elegans is a classic model experimental system for cell fate determination and patterning in development. Despite its apparent simplicity (six neighboring cells arranged in one dimension) and many experimental and computational efforts, the patterning strategy and mechanism remain controversial due to incomplete knowledge of the complex biology. Here, we carry out a comprehensive computational analysis and obtain a reservoir of all possible network topologies that are capable of VPC fate patterning under the simulation of various biological environments and regulatory rules. We identify three patterning strategies: sequential induction, morphogen gradient and lateral antagonism, depending on the features of the signal secreted from the anchor cell. The strategy of lateral antagonism, which has not been reported in previous studies of VPC patterning, employs a mutual inhibition of the 2 degrees cell fate in neighboring cells. Robust topologies are built upon minimal topologies with basic patterning strategies and have more flexible and redundant implementations of modular functions. By simulated mutation, we find that all three strategies can reproduce experimental error patterns of mutants. We show that the topology derived by mapping currently known biochemical pathways to our model matches one of our identified functional topologies. Furthermore, our robustness analysis predicts a possible missing link related to the lateral antagonism strategy. Overall, we provide a theoretical atlas of all possible functional networks in varying environments, which may guide novel discoveries of the biological interactions in vulval development of Caenorhabditis elegans and related species.	[Ping, Xianfeng; Tang, Chao] Peking Univ, Tsinghua Ctr Life Sci, Ctr Quantitat Biol & Peking, Beijing 100871, Peoples R China	Peking University	Tang, C (corresponding author), Peking Univ, Tsinghua Ctr Life Sci, Ctr Quantitat Biol & Peking, Beijing 100871, Peoples R China.	tangc@pku.edu.cn		Tang, Chao/0000-0003-1474-3705	National Natural Science Foundation of China [91430217]; Ministry of Science and Technology of the People's Republic of China (CN) [2015CB910300]; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China (CN); China Scholarship Council(China Scholarship Council)	This work was supported by National Natural Science Foundation of China (91430217) (http://www.nsfc.gov.cn/) and Ministry of Science and Technology of the People's Republic of China (CN) (2015CB910300) (http://www.most.gov.cn/). XP acknowledges supported by China Scholarship Council (http://www.csc.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Barkoulas M, 2013, DEV CELL, V24, P64, DOI 10.1016/j.devcel.2012.12.001; Berset T, 2001, SCIENCE, V291, P1055, DOI 10.1126/science.1055642; Braendle C, 2008, DEV CELL, V15, P714, DOI 10.1016/j.devcel.2008.09.011; Chen N, 2004, DEV CELL, V6, P183, DOI 10.1016/S1534-5807(04)00021-8; Corson F, 2012, P NATL ACAD SCI USA, V109, P5568, DOI 10.1073/pnas.1201505109; Felix MA, 2007, CURR BIOL, V17, P103, DOI 10.1016/j.cub.2006.12.024; Felix MA, 2012, TRENDS GENET, V28, P185, DOI 10.1016/j.tig.2012.01.002; Francois P, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026009; GALASSI M, 2002, GNU SCI LIB REFERENC; GREENWALD IS, 1983, CELL, V34, P435, DOI 10.1016/0092-8674(83)90377-X; Hoyos E, 2011, CURR BIOL, V21, P527, DOI 10.1016/j.cub.2011.02.040; KATZ WS, 1995, CELL, V82, P297, DOI 10.1016/0092-8674(95)90317-8; KOGA M, 1995, DEVELOPMENT, V121, P2655; Levitan D, 1998, DEVELOPMENT, V125, P3101; Lim WA, 2013, MOL CELL, V49, P202, DOI 10.1016/j.molcel.2012.12.020; Ma WZ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100111; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Reiner David J, 2011, Small GTPases, V2, P109; Schmid T, 2015, CURR OPIN GENET DEV, V32, P1, DOI 10.1016/j.gde.2015.01.006; SIMSKE JS, 1995, NATURE, V375, P142, DOI 10.1038/375142a0; Sneppen K, 2010, ANNU REV BIOPHYS, V39, P43, DOI 10.1146/annurev.biophys.093008.131241; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; STERNBERG PW, 1986, CELL, V44, P761, DOI 10.1016/0092-8674(86)90842-1; Sternberg PW, 2004, SCIENCE, V303, P637, DOI 10.1126/science.1094409; STERNBERG PW, 1989, CELL, V58, P679, DOI 10.1016/0092-8674(89)90103-7; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; Yao G, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.19; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; Zand TP, 2011, DEV CELL, V20, P84, DOI 10.1016/j.devcel.2010.12.004	33	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131397	10.1371/journal.pone.0131397	http://dx.doi.org/10.1371/journal.pone.0131397			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114587	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500151
J	van Nierop, BJ; Bax, NAM; Nelissen, JL; Arslan, F; Motaal, AG; de Graaf, L; Zwanenburg, JJM; Luijten, PR; Nicolay, K; Strijkers, GJ				van Nierop, Bastiaan J.; Bax, Noortje A. M.; Nelissen, Jules L.; Arslan, Fatih; Motaal, Abdallah G.; de Graaf, Larry; Zwanenburg, Jaco J. M.; Luijten, Peter R.; Nicolay, Klaas; Strijkers, Gustav J.			Assessment of Myocardial Fibrosis in Mice Using a T2*-Weighted 3D Radial Magnetic Resonance Imaging Sequence	PLOS ONE			English	Article							CONTRAST AGENT; INFARCT SIZE; HEART; MECHANISMS; MOUSE; DIFFUSION; T-1	Background Myocardial fibrosis is a common hallmark of many diseases of the heart. Late gadolinium enhanced MRI is a powerful tool to image replacement fibrosis after myocardial infarction (MI). Interstitial fibrosis can be assessed indirectly from an extracellular volume fraction measurement using contrast-enhanced T1 mapping. Detection of short T2* species resulting from fibrotic tissue may provide an attractive non-contrast-enhanced alternative to directly visualize the presence of both replacement and interstitial fibrosis. Objective To goal of this paper was to explore the use of a T2*-weighted radial sequence for the visualization of fibrosis in mouse heart. Methods C57BL/6 mice were studied with MI (n = 20, replacement fibrosis), transverse aortic constriction (TAC) (n = 18, diffuse fibrosis), and as control (n = 10). 3D center-out radial T2*-weighted images with varying TE were acquired in vivo and ex vivo (TE = 21 mu s-4 ms). Ex vivo T2*-weighted signal decay with TE was analyzed using a 3-component model. Subtraction of short-and long-TE images was used to highlight fibrotic tissue with short T2*. The presence of fibrosis was validated using histology and correlated to MRI findings. Results Detailed ex vivo T2*-weighted signal analysis revealed a fast (T2*(fast)), slow (T2*(slow)) and lipid (T2*(lipid)) pool. T2*(fast) remained essentially constant. Infarct T2*(slow) decreased significantly, while a moderate decrease was observed in remote tissue in post-MI hearts and in TAC hearts. T2*(slow) correlated with the presence of diffuse fibrosis in TAC hearts (r = 0.82, P = 0.01). Ex vivo and in vivo subtraction images depicted a positive contrast in the infarct co-localizing with the scar. Infarct volumes from histology and subtraction images linearly correlated (r = 0.94, P<0.001). Region-of-interest analysis in the in vivo post-MI and TAC hearts revealed significant T2*shortening due to fibrosis, in agreement with the ex vivo results. However, in vivo contrast on subtraction images was rather poor, hampering a straightforward visual assessment of the spatial distribution of the fibrotic tissue.	[van Nierop, Bastiaan J.; Nelissen, Jules L.; Motaal, Abdallah G.; de Graaf, Larry; Nicolay, Klaas; Strijkers, Gustav J.] Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR, NL-5600 MB Eindhoven, Netherlands; [Bax, Noortje A. M.] Eindhoven Univ Technol, Dept Biomed Engn, Soft Tissue Biomech & Engn, NL-5600 MB Eindhoven, Netherlands; [Arslan, Fatih] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Arslan, Fatih] Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands; [Zwanenburg, Jaco J. M.; Luijten, Peter R.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Strijkers, Gustav J.] Univ Amsterdam, Acad Med Ctr, Biomed Engn & Phys, NL-1105 AZ Amsterdam, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Strijkers, GJ (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR, POB 513, NL-5600 MB Eindhoven, Netherlands.	g.j.strijkers@amc.uva.nl	Arslan, Fatih/AAH-8006-2021; Zwanenburg, Jaco J.M./B-3857-2009	Bax, Noortje/0000-0002-3602-6400; Zwanenburg, Jaco J.M./0000-0002-4282-5719; Strijkers, Gustav/0000-0001-6700-5058; Arslan, Fatih/0000-0001-6598-8599; Nicolay, Klaas/0000-0002-4179-616X	Center for Translational Molecular Medicine [01C-103]; Netherlands Heart Foundation; Dutch government [FES0908]; Netherlands Heart Foundation [2010.T001]; Netherlands Genomics Initiative; ZonMw [40-41300-98-11028]	Center for Translational Molecular Medicine; Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch government; Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Genomics Initiative; ZonMw(Netherlands Organization for Health Research and Development)	This research was performed within the framework of the Center for Translational Molecular Medicine (grant 01C-103), and supported by the Netherlands Heart Foundation. NAB was supported by a grant from the Dutch government to the Netherlands Institute for Regenerative Medicine (grant FES0908). FA was supported by research grants from the Netherlands Heart Foundation (contract 2010.T001), Netherlands Genomics Initiative & ZonMw (contract 40-41300-98-11028).	Abdel-Aty H, 2009, J AM COLL CARDIOL, V53, P1194, DOI 10.1016/j.jacc.2008.10.065; Aguor ENE, 2012, QUANTITATIVE T 2 ASS; ATALAY MK, 1995, MAGNET RESON MED, V34, P623, DOI 10.1002/mrm.1910340420; Beyers RJ, 2012, MAGN RESON MED, V67, P201, DOI 10.1002/mrm.22975; BRIX G, 1990, PHYS MED BIOL, V35, P53, DOI 10.1088/0031-9155/35/1/006; Bun SS, 2012, INVEST RADIOL, V47, P319, DOI 10.1097/RLI.0b013e318243e062; Caravan P, 2007, ANGEW CHEM INT EDIT, V46, P8171, DOI 10.1002/anie.200700700; Coolen BF, 2010, MAGN RESON MED, V64, P1658, DOI 10.1002/mrm.22588; Creemers EE, 2011, CARDIOVASC RES, V89, P265, DOI 10.1093/cvr/cvq308; de Jong S, 2011, J MOL CELL CARDIOL, V51, P974, DOI 10.1016/j.yjmcc.2011.08.024; Debessa CRG, 2001, MECH AGEING DEV, V122, P1049; Diez J, 2005, NAT CLIN PRACT CARD, V2, P209, DOI 10.1038/ncpcardio0158; Duyn JH, 1998, J MAGN RESON, V132, P150, DOI 10.1006/jmre.1998.1396; Eitel I, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-13; Ellims AH, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-76; Gatehouse PD, 2003, CLIN RADIOL, V58, P1, DOI 10.1053/crad.2003.1157; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Heijman E, 2007, NMR BIOMED, V20, P439, DOI 10.1002/nbm.1110; Ibrahim T, 2005, J AM COLL CARDIOL, V45, P544, DOI 10.1016/j.jacc.2004.10.058; Iles L, 2008, J AM COLL CARDIOL, V52, P1574, DOI 10.1016/j.jacc.2008.06.049; Jackson E, 2007, CLIN RADIOL, V62, P395, DOI 10.1016/j.crad.2006.11.013; Jellis C, 2010, J AM COLL CARDIOL, V56, P89, DOI 10.1016/j.jacc.2010.02.047; Kali A, 2013, CIRC-CARDIOVASC IMAG, V6, P218, DOI 10.1161/CIRCIMAGING.112.000133; Karamitsos TD, 2009, J AM COLL CARDIOL, V54, P1407, DOI 10.1016/j.jacc.2009.04.094; Kass DA, 2004, CIRC RES, V94, P1533, DOI 10.1161/01.RES.0000129254.25507.d6; Lutgens E, 1999, CARDIOVASC RES, V41, P586, DOI 10.1016/S0008-6363(98)00216-8; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Milano AD, 2012, J THORAC CARDIOV SUR, V144, P830, DOI 10.1016/j.jtcvs.2011.11.024; Moreo A, 2009, CIRC-CARDIOVASC IMAG, V2, P437, DOI 10.1161/CIRCIMAGING.108.838367; O'Regan DP, 2008, EUR RADIOL, V18, P800, DOI 10.1007/s00330-007-0814-8; Oshinski JN, 2001, CIRCULATION, V104, P2838, DOI 10.1161/hc4801.100351; PICANO E, 1990, CIRCULATION, V81, P58, DOI 10.1161/01.CIR.81.1.58; Robert B, 2009, MAGN RESON MED, V62, P1155, DOI 10.1002/mrm.22124; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; ROZENMAN Y, 1990, RADIOLOGY, V175, P655, DOI 10.1148/radiology.175.3.2343109; Strijkers GJ, 2009, NMR BIOMED, V22, P182, DOI 10.1002/nbm.1299; THICKMAN DI, 1983, RADIOLOGY, V148, P183, DOI 10.1148/radiology.148.1.6856832; Tilak GS, 2008, INVEST RADIOL, V43, P7, DOI 10.1097/RLI.0b013e3181558822; van Nierop BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055424; van Oorschot JW, 2014, J MAGN RESON IMAGING; Weller A., 2013, PEDIAT NEPHROL, DOI DOI 10.1007/	41	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129899	10.1371/journal.pone.0129899	http://dx.doi.org/10.1371/journal.pone.0129899			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115443	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500042
J	Dreher, CE; Cummings, ME; Prohl, H				Dreher, Corinna E.; Cummings, Molly E.; Proehl, Heike			An Analysis of Predator Selection to Affect Aposematic Coloration in a Poison Frog Species	PLOS ONE			English	Article							WARNING SIGNALS; NATURAL-SELECTION; SEXUAL SELECTION; OOPHAGA-PUMILIO; VISUAL PIGMENTS; FIDDLER-CRAB; UCA-TANGERI; BODY-SIZE; CONSPICUOUSNESS; EVOLUTION	Natural selection is widely noted to drive divergence of phenotypic traits. Predation pressure can facilitate morphological divergence, for example the evolution of both cryptic and conspicuous coloration in animals. In this context Dendrobatid frogs have been used to study evolutionary forces inducing diversity in protective coloration. The polytypic strawberry poison frog (Oophaga pumilio) shows strong divergence in aposematic coloration among populations. To investigate whether predation pressure is important for color divergence among populations of O. pumilio we selected four mainland populations and two island populations from Costa Rica and Panama. Spectrometric measurements of body coloration were used to calculate color and brightness contrasts of frogs as an indicator of conspicuousness for the visual systems of several potential predators (avian, crab and snake) and a conspecific observer. Additionally, we conducted experiments using clay model frogs of different coloration to investigate whether the local coloration of frogs is better protected than non-local color morphs, and if predator communities vary among populations. Overall predation risk differed strongly among populations and interestingly was higher on the two island populations. Imprints on clay models indicated that birds are the main predators while attacks of other predators were rare. Furthermore, clay models of local coloration were equally likely to be attacked as those of non-local coloration. Overall conspicuousness (and brightness contrast) of local frogs was positively correlated with attack rates by birds across populations. Together with results from earlier studies we conclude that conspicuousness honestly indicates toxicity to avian predators. The different coloration patterns among populations of strawberry poison frogs in combination with behavior and toxicity might integrate into equally efficient anti-predator strategies depending on local predation and other ecological factors.	[Dreher, Corinna E.; Proehl, Heike] Univ Vet Med Hannover, Inst Zool, Hannover, Germany; [Cummings, Molly E.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	University of Veterinary Medicine Hannover, Foundation; University of Texas System; University of Texas Austin	Dreher, CE (corresponding author), Univ Vet Med Hannover, Inst Zool, Hannover, Germany.	corinna.dreher@tiho-hannover.de			Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Leibniz Universitat Hannover; German Research Foundation DFG [PR 626/4-1, PR 626/4-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Leibniz Universitat Hannover; German Research Foundation DFG(German Research Foundation (DFG))	German Research Foundation DFG (PR 626/4-1 and PR 626/4-2). http://www.dfg.de/en/ Graduate Academy of the Leibniz University of Hannover. http://www.graduiertenakademie.unihannover.de/ German Academic Exchange Service. https://www.daad.de/en/. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Leibniz Universitat Hannover. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCOVER JA, 1994, BIOSCIENCE, V44, P12, DOI 10.2307/1312401; Aronsson M, 2008, ANIM BEHAV, V75, P417, DOI 10.1016/j.anbehav.2007.05.006; Blazquez MC, 1997, ETHOLOGY, V103, P990; Brown JL, 2010, J BIOGEOGR, V37, P891, DOI 10.1111/j.1365-2699.2009.02260.x; Chouteau M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034028; Chouteau M, 2011, AM NAT, V178, P810, DOI 10.1086/662667; Crothers LR, 2013, AM NAT, V181, pE116, DOI 10.1086/670010; Cummings ME, 2008, ANIM BEHAV, V75, P175, DOI 10.1016/j.anbehav.2007.04.016; Cummings ME, 2013, EVOL ECOL, V27, P693, DOI 10.1007/s10682-013-9648-9; DALY JW, 1967, SCIENCE, V156, P970, DOI 10.1126/science.156.3777.970; Darst CR, 2006, P NATL ACAD SCI USA, V103, P5852, DOI 10.1073/pnas.0600625103; Endler JA, 2004, AM NAT, V163, P532, DOI 10.1086/382662; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; Exnerova A, 2006, BIOL J LINN SOC, V88, P143, DOI 10.1111/j.1095-8312.2006.00611.x; Finkbeiner SD, 2014, EVOLUTION, V68, P3410, DOI 10.1111/evo.12524; Gehara M, 2013, EVOL ECOL, V27, P797, DOI 10.1007/s10682-013-9652-0; GEORGE TL, 1987, ECOLOGY, V68, P1393, DOI 10.2307/1939223; Hart NS, 1998, J EXP BIOL, V201, P1433; Hegna RH, 2013, EVOL ECOL, V27, P831, DOI 10.1007/s10682-012-9605-z; Hegna RH, 2011, ANN ZOOL FENN, V48, P29, DOI 10.5735/086.048.0103; Hernandez-Jimenez A, 2012, ANIM BEHAV, V84, P1051, DOI 10.1016/j.anbehav.2012.08.004; Holen OH, 2012, AM NAT, V180, P629, DOI 10.1086/667890; Horch K, 2002, J COMP PHYSIOL A, V188, P493, DOI 10.1007/s00359-002-0325-7; Jordao JM, 2007, J EXP BIOL, V210, P447, DOI 10.1242/jeb.02658; Maan ME, 2008, EVOLUTION, V62, P2334, DOI 10.1111/j.1558-5646.2008.00454.x; Maan ME, 2012, AM NAT, V179, pE1, DOI 10.1086/663197; Macedonia JM, 2009, BIOL J LINN SOC, V97, P749, DOI 10.1111/j.1095-8312.2009.01217.x; Mappes J, 2005, TRENDS ECOL EVOL, V20, P598, DOI 10.1016/j.tree.2005.07.011; Meiri S, 2005, ECOL LETT, V8, P1211, DOI 10.1111/j.1461-0248.2005.00825.x; Morgans CL, 2014, BMC EVOL BIOL, V14, DOI [10.1186/1471-2148-14-97, 10.1186/s12883-014-0203-2]; NILSSON SG, 1985, OECOLOGIA, V66, P511, DOI 10.1007/BF00379342; Nokelainen O, 2012, P ROY SOC B-BIOL SCI, V279, P257, DOI 10.1098/rspb.2011.0880; Noonan BP, 2009, BIOL LETTERS, V5, P51, DOI 10.1098/rsbl.2008.0586; Paluh DJ, 2014, J HERPETOL, V48, P249, DOI 10.1670/13-027; Pegram KV, 2014, ANIM BEHAV, V92, P1, DOI 10.1016/j.anbehav.2014.03.017; Prohl H, 2007, ETHOLOGY, V113, P825, DOI 10.1111/j.1439-0310.2007.01396.x; Prohl H, 2013, EVOL ECOL RES, V15, P667; Prohl H, 2011, EVOL ECOL, V25, P993, DOI 10.1007/s10682-010-9455-5; Prudic KL, 2007, BEHAV ECOL, V18, P41, DOI 10.1093/beheco/arl046; R Developmental Core Team, 2012, R A LANGUAGE AND ENV; Richards-Zawacki CL, 2013, EVOL ECOL, V27, P783, DOI 10.1007/s10682-013-9636-0; Rudh A, 2013, BIOL J LINN SOC, V108, P116, DOI 10.1111/j.1095-8312.2012.02006.x; Rudh A, 2011, EVOLUTION, V65, P1271, DOI 10.1111/j.1558-5646.2010.01210.x; Ruxton G.D, 2004, AVOIDING ATTACK EVOL; Saporito RA, 2007, COPEIA, P1006, DOI 10.1643/0045-8511(2007)7[1006:EEFAIT]2.0.CO;2; Saporito RA, 2007, TOXICON, V50, P757, DOI 10.1016/j.toxicon.2007.06.022; Savage J. M., 2002, THE AMPHIBIANS AND R; Siddiqi A, 2004, J EXP BIOL, V207, P2471, DOI 10.1242/jeb.01047; Sillman AJ, 1997, J COMP PHYSIOL A, V181, P89, DOI 10.1007/s003590050096; Stevens M, 2006, P R SOC B, V273, P2433, DOI 10.1098/rspb.2006.3614; Stobbe N, 2008, P ROY SOC B-BIOL SCI, V275, P1535, DOI 10.1098/rspb.2008.0209; Stuart YE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048497; Summers K, 1997, J HERED, V88, P8, DOI 10.1093/oxfordjournals.jhered.a023065; Summers K, 2003, J BIOGEOGR, V30, P35, DOI 10.1046/j.1365-2699.2003.00795.x; Symula R, 2001, P ROY SOC B-BIOL SCI, V268, P2415, DOI 10.1098/rspb.2001.1812; Wang IJ, 2008, EVOLUTION, V62, P2742, DOI 10.1111/j.1558-5646.2008.00507.x; Wang IJ, 2011, EVOLUTION, V65, P1637, DOI 10.1111/j.1558-5646.2011.01257.x; Wiens J, 1992, THE ECOLOGY OF BIRD; Williamson M. H., 1981, ISLAND POPULATIONS; Willink B, 2014, BIOL J LINN SOC, V113, P580, DOI 10.1111/bij.12355; Willink B, 2013, EVOLUTION, V67, P2783, DOI 10.1111/evo.12153	61	33	33	2	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130571	10.1371/journal.pone.0130571	http://dx.doi.org/10.1371/journal.pone.0130571			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110826	Green Published, gold			2022-12-27	WOS:000356933800064
J	Ekouevl, DK; Avettand-Fenoel, V; Tchounga, BK; Coffie, PA; Sawadogo, A; Minta, D; Minga, A; Eholie, SP; Plantier, JC; Damond, F; Dabis, F; Rouzioux, C				Ekouevl, Didier K.; Avettand-Fenoel, Veronique; Tchounga, Boris K.; Coffie, Patrick A.; Sawadogo, Adrien; Minta, Daouda; Minga, Albert; Eholie, Serge P.; Plantier, Jean-Christophe; Damond, Florence; Dabis, Francois; Rouzioux, Christine		IeDEA West Africa Collaboration	Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration	PLOS ONE			English	Article							VIRAL LOAD ASSAY; ANTIRETROVIRAL THERAPY; CLINICAL-USE; GROUP-A; COHORT; PCR; QUANTIFICATION; TRANSMISSION; VALIDATION; INFECTION	Background Plasma HIV-1 RNA monitoring is one of the standard tests for the management of HIV-1 infection. While HIV-1 RNA can be quantified using several commercial tests, no test has been commercialized for HIV-2 RNA quantification. We studied the relationship between plasma HIV-2 viral load (VL) and CD4 count in West African patients who were either receiving antiretroviral therapy (ART) or treatment-naive. Method A cross sectional survey was conducted among HIV-2-infected individuals followed in three countries in West Africa from March to December 2012. All HIV-2 infected-patients who attended one of the participating clinics were proposed a plasma HIV-2 viral load measurement. HIV-2 RNA was quantified using the new ultrasensitive in-house real-time PCR assay with a detection threshold of 10 copies/mL (cps/mL). Results A total of 351 HIV-2-infected individuals participated in this study, of whom 131 (37.3%) were treatment naive and 220 (62.7%) had initiated ART. Among treatment-naive patients, 60 (46.5%) had undetectable plasma HIV-2 viral load (<10 cps/mL), it was detectable between 10-100 cps/mL in 35.8%, between 100-1000 cps/mL in 11.7% and >1000 cps/mL in 6.0% of the patients. Most of the treatment-naive patients (70.2%) had CD4-T cell count >= 500 cells/mm(3) and 43 (46.7%) of these patients had a detectable VL (>= 10 cps/mL). Among the 220 patients receiving ART, the median CD4-T cell count rose from 231 to 393 cells/mm(3) (IQR [259-561]) after a median follow-up duration of 38 months and 145 (66.0%) patients had CD4-T cell count >= 500 cells/mm(3) with a median viral load of 10 cps/mL (IQR [10-33]). Seventy five (34.0%) patients had CD4-T cell count >= 500 cells/mm(3), among them 14 (18.7%) had a VL between 10-100 cps/mL and 2 (2.6%) had VL > 100 cps/mL. Conclusion This study suggests that the combination of CD4-T cell count and ultrasensitive HIV-2 viral load quantification with a threshold of 10 cps/mL, could improve ART initiation among treatment naive HIV-2-infected patients and the monitoring of ART response among patients receiving treatment.	[Ekouevl, Didier K.; Tchounga, Boris K.] Univ Bordeaux, ISPED, Ctr INSERM U897, Epidemiol Biostat, Bordeaux, France; [Ekouevl, Didier K.; Tchounga, Boris K.; Dabis, Francois] Univ Bordeaux, ISPED, Inserm U897, Bordeaux, France; [Ekouevl, Didier K.; Tchounga, Boris K.; Coffie, Patrick A.] Site Rech ANRS, Programme PACCI, Abidjan, Cote Ivoire; [Ekouevl, Didier K.] Univ Lome, Dept Sante Publ, Lome, Togo; [Avettand-Fenoel, Veronique; Rouzioux, Christine] Hop Necker Enfants Malad, AP HP, Virol Lab, Paris, France; [Avettand-Fenoel, Veronique; Rouzioux, Christine] Univ Paris 05, Sorbonne Paris Cite, Fac Med, EA7327, Paris, France; [Coffie, Patrick A.; Eholie, Serge P.] CHU Treichville, Serv Malad Infectieuses & Trop, Abidjan, Cote Ivoire; [Sawadogo, Adrien] CHU SouroSanou, Hop Jour, Serv Malad Infectieuses & Trop, Bobo Dioulasso, Burkina Faso; [Minta, Daouda] Hop Point G, Ctr Prise Charge Personnes Vivant Avec VIH, Serv Malad Infectieuses, Bamako, Mali; [Minga, Albert] CNTS, PRIMO CI, Ctr Med Suivi Donneurs Sang, Abidjan, Cote Ivoire; [Plantier, Jean-Christophe] CHU Rouen, Hop Charles Nicolle, Ctr Natl Reference VIH, Lab Associe, Rouen, France; [Plantier, Jean-Christophe; Dabis, Francois] Univ Rouen, Fac Med Pharm, Inst Rech & Innovat Biomed, GRAM,Equipe Accueil 2656, Rouen, France; [Dabis, Francois] INSERM, IAME, UMR 1137, Paris, France; [Damond, Florence] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Damond, Florence] Hop Bichat Claude Bernard, AP HP, Virol Lab, F-75877 Paris 18, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU de Rouen; Universite de Rouen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Ekouevl, DK (corresponding author), Univ Bordeaux, ISPED, Ctr INSERM U897, Epidemiol Biostat, Bordeaux, France.	didier.ekouevi@gmail.com	Avettand-Fenoel, Véronique/O-6285-2017; DABIS, FRANCOIS/S-9298-2019; Eholie, Serge/T-6008-2019; EKOUEVI, Didier K/E-7960-2014	Avettand-Fenoel, Véronique/0000-0002-7022-2990; DABIS, FRANCOIS/0000-0002-1614-8857; Tchounga, Boris Kevin/0000-0002-8747-9610; PLANTIER, Jean-Christophe/0000-0001-6417-4083	National Cancer Institute (NCI); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute of Allergy and Infectious Diseases (NIAID) of the US National Institutes of Health (NIH), International Epidemiologic Databases to Evaluate AIDS (IeDEA) [U01AI069919]; ANRS (France REcherche Nord & sudSida-hivHepatites: FRENSH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069919] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Allergy and Infectious Diseases (NIAID) of the US National Institutes of Health (NIH), International Epidemiologic Databases to Evaluate AIDS (IeDEA); ANRS (France REcherche Nord & sudSida-hivHepatites: FRENSH)(French National Research Agency (ANR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The HIV-2 Cohort of the WADA Collaboration is partly funded by the National Cancer Institute (NCI), the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), and the National Institute of Allergy and Infectious Diseases (NIAID) of the US National Institutes of Health (NIH), as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) under Award # U01AI069919. The ANRS (France REcherche Nord & sudSida-hivHepatites: FRENSH) supported part of the laboratory work performed within this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avettand-Fenoel V, 2014, J CLIN MICROBIOL, V52, P3017, DOI 10.1128/JCM.00724-14; Ayouba A, 2013, AIDS, V27, P2488, DOI 10.1097/01.aids.0000432443.22684.50; Brower ET, 2008, CHEM BIOL DRUG DES, V71, P298, DOI 10.1111/j.1747-0285.2008.00647.x; Burgard M, 2010, CLIN INFECT DIS, V51, P833, DOI 10.1086/656284; Campbell-Yesufu OT, 2011, CLIN INFECT DIS, V52, P780, DOI 10.1093/cid/ciq248; Cavaco-Silva J, 2013, J ANTIMICROB CHEMOTH, V68, P190, DOI 10.1093/jac/dks363; Chang M, 2012, J CLIN VIROL, V55, P128, DOI 10.1016/j.jcv.2012.06.024; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Damond F, 2004, ANTIVIR THER, V9, P635; Damond F, 2005, J CLIN MICROBIOL, V43, P4234, DOI 10.1128/JCM.43.8.4234-4236.2005; Damond F, 2011, J CLIN MICROBIOL, V49, P3491, DOI 10.1128/JCM.02389-10; Delarue S, 2013, J CLIN VIROL, V58, P461, DOI 10.1016/j.jcv.2013.08.003; Desbois D, 2008, ANTIMICROB AGENTS CH, V52, P1545, DOI 10.1128/AAC.01284-07; Drylewicz J, 2008, AIDS, V22, P457, DOI 10.1097/QAD.0b013e3282f4ddfc; Drylewicz J, 2010, AIDS, V24, P1043, DOI 10.1097/QAD.0b013e3283377a06; Egger M, 2012, INT J EPIDEMIOL, V41, P1256, DOI 10.1093/ije/dyr080; Ekouevi DK, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-461; Ekouevi DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066135; Ferns RB, 2006, J VIROL METHODS, V135, P102, DOI 10.1016/j.jviromet.2006.02.005; Gottlieb GS, 2009, CLIN INFECT DIS, V48, P476, DOI 10.1086/596504; KANKI PJ, 1994, LANCET, V343, P943, DOI 10.1016/S0140-6736(94)90065-5; Matheron S, 2006, AIDS, V20, P459, DOI 10.1097/01.aids.0000199829.57112.2f; Morlat P, 2013, RAPPORT 2013; Peterson K, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/463704; Simon F, 2001, AIDS RES HUM RETROV, V17, P937, DOI 10.1089/088922201750290050; Smith NA, 2001, J INFECTION, V42, P126, DOI 10.1053/jinf.2001.0792; Styer LM, 2013, J CLIN VIROL, V58, pE127, DOI 10.1016/j.jcv.2013.09.007; Tchounga BK, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19380; Tchounga BK, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19064; UNAIDS. 2014 Global AIDS response, PROGRESS REPORTING; van der Loeff MFS, 2002, AIDS, V16, P1775, DOI 10.1097/00002030-200209060-00010; WHO, 2013, RECOMMENDATIONS FOR; WHO, 2010, RECOMMENDATIONS FOR; WHO (2013) World Health Organization, 2013, HIV TEST KIT EVALUAT	34	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0129886	10.1371/journal.pone.0129886	http://dx.doi.org/10.1371/journal.pone.0129886			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111242	gold, Green Submitted, Green Published			2022-12-27	WOS:000356933800032
J	Martinez, VG; Sacedon, R; Hidalgo, L; Valencia, J; Fernandez-Sevilla, LM; Hernandez-Lopez, C; Vicente, A; Varas, A				Martinez, Vctor G.; Sacedon, Rosa; Hidalgo, Laura; Valencia, Jaris; Fernandez-Sevilla, Lidia M.; Hernandez-Lopez, Carmen; Vicente, Angeles; Varas, Alberto			The BMP Pathway Participates in Human Naive CD4(+) T Cell Activation and Homeostasis	PLOS ONE			English	Article							MORPHOGENETIC PROTEINS; SIGNALING PATHWAYS; CYCLE PROGRESSION; BONE; IL-7; DIFFERENTIATION; PROLIFERATION; EXPRESSION; RECEPTORS; INDUCTION	Bone Morphogenetic Proteins (BMPs) form a group of secreted factors that belongs to the TGF-beta superfamily. Among different roles in a number of immune cell types, BMPs are known to regulate T cell development within the thymus, although the role of BMP signaling in human mature T cells remains elusive. In this study, we demonstrate that canonical BMP signaling is necessary during two critical events that regulate the size and function of human naive CD4(+) T cell population: activation and homeostasis. Upon stimulation via TCR, naive CD4(+) T cells upregulate the expression of BMP ligands triggering canonical BMP signaling in CD25(+) cells. Blockade of BMP signaling severely impairs CD4(+) T cell proliferation after activation mainly through regulation of IL-2, since the addition of this cytokine recuperates normal T cell expansion after inhibition of BMP signaling. Similarly, activation of canonical BMP pathway is required for both the maintenance of cell survival and the homeostatic proliferation induced by IL-7, a key factor for T cell homeostasis. Moreover, upregulation of two critical receptors for T cell homeostasis, CXCR4 and CCR9, triggered by IL-7 is also abrogated in the absence of BMP signaling. Collectively, we describe important roles of the canonical BMP signaling in human naive CD4(+) T cell activation and homeostasis that could be valuable for clinical application.	[Martinez, Vctor G.; Sacedon, Rosa; Hidalgo, Laura; Valencia, Jaris; Fernandez-Sevilla, Lidia M.; Hernandez-Lopez, Carmen; Vicente, Angeles; Varas, Alberto] Univ Complutense, Fac Med, Dept Cell Biol, E-28040 Madrid, Spain	Complutense University of Madrid	Varas, A (corresponding author), Univ Complutense, Fac Med, Dept Cell Biol, E-28040 Madrid, Spain.	avaras@ucm.es	Hernández López, Carmen/H-4415-2015; Sacedon, Rosa/B-8024-2015; Vicente, Angeles/B-7951-2015; Valencia, Jaris/S-2364-2016; Varas, Alberto/B-8292-2015; MARTINEZ, VICTOR MANUEL GARCIA/AAB-6762-2019; Fernández-Sevilla, Lidia M./U-6455-2019	Hernández López, Carmen/0000-0002-6131-8923; Sacedon, Rosa/0000-0002-7486-7120; Vicente, Angeles/0000-0002-9456-5541; Valencia, Jaris/0000-0002-3112-5944; Varas, Alberto/0000-0001-8329-6457; MARTINEZ, VICTOR MANUEL GARCIA/0000-0002-5515-0626; Fernández-Sevilla, Lidia M./0000-0003-0076-3254	Ministerio de Economia y Competitividad [SAF2012-33180]; Comunidad de Madrid [S2010/BMD-2420]; Instituto de Salud Carlos III [RD12/0019/0007]; Ministerio de Educacion, Cultura y Deporte [AP2009-4324]	Ministerio de Economia y Competitividad(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Educacion, Cultura y Deporte(Spanish Government)	This work was supported by grants SAF2012-33180 (Ministerio de Economia y Competitividad), S2010/BMD-2420 (Comunidad de Madrid) and RD12/0019/0007 (Instituto de Salud Carlos III). L.H. is supported by pre-doctoral fellowships (AP2009-4324) from the Ministerio de Educacion, Cultura y Deporte.	Barata JT, 2001, BLOOD, V98, P1524, DOI 10.1182/blood.V98.5.1524; Barneda-Zahonero B, 2009, MOL BIOL CELL, V20, P5051, DOI 10.1091/mbc.E09-05-0424; Borghans JAM, 2007, IMMUNOL REV, V216, P35; Catalfamo M, 2008, P NATL ACAD SCI USA, V105, P19851, DOI 10.1073/pnas.0810032105; Cejalvo T, 2007, IMMUNOLOGY, V121, P94, DOI 10.1111/j.1365-2567.2007.02541.x; Cimbro R, 2012, BLOOD, V120, P2610, DOI 10.1182/blood-2012-06-434779; Fu S, 2011, J ORAL PATHOL MED, V40, P490, DOI 10.1111/j.1600-0714.2010.00988.x; Guan JH, 2013, BIOCHEM BIOPH RES CO, V441, P560, DOI 10.1016/j.bbrc.2013.10.121; Guo M, 2014, CARCINOGENESIS, V35, P1698, DOI 10.1093/carcin/bgu030; Hager-Theodorides AL, 2002, J IMMUNOL, V169, P5496, DOI 10.4049/jimmunol.169.10.5496; Hager-Theodorides AL, 2014, CELL CYCLE, V13, P324, DOI 10.4161/cc.27118; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Icli B, 2013, CIRC RES, V113, P1231, DOI 10.1161/CIRCRESAHA.113.301780; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Kersten C, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-9; Kim HR, 2008, CRIT REV IMMUNOL, V28, P325, DOI 10.1615/CritRevImmunol.v28.i4.40; Lee MY, 2009, STEM CELLS, V27, P1858, DOI 10.1002/stem.124; Li WQ, 2006, J EXP MED, V203, P573, DOI 10.1084/jem.20051520; Lin Jian-Xin, 1997, Cytokine and Growth Factor Reviews, V8, P313; Lu L, 2010, EUR J IMMUNOL, V40, P142, DOI 10.1002/eji.200939618; Lundstrom W, 2012, SEMIN IMMUNOL, V24, P218, DOI 10.1016/j.smim.2012.02.005; Mancebo E, 2008, CLIN EXP IMMUNOL, V154, P375, DOI 10.1111/j.1365-2249.2008.03771.x; Martinez CG, 2011, IMMUNOL CELL BIOL, V89, P610, DOI 10.1038/icb.2010.135; Martinez VG, 2014, EUR J IMMUNOL, V44, P1031, DOI 10.1002/eji.201343693; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Murray JM, 2003, IMMUNOL CELL BIOL, V81, P487, DOI 10.1046/j.1440-1711.2003.01191.x; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Palmer DB, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00316; Robson NC, 2014, CANCER RES, V74, P5019, DOI 10.1158/0008-5472.CAN-13-2845; Sauce D, 2012, J IMMUNOL, V189, P5541, DOI 10.4049/jimmunol.1201235; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Sivertsen EA, 2007, EUR J IMMUNOL, V37, P2937, DOI 10.1002/eji.200636759; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stenstad H, 2006, BLOOD, V107, P3447, DOI 10.1182/blood-2005-07-2860; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Takai S, 2010, INT J MOL MED, V25, P105, DOI 10.3892/ijmm_00000319; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Varas A, 2009, CELL CYCLE, V8, P4119, DOI 10.4161/cc.8.24.10149; Wagner DO, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3107mr1; Wong WF, 2011, J BIOL CHEM, V286, P11110, DOI 10.1074/jbc.M110.166694; Xu X, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/282870; Yoshioka Y, 2012, EUR J IMMUNOL, V42, P749, DOI 10.1002/eji.201141702; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhou J, 2012, P NATL ACAD SCI USA, V109, P7770, DOI 10.1073/pnas.1205476109	50	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131453	10.1371/journal.pone.0131453	http://dx.doi.org/10.1371/journal.pone.0131453			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110906	gold, Green Published, Green Submitted			2022-12-27	WOS:000356933800150
J	Parthiban, ABR; Mahapatra, M; Gubbins, S; Parida, S				Parthiban, Aravindh Babu R.; Mahapatra, Mana; Gubbins, Simon; Parida, Satya			Virus Excretion from Foot-And-Mouth Disease Virus Carrier Cattle and Their Potential Role in Causing New Outbreaks	PLOS ONE			English	Article							DIRECT-CONTACT CHALLENGE; PERSISTENTLY INFECTED CATTLE; BUFFALO SYNCERUS CAFFER; EXPERIMENTAL TRANSMISSION; VACCINATED PIGS; PROTECTION; REPLICATION; ZIMBABWE; EXPOSURE; RNA	The role of foot-and-mouth disease virus (FMDV) carrier cattle in causing new outbreaks is still a matter of debate and it is important to find out these carrier animals by post-outbreak serosurveillance to declare freedom from FMDV infection. In this study we explore the differences in viral shedding between carrier and non-carrier animals, quantify the transmission rate of FMDV infection from carriers to susceptible animals and identify potential viral determinants of viral persistence. We collected nasal and saliva samples from 32 vaccinated and 7 unvaccinated FMDV carrier cattle and 48 vaccinated and 13 unvaccinated non-carrier cattle (total n=100) during the acute phase of infection (up to 28 days post-challenge) and then from limited number of animals up to a maximum 168 days post-challenge. We demonstrate that unvaccinated cattle excrete significantly higher levels of virus for longer periods compared with vaccinated cattle and this is independent of whether or not they subsequently become carriers. By introducing naive cattle in to the FMDV carrier population we show the risk of new outbreaks is clearly very low in controlled conditions, although there could still be a potential threat of these carrier animals causing new outbreaks in the field situation. Finally, we compared the complete genome sequences of viruses from carrier cattle with the challenge virus and found no evidence for viral determinants of the carrier state.	[Parthiban, Aravindh Babu R.; Mahapatra, Mana; Gubbins, Simon; Parida, Satya] Pirbright Inst, Pirbright GU24 0NF, Surrey, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Parida, S (corresponding author), Pirbright Inst, Ash Rd, Pirbright GU24 0NF, Surrey, England.	satya.parida@pirbright.ac.uk	Ibrahim, Essam Hassan/G-1960-2018; Parthiban, Aravindh Babu R./J-6966-2019; Parida, Satya/E-5463-2015	Ibrahim, Essam Hassan/0000-0003-0130-2257; Parthiban, Aravindh Babu R./0000-0001-9487-9017; Parida, Satya/0000-0001-8253-9461; Gubbins, Simon/0000-0003-0538-4173; Mahapatra, Mana/0000-0002-3977-1465	Department for Environment, Food and Rural Affairs (Defra) [SE1122, SE1125]; Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BBS/E/I/00001703, BBS/E/I/00001717, BBS/E/I/00001192, BBS/E/I/00001702] Funding Source: researchfish; BBSRC [BBS/E/I/00001702, BBS/E/I/00001703, BBS/E/I/00001717] Funding Source: UKRI	Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Department for Environment, Food and Rural Affairs (Defra) (grant numbers: SE1122 and SE1125) and carried out in facilities funded by the Biotechnology and Biological Sciences Research Council (BBSRC).	Alexandersen S, 2003, J COMP PATHOL, V129, P268, DOI 10.1016/S0021-9975(03)00045-8; Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Alexandersen S, 2002, MICROBES INFECT, V4, P1099, DOI 10.1016/S1286-4579(02)01634-9; Charleston B, 2011, SCIENCE, V332, P726, DOI 10.1126/science.1199884; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cox SJ, 2007, VACCINE, V25, P7687, DOI 10.1016/j.vaccine.2007.07.067; Cox SJ, 2006, VACCINE, V24, P3184, DOI 10.1016/j.vaccine.2006.01.037; Cox SJ, 2005, VACCINE, V23, P1106, DOI 10.1016/j.vaccine.2004.08.034; DAWE PS, 1994, VET REC, V134, P230, DOI 10.1136/vr.134.10.230; DAWE PS, 1994, VET REC, V134, P211, DOI 10.1136/vr.134.9.211; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; GEBAUER F, 1988, J VIROL, V62, P2041, DOI 10.1128/JVI.62.6.2041-2049.1988; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hanada K, 2004, MOL BIOL EVOL, V21, P1074, DOI 10.1093/molbev/msh109; Horsington J, 2007, VIRUS RES, V125, P114, DOI 10.1016/j.virusres.2006.12.008; Juleff N, 2013, J GEN VIROL, V94, P108, DOI 10.1099/vir.0.046029-0; Moonen P, 2000, VET QUART, V22, P193, DOI 10.1080/01652176.2000.9695056; Orsel K, 2007, VACCINE, V25, P6381, DOI 10.1016/j.vaccine.2007.06.010; Orsel K, 2005, VACCINE, V23, P4887, DOI 10.1016/j.vaccine.2005.05.014; Pacheco JM, 2010, VET J, V183, P46, DOI 10.1016/j.tvjl.2008.08.023; Parida S, 2007, VACCINE, V25, P7806, DOI 10.1016/j.vaccine.2007.08.058; Parida S, 2006, VACCINE, V24, P1107, DOI 10.1016/j.vaccine.2005.09.006; Parida S, 2005, VACCINE, V23, P5186, DOI 10.1016/j.vaccine.2005.06.012; Parida S, 2009, EXPERT REV VACCINES, V8, P347, DOI 10.1586/14760584.8.3.347; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quan M, 2004, J COMP PATHOL, V131, P294, DOI 10.1016/j.jcpa.2004.05.002; SALT JS, 1993, BRIT VET J, V149, P207, DOI 10.1016/S0007-1935(05)80168-X; Schley D, 2009, EPIDEMIOL INFECT, V137, P1494, DOI 10.1017/S0950268809002349; Steinway SN, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-284; Stenfeldt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106859; Stenfeldt C, 2012, VET MICROBIOL, V154, P230, DOI 10.1016/j.vetmic.2011.07.007; Sutmoller P, 2003, VIRUS RES, V91, P101, DOI 10.1016/S0168-1702(02)00262-9; Sutmoller P, 2002, REV SCI TECH OIE, V21, P519, DOI 10.20506/rst.21.3.1366; Sutmoller P, 2004, P EUFMD FAO CRETE, P1; Tenzin, 2008, RISK ANAL, V28, P303, DOI 10.1111/j.1539-6924.2008.01020.x; Thomson G., 1996, OIE COMPREHENSIVE RE, P87; Valdazo-Gonzalez B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049650; Zhang ZD, 2003, J VIROL METHODS, V111, P95, DOI 10.1016/S0166-0934(03)00165-4	39	43	43	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0128815	10.1371/journal.pone.0128815	http://dx.doi.org/10.1371/journal.pone.0128815			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110772	gold, Green Submitted, Green Published			2022-12-27	WOS:000356933800014
J	Pfortmueller, CA; Pauchard-Neuwerth, SE; Leichtle, AB; Fiedler, GM; Exadaktylos, AK; Lindner, G				Pfortmueller, Carmen Andrea; Pauchard-Neuwerth, Sandra Elisabeth; Leichtle, Alexander Benedikt; Fiedler, Georg Martin; Exadaktylos, Aristomenis Konstantinos; Lindner, Gregor			Primary Hyperventilation in the Emergency Department: A First Overview	PLOS ONE			English	Article							RESPONSES	Background Primary hyperventilation is defined as a state of alveolar ventilation in excess of metabolic requirements, leading to decreased arterial partial pressure of carbon dioxide. The primary aim of this study was to characterise patients diagnosed with primary hyperventilation in the ED. Methods Our retrospective cohort study comprised adult (>= 16 years) patients admitted to our ED between 1 January 2006 and 31 December 2012 with the primary diagnosis of primary (= psychogenic) hyperventilation. Results A total of 616 patients were eligible for study. Participants were predominantely female (341 [55.4%] female versus 275 [44.6%] male respectively, p < 0.01). The mean age was 36.5 years (SD 15.52, range 16-85). Patients in their twenties were the most common age group (181, 29.4%), followed by patients in their thirties (121, 19.6%). Most patients presented at out-of-office hours (331 [53.7%]. The most common symptom was fear (586, 95.1%), followed by paraesthesia (379, 61.5%) and dizziness (306, 49.7%). Almost a third (187, 30.4%) of our patients had previously experienced an episode of hyperventilation and half (311, 50.5%) of patients had a psychiatric co-morbidity. Conclusion Hyperventilation is a diagnostic chimera with a wide spectrum of symptoms. Patients predominantly are of young age, female sex and often have psychiatric comorbidities. The severity of symptoms accompanied with primary hyperventilation most often needs further work-up to rule out other diagnosis in a mostly young population. In the future, further prospective multicentre studies are needed to evaluate and establish clear diagnostic criteria for primary hyperventilation and possible screening instruments.	[Pfortmueller, Carmen Andrea] Med Univ Vienna, Dept Anesthesiol & Intens Care Med, Vienna, Austria; [Pauchard-Neuwerth, Sandra Elisabeth; Exadaktylos, Aristomenis Konstantinos; Lindner, Gregor] Univ Hosp Bern, Dept Emergency Med, CH-3010 Bern, Switzerland; [Pauchard-Neuwerth, Sandra Elisabeth; Exadaktylos, Aristomenis Konstantinos; Lindner, Gregor] Univ Bern, Bern, Switzerland; [Leichtle, Alexander Benedikt; Fiedler, Georg Martin] Univ Hosp Bern, Univ Inst Clin Chem, Inselspital, Ctr Lab Med, CH-3010 Bern, Switzerland; [Lindner, Gregor] Otto Wagner Hosp Vienna, Dept Resp & Crit Care Med, Vienna, Austria; [Lindner, Gregor] Ludwig Boltzmann Inst COPD & Resp Epidemiol, Vienna, Austria	Medical University of Vienna; University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; Ludwig Boltzmann Institute	Pfortmueller, CA (corresponding author), Med Univ Vienna, Dept Anesthesiol & Intens Care Med, Vienna, Austria.	cpfortmueller@gmail.com	Fiedler, Georg Martin/C-8341-2011; Leichtle, Alexander/C-7262-2011; Lindner, Gregor/AAR-6761-2020	Fiedler, Georg Martin/0000-0001-5689-4574; Lindner, Gregor/0000-0001-5551-8227; Pfortmueller, Carmen/0000-0003-0326-2770				Bass C, 1997, J PSYCHOSOM RES, V42, P421, DOI 10.1016/S0022-3999(96)00365-0; Bott J, 2009, THORAX, V64, P1, DOI 10.1136/thx.2008.110726; Gardner WN, 2004, AM J RESP CRIT CARE, V170, P105, DOI 10.1164/rccm.2405003; Gibson D, 2007, J ALTERN COMPLEM MED, V13, P39, DOI 10.1089/acm.2006.5283; Hoehn-Saric R, 2004, ARCH GEN PSYCHIAT, V61, P913, DOI 10.1001/archpsyc.61.9.913; Hornsveld HK, 1996, LANCET, V348, P154, DOI 10.1016/S0140-6736(96)02024-7; Jack S, 2004, AM J RESP CRIT CARE, V170, P118, DOI 10.1164/rccm.200207-720OC; Jones M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009041.pub2; Kerr W J, 1938, Cal West Med, V48, P12; LEWIS RA, 1986, B EUR PHYSIOPATH RES, V22, P201; Malmberg LP, 2000, THORAX, V55, P295, DOI 10.1136/thorax.55.4.295; ter Avest E, 2011, EMERG MED J, V28, P269, DOI 10.1136/emj.2009.084103	12	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0129562	10.1371/journal.pone.0129562	http://dx.doi.org/10.1371/journal.pone.0129562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110771	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800026
J	Pilotto, A; Panza, F; Copetti, M; Simonato, M; Sancarlo, D; Gallina, P; Strandberg, T				Pilotto, Alberto; Panza, Francesco; Copetti, Massimiliano; Simonato, Matteo; Sancarlo, Daniele; Gallina, Pietro; Strandberg, Timo		MPI AGE Project Investigators	Statin Treatment and Mortality in Community-Dwelling Frail Older Patients with Diabetes Mellitus: A Retrospective Observational Study	PLOS ONE			English	Article							MULTIDIMENSIONAL PROGNOSTIC INDEX; CHOLESTEROL; PREVENTION; VALIDATION; BENEFITS; WOMEN; RISK	Background Older adults are often excluded from clinical trials. Decision making for administration of statins to older patients with diabetes mellitus (DM) is under debate, particularly in frail older patients with comorbidity and high mortality risk. We tested the hypothesis that statin treatment in older patients with DM was differentially effective across strata of mortality risk assessed by the Multidimensional Prognostic Index (MPI), based on information collected with the Standardized Multidimensional Assessment Schedule for Adults and Aged Persons (SVaMA). Methods In this retrospective observational study, we estimated the mortality risk in 1712 community-dwelling subjects with DM >= 65 years who underwent a SVaMA evaluation to establish accessibility to homecare services/nursing home admission from 2005 to 2013 in the Padova Health District, Italy. Mild (MPI-SVaMA-1), moderate (MPI-SVaMA-2), and high (MPI-SVaMA-3) risk of mortality at baseline and propensity score-adjusted hazard ratios (HR) of three-year mortality were calculated according to statin treatment. Results Higher MPI-SVaMA scores were associated with lower rates of statin treatment (MPI-SVaMA-1 = 39% vs MPI-SVaMA-2 = 36% vs MPI-SVaMA-3 = 24.9%. p<0.001) and higher three-year mortality (MPI-SVaMA-1 = 12.9% vs MPI-SVaMA-2 = 24% vs MPI-SVaMA-3 = 34.4%, p<0.001). After adjustment for propensity score quintiles, statin treatment was significantly associated with lower three-year mortality irrespective of MPI-SVaMA group (interaction test p = 0.303). HRs [95% confidence interval (CI)] were 0.19 (0.14-0.27), 0.28 (0.21-0.36), and 0.26 (0.20-0.34) in the MPI-SVaMA-1, MPI-SVaMA-2, and MPI-SVaMA-3 groups, respectively. Subgroup analyses showed that statin treatment was also beneficial irrespective of age. HRs (95% CI) were 0.21 (0.15-0.31), 0.26 (0.20-0.33), and 0.26 (0.20-0.35) among patients aged 65-74, 75-84, and >= 85 years, respectively (interaction test p=0.812). Conclusions Statin treatment was significantly associated with reduced three-year mortality independently of age and multidimensional impairment in community-dwelling frail older patients with DM.	[Pilotto, Alberto] Natl Relevance & High Specializat Hosp, EO Galliera Hosp, Dept OrthoGeriatr Rehabil & Stabilizat, Frailty Area, Genoa, Italy; [Pilotto, Alberto; Simonato, Matteo] S Antonio Hosp, Geriatr Unit, Azienda ULSS Padova 16, Padua, Italy; [Panza, Francesco] Univ Bari Aldo Moro, Neurodegenerat Dis Unit, Dept Basic Med Neurosci & Sense Organs, Bari, Italy; [Panza, Francesco; Sancarlo, Daniele] IRCCS Casa Sollievo Sofferenza, Gerontol Geriatr Res Lab, San Giovanni Rotondo, Italy; [Copetti, Massimiliano] IRCCS Casa Sollievo Sofferenza, Biostat Unit, Foggia, Italy; [Gallina, Pietro] Hlth Directorate, Azienda ULSS 16, Padua, Italy; [Strandberg, Timo] Univ Helsinki, Dept Med, Geriatr Clin, Helsinki, Finland; [Strandberg, Timo] Univ Oulu, Inst Hlth Sci Geriatr, Oulu, Finland; [Strandberg, Timo] Oulu Univ, Oulu, Finland	Ente Ospedaliero Ospedali Galliera; ULSS 6 Euganea; Ospedale Sant'antonio Padova; Universita degli Studi di Bari Aldo Moro; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; University of Helsinki; University of Oulu; University of Oulu	Pilotto, A (corresponding author), Natl Relevance & High Specializat Hosp, EO Galliera Hosp, Dept OrthoGeriatr Rehabil & Stabilizat, Frailty Area, Genoa, Italy.	alberto.pilotto@galliera.it; geriat.dot@geriatria.uniba.it	Cruz-Jentoft, Alfonso J/G-2675-2015; Raso, Francesco Mattace-/L-2541-2015; Trifiro, Gianluca/K-9744-2016; Topinkova, Eva/A-5076-2019; Sancarlo, Daniele/C-1056-2017; Copetti, Massimiliano/K-3186-2016; Fontana, Andrea/J-8584-2016; Panza, Francesco/M-6804-2017; Panza, Francesco/Y-2539-2019; COPETTI, MASSIMILIANO/AAG-1473-2021	Cruz-Jentoft, Alfonso J/0000-0001-7628-4861; Trifiro, Gianluca/0000-0003-1147-7296; Topinkova, Eva/0000-0002-6786-4116; Sancarlo, Daniele/0000-0001-9541-6364; Copetti, Massimiliano/0000-0002-7960-5947; Fontana, Andrea/0000-0002-6660-5315; Panza, Francesco/0000-0002-7220-0656; Panza, Francesco/0000-0002-7220-0656; COPETTI, MASSIMILIANO/0000-0002-7960-5947; Welmer, Anna-Karin/0000-0001-5819-8724; Mattace-Raso, Francesco/0000-0002-1688-6497; strandberg, timo/0000-0001-6299-925X	MPI_AGE European project; Executive Agency for Health and Consumers (EAHC) of European Innovation Partnership on Active and Healthy Ageing Second Health Programme	MPI_AGE European project; Executive Agency for Health and Consumers (EAHC) of European Innovation Partnership on Active and Healthy Ageing Second Health Programme	Funding for this study was provided by the MPI_AGE European project co-funded by the Executive Agency for Health and Consumers (EAHC) in the frame of the European Innovation Partnership on Active and Healthy Ageing Second Health Programme 2008-2013.	Afilalo J, 2008, J AM COLL CARDIOL, V51, P37, DOI 10.1016/j.jacc.2007.06.063; Anglemyer A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000034.pub2; Culver AL, 2012, ARCH INTERN MED, V172, P144, DOI 10.1001/archinternmed.2011.625; Fontana L, 2013, AGING CELL, V12, P459, DOI 10.1111/acel.12068; Gnjidic D, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002333; Gray SL, 2012, J AM GERIATR SOC, V60, P2206, DOI 10.1111/jgs.12029; Jacobs JM, 2013, J AM MED DIR ASSOC, V14, P883, DOI 10.1016/j.jamda.2013.08.012; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; LaCroix AZ, 2008, J GERONTOL A-BIOL, V63, P369, DOI 10.1093/gerona/63.4.369; Lee DSH, 2014, JAMA INTERN MED, V174, P1263, DOI 10.1001/jamainternmed.2014.2266; Morley JE, 2013, J AM MED DIR ASSOC, V14, P853, DOI 10.1016/j.jamda.2013.09.016; Morley JE, 2011, J AM GERIATR SOC, V59, P1955, DOI 10.1111/j.1532-5415.2011.03594.x; Olafsdottir E, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000132; Parikh S, 2010, J GEN INTERN MED, V25, P1293, DOI 10.1007/s11606-010-1473-z; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pilotto A, 2008, REJUV RES, V11, P151, DOI 10.1089/rej.2007.0569; Pilotto A, 2013, J AM MED DIR ASSOC, V14, P287, DOI 10.1016/j.jamda.2013.01.005; Pilotto A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029090; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Ridker PM, 2012, LANCET, V380, P565, DOI 10.1016/S0140-6736(12)61190-8; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Savarese G, 2013, J AM COLL CARDIOL, V62, P2090, DOI 10.1016/j.jacc.2013.07.069; Siontis GCM, 2011, ARCH INTERN MED, V171, P1721, DOI 10.1001/archinternmed.2011.334; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Strandberg TE, 2007, LANCET, V369, P1328, DOI 10.1016/S0140-6736(12)62167-9; Strandberg TE, 2014, JAMA-J AM MED ASSOC, V312, P1136, DOI 10.1001/jama.2014.10924; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Yanovitzky I, 2005, EVAL PROGRAM PLANN, V28, P209, DOI 10.1016/j.evalprogplan.2005.01.004; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966	30	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130946	10.1371/journal.pone.0130946	http://dx.doi.org/10.1371/journal.pone.0130946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110884	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800101
J	Brashers-Krug, T; Jorge, R				Brashers-Krug, Tom; Jorge, Ricardo			Bi-Directional Tuning of Amygdala Sensitivity in Combat Veterans Investigated with fMRI	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MEDIAL PREFRONTAL CORTEX; SKIN-CONDUCTANCE RESPONSES; SCRIPT-DRIVEN IMAGERY; UNILATERAL TEMPORAL LOBECTOMY; POSITRON-EMISSION-TOMOGRAPHY; ANTERIOR CINGULATE CORTEX; TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; FEAR EXTINCTION	Objectives Combat stress can be followed by persistent emotional consequences. It is thought that these emotional consequences are caused in part by increased amygdala reactivity. It is also thought that amygdala hyper-reactivity results from decreased inhibition from portions of the anterior cingulate cortex (ACC) in which activity is negatively correlated with activity in the amygdala. However, experimental support for these proposals has been inconsistent. Methods We showed movies of combat and civilian scenes during a functional magnetic resonance imaging (fMRI) session to 50 veterans of recent combat. We collected skin conductance responses (SCRs) as measures of emotional arousal. We examined the relation of blood oxygenation-level dependent (BOLD) signal in the amygdala and ACC to symptom measures and to SCRs. Results Emotional arousal, as measured with SCR, was greater during the combat movie than during the civilian movie and did not depend on symptom severity. As expected, amygdala signal during the less-arousing movie increased with increasing symptom severity. Surprisingly, during the more-arousing movie amygdala signal decreased with increasing symptom severity. These differences led to the unexpected result that amygdala signal in highly symptomatic subjects was lower during the more-arousing movie than during the less-arousing movie. Also unexpectedly, we found no significant inverse correlation between any portions of the amygdala and ACC. Rather, signal throughout more than 80% of the ACC showed a strong positive correlation with signal throughout more than 90% of the amygdala. Conclusions Amygdala reactivity can be tuned bi-directionally, either up or down, in the same person depending on the stimulus and the degree of post-traumatic symptoms. The exclusively positive correlations in BOLD activity between the amygdala and ACC contrast with findings that have been cited as evidence for inhibitory control of the amygdala by the ACC. The conceptualization of post-traumatic changes in neural function should be reconsidered.	[Brashers-Krug, Tom] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA; [Brashers-Krug, Tom] Iowa City VA Healthcare Syst, Dept Psychiat, Iowa City, IA USA; [Jorge, Ricardo] Vet Affairs Med Ctr, Mental Hlth Serv Line, Houston, TX 77030 USA; [Jorge, Ricardo] Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baylor College of Medicine	Brashers-Krug, T (corresponding author), Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA.	tom.brashers-krug@va.gov			Mood and Anxiety Disorders Due to TBI among OIF/OEF Veterans, Veterans Administration Merit Award [1/01/08-1/01/11]	Mood and Anxiety Disorders Due to TBI among OIF/OEF Veterans, Veterans Administration Merit Award	Grant Support: Mood and Anxiety Disorders Due to TBI among OIF/OEF Veterans, Veterans Administration Merit Award 1/01/08-1/01/11 PI: RE Jorge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2010, NAT NEUROSCI, V13, P489, DOI 10.1038/nn.2499; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Berntson GG, 2007, SOC COGN AFFECT NEUR, V2, P123, DOI 10.1093/scan/nsm008; Berretta S, 2005, NEUROSCIENCE, V132, P943, DOI 10.1016/j.neuroscience.2005.01.020; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Bremner JD, 1997, ARCH GEN PSYCHIAT, V54, P246; Britton JC, 2005, BIOL PSYCHIAT, V57, P832, DOI 10.1016/j.biopsych.2004.12.025; Choi DC, 2010, P NATL ACAD SCI USA, V107, P2675, DOI 10.1073/pnas.0909359107; Christakou A., 2012, MOL PSYCHOL, P1; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Critchley HD, 2000, J NEUROSCI, V20, P3033; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Felmingham KL, 2009, PSYCHIAT RES-NEUROIM, V173, P59, DOI 10.1016/j.pscychresns.2008.12.005; Funayama ES, 2001, J COGNITIVE NEUROSCI, V13, P721, DOI 10.1162/08989290152541395; Gilboa A, 2004, BIOL PSYCHIAT, V55, P263, DOI 10.1016/j.biopsych.2003.08.004; Gilmartin MR, 2005, BEHAV NEUROSCI, V119, P1496, DOI 10.1037/0735-7044.119.6.1496; Glover EM, 2011, DEPRESS ANXIETY, V28, P1058, DOI 10.1002/da.20880; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hermans EJ, 2011, SCIENCE, V334, P1151, DOI 10.1126/science.1209603; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; Hou CL, 2007, BRAIN RES, V1144, P165, DOI 10.1016/j.brainres.2007.01.089; Hurley RA, 2000, J NEUROPSYCH CLIN N, V12, P421, DOI 10.1176/appi.neuropsych.12.4.421; Jaffee MS, 2009, J REHABIL RES DEV, V46, P655, DOI 10.1682/JRRD.2008.09.0114; Jovanovic T, 2012, NEUROPHARMACOLOGY, V62, P695, DOI 10.1016/j.neuropharm.2011.02.023; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; LABAR KS, 1995, J NEUROSCI, V15, P6846; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Lanius RA, 2004, AM J PSYCHIAT, V161, P36, DOI 10.1176/appi.ajp.161.1.36; Lanius RA, 2001, AM J PSYCHIAT, V158, P1920, DOI 10.1176/appi.ajp.158.11.1920; Lanius RA, 2010, J PSYCHIATR NEUROSCI, V35, P80, DOI 10.1503/jpn.090047; Lebron K, 2004, LEARN MEMORY, V11, P544, DOI 10.1101/lm.78604; Liberzon I, 1999, BIOL PSYCHIAT, V45, P817, DOI 10.1016/S0006-3223(98)00246-7; Likhtik E, 2005, J NEUROSCI, V25, P7429, DOI 10.1523/JNEUROSCI.2314-05.2005; Lm S, 1997, ARCH GEN PSYCHIAT, V54, P233; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Milad MR, 2008, J PSYCHIATR RES, V42, P515, DOI 10.1016/j.jpsychires.2008.01.017; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Oya H, 2002, J NEUROSCI, V22, P9502; Phan KL, 2003, NEUROPSYCHOPHARMACOL, V28, P1344, DOI 10.1038/sj.npp.1300186; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Pole N, 2007, PSYCHOL BULL, V133, P725, DOI 10.1037/0033-2909.133.5.725; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Reinert DF, 2002, ALCOHOL CLIN EXP RES, V26, P272, DOI 10.1111/j.1530-0277.2002.tb02534.x; Sakamoto H, 2005, NEUROIMAGE, V26, P813, DOI 10.1016/j.neuroimage.2005.02.032; Schmuckler MA, 2001, INFANCY, V2, P419, DOI 10.1207/S15327078IN0204_02; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shin L, 2005, FUNCTIONAL MAGNETIC, P1; Shin LM, 2009, J TRAUMA STRESS, V22, P409, DOI 10.1002/jts.20442; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Shin LM, 1999, AM J PSYCHIAT, V156, P575; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; SOLOMON RL, 1954, PSYCHOL REV, V61, P353, DOI 10.1037/h0054540; Stefanacci L, 2002, J COMP NEUROL, V451, P301, DOI 10.1002/cne.10339; TRANEL D, 1994, PSYCHOPHYSIOLOGY, V31, P427, DOI 10.1111/j.1469-8986.1994.tb01046.x; TRANEL D, 1989, NEUROPSYCHOLOGIA, V27, P381, DOI 10.1016/0028-3932(89)90046-8; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; van Wingen GA, 2011, MOL PSYCHIATR, V16, P664, DOI 10.1038/mp.2010.132; Williams LM, 2006, NEUROIMAGE, V29, P347, DOI 10.1016/j.neuroimage.2005.03.047	76	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130246	10.1371/journal.pone.0130246	http://dx.doi.org/10.1371/journal.pone.0130246			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26120848	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400035
J	Huai, DX; Zhang, YY; Zhang, CY; Cahoon, EB; Zhou, YM				Huai, Dongxin; Zhang, Yuanyuan; Zhang, Chunyu; Cahoon, Edgar B.; Zhou, Yongming			Combinatorial Effects of Fatty Acid Elongase Enzymes on Nervonic Acid Production in Camelina sativa	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; ARABIDOPSIS-THALIANA; LUNARIA-ANNUA; FAE1 GENE; EXPRESSION; OIL; BIOSYNTHESIS; PLANTS; BIOTECHNOLOGY; COMPLEMENTS	Very long chain fatty acids (VLCFAs) with chain lengths of 20 carbons and longer provide feedstocks for various applications; therefore, improvement of VLCFA contents in seeds has become an important goal for oilseed enhancement. VLCFA biosynthesis is controlled by a multi-enzyme protein complex referred to as fatty acid elongase, which is composed of beta-ketoacyl-CoA synthase (KCS), beta-ketoacyl-CoA reductase (KCR), beta-hydroxyacyl-CoA dehydratase (HCD) and enoyl reductase (ECR). KCS has been identified as the rate-limiting enzyme, but little is known about the involvement of other three enzymes in VLCFA production. Here, the combinatorial effects of fatty acid elongase enzymes on VLCFA production were assessed by evaluating the changes in nervonic acid content. A KCS gene from Lunaria annua (LaKCS) and the other three elongase genes from Arabidopsis thaliana were used for the assessment. Five seed-specific expressing constructs, including LaKCS alone, LaKCS with AtKCR, LaKCS with AtHCD, LaKCS with AtECR, and LaKCS with AtKCR and AtHCD, were transformed into Camelina sativa. The nervonic acid content in seed oil increased from null in wild type camelina to 6-12% in LaKCS-expressing lines. However, compared with that from the LaKCS-expressing lines, nervonic acid content in mature seeds from the co-expressing lines with one or two extra elongase genes did not show further increases. Nervonic acid content from LaKCS, AtKCR and AtHCD co-expressing line was significantly higher than that in LaKCS-expressing line during early seed development stage, while the ultimate nervonic acid content was not significantly altered. The results from this study thus provide useful information for future engineering of oilseed crops for higher VLCFA production.	[Huai, Dongxin; Zhang, Yuanyuan; Zhang, Chunyu; Cahoon, Edgar B.; Zhou, Yongming] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Huai, Dongxin; Zhang, Yuanyuan; Zhang, Chunyu; Cahoon, Edgar B.; Zhou, Yongming] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Huai, Dongxin; Cahoon, Edgar B.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE USA; [Huai, Dongxin; Cahoon, Edgar B.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA	Huazhong Agricultural University; Huazhong Agricultural University; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Cahoon, EB (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	ecahoon2@unl.edu; ymzhou@mail.hzau.edu.cn	Zhang, Chun-yu/HDP-5776-2022; zhang, yuanyuan/GYA-4428-2022		Ministry of Science and Technology of China [2014DFA32210]; Huazhong Agricultural University Scientific & Technological Self-innovation Foundation [2015RC010]; China Scholarship Council [2010676021]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Huazhong Agricultural University Scientific & Technological Self-innovation Foundation; China Scholarship Council(China Scholarship Council)	The Ministry of Science and Technology of China (grant 2014DFA32210) (http://www.istcp.org.cn/) to YZ, Huazhong Agricultural University Scientific & Technological Self-innovation Foundation (Program No. 2015RC010)(http://kjc.hzau.edu.cn/) to EC, China Scholarship Council grant 2010676021 (http://www.csc.edu.cn/) to DH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amminger GP, 2012, MOL PSYCHIATR, V17, P1150, DOI 10.1038/mp.2011.167; Bach L, 2008, P NATL ACAD SCI USA, V105, P14727, DOI 10.1073/pnas.0805089105; Beaudoin F, 2009, PLANT PHYSIOL, V150, P1174, DOI 10.1104/pp.109.137497; BRAMM A, 1990, LANDBAUFORSCH VOLK, V40, P107; Cahoon EB, 2000, PLANT PHYSIOL, V124, P243, DOI 10.1104/pp.124.1.243; Cahoon EB, 2014, ANN M EXH 2014 JUL 2; Cahoon EB, 2006, PHYTOCHEMISTRY, V67, P1166, DOI 10.1016/j.phytochem.2006.04.013; Carlsson AS, 2014, BIOCATAL AGRIC BIOTE, V3, P58, DOI 10.1016/j.bcab.2013.12.007; CASSAGNE C, 1994, PROG LIPID RES, V33, P55, DOI 10.1016/0163-7827(94)90009-4; Dingess K, 2014, FASEB J, V28; FEHLING E, 1991, BIOCHIM BIOPHYS ACTA, V1082, P239, DOI 10.1016/0005-2760(91)90198-Q; Gugel RK, 2006, CAN J PLANT SCI, V86, P1047, DOI 10.4141/P04-081; Guo YM, 2009, PLANT MOL BIOL, V69, P565, DOI 10.1007/s11103-008-9439-9; Gutierrez RA, 1999, TRENDS PLANT SCI, V4, P429, DOI 10.1016/S1360-1385(99)01484-3; Han JX, 2001, PLANT MOL BIOL, V46, P229, DOI 10.1023/A:1010665121980; Haslam TM, 2013, PLANT SCI, V210, P93, DOI 10.1016/j.plantsci.2013.05.008; Horn PJ, 2013, PLANT J, V76, P138, DOI 10.1111/tpj.12278; Iskandarov U., 2014, PLANTS AND BIOENERGY, VVolume 4, P131; JAMES DW, 1995, PLANT CELL, V7, P309, DOI 10.2307/3869853; Joubes J, 2008, PLANT MOL BIOL, V67, P547, DOI 10.1007/s11103-008-9339-z; Katavic V, 2001, CROP SCI, V41, P739, DOI 10.2135/cropsci2001.413739x; Katz L, 2003, GENOME RES, V13, P2042, DOI 10.1101/gr.1257503; Kim J, 2013, PLANT PHYSIOL, V162, P567, DOI 10.1104/pp.112.210450; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Kunst L, 2003, PROG LIPID RES, V42, P51, DOI 10.1016/S0163-7827(02)00045-0; Lange W, 2000, AIRCT931817; Lassner MW, 1996, PLANT CELL, V8, P281, DOI 10.1105/tpc.8.2.281; Lu CF, 2008, PLANT CELL REP, V27, P273, DOI 10.1007/s00299-007-0454-0; Lu CF, 2011, CURR OPIN BIOTECH, V22, P252, DOI 10.1016/j.copbio.2010.11.006; Lu Y, 1996, P NATL ACAD SCI USA, V93, P14462, DOI 10.1073/pnas.93.25.14462; Mastebroek HD, 2000, IND CROP PROD, V11, P139, DOI 10.1016/S0926-6690(99)00056-4; Mietkiewska E, 2004, PLANT PHYSIOL, V136, P2665, DOI 10.1104/pp.104.046839; Mietkiewska E, 2007, PLANT SCI, V173, P198, DOI 10.1016/j.plantsci.2007.05.001; Mietkiewska E, 2007, PLANT BIOTECHNOL J, V5, P636, DOI 10.1111/j.1467-7652.2007.00268.x; Millar AA, 1997, PLANT J, V12, P121, DOI 10.1046/j.1365-313X.1997.12010121.x; Nguyen HT, 2014, PLANT BIOTECHNOLOGY; Nguyen HT, 2013, PLANT BIOTECHNOL J, V11, P759, DOI 10.1111/pbi.12068; Ntoumani E, 2013, PROSTAG LEUKOTR ESS, V89, P241, DOI 10.1016/j.plefa.2013.06.005; Piazza GJ, 2001, EUR J LIPID SCI TECH, V103, P450; Pilgeram A.L., 2007, ISSUES NEW CROPS NEW; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Sala-Vila A, 2004, J NUTR, V134, P868, DOI 10.1093/jn/134.4.868; SARGENT JR, 1994, MED HYPOTHESES, V42, P237, DOI 10.1016/0306-9877(94)90122-8; Sonntag N, 1995, IND UTILIZATION LONG, P339; Suzuki Y, 2004, BIOTECHNIQUES, V37, P542, DOI 10.2144/04374BM03; Tanaka K, 2007, BRAIN DEV-JPN, V29, P586, DOI 10.1016/j.braindev.2007.02.005; Tang TF, 2013, IND CROP PROD, V43, P1, DOI 10.1016/j.indcrop.2012.07.003; Taylor DC, 2009, PLANT BIOTECHNOL J, V7, P925, DOI 10.1111/j.1467-7652.2009.00454.x; Umemoto H, 2014, J OLEO SCI, V63, P671, DOI 10.5650/jos.ess14029; VONWETTSTEINKNOWLES P, 1982, PHYSIOL VEG, V20, P797; Wang X-Y, 2005, CHINA OILS FATS, V9; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Zhang YY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00343; Zheng HQ, 2005, PLANT CELL, V17, P1467, DOI 10.1105/tpc.104.030155	54	31	34	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131755	10.1371/journal.pone.0131755	http://dx.doi.org/10.1371/journal.pone.0131755			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121034	gold, Green Published			2022-12-27	WOS:000358150400153
J	Liao, MZ; Wang, M; Shen, XJ; Huang, PX; Yang, XG; Hao, LZ; Cox, C; Wu, PS; Tao, XR; Kang, DM; Jia, YJ				Liao, Meizhen; Wang, Mei; Shen, Xingjie; Huang, Pengxiang; Yang, Xingguang; Hao, Lianzheng; Cox, Catherine; Wu, Pingsheng; Tao, Xiaorun; Kang, Dianmin; Jia, Yujiang			Bisexual Behaviors, HIV Knowledge, and Stigmatizing/Discriminatory Attitudes among Men Who Have Sex with Men	PLOS ONE			English	Article							STIGMA; PREVALENCE; INFECTION; EPIDEMIC; WOMEN	Objective To assess the correlates for bisexual behaviors, HIV knowledge, and HIV/AIDS-related stigmatizing/discriminatory attitudes among men who have sex with men (MSM). Methods A cross-sectional survey among MSM was conducted in 2011 to provide demographics, sexual behaviors, HIV knowledge, HIV/AIDS-related stigmatizing/discriminatory attitudes, and services in Jinan, Qingdao, and Yantai of Shandong Province of China. Results Of 1230 participants, 82.8% were single, 85.7% aged <35 years, and 47.2% received college or higher education. There were 28.6% MSM who reported to be married or cohabitating or ever had sex with woman in the past 6 months (P6M). 74.5% had >= 6 HIV-related knowledge score. The average total score of stigmatizing/discriminatory attitude was 37.4 +/- 4.4(standard deviation). Bisexual behavior was independently associated with higher levels of HIV/AIDS-related stigma/discrimination(AOR = 1.1, 95% CI:1.0-1.1), older age (AOR = 1.2, 95% CI:1.1-1.2), and lower HIV-related knowledge score(AOR = 1.6, 95% CI:1.2-2.2). HIV knowledge score >= 6 was independently associated with lower levels of HIV/AIDS-related stigma/discrimination(AOR = 1.3, 95% CI:1.2-1.3), less bisexual behaviors( AOR = 0.6, 95% CI:0.5-0.9), ever received a test for HIV in the past 12 months (P12M) (AOR = 3.2, 95% CI:2.3-4.5), college or higher level education(AOR = 1.9, 95% CI:1.4-2.6), consistent condom use with men in P6M(AOR=6.9, 95% CI:4.6-10.6), recruited from internet or HIV testing sites(AOR = 11.2, 95% CI:8.0-16.1) and bars, night clubs, or tea houses(AOR = 2.5, 95% CI:1.7-4.8). Expressing higher levels of HIV/AIDS-related stigmatizing/discriminatory attitudes was independently associated with bisexual behaviors(A beta = 0.9, 95% CI:0.4-1.4), lower HIV-related knowledge score(A beta = 3.6, 95% CI:3.0-4.1), the number of male sex partners in the past week >= 2(A beta = 1.4, 95% CI:1.0-1.9), unprotected male anal sex in P6M(A beta = 1.0, 95% CI:0.5-1.6), and inversely associated with ever received HIV test(A beta = 1.4, 95% CI:0.8-2.0) and peer education in P12M(A beta = 1.4, 95% CI:0.9-1.9). Conclusion HIV/AIDS-related stigmatizing/discriminatory attitudes were associated with bisexual behaviors, low HIV testing rate, lower HIV-related knowledge and risk behaviors. This study called for innovative programs that would reduce HIV/AIDS-related stigmatizing/discriminatory attitudes and bisexual behaviors and improve the uptake of prevention service among MSM.	[Liao, Meizhen; Wang, Mei; Huang, Pengxiang; Yang, Xingguang; Hao, Lianzheng; Tao, Xiaorun; Kang, Dianmin] Inst AIDS STD Control & Prevent, Jinan 250014, Shandong, Peoples R China; [Liao, Meizhen; Wang, Mei; Huang, Pengxiang; Yang, Xingguang; Hao, Lianzheng; Tao, Xiaorun; Kang, Dianmin] Shandong Key Lab Epidem Dis Control & Prevent, Shandong CDC, Jinan 250014, Shandong, Peoples R China; [Shen, Xingjie] Shandong Univ, Jinan Cent Hosp Affiliated, Jinan 250014, Shandong, Peoples R China; [Cox, Catherine] Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA; [Wu, Pingsheng] Vanderbilt Univ, Dept Biostat, Nashville, TN 37232 USA; [Jia, Yujiang] Vanderbilt Univ, Dept Hlth Policy, Nashville, TN 37232 USA	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University System of Maryland; University of Maryland College Park; Vanderbilt University; Vanderbilt University	Kang, DM (corresponding author), Inst AIDS STD Control & Prevent, Jinan 250014, Shandong, Peoples R China.	dmkang@sohu.com; jiayj@aol.com			Development of Medical Science and Technology Project of Shandong Province [2013WS0160]	Development of Medical Science and Technology Project of Shandong Province	This study was supported for data collection and analysis and decision to publish by The Development of Medical Science and Technology Project of Shandong Province (#2013WS0160).	Bharat S, 2011, SAHARA J-J SOC ASP H, V8, P138, DOI 10.1080/17290376.2011.9724996; Carr D, 2010, SCALING RESPONSE HIV; China CDC, 2012, NAT BEH BIOL SURV RE; Dias SF, 2006, AIDS CARE, V18, P208, DOI 10.1080/09540120500456177; Genberg BL, 2008, AIDS BEHAV, V12, P772, DOI 10.1007/s10461-007-9340-6; Genberg BL, 1982, SOC SCI MED, V68, P2279; Grossman A H, 1991, J Assoc Nurses AIDS Care, V2, P28; He Q, 2006, AIDS BEHAV, V10, pS17, DOI 10.1007/s10461-006-9125-3; Huang DY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/174870; Jia Yujiang, 2014, Biomed Res Int, V2014, P497543, DOI 10.1155/2014/497543; Khan SI, 2005, CULT HEALTH SEX, V7, P159, DOI 10.1080/13691050412331321258; Lau JTF, 2008, SEX TRANSM DIS, V35, P406, DOI 10.1097/OLQ.0b013e318164467f; Letamo G, 2003, J HEALTH POPUL NUTR, V21, P347; Li XF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/563517; Li XF, 2012, AIDS BEHAV, V16, P499, DOI 10.1007/s10461-012-0161-x; Liao MZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/143738; Liao MZ, 2011, AIDS PATIENT CARE ST, V25, P683, DOI 10.1089/apc.2010.0371; Ma W, 2007, AIDS, V21, pS129, DOI 10.1097/01.aids.0000304708.64294.3f; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Ministry of Health and Joint United Nations Programme on HIV/AIDS, 2012, 2011 EST HIV AIDS EP; Ross MW, 2003, SEX TRANSM DIS, V30, P110, DOI 10.1097/00007435-200302000-00003; Shandong CDC, 2014, SHAND PROV BEH BIOL; Ti L, 2004, HARM REDUCT J, V10, P20; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; Wei CY, 2009, AM J PUBLIC HEALTH, V99, P1978, DOI 10.2105/AJPH.2008.150037; Wu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098366; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; Zeng YL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/498987; Zhang Bing, 2002, Computer Integrated Manufacturing Systems, V8, P197	29	13	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130866	10.1371/journal.pone.0130866	http://dx.doi.org/10.1371/journal.pone.0130866			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1BL	26121250	Green Submitted, Green Published, gold			2022-12-27	WOS:000358150400065
J	Roberts, SE; Thorne, K; Akbari, A; Samuel, DG; Williams, JG				Roberts, Stephen E.; Thorne, Kymberley; Akbari, Ashley; Samuel, David G.; Williams, John G.			Mortality following Stroke, the Weekend Effect and Related Factors: Record Linkage Study	PLOS ONE			English	Article							IN-HOSPITAL MORTALITY; ADMISSION; WEEKDAY; CARE; CENTERS; QUALITY; TIME; PATTERNS; ENGLAND; COHORT	Background Increased mortality following hospitalisation for stroke has been reported from many but not all studies that have investigated a 'weekend effect' for stroke. However, it is not known whether the weekend effect is affected by factors including hospital size, season and patient distance from hospital. Objective To assess changes over time in mortality following hospitalisation for stroke and how any increased mortality for admissions on weekends is related to factors including the size of the hospital, seasonal factors and distance from hospital. Methods A population study using person linked inpatient, mortality and primary care data for stroke from 2004 to 2012. The outcome measures were, firstly, mortality at seven days and secondly, mortality at 30 days and one year. Results Overall mortality for 37 888 people hospitalised following stroke was 11.6% at seven days, 21.4% at 30 days and 37.7% at one year. Mortality at seven and 30 days fell significantly by 1.7% and 3.1% per annum respectively from 2004 to 2012. When compared with week days, mortality at seven days was increased significantly by 19% for admissions on weekends, although the admission rate was 21% lower on weekends. Although not significant, there were indications of increased mortality at seven days for weekend admissions during winter months (31%), in community (81%) rather than large hospitals (8%) and for patients resident furthest from hospital (32% for distances of > 20 kilometres). The weekend effect was significantly increased (by 39%) for strokes of 'unspecified' subtype. Conclusions Mortality following stroke has fallen over time. Mortality was increased for admissions at weekends, when compared with normal week days, but may be influenced by a higher stroke severity threshold for admission on weekends. Other than for unspecified strokes, we found no significant variation in the weekend effect for hospital size, season and distance from hospital.	[Roberts, Stephen E.; Thorne, Kymberley; Akbari, Ashley; Samuel, David G.; Williams, John G.] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Samuel, David G.] West Wales Gen Hosp, Carmarthen, Dyfed, Wales	Swansea University	Roberts, SE (corresponding author), Swansea Univ, Coll Med, Swansea, W Glam, Wales.	stephen.e.roberts@swansea.ac.uk	Carter, Kymberley/E-4038-2013	Carter, Kymberley/0000-0003-0691-6282; Akbari, Ashley/0000-0003-0814-0801	Wellcome Trust [093564/Z/10/Z]; Medical Research Council [MR/K006525/1] Funding Source: researchfish; MRC [MR/K006525/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust [Grant No: 093564/Z/10/Z]. The views expressed in this paper are those of the authors and not those of the funding body. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albright KC, 2012, CEREBROVASC DIS, V34, P424, DOI 10.1159/000345077; Bejot Y, 2013, EUR J NEUROL, V20, P1177, DOI 10.1111/ene.12154; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Bray BD, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001705; Campbell JTP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087946; Clarke MS, 2010, INTERN MED J, V40, P777, DOI 10.1111/j.1445-5994.2009.02067.x; Communities and Local Government, ENGL IND DEPR 2010; Concha OP, 2014, BMJ QUAL SAF, V23, P215, DOI 10.1136/bmjqs-2013-002218; Crowley RW, 2009, STROKE, V40, P2387, DOI 10.1161/STROKEAHA.108.546572; ELLIOT AJ, 2005, J PUBLIC HLTH OXF, V30, P91; Fleming DM, 2005, EPIDEMIOL INFECT, V133, P255, DOI 10.1017/S0950268804003231; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Goddard AF, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e67; Hoh BL, 2010, STROKE, V41, P2323, DOI 10.1161/STROKEAHA.110.591081; Intercollegiate Stroke Working Party, 2012, NAT CLIN GUID STROK; Janszky I, 2007, STROKE, V38, pE94, DOI 10.1161/STROKEAHA.107.491449; Jauss M, 2010, EUR J NEUROL, V17, P555, DOI 10.1111/j.1468-1331.2009.02845.x; Kazley AS, 2010, ARCH NEUROL-CHICAGO, V67, P39, DOI 10.1001/archneurol.2009.286; Kwok Chun Shing, 2014, BMC Res Notes, V7, P342, DOI 10.1186/1756-0500-7-342; Lopman BA, 2003, EMERG INFECT DIS, V9, P71; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; McAllister DA, 2013, PRIM CARE RESP J, V22, P296, DOI 10.4104/pcrj.2013.00066; McKinney JS, 2011, STROKE, V42, P2403, DOI 10.1161/STROKEAHA.110.612317; Niewada M, 2012, NEUROL NEUROCHIR POL, V46, P15, DOI 10.5114/ninp.2012.27209; O'Brien EC, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/383012; Ogbu UC, 2011, J NEUROL NEUROSUR PS, V82, P8, DOI 10.1136/jnnp.2009.202176; Palmer WL, 2012, ARCH NEUROL-CHICAGO, V69, P1296, DOI 10.1001/archneurol.2012.1030; Roberts SE, 2011, FRONTLINE GASTROENTE, V2, P153, DOI 10.1136/fg.2009.000208; Royal College of Physicians, 2013, STROK IMPR NAT AUD P; Royal College of Physicians Intercollegiate Stroke Working Party, 2011, NAT SENT STROK CLIN; Rudd AG, 2007, AGE AGEING, V36, P247, DOI 10.1093/ageing/afm007; Saposnik G, 2007, STROKE, V38, P1211, DOI 10.1161/01.STR.0000259622.78616.ea; Schilling PL, 2010, MED CARE, V48, P224, DOI 10.1097/MLR.0b013e3181c162c0; Schneider EB, 2012, J SURG RES, V177, P295, DOI 10.1016/j.jss.2012.06.022; Simonsen SA, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0065-z; Welsh Assembly Government, MIGR STAT WAL 2011; Welsh Assembly Government, WELSH IND MULT DEPR	37	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131836	10.1371/journal.pone.0131836	http://dx.doi.org/10.1371/journal.pone.0131836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121338	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400165
J	Yang, QC; Meng, FZ; Li, K; Wang, T; Nie, QY; Che, Z; Liu, M; Sun, Y; Zhao, L				Yang, Quancheng; Meng, Fanzheng; Li, Kai; Wang, Tong; Nie, Qingyuan; Che, Zi; Liu, Min; Sun, Yan; Zhao, Lin			Safety and Efficacy of Thermal Ablation for Small Renal Masses in Solitary Kidney: Evidence from Meta-Analysis of Comparative Studies	PLOS ONE			English	Article							LAPAROSCOPIC PARTIAL NEPHRECTOMY; RADIOFREQUENCY ABLATION; FUNCTIONAL OUTCOMES; ONCOLOGIC OUTCOMES; CRYOABLATION; TUMORS; IMPACT	Objective To evaluate comparative renal functional preservation, perioperative and oncologic outcomes, and complications of thermal ablation (TA) versus partial nephrectomy (PN) in management of Small renal masses (SRMs) in solitary kidney. Methods and Findings Medline, Embase, Web of Science and the Cochrane Library were systematically searched. A meta-analysis for comparative studies comparing TA with PN was performed. According to predefined inclusion criteria, seven datasets were identified from 8 observational studies including a total of 628 patients. Cumulated data showed the changes of creatinine (p=0.02) and estimated glomerular filtration rate (eGFR) (p<0.0001) in TA arm were significantly less than these in PN arm. Significantly less new-set chronic kidney disease (CKD) was observed in TA group (p=0.04). In terms of postoperative dialysis rate, the difference favoring TA was also noted, though there is no statistical significance (p=0.09). With regard to perioperative outcomes, our data demonstrated that patients who underwent TA had significantly shorter operation time (p=0.002), less blood loss (p<0.0001), shorter length of stay (p<0.00001), and less transfusion rate (p=0.01) than those underwent PN. In addition, patients underwent TA suffered less intra- and postoperative complications (p=0.007, p<0.00001; respectively). With regard to oncologic outcomes, disease-free survival (DFS) (p<0.00001) and cancer-specific survival (CSS) (p=0.01) in the PN arm were significantly better than these of the TA arm. But, TA yielded a comparable overall survival to PN (p=0.40). Sensitivity analyses led to very similar results with overall results, and confirmed its stability. Conclusions Our analysis indicates that PN have advantage in controlling cancer recurrence. However, TA is associated with significantly better renal functional preservation and perioperative outcomes, and less complications without increasing overall death. Our data suggest that indication for TA may be extended to select younger, healthier patients who desire a much less invasive therapeutic option.	[Yang, Quancheng; Wang, Tong; Nie, Qingyuan; Che, Zi; Liu, Min] Cent Hosp Zibo, Dept Urol, Zibo, Peoples R China; [Meng, Fanzheng] Tianjin Med Univ, Tianjin Nankai Hosp, Dept Neurol, Tianjin, Peoples R China; [Li, Kai] Tianjin Third Cent Hosp, Dept Urol, Tianjin, Peoples R China; [Sun, Yan] Cent Hosp Zibo, Dept Pharm, Zibo, Peoples R China; [Zhao, Lin] Tianjin Med Univ, Int Med Sch, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Yang, QC (corresponding author), Cent Hosp Zibo, Dept Urol, Zibo, Peoples R China.	quanchengyang_uro@163.com; manwumudi705@163.com						Campbell S C, 1995, Semin Urol Oncol, V13, P281; Campbell SC, 2009, J UROLOGY, V182, P1271, DOI 10.1016/j.juro.2009.07.004; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goyal J, 2011, KOREAN J UROL, V52, P384, DOI 10.4111/kju.2011.52.6.384; Haber GP, 2012, BJU INT, V109, P118, DOI 10.1111/j.1464-410X.2011.10287.x; Handoll HH, 2006, ARCH PHYS MED REHAB, V87, P875, DOI 10.1016/j.apmr.2006.04.006; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hruby G, 2006, UROLOGY, V67, P50, DOI 10.1016/j.urology.2005.07.031; Kane CJ, 2008, CANCER, V113, P78, DOI 10.1002/cncr.23518; Klatte T, 2011, EUR UROL, V60, P435, DOI 10.1016/j.eururo.2011.05.002; Kunkle DA, 2008, CANCER, V113, P2671, DOI 10.1002/cncr.23896; La Rochelle J, 2009, J UROLOGY, V181, P2037, DOI 10.1016/j.juro.2009.01.024; Lane BR, 2008, J UROLOGY, V179, P847, DOI 10.1016/j.juro.2007.10.050; Lane BR, 2011, J UROLOGY, V185, P421, DOI 10.1016/j.juro.2010.09.131; Ljungberg B, 2015, EUR UROL, V67, P913, DOI 10.1016/j.eururo.2015.01.005; Matsumoto ED, 2005, UROLOGY, V65, P877, DOI 10.1016/j.urology.2004.12.011; McKiernan J, 2002, UROLOGY, V60, P1003, DOI 10.1016/S0090-4295(02)01967-2; Mitchell CR, 2011, J UROLOGY, V186, P1786, DOI 10.1016/j.juro.2011.07.036; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mottrie A, 2010, EUR UROL, V58, P127, DOI 10.1016/j.eururo.2010.03.045; Mues AC, 2012, J ENDOUROL, V26, P1361, DOI 10.1089/end.2012.0114; Nisbet AA, 2009, J ENDOUROL, V23, P431, DOI 10.1089/end.2008.0228; Olweny EO, 2012, EUR UROL, V61, P1156, DOI 10.1016/j.eururo.2012.01.001; Panumatrassamee K, 2013, J UROLOGY, V189, P818, DOI 10.1016/j.juro.2012.09.075; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Raman JD, 2010, BJU INT, V105, P496, DOI 10.1111/j.1464-410X.2009.08776.x; Stern JM, 2007, BJU INT, V100, P287, DOI 10.1111/j.1464-410X.2007.06937.x; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thompson RH, 2008, J UROLOGY, V179, P468, DOI 10.1016/j.juro.2007.09.077; Turna B, 2009, J UROLOGY, V182, P2150, DOI 10.1016/j.juro.2009.07.066; Varkarakis IM, 2005, J UROLOGY, V174, P456, DOI 10.1097/01.ju.0000165655.91152.c5; Wells GA., 2015, NEWCASTLE OTTAWA SCA	33	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131290	10.1371/journal.pone.0131290	http://dx.doi.org/10.1371/journal.pone.0131290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121336	Green Published, Green Submitted, gold			2022-12-27	WOS:000358150400093
J	den Hertog, AL; Montero-Martin, M; Saunders, RL; Blakiston, M; Menting, S; Sherchand, JB; Lawson, L; Oladimeji, O; Abdurrahman, ST; Cuevas, LE; Anthony, RM				den Hertog, Alice L.; Montero-Martin, Maria; Saunders, Rachel L.; Blakiston, Matthew; Menting, Sandra; Sherchand, Jeevan B.; Lawson, Lovett; Oladimeji, Olanrewaju; Abdurrahman, Saddiq T.; Cuevas, Luis E.; Anthony, Richard M.			Cytokine Kinetics in the First Week of Tuberculosis Therapy as a Tool to Confirm a Clinical Diagnosis and Guide Therapy	PLOS ONE			English	Article							IFN-GAMMA; BIOMARKERS; EFFICACY; CULTURE; DISEASE	Background Many patients treated for tuberculosis (TB) in low and middle income countries are treated based on clinical suspicion without bacteriological confirmation. This is often due to lack of rapid simple accurate diagnostics and low healthcare provider confidence in the predictive value of current tests. We previously reported in an animal TB model that levels of host markers rapidly change in response to treatment initiation. Methods We assessed the potential of host biomarker kinetics of TB patients during the first two weeks of therapy to identify patients responding to treatment. Adult patients clinically diagnosed with and treated for TB, 29 in Nigeria and 24 in Nepal, were analyzed. Results Changes in concentrations of non-specific host biomarkers, particularly IP-10, in response to the first week of anti-TB therapy were strongly associated with bacteriological confirmation of TB. A decrease in IP-10 level of > 300pg/ml between 0 and 7 days of treatment identified 75% of both smear-positive and smear-negative culture positive patients and correctly excluded TB in all nine culture negative patients. Conclusions Monitoring of early IP-10 responses to treatment could form the basis of a simplified assay and could help identify patients who were erroneously clinically diagnosed with TB or those infected with drug resistant strains on inappropriate treatment. We believe this approach may be particularly appropriate for difficult to diagnose patients, e.g. smear-negative HIV-positive, or those with extra-pulmonary TB, often treated without bacterial confirmation.	[den Hertog, Alice L.; Menting, Sandra; Anthony, Richard M.] Royal Trop Inst KIT, KIT Biomed Res, Amsterdam, Netherlands; [Montero-Martin, Maria; Saunders, Rachel L.; Blakiston, Matthew; Cuevas, Luis E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Sherchand, Jeevan B.] Tribhuvan Univ, Inst Med, Kathmandu, Nepal; [Lawson, Lovett; Oladimeji, Olanrewaju] Zankli Med Ctr, Abuja, Nigeria; [Abdurrahman, Saddiq T.] Abuja Fed Capital Terr TB Control Programme, Abuja, Nigeria	Liverpool School of Tropical Medicine; University of Liverpool; Tribhuvan University; Institute of Medicine (IoM) - Nepal	den Hertog, AL (corresponding author), Royal Trop Inst KIT, KIT Biomed Res, Amsterdam, Netherlands.	a.d.hertog@kit.nl	Oladimeji, Olanrewaju/AAE-9633-2019; Anthony, Richard/AAP-3406-2020; Cuevas, Luis E/I-3697-2015	Oladimeji, Olanrewaju/0000-0002-5356-901X; Anthony, Richard/0000-0002-0550-5273; Cuevas, Luis E/0000-0002-6581-0587	LSTM bench fee awards; wave 2 WHO TB REACH award; Top Institute Pharma project [T4-303]; FIND	LSTM bench fee awards; wave 2 WHO TB REACH award; Top Institute Pharma project; FIND	The study was partly funded by LSTM bench fee awards for MSc dissertations for MMM, RS and MB, a wave 2 WHO TB REACH award to the Federal Capital Territory Tuberculosis and Leprosy Control Programme (FCT-TBLCP), Top Institute Pharma project T4-303, and FIND. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TB TREATM GUID; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Bothamley GH, 2004, CLIN DIAGN LAB IMMUN, V11, P942, DOI 10.1128/CDLI.11.5.942-951.2004; Chowdhury IH, 2014, MOL IMMUNOL, V62, P159, DOI 10.1016/j.molimm.2014.06.002; Dartois V, 2013, BIOORG MED CHEM LETT, V23, P4741, DOI 10.1016/j.bmcl.2013.07.006; den Hertog AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057997; den Hertog AL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002207; Djoba Siawaya JF, 2009, CLIN EXP IMMUNOL, V156, P69, DOI 10.1111/j.1365-2249.2009.03875.x; Donald PR, 2008, TUBERCULOSIS, V88, pS75, DOI 10.1016/S1472-9792(08)70038-6; Honeyborne I, 2014, J CLIN MICROBIOL, V52, P3064, DOI 10.1128/JCM.01128-14; Hong JY, 2014, J INFECTION, V68, P252, DOI 10.1016/j.jinf.2013.09.033; Hong JY, 2012, INT J INFECT DIS, V16, pE855, DOI 10.1016/j.ijid.2012.07.013; Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Mattos AMM, 2010, INT IMMUNOL, V22, P775, DOI 10.1093/intimm/dxq429; Mihret A, 2013, J INFECTION, V66, P357, DOI 10.1016/j.jinf.2012.11.005; Riou C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102178; Riou C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036886; Sousa AO, 2000, TUBERCLE LUNG DIS, V80, P27, DOI 10.1054/tuld.1999.0230; Theron G, 2014, LANCET INFECT DIS, V14, P527, DOI 10.1016/S1473-3099(13)70360-8; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Walzl G, 2008, J INFECTION, V57, P103, DOI 10.1016/j.jinf.2008.06.007; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; World Health Organization, 2014, GLOBAL TUBERCULOSIS; Yakhelef N, 2014, INT J TUBERC LUNG D, V18, P541, DOI 10.5588/ijtld.13.0630	25	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129552	10.1371/journal.pone.0129552	http://dx.doi.org/10.1371/journal.pone.0129552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115421	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000358147500029
J	Jakobs, C; Perner, S; Hornung, V				Jakobs, Christopher; Perner, Sven; Hornung, Veit			AIM2 Drives Joint Inflammation in a Self-DNA Triggered Model of Chronic Polyarthritis	PLOS ONE			English	Article							AICARDI-GOUTIERES SYNDROME; CYTOPLASMIC DNA; HOST DEFENSES; CYTOSOLIC DNA; CELL-DEATH; ACTIVATION; ARTHRITIS; RECOGNITION; DEGRADATION; MACROPHAGES	Mice lacking DNase II display a polyarthritis-like disease phenotype that is driven by translocation of self-DNA into the cytoplasm of phagocytic cells, where it is sensed by pattern recognition receptors. While pro-inflammatory gene expression is non-redundantly linked to the presence of STING in these mice, the contribution of the inflammasome pathway has not been explored. To this end, we studied the role of the DNA-sensing inflammasome receptor AIM2 in this self-DNA driven disease model. Arthritis-prone mice lacking AIM2 displayed strongly decreased signs of joint inflammation and associated histopathological findings. This was paralleled with a reduction of caspase-1 activation and pro-inflammatory cytokine production in diseased joints. Interestingly, systemic signs of inflammation that are associated with the lack of DNase II were not dependent on AIM2. Taken together, these data suggest a tissue-specific role for the AIM2 inflammasome as a sensor for endogenous DNA species in the course of a ligand-dependent autoinflammatory condition.	[Jakobs, Christopher; Hornung, Veit] Univ Bonn, Univ Hosp Bonn, Inst Mol Med, Bonn, Germany; [Perner, Sven] Univ Hosp Bonn, Ctr Integrated Oncol Koln, Inst Pathol, Dept Prostate Canc Res, Bonn, Germany	University of Bonn; University of Bonn	Hornung, V (corresponding author), Univ Bonn, Univ Hosp Bonn, Inst Mol Med, Bonn, Germany.	veit.hornung@uni-bonn.de	Hornung, Veit/C-3565-2012	Hornung, Veit/0000-0002-4150-194X	German Research Foundation [SFB704, SFB670]; European Research Council [ERC-2009-StG 243046]	German Research Foundation(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	This work was supported by grants from the German Research Foundation (SFB704 and SFB670) and the European Research Council (ERC-2009-StG 243046) to V.H. V.H. is member of the excellence cluster ImmunoSensation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2013, CLIN IMMUNOL, V147, P207, DOI 10.1016/j.clim.2013.01.003; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Baum R, 2015, J IMMUNOL, V194, P873, DOI 10.4049/jimmunol.1402573; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Chiliveru S, 2014, J IMMUNOL, V192, P2395, DOI 10.4049/jimmunol.1302120; Crow YJ, 2013, HAND CLINIC, V113, P1629, DOI 10.1016/B978-0-444-59565-2.00031-9; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Hornung V, 2014, NAT REV IMMUNOL, V14, P521, DOI 10.1038/nri3719; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jakobs Christopher, 2013, Methods Mol Biol, V1040, P103, DOI 10.1007/978-1-62703-523-1_9; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kawane K, 2010, P NATL ACAD SCI USA, V107, P19432, DOI 10.1073/pnas.1010603107; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Lan YY, 2014, CELL REP, V9, P180, DOI 10.1016/j.celrep.2014.08.074; Lee-Kirsch MA, 2014, CLIN EXP IMMUNOL, V175, P17, DOI 10.1111/cei.12160; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mellins ED, 2011, NAT REV RHEUMATOL, V7, P416, DOI 10.1038/nrrheum.2011.68; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Nagata S, 2011, ADV IMMUNOL, V110, P139, DOI 10.1016/B978-0-12-387663-8.00004-1; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Panchanathan R, 2010, J IMMUNOL, V185, P7385, DOI 10.4049/jimmunol.1002468; Pierini R, 2012, CELL DEATH DIFFER, V19, P1709, DOI 10.1038/cdd.2012.51; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; Schattgen SA, 2011, IMMUNOL REV, V243, P109, DOI 10.1111/j.1600-065X.2011.01053.x; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Suschak JJ, 2015, J IMMUNOL, V194, P630, DOI 10.4049/jimmunol.1402530; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	33	59	62	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131702	10.1371/journal.pone.0131702	http://dx.doi.org/10.1371/journal.pone.0131702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114879	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500179
J	Ngwira, A; Stanley, CC				Ngwira, Alfred; Stanley, Christopher C.			Determinants of Low Birth Weight in Malawi: Bayesian Geo-Additive Modelling	PLOS ONE			English	Article							RISK-FACTORS; REGRESSION; HOSPITALS	Studies on factors of low birth weight in Malawi have neglected the flexible approach of using smooth functions for some covariates in models. Such flexible approach reveals detailed relationship of covariates with the response. The study aimed at investigating risk factors of low birth weight in Malawi by assuming a flexible approach for continuous covariates and geographical random effect. A Bayesian geo-additive model for birth weight in kilograms and size of the child at birth (less than average or average and higher) with district as a spatial effect using the 2010 Malawi demographic and health survey data was adopted. A Gaussian model for birth weight in kilograms and a binary logistic model for the binary outcome (size of child at birth) were fitted. Continuous covariates were modelled by the penalized (p) splines and spatial effects were smoothed by the two dimensional p-spline. The study found that child birth order, mother weight and height are significant predictors of birth weight. Secondary education for mother, birth order categories 2-3 and 4-5, wealth index of richer family and mother height were significant predictors of child size at birth. The area associated with low birth weight was Chitipa and areas with increased risk to less than average size at birth were Chitipa and Mchinji. The study found support for the flexible modelling of some covariates that clearly have nonlinear influences. Nevertheless there is no strong support for inclusion of geographical spatial analysis. The spatial patterns though point to the influence of omitted variables with some spatial structure or possibly epidemiological processes that account for this spatial structure and the maps generated could be used for targeting development efforts at a glance.	[Ngwira, Alfred] Lilongwe Univ Agr & Nat Resources, Dept Basic Sci, Lilongwe, Malawi; [Stanley, Christopher C.] Univ North Carolina Project, Kamuzu Cent Hosp, Lilongwe, Malawi	Lilongwe University of Agriculture & Natural Resources	Ngwira, A (corresponding author), Lilongwe Univ Agr & Nat Resources, Dept Basic Sci, Lilongwe, Malawi.	alfngwira@yahoo.com	Ngwira, Alfred/AAX-4777-2021	Ngwira, Alfred/0000-0001-7026-4894				[Anonymous], 2012, INT J BIOL MED RES; Badshah S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-197; Besag J, 1995, BIOMETRIKA, V82, P733, DOI 10.2307/2337341; Chuku SN, 2008, THESIS I SOCIAL STUD; de Moraes AB, 2012, CAD SAUDE PUBLICA, V28, P2293, DOI 10.1590/S0102-311X2012001400008; Fahrmeir L, 2004, STAT SINICA, V14, P731; Kammann EE, 2003, J R STAT SOC C-APPL, V52, P1, DOI 10.1111/1467-9876.00385; Kneib T, 2004, BAYESIAN SEMIPARAMET; Magadi MA, 2000, INDIVIDUAL COMMUNITY; Mumbare SS, 2012, INDIAN PEDIATR, V49, P25, DOI 10.1007/s13312-012-0010-z; Muula AS, 2011, AFR HEALTH SCI, V11, P65; Nascimento LFC, 2005, REV PAUL PEDIATR, V23, P76; Nascimento Luiz Fernando C., 2013, Rev. paul. pediatr., V31, P466, DOI 10.1590/S0103-05822013000400008; Nascimento LFC, 2009, CAD SAUDE PUBLICA, V25, P1791, DOI 10.1590/S0102-311X2009000800015; Nelson R., 1998, W GEOGRAPHY, V8, P31; NSO, 2011, MAL DHS 2010 FIN REP; OCampo P, 1997, AM J PUBLIC HEALTH, V87, P1113, DOI 10.2105/AJPH.87.7.1113; Osei FB, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-118; Sellstrom E, 2006, SCAND J PUBLIC HEALT, V34, P544, DOI 10.1080/14034940600551251; United Nations Children's Fund and World Health Organization, 2004, LOW BIRTHW COUNTR RE; Viengsakhone L, 2010, NAGOYA J MED SCI, V72, P51; World Health Organization, 1992, LOW BIRTH WEIGHT TAB	22	18	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130057	10.1371/journal.pone.0130057	http://dx.doi.org/10.1371/journal.pone.0130057			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114866	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500049
J	Perry, EB; Barrick, JE; Bohannan, BJM				Perry, Elizabeth B.; Barrick, Jeffrey E.; Bohannan, Brendan J. M.			The Molecular and Genetic Basis of Repeatable Coevolution between Escherichia coli and Bacteriophage T3 in a Laboratory Microcosm	PLOS ONE			English	Article							LONG-TERM EXPERIMENT; ANTAGONISTIC COEVOLUTION; CONFERS PROCESSIVITY; PHAGE; EVOLUTION; THIOREDOXIN; MODEL; LIPOPOLYSACCHARIDE; ADAPTATION; COMMUNITY	The objective of this study was to determine the genomic changes that underlie coevolution between Escherichia coli B and bacteriophage T3 when grown together in a laboratory microcosm. We also sought to evaluate the repeatability of their evolution by studying replicate coevolution experiments inoculated with the same ancestral strains. We performed the coevolution experiments by growing Escherichia coli B and the lytic bacteriophage T3 in seven parallel continuous culture devices (chemostats) for 30 days. In each of the chemostats, we observed three rounds of coevolution. First, bacteria evolved resistance to infection by the ancestral phage. Then, a new phage type evolved that was capable of infecting the resistant bacteria as well as the sensitive bacterial ancestor. Finally, we observed second-order resistant bacteria evolve that were resistant to infection by both phage types. To identify the genetic changes underlying coevolution, we isolated first-and second-order resistant bacteria as well as a host-range mutant phage from each chemostat and sequenced their genomes. We found that first-order resistant bacteria consistently evolved resistance to phage via mutations in the gene, waaG, which codes for a glucosyltransferase required for assembly of the bacterial lipopolysaccharide (LPS). Phage also showed repeatable evolution, with each chemostat producing host-range mutant phage with mutations in the phage tail fiber gene T3p48 which binds to the bacterial LPS during adsorption. Two second-order resistant bacteria evolved via mutations in different genes involved in the phage interaction. Although a wide range of mutations occurred in the bacterial waaG gene, mutations in the phage tail fiber were restricted to a single codon, and several phage showed convergent evolution at the nucleotide level. These results are consistent with previous studies in other systems that have documented repeatable evolution in bacteria at the level of pathways or genes and repeatable evolution in viruses at the nucleotide level. Our data are also consistent with the expectation that adaptation via loss-of-function mutations is less constrained than adaptation via gain-of-function mutations.	[Perry, Elizabeth B.; Bohannan, Brendan J. M.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA; [Barrick, Jeffrey E.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA; [Perry, Elizabeth B.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	University of Oregon; University of Texas System; University of Texas Austin; Memorial Sloan Kettering Cancer Center	Perry, EB (corresponding author), Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA.	ElizabethBPerry@gmail.com	Bohannan, Brendan J. M./R-1582-2017	Bohannan, Brendan J. M./0000-0003-2907-1016	US National Science Foundation BEACON Center for the Study of Evolution in Action [DBI-0939454]; US National Institutes of Health [R00-GM087550]; NIH [5T32GM007413, 5T32CA160001]; NIH Loan Repayment Program [1 L40 CA189061-01]; NATIONAL CANCER INSTITUTE [T32CA160001] Funding Source: NIH RePORTER	US National Science Foundation BEACON Center for the Study of Evolution in Action; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Loan Repayment Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by the US National Science Foundation BEACON Center for the Study of Evolution in Action (DBI-0939454) and US National Institutes of Health (R00-GM087550). E.B.P. was supported by NIH training grants 5T32GM007413, 5T32CA160001 and the NIH Loan Repayment Program 1 L40 CA189061-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BARNET YM, 1981, J APPL BACTERIOL, V51, P541, DOI 10.1111/j.1365-2672.1981.tb01273.x; Barrick JE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1039; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bedford E, 1997, P NATL ACAD SCI USA, V94, P479, DOI 10.1073/pnas.94.2.479; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Bohannan BJM, 1999, AM NAT, V153, P73, DOI 10.1086/303151; Bohannan BJM, 1997, ECOLOGY, V78, P2303; Brockhurst MA, 2003, ECOL LETT, V6, P975, DOI 10.1046/j.1461-0248.2003.00531.x; Brockhurst MA, 2007, INFECT GENET EVOL, V7, P547, DOI 10.1016/j.meegid.2007.01.005; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Bull JJ, 1997, GENETICS, V147, P1497; CAMPBELL A, 1961, EVOLUTION, V15, P153, DOI 10.2307/2406076; CHAO L, 1977, ECOLOGY, V58, P369, DOI 10.2307/1935611; Dardick C, 2006, PLOS PATHOG, V2, P14, DOI 10.1371/journal.ppat.0020002; Deatherage DE, 2014, METHODS MOL BIOL, V1151, P165, DOI 10.1007/978-1-4939-0554-6_12; Diaz-Munoz SL, 2014, ADV APPL MICROBIOL, V89, P135, DOI 10.1016/B978-0-12-800259-9.00004-4; Engelhardt T, 2014, ISME J, V8, P1503, DOI 10.1038/ismej.2013.245; Feldman CR, 2009, P NATL ACAD SCI USA, V106, P13415, DOI 10.1073/pnas.0901224106; Forde SE, 2004, NATURE, V431, P841, DOI 10.1038/nature02906; Garcia-Doval C, 2012, P NATL ACAD SCI USA, V109, P9390, DOI 10.1073/pnas.1119719109; Hall AR, 2011, ECOL LETT, V14, P635, DOI 10.1111/j.1461-0248.2011.01624.x; Hall AR, 2011, AM NAT, V177, P44, DOI 10.1086/657441; Heinrichs DE, 1998, MOL MICROBIOL, V30, P221, DOI 10.1046/j.1365-2958.1998.01063.x; HOLMGREN A, 1978, J BIOL CHEM, V253, P430; HORNE MT, 1970, SCIENCE, V168, P992, DOI 10.1126/science.168.3934.992-a; Hyman P, 2010, ADV APPL MICROBIOL, V70, P217, DOI 10.1016/S0065-2164(10)70007-1; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Jessup CM, 2008, ECOL LETT, V11, P947, DOI 10.1111/j.1461-0248.2008.01205.x; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Koskella B, 2014, FEMS MICROBIOL REV, V38, P916, DOI 10.1111/1574-6976.12072; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; LAIRD MW, 1994, J BACTERIOL, V176, P2259, DOI 10.1128/JB.176.8.2259-2264.1994; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; LENSKI RE, 1988, ADV MICROB ECOL, V10, P1; LEVIN BR, 1977, AM NAT, V111, P3, DOI 10.1086/283134; LINDBERG AA, 1973, ANNU REV MICROBIOL, V27, P205, DOI 10.1146/annurev.mi.27.100173.001225; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; Meyer JR, 2012, SCIENCE, V335, P428, DOI 10.1126/science.1214449; Nechaev S, 2008, CURR OPIN MICROBIOL, V11, P186, DOI 10.1016/j.mib.2008.02.009; NOVICK A, 1950, SCIENCE, V112, P715, DOI 10.1126/science.112.2920.715; Pajunen MI, 2002, J MOL BIOL, V319, P1115, DOI 10.1016/S0022-2836(02)00384-4; Paterson S, 2010, NATURE, V464, P275, DOI 10.1038/nature08798; PREHM P, 1976, J MOL BIOL, V101, P277, DOI 10.1016/0022-2836(76)90377-6; Qimron U, 2006, P NATL ACAD SCI USA, V103, P19039, DOI 10.1073/pnas.0609428103; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096; Schrag SJ, 1996, AM NAT, V148, P348, DOI 10.1086/285929; SOMMER H, 1981, MOL GEN GENET, V184, P300, DOI 10.1007/BF00272921; STEVEN AC, 1988, J MOL BIOL, V200, P351, DOI 10.1016/0022-2836(88)90246-X; TABOR S, 1987, J BIOL CHEM, V262, P16212; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Wei Y, 2011, AM NAT, V178, P715, DOI 10.1086/662677; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103	58	23	24	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130639	10.1371/journal.pone.0130639	http://dx.doi.org/10.1371/journal.pone.0130639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114300	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500083
J	Satdichanh, M; Millet, J; Heinimann, A; Nanthavong, K; Harrison, RD				Satdichanh, Manichanh; Millet, Jerome; Heinimann, Andreas; Nanthavong, Khamseng; Harrison, Rhett D.			Using Plant Functional Traits and Phylogenies to Understand Patterns of Plant Community Assembly in a Seasonal Tropical Forest in Lao PDR	PLOS ONE			English	Article							RAIN-FOREST; DIVERSITY; DISTANCE; DENSITY; SCALES; TREES	Plant functional traits reflect different evolutionary responses to environmental variation, and among extant species determine the outcomes of interactions between plants and their environment, including other plant species. Thus, combining phylogenetic and trait-based information can be a powerful approach for understanding community assembly processes across a range of spatial scales. We used this approach to investigate tree community composition at Phou Khao Khouay National Park (18 degrees 14'-18 degrees 32'N; 102 degrees 38'-102 degrees 59' E), Laos, where several distinct forest types occur in close proximity. The aim of our study was to examine patterns of plant community assembly across the strong environmental gradients evident at our site. We hypothesized that differences in tree community composition were being driven by an underlying gradient in soil conditions. Thus, we predicted that environmental filtering would predominate at the site and that the filtering would be strongest on sandier soil with low pH, as these are the conditions least favorable to plant growth. We surveyed eleven 0.25 ha (50x50 m) plots for all trees above 10 cm dbh (1221 individual trees, including 47 families, 70 genera and 123 species) and sampled soils in each plot. For each species in the community, we measured 11 commonly studied plant functional traits covering both the leaf and wood economic spectrum traits and we reconstructed a phylogenetic tree for 115 of the species in the community using rbcL and matK sequences downloaded from Genebank (other species were not available). Finally we compared the distribution of trait values and species at two scales (among plots and 10x10m subplots) to examine trait and phylogenetic community structures. Although there was strong evidence that an underlying soil gradient was determining patterns of species composition at the site, our results did not support the hypothesis that the environmental filtering dominated community assembly processes. For the measured plant functional traits there was no consistent pattern of trait dispersion across the site, either when traits were considered individually or when combined in a multivariate analysis. However, there was a significant correlation between the degree of phylogenetic dispersion and the first principle component axis (PCA1) for the soil parameters. Moreover, the more phylogenetically clustered plots were on sandier soils with lower pH. Hence, we suggest that the community assembly processes across our sitemay reflect the influence of more conserved traits that we did not measure. Nevertheless, our results are equivocal and other interpretations are possible. Our study illustrates some difficulties in combining trait and phylogenetic approaches that may result from the complexities of integrating spatial and evolutionary processes that vary at different scales.	[Satdichanh, Manichanh] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Satdichanh, Manichanh] Univ Chinese Acad Sci, Beijing, Peoples R China; [Satdichanh, Manichanh; Nanthavong, Khamseng] Natl Univ Laos, Fac Forestry Sci, Viangchan, Laos; [Millet, Jerome] Fed Conservatoires Bot Nationaux, Montreuil, France; [Heinimann, Andreas] Univ Bern, Ctr Dev & Environm, Bern, Switzerland; [Heinimann, Andreas] Univ Bern, Inst Geog, Bern, Switzerland; [Harrison, Rhett D.] World Agroforestry Ctr East & Cent Asia Reg Off, Kunming, Yunnan, Peoples R China; [Harrison, Rhett D.] Chinese Acad Sci, Key Lab Plant Divers & Biogeog East Asia, Kunming Inst Bot, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Bern; University of Bern; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Harrison, RD (corresponding author), World Agroforestry Ctr East & Cent Asia Reg Off, Kunming, Yunnan, Peoples R China.	r.harrison@cgiar.org	Satdichanh, Manichanh/AAO-3435-2020	Heinimann, Andreas/0000-0001-8905-8169; Harrison, Rhett/0000-0001-9055-3546; Satdichanh, PhD, Manichanh/0000-0003-3184-4719	Centre for Development and Environment (CDE), University of Burn, Switzerland; Graduate University of the Chinese Academy of Sciences	Centre for Development and Environment (CDE), University of Burn, Switzerland; Graduate University of the Chinese Academy of Sciences	This study was partially funded by Centre for Development and Environment (CDE), University of Burn, Switzerland and through a foreign student fellowship to MS from the Graduate University of the Chinese Academy of Sciences. The funders did not have any role in the study design, data collection and analysis, and preparation of the manuscript.	Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Aiba M, 2013, ECOLOGY, V94, P2873, DOI 10.1890/13-0269.1; Baraloto C, 2012, J ECOL, V100, P690, DOI 10.1111/j.1365-2745.2012.01966.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chase MW, 2009, BOT J LINN SOC, V161, P122, DOI 10.1111/j.1095-8339.2009.01002.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cornwell WK, 2010, J ECOL, V98, P814, DOI 10.1111/j.1365-2745.2010.01662.x; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Ding Y, 2012, OIKOS, V121, P1263, DOI 10.1111/j.1600-0706.2011.19992.x; Donovan LA, 2011, TRENDS ECOL EVOL, V26, P88, DOI 10.1016/j.tree.2010.11.011; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hardy OJ, 2008, J ECOL, V96, P914, DOI 10.1111/j.1365-2745.2008.01421.x; Iida Y, 2014, J ECOL, V102, P641, DOI 10.1111/1365-2745.12221; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lucas C, 2013, J TROP FOR SCI, V25, P410; Osunkoya OO, 2007, AM J BOT, V94, P1951, DOI 10.3732/ajb.94.12.1951; Parmentier I, 2014, J ECOL, V102, P1008, DOI 10.1111/1365-2745.12254; R Core Team, 2021, R LANGUAGE ENV STAT; Reich PB, 1998, INHERENT VARIATION IN PLANT GROWTH, P467; Schamp BS, 2008, J ECOL, V96, P204, DOI 10.1111/j.1365-2745.2007.01328.x; Scoffoni C, QUANTIFYING LEAF VEI; Swenson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021264; Swenson NG, 2011, AM J BOT, V98, P472, DOI 10.3732/ajb.1000289; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Uhl D, 1999, PALAEOGEOGR PALAEOCL, V149, P15, DOI 10.1016/S0031-0182(98)00189-8; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Vile D, 2005, ANN BOT-LONDON, V96, P1129, DOI 10.1093/aob/mci264; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Williamson GB, 2010, AM J BOT, V97, P519, DOI 10.3732/ajb.0900243; WITKOWSKI ETF, 1991, OECOLOGIA, V88, P486, DOI 10.1007/BF00317710; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Xu F, 2009, PROG NAT SCI-MATER, V19, P1789, DOI 10.1016/j.pnsc.2009.10.001; Zhu YH, 2012, TREES-STRUCT FUNCT, V26, P597, DOI 10.1007/s00468-011-0624-0	39	17	18	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130151	10.1371/journal.pone.0130151	http://dx.doi.org/10.1371/journal.pone.0130151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115369	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500054
J	Silva, LD; Ossa, DPT; Casto, SVD; Pires, LB; de Oliveira, CMA; da Silva, CC; Coelho, NP; Bailao, AM; Parente-Rocha, JA; Soares, CMD; Ruiz, OH; Ochoa, JGM; Pereira, M				Silva, Livia do Carmo; Tamayo Ossa, Diana Patricia; da Conceicao Casto, Symone Vitoriano; Pires, Ludmila Bringel; Alves de Oliveira, Cecilia Maria; da Silva, Cleuza Conceicao; Coelho, Narcimario Pereira; Bailao, Alexandre Melo; Parente-Rocha, Juliana Alves; de Almeida Soares, Celia Maria; Hernandez Ruiz, Orville; McEwen Ochoa, Juan G.; Pereira, Maristela			Transcriptome Profile of the Response of Paracoccidioides spp. to a Camphene Thiosemicarbazide Derivative	PLOS ONE			English	Article							CANDIDA-ALBICANS; OXIDATIVE STRESS; MALATE SYNTHASE; CRYPTOCOCCUS-NEOFORMANS; ASPERGILLUS-FUMIGATUS; ANTIFUNGAL AGENTS; MOLECULAR-CLONING; ESCHERICHIA-COLI; ABC TRANSPORTERS; YEAST-CELLS	Paracoccidioidomycosis (PCM) is a systemic granulomatous human mycosis caused by fungi of the genus Paracoccidioides, which is geographically restricted to Latin America. Inhalation of spores, the infectious particles of the fungus, is a common route of infection. The PCM treatment of choice is azoles such as itraconazole, but sulfonamides and amphotericin B are used in some cases despite their toxicity to mammalian cells. The current availability of treatments highlights the need to identify and characterize novel targets for antifungal treatment of PCM as well as the need to search for new antifungal compounds obtained from natural sources or by chemical synthesis. To this end, we evaluated the antifungal activity of a camphene thiosemicarbazide derivative (TSC-C) compound on Paracoccidioides yeast. To determine the response of Paracoccidioides spp. to TSC-C, we analyzed the transcriptional profile of the fungus after 8 h of contact with the compound. The results demonstrate that Paracoccidioides lutzii induced the expression of genes related to metabolism; cell cycle and DNA processing; biogenesis of cellular components; cell transduction/signal; cell rescue, defense and virulence; cellular transport, transport facilities and transport routes; energy; protein synthesis; protein fate; transcription; and other proteins without classification. Additionally, we observed intensely inhibited genes related to protein synthesis. Analysis by fluorescence microscopy and flow cytometry revealed that the compound induced the production of reactive oxygen species. Using an isolate with down-regulated SOD1 gene expression (SOD1-aRNA), we sought to determine the function of this gene in the defense of Paracoccidioides yeast cells against the compound. Mutant cells were more susceptible to TSC-C, demonstrating the importance of this gene in response to the compound. The results presented herein suggest that TSC-C is a promising candidate for PCM treatment.	[Silva, Livia do Carmo; da Conceicao Casto, Symone Vitoriano; Bailao, Alexandre Melo; Parente-Rocha, Juliana Alves; de Almeida Soares, Celia Maria; Pereira, Maristela] Univ Fed Goias, Inst Patol Trop Saude Publ, Mol Biol Lab, Goiania, Go, Brazil; [Tamayo Ossa, Diana Patricia; Hernandez Ruiz, Orville; McEwen Ochoa, Juan G.] Univ Antioquia, CIB, Unidad Biol Celular & Mol, Medellin, Colombia; [Tamayo Ossa, Diana Patricia; Hernandez Ruiz, Orville; McEwen Ochoa, Juan G.] Univ Antioquia, Fac Med, Medellin, Colombia; [Pires, Ludmila Bringel; Alves de Oliveira, Cecilia Maria] Univ Fed Goias, Inst Quim, Lab Prod Nat, Goiania, Go, Brazil; [da Silva, Cleuza Conceicao; Coelho, Narcimario Pereira] Univ Estadual Maringa, Dept Quim, Lab Fitoquim & Sintese Organ, Maringa, Parana, Brazil	Universidade Federal de Goias; Universidad de Antioquia; Universidad de Antioquia; Universidade Federal de Goias; Universidade Estadual de Maringa	Pereira, M (corresponding author), Univ Fed Goias, Inst Patol Trop Saude Publ, Mol Biol Lab, Goiania, Go, Brazil.	maristelaufg@gmail.com	Silva, Lívia do Carmo/ABA-3999-2020; Pereira, Maristela/AAT-5765-2021; Bailao, Alexandre Melo/H-1272-2013; Parente-Rocha, Juliana/GNP-7393-2022; de Oliveira, Cecilia M A/C-5830-2013	Bailao, Alexandre Melo/0000-0001-7754-4047; de Oliveira, Cecilia M A/0000-0003-3339-5363; McEwen, Juan Guillermo/0000-0001-8594-9087; Tamayo, Diana/0000-0002-2826-8573	MCTI/CNPq (Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FNDCT (Fundo Nacional de Desenvolvimento Cientifico e Tecnologico); FAPEG (Fundacao de Amparo a Pesquisa do Estado de Goias); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FINEP (Financiadora de Estudos e Projetos); INCT-IF (Instituto Nacional de Ciencia e Tecnologia para Inovacao Farmaceutica); CNPq; CAPES	MCTI/CNPq (Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FNDCT (Fundo Nacional de Desenvolvimento Cientifico e Tecnologico); FAPEG (Fundacao de Amparo a Pesquisa do Estado de Goias); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FINEP (Financiadora de Estudos e Projetos)(Financiadora de Inovacao e Pesquisa (Finep)); INCT-IF (Instituto Nacional de Ciencia e Tecnologia para Inovacao Farmaceutica); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work performed at Universidade Federal de Goias was supported by MCTI/CNPq (Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), FNDCT (Fundo Nacional de Desenvolvimento Cientifico e Tecnologico), FAPEG (Fundacao de Amparo a Pesquisa do Estado de Goias), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), FINEP (Financiadora de Estudos e Projetos), and INCT-IF (Instituto Nacional de Ciencia e Tecnologia para Inovacao Farmaceutica). Additionally, LCS was supported by fellowship from CNPq and SVCC, LBP, NPC from CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AJ, 2007, FUNGAL GENET BIOL, V44, P1387, DOI 10.1016/j.fgb.2007.04.004; Andrade AC, 2000, MOL GEN GENET, V263, P966, DOI 10.1007/PL00008697; Angelova MB, 2005, MYCOL RES, V109, P150, DOI 10.1017/S0953756204001352; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bagagli E, 2008, MYCOPATHOLOGIA, V165, P197, DOI 10.1007/s11046-007-9050-7; Bailao AM, 2012, RES MICROBIOL, V163, P182, DOI 10.1016/j.resmic.2012.01.004; Bocca AL, 2013, FUTURE MICROBIOL, V8, P1177, DOI 10.2217/fmb.13.68; Bonfim SMRC, 2006, FEMS IMMUNOL MED MIC, V46, P269, DOI 10.1111/j.1574-695X.2005.00036.x; Bookout Angie L, 2006, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1508s73; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clinical and Laboratory Standards Institute, 2002, REF METH BROTH DIL A; Borges SRC, 2014, MED MYCOL, V52, P303, DOI 10.1093/mmy/myt012; Santana LAD, 2012, MEM I OSWALDO CRUZ, V107, P310, DOI 10.1590/S0074-02762012000300004; da Silva AP, 2010, EUR J MED CHEM, V45, P2987, DOI 10.1016/j.ejmech.2010.03.026; Cruz AHD, 2011, FEBS J, V278, P2318, DOI 10.1111/j.1742-4658.2011.08150.x; Neto BRD, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-272; DANCIS A, 1994, J BIOL CHEM, V269, P25660; de Oliveira KM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-107; Silva ACADE, 2013, J CLIN MICROBIOL, V51, P1250, DOI 10.1128/JCM.02914-12; Delattin N, 2014, FUTURE MED CHEM, V6, P77, DOI [10.4155/FMC.13.189, 10.4155/fmc.13.189]; Delobel P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084645; den Dulk-Ras A, 1995, Methods Mol Biol, V55, P63; Dias N, 2005, BIOCHEM PHARMACOL, V70, P1, DOI 10.1016/j.bcp.2005.03.021; Dimroth P, 2000, J EXP BIOL, V203, P51; do Prado RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094832; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Figueiredo IM, 2006, J BRAZIL CHEM SOC, V17, P954, DOI 10.1590/S0103-50532006000500020; Franz R, 1998, GENE, V220, P91, DOI 10.1016/S0378-1119(98)00412-0; Frazier AD, 2013, CURR MICROBIOL, V67, P226, DOI 10.1007/s00284-013-0350-5; Freiberg C, 2005, DRUG DISCOV TODAY, V10, P927, DOI 10.1016/S1359-6446(05)03474-4; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; GOFFEAU A, 2004, CHEMISTRY, V1, P1; Grivicich I, 2005, ONCOL RES, V15, P385, DOI 10.3727/096504005776449680; Grossklaus DD, 2013, MICROBES INFECT, V15, P347, DOI 10.1016/j.micinf.2012.12.002; Haraguchi SK, 2011, MOLECULES, V16, P1166, DOI 10.3390/molecules16021166; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hwang CS, 2002, MICROBIOL-SGM, V148, P3705, DOI 10.1099/00221287-148-11-3705; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Marques SA, 2013, AN BRAS DERMATOL, V88, P700, DOI 10.1590/abd1806-4841.20132463; MARTIN J, 1991, J BIOL CHEM, V266, P18051; Moreno-Sanchez R, 1999, BIOCHEM PHARMACOL, V57, P743, DOI 10.1016/S0006-2952(98)00330-X; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; NETTO C F, 1955, Arq Cir Clin Exp, V18, P197; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; Park HJ, 2012, ENVIRON SCI TECHNOL, V46, P11299, DOI 10.1021/es302379q; Pena MMO, 2000, J BIOL CHEM, V275, P33244, DOI 10.1074/jbc.M005392200; Pereira M, 2010, BBA-MOL CELL BIOL L, V1801, P1163, DOI 10.1016/j.bbalip.2010.06.007; Piochon M, 2009, PHYTOCHEMISTRY, V70, P228, DOI 10.1016/j.phytochem.2008.11.013; Posteraro B, 2003, MOL MICROBIOL, V47, P357, DOI 10.1046/j.1365-2958.2003.03281.x; PRASAD R, 1995, CURR GENET, V27, P320, DOI 10.1007/BF00352101; Rappleye CA, 2004, MOL MICROBIOL, V53, P153, DOI 10.1111/j.1365-2958.2004.04131.x; RESTREPO A, 1980, J CLIN MICROBIOL, V12, P279, DOI 10.1128/JCM.12.2.279-281.1980; Ruy F, 2006, J BIOENERG BIOMEMBR, V38, P129, DOI 10.1007/s10863-006-9012-7; Samanovic MI, 2012, CELL HOST MICROBE, V11, P106, DOI 10.1016/j.chom.2012.01.009; Santos GD, 2007, MED MYCOL, V45, P609, DOI 10.1080/13693780701502108; Slaven JW, 2002, FUNGAL GENET BIOL, V36, P199, DOI 10.1016/S1087-1845(02)00016-6; Tobin MB, 1997, GENE, V200, P11, DOI 10.1016/S0378-1119(97)00281-3; Tomazett PK, 2011, FUNGAL BIOL-UK, V115, P62, DOI 10.1016/j.funbio.2010.10.005; Tomazett PK, 2010, FUNGAL BIOL-UK, V114, P809, DOI 10.1016/j.funbio.2010.07.007; Travassos LR, 2008, EXPERT REV ANTI-INFE, V6, P251, DOI 10.1586/14787210.6.2.251; Vandenbosch D, 2010, J ANTIMICROB CHEMOTH, V65, P694, DOI 10.1093/jac/dkq019; Vercesi AE, 1997, BIOSCIENCE REP, V17, P43, DOI 10.1023/A:1027335217774; Waterman SR, 2007, J CLIN INVEST, V117, P794, DOI 10.1172/JCI30006; Yamaguchi MU, 2009, MOLECULES, V14, P1796, DOI 10.3390/molecules14051796; Yasuda MAS, 2005, EXPERT OPIN PHARMACO, V6, P385, DOI 10.1517/14656566.6.3.385; Youseff BH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002713; Zambuzzi-Carvalho PF, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-227; Zambuzzi-Carvalho PF, 2009, MED MYCOL, V47, P734, DOI 10.3109/13693780802609620	70	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130703	10.1371/journal.pone.0130703	http://dx.doi.org/10.1371/journal.pone.0130703			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114868	Green Published, Green Submitted, gold			2022-12-27	WOS:000358147500088
J	Sonobe, T; Chenuel, B; Cooper, TK; Haouzi, P				Sonobe, Takashi; Chenuel, Bruno; Cooper, Timothy K.; Haouzi, Philippe			Immediate and Long-Term Outcome of Acute H2S Intoxication Induced Coma in Unanesthetized Rats: Effects of Methylene Blue	PLOS ONE			English	Article							MORRIS WATER MAZE; CAUDATE-PUTAMEN LESIONS; HYDROGEN-SULFIDE; NITRIC-OXIDE; SEPTIC SHOCK; CARDIOPULMONARY-RESUSCITATION; CYTOCHROME-OXIDASE; REPERFUSION INJURY; CARDIAC-SURGERY; SODIUM-NITRITE	Background Acute hydrogen sulfide (H2S) poisoning produces a coma, the outcome of which ranges from full recovery to severe neurological deficits. The aim of our study was to 1-describe the immediate and long-term neurological effects following H2S-induced coma in un-anesthetized rats, and 2-determine the potential benefit of methylene blue (MB), a compound we previously found to counteract acute sulfide cardiac toxicity. Methods NaHS was administered IP in un-sedated rats to produce a coma (n = 34). One minute into coma, the rats received MB (4 mg/kg IV) or saline. The surviving rats were followed clinically and assigned to Morris water maze (MWM) and open field testing then sacrificed at day 7. Results Sixty percent of the non-treated comatose rats died by pulseless electrical activity. Nine percent recovered with neurological deficits requiring euthanasia, their brain examination revealed major neuronal necrosis of the superficial and middle layers of the cerebral cortex and the posterior thalamus, with variable necrosis of the caudate putamen, but no lesions of the hippocampus or the cerebellum, in contrast to the typical distribution of post-ischemic lesions. The remaining animals displayed, on average, a significantly less effective search strategy than the control rats (n = 21) during MWM testing. Meanwhile, 75% of rats that received MB survived and could perform the MWM test (P < 0.05 vs non-treated animals). The treated animals displayed a significantly higher occurrence of spatial search than the non-treated animals. However, a similar proportion of cortical necrosis was observed in both groups, with a milder clinical presentation following MB. Conclusion In conclusion, in rats surviving H2S induced coma, spatial search patterns were used less frequently than in control animals. A small percentage of rats presented necrotic neuronal lesions, which distribution differed from post-ischemic lesions. MB dramatically improved the immediate survival and spatial search strategy in the surviving rats.	[Sonobe, Takashi; Chenuel, Bruno; Haouzi, Philippe] Penn State Univ, Coll Med, Dept Med, Div Pulm & Crit Care Med, Hershey, PA 17033 USA; [Cooper, Timothy K.] Penn State Univ, Coll Med, Dept Comparat Med, Hershey, PA USA; [Cooper, Timothy K.] Penn State Univ, Coll Med, Dept Pathol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Haouzi, P (corresponding author), Penn State Univ, Coll Med, Dept Med, Div Pulm & Crit Care Med, Hershey, PA 17033 USA.	phaouzi@hmc.psu.edu	Sonobe, Takashi/Q-6600-2016; Chenuel, Bruno/G-4320-2015	Sonobe, Takashi/0000-0003-3589-0405; Chenuel, Bruno/0000-0001-6619-6577	NIH OD [1R21NS0800788-01, 1R21NS090017-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS090017] Funding Source: NIH RePORTER	NIH OD; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by NIH OD, 1R21NS0800788-01 and 1R21NS090017-01.	Ali MY, 2006, BRIT J PHARMACOL, V149, P625, DOI 10.1038/sj.bjp.0706906; Almeida AF, 2008, INT J TOXICOL, V27, P287, DOI 10.1080/10915810802210166; Almeida AF, 1999, TOXICOL SCI, V50, P287, DOI 10.1093/toxsci/50.2.287; Altaany Z, 2013, J CELL MOL MED, V17, P879, DOI 10.1111/jcmm.12077; BALDELLI RJ, 1993, J APPL PHYSIOL, V75, P1348, DOI 10.1152/jappl.1993.75.3.1348; Barnett SA, 1963, RAT STUDY BEHAV, Vxvi; BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; BITTERMAN N, 1986, TOXICOL APPL PHARM, V84, P325, DOI 10.1016/0041-008X(86)90140-7; Bolon B, 2013, TOXICOL PATHOL, V41, P1028, DOI 10.1177/0192623312474865; Bouillaud F, 2011, ANTIOXID REDOX SIGN, V15, P379, DOI 10.1089/ars.2010.3678; BRADY AJB, 1992, AM J PHYSIOL, V263, pH1963, DOI 10.1152/ajpheart.1992.263.6.H1963; BRIERLEY JB, 1966, BRAIN, V89, P269, DOI 10.1093/brain/89.2.269; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Buckler KJ, 2012, PFLUG ARCH EUR J PHY, V463, P743, DOI 10.1007/s00424-012-1089-8; Bures J, 1976, TECHNIQUES BASIC EXP, Vxi; BURNETT WW, 1977, CAN MED ASSOC J, V117, P1277; BURROWS GE, 1984, J VET PHARMACOL THER, V7, P225, DOI 10.1111/j.1365-2885.1984.tb00904.x; Callaway NL, 2002, NEUROSCI LETT, V332, P83, DOI 10.1016/S0304-3940(02)00827-3; Chenuel B, 2015, CLIN TOXICOL, V53, P93, DOI 10.3109/15563650.2014.996570; Coletta C, 2012, P NATL ACAD SCI USA, V109, P9161, DOI 10.1073/pnas.1202916109; Cooper CE, 2008, J BIOENERG BIOMEMBR, V40, P533, DOI 10.1007/s10863-008-9166-6; Devan BD, 1999, BEHAV BRAIN RES, V100, P5, DOI 10.1016/S0166-4328(98)00107-7; Donati A, 2002, CRIT CARE MED, V30, P2271, DOI 10.1097/00003246-200210000-00015; Egi M, 2007, ANN THORAC SURG, V83, P715, DOI 10.1016/j.athoracsur.2006.08.041; EPA, 2003, 77830604 US EPA CAC; Evora PRB, 1997, ANN THORAC SURG, V63, P1212; Gachot B, 1995, INTENS CARE MED, V21, P1027, DOI 10.1007/BF01700666; Garthe A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00063; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Ginimuge Prashant R, 2010, J Anaesthesiol Clin Pharmacol, V26, P517; GRAHAM DI, 1990, STROKE, V21, P428, DOI 10.1161/01.STR.21.3.428; Grayling M, 2003, J THORAC CARDIOV SUR, V125, P426, DOI 10.1067/mtc.2003.140; GRUETTER CA, 1981, CAN J PHYSIOL PHARM, V59, P150, DOI 10.1139/y81-025; Guidotti TL, 2010, INT J TOXICOL, V29, P569, DOI 10.1177/1091581810384882; GUIDOTTI TL, 1994, INT ARCH OCC ENV HEA, V66, P153, DOI 10.1007/BF00380773; Guidotti TL, 1996, OCCUP MED-OXFORD, V46, P367, DOI 10.1093/occmed/46.5.367; Haggard HW, 1921, J BIOL CHEM, V49, P519; Haouzi P, 2015, CLIN TOXICOL, V53, P28, DOI 10.3109/15563650.2014.990976; Haouzi P, 2014, TOXICOL SCI, V141, P493, DOI 10.1093/toxsci/kfu140; Haouzi P, 2011, CRIT CARE MED, V39, P2290, DOI 10.1097/CCM.0b013e3182227550; Haouzi P, 2009, RESP PHYSIOL NEUROBI, V167, P316, DOI 10.1016/j.resp.2009.06.006; Hooser SB, 2000, J VET DIAGN INVEST, V12, P272, DOI 10.1177/104063870001200315; IWASAKI Y, 1989, J NEUROL SCI, V90, P155, DOI 10.1016/0022-510X(89)90098-1; Kamoun P, 2004, AMINO ACIDS, V26, P243, DOI 10.1007/s00726-004-0072-x; KHAN AA, 1990, TOXICOL APPL PHARM, V103, P482, DOI 10.1016/0041-008X(90)90321-K; KILBURN KH, 1993, AM J MED SCI, V306, P301, DOI 10.1097/00000441-199311000-00005; Klingerman CM, 2013, AM J PHYSIOL-REG I, V305, pR630, DOI 10.1152/ajpregu.00218.2013; Kofidis T, 2001, J THORAC CARDIOV SUR, V122, P823, DOI 10.1067/mtc.2001.115153; Kohn MC, 2002, DRUG METAB DISPOS, V30, P676, DOI 10.1124/dmd.30.6.676; Kolluru GK, 2013, REDOX BIOL, V1, P313, DOI 10.1016/j.redox.2013.05.001; Lagoutte E, 2010, BBA-BIOENERGETICS, V1797, P1500, DOI 10.1016/j.bbabio.2010.04.004; Levin RL, 2004, ANN THORAC SURG, V77, P496, DOI 10.1016/S0003-4975(03)01510-8; Leyh RG, 2003, J THORAC CARDIOV SUR, V125, P1426, DOI 10.1016/S0022-5223(02)73284-4; LINDAHL PE, 1961, EXP CELL RES, V23, P228, DOI 10.1016/0014-4827(61)90033-7; Lindner MD, 1997, COGNITIVE BRAIN RES, V5, P329, DOI 10.1016/S0926-6410(97)00006-2; LOPEZ A, 1989, FUND APPL TOXICOL, V12, P367, DOI 10.1016/0272-0590(89)90053-5; Maei HR, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.004.2009; Martijn C, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-27; MARTIN W, 1985, J PHARMACOL EXP THER, V232, P708; MAYER B, 1993, BIOCHEM PHARMACOL, V45, P367, DOI 10.1016/0006-2952(93)90072-5; Menardi AC, 2011, ACTA CIR BRAS, V26, P481, DOI 10.1590/S0102-86502011000600013; Miclescu A, 2007, RESUSCITATION, V75, P88, DOI 10.1016/j.resuscitation.2007.03.014; Midescu A, 2006, CRIT CARE MED, V34, P2806, DOI 10.1097/01.CCM.0000242517.23324.27; Mihajlovic A, 1999, THESIS TORONTO; MILBY THOMAS H., 1962, JOUR OCCUPATIONAL MED, V4, P431; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moulin FJM, 2002, TOXICOL SCI, V66, P7, DOI 10.1093/toxsci/66.1.7; Nam B, 2004, IND HEALTH, V42, P83, DOI 10.2486/indhealth.42.83; NICHOLLS P, 1961, BIOCHEM J, V81, P374, DOI 10.1042/bj0810374; Ohlow MJ, 2011, DRUG DISCOV TODAY, V16, P119, DOI 10.1016/j.drudis.2011.01.001; Olgart C, 1997, NEUROREPORT, V8, P3355, DOI 10.1097/00001756-199710200-00032; Oz M, 2011, MED RES REV, V31, P93, DOI 10.1002/med.20177; Paciullo CA, 2010, PHARMACOTHERAPY, V30, P702, DOI 10.1592/phco.30.7.702; Percy DH, 2007, PATHOLOGY LAB RODENT, Vvii; Peter C, 2000, EUR J CLIN PHARMACOL, V56, P247, DOI 10.1007/s002280000124; PREISER JC, 1995, CRIT CARE MED, V23, P259, DOI 10.1097/00003246-199502000-00010; Prusky GT, 2000, BEHAV BRAIN RES, V116, P135, DOI 10.1016/S0166-4328(00)00267-9; Rao DB, 2014, TOXICOL PATHOL, V42, P487, DOI 10.1177/0192623313501893; Rastaldo R, 2007, LIFE SCI, V81, P779, DOI 10.1016/j.lfs.2007.07.019; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pa.32.040192.000545; Riha PD, 2011, NEUROIMAGE, V54, P2623, DOI 10.1016/j.neuroimage.2010.11.023; Rojas JC, 2012, PROG NEUROBIOL, V96, P32, DOI 10.1016/j.pneurobio.2011.10.007; SALARIS SC, 1991, BIOCHEM PHARMACOL, V42, P499, DOI 10.1016/0006-2952(91)90311-R; Schneider JS, 1998, OCCUP MED-OXFORD, V48, P255, DOI 10.1093/occmed/48.4.255; SCOTT A, 1966, J BIOL CHEM, V241, P1060; Simonova Z, 2003, BEHAV BRAIN RES, V141, P195; SMILKSTEIN M J, 1985, Journal of Emergency Medicine, V3, P27, DOI 10.1016/0736-4679(85)90216-1; SMITH L, 1977, BIOCHEM PHARMACOL, V26, P2247, DOI 10.1016/0006-2952(77)90287-8; SMITH RP, 1969, TOXICOL APPL PHARM, V15, P505, DOI 10.1016/0041-008X(69)90052-0; SMITH RP, 1966, TOXICOL APPL PHARM, V8, P159, DOI 10.1016/0041-008X(66)90112-8; SMITH RP, 1976, ARCH ENVIRON HEALTH, V31, P166, DOI 10.1080/00039896.1976.10667212; SMITH RP, 1976, ANNU REV PHARMACOL, V16, P189, DOI 10.1146/annurev.pa.16.040176.001201; SMITH RP, 1979, J OCCUP ENVIRON MED, V21, P93, DOI 10.1097/00043764-197902000-00008; SMITH RP, 1967, MOL PHARMACOL, V3, P378; SNYDER JW, 1995, AM J EMERG MED, V13, P199, DOI 10.1016/0735-6757(95)90094-2; Sonobe T, 2016, CARDIOVASC TOXICOL, V16, P67, DOI 10.1007/s12012-015-9309-z; Sonobe T, 2015, CLIN TOXICOL, V53, P525, DOI 10.3109/15563650.2015.1043440; Sun YG, 2008, CARDIOVASC RES, V79, P632, DOI 10.1093/cvr/cvn140; Terry AV, 2009, FRONT NEUROSCI, P267; Truong DH, 2007, TOXICOLOGY, V242, P16, DOI 10.1016/j.tox.2007.09.009; TVEDT B, 1991, ACTA NEUROL SCAND, V84, P348, DOI 10.1111/j.1600-0404.1991.tb04967.x; TVEDT B, 1991, AM J IND MED, V20, P91, DOI 10.1002/ajim.4700200109; Van de Louw A, 2013, ANTIOXID REDOX SIGN, V19, P510, DOI 10.1089/ars.2012.4513; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wainwright M, 2005, TROP MED INT HEALTH, V10, P501, DOI 10.1111/j.1365-3156.2005.01417.x; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; WARENYCIA MW, 1990, ARCH TOXICOL, V64, P650, DOI 10.1007/BF01974693; WHISHAW IQ, 1987, BEHAV BRAIN RES, V24, P125, DOI 10.1016/0166-4328(87)90250-6; Wiklund L, 2013, ACTA ANAESTH SCAND, V57, P1073, DOI 10.1111/aas.12106; Wiklund L, 2007, ANN NY ACAD SCI, V1122, P231, DOI 10.1196/annals.1403.016; Wolfer DP, 2000, EXP PHYSIOL, V85, P627, DOI 10.1017/S0958067000020959; Wu B, 2012, BRIT J PHARMACOL, V167, P1492, DOI 10.1111/j.1476-5381.2012.02113.x; Zhang RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037073; Zhang XA, 2006, NEUROTOX RES, V9, P47, DOI 10.1007/BF03033307	115	26	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131340	10.1371/journal.pone.0131340	http://dx.doi.org/10.1371/journal.pone.0131340			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115032	gold, Green Published			2022-12-27	WOS:000358147500142
J	Yin, GD; Zhang, Y; Sun, Y; Wang, T; Zeng, ZZ; Piao, SL				Yin, Guodong; Zhang, Yuan; Sun, Yan; Wang, Tao; Zeng, Zhenzhong; Piao, Shilong			MODIS Based Estimation of Forest Aboveground Biomass in China	PLOS ONE			English	Article							CARBON STOCKS; MODERATE RESOLUTION; WOODY BIOMASS; INVENTORY; ECOSYSTEMS; EMISSIONS; STORAGE; WORLDS; SINKS; AGE	Accurate estimation of forest biomass C stock is essential to understand carbon cycles. However, current estimates of Chinese forest biomass are mostly based on inventorybased timber volumes and empirical conversion factors at the provincial scale, which could introduce large uncertainties in forest biomass estimation. Here we provide a data-driven estimate of Chinese forest aboveground biomass from 2001 to 2013 at a spatial resolution of 1 km by integrating a recently reviewed plot-level ground-measured forest aboveground biomass database with geospatial information from 1-km Moderate-Resolution Imaging Spectroradiometer (MODIS) dataset in a machine learning algorithm (the model tree ensemble, MTE). We show that Chinese forest aboveground biomass is 8.56 Pg C, which is mainly contributed by evergreen needle-leaf forests and deciduous broadleaf forests. The mean forest aboveground biomass density is 56.1 Mg C ha(-1), with high values observed in temperate humid regions. The responses of forest aboveground biomass density to mean annual temperature are closely tied to water conditions; that is, negative responses dominate regions with mean annual precipitation less than 1300 mm y(-1) and positive responses prevail in regions with mean annual precipitation higher than 2800 mm y(-1). During the 2000s, the forests in China sequestered C by 61.9 Tg C y(-1), and this C sink is mainly distributed in north China and may be attributed to warming climate, rising CO2 concentration, N deposition, and growth of young forests.	[Yin, Guodong; Zhang, Yuan; Sun, Yan; Zeng, Zhenzhong; Piao, Shilong] Peking Univ, Coll Urban & Environm Sci, Beijing 100871, Peoples R China; [Wang, Tao; Piao, Shilong] Chinese Acad Sci, Inst Tibetan Plateau Res, Beijing, Peoples R China	Peking University; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS	Piao, SL (corresponding author), Peking Univ, Coll Urban & Environm Sci, Beijing 100871, Peoples R China.	slpiao@pku.edu.cn	wang, tao/H-2830-2013; Zeng, Zhenzhong/A-2212-2019; Wang, Tao/ABE-7107-2020	wang, tao/0000-0003-4792-5898; Zeng, Zhenzhong/0000-0001-6851-2756; yin, guodong/0000-0003-3926-2609	National Natural Science Foundation of China [41125004]; Chinese Ministry of Environmental Protection Grant [201209031]; National Youth Top-notch Talent Support Program in China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Environmental Protection Grant; National Youth Top-notch Talent Support Program in China	This study was supported by the National Natural Science Foundation of China (41125004), the Chinese Ministry of Environmental Protection Grant (201209031), and the National Youth Top-notch Talent Support Program in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaya JA, 2009, FOREST ECOL MANAG, V257, P1237, DOI 10.1016/j.foreco.2008.11.016; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Baccini A, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/045011; Barriopedro D, 2012, J HYDROMETEOROL, V13, P1251, DOI 10.1175/JHM-D-11-074.1; Beaudoin A, 2014, CAN J FOREST RES, V44, P521, DOI 10.1139/cjfr-2013-0401; Blackard JA, 2008, REMOTE SENS ENVIRON, V112, P1658, DOI 10.1016/j.rse.2007.08.021; Boden TA, 2013, REGIONAL NATL FOSSIL, DOI [10.3334/CDIAC/00001_V2013, DOI 10.3334/CDIAC/00001_V2013]; Brown SL, 1999, ECOL APPL, V9, P968, DOI 10.1890/1051-0761(1999)009[0968:SPOAPA]2.0.CO;2; Drake JB, 2002, REMOTE SENS ENVIRON, V81, P378, DOI 10.1016/S0034-4257(02)00013-5; Du L, 2014, FORESTS, V5, P1267, DOI 10.3390/f5061267; Fang JY, 2007, SCI CHINA SER D, V50, P92, DOI 10.1007/s11430-007-2031-3; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Fang JY, 1998, ECOL APPL, V8, P1084, DOI 10.2307/2640963; FAO, 2006, 147 FAO; Gallaun H, 2010, FOREST ECOL MANAG, V260, P252, DOI 10.1016/j.foreco.2009.10.011; Gasparri NI, 2008, ECOSYSTEMS, V11, P1247, DOI 10.1007/s10021-008-9190-8; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Guo ZD, 2010, FOREST ECOL MANAG, V259, P1225, DOI 10.1016/j.foreco.2009.09.047; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Houghton RA, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045032; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; Institute of Geography Chinese Academy of Sciences, 1996, DIG VEG MAP CHIN MAP; Jung M, 2009, BIOGEOSCIENCES, V6, P2001, DOI 10.5194/bg-6-2001-2009; Keenan TF, 2014, NAT CLIM CHANGE, V4, P598, DOI [10.1038/nclimate2253, 10.1038/NCLIMATE2253]; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; Larjavaara M, 2012, GLOBAL ECOL BIOGEOGR, V21, P998, DOI 10.1111/j.1466-8238.2011.00740.x; Lefsky MA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023971; Lu CQ, 2012, ECOL APPL, V22, P53, DOI 10.1890/10-1685.1; Lu CQ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007990; Luo YJ, 2014, ECOLOGY, V95, P2026, DOI 10.1890/13-2089.1; Moriarty R, 2014, EARTH SYST SCI DATA, V7, P521, DOI DOI 10.5194/ESSDD-7-521-2014; Myneni RB, 2001, P NATL ACAD SCI USA, V98, P14784, DOI 10.1073/pnas.261555198; Ni J, 2001, ANN FOR SCI, V58, P351, DOI 10.1051/forest:2001131; Norby RJ, 2005, P NATL ACAD SCI USA, V102, P18052, DOI 10.1073/pnas.0509478102; Pan YD, 2004, CLIMATIC CHANGE, V67, P211, DOI 10.1007/s10584-004-2799-5; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Peng S., 2012, THESIS PEKING U BEIJ; Piao SL, 2005, J GEOPHYS RES-BIOGEO, V110, DOI 10.1029/2005JG000014; Piao SL, 2015, GLOBAL CHANGE BIOL, V21, P1601, DOI 10.1111/gcb.12795; Piao SL, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003339; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Rejou-Mechain M, 2014, BIOGEOSCIENCES, V11, P6827, DOI 10.5194/bg-11-6827-2014; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Schroeder P, 1997, FOREST SCI, V43, P424; Stegen JC, 2011, GLOBAL ECOL BIOGEOGR, V20, P744, DOI 10.1111/j.1466-8238.2010.00645.x; Tan K, 2007, FOREST ECOL MANAG, V240, P114, DOI 10.1016/j.foreco.2006.12.018; Yu GR, 2014, P NATL ACAD SCI USA, V111, P4910, DOI 10.1073/pnas.1317065111; Zhang CH, 2014, J GEOPHYS RES-BIOGEO, V119, P1163, DOI 10.1002/2013JG002515; Zhang L, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045706; Zhang XY, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025879	50	25	29	9	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130143	10.1371/journal.pone.0130143	http://dx.doi.org/10.1371/journal.pone.0130143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115195	gold, Green Published, Green Submitted			2022-12-27	WOS:000358147500053
J	Price, SJ; Garner, TWJ; Balloux, F; Ruis, C; Paszkiewicz, KH; Moore, K; Griffiths, AGF				Price, Stephen J.; Garner, Trenton W. J.; Balloux, Francois; Ruis, Chris; Paszkiewicz, Konrad H.; Moore, Karen; Griffiths, Amber G. F.			A de novo Assembly of the Common Frog (Rana temporaria) Transcriptome and Comparison of Transcription Following Exposure to Ranavirus and Batrachochytrium dendrobatidis	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; RNA-SEQ DATA; CHYTRID FUNGUS; GENE ONTOLOGY; CHYTRIDIOMYCOSIS; INFECTION; VIRUS; QUANTIFICATION; METAMORPHOSIS; INACTIVATION	Amphibians are experiencing global declines and extinctions, with infectious diseases representing a major factor. In this study we examined the transcriptional response of metamorphic hosts (common frog, Rana temporaria) to the two most important amphibian pathogens: Batrachochytrium dendrobatidis (Bd) and Ranavirus. We found strong up-regulation of a gene involved in the adaptive immune response (AP4S1) at four days post-exposure to both pathogens. We detected a significant transcriptional response to Bd, covering the immune response (innate and adaptive immunity, complement activation, and general inflammatory responses), but relatively little transcriptional response to Ranavirus. This may reflect the higher mortality rates found in wild common frogs infected with Ranavirusas opposed to Bd. These data provide a valuable genomic resource for the amphibians, contribute insight into gene expression changes after pathogen exposure, and suggest potential candidate genes for future host-pathogen research.	[Price, Stephen J.; Balloux, Francois; Ruis, Chris] UCL, Genet Inst, London, England; [Price, Stephen J.; Garner, Trenton W. J.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Paszkiewicz, Konrad H.; Moore, Karen] Univ Exeter, Wellcome Trust Biomed Informat Hub, Biosci, Exeter, Devon, England; [Griffiths, Amber G. F.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	University of London; University College London; Zoological Society of London; University of Exeter; University of Exeter	Price, SJ (corresponding author), UCL, Genet Inst, Darwin Bldg,Gower St, London, England.	s.price@ucl.ac.uk; a.griffiths3@exeter.ac.uk	Balloux, Francois/X-7856-2019; Price, Stephen J./Q-1535-2019; Garner, Trenton WJ/D-6873-2011; Balloux, Francois/D-4783-2009	Balloux, Francois/0000-0003-1978-7715; Price, Stephen J./0000-0001-6983-6250; Garner, Trenton WJ/0000-0002-0336-9706; Balloux, Francois/0000-0003-1978-7715; Griffiths, Amber/0000-0002-7455-6795	Marie Curie Intra-European Fellowship EIDpop [327293]; Royal Society Research Grant [RG130460]; Zoological Society of London; European Research Council [260801-BIG-IDEA]; Wellcome Trust Institutional Strategic Support Fund [WT097835MF]; Wellcome Trust Multi User Equipment Award [WT101650MA]; Biotechnology and Biological Sciences, Research Council (BBSRC) Strategic Longer and Larger grants (sLoLas) [BB/K003240/1]; Biotechnology and Biological Sciences Research Council [BB/K003240/1] Funding Source: researchfish; Natural Environment Research Council [NE/K014455/1, NE/M00080X/1, NE/K012509/1, NE/M000338/1] Funding Source: researchfish; BBSRC [BB/K003240/1] Funding Source: UKRI; NERC [NE/M000338/1, NE/K012509/1, NE/K014455/1, NE/M00080X/1] Funding Source: UKRI	Marie Curie Intra-European Fellowship EIDpop; Royal Society Research Grant(Royal Society of London); Zoological Society of London; European Research Council(European Research Council (ERC)European Commission); Wellcome Trust Institutional Strategic Support Fund(Wellcome Trust); Wellcome Trust Multi User Equipment Award; Biotechnology and Biological Sciences, Research Council (BBSRC) Strategic Longer and Larger grants (sLoLas)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Marie Curie Intra-European Fellowship EIDpop, (http://ec.europa.eu/research/mariecurieactions/about-mca/actions/ief/index_en.htm), grant number 327293, AGFG, Royal Society Research Grant, (https://royalsociety.org/grants/schemes/research-grants/), grant number RG130460, AGFG), Zoological Society of London internal funding, TWJG, European Research Council, (http://erc.europa.eu/funding-and-grants), grant number 260801-BIG-IDEA, FB, the sequencing was supported by the Wellcome Trust Institutional Strategic Support Fund (http://www.wellcome.ac.uk/Funding/WTP057769.htm, grant number WT097835MF), Wellcome Trust Multi User Equipment Award (http://www.wellcome.ac.uk/Funding/Biomedical-science/Funding-schemes/Strategic-awards-and-initiatives/WTDV031728.htm, grant number WT101650MA) and Biotechnology and Biological Sciences, Research Council (BBSRC) Strategic Longer and Larger grants (sLoLas) (http:// www.bbsrc.ac.uk/funding/grants/lola/lola-index.aspx, grant number BB/K003240/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2015, FASTQC QUAL CONTR TO; Aronesty E., 2011, EA UTILS COMMAND LIN; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balaz V, 2014, CONSERV BIOL, V28, P213, DOI 10.1111/cobi.12128; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benjamini Y, 1995, J R STAT SOC B; Chen GC, 2011, VIRUSES-BASEL, V3, P2065, DOI 10.3390/v3112065; Chinchar VG, 2004, VIROLOGY, V323, P268, DOI 10.1016/j.virol.2004.02.029; Chinchar VG, 2001, VIROLOGY, V288, P351, DOI 10.1006/viro.2001.1080; Cotter JD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-493; Cunningham AA, 2007, EPIDEMIOL INFECT, V135, P1200, DOI 10.1017/S0950268806007679; Cunningham AA, 1996, PHILOS T ROY SOC B, V351, P1539, DOI 10.1098/rstb.1996.0140; Ellison AR, 2015, GENOME BIOL EVOL, V7, P286, DOI 10.1093/gbe/evu285; Ellison AR, 2014, G3-GENES GENOM GENET, V4, P1275, DOI 10.1534/g3.114.010744; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fites JS, 2013, SCIENCE, V342, P366, DOI 10.1126/science.1243316; FLAJNIK MF, 1987, IMMUNOL TODAY, V8, P58, DOI 10.1016/0167-5699(87)90240-4; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grayfer L, 2012, VIRUSES-BASEL, V4, P1075, DOI 10.3390/v4071075; Green DE, 2002, ANN NY ACAD SCI, V969, P323, DOI 10.1111/j.1749-6632.2002.tb04400.x; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Jancovich JK, 2010, J VIROL, V84, P2636, DOI 10.1128/JVI.01991-09; Jancovich JK, 1997, DIS AQUAT ORGAN, V31, P161, DOI 10.3354/dao031161; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim BH, 2012, CELL HOST MICROBE, V12, P432, DOI 10.1016/j.chom.2012.09.007; Kriger KM, 2009, ECOHEALTH, V6, P6, DOI 10.1007/s10393-009-0228-y; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lacy P, 2011, BLOOD, V118, P9, DOI 10.1182/blood-2010-08-265892; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marr S, 2007, J IMMUNOL, V179, P6783, DOI 10.4049/jimmunol.179.10.6783; Miller D, 2011, VIRUSES-BASEL, V3, P2351, DOI 10.3390/v3112351; Morales HD, 2010, J VIROL, V84, P4912, DOI 10.1128/JVI.02486-09; Panchanathan V, 2010, IMMUNOL CELL BIOL, V88, P461, DOI 10.1038/icb.2009.110; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Price SJ, 2014, CURR BIOL, V24, P2586, DOI 10.1016/j.cub.2014.09.028; Reed LJ, 1938, AM J HYG, V27, P493, DOI DOI 10.1093/OXFORDJOURNALS.AJE.A118408; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Rollins-Smith LA, 1998, IMMUNOL REV, V166, P221, DOI 10.1111/j.1600-065X.1998.tb01265.x; Rosenblum EB, 2012, MOL ECOL, V21, P3110, DOI 10.1111/j.1365-294X.2012.05481.x; Savage AE, 2014, GENE, V542, P98, DOI 10.1016/j.gene.2014.03.051; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Schock DM, 2008, COPEIA, P133, DOI 10.1643/CP-06-134; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Teacher AGF, 2010, ANIM CONSERV, V13, P514, DOI 10.1111/j.1469-1795.2010.00373.x; Teacher AGF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004616; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Watts C, 2012, BBA-PROTEINS PROTEOM, V1824, P14, DOI 10.1016/j.bbapap.2011.07.006	57	25	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130500	10.1371/journal.pone.0130500	http://dx.doi.org/10.1371/journal.pone.0130500			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111016	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800055
J	Recchia, AG; Caruso, N; Bossio, S; Pellicano, M; De Stefano, L; Franzese, S; Palummo, A; Abbadessa, V; Lucia, E; Gentile, M; Vigna, E; Caracciolo, C; Agostino, A; Galimberti, S; Levato, L; Stagno, F; Molica, S; Martino, B; Vigneri, P; Di Raimondo, F; Morabito, F				Recchia, Anna Grazia; Caruso, Nadia; Bossio, Sabrina; Pellicano, Mariavaleria; De Stefano, Laura; Franzese, Stefania; Palummo, Angela; Abbadessa, Vincenzo; Lucia, Eugenio; Gentile, Massimo; Vigna, Ernesto; Caracciolo, Clementina; Agostino, Antolino; Galimberti, Sara; Levato, Luciano; Stagno, Fabio; Molica, Stefano; Martino, Bruno; Vigneri, Paolo; Di Raimondo, Francesco; Morabito, Fortunato			Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR Techniques	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; COMPLETE CYTOGENETIC RESPONSE; DIAGNOSED CHRONIC-PHASE; COMPLETE MOLECULAR REMISSION; ABL TRANSCRIPT LEVELS; PHILADELPHIA-CHROMOSOME; FOLLOW-UP; IMATINIB TREATMENT; CML; NILOTINIB	Chronic Myeloid Leukemia (CML) is characterized by a balanced translocation juxtaposing the Abelson (ABL) and breakpoint cluster region (BCR) genes. The resulting BCR-ABL1 oncogene leads to increased proliferation and survival of leukemic cells. Successful treatment of CML has been accompanied by steady improvements in our capacity to accurately and sensitively monitor therapy response. Currently, measurement of BCR-ABL1 mRNA transcript levels by real-time quantitative PCR (RQ-PCR) defines critical response endpoints. An antibody-based technique for BCR-ABL1 protein recognition could be an attractive alternative to RQ-PCR. To date, there have been no studies evaluating whether flow-cytometry based assays could be of clinical utility in evaluating residual disease in CML patients. Here we describe a flow-cytometry assay that detects the presence of BCR-ABL1 fusion proteins in CML lysates to determine the applicability, reliability, and specificity of this method for both diagnosis and monitoring of CML patients for initial response to therapy. We show that: i) CML can be properly diagnosed at onset, (ii) follow-up assessments show detectable fusion protein (i.e. relative mean fluorescent intensity, rMFI%>1) when BCRABL1(IS) transcripts are between 1-10%, and (iii) rMFI% levels predict CCyR as defined by FISH analysis. Overall, the FCBA assay is a rapid technique, fully translatable to the routine management of CML patients.	[Recchia, Anna Grazia; Bossio, Sabrina; Pellicano, Mariavaleria; De Stefano, Laura; Palummo, Angela; Morabito, Fortunato] ASP Cosenza, Biotechnol Res Unit, Aprigliano, Italy; [Caruso, Nadia; Franzese, Stefania; Lucia, Eugenio; Gentile, Massimo; Vigna, Ernesto; Morabito, Fortunato] Azienda Osped Annunziata Cosenza, Hematol Unit, Cosenza, Italy; [Abbadessa, Vincenzo; Caracciolo, Clementina] Univ Palermo, Hematol & Bone Marrow Transplantat Unit, Dept Oncol, Policlin P Giaccone, Palermo, Italy; [Agostino, Antolino] Ctr Trasfusionale Osped, Azienda Sanitaria Prov, Ragusa, Italy; [Galimberti, Sara] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Levato, Luciano; Molica, Stefano] Azienda Osped Pugliese Ciaccio, Hematol Oncol Dept, Med Oncol Unit, Catanzaro, Italy; [Stagno, Fabio; Di Raimondo, Francesco] Univ Catania, Div Ematol, Osped Ferrarotto, Catania, Italy; [Martino, Bruno] UOC Ematol Azienda Bianchi Melacrino Morelli Regg, Reggio Di Calabria, Italy; [Vigneri, Paolo] Univ Catania, Dipartimento Sci Med & Pediat, Catania, Italy	University of Palermo; University of Pisa; University of Catania; University of Catania	Morabito, F (corresponding author), ASP Cosenza, Biotechnol Res Unit, Aprigliano, Italy.	fortunato_morabito@tin.it	Di Raimondo, Francesco/K-7965-2016; Morabito, Francesco Carlo/AAB-9698-2019; Recchia, Anna Grazia/ABA-5228-2020; Gentile, Massimo/R-3270-2016; Molica, Stefano/ACY-2666-2022; Vigneri, Paolo G/K-8504-2016; Stagno, Fabio/AAH-2033-2020; Galimberti, Sara/AAB-3705-2019; Bossio, Sabrina/GVS-5999-2022	Di Raimondo, Francesco/0000-0002-7749-0293; Morabito, Francesco Carlo/0000-0003-0734-9136; Gentile, Massimo/0000-0002-5256-0726; Vigneri, Paolo G/0000-0002-5943-6066; Stagno, Fabio/0000-0002-7947-158X; , sara/0000-0001-7899-5966	Fondazione 'Amelia Scorza' Onlus, Cosenza, Italy; Progetto Screen grant	Fondazione 'Amelia Scorza' Onlus, Cosenza, Italy; Progetto Screen grant	Funding for this work came from Fondazione 'Amelia Scorza' Onlus, Cosenza, Italy to F.Mo. and A.G.R. and a Progetto Screen grant to S.F..	Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Branford S, 2008, BLOOD, V112, P3330, DOI 10.1182/blood-2008-04-150680; Branford S, 2014, BLOOD, V124, P511, DOI 10.1182/blood-2014-03-566323; Cortes J, 2009, BLOOD, V114, P267; Deininger Michael W, 2008, Hematology Am Soc Hematol Educ Program, P419, DOI 10.1182/asheducation-2008.1.419; Dekking E, 2010, BEST PRACT RES CL HA, V23, P333, DOI 10.1016/j.beha.2010.09.010; Dekking EHA, 2012, LEUKEMIA, V26, P1976, DOI 10.1038/leu.2012.125; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Gentile M, 2014, LEUKEMIA LYMPHOMA, V55, P709, DOI 10.3109/10428194.2013.811240; Goh HG, 2011, LEUKEMIA LYMPHOMA, V52, P896, DOI 10.3109/10428194.2011.555569; Goldman John M, 2007, Clin Adv Hematol Oncol, V5, P270; Hanfstein B, 2012, LEUKEMIA, V26, P2096, DOI 10.1038/leu.2012.85; Hasford J, 1998, JNCI-J NATL CANCER I, V90, P850, DOI 10.1093/jnci/90.11.850; Hasford J, 2011, BLOOD, V118, P686, DOI 10.1182/blood-2010-12-319038; Hochhaus A, 2011, BLOOD, V118, P1190; Hoffmann VS, 2015, LEUKEMIA, V29, P1336, DOI 10.1038/leu.2015.73; Huang XL, 2012, CANCER-AM CANCER SOC, V118, P3123, DOI 10.1002/cncr.26679; Hughes TP, 2014, BLOOD, V123, P1353, DOI 10.1182/blood-2013-06-510396; Hughes TP, 2010, BLOOD, V116, P3758, DOI 10.1182/blood-2010-03-273979; Hughes TP, 2003, NEW ENGL J MED, V349, P1423, DOI 10.1056/NEJMoa030513; Iacobucci I, 2006, CLIN CANCER RES, V12, P3037, DOI 10.1158/1078-0432.CCR-05-2574; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Kantarjian HM, 2012, BLOOD, V119, P1123, DOI 10.1182/blood-2011-08-376087; Kantarjian HM, 2011, LANCET ONCOL, V12, P841, DOI 10.1016/S1470-2045(11)70201-7; Lapusan S, 2015, EUR J HAEMATOL, V95, P103, DOI 10.1111/ejh.12453; Larson RA, 2012, LEUKEMIA, V26, P2197, DOI 10.1038/leu.2012.134; Lauseker M, 2014, J CANCER RES CLIN, V140, P1965, DOI 10.1007/s00432-014-1746-8; Lucas CM, 2011, HAEMATOL-HEMATOL J, V96, P1077, DOI 10.3324/haematol.2011.043166; Mahon F-X, 2010, BLOOD, V116, P2298; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Mori S., 2013, BLOOD, V122, P4040; Muller MC, 2009, LEUKEMIA, V23, P1957, DOI 10.1038/leu.2009.168; Patel H, 2007, BLOOD, V109, P1335, DOI 10.1182/blood-2006-10-050799; Press RD, 2006, BLOOD, V107, P4250, DOI 10.1182/blood-2005-11-4406; Press RD, 2007, CLIN CANCER RES, V13, P6136, DOI 10.1158/1078-0432.CCR-07-1112; Quintas-Cardama A, 2009, BLOOD, V113, P6315, DOI 10.1182/blood-2008-07-166694; Raponi S, 2009, HAEMATOL-HEMATOL J, V94, P1767, DOI 10.3324/haematol.2009.010900; Rea D, 2011, ASH ANN M ABSTR, V118, P604; Russo D, 2013, BLOOD, V121, P5138, DOI 10.1182/blood-2013-01-480194; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Sobrinho-Simoes M, 2010, BLOOD, V116, P1329, DOI 10.1182/blood-2009-11-255109; SOKAL JE, 1984, BLOOD, V63, P789, DOI 10.1182/blood.V63.4.789.789; Weerkamp F, 2009, LEUKEMIA, V23, P1106, DOI 10.1038/leu.2009.93	45	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130360	10.1371/journal.pone.0130360	http://dx.doi.org/10.1371/journal.pone.0130360			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111048	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800043
J	Shen, K; Ramirez, B; Mapes, B; Shen, GR; Gokhale, V; Brown, ME; Santarsiero, B; Ishii, Y; Dudek, SM; Wang, T; Garcia, JGN				Shen, Kui; Ramirez, Benjamin; Mapes, Brandon; Shen, Grace R.; Gokhale, Vijay; Brown, Mary E.; Santarsiero, Bernard; Ishii, Yoshitaka; Dudek, Steven M.; Wang, Ting; Garcia, Joe G. N.			Structure-Function Analysis of the Non-Muscle Myosin Light Chain Kinase (nmMLCK) Isoform by NMR Spectroscopy and Molecular Modeling: Influence of MYLK Variants	PLOS ONE			English	Article							BARRIER DYSFUNCTION; SPHINGOSINE 1-PHOSPHATE; PROTEIN-PHOSPHORYLATION; LUNG INJURY; CONFER RISK; GENE; ENDOTHELIUM; MIGRATION; CORTACTIN; COMPLEX	The MYLK gene encodes the multifunctional enzyme, myosin light chain kinase (MLCK), involved in isoform-specific non-muscle and smooth muscle contraction and regulation of vascular permeability during inflammation. Three MYLK SNPs (P21H, S147P, V261A) alter the N-terminal amino acid sequence of the non-muscle isoform of MLCK (nmMLCK) and are highly associated with susceptibility to acute lung injury (ALI) and asthma, especially in individuals of African descent. To understand the functional effects of SNP associations, we examined the N-terminal segments of nmMLCK by H-1-N-15 heteronuclear single quantum correlation (HSQC) spectroscopy, a 2-D NMR technique, and by in silico molecular modeling. Both NMR analysis and molecular modeling indicated SNP localization to loops that connect the immunoglobulin-like domains of nmMLCK, consistent with minimal structural changes evoked by these SNPs. Molecular modeling analysis identified protein-protein interaction motifs adversely affected by these MYLK SNPs including binding by the scaffold protein 14-3-3, results confirmed by immunoprecipitation and western blot studies. These structure-function studies suggest novel mechanisms for nmMLCK regulation, which may confirm MYLK as a candidate gene in inflammatory lung disease and advance knowledge of the genetic underpinning of lung-related health disparities.	[Shen, Kui; Mapes, Brandon; Shen, Grace R.; Brown, Mary E.; Dudek, Steven M.; Wang, Ting; Garcia, Joe G. N.] Univ Illinois, Inst Personalized Resp Med, Sect Pulm Crit Care Sleep & Allergy, Chicago, IL 60607 USA; [Ramirez, Benjamin; Santarsiero, Bernard; Ishii, Yoshitaka] Univ Illinois, Struct Biol Ctr, Chicago, IL USA; [Gokhale, Vijay] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA; [Gokhale, Vijay] Univ Arizona, Inst BIO5, Tucson, AZ 85721 USA; [Wang, Ting; Garcia, Joe G. N.] Univ Arizona, Arizona Resp Ctr, Tucson, AZ 85721 USA; [Wang, Ting; Garcia, Joe G. N.] Univ Arizona, Dept Med, Tucson, AZ 85721 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Arizona; University of Arizona; University of Arizona; University of Arizona	Garcia, JGN (corresponding author), Univ Illinois, Inst Personalized Resp Med, Sect Pulm Crit Care Sleep & Allergy, Chicago, IL 60607 USA.	skipgarcia@email.arizona.edu	Ishii, Yoshitaka/F-4558-2014; Santarsiero, Bernard D/N-9249-2018	Ishii, Yoshitaka/0000-0002-7724-6469; Santarsiero, Bernard D/0000-0002-9032-9699; Mapes, Brandon/0000-0001-8495-3439	National Institutes of Health / National Heart Lung and Blood Institute [HL091889, HL058064]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058064, R01HL091889] Funding Source: NIH RePORTER	National Institutes of Health / National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study is supported by National Institutes of Health / National Heart Lung and Blood Institute (http://www.nhlbi.nih.gov/) grants: HL091889 and HL058064. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Birukov KG, 2001, J BIOL CHEM, V276, P8567, DOI 10.1074/jbc.M005270200; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Brown M, 2010, MICROVASC RES, V80, P75, DOI 10.1016/j.mvr.2009.12.010; Chen Q, 2013, J CELL SCI, V126, P186, DOI 10.1242/jcs.111278; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Dudek SM, 2004, J BIOL CHEM, V279, P24692, DOI 10.1074/jbc.M313969200; Dudek SM, 2002, BIOCHEM BIOPH RES CO, V298, P511, DOI 10.1016/S0006-291X(02)02492-0; Dudek SM, 2010, MOL BIOL CELL, V21, P4042, DOI 10.1091/mbc.E09-10-0876; Fiaux J, 2002, NATURE, V418, P207, DOI 10.1038/nature00860; FIOL CJ, 1990, J BIOL CHEM, V265, P6061; Flores C, 2007, GENET EPIDEMIOL, V31, P296, DOI 10.1002/gepi.20210; Gao L, 2006, AM J RESP CELL MOL, V34, P487, DOI 10.1165/rcmb.2005-0404OC; Gao L, 2007, J ALLERGY CLIN IMMUN, V119, P1111, DOI 10.1016/j.jaci.2007.03.019; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Garcia JGN, 1998, J APPL PHYSIOL, V84, P1817, DOI 10.1152/jappl.1998.84.5.1817; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Garcia JGN, 1999, AM J PHYSIOL-LUNG C, V276, pL989, DOI 10.1152/ajplung.1999.276.6.L989; Garcia JGN, 1997, AM J RESP CELL MOL, V16, P489, DOI 10.1165/ajrcmb.16.5.9160829; Garcia Joe G. N., 1996, Seminars in Thrombosis and Hemostasis, V22, P309, DOI 10.1055/s-2007-999025; Gassner NC, 1999, BIOCHEMISTRY-US, V38, P14451, DOI 10.1021/bi9915519; Goswami T, 2012, PROTEOMICS, V12, P2185, DOI 10.1002/pmic.201200003; Gregoret LM, 1998, FOLD DES, V3, P119, DOI 10.1016/S1359-0278(98)00017-0; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; IMOTO T, 1987, PROTEIN ENG, V1, P333, DOI 10.1093/protein/1.4.333; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Koga Y, 2008, MOL BIOL CELL, V19, P1062, DOI 10.1091/mbc.E07-07-0668; Lazar V, 1999, GENOMICS, V57, P256, DOI 10.1006/geno.1999.5774; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Liu F, 2002, FASEB J, V16, P950, DOI 10.1096/fj.01-0870com; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Pendergast AM, 2005, NAT CELL BIOL, V7, P213, DOI 10.1038/ncb0305-213; Poperechnaya A, 2000, J CELL BIOL, V151, P697, DOI 10.1083/jcb.151.3.697; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Saito H, 1998, J IMMUNOL, V161, P1533; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shen K, 2005, BBA-PROTEINS PROTEOM, V1754, P65, DOI 10.1016/j.bbapap.2005.08.020; Shen K, 2012, ATLAS GENET CYTOGENE, V16, P901; Shen K, 2007, METHODS, V42, P234, DOI 10.1016/j.ymeth.2007.03.003; Shi S, 2000, AM J PHYSIOL-LUNG C, V279, pL441, DOI 10.1152/ajplung.2000.279.3.L441; Shi S, 1998, ENDOTHELIUM-J ENDOTH, V6, P153, DOI 10.3109/10623329809072202; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Songyang Z., 1994, CURR BIOL, V4, P973, DOI DOI 10.1016/S0960-9822(00)00221-9; Tinsley JH, 2000, AM J PHYSIOL-CELL PH, V279, pC1285, DOI 10.1152/ajpcell.2000.279.4.C1285; Verin AD, 1998, AM J RESP CELL MOL, V19, P767, DOI 10.1165/ajrcmb.19.5.3126; Von Castelmur E, 2008, P NATL ACAD SCI USA, V105, P1186, DOI 10.1073/pnas.0707163105; Wadgaonkar R, 2005, J CELL BIOCHEM, V95, P849, DOI 10.1002/jcb.20472; Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100; Watanabe H, 1998, FASEB J, V12, P341, DOI 10.1096/fasebj.12.3.341; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Zhao J, 2009, J ORGAN DYSFUNCTION, V5, P242; Zhao J, 2009, CELL SIGNAL, V21, P1945, DOI 10.1016/j.cellsig.2009.09.002; Zou PJ, 2006, NATURE, V439, P229, DOI 10.1038/nature04343	61	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130515	10.1371/journal.pone.0130515	http://dx.doi.org/10.1371/journal.pone.0130515			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111161	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800056
J	Huang, XC; Ci, XQ; Conran, JG; Li, J				Huang, Xiao-cui; Ci, Xiu-qin; Conran, John G.; Li, Jie			Application of DNA Barcodes in Asian Tropical Trees - A Case Study from Xishuangbanna Nature Reserve, Southwest China	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; IDENTIFICATION; PLANTS; IDENTIFY; DISCRIMINATE; COMMUNITY; PROSPECTS; TAXONOMY; PROGRESS; HISTORY	Background Within a regional floristic context, DNA barcoding is more useful to manage plant diversity inventories on a large scale and develop valuable conservation strategies. However, there are no DNA barcode studies from tropical areas of China, which represents one of the biodiversity hotspots around the world. Methodology and Principal Findings A DNA barcoding database of an Asian tropical trees with high diversity was established at Xishuangbanna Nature Reserve, Yunnan, southwest China using rbcL and matK as standard barcodes, as well as trnH-psbA and ITS as supplementary barcodes. The performance of tree species identification success was assessed using 2,052 accessions from four plots belonging to two vegetation types in the region by three methods: Neighbor-Joining, Maximum-Likelihood and BLAST. We corrected morphological field identification errors (9.6%) for the three plots using rbcL and matK based on Neighbor-Joining tree. The best barcode region for PCR and sequencing was rbcL (97.6%, 90.8%), followed by trnH-psbA (93.6%, 85.6%), while matK and ITS obtained relative low PCR and sequencing success rates. However, ITS performed best for both species (44.6-58.1%) and genus (72.8-76.2%) identification. With trnH-psbA slightly less effective for species identification. The two standard barcode rbcL and matK gave poor results for species identification (24.728.5% and 31.6-35.3%). Compared with other studies from comparable tropical forests (e.g. Cameroon, the Amazon and India), the overall performance of the four barcodes for species identification was lower for the Xishuangbanna Nature Reserve, possibly because of species/genus ratios and species composition between these tropical areas. Conclusions/Significance Although the core barcodes rbcL and matK were not suitable for species identification of tropical trees from Xishuangbanna Nature Reserve, they could still help with identification at the family and genus level. Considering the relative sequence recovery and the species identification performance, we recommend the use of trnH-psbA and ITS in combination as the preferred barcodes for tropical tree species identification in China.	[Huang, Xiao-cui; Ci, Xiu-qin; Li, Jie] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Lab Plant Phylogenet & Conservat, Kunming, Yunnan, Peoples R China; [Huang, Xiao-cui; Ci, Xiu-qin; Li, Jie] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Menglun, Yunnan, Peoples R China; [Huang, Xiao-cui; Ci, Xiu-qin; Li, Jie] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Plant Resources & Sustainable Use, Menglun, Yunnan, Peoples R China; [Huang, Xiao-cui; Ci, Xiu-qin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Conran, John G.] Univ Adelaide, Ctr Evolutionary Biol & Biodivers, Adelaide, SA 5005, Australia; [Conran, John G.] Univ Adelaide, Sch Biol Sci, Sprigg Geobiol Ctr, Adelaide, SA 5005, Australia	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Adelaide; University of Adelaide	Li, J (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Lab Plant Phylogenet & Conservat, Kunming, Yunnan, Peoples R China.	jieli@xtbg.ac.cn			Ministry of Science and Technology (MOST) [2012FY110400]; National Nature Science Foundation of China [31011120470-03]; CAS 135 program [XTBG-T01]; Direct For Biological Sciences [1354741] Funding Source: National Science Foundation	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS 135 program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding: The study was supported by a Ministry of Science and Technology (MOST) Grant (2012FY110400), the National Nature Science Foundation of China (31011120470-03), and the CAS 135 program (XTBG-T01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arca M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034089; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Bleeker W, 2008, BIOL CONSERV, V141, P692, DOI 10.1016/j.biocon.2007.12.015; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Bruni I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043256; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; Costion C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026841; Cowan RS, 2006, TAXON, V55, P611, DOI 10.2307/25065638; Dainou K, 2010, MOL ECOL, V19, P4462, DOI 10.1111/j.1365-294X.2010.04831.x; de Vere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037945; DeSaille R, 2007, BIOESSAYS, V29, P1289, DOI 10.1002/bies.20667; Devey DS, 2009, TAXON, V58, P7, DOI 10.1002/tax.581003; Dexter KG, 2010, ECOL MONOGR, V80, P267, DOI 10.1890/09-0267.1; Ebihara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015136; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Gu J, 2011, J SYST EVOL, V49, P213, DOI 10.1111/j.1759-6831.2011.00136.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; JANZEN DH, 1988, SCIENCE, V239, P243, DOI 10.1126/science.239.4837.243; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015409; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lanfear R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2836; Le Clerc-Blain J, 2010, MOL ECOL RESOUR, V10, P69, DOI 10.1111/j.1755-0998.2009.02725.x; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Liu J, 2012, INT J MOL SCI, V13, P8740, DOI 10.3390/ijms13078740; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Luo K, 2010, SCI CHINA LIFE SCI, V53, P701, DOI 10.1007/s11427-010-4009-1; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Mort ME, 2010, TAXON, V59, P581, DOI 10.1002/tax.592022; Muellner AN, 2011, MOL ECOL RESOUR, V11, P450, DOI 10.1111/j.1755-0998.2011.02984.x; Newmaster SG, 2008, MOL ECOL RESOUR, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Pang XH, 2011, CLADISTICS, V27, P165, DOI 10.1111/j.1096-0031.2010.00328.x; Parmentier I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054921; Piredda R, 2011, MOL ECOL RESOUR, V11, P72, DOI 10.1111/j.1755-0998.2010.02900.x; Ragupathy S, 2009, MOL ECOL RESOUR, V9, P164, DOI 10.1111/j.1755-0998.2009.02641.x; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripathi AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057934; Van De Wiel CCM, 2009, MOL ECOL RESOUR, V9, P1086, DOI 10.1111/j.1755-0998.2009.02547.x; Wang WQ, 2010, BMC PLANT BIOL, V10, DOI [10.1186/1471-2229-10-205, 10.1186/1471-2229-10-14]; Wang YiHong, 2009, Acta Horticulturae Sinica, V36, P1651; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; Zhu H, 2006, BIOTROPICA, V38, P310, DOI 10.1111/j.1744-7429.2006.00147.x; Zhu H, 2007, CLASSIFICATION FORES	63	23	26	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0129295	10.1371/journal.pone.0129295	http://dx.doi.org/10.1371/journal.pone.0129295			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121045	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400018
J	Lugo, JS; Cadavid, LF				Lugo, Juan S.; Cadavid, Luis F.			Patterns of MHC-G-Like and MHC-B Diversification in New World Monkeys	PLOS ONE			English	Article							CLASS-I GENES; MAJOR HISTOCOMPATIBILITY COMPLEX; RECEPTORS; EVOLUTION; INFERENCE; PRIMATE; PROTEIN; REGION; LOCUS; RECOGNITION	The MHC class I (MHC-I) region in New World monkeys (Platyrrhini) has remained relatively understudied. To evaluate the diversification patterns and transcription behavior of MHC-I in Platyrrhini, we first analyzed public genomic sequences from the MHC-G-like subregion in Saimiri boliviensis, Ateles geoffroyi and Callicebus moloch, and from the MHC-B subregion in Saimiri boliviensis. While S. boliviensis showed multiple copies of both MHC-G-like (10) and -B (15) loci, A. geoffroyi and C. moloch had only three and four MHC-G-like genes, respectively, indicating that not all Platyrrhini species have expanded their MHC-I loci. We then sequenced MHC-G-like and -B cDNAs from nine Platyrrhini species, recovering two to five unique cDNAs per individual for both loci classes. In two Saguinus species, however, no MHC-B cDNAs were found. In phylogenetic trees, MHC-G-like cDNAs formed genus-specific clusters whereas the MHC-B cDNAs grouped by Platyrrhini families, suggesting a more rapid diversification of the former. Furthermore, cDNA sequencing in 12 capuchin monkeys showed that they transcribe at least four MHC-G-like and five MHC-B polymorphic genes, showing haplotypic diversity for gene copy number and signatures of positive natural selection at the peptide binding region. Finally, a quantitative index for MHC:KIR affinity was proposed and tested to predict putative interacting pairs. Altogether, our data indicate that i) MHC-I genes has expanded differentially among Platyrrhini species, ii) Callitrichinae (tamarins and marmosets) MHC-B loci have limited or tissue-specific expression, iii) MHC-G-like genes have diversified more rapidly than MHC-B genes, and iv) the MHC-I diversity is generated mainly by genetic polymorphism and gene copy number variation, likely promoted by natural selection for ligand binding.	[Cadavid, Luis F.] Univ Nacl Colombia, Dept Biol, Bogota, Colombia; Univ Nacl Colombia, Inst Genet, Bogota, Colombia	Universidad Nacional de Colombia; Universidad Nacional de Colombia	Cadavid, LF (corresponding author), Univ Nacl Colombia, Dept Biol, Bogota, Colombia.	lfcadavidg@unal.edu.co	Lugo-Ramos, Juan Sebastian/AAO-7191-2020	Lugo Ramos, Juan Sebastian/0000-0003-3471-3503; Cadavid, Luis F./0000-0002-6778-7958				Abi-Rached L, 2010, J IMMUNOL, V184, P1379, DOI 10.4049/jimmunol.0903016; Adams EJ, 2001, IMMUNOL REV, V183, P41, DOI 10.1034/j.1600-065x.2001.1830104.x; Aguilar AMO, 2011, IMMUNOGENETICS, V63, P543, DOI 10.1007/s00251-011-0527-7; Aguilar AMO, 2010, J IMMUNOL, V185, P4238, DOI 10.4049/jimmunol.1001494; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker M, 2012, NAT METHODS, V9, P333, DOI 10.1038/nmeth.1935; Cadavid LF, 1997, P NATL ACAD SCI USA, V94, P14536, DOI 10.1073/pnas.94.26.14536; Cadavid LF, 2013, IMMUNOGENETICS, V65, P725, DOI 10.1007/s00251-013-0719-4; Champ PC, 2007, NUCLEIC ACIDS RES, V35, pW556, DOI 10.1093/nar/gkm326; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Daza-Vamenta R, 2004, GENOME RES, V14, P1501, DOI 10.1101/gr.2134504; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Eimes JA, 2013, IMMUNOGENETICS, V65, P133, DOI 10.1007/s00251-012-0664-7; Ellis S, 2004, VET IMMUNOL IMMUNOP, V102, P1, DOI 10.1016/j.vetimm.2004.06.007; Fukami-Kobayashi K, 2005, P NATL ACAD SCI USA, V102, P9230, DOI 10.1073/pnas.0500770102; Gaudieri S, 1999, GENOME RES, V9, P541; Hammond JA, 2012, IMMUNOGENETICS, V64, P915, DOI 10.1007/s00251-012-0651-z; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Knapp LA, 1998, J IMMUNOL, V160, P189; Kono A, 2014, J IMMUNOL, V192, P3239, DOI 10.4049/jimmunol.1302745; LEBOUTEILLER P, 1994, CRIT REV IMMUNOL, V14, P89, DOI 10.1615/CritRevImmunol.v14.i2.10; McConnell SC, 2014, IMMUNOGENETICS, V66, P199, DOI 10.1007/s00251-013-0749-y; Moesta AK, 2009, J IMMUNOL, V182, P3628, DOI 10.4049/jimmunol.0803401; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Nikolich-Zugich J, 2004, MICROBES INFECT, V6, P501, DOI 10.1016/j.micinf.2004.01.006; Otting N, 2005, P NATL ACAD SCI USA, V102, P1626, DOI 10.1073/pnas.0409084102; Parham P, 2013, NAT REV IMMUNOL, V13, P133, DOI 10.1038/nri3370; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosner C, 2011, J IMMUNOL, V186, P2156, DOI 10.4049/jimmunol.1002634; Sawai H, 2004, GENETICS, V166, P1897, DOI 10.1534/genetics.166.4.1897; Schrago CG, 2007, AM J PHYS ANTHROPOL, V132, P344, DOI 10.1002/ajpa.20459; Shiina T, 2011, IMMUNOGENETICS, V63, P485, DOI 10.1007/s00251-011-0526-8; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van der Wiel MK, 2013, IMMUNOGENETICS, V65, P841, DOI 10.1007/s00251-013-0732-7; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; WATKINS DI, 1990, NATURE, V346, P60, DOI 10.1038/346060a0; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	42	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131343	10.1371/journal.pone.0131343	http://dx.doi.org/10.1371/journal.pone.0131343			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121030	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400099
J	Nagayasu-Tanaka, T; Anzai, J; Takaki, S; Shiraishi, N; Terashima, A; Asano, T; Nozaki, T; Kitamura, M; Murakami, S				Nagayasu-Tanaka, Toshie; Anzai, Jun; Takaki, Shu; Shiraishi, Noriko; Terashima, Akio; Asano, Taiji; Nozaki, Takenori; Kitamura, Masahiro; Murakami, Shinya			Action Mechanism of Fibroblast Growth Factor-2 (FGF-2) in the Promotion of Periodontal Regeneration in Beagle Dogs	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; III FURCATION DEFECTS; MARROW STROMAL CELLS; LIGAMENT CELLS; WOUND HEALING/REGENERATION; OSTEOGENIC DIFFERENTIATION; DIABETIC MICE; STEM-CELLS; IN-VITRO; ATTACHMENT	Fibroblast growth factor-2 (FGF-2) enhances the formation of new alveolar bone, cementum, and periodontal ligament (PDL) in periodontal defect models. However, the mechanism through which FGF-2 acts in periodontal regeneration in vivo has not been fully clarified yet. To reveal the action mechanism, the formation of regenerated tissue and gene expression at the early phase were analyzed in a beagle dog 3-wall periodontal defect model. FGF-2 (0.3%) or the vehicle (hydroxypropyl cellulose) only were topically applied to the defect in FGF-2 and control groups, respectively. Then, the amount of regenerated tissues and the number of proliferating cells at 3, 7, 14, and 28 days and the number of blood vessels at 7 days were quantitated histologically. Additionally, the expression of osteogenic genes in the regenerated tissue was evaluated by real-time PCR at 7 and 14 days. Compared with the control, cell proliferation around the existing bone and PDL, connective tissue formation on the root surface, and new bone formation in the defect at 7 days were significantly promoted by FGF-2. Additionally, the number of blood vessels at 7 days was increased by FGF-2 treatment. At 28 days, new cementum and PDL were extended by FGF-2. Moreover, FGF-2 increased the expression of bone morphogenetic protein 2 (BMP-2) and osteoblast differentiation markers (osterix, alkaline phosphatase, and osteocalcin) in the regenerated tissue. We revealed the facilitatory mechanisms of FGF-2 in periodontal regeneration in vivo. First, the proliferation of fibroblastic cells derived from bone marrow and PDL was accelerated and enhanced by FGF-2. Second, angiogenesis was enhanced by FGF-2 treatment. Finally, osteoblastic differentiation and bone formation, at least in part due to BMP-2 production, were rapidly induced by FGF-2. Therefore, these multifaceted effects of FGF-2 promote new tissue formation at the early regeneration phase, leading to enhanced formation of new bone, cementum, and PDL.	[Nagayasu-Tanaka, Toshie; Anzai, Jun; Takaki, Shu; Shiraishi, Noriko; Terashima, Akio; Asano, Taiji] Kaken Pharmaceut Co LTD, Drug Res Ctr, Dept Pharmacol, Kyoto, Kyoto, Japan; [Nagayasu-Tanaka, Toshie; Nozaki, Takenori; Kitamura, Masahiro; Murakami, Shinya] Osaka Univ, Dept Periodontol, Grad Sch Dent, Suita, Osaka, Japan	Kaken Pharmaceutical Co Ltd; Osaka University	Murakami, S (corresponding author), Osaka Univ, Dept Periodontol, Grad Sch Dent, Suita, Osaka, Japan.	ipshinya@dent.osaka-u.ac.jp		Murakami, Shinya/0000-0002-5230-452X	Kaken Pharmaceutical Co., Ltd.; Osaka University Graduate School of Dentistry	Kaken Pharmaceutical Co., Ltd.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Osaka University Graduate School of Dentistry	This study was supported by Kaken Pharmaceutical Co., Ltd. and Osaka University Graduate School of Dentistry, which proposed study protocol and was responsible for data collection and prespecified statistical analysis.	Anzai J, 2010, BIOCHEM BIOPH RES CO, V403, P345, DOI 10.1016/j.bbrc.2010.11.032; Celil AB, 2005, J CELL BIOCHEM, V95, P518, DOI 10.1002/jcb.20429; Chen D, 1997, CALCIFIED TISSUE INT, V60, P283, DOI 10.1007/s002239900230; CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277; Cohen MM, 2002, AM J MED GENET, V109, P87, DOI 10.1002/ajmg.10289; Dickinson DP, 2013, J CLIN PERIODONTOL, V40, P527, DOI 10.1111/jcpe.12055; Fang TD, 2005, J BONE MINER RES, V20, P1114, DOI 10.1359/JBMR.050301; Farhadi J, 2005, PLAST RECONSTR SURG, V116, P1379, DOI 10.1097/01.prs.0000182355.67397.5a; Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174; Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P669, DOI 10.1111/j.1600-051X.1997.tb00248.x; Hanada K, 1997, J BONE MINER RES, V12, P1606, DOI 10.1359/jbmr.1997.12.10.1606; HERR Y, 1995, J PERIODONTOL, V66, P716, DOI 10.1902/jop.1995.66.8.716; Kim TG, 2009, J CLIN PERIODONTOL, V36, P589, DOI 10.1111/j.1600-051X.2009.01420.x; Kinoshita A, 1997, J PERIODONTOL, V68, P103, DOI 10.1902/jop.1997.68.2.103; Kitamura M, 2011, J DENT RES, V90, P35, DOI 10.1177/0022034510384616; Kitamura M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002611; Kono K, 2013, CELL TISSUE RES, V352, P249, DOI 10.1007/s00441-012-1543-0; LYNCH SE, 1989, J CLIN PERIODONTOL, V16, P545, DOI 10.1111/j.1600-051X.1989.tb02334.x; MAYAHARA H, 1993, GROWTH FACTORS, V9, P73, DOI 10.3109/08977199308991583; Murakami S, 2003, J PERIODONTAL RES, V38, P97, DOI 10.1034/j.1600-0765.2003.00640.x; Murakami S, 1999, J PERIODONTAL RES, V34, P425, DOI 10.1111/j.1600-0765.1999.tb02277.x; Murakami Y, 2003, J PERIODONTOL, V74, P780, DOI 10.1902/jop.2003.74.6.780; NAKAMURA T, 1995, ENDOCRINOLOGY, V136, P1276, DOI 10.1210/en.136.3.1276; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nevins M, 2005, J PERIODONTOL, V76, P2205, DOI 10.1902/jop.2005.76.12.2205; Nishimura F, 1996, J DENT RES, V75, P986, DOI 10.1177/00220345960750041401; NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x; Okumura M, 1996, BIOL PHARM BULL, V19, P530; OWEN M, 1988, J CELL SCI, P63; PITARU S, 1993, J BONE MINER RES, V8, P919; Pri-Chen S, 1998, BONE, V23, P111, DOI 10.1016/S8756-3282(98)00087-8; Rossa C, 2000, J PERIODONTOL, V71, P775, DOI 10.1902/jop.2000.71.5.775; Sato Y, 2004, J PERIODONTOL, V75, P243, DOI 10.1902/jop.2004.75.2.243; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; SIGURDSSON TJ, 1995, J PERIODONTOL, V66, P131, DOI 10.1902/jop.1995.66.2.131; Takahashi D, 2005, J PERIODONTAL RES, V40, P299, DOI 10.1111/j.1600-0765.2005.00794.x; Takayama S, 2001, J DENT RES, V80, P2075, DOI 10.1177/00220345010800121001; Takayama S, 1997, J PERIODONTAL RES, V32, P667, DOI 10.1111/j.1600-0765.1997.tb00577.x; Takeda K, 2005, TISSUE ENG, V11, P1618, DOI 10.1089/ten.2005.11.1618; Tanaka E, 1996, BIOL PHARM BULL, V19, P1141; TERRANOVA VP, 1989, J PERIODONTOL, V60, P293, DOI 10.1902/jop.1989.60.6.293; Wikesjo UME, 1999, J CLIN PERIODONTOL, V26, P392, DOI 10.1034/j.1600-051X.1999.260610.x; Yanagita M, 2014, J DENT RES, V93, P89, DOI 10.1177/0022034513511640	43	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131870	10.1371/journal.pone.0131870	http://dx.doi.org/10.1371/journal.pone.0131870			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26120833	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400170
J	Qian, Y; Tang, LN; Qiu, QY; Xu, T; Liao, JF				Qian, Yao; Tang, Lina; Qiu, Quanyi; Xu, Tong; Liao, Jiangfu			A Comparative Analysis on Assessment of Land Carrying Capacity with Ecological Footprint Analysis and Index System Method	PLOS ONE			English	Article							SUSTAINABILITY; CONSTRUCTION	Land carrying capacity (LCC) explains whether the local land resources are effectively used to support economic activities and/or human population. LCC can be evaluated commonly with two approaches, namely ecological footprint analysis (EFA) and the index system method (ISM). EFA is helpful to investigate the effects of different land categories whereas ISM can be used to evaluate the contributions of social, environmental, and economic factors. Here we compared the two LCC-evaluation approaches with data collected from Xiamen City, a typical region where rapid economic growth and urbanization are found in China. The results show that LCC assessments with EFA and ISM not only complement each other but also are mutually supportive. Both assessments suggest that decreases in arable land and increasingly high energy consumption have major negative effects on LCC and threaten sustainable development for Xiamen City. It is important for the local policy makers, planners and designers to reduce ecological deficits by controlling fossil energy consumption, protecting arable land and forest land from converting into other land types, and slowing down the speed of urbanization, and to promote sustainability by controlling rural-to-urban immigration, increasing hazard-free treatment rate of household garbage, and raising energy consumption per unit industrial added value. Although EFA seems more appropriate for estimating LCC for a resource-output or self-sufficient region and ISM is more suitable for a resource-input region, both approaches should be employed when perform LCC assessment in any places around the world.	[Qian, Yao; Tang, Lina; Qiu, Quanyi; Xu, Tong; Liao, Jiangfu] Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China	Chinese Academy of Sciences; Institute of Urban Environment, CAS	Tang, LN (corresponding author), Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China.	lntang@iue.ac.cn	CAS, KLUEH/T-5743-2019; Tang, Lina/N-8708-2019	Tang, Lina/0000-0001-7975-2472; Xu, Tong/0000-0002-9713-9281	National Natural Science Foundation of China [41101143]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (41101143).	Bagliani M, 2008, J ENVIRON MANAGE, V86, P354, DOI 10.1016/j.jenvman.2006.04.015; Blomqvist L, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001700; Chambers N, 2000, SHARING NATURES INTE; Chen B.M., 1991, J NAT RESOUR, V6, P197; FAO Subregional Office for Southern and East Africa Harare, 2004, DROUGHT IMP MIT PREV; Fiala N, 2008, ECOL ECON, V67, P519, DOI 10.1016/j.ecolecon.2008.07.023; Guo ZW, 2008, URBAN STUD, V15, P24; Hopton ME, 2012, J ENVIRON MANAGE, V111, P279, DOI 10.1016/j.jenvman.2011.07.005; Justice C, 2015, J ENVIRON MANAGE, V148, P4, DOI 10.1016/j.jenvman.2014.12.004; KESSLER JJ, 1994, AGR ECOSYST ENVIRON, V48, P273, DOI 10.1016/0167-8809(94)90109-0; Kitzes J, 2009, ECOL ECON, V68, P1991, DOI 10.1016/j.ecolecon.2008.06.022; Komatsu Y, 2005, AGR ECOSYST ENVIRON, V108, P29, DOI 10.1016/j.agee.2004.12.017; Lan DD, 2007, J SHENYANG NORMAL U, V25, P252; Lane M, 2010, LAND USE POLICY, V27, P1038, DOI 10.1016/j.landusepol.2010.01.006; Liu LW, 2012, THESIS NE AGR U; Liu Mou-cheng, 2010, Shengtaixue Zazhi, V29, P592; Liu XL, 2008, ENV SCI MANAGEMENT, V33, P54; Ma HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030396; Malthus T. R., 1986, ESSAY PRINCIPLE POPU; McManus P, 2006, ENVIRON URBAN, V18, P113, DOI 10.1177/0956247806063963; Moore J, 2013, J ENVIRON MANAGE, V124, P51, DOI 10.1016/j.jenvman.2013.03.009; Qiu DD, 2011, PROCEDIA ENGINEER, V21, P439, DOI 10.1016/j.proeng.2011.11.2036; Rees W.E., 1996, OUR ECOLOGICAL FOOTP; Rees WE, 2000, ECOL ECON, V32, P371; Rees WE, 2013, ENCY BIODI VERSITY, V2, P701, DOI [10.1016/B978-0-12-384719-5.00037-X, DOI 10.1016/B978-0-12-384719-5.00037-X]; Seidl I, 1999, ECOL ECON, V31, P395, DOI 10.1016/S0921-8009(99)00063-4; Shi YS, 2013, COMPUT ENVIRON URBAN, V39, P27, DOI 10.1016/j.compenvurbsys.2013.02.002; Tang LN, 2013, CITIES, V31, P615, DOI 10.1016/j.cities.2012.09.001; Vogt William, 1948, ROAD SURVIVAL; Wackernagel M, 1999, ECOL ECON, V29, P375, DOI 10.1016/S0921-8009(98)90063-5; Wackernagel M, 2002, P NATL ACAD SCI USA, V99, P9266, DOI 10.1073/pnas.142033699; WANG SH, 2001, J NATURAL RESOURCES, V16, P248; Wei C, 2014, OCEAN COAST MANAGE, V93, P51, DOI 10.1016/j.ocecoaman.2014.02.009; World Wild Fund for Nature, 2012, CHIN EC FOOTPR REP 2; World Wild Fund for Nature, 2010, CHIN EC FOOTPR REP 2; World Wild Fund for Nature, 2014, EC FOOTPR SUST CONS; [夏春云 XIA Chunyun], 2006, [中国土地科学, China Land Science], V20, P19; Zhao Jing-zhu, 2009, Huanjing Kexue, V30, P1244; Zhao JZ, 2013, INT J SUST DEV WORLD, V20, P195, DOI 10.1080/13504509.2013.784882; Zhu Y, 2007, THESIS E CHINA NORMA	40	11	12	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0130315	10.1371/journal.pone.0130315	http://dx.doi.org/10.1371/journal.pone.0130315			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121142	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400037
J	Strobele, S; Schneider, M; Schneele, L; Siegelin, MD; Nonnenmacher, L; Zhou, SX; Karpel-Massle, G; Westhoff, MA; Halatsch, ME; Debatin, KM				Stroebele, Stephanie; Schneider, Matthias; Schneele, Lukas; Siegelin, Markus D.; Nonnenmacher, Lisa; Zhou, Shaoxia; Karpel-Massle, Georg; Westhoff, Mike-Andrew; Halatsch, Marc-Eric; Debatin, Klaus-Michael			A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy	PLOS ONE			English	Article							GLIOMA-CELL LINES; MALIGNANT GLIOMA; GENE-EXPRESSION; DUAL INHIBITOR; CANCER; DIFFERENTIATION; PROTEIN; TEMOZOLOMIDE; APOPTOSIS; 3-KINASE	Glioblastoma multiforme (GBM) is the most common primary brain tumor and among the most difficult to treat malignancies per se. In almost 90% of all GBM alterations in the PI3K/Akt/ mTOR have been found, making this survival cascade a promising therapeutic target, particular for combination therapy that combines an apoptosis sensitizer, such as a pharmacological inhibitor of PI3K, with an apoptosis inducer, such as radio- or chemotherapy. However, while in vitro data focusing mainly on established cell lines has appeared rather promising, this has not translated well to a clinical setting. In this study, we analyze the effects of the dual kinase inhibitor PI-103, which blocks PI3K and mTOR activity, on three matched pairs of GBM stem cells/differentiated cells. While blocking PI3K-mediated signaling has a profound effect on cellular proliferation, in contrast to data presented on two GBM cell lines (A172 and U87) PI-103 actually counteracts the effect of chemotherapy. While we found no indications for a potential role of the PI3K signaling cascade in differentiation, we saw a clear and strong contribution to cellular motility and, by extension, invasion. While blocking PI3K-mediated signaling concurrently with application of chemotherapy does not appear to be a valid treatment option, pharmacological inhibitors, such as PI-103, nevertheless have an important place in future therapeutic approaches.	[Stroebele, Stephanie; Schneider, Matthias; Schneele, Lukas; Nonnenmacher, Lisa; Westhoff, Mike-Andrew; Debatin, Klaus-Michael] Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Ulm, Germany; [Stroebele, Stephanie; Schneider, Matthias; Karpel-Massle, Georg; Halatsch, Marc-Eric] Univ Med Ctr Ulm, Dept Neurosurg, Ulm, Germany; [Siegelin, Markus D.; Karpel-Massle, Georg] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY USA; [Zhou, Shaoxia] Univ Med Ctr Ulm, Dept Clin Chem, Ulm, Germany	Ulm University; Ulm University; Columbia University; Ulm University	Westhoff, MA (corresponding author), Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Ulm, Germany.	andrew.westhoff@uniklinik-ulm.de	Halatsch, Marc-Eric/B-7807-2008; Debatin, Klaus-Michael/J-9704-2014; Westhoff, Mike-Andrew/ABA-9272-2021	Debatin, Klaus-Michael/0000-0002-8397-1886; Westhoff, Mike-Andrew/0000-0003-3256-7100	Forderkreis fur tumor- und leukamiekranke Kinder Ulm e.V.; Bausteinforderung of Ulm University; Dr. Mildred Scheel postdoctoral scholarship of the German Cancer Aid	Forderkreis fur tumor- und leukamiekranke Kinder Ulm e.V.; Bausteinforderung of Ulm University; Dr. Mildred Scheel postdoctoral scholarship of the German Cancer Aid	MAW and KMD were partially supported by the Forderkreis fur tumor- und leukamiekranke Kinder Ulm e.V., LN by the Bausteinforderung of Ulm University and GKM by a Dr. Mildred Scheel postdoctoral scholarship of the German Cancer Aid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan D, 2010, NEURO-ONCOLOGY, V12, P882, DOI 10.1093/neuonc/noq052; Bagci-Onder T, 2011, CANCER RES, V71, P154, DOI 10.1158/0008-5472.CAN-10-1601; Burris HA, 2013, CANCER CHEMOTH PHARM, V71, P829, DOI 10.1007/s00280-012-2043-3; Carragher NO, 2003, CURR BIOL, V13, P1442, DOI 10.1016/S0960-9822(03)00544-X; Chabot GG, 1997, CLIN PHARMACOKINET, V33, P245, DOI 10.2165/00003088-199733040-00001; Chen DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087281; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choi EJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-17; Cloughesy TF, 2014, ANNU REV PATHOL-MECH, V9, P1, DOI 10.1146/annurev-pathol-011110-130324; Cong ZX, 2013, ONCOL REP, V30, P715, DOI 10.3892/or.2013.2485; del Alcazar CRG, 2014, CLIN CANCER RES, V20, P1235, DOI 10.1158/1078-0432.CCR-13-1607; Edwards LA, 2006, MOL CANCER THER, V5, P645, DOI 10.1158/1535-7163.MCT-05-0099; Ene CI, 2011, CANCER CELL, V20, P695, DOI 10.1016/j.ccr.2011.11.018; Enzenmuller S, 2012, CANC LETT; Evans C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076505; Fan QW, 2011, CURR TOP MICROBIOL, V347, P279, DOI 10.1007/82_2010_67; Georgakis GV, 2006, BRIT J HAEMATOL, V132, P503, DOI 10.1111/j.1365-2141.2005.05881.x; Giese A, 2003, ACT NEUR S, V88, P153; Gilbert CA, 2009, J CELL BIOCHEM, V108, P1031, DOI 10.1002/jcb.22350; Gont A, 2013, ONCOTARGET, V4, P1266, DOI 10.18632/oncotarget.1164; Hamer PCDW, 2008, ONCOGENE, V27, P2091, DOI 10.1038/sj.onc.1210850; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Johannessen TCA, 2008, CANCER TREAT REV, V34, P558, DOI 10.1016/j.ctrv.2008.03.125; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Karpel-Massler G, 2014, ANTI-CANCER AGENT ME, V14, P313, DOI 10.2174/18715206113136660340; Kil WJ, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-25; Kuger S, 2013, TRANSL ONCOL, V6, P169, DOI 10.1593/tlo.12364; Kyurkchiev D, 2014, CELL MOL NEUROBIOL, V34, P479, DOI 10.1007/s10571-014-0031-3; Lefranc F, 2009, ADV TECH STAND NEURO, V34, P3, DOI 10.1007/978-3-211-78741-0_1; Leszczyniecka M, 2001, PHARMACOL THERAPEUT, V90, P105, DOI 10.1016/S0163-7258(01)00132-2; Li AG, 2008, MOL CANCER RES, V6, P21, DOI 10.1158/1541-7786.MCR-07-0280; Li Y, 2010, ACTA PHARMACOL SIN, V31, P355, DOI 10.1038/aps.2010.10; Liu ZL, 2014, INT J ONCOL, V44, P1571, DOI 10.3892/ijo.2014.2322; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Mendiburu-Elicable M, 2014, CLIN TRANSL ONCOL, V16, P495, DOI 10.1007/s12094-013-1109-y; Mitchison TJ, 2012, MOL BIOL CELL, V23, P1, DOI 10.1091/mbc.E10-04-0335; Nonnenmacher L, 2015, INT J CANCER, V136, pE173, DOI 10.1002/ijc.29138; Opel D, 2008, CANCER RES, V68, P6271, DOI 10.1158/0008-5472.CAN-07-6769; Park S, 2008, LEUKEMIA, V22, P1698, DOI 10.1038/leu.2008.144; Rixe O, 2007, CLIN CANCER RES, V13, P7280, DOI 10.1158/1078-0432.CCR-07-2141; See WL, 2012, CANCER RES, V72, P3350, DOI 10.1158/0008-5472.CAN-12-0334; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2007, NAT BIOTECHNOL, V25, P193, DOI 10.1038/nbt0207-193; Sunayama J, 2011, STEM CELLS, V29, P1327, DOI 10.1002/stem.696; Sunayama J, 2010, NEURO-ONCOLOGY, V12, P1205, DOI 10.1093/neuonc/noq103; TISDALE MJ, 1985, BRIT J CANCER, V52, P789, DOI 10.1038/bjc.1985.259; Vogel TW, 2005, CLIN CANCER RES, V11, P3624, DOI 10.1158/1078-0432.CCR-04-2115; Wang MH, 2013, MOL MED REP, V7, P1912, DOI 10.3892/mmr.2013.1434; Westhoff MA, 2008, ONCOGENE, V27, P5169, DOI 10.1038/onc.2008.148; Westhoff MA, 2009, ONCOGENE, V28, P3586, DOI 10.1038/onc.2009.215; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004; Westhoff Mike-Andrew, 2014, Mol Cell Ther, V2, P32, DOI 10.1186/2052-8426-2-32; Westhoff MA, 2014, INT J MOL SCI, V15, P3746, DOI 10.3390/ijms15033746; Westhoff MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083128; Yao YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095060; Zhu YN, 2014, CANCER BIOL THER, V15, P815, DOI 10.4161/cbt.28585; Zou ZQ, 2009, INT J MOL MED, V24, P97, DOI 10.3892/ijmm_00000212	60	33	35	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131670	10.1371/journal.pone.0131670	http://dx.doi.org/10.1371/journal.pone.0131670			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121251	gold, Green Published, Green Submitted			2022-12-27	WOS:000358150400137
J	Xiao, D; Yang, T; Desneux, N; Han, P; Gao, XW				Xiao, Da; Yang, Ting; Desneux, Nicolas; Han, Peng; Gao, Xiwu			Assessment of Sublethal and Transgenerational Effects of Pirimicarb on the Wheat Aphids Rhopalosiphum padi and Sitobion avenae	PLOS ONE			English	Article							PLUTELLA-XYLOSTELLA L; DIAMONDBACK MOTH; CHEMISTRY INSECTICIDES; BENEFICIAL ARTHROPODS; LEPIDOPTERA-NOCTUIDAE; HOMOPTERA-APHIDIDAE; BIOLOGICAL TRAITS; PEST-MANAGEMENT; ENZYME-ACTIVITY; ACETYLCHOLINESTERASE	The wheat aphids, Rhopalosiphum padi (Linnaeus) and Sitobion avenae (Fabricius), are key pests on wheat crops worldwide. Management practices rely primarily on insecticides. The pirimicarb (carbamate) is used extensively as an effective insecticide to control these two aphids. In addition to the mortality caused by pirimicarb, various sublethal effects may occur in aphids when exposed to low lethal or sublethal doses. Understanding the general effect of pirimicarb on aphids could help increasing rational use of this insecticide. Under laboratory conditions, we assessed the sublethal effects of a low lethal concentration of pirimicarb (LC25) on biological traits and acetylcholinesterase (AChE) activity of R. padi and S. avenae. Both direct and transgenerational effects, i.e. on parent and the F1 generations were assessed, respectively. We found that R. padi and S. avenae responded differentially to the LC25 of pirimicarb. The parent generation of R. padi showed a 39% decrease in fecundity and multiple transgenerational effects were observed in the F1 generation; overall juvenile development, reproductive period, adult longevity and lifespan were longer than those of the control group. By contrast, LC25 of pirimicarb showed almost no effects on S. avenae biological traits in both the parent and F1 generations; only the pre-reproductive duration was reduced in F1 generations. Demographic parameter estimates (e.g. r(m)) showed similar trend, i.e. significant negative effect on R. padi population growth and no effect on S. avenae. However, AChE activity decreased in both R. padi and S. avenae treated by the LC25 of pirimicarb. We demonstrated sublethal and transgenerational effects of pirimicarb in the two wheat aphid species; it hinted at the importance of considering sublethal effects (including hormesis) of pirimicarb for optimizing Integrated Pest Management (IPM) of wheat aphids.	[Xiao, Da; Yang, Ting; Gao, Xiwu] China Agr Univ, Dept Entomol, Beijing 100193, Peoples R China; [Desneux, Nicolas; Han, Peng] Univ Nice Sophia Antipolis, CNRS, French Natl Inst Agr Res INRA, Inst Sophia Agrobiotech,UMR 1355 7254, F-06903 Sophia Antipolis, France	China Agricultural University; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Gao, XW (corresponding author), China Agr Univ, Dept Entomol, Beijing 100193, Peoples R China.	gaoxiwu@263.net.cn	Desneux, Nicolas/J-6262-2013; Han, Peng/Y-4457-2019		National Basic Research Program of China [2012CB114103]; National Natural Science Foundation of China [31330064, 30871661]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This research was supported by National Basic Research Program of China (Contract No. 2012CB114103) and the National Natural Science Foundation of China (31330064 and 30871661).	ALFORD AR, 1986, J ECON ENTOMOL, V79, P31, DOI 10.1093/jee/79.1.31; Aqueel MA, 2011, CROP PROT, V30, P216, DOI 10.1016/j.cropro.2010.09.013; Bao HB, 2009, PEST MANAG SCI, V65, P170, DOI 10.1002/ps.1664; Biondi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076548; Biondi A, 2012, PEST MANAG SCI, V68, P1523, DOI 10.1002/ps.3396; Booth LH, 2007, J ECON ENTOMOL, V100, P11, DOI 10.1603/0022-0493(2007)100[11:EORROT]2.0.CO;2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brault V, 2007, MICRON, V38, P302, DOI 10.1016/j.micron.2006.04.005; Caballero-Lopez B, 2012, J PEST SCI, V85, P81, DOI 10.1007/s10340-011-0409-7; Cabral S, 2008, BIOCONTROL SCI TECHN, V18, P307, DOI 10.1080/09583150801902072; Calabrese EJ, 2003, NATURE, V421, P691, DOI 10.1038/421691a; Chen MH, 2007, PESTIC BIOCHEM PHYS, V87, P189, DOI 10.1016/j.pestbp.2006.07.009; Croft B. A., 1990, ARTHROPOD BIOL CONTR; Cutler GC, 2013, DOSE-RESPONSE, V11, P154, DOI 10.2203/dose-response.12-008.Cutler; Desneux N, 2005, J ECON ENTOMOL, V98, P9, DOI 10.1603/0022-0493-98.1.9; Desneux N, 2004, CHEMOSPHERE, V54, P619, DOI 10.1016/j.chemosphere.2003.09.007; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Desneux N, 2006, ENVIRON TOXICOL CHEM, V25, P2675, DOI 10.1897/05-562R.1; Desneux N, 2012, ECOL LETT, V15, P453, DOI 10.1111/j.1461-0248.2012.01754.x; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Finney D.J., 1971, PROBIT ANAL; Fogel MN, 2013, ECOTOXICOLOGY, V22, P1063, DOI 10.1007/s10646-013-1094-5; Gao XW, 1987, CHINESE BULL ENTOMOL, V33, P245; Gianoli E, 2000, ENVIRON ENTOMOL, V29, P213, DOI 10.1603/0046-225X(2000)029[0213:CICAHA]2.0.CO;2; Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669; Guo L, 2013, CROP PROT, V48, P29, DOI 10.1016/j.cropro.2013.02.009; He YX, 2013, INT J BIOL SCI, V9, P246, DOI 10.7150/ijbs.5762; Hodge Simon, 2000, Australasian Journal of Ecotoxicology, V6, P109; Kerns DL, 2000, ENTOMOL EXP APPL, V94, P41, DOI 10.1023/A:1003972510397; KUMAR K, 1984, PESTIC SCI, V15, P344, DOI 10.1002/ps.2780150404; Kumrungsee N, 2014, J PEST SCI, V87, P721, DOI 10.1007/s10340-014-0602-6; Larsson H, 2005, CROP PROT, V24, P397, DOI 10.1016/j.cropro.2004.08.011; Lee CY., 2000, J BIOSCIENCES, V11, P107, DOI DOI 10.5772/66461; Liang P, 2012, ECOTOXICOLOGY, V21, P1889, DOI 10.1007/s10646-012-0922-3; Liu Bo, 2003, Acta Entomologica Sinica, V46, P691; Lu Y, 2009, B ENTOMOL RES, V99, P611, DOI 10.1017/S0007485309006725; Lu YH, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.0901; Lu Yan-Hui, 2009, Acta Entomologica Sinica, V52, P52; Lu Yan-Hui, 2007, Chinese Bulletin of Entomology, V44, P289; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Moores GD, 1996, PESTIC BIOCHEM PHYS, V56, P102, DOI 10.1006/pest.1996.0064; Pan HS, 2014, J PEST SCI, V87, P731, DOI 10.1007/s10340-014-0610-6; Papachristos DP, 2008, BIOL CONTROL, V47, P77, DOI 10.1016/j.biocontrol.2008.06.009; Peng Y, 2013, ECOTOXICOLOGY, V22, P1384, DOI 10.1007/s10646-013-1124-3; Planes L, 2013, J PEST SCI, V86, P321, DOI 10.1007/s10340-012-0440-3; Rumpf S, 1997, J ECON ENTOMOL, V90, P102, DOI 10.1093/jee/90.1.102; Saber M, 2013, J PEST SCI, V86, P685, DOI 10.1007/s10340-013-0528-4; Sanil D, 2012, PARASITOL RES, V111, P423, DOI 10.1007/s00436-012-2857-2; Savaris M, 2013, NEOTROP ENTOMOL, V42, P539, DOI 10.1007/s13744-013-0158-9; Shad SA, 2012, J PEST SCI, V85, P153, DOI 10.1007/s10340-011-0404-z; Shea K, 2004, ECOL LETT, V7, P491, DOI 10.1111/j.1461-0248.2004.00600.x; Stark JD, 2003, ANNU REV ENTOMOL, V48, P505, DOI 10.1146/annurev.ento.48.091801.112621; Tan Y, 2012, ECOTOXICOLOGY, V21, P1989, DOI 10.1007/s10646-012-0933-0; Tong H, 2013, J PEST SCI, V86, P599, DOI 10.1007/s10340-013-0505-y; Vanaclocha P, 2013, J PEST SCI, V86, P329, DOI 10.1007/s10340-012-0448-8; Wang XY, 2008, J APPL ENTOMOL, V132, P135, DOI 10.1111/j.1439-0418.2007.01225.x; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122; [曾春祥 Zeng Chunxiang], 2007, [植物保护, Plant Protection], V33, P50	58	39	43	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0128936	10.1371/journal.pone.0128936	http://dx.doi.org/10.1371/journal.pone.0128936			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121265	Green Published, gold, Green Submitted			2022-12-27	WOS:000358150400011
J	Guo, JL; Fu, XW; Wu, X; Zhao, XC; Wu, KM				Guo, Jianglong; Fu, Xiaowei; Wu, Xiao; Zhao, Xincheng; Wu, Kongming			Annual Migration of Agrotis segetum (Lepidoptera: Noctuidae): Observed on a Small Isolated Island in Northern China	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; SOGATELLA-FURCIFERA HEMIPTERA; NILAPARVATA-LUGENS; GRANULOSIS-VIRUS; BOHAI SEA; AUTUMN MIGRATION; INSECT MIGRATION; TURNIP MOTH; SUGAR-BEET; RADAR	Migration behavior of the turnip moth, Agrotis segetum (Lepidoptera: Noctuidae), is not well known by far. Here, we present the data from an 11-year study on A. segetum by means of searchlight trapping and ovarian dissection on Beihuang (BH) Island, which located in the center of the Bohai Strait in northern China. The data showed a large number of A. segetum flight across the strait each year, which provides direct evidence that A. segetum is a longdistance migrant, migrating at least 40 - 60 km to reach the trapping site. The migration period during 2003-2013 ranged from 115 to 172 d. Among the catches, the proportion of females was significantly higher than that of males in each month from May to September. Ovarian dissection showed that the proportion of mated females and the proportion of sexually mature females was significantly higher than that of unmated females and sexually immature females in early summer, respectively, but conversely in autumn. The early summer populations migrate in a south-north direction, which might undertake a long-distance flight on several successive nights. The autumn populations migrate in a north-south direction, which might originate not far from the trapping site. Based on these findings, the migratory physiology of A. segetum was discussed.	[Guo, Jianglong; Fu, Xiaowei; Wu, Xiao; Wu, Kongming] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Guo, Jianglong; Wu, Xiao; Zhao, Xincheng] Henan Agr Univ, Coll Plant Protect, Dept Entomol, Zhengzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Henan Agricultural University	Wu, KM (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	kmwu@ippcaas.cn			National Natural Science Foundation of China [31321004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (grant number 31321004), http://www.nsfc.gov.cn/, (KMW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, IBM CORPORATION; Ben Hamadou-Charfi D, 2013, J INVERTEBR PATHOL, V114, P139, DOI 10.1016/j.jip.2013.07.003; CABALLERO P, 1991, ENTOMOL EXP APPL, V58, P55, DOI 10.1007/BF00163313; CABALLERO P, 1991, J APPL ENTOMOL, V112, P59, DOI 10.1111/j.1439-0418.1991.tb01029.x; Chapman JW, 2011, ANNU REV ENTOMOL, V56, P337, DOI 10.1146/annurev-ento-120709-144820; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; El-Salamouny S, 2003, J INVERTEBR PATHOL, V84, P75, DOI 10.1016/j.jip.2003.08.005; Erasmus A, 2010, ENVIRON ENTOMOL, V39, P702, DOI 10.1603/EN09150; Esbjerg P, 2014, CROP PROT, V62, P64, DOI 10.1016/j.cropro.2014.04.003; Esbjerg P, 2010, ACTA AGR SCAND B-S P, V60, P89, DOI 10.1080/09064710902741956; Feng HQ, 2008, ENVIRON ENTOMOL, V37, P774, DOI 10.1603/0046-225X(2008)37[774:AMOMSL]2.0.CO;2; Feng HQ, 2006, ECOL ENTOMOL, V31, P511, DOI 10.1111/j.1365-2311.2006.00813.x; Feng HQ, 2009, J ECON ENTOMOL, V102, P95, DOI 10.1603/029.102.0114; Feng HQ, 2005, J INSECT BEHAV, V18, P335, DOI 10.1007/s10905-005-3694-2; Feng HQ, 2004, J ECON ENTOMOL, V97, P1874, DOI 10.1603/0022-0493-97.6.1874; Feng HQ, 2004, ENVIRON ENTOMOL, V33, P1253, DOI 10.1603/0046-225X-33.5.1253; Feng HQ, 2003, B ENTOMOL RES, V93, P115, DOI 10.1079/BER2002221; Feng HQ, 2010, Beijing, China, Patent No. [CN201020229775.3, 201020229775]; Fu XW, 2014, CROP PROT, V64, P143, DOI 10.1016/j.cropro.2014.06.021; Fu XW, 2014, J ECON ENTOMOL, V107, P1399, DOI 10.1603/EC13380; GOMAA A A, 1978, Zeitschrift fuer Angewandte Zoologie, V65, P45; Hulbert D., 1983, Beitraege zur Entomologie, V33, P383; Jana A.K., 1994, Annals of Entomology (Dehra Dun), V12, P95; JOHNSON CG, 1963, NATURE, V198, P423, DOI 10.1038/198423a0; JOHNSON CG, 1960, NATURE, V186, P348, DOI 10.1038/186348a0; JOHNSON CG, 1966, ANNU REV ENTOMOL, V11, P233, DOI 10.1146/annurev.en.11.010166.001313; Johnson CG., 1969, MIGRATION AND DISPER; KENNEDY JS, 1961, NATURE, V189, P785, DOI 10.1038/189785a0; Khalifa A, 1950, P R ENT SCO LOND, V25, P32; KISIMOTO R, 1976, ECOL ENTOMOL, V1, P95, DOI 10.1111/j.1365-2311.1976.tb01210.x; Li RD, 1987, OVARIAN DISSECTION O; Lu Zhaozhi, 2006, Shengtaixue Zazhi, V25, P1532; Matsumoto Y, 2013, B ENTOMOL RES, V103, P382, DOI 10.1017/S000748531200082X; MEYER HW, 1978, BIOL CYBERN, V31, P7, DOI 10.1007/BF00337366; Mun JH, 1999, B ENTOMOL RES, V89, P245, DOI 10.1017/S000748539900036X; Muska F, 2009, LISTY CUKROV REPAR, V125, P170; Qi G.J., 2011, CHINA PLANT PROT, V31, P18; [齐国君 Qi Guojun], 2010, [生态学报, Acta Ecologica Sinica], V30, P462; SAS Institute, 1990, SAS STAT USERS GUIDE, V4th; SHERLOCK PL, 1979, ENTOMOL EXP APPL, V26, P245, DOI 10.1111/j.1570-7458.1979.tb02925.x; Showers WB, 1997, ANNU REV ENTOMOL, V42, P393, DOI 10.1146/annurev.ento.42.1.393; SLANSKY F, 1980, ENTOMOL EXP APPL, V28, P277, DOI 10.1007/BF00366314; SOUTHWOOD TRE, 1962, BIOL REV, V37, P171, DOI 10.1111/j.1469-185X.1962.tb01609.x; Vosta M, 2008, LISTY CUKROV REPAR, V124, P260; Wood CR, 2009, B ENTOMOL RES, V99, P525, DOI 10.1017/S0007485308006548; Wu Kong-Ming, 2002, Acta Ecologica Sinica, V22, P1075; Wu Kong-ming, 2006, Acta Phytophylacica Sinica, V33, P163; Wu Kongming, 1998, Acta Phytophylacica Sinica, V25, P337; Yin FF, 2008, J VIROL, V82, P8922, DOI 10.1128/JVI.00493-08; ZETHNER O, 1987, ENTOMOPHAGA, V32, P449, DOI 10.1007/BF02373513; Zhao XC, 2009, J INSECT PHYSIOL, V55, P1039, DOI 10.1016/j.jinsphys.2009.07.007; Zheng DB, 2014, J APPL ENTOMOL, V138, P67, DOI 10.1111/jen.12067; [No title captured]	53	17	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131639	10.1371/journal.pone.0131639	http://dx.doi.org/10.1371/journal.pone.0131639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114576	gold, Green Submitted, Green Published			2022-12-27	WOS:000358147500176
J	Paiva, MC; Avila, MP; Reis, MP; Costa, PS; Nardi, RMD; Nascimento, AMA				Paiva, Magna C.; Avila, Marcelo P.; Reis, Mariana P.; Costa, Patricia S.; Nardi, Regina M. D.; Nascimento, Andrea M. A.			The Microbiota and Abundance of the Class 1 Integron-Integrase Gene in Tropical Sewage Treatment Plant Influent and Activated Sludge	PLOS ONE			English	Article							WASTE-WATER TREATMENT; ANTIBIOTIC-RESISTANCE GENES; BACTERIAL COMMUNITY; DIVERSITY; QUANTIFICATION; IDENTIFICATION; HYBRIDIZATION; CASSETTES; EFFLUENT; LIMITS	Bacteria are assumed to efficiently remove organic pollutants from sewage in sewage treatment plants, where antibiotic-resistance genes can move between species via mobile genetic elements known as integrons. Nevertheless, few studies have addressed bacterial diversity and class 1 integron abundance in tropical sewage. Here, we describe the extant microbiota, using V6 tag sequencing, and quantify the class 1 integron-integrase gene (intI1) in raw sewage (RS) and activated sludge (AS). The analysis of 1,174,486 quality-filtered reads obtained from RS and AS samples revealed complex and distinct bacterial diversity in these samples. The RS sample, with 3,074 operational taxonomic units, exhibited the highest alpha-diversity indices. Among the 25 phyla, Proteobacteria, Bacteroidetes and Firmicutes represented 85% (AS) and 92% (RS) of all reads. Increased relative abundance of Micrococcales, Myxococcales, and Sphingobacteriales and reduced pathogen abundance were noted in AS. At the genus level, differences were observed for the dominant genera Simplicispira and Diaphorobacter (AS) as well as for Enhydrobacter (RS). The activated sludge process decreased (55%) the amount of bacteria harboring the intI1 gene in the RS sample. Altogether, our results emphasize the importance of biological treatment for diminishing pathogenic bacteria and those bearing the intI1 gene that arrive at a sewage treatment plant.	[Paiva, Magna C.; Nardi, Regina M. D.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil; [Paiva, Magna C.] Univ Fed Sao Joao Rei, Divinopolis, MG, Brazil; [Avila, Marcelo P.; Reis, Mariana P.; Costa, Patricia S.; Nascimento, Andrea M. A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Sao Joao del-Rei; Universidade Federal de Minas Gerais	Nascimento, AMA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil.	amaral@ufmg.br	Paiva, Magna/AAE-3951-2019; Nascimento, Andréa/ABD-9042-2020	Nascimento, Andréa/0000-0002-0447-3505; PAIVA, MAGNA/0000-0001-9375-7261; Costa, Patricia/0000-0002-2166-9497	FAPEMIG [CBB-APQ-01655-11]; CNPq [480837/2011, 472411/2012-8]	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPEMIG CBB-APQ-01655-11, CNPq 480837/2011 and CNPq 472411/2012-8. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, J VC ON LINE BRASIL; Cai L, 2013, ENVIRON SCI TECHNOL, V47, P5433, DOI 10.1021/es400275r; Cardinali-rezende J, 2013, VANLEEUW J MICROB, V104, P993; Corpe WA, 1996, APPL MICROBIOL BIOT, V46, P622, DOI 10.1007/s002530050872; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ferreira F. D., 2008, Revista Academica Ciencias Agrarias e Ambientais, V6, P259; Gill M, 2014, INTERD DISABIL STUD, P1; Gillings M, 2008, J BACTERIOL, V190, P5095, DOI 10.1128/JB.00152-08; Grima EM, 2003, BIOTECHNOL ADV, V20, P491; Hardwick SA, 2008, FEMS MICROBIOL LETT, V278, P207, DOI 10.1111/j.1574-6968.2007.00992.x; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Hu M, 2012, BIORESOURCE TECHNOL, V117, P72, DOI 10.1016/j.biortech.2012.04.061; Khan ST, 2002, J GEN APPL MICROBIOL, V48, P299; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; LaPara TM, 2011, ENVIRON SCI TECHNOL, V45, P9543, DOI 10.1021/es202775r; Ma LP, 2013, J ENVIRON BIOL, V34, P391; MANZ W, 1994, WATER RES, V28, P1715, DOI 10.1016/0043-1354(94)90243-7; McLellan SL, 2010, ENVIRON MICROBIOL, V12, P378, DOI 10.1111/j.1462-2920.2009.02075.x; McMurdie PJ, 2012, BASIC STORAGE ACCESS; Mehta-Kolte MG, 2012, APPL ENVIRON MICROB, V78, P6987, DOI 10.1128/AEM.01460-12; Metcalf E.G., 1991, WASTEWATER ENG TREAT, Vsecond; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Naidoo S, 2014, INT J ENV RES PUB HE, V11, P249, DOI 10.3390/ijerph110100249; Nielsen PH, 2012, CURR OPIN BIOTECH, V23, P452, DOI 10.1016/j.copbio.2011.11.027; Osaka T, 2008, FEMS MICROBIOL ECOL, V64, P494, DOI 10.1111/j.1574-6941.2008.00473.x; Pang CM, 2006, APPL ENVIRON MICROB, V72, P5702, DOI 10.1128/AEM.02982-05; Pellegrini C, 2011, MICROB DRUG RESIST, V17, P229, DOI 10.1089/mdr.2010.0117; Poeta P, 2008, APPL ENVIRON MICROB, V74, P7439, DOI 10.1128/AEM.00949-08; Power ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063017; Pruden A, 2013, ENVIRON HEALTH PERSP, V121, P878, DOI 10.1289/ehp.1206446; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2012, R LANG ENV STAT COMP; RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1232, DOI 10.1128/AEM.60.4.1232-1240.1994; Reis MP, 2013, EXTREMOPHILES, V17, P301, DOI 10.1007/s00792-013-0517-9; Rosewarne CP, 2010, FEMS MICROBIOL ECOL, V72, P35, DOI 10.1111/j.1574-6941.2009.00823.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shanks OC, 2013, APPL ENVIRON MICROB, V79, P2906, DOI 10.1128/AEM.03448-12; Shimizu Y, 1996, ANNU REV MICROBIOL, V50, P431, DOI 10.1146/annurev.micro.50.1.431; Shimkets L.J., 2006, PROKARYOTES, P31, DOI [10.1007/0-387-30747-8_3, DOI 10.1007/0-387-30747-8_3]; Snaidr J, 1997, APPL ENVIRON MICROB, V63, P2884, DOI 10.1128/AEM.63.7.2884-2896.1997; Stalder T, 2014, ISME J, V8, P768, DOI 10.1038/ismej.2013.189; STALEY JT, 1987, INT J SYST BACTERIOL, V37, P289, DOI 10.1099/00207713-37-3-289; Staroscik A., 2004, CALCULATOR DETERMINI; Stokes HW, 2011, FEMS MICROBIOL REV, V35, P790, DOI 10.1111/j.1574-6976.2011.00273.x; Tennstedt T, 2003, FEMS MICROBIOL ECOL, V45, P239, DOI 10.1016/S0168-6496(03)00164-8; Von Sperling M, 1996, PRINCIPIOS BASICOS T; Wagner M, 2002, CURR OPIN BIOTECH, V13, P218, DOI 10.1016/S0958-1669(02)00315-4; Wery N, 2008, WATER RES, V42, P53, DOI 10.1016/j.watres.2007.06.048; Wilen BM, 2008, WATER RES, V42, P2300, DOI 10.1016/j.watres.2007.12.013; Yadav TC, 2014, BIORESOURCE TECHNOL, V165, P257, DOI 10.1016/j.biortech.2014.03.007; Ye L, 2013, APPL MICROBIOL BIOT, V97, P2681, DOI 10.1007/s00253-012-4082-4; Ye L, 2011, WATER RES, V45, P4390, DOI 10.1016/j.watres.2011.05.028; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y; Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160	55	11	11	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131532	10.1371/journal.pone.0131532	http://dx.doi.org/10.1371/journal.pone.0131532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115093	gold, Green Submitted, Green Published			2022-12-27	WOS:000358147500169
J	Pongiglione, B; De Stavola, BL; Ploubidis, GB				Pongiglione, Benedetta; De Stavola, Bianca L.; Ploubidis, George B.			A Systematic Literature Review of Studies Analyzing Inequalities in Health Expectancy among the Older Population	PLOS ONE			English	Article							ACTIVE LIFE EXPECTANCY; DISABILITY-FREE LIFE; MRC COGNITIVE FUNCTION; US ELDERLY POPULATION; GENDER-DIFFERENCES; EDUCATIONAL-DIFFERENCES; MORTALITY TRANSITIONS; SOCIOECONOMIC-STATUS; SOCIAL INEQUALITIES; FUNCTIONAL STATUS	Aim To collect, organize and appraise evidence of socioeconomic and demographic inequalities in health and mortality among the older population using a summary measure of population health: Health Expectancy. Methods A systematic literature review was conducted. Literature published in English before November 2014 was searched via two possible sources: three electronic databases (Web of Science, Medline and Embase), and references in selected articles. The search was developed combining terms referring to outcome, exposure and participants, consisting in health expectancy, socioeconomic and demographic groups, and older population, respectively. Results Of 256 references identified, 90 met the inclusion criteria. Six references were added after searching reference lists of included articles. Thirty-three studies were focused only on gender-based inequalities; the remaining sixty-three considered gender along with other exposures. Findings were organized according to two leading perspectives: the type of inequalities considered and the health indicators chosen to measure health expectancy. Evidence of gender-based differentials and a socioeconomic gradient were found in all studies. A remarkable heterogeneity in the choice of health indicators used to compute health expectancy emerged as well as a non-uniform way of defining same health conditions. Conclusions Health expectancy is a useful and convenient measure to monitor and assess the quality of ageing and compare different groups and populations. This review showed a general agreement of results obtained in different studies with regard to the existence of inequalities associated with several factors, such as gender, education, behaviors, and race. However, the lack of a standardized definition of health expectancy limits its comparability across studies. The need of conceiving health expectancy as a comparable and repeatable measure was highlighted as fundamental to make it an informative instrument for policy makers.	[Pongiglione, Benedetta; De Stavola, Bianca L.] Univ London, London Sch Hyg & Trop Med, Dept Med Stat, Fac Epidemiol & Populat Hlth, London, England; [Ploubidis, George B.] Ctr Longitudinal Studies, Inst Educ, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; UCL Institute of Education	Pongiglione, B (corresponding author), Univ London, London Sch Hyg & Trop Med, Dept Med Stat, Fac Epidemiol & Populat Hlth, London, England.	benedetta.pongiglione@lshtm.ac.uk	Ploubidis, George B/G-9531-2011	Ploubidis, George B/0000-0002-8198-5790; De Stavola, Bianca Lucia/0000-0001-7853-0528; Pongiglione, Benedetta/0000-0001-8539-1554	Economic and Social Research Council (ESRC)+3 Studentship grant [ES/J500021/1]; Economic and Social Research Council [1359889] Funding Source: researchfish	Economic and Social Research Council (ESRC)+3 Studentship grant(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	All relevant data are within the paper, the reference list and its Supporting Information files. The authors have declared that no competing interests exist. This work has been supported by the Economic and Social Research Council (ESRC)+3 Studentship grant award (URL: http://www.esrc.ac.uk/). The grant number is ES/J500021/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Snih S, 2007, ARCH INTERN MED, V167, P774, DOI 10.1001/archinte.167.8.774; Belon AP, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-88; Beltran-Sanchez H, 2013, J AGING HEALTH, V25, P815, DOI 10.1177/0898264313491425; Berger N, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/1471-2288-15-1; BRANCH LG, 1991, J GERONTOL, V46, pM145, DOI 10.1093/geronj/46.4.M145; Brayne C, 2001, AGE AGEING, V30, P53, DOI 10.1093/ageing/30.1.53; Bronnum-Hansen H, 2005, EUR J PUBLIC HEALTH, V15, P20, DOI 10.1093/eurpub/cki106; Bronnum-Hansen H, 2006, J AGING HEALTH, V18, P491, DOI 10.1177/0898264305286074; Cai LM, 2007, DEMOGRAPHY, V44, P479, DOI 10.1353/dem.2007.0022; Cai LM, 2013, HEALTH SERV RES, V48, P218, DOI 10.1111/j.1475-6773.2012.01432.x; Cambois E, 2001, DEMOGRAPHY, V38, P513, DOI 10.1353/dem.2001.0033; Cambois E, 2013, EUR J PUBLIC HEALTH, V23, P575, DOI 10.1093/eurpub/cks136; Cambois E, 2011, DEMOGR RES, V25, P407, DOI 10.4054/DemRes.2011.25.12; Campolina AG, 2013, REV SAUDE PUBL, V47, P514, DOI 10.1590/S0034-8910.2013047004570; Chan A, 2011, J AGING HEALTH, V23, P1285, DOI 10.1177/0898264311408417; Cheung KSL, 2010, EUR J AGEING, V7, P257, DOI 10.1007/s10433-010-0171-3; Crimmins E, 2003, DETERMINING HLTH EXP, P111; Crimmins EM, 2009, DEMOGRAPHY, V46, P627, DOI 10.1353/dem.0.0070; Crimmins EM, 1996, J GERONTOL B-PSYCHOL, V51, pS111, DOI 10.1093/geronb/51B.3.S111; Crimmins EM, 2001, SOC SCI MED, V52, P1629, DOI 10.1016/S0277-9536(00)00273-2; Crimmins EM, 1989, CHANGES LIFE EXPECTA; Deeg DJH, 2002, J WOMEN AGING, V14, P27, DOI 10.1300/J074v14n01_03; Diehr P, 2002, CURR CONTR TRIALS C, V3, DOI 10.1186/1468-6708-3-1; Diehr P, 2008, J AM GERIATR SOC, V56, P76, DOI 10.1111/j.1532-5415.2007.01500.x; Andrade FCD, 2011, WOMEN HEALTH ISS, V21, P64, DOI 10.1016/j.whi.2010.08.007; Ferrucci L, 1999, AM J EPIDEMIOL, V149, P645, DOI 10.1093/oxfordjournals.aje.a009865; Flegal KM, 2014, AM J EPIDEMIOL, V180, P288, DOI 10.1093/aje/kwu111; Fries JF, 1980, GERONTOLOGICAL PERSP, V1, P5; Gu D, 2009, SOC SCI MED, V68, P2170, DOI 10.1016/j.socscimed.2009.03.031; GURALNIK JM, 1993, NEW ENGL J MED, V329, P110, DOI 10.1056/NEJM199307083290208; Hayward MD, 2014, POPUL RES POLICY REV, V33, P81, DOI 10.1007/s11113-013-9312-7; Hayward MD, 1998, J AGING HEALTH, V10, P192, DOI 10.1177/089826439801000205; Hidajat MM, 2007, POPUL RES POLICY REV, V26, P219, DOI 10.1007/s11113-007-9025-x; Ishizaki T, 2002, ARCH GERONTOL GERIAT, V35, P107, DOI 10.1016/S0167-4943(02)00002-X; Izmirlian G, 2000, BIOMETRICS, V56, P244, DOI 10.1111/j.0006-341X.2000.00244.x; Jagger C, 2002, J WOMEN AGING, V14, P85, DOI 10.1300/J074v14n01_06; Jagger C., 2007, HLTH EXPECTANCY CALC; Jagger C, 2007, J GERONTOL A-BIOL, V62, P408, DOI 10.1093/gerona/62.4.408; Jagger C, 2007, INT J EPIDEMIOL, V36, P358, DOI 10.1093/ije/dyl307; Jagger C, 2011, J EPIDEMIOL COMMUN H, V65, P1030, DOI 10.1136/jech.2010.117705; Jeune B, 2008, EUR J AGEING, V5, P279, DOI 10.1007/s10433-008-0100-x; Jiawiwatkul U, 2012, ASIA-PAC J PUBLIC HE, V24, P915, DOI 10.1177/1010539511409923; Jitapunkul S, 2003, AGE AGEING, V32, P401, DOI 10.1093/ageing/32.4.401; JITAPUNKUL S, 1994, AGE AGEING, V23, P97, DOI 10.1093/ageing/23.2.97; Jitapunkul Sutthichai, 2001, Journal of the Medical Association of Thailand, V84, P349; Jitapunkul Sutthichai, 2000, Journal of the Medical Association of Thailand, V83, P861; Kai I, 1993, B PHYS FITNESS RES I, P19; Kaneda T, 2005, DISABIL REHABIL, V27, P241, DOI 10.1080/09638280400006481; Karcharnubarn R, 2013, HEALTH PLACE, V24, P1, DOI 10.1016/j.healthplace.2013.08.002; KATZ S, 1983, NEW ENGL J MED, V309, P1218, DOI 10.1056/NEJM198311173092005; Klijs B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-378; Konno K, 2004, ARCH GERONTOL GERIAT, V38, P153, DOI 10.1016/j.archger.2003.09.002; KRAMER M, 1980, ACTA PSYCHIAT SCAND, V62, P382, DOI 10.1111/j.1600-0447.1980.tb07714.x; Laditka SB, 2014, AM J ALZHEIMERS DIS, V29, P436, DOI 10.1177/1533317513518648; Laditka SB, 2002, J WOMEN AGING, V14, P163, DOI 10.1300/J074v14n01_11; Lai DJ, 2009, SOC INDIC RES, V90, P257, DOI 10.1007/s11205-008-9256-1; Lai DJ, 2000, PUBLIC HEALTH, V114, P330, DOI 10.1016/S0033-3506(00)00358-9; LAND KC, 1994, DEMOGRAPHY, V31, P297, DOI 10.2307/2061887; Larson C, 2004, CAN MED ASSOC J, V171, P1199, DOI 10.1503/cmaj.1021409; Lievre A, 2007, J NUTR HEALTH AGING, V11, P508; Liu JF, 2009, J AGING HEALTH, V21, P266, DOI 10.1177/0898264308328978; LIU X, 1995, J GERONTOL B-PSYCHOL, V50, pS383, DOI 10.1093/geronb/50B.6.S383; MAHONEY F I, 1965, Md State Med J, V14, P61; Majer IM, 2011, J EPIDEMIOL COMMUN H, V65, P972, DOI 10.1136/jech.2010.111492; Manton KG, 2008, J GERONTOL B-PSYCHOL, V63, pS269, DOI 10.1093/geronb/63.5.S269; Manton KG, 1997, J AGING HEALTH, V9, P419, DOI 10.1177/089826439700900401; MANTON KG, 1982, MILBANK FUND Q, V60, P183, DOI 10.2307/3349767; Matthews FE, 2006, BMC PUBLIC HLTH, V6; Matthews RJ, 2006, SOC SCI MED, V62, P2489, DOI 10.1016/j.socscimed.2005.11.019; Melzer D, 2000, J EPIDEMIOL COMMUN H, V54, P286, DOI 10.1136/jech.54.4.286; Minicuci N, 2005, EXP GERONTOL, V40, P997, DOI 10.1016/j.exger.2005.08.011; Minicuci N, 2005, DISABIL REHABIL, V27, P221, DOI 10.1080/09638280400006432; Minicuci N, 2011, J AGING HEALTH, V23, P629, DOI 10.1177/0898264310390940; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Montez JK, 2014, DEMOGRAPHY, V51, P413, DOI 10.1007/s13524-013-0261-x; Muangpaisan W, 2011, ARCH GERONTOL GERIAT, V53, P3, DOI 10.1016/j.archger.2010.05.012; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P981; Mutafova M, 1997, B WORLD HEALTH ORGAN, V75, P147; NATHANSON CA, 1975, SOC SCI MED, V9, P57, DOI 10.1016/0037-7856(75)90094-3; Newman AB, 2001, EPIDEMIOL REV, V23, P343, DOI 10.1093/oxfordjournals.epirev.a000810; Ofstedal MB., 2004, HALLYM INT J AGING, V6, P95, DOI DOI 10.2190/0DM2-GDRT-E6J9-2DXQ; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Peres K, 2008, INT J GERIATR PSYCH, V23, P643, DOI 10.1002/gps.1955; Reyes-Beaman S, 2005, DISABIL REHABIL, V27, P213, DOI 10.1080/09638280400006424; Reynolds SL, 2008, AM J GERIAT PSYCHIAT, V16, P425, DOI 10.1097/JGP.0b013e31816ff32e; Reynolds SL, 2009, OBESITY, V17, P363, DOI 10.1038/oby.2008.534; Reynolds SL, 2005, GERONTOLOGIST, V45, P438, DOI 10.1093/geront/45.4.438; Robine JM, 2002, J WOMEN AGING, V14, P119, DOI 10.1300/J074v14n01_08; ROBINE JM, 1993, COLLOQ INSE, V226, P269; ROGERS RG, 1989, MILBANK Q, V67, P370, DOI 10.2307/3350221; Romero-Ortuno R, 2014, AGE AGEING, V43, P222, DOI 10.1093/ageing/aft115; Sagardui-Villamor J, 2005, J GERONTOL A-BIOL, V60, P1028, DOI 10.1093/gerona/60.8.1028; Saito Yasuhiko, 2014, Stat J IAOS, V30, P209, DOI 10.3233/SJI-140840; SANDERS BS, 1964, AM J PUBLIC HEALTH N, V54, P1063, DOI 10.2105/AJPH.54.7.1063; Camargos MCS, 2008, AGEING SOC, V28, P35, DOI 10.1017/S0144686X07006277; Camargos MC, 2008, CAD SAUDE PUBLICA, V24, P845, DOI 10.1590/S0102-311X2008000400015; Camargos MCS, 2007, J BIOSOC SCI, V39, P455, DOI 10.1017/S0021932006001428; Sauvaget C, 1999, J AM GERIATR SOC, V47, P1326, DOI 10.1111/j.1532-5415.1999.tb07433.x; Sauvaget C, 2001, AGE AGEING, V30, P509, DOI 10.1093/ageing/30.6.509; Schrijvers CTM, 1999, AM J PUBLIC HEALTH, V89, P535, DOI 10.2105/AJPH.89.4.535; Stowasser T, 2011, REVISITED ANAL CAUSA, P267; SULLIVAN DF, 1971, HSMHA HEALTH REP, V86, P347, DOI 10.2307/4594169; Szwarcwald CL, 2011, AM J PUBLIC HEALTH, V101, P517, DOI 10.2105/AJPH.2010.195453; Tareque MI, 2013, J AGING HEALTH, V25, P1299, DOI 10.1177/0898264313501388; Tian XB, 2011, J EPIDEMIOL, V21, P376, DOI 10.2188/jea.JE20110001; TSUJI I, 1995, J GERONTOL A-BIOL, V50, pM173, DOI 10.1093/gerona/50A.3.M173; Tsuji I, 2002, J WOMEN AGING, V14, P135, DOI 10.1300/J074v14n01_09; United Nations, 2013, WORLD POP AG 2013; VANDENBOS GAM, 1993, COLLOQ INSE, V226, P193; VERBRUGGE LM, 1982, PUBLIC HEALTH REP, V97, P417; Walter S, 2009, INT J OBESITY, V33, P1410, DOI 10.1038/ijo.2009.176; Washington Group on Disability Statistics, 2010, CENS QUEST DIS END W; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Health Organization (WHO), 2013, HLTH LIF EXP BIRTH; Yardim N, 2009, TURK GERIATRI DERG, V12, P111; Yi Z, 2004, DEMOGRAPHY, V41, P335, DOI 10.1353/dem.2004.0018; Yi Zeng, 2001, Population (Paris), V56, P109; Yong V, 2011, J CROSS-CULT GERONTO, V26, P189, DOI 10.1007/s10823-011-9143-0; Yong V, 2012, J GERONTOL B-PSYCHOL, V67, P343, DOI 10.1093/geronb/gbs029; Yong V, 2009, DEMOGR RES, V20, P467, DOI 10.4054/DemRes.2009.20.19; Zimmer Z, 2010, SOC FORCES, V88, P1885	121	60	61	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130747	10.1371/journal.pone.0130747	http://dx.doi.org/10.1371/journal.pone.0130747			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1AM	26115099	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000358147500091
J	Rubio-Villena, C; Sanz, P; Garcia-Gimeno, MA				Rubio-Villena, Carla; Sanz, Pascual; Adelaida Garcia-Gimeno, Maria			Structure-Function Analysis of PPP1R3D, a Protein Phosphatase 1 Targeting Subunit, Reveals a Binding Motif for 14-3-3 Proteins which Regulates its Glycogenic Properties	PLOS ONE			English	Article							SWISS-MODEL; GLUCOSE; PHOSPHOPROTEOME; METABOLISM; CELLS; ACCUMULATION; SYNTHASE; INSULIN; COMPLEX; LAFORIN	Protein phosphatase 1 (PP1) is one of the major protein phosphatases in eukaryotic cells. It plays a key role in regulating glycogen synthesis, by dephosphorylating crucial enzymes involved in glycogen homeostasis such as glycogen synthase (GS) and glycogen phosphorylase (GP). To play this role, PP1 binds to specific glycogen targeting subunits that, on one hand recognize the substrates to be dephosphorylated and on the other hand recruit PP1 to glycogen particles. In this work we have analyzed the functionality of the different protein binding domains of one of these glycogen targeting subunits, namely PPP1R3D (R6) and studied how binding properties of different domains affect its glycogenic properties. We have found that the PP1 binding domain of R6 comprises a conserved RVXF motif (R102VRF) located at the N-terminus of the protein. We have also identified a region located at the C-terminus of R6 (W267DNND) that is involved in binding to the PP1 glycogenic substrates. Our results indicate that although binding to PP1 and glycogenic substrates are independent processes, impairment of any of them results in lack of glycogenic activity of R6. In addition, we have characterized a novel site of regulation in R6 that is involved in binding to 14-3-3 proteins (RARS(74)LP). We present evidence indicating that when binding of R6 to 14-3-3 proteins is prevented, R6 displays hyper-glycogenic activity although is rapidly degraded by the lysosomal pathway. These results define binding to 14-3-3 proteins as an additional pathway in the control of the glycogenic properties of R6.	[Sanz, Pascual] CSIC, Inst Biomed Valencia, Valencia, Spain; Ctr Invest Red Enfermedades Raras CIBERER, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Sanz, P (corresponding author), CSIC, Inst Biomed Valencia, Jaime Roig 11, Valencia, Spain.	sanz@ibv.csic.es	Rubio-Villena, Carla/AAN-7309-2021; García-Gimeno, María Adelaida/K-9855-2014; Sanz, Pascual/K-2751-2014	García-Gimeno, María Adelaida/0000-0002-6483-3912; Sanz, Pascual/0000-0002-2399-4103; Rubio-Villena, Carla/0000-0003-0915-8421	Spanish Ministry of Education and Science [SAF2011-27442]; Generalitat Valenciana [PrometeoII/2014/029]	Spanish Ministry of Education and Science(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work has been supported by grants from the Spanish Ministry of Education and Science SAF2011-27442 and a grant from Generalitat Valenciana (PrometeoII/2014/029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggen JB, 2000, CHEM BIOL, V7, pR13, DOI 10.1016/S1074-5521(00)00069-7; Armstrong CG, 1997, FEBS LETT, V418, P210, DOI 10.1016/S0014-5793(97)01385-9; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Benzinger A, 2005, MOL CELL PROTEOMICS, V4, P785, DOI 10.1074/mcp.M500021-MCP200; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; Christiansen C, 2009, FEBS J, V276, P5006, DOI 10.1111/j.1742-4658.2009.07221.x; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Esteves SLC, 2012, OMICS, V16, P3, DOI 10.1089/omi.2011.0041; Fernandez-Sanchez ME, 2003, HUM MOL GENET, V12, P3161, DOI 10.1093/hmg/ddg340; Fong NM, 2000, J BIOL CHEM, V275, P35034, DOI 10.1074/jbc.M005541200; Garcia-Haro L, 2010, FASEB J, V24, P5080, DOI 10.1096/fj.10-166306; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; Kelsall IR, 2011, J NEUROCHEM, V118, P596, DOI 10.1111/j.1471-4159.2011.07345.x; Knecht E, 2009, CELL MOL LIFE SCI, V66, P2427, DOI 10.1007/s00018-009-0030-6; Lesage B, 2007, BIOCHEMISTRY-US, V46, P8909, DOI 10.1021/bi7003119; Liu J, 2000, J BIOL CHEM, V275, P26074, DOI 10.1074/jbc.M003843200; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ludin K, 1998, P NATL ACAD SCI USA, V95, P6245, DOI 10.1073/pnas.95.11.6245; Machovic M, 2006, CELL MOL LIFE SCI, V63, P2710, DOI 10.1007/s00018-006-6246-9; Montori-Grau M, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-57; Munro S, 2005, FEBS J, V272, P1478, DOI 10.1111/j.1742-4658.2005.04585.x; Newgard CB, 2000, DIABETES, V49, P1967, DOI 10.2337/diabetes.49.12.1967; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Parua PK, 2014, EUKARYOT CELL, V13, P21, DOI 10.1128/EC.00240-13; Paumi CM, 2007, MOL CELL, V26, P15, DOI 10.1016/j.molcel.2007.03.011; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Raijmakers R, 2010, ANAL CHEM, V82, P824, DOI 10.1021/ac901764g; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Rubio-Villena C, 2013, INT J BIOCHEM CELL B, V45, P1479, DOI 10.1016/j.biocel.2013.04.019; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Zhou HJ, 2013, J PROTEOME RES, V12, P260, DOI 10.1021/pr300630k	36	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131476	10.1371/journal.pone.0131476	http://dx.doi.org/10.1371/journal.pone.0131476			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114292	Green Submitted, Green Published, gold			2022-12-27	WOS:000358147500161
J	Denard, B; Pavia-Jimenez, A; Chen, WN; Williams, NS; Naina, H; Collins, R; Brugarolas, J; Ye, J				Denard, Bray; Pavia-Jimenez, Andrea; Chen, Weina; Williams, Noelle S.; Naina, Harris; Collins, Robert; Brugarolas, James; Ye, Jin			Identification of CREB3L1 as a Biomarker Predicting Doxorubicin Treatment Outcome	PLOS ONE			English	Article							DOSE INTENSITY; CHEMOTHERAPY; OASIS; BONE	Background Doxorubicin has been shown to inhibit proliferation of cancer cells through proteolytic activation of CREB3L1 (cAMP response element binding protein 3-like 1), a transcription factor synthesized as a membrane-bound precursor. Upon doxorubicin treatment, CREB3L1 is cleaved so that the N-terminal domain of the protein can reach the nucleus where it activates transcription of genes that inhibit cell proliferation. These results suggest that the level of CREB3L1 in cancer cells may determine their sensitivity to doxorubicin. Methods Mice transplanted with 6 lines of renal cell carcinoma (RCC) were injected with doxorubicin to observe the effect of the chemotherapy on tumor growth. Immunohistochemistry and bioinformatics analyses were performed to compare CREB3L1 levels in types of cancer known to respond to doxorubicin versus those resistant to doxorubicin. Results Higher levels of CREB3L1 protein are correlated with increased doxorubicin sensitivity of xenograft RCC tumors (p = 0.017 by Pearson analysis). From patient tumor biopsies we analyzed, CREB3L1 was expressed in 19% of RCC, which is generally resistant to doxorubicin, but in 70% of diffuse large B-cell lymphoma that is sensitive to doxorubicin. Doxorubicin is used as the standard treatment for cancers that express the highest levels of CREB3L1 such as osteosarcoma and malignant fibrous histiocytoma but is not generally used to treat those that express the lowest levels of CREB3L1 such as RCC. Conclusion Identification of CREB3L1 as the biomarker for doxorubicin sensitivity may markedly improve the doxorubicin response rate by applying doxorubicin only to patients with cancers expressing CREB3L1.	[Denard, Bray; Ye, Jin] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Pavia-Jimenez, Andrea; Naina, Harris; Collins, Robert; Brugarolas, James] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hematol Oncol, Dallas, TX 75390 USA; [Pavia-Jimenez, Andrea; Brugarolas, James] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Chen, Weina] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Williams, Noelle S.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Brugarolas, James] Univ Texas SW Med Ctr Dallas, Kidney Canc Program, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ye, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	jin.ye@utsouthwestern.edu		Brugarolas, James/0000-0002-8575-499X	National Institutes of Health [AI090119, HL20948, AI70116]; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI070116, R01AI090119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study is funded by National Institutes of Health (www.nih.gov): AI090119 and HL20948 for JY, AI70116 for BD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azim HA, 2010, ANN ONCOL, V21, P1064, DOI 10.1093/annonc/mdp425; Bramwell VHC, 1999, J CLIN ONCOL, V17, P3260, DOI 10.1200/JCO.1999.17.10.3260; Chen QY, 2013, J VIROL, V87, P659, DOI 10.1128/JVI.01984-12; Damron T A, 1995, Oncology (Williston Park), V9, P327; Denard B, 2012, ELIFE, V1, DOI 10.7554/eLife.00090; Denard B, 2011, CELL HOST MICROBE, V10, P65, DOI 10.1016/j.chom.2011.06.006; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Kaufman PA, 1999, SEMIN ONCOL, V26, P39; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Lopez-Gonzalez A, 2013, ANN TRANSL MED, V1, DOI 10.3978/j.issn.2305-5839.2013.01.05; Mellor P, 2013, MOL CELL BIOL, V33, P4985, DOI 10.1128/MCB.00959-13; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Pavia-Jimenez A, 2014, NAT PROTOC, V9, P1848, DOI 10.1038/nprot.2014.108; Raja FA, 2012, ANN ONCOL, V23, P118, DOI 10.1093/annonc/mds315; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sivanand S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003643; Su D, 2014, CURR OPIN ONCOL, V26, P321, DOI 10.1097/CCO.0000000000000069; TWELVES CJ, 1991, CANCER CHEMOTH PHARM, V28, P302; Yang F, 2014, BBA-REV CANCER, V1845, P84, DOI 10.1016/j.bbcan.2013.12.002; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919	22	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0129233	10.1371/journal.pone.0129233	http://dx.doi.org/10.1371/journal.pone.0129233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110425	Green Submitted, Green Published, gold			2022-12-27	WOS:000356933800022
J	Lawes, MJ; Fisher, DO; Johnson, CN; Blomberg, SP; Frank, ASK; Fritz, SA; McCallum, H; VanDerWal, J; Abbott, BN; Legge, S; Letnic, M; Thomas, CR; Thurgate, N; Fisher, A; Gordon, IJ; Kutt, A				Lawes, Michael J.; Fisher, Diana O.; Johnson, Chris N.; Blomberg, Simon P.; Frank, Anke S. K.; Fritz, Susanne A.; McCallum, Hamish; VanDerWal, Jeremy; Abbott, Brett N.; Legge, Sarah; Letnic, Mike; Thomas, Colette R.; Thurgate, Nikki; Fisher, Alaric; Gordon, Iain J.; Kutt, Alex			Correlates of Recent Declines of Rodents in Northern and Southern Australia: Habitat Structure Is Critical	PLOS ONE			English	Article							EXTINCTION RISK; SMALL MAMMALS; TROPICAL MARSUPIALS; CONSERVATION STATUS; FIRE; PATTERNS; IMPACTS; HISTORY; VERTEBRATES; RESOURCES	Australia has experienced dramatic declines and extinctions of its native rodent species over the last 200 years, particularly in southern Australia. In the tropical savanna of northern Australia significant declines have occurred only in recent decades. The later onset of these declines suggests that the causes may differ from earlier declines in the south. We examine potential regional effects (northern versus southern Australia) on biological and ecological correlates of range decline in Australian rodents. We demonstrate that rodent declines have been greater in the south than in the tropical north, are strongly influenced by phylogeny, and are consistently greater for species inhabiting relatively open or sparsely vegetated habitat. Unlike in marsupials, where some species have much larger body size than rodents, body mass was not an important predictor of decline in rodents. All Australian rodent species are within the prey-size range of cats (throughout the continent) and red foxes (in the south). Contrary to the hypothesis that mammal declines are related directly to ecosystem productivity (annual rainfall), our results are consistent with the hypothesis that disturbances such as fire and grazing, which occur in non-rainforest habitats and remove cover used by rodents for shelter, nesting and foraging, increase predation risk. We agree with calls to introduce conservation management that limits the size and intensity of fires, increases fire patchiness and reduces grazing impacts at ecological scales appropriate for rodents. Controlling feral predators, even creating predator-free reserves in relatively sparsely-vegetated habitats, is urgently required to ensure the survival of rodent species, particularly in northern Australia where declines are not yet as severe as those in the south.	[Lawes, Michael J.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Fisher, Diana O.; Blomberg, Simon P.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Johnson, Chris N.; Frank, Anke S. K.] Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia; [Fritz, Susanne A.] Biodivers & Climate Res Ctr BiKF, Frankfurt, Germany; [Fritz, Susanne A.] Senckenberg Gesell Naturforsch, Frankfurt, Germany; [McCallum, Hamish] Griffith Univ, Sch Environm, Sydney, NSW, Australia; [VanDerWal, Jeremy] James Cook Univ, Sch Marine & Trop Biol, Ctr Climate Change & Trop Biol, Townsville, Qld 4811, Australia; [Abbott, Brett N.] CSIRO, Land & Water Australian Trop Sci Precinct, PMB PO, Aitkenvale, Qld 4814, Australia; [Frank, Anke S. K.; Fisher, Alaric] Northern Terr Dept Land Resource Management, Flora & Fauna Div, Darwin, NT, Australia; [Legge, Sarah] Australian Wildlife Conservancy, Perth, WA, Australia; [Legge, Sarah; Fisher, Alaric] Charles Darwin Univ, Natl Environm Res Program Northern Australia Hub, Darwin, NT 0909, Australia; [Letnic, Mike] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Thomas, Colette R.] James Cook Univ, TropWATER, Townsville, Qld 4811, Australia; [Thurgate, Nikki] Univ Adelaide, Sch Earth & Environm Sci, Terr Ecosyst Res Network, Adelaide, SA, Australia; [Gordon, Iain J.] James Hutton Inst, Invergowrie Dundee, Scotland; [Kutt, Alex] Univ Melbourne, Sch Biosci, ARCUE, Melbourne, Vic, Australia	Charles Darwin University; University of Queensland; University of Tasmania; Senckenberg Gesellschaft fur Naturforschung (SGN); Griffith University; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Charles Darwin University; University of New South Wales Sydney; James Cook University; University of Adelaide; James Hutton Institute; University of Melbourne	Lawes, MJ (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia.	Michael.Lawes@cdu.edu.au	Legge, Sarah/AAB-7229-2019; Lawes, Michael J/N-2132-2013; Frank, Anke S. K./J-7789-2014; Fritz, Susanne/M-9872-2014; Gordon, Iain J/K-8636-2012; Blomberg, Simone P/B-7613-2008; McCallum, Hamish/E-1638-2013; Gordon, Iain/S-8076-2019; Johnson, Christopher/J-7894-2014; Fisher, Diana O/C-1324-2010; Legge, Sarah/GYE-1554-2022; Abbott, Brett/H-4985-2014	Legge, Sarah/0000-0001-6968-2781; Lawes, Michael J/0000-0002-2381-6147; Frank, Anke S. K./0000-0002-0177-4898; Fritz, Susanne/0000-0002-4085-636X; Gordon, Iain J/0000-0001-9704-0946; Blomberg, Simone P/0000-0003-1062-0839; McCallum, Hamish/0000-0002-3493-0412; Gordon, Iain/0000-0001-9704-0946; Johnson, Christopher/0000-0002-9719-3771; Fisher, Diana O/0000-0002-4017-3710; Abbott, Brett/0000-0003-3377-1736; Kutt, Alex/0000-0001-9679-2206; Letnic, Michael/0000-0003-4191-8427	ARC [LP100100033, DP0773920, FT110100191, DP110103069, FT110100057]; CSIRO Building Resilient Australian Biodiversity Assets Theme; ARC Linkage grant [LP100100033]; LOEWE funding programme of Hesse's Ministry of Higher Education, Research; Arts	ARC(Australian Research Council); CSIRO Building Resilient Australian Biodiversity Assets Theme; ARC Linkage grant(Australian Research Council); LOEWE funding programme of Hesse's Ministry of Higher Education, Research; Arts	M.J.L., D.O.F., H.M., C.N.J., A.S.K.F. and M.L. were supported by ARC Fellowships and grants (LP100100033, DP0773920, FT110100191, DP110103069 and FT110100057). A.K. and C.R.T. were supported by funding from the CSIRO Building Resilient Australian Biodiversity Assets Theme. A.S.K.F. was supported by an ARC Linkage grant (LP100100033). S.A.F. was supported by the LOEWE funding programme of Hesse's Ministry of Higher Education, Research, and the Arts. I.J.G. was funded by the CSIRO Building Resilient Australian Biodiversity Assets Theme.	Amori G, 2008, QUATERN INT, V182, P6, DOI 10.1016/j.quaint.2007.05.014; [Anonymous], 2015, PLOS ONE; Armstrong K.N., 2008, MAMMALS AUSTR, P470; Armsworth PR, 2014, ANN NY ACAD SCI, V1322, P61, DOI 10.1111/nyas.12455; Banks PB, 2012, WILDLIFE RES, V39, P78, DOI 10.1071/WR11086; Bielby J, 2010, BIODIVERS CONSERV, V19, P113, DOI 10.1007/s10531-009-9709-0; Breed B, 2007, NATIVE MICE AND RATS; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Burbidge A.A., 2014, P15; BURBIDGE AA, 1989, BIOL CONSERV, V50, P143, DOI 10.1016/0006-3207(89)90009-8; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2004, J ZOOL, V264, P11, DOI 10.1017/S0952836904005539; Cole JR, 2000, WILDLIFE RES, V27, P437, DOI 10.1071/WR97053; Colman NJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3094; Cowie RH, 2001, BIOL CONSERV, V99, P207, DOI 10.1016/S0006-3207(00)00181-6; Crowley G, 2013, BNBP0755 MEAT LIV AU; Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106; Denny EA, 2010, REVIEW OF CAT ECOLOG; Di Marco M, 2012, CONSERV LETT, V5, P134, DOI 10.1111/j.1755-263X.2011.00219.x; DICKMAN CR, 1993, BIOL CONSERV, V65, P219, DOI 10.1016/0006-3207(93)90056-7; Fisher DO, 2015, GLOBAL ECOL BIOGEOGR, V24, P123, DOI 10.1111/geb.12252; Fisher DO, 2014, GLOBAL ECOL BIOGEOGR, V23, P181, DOI 10.1111/geb.12088; Fisher DO, 2011, BIOL CONSERV, V144, P1712, DOI 10.1016/j.biocon.2011.03.005; Fisher DO, 2004, TRENDS ECOL EVOL, V19, P391, DOI 10.1016/j.tree.2004.05.004; Fisher DO, 2003, P ROY SOC B-BIOL SCI, V270, P1801, DOI 10.1098/rspb.2003.2447; Fisher DO, 2001, ECOLOGY, V82, P3531, DOI 10.1890/0012-9658(2001)082[3531:TEBOLH]2.0.CO;2; Ford FD, 2004, CONILURINE RODENT EV; Ford F, 2006, BIOL J LINN SOC, V89, P117, DOI 10.1111/j.1095-8312.2006.00663.x; Frank ASK, 2014, J APPL ECOL, V51, P1486, DOI 10.1111/1365-2664.12323; FRIEND GR, 1985, AUST J ECOL, V10, P173, DOI 10.1111/j.1442-9993.1985.tb00879.x; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Geffen E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019199; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gordon CE, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2870; Haslem A, 2011, J APPL ECOL, V48, P247, DOI 10.1111/j.1365-2664.2010.01906.x; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; IUCN, 2013, IUCN RED LIST THREAT; IUCN, 2012, IUCN RED LIST THREAT; Johnson, 2006, AUSTRALIAS MAMMAL EX; Johnson CN, 2009, AUSTRAL ECOL, V34, P35, DOI 10.1111/j.1442-9993.2008.01878.x; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kelly LT, 2011, DIVERS DISTRIB, V17, P462, DOI 10.1111/j.1472-4642.2011.00754.x; Kutt AS, 2012, ANIM CONSERV, V15, P416, DOI 10.1111/j.1469-1795.2012.00530.x; Kutt AS, 2012, J ZOOL, V287, P292, DOI 10.1111/j.1469-7998.2012.00915.x; Kutt AS, 2007, J TROP ECOL, V23, P95, DOI 10.1017/S0266467406003579; Lawes MJ, 2015, INT J WILDLAND FIRE; Leahy L, AMPLIFIED PREDATION; Legge S, 2008, WILDLIFE RES, V35, P33, DOI 10.1071/WR07016; Legge S, 2011, AUSTRAL ECOL, V36, P791, DOI 10.1111/j.1442-9993.2010.02218.x; Letnic M, 2010, BIOL REV, V85, P501, DOI 10.1111/j.1469-185X.2009.00113.x; Letnic M, 2009, ANIM CONSERV, V12, P302, DOI 10.1111/j.1469-1795.2009.00250.x; Letnic M, 2006, BIODIVERS CONSERV, V15, P3847, DOI 10.1007/s10531-005-0601-2; Letnic M, 2013, AUSTRAL ECOL, V38, P841, DOI 10.1111/aec.12063; Letnic M, 2011, ECOGRAPHY, V34, P827, DOI 10.1111/j.1600-0587.2010.06516.x; Letnic M, 2011, GLOBAL ECOL BIOGEOGR, V20, P343, DOI 10.1111/j.1466-8238.2010.00600.x; MacPhee R.D.E., 1999, P333; McGregor HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109097; McKenzie NL, 2007, J BIOGEOGR, V34, P597, DOI 10.1111/j.1365-2699.2006.01639.x; Murphy BP, 2014, GLOBAL ECOL BIOGEOGR, V23, P1058, DOI 10.1111/geb.12173; Murphy BP, 2011, NEW PHYTOL, V192, P316, DOI 10.1111/j.1469-8137.2011.03893.x; Murray KA, 2011, P ROY SOC B-BIOL SCI, V278, P1515, DOI 10.1098/rspb.2010.1872; Neal RM, 2011, CH CRC HANDB MOD STA, P113; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Radford IJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092341; Radford IJ, 2012, AUSTRAL ECOL, V37, P926, DOI 10.1111/j.1442-9993.2011.02352.x; Radford IJ, 2012, AUSTRAL ECOL, V37, P733, DOI 10.1111/j.1442-9993.2012.02413.x; Saunders GR, 2010, MAMMAL REV, V40, P181, DOI 10.1111/j.1365-2907.2010.00159.x; Smith AP, 1996, BIOL CONSERV, V77, P243, DOI 10.1016/0006-3207(96)00002-X; Specht RL., 1970, AUSTR ENV, P44; Stan Development Team, STAN C LIB PROB SAMP; Sutherland EF, 1999, WILDLIFE RES, V26, P405, DOI 10.1071/WR97045; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Wiles GJ, 2003, CONSERV BIOL, V17, P1350, DOI 10.1046/j.1523-1739.2003.01526.x; WILSON G, 1992, PEST ANIMALS AUSTR S; WITTE F, 1992, ENVIRON BIOL FISH, V34, P1, DOI 10.1007/BF00004782; Woinarski JCZ, 2010, WILDLIFE RES, V37, P116, DOI 10.1071/WR09125; Woinarski JCZ, 2000, WILDLIFE RES, V27, P421, DOI 10.1071/WR97047; Yates CP, 2008, INT J WILDLAND FIRE, V17, P768, DOI 10.1071/WF07150	82	26	28	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130626	10.1371/journal.pone.0130626	http://dx.doi.org/10.1371/journal.pone.0130626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26111037	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000356933800068
J	Bachle, C; Lange, K; Stahl-Pehe, A; Castillo, K; Scheuing, N; Holl, RW; Giani, G; Rosenbauer, J				Baechle, Christina; Lange, Karin; Stahl-Pehe, Anna; Castillo, Katty; Scheuing, Nicole; Holl, Reinhard W.; Giani, Guido; Rosenbauer, Joachim			Symptoms of Eating Disorders and Depression in Emerging Adults with Early-Onset, Long-Duration Type 1 Diabetes and Their Association with Metabolic Control	PLOS ONE			English	Article							YOUNG-ADULTS; GLYCEMIC CONTROL; COMPLICATIONS TRIAL/EPIDEMIOLOGY; ADOLESCENTS; PREVALENCE; HEALTH; INTERVENTIONS; CHILDREN; BEHAVIOR; YOUTH	Background This study analyzed the prevalence of and association between symptoms of eating disorders and depression in female and male emerging adults with early-onset, long-duration type 1 diabetes and investigated how these symptoms are associated with metabolic control. Methods In a nationwide population-based survey, 211 type 1 diabetes patients aged 18-21 years completed standardized questionnaires, including the SCOFF questionnaire for eating disorder symptoms and the Patient Health Questionnaire (PHQ-9) for symptoms of depression and severity of depressive symptoms (PHQ-9 score). Multiple linear and logistic regression models were used to analyze the association between eating disorder and depressive symptoms and their associations with HbA1c. Results A total of 30.2% of the women and 9.5% of the men were screening positive for eating disorders. The mean PHQ-9 score (standard deviation) was 5.3 (4.4) among women and 3.9 (3.6) among men. Screening positive for an eating disorder was associated with more severe depressive symptoms among women (beta(women) 3.8, p<0.001). However, neither eating disorder symptoms nor severity of depressive symptoms were associated with HbA1c among women, while HbA1c increased with the severity of depressive symptoms among men (beta(men) 0.14, p= 0.006). Conclusions Because of the high prevalence of eating disorder and depressive symptoms, their interrelationship, and their associations with metabolic control, particularly among men, regular mental health screening is recommended for young adults with type 1 diabetes.	[Baechle, Christina; Stahl-Pehe, Anna; Castillo, Katty; Giani, Guido; Rosenbauer, Joachim] German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Baechle, Christina; Stahl-Pehe, Anna; Castillo, Katty; Scheuing, Nicole; Holl, Reinhard W.; Giani, Guido; Rosenbauer, Joachim] German Ctr Diabet Res DZD, Neuherberg, Germany; [Lange, Karin] Hannover Med Sch, Dept Med Psychol, Hannover, Germany; [Scheuing, Nicole; Holl, Reinhard W.] Univ Ulm, Inst Epidemiol & Med Biometry, ZIBMT, D-89069 Ulm, Germany	Deutsches Diabetes-Zentrum (DDZ); Hannover Medical School; Ulm University	Bachle, C (corresponding author), German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany.	christina.baechle@ddz.uni-duesseldorf.de		Stahl-Pehe, Anna/0000-0002-5281-6023; Holl, Reinhard/0000-0003-1395-4842	Competence Network Diabetes Mellitus by the German Federal Ministry of Education and Research (BMBF) [FKZ 01GI0802, 01GI1109A, 0GI0859, 01GI1106]; German Center for Diabetes Research (DZD); German Federal Ministry of Health (BMG); Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW); European Foundation for the Study of Diabetes (EFSD); Dr. Burger-Busing Foundation; European Foundation for the Study of Diabetes [AZ Macrov 2014_2] Funding Source: researchfish	Competence Network Diabetes Mellitus by the German Federal Ministry of Education and Research (BMBF); German Center for Diabetes Research (DZD); German Federal Ministry of Health (BMG); Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW); European Foundation for the Study of Diabetes (EFSD); Dr. Burger-Busing Foundation; European Foundation for the Study of Diabetes	This study was supported by the Competence Network Diabetes Mellitus by the German Federal Ministry of Education and Research (BMBF; FKZ 01GI0802, 01GI1109A, 01GI0859, 01GI1106) and the German Center for Diabetes Research (DZD). The German Diabetes Center is institutionally funded by the German Federal Ministry of Health (BMG) and the Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW). The DPV initiative is supported by the European Foundation for the Study of Diabetes (EFSD), and the Dr. Burger-Busing Foundation. The funding sources were not involved in the study design; the data collection, analysis or interpretation; the writing of the report; the decision to submit the article for publication; or any other aspect of the study.	Ahola AJ, 2012, DIABETOLOGIA, V55, P73, DOI 10.1007/s00125-011-2347-6; Albers JW, 2010, DIABETES CARE, V33, P1090, DOI 10.2337/dc09-1941; Anderson B.J., 2010, DIABETES SPECTR, V23, P32; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Baechle C, 2014, INT J EAT DISORDER, V47, P342, DOI 10.1002/eat.22238; Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x; Bernstein CM, 2013, CLIN PEDIATR, V52, P10, DOI 10.1177/0009922812459950; Bryden KS, 2003, DIABETES CARE, V26, P1052, DOI 10.2337/diacare.26.4.1052; Carreira M, 2010, MED CLIN-BARCELONA, V135, P151, DOI 10.1016/j.medcli.2010.02.027; Colton PA, 2007, DIABETES CARE, V30, P2861, DOI 10.2337/dc07-1057; Colton PA, 2013, PEDIATR DIABETES, V14, P372, DOI 10.1111/pedi.12016; Dabelea D, 2009, LANCET, V373, P1999, DOI 10.1016/S0140-6736(09)60874-6; de Boer IH, 2011, NEW ENGL J MED, V365, P2366, DOI 10.1056/NEJMoa1111732; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; Ferreiro F, 2011, J CLIN CHILD ADOLESC, V40, P500, DOI 10.1080/15374416.2011.563465; Frohlich-Reiterer EE, 2014, ARCH DIS CHILD, V99, P738, DOI 10.1136/archdischild-2013-304237; Gendelman N, 2009, DIABETES CARE, V32, P575, DOI 10.2337/dc08-1835; Hautala L, 2011, INT J NURS STUD, V48, P959, DOI 10.1016/j.ijnurstu.2011.01.014; Helgeson VS, 2009, J PEDIATR PSYCHOL, V34, P254, DOI 10.1093/jpepsy/jsn079; Hill LS, 2010, INT J EAT DISORDER, V43, P344, DOI 10.1002/eat.20679; Hislop AL, 2008, DIABETIC MED, V25, P91, DOI 10.1111/j.1464-5491.2007.02310.x; Johnson B, 2013, DIABETIC MED, V30, P199, DOI 10.1111/j.1464-5491.2012.03721.x; Korbel CD, 2007, CHILD HEALTH CARE, V36, P83, DOI 10.1080/02739610701316936; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; Lange M, 2007, BUNDESGESUNDHEITSBLA, V50, P578, DOI 10.1007/s00103-007-0219-5; Lawrence JM, 2006, PEDIATRICS, V117, P1348, DOI 10.1542/peds.2005-1398; Lotstein DS, 2013, PEDIATRICS, V131, pE1062, DOI 10.1542/peds.2012-1450; Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9; Lowe B, 2002, PHQ D MANUAL KOMPLET; Lyoo IK, 2012, ARCH GEN PSYCHIAT, V69, P1267, DOI 10.1001/archgenpsychiatry.2012.543; Manarte LF, 2010, ACTA DIABETOL, V47, P201, DOI 10.1007/s00592-009-0110-y; Melin EO, 2013, EUR J ENDOCRINOL, V168, P861, DOI 10.1530/EJE-13-0137; Morgan JF, 1999, BRIT MED J, V319, P1467, DOI 10.1136/bmj.319.7223.1467; Muro-Sans P, 2008, J PSYCHOSOM RES, V64, P81, DOI 10.1016/j.jpsychores.2007.06.011; Nathan DM, 2013, DIABETES, V62, P3976, DOI 10.2337/db13-1093; Northam EA, 2010, DIABETES CARE, V33, P1430, DOI 10.2337/dc09-2232; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Peveler RC, 2005, DIABETES CARE, V28, P84, DOI 10.2337/diacare.28.1.84; Polak JF, 2011, DIABETES, V60, P607, DOI 10.2337/db10-0296; Pop-Busui R, 2010, CURR DIABETES REP, V10, P276, DOI 10.1007/s11892-010-0120-8; Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6; Sacco WP, 2010, DIABETES RES CLIN PR, V90, P141, DOI 10.1016/j.diabres.2010.06.026; Sassmann H, 2015, DIABET MED; Scheuing N, 2014, DIABETES CARE, V37, P1581, DOI 10.2337/dc13-2156; Shaban C, 2009, DIABETES RES CLIN PR, V85, pE26, DOI 10.1016/j.diabres.2009.05.006; Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186; Stahl A, 2012, DIABETES CARE, V35, P1736, DOI 10.2337/dc11-2438; Steinsdottir FK, 2008, LAEKNABLADID, V94, P823; Tanofsky-Kraff M, 2011, J ABNORM PSYCHOL, V120, P108, DOI 10.1037/a0021406; van Steenbergen-Weijenburg KM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-235; W.H.O. (World Health Organization), 2008, BMI CLASS; White NH, 2010, DIABETES, V59, P1244, DOI 10.2337/db09-1216; Young V, 2013, DIABETIC MED, V30, P189, DOI 10.1111/j.1464-5491.2012.03771.x	53	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131027	10.1371/journal.pone.0131027	http://dx.doi.org/10.1371/journal.pone.0131027			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1BL	26121155	gold, Green Published, Green Submitted			2022-12-27	WOS:000358150400073
J	Zhang, GZ; Sharon, D; Jovel, J; Liu, L; Wine, E; Tahbaz, N; Indik, S; Mason, A				Zhang, Guangzhi; Sharon, David; Jovel, Juan; Liu, Lei; Wine, Eytan; Tahbaz, Nasser; Indik, Stanislav; Mason, Andrew			Pericentriolar Targeting of the Mouse Mammary Tumor Virus GAG Protein	PLOS ONE			English	Article							ENDOGENOUS RETROVIRUS; MEMBRANE-BINDING; MATRIX PROTEIN; TRANSPORT ELEMENT; RETENTION SIGNAL; DEPENDENT MANNER; IDENTIFICATION; REGION; DOMAINS; CELLS	The Gag protein of the mouse mammary tumor virus (MMTV) is the chief determinant of subcellular targeting. Electron microscopy studies show that MMTV Gag forms capsids within the cytoplasm and assembles as immature particles with MMTV RNA and the Y box binding protein-1, required for centrosome maturation. Other betaretroviruses, such as Mason-Pfizer monkey retrovirus (M-PMV), assemble adjacent to the pericentriolar region because of a cytoplasmic targeting and retention signal in the Matrix protein. Previous studies suggest that the MMTV Matrix protein may also harbor a similar cytoplasmic targeting and retention signal. Herein, we show that a substantial fraction of MMTV Gag localizes to the pericentriolar region. This was observed in HEK293T, HeLa human cell lines and the mouse derived NMuMG mammary gland cells. Moreover, MMTV capsids were observed adjacent to centrioles when expressed from plasmids encoding either MMTV Gag alone, Gag-Pro-Pol or full-length virus. We found that the cytoplasmic targeting and retention signal in the MMTV Matrix protein was sufficient for pericentriolar targeting, whereas mutation of the glutamine to alanine at position 56 (D56/A) resulted in plasma membrane localization, similar to previous observations from mutational studies of M-PMV Gag. Furthermore, transmission electron microscopy studies showed that MMTV capsids accumulate around centrioles suggesting that, similar to M-PMV, the pericentriolar region may be a site for MMTV assembly. Together, the data imply that MMTV Gag targets the pericentriolar region as a result of the MMTV cytoplasmic targeting and retention signal, possibly aided by the Y box protein-1 required for the assembly of centrosomal microtubules.	[Zhang, Guangzhi; Sharon, David; Jovel, Juan; Mason, Andrew] Univ Alberta, Dept Med, Div Gastroenterol, Edmonton, AB, Canada; [Liu, Lei; Wine, Eytan] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Tahbaz, Nasser] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada; [Indik, Stanislav] Univ Vet Med Vienna, Res Inst Virol & Biomed, A-1210 Vienna, Austria	University of Alberta; University of Alberta; University of Alberta; University of Veterinary Medicine Vienna	Mason, A (corresponding author), Univ Alberta, Dept Med, Div Gastroenterol, Edmonton, AB, Canada.	andrew.mason@ualberta.ca	; Mason, Andrew/D-2938-2013	Indik, Stanislav/0000-0001-8255-6544; Mason, Andrew/0000-0002-0470-9522	Alberta Cancer Foundation; Alberta Innovates Health Solutions; Alberta Innovates Technology Futures; Canadian Institutes for Health Research; Canadian Liver Foundation	Alberta Cancer Foundation; Alberta Innovates Health Solutions; Alberta Innovates Technology Futures; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Liver Foundation	This study was supported by the Alberta Cancer Foundation, Alberta Innovates Health Solutions, Alberta Innovates Technology Futures, the Canadian Institutes for Health Research and Canadian Liver Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud F, 2007, J VIROL, V81, P11441, DOI 10.1128/JVI.01214-07; Bann DV, 2014, J VIROL, V88, P4434, DOI 10.1128/JVI.02607-13; Beyer AR, 2013, J VIROL, V87, P1069, DOI 10.1128/JVI.02463-12; Boeras I, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-8; Boutros R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067822; Choi G, 1999, J VIROL, V73, P5431, DOI 10.1128/JVI.73.7.5431-5437.1999; Clark J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083863; Dangel AW, 2002, J VIROL, V76, P3292, DOI 10.1128/JVI.76.7.3292-3300.2002; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Garnier L, 1998, AIDS, V12 Suppl A, pS5; HIZI A, 1989, J VIROL, V63, P2543, DOI 10.1128/JVI.63.6.2543-2549.1989; Hohenadl C, 2012, J GEN VIROL, V93, P308, DOI 10.1099/vir.0.035196-0; HONG SS, 1993, J VIROL, V67, P2787, DOI 10.1128/JVI.67.5.2787-2798.1993; Indik S, 2005, VIROLOGY, V337, P1, DOI 10.1016/j.virol.2005.03.040; Indik S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-73; Kawaguchi A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08768; Konstantoulas CJ, 2015, J GEN VIROL, V96, P650, DOI 10.1099/jgv.0.000006; Lee YM, 1998, J VIROL, V72, P9061, DOI 10.1128/JVI.72.11.9061-9068.1998; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Mertz JA, 2005, J VIROL, V79, P14737, DOI 10.1128/JVI.79.23.14737-14747.2005; Mertz JA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-10; Mullner M, 2008, NUCLEIC ACIDS RES, V36, P6284, DOI 10.1093/nar/gkn608; Mura M, 2004, P NATL ACAD SCI USA, V101, P11117, DOI 10.1073/pnas.0402877101; Murcia PR, 2007, J VIROL, V81, P1762, DOI 10.1128/JVI.01859-06; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; PAYNE AL, 1983, ONDERSTEPOORT J VET, V50, P317; RHEE SS, 1991, EMBO J, V10, P535, DOI 10.1002/j.1460-2075.1991.tb07980.x; RHEE SS, 1990, J VIROL, V64, P3844, DOI 10.1128/JVI.64.8.3844-3852.1990; RHEE SS, 1990, CELL, V63, P77, DOI 10.1016/0092-8674(90)90289-Q; Rizvi TA, 2009, VIROLOGY, V385, P464, DOI 10.1016/j.virol.2008.12.027; Ross SR, 2010, VIRUSES-BASEL, V2, P2000, DOI 10.3390/v2092000; SALMONS B, 1985, VIROLOGY, V144, P101, DOI 10.1016/0042-6822(85)90309-5; Sanfacon Helene, 2008, V451, P361, DOI 10.1007/978-1-59745-102-4_25; Sfakianos JN, 2003, TRAFFIC, V4, P660, DOI 10.1034/j.1600-0854.2003.00125.x; Sfakianos JN, 2003, TRAFFIC, V4, P671, DOI 10.1034/j.1600-0854.2003.00126.x; SPEARMAN P, 1994, J VIROL, V68, P3232, DOI 10.1128/JVI.68.5.3232-3242.1994; Vallejos M, 2010, NUCLEIC ACIDS RES, V38, P618, DOI 10.1093/nar/gkp890; Wang W, 2015, ALIMENT PHARM THER, V41, P393, DOI 10.1111/apt.13054; White RA, 2000, MICROSC RES TECHNIQ, V49, P451, DOI 10.1002/(SICI)1097-0029(20000601)49:5<451::AID-JEMT7>3.0.CO;2-9; Wodrich H, 2000, NUCLEIC ACIDS RES, V28, P901, DOI 10.1093/nar/28.4.901; Yu SYF, 2006, TRAFFIC, V7, P966, DOI 10.1111/j.1600-0854.2006.00448.x; Zabransky A, 2005, VIROLOGY, V332, P659, DOI 10.1016/j.virol.2004.12.007; Zabransky A, 2009, VIROLOGY, V384, P33, DOI 10.1016/j.virol.2008.10.038; Zabransky A, 2010, J VIROL, V84, P11555, DOI 10.1128/JVI.00652-10; Zhang GZ, 2011, J HEPATOL, V55, P876, DOI 10.1016/j.jhep.2011.01.037; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; ZHOU WJ, 1994, J VIROL, V68, P2556, DOI 10.1128/JVI.68.4.2556-2569.1994	47	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2015	10	6							e0131515	10.1371/journal.pone.0131515	http://dx.doi.org/10.1371/journal.pone.0131515			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1BL	26121257	Green Published, Green Submitted, gold			2022-12-27	WOS:000358150400119
J	Babadjanova, Z; Wiedinger, K; Gosselin, EJ; Bitsaktsis, C				Babadjanova, Zulfia; Wiedinger, Kari; Gosselin, Edmund J.; Bitsaktsis, Constantine			Targeting of a Fixed Bacterial Immunogen to Fc Receptors Reverses the Anti-Inflammatory Properties of the Gram-Negative Bacterium, Francisella tularensis, during the Early Stages of Infection	PLOS ONE			English	Article							LIVE VACCINE STRAIN; IFN-GAMMA; INNATE IMMUNITY; HUMAN MONOCYTES; INTRACELLULAR BACTERIUM; RESPIRATORY-INFECTION; IL-10-DEFICIENT MICE; ACQUIRED-IMMUNITY; PROSTAGLANDIN E-2; HIV-INFECTION	Production of pro-inflammatory cytokines by innate immune cells at the early stages of bacterial infection is important for host protection against the pathogen. Many intracellular bacteria, including Francisella tularensis, the agent of tularemia, utilize the anti-inflammatory cytokine IL-10, to evade the host immune response. It is well established that IL-10 has the ability to inhibit robust antigen presentation by dendritic cells and macrophages, thus suppressing the generation of protective immunity. The pathogenesis of F. tularensis is not fully understood, and research has failed to develop an effective vaccine to this date. In the current study, we hypothesized that F. tularensis polarizes antigen presenting cells during the early stages of infection towards an anti-inflammatory status characterized by increased synthesis of IL-10 and decreased production of IL-12p70 and TNF-alpha in an IFN-gamma-dependent fashion. In addition, F. tularensis drives an alternative activation of alveolar macrophages within the first 48 hours post-infection, thus allowing the bacterium to avoid protective immunity. Furthermore, we demonstrate that targeting inactivated F. tularensis (iFt) to Fc gamma receptors (Fc gamma Rs) via intranasal immunization with mAb-iFt complexes, a proven vaccine strategy in our laboratories, reverses the anti-inflammatory effects of the bacterium on macrophages by down-regulating production of IL-10. More specifically, we observed that targeting of iFt to Fc gamma Rs enhances the classical activation of macrophages not only within the respiratory mucosa, but also systemically, at the early stages of infection. These results provide important insight for further understanding the protective immune mechanisms generated when targeting immunogens to Fc receptors.	[Babadjanova, Zulfia; Wiedinger, Kari; Bitsaktsis, Constantine] Seton Hall Univ, Dept Biol Sci, S Orange, NJ 07079 USA; [Gosselin, Edmund J.] Albany Med Coll, Dept Immunol & Microbial Dis, Albany, NY 12208 USA	Seton Hall University; Albany Medical College	Bitsaktsis, C (corresponding author), Seton Hall Univ, Dept Biol Sci, S Orange, NJ 07079 USA.	Constantine.bitsaktsis@shu.edu			Seton Hall University Start Up Funds; National Institutes of Health [R01 AI076408, P01 AI05632]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076408] Funding Source: NIH RePORTER	Seton Hall University Start Up Funds; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was financially supported by Seton Hall University (www.shu.edu) Start Up Funds and the National Institutes of Health (www.nih.gov; R01 AI076408, P01 AI05632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsohn IA, 1996, EXP PARASITOL, V84, P231, DOI 10.1006/expr.1996.0109; Alfano M, 2005, MOL IMMUNOL, V42, P161, DOI 10.1016/j.molimm.2004.06.016; Ancuta P, 1996, INFECT IMMUN, V64, P2041, DOI 10.1128/IAI.64.6.2041-2046.1996; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Barker JH, 2006, INFECT IMMUN, V74, P3277, DOI 10.1128/IAI.02011-05; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bitsaktsis C, 2015, INFECT IMMUN, V83, P77, DOI 10.1128/IAI.02289-14; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Bosio CM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00009; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Brustoski K, 2005, J IMMUNOL, V174, P1738, DOI 10.4049/jimmunol.174.3.1738; Cope A, 2011, TRENDS IMMUNOL, V32, P278, DOI 10.1016/j.it.2011.03.010; Dai WJ, 1997, J IMMUNOL, V158, P2259; DING L, 1993, J IMMUNOL, V151, P1224; DONNELLY RP, 1995, J IMMUNOL, V155, P1420; Dotson RJ, 2013, J BIOL CHEM, V288, P23844, DOI 10.1074/jbc.M113.490086; Duckett NS, 2005, INFECT IMMUN, V73, P2306, DOI 10.1128/IAI.73.4.2306-2311.2005; Duenas AI, 2006, INT IMMUNOL, V18, P785, DOI 10.1093/intimm/dxl015; Elkins KL, 2003, MICROBES INFECT, V5, P135, DOI 10.1016/S1286-4579(02)00084-9; GOSSELIN EJ, 1992, J IMMUNOL, V149, P3477; Hajjar AM, 2006, INFECT IMMUN, V74, P6730, DOI 10.1128/IAI.00934-06; Huang MTH, 2010, J IMMUNOL, V185, P5476, DOI 10.4049/jimmunol.1002154; Iglesias BV, 2013, IMMUNOL CELL BIOL, V91, P139, DOI 10.1038/icb.2012.66; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Katakura T, 2004, J IMMUNOL, V172, P1407, DOI 10.4049/jimmunol.172.3.1407; Lacy P, 2011, BLOOD, V118, P9, DOI 10.1182/blood-2010-08-265892; LEIBY DA, 1992, INFECT IMMUN, V60, P84, DOI 10.1128/IAI.60.1.84-89.1992; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mares CA, 2008, INFECT IMMUN, V76, P3001, DOI 10.1128/IAI.00215-08; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Metzger DW, 2007, ANN NY ACAD SCI, V1105, P266, DOI 10.1196/annals.1409.007; Metzger DW, 2013, INFECT IMMUN, V81, P2022, DOI 10.1128/IAI.00024-13; Pashine A, 2005, NAT MED, V11, pS63, DOI 10.1038/nm1210; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Rawool DB, 2008, J IMMUNOL, V180, P5548, DOI 10.4049/jimmunol.180.8.5548; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Salek-Ardakani S, 2002, VIROLOGY, V304, P342, DOI 10.1006/viro.2002.1716; Santic M, 2005, CELL MICROBIOL, V7, P957, DOI 10.1111/j.1462-5822.2005.00529.x; Sharma J, 2009, INFECT IMMUN, V77, P4314, DOI 10.1128/IAI.00654-09; Shibata Y, 1998, J IMMUNOL, V161, P4283; Shinozawa Y, 2002, J MED MICROBIOL, V51, P225, DOI 10.1099/0022-1317-51-3-225; Shirey KA, 2008, J IMMUNOL, V181, P4159, DOI 10.4049/jimmunol.181.6.4159; Sing A, 2002, J IMMUNOL, V168, P1315, DOI 10.4049/jimmunol.168.3.1315; Singh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058513; Tomioka H, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/635451; Ulland TK, 2010, J IMMUNOL, V185, P2670, DOI 10.4049/jimmunol.1001610; Walters KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062412; Woolard MD, 2007, J IMMUNOL, V178, P2065, DOI 10.4049/jimmunol.178.4.2065	49	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0129981	10.1371/journal.pone.0129981	http://dx.doi.org/10.1371/journal.pone.0129981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114641	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500047
J	He, J; Yang, WQ; Li, H; Xu, LY; Ni, XY; Tan, B; Zhao, YY; Wu, FZ				He, Jie; Yang, Wanqin; Li, Han; Xu, Liya; Ni, Xiangyin; Tan, Bo; Zhao, Yeyi; Wu, Fuzhong			Forest Gaps Inhibit Foliar Litter Pb and Cd Release in Winter and Inhibit Pb and Cd Accumulation in Growing Season in an Alpine Forest	PLOS ONE			English	Article							HEAVY-METAL DYNAMICS; TERRESTRIAL ECOSYSTEMS; PHRAGMITES-AUSTRALIS; MICROBIAL BIOMASS; CLIMATE-CHANGE; PLANT LITTER; DECOMPOSITION; NUTRIENT; QUALITY; SOIL	Aims The release of heavy metals (such as Pb and Cd) from foliar litter play an important role in element cycling in alpine forest ecosystems. Although natural forest gaps could play important roles in the release of heavy metals from foliar litter by affecting the snow cover during the winter and solar irradiation during the growing season, few studies have examined these potential roles. The objectives of this study were to document changes in Pb and Cd dynamics during litter decomposition in the center of gaps and under closed canopies and to investigate the factors that controlled these changes during the winter and growing seasons. Methods Senesced foliar litter from six dominant species, including Kangding willow (Salix paraplesia), Masters larch (Larix mastersiana), Mingjiang fir (Abies faxoniana), Alpine azalea (Rhododendron lapponicum), Red birch (Betula albosinensis) and Mourning cypress (Sabina saltuaria), was placed in litterbags and incubated between the gap center and closed canopy conditions in an alpine forest in the eastern region of the Tibetan Plateau. The litterbags were sampled at the snow formation stage, snow coverage stage, snow melt stage and during the growing season. The Pb and Cd concentrations in the sampled foliar litter were determined by acid digestion (HNO3/HClO4). Important findings Over one year of decomposition, Pb accumulation and Cd release from the foliar litter occurred, regardless of the foliar litter species. However, Pb and Cd were both released from the foliar litter during the winter and accumulated during the growing season. Compared with the gap center and the canopy gap edge, the extended gap edge and the closed canopy showed higher Pb and Cd release rates in winter and higher Pb and Cd accumulation rates during the growing season, respectively. Statistical analyses indicate that the dynamics of Pb were significantly influenced by frequent freeze-thaw cycles in winter and appropriate hydrothermal conditions during the growing season, the dynamics of Cd were strongly influenced by species and the presence of a forest gap at different decomposition stages. These results show that forest gaps could inhibit Pb and Cd release from foliar litter in the alpine forest of western Sichuan. In addition, a decrease in the snow depth in the winter warming scenario would promote the release of Pb during foliar litter decomposition. There exist some difference that may be influenced by litter quality, microenvironment and microtopography during litter decomposition.	[He, Jie; Yang, Wanqin; Li, Han; Xu, Liya; Ni, Xiangyin; Tan, Bo; Zhao, Yeyi; Wu, Fuzhong] Sichuan Agr Univ, Inst Ecol & Forestry, Key Lab Ecol Forestry Engn, Long Term Res Stn Alpine Forest Ecosyst, Chengdu 611130, Peoples R China	Sichuan Agricultural University	Wu, FZ (corresponding author), Sichuan Agr Univ, Inst Ecol & Forestry, Key Lab Ecol Forestry Engn, Long Term Res Stn Alpine Forest Ecosyst, Chengdu 611130, Peoples R China.	wufzchina@163.com		Ni, Xiangyin/0000-0002-2507-3463	National Natural Science Foundation of China [31170423, 31270498]; National Key Technologies R & D Program of China [2011BAC09B05]; Post-doctoral Foundation of China [2012T50782]; Sichuan Youth Science & Technology Foundation [2012JQ0008, 2012JQ0059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies R & D Program of China(National Key Technology R&D Program); Post-doctoral Foundation of China(China Postdoctoral Science Foundation); Sichuan Youth Science & Technology Foundation	The project was financially supported by the National Natural Science Foundation of China (31170423, 31270498), the National Key Technologies R & D Program of China (2011BAC09B05), the Post-doctoral Foundation of China (2012T50782) and the Sichuan Youth Science & Technology Foundation (2012JQ0008, 2012JQ0059).	Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Arunachalam A, 2000, PLANT SOIL, V223, P187, DOI 10.1023/A:1004828221756; Baptist F, 2010, PLANT SOIL, V328, P397, DOI 10.1007/s11104-009-0119-6; Batty LC, 2007, CHEMOSPHERE, V66, P158, DOI 10.1016/j.chemosphere.2006.05.039; Berg B., 1980, Ecological Bulletins, V32, P373; Brokaw N, 2000, TRENDS ECOL EVOL, V15, P183, DOI 10.1016/S0169-5347(00)01822-X; Brun CB, 2008, PLANT SOIL, V306, P199, DOI 10.1007/s11104-008-9572-x; Burgos A, 2013, AQUAT TOXICOL, V140, P324, DOI 10.1016/j.aquatox.2013.06.022; Caliz J, 2013, J SOIL SEDIMENT, V13, P413, DOI 10.1007/s11368-012-0609-7; Carlson DW, 1997, AGR FOREST METEOROL, V87, P313, DOI 10.1016/S0168-1923(95)02305-4; Christenson LM, 2010, GLOBAL CHANGE BIOL, V16, P2589, DOI 10.1111/j.1365-2486.2009.02115.x; Conn C, 2000, SOIL BIOL BIOCHEM, V32, P489, DOI 10.1016/S0038-0717(99)00178-9; Covelo EF, 2007, J HAZARD MATER, V147, P852, DOI 10.1016/j.jhazmat.2007.01.123; Du Laing G, 2006, CHEMOSPHERE, V63, P1815, DOI 10.1016/j.chemosphere.2005.10.034; Edmonds RL, 2010, FOREST ECOL MANAG, V259, P2375, DOI 10.1016/j.foreco.2010.03.011; Elliott J, 2013, CAN J SOIL SCI, V93, P435, DOI [10.4141/CJSS2012-050, 10.4141/cjss2012-050]; Freppaz M, 2007, APPL SOIL ECOL, V35, P247, DOI 10.1016/j.apsoil.2006.03.012; Gadd GM, 2004, GEODERMA, V122, P109, DOI 10.1016/j.geoderma.2004.01.002; Giller KE, 1998, SOIL BIOL BIOCHEM, V30, P1389, DOI 10.1016/S0038-0717(97)00270-8; Groffman PM, 2001, BIOGEOCHEMISTRY, V56, P191, DOI 10.1023/A:1013024603959; He Wei, 2013, Chinese Journal of Plant Ecology, V37, P306, DOI 10.3724/SP.J.1258.2013.00030; Heinlaan M, 2008, CHEMOSPHERE, V71, P1308, DOI 10.1016/j.chemosphere.2007.11.047; HUTCHINS SR, 1986, ANNU REV MICROBIOL, V40, P311, DOI 10.1146/annurev.mi.40.100186.001523; INMAN JC, 1978, ENVIRON POLLUT, V17, P39, DOI 10.1016/0013-9327(78)90054-X; Jacob M, 2009, SOIL BIOL BIOCHEM, V41, P2122, DOI 10.1016/j.soilbio.2009.07.024; Kaila A, 2012, FOREST ECOL MANAG, V277, P141, DOI 10.1016/j.foreco.2012.03.024; Kantar C, 2011, CHEMOSPHERE, V82, P1496, DOI 10.1016/j.chemosphere.2010.11.001; LASKOWSKI R, 1995, ECOLOGY, V76, P1393, DOI 10.2307/1938143; LASKOWSKI R, 1993, SCAND J FOREST RES, V8, P446, DOI 10.1080/02827589309382791; Lehto T, 2010, PLANT SOIL, V329, P195, DOI 10.1007/s11104-009-0145-4; Lemma B, 2007, SOIL BIOL BIOCHEM, V39, P2317, DOI 10.1016/j.soilbio.2007.03.032; Leroy CJ, 2006, FRESHWATER BIOL, V51, P605, DOI 10.1111/j.1365-2427.2006.01512.x; Liu J., 2013, ACTA ECOL SIN, V33, P32, DOI [10.1016/j.chnaes.2012.12.005, DOI 10.1016/J.CHNAES.2012.12.005]; Lu R., 1999, SOIL AGROCHEMICAL AN, P146; Muscolo A, 2007, FOREST ECOL MANAG, V242, P412, DOI 10.1016/j.foreco.2007.01.058; Pereira P, 2007, SCI TOTAL ENVIRON, V380, P93, DOI 10.1016/j.scitotenv.2007.01.056; Pesch ML, 2013, GEOBIOLOGY, V11, P44, DOI 10.1111/gbi.12010; Pu GZ, 2014, ECOL ENG, V67, P144, DOI 10.1016/j.ecoleng.2014.03.095; RASHID MA, 1974, CHEM GEOL, V13, P115, DOI 10.1016/0009-2541(74)90003-5; Saccone P, 2013, PLANT SOIL, V363, P215, DOI 10.1007/s11104-012-1307-3; Schliemann SA, 2011, FOREST ECOL MANAG, V261, P1143, DOI 10.1016/j.foreco.2011.01.011; Schmitt A, 2008, J PLANT NUTR SOIL SC, V171, P707, DOI 10.1002/jpln.200700334; Stan AB, 2014, FOREST ECOL MANAG, V313, P98, DOI 10.1016/j.foreco.2013.11.004; Tagliavini M, 2007, AGR ECOSYST ENVIRON, V118, P191, DOI 10.1016/j.agee.2006.05.018; Tan B., 2010, ACTA ECOLOGICA SINIC, V30, P93, DOI DOI 10.1016/J.CHNAES.2010.03.008; Tan B, 2014, APPL SOIL ECOL, V76, P34, DOI 10.1016/j.apsoil.2013.11.015; Vorobeichik EL, 2009, EURASIAN SOIL SCI+, V42, P861, DOI 10.1134/S1064229309080043; Windham L, 2004, ENVIRON TOXICOL CHEM, V23, P1520, DOI 10.1897/03-284; Wu FZ, 2010, ACTA OECOL, V36, P135, DOI 10.1016/j.actao.2009.11.002; Wu Qinggui, 2013, Chinese Journal of Applied and Environmental Biology, V19, P922, DOI 10.3724/SP.J.1145.2013.00922; Yang WQ, 2006, PEDOSPHERE, V16, P788, DOI 10.1016/S1002-0160(06)60115-X; Yang Wan-qin, 2007, Yingyong Shengtai Xuebao, V18, P2889; Yang XD, 2009, SOIL BIOL BIOCHEM, V41, P910, DOI 10.1016/j.soilbio.2008.12.028; Zhang DQ, 2008, J PLANT ECOL, V1, P85, DOI 10.1093/jpe/rtn002; Zhu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062073; Zhu JX, 2012, SCAND J FOREST RES, V27, P586, DOI 10.1080/02827581.2012.670726	56	1	1	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131528	10.1371/journal.pone.0131528	http://dx.doi.org/10.1371/journal.pone.0131528			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115012	gold, Green Submitted, Green Published			2022-12-27	WOS:000358147500168
J	Ortiz, M; Rodriguez-Zaragoza, F; Hermosillo-Nunez, B; Jordan, F				Ortiz, Marco; Rodriguez-Zaragoza, Fabin; Hermosillo-Nunez, Brenda; Jordan, Ferenc			Control Strategy Scenarios for the Alien Lionfish Pterois volitans in Chinchorro Bank (Mexican Caribbean): Based on Semi-Quantitative Loop Analysis	PLOS ONE			English	Article							INDO-PACIFIC LIONFISH; INVASIVE LIONFISH; FOOD-WEB; ATLANTIC; MODEL; COAST; PREDATOR; SYSTEMS; CHILE; SPP.	Ecological and eco-social network models were constructed with different levels of complexity in order to represent and evaluate management strategies for controlling the alien species Pterois volitans in Chinchorro bank (Mexican Caribbean). Levins's loop analysis was used as a methodological framework for assessing the local stability (considered as a component of sustainability) of the modeled management interventions represented by various scenarios. The results provided by models of different complexity (models 1 through 4) showed that a reduction of coral species cover would drive the system to unstable states. In the absence of the alien lionfish, the simultaneous fishing of large benthic epifaunal species, adult herbivorous fish and adult carnivorous fish could be sustainable only if the coral species present high levels of cover (models 2 and 3). Once the lionfish is added to the simulations (models 4 and 5), the analysis suggests that although the exploitation or removal of lionfish from shallow waters may be locally stable, it remains necessary to implement additional and concurrent human interventions that increase the holistic sustainability of the control strategy. The supplementary interventions would require the implementation of programs for: (1) the restoration of corals for increasing their cover, (2) the exploitation or removal of lionfish from deeper waters (decreasing the chance of source/sink meta-population dynamics) and (3) the implementation of bans and re-stocking programs for carnivorous fishes (such as grouper) that increase the predation and competition pressure on lionfish (i.e. biological control). An effective control management for the alien lionfish at Chinchorro bank should not be optimized for a single action plan: instead, we should investigate the concurrent implementation of multiple strategies.	[Ortiz, Marco] Univ Antofagasta, Fac Recursos Mar, Inst Antofagasta, Inst Invest Oceanol, Antofagasta, Chile; [Rodriguez-Zaragoza, Fabin] Univ Guadalajara, Lab Ecosistemas Marinos & Acuicultura, Dept Ecol, Ctr Univ Ciencias Biol & Agr, Zapopan 45110, Jalisco, Mexico; [Hermosillo-Nunez, Brenda] Univ Antofagasta, Programa Doctorado Ciencias Aplicadas, Menc Sistemas Marinos Costeros, Fac Recursos Mar, Antofagasta, Chile; [Jordan, Ferenc] Hungarian Acad Sci, Ctr Ecol Res, Budapest, Hungary; [Jordan, Ferenc] Microsoft Res COSBI, Rovereto, Italy	Universidad de Antofagasta; Universidad de Guadalajara; Universidad de Antofagasta; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research	Ortiz, M (corresponding author), Univ Antofagasta, Fac Recursos Mar, Inst Antofagasta, Inst Invest Oceanol, Antofagasta, Chile.	marco.ortiz@uantof.cl	Zaragoza, Fabian Alejandro Rodriguez/B-3477-2015; Jordan, Ferenc/A-9940-2009	Zaragoza, Fabian Alejandro Rodriguez/0000-0002-0066-4275; Jordan, Ferenc/0000-0002-0224-6472; Hermosillo-Nunez, Brenda B./0000-0003-3308-0257				Abelson A, 2006, B MAR SCI, V78, P151; Agliardi E, 1998, POSITIVE FEEDBACKS E; Albins MA, 2013, BIOL INVASIONS, V15, P29, DOI 10.1007/s10530-012-0266-1; Albins MA, 2013, ENVIRON BIOL FISH, V96, P1151, DOI 10.1007/s10641-011-9795-1; Barbour AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019666; Barbour AB, 2010, MAR ECOL PROG SER, V401, P291, DOI 10.3354/meps08373; Benkwitt CE, 2015, BIOL INVASIONS, V17, P1383, DOI 10.1007/s10530-014-0801-3; BRIAND F, 1978, NATURE, V273, P228, DOI 10.1038/273228a0; CARPENTER SR, 1989, ECOLOGY, V70, P453, DOI 10.2307/1937550; Coleman FC, 2000, FISHERIES, V25, P14, DOI 10.1577/1548-8446(2000)025<0014:LRF>2.0.CO;2; Cote IM, 2013, BIOL CONSERV, V164, P50, DOI 10.1016/j.biocon.2013.04.014; Dambacher JM, 2009, FISH FISH, V10, P305, DOI 10.1111/j.1467-2979.2008.00323.x; Arias-Gonzalez JE, 2011, ENVIRON RES, V111, P917, DOI 10.1016/j.envres.2011.07.008; Frazer TK, 2012, REV FISH SCI, V20, P185, DOI 10.1080/10641262.2012.700655; Green SJ, 2009, CORAL REEFS, V28, P107, DOI 10.1007/s00338-008-0446-8; Green SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032596; Hackerott S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068259; Hulot FD, 2000, NATURE, V405, P340, DOI 10.1038/35012591; INE, 2000, PROGR MAN RES BANC C; JORDAN E, 1987, Atoll Research Bulletin, P1; Jud ZR, 2012, J EXP MAR BIOL ECOL, V414, P69, DOI 10.1016/j.jembe.2012.01.015; Kulbicki M, 2012, MAR ECOL PROG SER, V446, P189, DOI 10.3354/meps09442; LANE PA, 1986, ECOLOGY, V67, P223, DOI 10.2307/1938522; Levin SA, 2000, ECOSYSTEMS, V3, P498, DOI 10.1007/s100210000044; LEVINS R, 1966, AM SCI, V54, P421; LEVINS R, 1994, ANN NY ACAD SCI, V740, P260, DOI 10.1111/j.1749-6632.1994.tb19876.x; Levins R., 1970, SOME MATH PROBLEMS B, P77; Levins R., 1998, ECOSYSTEM HLTH EDITE, P178; Levins R. A., 1990, Agroecology., P341; LEVINS RICHARD, 1968; Levins Richard, 1985, DIALECTICAL BIOL; Maljkovic A, 2008, CORAL REEFS, V27, P501, DOI 10.1007/s00338-008-0372-9; Morris J.A., 2009, NOAA TECH MEMO NOS N, V99, P1; Morris JA, 2011, BIOL INVASIONS, V13, P7, DOI 10.1007/s10530-010-9786-8; Mumby PJ, 2012, MAR ECOL PROG SER, V445, P13, DOI 10.3354/meps09450; Mumby PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021510; Nunez MA, 2012, CONSERV LETT, V5, P334, DOI 10.1111/j.1755-263X.2012.00250.x; Ortiz M, 2008, AQUAT CONSERV, V18, P923, DOI 10.1002/aqc.869; Ortiz M, 2007, AQUAT CONSERV, V17, P89, DOI 10.1002/aqc.791; Ortiz M, 2011, OIKOS, V120, P1402, DOI 10.1111/j.1600-0706.2011.19041.x; Perry CT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2409; Puccia C.J., 1985, QUALITATIVE MODELING; Ramsey D, 2005, J ANIM ECOL, V74, P905, DOI 10.1111/j.1365-2656.2005.00986.x; Richard Lewontin, 1998, CAPITAL NAT SOCIAL, P85; Schofield Pamela J., 2009, Aquatic Invasions, V4, P473; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Valdez-Moreno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036636; Vega-Zepeda A, 2007, CORAL REEFS, V26, P671, DOI 10.1007/s00338-007-0245-7; Whitfield PE, 2007, BIOL INVASIONS, V9, P53, DOI 10.1007/s10530-006-9005-9; Whitfield PE, 2002, MAR ECOL PROG SER, V235, P289, DOI 10.3354/meps235289	51	11	12	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130261	10.1371/journal.pone.0130261	http://dx.doi.org/10.1371/journal.pone.0130261			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114745	Green Published, gold, Green Submitted			2022-12-27	WOS:000358147500061
J	Park, Y; Kim, H; Park, L; Min, D; Park, J; Choi, S; Park, MH				Park, Yongsoo; Kim, Hyunok; Park, Leejin; Min, Dongsoo; Park, Jinseu; Choi, Sooyoung; Park, Moon Hyang			Effective Delivery of Endogenous Antioxidants Ameliorates Diabetic Nephropathy	PLOS ONE			English	Article							KAPPA-B ACTIVATION; OXIDATIVE STRESS; PROTEIN TRANSDUCTION; ENHANCED DELIVERY; METALLOTHIONEIN; KINASE; MECHANISMS; EXPRESSION; INJURY	Background Diabetic nephropathy (DN) is thought to be partially due to the injury of renal cells and the renal micro-environment by free radicals. Free radial scavenging agents that inhibit free radical damage may well prevent the development of underlying conditions such as mesangial expansion (by inhibiting extracellular matrix expression) in these patients. Methods Using techniques for intra-cellular delivery of peptides, we made metallothionein (MT) and superoxide dismutase (SOD), potent endogenous antioxidants, readily transducible into cell membrane and tested their protective effect against the development of DN in OLETF rats. Herein, we study antioxidant peptides for their ability to prevent oxidative damage to primary rat mesangial cells (MCs), which are important constituents of renal glomeruli. Results Intraperitoneal administration of these antioxidants resulted in delivery to the kidney and decreased ROS and the expression of downstream signals in renal cells and postponed the usual progression to DN. In in vitro experiments, MT and SOD were efficiently transferred to MCs, and the increased removal of ROS by MT and SOD was proportional to the degree of scavenging enzymes delivered. MT and SOD decreased three major oxidative injuries (hyperglycemia, AGE and ROS exposure) and also injuries directly mediated by angiotensin II in MCs while changing downstream signal transduction. Conclusions The protective effects of MT and SOD for the progression of DN in experimental animals may be associated with the scavenging of ROS by MT and SOD and correlated changes in signal transduction downstream. Concomitant administration of these antioxidant peptides may prove to be a new approach for the prevention and therapy of DN.	[Park, Yongsoo; Kim, Hyunok; Park, Leejin; Min, Dongsoo] Hanyang Univ, Coll Med & Engn, Dept Internal Med & Bioengn, Seoul 133791, South Korea; [Park, Jinseu; Choi, Sooyoung] Hallym Univ, Dept Biomed Sci, Chunchon, South Korea; [Park, Jinseu; Choi, Sooyoung] Hallym Univ, Res Inst Biosci & Biotechnol, Chunchon, South Korea; [Park, Moon Hyang] Hanyang Univ, Dept Pathol, Coll Med, Seoul 133791, South Korea	Hanyang University; Hallym University; Hallym University; Hanyang University	Park, Y (corresponding author), Hanyang Univ, Coll Med & Engn, Dept Internal Med & Bioengn, Seoul 133791, South Korea.	parkys@hanyang.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2010-0010898]; Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea [A102065]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0010898) and the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (A102065).	Becker-Hapak M, 2001, METHODS, V24, P247, DOI 10.1006/meth.2001.1186; Chandel NS, 2007, FREE RADICAL BIO MED, V42, P165, DOI 10.1016/j.freeradbiomed.2006.10.048; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Fioretto P, 2007, SEMIN NEPHROL, V27, P195, DOI 10.1016/j.semnephrol.2007.01.012; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Guijarro C, 2001, KIDNEY INT, V59, P415, DOI 10.1046/j.1523-1755.2001.059002415.x; Ha HJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134894; Johnson RM, 2011, METHODS MOL BIOL, V683, P535, DOI 10.1007/978-1-60761-919-2_38; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Koya D, 2003, J AM SOC NEPHROL, V14, pS250, DOI 10.1097/01.ASN.0000077412.07578.44; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mankhey RW, 2007, AM J PHYSIOL-REG I, V292, pR769, DOI 10.1152/ajpregu.00375.2006; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Min D, 2012, ENDOCRINOLOGY, V153, P81, DOI 10.1210/en.2011-1639; Mohamed AK, 1999, BIOFACTORS, V10, P157, DOI 10.1002/biof.5520100211; Nagai Y, 2005, J AM SOC NEPHROL, V16, P703, DOI 10.1681/ASN.2004080649; Noh H, 2011, CONTRIB NEPHROL, V170, P102, DOI 10.1159/000324955; Park L, 2011, DIABETES-METAB RES, V27, P802, DOI 10.1002/dmrr.1254; Park L, 2011, FREE RADICAL BIO MED, V51, P1666, DOI 10.1016/j.freeradbiomed.2011.07.019; Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506; Sachse A, 2007, J AM SOC NEPHROL, V18, P2439, DOI 10.1681/ASN.2007020149; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Song CY, 2008, TRANSL RES, V151, P27, DOI 10.1016/j.trsl.2007.09.008; Ton ALY, 2007, SEMIN NEPHROL, V27, P130, DOI 10.1016/j.semnephrol.2007.01.006; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Wolf G, 2007, NEPHRON PHYSIOL, V106, P26, DOI 10.1159/000101797; Zhou T, 2012, DIABETOLOGIA, V55, P255, DOI 10.1007/s00125-011-2314-2	30	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130815	10.1371/journal.pone.0130815	http://dx.doi.org/10.1371/journal.pone.0130815			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114547	gold, Green Published, Green Submitted			2022-12-27	WOS:000358147500098
J	Rose, SB; Spalek, K; Rahman, RA				Rose, Sebastian Benjamin; Spalek, Katharina; Rahman, Rasha Abdel			Listening to Puns Elicits the Co-Activation of Alternative Homophone Meanings during Language Production	PLOS ONE			English	Article							PICTURE-WORD INTERFERENCE; SPEECH PRODUCTION; LEXICAL ACCESS; PHONOLOGICAL PROCESSES; SEMANTIC INTERFERENCE; FREQUENCY; INFORMATION; HUMOR; COMPREHENSION; ACTIVATION	Recent evidence suggests that lexical-semantic activation spread during language production can be dynamically shaped by contextual factors. In this study we investigated whether semantic processing modes can also affect lexical-semantic activation during word production. Specifically, we tested whether the processing of linguistic ambiguities, presented in the form of puns, has an influence on the co-activation of unrelated meanings of homophones in a subsequent language production task. In a picture-word interference paradigm with word distractors that were semantically related or unrelated to the non-depicted meanings of homophones we found facilitation induced by related words only when participants listened to puns before object naming, but not when they heard jokes with unambiguous linguistic stimuli. This finding suggests that a semantic processing mode of ambiguity perception can induce the co-activation of alternative homophone meanings during speech planning.	[Rose, Sebastian Benjamin; Rahman, Rasha Abdel] Humboldt Univ, Inst Psychol, D-10099 Berlin, Germany; [Spalek, Katharina] Humboldt Univ, Inst Deutsch Sprache & Linguist, D-10099 Berlin, Germany	Humboldt University of Berlin; Humboldt University of Berlin	Rose, SB (corresponding author), Humboldt Univ, Inst Psychol, D-10099 Berlin, Germany.	sebastian.rose@hu-berlin.de; rasha.abdel.rahman@hu-berlin.de	Rahman, Rasha Abdel/J-4687-2015	Rahman, Rasha Abdel/0000-0002-8438-1570; Spalek, Katharina/0000-0001-7641-7310	German Research Council [AB 277 4-2]	German Research Council(German Research Foundation (DFG))	This research was supported by grant (AB 277 4-2) from the German Research Council to Rasha Abdel Rahman. The German Research Council had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alario FX, 2000, Q J EXP PSYCHOL-A, V53, P741, DOI 10.1080/027249800410535; Baayen R. H., 2008, ANALYZING LINGUISTIC; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bartolo A, 2006, J COGNITIVE NEUROSCI, V18, P1789, DOI 10.1162/jocn.2006.18.11.1789; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Bekinschtein TA, 2011, J NEUROSCI, V31, P9665, DOI 10.1523/JNEUROSCI.5058-10.2011; Bolte A, 2003, PSYCHOL SCI, V14, P416, DOI 10.1111/1467-9280.01456; Bonin P, 2002, EUR J COGN PSYCHOL, V14, P289, DOI 10.1080/09541440143000078; Burke DM, 2004, PSYCHOL SCI, V15, P164, DOI 10.1111/j.0956-7976.2004.01503004.x; Caramazza A, 1997, COGNITIVE NEUROPSYCH, V14, P177, DOI 10.1080/026432997381664; Caramazza A, 2004, J EXP PSYCHOL LEARN, V30, P278, DOI 10.1037/0278-7393.30.1.278; Chang F, 2006, PSYCHOL REV, V113, P234, DOI 10.1037/0033-295X.113.2.234; Chao LL, 2002, CEREB CORTEX, V12, P545, DOI 10.1093/cercor/12.5.545; Coulson S, 2005, J COGNITIVE NEUROSCI, V17, P494, DOI 10.1162/0898929053279568; Coulson S, 2001, NEUROSCI LETT, V316, P71, DOI 10.1016/S0304-3940(01)02387-4; Coulson S, 2007, BRAIN LANG, V100, P172, DOI 10.1016/j.bandl.2005.08.009; Cutting JC, 1999, J EXP PSYCHOL LEARN, V25, P318, DOI 10.1037/0278-7393.25.2.318; Damian MF, 2003, PSYCHON B REV, V10, P111, DOI 10.3758/BF03196474; Damian MF, 1999, J EXP PSYCHOL LEARN, V25, P345, DOI 10.1037/0278-7393.25.2.345; de Zubicaray, 2013, J EXPT PSYCHOL GEN, V142, P131, DOI [10.1037/a0028717, DOI 10.1037/A0028717]; DELL GS, 1985, COGNITIVE SCI, V9, P3, DOI 10.1016/S0364-0213(85)80007-0; DELL GS, 1991, PSYCHOL REV, V98, P604, DOI 10.1037/0033-295X.98.4.604; DEZUBICARAY, 2009, COGN AFFECT BEHAV NE, V9, P260, DOI DOI 10.3758/CABN.9.3.260; Faust ME, 1999, PSYCHOL BULL, V125, P777, DOI 10.1037/0033-2909.125.6.777; Ferreira VS, 2005, COGNITION, V96, P263, DOI 10.1016/j.cognition.2004.09.002; Ferreira VS, 2003, PSYCHOL SCI, V14, P86, DOI 10.1111/1467-9280.01424; Glucksberg S, 2003, TRENDS COGN SCI, V7, P92, DOI 10.1016/S1364-6613(02)00040-2; Griffin ZM, 1999, BEHAV RES METH INS C, V31, P520, DOI 10.3758/BF03200731; Harm MW, 2004, PSYCHOL REV, V111, P662, DOI 10.1037/0033-295X.111.3.662; Jescheniak JD, 1998, J EXP PSYCHOL LEARN, V24, P1256, DOI 10.1037/0278-7393.24.5.1256; Jescheniak JD, 2003, J EXP PSYCHOL LEARN, V29, P432, DOI 10.1037/0278-7393.29.3.432; JESCHENIAK JD, 1994, J EXP PSYCHOL LEARN, V20, P824, DOI 10.1037/0278-7393.20.4.824; Joubert OR, 2008, J VISION, V8, DOI 10.1167/8.13.11; Kachergis G, 2013, PROCEEDINGS OF THE 3; Kiefer M, 2012, FRONTIERS IN HUMAN N, V6; Kiefer M, 2007, CEREB CORTEX, V17, P1516, DOI 10.1093/cercor/bhl062; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Mahon BZ, 2007, J EXP PSYCHOL LEARN, V33, P503, DOI 10.1037/0278-7393.33.3.503; Marinkovic K, 2011, COGN AFFECT BEHAV NE, V11, P113, DOI 10.3758/s13415-010-0017-7; Miozzo M, 2005, J EXP PSYCHOL LEARN, V31, P1360, DOI 10.1037/0278-7393.31.6.1360; Moran JM, 2004, NEUROIMAGE, V21, P1055, DOI 10.1016/j.neuroimage.2003.10.017; Peterson RR, 1998, J EXP PSYCHOL LEARN, V24, P539, DOI 10.1037/0278-7393.24.3.539; Pickering MJ, 2008, PSYCHOL BULL, V134, P427, DOI 10.1037/0033-2909.134.3.427; Rahman RA, 2008, Q J EXP PSYCHOL, V61, P1410, DOI 10.1080/17470210701560724; Rahman RA, 2007, J EXP PSYCHOL LEARN, V33, P604, DOI 10.1037/0278-7393.33.3.604; Rahman RA, 2011, J EXP PSYCHOL LEARN, V37, P149, DOI 10.1037/a0021208; Rahman RA, 2009, LANG COGNITIVE PROC, V24, P713, DOI 10.1080/01690960802597250; Regel S, 2010, BRAIN RES, V1311, P121, DOI 10.1016/j.brainres.2009.10.077; Salthouse TA, 2002, J CLIN EXP NEUROPSYC, V24, P858, DOI 10.1076/jcen.24.7.858.8392; SCHRIEFERS H, 1990, J MEM LANG, V29, P86, DOI 10.1016/0749-596X(90)90011-N; Sheridan H, 2009, PSYCHON B REV, V16, P875, DOI 10.3758/PBR.16.5.875; Storbeck J, 2008, EMOTION, V8, P208, DOI 10.1037/1528-3542.8.2.208; Strick M, 2009, EMOTION, V9, P574, DOI 10.1037/a0015951; Taylor JK, 2002, PSYCHOL AGING, V17, P662, DOI 10.1037//0882-7974.17.4.662; van Gompel RPG, 2006, J MEM LANG, V55, P335, DOI 10.1016/j.jml.2006.06.004	55	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0130853	10.1371/journal.pone.0130853	http://dx.doi.org/10.1371/journal.pone.0130853			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1AM	26114942	gold, Green Published			2022-12-27	WOS:000358147500102
J	Song, Y; Zheng, JJ; Yan, MW; Ding, WD; Xu, K; Fan, QY; Li, Z				Song, Yue; Zheng, Jingjing; Yan, Mingwei; Ding, Weidong; Xu, Kui; Fan, Qingyu; Li, Zhao			The Effects of Irreversible Electroporation on the Achilles Tendon: An Experimental Study in a Rabbit Model	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; PATELLAR TENDON; RADIOFREQUENCY ENERGY; MECHANICAL-PROPERTIES; RECONSTRUCTION; REVASCULARIZATION; ALLOGRAFT; ABLATION; ANGIOGENESIS; REPLACEMENT	Background To evaluate the potential effects of irreversible electroporation ablation on the Achilles tendon in a rabbit model and to compare the histopathological and biomechanical changes between specimens following electroporation ablation and radiofrequency ablation. Methods A total of 140 six-month-old male New Zealand rabbits were used. The animals were randomly divided into two groups, 70 in the radiofrequency ablation group and 70 in the electroporation group. In situ ablations were applied directly to the Achilles tendons of rabbits using typical electroporation (1800 V/cm, 90 pulses) and radiofrequency ablation (power control mode) protocols. Histopathological and biomechanical evaluations were performed to examine the effects of electroporation ablation and radiofrequency ablation over time. Results Both electroporation and radiofrequency ablation produced complete cell ablation in the target region. Thermal damage resulted in tendon rupture 3 days post radiofrequency ablation. In contrast, electroporation-ablated Achilles tendons preserved their biomechanical properties and showed no detectable rupture at this time point. The electroporation-ablated tendons exhibited signs of recovery, including tenoblast regeneration and angiogenesis within 2 weeks, and the restoration of their integral structure was evident within 12 weeks. Conclusions When applying electroporation to ablate solid tumors, major advantage could be that collateral damage to adjacent tendons or ligaments is minimized due to the unique ability of electroporation ablation to target the cell membrane. This advantage could have a significant impact on the field of tumor ablation near vital tendons or ligaments.	[Song, Yue; Xu, Kui; Fan, Qingyu; Li, Zhao] Fourth Mil Med Univ, Tangdu Hosp, Orthoped Oncol Inst Chinese PLA, Xian 710032, Peoples R China; [Song, Yue; Xu, Kui; Fan, Qingyu; Li, Zhao] Fourth Mil Med Univ, Tangdu Hosp, Dept Orthoped, Xian 710032, Peoples R China; [Song, Yue] 202 Hosp PLA, Dept Gen Surg, Shenyang, Liaoning, Peoples R China; [Zheng, Jingjing] Fourth Mil Med Univ, Dept Neurobiol, Xian 710032, Shaanxi, Peoples R China; [Yan, Mingwei; Ding, Weidong] Xi An Jiao Tong Univ, Dept Elect Engn, Xian 710049, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Xi'an Jiaotong University	Fan, QY (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Orthoped Oncol Inst Chinese PLA, Xian 710032, Peoples R China.	bonetm@fmmu.edu.cn; Leelieber@gmail.com		, Yue/0000-0003-2731-3464; Li, Zhao/0000-0002-9276-9129	National Natural Science Foundation of China [81272489]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from The National Natural Science Foundation of China (grant numbers: 81272489 http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOCZKY SP, 1982, J BONE JOINT SURG AM, V64, P217, DOI 10.2106/00004623-198264020-00011; ARNOCZKY SP, 1986, J BONE JOINT SURG AM, V68A, P376, DOI 10.2106/00004623-198668030-00010; Ball C, 2010, ANESTH ANALG, V110, P1305, DOI 10.1213/ANE.0b013e3181d27b30; BALLOCK RT, 1989, J ORTHOP RES, V7, P474, DOI 10.1002/jor.1100070404; Bickels J, 2000, CLIN ORTHOP RELAT R, P218; Blickenstaff KR, 1997, AM J SPORT MED, V25, P554, DOI 10.1177/036354659702500420; CARR AJ, 1989, J BONE JOINT SURG BR, V71, P100, DOI 10.1302/0301-620X.71B1.2914976; COHEN RE, 1974, NATURE, V247, P59, DOI 10.1038/247059a0; Dheerendra Sujay K, 2012, Open Orthop J, V6, P281, DOI 10.2174/1874325001206010281; Dodds SD, 2004, CLIN BIOMECH, V19, P175, DOI 10.1016/j.clinbiomech.2003.10.009; DRAGANICH LF, 1991, J BONE JOINT SURG AM, V73A, P575, DOI 10.2106/00004623-199173040-00014; Dustmann M, 2008, KNEE SURG SPORT TR A, V16, P360, DOI 10.1007/s00167-007-0471-0; Erler K, 2004, KNEE, V11, P489, DOI 10.1016/j.knee.2003.10.005; GELBERMAN R H, 1984, Journal of Orthopaedic Research, V2, P39, DOI 10.1002/jor.1100020107; Gillams Alice, 2009, Cancer Imaging, V9 Spec No A, pS68, DOI 10.1102/1470-7330.2009.9028; Ilhami K, 2004, CLIN BIOMECH, V19, P184, DOI 10.1016/j.clinbiomech.2003.10.011; Janssen RPA, 2014, KNEE SURG SPORT TR A, V22, P2102, DOI 10.1007/s00167-013-2634-5; Klepps S, 2004, AM J SPORT MED, V32, P1716, DOI 10.1177/0363546504265262; KRUEGERFRANKE M, 1995, BRIT J SPORT MED, V29, P121, DOI 10.1136/bjsm.29.2.121; Larsen M, 2010, J ORTHOP RES, V28, P1015, DOI 10.1002/jor.21098; Lee EW, 2007, TECHNOL CANCER RES T, V6, P287, DOI 10.1177/153303460700600404; Lee EW, 2010, RADIOLOGY, V255, P426, DOI 10.1148/radiol.10090337; Magnusson SP, 2003, SCAND J MED SCI SPOR, V13, P211, DOI 10.1034/j.1600-0838.2003.00308.x; Miller L, 2005, TECHNOL CANCER RES T, V4, P699, DOI 10.1177/153303460500400615; Muramatsu K, 2008, ARTHROSCOPY, V24, P1038, DOI 10.1016/j.arthro.2008.05.014; Nightingale EJ, 2005, ARTHROSCOPY, V21, P1479, DOI 10.1016/j.arthro.2005.09.010; OBrien M, 1997, SCAND J MED SCI SPOR, V7, P55; Ohno K, 1996, CLIN BIOMECH, V11, P207, DOI 10.1016/0268-0033(95)00075-5; Pech M, 2011, CARDIOVASC INTER RAD, V34, P132, DOI 10.1007/s00270-010-9964-1; Petersen W, 2004, ARCH ORTHOP TRAUM SU, V124, P603, DOI 10.1007/s00402-003-0582-0; Phillips MA, 2012, BRIT J CANCER, V106, P490, DOI 10.1038/bjc.2011.582; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P255, DOI 10.1177/153303460700600401; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Schoellnast H, 2011, RADIOLOGY, V260, P421, DOI 10.1148/radiol.11103505; SHINO K, 1988, J BONE JOINT SURG BR, V70, P556, DOI 10.1302/0301-620X.70B4.3403597; Tohyama Harukazu, 2009, Chang Gung Med J, V32, P133; Unterhauser FN, 2003, CLIN ORTHOP RELAT R, P276, DOI 10.1097/01.blo.0000079442.64912.51; Weiler A, 2002, ARTHROSCOPY, V18, P113, DOI 10.1053/jars.2002.30656; Wieloch P, 2004, J BIOMECH, V37, P1719, DOI 10.1016/j.jbiomech.2004.01.027; Willems WF, 2012, CLIN ORTHOP RELAT R, V470, P2496, DOI 10.1007/s11999-012-2442-0; WILLIAMS JGP, 1993, SPORTS MED, V16, P216, DOI 10.2165/00007256-199316030-00006	41	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0131404	10.1371/journal.pone.0131404	http://dx.doi.org/10.1371/journal.pone.0131404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26114962	gold, Green Published, Green Submitted			2022-12-27	WOS:000358147500155
J	Watson-Jones, D; Mugo, N; Lees, S; Mathai, M; Vusha, S; Ndirangu, G; Ross, DA				Watson-Jones, Deborah; Mugo, Nelly; Lees, Shelley; Mathai, Muthoni; Vusha, Sophie; Ndirangu, Gathari; Ross, David A.			Access and Attitudes to HPV Vaccination amongst Hard-To-Reach Populations in Kenya	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; IMMUNIZATION COVERAGE; DELIVERY STRATEGIES; HEALTH; ACCEPTABILITY; PASTORALISTS; SETTLEMENTS; TANZANIA	Background Sub-Saharan Africa bears the greatest burden of cervical cancer. Human papillomavirus (HPV) vaccination programmes to prevent the disease will need to reach vulnerable girls who may not be able access health and screening services in the future. We conducted formative research on facilitators and barriers to HPV vaccination and potential acceptability of a future HPV vaccination programme amongst girls living in hard-to-reach populations in Kenya. Methods Stakeholder interviews with Ministry of Health staff explored barriers to and support for the uptake of HPV vaccination. A situation assessment was conducted to assess community services in Maasai nomadic pastoralist communities in Kajiado County and in Korogocho informal settlement in Nairobi city, followed by focus group discussions (n=14) and semi-structured interviews (n=28) with health workers, parents, youth, and community and religious leaders. These covered marriage, knowledge of cervical cancer and HPV, factors that might inhibit or support HPV vaccine uptake and intention to accept HPV vaccine if a programme was in place. Results Reported challenges to an HPV vaccination programme included school absenteeism and drop-out, early age of sex and marriage, lack of parental support, population mobility and distance from services. Despite little prior knowledge of cervical cancer and HPV, communities were interested in receiving HPV vaccination. Adequate social mobilisation and school-based vaccination, supplemented by out-reach activities, were considered important facilitating factors to achieve high coverage. There was some support for a campaign approach to vaccine delivery. Conclusions Given the high level of support for a vaccine against cervical cancer and the experience of reaching pastoralist and slum-dwellers for other immunizations, implementing an HPV vaccine programme should be feasible in such hard-to-reach communities. This may require additional delivery strategies in addition to the standard school-based delivery, with vaccine offered at multiple venues, potentially through a campaign approach.	[Watson-Jones, Deborah; Lees, Shelley; Ross, David A.] London Sch Hyg & Trop Med, London WC1, England; [Watson-Jones, Deborah] Natl Inst Med Res, Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Mugo, Nelly] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Mathai, Muthoni; Vusha, Sophie] Univ Nairobi, Nairobi, Kenya; [Ndirangu, Gathari] Minist Hlth, Div Reprod Hlth, Nairobi, Kenya	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; Kenya Medical Research Institute; University of Nairobi	Watson-Jones, D (corresponding author), London Sch Hyg & Trop Med, Keppel St, London WC1, England.	Deborah.Watson-Jones@lshtm.ac.uk			World Health Organization [200660631]	World Health Organization(World Health Organization)	Funding provided by World Health Organization (http://www.who.int/en/), PO number 200660631, DWJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker-Dreps S, 2010, VACCINE, V28, P4864, DOI 10.1016/j.vaccine.2010.05.034; Binagwaho A, 2012, B WORLD HEALTH ORGAN, V90, P623, DOI 10.2471/BLT.11.097253; Coleman MA, 2011, VACCINE, V29, P3945, DOI 10.1016/j.vaccine.2011.03.093; Cummings MJ, 2014, ACTA TROP, V137, P19, DOI 10.1016/j.actatropica.2014.04.025; Duba H H, 2001, Int J Integr Care, V1, pe13; Francis SA, 2011, VACCINE, V29, P8760, DOI 10.1016/j.vaccine.2011.07.116; IARC. GLOBOCAN, 2012, CERV CANC EST INC MO; Katahoire R A, 2008, Afr J Reprod Health, V12, P159; Kruger C, 2013, RURAL REMOTE HEALTH, V13; LaMontagne DS, 2011, B WORLD HEALTH ORGAN, V89, P821, DOI [10.2471/BLT.11.089862, 10.2471/BLT.11.08986]; Marston M, 2013, INT PERSPECT SEX R H, V39, P22, DOI 10.1363/3902213; Montavon A, 2013, TROP MED INT HEALTH, V18, P1044, DOI 10.1111/tmi.12147; Mutua MK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-6; Nguyen QN, 2010, SEX HEALTH, V7, P262, DOI 10.1071/SH09123; Perlman S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090912; Remes P, 2012, VACCINE, V30, P5363, DOI 10.1016/j.vaccine.2012.06.025; Sarode VM, 2013, MIDDLE E J FAMILY ME, V8, P9; Uddin MJ, 2010, HEALTH POLICY PLANN, V25, P50, DOI 10.1093/heapol/czp041; Unger A, 2013, ARCH DIS CHILD, V98, P799, DOI 10.1136/archdischild-2011-301621; United Nations Human Settlements Programme (UN -Habitat), 2003, CHALL SLUMS GLOB REP; Vallely A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-133; Watson-Jones D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045231; Watson-Jones D, 2012, J INFECT DIS, V206, P678, DOI 10.1093/infdis/jis407	23	20	20	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0123701	10.1371/journal.pone.0123701	http://dx.doi.org/10.1371/journal.pone.0123701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	26115523	Green Published, Green Accepted, gold			2022-12-27	WOS:000358147500004
J	Lau, C; Yu, R; Woo, J				Lau, Caren; Yu, Ruby; Woo, Jean			Effects of a 12-Week Hatha Yoga Intervention on Metabolic Risk and Quality of Life in Hong Kong Chinese Adults with and without Metabolic Syndrome	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; RANDOMIZED CONTROLLED-TRIAL; RESISTANCE-RELATED INDEXES; PHYSICAL-ACTIVITY; CHRONIC STRESS; HEALTH; EXERCISE; BENEFITS; HYPERTENSION; PREVALENCE	Objective To determine the efficacy of a 12-week Hatha yoga intervention to improve metabolic risk profiles and health-related quality of life (HRQoL) in Chinese adults with and without metabolic syndrome (MetS). Methods We conducted a controlled trial within an university-affiliated hospital. 173 Chinese men and women aged 18 or above were assigned to either the yoga intervention group (n = 87) or the control group (n = 86). Primary outcomes included 12-week change in metabolic risk factors and MetS z score. Secondary outcome was HRQoL (Medical Outcomes Short Form Survey at 12 weeks). Results The mean age of participants was 52.0 (SD 7.4, range 31-71) years. Analysis involving the entire study population revealed that the yoga group achieved greater decline in waist circumference (p<0.001), fasting glucose (p<0.01), triglycerides (p<0.05), and MetS z score (p<0.01). Yoga training also improved general health perceptions (p<0.01), physical component score (p<0.01), and social functioning (p<0.01) domains score of HRQoL. However, no significant differences between groups were observed in the mean change of systolic/diastolic blood pressures or high-density lipid protein cholesterol (all p>0.05). There were no significant differences in the intervention effects on waist circumference and MetS z score between the MetS subgroups (both p>0.05). Conclusion A 12-week Hatha yoga intervention improves metabolic risk profiles and HRQoL in Chinese adults with and without MetS.	[Lau, Caren; Yu, Ruby; Woo, Jean] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	Yu, R (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	rubyyu@cuhk.edu.hk	Woo, Jean/K-2625-2014; Yu, Ruby/N-5006-2015	Woo, Jean/0000-0001-7593-3081; 				Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Bernardi L, 1998, LANCET, V351, P1308, DOI 10.1016/S0140-6736(97)10341-5; Chen KM, 2008, J CLIN NURS, V17, P2634, DOI 10.1111/j.1365-2702.2008.02338.x; Cohen Beth E., 2008, Metabolic Syndrome and Related Disorders, V6, P223, DOI 10.1089/met.2008.0016; Cowen VS, 2005, J BODYW MOV THER, V9, P211, DOI 10.1016/j.jbmt.2004.08.001; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Crow R., 1999, HEALTH TECHNOL ASSES, V3, P1, DOI [DOI 10.3310/HTA3030, DOI 10.3310/hta3030]; Ding Ding, 2014, BMC Res Notes, V7, P172, DOI 10.1186/1756-0500-7-172; Feuerstein Georg, 2003, DEEPER DIMENSION YOG; Gordon LA, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-21; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Hagins Marshall, 2007, BMC Complement Altern Med, V7, P40, DOI 10.1186/1472-6882-7-40; Hedner T, 2005, BLOOD PRESSURE, V14, P131, DOI 10.1080/08037051510034310; Hegde SV, 2011, DIABETES CARE, V34, P2208, DOI 10.2337/dc10-2430; Hughes JW, 2013, PSYCHOSOM MED, V75, P721, DOI 10.1097/PSY.0b013e3182a3e4e5; Hunter SD, 2013, J ALTERN COMPLEM MED, V19, P930, DOI 10.1089/acm.2012.0709; Innes KE, 2007, ALTERN THER HEALTH M, V13, P44; Innes KE, 2007, EVID-BASED COMPL ALT, V4, P469, DOI 10.1093/ecam/nel103; Innes KE, 2007, ALTERN THER HEALTH M, V13, P46; Johnson JL, 2007, AM J CARDIOL, V100, P1759, DOI 10.1016/j.amjcard.2007.07.027; Khatri Deepali, 2007, Diabetes Res Clin Pract, V78, pe9, DOI 10.1016/j.diabres.2007.05.002; Kristal AR, 2005, ALTERN THER HEALTH M, V11, P28; Lakka TA, 2007, APPL PHYSIOL NUTR ME, V32, P76, DOI [10.1139/H06-113, 10.1139/h06-113]; Lam CL, 1999, HONG KONG PRACTITION, V21, P460; Lam CLK, 1998, J CLIN EPIDEMIOL, V51, P1139, DOI 10.1016/S0895-4356(98)00105-X; Lee JA, 2012, MENOPAUSE, V19, P296, DOI 10.1097/gme.0b013e31822d59a2; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Littman AJ, 2012, SUPPORT CARE CANCER, V20, P267, DOI 10.1007/s00520-010-1066-8; Malathi A., 2000, Indian Journal of Physiology and Pharmacology, V44, P202; McIver S, 2009, COMPLEMENT THER MED, V17, P196, DOI 10.1016/j.ctim.2009.05.002; Moadel AB, 2007, J CLIN ONCOL, V25, P4387, DOI 10.1200/JCO.2006.06.6027; Parati G, 2007, J HYPERTENS, V25, P57, DOI 10.1097/HJH.0b013e328012bf0f; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Pullen PR, 2010, MED SCI SPORT EXER, V42, P651, DOI 10.1249/MSS.0b013e3181bf24c4; RAGLAND DR, 1992, EPIDEMIOLOGY, V3, P434, DOI 10.1097/00001648-199209000-00009; Ross A, 2013, COMPLEMENT THER MED, V21, P313, DOI 10.1016/j.ctim.2013.04.001; Saquib N, 2013, BMC PUBLIC HLTH, V13; Scholze J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-529; Seeman TE, 1996, ANN EPIDEMIOL, V6, P442, DOI 10.1016/S1047-2797(96)00095-6; Sullivan PW, 2007, OBESITY, V15, P511, DOI 10.1038/oby.2007.580; Ware J., 1993, SF 36 HLTH SURVEY MA; West J, 2004, ANN BEHAV MED, V28, P114, DOI 10.1207/s15324796abm2802_6; Wijndaele K, 2009, EUR J CLIN NUTR, V63, P421, DOI 10.1038/sj.ejcn.1602944; Wolff M, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-111	44	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130731	10.1371/journal.pone.0130731	http://dx.doi.org/10.1371/journal.pone.0130731			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL4OY	26111165	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800079
J	Munir, A; Shahzad, A; Khan, M				Munir, Asif; Shahzad, Azeem; Khan, Masood			Convective Flow of Sisko Fluid over a Bidirectional Stretching Surface	PLOS ONE			English	Article							3-DIMENSIONAL FLOW	The present investigation focuses the flow and heat transfer characteristics of the steady three-dimensional Sisko fluid driven by a bidirectional stretching sheet. The modeled partial differential equations are reduced to coupled ordinary differential equations by a suitable transformation. The resulting equations are solved numerically by the shooting method using adaptive Runge Kutta algorithm in combination with Newton's method in the domain [0,infinity). The numerical results for the velocity and temperature fields are graphically presented and effects of the relevant parameters are discussed in detail. Moreover, the skin-riction coefficient and local Nusselt number for different values of the power-law index and stretching ratio parameter are presented through tabulated data. The numerical results are also verified with the results obtained analytically by the homotopy analysis method (HAM). Additionally, the results are validated with previously published pertinent literature as a limiting case of the problem.	[Munir, Asif; Khan, Masood] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Shahzad, Azeem] UET, Dept Basic Sci, Taxila, Pakistan	Quaid I Azam University	Munir, A (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	asifmunir1000@yahoo.com	khan, Masood/F-7143-2015; KHAN, Masood/AAA-7384-2020; Shahzad, Azeem/P-9740-2019	KHAN, Masood/0000-0003-4404-1456; 	Higher Education Commission of Pakistan	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	Sincere thanks are due to Higher Education Commission of Pakistan for granting scholarship in Indigenous Ph.D. Fellowship Program to carry out Ph.D. studies. Moreover, the authors would like to thank the reviewers for their careful assessment and fruitful suggestions.	Ahmad I, 2011, THERM SCI, V15, pS205, DOI 10.2298/TSCI100926006A; Ariel PD, 2003, Z ANGEW MATH MECH, V83, P844, DOI 10.1002/zamm.200310052; GORLA RSR, 1995, Z ANGEW MATH MECH, V75, P389, DOI 10.1002/zamm.19950750508; Lakshmisha KN, 2009, J HEAT TRANSF, V110, P590; Liao S., 2012, HOMOTOPY ANAL METHOD; Liu IC, 2008, INT J HEAT MASS TRAN, V51, P4018, DOI 10.1016/j.ijheatmasstransfer.2007.10.041; Nadeem S, 2013, ALEX ENG J, V52, P577, DOI 10.1016/j.aej.2013.08.005; Shehzad SA, 2014, J CENT SOUTH UNIV, V21, P1428, DOI 10.1007/s11771-014-2081-6; Shehzad SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078240; Shehzad SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068139; WANG CY, 1984, PHYS FLUIDS, V27, P1915, DOI 10.1063/1.864868	11	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0130342	10.1371/journal.pone.0130342	http://dx.doi.org/10.1371/journal.pone.0130342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110873	Green Published, gold, Green Submitted			2022-12-27	WOS:000356933800041
J	Opondo, D; Visscher, S; Eslami, S; Verheij, RA; Korevaar, JC; Abu-Hanna, A				Opondo, Dedan; Visscher, Stefan; Eslami, Saeid; Verheij, Robert A.; Korevaar, Joke C.; Abu-Hanna, Ameen			Quality of Co-Prescribing NSAID and Gastroprotective Medications for Elders in The Netherlands and Its Association with the Electronic Medical Record	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; VULNERABLE ELDERS; CARE; PRESCRIPTION; INDICATORS; PREVALENCE; STRATEGIES; USERS	Objective To assess guideline adherence of co-prescribing NSAID and gastroprotective medications for elders in general practice over time, and investigate its potential association with the electronic medical record (EMR) system brand used. Methods We included patients 65 years and older who received NSAIDs between 2005 and 2010. Prescription data were extracted from EMR systems of GP practices participating in the Dutch NIVEL Primary Care Database. We calculated the proportion of NSAID prescriptions with co-prescription of gastroprotective medication for each GP practice at intervals of three months. Association between proportion of gastroprotection, brand of electronic medical record (EMR), and type of GP practice were explored. Temporal trends in proportion of gastroprotection between electronic medical records systems were analyzed using a random effects linear regression model. Results We included 91,521 patient visits with NSAID prescriptions from 77 general practices between 2005 and 2010. Overall proportion of NSAID prescriptions to the elderly with coprescription of gastroprotective medication was 43%. Mean proportion of gastroprotection increased from 27% (CI 25-29%) in the first quarter of 2005 with a rate of 1.2% every 3 months to 55%(CI 52-58%) at the end of 2010. Brand of EMR and type of GP practice were independently associated with co-prescription of gastroprotection. Conclusion Although prescription of gastroprotective medications to elderly patients who receive NSAIDs increased in The Netherlands, they are not co-prescribed in about half of the indicated cases. Brand of EMR system is associated with differences in prescription of gastroprotective medication. Optimal design and utilization of EMRs is a potential area of intervention to improve quality of prescription.	[Opondo, Dedan; Eslami, Saeid; Abu-Hanna, Ameen] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, NL-1105 AZ Amsterdam, Netherlands; [Visscher, Stefan; Verheij, Robert A.; Korevaar, Joke C.] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Institute for Health Services Research	Opondo, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Informat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	dedan.opondo@gmail.com	Eslami, Saeid/AAZ-6005-2020	Eslami, Saeid/0000-0003-3755-1212; Abu-Hanna, Ameen/0000-0003-4324-7954	ZonMw (The Netherlands Organization for Health Research and Development) [311020302]	ZonMw (The Netherlands Organization for Health Research and Development)(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	This work was supported by ZonMw (The Netherlands Organization for Health Research and Development) by a grant to the ICOVE project (#311020302). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NS, 2008, AM J GASTROENTEROL, V103, P323, DOI 10.1111/j.1572-0241.2007.01595.x; Bardou M, 2010, JOINT BONE SPINE, V77, P6, DOI 10.1016/j.jbspin.2009.11.008; CCMO CcoRIHS, 2013, DOES YOUR STUD HAV R; CROOK J, 1984, PAIN, V18, P299, DOI 10.1016/0304-3959(84)90824-8; Davis G C, 1997, J Gerontol Nurs, V23, P16; Hartnell Nicole R, 2004, Am J Geriatr Pharmacother, V2, P171, DOI 10.1016/j.amjopharm.2004.09.001; Lanas A, 2012, GASTROENT HEPAT-BARC, V35, P1, DOI 10.1016/j.gastrohep.2011.10.004; MacLean CH, 2007, J AM GERIATR SOC, V55, pS383, DOI 10.1111/j.1532-5415.2007.01346.x; Medlock S, 2013, CLIN GASTROENTEROL H, V11, P1259, DOI 10.1016/j.cgh.2013.05.034; Opondo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043617; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; Sturkenboom MCJM, 2003, RHEUMATOLOGY, V42, P23, DOI 10.1093/rheumatology/keg495; TALLEY NJ, 1995, DIGEST DIS SCI, V40, P1345, DOI 10.1007/BF02065549; Tsai YF, 2004, J PAIN SYMPTOM MANAG, V28, P579, DOI 10.1016/j.jpainsymman.2004.03.007; Tsai YF, 2010, J PAIN SYMPTOM MANAG, V40, P575, DOI 10.1016/j.jpainsymman.2010.02.013; van der Ploeg E, 2008, QUAL SAF HEALTH CARE, V17, P291, DOI 10.1136/qshc.2007.023226; Wrestling H, 2009, VOORSTEL EXPERTGROEP	17	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0129515	10.1371/journal.pone.0129515	http://dx.doi.org/10.1371/journal.pone.0129515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110650	Green Published, Green Submitted, gold			2022-12-27	WOS:000356933800025
J	Yang, T; Rubart, M; Soonpaa, MH; Didie, M; Christalla, P; Zimmermann, WH; Field, LJ				Yang, Tao; Rubart, Michael; Soonpaa, Mark H.; Didie, Michael; Christalla, Peter; Zimmermann, Wolfram-Hubertus; Field, Loren J.			Cardiac Engraftment of Genetically-Selected Parthenogenetic Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							INFARCTED RAT HEARTS; MYOCARDIUM; GRAFTS; PROLIFERATION; SHEETS; REPAIR; MICE	Parthenogenetic stem cells (PSCs) are a promising candidate donor for cell therapy applications. Similar to embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), PSCs exhibit self-renewing capacity and clonogenic proliferation in vitro. PSCs exhibit largely haploidentical genotype, and as such may constitute an attractive population for allogenic applications. In this study, PSCs isolated from transgenic mice carrying a cardiomyocyte-restricted reporter transgene to permit tracking of donor cells were genetically modified to carry a cardiomyocyte-restricted aminoglycoside phosphotransferase expression cassette (MHC-neor/pGK-hygror) to permit the generation of highly enriched cardiomyocyte cultures from spontaneously differentiating PSCs by simple selection with the neomycin analogue G148. Following engraftment into isogenic recipient hearts, the selected cardiomyocytes formed a functional syncytium with the host myocardium as evidenced by the presence of entrained intracellular calcium transients. These cells thus constitute a potential source of therapeutic donor cells.	[Yang, Tao] Tongji Univ, Res Ctr Translat Med, Shanghai East Hosp, Sch Med, Shanghai 200092, Peoples R China; [Yang, Tao; Rubart, Michael; Soonpaa, Mark H.; Field, Loren J.] Indiana Univ, Riley Heart Res Ctr, Herman B Wells Ctr Pediat Res, Sch Med, Indianapolis, IN 46204 USA; [Rubart, Michael; Soonpaa, Mark H.; Field, Loren J.] Indiana Univ, Krannert Inst Cardiol, Sch Med, Indianapolis, IN 46204 USA; [Didie, Michael; Christalla, Peter; Zimmermann, Wolfram-Hubertus] Univ Med Ctr Gottingen, Inst Pharmacol, Gottingen, Germany; [Didie, Michael; Christalla, Peter; Zimmermann, Wolfram-Hubertus] DZHK German Ctr Cardiovasc Res, Gottingen, Germany	Tongji University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Gottingen; German Centre for Cardiovascular Research	Yang, T (corresponding author), Tongji Univ, Res Ctr Translat Med, Shanghai East Hosp, Sch Med, Shanghai 200092, Peoples R China.	taoyang@tongji.edu.cn	Zimmermann, Wolfram-Hubertus H/I-6838-2012	Zimmermann, Wolfram-Hubertus H/0000-0003-1190-4040	National Natural Science Foundation of China [81372750]; Shanghai Natural Science Foundation of China [12ZR1425200]; Science & Technology Development Fund of Shanghai Pudong [PKJ2014-Y10]; Scientific Research Foundation for the Returned Overseas Chinese Scholars from State Education Ministry of China [2013-1792]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083126] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Development Fund of Shanghai Pudong; Scientific Research Foundation for the Returned Overseas Chinese Scholars from State Education Ministry of China(Scientific Research Foundation for the Returned Overseas Chinese Scholars); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Natural Science Foundation of China (grant No. 81372750; http://www.nsfc.gov.cn/publish/portal1/) to TY, Shanghai Natural Science Foundation of China (grant No. 12ZR1425200; http://www.stcsm.gov.cn/) to TY, Science & Technology Development Fund of Shanghai Pudong (grant No. PKJ2014-Y10; http://www.techpudong.gov.cn/) to TY, and Scientific Research Foundation for the Returned Overseas Chinese Scholars from State Education Ministry of China (grant No. 2013-1792; http://fund.cscse.edu.cn/) to TY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Chen JH, 2013, CIRC RES, V112, P1557, DOI 10.1161/CIRCRESAHA.112.300658; Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233; Cibelli JB, 2002, SCIENCE, V295, P819, DOI 10.1126/science.1065637; Didie M, 2013, J CLIN INVEST, V123, P1285, DOI 10.1172/JCI66854; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Huang GN, 2012, SCIENCE, V338, P1599, DOI 10.1126/science.1229765; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; KOH GY, 1995, J CLIN INVEST, V96, P2034, DOI 10.1172/JCI118251; Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Rubart M, 2003, CIRC RES, V92, P1217, DOI 10.1161/01.RES.0000075089.39335.8C; Schroeder M, 2005, BIOTECHNOL BIOENG, V92, P920, DOI 10.1002/bit.20668; Sekine H, 2008, CIRCULATION, V118, pS145, DOI 10.1161/CIRCULATIONAHA.107.757286; SOONPAA MH, 1994, SCIENCE, V264, P98, DOI 10.1126/science.8140423; Testa G, 2011, CYTOTHERAPY, V13, P350, DOI 10.3109/14653249.2010.520311; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; Weng ZH, 2014, STEM CELLS DEV, V23, P1704, DOI 10.1089/scd.2013.0509; Ye L, 2006, EXP BIOL MED, V231, P8; Zandstra PW, 2003, TISSUE ENG, V9, P767, DOI 10.1089/107632703768247449; Zaruba MM, 2010, CIRCULATION, V121, P1992, DOI 10.1161/CIRCULATIONAHA.109.909093; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394	29	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2015	10	6							e0131511	10.1371/journal.pone.0131511	http://dx.doi.org/10.1371/journal.pone.0131511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL4OY	26110646	Green Published, gold			2022-12-27	WOS:000356933800157
